PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Monfredi, O; Maltseva, LA; Spurgeon, HA; Boyett, MR; Lakatta, EG; Maltsev, VA				Monfredi, Oliver; Maltseva, Larissa A.; Spurgeon, Harold A.; Boyett, Mark R.; Lakatta, Edward G.; Maltsev, Victor A.			Beat-to-Beat Variation in Periodicity of Local Calcium Releases Contributes to Intrinsic Variations of Spontaneous Cycle Length in Isolated Single Sinoatrial Node Cells	PLOS ONE			English	Article							PACEMAKER CELLS; DIASTOLIC DEPOLARIZATION; RYANODINE RECEPTOR; CA2+ RELEASES	Spontaneous, submembrane local Ca2+ releases LCRs) generated by the sarcoplasmic reticulum in sinoatrial nodal cells, the cells of the primary cardiac pacemaker, activate inward Na+/Ca2+-exchange current to accelerate the diastolic depolarization rate, and therefore to impact on cycle length. Since LCRs are generated by Ca2+ release channel i.e. ryanodine receptor) openings, they exhibit a degree of stochastic behavior, manifested as notable cycle-to-cycle variations in the time of their occurrence. Aim: The present study tested whether variation in LCR periodicity contributes to intrinsic beat-to-beat) cycle length variability in single sinoatrial nodal cells. Methods: We imaged single rabbit sinoatrial nodal cells using a 2D-camera to capture LCRs over the entire cell, and, in selected cells, simultaneously measured action potentials by perforated patch clamp. Results: LCRs begin to occur on the descending part of the action potential-induced whole-cell Ca2+ transient, at about the time of the maximum diastolic potential. Shortly after the maximum diastolic potential mean 54 +/- 7.7 ms, n = 14), the ensemble of waxing LCR activity converts the decay of the global Ca2+ transient into a rise, resulting in a late, whole-cell diastolic Ca2+ elevation, accompanied by a notable acceleration in diastolic depolarization rate. On average, cells n = 9) generate 13.2 +/- 3.7 LCRs per cycle mean +/- SEM), varying in size 7.1 +/- 4.2 mu m) and duration 44.2 +/- 27.1 ms), with both size and duration being greater for later-occurring LCRs. While the timing of each LCR occurrence also varies, the LCR period i.e. the time from the preceding Ca2+ transient peak to an LCR's subsequent occurrence) averaged for all LCRs in a given cycle closely predicts the time of occurrence of the next action potential, i.e. the cycle length. Conclusion: Intrinsic cycle length variability in single sinoatrial nodal cells is linked to beat-to-beat variations in the average period of individual LCRs each cycle.	[Monfredi, Oliver; Maltseva, Larissa A.; Spurgeon, Harold A.; Lakatta, Edward G.; Maltsev, Victor A.] NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Monfredi, Oliver; Boyett, Mark R.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Manchester	Maltsev, VA (corresponding author), NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	MaltsevVi@grc.nia.nih.gov	Lakatta, Edward G/AAL-1447-2020; Monfredi, Oliver/AAH-9507-2021; Maltsev, Victor/AAY-9460-2020	Maltsev, Victor/0000-0002-3832-791X; Monfredi, Oliver/0000-0003-1292-2902; Lakatta, Edward/0000-0002-4772-0035; Boyett, Mark/0000-0003-3931-2020	National Institutes of Health, National Institute on Aging; British Cardiovascular Society; University of Manchester; Higher Education Funding Council for England; British Heart Foundation [RG/11/18/29257] Funding Source: researchfish	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Cardiovascular Society; University of Manchester; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); British Heart Foundation(British Heart Foundation)	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute on Aging and by the British Cardiovascular Society (OM), the University of Manchester (OM, MRB) and the Higher Education Funding Council for England (MRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdanov KY, 2006, CIRC RES, V99, P979, DOI 10.1161/01.RES.0000247933.66532.0b; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Costa M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198102; Fan JS, 1998, PFLUG ARCH EUR J PHY, V436, P1021, DOI 10.1007/PL00008086; Joung B, 2009, CIRCULATION, V119, P788, DOI 10.1161/CIRCULATIONAHA.108.817379; Kim JJ, 2013, AM J PHYSIOL-HEART C, V304, pH848, DOI 10.1152/ajpheart.00787.2012; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lyashkov AE, 2007, CIRC RES, V100, P1723, DOI 10.1161/CIRCRESAHA.107.153676; Maltsev AV, 2011, BIOPHYS J, V100, P271, DOI 10.1016/j.bpj.2010.11.081; Maltsev VA, 2004, BIOPHYS J, V86, P2596, DOI 10.1016/S0006-3495(04)74314-3; Neco P, 2012, CIRCULATION, V126, P392, DOI 10.1161/CIRCULATIONAHA.111.075382; OPTHOF T, 1987, J MOL CELL CARDIOL, V19, P923, DOI 10.1016/S0022-2828(87)80621-1; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Vinogradova TM, 2000, CIRC RES, V87, P760, DOI 10.1161/01.RES.87.9.760; Vinogradova TM, 2004, CIRC RES, V94, P802, DOI 10.1161/01.RES.0000122045.55331.0F; WILDERS R, 1993, BIOPHYS J, V65, P2601, DOI 10.1016/S0006-3495(93)81289-X; Wilders R, 2007, MED BIOL ENG COMPUT, V45, P189, DOI 10.1007/s11517-006-0127-0; Yaniv Y, 2011, J MOL CELL CARDIOL, V51, P902, DOI 10.1016/j.yjmcc.2011.08.029	19	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67247	10.1371/journal.pone.0067247	http://dx.doi.org/10.1371/journal.pone.0067247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826247	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000048
J	van Walraven, C; Musselman, R				van Walraven, Carl; Musselman, Reilly			The Surgical Site Infection Risk Score (SSIRS): A Model to Predict the Risk of Surgical Site Infections	PLOS ONE			English	Article							NOSOCOMIAL INFECTIONS; SURGERY; INDEX	Background: Surgical site infections (SSI) are an important cause of peri-surgical morbidity with risks that vary extensively between patients and surgeries. Quantifying SSI risk would help identify candidates most likely to benefit from interventions to decrease the risk of SSI. Methods: We randomly divided all surgeries recorded in the National Surgical Quality Improvement Program from 2010 into a derivation and validation population. We used multivariate logistic regression to determine the independent association of patient and surgical covariates with the risk of any SSI (including superficial, deep, and organ space SSI) within 30 days of surgery. To capture factors particular to specific surgeries, we developed a surgical risk score specific to all surgeries having a common first 3 numbers of their CPT code. Results: Derivation (n = 181 894) and validation (n = 181 146) patients were similar for all demographics, past medical history, and surgical factors. Overall SSI risk was 3.9%. The SSI Risk Score (SSIRS) found that risk increased with patient factors (smoking, increased body mass index), certain comorbidities (peripheral vascular disease, metastatic cancer, chronic steroid use, recent sepsis), and operative characteristics (surgical urgency; increased ASA class; longer operation duration; infected wounds; general anaesthesia; performance of more than one procedure; and CPT score). In the validation population, the SSIRS had good discrimination (c-statistic 0.800, 95% CI 0.795-0.805) and calibration. Conclusion: SSIRS can be calculated using patient and surgery information to estimate individual risk of SSI for a broad range of surgery types.	[van Walraven, Carl] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Musselman, Reilly] Univ Ottawa, Dept Surg, Ottawa, ON, Canada; [van Walraven, Carl] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [van Walraven, Carl] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto	van Walraven, C (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.	carlv@ohri.ca						Bowater RJ, 2009, ANN SURG, V249, P551, DOI 10.1097/SLA.0b013e318199f202; BOYCE JM, 1990, INFECT CONT HOSP EP, V11, P89; CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z; DALY L, 1992, COMPUT BIOL MED, V22, P351, DOI 10.1016/0010-4825(92)90023-G; de Blacam C, 2012, ANN SURG, V255, P551, DOI 10.1097/SLA.0b013e318246c294; Ercole FF, 2007, BRAZ J INFECT DIS, V11, P134, DOI 10.1590/S1413-86702007000100028; Gaynes RP, 2000, INFECT CONT HOSP EP, V21, P184, DOI 10.1086/501740; Gibbons C, 2011, HEALTH TECHNOL ASSES, V15, P1; Gu┬nen M., 2007, ANAL RECEIVER OPERAT, V3, P15; HORAN TC, 1993, INFECT CONT HOSP EP, V14, P73, DOI 10.2307/30147164; Hosmer DW, 1997, STAT MED, V16, P965; Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146; Mu Y, 2011, INFECT CONT HOSP EP, V32, P970, DOI 10.1086/662016; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; Raval MV, 2010, J AM COLL SURGEONS, V211, P715, DOI 10.1016/j.jamcollsurg.2010.07.021; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033	19	62	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67167	10.1371/journal.pone.0067167	http://dx.doi.org/10.1371/journal.pone.0067167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826224	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000038
J	Chakrabarty, P; Rosario, A; Cruz, P; Siemienski, Z; Ceballos-Diaz, C; Crosby, K; Jansen, K; Borchelt, DR; Kim, JY; Jankowsky, JL; Golde, TE; Levites, Y				Chakrabarty, Paramita; Rosario, Awilda; Cruz, Pedro; Siemienski, Zoe; Ceballos-Diaz, Carolina; Crosby, Keith; Jansen, Karen; Borchelt, David R.; Kim, Ji-Yoen; Jankowsky, Joanna L.; Golde, Todd E.; Levites, Yona			Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; WIDESPREAD GENE DELIVERY; AMYLOID-BETA; MOUSE-BRAIN; EXPRESSION; DISEASE; CNS; EFFICIENT; PATTERNS; THERAPY	Adeno-associated virus (AAV) mediated gene expression is a powerful tool for gene therapy and preclinical studies. A comprehensive analysis of CNS cell type tropism, expression levels and biodistribution of different capsid serotypes has not yet been undertaken in neonatal rodents. Our previous studies show that intracerebroventricular injection with AAV2/1 on neonatal day P0 results in widespread CNS expression but the biodistribution is limited if injected beyond neonatal day P1. To extend these observations we explored the effect of timing of injection on tropism and biodistribution of six commonly used pseudotyped AAVs delivered in the cerebral ventricles of neonatal mice. We demonstrate that AAV2/8 and 2/9 resulted in the most widespread biodistribution in the brain. Most serotypes showed varying biodistribution depending on the day of injection. Injection on neonatal day P0 resulted in mostly neuronal transduction, whereas administration in later periods of development (24-84 hours postnatal) resulted in more non-neuronal transduction. AAV2/5 showed widespread transduction of astrocytes irrespective of the time of injection. None of the serotypes tested showed any microglial transduction. This study demonstrates that both capsid serotype and timing of injection influence the regional and cell-type distribution of AAV in neonatal rodents, and emphasizes the utility of pseudotyped AAV vectors for translational gene therapy paradigms.	[Chakrabarty, Paramita; Rosario, Awilda; Cruz, Pedro; Siemienski, Zoe; Ceballos-Diaz, Carolina; Crosby, Keith; Borchelt, David R.; Golde, Todd E.; Levites, Yona] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Chakrabarty, Paramita; Rosario, Awilda; Cruz, Pedro; Siemienski, Zoe; Ceballos-Diaz, Carolina; Crosby, Keith; Borchelt, David R.; Golde, Todd E.; Levites, Yona] Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Jansen, Karen] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Kim, Ji-Yoen; Jankowsky, Joanna L.] Baylor Coll Med, Huffington Ctr Aging, Dept Neurosci, Houston, TX 77030 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mayo Clinic; Baylor College of Medicine	Levites, Y (corresponding author), Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	levites.yona@ufl.edu			NIH-NINDS; Alzheimer's Association; Ellison Foundation; NATIONAL INSTITUTE ON AGING [R21AG038856] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by: NIH-NINDS, Alzheimer's Association and the Ellison Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Cearley CN, 2008, MOL THER, V16, P1710, DOI 10.1038/mt.2008.166; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chakrabarty P, 2011, NAT NEUROSCI, V14, P694, DOI 10.1038/nn.2829; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Conlon TJ, 2004, EXPERT OPIN BIOL TH, V4, P1093, DOI 10.1517/14712598.4.7.1093; Cucchiarini M, 2003, GENE THER, V10, P657, DOI 10.1038/sj.gt.3301925; Fleming J, 2005, HUM GENE THER, V16, P947, DOI 10.1089/hum.2005.16.947; Gadalla KKE, 2013, MOL THER, V21, P18, DOI 10.1038/mt.2012.200; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Homs J, 2011, GENE THER, V18, P622, DOI 10.1038/gt.2011.7; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Kou JH, 2011, J ALZHEIMERS DIS, V27, P23, DOI 10.3233/JAD-2011-110230; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Liu G, 2005, GENE THER, V12, P1503, DOI 10.1038/sj.gt.3302554; Maguire CA, 2008, MOL THER, V16, P1695, DOI 10.1038/mt.2008.168; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; McCown TJ, 2011, CURR GENE THER, V11, P181; McCown TJ, 2005, CURR GENE THER, V5, P333, DOI 10.2174/1566523054064995; Miyake N, 2011, BRAIN RES, V1389, P19, DOI 10.1016/j.brainres.2011.03.014; Passini MA, 2002, J NEUROSCI, V22, P6437; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Passini MA, 2001, J VIROL, V75, P12382, DOI 10.1128/JVI.75.24.12382-12392.2001; Rafi MA, 2005, MOL THER, V11, P734, DOI 10.1016/j.ymthe.2004.12.020; Rahim AA, 2012, GENE THER, V19, P936, DOI 10.1038/gt.2011.157; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Verbeeck C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-53; Weinberg MS, 2011, GENE THER, V18, P961, DOI 10.1038/gt.2011.49; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	40	102	112	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67680	10.1371/journal.pone.0067680	http://dx.doi.org/10.1371/journal.pone.0067680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825679	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000114
J	Kemmett, K; Humphrey, T; Rushton, S; Close, A; Wigley, P; Williams, NJ				Kemmett, Kirsty; Humphrey, Tom; Rushton, Steven; Close, Andrew; Wigley, Paul; Williams, Nicola J.			A Longitudinal Study Simultaneously Exploring the Carriage of APEC Virulence Associated Genes and the Molecular Epidemiology of Faecal and Systemic E. coli in Commercial Broiler Chickens	PLOS ONE			English	Article							PATHOGENIC-ESCHERICHIA-COLI; STRAINS; SALMONELLA; IDENTIFICATION; EXPRESSION; SEQUENCE; COLONIZATION; PERSISTENCE; MENINGITIS; MICROFLORA	Colibacillosis is an economically important syndromic disease of poultry caused by extra-intestinal avian pathogenic Escherichia coli (APEC) but the pathotype remains poorly defined. Combinations of virulence-associated genes (VAGs) have aided APEC identification. The intestinal microbiota is a potential APEC reservoir. Broiler chickens are selectively bred for fast, uniform growth. Here we simultaneously investigate intestinal E. coli VAG carriage in apparently healthy birds and characterise systemic E. coli from diseased broiler chickens from the same flocks. Four flocks were sampled longitudinally from chick placement until slaughter. Phylogrouping, macro-restriction pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were performed on an isolate subset from one flock to investigate the population structure of faecal and systemic E. coli. Early in production, VAG carriage among chick intestinal E. coli populations was diverse (average Simpson's D value = 0.73); 24.05% of intestinal E. coli (n = 160) from 1 day old chicks were carrying >= 5 VAGs. Generalised Linear models demonstrated VAG prevalence in potential APEC populations declined with age; 1% of E. coli carrying >= 5 VAGs at slaughter and demonstrated high strain diversity. A variety of VAG profiles and high strain diversity were observed among systemic E. coli. Thirty three new MLST sequence types were identified among 50 isolates and a new sequence type representing 22.2% (ST-2999) of the systemic population was found, differing from the pre-defined pathogenic ST-117 at a single locus. For the first time, this study takes a longitudinal approach to unravelling the APEC paradigm. Our findings, supported by other studies, highlight the difficulty in defining the APEC pathotype. Here we report a high genetic diversity among systemic E. coli between and within diseased broilers, harbouring diverse VAG profiles rather than single and/or highly related pathogenic clones suggesting host susceptibility in broilers plays an important role in APEC pathogenesis.	[Kemmett, Kirsty; Humphrey, Tom; Wigley, Paul] Univ Liverpool, Sch Vet Sci, Dept Infect Biol, Inst Infect & Global Hlth, Neston, Cheshire, England; [Williams, Nicola J.] Univ Liverpool, Sch Vet Sci, Dept Epidemiol & Populat Hlth, Inst Infect & Global Hlth, Neston, Cheshire, England; [Rushton, Steven; Close, Andrew] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Liverpool; University of Liverpool; Newcastle University - UK	Kemmett, K (corresponding author), Univ Liverpool, Sch Vet Sci, Dept Infect Biol, Inst Infect & Global Hlth, Neston, Cheshire, England.	K.Kemmett@liv.ac.uk		Humphrey, Tom/0000-0001-7965-8988; Wigley, Paul/0000-0001-6563-0773; Williams, Nicola/0000-0003-4709-4190	Biotechnical and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/I024674/1] Funding Source: researchfish; BBSRC [BB/I024674/1] Funding Source: UKRI	Biotechnical and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnical and Biological Sciences Research Council (BBSRC). www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES EM, 1972, BRIT POULTRY SCI, V13, P311, DOI 10.1080/00071667208415953; Barnes H.J., 1999, DIS POULTRY, P131; Brown PK, 1996, P NATL ACAD SCI USA, V93, P11149, DOI 10.1073/pnas.93.20.11149; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Christensen JP, 2003, P 13 C WORLD VET POU, P83; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; DOMINICK MA, 1984, AM J VET RES, V45, P2331; Dziva F., 2010, CURRENT RES TECHNOLO, V1, P746; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2005, AVIAN DIS, V49, P269, DOI 10.1637/7293-102604R; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Fasenko GM, 2009, POULTRY SCI, V88, P1121, DOI 10.3382/ps.2008-00359; Francis Dziva HH, 2012, INFECT IMMUNITY; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kariyawasam S, 2006, AVIAN DIS, V50, P405, DOI 10.1637/7462-102705R.1; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Manges AR, CLIN INFECT IN PRESS; McDaniels AE, 1996, APPL ENVIRON MICROB, V62, P3350, DOI 10.1128/AEM.62.9.3350-3354.1996; McPeake SJM, 2005, VET MICROBIOL, V110, P245, DOI 10.1016/j.vetmic.2005.08.001; Mellata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004232; Mora A, 2012, VET MICROBIOL, V156, P347, DOI 10.1016/j.vetmic.2011.10.033; Morris JG, 1997, EMERG INFECT DIS, V3, P435, DOI 10.3201/eid0304.970404; NAGARAJA KV, 1984, AM J VET RES, V45, P392; Nowrouzian FL, 2005, J INFECT DIS, V191, P1078, DOI 10.1086/427996; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ozawa M, 2010, J VET MED SCI, V72, P1517, DOI 10.1292/jvms.10-0174; Petersen A, 2006, VET MICROBIOL, V116, P120, DOI 10.1016/j.vetmic.2006.03.015; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; SALANITRO JP, 1974, APPL MICROBIOL, V27, P678, DOI 10.1128/AEM.27.4.678-687.1974; Schouler C, 2012, J CLIN MICROBIOL, V50, P1673, DOI 10.1128/JCM.05057-11; Skyberg JA, 2003, AVIAN DIS, V47, P1441, DOI 10.1637/7030; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; SYED S A, 1970, Infection and Immunity, V2, P376; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Timothy S, 2008, AVIAN PATHOL, V37, P375, DOI 10.1080/03079450802216579; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Vincent C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/eid1601.091118; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wells LL, 1998, DEV COMP IMMUNOL, V22, P103, DOI 10.1016/S0145-305X(97)00024-4; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Withanage GSK, 2005, INFECT IMMUN, V73, P5173, DOI 10.1128/IAI.73.8.5173-5182.2005; Withanage GSK, 2004, INFECT IMMUN, V72, P2152, DOI 10.1128/IAI.72.4.2152-2159.2004; Yassin H, 2009, POULTRY SCI, V88, P798, DOI 10.3382/ps.2008-00292	61	44	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67749	10.1371/journal.pone.0067749	http://dx.doi.org/10.1371/journal.pone.0067749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825682	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000116
J	Walsh, SA; Iwaniuk, AN; Knoll, MA; Bourdon, E; Barrett, PM; Milner, AC; Nudds, RL; Abel, RL; Dello Sterpaio, P				Walsh, Stig A.; Iwaniuk, Andrew N.; Knoll, Monja A.; Bourdon, Estelle; Barrett, Paul M.; Milner, Angela C.; Nudds, Robert L.; Abel, Richard L.; Dello Sterpaio, Patricia			Avian Cerebellar Floccular Fossa Size Is Not a Proxy for Flying Ability in Birds	PLOS ONE			English	Article							LOWER EOCENE; EVOLUTION; THEROPOD; BRAIN; REPTILES; FLIGHT; HEAD; ORGANIZATION; DINOSAURS; MOVEMENT	Extinct animal behavior has often been inferred from qualitative assessments of relative brain region size in fossil endocranial casts. For instance, flight capability in pterosaurs and early birds has been inferred from the relative size of the cerebellar flocculus, which in life protrudes from the lateral surface of the cerebellum. A primary role of the flocculus is to integrate sensory information about head rotation and translation to stabilize visual gaze via the vestibulo-occular reflex (VOR). Because gaze stabilization is a critical aspect of flight, some authors have suggested that the flocculus is enlarged in flying species. Whether this can be further extended to a floccular expansion in highly maneuverable flying species or floccular reduction in flightless species is unknown. Here, we used micro computed-tomography to reconstruct "virtual" endocranial casts of 60 extant bird species, to extract the same level of anatomical information offered by fossils. Volumes of the floccular fossa and entire brain cavity were measured and these values correlated with four indices of flying behavior. Although a weak positive relationship was found between floccular fossa size and brachial index, no significant relationship was found between floccular fossa size and any other flight mode classification. These findings could be the result of the bony endocranium inaccurately reflecting the size of the neural flocculus, but might also reflect the importance of the flocculus for all modes of locomotion in birds. We therefore conclude that the relative size of the flocculus of endocranial casts is an unreliable predictor of locomotor behavior in extinct birds, and probably also pterosaurs and non-avian dinosaurs.	[Walsh, Stig A.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Iwaniuk, Andrew N.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Knoll, Monja A.] Univ West Scotland, Sch Social Sci, Paisley, Renfrew, Scotland; [Bourdon, Estelle; Barrett, Paul M.; Milner, Angela C.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Nudds, Robert L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Abel, Richard L.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Dello Sterpaio, Patricia] Univ Abertay, Sch Engn Comp & Appl Math, Dundee, Scotland	University of Lethbridge; University of West Scotland; Natural History Museum London; University of Manchester; Imperial College London; University of Abertay Dundee	Walsh, SA (corresponding author), Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland.	s.walsh@nms.ac.uk	Bourdon, Estelle/B-1115-2011; Iwaniuk, Andrew/H-7255-2019; Barrett, Paul M/A-2648-2010	Bourdon, Estelle/0000-0002-5989-1982; Iwaniuk, Andrew/0000-0001-9273-3655; Barrett, Paul M/0000-0003-0412-3000; Walsh, Stig/0000-0002-7002-1005	Natural Environment Research Council [NE/H012176/1]; NERC [NE/H012176/1, NE/E008380/1] Funding Source: UKRI; Natural Environment Research Council [NE/E008380/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by Natural Environment Research Council (http://www.nerc.ac.uk/) Small Grant NE/H012176/1 to SAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel RL, 2012, PALAEONTOL ELECTRON, V15, P1, DOI DOI 10.26879/284; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Balanoff AM, 2009, AM MUS NOVIT, P1, DOI 10.1206/644.1; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P407; Burnham DA, 2004, LIFE O PAST, P67; Corfield JR, 2012, BRAIN BEHAV EVOLUT, V80, P181, DOI 10.1159/000339828; Corfield JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022945; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Dyke GJ, 2005, ACTA PALAEONTOL POL, V50, P101; Feduccia A, 2011, RIDDLE FEATHERED DRA; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; Fujita M, 2002, J ZOOL, V257, P373, DOI 10.1017/S0952836902000973; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Iwaniuk AN, 2007, BRAIN BEHAV EVOLUT, V69, P196, DOI 10.1159/000096987; Iwaniuk AN, 2007, J COMP NEUROL, V500, P211, DOI 10.1002/cne.21098; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kavanau JL, 2010, MED HYPOTHESES, V74, P275, DOI 10.1016/j.mehy.2009.09.015; Kennedy M, 2002, AUK, V119, P88, DOI 10.1642/0004-8038(2002)119[0088:SSCPEO]2.0.CO;2; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P499, DOI 10.1007/s00114-007-0219-1; Larsell O, 1926, J COMP NEUROL, V41, P59, DOI 10.1002/cne.900410103; Larsell O, 1932, J COMP NEUROL, V56, P299, DOI 10.1002/cne.900560204; Larsell O, 1967, COMP ANATOMY HISTOLO; Lautenschlager S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052289; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Maddison WP, 2019, MESQUITE MODULAR SYS; Midford PE, 2008, PDAP MESQUITE TRANSL; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Muir GD, 2005, J NEUROPHYSIOL, V94, P3691, DOI 10.1152/jn.01121.2004; Necker R, 2007, J COMP PHYSIOL A, V193, P1177, DOI 10.1007/s00359-007-0281-3; Norberg U., 1990, VERTEBRATE FLIGHT ME; Norell MA, 2009, AM MUS NOVIT, P1; Northcutt RG, 2001, BRAIN RES BULL, V55, P663, DOI 10.1016/S0361-9230(01)00560-3; Nudds RL, 2007, J ZOOL, V272, P218, DOI 10.1111/j.1469-7998.2006.00261.x; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; Pakan JMP, 2011, VISUAL NEUROSCI, V28, P163, DOI 10.1017/S0952523810000532; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Ridgely R, 2008, J VERTEBR PALEONTOL, V28, p131A; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Voogd J, 2004, J COMP NEUROL, V470, P107, DOI 10.1002/cne.11022; Walsh SA, 2013, SPRINGER HDB AUDITOR; Walsh SA, 2011, LIVING DINOSAURS EVO, P282; Walsh S, 2011, J SYST PALAEONTOL, V9, P173, DOI 10.1080/14772019.2010.513703; Walsh SA, 2011, SPEC PAP PALAEONTOL, P263, DOI 10.1111/j.1475-4983.2011.01085.x; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Wang Xia, 2011, PLoS ONE, V6, P1, DOI 10.1371/journal.pone.0028672; Warrick DR, 2002, INTEGR COMP BIOL, V42, P141, DOI 10.1093/icb/42.1.141; Witmer LM, 2007, J MORPHOL, V268, P1150; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Wylie Douglas R., 2012, P289; Wylie DRW, 1999, J NEUROPHYSIOL, V81, P256, DOI 10.1152/jn.1999.81.1.256; Zelenitsky DK, 2011, P ROY SOC B-BIOL SCI, V278, P3625, DOI 10.1098/rspb.2011.0238	61	37	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67176	10.1371/journal.pone.0067176	http://dx.doi.org/10.1371/journal.pone.0067176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825638	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000086
J	Asbach, S; Hartmann, M; Wengenmayer, T; Graf, E; Bode, C; Biermann, J				Asbach, Stefan; Hartmann, Maximilian; Wengenmayer, Tobias; Graf, Erika; Bode, Christoph; Biermann, Juergen			Vector Selection of a Quadripolar Left Ventricular Pacing Lead Affects Acute Hemodynamic Response to Cardiac Resynchronization Therapy: A Randomized Cross-Over Trial	PLOS ONE			English	Article							HEART-FAILURE PATIENTS; CORONARY-SINUS; FOLLOW-UP; STIMULATION; SITES; OPTIMIZATION; MULTICENTER; EXPERIENCE	Background: A suboptimal left ventricular (LV) pacing site may account for non-responsiveness of patients to cardiac resynchronization therapy (CRT). The vector selection of a novel quadripolar LV pacing lead, which was mainly developed to overcome technical issues with stimulation thresholds and phrenic nerve capture, may affect hemodynamic response, and was therefore assessed in this study. (German Clinical Trials Register DRKS00000573). Methods and Results: Hemodynamic effects of a total of 145 LVPCs (9.1 per patient) of CRT devices with a quadripolar LV lead (Quartet (TM), St. Jude Medical) were assessed in 16/20 consecutive patients by invasive measurement of LV+dP/dt(max) at an invasively optimized AV-interval in random order. Optimal (worst) LVPCs per patient were identified as those with maximal (minimal) %change in LV+dP/dt(max) (%Delta LV+dP/dt(max)) as compared to a preceding baseline. LV+dP/dt(max) significantly increased in all 145 LVPCs (p<0.0001 compared to baseline) with significant intraindividual differences between LVPCs (p<0.0001). Overall, CRT acutely augmented %Delta LV+dP/dt(max) by 31.3% (95% CI 24%-39%) in the optimal, by 21.3% (95% CI: 15%-27%) in the worst and by 28.2% (95% CI: 21%-36%) in a default distal LVPC. This resulted in an absolute additional acute increase in %Delta LV+dP/dt(max) of 10.0% (95% CI: 7%-13%) of the optimal when compared to the worst (p<0.0001), and of 3.1% (95% CI: 1%-5%) of the optimal when compared to the default distal LVPC (p<0.001). Optimal LVPCs were not programmable with a standard bipolar lead in 44% (7/16) of patients. Conclusion: The pacing configuration of a quadripolar LV lead determinates acute hemodynamic response. Pacing in the individually optimized configuration gives rise to an additional absolute 10% increase in %Delta LV+dP/dt(max) when comparing optimal and worst vectors.	[Asbach, Stefan; Hartmann, Maximilian; Wengenmayer, Tobias; Bode, Christoph; Biermann, Juergen] Univ Heart Ctr Freiburg, Freiburg, Germany; [Graf, Erika] Univ Med Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany	Universitats Herzzentrum Freiburg; University of Freiburg	Asbach, S (corresponding author), Univ Heart Ctr Freiburg, Freiburg, Germany.	stefan.asbach@universitaets-herzzentrum.de	Wengenmayer, Tobias/ABD-7064-2020	Wengenmayer, Tobias/0000-0002-3659-0407; Graf, Erika/0000-0002-6831-0756	St. Jude Medical	St. Jude Medical(St. Jude Medical)	The authors have read the journal's policy and have the following conflicts: SA, MH and JB are investigators in Clinical Trials sponsored by St. Jude Medical. KL, AB, AK, KJ and AH, all St. Jude Medical, provided technical assistance for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Auricchio A, 2011, J AM COLL CARDIOL, V58, P2183, DOI 10.1016/j.jacc.2011.06.061; Bogaard MD, 2011, EUR J HEART FAIL, V13, P1126, DOI 10.1093/eurjhf/hfr094; Bordachar P, 2010, J AM COLL CARDIOL, V56, P747, DOI 10.1016/j.jacc.2010.04.038; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Butter C, 2001, CIRCULATION, V104, P3026, DOI 10.1161/hc5001.102229; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cuoco FA, 2012, J CARDIOVASC ELECTR, V23, P110, DOI 10.1111/j.1540-8167.2011.02235.x; Daubert JC, 2012, HEART RHYTHM, V9, P1524, DOI 10.1016/j.hrthm.2012.07.025; Delgado V, 2011, CIRCULATION, V123, P70, DOI 10.1161/CIRCULATIONAHA.110.945345; Derval N, 2010, J AM COLL CARDIOL, V55, P566, DOI 10.1016/j.jacc.2009.08.045; Dickstein K, 2010, EUR HEART J, V31, P2677, DOI 10.1093/eurheartj/ehq337; Duckett SG, 2011, J AM COLL CARDIOL, V58, P1128, DOI 10.1016/j.jacc.2011.04.042; Forleo GB, 2012, HEART RHYTHM, V9, P1822, DOI 10.1016/j.hrthm.2012.07.021; Gold MR, 2005, HEART RHYTHM, V2, P376, DOI 10.1016/j.hrthm.2004.12.025; Helm RH, 2007, CIRCULATION, V115, P953, DOI 10.1161/CIRCULATIONAHA.106.643718; Khan FZ, 2012, J AM COLL CARDIOL, V59, P1509, DOI 10.1016/j.jacc.2011.12.030; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Padeletti L, 2012, CIRC-ARRHYTHMIA ELEC, V5, P460, DOI 10.1161/CIRCEP.111.970277; Prinzen FW, 2012, J CARDIOVASC TRANSL, V5, P188, DOI 10.1007/s12265-011-9331-x; Saxon LA, 2009, J CARDIOVASC ELECTR, V20, P764, DOI 10.1111/j.1540-8167.2009.01444.x; Shetty AK, 2012, PACE, V35, P196, DOI 10.1111/j.1540-8159.2011.03268.x; Shetty AK, 2011, PACE, V34, P484, DOI 10.1111/j.1540-8159.2010.03003.x; Singh JP, 2011, CIRCULATION, V123, P1159, DOI 10.1161/CIRCULATIONAHA.110.000646; Sperzel J, 2012, EUROPACE, V14, P365, DOI 10.1093/europace/eur322; Spragg DD, 2010, J AM COLL CARDIOL, V56, P774, DOI 10.1016/j.jacc.2010.06.014; Whinnett Z, 2012, CURR OPIN CARDIOL, V27, P19, DOI 10.1097/HCO.0b013e32834dc3d4; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Zhang Q, 2008, INT J CARDIOL, V124, P211, DOI 10.1016/j.ijcard.2007.02.043	30	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67235	10.1371/journal.pone.0067235	http://dx.doi.org/10.1371/journal.pone.0067235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826245	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400125
J	Hein, I; Suzuki, T; Kadow, ICG				Hein, Irina; Suzuki, Takashi; Kadow, Ilona C. Grunwald			Gogo Receptor Contributes to Retinotopic Map Formation and Prevents R1-6 Photoreceptor Axon Bundling	PLOS ONE			English	Article							DROSOPHILA VISUAL-SYSTEM; N-CADHERIN; TARGET INTERACTIONS; TYROSINE KINASE; LIPRIN-ALPHA; SPECIFICITY; FLAMINGO; MELANOGASTER; SELECTION; GUIDANCE	Background: Topographic maps form the basis of neural processing in sensory systems of both vertebrate and invertebrate species. In the Drosophila visual system, neighboring R1-R6 photoreceptor axons innervate adjacent positions in the first optic ganglion, the lamina, and thereby represent visual space as a continuous map in the brain. The mechanisms responsible for the establishment of retinotopic maps remain incompletely understood. Results: Here, we show that the receptor Golden goal (Gogo) is required for R axon lamina targeting and cartridge elongation in a partially redundant fashion with local guidance cues provided by neighboring axons. Loss of function of Gogo in large clones of R axons results in aberrant R1-R6 fascicle spacing. Gogo affects target cartridge selection only indirectly as a consequence of the disordered lamina map. Interestingly, small clones of gogo deficient R axons perfectly integrate into a proper retinotopic map suggesting that surrounding R axons of the same or neighboring fascicles provide complementary spatial guidance. Using single photoreceptor type rescue, we show that Gogo expression exclusively in R8 cells is sufficient to mediate targeting of all photoreceptor types in the lamina. Upon lamina targeting and cartridge selection, R axons elongate within their individual cartridges. Interestingly, here Gogo prevents bundling of extending R1-6 axons. Conclusion: Taken together, we propose that Gogo contributes to retinotopic map formation in the Drosophila lamina by controlling the distribution of R1-R6 axon fascicles. In a later developmental step, the regular position of R1-R6 axons along the lamina plexus is crucial for target cartridge selection. During cartridge elongation, Gogo allows R1-R6 axons to extend centrally in the lamina cartridge.	[Hein, Irina; Kadow, Ilona C. Grunwald] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Suzuki, Takashi] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 227, Japan	Max Planck Society; Tokyo Institute of Technology	Suzuki, T (corresponding author), Tokyo Inst Technol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 227, Japan.	suzukit@bio.titech.ac.jp; ikadow@neuro.mpg.de	Suzuki, Takashi/D-3651-2019	Suzuki, Takashi/0000-0001-9093-2562; Grunwald Kadow, Ilona/0000-0002-9085-4274	MPS	MPS	This work was supported by the MPS (to TS and IG-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascher D., 2001, NUMERICAL PYTHON; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Chen PL, 2008, NEURON, V58, P26, DOI 10.1016/j.neuron.2008.01.007; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Choe KM, 2006, P NATL ACAD SCI USA, V103, P11601, DOI 10.1073/pnas.0601185103; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Gontang AC, 2011, DEVELOPMENT, V138, P4899, DOI 10.1242/dev.069930; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; Hamanaka Y, 2010, J COMP NEUROL, V518, P1133, DOI 10.1002/cne.22268; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Jones E., 2001, SCIPY OPEN SOURCE SC; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Prakash S, 2009, DEV BIOL, V336, P10, DOI 10.1016/j.ydbio.2009.09.016; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Timofeev K, 2012, NEURON, V75, P80, DOI 10.1016/j.neuron.2012.04.037; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; White NM, 2000, DEVELOPMENT, V127, P1681; Wolff T, 1993, DEV DROSOPHILA MELAN; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469	38	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66868	10.1371/journal.pone.0066868	http://dx.doi.org/10.1371/journal.pone.0066868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826162	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400073
J	Singh, BK; Bockarie, MJ; Gambhir, M; Siba, PM; Tisch, DJ; Kazura, J; Michael, E				Singh, Brajendra K.; Bockarie, Moses J.; Gambhir, Manoj; Siba, Peter M.; Tisch, Daniel J.; Kazura, James; Michael, Edwin			Sequential Modelling of the Effects of Mass Drug Treatments on Anopheline-Mediated Lymphatic Filariasis Infection in Papua New Guinea	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI INFECTION; DISEASE TRANSMISSION MODELS; CULEX-QUINQUEFASCIATUS; BIOLOGICAL ROBUSTNESS; MATHEMATICAL-MODELS; SIMULATION-MODELS; GLOBAL PROGRAM; VECTOR CONTROL; ENDEMIC AREA; SOUTH-INDIA	Background: Lymphatic filariasis (LF) has been targeted by the WHO for global eradication leading to the implementation of large scale intervention programs based on annual mass drug administrations (MDA) worldwide. Recent work has indicated that locality-specific bio-ecological complexities affecting parasite transmission may complicate the prediction of LF extinction endpoints, casting uncertainty on the achievement of this initiative. One source of difficulty is the limited quantity and quality of data used to parameterize models of parasite transmission, implying the important need to update initially-derived parameter values. Sequential analysis of longitudinal data following annual MDAs will also be important to gaining new understanding of the persistence dynamics of LF. Here, we apply a Bayesian statistical-dynamical modelling framework that enables assimilation of information in human infection data recorded from communities in Papua New Guinea that underwent annual MDAs, into our previously developed model of parasite transmission, in order to examine these questions in LF ecology and control. Results: Biological parameters underlying transmission obtained by fitting the model to longitudinal data remained stable throughout the study period. This enabled us to reliably reconstruct the observed baseline data in each community. Endpoint estimates also showed little variation. However, the updating procedure showed a shift towards higher and less variable values for worm kill but not for any other drug-related parameters. An intriguing finding is that the stability in key biological parameters could be disrupted by a significant reduction in the vector biting rate prevailing in a locality. Conclusions: Temporal invariance of biological parameters in the face of intervention perturbations indicates a robust adaptation of LF transmission to local ecological conditions. The results imply that understanding the mechanisms that underlie locally adapted transmission dynamics will be integral to identifying points of system fragility, and thus countermeasures to reliably facilitate LF extinction both locally and globally.	[Singh, Brajendra K.; Michael, Edwin] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Bockarie, Moses J.] Univ Liverpool, Liverpool Sch Trop Med & Hyg, Liverpool L69 3BX, Merseyside, England; [Gambhir, Manoj] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Siba, Peter M.] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Tisch, Daniel J.; Kazura, James] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	University of Notre Dame; Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London; PNG Institute Of Medical Research; Case Western Reserve University	Singh, BK (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	bsingh1@nd.edu	Michael, Edwin/D-3388-2014; Bockarie, Moses/AAW-3130-2021; Singh, Brajendra Kumar/C-3787-2012; Bockarie, Moses/AAV-4578-2020; Tisch, Daniel/Q-5044-2019	Singh, Brajendra Kumar/0000-0001-5847-8750; Gambhir, Manoj/0000-0002-4831-6261	National Institutes of Health [RO1 AI069387-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	EM and BKS acknowledge National Institutes of Health grant no: RO1 AI069387-01A1 for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ELEMENTS COMPUTATION; Beven K., 2004, Hydrology: science and practice for the 21st century, Volume 1. Proceedings of the British Hydrological Society International Conference, Imperial College, London, July 2004, P244; Bockarie MJ, 1998, LANCET, V351, P162, DOI 10.1016/S0140-6736(97)07081-5; Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309; Bockarie MJ, 2009, ANNU REV ENTOMOL, V54, P469, DOI 10.1146/annurev.ento.54.110807.090626; Brockarie M, 1996, AM J TROP MED HYG, V54, P577, DOI 10.4269/ajtmh.1996.54.577; Brugnach M, 2008, DEV INTEG ENVIRON, V3, P49, DOI 10.1016/S1574-101X(08)00604-2; Chan MS, 1998, AM J TROP MED HYG, V59, P606, DOI 10.4269/ajtmh.1998.59.606; Coelho FC, 2008, CAD SAUDE PUBLICA, V24, P853, DOI 10.1590/S0102-311X2008000400016; Coelho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019616; Das PK, 1992, EPIDEMIOL INFECT, V108, P483; de Kraker MEA, 2006, TROP MED INT HEALTH, V11, P718, DOI 10.1111/j.1365-3156.2006.01606.x; Dowd M, 2006, ENVIRONMETRICS, V17, P435, DOI 10.1002/env.780; Dowd M, 2011, ENVIRONMETRICS, V22, P501, DOI 10.1002/env.1083; Dreyer G, 2006, T ROY SOC TROP MED H, V100, P1118, DOI 10.1016/j.trstmh.2006.04.006; Duerr HP, 2005, TRENDS PARASITOL, V21, P88, DOI 10.1016/j.pt.2004.11.011; EVANS DB, 1993, ACTA TROP, V53, P1, DOI 10.1016/0001-706X(93)90002-S; Gambhir M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-22; Gambhir M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002874; HAIRSTON NG, 1968, B WORLD HEALTH ORGAN, V38, P935; HO BC, 1967, T ROY SOC TROP MED H, V61, P663, DOI 10.1016/0035-9203(67)90130-7; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kyelem D, 2008, AM J TROP MED HYG, V79, P480; LaDeau SL, 2011, ECOL APPL, V21, P1443, DOI 10.1890/09-1409.1; Liang S, 2007, P NATL ACAD SCI USA, V104, P7110, DOI 10.1073/pnas.0701878104; Luo YQ, 2011, ECOL APPL, V21, P1429; MAY RM, 1977, MATH BIOSCI, V35, P301, DOI 10.1016/0025-5564(77)90030-X; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 2007, ADV PARASIT, V65, P191, DOI 10.1016/S0065-308X(07)65003-9; Michael E, 2006, TRENDS PARASITOL, V22, P529, DOI 10.1016/j.pt.2006.08.011; Michael E, 2006, TRENDS PARASITOL, V22, P226, DOI 10.1016/j.pt.2006.03.005; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Norman RA, 2000, EPIDEMIOL INFECT, V124, P529, DOI 10.1017/S0950268899003702; Norton JP, 2008, DEV INTEG ENVIRON, V3, P181, DOI 10.1016/S1574-101X(08)00611-X; OTTESEN EA, 1995, PARASITOL TODAY, V11, P129, DOI 10.1016/0169-4758(95)80128-6; Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Plaisier AP, 1999, PARASITOLOGY, V119, P385, DOI 10.1017/S0031182099004783; Plaisier AP, 2000, PARASITOL TODAY, V16, P298, DOI 10.1016/S0169-4758(00)01691-4; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Raftery AE, 2010, BIOMETRICS, V66, P1162, DOI 10.1111/j.1541-0420.2010.01399.x; RAFTERY AE, 1995, J AM STAT ASSOC, V90, P402, DOI 10.2307/2291048; Rajagopalan P.K., 1980, Proceedings of the Indian National Science Academy Part B Biological Sciences, V46, P745; Ramin M, 2011, ENVIRON MODELL SOFTW, V26, P337, DOI 10.1016/j.envsoft.2010.08.006; Scott BC, 2004, TRENDS ECOL EVOL, V19, P365; Sevcikova H, 2007, TRANSPORT RES B-METH, V41, P652, DOI 10.1016/j.trb.2006.11.001; Spear RC, 2002, ENVIRON HEALTH PERSP, V110, P907, DOI 10.1289/ehp.02110907; Spear RC, 2012, J R SOC INTERFACE, V9, P272, DOI 10.1098/rsif.2011.0285; Spear RC, 2010, ADV EXP MED BIOL, V673, P99; Stolk WA, 2008, PARASITOLOGY, V135, P1583, DOI 10.1017/S0031182008000437; SUBRAMANIAN S, 1994, AM J TROP MED HYG, V51, P244, DOI 10.4269/ajtmh.1994.51.244; SUBRAMANIAN S, 1989, EPIDEMIOL INFECT, V103, P693, DOI 10.1017/S0950268800031095; Subramanian S, 1998, PARASITOLOGY, V116, P243, DOI 10.1017/S0031182097002254; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Tisch DJ, 2008, AM J TROP MED HYG, V78, P289, DOI 10.4269/ajtmh.2008.78.289; Tisch DJ, 2005, LANCET INFECT DIS, V5, P514, DOI 10.1016/S1473-3099(05)70192-4; Tisch DJ, 2001, J INFECT DIS, V184, P898, DOI 10.1086/323324; VANAMAIL P, 1990, INDIAN J MED RES-A, V91, P293; Vanamail P, 1996, T ROY SOC TROP MED H, V90, P119, DOI 10.1016/S0035-9203(96)90106-6; Waller LA, 2003, ECOL MODEL, V164, P49, DOI 10.1016/S0304-3800(03)00011-5; Weisstein E.W., KOLMOGOROV SMIRNOV T; Whitacre JM, 2012, FRONTIERS GENETICS, V3; Ziadinov I, 2008, INT J PARASITOL, V38, P1179, DOI 10.1016/j.ijpara.2008.01.009; Zimmermann HJ, 2000, EUR J OPER RES, V122, P190, DOI 10.1016/S0377-2217(99)00228-3	69	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67004	10.1371/journal.pone.0067004	http://dx.doi.org/10.1371/journal.pone.0067004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826185	gold, Green Published, Green Accepted			2022-12-27	WOS:000321738400093
J	Nguyen, HD; Becker, J; Thu, YM; Costanzo, M; Koch, EN; Smith, S; Myung, K; Myers, CL; Boone, C; Bielinsky, AK				Nguyen, Hai Dang; Becker, Jordan; Thu, Yee Mon; Costanzo, Michael; Koch, Elizabeth N.; Smith, Stephanie; Myung, Kyungjae; Myers, Chad L.; Boone, Charles; Bielinsky, Anja-Katrin			Unligated Okazaki Fragments Induce PCNA Ubiquitination and a Requirement for Rad59-Dependent Replication Fork Progression	PLOS ONE			English	Article							DNA-LIGASE-I; NEARBY INVERTED REPEATS; CELL NUCLEAR ANTIGEN; SACCHAROMYCES-CEREVISIAE; EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; COMPLEX-FORMATION; CDC9 GENE; YEAST	Deficiency in DNA ligase I, encoded by CDC9 in budding yeast, leads to the accumulation of unligated Okazaki fragments and triggers PCNA ubiquitination at a non-canonical lysine residue. This signal is crucial to activate the S phase checkpoint, which promotes cell cycle delay. We report here that a pol30-K107 mutation alleviated cell cycle delay in cdc9 mutants, consistent with the idea that the modification of PCNA at K107 affects the rate of DNA synthesis at replication forks. To determine whether PCNA ubiquitination occurred in response to nicks or was triggered by the lack of PCNA-DNA ligase interaction, we complemented cdc9 cells with either wild-type DNA ligase I or a mutant form, which fails to interact with PCNA. Both enzymes reversed PCNA ubiquitination, arguing that the modification is likely an integral part of a novel nick-sensory mechanism and not due to non-specific secondary mutations that could have occurred spontaneously in cdc9 mutants. To further understand how cells cope with the accumulation of nicks during DNA replication, we utilized cdc9-1 in a genome-wide synthetic lethality screen, which identified RAD59 as a strong negative interactor. In comparison to cdc9 single mutants, cdc9 rad59D double mutants did not alter PCNA ubiquitination but enhanced phosphorylation of the mediator of the replication checkpoint, Mrc1. Since Mrc1 resides at the replication fork and is phosphorylated in response to fork stalling, these results indicate that Rad59 alleviates nick-induced replication fork slowdown. Thus, we propose that Rad59 promotes fork progression when Okazaki fragment processing is compromised and counteracts PCNA-K107 mediated cell cycle arrest.	[Nguyen, Hai Dang; Becker, Jordan; Thu, Yee Mon; Bielinsky, Anja-Katrin] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Costanzo, Michael; Boone, Charles] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON, Canada; [Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Koch, Elizabeth N.; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Smith, Stephanie; Myung, Kyungjae] Natl Inst Hlth, Natl Human Genome Res Inst, Genet & Mol Biol Branch, Genome Instabil Sect, Bethesda, MD USA	University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; University of Toronto; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bielinsky, AK (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	bieli003@umn.edu		Becker, Jordan/0000-0002-6827-0002; Bielinsky, Anja/0000-0003-1783-619X	National Institutes of Health (NIH) [GM074917]; National Human Genome Research Institute; NIH [HG005084, HG005853]; NSF [DBI0953881]; Canadian Institutes of Health Research [MOP-102629, MOP-97939]; Ontario Research Fund [GL2-0122]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG012003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074917] Funding Source: NIH RePORTER; Direct For Biological Sciences [0953881] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health (NIH) grant GM074917 to AKB, who is a Scholar of the Leukemia and Lymphoma Society. The intramural Research Programs of the National Human Genome Research Institute supported KM. EK is a National Science Foundation (NSF) Graduate Research Fellow. EK and CLM were supported by a grant from the NIH (HG005084), and the NSF (DBI0953881). CB and CLM are supported by a grant from the NIH (HG005853). CB is supported by grants from the Canadian Institutes of Health Research (MOP-102629 and MOP-97939) and the Ontario Research Fund (GL2-0122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; BAILLY V, 1992, P NATL ACAD SCI USA, V89, P8273, DOI 10.1073/pnas.89.17.8273; Barlow JH, 2009, EMBO J, V28, P1121, DOI 10.1038/emboj.2009.43; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Ben-Aroya S, 2010, METHOD ENZYMOL, V470, P181, DOI 10.1016/S0076-6879(10)70008-2; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Brachmann CB, 1998, YEAST, V14, P115; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Budd ME, 2011, CELL CYCLE, V10, P1690, DOI 10.4161/cc.10.10.15643; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Chanet R, 2003, CURR GENET, V43, P337, DOI 10.1007/s00294-003-0407-2; Chen C, 1999, MOL CELL BIOL, V19, P7801; COLLINGE MA, 1994, MOL GEN GENET, V245, P686, DOI 10.1007/BF00297275; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Das-Bradoo S, 2010, CELL CYCLE, V9, P3674, DOI 10.4161/cc.9.18.13121; Das-Bradoo S, 2010, NAT CELL BIOL, V12, P74, DOI 10.1038/ncb2007; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; GAME JC, 1979, P NATL ACAD SCI USA, V76, P4589, DOI 10.1073/pnas.76.9.4589; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Guzder SN, 2006, MOL CELL BIOL, V26, P1135, DOI 10.1128/MCB.26.3.1135-1141.2006; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; IVANOV EL, 1995, MOL CELL BIOL, V15, P2245; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; MONTELONE BA, 1981, J BACTERIOL, V147, P517, DOI 10.1128/JB.147.2.517-525.1981; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Motegi A, 2007, METHODS, V41, P168, DOI 10.1016/j.ymeth.2006.07.025; Mott C, 2011, DNA REPAIR, V10, P408, DOI 10.1016/j.dnarep.2011.01.007; Naiki T, 2004, MOL CELL BIOL, V24, P3277, DOI 10.1128/MCB.24.8.3277-3285.2004; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nakada D, 2004, MOL CELL BIOL, V24, P10016, DOI 10.1128/MCB.24.22.10016-10025.2004; Naylor ML, 2009, P NATL ACAD SCI USA, V106, P12765, DOI 10.1073/pnas.0904623106; Paek AL, 2009, GENE DEV, V23, P2861, DOI 10.1101/gad.1862709; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Subramanian J, 2005, GENETICS, V171, P427, DOI 10.1534/genetics.105.042861; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Szyjka SJ, 2008, GENE DEV, V22, P1906, DOI 10.1101/gad.1660408; Toh GWL, 2010, DNA REPAIR, V9, P718, DOI 10.1016/j.dnarep.2010.02.013; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; WEINERT TA, 1993, GENETICS, V134, P63; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wu XH, 1999, BIOCHEMISTRY-US, V38, P2628, DOI 10.1021/bi982592s; Wu Y, 2006, J BIOL CHEM, V281, P15441, DOI 10.1074/jbc.M601827200; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	64	15	15	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66379	10.1371/journal.pone.0066379	http://dx.doi.org/10.1371/journal.pone.0066379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824283	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400098
J	Liu, ZQ; Baker, PJ; Cheng, F; Xue, YP; Zheng, YG; Shen, YC				Liu, Zhi-Qiang; Baker, Peter James; Cheng, Feng; Xue, Ya-Ping; Zheng, Yu-Guo; Shen, Yin-Chu			Screening and Improving the Recombinant Nitrilases and Application in Biotransformation of Iminodiacetonitrile to Iminodiacetic Acid	PLOS ONE			English	Article							ESCHERICHIA-COLI; EPOXIDE HYDROLASE; HYDROLYSIS; GENE; EXPRESSION; CLONING; BIOCATALYSIS; GLYPHOSATE; VERSATILE; FAMILY	In this study, several nitrilase genes from phylogenetically distinct organisms were expressed and purified in E. coli in order to study their ability to mediate the biotransformation of nitriles. We identified three nitrilases: Acidovorax facilis nitrilase (AcN); Alcaligenes fecalis nitrilase (AkN); and Rhodococcus rhodochrous nitrilase (RkN), which catalyzed iminodiacetonitrile (IDAN) to iminodiacetic acid (IDA). AcN demonstrated 8.8-fold higher activity for IDAN degradation as compared to AkN and RkN. Based on homology modeling and previously described 'hot spot' mutations, several AcN mutants were screened for improved activity. One mutant M3 (F168V/L201N/S192F) was identified, which demonstrates a 41% enhancement in the conversion as well as a 2.4-fold higher catalytic efficiency towards IDAN as compared to wild-type AcN.	[Liu, Zhi-Qiang; Baker, Peter James; Cheng, Feng; Xue, Ya-Ping; Zheng, Yu-Guo; Shen, Yin-Chu] Zhejiang Univ Technol, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology	Zheng, YG (corresponding author), Zhejiang Univ Technol, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China.	zhengyg@zjut.edu.cn		Liu, Zhi-Qiang/0000-0003-3259-6796	National High Technology Research and Development Program of China (863 Program) [2011AA02A210]; Natural Science Foundation of Zhejiang Province [R3110155, Z4090612, Y4110409]; Qianjiang Talent Project of Zhejiang Province	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Qianjiang Talent Project of Zhejiang Province	This work was financially supported by the National High Technology Research and Development Program of China (863 Program) (No. 2011AA02A210), Natural Science Foundation of Zhejiang Province (No. R3110155, Z4090612 and Y4110409) and Qianjiang Talent Project of Zhejiang Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee A, 2003, BIOTECHNOL APPL BIOC, V37, P289, DOI 10.1042/BA20020106; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; Barglow KT, 2008, BIOCHEMISTRY-US, V47, P13514, DOI 10.1021/bi801786y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauhan S, 2003, APPL MICROBIOL BIOT, V61, P118, DOI 10.1007/s00253-002-1192-4; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Duan PG, 2007, CHEM ENG TECHNOL, V30, P265, DOI 10.1002/ceat.200600298; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Gavagan JE, 1999, APPL MICROBIOL BIOT, V52, P654, DOI 10.1007/s002530051574; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Hann EC, 2003, ADV SYNTH CATAL, V345, P775, DOI 10.1002/adsc.200303007; Hiromoto T, 2006, J MOL BIOL, V364, P863, DOI 10.1016/j.jmb.2006.08.098; KOBAYASHI M, 1994, FEMS MICROBIOL LETT, V120, P217, DOI 10.1016/0378-1097(94)90474-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin ZJ, 2009, AGROCHEMICALS, V48, P547; Liu ZQ, 2012, J MOL MICROB BIOTECH, V22, P35, DOI 10.1159/000337055; Liu ZQ, 2011, CATAL COMMUN, V16, P133, DOI 10.1016/j.catcom.2011.09.010; Liu ZQ, 2011, J AGR FOOD CHEM, V59, P11560, DOI 10.1021/jf202746a; Liu ZQ, 2011, BIOTECHNOL PROGR, V27, P698, DOI 10.1002/btpr.603; Liu ZQ, 2007, APPL MICROBIOL BIOT, V74, P99, DOI 10.1007/s00253-006-0635-8; Martinkova L, 2003, CURR ORG CHEM, V7, P1279, DOI 10.2174/1385272033486486; Martinkova L, 2010, CURR OPIN CHEM BIOL, V14, P130, DOI 10.1016/j.cbpa.2009.11.018; Martinkova L, 2009, BIOTECHNOL ADV, V27, P661, DOI 10.1016/j.biotechadv.2009.04.027; Nagasawa T, 2000, EUR J BIOCHEM, V267, P138, DOI 10.1046/j.1432-1327.2000.00983.x; Nestl BM, 2011, CURR OPIN CHEM BIOL, V15, P187, DOI 10.1016/j.cbpa.2010.11.019; Olson AJ, 1998, SAR QSAR ENVIRON RES, V8, P273, DOI 10.1080/10629369808039144; PACE CN, 1988, J BIOL CHEM, V263, P11820; Pace HC, 2001, GENOME BIOL, V2; Podar M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-42; Raczynska JE, 2011, J STRUCT BIOL, V173, P294, DOI 10.1016/j.jsb.2010.11.017; Robertson DE, 2004, APPL ENVIRON MICROB, V70, P2429, DOI 10.1128/AEM.70.4.2429-2436.2004; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Sakai N, 2004, PROTEINS, V57, P869, DOI 10.1002/prot.20259; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Straathof AJJ, 2002, CURR OPIN BIOTECH, V13, P548, DOI 10.1016/S0958-1669(02)00360-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thuku RN, 2009, J APPL MICROBIOL, V106, P703, DOI 10.1111/j.1365-2672.2008.03941.x; Vink Mandy K. S., 2006, Biotechnology Journal, V1, P569, DOI 10.1002/biot.200600028; Woodburn AT, 2000, PEST MANAG SCI, V56, P309, DOI 10.1002/(SICI)1526-4998(200004)56:4<309::AID-PS143>3.3.CO;2-3; Wu SJ, 2008, BIOTECHNOL BIOENG, V99, P717, DOI 10.1002/bit.21643; Wu SJ, 2007, BIOTECHNOL BIOENG, V97, P689, DOI 10.1002/bit.21289; YAMAMOTO K, 1991, APPL ENVIRON MICROB, V57, P3028, DOI 10.1128/AEM.57.10.3028-3032.1991; Yu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046388; Zhang JF, 2012, ENG LIFE SCI, V12, P69, DOI 10.1002/elsc.201100090; Zhu D, 2007, ADV SYNTH CATAL, V349, P1667, DOI 10.1002/adsc.200700067	46	22	24	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67197	10.1371/journal.pone.0067197	http://dx.doi.org/10.1371/journal.pone.0067197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826231	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000042
J	Grygorowicz, M; Piontek, T; Dudzinski, W				Grygorowicz, Monika; Piontek, Tomasz; Dudzinski, Witold			Evaluation of Functional Limitations in Female Soccer Players and Their Relationship with Sports Level - A Cross Sectional Study	PLOS ONE			English	Article							CRUCIATE LIGAMENT INJURIES; MOVEMENT SCREEN; GENDER-DIFFERENCES; INTRARATER RELIABILITY; INTERRATER RELIABILITY; PROFESSIONAL SOCCER; KNEE INJURIES; RISK; FLEXIBILITY; STRENGTH	The main objective(s) of the study: The aim of this study was to analyze: a) abnormalities in the length of lower limb muscles, b) the correctness of movement patterns, and c) the impact of functional limitations of muscles on the correctness of fundamental movement patterns in a group of female soccer players, in relation to their skill level. Materials and Methods: 21 female soccer players from Polish Ekstraklasa and 22 players from the 1st Division were tested for lower limb muscle length restrictions and level of fundamental movement skills (with the Fundamental Movement Screen (TM) test concept by Gray Cook). Chi-square test was used for categorical unrelated variables. Differences between groups in absolute point values were analyzed using the non-parametric Mann-Whitney U test. Statistical significance was set at p<0.05. Results: Statistically significant higher number of measurements indicating an abnormal length of rectus femoris was observed in the 1st Division group (p = 0.0433). In the group of Ekstraklasa the authors obtained a significantly higher number of abnormal hamstring test results (p = 0.0006). Ekstraklasa players scored higher in the rotational stability test of the trunk (p = 0.0008), whereas the 1st Division players scored higher in the following tests: deep squat (p = 0.0220), in-line lunge (p = 0.0042) and active straight leg raise (p = 0.0125). The results suggest that there are different functional reasons affecting point values obtained in the FMS (TM) tests in both analyzed groups. Conclusions: The differences in the flexibility of rectus femoris and hamstring muscle observed between female soccer players with different levels of training, may result from a long-term impact of soccer training on the muscle-tendon system and articular structures. Different causes of abnormalities in fundamental movement patterns in both analyzed groups suggest the need for tailoring prevention programs to the level of sport skills represented by the players.	[Grygorowicz, Monika] Rehasport Clin, Dept Res & Dev, Poznan, Poland; [Piontek, Tomasz; Dudzinski, Witold] Rehasport Clin, Dept Orthopaed, Poznan, Poland; [Grygorowicz, Monika] Stanislaw Stasz State Sch Higher Vocat Educ Pila, Inst Hlth Protect, Dept Physiotherapy, Pila, Poland		Grygorowicz, M (corresponding author), Rehasport Clin, Dept Res & Dev, Poznan, Poland.	monika.grygorowicz@rehasport.pl	Grygorowicz, Monika Małgorzata/A-1357-2012; Grygorowicz, Monika/GWU-5803-2022	Grygorowicz, Monika Małgorzata/0000-0002-9575-2074; Grygorowicz, Monika/0000-0002-9575-2074	Rehasport Clinic Fundation	Rehasport Clinic Fundation	Rehasport Clinic Fundation was the source of funding that have supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; [Anonymous], 2001, J STRENGTH COND RES; [Anonymous], 2004, J STRENGTH COND RES; [Anonymous], 2008, FIZJOTERAPIA; [Anonymous], 2011, BRIT J SPORT MED; Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Barfield William Roy, 2002, J Sports Sci Med, V1, P72; Blackburn JT, 2009, CLIN BIOMECH, V24, P65, DOI 10.1016/j.clinbiomech.2008.10.001; Brechue William F., 2011, IJASS(International Journal of Applied Sports Sciences), V23, P313; Burfeind K, 2012, ISOKINET EXERC SCI, V20, P115, DOI 10.3233/IES-2012-0449; Chorba Rita S, 2010, N Am J Sports Phys Ther, V5, P47; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P62; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P132; Devan MR, 2004, J ATHL TRAINING, V39, P263; EKSTRAND J, 1983, INT J SPORTS MED, V4, P124, DOI 10.1055/s-2008-1026025; Fagenbaum R, 2003, AM J SPORT MED, V31, P233, DOI 10.1177/03635465030310021301; FIFA Communications Division Information Services, 2007, FIFA BIG COUNT 2006; Gatz G, 2009, COMPLETE CONDITIONIN; Giza E, 2005, BRIT J SPORT MED, V39, P212, DOI 10.1136/bjsm.2004.011973; Gribble PA, 2013, J STRENGTH COND RES, V27, P978, DOI 10.1519/JSC.0b013e31825c32a8; Hagglund M, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-75; Harvey D, 1998, BRIT J SPORT MED, V32, P68, DOI 10.1136/bjsm.32.1.68; Hewett TE, 2006, J ORTHOP RES, V24, P416, DOI 10.1002/jor.20056; Hewett TE, 2007, AM J SPORT MED, V35, P659, DOI 10.1177/0363546506295699; Ibrahim A, 2007, J Orthop Surg (Hong Kong), V15, P46; Kiesel K, 2009, SCAND J MED SCI SPOR; Kiesel Kyle, 2007, N Am J Sports Phys Ther, V2, P147; Kuszewski M, 2009, SCAND J MED SCI SPOR, V19, P260, DOI 10.1111/j.1600-0838.2008.00793.x; Kuszewski M., 2008, PROBL HIG EPIDEMIOL, V89, P47; Landry SC, 2007, AM J SPORT MED, V35, P1901, DOI 10.1177/0363546507307400; Lehance C, 2009, SCAND J MED SCI SPOR, V19, P243, DOI 10.1111/j.1600-0838.2008.00780.x; Lephart SM, 2002, CLIN ORTHOP RELAT R, P162; Lesiak Andrzej, 2005, Reumatologia (Warsaw), V43, P63; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; Minick KI, 2010, J STRENGTH COND RES, V24, P479, DOI 10.1519/JSC.0b013e3181c09c04; Nijs J, 2006, MANUAL THER, V11, P69, DOI 10.1016/j.math.2005.04.002; Onate JA, 2012, J STRENGTH COND RES, V26, P408, DOI 10.1519/JSC.0b013e318220e6fa; Pollard CD, 2007, CLIN J SPORT MED, V17, P38, DOI 10.1097/JSM.0b013e3180305de8; Rozzi SL, 1999, AM J SPORT MED, V27, P312, DOI 10.1177/03635465990270030801; Schneiders AG, 2011, INT J SPORTS PHYS TH, V6, P75; Silvers HJ, 2007, BRIT J SPORT MED, V41, pI52, DOI 10.1136/bjsm.2007.037200; Smith CA, 2013, J STRENGTH COND RES, V27, P982, DOI 10.1519/JSC.0b013e3182606df2; Soderman K, 2002, SCAND J MED SCI SPOR, V12, P65, DOI 10.1034/j.1600-0838.2002.120201.x; Soderman K, 2001, KNEE SURG SPORT TR A, V9, P313, DOI 10.1007/s001670100228; Teyhen DS, 2012, J ORTHOP SPORT PHYS, V42, P530, DOI 10.2519/jospt.2012.3838; Tscholl P, 2007, BRIT J SPORT MED, V41, pI8, DOI 10.1136/bjsm.2007.036871; Tyler TF, 2001, AM J SPORT MED, V29, P124, DOI 10.1177/03635465010290020301; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197; Witvrouw E, 2003, AM J SPORT MED, V31, P41, DOI 10.1177/03635465030310011801	49	17	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66871	10.1371/journal.pone.0066871	http://dx.doi.org/10.1371/journal.pone.0066871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825579	gold, Green Published			2022-12-27	WOS:000321223000038
J	Knowles, ED; Lowery, BS; Shulman, EP; Schaumberg, RL				Knowles, Eric D.; Lowery, Brian S.; Shulman, Elizabeth P.; Schaumberg, Rebecca L.			Race, Ideology, and the Tea Party: A Longitudinal Study	PLOS ONE			English	Article							US PRESIDENTIAL-ELECTION; AFFIRMATIVE-ACTION; SYMBOLIC RACISM; POLITICAL ALIENATION; GROUP POSITION; HEALTH-CARE; IN-GROUP; ATTITUDES; PREJUDICE; CONSERVATISM	The Tea Party movement, which rose to prominence in the United States after the election of President Barack Obama, provides an ideal context in which to examine the roles of racial concerns and ideology in politics. A three-wave longitudinal study tracked changes in White Americans' self-identification with the Tea Party, racial concerns (prejudice and racial identification), and ideologies (libertarianism and social conservatism) over nine months. Latent Growth Modeling (LGM) was used to evaluate potential causal relationships between Tea Party identification and these factors. Across time points, racial prejudice was indirectly associated with movement identification through Whites' assertions of national decline. Although initial levels of White identity did not predict change in Tea Party identification, initial levels of Tea Party identification predicted increases in White identity over the study period. Across the three assessments, support for the Tea Party fell among libertarians, but rose among social conservatives. Results are discussed in terms of legitimation theories of prejudice, the "racializing" power of political judgments, and the ideological dynamics of the Tea Party.	[Knowles, Eric D.] NYU, Dept Psychol, New York, NY 10003 USA; [Lowery, Brian S.; Schaumberg, Rebecca L.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Shulman, Elizabeth P.] Univ Penn, Posit Psychol Ctr, Philadelphia, PA 19104 USA; [Shulman, Elizabeth P.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA	New York University; Stanford University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Knowles, ED (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	eric.knowles@nyu.edu		Knowles, Eric/0000-0001-8525-1930	Stanford Graduate School of Business	Stanford Graduate School of Business	This research was funded by research monies allocated to the second author by the Stanford Graduate School of Business. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Baron J, 2001, J CONFLICT RESOLUT, V45, P283, DOI 10.1177/0022002701045003002; BLUMER H, 1958, PAC SOCIOL REV, V1, P3; Bobo L, 1996, AM SOCIOL REV, V61, P951, DOI 10.2307/2096302; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Castano E, 2003, EUR J SOC PSYCHOL, V33, P735, DOI 10.1002/ejsp.175; Cattell R. B., 1988, HDB MULTIVARIATE EXP, V2, P561, DOI DOI 10.1007/978-1-4613-0893-5_17; CITRIN J, 1975, BRIT J POLIT SCI, V5, P1, DOI 10.1017/S0007123400008024; Converse HD, 1964, IDEOLOGY DISCONTENT, P206; Courser Z, 2012, SOCIETY, V49, P43, DOI 10.1007/s12115-011-9501-0; DiMaggio A, 2011, RISE TEA PARTY POLIT; Dovidio JF, 1996, J SOC ISSUES, V52, P51, DOI 10.1111/j.1540-4560.1996.tb01848.x; Federico CM, 2002, J PERS SOC PSYCHOL, V82, P488, DOI 10.1037//0022-3514.82.4.488; Feldman S., 2013, OXFORD HDB POLITICAL, P477; FINIFTER AW, 1970, AM POLIT SCI REV, V64, P389, DOI 10.2307/1953840; Finn C, 2010, ANAL SOC ISS PUB POL, V10, P262, DOI 10.1111/j.1530-2415.2010.01206.x; FrankeRuta G., 2009, WASHINGTON POST; Gaertner SL, 1996, INT J INTERCULT REL, V20, P271, DOI 10.1016/0147-1767(96)00019-3; Green EGT, 2006, LAW HUMAN BEHAV, V30, P435, DOI 10.1007/s10979-006-9020-5; Greenwald AG, 2009, ANAL SOC ISS PUB POL, V9, P241, DOI 10.1111/j.1530-2415.2009.01195.x; GURIN P, 1986, BRIT J SOC PSYCHOL, V25, P139, DOI 10.1111/j.2044-8309.1986.tb00712.x; Hitchens Christopher, 2010, SLATE; Jackman M.R., 1994, VELVET GLOVE; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Jost JT, 2001, PSYCHOLOGY OF LEGITIMACY, P363; KATZ I, 1988, J PERS SOC PSYCHOL, V55, P893, DOI 10.1037/0022-3514.55.6.893; KINDER DR, 1981, J PERS SOC PSYCHOL, V40, P414, DOI 10.1037/0022-3514.40.3.414; Kinder DR, 2000, STUD COMMUN MEDIA, P44; Kirby D, 2010, TEA PARTYS OTHER HAL; KIRBY David, 2012, LIBERTARIAN ROOTS TE; Knowles ED, 2012, SELF IDENTITY, V11, P202, DOI 10.1080/15298868.2010.542015; Knowles ED, 2010, J EXP SOC PSYCHOL, V46, P420, DOI 10.1016/j.jesp.2009.10.011; Knowles ED, 2009, J EXP SOC PSYCHOL, V45, P965, DOI 10.1016/j.jesp.2009.05.005; Knuckey J, 2000, SOC SCI QUART, V81, P1027; Krauthammer Charles, 2010, WASHINGTON POST; Lowery BS, 2006, J PERS SOC PSYCHOL, V90, P961, DOI 10.1037/0022-3514.90.6.961; Lowery BS, 2007, PERS SOC PSYCHOL B, V33, P1237, DOI 10.1177/0146167207303016; Malka A, 2010, SOC JUSTICE RES, V23, P156, DOI 10.1007/s11211-010-0114-3; MCCONAHAY JB, 1981, J CONFLICT RESOLUT, V25, P563, DOI 10.1177/002200278102500401; McConahay JB., 1986, PREJUDICE DISCRIMINA, P91; Mehrabian A, 1996, BASIC APPL SOC PSYCH, V18, P469, DOI 10.1207/s15324834basp1804_7; Murphy Reg, 1971, SO STRATEGY; Muthen L. K., 2008, MPLUS; Neiwert D, 2008, B BENNETT OBAMAS WIN; Olsen ME, 1968, SOC FORCES, V47, P288; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Quraishi Jen, 2010, MOTHER JONES; Raden D, 2003, POLIT PSYCHOL, V24, P803, DOI 10.1046/j.1467-9221.2003.00355.x; Rasmussen Scott, 2010, MAD HELL TEA PARTY M; Rich Frank, 2010, NY TIMES; Sears David., 2000, RACIALIZED POLITICS; Sears DO, 2006, POLIT PSYCHOL, V27, P895, DOI 10.1111/j.1467-9221.2006.00542.x; Sears David O., 1990, SELF INTEREST, P147; Sears DO, 1988, ELIMINATING RACISM P, P53; Sears DO, 1990, J BEHAV EC, V19, P247, DOI DOI 10.1016/0090-5720(90)90030-B; Sherif M., 1966, GROUP CONFLICT COOPE; Sidanius J, 1996, J PERS SOC PSYCHOL, V70, P476, DOI 10.1037/0022-3514.70.3.476; Sidanius J, 2004, J PERS SOC PSYCHOL, V87, P96, DOI 10.1037/0022-3514.87.1.96; SIDANIUS J, 1993, POLIT PSYCHOL, V14, P381, DOI 10.2307/3791704; Sidanius J., 1999, SOCIAL DOMINANCE INT; SNIDERMAN PM, 1986, J SOC ISSUES, V42, P129, DOI 10.1111/j.1540-4560.1986.tb00229.x; SNIDERMAN PM, 1991, AM J POLIT SCI, V35, P423, DOI 10.2307/2111369; SNIDERMAN PM, 1986, J SOC ISSUES, V42, P173, DOI 10.1111/j.1540-4560.1986.tb00231.x; Sniderman PM., 2004, STUDIES PUBLIC OPINI, P337; Tesler M, 2012, AM J POLIT SCI, V56, P690, DOI 10.1111/j.1540-5907.2011.00577.x; VEILLEUX F, 1989, INT J PSYCHOL, V24, P485, DOI 10.1080/00207594.1989.10600060; Williams Jody, 2008, BOSTON GLOBE; Zernike K, 2010, BOILING MAD INSIDE T; Zernike Kate, 2010, NY TIMES	71	20	20	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67110	10.1371/journal.pone.0067110	http://dx.doi.org/10.1371/journal.pone.0067110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175IB	23825630	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000080
J	Krejsa, CM; Holly, RD; Heipel, M; Bannink, KM; Johnson, R; Roque, R; Heffernan, J; Hill, J; Chin, L; Wagener, F; Shiota, F; Henderson, K; Sivakumar, PV; Ren, HP; Barahmand-pour, F; Foster, D; Clegg, C; Kindsvogel, W; Ponce, R; Hughes, SD; Waggie, K				Krejsa, Cecile M.; Holly, Rick D.; Heipel, Mark; Bannink, Ken M.; Johnson, Rebecca; Roque, Richard; Heffernan, Jane; Hill, Julie; Chin, Lay; Wagener, Felecia; Shiota, Faith; Henderson, Katherine; Sivakumar, Pallavur V.; Ren, Hong-Ping; Barahmand-pour, Fariba; Foster, Don; Clegg, Chris; Kindsvogel, Wayne; Ponce, Rafael; Hughes, Steven D.; Waggie, Kim			Interleukin-21 Enhances Rituximab Activity in a Cynomolgus Monkey Model of B Cell Depletion and in Mouse B Cell Lymphoma Models	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; ANTI-CD20 MONOCLONAL-ANTIBODY; COMMON GAMMA-CHAIN; IN-VIVO; IL-21 RECEPTOR; RECOMBINANT INTERLEUKIN-2; MACACA-FASCICULARIS; ANTITUMOR-ACTIVITY; PHASE-I; ACTIVATION	Rituximab, a monoclonal antibody targeting CD20 on B cells, is currently used to treat many subtypes of B cell lymphomas. However, treatment is not curative and response rates are variable. Recombinant interleukin-21 (rIL-21) is a cytokine that enhances immune effector function and affects both primary and transformed B cell differentiation. We hypothesized that the combination of rIL-21 plus rituximab would be a more efficacious treatment for B cell malignancies than rituximab alone. We cultured human and cynomolgus monkey NK cells with rIL-21 and found that their activity was increased and proteins associated with antibody dependent cytotoxicity were up-regulated. Studies in cynomolgus monkeys modeled the effects of rIL-21 on rituximab activity against CD20 B cells. In these studies, rIL-21 activated innate immune effectors, increased ADCC and mobilized B cells into peripheral blood. When rIL-21 was combined with rituximab, deeper and more durable B cell depletion was observed. In another series of experiments, IL-21 was shown to have direct antiproliferative activity against a subset of human lymphoma cell lines, and combination of murine IL-21 with rituximab yielded significant survival benefits over either agent alone in xenogeneic mouse tumor models of disseminated lymphoma. Therefore, our results do suggest that the therapeutic efficacy of rituximab may be improved when used in combination with rIL-21.	[Krejsa, Cecile M.; Bannink, Ken M.; Roque, Richard; Heffernan, Jane; Hill, Julie; Chin, Lay; Wagener, Felecia; Ren, Hong-Ping; Ponce, Rafael; Hughes, Steven D.; Waggie, Kim] ZymoGenetics Inc, Dept Preclin Dev, Seattle, WA USA; [Holly, Rick D.; Heipel, Mark; Johnson, Rebecca; Shiota, Faith; Henderson, Katherine; Sivakumar, Pallavur V.; Barahmand-pour, Fariba; Foster, Don; Clegg, Chris; Kindsvogel, Wayne] ZymoGenetics Inc, Dept Res, Seattle, WA USA	Zymogenet Inc.; Zymogenet Inc.	Waggie, K (corresponding author), ZymoGenetics Inc, Dept Preclin Dev, Seattle, WA USA.	Kim.Waggie@bms.com			ZymoGenetics, Inc.	ZymoGenetics, Inc.	The authors have read the journal's policy and have the following conflicts: at the time this research was conducted all the authors were employees of ZymoGenetics, Inc., the commercial funder of the research. However, this does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Andorsky DJ, 2008, EXPERT OPIN BIOL TH, V8, P1295, DOI [10.1517/14712598.8.9.1295, 10.1517/14712598.8.9.1295 ]; Ansell SM, 2006, CLIN CANCER RES, V12, P6056, DOI 10.1158/1078-0432.CCR-06-1245; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Boye J, 2003, ANN ONCOL, V14, P520, DOI 10.1093/annonc/mdg175; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; de Menezes DEL, 2007, J IMMUNOTHER, V30, P64, DOI 10.1097/01.cji.0000211315.21116.07; de Totero D, 2006, BLOOD, V107, P3708, DOI 10.1182/blood-2005-09-3535; Eskelund CW, 2011, LEUKEMIA RES, V35, P914, DOI 10.1016/j.leukres.2011.02.006; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; FRASER CC, 1995, BLOOD, V86, P183, DOI 10.1182/blood.V86.1.183.bloodjournal861183; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Hamaguchi Y, 2005, J IMMUNOL, V174, P4389, DOI 10.4049/jimmunol.174.7.4389; Hashmi MH, 2010, EXPERT OPIN BIOL TH, V10, P807, DOI 10.1517/14712598.2010.480971; Hernandez-Ilizaliturri FJ, 2003, CLIN CANCER RES, V9, P5866; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Jungel A, 2004, ARTHRITIS RHEUM, V50, P1468, DOI 10.1002/art.20218; Khan KD, 2006, CLIN CANCER RES, V12, P7046, DOI 10.1158/1078-0432.CCR-06-1571; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Manches O, 2003, BLOOD, V101, P949, DOI 10.1182/blood-2002-02-0469; McEarchern JA, 2007, BLOOD, V109, P1185, DOI 10.1182/blood-2006-07-034017; Mordue DG, 2003, J LEUKOCYTE BIOL, V74, P1015, DOI 10.1189/jlb.0403164; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pelletier M, 2004, J IMMUNOL, V173, P7521, DOI 10.4049/jimmunol.173.12.7521; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Rastetter W, 2004, ANNU REV MED, V55, P477, DOI 10.1146/annurev.med.55.091902.104249; REFF ME, 1994, BLOOD, V83, P435; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Sarosiek KA, 2010, BLOOD, V115, P570, DOI 10.1182/blood-2009-08-239996; Shan D, 1998, BLOOD, V91, P1644, DOI 10.1182/blood.V91.5.1644.1644_1644_1652; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Sondergaard H, 2007, CANCER IMMUNOL IMMUN, V56, P1417, DOI 10.1007/s00262-007-0285-4; Strengell M, 2006, J LEUKOCYTE BIOL, V79, P1279, DOI 10.1189/jlb.0905503; Tedder TF, 2006, SPRINGER SEMIN IMMUN, V28, P351, DOI 10.1007/s00281-006-0057-9; Timmerman JM, 2012, CLIN CANCER RES, V18, P5752, DOI 10.1158/1078-0432.CCR-12-0456; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Vugmeyster Y, 2004, CYTOM PART A, V61A, P69, DOI 10.1002/cyto.a.20039; Vugmeyster Y, 2003, INT IMMUNOPHARMACOL, V3, P1477, DOI 10.1016/S1567-5769(03)00147-4; Vugmeyster Y, 2003, CYTOM PART A, V52A, P101, DOI 10.1002/cyto.a.10030; Waggie KS, 2012, INT J TOXICOL, V31, P303, DOI 10.1177/1091581812449661; Wang G, 2003, CANCER RES, V63, P9016	41	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67256	10.1371/journal.pone.0067256	http://dx.doi.org/10.1371/journal.pone.0067256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825648	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000093
J	Lekva, T; Berg, JP; Heck, A; Fougner, SL; Olstad, OK; Ringstad, G; Bollerslev, J; Ueland, T				Lekva, Tove; Berg, Jens Petter; Heck, Ansgar; Fougner, Stine Lyngvi; Olstad, Ole Kristoffer; Ringstad, Geir; Bollerslev, Jens; Ueland, Thor			Attenuated RORC Expression in the Presence of EMT Progression in Somatotroph Adenomas following Treatment with Somatostatin Analogs Is Associated with Poor Clinical Recovery	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IN-VIVO; CANCER-THERAPY; STEM-CELLS; RECEPTOR; DOWNSTREAM; INHIBITOR; REGULATOR; MIGRATION; PATHWAYS	Somatostatin analogs (SA) have been established as the first line medical treatment for acromegaly, but following long-term treatment, SA normalizes GH and IGF-I levels in only 40-60% of patients. The epithelial marker E-cadherin plays a crucial role in the epithelial mesenchymal transition (EMT) and is associated with a poor response to SA treatment. We hypothesized that the characterization of transcripts regulated by SA in somatotroph adenomas with high and low E-cadherin expression may identify signaling pathways and mediators that can explain the poor response to SA treatment. We performed a microarray analysis of sixteen adenomas with different levels of E-cadherin and SA treatment to identify regulated transcripts. Candidate transcripts were further explored in vivo in sixty-five adenomas, and interactions between SA treatment and EMT progression on mRNA expression profiles and associations with clinical recovery were assessed. Finally, the effects of SA treatment on adenoma cells in vitro from acromegalic patients were determined. Microarray analysis of selected adenomas with differential E-cadherin expression, as a marker of EMT progression, identified 172 genes that displayed differential expression that was dependent on SA treatment. The validation of selected candidates in the entire cohort identified 9 transcripts that showed an interaction between E-cadherin expression and SA treatment. Further analysis of the impact of these genes suggests that attenuated RORC expression in somatotroph adenomas is associated with increased tumor size and a blunted clinical response. Our study indicates that attenuated RORC may be involved in the poor clinical response to SA treatment in patients with acromegaly.	[Lekva, Tove; Heck, Ansgar; Bollerslev, Jens] Oslo Univ Hosp, Dept Endocrinol, Sect Specialized Endocrinol, Oslo, Norway; [Lekva, Tove; Ueland, Thor] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Lekva, Tove; Heck, Ansgar; Bollerslev, Jens; Ueland, Thor] Univ Oslo, Fac Med, Oslo, Norway; [Berg, Jens Petter] Oslo Univ Hosp, Inst Clin Med, Oslo, Norway; [Berg, Jens Petter; Olstad, Ole Kristoffer] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Fougner, Stine Lyngvi] Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [Ringstad, Geir] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo	Lekva, T (corresponding author), Oslo Univ Hosp, Dept Endocrinol, Sect Specialized Endocrinol, Oslo, Norway.	tove.lekva@medisin.uio.no	Heck, Ansgar/E-6757-2018; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Berg, Jens P/G-1455-2012	Heck, Ansgar/0000-0002-3443-884X; Berg, Jens P/0000-0003-0157-5888; Ringstad, Geir/0000-0003-0919-4510; Lekva, Tove/0000-0002-7962-4726				Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; Casarini APM, 2009, PITUITARY, V12, P297, DOI 10.1007/s11102-009-0175-1; Chen YK, 2012, J NEUROSCI, V32, P1043, DOI 10.1523/JNEUROSCI.4405-11.2012; Delassus GS, 2010, J CELL PHYSIOL, V224, P549, DOI 10.1002/jcp.22157; Feng QT, 2010, MOL CELL BIOL, V30, P3711, DOI 10.1128/MCB.00420-10; Fougner SL, 2008, CLIN ENDOCRINOL, V68, P458, DOI 10.1111/j.1365-2265.2007.03065.x; Fougner SL, 2012, CLIN ENDOCRINOL, V76, P96, DOI 10.1111/j.1365-2265.2011.04163.x; Fougner SL, 2010, J CLIN ENDOCR METAB, V95, P2334, DOI 10.1210/jc.2009-2197; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Heck A, 2012, CLIN ENDOCRINOL, V77, P72, DOI 10.1111/j.1365-2265.2011.04286.x; Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200; Himes AD, 2011, MOL ENDOCRINOL, V25, P482, DOI 10.1210/me.2010-0313; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hofland LJ, 2004, J CLIN ENDOCR METAB, V89, P1577, DOI 10.1210/jc.2003-031344; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; Jang C, 2011, FASEB J, V25, P4174, DOI 10.1096/fj.11-185926; Jetten AM, 2009, NUCL RECEPT SIGNAL, V7, pe003; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; Jung YS, 2012, PLOS ONE, V7; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Lekva T, 2012, J CLIN ENDOCR METAB, V97, pE1506, DOI 10.1210/jc.2012-1760; Li WQ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-86; McAlhany SJ, 2004, PROSTATE, V61, P182, DOI 10.1002/pros.20085; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Petrucci C, 2000, BRIT J PHARMACOL, V129, P471, DOI 10.1038/sj.bjp.0703075; Saveanu A, 2001, J CLIN ENDOCR METAB, V86, P140, DOI 10.1210/jc.86.1.140; Sherlock M, 2011, NAT REV ENDOCRINOL, V7, P291, DOI 10.1038/nrendo.2011.42; Sours-Brothers S, 2009, FRONT BIOSCI-LANDMRK, V14, P1851, DOI 10.2741/3346; Sun HY, 2011, EXP BIOL MED, V236, P352, DOI 10.1258/ebm.2010.010106; Taboada GF, 2008, EUR J ENDOCRINOL, V158, P295, DOI 10.1530/EJE-07-0562; Takeda Y, 2012, NUCLEIC ACIDS RES, V40, P8519, DOI 10.1093/nar/gks630; Takeda Y, 2011, NUCLEIC ACIDS RES, V39, P4769, DOI 10.1093/nar/gkq1335; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Xiao L, 2012, FREE RADICAL RES, V46, P174, DOI 10.3109/10715762.2011.647688; Yakovlev S, 2012, BLOOD, V119, P637, DOI 10.1182/blood-2011-09-382580	36	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66927	10.1371/journal.pone.0066927	http://dx.doi.org/10.1371/journal.pone.0066927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825587	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000044
J	Liang, L; Shen, YY; Pan, XW; Zhou, TC; Yang, C; Irwin, DM; Zhang, YP				Liang, Lu; Shen, Yong-Yi; Pan, Xiao-Wei; Zhou, Tai-Cheng; Yang, Chao; Irwin, David M.; Zhang, Ya-Ping			Adaptive Evolution of the Hox Gene Family for Development in Bats and Dolphins	PLOS ONE			English	Article							TAILED FRUIT BAT; BROWN BAT; HOMEOBOX GENES; EXPRESSION; FLIGHT; ORIGIN; SELECTION; MUSCLE; PHYLOGENETICS; PLASTICITY	Bats and cetaceans (i.e., whales, dolphins, porpoises) are two kinds of mammals with unique locomotive styles and occupy novel niches. Bats are the only mammals capable of sustained flight in the sky, while cetaceans have returned to the aquatic environment and are specialized for swimming. Associated with these novel adaptations to their environment, various development changes have occurred to their body plans and associated structures. Given the importance of Hox genes in many aspects of embryonic development, we conducted an analysis of the coding regions of all Hox gene family members from bats (represented by Pteropus vampyrus, Pteropus alecto, Myotis lucifugus and Myotis davidii) and cetaceans (represented by Tursiops truncatus) for adaptive evolution using the available draft genome sequences. Differences in the selective pressures acting on many Hox genes in bats and cetaceans were found compared to other mammals. Positive selection, however, was not found to act on any of the Hox genes in the common ancestor of bats and only upon Hoxb9 in cetaceans. PCR amplification data from additional bat and cetacean species, and application of the branch-site test 2, showed that the Hoxb2 gene within bats had significant evidence of positive selection. Thus, our study, with genomic and newly sequenced Hox genes, identifies two candidate Hox genes that may be closely linked with developmental changes in bats and cetaceans, such as those associated with the pancreatic, neuronal, thymus shape and forelimb. In addition, the difference in our results from the genome-wide scan and newly sequenced data reveals that great care must be taken in interpreting results from draft genome data from a limited number of species, and deep genetic sampling of a particular clade is a powerful tool for generating complementary data to address this limitation.	[Liang, Lu; Shen, Yong-Yi; Irwin, David M.; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Shen, Yong-Yi] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Liang, Lu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Pan, Xiao-Wei; Zhou, Tai-Cheng; Yang, Chao; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Xiamen University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University; University of Toronto; University of Toronto	Shen, YY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	shenyy@xmu.edu.cn; zhangyp@mail.kiz.ac.cn	Shen, Yongyi/GWU-8031-2022	Irwin, David/0000-0001-6131-4933	National Basic Research Program of China (973 Program) [2007CB411600]; National Natural Science Foundation of China [30621092, 31172080]; Key Program of West Light Foundation of the Chinese Academy of Sciences [Y102281081]; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of West Light Foundation of the Chinese Academy of Sciences; Bureau of Science and Technology of Yunnan Province	This work was supported by the National Basic Research Program of China to Y-PZ (973 Program, 2007CB411600), National Natural Science Foundation of China (30621092 and 31172080), Key Program of West Light Foundation of the Chinese Academy of Sciences to YYS (Y102281081), and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R. A., 2000, ONTOGENY FUNCTIONAL; ADAMS RA, 1992, J MAMMAL, V73, P160, DOI 10.2307/1381878; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BERTA A, 2006, MARINE MAMMALS EVOLU; BRIGHAM RM, 1990, J COMP PHYSIOL B, V160, P183, DOI 10.1007/BF00300951; Chen CH, 2005, EVOL DEV, V7, P130, DOI 10.1111/j.1525-142X.2005.05015.x; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Chew KY, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-2; Cooper LN, 2007, ANAT REC, V290, P654, DOI 10.1002/ar.20532; Cretekos CJ, 2007, INT J DEV BIOL, V51, P333, DOI 10.1387/ijdb.062257cc; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davenne M, 1999, NEURON, V22, P677, DOI 10.1016/S0896-6273(00)80728-X; DeLynn R, 2011, J WILDLIFE DIS, V47, P979, DOI 10.7589/0090-3558-47.4.979; Di Bonito M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003249; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; FORDYCE RE, 1994, ANNU REV EARTH PL SC, V22, P419, DOI 10.1146/annurev.ea.22.050194.002223; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Hockman D, 2008, P NATL ACAD SCI USA, V105, P16982, DOI 10.1073/pnas.0805308105; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; JONES FS, 1993, P NATL ACAD SCI USA, V90, P6557, DOI 10.1073/pnas.90.14.6557; Kanwisher J, 1966, THERMAL REGULATION C; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kunz TH, 2003, BAT ECOLOGY, P3; MAINA JN, 1984, J EXP BIOL, V111, P43; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; POWERS LV, 1991, J COMP PHYSIOL A, V168, P675; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHUTT WA, 1994, J MORPHOL, V220, P295, DOI 10.1002/jmor.1052200308; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; Taghon T, 2002, BLOOD, V99, P1197, DOI 10.1182/blood.V99.4.1197; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; THEWISSEN JGM, 1992, BIOSCIENCE, V42, P340, DOI 10.2307/1311780; Thim VV, 2005, HUM MUTAT, V25, P384, DOI 10.1002/humu.20155; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vaughan T. A., 2010, MAMMALOGY; Wang Z, 2009, MOL BIOL EVOL, V26, P613, DOI 10.1093/molbev/msn282; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Wyngaarden LA, 2008, DEV BIOL, V313, P225, DOI 10.1016/j.ydbio.2007.10.039; Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yueh YG, 1998, P NATL ACAD SCI USA, V95, P9956, DOI 10.1073/pnas.95.17.9956; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	60	15	18	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e65944	10.1371/journal.pone.0065944	http://dx.doi.org/10.1371/journal.pone.0065944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825528	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000007
J	McCormick, SA; Causer, J; Holmes, PS				McCormick, Sheree A.; Causer, Joe; Holmes, Paul S.			Active Vision during Action Execution, Observation and Imagery: Evidence for Shared Motor Representations	PLOS ONE			English	Article							MENTAL-IMAGERY; EYE-MOVEMENTS; FITTSS LAW; PERFORMANCE; PERCEPTION; MIRROR; BRAIN; TASK; COORDINATION; MECHANISMS	The concept of shared motor representations between action execution and various covert conditions has been demonstrated through a number of psychophysiological modalities over the past two decades. Rarely, however, have researchers considered the congruence of physical, imaginary and observed movement markers in a single paradigm and never in a design where eye movement metrics are the markers. In this study, participants were required to perform a forward reach and point Fitts' Task on a digitizing tablet whilst wearing an eye movement system. Gaze metrics were used to compare behaviour congruence between action execution, action observation, and guided and unguided movement imagery conditions. The data showed that participants attended the same task-related visual cues between conditions but the strategy was different. Specifically, the number of fixations was significantly different between action execution and all covert conditions. In addition, fixation duration was congruent between action execution and action observation only, and both conditions displayed an indirect Fitts' Law effect. We therefore extend the understanding of the common motor representation by demonstrating, for the first time, common spatial eye movement metrics across simulation conditions and some specific temporal congruence for action execution and action observation. Our findings suggest that action observation may be an effective technique in supporting motor processes. The use of video as an adjunct to physical techniques may be beneficial in supporting motor planning in both performance and clinical rehabilitation environments.	[McCormick, Sheree A.; Holmes, Paul S.] Manchester Metropolitan Univ, Inst Performance Res, Crewe, England; [Causer, Joe] Liverpool John Moores Univ, Brain & Behav Lab, Liverpool L3 5UX, Merseyside, England	Manchester Metropolitan University; Liverpool John Moores University	Holmes, PS (corresponding author), Manchester Metropolitan Univ, Inst Performance Res, Crewe, England.	p.s.holmes@mmu.ac.uk	McCormick, Sheree/AAW-6493-2021; McCormick, Sheree/GWR-5720-2022; Causer, Joe/M-1502-2019	Causer, Joe/0000-0002-8939-8769; Holmes, Paul/0000-0003-0821-3580				ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Bandura A., 1962, NEBRASKA S MOTIVATIO; Borst G, 2008, MEM COGNITION, V36, P849, DOI 10.3758/MC.36.4.849; Caeyenberghs K, 2009, DEVELOPMENTAL SCI, V12, P474, DOI 10.1111/j.1467-7687.2008.00803.x; Calmels C, 2006, J MOTOR BEHAV, V38, P339, DOI 10.3200/JMBR.38.5.339-348; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; DROR IE, 1994, PSYCHOL AGING, V9, P90, DOI 10.1037/0882-7974.9.1.90; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gesierich B, 2008, ACTA PSYCHOL, V128, P324, DOI 10.1016/j.actpsy.2008.03.006; Gregg M, 2010, EVID-BASED COMPL ALT, V7, P249, DOI 10.1093/ecam/nem170; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Gueugneau N, 2008, BRAIN RES, V1187, P95, DOI 10.1016/j.brainres.2007.10.042; HEBB DO, 1968, PSYCHOL REV, V75, P466, DOI 10.1037/h0026771; Heremans E, 2011, NEUROSCIENCE, V195, P37, DOI 10.1016/j.neuroscience.2011.07.030; Heremans E, 2008, BEHAV BRAIN RES, V187, P351, DOI 10.1016/j.bbr.2007.09.028; Heremans E, 2009, BRAIN RES, V1278, P50, DOI 10.1016/j.brainres.2009.04.041; Holmes P, 2008, J MOTOR BEHAV, V40, P433, DOI 10.3200/JMBR.40.5.433-445; JEANNEROD M, 1986, NEUROPSYCHOLOGIA, V24, P41, DOI 10.1016/0028-3932(86)90042-4; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; KOSSLYN SM, 1975, COGNITIVE PSYCHOL, V7, P341, DOI 10.1016/0010-0285(75)90015-8; Kourtis D, 2012, PSYCHOL RES-PSYCH FO, V76, P514, DOI 10.1007/s00426-012-0418-z; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; LANG PJ, 1979, PSYCHOPHYSIOLOGY, V16, P495, DOI 10.1111/j.1469-8986.1979.tb01511.x; Lankford C, 2000, P EYE TRACK RES APPL, P57; Lotze M, 2010, NEUROPHYSIOLOGICAL F, P31, DOI [10.1093/acprof:oso/9780199546251.003.0003, DOI 10.1093/ACPROF:OSO/9780199546251.003.0003]; Macuga KL, 2011, NEUROIMAGE, P2798, DOI DOI 10.1016/J.NEUROIMAGE.2011.09.083; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Maruff P, 1999, NEUROPSYCHOLOGIA, V37, P379, DOI 10.1016/S0028-3932(98)00064-5; McCormick SA, 2012, BRAIN COGNITION, V80, P83, DOI 10.1016/j.bandc.2012.04.010; Mottet D, 2001, J EXP PSYCHOL HUMAN, V27, P1275, DOI 10.1037//0096-1523.27.6.1275; Mulder T, 2005, EXP BRAIN RES, V163, P344, DOI 10.1007/s00221-004-2179-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; PYLYSHYN ZW, 1973, PSYCHOL BULL, V80, P1, DOI 10.1037/h0034650; Ram N, 2007, J SPORT SCI, V25, P587, DOI 10.1080/02640410600947132; Richardson DC, 2000, COGNITION, V76, P269, DOI 10.1016/S0010-0277(00)00084-6; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roure R, 1999, PHYSIOL BEHAV, V66, P63, DOI 10.1016/S0031-9384(99)00026-8; Ryan JD, 2009, VIS COGN, V17, P254, DOI 10.1080/13506280802336362; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Vickers J.N., 2007, HUMAN KINETICS; Viviani P, 1990, Rev Oculomot Res, V4, P353; Williams AM, 2002, J MOTOR BEHAV, V34, P197, DOI 10.1080/00222890209601941	53	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67761	10.1371/journal.pone.0067761	http://dx.doi.org/10.1371/journal.pone.0067761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175IB	23825683	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000117
J	Orlicky, DJ; Monks, J; Stefanski, AL; McManaman, JL				Orlicky, David J.; Monks, Jenifer; Stefanski, Adrianne L.; McManaman, James L.			Dynamics and Molecular Determinants of Cytoplasmic Lipid Droplet Clustering and Dispersion	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; PROTEIN-KINASE; PERILIPIN-A; ANCHORING PROTEIN; STIMULATED LIPOLYSIS; ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; GAMMA-TUBULIN; MICROTUBULE; ADIPOCYTES	Perilipin-1 (Plin1), a prominent cytoplasmic lipid droplet (CLD) binding phosphoprotein and key physiological regulator of triglyceride storage and lipolysis in adipocytes, is thought to regulate the fragmentation and dispersion of CLD that occurs in response to beta-adrenergic activation of adenylate cyclase. Here we investigate the dynamics and molecular determinants of these processes using cell lines stably expressing recombinant forms of Plin1 and/or other members of the perilipin family. Plin1 and a C-terminal CLD-binding fragment of Plin1 (Plin1CT) induced formation of single dense CLD clusters near the microtubule organizing center, whereas neither an N-terminal CLD-binding fragment of Plin1, nor Plin2 or Plin3 induced clustering. Clustered CLD coated by Plin1, or Plin1CT, dispersed in response to isoproterenol, or other agents that activate adenylate cyclase, in a process inhibited by the protein kinase A inhibitor, H89, and blocked by microtubule disruption. Isoproterenol-stimulated phosphorylation of CLD-associated Plin1 on serine 492 preceded their dispersion, and live cell imaging showed that cluster dispersion involved initial fragmentation of tight clusters into multiple smaller clusters, which then fragmented into well-dispersed individual CLD. siRNA knockdown of the cortical actin binding protein, moesin, induced disaggregation of tight clusters into multiple smaller clusters, and inhibited the reaggregation of dispersed CLD into tight clusters. Together these data suggest that the clustering and dispersion processes involve a complex orchestration of phosphorylation-dependent, microtubule-dependent and independent, and microfilament dependent steps.	[Orlicky, David J.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Monks, Jenifer; Stefanski, Adrianne L.; McManaman, James L.] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Div Basic Reprod Sci, Aurora, CO USA; [Stefanski, Adrianne L.; McManaman, James L.] Univ Colorado, Sch Med, Grad Program Reprod Sci, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McManaman, JL (corresponding author), Univ Colorado, Sch Med, Dept Obstet & Gynecol, Div Basic Reprod Sci, Aurora, CO USA.	jim.mcmanaman@ucdenver.edu	Monks, Jenifer/GLS-6662-2022	Monks, Jenifer/0000-0002-7990-3389	National Institutes of Health [RO1-HD045962, PO1-HD38129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045965, P01HD038129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Institutes of Health grants RO1-HD045962 and PO1-HD38129 to JLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Bartz R, 2007, MOL BIOL CELL, V18, P3015, DOI 10.1091/mbc.E06-09-0869; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Diviani D, 2001, J CELL SCI, V114, P1431; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2004, AM J PHYSIOL-ENDOC M, V287, pE574, DOI 10.1152/ajpendo.00567.2003; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; Greenwald EC, 2011, J CARDIOVASC PHARM, V58, P462, DOI 10.1097/FJC.0b013e31822001e3; Gross DN, 2006, MOL ENDOCRINOL, V20, P459, DOI 10.1210/me.2005-0323; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Haedicke J, 2008, J VIROL, V82, P4665, DOI 10.1128/JVI.02403-07; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V171, P189, DOI 10.1016/0006-291X(90)91375-3; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Jiang K, 2011, CURR OPIN CELL BIOL, V23, P94, DOI 10.1016/j.ceb.2010.08.008; LI QQ, 1995, J CELL BIOL, V131, P207, DOI 10.1083/jcb.131.1.207; Manneville JB, 2003, J CELL SCI, V116, P3927, DOI 10.1242/jcs.00672; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Orlicky DJ, 2008, J CELL SCI, V121, P2921, DOI 10.1242/jcs.026153; Orlicky DJ, 2011, ALCOHOL CLIN EXP RES, V35, P1020, DOI 10.1111/j.1530-0277.2011.01434.x; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P49, DOI 10.1161/01.ATV.0000191639.08082.04; Semenova I, 2009, TRAFFIC, V10, P153, DOI 10.1111/j.1600-0854.2008.00852.x; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200	48	24	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66837	10.1371/journal.pone.0066837	http://dx.doi.org/10.1371/journal.pone.0066837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825572	gold, Green Submitted, Green Published			2022-12-27	WOS:000321223000033
J	Underwood, JG; Silbernagle, M; Nishimoto, M; Uyehara, K				Underwood, Jared G.; Silbernagle, Mike; Nishimoto, Mike; Uyehara, Kim			Managing Conservation Reliant Species: Hawai'i's Endangered Endemic Waterbirds	PLOS ONE			English	Article								Hawai'I's coastal plain wetlands are inhabited by five endangered endemic waterbird species. These include the Hawaiian Coot ('alae ke'oke'o), Hawaiian Duck (koloa maoli), Hawaiian Stilt (ae'o), Hawaiian Gallinule (Moorhen) ('alae 'ula), and Hawaiian Goose (nene). All five species are categorized as being "conservation reliant." The current strategy to recover these endangered birds includes land protection and active management of wetlands. To assess the effectiveness of the current management paradigm, we compared species population trends across the state to those on six actively managed wetland national wildlife refuges (Refuges) thought to be critical for the survival of these endangered species. To perform the evaluation we relied on systematic semiannual population counts that have been conducted across most wetlands in the state and monthly population counts that have occurred on Refuges during the same time period. We found that statewide and Refuge populations of the Hawaiian Coot, Stilt and Gallinule have rebounded from historic lows and over the last 20 years have slowly increased or remained stable. We also documented that Refuges are important to each species year-round and that a disproportionately larger percentage of the population for each species is found on them. Understanding of why Refuges successfully house a disproportionate percentage of these "conservation reliant" species can inform current and future conservation efforts as well as ensure long-term population viability for these species.	[Underwood, Jared G.] US Fish & Wildlife Serv, Honolulu, HI USA; [Silbernagle, Mike] US Fish & Wildlife Serv, Haleiwa, HI USA; [Nishimoto, Mike] US Fish & Wildlife Serv, Kihei, HI USA; [Uyehara, Kim] US Fish & Wildlife Serv, Kilauea, HI USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Underwood, JG (corresponding author), US Fish & Wildlife Serv, Pacific Reefs Natl Wildlife Refuge Complex, Honolulu, HI USA.	Jared_Underwood@fws.gov		Underwood, Jared/0000-0002-8608-190X				[Anonymous], 2010, R LANG ENV STAT COMP; CHANG PR, 1990, THESIS U MASSACHUSET; Clough JS, 2010, APPL SEA LEVEL AFFEC; DesRochers DW, 2008, J FIELD ORNITHOL, V79, P448, DOI 10.1111/j.1557-9263.2008.00190.x; Ducks Unlimited Inc., 2001, CONS PLAN HAW STILT; ENGILIS A, 1993, WILSON BULL, V105, P142; Hatch G, 1950, ELEPAIO, V10, P45; Hawai'i Audubon Society, 2005, ELEPAIO, V65, P41; Hawai'i Division of Forestry and Wildlife, 1980, SEM HAW WAT SURV DAT; Hawai'i Division of Forestry and Wildlife (DOFAW), 2005, HAW WAT SURV INSTR I; Intergovernmental Panel on Climate Cahnge, 2007, CONTRIBUTION WORKING; Kaigler C. G., 1970, Elepaio, V30, P70; North American Bird Conservation Initiative (NBCI) U.S. Committee, 2011, STAT BIRDS 2011 REP; Pannekoek J., 2001, TRIM 3 0 WINDOWS TRE; Pannekoek J, 2006, TRIM 3 53 MANUAL TRE; Peterson HD, 1951, ELEPAIO, V11, P42; Reed JM, 2012, BIOSCIENCE, V62, P881, DOI 10.1525/bio.2012.62.10.8; Reed JM, 2011, POPUL ECOL, V53, P473, DOI 10.1007/s10144-011-0262-9; Reed JM, 1998, AUK, V115, P791, DOI 10.2307/4089431; REED JM, 2007, ANAL ECOLOGICAL DATA, P615; Robinson J., 1999, BIRDS N AM ONLINE; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Scott JM, 2005, FRONT ECOL ENVIRON, V3, P383, DOI 10.1890/1540-9295(2005)003[0383:ROISUT]2.0.CO;2; Shallenberger RJ, 1989, FRESHWATER WETLANDS, P1165; State of Hawai'i, 1996, HAW COAST NONP POL 2; U.S. Fish and Wildlife Service (USFWS), 2004, REV REC PLA IN PRESS; USFWS, 2011, REC PLAN HAW WAT 2 R; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106	28	21	21	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67872	10.1371/journal.pone.0067872	http://dx.doi.org/10.1371/journal.pone.0067872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825687	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000121
J	Huang, CJ; Yang, SH; Lee, CL; Cheng, YC; Tai, SY; Chien, CC				Huang, Chi-Jung; Yang, Shung-Haur; Lee, Chia-Long; Cheng, Yu-Che; Tai, Szu-Yun; Chien, Chih-Cheng			Ribosomal Protein S27-Like in Colorectal Cancer: A Candidate for Predicting Prognoses	PLOS ONE			English	Article							DNA-REPAIR; STAGE-II; P53; REPLICATION; TRANSLATION; ACTIVATION; EXPRESSION; RESISTANCE; MUTATIONS; SURVIVAL	Background: The development and progression of colorectal cancer (CRC) involve a complex process of multiple genetic changes. Tumor suppressor p53 is capable of determining the fate of CRC cells. However, the role of a p53-inducible modulator, ribosomal protein S27-like (RPS27L), in CRC is unknown. Methods: Here, the differential expression of RPS27L was examined in the feces and colonic tissues of CRC patients, to explore its possible correlation with patient survival and to investigate the cellular mechanisms underlying their clinical outcomes. Eighty intermediate-stage CRC patients (42 at stage II and 38 at stage III) were divided into two groups according to their fecal RPS27L mRNA levels. The survival probabilities of the groups were estimated using the Kaplan-Meier method. The RPS27L protein in the colonic tissues of stage III patients with different prognoses was further examined immunohistochemically. RPS27L expression in LoVo cells was manipulated to examine the possible cellular responses in vitro. Results: Elevated RPS27L expression, in either feces or tissues, was related to a better prognosis. In vitro, RPS27L-expressing LoVo cells ceased DNA synthesis and apoptotic activity while the expression of their DNA repair molecules was upregulated. Conclusions: Elevated RPS27L may improve the prognoses of certain CRC patients by enhancing the DNA repair capacity of their colonic cells, and can be determined in feces. By integrating clinical, molecular, and cellular data, our study demonstrates that fecal RPS27L may be a useful index for predicting prognoses and guiding personalized therapeutic strategies, especially in patients with intermediate-stage CRC.	[Huang, Chi-Jung; Cheng, Yu-Che; Tai, Szu-Yun; Chien, Chih-Cheng] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan; [Huang, Chi-Jung; Chien, Chih-Cheng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Huang, Chi-Jung] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Yang, Shung-Haur] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Yang, Shung-Haur] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lee, Chia-Long] Hsinchu Cathay Gen Hosp, Dept Internal Med, Hsinchu, Taiwan; [Lee, Chia-Long] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Chien, Chih-Cheng] Sijhih Cathay Gen Hosp, Dept Anesthesiol, New Taipei, Taiwan	Cathay General Hospital; Fu Jen Catholic University; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Cathay General Hospital; Taipei Medical University; Cathay General Hospital	Chien, CC (corresponding author), Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan.	chiencmail@yahoo.com.tw		Cheng, Yu-Che/0000-0002-5346-3610; Chien, Chih-Cheng/0000-0002-8368-2005	National Science Council [NSC96-2320-B-281-001-MY3, NSC100-2320-B-281-001]; Cathay General Hospital [CGH-MR-9919]; National Research Program for Genomic Medicine Grants of NSC [NSC 97-3112-B-001-016]	National Science Council(Ministry of Science and Technology, Taiwan); Cathay General Hospital; National Research Program for Genomic Medicine Grants of NSC	This work was supported by NSC96-2320-B-281-001-MY3 and NSC100-2320-B-281-001 from the National Science Council, and CGH-MR-9919 from Cathay General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Drs. Jen-Kou Lin and Shih-Ching Chang (both from Department of Surgery, Taipei-Veterans General Hospital) who informed us the clinical data of some patients and Dr. Yih-Yiing Wu for his superior support in pathology. We also thank National RNAi Core Facility at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica to provide RNAi reagents which were supported by the National Research Program for Genomic Medicine Grants of NSC (NSC 97-3112-B-001-016).	BAKER SJ, 1990, CANCER RES, V50, P7717; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Chen D, 2008, J BIOL CHEM, V283, P15381, DOI 10.1074/jbc.M710296200; Chen F, 2010, BIOCHEM PHARMACOL, V80, P724, DOI 10.1016/j.bcp.2010.04.031; Chien CC, 2007, TRANSL RES, V149, P96, DOI 10.1016/j.trsl.2006.09.006; Chun Patrick, 2009, Gastrointest Cancer Res, V3, P191; Deming DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060709; Diaz-Perales A, 2005, J BIOL CHEM, V280, P30367, DOI 10.1074/jbc.M504533200; Farina-Sarasqueta A, 2010, ANN ONCOL, V21, P2396, DOI 10.1093/annonc/mdq258; Fernandez-Pol JA, 2011, CANCER GENOM PROTEOM, V8, P105; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Hansen LT, 2003, INT J CANCER, V105, P472, DOI 10.1002/ijc.11106; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Huang CJ, 2008, J CELL MOL MED, V12, P1936, DOI 10.1111/j.1582-4934.2008.00253.x; Iacopetta B, 2003, HUM MUTAT, V21, P271, DOI 10.1002/humu.10175; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jass Jeremy R., 2006, Critical Reviews in Oncogenesis, V12, P273; Kapoor NR, 2013, FEBS LETT, V587, P1287, DOI 10.1016/j.febslet.2013.03.004; Katoh H, 2008, ANTICANCER RES, V28, P1933; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kosmider S, 2007, WORLD J GASTROENTERO, V13, P3799; Li J, 2007, CANCER RES, V67, P11317, DOI 10.1158/0008-5472.CAN-07-1088; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Pan J, 2011, TUMOR BIOL, V32, P729, DOI 10.1007/s13277-011-0174-5; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Rousseau B, 2010, CANCER J, V16, P202, DOI 10.1097/PPO.0b013e3181ddc5bf; Svobodova S, 2011, ANTICANCER RES, V31, P373; Takahashi M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198804; Tell G, 2010, CELL MOL LIFE SCI, V67, P3569, DOI 10.1007/s00018-010-0484-6; Thomas EA, 2000, J NEUROCHEM, V74, P2259, DOI 10.1046/j.1471-4159.2000.0742259.x; Tien LT, 2010, FU JEN J MED, V8, P11; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yang SH, 2004, J SURG ONCOL, V87, P167, DOI 10.1002/jso.20109; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	37	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67043	10.1371/journal.pone.0067043	http://dx.doi.org/10.1371/journal.pone.0067043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826192	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400097
J	Keane, C; O'Shea, D; Reiberger, T; Peck-Radosavljevic, M; Farrell, G; Bergin, C; Gardiner, CM				Keane, Ciara; O'Shea, Daire; Reiberger, Thomas; Peck-Radosavljevic, Markus; Farrell, Gillian; Bergin, Colm; Gardiner, Clair M.			Variation in Both IL28B and KIR2DS3 Genes Influence Pegylated Interferon and Ribavirin Hepatitis C Treatment Outcome in HIV-1 Co-Infection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; NATURAL-KILLER-CELLS; GENOTYPE 1 INFECTION; VIRUS-INFECTION; PLUS RIBAVIRIN; PREDICTION; POLYMORPHISM; INDIVIDUALS; ASSOCIATION; BOCEPREVIR	Pegylated-IFN and ribavirin remains the current treatment for chronic HCV infection in patients co-infected with HIV-1, but this regimen has low efficacy rates, particularly for HCV genotype 1/4 infection, has severe side effects and is extremely costly. Therefore, accurate prediction of treatment response is urgently required. We have recently shown that the NK cell gene, KIR2DS3 and a SNP associated with the IL28B gene synergise to increase the risk of chronic infection in primary HCV mono-infected patients. Identification of SNPs associated with the IL28B gene has also proven very powerful for predicting patient response to treatment. Patients co-infected with HIV-1 are of particular concern given they respond less well to HCV treatment, have more side effects and suffer a more rapid liver disease progression. In this study, we examined both IL28B and KIR2DS3 for their ability to predict treatment response in a cohort of HIV-1/HCV co-infected patients attending two treatment centres in Europe. We found that variation in both host genetic risk factors, IL28B and KIR2DS3, was strongly associated with sustained virological response (SVR) to treatment in our co-infected cohort (n = 149). The majority of patients who achieved a rapid virological response (RVR) achieved a SVR. However, it is currently impossible to predict treatment outcome in patients who fail to achieve an RVR. In our cohort, the presence of host genetic risk factors, IL28B-T and KIR2DS3 alleles, resulted in increased odds of treatment failure in these RVR negative patients (n = 88). Our data suggests that testing for host genetic factors will improve predicting treatment responsiveness in the clinical management of co-infected patients, and provides further evidence of the importance of the innate immune system in the immune response to HCV.	[Keane, Ciara; Gardiner, Clair M.] Trinity Coll Dublin, Sch Biochem & Immunol, Nat Killer Cell Grp, Dublin, Ireland; [O'Shea, Daire; Farrell, Gillian; Bergin, Colm] St James Hosp, Dept GU Med & Infect Dis, Dublin, Ireland; [Reiberger, Thomas; Peck-Radosavljevic, Markus] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria	Trinity College Dublin; Trinity College Dublin; Medical University of Vienna	Gardiner, CM (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Nat Killer Cell Grp, Dublin, Ireland.	clair.gardiner@tcd.ie	Reiberger, Thomas/H-7613-2019; Peck-Radosavljevic, Markus/J-6353-2013	Reiberger, Thomas/0000-0002-4590-3583; Peck-Radosavljevic, Markus/0000-0002-0597-2728; Gardiner, Clair/0000-0001-5643-9432	Irish Health Research Board [HRA_POR/2011/19]; Irish Haemophilia Society	Irish Health Research Board; Irish Haemophilia Society	Funding for this project came from the Irish Health Research Board (HRA_POR/2011/19; www.hrb.ie) and the Irish Haemophilia Society (www.haemophilia.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Asselah T, 2010, J HEPATOL, V52, P452, DOI 10.1016/j.jhep.2009.11.016; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Guinan KJ, 2010, GENES IMMUN, V11, P467, DOI 10.1038/gene.2010.9; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Payer BA, 2012, EUR J CLIN INVEST, V42, P599, DOI 10.1111/j.1365-2362.2011.02623.x; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Shea DO, 2008, J VIRAL HEPATITIS, V15, P482, DOI 10.1111/j.1365-2893.2008.00969.x; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2012, CLIN INFECT DIS, V54, P979, DOI 10.1093/cid/cir882; VandenBussche CJ, 2009, GENES IMMUN, V10, P162, DOI 10.1038/gene.2008.91; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Vogel M, 2012, CLIN INFECT DIS, V54, P556, DOI 10.1093/cid/cir854; Wapner J, 2010, SCIENCE, V330, P579, DOI 10.1126/science.330.6004.579	25	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66831	10.1371/journal.pone.0066831	http://dx.doi.org/10.1371/journal.pone.0066831			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826153	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400064
J	Mazumder, N; Lyn, RK; Singaravelu, R; Ridsdale, A; Moffatt, DJ; Hu, CW; Tsai, HR; McLauchlan, J; Stolow, A; Kao, FJ; Pezacki, JP				Mazumder, Nirmal; Lyn, Rodney K.; Singaravelu, Ragunath; Ridsdale, Andrew; Moffatt, Douglas J.; Hu, Chih-Wei; Tsai, Han-Ruei; McLauchlan, John; Stolow, Albert; Kao, Fu-Jen; Pezacki, John Paul			Fluorescence Lifetime Imaging of Alterations to Cellular Metabolism by Domain 2 of the Hepatitis C Virus Core Protein	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; FATTY-ACID SYNTHASE; LIPID DROPLETS; VIRAL-HEPATITIS; MULTIPHOTON MICROSCOPY; OXIDATIVE STRESS; GENOTYPE-3A CORE; CARS MICROSCOPY; INFECTION; NADH	Hepatitis C virus (HCV) co-opts hepatic lipid pathways to facilitate its pathogenesis. The virus alters cellular lipid biosynthesis and trafficking, and causes an accumulation of lipid droplets (LDs) that gives rise to hepatic steatosis. Little is known about how these changes are controlled at the molecular level, and how they are related to the underlying metabolic states of the infected cell. The HCV core protein has previously been shown to independently induce alterations in hepatic lipid homeostasis. Herein, we demonstrate, using coherent anti-Stokes Raman scattering (CARS) microscopy, that expression of domain 2 of the HCV core protein (D2) fused to GFP is sufficient to induce an accumulation of larger lipid droplets (LDs) in the perinuclear region. Additionally, we performed fluorescence lifetime imaging of endogenous reduced nicotinamide adenine dinucleotides [NAD(P)H], a key coenzyme in cellular metabolic processes, to monitor changes in the cofactor's abundance and conformational state in D2-GFP transfected cells. When expressed in Huh-7 human hepatoma cells, we observed that the D2-GFP induced accumulation of LDs correlated with an increase in total NAD(P)H fluorescence and an increase in the ratio of free to bound NAD(P)H. This is consistent with an approximate 10 fold increase in cellular NAD(P)H levels. Furthermore, the lifetimes of bound and free NAD(P)H were both significantly reduced - indicating viral protein-induced alterations in the cofactors' binding and microenvironment. Interestingly, the D2-expressing cells showed a more diffuse localization of NAD(P)H fluorescence signal, consistent with an accumulation of the co-factor outside the mitochondria. These observations suggest that HCV causes a shift of metabolic control away from the use of the coenzyme in mitochondrial electron transport and towards glycolysis, lipid biosynthesis, and building of new biomass. Overall, our findings demonstrate that HCV induced alterations in hepatic metabolism is tightly linked to alterations in NAD(P)H functional states.	[Mazumder, Nirmal; Hu, Chih-Wei; Tsai, Han-Ruei; Kao, Fu-Jen] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Lyn, Rodney K.; Singaravelu, Ragunath; Ridsdale, Andrew; Moffatt, Douglas J.; Stolow, Albert; Pezacki, John Paul] Natl Res Council Canada, Ottawa, ON, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Singaravelu, Ragunath; Pezacki, John Paul] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [McLauchlan, John] Univ Glasgow, Med Res Council, Ctr Virus Res, Glasgow, Lanark, Scotland; [Stolow, Albert] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada	National Yang Ming Chiao Tung University; National Research Council Canada; University of Ottawa; University of Ottawa; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow; Queens University - Canada	Kao, FJ (corresponding author), Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan.	fjkao@ym.edu.tw; John.Pezacki@nrc.ca	Mazumder, Nirmal/AAF-5047-2020; Kao, Fu-Jen/GYQ-6902-2022; Stolow, Albert/AAN-5609-2020; Mazumder, Nirmal/B-3913-2010; Kao, Fu-Jen/C-8269-2012	Mazumder, Nirmal/0000-0001-8068-6484; Singaravelu, Ragunath/0000-0002-2692-3650; Kao, Fu-Jen/0000-0001-8361-3942	joint NRC-NSC-ITRI Canada-Taiwan Cooperation project; Taiwan National Science Council; National Research Council of Canada; Ontario Graduate Scholarship; NSERC, in the form of a Vanier Canadian Graduate Scholarship; National CIHR Research Training Program in Hepatitis C (NCRTP-HepC); MRC [MC_U130184143, MC_UU_12014/1] Funding Source: UKRI; Medical Research Council [MC_U130184143, MC_UU_12014/1] Funding Source: researchfish	joint NRC-NSC-ITRI Canada-Taiwan Cooperation project; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Research Council of Canada; Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC, in the form of a Vanier Canadian Graduate Scholarship; National CIHR Research Training Program in Hepatitis C (NCRTP-HepC)(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by a joint NRC-NSC-ITRI Canada-Taiwan Cooperation project supported by the Taiwan National Science Council and the National Research Council of Canada. RKL received funding from the Ontario Graduate Scholarship. RS received funding from NSERC, in the form of a Vanier Canadian Graduate Scholarship, and the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Assis DN, 2012, CLIN PHARMACOL THER, V92, P294, DOI 10.1038/clpt.2012.103; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Buryakina TY, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.101503; Cheng Y, 2005, WORLD J GASTROENTERO, V11, P7591, DOI 10.3748/wjg.v11.i48.7591; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; De Giorgi V, 2009, J EUR ACAD DERMATOL, V23, P314, DOI 10.1111/j.1468-3083.2008.03045.x; De Gottardi A, 2006, ALIMENT PHARM THER, V23, P107, DOI 10.1111/j.1365-2036.2006.02729.x; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fan ZY, 1999, J MED VIROL, V59, P131, DOI 10.1002/(SICI)1096-9071(199910)59:2<131::AID-JMV1>3.3.CO;2-3; Ghukasyan VV, 2009, J PHYS CHEM C, V113, P11532, DOI 10.1021/jp810931u; Guo HW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2990752; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Jackel-Cram C, 2010, J GEN VIROL, V91, P1388, DOI 10.1099/vir.0.017418-0; Jiang LN, 2012, BIOTECHNOL LETT, V34, P2205, DOI 10.1007/s10529-012-1034-0; Kennedy DC, 2011, J AM CHEM SOC, V133, P17993, DOI 10.1021/ja2083027; Kennedy DC, 2009, J AM CHEM SOC, V131, P2444, DOI 10.1021/ja809451w; Konig K, 1999, OPT LETT, V24, P113, DOI 10.1364/OL.24.000113; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li D, 2008, OPT LETT, V33, P2365, DOI 10.1364/OL.33.002365; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyn RK, 2010, BIOCHEM BIOPH RES CO, V399, P518, DOI 10.1016/j.bbrc.2010.07.101; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Miyoshi H, 2011, J HEPATOL, V54, P432, DOI 10.1016/j.jhep.2010.07.039; Moriya K, 2009, AM J PATHOL, V175, P1515, DOI 10.2353/ajpath.2009.090102; Nan XL, 2006, CHEMBIOCHEM, V7, P1895, DOI 10.1002/cbic.200600330; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Ogikubo S, 2011, J PHYS CHEM B, V115, P10385, DOI 10.1021/jp2058904; Pegoraro AF, 2009, OPT EXPRESS, V17, P20700, DOI 10.1364/OE.17.020700; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Pezacki JP, 2010, MOL BIOSYST, V6, P1131, DOI 10.1039/b924668c; Piccoli C, 2009, BBA-BIOENERGETICS, V1787, P539, DOI 10.1016/j.bbabio.2008.11.008; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Popescu CI, 2010, BIOL CELL, V102, P63, DOI 10.1042/BC20090125; Rakic B, 2006, CHEM BIOL, V13, P23, DOI 10.1016/j.chembiol.2005.10.006; Rodgers MA, 2012, J AM CHEM SOC, V134, P6896, DOI 10.1021/ja207391q; Roe B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023641; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Seronello S, 2010, J BIOL CHEM, V285, P845, DOI 10.1074/jbc.M109.045740; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shimoike T, 1999, J VIROL, V73, P9718, DOI 10.1128/JVI.73.12.9718-9725.1999; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Squirrell JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043708; Szaszak M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002108; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Tripathi LP, 2010, MOL BIOSYST, V6, P2539, DOI 10.1039/c0mb00103a; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Yang MS, 2008, TOXICOLOGY, V247, P6, DOI 10.1016/j.tox.2008.01.021	72	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66738	10.1371/journal.pone.0066738	http://dx.doi.org/10.1371/journal.pone.0066738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826122	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000321738400042
J	Sengupta, A; Ghosh, S; Sharma, S; Sonawat, HM				Sengupta, Arjun; Ghosh, Soumita; Sharma, Shobhona; Sonawat, Haripalsingh M.			H-1 NMR Metabonomics Indicates Continued Metabolic Changes and Sexual Dimorphism Post-Parasite Clearance in Self-Limiting Murine Malaria Model	PLOS ONE			English	Article							PLASMODIUM-CHABAUDI; ACETYLCHOLINE; INFECTION; BRAIN; SERUM; SPECTROSCOPY; MECHANISMS; MYOCLONUS; PLASMA; URINE	Malaria, a mosquito-borne disease caused by Plasmodium spp. is considered to be a global threat, specifically for the developing countries. In human subjects considerable information exists regarding post-malarial physiology. However, most murine malarial models are lethal, and most studies deal with acute phases occurring as disease progresses. Much less is known regarding physiological status post-parasite clearance. We have assessed the physiological changes at the organ levels using H-1 NMR based metabonomics in a non lethal self-clearing murine malarial model of P. chabaudi parasites and Balb/C, far beyond the parasite clearance point. The results showed distinct metabolic states between uninfected and infected mice at the peak parasitemia, as well as three weeks post-parasite clearance. Our data also suggests that the response at the peak infection as well as recovery exhibited distinct sexual dimorphism. Specifically, we observed accumulation of acetylcholine in the brain metabolic profile of both the sexes. This might have important implication in understanding the pathophysiology of the post malarial neurological syndromes. In addition, the female liver showed high levels of glucose, dimethylglycine, methylacetoacetate and histidine after three weeks post-parasite clearance, while the males showed accumulation of branched chain amino acids, lysine, glutamine and bile acids.	[Sengupta, Arjun; Ghosh, Soumita; Sonawat, Haripalsingh M.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Sharma, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sharma@tifr.res.in; hms@tifr.res.in	Sengupta, Arjun/AAS-8787-2021; Sengupta, Arjun/R-5802-2019	Sengupta, Arjun/0000-0003-2210-1876; 	Tata Institute of Fundamental Research	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	Sources of funding: In-house funding of Tata Institute of Fundamental Research. url: www.tifr.res.in The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basant A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-110; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Ben Mamoun C, 2010, DRUG DEVELOP RES, V71, P44, DOI 10.1002/ddr.20347; Chakravarty A, 2004, NEUROL INDIA, V52, P130; COX B, 1969, BRIT J PHARMACOL, V35, P295, DOI 10.1111/j.1476-5381.1969.tb07988.x; COX J, 1987, PARASITE IMMUNOL, V9, P543, DOI 10.1111/j.1365-3024.1987.tb00529.x; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; de Silva H J, 1986, Ceylon Med J, V31, P147; Doherty CP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002133; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Ghosh S, 2012, J PROTEOME RES, V11, P4992, DOI 10.1021/pr300562m; Ghosh S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-330; GILKS CF, 1990, PARASITE IMMUNOL, V12, P45, DOI 10.1111/j.1365-3024.1990.tb00935.x; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Joosen MJA, 2007, EUR J PHARMACOL, V555, P122, DOI 10.1016/j.ejphar.2006.10.006; LALLEMENT G, 1992, NEUROTOXICOLOGY, V13, P557; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Mai NTH, 1996, LANCET, V348, P917, DOI 10.1016/S0140-6736(96)01409-2; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Marsala SZ, 2006, NEUROL SCI, V27, P442, DOI 10.1007/s10072-006-0728-2; Mehta M, 2005, FEBS LETT, V579, P6151, DOI 10.1016/j.febslet.2005.09.088; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nieman AE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-277; NILSSONEHLE I, 1990, J INTERN MED, V227, P151, DOI 10.1111/j.1365-2796.1990.tb00136.x; Planche T, 2006, CURR MOL MED, V6, P141, DOI 10.2174/156652406776055177; Prendki V, 2008, AM J TROP MED HYG, V78, P699, DOI 10.4269/ajtmh.2008.78.699; Schnorf H, 1998, ARCH NEUROL-CHICAGO, V55, P417, DOI 10.1001/archneur.55.3.417; Sengupta A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-384; Serkova Natalie J., 2009, V520, P273, DOI 10.1007/978-1-60327-811-9_20; Shih TM, 1997, J APPL TOXICOL, V17, P255, DOI 10.1002/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.3.CO;2-4; SLATER P, 1982, NEUROSCI LETT, V28, P253, DOI 10.1016/0304-3940(82)90066-0; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; Sonawat HM, 2012, CLIN LAB MED, V32, P129, DOI 10.1016/j.cll.2012.04.005; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; Wang YL, 2004, P NATL ACAD SCI USA, V101, P12676, DOI 10.1073/pnas.0404878101; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Zimmerman G, 2008, EUR J NEUROSCI, V27, P965, DOI 10.1111/j.1460-9568.2008.06070.x	40	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66954	10.1371/journal.pone.0066954	http://dx.doi.org/10.1371/journal.pone.0066954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826178	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400087
J	Tang, JLW; Nicolle, A; Pantelic, J; Klettner, CA; Su, R; Kalliomaki, P; Saarinen, P; Koskela, H; Reijula, K; Mustakallio, P; Cheong, DKW; Sekhar, C; Tham, KW				Tang, Julian W.; Nicolle, Andre; Pantelic, Jovan; Klettner, Christian A.; Su, Ruikun; Kalliomaki, Petri; Saarinen, Pekka; Koskela, Hannu; Reijula, Kari; Mustakallio, Panu; Cheong, David K. W.; Sekhar, Chandra; Tham, Kwok Wai			Different Types of Door-Opening Motions as Contributing Factors to Containment Failures in Hospital Isolation Rooms	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFECTION-CONTROL; TUBERCULOSIS; VENTILATION; MODEL; SARS	Hospital isolation rooms are vital for the containment (when under negative pressure) of patients with, or the protection (when under positive pressure) of patients, from airborne infectious agents. Such facilities were essential for the management of highly contagious patients during the 2003 severe acute respiratory syndrome (SARS) outbreaks and the more recent 2009 A/H1N1 influenza pandemic. Many different types of door designs are used in the construction of such isolation rooms, which may be related to the space available and affordability. Using colored food dye as a tracer, the qualitative effects of door-opening motions on the dissemination of potentially contaminated air into and out of a single isolation room were visualized and filmed using Reynolds-number-equivalent, small-scale, water-tank models fitted with programmable door-opening and moving human figure motions. Careful scaling considerations involved in the design and construction of these water-tank models enabled these results to be accurately extrapolated to the full-scale situation. Four simple types of door design were tested: variable speed single and double, sliding and hinged doors, in combination with the moving human figure. The resulting video footage was edited, synchronized and presented in a series of split-screen formats. From these experiments, it is clear that double-hinged doors pose the greatest risk of leakage into or out of the room, followed by (in order of decreasing risk) single-hinged, double-sliding and single-sliding doors. The relative effect of the moving human figure on spreading any potential contamination was greatest with the sliding doors, as the bulk airflows induced were large relative to those resulting from these door-opening motions. However, with the hinged doors, the airflows induced by these door-opening motions were significantly greater. Further experiments involving a simulated ventilated environment are required, but from these findings alone, it appears that sliding-doors are far more effective for hospital isolation room containment.	[Tang, Julian W.; Nicolle, Andre; Klettner, Christian A.; Su, Ruikun] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Tang, Julian W.] Alberta Prov Lab Publ Hlth, Edmonton, AB, Canada; [Tang, Julian W.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Pantelic, Jovan; Cheong, David K. W.; Sekhar, Chandra; Tham, Kwok Wai] Natl Univ Singapore, Sch Design & Environm, Dept Bldg, Singapore 117548, Singapore; [Kalliomaki, Petri; Saarinen, Pekka; Koskela, Hannu; Reijula, Kari] Finnish Inst Occupat Hlth, Helsinki, Finland; [Mustakallio, Panu] Oy Halton Grp Ltd, Vantaa, Finland	National University of Singapore; University of Alberta; National University of Singapore; Finnish Institute of Occupational Health	Tang, JLW (corresponding author), Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.	jwtang49@hotmail.com	THAM, Kwok Wai/B-6541-2009; Sekhar, Chandra/F-3253-2017	THAM, Kwok Wai/0000-0002-2957-1152; Sekhar, Chandra/0000-0002-0814-8662; Mustakallio, Panu/0000-0002-9042-8240; Tang, Julian/0000-0002-4963-1028; Pantelic, Jovan/0000-0001-7541-8274; Saarinen, Pekka/0000-0003-0152-7237; Cheong, David/0000-0001-7680-4281	Agency for Science, Technology and Research (A*STAR) in Singapore [SERC 1021290099]	Agency for Science, Technology and Research (A*STAR) in Singapore(Agency for Science Technology & Research (A*STAR))	Funding for this study (and support for post-doctoral research fellow, C.A. Klettner) was provided by a grant to JWT from the Agency for Science, Technology and Research (A*STAR grant no.: SERC 1021290099) in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NJ, 2011, AM J INFECT CONTROL, V39, P91, DOI 10.1016/j.ajic.2010.05.025; Beauchene C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-58; Eames I, 2009, J R SOC INTERFACE, V6, pS757, DOI 10.1098/rsif.2009.0319.focus; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Ferguson JK, 2009, MED J AUSTRALIA, V191, P454, DOI 10.5694/j.1326-5377.2009.tb02886.x; Fung CP, 2004, INFECT CONT HOSP EP, V25, P1026, DOI 10.1086/502339; Fusco FM, 2009, J HOSP INFECT, V73, P15, DOI 10.1016/j.jhin.2009.06.009; Harries AD, 1997, B WORLD HEALTH ORGAN, V75, P477; Harrison JP, 2010, HEALTH CARE MANAG, V29, P11, DOI 10.1097/HCM.0b013e3181cd8ab1; Hayden CS, 2007, J OCCUP ENVIRON HYG, V4, P198, DOI 10.1080/15459620601177370; Humphreys H, 2007, J HOSP INFECT, V66, P1, DOI 10.1016/j.jhin.2007.01.007; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Johnson DL, 2009, AM J INFECT CONTROL, V37, P94, DOI 10.1016/j.ajic.2008.05.011; Lee NE, 2004, AM J INFECT CONTROL, V32, P377, DOI 10.1016/j.ajic.2004.03.005; Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003; Leung TF, 2004, J HOSP INFECT, V56, P215, DOI 10.1016/j.jhin.2003.11.004; Liu JW, 2006, INFECT CONT HOSP EP, V27, P466, DOI 10.1086/504501; Rice N, 2001, INFECT CONT HOSP EP, V22, P19, DOI 10.1086/501819; Rydock James P, 2002, Appl Occup Environ Hyg, V17, P486, DOI 10.1080/10473220290035688; Rydock JP, 2004, J HOSP INFECT, V57, P228, DOI 10.1016/j.jhin.2004.01.032; Saravia SA, 2007, AM J INFECT CONTROL, V35, P324, DOI 10.1016/j.ajic.2006.10.012; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2005, J HOSP INFECT, V61, P283, DOI 10.1016/j.jhin.2005.05.017; Wojgani H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040171	25	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66663	10.1371/journal.pone.0066663	http://dx.doi.org/10.1371/journal.pone.0066663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826109	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400029
J	Zhou, L; Ni, YY; Pineyro, P; Cossaboom, CM; Subramaniam, S; Sanford, BJ; Dryman, BA; Huang, YW; Meng, XJ				Zhou, Lei; Ni, Yan-Yan; Pineyro, Pablo; Cossaboom, Caitlin M.; Subramaniam, Sakthivel; Sanford, Brenton J.; Dryman, Barbara A.; Huang, Yao-Wei; Meng, Xiang-Jin			Broadening the Heterologous Cross-Neutralizing Antibody Inducing Ability of Porcine Reproductive and Respiratory Syndrome Virus by Breeding the GP4 or M genes	PLOS ONE			English	Article							MYSTERY SWINE DISEASE; INFECTIOUS CDNA-CLONE; NORTH-AMERICAN; LELYSTAD-VIRUS; STRUCTURAL PROTEINS; UNITED-STATES; BIOLOGICAL CHARACTERISTICS; EPIDEMIC ABORTION; VACCINE EFFICACY; ECONOMIC-IMPACT	Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most economically important swine pathogens, which causes reproductive failure in sows and respiratory disease in piglets. A major hurdle to control PRRSV is the ineffectiveness of the current vaccines to confer protection against heterologous strains. Since both GP4 and M genes of PRRSV induce neutralizing antibodies, in this study we molecularly bred PRRSV through DNA shuffling of the GP4 and M genes, separately, from six genetically different strains of PRRSV in an attempt to identify chimeras with improved heterologous cross-neutralizing capability. The shuffled GP4 and M genes libraries were each cloned into the backbone of PRRSV strain VR2385 infectious clone pIR-VR2385-CA. Three GP4-shuffled chimeras and five M-shuffled chimeras, each representing sequences from all six parental strains, were selected and further characterized in vitro and in pigs. These eight chimeric viruses showed similar levels of replication with their backbone strain VR2385 both in vitro and in vivo, indicating that the DNA shuffling of GP4 and M genes did not significantly impair the replication ability of these chimeras. Cross-neutralization test revealed that the GP4-shuffled chimera GP4TS14 induced significantly higher cross-neutralizing antibodies against heterologous strains FL-12 and NADC20, and similarly that the M-shuffled chimera MTS57 also induced significantly higher levels of cross-neutralizing antibodies against heterologous strains MN184B and NADC20, when compared with their backbone parental strain VR2385 in infected pigs. The results suggest that DNA shuffling of the GP4 or M genes from different parental viruses can broaden the cross-neutralizing antibody-inducing ability of the chimeric viruses against heterologous PRRSV strains. The study has important implications for future development of a broadly protective vaccine against PRRSV.	[Zhou, Lei; Ni, Yan-Yan; Pineyro, Pablo; Cossaboom, Caitlin M.; Subramaniam, Sakthivel; Sanford, Brenton J.; Dryman, Barbara A.; Huang, Yao-Wei; Meng, Xiang-Jin] Virginia Polytech Inst & State Univ, Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Zhou, Lei] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China; [Zhou, Lei] China Agr Univ, State Key Lab Agribiotechnol, Beijing 100094, Peoples R China	Virginia Polytechnic Institute & State University; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Meng, XJ (corresponding author), Virginia Polytech Inst & State Univ, Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	xjmeng@vt.edu	Huang, Yao-Wei/Q-9409-2019; Meng, X.J./B-8769-2009; Subramaniam, Sakthivel/L-2265-2016; Huang, Yaowei/B-1468-2009; Subramaniam, Sakthivel/AAQ-8092-2020	Huang, Yao-Wei/0000-0001-9755-8411; Meng, X.J./0000-0002-2739-1334; Subramaniam, Sakthivel/0000-0001-6299-3835; Huang, Yaowei/0000-0001-9755-8411; Zhou, Lei/0000-0002-8837-3965; Tripp, Ralph/0000-0002-2924-9956	U.S. Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) program [USDA-NIFA-2011-67015-30165]; USDA Porcine Reproductive and Respiratory Syndrome CAP (PRRS CAP) [USDA-NIFA-2008-55620-19132]	U.S. Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) program; USDA Porcine Reproductive and Respiratory Syndrome CAP (PRRS CAP)	This project was supported in part by grants from the U.S. Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) program (USDA-NIFA-2011-67015-30165) and the USDA Porcine Reproductive and Respiratory Syndrome CAP (PRRS CAP) (USDA-NIFA-2008-55620-19132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Callison S, 2005, VIRUS GENES, V31, P5, DOI 10.1007/s11262-004-2194-3; Cancel-Tirado SM, 2004, VET IMMUNOL IMMUNOP, V102, P249, DOI 10.1016/j.vetimm.2004.09.017; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chang CC, 2002, J VIROL, V76, P4750, DOI 10.1128/JVI.76.10.4750-4763.2002; Chang CCJ, 1999, NAT BIOTECHNOL, V17, P793, DOI 10.1038/11737; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; Costers S, 2010, VIRUS RES, V154, P104, DOI 10.1016/j.virusres.2010.08.026; Costers S, 2010, ARCH VIROL, V155, P371, DOI 10.1007/s00705-009-0582-7; Das PB, 2011, VIROLOGY, V410, P385, DOI 10.1016/j.virol.2010.12.002; Das PB, 2010, J VIROL, V84, P1731, DOI 10.1128/JVI.01774-09; de Lima M, 2009, VIROLOGY, V390, P31, DOI 10.1016/j.virol.2009.04.017; Dea S, 2000, ARCH VIROL, V145, P659, DOI 10.1007/s007050050662; Dokland T, 2010, VIRUS RES, V154, P86, DOI 10.1016/j.virusres.2010.07.029; Du YJ, 2012, VIROLOGY, V424, P18, DOI 10.1016/j.virol.2011.12.009; Dwivedi V, 2011, VACCINE; Dwivedi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051794; Fang Y, 2007, ARCH VIROL, V152, P1009, DOI 10.1007/s00705-007-0936-y; Fang Y, 2006, J VIROL, V80, P11447, DOI 10.1128/JVI.01032-06; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Forsberg R, 2002, VIROLOGY, V299, P38, DOI 10.1006/viro.2002.1450; Garner MG, 2001, REV SCI TECH OIE, V20, P671, DOI 10.20506/rst.20.3.1303; Guo BQ, 2013, VIROLOGY, V435, P372, DOI 10.1016/j.virol.2012.09.013; Han K, 2012, VET J; Han K, 2012, CLIN VACCINE IMMUNOL, V19, P319, DOI 10.1128/CVI.05639-11; Huang YW, 2010, VIRUS RES, V154, P141, DOI 10.1016/j.virusres.2010.07.020; Jiang YB, 2006, VACCINE, V24, P2869, DOI 10.1016/j.vaccine.2005.12.049; Johnson CR, 2011, J GEN VIROL; Keffaber K, 1989, AM ASS SWINE PRACT N, V1, P9; Kim WI, 2008, VIRUS GENES, V37, P380, DOI 10.1007/s11262-008-0278-1; Kim WI, 2008, J CLIN MICROBIOL, V46, P1758, DOI 10.1128/JCM.01927-07; Lee CH, 2004, VET IMMUNOL IMMUNOP, V102, P189, DOI 10.1016/j.vetimm.2004.09.020; Li J, 2012, VIROLOGY, V433, P367, DOI 10.1016/j.virol.2012.08.026; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; Locher CP, 2005, DNA CELL BIOL, V24, P256, DOI 10.1089/dna.2005.24.256; Lopez OJ, 2007, CLIN VACCINE IMMUNOL, V14, P269, DOI 10.1128/CVI.00304-06; Lunney JK, 2010, VIRUS RES, V154, P1, DOI 10.1016/j.virusres.2010.10.009; Mardassi H, 1996, VIROLOGY, V221, P98, DOI 10.1006/viro.1996.0356; MARDASSI H, 1995, ARCH VIROL, V140, P1405, DOI 10.1007/BF01322667; Meng XJ, 2000, VET MICROBIOL, V74, P309, DOI 10.1016/S0378-1135(00)00196-6; Meng XJ, 1996, J VET DIAGN INVEST, V8, P374, DOI 10.1177/104063879600800317; Meulenberg JJM, 1996, VIROLOGY, V225, P44, DOI 10.1006/viro.1996.0573; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Meulenberg JJM, 1998, ADV EXP MED BIOL, V440, P199; Murtaugh MP, 1998, ADV EXP MED BIOL, V440, P787; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Nelson E A, 1995, Adv Exp Med Biol, V380, P321; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Ni YY, 2013, J VIROL, V87, P304, DOI 10.1128/JVI.01789-12; Ni YY, 2011, VIRUS RES, V160, P264, DOI 10.1016/j.virusres.2011.06.027; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Pejsak Z, 1997, VET MICROBIOL, V55, P317, DOI 10.1016/S0378-1135(96)01326-0; Pekrun K, 2002, J VIROL, V76, P2924, DOI 10.1128/JVI.76.6.2924-2935.2002; Renukaradhya Gourapura J., 2012, Animal Health Research Reviews, V13, P21, DOI 10.1017/S1466252312000023; Ropp SL, 2004, J VIROL, V78, P3684, DOI 10.1128/JVI.78.7.3684-3703.2004; Shi M, 2010, J VIROL; Shi M, 2010, J VIROL, V84, P8700, DOI 10.1128/JVI.02551-09; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Soong NW, 2000, NAT GENET, V25, P436, DOI 10.1038/78132; Tian DB, 2012, J VIROL, V86, P3701, DOI 10.1128/JVI.06836-11; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Truong HM, 2004, VIROLOGY, V325, P308, DOI 10.1016/j.virol.2004.04.046; Vanhee M, 2011, VACCINE, V29, P4794, DOI 10.1016/j.vaccine.2011.04.071; Vanhee M, 2010, VIRAL IMMUNOL, V23, P403, DOI 10.1089/vim.2010.0025; vanNieuwstadt AP, 1996, J VIROL, V70, P4767, DOI 10.1128/JVI.70.7.4767-4772.1996; Weiand E, 1999, VET MICROBIOL, V66, P171, DOI 10.1016/S0378-1135(99)00006-1; WENSVOORT G, 1992, VET MICROBIOL, V33, P185, DOI 10.1016/0378-1135(92)90046-V; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wieringa R, 2004, J VIROL, V78, P13019, DOI 10.1128/JVI.78.23.13019-13027.2004; Wissink EHJ, 2005, J VIROL, V79, P12495, DOI 10.1128/JVI.79.19.12495-12506.2005; Wu WH, 2001, VIROLOGY, V287, P183, DOI 10.1006/viro.2001.1034; Yang L, 2000, ARCH VIROL, V145, P1599, DOI 10.1007/s007050070079; Yang L, 2009, P NATL ACAD SCI USA, V106, P3946, DOI 10.1073/pnas.0813207106; Zhang JH, 1997, P NATL ACAD SCI USA, V94, P4504, DOI 10.1073/pnas.94.9.4504; Zhou L, 2012, VIROLOGY, V434, P96, DOI 10.1016/j.virol.2012.09.005; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08	79	22	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66645	10.1371/journal.pone.0066645	http://dx.doi.org/10.1371/journal.pone.0066645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826108	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400028
J	Ali, I; O'Brien, P; Kumar, G; Zheng, T; Jones, NC; Pinault, D; French, C; Morris, MJ; Salzberg, MR; O'Brien, TJ				Ali, Idrish; O'Brien, Patrick; Kumar, Gaurav; Zheng, Thomas; Jones, Nigel C.; Pinault, Didier; French, Chris; Morris, Margaret J.; Salzberg, Michael R.; O'Brien, Terence J.			Enduring Effects of Early Life Stress on Firing Patterns of Hippocampal and Thalamocortical Neurons in Rats: Implications for Limbic Epilepsy	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; LOW-DOSE CORTICOSTERONE; KINDLING EPILEPTOGENESIS; ELECTRICAL-STIMULATION; NEONATAL ISOLATION; PILOCARPINE MODEL; ELEVATED ANXIETY; IN-VITRO; SEIZURES; NETWORK	Early life stress results in an enduring vulnerability to kindling-induced epileptogenesis in rats, but the underlying mechanisms are not well understood. Recent studies indicate the involvement of thalamocortical neuronal circuits in the progression of kindling epileptogenesis. Therefore, we sought to determine in vivo the effects of early life stress and amygdala kindling on the firing pattern of hippocampus as well as thalamic and cortical neurons. Eight week old male Wistar rats, previously exposed to maternal separation (MS) early life stress or early handling (EH), underwent amygdala kindling (or sham kindling). Once fully kindled, in vivo juxtacellular recordings in hippocampal, thalamic and cortical regions were performed under neuroleptic analgesia. In the thalamic reticular nucleus cells both kindling and MS independently lowered firing frequency and enhanced burst firing. Further, burst firing in the thalamic reticular nucleus was significantly increased in kindled MS rats compared to kindled EH rats (p<0.05). In addition, MS enhanced burst firing of hippocampal pyramidal neurons. Following a stimulation-induced seizure, somatosensory cortical neurons exhibited a more pronounced increase in burst firing in MS rats than in EH rats. These data demonstrate changes in firing patterns in thalamocortical and hippocampal regions resulting from both MS and amygdala kindling, which may reflect cellular changes underlying the enhanced vulnerability to kindling in rats that have been exposed to early life stress.	[Ali, Idrish; O'Brien, Patrick; Kumar, Gaurav; Zheng, Thomas; Jones, Nigel C.; French, Chris; Salzberg, Michael R.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Pinault, Didier] INSERM, U1114, Strasbourg, France; [Pinault, Didier] Univ Strasbourg, Federat Med Translat Strasbourg, Strasbourg, France; [Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia; [Salzberg, Michael R.] Univ Melbourne, Dept Psychiat, St Vincents Hosp, Melbourne, Vic 3010, Australia; [O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of New South Wales Sydney; St Vincent's Hospital Melbourne; University of Melbourne; Royal Melbourne Hospital	O'Brien, TJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia.	obrientj@unimelb.edu.au	Morris, Margaret J/J-4285-2013; Ali, Idrish/P-4989-2018; Didier, Pinault/E-5090-2013; Ali, Idrish/K-1706-2015; French, Chris/AHA-1801-2022; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021; Pinault, Didier/H-7816-2016	Ali, Idrish/0000-0002-0971-4654; Ali, Idrish/0000-0002-0971-4654; O'Brien, Terence/0000-0002-7198-8621; Pinault, Didier/0000-0003-3807-4817; French, Christopher/0000-0002-1445-8704; Kumar, Gaurav/0000-0002-2638-6429; Jones, Nigel/0000-0002-1080-8439; Morris, Margaret/0000-0003-2285-5117	NHMRC [566843]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the NHMRC (Project Grants #566843). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEC RE, 1981, ELECTROEN CLIN NEURO, V52, P451, DOI 10.1016/0013-4694(81)90029-8; ALDENHOFF JB, 1983, SCIENCE, V221, P875, DOI 10.1126/science.6603658; Ali I, 2011, PSYCHOPHARMACOLOGY, V214, P155, DOI 10.1007/s00213-010-2125-z; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Bertram EH, 2008, EPILEPSIA, V49, P256, DOI 10.1111/j.1528-1167.2007.01408.x; Bertram EH, 2001, EPILEPSIA, V42, P967, DOI 10.1046/j.1528-1157.2001.042008967.x; Bhatnagar S, 2002, J NEUROENDOCRINOL, V14, P403, DOI 10.1046/j.0007-1331.2002.00792.x; BONHAUS DW, 1986, J NEUROSCI, V6, P3024; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brooks-Kayal AR, 1998, J NEUROCHEM, V70, P1017; Cain SM, 2010, CHANNELS, V4, P475, DOI 10.4161/chan.4.6.14106; Cavdar S, 2008, J ANAT, V212, P249, DOI 10.1111/j.1469-7580.2008.00858.x; Chen S, 2011, J NEUROPHYSIOL, V105, P117, DOI 10.1152/jn.00184.2010; Crunelli V, 2011, PHILOS T R SOC A, V369, P3820, DOI 10.1098/rsta.2011.0126; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cymerblit-Sabba A, 2012, J NEUROPHYSIOL, V107, P1718, DOI 10.1152/jn.00327.2011; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Faas GC, 1996, NEUROSCIENCE, V75, P57, DOI 10.1016/0306-4522(96)00254-0; Freeman-Daniels E, 2011, PSYCHOPHARMACOLOGY, V213, P453, DOI 10.1007/s00213-010-2030-5; Graef JD, 2009, J NEUROSCI, V29, P4430, DOI 10.1523/JNEUROSCI.0198-09.2009; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; HIYOSHI T, 1988, ELECTROEN CLIN NEURO, V70, P339, DOI 10.1016/0013-4694(88)90052-1; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Jones NC, 2009, BEHAV BRAIN RES, V203, P81, DOI 10.1016/j.bbr.2009.04.023; Jouny CC, 2007, EPILEPSIA, V48, P297, DOI 10.1111/j.1528-1167.2006.00963.x; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Kapus GL, 2008, PSYCHOPHARMACOLOGY, V198, P231, DOI 10.1007/s00213-008-1121-z; Karst H, 1999, EUR J NEUROSCI, V11, P889, DOI 10.1046/j.1460-9568.1999.00495.x; Koe AS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.024.2009; Kumar G, 2007, PSYCHONEUROENDOCRINO, V32, P834, DOI 10.1016/j.psyneuen.2007.05.011; Kumar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024033; Lai Ming-Chi, 2008, Pediatr Neonatol, V49, P19, DOI 10.1016/S1875-9572(08)60006-6; Lai MC, 2009, PEDIATR RES, V66, P441, DOI 10.1203/PDR.0b013e3181b337d2; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; McFarlane Alexander, 2005, Journal of Integrative Neuroscience, V4, P27, DOI 10.1142/S0219635205000689; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Mraovitch S, 1999, J COMP NEUROL, V411, P145; MRAOVITCH S, 1995, NEUROREPORT, V6, P519, DOI 10.1097/00001756-199502000-00028; Nanobashvili Z, 2003, EXP NEUROL, V181, P224, DOI 10.1016/S0014-4886(03)00045-1; Nazer F, 2009, J NEUROPHYSIOL, V102, P1880, DOI 10.1152/jn.90795.2008; Ons S, 2004, J NEUROCHEM, V89, P1111, DOI 10.1111/j.1471-4159.2004.02396.x; Parr LA, 2012, DEV COGN NEUROS-NETH, V2, P181, DOI 10.1016/j.dcn.2011.09.003; PATEL S, 1988, EXP NEUROL, V101, P63, DOI 10.1016/0014-4886(88)90065-9; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Pinault D, 2005, J NEUROSCI METH, V141, P231, DOI 10.1016/j.jneumeth.2004.06.015; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Pinault D, 2001, NEUROSCIENCE, V105, P181, DOI 10.1016/S0306-4522(01)00182-8; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Salzberg M, 2007, EPILEPSIA, V48, P2079, DOI 10.1111/j.1528-1167.2007.01246.x; Sanabria ERG, 2002, EPILEPSIA, V43, P96, DOI 10.1046/j.1528-1157.43.s.5.31.x; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Scharfman HE, 2007, NEUROBIOLOGY OF DISEASE, P349, DOI 10.1016/B978-012088592-3/50035-9; SIGGINS GR, 1985, FED PROC, V44, P237; Skilbeck KJ, 2010, J NEUROCHEM, V112, P1115, DOI 10.1111/j.1471-4159.2009.06539.x; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Suarez M, 1998, PHYSIOL BEHAV, V64, P111, DOI 10.1016/S0031-9384(98)00028-6; Sutula TP, 2005, ADV BEHAV BIOL, V55, P147; Taher TR, 2005, NEUROPSYCHOPHARMACOL, V30, P1610, DOI 10.1038/sj.npp.1300709; TESKEY GC, 1993, BRAIN RES, V624, P11; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Tjong YW, 2010, NEUROENDOCRINOL LETT, V31, P215; Tringham E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003120; TSURU N, 1985, EPILEPSIA, V26, P488, DOI 10.1111/j.1528-1157.1985.tb05685.x; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Wang HL, 1998, EUR J NEUROSCI, V10, P3428, DOI 10.1046/j.1460-9568.1998.00352.x; Wimmer RD, 2012, J NEUROSCI, V32, P13917, DOI 10.1523/JNEUROSCI.2313-12.2012; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202; Xu C, 2012, BRAIN STIMUL; Xu L, 1997, EUR J PHARMACOL, V323, P59, DOI 10.1016/S0014-2999(97)00022-8	73	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66962	10.1371/journal.pone.0066962	http://dx.doi.org/10.1371/journal.pone.0066962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825595	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400171
J	Brunner, JL; Duerr, S; Keesing, F; Killilea, M; Vuong, H; Ostfeld, RS				Brunner, Jesse L.; Duerr, Shannon; Keesing, Felicia; Killilea, Mary; Vuong, Holly; Ostfeld, Richard S.			An Experimental Test of Competition among Mice, Chipmunks, and Squirrels in Deciduous Forest Fragments	PLOS ONE			English	Article							LONG-TERM DYNAMICS; PEROMYSCUS-LEUCOPUS; ACORN MAST; RODENT; COMMUNITY; PREDATION; POPULATIONS; LANDSCAPE; MAMMALS; RESPONSES	Mixed hardwood forests of the northeast United States support a guild of granivorous/omnivorous rodents including gray squirrels (Sciurus carolinensis), eastern chipmunks (Tamias striatus), and white-footed mice (Peromyscus leucopus). These species coincide geographically, co-occur locally, and consume similar food resources. Despite their idiosyncratic responses to landscape and patch variables, patch occupancy models suggest that competition may influence their respective distributions and abundances, and accordingly their influence on the rest of the forest community. Experimental studies, however, are wanting. We present the result of a large-scale experiment in which we removed white-footed mice or gray squirrels from small, isolated forest fragments in Dutchess County, New York, and added these mammals to other fragments in order to alter the abundance of these two species. We then used mark-recapture analyses to quantify the population-level and individual-level effects on resident mice, squirrels, and chipmunks. Overall, we found little evidence of competition. There were essentially no within-season numerical responses to changes in the abundance of putative competitors. Moreover, while individual-level responses (apparent survival and capture probability) did vary with competitor densities in some models, these effects were often better explained by site-specific parameters and were restricted to few of the 19 sites we studied. With only weak or nonexistent competition among these three common rodent species, we expect their patterns of habitat occupancy and population dynamics to be largely independent of one another.	[Brunner, Jesse L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Brunner, Jesse L.; Duerr, Shannon; Vuong, Holly; Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Keesing, Felicia] Bard Coll, Dept Biol, Annandale On Hudson, NY USA; [Killilea, Mary] NYU, Dept Biol, New York, NY 10003 USA; [Vuong, Holly] Rutgers State Univ, Dept Ecol & Evolut, New Brunswick, NJ 08903 USA	Washington State University; Cary Institute of Ecosystem Studies; New York University; Rutgers State University New Brunswick	Brunner, JL (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	jesse.brunner@wsu.edu	Brunner, Jesse L./B-1692-2013	Brunner, Jesse L./0000-0003-4894-8274; Ostfeld, Richard/0000-0002-3707-9301	Environmental Protection Agency (STAR) [83377601]; National Science Foundation-National Institutes of Health joint program in the Ecology of Infectious Diseases [EF0813035]; Division Of Environmental Biology [0949702] Funding Source: National Science Foundation	Environmental Protection Agency (STAR)(United States Environmental Protection Agency); National Science Foundation-National Institutes of Health joint program in the Ecology of Infectious Diseases; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants from the Environmental Protection Agency (STAR Grant 83377601) and the National Science Foundation-National Institutes of Health joint program in the Ecology of Infectious Diseases (EF0813035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burns CE, 2005, BEHAV ECOL, V16, P898, DOI 10.1093/beheco/ari070; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Cole RJ, 2009, BIOTROPICA, V41, P319, DOI 10.1111/j.1744-7429.2009.00490.x; DOUGLAS B, 2012, IME4 LINEAR MIXED EF; Elias SP, 2004, J MAMMAL, V85, P743, DOI 10.1644/BER-025; Ernest SKM, 2008, AM NAT, V172, pE257, DOI 10.1086/592402; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goheen JR, 2003, CAN J ZOOL, V81, P1636, DOI 10.1139/Z03-143; Hadley W., 2009, GGPLOT2 ELEGANT GRAP; Harris DB, 2007, ECOLOGY, V88, P2330, DOI 10.1890/06-1701.1; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Howe HF, 2006, ECOLOGY, V87, P3007, DOI 10.1890/0012-9658(2006)87[3007:MADEOM]2.0.CO;2; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jedrzejewski W, 1996, ACTA THERIOL, V41, P1; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Klinger R, 2009, ECOLOGY, V90, P1549, DOI 10.1890/07-2146.1; Koenker R., 2012, QUANTREG QUANTILE RE; Koprowski JL, 1996, J MAMMAL, V77, P1006, DOI 10.2307/1382781; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Manson RH, 1999, LANDSCAPE ECOL, V14, P355, DOI 10.1023/A:1008093823391; Manson RH, 2001, ECOLOGY, V82, P3320, DOI 10.2307/2680155; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Mendoza E, 2007, OIKOS, V116, P1841, DOI [10.1111/j.2007.0030-1299.15878.x, 10.1111/j.0030-1299.2007.15878.x]; MOEN J, 1993, OIKOS, V68, P401, DOI 10.2307/3544908; Moore JE, 2005, J WILDLIFE MANAGE, V69, P933, DOI 10.2193/0022-541X(2005)069[0933:MPOBFR]2.0.CO;2; Moore JE, 2007, OECOLOGIA, V151, P663, DOI 10.1007/s00442-006-0616-8; Nupp TE, 2001, MAMM BIOL, V66, P345; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Ostfeld RS, 1996, BIOSCIENCE, V46, P323, DOI 10.2307/1312946; Ostfeld RS, 1997, ECOLOGY, V78, P1531, DOI 10.1890/0012-9658(1997)078[1531:EOROSO]2.0.CO;2; Parker TS, 2012, LANDSCAPE URBAN PLAN, V106, P316, DOI 10.1016/j.landurbplan.2012.04.003; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; R Core Team, 2016, R FDN STAT COMP; RIEGE DA, 1991, J MAMMAL, V72, P152, DOI 10.2307/1381990; Schauber EM, 2009, ECOLOGY, V90, P240, DOI 10.1890/07-0980.1; Schmidt KA, 2003, OIKOS, V103, P548, DOI 10.1034/j.1600-0706.2003.12462.x; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Schnurr JL, 2004, ECOLOGY, V85, P741, DOI 10.1890/02-0644; Schnurr JL, 2002, OIKOS, V96, P402, DOI 10.1034/j.1600-0706.2002.960302.x; Seamon J, 1997, ACTA OECOL, V18, P637, DOI 10.1016/S1146-609X(97)80048-3; Thibault KM, 2010, J MAMMAL, V91, P787, DOI 10.1644/09-MAMM-S-142.1; Vandegrift KJ, 2009, J ANIM ECOL, V78, P202, DOI 10.1111/j.1365-2656.2008.01456.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690; Yunger JA, 2002, J MAMMAL, V83, P267, DOI 10.1644/1545-1542(2002)083<0267:ROTLDP>2.0.CO;2; [No title captured]	58	16	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66798	10.1371/journal.pone.0066798	http://dx.doi.org/10.1371/journal.pone.0066798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824654	Green Published, gold			2022-12-27	WOS:000320576400160
J	Eriksson, P; Aine, M; Sjodahl, G; Staaf, J; Lindgren, D; Hoglund, M				Eriksson, Pontus; Aine, Mattias; Sjodahl, Gottfrid; Staaf, Johan; Lindgren, David; Hoglund, Mattias			Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; INVASIVE BLADDER-CANCER; DNA-FORMING SEQUENCES; ARRAY-CGH DATA; COPY-NUMBER; HEPATOCELLULAR-CARCINOMA; MAMMALIAN-CELLS; GENE-EXPRESSION; HYBRIDIZATION; TUMORS	Background: Urothelial carcinoma shows frequent amplifications at 6p22 and 1q21-24. The main target gene at 6p22 is believed to be E2F3, frequently co-amplified with CDKAL1 and SOX4. There are however reports on 6p22 amplifications that do not include E2F3. Previous analyses have identified frequent aberrations occurring at 1q21-24. However, due to complex rearrangements it has been difficult to identify specific 1q21-24 target regions and genes. Methods: We selected 29 cases with 6p and 37 cases with 1q focal genomic amplifications from 261 cases of urothelial carcinoma analyzed by array-CGH for high resolution zoom-in oligonucleotide array analyses. Genomic analyses were combined with gene expression data and genomic sequence analyses to characterize and fine map 6p22 and 1q21-24 amplifications. Results: We show that the most frequently amplified gene at 6p22 is SOX4 and that SOX4 can be amplified and overexpressed without the E2F3 or CDKAL1 genes being included in the amplicon. Hence, our data point to SOX4 as an auxiliary amplification target at 6p22. We further show that at least three amplified regions are observed at 1q21-24. Copy number data, combined with gene expression data, highlighted BCL9 and CHD1L as possible targets in the most proximal region and MCL1, SETDB1, and HIF1B as putative targets in the middle region, whereas no obvious targets could be determined in the most distal amplicon. We highlight enrichment of G4 quadruplex sequence motifs and a high number of intraregional sequence duplications, both known to contribute to genomic instability, as prominent features of the 1q21-24 region. Conclusions: Our detailed analyses of the 6p22 amplicon suggest SOX4 as an auxiliary target gene for amplification. We further demonstrate three separate target regions for amplification at 1q21-24 and identified BCL9, CHD1L, and MCL1, SETDB1, and HIF1B as putative target genes within these regions.	[Eriksson, Pontus; Aine, Mattias; Sjodahl, Gottfrid; Staaf, Johan; Hoglund, Mattias] Lund Univ, Dept Oncol, Skane Univ Hosp, Lund, Sweden; [Staaf, Johan] Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden; [Lindgren, David] Lund Univ, Ctr Mol Pathol, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Hoglund, M (corresponding author), Lund Univ, Dept Oncol, Skane Univ Hosp, Lund, Sweden.	mattias.hoglund@med.lu.se	Aine, Mattias/Q-3205-2019; Aine, Mattias/AAU-7281-2020	Aine, Mattias/0000-0002-0851-5952; Sjodahl, Gottfrid/0000-0002-7869-0473; Hoglund, Mattias/0000-0001-9283-4421; Eriksson, Pontus/0000-0003-3317-865X	Swedish Cancer Society; Swedish Research Council [2011-17816-83790-87]; Crafoord Foundation; Gunnar Nilsson Foundation; Medical Faculty of Lund University Hospital; Swedish Society for Medical Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Gunnar Nilsson Foundation; Medical Faculty of Lund University Hospital; Swedish Society for Medical Research	This work supported by The Swedish Cancer Society, http://www.vr.se/(grant number 10 0517) The Swedish Research Council, (www.cancerfonden.se/) (grant number 2011-17816-83790-87), The Crafoord Foundation, (http://www.crafoord.se/vetenskaplig_forskning.asp), The Gunnar Nilsson Foundation, (http://www.cancerstiftelsen.com/), The Medical Faculty of Lund University Hospital, (http://www.med.lu.se/), and The Swedish Society for Medical Research, (http://www.ssmf.se/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Beekman JM, 2012, ONCOGENE, V31, P2668, DOI 10.1038/onc.2011.445; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Boan F, 2010, CHEMBIOCHEM, V11, P331, DOI 10.1002/cbic.200900612; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen LL, 2010, ACTA PHARMACOL SIN, V31, P1165, DOI 10.1038/aps.2010.94; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006727; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Deka J, 2010, CANCER RES, V70, P6619, DOI 10.1158/0008-5472.CAN-10-0148; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Fadl-Elmula Imad, 2005, Cell Chromosome, V4, P1, DOI 10.1186/1475-9268-4-1; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3; Hoglund M, 2001, CANCER RES, V61, P8241; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Hurst CD, 2012, CLIN CANC RES; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Knowles MA, 2001, J CLIN PATHOL-MOL PA, V54, P215, DOI 10.1136/mp.54.4.215; Knowles MA, 1999, ELECTROPHORESIS, V20, P269, DOI 10.1002/(SICI)1522-2683(19990201)20:2<269::AID-ELPS269>3.3.CO;2-Z; Konkel MK, 2010, SEMIN CANCER BIOL, V20, P211, DOI 10.1016/j.semcancer.2010.03.001; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lauss M, 2012, EPIGENETICS, V7; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Oeggerli M, 2006, ONCOGENE, V25, P6538, DOI 10.1038/sj.onc.1209946; Oeggerli M, 2004, ONCOGENE, V23, P5616, DOI 10.1038/sj.onc.1207749; Olsson AY, 2007, ONCOGENE, V26, P1028, DOI 10.1038/sj.onc.1209854; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Richter J, 1998, AM J PATHOL, V153, P1615, DOI 10.1016/S0002-9440(10)65750-1; Richter J, 1997, CANCER RES, V57, P2860; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SHEN MR, 1991, J MOL EVOL, V33, P311; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Sjodahl G., 2012, CLIN CANC RES; Sjodahl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018583; Staaf J, 2008, HUM MUTAT, V29, P555, DOI 10.1002/humu.20678; Staaf J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-382; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Veltman JA, 2003, CANCER RES, V63, P2872; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Zhao JM, 1999, CANCER RES, V59, P4658; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	68	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67222	10.1371/journal.pone.0067222	http://dx.doi.org/10.1371/journal.pone.0067222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825644	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400179
J	Jurelevicius, D; Alvarez, VM; Peixoto, R; Rosado, AS; Seldin, L				Jurelevicius, Diogo; Alvarez, Vanessa Marques; Peixoto, Raquel; Rosado, Alexandre S.; Seldin, Lucy			The Use of a Combination of alkB Primers to Better Characterize the Distribution of Alkane-Degrading Bacteria	PLOS ONE			English	Article							CAPTURE-RECAPTURE DATA; HYDROXYLASE GENES; POPULATION-SIZE; SOIL; DEGRADATION; DIVERSITY; BIODEGRADATION; HYDROCARBONS; COMMUNITIES; HEXADECANE	The alkane monooxygenase AlkB, which is encoded by the alkB gene, is a key enzyme involved in bacterial alkane degradation. To study the alkB gene within bacterial communities, researchers need to be aware of the variations in alkB nucleotide sequences; a failure to consider the sequence variations results in the low representation of the diversity and richness of alkane-degrading bacteria. To minimize this shortcoming, the use of a combination of three alkB-targeting primers to enhance the detection of the alkB gene in previously isolated alkane-degrading bacteria was proposed. Using this approach, alkB-related PCR products were detected in 79% of the strains tested. Furthermore, the chosen set of primers was used to study alkB richness and diversity in different soils sampled in Carmopolis, Brazil and King George Island, Antarctica. The DNA extracted from the different soils was PCR amplified with each set of alkB-targeting primers, and clone libraries were constructed, sequenced and analyzed. A total of 255 alkB phylotypes were detected. Venn diagram analyses revealed that only low numbers of alkB phylotypes were shared among the different libraries derived from each primer pair. Therefore, the combination of three alkB-targeting primers enhanced the richness of alkB phylotypes detected in the different soils by 45% to 139%, when compared to the use of a single alkB-targeting primer. In addition, a dendrogram analysis and beta diversity comparison of the alkB composition showed that each of the sampling sites studied had a particular set of alkane-degrading bacteria. The use of a combination of alkB primers was an efficient strategy for enhancing the detection of the alkB gene in cultivable bacteria and for better characterizing the distribution of alkane-degrading bacteria in different soil environments.	[Jurelevicius, Diogo; Alvarez, Vanessa Marques; Seldin, Lucy] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Geral, Lab Genet Microbiana, Rio De Janeiro, Brazil; [Peixoto, Raquel; Rosado, Alexandre S.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Geral, Lab Ecol Mol Microbiana, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Seldin, L (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Geral, Lab Genet Microbiana, Rio De Janeiro, Brazil.	lseldin@micro.ufrj.br	Rosado, Alexandre Soares/G-1955-2012; Jurelevicius, Diogo A/I-8235-2014; Seldin, Lucy/S-2530-2019; Peixoto, Raquel/V-2554-2019	Rosado, Alexandre Soares/0000-0001-5135-1394; Jurelevicius, Diogo A/0000-0002-5719-5713; Seldin, Lucy/0000-0002-4992-6395; Peixoto, Raquel/0000-0002-9536-3132	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brazilian Antarctic Program, PROANTAR, as part of the IPY Activity no. 403 'MIDIAPI Microbial Diversity of Terrestrial and Maritime Ecosystems in Antarctic Peninsula' [520194/2006-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Antarctic Program, PROANTAR, as part of the IPY Activity no. 403 'MIDIAPI Microbial Diversity of Terrestrial and Maritime Ecosystems in Antarctic Peninsula'	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The authors received financial and logistical support from the Brazilian Antarctic Program, PROANTAR, as part of the IPY Activity no. 403 'MIDIAPI Microbial Diversity of Terrestrial and Maritime Ecosystems in Antarctic Peninsula' (520194/2006-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Aislabie J, 2010, POLAR MICROBIOLOGY: THE ECOLOGY, BIODIVERSITY AND BIOREMEDIATION POTENTIAL OF MICROORGANISMS IN EXTREMELY COLD ENVIRONMENTS, P215; ALVAREZ VM, 2011, APPL ENVIRON SOIL SC, V2011, DOI DOI 10.1155/2011/156320; Baek KH, 2006, GEOMICROBIOL J, V23, P253, DOI 10.1080/01490450600760633; Boneh S, 1998, J AM STAT ASSOC, V93, P372, DOI 10.2307/2669633; CHAO A, 1992, BIOMETRICS, V48, P201, DOI 10.2307/2532750; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chao A, 2000, STAT SINICA, V10, P227; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chenier MR, 2003, APPL ENVIRON MICROB, V69, P5170, DOI 10.1128/AEM.69.9.5170-5177.2003; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Guibert LM, 2012, MICROB ECOL, V64, P605, DOI 10.1007/s00248-012-0051-9; Heiss-Blanquet S, 2005, J APPL MICROBIOL, V99, P1392, DOI 10.1111/j.1365-2672.2005.02715.x; Jurelevicius D.A., 2010, BIOREMEDIATION BIOTE, P133; Jurelevicius D, 2012, EUR J SOIL BIOL, V51, P37, DOI 10.1016/j.ejsobi.2012.03.006; Jurelevicius D, 2010, J MICROBIOL BIOTECHN, V20, P862, DOI 10.4014/jmb.0910.10012; Kloos K, 2006, J MICROBIOL METH, V66, P486, DOI 10.1016/j.mimet.2006.01.014; Koch DJ, 2009, APPL ENVIRON MICROB, V75, P337, DOI 10.1128/AEM.01758-08; Kuhn E, 2009, ENVIRON MICROBIOL, V11, P669, DOI 10.1111/j.1462-2920.2008.01843.x; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Luz AP, 2004, CAN J MICROBIOL, V50, P323, DOI 10.1139/W04-008; Marchant R, 2006, FEMS MICROBIOL ECOL, V56, P44, DOI 10.1111/j.1574-6941.2006.00061.x; Marques AV, 2008, J MICROBIOL BIOTECHN, V18, P1966, DOI 10.4014/jmb.0800.279; Paisse S, 2011, APPL MICROBIOL BIOT, V92, P835, DOI 10.1007/s00253-011-3381-5; Panicker G, 2010, ANTON LEEUW INT J G, V97, P275, DOI 10.1007/s10482-009-9408-6; Perez-de-Mora A, 2011, MICROB ECOL, V62, P959, DOI 10.1007/s00248-011-9858-z; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Powell SM, 2010, SOIL BIOL BIOCHEM, V42, P2012, DOI 10.1016/j.soilbio.2010.07.027; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulz S, 2012, ISME J, V6, P1763, DOI 10.1038/ismej.2012.17; Shannon C. E., 1949, MATH THEORY COMMUNIC; Smits THM, 1999, ENVIRON MICROBIOL, V1, P307, DOI 10.1046/j.1462-2920.1999.00037.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Beilen JB, 2007, APPL MICROBIOL BIOT, V74, P13, DOI 10.1007/s00253-006-0748-0; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006; van Beilen JB, 2005, CURR OPIN BIOTECH, V16, P308, DOI 10.1016/j.copbio.2005.04.005; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Vomberg A, 2000, J APPL MICROBIOL, V89, P339, DOI 10.1046/j.1365-2672.2000.01121.x; von der Weid I, 2007, SYST APPL MICROBIOL, V30, P331, DOI 10.1016/j.syapm.2006.11.001; Wang LP, 2010, ENVIRON MICROBIOL, V12, P1230, DOI 10.1111/j.1462-2920.2010.02165.x; Wang WP, 2010, MICROB ECOL, V60, P429, DOI 10.1007/s00248-010-9724-4; Wasmund K, 2009, APPL ENVIRON MICROB, V75, P7391, DOI 10.1128/AEM.01370-09; Wentzel A, 2007, APPL MICROBIOL BIOT, V76, P1209, DOI 10.1007/s00253-007-1119-1; Whyte LG, 2002, APPL ENVIRON MICROB, V68, P5933, DOI 10.1128/AEM.68.12.5933-5942.2002; Yergeau E, 2009, APPL ENVIRON MICROB, V75, P6258, DOI 10.1128/AEM.01029-09	47	43	43	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66565	10.1371/journal.pone.0066565	http://dx.doi.org/10.1371/journal.pone.0066565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825163	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400131
J	Ligasova, A; Strunin, D; Koberna, K				Ligasova, Anna; Strunin, Dmytro; Koberna, Karel			A New Method of the Visualization of the Double-Stranded Mitochondrial and Nuclear DNA	PLOS ONE			English	Article							DAPI; REPLICATION; BINDING; CELLS	The study describes the method of a sensitive detection of double-stranded DNA molecules in situ. It is based on the oxidative attack on the deoxyribose moiety by copper(I) in the presence of oxygen. We have shown previously that the oxidative attack leads to the formation of frequent gaps in DNA. Here we have demonstrated that the gaps can be utilized as the origins for an efficient synthesis of complementary labeled strands by DNA polymerase I and that such enzymatic detection of the double-stranded DNA is a sensitive approach enabling in-situ detection of both the nuclear and mitochondrial genomes in formaldehyde-fixed human cells.	[Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] Palacky Univ, Expt Med Lab, Inst Mol & Translat Med, Fac Med, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Ligasova, A (corresponding author), Palacky Univ, Expt Med Lab, Inst Mol & Translat Med, Fac Med, CR-77147 Olomouc, Czech Republic.	ligasova@gmail.com	Ligasová, Anna/P-5460-2015; KOBERNA, Karel/G-5551-2019	Ligasová, Anna/0000-0002-1564-3768; KOBERNA, Karel/0000-0002-7375-4298	Technology Agency of the Czech Republic [TA03010598, TA03010719]; Operational Program Research and Development for Innovations [CZ.1.05/2.1.00/01.0030]	Technology Agency of the Czech Republic; Operational Program Research and Development for Innovations(European Commission)	This work has been supported by the Technology Agency of the Czech Republic (TA03010598 and TA03010719). The infrastructural part of the project (Institute of Molecular and Translational Medicine) has been supported from the Operational Program Research and Development for Innovations (project CZ.1.05/2.1.00/01.0030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLSON P, 1995, J BIOMOL STRUCT DYN, V13, P351, DOI 10.1080/07391102.1995.10508845; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; HIRONS GT, 1994, CYTOMETRY, V15, P129, DOI 10.1002/cyto.990150206; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Lentz SI, 2010, J VIS EXP; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Ligasova A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq619; Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; RYE HS, 1992, NUCLEIC ACIDS RES, V20, P2803, DOI 10.1093/nar/20.11.2803; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; TANIOUS FA, 1992, BIOCHEMISTRY-US, V31, P3103, DOI 10.1021/bi00127a010; vandeCorput MPC, 1997, J HISTOCHEM CYTOCHEM, V45, P55; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200	16	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66864	10.1371/journal.pone.0066864	http://dx.doi.org/10.1371/journal.pone.0066864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825578	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400163
J	Summa, KC; Voigt, RM; Forsyth, CB; Shaikh, M; Cavanaugh, K; Tang, YM; Vitaterna, MH; Song, SW; Turek, FW; Keshavarzian, A				Summa, Keith C.; Voigt, Robin M.; Forsyth, Christopher B.; Shaikh, Maliha; Cavanaugh, Kate; Tang, Yueming; Vitaterna, Martha Hotz; Song, Shiwen; Turek, Fred W.; Keshavarzian, Ali			Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; SHIFT WORK; GASTROINTESTINAL PERMEABILITY; INSULIN-RESISTANCE; POSSIBLE MECHANISM; METABOLIC SYNDROME; IMMUNE ACTIVATION; LIVER-DISEASE; MOUSE MODEL; GUT	The circadian clock orchestrates temporal patterns of physiology and behavior relative to the environmental light: dark cycle by generating and organizing transcriptional and biochemical rhythms in cells and tissues throughout the body. Circadian clock genes have been shown to regulate the physiology and function of the gastrointestinal tract. Disruption of the intestinal epithelial barrier enables the translocation of proinflammatory bacterial products, such as endotoxin, across the intestinal wall and into systemic circulation; a process that has been linked to pathologic inflammatory states associated with metabolic, hepatic, cardiovascular and neurodegenerative diseases - many of which are commonly reported in shift workers. Here we report, for the first time, that circadian disorganization, using independent genetic and environmental strategies, increases permeability of the intestinal epithelial barrier (i.e., gut leakiness) in mice. Utilizing chronic alcohol consumption as a well-established model of induced intestinal hyperpermeability, we also found that both genetic and environmental circadian disruption promote alcohol-induced gut leakiness, endotoxemia and steatohepatitis, possibly through a mechanism involving the tight junction protein occludin. Circadian organization thus appears critical for the maintenance of intestinal barrier integrity, especially in the context of injurious agents, such as alcohol. Circadian disruption may therefore represent a previously unrecognized risk factor underlying the susceptibility to or development of alcoholic liver disease, as well as other conditions associated with intestinal hyperpermeability and an endotoxin-triggered inflammatory state.	[Summa, Keith C.; Cavanaugh, Kate; Vitaterna, Martha Hotz; Turek, Fred W.] Northwestern Univ, Ctr Sleep & Circadian Biol, Dept Neurobiol, Evanston, IL 60208 USA; [Summa, Keith C.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Voigt, Robin M.; Forsyth, Christopher B.; Shaikh, Maliha; Tang, Yueming; Keshavarzian, Ali] Rush Univ, Div Digest Dis & Nutr, Dept Internal Med, Med Ctr, Chicago, IL 60612 USA; [Forsyth, Christopher B.] Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA; [Song, Shiwen] Amer Soc Clin Pathologists, Chicago, IL USA; [Keshavarzian, Ali] Rush Univ, Dept Pharmacol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Dept Mol Biophys & Physiol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Fac Sci, Utrecht, Netherlands	Northwestern University; Northwestern University; Feinberg School of Medicine; Rush University; Rush University; Rush University; Rush University; Utrecht University	Summa, KC (corresponding author), Northwestern Univ, Ctr Sleep & Circadian Biol, Dept Neurobiol, Evanston, IL 60208 USA.	ksumma@fsm.northwestern.edu		Summa, Keith/0000-0001-9541-8458; Cavanaugh, Kate/0000-0001-9293-0296	National Institutes of Health [5R01AA020216]; National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) through a Northwestern University Clinical and Translational Sciences Institute Predoctoral Training Grant [8UL1TR000150]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH) through a Northwestern University Clinical and Translational Sciences Institute Predoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by the National Institutes of Health (5R01AA020216 to FWT and AK). KCS was supported in part by the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) through a Northwestern University Clinical and Translational Sciences Institute Predoctoral Training Grant (8UL1TR000150). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Del Valle-Pinero AY, 2013, CLIN CHIM ACTA, V418, P97, DOI 10.1016/j.cca.2012.12.032; Dentener MA, 2000, AM J RESP CELL MOL, V23, P146, DOI 10.1165/ajrcmb.23.2.3855; Donohue TM, 2007, ALCOHOL CLIN EXP RES, V31, P1053, DOI 10.1111/j.1530-0277.2007.00393.x; Douris N, 2011, CURR BIOL, V21, P1347, DOI 10.1016/j.cub.2011.07.018; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Forsyth CB, 2011, ALCOHOL CLIN EXP RES, V35, P1635, DOI 10.1111/j.1530-0277.2011.01510.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; GRUBE BJ, 1994, J BIOL CHEM, V269, P8477; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V298, pG143, DOI 10.1152/ajpgi.00402.2009; Keshavarzian A, 2000, AM J GASTROENTEROL, V95, P1124; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 1997, GENETICS, V146, P1049; Kirpich IA, 2008, ALCOHOL, V42, P675, DOI 10.1016/j.alcohol.2008.08.006; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KLION FM, 1966, AM J PATHOL, V48, P755; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Kudo Takashi, 2009, J Circadian Rhythms, V7, P4, DOI 10.1186/1740-3391-7-4; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; MARRA G, 1994, GASTROENTEROLOGY, V106, P982, DOI 10.1016/0016-5085(94)90757-9; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mcclung CA, 2007, COLD SPRING HARB SYM, V72, P637, DOI 10.1101/sqb.2007.72.031; Meddings JB, 1998, GASTROENTEROLOGY, V114, P83, DOI 10.1016/S0016-5085(98)70636-5; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Morris CJ, 2012, PROG BRAIN RES, V199, P337, DOI 10.1016/B978-0-444-59427-3.00019-8; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; Naylor E, 2000, J NEUROSCI, V20, P8138; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; Nojkov B, 2010, AM J GASTROENTEROL, V105, P842, DOI 10.1038/ajg.2010.48; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Penev PD, 1998, AM J PHYSIOL-HEART C, V275, pH2334; Portaluppi F, 2012, SLEEP MED REV, V16, P151, DOI 10.1016/j.smrv.2011.04.003; Preuss F, 2008, AM J PHYSIOL-REG I, V295, pR2034, DOI 10.1152/ajpregu.00118.2008; Purohit V, 2006, HEPATOLOGY, V43, P872, DOI 10.1002/hep.21107; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Summa KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037668; Swanson G, 2011, ALCOHOL CLIN EXP RES, V35, P1305, DOI 10.1111/j.1530-0277.2011.01466.x; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Takeda N, 2010, HYPERTENS RES, V33, P645, DOI 10.1038/hr.2010.68; Tang YM, 2009, SLEEP MED, V10, P597, DOI 10.1016/j.sleep.2008.12.009; Tipoe GL, 2008, ALCOHOL CLIN EXP RES, V32, P669, DOI 10.1111/j.1530-0277.2008.00623.x; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wang HJ, 2010, WORLD J GASTROENTERO, V16, P1304, DOI 10.3748/wjg.v16.i11.1304; Wimberly AL, 2013, ALCOHOL CLIN EXP RES, V37, pE199, DOI 10.1111/j.1530-0277.2012.01894.x; Wong RK, 2013, ALIMENT PHARM THER; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Zhang R, 2009, J NEUROIMMUNOL, V206, P121, DOI 10.1016/j.jneuroim.2008.09.017	82	153	159	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67102	10.1371/journal.pone.0067102	http://dx.doi.org/10.1371/journal.pone.0067102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825629	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400176
J	Toyoda, D; Taguchi, A; Chiga, M; Ohmori, T; Nishinakamura, R				Toyoda, Daichi; Taguchi, Atsuhiro; Chiga, Masahiko; Ohmori, Tomoko; Nishinakamura, Ryuichi			Sall4 Is Transiently Expressed in the Caudal Wolffian Duct and the Ureteric Bud, but Dispensable for Kidney Development	PLOS ONE			English	Article							TOWNES-BROCKS-SYNDROME; ZINC-FINGER PROTEIN; STEM-CELLS; OKIHIRO-SYNDROME; CAUSATIVE GENE; MURINE HOMOLOG; REGION; PROLIFERATION; PLURIPOTENCY; DROSOPHILA	The kidney, the metanephros, is formed by reciprocal interactions between the metanephric mesenchyme and the ureteric bud, the latter of which is derived from the Wolffian duct that elongates in the rostral-to-caudal direction. Sall1 expressed in the metanephric mesenchyme is essential for ureteric bud attraction in kidney development. Sall4, another member of the Sall gene family, is required for maintenance of embryonic stem cells and establishment of induced pluripotent stem cells, and is thus considered to be one of the stemness genes. Sall4 is also a causative gene for Okihiro syndrome and is essential for the formation of many organs in both humans and mice. However, its expression and role in kidney development remain unknown, despite the essential role of Sall1 in the metanephric mesenchyme. Here, we report that mouse Sall4 is expressed transiently in the Wolffian duct-derived lineage, and is nearly complementary to Sall1 expression. While Sall4 expression is excluded from the Wolffian duct at embryonic (E) day 9.5, Sall4 is expressed in the Wolffian duct weakly in the mesonephric region at E10.5 and more abundantly in the caudal metanephric region where ureteric budding occurs. Sall4 expression is highest at E11.5 in the Wolffian duct and ureteric bud, but disappears by E13.5. We further demonstrate that Sall4 deletion in the Wolffian duct and ureteric bud does not cause any apparent kidney phenotypes. Therefore, Sall4 is expressed transiently in the caudal Wolffian duct and the ureteric bud, but is dispensable for kidney development in mice.	[Toyoda, Daichi; Taguchi, Atsuhiro; Chiga, Masahiko; Ohmori, Tomoko; Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto, Japan; [Nishinakamura, Ryuichi] Kumamoto Univ, Japan Sci Promot Agcy, CREST, Kumamoto, Japan	Kumamoto University; Japan Science & Technology Agency (JST); Kumamoto University	Nishinakamura, R (corresponding author), Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto, Japan.	ryuichi@kumamoto-u.ac.jp		Taguchi, Atsuhiro/0000-0003-1741-2987	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency; CREST	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); CREST(Core Research for Evolutional Science and Technology (CREST))	This study was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Science and Technology Agency, CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Fujimura S, 2010, J AM SOC NEPHROL, V21, P803, DOI 10.1681/ASN.2009040353; Grote D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000316; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Kawakami Y, 2009, DEVELOPMENT, V136, P585, DOI 10.1242/dev.027748; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Nishinakamura R, 2008, KIDNEY INT, V73, P913, DOI 10.1038/sj.ki.5002784; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Ott T, 1996, MECH DEVELOP, V56, P117, DOI 10.1016/0925-4773(96)00516-3; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Sato A, 2004, BIOCHEM BIOPH RES CO, V319, P103, DOI 10.1016/j.bbrc.2004.04.156; Sato A, 2003, MOL CELL BIOL, V23, P62, DOI 10.1128/MCB.23.1.62-69.2003; Srinivas S, 1999, DEV GENET, V24, P241; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Yu J, 2002, DEVELOPMENT, V129, P5301; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14	24	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68508	10.1371/journal.pone.0068508	http://dx.doi.org/10.1371/journal.pone.0068508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825698	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400197
J	Glass, C; Wuertzer, C; Cui, XH; Bi, YT; Davuluri, R; Xiao, YY; Wilson, M; Owens, K; Zhang, Y; Perkins, A				Glass, Carolyn; Wuertzer, Charles; Cui, Xiaohui; Bi, Yingtao; Davuluri, Ramana; Xiao, Ying-Yi; Wilson, Michael; Owens, Kristina; Zhang, Yi; Perkins, Archibald			Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-2; ACUTE MYELOGENOUS LEUKEMIA; COLONY-STIMULATING FACTOR; ISG15 CONJUGATION SYSTEM; BINDING-PROTEIN EPSILON; ZINC-FINGER GENE; CELL-LINES; TRANSCRIPTION FACTORS; GRANULOCYTIC DIFFERENTIATION; RETINOBLASTOMA PROTEIN	The ecotropic virus integration site 1 (EVI1) transcription factor is associated with human myeloid malignancy of poor prognosis and is overexpressed in 8-10% of adult AML and strikingly up to 27% of pediatric MLL-rearranged leukemias. For the first time, we report comprehensive genomewide EVI1 binding and whole transcriptome gene deregulation in leukemic cells using a combination of ChIP-Seq and RNA-Seq expression profiling. We found disruption of terminal myeloid differentiation and cell cycle regulation to be prominent in EVI-induced leukemogenesis. Specifically, we identified EVI1 directly binds to and downregulates the master myeloid differentiation gene Cebpe and several of its downstream gene targets critical for terminal myeloid differentiation. We also found EVI1 binds to and downregulates Serpinb2 as well as numerous genes involved in the Jak-Stat signaling pathway. Finally, we identified decreased expression of several ATP-dependent P2X purinoreceptors genes involved in apoptosis mechanisms. These findings provide a foundation for future study of potential therapeutic gene targets for EVI1-induced leukemia.	[Glass, Carolyn; Wuertzer, Charles; Cui, Xiaohui; Wilson, Michael; Owens, Kristina; Zhang, Yi; Perkins, Archibald] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Bi, Yingtao; Davuluri, Ramana] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Xiao, Ying-Yi] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	University of Rochester; The Wistar Institute; Yale University	Zhang, Y (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.	yi_zhang@urmc.rochester.edu; archibald_perkins@urmc.rochester.edu	Glass, Carolyn/ADD-6348-2022	Zhang, Yi/0000-0003-2785-1780; Glass, Carolyn/0000-0002-8850-9906	National Institutes of Health (NIH) [R01CA120313]; New York State Stem Cell Science (NYSTEM) [C026423]; National Heart Lung Blood Institute; NATIONAL CANCER INSTITUTE [R01CA120313] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science (NYSTEM); National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health (NIH) (R01CA120313 to ASP), New York State Stem Cell Science (NYSTEM) (C026423 to YZ), and a National Heart Lung Blood Institute T32 post-doctoral fellowship grant under Dr. Thomas Pearson, Director of the University of Rochester Clinical Translational Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Akagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015419; Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Arai S, 2011, BLOOD, V117, P6304, DOI 10.1182/blood-2009-07-234310; Balgobind BV, 2010, LEUKEMIA, V24, P942, DOI 10.1038/leu.2010.47; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Bartholomew C, 1997, ONCOGENE, V14, P569, DOI 10.1038/sj.onc.1200864; BARTHOLOMEW C, 1994, ONCOGENE, V9, P939; Bi Y, 2011, TREE BASED POSITION; Bindels EMJ, 2012, BLOOD, V119, P5838, DOI 10.1182/blood-2011-11-393827; BORDEREAUX D, 1990, ONCOGENE, V5, P925; BRUCE AJ, 1992, MATER RES SOC SYMP P, V244, P157; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Buonamici S, 2003, BLOOD CELL MOL DIS, V31, P206, DOI 10.1016/S1079-9796(03)00159-1; Chakraborty S, 2001, J BIOL CHEM, V276, P44936, DOI 10.1074/jbc.M106733200; Chen AG, 2006, WORLD J GASTROENTERO, V12, P7859, DOI 10.3748/wjg.v12.i48.7859; Cong XL, 2010, BLOOD CELL MOL DIS, V45, P103, DOI 10.1016/j.bcmd.2010.05.009; Cristobal I, 2012, HAEMATOL-HEMATOL J, V97, P543, DOI 10.3324/haematol.2011.050542; Cuenco GM, 2004, ONCOGENE, V23, P569, DOI 10.1038/sj.onc.1207143; Darnell GA, 2003, MOL CELL BIOL, V23, P6520, DOI 10.1128/MCB.23.18.6520-6532.2003; De Braekeleer E, 2011, ANTICANCER RES, V31, P3441; De Weer A, 2011, BRIT J HAEMATOL, V154, P337, DOI 10.1111/j.1365-2141.2011.08737.x; Duan RQ, 2001, J BIOL CHEM, V276, P11590, DOI 10.1074/jbc.M005492200; Durfee LA, 2012, METHODS MOL BIOL, V832, P141, DOI 10.1007/978-1-61779-474-2_9; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Ferrari D, 1999, J BIOL CHEM, V274, P13205, DOI 10.1074/jbc.274.19.13205; Ferrari D, 1997, J CELL BIOL, V139, P1635, DOI 10.1083/jcb.139.7.1635; FUNABIKI T, 1994, ONCOGENE, V9, P1575; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; GROSS TJ, 1990, J IMMUNOL, V144, P1873; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Halene S, 2010, EXP HEMATOL, V38, P90, DOI 10.1016/j.exphem.2009.11.004; Hebenstreit D, 2005, DRUG NEWS PERSPECT, V18, P243, DOI 10.1358/dnp.2005.18.4.908658; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; HOLMES KL, 1985, P NATL ACAD SCI USA, V82, P6687, DOI 10.1073/pnas.82.19.6687; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Ihle J, 1984, ADV VIRAL ONCOL, P95; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Jazaeri AA, 2010, GYNECOL ONCOL, V118, P189, DOI 10.1016/j.ygyno.2010.04.007; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Khanna-Gupta A, 2005, EXP HEMATOL, V33, P42, DOI 10.1016/j.exphem.2004.09.009; KhannaGupta A, 1996, ONCOGENE, V12, P563; Kilbey A, 2005, BRIT J HAEMATOL, V130, P902, DOI 10.1111/j.1365-2141.2005.05709.x; Kilbey A, 1999, CELL GROWTH DIFFER, V10, P601; Kim JH, 1998, ONCOGENE, V17, P1527, DOI 10.1038/sj.onc.1202331; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Koos B, 2011, CLIN CANCER RES, V17, P3631, DOI 10.1158/1078-0432.CCR-11-0175; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; KREIDER BL, 1993, P NATL ACAD SCI USA, V90, P6454, DOI 10.1073/pnas.90.14.6454; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Levine R, 2011, CURR TOP MICROBIOL I; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2010, J CLIN ONCOL, V28, P3890, DOI 10.1200/JCO.2010.29.2771; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Mane SP, 2011, METHODS MOL BIOL, V678, P1, DOI 10.1007/978-1-60761-682-5_1; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; MORISHITA K, 1990, ONCOGENE, V5, P963; MORISHITA K, 1992, MOL CELL BIOL, V12, P183, DOI 10.1128/MCB.12.1.183; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Nakajima H, 2006, J BIOL CHEM, V281, P14494, DOI 10.1074/jbc.M600575200; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Pitha-Rowe IF, 2007, CYTOKINE GROWTH F R, V18, P409, DOI 10.1016/j.cytogfr.2007.06.017; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Pradhan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025370; Pradhan AK, 2011, BBA-GENE REGUL MECH, V1809, P269, DOI 10.1016/j.bbagrm.2011.04.007; Qiu Y, 2008, BIOCHEMISTRY-US, V47, P3697, DOI 10.1021/bi702524v; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; RITCHIE H, 1995, BLOOD, V86, P3428, DOI 10.1182/blood.V86.9.3428.bloodjournal8693428; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; SCHLEUNING WD, 1987, MOL CELL BIOL, V7, P4564, DOI 10.1128/MCB.7.12.4564; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; SHIMAMOTO T, 1994, LEUKEMIA, V8, P1176; Sitailo S, 1999, LEUKEMIA, V13, P1639, DOI 10.1038/sj.leu.2401585; Spiekermann K, 2001, EUR J HAEMATOL, V67, P63, DOI 10.1034/j.1600-0609.2001.t01-1-00385.x; Stringer B, 2012, J BIOL CHEM, V287, P10579, DOI 10.1074/jbc.M111.318758; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Suh BC, 2001, J IMMUNOL, V166, P6754, DOI 10.4049/jimmunol.166.11.6754; Swiatkowski S, 2003, EXP CELL RES, V282, P48, DOI 10.1006/excr.2002.5647; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Witt H, 2007, CHROMATIN IMMUNOPREC; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x; Yu H, 2002, BLOOD, V99, P2810, DOI 10.1182/blood.V99.8.2810; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhang XJ, 2009, ACTA BIOCH BIOPH SIN, V41, P362, DOI 10.1093/abbs/gmp016; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P10431, DOI 10.1021/bi200962u; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680	107	44	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67134	10.1371/journal.pone.0067134	http://dx.doi.org/10.1371/journal.pone.0067134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826213	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000031
J	Grossheinrich, N; Reinl, M; Pogarell, O; Karch, S; Mulert, C; Brueckl, M; Hennig-Fast, K; Rau, A; Epple, M; Hornig, A; Padberg, F				Grossheinrich, Nicola; Reinl, Maren; Pogarell, Oliver; Karch, Susanne; Mulert, Christoph; Brueckl, Monika; Hennig-Fast, Kristina; Rau, Anne; Epple, Maria; Hornig, Ariane; Padberg, Frank			Effects of Low Frequency Prefrontal Repetitive Transcranial Magnetic Stimulation on the N2 Amplitude in a GoNogo Task	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; ANTERIOR CINGULATE CORTEX; THETA-BURST STIMULATION; CEREBRAL-BLOOD-FLOW; SENSATION-SEEKING; RESPONSE-INHIBITION; GO/NOGO TASK; DOUBLE-BLIND; FUNCTIONAL CONNECTIVITY; PERSONALITY-TRAITS	During the last decade, repetitive transcranial magnetic stimulation (rTMS) of the prefrontal cortex has become established as a treatment for various mental diseases. The rational of prefrontal stimulation has been adapted from the mode of action known from rTMS using motor-evoked potentials though little is known about the precise effect of rTMS at prefrontal sites. The objective of the current study is to investigate the inhibitory effect of prefrontal 1 Hz rTMS by stimulating the generators of event-related potentials (ERP) which are located in the prefrontal cortex. Thus, 1 Hz rTMS was applied offline over the left dorsolateral prefrontal cortex (DLPFC) and the medial prefrontal cortex (MPFC) in 18 healthy subjects who subsequently underwent a GoNogo task. Both active conditions were compared to sham rTMS within a randomized and counterbalanced cross-over design in one day. ERPs were recorded during task performance and the N2 and the P3 were analysed. After 1 Hz rTMS of the left DLPFC (but not of the MPFC), an inhibitory effect on the N2 amplitude was observed, which was related to inhibitory control. In contrast, after 1 Hz rTMS of the MPFC (but not at the left DLPFC) a trend towards an increased P3 amplitude was found. There was no significant modulation of latencies and behavioural data. The results argue in favour of an inhibitory effect of 1 Hz rTMS on N2 amplitudes in a GoNogo task. Our findings suggest that rTMS may mildly modulate prefrontally generated ERP immediately after stimulation, even where behavioural effects are not measurable. Thus, combined rTMS-ERP approaches need to be further established in order to serve as paradigms in experimental neuroscience and clinical research.	[Grossheinrich, Nicola; Pogarell, Oliver; Karch, Susanne; Hennig-Fast, Kristina; Epple, Maria; Hornig, Ariane; Padberg, Frank] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Grossheinrich, Nicola] Rhein Westfal TH Aachen, Univ Hosp, Child Neuropsychol Sect, Dept Child & Adolescent Psychiat & Psychotherapy, D-52062 Aachen, Germany; [Reinl, Maren] Werner Reichardt Ctr Integrat Neurosci CIN, Tubingen, Germany; [Mulert, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Psychiat Neuroimaging Branch PNB, Hamburg, Germany; [Brueckl, Monika] Univ Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-80539 Munich, Germany; [Rau, Anne] Univ Tubingen, Dept Psychol, Tubingen, Germany	University of Munich; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Eberhard Karls University of Tubingen	Grossheinrich, N (corresponding author), Univ Munich, Dept Psychiat, D-80539 Munich, Germany.	ngrossheinrich@ukaachen.de	Mulert, Christoph/AAB-3210-2020; Großheinrich, Nicola/AAH-3401-2020; Mulert, Christoph/F-2576-2012					Albrecht B, 2008, BIOL PSYCHIAT, V64, P615, DOI 10.1016/j.biopsych.2007.12.016; Albrecht B, 2010, NEUROPSYCHOLOGIA, V48, P1171, DOI 10.1016/j.neuropsychologia.2009.12.018; Anokhin AP, 2004, NEUROSCI LETT, V368, P314, DOI 10.1016/j.neulet.2004.07.036; BALLENGER JC, 1983, PERS INDIV DIFFER, V4, P615, DOI 10.1016/0191-8869(83)90116-2; Beauducel A, 2003, DIAGNOSTICA, V49, P61, DOI 10.1026//0012-1924.49.2.61; Bekker EM, 2005, COGNITIVE BRAIN RES, V22, P221, DOI 10.1016/j.cogbrainres.2004.08.011; Beste C, 2010, NEUROPSYCHOLOGIA, V48, P366, DOI 10.1016/j.neuropsychologia.2009.09.023; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Brass M, 2005, J COGNITIVE NEUROSCI, V17, P1367, DOI 10.1162/0898929054985400; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fallgatter AJ, 2003, PSYCHIAT RES-NEUROIM, V124, P37, DOI 10.1016/S0925-4927(03)00072-6; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; Gallinat J, 2007, NEUROIMAGE, V34, P671, DOI 10.1016/j.neuroimage.2006.10.004; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Grossheinrich N, 2009, BIOL PSYCHIAT, V65, P778, DOI 10.1016/j.biopsych.2008.10.029; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Jonkman LM, 2007, CLIN NEUROPHYSIOL, V118, P1069, DOI 10.1016/j.clinph.2007.01.017; Kanda M, 2003, CLIN NEUROPHYSIOL, V114, P860, DOI 10.1016/S1388-2457(03)00034-8; Karch S, 2010, NEUROIMAGE, V51, P356, DOI 10.1016/j.neuroimage.2010.02.028; Klein E, 1999, ARCH GEN PSYCHIAT, V56, P315, DOI 10.1001/archpsyc.56.4.315; Knoch D, 2006, NEUROIMAGE, V31, P641, DOI 10.1016/j.neuroimage.2005.12.025; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Kropotov JD, 2011, NEUROIMAGE, V57, P565, DOI 10.1016/j.neuroimage.2011.04.060; Kwon HJ, 2011, NEUROSCI LETT, V492, P1, DOI 10.1016/j.neulet.2011.01.007; Lavric A, 2004, EUR J NEUROSCI, V20, P2483, DOI 10.1111/j.1460-9568.2004.03683.x; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; Mantovani A, 2006, INT J NEUROPSYCHOPH, V9, P95, DOI 10.1017/S1461145705005729; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mulert C, 2004, EUR ARCH PSY CLIN N, V254, P190, DOI 10.1007/s00406-004-0469-2; Netter P, 1996, NEUROPSYCHOBIOLOGY, V34, P155, DOI 10.1159/000119318; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Prasko J, 2006, NEUROENDOCRINOL LETT, V27, P327; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; Rollnik JD, 2004, CLIN NEUROPHYSIOL, V115, P145, DOI 10.1016/j.clinph.2003.05.001; Schutter DJLG, 2009, PSYCHOL MED, V39, P65, DOI 10.1017/S0033291708003462; Sehlmeyer C, 2010, NEUROPSYCHOLOGIA, V48, P2488, DOI 10.1016/j.neuropsychologia.2010.04.022; Shabani S, 2011, INT J PSYCHOPHYSIOL, V81, P225, DOI 10.1016/j.ijpsycho.2011.06.015; Speer AM, 2003, BIOL PSYCHIAT, V54, P826, DOI 10.1016/S0006-3223(03)00324-X; Stoel RD, 2006, BEHAV GENET, V36, P229, DOI 10.1007/s10519-005-9028-5; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Thibodeau R, 2006, J ABNORM PSYCHOL, V115, P715, DOI 10.1037/0021-843X.115.4.715; Upton DJ, 2010, CLIN EEG NEUROSCI, V41, P127, DOI 10.1177/155005941004100304; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Watts BV, 2012, BRAIN STIMUL, V5, P38, DOI 10.1016/j.brs.2011.02.002; Zuckerman M, 2007, PERS INDIV DIFFER, V43, P1303, DOI 10.1016/j.paid.2007.03.021	48	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67136	10.1371/journal.pone.0067136	http://dx.doi.org/10.1371/journal.pone.0067136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826214	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000032
J	Marsden, J; Budden, D; Craig, H; Moscato, P				Marsden, John; Budden, David; Craig, Hugh; Moscato, Pablo			Language Individuation and Marker Words: Shakespeare and His Maxwell's Demon	PLOS ONE			English	Article								Background: Within the structural and grammatical bounds of a common language, all authors develop their own distinctive writing styles. Whether the relative occurrence of common words can be measured to produce accurate models of authorship is of particular interest. This work introduces a new score that helps to highlight such variations in word occurrence, and is applied to produce models of authorship of a large group of plays from the Shakespearean era. Methodology: A text corpus containing 55,055 unique words was generated from 168 plays from the Shakespearean era (16th and 17th centuries) of undisputed authorship. A new score, CM1, is introduced to measure variation patterns based on the frequency of occurrence of each word for the authors John Fletcher, Ben Jonson, Thomas Middleton and William Shakespeare, compared to the rest of the authors in the study (which provides a reference of relative word usage at that time). A total of 50 WEKA methods were applied for Fletcher, Jonson and Middleton, to identify those which were able to produce models yielding over 90% classification accuracy. This ensemble of WEKA methods was then applied to model Shakespearean authorship across all 168 plays, yielding a Matthews' correlation coefficient (MCC) performance of over 90%. Furthermore, the best model yielded an MCC of 99%. Conclusions: Our results suggest that different authors, while adhering to the structural and grammatical bounds of a common language, develop measurably distinct styles by the tendency to over-utilise or avoid particular common words and phrasings. Considering language and the potential of words as an abstract chaotic system with a high entropy, similarities can be drawn to the Maxwell's Demon thought experiment; authors subconsciously favour or filter certain words, modifying the probability profile in ways that could reflect their individuality and style.	[Marsden, John; Budden, David; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Craig, Hugh] Univ Newcastle, Ctr Literary & Linguist Comp, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle	Moscato, P (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Budden, David/D-7106-2014	Moscato, Pablo/0000-0003-2570-5966; Budden, David/0000-0003-4372-8985; Craig, Hugh/0000-0002-9336-1678	University of Newcastle	University of Newcastle	This work has been supported by The University of Newcastle thanks to a funding contribution to the Priority Research Centre for Bioinformatics, Biomarker Discovery and Information-based Medicine (2006-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Burrows J., 2007, Literary & Linguistic Computing, V22. no 1, P27, DOI 10.1093/llc/fqi067; Burrows J. F., 1987, Literary & Linguistic Computing, V2, P61, DOI 10.1093/llc/2.2.61; Burrows J. F., 1988, EIGHTEENTH-CENT STUD, V21, P427; Coyotl-Morales RM, 2006, LECT NOTES COMPUT SC, V4225, P844; Craig H., 1999, Literary & Linguistic Computing, V14, P103, DOI 10.1093/llc/14.1.103; Craig H, 2012, SHAKESPEARE QUART, V63, P147, DOI 10.1353/shq.2012.0025; Craig H, 2010, LIT LINGUIST COMPUT, V25, P37, DOI 10.1093/llc/fqp033; Craig Hugh, 2012, SHAKESPEARE COMPUTER, P78; De Saussure F., 2011, COURSE GEN LINGUISTI; Ellegard A., 1962, ACTA U GOTHOBURGENSI, V13; Elliott WEY, 1996, COMPUT HUMANITIES, V30, P191, DOI 10.1007/BF00055107; Forsyth R. S., 1999, Literary & Linguistic Computing, V14, P375, DOI 10.1093/llc/14.3.375; Fox C., 1990, SIGIR Forum, V24, P19, DOI 10.1145/378881.378888; Geisser S, 1993, PREDICTIVE INFERENCE, V55; HIEATT AK, 1987, NOTES QUERIES, V34, P219; Holmes D. I., 2001, Literary & Linguistic Computing, V16, P403, DOI 10.1093/llc/16.4.403; Holmes D. I., 1998, Literary & Linguistic Computing, V13, P111, DOI 10.1093/llc/13.3.111; HOLMES DI, 1994, COMPUT HUMANITIES, V28, P87, DOI 10.1007/BF01830689; Hoover D. L., 2001, Literary & Linguistic Computing, V16, P421, DOI 10.1093/llc/16.4.421; Hope Jonathan, 1994, AUTHORSHIP SHAKESPEA; Hoy Cyrus, 1960, STUDIES BIBLIO, V13, P77; Johnstone B, 1997, LANG SOC, V26, P221, DOI 10.1017/S0047404500020911; JOHNSTONE B, 1996, LINGUISTIC INDIVIDUA; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Jowett John, 2007, GAME CHESS LATER FOR; Knott C, 1911, LIFE SCI WORKS PG TA, V1; Mack R, 1997, B JOHNSON J, V4, P47; Mosteller F, 1964, INFERENCE DISPUTED A; Rosso OA, 2009, PHYSICA A, V388, P916, DOI 10.1016/j.physa.2008.11.018; Rybicki J, 2011, LIT LINGUIST COMPUT, V26, P315, DOI 10.1093/llc/fqr031; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Taylor G, 2007, GAME CHESSE EARLY FO; Vickers B, 2012, SHAKESPEARE, V8, P13, DOI 10.1080/17450918.2012.660283; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; WILBUR WJ, 1992, J INF SCI, V18, P45, DOI 10.1177/016555159201800106; Witten IH, 2011, MOR KAUF D, P1	37	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66813	10.1371/journal.pone.0066813	http://dx.doi.org/10.1371/journal.pone.0066813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	174IX	23826143	Green Published, gold			2022-12-27	WOS:000321150000012
J	Wang, FF; Qiao, YD; Yu, J; Ren, XL; Wang, JM; Ding, Y; Zhang, XJ; Ma, WH; Ding, YQ; Liang, L				Wang, Feifei; Qiao, Yudan; Yu, Jiang; Ren, Xiaoli; Wang, Jianmei; Ding, Yi; Zhang, Xiaojing; Ma, Wenhui; Ding, Yanqing; Liang, Li			FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma	PLOS ONE			English	Article							F-BOX PROTEINS; GENE-EXPRESSION; CYCLIN-E; C-MYC; CANCER; FAMILY; DEGRADATION; PROGRESSION; PREDICTORS; RECURRENCE	Background: F-box only protein 8 (FBX8), a novel component of F-box proteins, is lost in several cancers and has been associated with invasiveness of cancer cells. However, its expression pattern and role in the progression of hepatocellular carcinoma remain unclear. This study investigated the prognostic significance of FBX8 in hepatocellular carcinoma samples and analyzed FBX8 function in hepatocellular carcinoma cells by gene manipulation. Methodology: The expression of FBX8 was detected in 120 cases of clinical paraffin-embedded hepatocellular carcinoma tissues, 20 matched pairs of fresh tissues and five hepatocellular carcinoma cell lines by immunohistochemistry with clinicopathological analyses, real-time RT-PCR or Western blot. The correlation of FBX8 expression with cell proliferation and invasion in five HCC cell lines was analyzed. Moreover, loss of function and gain of function assays were performed to evaluate the effect of FBX8 on cell proliferation, motility, invasion in vitro and metastasis in vivo. Conclusions: We found that FBX8 was obviously down-regulated in HCC tissues and cell lines (P<0.05). The FBX8 down-regulation correlated significantly with poor prognosis, and FBX8 status was identified as an independent significant prognostic factor. Over-expression of FBX8 decreased proliferation, migration and invasion in HepG2 and 97H cells, while knock-down of FBX8 in 7721 cells showed the opposite effect. FBX8 negatively correlated with cell proliferation and invasion in 7701, M3, HepG2 and 97H cell lines. In vivo functional assays showed FBX8 suppressed tumor growth and pulmonary metastatic potential in mice. Our results indicate that down-regulation of FBX8 significantly correlates with invasion, metastasis and poor survival in hepatocellular carcinoma patients. It may be a useful biomarker for therapeutic strategy and control in hepatocellular carcinoma treatment.	[Wang, Feifei; Qiao, Yudan; Ren, Xiaoli; Wang, Jianmei; Ding, Yanqing; Liang, Li] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wang, Feifei; Qiao, Yudan; Ren, Xiaoli; Wang, Jianmei; Ding, Yanqing; Liang, Li] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yu, Jiang; Ma, Wenhui] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Zhang, Xiaojing] Shenzhen Univ, Dept Pathol, Shenzhen, Guangdong, Peoples R China; [Ding, Yi] Southern Med Univ, Nanfang Hosp, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Shenzhen University; Southern Medical University - China	Liang, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	redsnow007@hotmail.com	Ding, Yi/CAG-6304-2022; liang, li/AAB-9126-2022; Wang, Jianmei/HHZ-0585-2022; ma, wenhui/GQZ-0052-2022		National Natural Science Foundation of China [81272759, 81172382, 81071735]; Major projects of National Natural Science Foundation of China [81090422]; Natural Science Foundation of Guangdong Province [S2012010009669]; Research Fund for Subject and Profession development of Higher Education of Guangdong Province [2012KJCX0026]; Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province [2011J2200074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major projects of National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Research Fund for Subject and Profession development of Higher Education of Guangdong Province; Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province	National Natural Science Foundation of China (81272759, 81172382, 81071735); Major projects of National Natural Science Foundation of China (81090422); Natural Science Foundation of Guangdong Province (S2012010009669); Research Fund for Subject and Profession development of Higher Education of Guangdong Province (2012KJCX0026); Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province (2011J2200074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Bengoechea-Alonso MT, 2010, ONCOGENE, V29, P5322, DOI 10.1038/onc.2010.278; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chen BB, 2012, ONCOGENE, V31, P2566, DOI 10.1038/onc.2011.432; Cheng YB, 2012, CANCER METAST REV, V31, P75, DOI 10.1007/s10555-011-9330-z; Cho HJ, 2010, MOL CELLS, V30, P355, DOI 10.1007/s10059-010-0134-8; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Guo Z, 2012, BIOCHEM BIOPH RES CO, V418, P426, DOI 10.1016/j.bbrc.2012.01.054; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; Iwatsuki M, 2010, INT J CANCER, V126, P1828, DOI 10.1002/ijc.24879; Jiang YF, 2000, WORLD J GASTROENTERO, V6, P61, DOI 10.3748/wjg.v6.i1.61; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Li JH, 2012, J CANCER RES CLIN, V138, P763, DOI 10.1007/s00432-012-1154-x; Li JQ, 2004, INT J ONCOL, V25, P87; Li KW, 2012, HEPATO-GASTROENTEROL, V59, P1944, DOI 10.5754/hge11845; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Sakata J, 2008, EJSO-EUR J SURG ONC, V34, P900, DOI 10.1016/j.ejso.2008.01.031; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Vaites LP, 2011, MOL CELL BIOL, V31, P4513, DOI 10.1128/MCB.05733-11; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yang YB, 2007, SURGERY, V141, P196, DOI 10.1016/j.surg.2006.06.033; Yano H, 2008, MOL BIOL CELL, V19, P822, DOI 10.1091/mbc.E07-08-0763; Yokobori T, 2012, INT J ONCOL, V41, P253, DOI 10.3892/ijo.2012.1436; Zhou J, 2006, HEPATO-GASTROENTEROL, V53, P275	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e65495	10.1371/journal.pone.0065495	http://dx.doi.org/10.1371/journal.pone.0065495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826080	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000004
J	Auguste, T; Travert, M; Tarte, K; Ame-Thomas, P; Artchounin, C; Martin-Garcia, N; de Reynies, A; de Leval, L; Gaulard, P; Delfau-Larue, MH				Auguste, Tiphanie; Travert, Marion; Tarte, Karin; Ame-Thomas, Patricia; Artchounin, Catherine; Martin-Garcia, Nadine; de Reynies, Aurelien; de Leval, Laurence; Gaulard, Philippe; Delfau-Larue, Marie-Helene			ROQUIN/RC3H1 Alterations Are Not Found in Angioimmunoblastic T-Cell Lymphoma	PLOS ONE			English	Article							COSTIMULATOR MESSENGER-RNA; POLYMERASE-CHAIN-REACTION; FOLLICULAR HELPER-CELLS; NEOPLASTIC-CELLS; B-CELLS; EXPRESSION; MUTATIONS; AUTOIMMUNITY; FEATURES; PROFILE	Angioimmunoblastic T-cell Lymphoma (AITL) is one of the most frequent T-cell lymphoma entities. Follicular helper T lymphocytes (TFH) are recognized as the normal cellular counterpart of the neoplastic component. Despite a clonal T-cell feature and few described recurrent cytogenetic abnormalities, a driving oncogenic event has not been identified so far. It has been recently reported that in mice, heterozygous inactivation of Roquin/Rc3h1, a RING type E3 ubiquitine ligase, recapitulates many of the clinical, histological, and cellular features associated with human AITL. In this study we explored whether ROQUIN alterations could be an initial event in the human AITL oncogenic process. Using microarray and RT-PCR analyses, we investigated the levels of ROQUIN transcripts in TFH tumor cells purified from AITL (n = 8) and reactive tonsils (n = 12) and found similar levels of ROQUIN expression in both. Moreover, we also demonstrated that ROQUIN protein was expressed by AITL TFH (PD1+) cells. We then analysed ROQUIN coding sequence in 12 tumor cell-rich AITL samples and found no mutation in any of the samples. Finally, we analysed the expression of MiR101, a putative partner of ROQUIN involved in the modulation of ICOS expression and found similar levels of expression in tumor and reactive TFH. Altogether, this study shows that neither alteration of ROQUIN gene nor deregulation of miR101 expression is likely to be a frequent recurrent event in AITL.	[Auguste, Tiphanie; Travert, Marion; Artchounin, Catherine; Martin-Garcia, Nadine; Gaulard, Philippe; Delfau-Larue, Marie-Helene] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Auguste, Tiphanie; Gaulard, Philippe; Delfau-Larue, Marie-Helene] Univ Paris Est, Fac Med, Creteil, France; [Tarte, Karin; Ame-Thomas, Patricia] INSERM, U917, Rennes, France; [de Reynies, Aurelien] Ligue Natl Canc, Programme Cartes Identite Tumeurs, Paris, France; [de Leval, Laurence] Inst Univ Pathol, Serv Pathol Clin, Lausanne, Switzerland; [Artchounin, Catherine; Martin-Garcia, Nadine; Gaulard, Philippe] Grp Hosp Henri Mondor Albert Chenevier, Dept Pathol, Creteil, France; [Delfau-Larue, Marie-Helene] Grp Henri Mondor Albert Chenevier, AP HP, Lab Immunol Biol, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Delfau-Larue, MH (corresponding author), Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France.	marie-helene.delfau@hmn.aphp.fr	de Leval, Laurence/M-4889-2017; de Reyniès, Aurélien/Q-8640-2017; Amé-Thomas, Patricia/C-3131-2017; tarte, karin/GXV-1815-2022	de Leval, Laurence/0000-0003-3994-516X; de Reyniès, Aurélien/0000-0002-1328-5290; Amé-Thomas, Patricia/0000-0001-8042-9250; tarte, karin/0000-0002-6809-917X	Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National du Cancer (INCA); Fondation pour la Recherche Medicale (equipe FRM) [FRM DEQ20100318253]; Plan Cancer (Belgium); Association pour la Recherche Therapeutique, Genetique et Immunologique dans les Lymphomes (ARTGIL); FRM	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale (equipe FRM)(Fondation pour la Recherche Medicale); Plan Cancer (Belgium); Association pour la Recherche Therapeutique, Genetique et Immunologique dans les Lymphomes (ARTGIL); FRM(Fondation pour la Recherche Medicale)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Institut National du Cancer (INCA), the Fondation pour la Recherche Medicale (equipe FRM, FRM DEQ20100318253), the Plan Cancer (Belgium), the Association pour la Recherche Therapeutique, Genetique et Immunologique dans les Lymphomes (ARTGIL). MT was supported by the FRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasopoulos V, 2010, FEBS J, V277, P2109, DOI 10.1111/j.1742-4658.2010.07628.x; Baseggio L, 2011, MODERN PATHOL, V24, P993, DOI 10.1038/modpathol.2011.53; Bruggemann M, 2007, LEUKEMIA, V21, P215, DOI 10.1038/sj.leu.2404481; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Chaligne R, 2007, BLOOD, V110, P3735, DOI 10.1182/blood-2007-05-089003; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; de Leval L, 2010, BRIT J HAEMATOL, V148, P673, DOI 10.1111/j.1365-2141.2009.08003.x; Delfau-Larue MH, 2012, HAEMATOL-HEMATOL J, V97, P1594, DOI 10.3324/haematol.2011.061507; Dupuis J, 2006, AM J SURG PATHOL, V30, P490, DOI 10.1097/00000478-200604000-00009; Ellyard JI, 2012, BLOOD, V120, P812, DOI 10.1182/blood-2011-07-365130; FRIZZERA G, 1974, LANCET, V1, P1070; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Grogg KL, 2005, BLOOD, V106, P1501, DOI 10.1182/blood-2005-03-1083; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Krenacs L, 2006, BLOOD, V108, P1110, DOI 10.1182/blood-2006-01-0394; Lemonnier F, 2012, BLOOD, V120, P1466, DOI 10.1182/blood-2012-02-408542; Marafioti T, 2010, HAEMATOL-HEMATOL J, V95, P432, DOI 10.3324/haematol.2009.010991; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Mourad N, 2008, BLOOD, V111, P4463, DOI 10.1182/blood-2007-08-105759; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Swerdlow SH, 2008, WHO CLASSIFICATION T; Theodorou I, 1996, J PATHOL, V178, P303; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Walker LSK, 2000, IMMUNOL TODAY, V21, P333, DOI 10.1016/S0167-5699(00)01636-4; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	28	11	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e64536	10.1371/journal.pone.0064536	http://dx.doi.org/10.1371/journal.pone.0064536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825522	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000002
J	Benkwitt, CE				Benkwitt, Cassandra E.			Density-Dependent Growth in Invasive Lionfish (Pterois volitans)	PLOS ONE			English	Article							POPULATION REGULATION; LIFE-HISTORY; FISH; MORTALITY; PREDATION; CONSEQUENCES; SCALE; SPP.	Direct demographic density dependence is necessary for population regulation and is a central concept in ecology, yet has not been studied in many invasive species, including any invasive marine fish. The red lionfish (Pterois volitans) is an invasive predatory marine fish that is undergoing exponential population growth throughout the tropical western Atlantic. Invasive lionfish threaten coral-reef ecosystems, but there is currently no evidence of any natural population control. Therefore, a manipulative field experiment was conducted to test for density dependence in lionfish. Juvenile lionfish densities were adjusted on small reefs and several demographic rates (growth, recruitment, immigration, and loss) were measured throughout an 8-week period. Invasive lionfish exhibited direct density dependence in individual growth rates, as lionfish grew slower at higher densities throughout the study. Individual growth in length declined linearly with increasing lionfish density, while growth in mass declined exponentially with increasing density. There was no evidence, however, for density dependence in recruitment, immigration, or loss (mortality plus emigration) of invasive lionfish. The observed density-dependent growth rates may have implications for which native species are susceptible to lionfish predation, as the size and type of prey that lionfish consume is directly related to their body size. The absence of density-dependent loss, however, contrasts with many native coral-reef fish species and suggests that for the foreseeable future manual removals may be the only effective local control of this invasion.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Oregon State University	Benkwitt, CE (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	benkwitc@science.oregonstate.edu		Benkwitt, Cassandra/0000-0001-6756-7958	National Science Foundation [08-51162, 12-33027]; Division Of Ocean Sciences [1233027] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by a National Science Foundation Graduate Research Fellowship awarded to CEB and National Science Foundation research grants (08-51162 and 12-33027) awarded to M. Hixon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Allen G.R., 1973, Pacific Discovery, V26, P3; Almany GR, 2003, ECOLOGY, V84, P1920, DOI 10.1890/0012-9658(2003)084[1920:PEICRF]2.0.CO;2; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Britton JR, 2008, J APPL ICHTHYOL, V24, P694, DOI 10.1111/j.1439-0426.2008.01163.x; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Carr MH, 2002, P NATL ACAD SCI USA, V99, P11241, DOI 10.1073/pnas.162653499; Forrester GE, 2000, ECOLOGY, V81, P2416; Frazer TK, 2012, REV FISH SCI, V20, P185, DOI 10.1080/10641262.2012.700655; Frederick JL, 1997, B MAR SCI, V61, P399; Govindarajulu P, 2005, ECOL APPL, V15, P2161, DOI 10.1890/05-0486; Green SJ, 2009, CORAL REEFS, V28, P107, DOI 10.1007/s00338-008-0446-8; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Gutowsky LFG, 2011, HYDROBIOLOGIA, V671, P27, DOI 10.1007/s10750-011-0701-9; Hixon MA, 2002, ECOLOGY, V83, P1490, DOI 10.2307/3071969; Hixon MA, 2005, ECOLOGY, V86, P2847, DOI 10.1890/04-1455; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hixon MA, 2012, ECOL MONOGR, V82, P467, DOI 10.1890/11-1525.1; Hixon Mark A., 2002, P303, DOI 10.1016/B978-012615185-5/50018-9; Jones G.P., 1991, P294; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; KIRKPATRICK M, 1984, ECOLOGY, V65, P1874, DOI 10.2307/1937785; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; O'Neal SL, 2011, T AM FISH SOC, V140, P623, DOI 10.1080/00028487.2011.585577; Osenberg CW, 2002, ECOL LETT, V5, P715, DOI 10.1046/j.1461-0248.2002.00377.x; Overholtzer-McLeod KL, 2006, ECOLOGY, V87, P1017, DOI 10.1890/0012-9658(2006)87[1017:COPRSF]2.0.CO;2; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Raby GD, 2010, ENVIRON BIOL FISH, V89, P143, DOI 10.1007/s10641-010-9705-y; Reiskind MH, 2010, BIOL INVASIONS, V12, P2319, DOI 10.1007/s10530-009-9646-6; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Steele MA, 2005, P NATL ACAD SCI USA, V102, P13513, DOI 10.1073/pnas.0504306102; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x	41	39	41	3	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66995	10.1371/journal.pone.0066995	http://dx.doi.org/10.1371/journal.pone.0066995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825604	Green Published, gold			2022-12-27	WOS:000321223000057
J	Ferriere, F; Habauzit, D; Pakdel, F; Saligaut, C; Flouriot, G				Ferriere, Francois; Habauzit, Denis; Pakdel, Farzad; Saligaut, Christian; Flouriot, Gilles			Unliganded Estrogen Receptor Alpha Promotes PC12 Survival during Serum Starvation	PLOS ONE			English	Article							BREAST-CANCER; ER-ALPHA; IN-VIVO; ACTIVATION; CELLS; SRC; PHOSPHORYLATION; APOPTOSIS; BETA; DIFFERENTIATION	Many studies have reported proliferative, differentiating or protective effects of estradiol, notably through estrogen receptor alpha (ER alpha). On the contrary, the ligand-independent action of ERa is currently poorly documented notably in cell protection. The stable transfection of wild type, substituted or truncated form of ER alpha in PC12 cells (ER alpha negative cell line) lead the specific study of its ligand-independent action. Hence, we demonstrate here that, in the absence of E-2, the expression of ER alpha prevents cells from apoptosis induced by serum deprivation. This protection is not due to an ERE-mediated transcription and does not require either AF-1 or AF-2 transactivation functions. It is afforded to the Y537 residue of ERa and activation of c-Src/Stat3 signaling pathway.	[Ferriere, Francois; Habauzit, Denis; Pakdel, Farzad; Saligaut, Christian; Flouriot, Gilles] Univ Rennes 1, INSERM, U1085, Transcript Environm & Canc Grp,IRSET, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Ferriere, F (corresponding author), Univ Rennes 1, INSERM, U1085, Transcript Environm & Canc Grp,IRSET, Rennes, France.	francois.ferriere@univ-rennes1.fr	Pakdel, Farzad/K-1700-2015; saligaut, christian/K-3360-2015; Flouriot, Gilles/K-1833-2015; Ferriere, François/K-1817-2015; Habauzit, Denis/K-1779-2015	Pakdel, Farzad/0000-0002-3067-3156; Flouriot, Gilles/0000-0001-6250-4173; Ferriere, François/0000-0002-9190-2397; Habauzit, Denis/0000-0001-8101-3839	Agence National de la Recherche [NEED: CES 2008-011]; CRITT-Sante Bretagne [08007968]; INERIS [NEMO: 189]; CNRS; University of Rennes I	Agence National de la Recherche(French National Research Agency (ANR)); CRITT-Sante Bretagne; INERIS; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes I	This work was supported by grants from Agence National de la Recherche (http://www.agence-nationale-recherche.fr/; project NEED: CES 2008-011), CRITT-Sante Bretagne (http://www.critt-sante.fr/; contract: 08007968) and INERIS (http://www.ineris.fr/; project NEMO: 189). The authors also thank the CNRS and the University of Rennes I to support their work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal MC, 2008, P NATL ACAD SCI USA, V105, P2433, DOI 10.1073/pnas.0712029105; ARNOLD SF, 1995, MOL ENDOCRINOL, V9, P24, DOI 10.1210/me.9.1.24; Barletta F, 2004, MOL ENDOCRINOL, V18, P1096, DOI 10.1210/me.2003-0335; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Brendel A, 2013, RESTOR NEUROL NEUROS, V31, P199, DOI 10.3233/RNN-120272; Cardamone MD, 2009, P NATL ACAD SCI USA, V106, P7420, DOI 10.1073/pnas.0903033106; CASTORIA G, 1993, BIOCHEMISTRY-US, V32, P1740, DOI 10.1021/bi00058a007; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; Ciana P, 2003, NAT MED, V9, P82, DOI 10.1038/nm809; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fernando RI, 2004, MOL BIOL CELL, V15, P3266, DOI 10.1091/mbc.E03-11-0823; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; FROISSARD P, 1994, NEUROCHEM INT, V24, P485, DOI 10.1016/0197-0186(94)90096-5; Gollapudi L, 1999, J NEUROSCI RES, V56, P99, DOI 10.1002/(SICI)1097-4547(19990401)56:1<99::AID-JNR13>3.0.CO;2-G; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Habauzit D, 2011, J TOXICOL ENV HEAL B, V14, P300, DOI 10.1080/10937404.2011.578554; Ju H, 2000, BIOCHEM J, V351, P257, DOI 10.1042/0264-6021:3510257; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li L, 2007, P NATL ACAD SCI USA, V104, P16468, DOI 10.1073/pnas.0704315104; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; Markov GV, 2011, MOL CELL ENDOCRINOL, V334, P21, DOI 10.1016/j.mce.2010.10.017; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Merot Y, 2005, J MOL ENDOCRINOL, V35, P257, DOI 10.1677/jme.1.01826; Merot Y, 2009, ENDOCRINOLOGY, V150, P200, DOI 10.1210/en.2008-0449; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Oka M, 2009, J BIOL CHEM, V284, P30416, DOI 10.1074/jbc.M109.001073; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Poulard C, 2012, EMBO MOL MED, V4, P1200, DOI 10.1002/emmm.201201615; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sun XG, 2010, FEBS J, V277, P4789, DOI 10.1111/j.1742-4658.2010.07884.x; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; Wade CNB, 2003, ENDOCRINOLOGY, V144, P832, DOI 10.1210/en.2002-220899; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; White R, 1997, EMBO J, V16, P1427, DOI 10.1093/emboj/16.6.1427	47	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e69081	10.1371/journal.pone.0069081	http://dx.doi.org/10.1371/journal.pone.0069081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825704	Green Published, gold			2022-12-27	WOS:000321223000132
J	Poisson, A; Ballanger, B; Metereau, E; Redoute, J; Comte, JC; Bernard, HG; Vidailhet, M; Broussolle, E; Thobois, S				Poisson, Alice; Ballanger, Benedicte; Metereau, Elise; Redoute, Jerome; Comte, Jean-Christophe; Bernard, Helene Gervais; Vidailhet, Marie; Broussolle, Emmanuel; Thobois, Stephane			A Functional Magnetic Resonance Imaging Study of Pathophysiological Changes Responsible for Mirror Movements in Parkinson's Disease	PLOS ONE			English	Article							INHIBITORY CONTROL; PREFRONTAL CORTEX; LATERAL PREMOTOR; DEFAULT MODE; NETWORK	Mirror movements correspond to involuntary movements observed in the limb contralateral to the one performing voluntary movement. They can be observed in Parkinson's disease (PD) but their pathophysiology remains unclear. The present study aims at identifying their neural correlates in PD using functional magnetic resonance imaging. Ten control subjects and 14-off drug patients with asymmetrical right-sided PD were included (8 with left-sided mirror movements during right-hand movements, and 6 without mirror movements). Between-group comparisons of BOLD signal were performed during right-hand movements and at rest (p<0.005 uncorrected). The comparison between PD patients with and without mirror movements showed that mirror movements were associated with an overactivation of the insula, precuneus/posterior cingulate cortex bilaterally and of the left inferior frontal cortex and with a deactivation of the right dorsolateral prefrontal cortex, medial prefrontal cortex, and pre-supplementary motor area and occipital cortex. These data suggest that mirror movements in Parkinson's disease are promoted by: 1- a deactivation of the non-mirroring inhibitory network (dorsolateral prefrontal cortex, pre-supplementary motor area); 2- an overactivation of prokinetic areas (notably the insula). The concomitant overactivation of a proactive inhibitory network (including the posterior cingulate cortex and precuneus) could reflect a compensatory inhibition of mirror movements.	[Poisson, Alice; Ballanger, Benedicte; Metereau, Elise; Bernard, Helene Gervais; Broussolle, Emmanuel; Thobois, Stephane] Univ Lyon, Face Med Lyon Sud Charles Merieux, Lyon, France; [Poisson, Alice; Ballanger, Benedicte; Metereau, Elise; Broussolle, Emmanuel; Thobois, Stephane] Ctr Neurosci Cognit, CNRS, UMR5229, Bron, France; [Poisson, Alice; Bernard, Helene Gervais; Broussolle, Emmanuel; Thobois, Stephane] Hospices Civils Lyon, Hosp Neurolog Pierre Wertheimer, Serv Neurol C, Lyon, France; [Ballanger, Benedicte; Metereau, Elise; Redoute, Jerome; Comte, Jean-Christophe; Bernard, Helene Gervais] CERMEP Imagerie Vivant, Lyon, France; [Vidailhet, Marie] CRICM, Fed Nurol, UMR S UPMC INSERM 975, Paris, France; Hop La Pitie Salpetriere, CNRS, UMR 7225, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Thobois, S (corresponding author), Univ Lyon, Face Med Lyon Sud Charles Merieux, Lyon, France.	stephane.thobois@chu-lyon.fr	Thobois, Stephane/H-5083-2017; Broussolle, Emmanuel/H-1592-2017; Ballanger, Benedicte/H-4446-2017; REDOUTE, Jerome/GRR-6921-2022; Metereau, Elise/G-9660-2017	Broussolle, Emmanuel/0000-0002-0410-9519; Ballanger, Benedicte/0000-0002-1901-3501; REDOUTE, Jerome/0000-0002-3741-1546; Metereau, Elise/0000-0001-6868-315X	Association France Parkinson; Societe Francaise de Neurologie	Association France Parkinson; Societe Francaise de Neurologie	This study was funded by a grant from the Association France Parkinson. A. Poisson was supported by a grant from the Societe Francaise de Neurologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Ballanger B, 2008, J NEUROL NEUROSUR PS, V79, P1110, DOI 10.1136/jnnp.2007.141689; Boulinguez P, 2009, CLIN NEUROPHYSIOL, V120, P730, DOI 10.1016/j.clinph.2009.02.167; BRINKMAN C, 1984, J NEUROSCI, V4, P918; CHAN JL, 1988, NEUROLOGY, V38, P59, DOI 10.1212/WNL.38.1.59; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cincotta M, 2006, MOVEMENT DISORD, V21, P1461, DOI 10.1002/mds.20972; Cincotta M, 2006, MOVEMENT DISORD, V21, P1019, DOI 10.1002/mds.20850; Cox Benjamin C, 2012, Tremor Other Hyperkinet Mov (N Y), V2, DOI 10.7916/D8VQ31DZ; Depienne C, 2012, AM J HUM GENET, V90, P301, DOI 10.1016/j.ajhg.2011.12.002; Espay AJ, 2006, J NEUROL NEUROSUR PS, V77, P1194, DOI 10.1136/jnnp.2005.086892; Espay AJ, 2005, J NEUROL NEUROSUR PS, V76, P1355, DOI 10.1136/jnnp.2005.062950; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; GarciaLarrea L, 1996, CORTEX, V32, P679, DOI 10.1016/S0010-9452(96)80038-4; Giovannelli F, 2006, EXP BRAIN RES, V175, P633, DOI 10.1007/s00221-006-0581-9; Hanakawa T, 1999, ANN NEUROL, V45, P329, DOI 10.1002/1531-8249(199903)45:3<329::AID-ANA8>3.0.CO;2-S; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; Jahanshahi M, 1998, BRAIN, V121, P1533, DOI 10.1093/brain/121.8.1533; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Li JY, 2007, MOVEMENT DISORD, V22, P813, DOI 10.1002/mds.21386; Mayston MJ, 1997, BRAIN, V120, P1199, DOI 10.1093/brain/120.7.1199; Mayston MJ, 1999, ANN NEUROL, V45, P583, DOI 10.1002/1531-8249(199905)45:5<583::AID-ANA6>3.0.CO;2-W; Ottaviani D, 2008, MOVEMENT DISORD, V23, P253, DOI 10.1002/mds.21825; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Thobois S, 2006, CLIN THER, V28, P1, DOI 10.1016/j.clinthera.2005.12.003; Thobois S, 2000, NEUROREPORT, V11, P785, DOI 10.1097/00001756-200003200-00026; Vidal JS, 2003, J NEUROL NEUROSUR PS, V74, P1352, DOI 10.1136/jnnp.74.9.1352; WOODS BT, 1978, NEUROLOGY, V28, P1152, DOI 10.1212/WNL.28.11.1152	33	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66910	10.1371/journal.pone.0066910	http://dx.doi.org/10.1371/journal.pone.0066910			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825583	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000040
J	Pirisinu, L; Nonno, R; Esposito, E; Benestad, SL; Gambetti, P; Agrimi, U; Zou, WQ				Pirisinu, Laura; Nonno, Romolo; Esposito, Elena; Benestad, Sylvie L.; Gambetti, Pierluigi; Agrimi, Umberto; Zou, Wen-Quan			Small Ruminant Nor98 Prions Share Biochemical Features with Human Gerstmann-Straussler-Scheinker Disease and Variably Protease-Sensitive Prionopathy	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; ATYPICAL SCRAPIE; PHENOTYPIC VARIABILITY; MONOCLONAL-ANTIBODIES; CLASSICAL SCRAPIE; STRAIN VARIATION; AMYLOID PROTEIN; SHEEP SCRAPIE; PRP	Prion diseases are classically characterized by the accumulation of pathological prion protein (PrPSc) with the protease resistant C-terminal fragment (PrPres) of 27-30 kDa. However, in both humans and animals, prion diseases with atypical biochemical features, characterized by PK-resistant PrP internal fragments (PrPres) cleaved at both the N and C termini, have been described. In this study we performed a detailed comparison of the biochemical features of PrPSc from atypical prion diseases including human Gerstmann-Straussler-Scheinker disease (GSS) and variably protease-sensitive prionopathy (VPSPr) and in small ruminant Nor98 or atypical scrapie. The kinetics of PrPres production and its cleavage sites after PK digestion were analyzed, along with the PrPSc conformational stability, using a new method able to characterize both protease- resistant and protease-sensitive PrPSc components. All these PrPSc types shared common and distinctive biochemical features compared to PrPSc from classical prion diseases such as sporadic Creutzfeldt-Jakob disease and scrapie. Notwithstanding, distinct biochemical signatures based on PrPres cleavage sites and PrPSc conformational stability were identified in GSS A117V, GSS F198S, GSS P102L and VPSPr, which allowed their specific identification. Importantly, the biochemical properties of PrPSc from Nor98 and GSS P102L largely overlapped, but were distinct from the other human prions investigated. Finally, our study paves the way towards more refined comparative approaches to the characterization of prions at the animal-human interface.	[Pirisinu, Laura; Nonno, Romolo; Esposito, Elena; Agrimi, Umberto] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Benestad, Sylvie L.] Norwegian Vet Inst, Oslo, Norway; [Gambetti, Pierluigi; Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Dept Pathol, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA	Istituto Superiore di Sanita (ISS); Norwegian Veterinary Institute; Case Western Reserve University	Pirisinu, L (corresponding author), Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy.	laura.pirisinu@iss.it; wenquan.zou@case.edu	Agrimi, Umberto/C-9956-2015; NONNO, ROMOLO/C-8323-2015; PIRISINU, LAURA/C-8993-2015; Zou, Wenquan/ABF-2875-2020; Zou, Wenquan/GWQ-3489-2022	Agrimi, Umberto/0000-0001-7828-0186; NONNO, ROMOLO/0000-0001-7556-1564; PIRISINU, LAURA/0000-0002-6548-8225; 	Italian Ministry of Health [RF-2009-1474624]; European Union (Neuroprion Network of Excellence) [CT-2004-506579]; National Institutes of Health (NIH) [NS062787]; NIH [AG-08012, AG-14359]; Alliance BioSecure; Center for Disease Control and Prevention [UR8/CCU515004]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359, P50AG008012] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); European Union (Neuroprion Network of Excellence)(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance BioSecure; Center for Disease Control and Prevention; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Italian Ministry of Health (RF-2009-1474624); the European Union (Neuroprion Network of Excellence CT-2004-506579); the National Institutes of Health (NIH) NS062787, NIH AG-08012, AG-14359; Alliance BioSecure, as well as the Center for Disease Control and Prevention Contract UR8/CCU515004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Arsac JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007300; Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; BAKER HF, 1990, BRAIN, V113, P1891, DOI 10.1093/brain/113.6.1891; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Bruce ME, 2007, VET REC, V160, P665, DOI 10.1136/vr.160.19.665; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Choi YP, 2010, J VIROL, V84, P12030, DOI 10.1128/JVI.01057-10; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Colussi S, 2008, J GEN VIROL, V89, P3173, DOI 10.1099/vir.0.2008/004150-0; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; European Commission D-GfHaC Directorate G-Veterinary and International Affairs Unit G4-Food Alert System and Training, 2011, REP MON TEST RUM PRE; Everest SJ, 2006, J GEN VIROL, V87, P471, DOI 10.1099/vir.0.81539-0; Fediaevsky A, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-9; Fediaevsky A, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-19; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Gambetti P, 2011, J MOL NEUROSCI, V45, P422, DOI 10.1007/s12031-011-9543-1; Gielbert A, 2009, J MASS SPECTROM, V44, P384, DOI 10.1002/jms.1516; Gotte DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027510; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; Griffiths PC, 2010, J GEN VIROL, V91, P2132, DOI 10.1099/vir.0.018986-0; Hill AF, 1998, NEUROSCI LETT, V255, P159, DOI 10.1016/S0304-3940(98)00736-8; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jeffrey M, 2006, J COMP PATHOL, V134, P171, DOI 10.1016/j.jcpa.2005.10.003; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Kittelberger R, 2010, J VET DIAGN INVEST, V22, P863, DOI 10.1177/104063871002200604; Klingeborn M, 2006, J GEN VIROL, V87, P1751, DOI 10.1099/vir.0.81618-0; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Loiacono CM, 2009, J VET DIAGN INVEST, V21, P454, DOI 10.1177/104063870902100406; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; Mazza M, 2010, RES VET SCI, V88, P478, DOI 10.1016/j.rvsc.2009.11.015; McIntyre KM, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-13; Migliore S, 2012, J GEN VIROL, V93, P450, DOI 10.1099/vir.0.035469-0; Miller MB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002128; Mitchell GB, 2010, J VET DIAGN INVEST, V22, P408, DOI 10.1177/104063871002200310; Monaco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032382; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; Muramoto T, 2000, NEUROSCI LETT, V288, P179, DOI 10.1016/S0304-3940(00)01232-5; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; O'Rourke KI, 1998, J CLIN MICROBIOL, V36, P1750; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Parchi P, 2010, BRAIN, V133, P3030, DOI 10.1093/brain/awq234; PATTISON IH, 1961, J COMP PATHOL THERAP, V71, P101, DOI 10.1016/S0368-1742(61)80013-1; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Piccardo P, 1996, J NEUROPATH EXP NEUR, V55, P1157, DOI 10.1097/00005072-199611000-00007; Piccardo P, 2001, AM J PATHOL, V158, P2201, DOI 10.1016/S0002-9440(10)64692-5; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Pirisinu L, 2011, EMERG INFECT DIS, V17, P695, DOI 10.3201/eid1704.101215; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; Polymenidou M, 2011, BRAIN PATHOL, V21, P209, DOI 10.1111/j.1750-3639.2010.00439.x; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Simmons Marion M, 2007, BMC Vet Res, V3, P20, DOI 10.1186/1746-6148-3-20; Simmons MM, 2011, EMERG INFECT DIS, V17, P848, DOI 10.3201/eid1705.101654; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Tang Y, 2012, J IMMUNOL METHODS, V380, P30, DOI 10.1016/j.jim.2012.03.004; Tateishi J, 1996, NEUROLOGY, V46, P532, DOI 10.1212/WNL.46.2.532; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Tranulis MA, 2011, TOP CURR CHEM, V305, P23, DOI 10.1007/128_2011_161; Vulin J, 2011, EMERG INFECT DIS, V17, P55, DOI 10.3201/eid1701.100891; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; Wemheuer WM, 2009, AM J PATHOL, V175, P2566, DOI 10.2353/ajpath.2009.090623; Xiao XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058786; Yuan J, 2008, CELL MOL LIFE SCI, V65, P631, DOI 10.1007/s00018-007-7478-z; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831	85	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66405	10.1371/journal.pone.0066405	http://dx.doi.org/10.1371/journal.pone.0066405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826096	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400018
J	Cassels, S; Manhart, L; Jenness, SM; Morris, M				Cassels, Susan; Manhart, Lisa; Jenness, Samuel M.; Morris, Martina			Short-term Mobility and Increased Partnership Concurrency among Men in Zimbabwe	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HIV-INFECTION; RESIDENTIAL-MOBILITY; MIGRATION; RISK; MIGRANT; SPREAD; POPULATION; BEHAVIOR; DISPARITIES	Background:Migration has long been understood as an underlying factor for HIV transmission, and sexual partner concurrency has been increasingly studied as an important component of HIV transmission dynamics. However, less work has examined the role of short-term mobility in sexual partner concurrency using a network approach. Short-term mobility may be a risk for HIV for the migrant's partner as well either through the partner's risk behaviors while the migrant is away, such as the partner having additional partners, or via exposure to the return migrant. Methods: Using data from the 2010-11 Zimbabwe Demographic and Health Survey, weighted generalized linear regression models were used to investigate the associations between short-term mobility and partnership concurrency at the individual and partnership levels. Results: At the individual level, we find strong evidence of an association between short-term mobility and concurrency. Men who traveled were more likely to have concurrent partnerships compared to men who did not travel and the relationship was non-linear: each trip was associated with a 2% higher probability of concurrency, with a diminishing risk at 60 trips (p<0.001). At the partnership level, short-term mobility by the male only or both partners was associated with male concurrency. Couples in which the female only traveled exhibited less male concurrency. Conclusions: Short-term mobility has the ability to impact population-level transmission dynamics by facilitating partnership concurrency and thus onward HIV transmission. Short-term migrants may be an important population to target for HIV testing, treatment, or social and behavioral interventions to prevent the spread of HIV.	[Cassels, Susan; Manhart, Lisa; Jenness, Samuel M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Cassels, Susan] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cassels, S (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	scassels@uw.edu	Morris, Martina/I-7510-2012		NICHD [R00 HD057533, 5R24HD042828]; UW Center for AIDS Research SPRC [P30 AI027757]; UW Center for Studies in Demography and Ecology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UW Center for AIDS Research SPRC; UW Center for Studies in Demography and Ecology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the NICHD (R00 HD057533) and the UW Center for AIDS Research SPRC (P30 AI027757). Computing support was provided by a NICHD research infrastructure grant (5R24HD042828), to the UW Center for Studies in Demography and Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah ASM, 2004, CLIN INFECT DIS, V39, P533, DOI 10.1086/422721; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Anglewicz Philip, 2012, Demography, V49, P239, DOI 10.1007/s13524-011-0072-x; [Anonymous], 2007, ZIMB DEM HLTH SURV 2; Bailey JA, 2011, ARCH SEX BEHAV, V40, P951, DOI 10.1007/s10508-010-9633-0; Brockerhoff M, 1999, INT MIGR REV, V33, P833, DOI 10.2307/2547354; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Carnegie NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043048; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Feliciano C, 2005, INT MIGR REV, V39, P841, DOI 10.1111/j.1747-7379.2005.tb00291.x; Gasper J, 2010, SOC SCI RES, V39, P459, DOI 10.1016/j.ssresearch.2009.08.009; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Greif MJ, 2011, HEALTH PLACE, V17, P86, DOI 10.1016/j.healthplace.2010.08.019; Haynie DL, 2006, SOCIOL QUART, V47, P693, DOI 10.1111/j.1533-8525.2006.00063.x; Hunter M, 2010, HEALTH PLACE, V16, P25, DOI 10.1016/j.healthplace.2009.08.003; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Kretzschmar M, 2010, AIDS, V24, P313, DOI 10.1097/QAD.0b013e328333eb9d; Kwena ZA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054523; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Lee D, 2007, AM J DRUG ALCOHOL AB, V33, P799, DOI 10.1080/00952990701653727; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Lydie N, 2004, JAIDS-J ACQ IMM DEF, V35, P67, DOI 10.1097/00126334-200401010-00010; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M., 2012, 19 INT AIDS C WASH D; Morris M, 2010, 18 INT AIDS C VIENN; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Mundandi C, 2006, TROP MED INT HEALTH, V11, P705, DOI 10.1111/j.1365-3156.2006.01614.x; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; QUINN TC, 1994, P NATL ACAD SCI USA, V91, P2407, DOI 10.1073/pnas.91.7.2407; Reniers G, 2010, AIDS, V24, P299, DOI 10.1097/QAD.0b013e328333af03; Sambisa W, 2006, RURAL SOCIOL, V71, P183, DOI 10.1526/003601106777789684; Thomas KJA, 2012, DEMOGRAPHY, V49, P477, DOI 10.1007/s13524-012-0091-2; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS Reference Grp Estimates Mod, 2010, LANCET, V375, P621, DOI 10.1016/S0140-6736(09)62040-7; Vissers DCJ, 2008, SEX TRANSM DIS, V35, P714, DOI 10.1097/OLQ.0b013e3181723d93; Voeten HACM, 2010, SEX TRANSM DIS, V37, P240, DOI 10.1097/OLQ.0b013e3181c3f2d0; Walker PT, 2008, SEX TRANSM INFECT, V84, pII42, DOI 10.1136/sti.2008.029975; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2; Zuma K, 2005, EPIDEMIOL INFECT, V133, P421, DOI 10.1017/S0950268804003607	46	21	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66342	10.1371/journal.pone.0066342	http://dx.doi.org/10.1371/journal.pone.0066342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23824635	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400090
J	Gao, H; Meng, J; Xu, MJ; Zhang, S; Ghose, B; Liu, J; Yao, P; Yan, H; Wang, D; Liu, LG				Gao, Hui; Meng, Jie; Xu, Mengjing; Zhang, Shun; Ghose, Bishwajit; Liu, Jun; Yao, Ping; Yan, Hong; Wang, Di; Liu, Liegang			Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population	PLOS ONE			English	Article							GRADE CHRONIC INFLAMMATION; HEAT-SHOCK PROTEINS; INSULIN-RESISTANCE; SYNDROME PCOS; OXIDATIVE STRESS; LEAN WOMEN; HSP70; EXPRESSION; MARKERS; HEALTH	Background: Polycystic ovary syndrome (PCOS) represents the most common cause of anovulatory infertility and affects 6-15% of women of reproductive age. However, the underlying etiology is still poorly understood. In this study, we attempted to examine the association between circulating heat shock protein 70 (Hsp70) concentrations and PCOS in a non-obese Chinese population. Methods and Results: Human peripheral blood from 52 patients with PCOS and 57 healthy controls, matched for age and BMI, were analyzed. Women with PCOS were found to have significantly higher fasting insulin (FI) levels, as well as Insulin resistance index (HOMA-IR) (P < 0.05). Identically, markers of oxidative stress (malondialdehyde (MDA), 8-Hydroxy-desoxyguanosine (8-OHdG), Nitric oxide (NO)) and inflammation (tumor necrosis factor-alpha (TNF-alpha), C-reactive protein (CRP)) were markedly increased when compared to controls (P < 0.05). Elevated serum Hsp70 was positively correlated with IR, oxidative stress and inflammation in PCOS, even after adjustment for age, BMI and gynecologic inflammation (GI). The receiver-operating characteristic curve (ROC) analysis yielded notably different discriminative value for PCOS, with or without an addition of Hsp70 (areas under the curves were 0.884 (95% CI 0.822-0.946) vs. 0.822 (95% CI 0.744-0.900); P for difference = 0.015). Conclusions and Significance: Increased serum Hsp70 levels are associated with the combination of IR, oxidative stress and low-grade chronic inflammation in PCOS individuals, which provides supportive evidence that Hsp70 plays a key role in the pathogenesis of PCOS. More consequent studies were warranted to confirm the clinical utility of circulating Hsp70, especially in diagnosis and prognosis of PCOS and its long-term health cost.	[Gao, Hui; Xu, Mengjing; Ghose, Bishwajit; Liu, Jun; Yao, Ping; Wang, Di; Liu, Liegang] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Sch Publ Hlth,Tongji Med Coll, Wuhan 430074, Peoples R China; [Gao, Hui; Xu, Mengjing; Zhang, Shun; Ghose, Bishwajit; Liu, Jun; Yao, Ping; Yan, Hong; Wang, Di; Liu, Liegang] Huazhong Univ Sci & Technol, MOE Key Lab Environm & Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wang, Di] Xiangyang Food & Drug Adm, Xiangyang, Peoples R China; [Meng, Jie] Huazhong Univ Sci & Technol, Reprod Med Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, D (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Sch Publ Hlth,Tongji Med Coll, Wuhan 430074, Peoples R China.	wad1983@126.com; lgliu@mails.tjmu.edu.cn	Ghose, Bishwajit/L-8479-2015; Zhang, Shun/AHD-3782-2022	Ghose, Bishwajit/0000-0003-4461-3821; 	National Science and Technology Support Program of China [2012BAI02B02]; National Natural Science Foundation of China [81202210]	National Science and Technology Support Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Science and Technology Support Program of China (2012BAI02B02) and National Natural Science Foundation of China (No. 81202210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Bironaite D, 2013, J CELL BIOCH; Black MH, 2013, J NUTR, V143, P479, DOI 10.3945/jn.112.170449; Bozdag G, 2010, EXPERT REV OBSTET GY, V5, P67, DOI [10.1586/eog.09.73, DOI 10.1586/E0G.09.73]; Chae JI, 2013, INT J CARDIOL, V165, P341, DOI 10.1016/j.ijcard.2012.07.013; Chittenden BG, 2009, REPROD BIOMED ONLINE, V19, P398, DOI 10.1016/S1472-6483(10)60175-7; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; Cohen IR, 2007, J AUTOIMMUN, V29, P246, DOI 10.1016/j.jaut.2007.07.016; de Groot PCM, 2011, HUM REPROD UPDATE, V17, P495, DOI 10.1093/humupd/dmr001; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gambineri A, 2012, DIABETES, V61, P2369, DOI 10.2337/db11-1360; Gonzalez F, 2006, J CLIN ENDOCR METAB, V91, P336, DOI 10.1210/jc.2005-1696; Gonzalez F, 2009, METABOLISM, V58, P954, DOI 10.1016/j.metabol.2009.02.022; JACQUIERSARLIN MR, 1994, EXPERIENTIA, V50, P1031, DOI 10.1007/BF01923458; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Karadeniz M, 2008, EXP CLIN ENDOCR DIAB, V116, P231, DOI 10.1055/s-2007-992154; Kelly CCJ, 2001, J CLIN ENDOCR METAB, V86, P2453, DOI 10.1210/jc.86.6.2453; Kurucz I, 2002, DIABETES, V51, P1102, DOI 10.2337/diabetes.51.4.1102; Lavie L, 2010, J SLEEP RES, V19, P139, DOI 10.1111/j.1365-2869.2009.00789.x; Liu Jin, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P187; Malyshev I., 2013, IMMUNITY TUMORS AGIN, V6, P113, DOI [10.1111/j.1365- 2702.2009.02945.x, DOI 10.1111/J.1365-2702.2009.02945.X]; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Marucci A, 2009, J MOL MED, V87, P139, DOI 10.1007/s00109-008-0429-9; McCarty MF, 2006, MED HYPOTHESES, V66, P527, DOI 10.1016/j.mehy.2004.08.033; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Molvarec A, 2010, CELL STRESS CHAPERON, V15, P237, DOI 10.1007/s12192-009-0146-5; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Murri M, 2013, HUM REPROD UPDATE, V19, P268, DOI 10.1093/humupd/dms059; Nakhjavani M, 2012, GENE, V498, P107, DOI 10.1016/j.gene.2012.01.085; Nakhjavani M, 2010, CELL STRESS CHAPERON, V15, P959, DOI 10.1007/s12192-010-0204-z; Narayansingh RM, 2004, CAN J PHYSIOL PHARM, V82, P363, DOI [10.1139/y04-032, 10.1139/Y04-032]; Nestler JE, 1997, J CLIN ENDOCR METAB, V82, P4075, DOI 10.1210/jc.82.12.4075; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pockley AG, 1998, IMMUNOL INVEST, V27, P367, DOI 10.3109/08820139809022710; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Shumak SL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b954; Tarkun I, 2004, J CLIN ENDOCR METAB, V89, P5592, DOI 10.1210/jc.2004-0751; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Teede HJ, 2010, FERTIL STERIL, V93, P184, DOI 10.1016/j.fertnstert.2008.09.034; Terry DF, 2004, ANN NY ACAD SCI, V1019, P502, DOI 10.1196/annals.1297.092; Vince RV, 2010, AMINO ACIDS, V38, P1423, DOI 10.1007/s00726-009-0354-4; Wieten L, 2010, ARTHRITIS RHEUM-US, V62, P1026, DOI 10.1002/art.27344; Wijeyaratne CN, 2011, HUM REPROD, V26, P202, DOI 10.1093/humrep/deq310; Wijeyaratne CN, 2002, CLIN ENDOCRINOL, V57, P343, DOI 10.1046/j.1365-2265.2002.01603.x; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Zhang XM, 2010, CELL STRESS CHAPERON, V15, P675, DOI 10.1007/s12192-010-0180-3; Zimmermann M, 2012, CLIN CHIM ACTA, V413, P1115, DOI 10.1016/j.cca.2012.03.008	50	19	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67727	10.1371/journal.pone.0067727	http://dx.doi.org/10.1371/journal.pone.0067727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825680	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400192
J	Hunsicker, ME; Ciannelli, L; Bailey, KM; Zador, S; Stige, LC				Hunsicker, Mary E.; Ciannelli, Lorenzo; Bailey, Kevin M.; Zador, Stephani; Stige, Leif Christian			Climate and Demography Dictate the Strength of Predator-Prey Overlap in a Subarctic Marine Ecosystem	PLOS ONE			English	Article							POLLOCK THERAGRA-CHALCOGRAMMA; EASTERN BERING-SEA; FUTURE CLIMATE; RECRUITMENT; SHIFTS; DISTRIBUTIONS; CANNIBALISM; TEMPERATURE; ABUNDANCE; SURVIVAL	There is growing evidence that climate and anthropogenic influences on marine ecosystems are largely manifested by changes in species spatial dynamics. However, less is known about how shifts in species distributions might alter predator-prey overlap and the dynamics of prey populations. We developed a general approach to quantify species spatial overlap and identify the biotic and abiotic variables that dictate the strength of overlap. We used this method to test the hypothesis that population abundance and temperature have a synergistic effect on the spatial overlap of arrowtooth flounder (predator) and juvenile Alaska walleye pollock (prey, age-1) in the eastern Bering Sea. Our analyses indicate that (1) flounder abundance and temperature are key variables dictating the strength of flounder and pollock overlap, (2) changes in the magnitude of overlap may be largely driven by density-dependent habitat selection of flounder, and (3) species overlap is negatively correlated to juvenile pollock recruitment when flounder biomass is high. Overall, our findings suggest that continued increases in flounder abundance coupled with the predicted long-term warming of ocean temperatures could have important implications for the predator-prey dynamics of arrowtooth flounder and juvenile pollock. The approach used in this study is valuable for identifying potential consequences of climate variability and exploitation on species spatial dynamics and interactions in many marine ecosystems.	[Hunsicker, Mary E.; Ciannelli, Lorenzo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Bailey, Kevin M.; Zador, Stephani] NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Stige, Leif Christian] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Oslo	Hunsicker, ME (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	hunsicker@nceas.ucsb.edu	Stige, Leif Christian/P-6806-2015	Stige, Leif Christian/0000-0002-6808-1383	National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) program; Research Council of Norway	National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) program; Research Council of Norway(Research Council of Norway)	The National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) (http://cameo.noaa.gov/) program funded MEH, LC, and KMB for this work and the Research Council of Norway provided support for LCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna E, 2008, AFSC181 NOAA NMFS US; [Anonymous], 2004, NMFSFSPO65 NOAA US D; Armistead CE, 1993, AFSC7 NOAA NMFS US D; Bacheler NM, 2010, FISH OCEANOGR, V19, P107, DOI 10.1111/j.1365-2419.2009.00531.x; Bailey KM, 2012, MAR ECOL PROG SER, V452, P205, DOI 10.3354/meps09614; BAILEY KM, 1989, MAR ECOL PROG SER, V53, P205, DOI 10.3354/meps053205; Bailey KM, 2000, MAR ECOL PROG SER, V198, P215, DOI 10.3354/meps198215; Boldt JL, 2012, FISH B-NOAA, V110, P293; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Ciannelli L, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P143; Ciannelli L, 2005, MAR ECOL PROG SER, V291, P227, DOI 10.3354/meps291227; Ciannelli L, 2004, ECOLOGY, V85, P3418, DOI 10.1890/03-0755; Ciannelli L, 2007, ECOLOGY, V88, P635, DOI 10.1890/05-2035; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Duffy-Anderson JT, 2003, BIG FISH BANG, P381; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; HOLLOWED AB, 1992, ICES MAR SC, V195, P433; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Ianelli J.N., 2011, STOCK ASSESSMENT FIS; Kotwicki S, 2005, FISH B-NOAA, V103, P574; Mueter FJ, 2006, PROG OCEANOGR, V68, P152, DOI 10.1016/j.pocean.2006.02.012; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Spencer PD, 2008, FISH OCEANOGR, V17, P396, DOI 10.1111/j.1365-2419.2008.00486.x; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Swain DP, 2006, FISH OCEANOGR, V15, P166, DOI 10.1111/j.1365-2419.2006.00357.x; Wang MY, 2012, DEEP-SEA RES PT II, V65-70, P46, DOI 10.1016/j.dsr2.2012.02.022; Wespestad VG, 2000, ICES J MAR SCI, V57, P272, DOI 10.1006/jmsc.2000.0640; Wilderbuer T.K., 2010, STOCK ASSESSMENT FIS; Wilderbuer TK, 2002, STOCK ASSESSMENT FIS; WILLIAMSON CE, 1993, ECOLOGY, V74, P320, DOI 10.2307/1939295; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wyllie-Echeverria T, 1998, FISH OCEANOGR, V7, P159, DOI 10.1046/j.1365-2419.1998.00058.x; Zador S, 2011, MAR ECOL PROG SER, V438, P229, DOI 10.3354/meps09316	46	39	39	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66025	10.1371/journal.pone.0066025	http://dx.doi.org/10.1371/journal.pone.0066025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824707	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400047
J	Kalhori, V; Kemppainen, K; Asghar, MY; Bergelin, N; Jaakkola, P; Tornquist, K				Kalhori, Veronica; Kemppainen, Kati; Asghar, Muhammad Yasir; Bergelin, Nina; Jaakkola, Panu; Tornquist, Kid			Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1 alpha in Thyroid Follicular Carcinoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PROTEIN-COUPLED RECEPTOR; P70 S6 KINASE; SPHINGOSINE 1-PHOSPHATE; FACTOR 1-ALPHA; HIF-ALPHA; PHOSPHORYLATION; EXPRESSION; ACTIVATION; EIF4E	Sphingosine-1-phosphate (S1P) is a bioactive lipid, which regulates several cancer-related processes including migration and angiogenesis. We have previously shown S1P to induce migration of follicular ML-1 thyroid cancer cells. Hypoxia-induced factor-1 (HIF-1) is an oxygen-sensitive transcription factor, which adapts cells to hypoxic conditions through increased survival, motility and angiogenesis. Due to these properties and its increased expression in response to intratumoral hypoxia, HIF-1 is considered a significant regulator of tumor biology. We found S1P to increase expression of the regulatory HIF-1 alpha subunit in normoxic ML-1 cells. S1P also increased HIF-1 activity and expression of HIF-1 target genes. Importantly, inhibition or knockdown of HIF-1 alpha attenuated the S1P-induced migration of ML-1 cells. S1P-induced HIF-1 alpha expression was mediated by S1P receptor 3 (S1P(3)), G(i) proteins and their downstream effectors MEK, PI3K, mTOR and PKC beta I. Half-life measurements with cycloheximide indicated that S1P treatment stabilized the HIF-1 alpha protein. On the other hand, S1P activated translational regulators eIF-4E and p70S6K, which are known to control HIF-1 alpha synthesis. In conclusion, we have identified S1P as a non-hypoxic regulator of HIF-1 activity in thyroid cancer cells, studied the signaling involved in S1P-induced HIF-1 alpha expression and shown S1P-induced migration to be mediated by HIF-1.	[Kalhori, Veronica; Kemppainen, Kati; Asghar, Muhammad Yasir; Bergelin, Nina; Tornquist, Kid] Abo Akad Univ, Dept Biosci, Turku, Finland; [Kalhori, Veronica; Bergelin, Nina; Tornquist, Kid] Minerva Fdn Inst, Helsinki, Finland; [Jaakkola, Panu] Turku Ctr Biotechnol, Turku, Finland	Abo Akademi University; University of Turku	Tornquist, K (corresponding author), Abo Akad Univ, Dept Biosci, Turku, Finland.	ktornqvi@abo.fi	Jaakkola, Panu M/B-4355-2012; Asghar, Muhammad Yasir/AAX-4895-2020	Asghar, Muhammad Yasir/0000-0002-1935-8462; Jaakkola, Panu/0000-0002-2365-4985; Kemppainen, Kati/0000-0003-3785-2269	Sigrid Juselius Foundation; Liv och Halsa Foundation; Academy of Finland; Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); cancer research funds; Magnus Ehrnrooth's Foundationand; Suomen Kulttuurirahasto Foundation; Stiftelsens for Abo Akademi forskningsinstitute; K. Albin Johanssos stiftelse; Receptor Research Program (Abo Akademi University); Receptor Research Program (University of Turku)	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Liv och Halsa Foundation; Academy of Finland(Academy of Finland); Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); cancer research funds; Magnus Ehrnrooth's Foundationand; Suomen Kulttuurirahasto Foundation; Stiftelsens for Abo Akademi forskningsinstitute; K. Albin Johanssos stiftelse; Receptor Research Program (Abo Akademi University); Receptor Research Program (University of Turku)	The study was supported in part by the Sigrid Juselius Foundation, the Liv och Halsa Foundation, The Academy of Finland, the Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University), by cancer research funds donated to Abo Akademi University, by the Magnus Ehrnrooth's Foundationand, by the Suomen Kulttuurirahasto Foundation, the Stiftelsens for Abo Akademi forskningsinstitute, K. Albin Johanssos stiftelse and the Receptor Research Program (Abo Akademi University and the University of Turku), which are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; Ahmad M, 2006, PROSTAG OTH LIPID M, V79, P278, DOI 10.1016/j.prostaglandins.2006.03.001; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Balthasar S, 2008, ENDOCR-RELAT CANCER, V15, P521, DOI 10.1677/ERC-07-0253; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Bergelin N, 2009, ENDOCRINOLOGY, V150, P2055, DOI 10.1210/en.2008-0625; Bergelin N, 2010, ENDOCRINOLOGY, V151, P2994, DOI [10.1210/en.2009-1387, 10.1210//en.2009-1387]; Burrows N, 2010, ENDOCR-RELAT CANCER, V17, P61, DOI 10.1677/ERC-08-0251; Chae SS, 2004, DEV BIOL, V268, P441, DOI 10.1016/j.ydbio.2004.01.001; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goodfellow IG, 2008, INT J BIOCHEM CELL B, V40, P2675, DOI 10.1016/j.biocel.2007.10.023; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Herr B, 2009, BLOOD, V114, P2140, DOI 10.1182/blood-2009-01-201889; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kim BS, 2011, BIOCHEM BIOPH RES CO, V413, P189, DOI 10.1016/j.bbrc.2011.08.055; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Koide Y, 2002, J MED CHEM, V45, P4629, DOI 10.1021/jm020080c; Lauzier MC, 2007, ENDOCRINOLOGY, V148, P4023, DOI 10.1210/en.2007-0285; Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Michaud MD, 2009, ARTERIOSCL THROM VAS, V29, P902, DOI 10.1161/ATVBAHA.109.185280; Moroz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005077; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Schwalm S, 2008, BIOCHEM BIOPH RES CO, V368, P1020, DOI 10.1016/j.bbrc.2008.01.132; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Silva RLA, 2008, CELL CYCLE, V7, P553, DOI 10.4161/cc.7.5.5486; Srinivasan S, 2008, DIABETES, V57, P484, DOI 10.2337/db07-0855; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Zhang QZ, 2007, CLIN CANCER RES, V13, P4686, DOI 10.1158/1078-0432.CCR-06-2898; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	49	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66189	10.1371/journal.pone.0066189	http://dx.doi.org/10.1371/journal.pone.0066189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824493	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400065
J	Wang, WJ; He, HS; Spetich, MA; Shifley, SR; Thompson, FR; Fraser, JS				Wang, Wen J.; He, Hong S.; Spetich, Martin A.; Shifley, Stephen R.; Thompson, Frank R., III; Fraser, Jacob S.			Modeling the Effects of Harvest Alternatives on Mitigating Oak Decline in a Central Hardwood Forest Landscape	PLOS ONE			English	Article							SPECIES COMPOSITION; MORTALITY; ARKANSAS; INDEX	Oak decline is a process induced by complex interactions of predisposing factors, inciting factors, and contributing factors operating at tree, stand, and landscape scales. It has greatly altered species composition and stand structure in affected areas. Thinning, clearcutting, and group selection are widely adopted harvest alternatives for reducing forest vulnerability to oak decline by removing susceptible species and declining trees. However, the long-term, landscape-scale effects of these different harvest alternatives are not well studied because of the limited availability of experimental data. In this study, we applied a forest landscape model in combination with field studies to evaluate the effects of the three harvest alternatives on mitigating oak decline in a Central Hardwood Forest landscape. Results showed that the potential oak decline in high risk sites decreased strongly in the next five decades irrespective of harvest alternatives. This is because oak decline is a natural process and forest succession (e.g., high tree mortality resulting from intense competition) would eventually lead to the decrease in oak decline in this area. However, forest harvesting did play a role in mitigating oak decline and the effectiveness varied among the three harvest alternatives. The group selection and clearcutting alternatives were most effective in mitigating oak decline in the short and medium terms, respectively. The long-term effects of the three harvest alternatives on mitigating oak decline became less discernible as the role of succession increased. The thinning alternative had the highest biomass retention over time, followed by the group selection and clearcutting alternatives. The group selection alternative that balanced treatment effects and retaining biomass was the most viable alternative for managing oak decline. Insights from this study may be useful in developing effective and informed forest harvesting plans for managing oak decline.	[Wang, Wen J.; He, Hong S.; Fraser, Jacob S.] Univ Missouri, Sch Nat Resources, Columbia, MO 65211 USA; [Spetich, Martin A.] US Forest Serv, USDA, Arkansas Forestry Sci Lab, Southern Res Stn, Hot Spring, AR USA; [Shifley, Stephen R.; Thompson, Frank R., III] US Forest Serv, USDA, No Res Stn, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia	He, HS (corresponding author), Univ Missouri, Sch Nat Resources, Columbia, MO 65211 USA.	heh@missouri.edu		Fraser, Jacob/0000-0002-4960-3713; He, Hong S./0000-0002-3983-2512	U.S Forest Service South Central Research Station; University of Missouri GIS Mission Enhancement Program	U.S Forest Service South Central Research Station; University of Missouri GIS Mission Enhancement Program	This research was funded by the U.S Forest Service South Central Research Station, and the University of Missouri GIS Mission Enhancement Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns R.M., 1990, USDA FOREST SERVICE, V2; Burrill EA, 1999, CAN J FOREST RES, V29, P347, DOI 10.1139/cjfr-29-3-347; Chapman RA, 2006, FOREST ECOL MANAG, V236, P85, DOI 10.1016/j.foreco.2006.08.341; Clatterbuck WK, 2005, PROFESSIONAL HARDWOO; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Dijak William, 2013, Computational Ecology and Software, V3, P17; Dwyer JP, 2007, NORTH J APPL FOR, V24, P123, DOI 10.1093/njaf/24.2.123; Fan ZF, 2008, FOREST ECOL MANAG, V255, P2297, DOI 10.1016/j.foreco.2007.12.041; Fan ZF, 2011, NORTH J APPL FOR, V28, P19, DOI 10.1093/njaf/28.1.19; Foti T. L., 2004, General Technical Report - Southern Research Station, USDA Forest Service, P21; Fraser JS, 2013, CANADIAN J IN PRESS; Heitzman E, 2003, SOUTH J APPL FOR, V27, P264, DOI 10.1093/sjaf/27.4.264; Heitzman E, 2007, SOUTH J APPL FOR, V31, P17, DOI 10.1093/sjaf/31.1.17; Hulting DJ, 2006, THESIS U MISSOURI; Johnson P. S., 2009, The ecology and silviculture of oaks, DOI 10.1079/9781845934743.0000; Kabrick J. M., 2007, General Technical Report - Southern Research Station, USDA Forest Service, P181; KABRICK JM, 2004, P 14 CENTR HARDW FOR, P27; Kabrick JM, 2008, FOREST ECOL MANAG, V255, P1409, DOI 10.1016/j.foreco.2007.10.054; Kessler Jr KJ, 1992, NC362 USDA FOR SERV; Loewenstein EF, 2000, CAN J FOREST RES, V30, P1060, DOI 10.1139/cjfr-30-7-1060; Luo YQ, 2011, ECOL APPL, V21, P1429; Manion P. D., 1991, Tree disease concepts.; Manion P.D., 1992, FOREST DECLINE CONCE; Moorcroft PR, 2006, TRENDS ECOL EVOL, V21, P400, DOI 10.1016/j.tree.2006.04.009; Oak S, 1996, ANN SCI FOREST, V53, P721, DOI 10.1051/forest:19960248; Oak SW, 2004, P UPL OAK EC S HIST, P217; Oliver C.D., 1996, FOREST STAND DYNAMIC; Poole E. A., 2006, General Technical Report - Southern Research Station, USDA Forest Service, P428; Reineke LH, 1933, J AGRIC RES, V46, P0627; Revised and resource management plan Ozark-ST. Francis National forests, 2005, USDA MAN B, VR8-MB 125A; Shifley SR, 2006, FOREST ECOL MANAG, V229, P16, DOI 10.1016/j.foreco.2006.03.033; Spetich M. A., 2004, P UPL OAK EC S HIST, P3; Spetich MA, 2004, P 14 CENTR HARDW FOR, P21; Spetich MA, 2008, FOREST ECOL MANAG, V254, P454, DOI 10.1016/j.foreco.2007.09.087; Starkey D. A., 2004, General Technical Report - Southern Research Station, USDA Forest Service, P217; Wang WJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00040.1; Ward JS, 2005, NORTH J APPL FOR, V22, P59, DOI 10.1093/njaf/22.1.59; Welker SL, 2008, FOREST SCI, V54, P8; Woodall CW, 2011, NRSGTR88 US FOR SERV; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107	40	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66713	10.1371/journal.pone.0066713	http://dx.doi.org/10.1371/journal.pone.0066713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825560	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400153
J	Li, P; Li, SF; Han, HY; Dong, ZY; Luo, J; Guo, ZH; Xiong, HF; Zang, YF; Li, ZJ				Li Ping; Li Su-Fang; Han Hai-Ying; Dong Zhang-Ye; Luo Jia; Guo Zhi-Hua; Xiong Hong-Fang; Zang Yu-Feng; Li Zhan-Jiang			Abnormal Spontaneous Neural Activity in Obsessive-Compulsive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							REGIONAL HOMOGENEITY; RESPONSE-INHIBITION; COGNITIVE FLEXIBILITY; SYMPTOM IMPROVEMENT; BRAIN ACTIVATION; MOTOR INHIBITION; DEFAULT MODE; CONNECTIVITY; CORTEX; DEPRESSION	Neuroimaging studies of obsessive-compulsive disorder have found abnormalities in orbitofronto-striato-thalamic circuitry, including the orbitofrontal cortex, anterior cingulate cortex, caudate, and thalamus, but few studies have explored abnormal intrinsic or spontaneous brain activity in the resting state. We investigated both intra- and inter-regional synchronized activity in twenty patients with obsessive-compulsive disorder and 20 healthy controls using resting-state functional magnetic resonance imaging. Regional homogeneity (ReHo) and functional connectivity methods were used to analyze the intra- and inter-regional synchronized activity, respectively. Compared with healthy controls, patients with obsessive-compulsive disorder showed significantly increased ReHo in the orbitofrontal cortex, cerebellum, and insula, and decreased ReHo in the ventral anterior cingulate cortex, caudate, and inferior occipital cortex. Based on ReHo results, we determined functional connectivity differences between the orbitofrontal cortex and other brain regions in both patients with obsessive-compulsive disorder and controls. We found abnormal functional connectivity between the orbitofrontal cortex and ventral anterior cingulate cortex in patients with obsessive-compulsive disorder compared with healthy controls. Moreover, ReHo in the orbitofrontal cortex was correlated with the duration of obsessive-compulsive disorder. These findings suggest that increased intra- and inter-regional synchronized activity in the orbitofrontal cortex may have a key role in the pathology of obsessive-compulsive disorder. In addition to orbitofronto-striato-thalamic circuitry, brain regions such as the insula and cerebellum may also be involved in the pathophysiology of obsessive-compulsive disorder.	[Li Ping] Qiqihaer Med Univ, Dept Psychiat, Qiqihar, Heilongjiang, Peoples R China; [Li Ping; Han Hai-Ying; Luo Jia; Guo Zhi-Hua; Xiong Hong-Fang; Li Zhan-Jiang] Capital Med Univ, Beijing Anding Hosp, Dept Psychiat & Clin Psychol, Beijing, Peoples R China; [Li Su-Fang; Dong Zhang-Ye; Zang Yu-Feng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zang Yu-Feng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Zang Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China	Qiqihar Medical University; Capital Medical University; Beijing Normal University; Hangzhou Normal University; Hangzhou Normal University	Zang, YF (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zangyf@gmail.com; Lizhj8@ccmu.edu.cn	ZANG, Yu-Feng/J-1558-2012; Li, Sufang/N-5697-2016	ZANG, Yu-Feng/0000-0003-1833-8010; Li, Sufang/0000-0002-4716-4761	Natural Sciences Foundation of China [81141016]; Beijing Natural Science Foundation [7122082]; National Technology Support Programs [2009BAI77B11]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, China [ICBIR_C_0044_001]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Technology Support Programs; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, China	This work was supported by the Natural Sciences Foundation of China (81141016); Beijing Natural Science Foundation (7122082); National Technology Support Programs (2009BAI77B11); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, China (ICBIR_C_0044_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Chamberlain SR, 2007, AM J PSYCHIAT, V164, P335, DOI 10.1176/appi.ajp.164.2.335; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; DiNardo Brown Barlow, 1994, ANXIETY DISORDERS IN; First MB, 2001, STRUCTURED CLIN INTE; Fitzgerald KD, 2010, BIOL PSYCHIAT, V68, P1039, DOI 10.1016/j.biopsych.2010.08.018; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freyer T, 2010, PSYCHOL MED, V1, P1; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hansen ES, 2002, INT J NEUROPSYCHOPH, V5, P1, DOI [10.1017/S1461145701002681, 10.1017/S14611457011002681]; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Jang JH, 2006, AM J PSYCHIAT, V163, P1202, DOI 10.1176/appi.ajp.163.7.1202; Jang JH, 2010, NEUROSCI LETT, V474, P158, DOI 10.1016/j.neulet.2010.03.031; Kwon JS, 2009, EXPERT REV NEUROTHER, V9, P255, DOI 10.1586/14737175.9.2.255; Lazaro L, 2008, J PSYCHIATR RES, V42, P1051, DOI 10.1016/j.jpsychires.2007.12.007; Li P, 2012, NEUROREPORT, V23, P681, DOI 10.1097/WNR.0b013e328355a5fe; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nabeyama M, 2008, PSYCHIAT RES-NEUROIM, V163, P236, DOI 10.1016/j.pscychresns.2007.11.001; Nakao T, 2005, BIOL PSYCHIAT, V57, P901, DOI 10.1016/j.biopsych.2004.12.039; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Penades R, 2007, EUR PSYCHIAT, V22, P404, DOI 10.1016/j.eurpsy.2006.05.001; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Roth RM, 2007, BIOL PSYCHIAT, V62, P901, DOI 10.1016/j.biopsych.2006.12.007; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Salkovskis P. M., 1995, BEHAV COGN PSYCHOTH, V23, P281, DOI DOI 10.1017/S1352465800015885; Sanematsu H, 2010, J PSYCHIATR RES, V44, P193, DOI 10.1016/j.jpsychires.2009.08.007; Saxena S, 1999, NEUROPSYCHOPHARMACOL, V21, P683, DOI 10.1016/S0893-133X(99)00082-2; Saxena S, 2001, BIOL PSYCHIAT, V50, P159, DOI 10.1016/S0006-3223(01)01123-4; Schienle A, 2005, INT J PSYCHOPHYSIOL, V57, P69, DOI 10.1016/j.ijpsycho.2004.12.013; Schwartz JM., 1999, J CONSCIOUSNESS STUD, V6, P115; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P301, DOI 10.1001/archpsyc.62.3.301; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang TJ, 2011, J PSYCHIATR NEUROSCI, V36, P23, DOI 10.1503/jpn.100006	58	18	25	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67262	10.1371/journal.pone.0067262	http://dx.doi.org/10.1371/journal.pone.0067262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826251	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000051
J	Chou, CH; Lai, SL; Chen, CN; Lee, PH; Peng, FC; Kuo, ML; Lai, HS				Chou, Chia-Hung; Lai, Shuo-Lun; Chen, Chiung-Nien; Lee, Po-Huang; Peng, Fu-Chuo; Kuo, Min-Liang; Lai, Hong-Shiee			IL-6 Regulates Mcl-(1L) Expression through the JAK/PI3K/Akt/CREB Signaling Pathway in Hepatocytes: Implication of an Anti-Apoptotic Role during Liver Regeneration	PLOS ONE			English	Article							PARTIAL-HEPATECTOMY; MURINE LIVER; CELLS; MCL-1; INTERLEUKIN-6; DAMAGE; RATS; PROLIFERATION; INVOLVEMENT; ACTIVATION	Aims: To investigate the role and the regulation of the long variant of myeloid cell leukemia-1 protein (Mcl-1(L)) during liver regeneration. Background: Liver regeneration is an important phenomenon after liver injury. The rat partial hepatectomy (PH) model was used to characterize liver regeneration and Mcl-1(L) expression after PH. Methods: Male Wistar rats were subjected to 70% PH. The expression of mcl-1(L) mRNA was determined by quantitative RTPCR, and protein levels were analyzed by Western blot analysis and immunohistochemistry during liver regeneration. Functional evaluations of Mcl-1(L) were tested using chemical inhibition (flavopiridol), genetic inhibition (siRNA) of Mcl-1(L) production, and by assaying for annexin V levels and DNA ladder formation. Serum IL-6 levels were determined by enzyme immunoassays; signal transduction of IL-6-regulated Mcl-1(L) expression was verified by chemical inhibitors and decoy double-stranded oligodeoxynucleotides. Results: High levels of Mcl-1(L) were observed in remnant tissue at 4 h after PH. Administration of flavopiridol decreased Mcl-1(L) accumulation and also inhibited liver regeneration. IL-6 administration promoted the accumulation of Mcl-1(L) in rat hepatocytes, an effect that was impaired by siRNA treatments that reduced Mcl-1(L) production. Chemical inhibition and decoy oligonucleotide competition demonstrated that IL-6-induced Mcl-1(L) production required signaling mediated by JAK kinase, phosphoinositide 3-kinase (PI3K), and cAMP response-element-binding (CREB) proteins. Conclusion: Mcl-1(L) is an anti-apoptotic protein induced during liver regeneration after PH in rats. The expression of Mcl-1(L) is induced by IL-6 through the JAK/PI3K/Akt/CREB signaling pathway. Chemotherapy drugs that depend on Mcl-1(L)-or IL-6-related signaling should be considered carefully before use in patients undergoing hepatectomy for malignant tumor resection.	[Chou, Chia-Hung; Lai, Shuo-Lun; Chen, Chiung-Nien; Lee, Po-Huang; Lai, Hong-Shiee] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chou, Chia-Hung; Lai, Shuo-Lun; Chen, Chiung-Nien; Lee, Po-Huang; Lai, Hong-Shiee] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chou, Chia-Hung; Peng, Fu-Chuo; Kuo, Min-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Lai, HS (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	hslai@ntu.edu.tw		Lai, Hong-Shiee/0000-0002-7958-2183; Lai, Shuo-Lun/0000-0002-2480-4252; PENG, FU-CHUO/0000-0003-4385-8499; KUO, MIN-LIANG/0000-0002-7139-0144; CHEN, CHIUNG-NIEN/0000-0003-1192-5220; LEE, PO-HUANG/0000-0001-5831-035X	Taiwan National Science Council [NSC 96-2314-B-002-079-MY3, NSC 100-2314-B-002-019-MY3]; National Taiwan University Hospital [NTUH100-S1491]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by Taiwan National Science Council grants NSC 96-2314-B-002-079-MY3 and NSC 100-2314-B-002-019-MY3, and National Taiwan University Hospital Grant NTUH100-S1491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; [Anonymous], 2005, J BIOL CHEM; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Blechacz BRA, 2009, HEPATOLOGY, V50, P1861, DOI 10.1002/hep.23214; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Drucker C, 2010, J AUTOIMMUN, V34, P29, DOI 10.1016/j.jaut.2009.08.003; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Galun E, 2000, FASEB J, V14, P1979, DOI 10.1096/fj.99-0913com; Gewiese-Rabsch J, 2010, BBA-MOL BASIS DIS, V1802, P1054, DOI 10.1016/j.bbadis.2010.07.023; Hamada T, 2007, AM J PATHOL, V171, P872, DOI 10.2353/ajpath.2007.060972; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hikita H, 2009, HEPATOLOGY, V50, P1972, DOI 10.1002/hep.23207; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Hussain SRA, 2008, BLOOD, V111, P3190, DOI 10.1182/blood-2007-10-115733; Ikeda O, 2009, J SURG RES, V152, P218, DOI 10.1016/j.jss.2008.02.059; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Jackson RS, 2012, NEOPLASIA, V14, P656, DOI 10.1593/neo.12640; Kawasaki T, 2010, J HEPATOL, V53, P648, DOI 10.1016/j.jhep.2010.04.021; Kuo ML, 2001, ONCOGENE, V20, P677, DOI 10.1038/sj.onc.1204140; Lai HS, 2009, AM SURGEON, V75, P49; Liu LM, 2010, EUR J CLIN INVEST, V40, P127, DOI 10.1111/j.1365-2362.2009.02235.x; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Palve VC, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-135; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Schleimer K, 2008, J SURG RES, V149, P250, DOI 10.1016/j.jss.2008.01.021; Sudo K, 2008, BBA-MOL BASIS DIS, V1782, P671, DOI 10.1016/j.bbadis.2008.09.010; Suh HN, 2008, CELL PHYSIOL BIOCHEM, V22, P673, DOI 10.1159/000185551; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Togo S, 2004, J HEPATOL, V40, P464, DOI 10.1016/j.jhep.2003.11.005; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Volkmann X, 2008, HEPATOLOGY, V47, P1624, DOI 10.1002/hep.22237; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Yamashita T, 2010, CANCER RES, V70, P4687, DOI 10.1158/0008-5472.CAN-09-4210; Zang Y, 2012, CLIN CANCER RES, V18, P5639, DOI 10.1158/1078-0432.CCR-12-1213; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	37	28	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66268	10.1371/journal.pone.0066268	http://dx.doi.org/10.1371/journal.pone.0066268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825534	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000013
J	den Bakker, HC; Desjardins, CA; Griggs, AD; Peters, JE; Zeng, QD; Young, SK; Kodira, CD; Yandava, C; Hepburn, TA; Haas, BJ; Birren, BW; Wiedmann, M				den Bakker, Henk C.; Desjardins, Christopher A.; Griggs, Allison D.; Peters, Joseph E.; Zeng, Qiandong; Young, Sarah K.; Kodira, Chinnappa D.; Yandava, Chandri; Hepburn, Theresa A.; Haas, Brian J.; Birren, Bruce W.; Wiedmann, Martin			Evolutionary Dynamics of the Accessory Genome of Listeria monocytogenes	PLOS ONE			English	Article							TEICHOIC-ACID GLYCOSYLATION; SEROTYPE 4B; SURFACE-ANTIGENS; SEQUENCE; GENES; ALIGNMENT; IDENTIFICATION; STRAINS; GTCA; ANNOTATION	Listeria monocytogenes, a foodborne bacterial pathogen, is comprised of four phylogenetic lineages that vary with regard to their serotypes and distribution among sources. In order to characterize lineage-specific genomic diversity within L. monocytogenes, we sequenced the genomes of eight strains from several lineages and serotypes, and characterized the accessory genome, which was hypothesized to contribute to phenotypic differences across lineages. The eight L. monocytogenes genomes sequenced range in size from 2.85-3.14 Mb, encode 2,822-3,187 genes, and include the first publicly available sequenced representatives of serotypes 1/2c, 3a and 4c. Mapping of the distribution of accessory genes revealed two distinct regions of the L. monocytogenes chromosome: an accessory-rich region in the first 65 degrees adjacent to the origin of replication and a more stable region in the remaining 295 degrees. This pattern of genome organization is distinct from that of related bacteria Staphylococcus aureus and Bacillus cereus. The accessory genome of all lineages is enriched for cell surface-related genes and phosphotransferase systems, and transcriptional regulators, highlighting the selective pressures faced by contemporary strains from their hosts, other microbes, and their environment. Phylogenetic analysis of O-antigen genes and gene clusters predicts that serotype 4 was ancestral in L. monocytogenes and serotype 1/2 associated gene clusters were putatively introduced through horizontal gene transfer in the ancestral population of L. monocytogenes lineage I and II.	[den Bakker, Henk C.; Wiedmann, Martin] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Peters, Joseph E.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Cornell University; Cornell University	den Bakker, HC (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	hcd5@cornell.edu	Peters, Joseph/P-7130-2019; Wiedmann, Martin/A-9683-2008; Bakker, Henk den/AAF-8282-2020; Zeng, Qiandong/AAF-3305-2019; den Bakker, Henk/A-8136-2010	Peters, Joseph/0000-0001-8309-3297; Wiedmann, Martin/0000-0002-4168-5662; Desjardins, Christopher/0000-0002-3160-4734; den Bakker, Henk/0000-0002-4086-1580	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900018C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272200900018C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bille J, 1996, INT J FOOD MICROBIOL, V32, P251, DOI 10.1016/S0168-1605(96)01140-3; BORODOVSKY M, 1993, BIOSYSTEMS, V30, P161, DOI 10.1016/0303-2647(93)90068-N; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cheng Y, 2008, APPL ENVIRON MICROB, V74, P1653, DOI 10.1128/AEM.01773-07; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; den Bakker HC, 2012, APPL ENVIRON MICROB, V78, P1876, DOI 10.1128/AEM.06969-11; den Bakker HC, 2010, APPL ENVIRON MICROB, V76, P6085, DOI 10.1128/AEM.00447-10; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Doumith M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004; Doyon JP, 2011, BRIEF BIOINFORM, V12, P392, DOI 10.1093/bib/bbr045; Dunn KA, 2009, MOL BIOL EVOL, V26, P2605, DOI 10.1093/molbev/msp176; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500; Faith N, 2009, FOODBORNE PATHOG DIS, V6, P39, DOI 10.1089/fpd.2008.0154; FIEDLER F, 1988, INFECTION, V16, pS92, DOI 10.1007/BF01639729; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Glaser P, 2001, SCIENCE, V294, P849; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hain T, 2006, J BIOTECHNOL, V126, P37, DOI 10.1016/j.jbiotec.2006.03.047; Hain T, 2006, J BACTERIOL, V188, P7405, DOI 10.1128/JB.00758-06; Holder JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002219; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Janssen PJ, 2001, NUCLEIC ACIDS RES, V29, P4395, DOI 10.1093/nar/29.21.4395; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; KAMISANGO K, 1983, J BIOCHEM-TOKYO, V93, P1401, DOI 10.1093/oxfordjournals.jbchem.a134275; Kjos M, 2010, J BACTERIOL, V192, P5906, DOI 10.1128/JB.00777-10; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lan Z, 2000, J BACTERIOL, V182, P6161, DOI 10.1128/JB.182.21.6161-6168.2000; Lazarevic V, 2002, MICROBIOL-SGM, V148, P815, DOI 10.1099/00221287-148-3-815; Lei XH, 2001, J BACTERIOL, V183, P1133, DOI 10.1128/JB.183.4.1133-1139.2001; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Orsi RH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-233; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Promadej N, 1999, J BACTERIOL, V181, P418, DOI 10.1128/JB.181.2.418-425.1999; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Roberts A, 2006, MICROBIOL-SGM, V152, P685, DOI 10.1099/mic.0.28503-0; Seeliger H.P.R., 1979, METHOD MICROBIOL, V13, P31, DOI [10.1016/S0580-9517(08)70372-6, DOI 10.1016/S0580-9517(08)70372-6]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steele CL, 2011, J BACTERIOL, V193, P3679, DOI 10.1128/JB.05236-11; Steinweg C, 2010, J BACTERIOL, V192, P1473, DOI 10.1128/JB.01415-09; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Thiel A, 2012, PLOS GENET, V8, P564, DOI 10.1371/journal.pgen.1002672; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; UCHIKAWA KI, 1986, J BIOCHEM-TOKYO, V99, P315, DOI 10.1093/oxfordjournals.jbchem.a135486; UCHIKAWA KI, 1986, J BACTERIOL, V168, P115, DOI 10.1128/jb.168.1.115-122.1986; Ward TJ, 2008, APPL ENVIRON MICROB, V74, P7629, DOI 10.1128/AEM.01127-08; Webb AJ, 2009, MOL MICROBIOL, V74, P299, DOI 10.1111/j.1365-2958.2009.06829.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang CM, 2003, J BACTERIOL, V185, P5573, DOI 10.1128/JB.185.18.5573-5584.2003	75	47	48	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67511	10.1371/journal.pone.0067511	http://dx.doi.org/10.1371/journal.pone.0067511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825666	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000106
J	Negri, A; Oliveri, C; Sforzini, S; Mignione, F; Viarengo, A; Banni, M				Negri, Alessandro; Oliveri, Catherina; Sforzini, Susanna; Mignione, Flavio; Viarengo, Aldo; Banni, Mohamed			Transcriptional Response of the Mussel Mytilus galloprovincialis (Lam.) following Exposure to Heat Stress and Copper	PLOS ONE			English	Article							REAL-TIME PCR; CLIMATE-CHANGE; OXIDATIVE STRESS; MEMBRANE INTEGRITY; EXPRESSION; SHOCK; TEMPERATURE; PROTEIN; CELLS; WATER	Global warming is a major factor that may affect biological organization, especially in marine ecosystems and in coastal areas that are particularly subject to anthropogenic pollution. We evaluated the effects of simultaneous changes in temperature and copper concentrations on lysosomal membrane stability (N-acetyl-hexosaminidase activity) and malondialdehyde accumulation (MDA) in the gill of the blue mussel Mytilus galloprovincialis (Lam.). Temperature and copper exerted additive effects on lysosomal membrane stability, exacerbating the toxic effects of metal cations present in non-physiological concentrations. Mussel lysosomal membrane stability is known to be positively related to scope for growth, indicating possible effects of increasing temperature on mussel populations in metal-polluted areas. To clarify the molecular response to environmental stressors, we used a cDNA microarray with 1,673 sequences to measure the relative transcript abundances in the gills of mussels exposed to copper (40 mu g/L) and a temperature gradient (16 degrees C, 20 degrees C, and 24 degrees C). In animals exposed only to heat stress, hierarchical clustering of the microarray data revealed three main clusters, which were largely dominated by down-regulation of translation-related differentially expressed genes, drastic up-regulation of protein folding related genes, and genes involved in chitin metabolism. The response of mussels exposed to copper at 24 degrees C was characterized by an opposite pattern of the genes involved in translation, most of which were up-regulated, as well as the down-regulation of genes encoding heat shock proteins and "microtubule-based movement" proteins. Our data provide novel information on the transcriptomic modulations in mussels facing temperature increases and high copper concentrations; these data highlight the risk of marine life exposed to toxic chemicals in the presence of temperature increases due to climate change.	[Negri, Alessandro; Oliveri, Catherina; Sforzini, Susanna; Mignione, Flavio; Viarengo, Aldo; Banni, Mohamed] Univ Piemonte Orientale Vercelli Novara Alessandr, Dept Environm & Life Sci, Alessandria, Italy; [Banni, Mohamed] ISA, Lab Biochem & Environm Toxicol, Chott Mariem, Sousse, Tunisia	University of Eastern Piedmont Amedeo Avogadro; Universite de Tunis-El-Manar; Institut Salah Azaiez	Banni, M (corresponding author), Univ Piemonte Orientale Vercelli Novara Alessandr, Dept Environm & Life Sci, Alessandria, Italy.	m_banni@yahoo.fr	Banni, Mohamed/M-2144-2014	Banni, Mohamed/0000-0001-9764-0343; Sforzini, Susanna/0000-0002-7310-7605; Viarengo, Aldo/0000-0002-1557-6526	Theme 6 of the EC seventh framework program through the Marine Ecosystem Evolution in a Changing Environment (MEECE) Collaborative Project [212085]	Theme 6 of the EC seventh framework program through the Marine Ecosystem Evolution in a Changing Environment (MEECE) Collaborative Project	This work was funded by Theme 6 of the EC seventh framework program through the Marine Ecosystem Evolution in a Changing Environment (MEECE, No 212085) Collaborative Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Refaii A, 2009, MOL MICROBIOL, V71, P748, DOI 10.1111/j.1365-2958.2008.06561.x; Allen JI, 2004, MAR ENVIRON RES, V58, P227, DOI 10.1016/j.marenvres.2004.03.119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bado-Nilles A, 2013, ENVIRON SCI POLLUT R, V20, P2692, DOI 10.1007/s11356-012-1410-2; Baines SB, 2008, ENVIRON SCI TECHNOL, V42, P3277, DOI 10.1021/es702336q; Banni M, 2007, BIOMARKERS, V12, P369, DOI 10.1080/13547500701217061; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; BAYNE BL, 1979, PHILOS T ROY SOC B, V286, P563, DOI 10.1098/rstb.1979.0046; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; Cevik U, 2008, J HAZARD MATER, V160, P396, DOI 10.1016/j.jhazmat.2008.03.010; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Colaco A, 2006, CHEMOSPHERE, V65, P2260, DOI 10.1016/j.chemosphere.2006.05.034; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connolly MH, 2008, INT J DEV BIOL, V52, P71, DOI 10.1387/ijdb.062241mc; Crowe TP, 2004, J APPL ECOL, V41, P114, DOI 10.1111/j.1365-2664.2004.00882.x; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; Dondero F, 2006, AQUAT TOXICOL, V78, pS13, DOI 10.1016/j.aquatox.2006.02.025; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Elliott JA, 2012, WATER RES, V46, P1364, DOI 10.1016/j.watres.2011.12.018; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Gomes EC, 2011, EUR J APPL PHYSIOL, V111, P2089, DOI 10.1007/s00421-011-1839-x; Handy RD, 2003, COMP BIOCHEM PHYS A, V135, P25, DOI 10.1016/S1095-6433(03)00018-7; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; HOFMANN GE, 1995, J EXP BIOL, V198, P1509; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kamel N, 2012, ARCH ENVIRON CON TOX, V63, P534, DOI 10.1007/s00244-012-9790-3; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; McVeigh A, 2004, MAR ENVIRON RES, V58, P821, DOI 10.1016/j.marenvres.2004.03.099; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mokany K, 2010, TRENDS ECOL EVOL, V25, P550, DOI 10.1016/j.tree.2010.06.014; MOORE MN, 1976, CELL TISSUE RES, V175, P279; Morillo J, 2008, ECOTOX ENVIRON SAFE, V71, P851, DOI 10.1016/j.ecoenv.2008.01.016; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pytharopoulou S, 2011, AQUAT TOXICOL, V105, P157, DOI 10.1016/j.aquatox.2011.06.007; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Silvestre F, 2010, SCI TOTAL ENVIRON, V408, P3176, DOI 10.1016/j.scitotenv.2010.04.005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Tomanek L, 2010, J EXP BIOL, V213, P3559, DOI 10.1242/jeb.041228; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Verlecar XN, 2007, CHEM-BIOL INTERACT, V167, P219, DOI 10.1016/j.cbi.2007.01.018; Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011; VIARENGO A, 1980, COMP BIOCHEM PHYS C, V67, P215, DOI 10.1016/0306-4492(80)90021-0; Vicente-Martorell JJ, 2009, J HAZARD MATER, V162, P823, DOI 10.1016/j.jhazmat.2008.05.106; Yao CL, 2012, J EXP BIOL, V215, P4267, DOI 10.1242/jeb.073577	53	62	62	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66802	10.1371/journal.pone.0066802	http://dx.doi.org/10.1371/journal.pone.0066802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825565	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000027
J	Laursen, TM; Wahlbeck, K; Hallgren, J; Westman, J; Osby, U; Alinaghizadeh, H; Gissler, M; Nordentoft, M				Laursen, Thomas Munk; Wahlbeck, Kristian; Hallgren, Jonas; Westman, Jeanette; Osby, Urban; Alinaghizadeh, Hassan; Gissler, Mika; Nordentoft, Merete			Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; EXCESS MORTALITY; PREMATURE MORTALITY; MENTAL-DISORDER; ILLNESS; SWEDEN; RISK; CERTIFICATES; STATISTICS; REGISTER	Objective: Excess mortality from diseases and medical conditions (natural death) in persons with psychiatric disorders has been extensively reported. Even in the Nordic countries with well-developed welfare systems, register based studies find evidence of an excess mortality. In recent years, cardiac mortality and death by diseases of the circulatory system has seen a decline in all the Nordic countries, but a recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease. The aim of this study was to compare the mortality by diseases of the circulatory system among patients with bipolar disorder or schizophrenia in the three Nordic countries Denmark, Sweden, and Finland. Furthermore, the aim was to examine and compare life expectancy among these patients. Cause specific Standardized Mortality Rates (SMRs) were calculated for each specific subgroup of mortality. Life expectancy was calculated using Wiesler's method. Results: The SMR for bipolar disorder for diseases of the circulatory system was approximately 2 in all countries and both sexes. SMR was slightly higher for people with schizophrenia for both genders and in all countries, except for men in Denmark. Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter. Conclusion: Our data show that persons in the Nordic countries with schizophrenia or bipolar disorder have a substantially reduced life expectancy. An evaluation of the reasons for these increased mortality rates should be prioritized when planning healthcare in the coming years.	[Laursen, Thomas Munk] Aarhus Univ, Natl Ctr Register Based Res, iPSYCH, Aarhus, Denmark; [Nordentoft, Merete] Univ Copenhagen, Fac Hlth Sci, Psychiat Ctr Copenhagen, Copenhagen, Denmark; [Laursen, Thomas Munk; Wahlbeck, Kristian; Gissler, Mika; Nordentoft, Merete] Nordic Sch Publ Hlth, Nordic Res Acad Mental Hlth, Gothenburg, Sweden; [Hallgren, Jonas] Karolinska Inst, Dept Med Epidemiol & Biostat MEB, Stockholm, Sweden; [Westman, Jeanette; Osby, Urban; Alinaghizadeh, Hassan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Family Med, Stockholm, Sweden; [Osby, Urban] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Osby, Urban] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Osby, Urban] Tiohundra AB, Dept Psychiat, Norrtalje, Sweden; [Wahlbeck, Kristian; Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland	Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Finland National Institute for Health & Welfare	Laursen, TM (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, iPSYCH, Aarhus, Denmark.	tml@ncrr.dk	Nordentoft, Merete/AAH-3253-2019; Laursen, Thomas Munk/AFQ-8066-2022; Wahlbeck, Kristian/F-8394-2011	Wahlbeck, Kristian/0000-0003-3754-3933; Westman, Jeanette/0000-0001-8701-4226; Laursen, Thomas Munk/0000-0001-6934-1784; Gissler, Mika/0000-0001-8254-7525; Alinaghizadeh, Hassan/0000-0002-9455-0753	Stanley Medical Research Institute; Lundbeck Foundation; MRC [MR/K006525/1] Funding Source: UKRI; Lundbeck Foundation [R155-2012-11280] Funding Source: researchfish; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Stanley Medical Research Institute; Lundbeck Foundation(Lundbeckfonden); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by The Stanley Medical Research Institute. The Lundbeck Foundation is acknowledged for financial support of TML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2012, INT J PSYCHIAT CLIN, V16, P170, DOI 10.3109/13651501.2011.653377; Angst J, 2002, SCHIZOPHR RES, V57, P5, DOI 10.1016/S0920-9964(02)00328-6; Bradley AJ, 2010, J PSYCHOPHARMACOL, V24, P91, DOI 10.1177/1359786810385491; Breslow NE., 1987, STATISTICAL METHODS, P48; Bushe CJ, 2010, J PSYCHOPHARMACOL, V24, P17, DOI 10.1177/1359786810382468; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Doll R, 2005, BRIT J CANCER, V92, P426, DOI 10.1038/sj.bjc.6602359; Greenland S, 2008, MODERN EPIDEMIOLOGY, P32; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Hills, 1993, STAT MODELS EPIDEMIO; Johansson LA, 2000, INT J EPIDEMIOL, V29, P495, DOI 10.1093/ije/29.3.495; Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498; Juel K, 1999, DAN MED BULL, V46, P354; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Laursen TM, 2010, SCHIZOPHR RES, V121, P234, DOI 10.1016/j.schres.2010.05.018; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P899, DOI 10.4088/JCP.v68n0612; Laursen TM, 2011, SCHIZOPHR RES, V131, P101, DOI 10.1016/j.schres.2011.06.008; Laursen TM, 2011, J PSYCHIATR RES, V45, P29, DOI 10.1016/j.jpsychires.2010.04.027; Laursen TM, 2009, ARCH GEN PSYCHIAT, V66, P713, DOI 10.1001/archgenpsychiatry.2009.61; Laursen TM, 2006, THESIS; Lawrence D, 2010, CAN J PSYCHIAT, V55, P752, DOI 10.1177/070674371005501202; Manderbacka K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000831; Mitchell AJ, 2010, J PSYCHOPHARMACOL, V24, P69, DOI 10.1177/1359786810382056; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; MORTENSEN PB, 1993, BRIT J PSYCHIAT, V163, P183, DOI 10.1192/bjp.163.2.183; Munk-Jorgensen P, 2010, INDIAN J MED RES, V132, P353; Murray DP, 2009, CURR PSYCHIAT REP, V11, P475, DOI 10.1007/s11920-009-0072-3; NOMESCO, 2009, HLTH STAT NORD COUNT; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Osby U, 2000, SCHIZOPHR RES, V45, P21, DOI 10.1016/S0920-9964(99)00191-7; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Raedler TJ, 2010, CURR OPIN PSYCHIATR, V23, P574, DOI 10.1097/YCO.0b013e32833f46c9; Sikdar KC, 2010, QUAL LIFE RES, V19, P781, DOI 10.1007/s11136-010-9641-5; Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718; Uter W, 1999, BIOMETRICAL J, V41, P985; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; Weiner M, 2011, ANN CLIN PSYCHIATRY, V23, P40; Westman J, 2012, EUR J PUBLIC HEALTH, V22, P604, DOI 10.1093/eurpub/ckr068; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wiesler H, 1954, P 1 WORLD POP C ROM, V4; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P37, DOI 10.1177/1359786810384639; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P9, DOI 10.1177/1359786810382149; World Health Organization, 1994, WHO ICD 10 PSYK LID; World Health Organization, 1971, KLASS SYGD UDV DANSK, V8	47	196	196	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67133	10.1371/journal.pone.0067133	http://dx.doi.org/10.1371/journal.pone.0067133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23826212	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400109
J	Mente, A; Meyre, D; Lanktree, MB; Heydarpour, M; Davis, AD; Miller, R; Gerstein, H; Hegele, RA; Yusuf, S; Anand, SS				Mente, Andrew; Meyre, David; Lanktree, Matthew B.; Heydarpour, Mahyar; Davis, A. Darlene; Miller, Ruby; Gerstein, Hertzel; Hegele, Robert A.; Yusuf, Salim; Anand, Sonia S.		SHARE Investigator; SHARE-AP Investigator	Causal Relationship between Adiponectin and Metabolic Traits: A Mendelian Randomization Study in a Multiethnic Population	PLOS ONE			English	Article							DENSITY LIPOPROTEIN-CHOLESTEROL; GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; ADIPOCYTE-DERIVED PROTEIN; CORONARY-ARTERY-DISEASE; FATTY-ACID OXIDATION; TYPE-2 DIABETES RISK; ETHNIC-GROUPS SHARE; INSULIN-RESISTANCE; PLASMA ADIPONECTIN	Background: Adiponectin, a secretagogue exclusively produced by adipocytes, has been associated with metabolic features, but its role in the development of the metabolic syndrome remains unclear. Objectives: We investigated the association between serum adiponectin level and metabolic traits, using both observational and genetic epidemiologic approaches in a multiethnic population assembled in Canada. Methods: Clinical data and serum adiponectin level were collected in 1,157 participants of the SHARE/SHARE-AP studies. Participants were genotyped for the functional rs266729 and rs1260326 SNPs in ADIPOQ and GCKR genes. Results: Adiponectin level was positively associated with HDL cholesterol and negatively associated with body mass index, waist-to-hip ratio, triglycerides, fasting glucose, fasting insulin, systolic and diastolic pressure (all P<0.002). The rs266729 minor G allele was associated with lower adiponectin and higher HOMA-IR (P = 0.004 and 0.003, respectively). The association between rs266729 SNP and HOMA-IR was no longer significant after adjustment for adiponectin concentration (P = 0.10). The rs266729 SNP was associated with HOMA-IR to an extent that exceeded its effect on adiponectin level (0.15 SD 95% C.I. [0.06, 0.24], P<0.001). There was no significant interaction between rs266729 SNP and ethnicity on adiponectin or HOMA-IR. In contrast, the SNP rs1260326 in GCKR was associated with HOMA-IR (P<0.001), but not with adiponectin level (P = 0.67). Conclusion: The association of the functional promoter polymorphism rs266729 with lower serum adiponectin and increased insulin resistance in diverse ethnic groups may suggest a causal relationship between adiponectin level and insulin resistance.	[Mente, Andrew; Meyre, David; Heydarpour, Mahyar; Gerstein, Hertzel; Yusuf, Salim; Anand, Sonia S.] Populat Hlth Res Inst, Hamilton, ON, Canada; [Mente, Andrew; Meyre, David; Gerstein, Hertzel; Yusuf, Salim; Anand, Sonia S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Lanktree, Matthew B.; Hegele, Robert A.] Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON N6A 5C1, Canada; [Hegele, Robert A.] Univ Western Ontario, Dept Med, London, ON, Canada; [Davis, A. Darlene; Miller, Ruby] Six Nations Hlth Serv, Ohsweken, ON, Canada; [Lanktree, Matthew B.; Gerstein, Hertzel; Yusuf, Salim; Anand, Sonia S.] McMaster Univ, Dept Med, Hamilton, ON, Canada	Population Health Research Institute; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University	Anand, SS (corresponding author), Populat Hlth Res Inst, Hamilton, ON, Canada.	anands@mcmaster.ca	Gerstein, Hertzel/ABB-8781-2020; Hegele, Robert/AAF-6482-2020; Meyre, David/D-7315-2011; Gerstein, Hertzel C/B-1235-2013; Hegele, Robert/G-3301-2011; Lanktree, Matthew Bruce/I-9790-2019	Gerstein, Hertzel/0000-0001-8072-2836; Hegele, Robert/0000-0003-2861-5325; Meyre, David/0000-0003-4850-7444; Gerstein, Hertzel C/0000-0001-8072-2836; Lanktree, Matthew Bruce/0000-0002-5750-6286; Yusuf, Salim/0000-0003-4776-5601	Early Career Award from Hamilton Health Sciences Foundation; Canada Research Chair in Genetics of Obesity and Diabetes; Canadian Institutes of Health Research (CIHR) MD/PhD Studentship Award; University of Western Ontario MD/PhD Program; CIHR [MOP-13430, MOP-79523, CTP-79853]; Heart and Stroke Foundation of Ontario [NA-6059, T-6018, PRG-4854, NA-03785]; Genome Canada through the Ontario Genomics Institute; Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic Research Award	Early Career Award from Hamilton Health Sciences Foundation; Canada Research Chair in Genetics of Obesity and Diabetes; Canadian Institutes of Health Research (CIHR) MD/PhD Studentship Award; University of Western Ontario MD/PhD Program; CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Genome Canada through the Ontario Genomics Institute(Genome Canada); Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic Research Award	A. Mente is supported by an Early Career Award from Hamilton Health Sciences Foundation. D. Meyre is supported by a Canada Research Chair in Genetics of Obesity and Diabetes. M.B. Lanktree was supported by the Canadian Institutes of Health Research (CIHR) MD/PhD Studentship Award and the University of Western Ontario MD/PhD Program and is a CIHR Fellow in Vascular Research. R.A. Hegele is a Career Investigator of the Heart and Stroke Foundation of Ontario and holds the Edith Schulich Vinet Canada Research Chair (Tier I) in Human Genetics, the Martha G. Blackburn Chair in Cardiovascular Research, and the Jacob J. Wolfe Distinguished Medical Research Chair at the University of Western Ontario. H. Gerstein holds a Aventis Population Health Institute Chair in Diabetes Research, McMaster University. S. Yusuf holds an endowed chair in Cardiovascular Research from the Heart and Stroke Foundation of Ontario. S.S. Anand holds the Michael G. DeGroote/Heart and Stroke Foundation of Ontario endowed Chair in Population Health Research, Canada Research Chair in Ethnicity and Cardiovascular Disease, and the Eli Lilly-May Cohen Chair in Women's Health Research. This work was supported by CIHR (MOP-13430, MOP-79523, CTP-79853), the Heart and Stroke Foundation of Ontario (NA-6059, T-6018, PRG-4854, NA-03785), Genome Canada through the Ontario Genomics Institute, and the Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Anand SS, 1998, CAN J CARDIOL, V14, P1349; Anand SS, 2001, LANCET, V358, P1147, DOI 10.1016/S0140-6736(01)06255-9; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Buzzetti R, 2007, INT J OBESITY, V31, P424, DOI 10.1038/sj.ijo.0803419; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Croteau-Chonka DC, 2012, HUM MOL GENET, V21, P463, DOI 10.1093/hmg/ddr480; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Ferguson JF, 2010, AM J CLIN NUTR, V91, P794, DOI 10.3945/ajcn.2009.28255; Ferris WF, 2005, HORM METAB RES, V37, P695, DOI 10.1055/s-2005-870580; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Goropashnaya AV, 2009, METABOLISM, V58, P22, DOI 10.1016/j.metabol.2008.09.002; Han LY, 2011, DIABETOLOGIA, V54, P2303; Hanley AG, 2003, DIABETES CARE, V26, P3219, DOI 10.2337/diacare.26.12.3219; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Henneman P, 2010, DIABETES CARE, V33, P908, DOI 10.2337/dc09-1385; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Karinenc I, 2012, ARCH MED RES, V43, P145; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Khoo CM, 2011, DIABETES CARE, V34, P1120, DOI 10.2337/dc10-2097; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Laughlin GA, 2007, AM J EPIDEMIOL, V165, P164, DOI 10.1093/aje/kwk001; Laumen H, 2009, DIABETES, V58, P984, DOI 10.2337/db07-1646; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; MCGOWAN MW, 1983, CLIN CHEM, V29, P538; Mente A, 2010, DIABETES CARE, V33, P1629, DOI 10.2337/dc09-1392; NEELEY WE, 1972, CLIN CHEM, V18, P509; Ong KL, 2010, EUR J ENDOCRINOL, V163, P251, DOI 10.1530/EJE-10-0251; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Perez-Martinez P, 2008, J NUTR, V138, P1609, DOI 10.1093/jn/138.9.1609; Petrone A, 2006, OBESITY, V14, P1498, DOI 10.1038/oby.2006.172; Povel CM, 2011, MOL GENET METAB, V104, P666, DOI 10.1016/j.ymgme.2011.08.035; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rees MG, 2012, DIABETOLOGIA, V55, P114, DOI 10.1007/s00125-011-2348-5; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Robiou-du-Pont S, 2012, INT J OBES IN PRESS; Saito K, 1999, GENE, V229, P67, DOI 10.1016/S0378-1119(99)00041-4; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shetty S, 2012, ENDOCRINOLOGY, V153, P113, DOI 10.1210/en.2011-1339; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Vozarova B, 2002, DIABETES, V51, P2964, DOI 10.2337/diabetes.51.10.2964; Wagner A, 2008, DIABETES METAB, V34, P465, DOI 10.1016/j.diabet.2008.02.006; Wallace TM, 2002, DIABETIC MED, V19, P527, DOI 10.1046/j.1464-5491.2002.00745.x; WARNICK GR, 1985, CLIN CHEM, V31, P217; Warren LL, 2012, DIABETES, V61, P1297, DOI 10.2337/db11-0985; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wildman RP, 2008, INT J OBESITY, V32, P740, DOI 10.1038/sj.ijo.0803782; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yamamoto Y, 2004, J CLIN ENDOCR METAB, V89, P87, DOI 10.1210/jc.2003-031163; Yamamoto Y, 2002, CLIN SCI, V103, P137, DOI 10.1042/CS20010336; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang Y, 2012, THROMB RES, V130, P58, DOI 10.1016/j.thromres.2012.01.018	69	45	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66808	10.1371/journal.pone.0066808	http://dx.doi.org/10.1371/journal.pone.0066808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826141	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400056
J	Su, T; Han, X; Chen, F; Du, Y; Zhang, HW; Yin, JH; Tan, XJ; Chang, WJ; Ding, YB; Han, YF; Cao, GW				Su, Tong; Han, Xue; Chen, Fei; Du, Yan; Zhang, Hongwei; Yin, Jianhua; Tan, Xiaojie; Chang, Wenjun; Ding, Yibo; Han, Yifang; Cao, Guangwen			Knowledge Levels and Training Needs of Disaster Medicine among Health Professionals, Medical Students, and Local Residents in Shanghai, China	PLOS ONE			English	Article							EDUCATION; EMERGENCY; PROGRAM; PERSPECTIVES; CURRICULUM; EARTHQUAKE; WORKFORCE	Background: Disaster is a serious public health issue. Health professionals and community residents are main players in disaster responses but their knowledge levels of disaster medicine are not readily available. This study aimed to evaluate knowledge levels and training needs of disaster medicine among potential disaster responders and presented a necessity to popularize disaster medicine education. Methods: A self-reporting questionnaire survey on knowledge level and training needs of disaster medicine was conducted in Shanghai, China, in 2012. A total of randomly selected 547 health professionals, 456 medical students, and 1,526 local residents provided intact information. The total response rate was 93.7%. Results: Overall, 1.3% of these participants have received systematic disaster medicine training. News media (87.1%) was the most common channel to acquire disaster medicine knowledge. Although health professionals were more knowledgeable than community residents, their knowledge structure of disaster medicine was not intact. Medical teachers were more knowledgeable than medical practitioners and health administrators (p = 0.002). Clinicians performed better than public health physicians (p<0.001), whereas public health students performed better than clinical medical students (p<0.001). In community residents, education background significantly affected the knowledge level on disaster medicine (p<0.001). Training needs of disaster medicine were generally high among the surveyed. 'Lecture' and 'practical training' were preferred teaching methods. The selected key and interested contents on disaster medicine training were similar between health professionals and medical students, while the priorities chosen by local residents were quite different from health professionals and medical students (p<0.001). Conclusions: Traditional clinical-oriented medical education might lead to a huge gap between the knowledge level on disaster medicine and the current needs of disaster preparedness. Continuing medical education and public education plans on disaster medicine via media should be practice-oriented, and selectively applied to different populations and take the knowledge levels and training needs into consideration.	[Su, Tong; Chen, Fei; Du, Yan; Zhang, Hongwei; Yin, Jianhua; Tan, Xiaojie; Chang, Wenjun; Ding, Yibo; Han, Yifang; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Han, Xue] Ctr Dis Control & Prevent Yangpu Dist, Dept Chron Dis, Shanghai, Peoples R China	Naval Medical University; Shanghai Center for Disease Control & Prevention	Cao, GW (corresponding author), Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China.	gcao@smmu.edu.cn	tan, xiao/GZL-0264-2022; Du, Yan/AAD-5510-2020	Du, Yan/0000-0001-5413-7836; Cao, Guangwen/0000-0002-8094-1278	Education Research Foundation of Shanghai, China [A1016]	Education Research Foundation of Shanghai, China	This study was supported by the Education Research Foundation of Shanghai, China (No. A1016 to GC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley BH, 2006, PREHOSP DISASTER MED, V21, P249, DOI 10.1017/S1049023X00003782; Chan SSS, 2010, J NURS SCHOLARSHIP, V42, P405, DOI 10.1111/j.1547-5069.2010.01363.x; Delooz H, 2007, EUR J EMERG MED, V14, P25, DOI 10.1097/01.mej.0000224432.43999.87; Feng D, 2009, TROP MED INT HEALTH, V14, P4, DOI 10.1111/j.1365-3156.2008.02145.x; Gao TQ, 1999, MED EDUC, V33, P768, DOI 10.1046/j.1365-2923.1999.00313.x; Haraoka T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047203; Hsu Edbert B, 2006, BMC Med Educ, V6, P19, DOI 10.1186/1472-6920-6-19; Huang B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-89; HUANG JS, 1992, MED EDUC, V26, P333, DOI 10.1111/j.1365-2923.1992.tb00178.x; Huntington MK, 2011, FAM MED, V43, P13; Kaiser HE, 2009, DISASTER MED PUBLIC, V3, P210, DOI 10.1097/DMP.0b013e3181aa242a; Kaji AH, 2010, TEACH LEARN MED, V22, P116, DOI 10.1080/10401331003656561; Lam TP, 2006, MED EDUC, V40, P940, DOI 10.1111/j.1365-2929.2006.02552.x; Ng C, 2009, AUSTRALAS PSYCHIATRY, V17, P51, DOI 10.1080/10398560802444069; Pang SMC, 2009, NURS HEALTH SCI, V11, P367, DOI 10.1111/j.1442-2018.2009.00499.x; Pfenninger EG, 2010, INT J EMERG MED, V3, P9, DOI 10.1007/s12245-009-0140-9; Pietrzak RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038964; Qiu J, 2010, CHIN J TRAUMATOL, V13, P297, DOI 10.3760/cma.j.issn.1008-1275.2010.05.009; Russell ML, 2009, CAN J PUBLIC HEALTH, V100, P199, DOI 10.1007/BF03405540; Scott LA, 2010, J EMERG MED, V39, P220, DOI 10.1016/j.jemermed.2009.08.064; Summerhill EM, 2008, MED TEACH, V30, pE145, DOI 10.1080/01421590802047257; Usami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050721; Wang CJ, 2008, PUBLIC HEALTH, V122, P471, DOI 10.1016/j.puhe.2007.08.006; Wang CJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-377; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Woltring Carol, 2003, J Public Health Manag Pract, V9, P103; Xu GZ, 2012, DISASTER MED PUBLIC, V6, P363, DOI 10.1001/dmp.2012.69; You CM, 2009, J PUBLIC HEALTH POL, V30, P379, DOI 10.1057/jphp.2009.30; Zhang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029651, 10.1371/journal.pone.0046449, 10.1371/journal.pone.0030551]	29	31	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67041	10.1371/journal.pone.0067041	http://dx.doi.org/10.1371/journal.pone.0067041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23826190	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400096
J	Tsai, DC; Chen, SJ; Huang, CC; Chou, P; Chung, CM; Huang, PH; Lin, SJ; Chen, JW; Chen, TJ; Leu, HB; Chan, WL				Tsai, Der-Chong; Chen, Shih-Jen; Huang, Chin-Chou; Chou, Pesus; Chung, Chia-Min; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Chen, Tseng-Ji; Leu, Hsin-Bang; Chan, Wan-Leong			Epidemiology of Idiopathic Central Serous Chorioretinopathy in Taiwan, 2001-2006: A Population-based Study	PLOS ONE			English	Article							RETINAL VEIN OCCLUSION; PSYCHOLOGICAL STRESS; SLEEP-APNEA; A BEHAVIOR; RISK; UPDATE	Objectives: The epidemiology of idiopathic central serous chorioretinopathy (CSCR) is not well understood in an Asian population. The present study aimed to investigate the incidence and risk factors for corticosteroid-unrelated CSCR using Taiwan's National Health Insurance Research Database. Methods and Results: From 2001 to 2006, a total of 786 patients (500 [63.6%] males) who were newly diagnosed with CSCR, aged from 20 to 64 years and had no history of corticosteroid prescription were identified as incident cases of idiopathic CSCR. 3606 age-, gender-, and enrollment time-matched subjects were randomly selected as the control group. The mean annual incidence was 0.21% (0.27% for males, and 0.15% for females; P<0.001), with a male/female ratio of 1.74. The peak incidence was in the 35-to 39-year-old age group (0.30%), followed by the 40- to 44-year-old age group (0.26%). Males had a significantly higher mean annual incidence than female only in the middle age groups. Conditional logistic regression was used to estimate the odds ratios (ORs) for potential risk factors of idiopathic CSCR. Only exposure to anti-anxiety drugs (OR, 1.63; 95% confidence interval, 1.09-2.44) was found to be independently associated with idiopathic CSCR among males. No risk factors of idiopathic CSCR were found for females. Conclusions: This study provides the nationwide, population-based data on the incidence of idiopathic CSCR in adult Asians, and suggests that exposure to anti-anxiety drugs is an independent risk factor for idiopathic CSCR among males.	[Tsai, Der-Chong; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Tsai, Der-Chong; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Tsai, Der-Chong] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan; [Chen, Shih-Jen] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Huang, Chin-Chou; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang] Natl Yang Ming Univ, Sch Med, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Chin-Chou; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang; Chan, Wan-Leong] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Huang, Chin-Chou; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chung, Chia-Min] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong; Leu, Hsin-Bang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Leu, Hsin-Bang; Chan, Wan-Leong] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Chen, Tseng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tseng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Leu, HB (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	hbleu@vghtpe.gov.tw			National Yang-Ming University Hospital, Yilan, Taiwan [RD 2010-028, RD2011-020]; Taipei Veterans General Hospital, Taipei, Taiwan [V99B1-011, V99C1-125, V100B-013]; Yen Tjing Ling Medical Foundation, Taipei, Taiwan [CI-97-13, CI-98-16]; National Science Council [NSC 100-2314-B-075-055]; UST-UCSD International Center of Excellence in Advanced Bio-engineering [NSC-99-2911-I-009-101]; Taiwan National Science Council I-RiCE Program	National Yang-Ming University Hospital, Yilan, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Yen Tjing Ling Medical Foundation, Taipei, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council I-RiCE Program	The present study was partly supported by research grants from RD 2010-028 and RD2011-020 from National Yang-Ming University Hospital, Yilan, Taiwan; V99B1-011, V99C1-125, and V100B-013 from Taipei Veterans General Hospital, Taipei, Taiwan; CI-97-13 and CI-98-16 from the Yen Tjing Ling Medical Foundation, Taipei, Taiwan; NSC 100-2314-B-075-055 from the National Science Council, and NSC-99-2911-I-009-101 from the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council I-RiCE Program. The sponsor or funding organization had no role in the design or conduct of this research.	BOUZAS EA, 1993, ARCH OPHTHALMOL-CHIC, V111, P1229, DOI 10.1001/archopht.1993.01090090081024; Bouzas EA, 2002, SURV OPHTHALMOL, V47, P431, DOI 10.1016/S0039-6257(02)00338-7; Carvalho-Recchia CA, 2002, OPHTHALMOLOGY, V109, P1834, DOI 10.1016/S0161-6420(02)01117-X; Chan WM, 2006, JPN J OPHTHALMOL, V50, P161, DOI 10.1007/s10384-005-0259-z; Chou KT, 2012, AM J OPHTHALMOL, V154, P200, DOI 10.1016/j.ajo.2012.01.011; Conrad R, 2000, OPHTHALMOLOGE, V97, P527, DOI 10.1007/s003470070059; Desai UR, 2003, J NATL MED ASSOC, V95, P553; Fukunaga K, 1969, Nippon Ganka Gakkai Zasshi, V73, P1468; GELBER GS, 1987, AM J PSYCHIAT, V144, P46; Gemenetzi M, 2010, EYE, V24, P1743, DOI 10.1038/eye.2010.130; Haimovici R, 2004, OPHTHALMOLOGY, V111, P244, DOI 10.1016/j.ophtha.2003.09.024; HARBIN TJ, 1989, PSYCHOPHYSIOLOGY, V26, P110, DOI 10.1111/j.1469-8986.1989.tb03138.x; Hu CC, 2009, BRIT J OPHTHALMOL, V93, P717, DOI 10.1136/bjo.2008.151605; Hu CC, 2010, STROKE, V41, P613, DOI 10.1161/STROKEAHA.109.571000; Karadimas P, 2004, GRAEF ARCH CLIN EXP, V242, P800, DOI 10.1007/s00417-004-0885-z; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; Kitzmann AS, 2008, OPHTHALMOLOGY, V115, P169, DOI [10.1016/j.ophtha.2007.02.032, 10.1016/j.ophtha.2008.01.009]; Leveque TK, 2007, SLEEP BREATH, V11, P253, DOI 10.1007/s11325-007-0112-3; Quillen DA, 1996, OPHTHALMOLOGY, V103, P72, DOI 10.1016/S0161-6420(96)30730-6; Ross A, 2011, CURR OPIN OPHTHALMOL, V22, P166, DOI 10.1097/ICU.0b013e3283459826; Spaide RF, 1996, OPHTHALMOLOGY, V103, P2070, DOI 10.1016/S0161-6420(96)30386-2; Tittl MK, 1999, AM J OPHTHALMOL, V128, P63, DOI 10.1016/S0002-9394(99)00075-6; Tsai DC, 2012, ACTA OPHTHA IN PRESS; Tsai DC, 2012, BRIT J OPHTHALMOL, V96, P1484, DOI 10.1136/bjophthalmol-2012-301810; WAKAKURA M, 1984, BRIT J OPHTHALMOL, V68, P329, DOI 10.1136/bjo.68.5.329; Wakakura M, 1997, JPN J OPHTHALMOL, V41, P180, DOI 10.1016/S0021-5155(97)00027-0; Wang M, 2008, ACTA OPHTHALMOL, V86, P126, DOI 10.1111/j.1600-0420.2007.00889.x; YANNUZZI LA, 1987, RETINA-J RET VIT DIS, V7, P111, DOI 10.1097/00006982-198700720-00009	28	75	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66858	10.1371/journal.pone.0066858	http://dx.doi.org/10.1371/journal.pone.0066858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826160	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400070
J	Wang, YX; Pan, Z; Zhao, L; You, QS; Xu, L; Jonas, JB				Wang, Ya Xing; Pan, Zhe; Zhao, Liang; You, Qi Sheng; Xu, Liang; Jonas, Jost B.			Retinal Nerve Fiber Layer Thickness. The Beijing Eye Study 2011	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SCANNING LASER POLARIMETRY; GLAUCOMATOUS EYES; AGE; POPULATION; COUNT; SIZE; DETERMINANTS; HEAD; DISK	Purpose: To measure retinal nerve fiber layer (RNFL) thickness in a population-based setting. Methods: In the population-based Beijing Eye Study 2011 with 3468 individuals, RNFL thickness was measured in a subgroup of 1654 (47.7%) study participants by spectral domain optical coherence tomography (iVue SD-OCT). Results: Mean RNFL thickness was significantly (P<0.001) higher in the inferior sector (131.4 +/- 20.6 mu m) than the superior sector (126.1 +/- 19.1 mu m), where it was higher than in the temporal sector (79.8 +/- 12.2 mu m;P<0.001), where it was higher than in the nasal sector (75.1 +/- 12.6 mu m;P<0.001). In multivariate analysis, mean global RNFL thickness (103.2 +/- 12.6 mu m) increased significantly with younger age (standardized correlation coefficient beta:-0.30;P<0.001), larger neuroretinal rim area (beta:0.26;P<0.001), shorter axial length (beta:-0.21;P<0.001), thicker subfoveal choroidal thickness (beta:0.15;P<0.001), larger optic disc area (beta:0.10;P<0.001), less refractive lens power (beta:0.10;P<0.001), flatter anterior cornea (beta:0.07;P = 0.01) and female gender (beta:0.05;P = 0.03). In this population with an age of 50+ years, the age-related decline in RNFL thickness was 0.5 mu m per year of life or 0.36% of an original RNFL thickness of 137 mu m at baseline of the study at 50 years of age. Mean global RNFL thickness decreased by 2.4 mu m for each mm enlargement of axial length. Conclusions: The RNFL profile shows a double hump configuration with the thickest part in the inferior sector, followed by the superior sector, temporal sector and nasal sector. Factors influencing global RNFL thickness were younger age, larger neuroretinal rim, shorter axial length, thicker subfoveal choroid, larger optic disc, less refractive lens power, flatter anterior cornea and female gender. Beyond an age of 50+ years, RNFL decreased by about 0.3% per year of life at an age of 50+ years and by 2.4 mu m per mm of axial elongation. These findings may be of interest for the knowledge of the normal anatomy of the eye and may be of help to diagnose diseases affecting the RNFL.	[Wang, Ya Xing; Pan, Zhe; Zhao, Liang; You, Qi Sheng; Xu, Liang; Jonas, Jost B.] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Fac Clin Med Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio@yahoo.cn; Jost.Jonas@augen.ma.uni-heidelberg.de	You, Qisheng/A-3619-2014; wang, YA XING/K-9671-2016; You, Qisheng/AAG-7153-2020	You, Qisheng/0000-0003-0743-7320; wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1984, AM J OPHTHALMOL, V98, P566, DOI 10.1016/0002-9394(84)90242-3; [Anonymous], 2007, RTVUE US MAN; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; Dichtl A, 1999, GRAEF ARCH CLIN EXP, V237, P474, DOI 10.1007/s004170050264; Eid TM, 1997, J GLAUCOMA, V6, P221; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Girkin CA, 2011, OPHTHALMOLOGY, V118, P2403, DOI 10.1016/j.ophtha.2011.06.013; Hoh ST, 2000, AM J OPHTHALMOL, V129, P129, DOI 10.1016/S0002-9394(99)00294-9; JONAS JB, 1989, OPHTHALMOLOGY, V96, P627; JONAS JB, 1993, GRAEF ARCH CLIN EXP, V231, P207, DOI 10.1007/BF00918842; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; JONAS JB, 1990, INVEST OPHTH VIS SCI, V31, P736; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Leung CKS, 2012, OPHTHALMOLOGY, V119, P731, DOI 10.1016/j.ophtha.2011.10.010; Li YB, 2006, AM J OPHTHALMOL, V142, P788, DOI 10.1016/j.ajo.2006.06.001; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; PANDAJONAS S, 1994, OPHTHALMOLOGY, V101, P519; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; TjonFoSang MJ, 1997, AM J OPHTHALMOL, V123, P62, DOI 10.1016/S0002-9394(14)70993-6; Varma R, 1996, OPHTHALMOLOGY, V103, P2114, DOI 10.1016/S0161-6420(96)30381-3; Vogt A, 1913, GRAEFES ARHIV OPHTHA, V84, P293; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	28	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66763	10.1371/journal.pone.0066763	http://dx.doi.org/10.1371/journal.pone.0066763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826129	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400047
J	Bavarva, JH; Tae, H; Settlage, RE; Garner, HR				Bavarva, Jasmin H.; Tae, Hongseok; Settlage, Robert E.; Garner, Harold R.			Characterizing the Genetic Basis for Nicotine Induced Cancer Development: A Transcriptome Sequencing Study	PLOS ONE			English	Article							BREAST-CANCER; RNA-SEQ; MESSENGER-RNA; TUMOR-GROWTH; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; CARCINOMA-CELLS; PASSIVE SMOKING; KAPPA-B; EXPRESSION	Nicotine is a known risk factor for cancer development and has been shown to alter gene expression in cells and tissue upon exposure. We used Illumina (R) Next Generation Sequencing (NGS) technology to gain unbiased biological insight into the transcriptome of normal epithelial cells (MCF-10A) to nicotine exposure. We generated expression data from 54,699 transcripts using triplicates of control and nicotine stressed cells. As a result, we identified 138 differentially expressed transcripts, including 39 uncharacterized genes. Additionally, 173 transcripts that are primarily associated with DNA replication, recombination, and repair showed evidence for alternative splicing. We discovered the greatest nicotine stress response by HPCAL4 (up-regulated by 4.71 fold) and NPAS3 (down-regulated by -2.73 fold); both are genes that have not been previously implicated in nicotine exposure but are linked to cancer. We also discovered significant down-regulation (-2.3 fold) and alternative splicing of NEAT1 (lncRNA) that may have an important, yet undiscovered regulatory role. Gene ontology analysis revealed nicotine exposure influenced genes involved in cellular and metabolic processes. This study reveals previously unknown consequences of nicotine stress on the transcriptome of normal breast epithelial cells and provides insight into the underlying biological influence of nicotine on normal cells, marking the foundation for future studies.	[Bavarva, Jasmin H.; Tae, Hongseok; Settlage, Robert E.; Garner, Harold R.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Garner, HR (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	garner@vbi.vt.edu			Medical Informatics and Systems Division director's fund at Virginia Bioinformatics Institute	Medical Informatics and Systems Division director's fund at Virginia Bioinformatics Institute	This work was supported by the Medical Informatics and Systems Division director's fund at Virginia Bioinformatics Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 1998, HUM PATHOL, V29, P155, DOI 10.1016/S0046-8177(98)90226-X; Barr J, 2007, MOL CELL BIOCHEM, V297, P93, DOI 10.1007/s11010-006-9333-1; Bartel F, 2002, CANCER CELL, V2, P9, DOI 10.1016/S1535-6108(02)00091-0; Bieche I, 2001, ONCOGENE, V20, P6955, DOI 10.1038/sj.onc.1204739; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Choschzick M, 2010, MODERN PATHOL, V23, P603, DOI 10.1038/modpathol.2010.5; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Disher K, 2007, GENOME, V50, P946, DOI 10.1139/G07-074; Dunckley T, 2006, BRAIN RES, V1116, P39, DOI 10.1016/j.brainres.2006.07.111; Elsir T, 2012, CANCER METAST REV, V31, P793, DOI 10.1007/s10555-012-9390-8; Funk SD, 2012, ARTERIOSCL THROM VAS, V32, P686, DOI 10.1161/ATVBAHA.111.242792; Gilon M, 2008, DIFFERENTIATION, V76, P518, DOI 10.1111/j.1432-0436.2007.00246.x; Gomez-Pina V, 2012, J LEUKOCYTE BIOL, V91, P933, DOI 10.1189/jlb.0711340; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Henderson LJ, 2005, BRIT J CANCER, V92, P1553, DOI 10.1038/sj.bjc.6602452; Ito K, 2012, CANCER METAST REV, V31, P763, DOI 10.1007/s10555-012-9388-2; Kalra R, 2004, CLIN DIAGN LAB IMMUN, V11, P563, DOI 10.1128/CDLI.11.3.563-568.2004; La Salle S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095752; Li YG, 2012, FEBS J, V279, P2247, DOI 10.1111/j.1742-4658.2012.08607.x; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; LINDELL G, 1993, SCAND J GASTROENTERO, V28, P487, DOI 10.3109/00365529309098254; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McKiernan E, 2011, TUMOR BIOL, V32, P441, DOI 10.1007/s13277-010-0137-2; Midorikawa Y, 2004, CANCER RES, V64, P7263, DOI 10.1158/0008-5472.CAN-04-1275; Moreira F, 2011, AM J PATHOL, V179, P462, DOI 10.1016/j.ajpath.2011.03.044; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Nishioka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018619; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Slattery ML, 2008, BREAST CANCER RES TR, V109, P101, DOI 10.1007/s10549-007-9629-1; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; So AI, 2008, CLIN CANCER RES, V14, P6944, DOI 10.1158/1078-0432.CCR-08-0408; Talvensaari-Mattila A, 2001, BREAST CANCER RES TR, V65, P55, DOI 10.1023/A:1006458601568; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang YS, 2012, BOSNIAN J BASIC MED, V12, P94; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; ZBINDEN G, 1981, ARCH TOXICOL, V47, P77, DOI 10.1007/BF00332351; Zhang SL, 2001, PHYSIOL GENOMICS, V5, P187, DOI 10.1152/physiolgenomics.2001.5.4.187; Zong Y, 2009, WORLD J GASTROENTERO, V15, P2500, DOI 10.3748/wjg.15.2500	46	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67252	10.1371/journal.pone.0067252	http://dx.doi.org/10.1371/journal.pone.0067252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825647	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400181
J	Charnley, M; Anderegg, F; Holtackers, R; Textor, M; Meraldi, P				Charnley, Mirren; Anderegg, Fabian; Holtackers, Rene; Textor, Marcus; Meraldi, Patrick			Effect of Cell Shape and Dimensionality on Spindle Orientation and Mitotic Timing	PLOS ONE			English	Article							CONTACT GUIDED CELLS; CENTROSOME SEPARATION; PROTEIN ADSORPTION; OXIDE SURFACES; SINGLE CELLS; PTK2 CELLS; DIVISION; ACTIN; MITOSIS; MYOSIN	The formation and orientation of the mitotic spindle is a critical feature of mitosis. The morphology of the cell and the spatial distribution and composition of the cells' adhesive microenvironment all contribute to dictate the position of the spindle. However, the impact of the dimensionality of the cells' microenvironment has rarely been studied. In this study we present the use of a microwell platform, where the internal surfaces of the individual wells are coated with fibronectin, enabling the three-dimensional presentation of adhesive ligands to single cells cultured within the microwells. This platform was used to assess the effect of dimensionality and cell shape in a controlled microenvironment. Single HeLa cells cultured in circular microwells exhibited greater tilting of the mitotic spindle, in comparison to cells cultured in square microwells. This correlated with an increase in the time required to align the chromosomes at the metaphase plate due to prolonged activation of the spindle checkpoint in an actin dependent process. The comparison to 2D square patterns revealed that the dimensionality of cell adhesions alone affected both mitotic timings and spindle orientation; in particular the role of actin varied according to the dimensionality of the cells' microenvironment. Together, our data revealed that cell shape and the dimensionality of the cells' adhesive environment impacted on both the orientation of the mitotic spindle and progression through mitosis.	[Charnley, Mirren; Anderegg, Fabian; Textor, Marcus] ETH, Lab Surface Sci & Technol, Zurich, Switzerland; [Holtackers, Rene; Meraldi, Patrick] ETH, Inst Biochem, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Charnley, M (corresponding author), Swinburne Univ Technol, Fac Engn & Ind Sci, Ctr Microphoton, Hawthorn, Vic 3122, Australia.	mcharnley@swin.edu.au	Meraldi, Patrick/D-6190-2013	Charnley, Mirren/0000-0003-3845-9290; Meraldi, Patrick/0000-0001-9742-8756	Swiss National Science Foundation (SNSF) [CR23I2_125290/1]; Competence Centre for Materials Science and Technoloy (CCMX); National Centers for Competence in Research (NCCR) [03]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Competence Centre for Materials Science and Technoloy (CCMX); National Centers for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	The authors thank the Swiss National Science Foundation (SNSF; www.snf.ch; grant number CR23I2_125290/1), the Competence Centre for Materials Science and Technoloy (CCMX; www.ccmx.ch), and the National Centers for Competence in Research (NCCR; www.nccr.ch; Nano-P5, project 03) for their financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBIN JE, 1980, J CELL SCI, V43, P177; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Charnley M, 2012, INTEGR BIOL-UK, V4, P1059, DOI 10.1039/c2ib20111a; Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Concha ML, 1998, DEVELOPMENT, V125, P983; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Hakanson M, 2011, INTEGR BIOL-UK, V3, P31, DOI 10.1039/c0ib00074d; Hakanson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040141; Haraguchi T, 1997, GENES CELLS, V2, P369, DOI 10.1046/j.1365-2443.1997.1280326.x; Hawkins ED, 2008, ONCOGENE, V27, P7003, DOI 10.1038/onc.2008.350; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m; Khodjakov A, 2010, NAT CELL BIOL, V12, P919, DOI 10.1038/ncb1010-919; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Krzysiek-Maczka G, 2008, FOLIA BIOL-KRAKOW, V56, P13, DOI 10.3409/fb56_1-2.13-19; Krzysiek-Maczka G, 2010, FOLIA BIOL-KRAKOW, V58, P21, DOI 10.3409/fb58_1-2.21-27; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Ma HT, 2011, BIOCHEM J, V435, P17, DOI 10.1042/BJ20100284; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Miserey-Lenkei S, 2006, EMBO J, V25, P278, DOI 10.1038/sj.emboj.7600929; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Ochsner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009445; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y; RATTNER JB, 1976, CHROMOSOMA, V54, P387, DOI 10.1007/BF00292817; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Russell SM, 2008, IMMUNOL CELL BIOL, V86, P423, DOI 10.1038/icb.2008.24; SANGER JM, 1989, CELL MOTIL CYTOSKEL, V14, P201, DOI 10.1002/cm.970140207; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Uzbekov R, 2002, BIOL CELL, V94, P275, DOI 10.1016/S0248-4900(02)01202-9; Vasiliev JM, 2004, P NATL ACAD SCI USA, V101, P12526, DOI 10.1073/pnas.0404723101; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Whitehead CM, 1996, CELL MOTIL CYTOSKEL, V35, P298, DOI 10.1002/(SICI)1097-0169(1996)35:4<298::AID-CM3>3.0.CO;2-3; Zhao L, 2011, J BIOMECH, V44, P2388, DOI 10.1016/j.jbiomech.2011.06.033	58	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66918	10.1371/journal.pone.0066918	http://dx.doi.org/10.1371/journal.pone.0066918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825020	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400168
J	Lee, CF; Ullevig, S; Kim, HS; Asmis, R				Lee, Chi Fung; Ullevig, Sarah; Kim, Hong Seok; Asmis, Reto			Regulation of Monocyte Adhesion and Migration by Nox4	PLOS ONE			English	Article							REDOX REGULATION; MITOCHONDRIAL DYSFUNCTION; GLUTATHIONE-REDUCTASE; TYROSINE-PHOSPHATASE; SIGNAL-TRANSDUCTION; HUMAN MACROPHAGES; CELL-MIGRATION; BETA-ACTIN; KINASE; SUPEROXIDE	We showed that metabolic disorders promote thiol oxidative stress in monocytes, priming monocytes for accelerated chemokine-induced recruitment, and accumulation at sites of vascular injury and the progression of atherosclerosis. The aim of this study was to identify both the source of reactive oxygen species (ROS) responsible for thiol oxidation in primed and dysfunctional monocytes and the molecular mechanisms through which ROS accelerate the migration and recruitment of monocyte-derived macrophages. We found that Nox4, a recently identified NADPH oxidase in monocytes and macrophages, localized to focal adhesions and the actin cytoskeleton, and associated with phospho-FAK, paxillin, and actin, implicating Nox4 in the regulation of monocyte adhesion and migration. We also identified Nox4 as a new, metabolic stress-inducible source of ROS that controls actin S-glutathionylation and turnover in monocytes and macrophages, providing a novel mechanistic link between Nox4-derived H2O2 and monocyte adhesion and migration. Actin associated with Nox4 was S-glutathionylated, and Nox4 association with actin was enhanced in metabolically-stressed monocytes. Metabolic stress induced Nox4 and accelerated monocyte adhesion and chemotaxis in a Nox4-dependent mechanism. In conclusion, our data suggest that monocytic Nox4 is a central regulator of actin dynamics, and induction of Nox4 is the rate-limiting step in metabolic stress-induced monocyte priming and dysfunction associated with accelerated atherosclerosis and the progression of atherosclerotic plaques.	[Lee, Chi Fung; Ullevig, Sarah; Asmis, Reto] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, Sch Hlth Profess, San Antonio, TX 78229 USA; [Kim, Hong Seok; Asmis, Reto] Univ Texas Hlth Sci Ctr San Antonio, Dept Clin Lab Sci, Sch Hlth Profess, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Asmis, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, Sch Hlth Profess, San Antonio, TX 78229 USA.	asmis@uthscsa.edu	Asmis, Reto/W-1344-2019	Lee, Chi Fung/0000-0002-5395-6925; Ullevig, Sarah/0000-0001-5322-2801	American Heart Association (AHA) Southwest Affiliate Predoctoral Fellowship [10PRE3460002]; NIH [HL-70963]; AHA [0855011F]; UTHSCSA [NIH-NCI P30 CA54174, NIH-NIA P30 AG013319, NIH-NIA P01AG19316]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319] Funding Source: NIH RePORTER	American Heart Association (AHA) Southwest Affiliate Predoctoral Fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); UTHSCSA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants to C.F.L. from the American Heart Association (AHA) Southwest Affiliate Predoctoral Fellowship 10PRE3460002, and R.A. from the NIH HL-70963 and the AHA 0855011F. Confocal images were acquired in the Core Optical Imaging Facility, which is supported by UTHSCSA, NIH-NCI P30 CA54174 (San Antonio Cancer Institute), NIH-NIA P30 AG013319 (Nathan Shock Center) and (NIH-NIA P01AG19316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Asmis R, 2003, CIRC RES, V92, pE20, DOI 10.1161/01.RES.0000051886.43510.90; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Chaubey S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054869; CHEN K, 2009, ANTIOXID REDOX SIGNA; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; GUZIK TJ, 2009, ANTIOXID REDOX SIGNA; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Johansson Magnus, 2007, BMC Biochemistry, V8, P26, DOI 10.1186/1471-2091-8-26; Kanda M, 2006, J BIOL CHEM, V281, P28518, DOI 10.1074/jbc.M604359200; Kim HS, 2012, P NATL ACAD SCI USA, V109, pE2803, DOI 10.1073/pnas.1212596109; Kirk EA, 2000, ARTERIOSCL THROM VAS, V20, P1529, DOI 10.1161/01.ATV.20.6.1529; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee CF, 2010, CIRC RES, V106, P1489, DOI 10.1161/CIRCRESAHA.109.215392; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; QIAO M, 2009, ARTERIOSCLER THROMB; Qiao M, 2007, ARTERIOSCL THROM VAS, V27, P1375, DOI 10.1161/ATVBAHA.107.142109; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Taddei ML, 2007, ANTIOXID REDOX SIGN, V9, P469, DOI 10.1089/ars.2006.1392; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; Ullevig S, 2012, ARTERIOSCL THROM VAS, V32, P415, DOI 10.1161/ATVBAHA.111.238899; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang YM, 2006, FREE RADICAL BIO MED, V41, P775, DOI 10.1016/j.freeradbiomed.2006.05.029; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Wintergerst ES, 1998, HISTOCHEM CELL BIOL, V110, P231, DOI 10.1007/s004180050285; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09	60	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66964	10.1371/journal.pone.0066964	http://dx.doi.org/10.1371/journal.pone.0066964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825596	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400172
J	Rauner, G; Leviav, A; Mavor, E; Barash, I				Rauner, Gat; Leviav, Amos; Mavor, Eliezer; Barash, Itamar			Development of Foreign Mammary Epithelial Morphology in the Stroma of Immunodeficient Mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR RECEPTOR; ATHYMIC NUDE-MICE; GENE-EXPRESSION; PROGESTERONE-RECEPTOR; STEROID-RECEPTORS; GLAND DEVELOPMENT; CANCER-CELLS; STEM-CELLS; FAT-PADS	Systemic growth and branching stimuli, and appropriate interactions with the host stroma are essential for the development of foreign epithelia in the mammary gland of immunodeficient mice. These factors were manipulated to promote and investigate the generation of representative bovine epithelial morphology in the transplanted mouse mammary stroma. The bovine mammary epithelium is unique in its commitment to rapid proliferation and high rate of differentiation. Its morphological organization within a fibrotic stroma resembles that of the human breast, and differs significantly from the rudimentary ductal network that penetrates a fatty stroma in mice. Transplantation of bovine mammary epithelial cells into the cleared mammary fat pad of NOD-SCID mice led to continuous growth of epithelial structures. Multilayered hollow spheres developed within fibrotic areas, but in contrast to mice, no epithelial organization was formed between adipocytes. The multilayered spheres shared characteristics with the heifer gland's epithelium, including lumen size, cell proliferation, cytokeratin orientation, estrogen/progesterone receptor expression and localization, and milk protein synthesis. However, they did not extend into the mouse fat pad via ductal morphology. Pre-transplantation of fibroblasts increased the number of spheres, but did not promote extension of bovine morphology. The bovine cells preserved their fate and rarely participated in chimeric mouse-bovine outgrowths. Nevertheless, a single case of terminal ductal lobuloalveolar unit (TDLU) development was recorded in mice treated with estrogen and progesterone, implying the feasibility of this representative bovine morphology's development. In vitro extension of these studies revealed paracrine inhibition of bovine epithelial mammosphere development by adipocytes, which was also generalized to breast epithelial mammosphere formation. The rescue of mammosphere development by fibroblast growth factor administration evidences an active equilibrium between inhibitory and supportive effects exerted by the adipose and fibrotic regions of the stroma, respectively, which determines the development of foreign epithelium.	[Rauner, Gat; Barash, Itamar] Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel; [Rauner, Gat] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Jerusalem, Israel; [Leviav, Amos] Kaplan Med Ctr, Dept Plast Surg, Rehovot, Israel; [Mavor, Eliezer] Kaplan Med Ctr, Dept Surg, Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center	Barash, I (corresponding author), Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel.	itamar.barash@mail.huji.ac.il			Israeli Ministry of Agriculture (Biotechnology and Animal Science); Israel Dairy Board and the Israel Science Foundation; Israel Academy of Sciences [289/11]	Israeli Ministry of Agriculture (Biotechnology and Animal Science); Israel Dairy Board and the Israel Science Foundation; Israel Academy of Sciences	This study was supported by the Chief Scientist, Israeli Ministry of Agriculture (Biotechnology and Animal Science), the Israel Dairy Board and the Israel Science Foundation, Israel Academy of Sciences, contract no. 289/11 to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 2004, J MAMMARY GLAND BIOL, V9, P3, DOI 10.1023/B:JOMG.0000023584.01750.16; Arendt LM, 2010, SEMIN CELL DEV BIOL, V21, P11, DOI 10.1016/j.semcdb.2009.10.003; Athie F, 1996, J DAIRY SCI, V79, P220, DOI 10.3168/jds.S0022-0302(96)76354-3; BANISACCHI T, 1987, ACTA ANAT, V129, P1, DOI 10.1159/000146368; BARASH I, 1993, TRANSGENIC RES, V2, P266, DOI 10.1007/BF01968839; BARASH I, 1995, MOL CELL BIOCHEM, V144, P175, DOI 10.1007/BF00944397; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; BEAMER PD, 1983, VET PATHOL, V20, P509, DOI 10.1177/030098588302000418; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Booth BW, 2011, ONCOGENE, V30, P679, DOI 10.1038/onc.2010.439; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Boulanger CA, 2012, STEM CELLS DEV, V21, P948, DOI 10.1089/scd.2011.0148; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Bruno RD, 2012, SEMIN CELL DEV BIOL, V23, P591, DOI 10.1016/j.semcdb.2012.03.007; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Capuco AV, 2012, ANIMAL, V6, P382, DOI 10.1017/S1751731111002369; Capuco AV, 2005, J MAMMARY GLAND BIOL, V10, P5, DOI 10.1007/s10911-005-2536-3; Capuco AV, 2002, TISSUE CELL, V34, P143, DOI 10.1016/S0040-8166(02)00024-1; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; COLEMANKRNACIK S, 1994, MOL ENDOCRINOL, V8, P218, DOI 10.1210/me.8.2.218; Connor EE, 2007, J DAIRY SCI, V90, pE55, DOI 10.3168/jds.2006-466; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; DEOME KB, 1959, CANCER RES, V19, P515; Dillon C, 2004, J MAMMARY GLAND BIOL, V9, P207, DOI 10.1023/B:JOMG.0000037163.56461.1e; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Hovey RC, 1999, J MAMMARY GLAND BIOL, V4, P53, DOI 10.1023/A:1018704603426; Hovey RC, 2010, J MAMMARY GLAND BIOL, V15, P279, DOI 10.1007/s10911-010-9187-8; JOHNSTON PG, 1992, CANCER RES, V52, P6860; Kamikawa A, 2009, DEV DYNAM, V238, P1092, DOI 10.1002/dvdy.21947; KORDON EC, 1995, DEV BIOL, V168, P47, DOI 10.1006/dbio.1995.1060; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Maple RL, 1998, DOMEST ANIM ENDOCRIN, V15, P489, DOI 10.1016/S0739-7240(98)00037-X; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; MCFADDEN TB, 1993, PROC NEW ZEAL SOC AN, V53, P143; Motta M, 2007, MOL CELL ENDOCRINOL, V263, P149, DOI 10.1016/j.mce.2006.09.010; Mroue Rana, 2013, Methods Mol Biol, V945, P221, DOI 10.1007/978-1-62703-125-7_14; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Parmar H, 2004, ENDOCR-RELAT CANCER, V11, P437, DOI 10.1677/erc.1.00659; Parmar H, 2002, ENDOCRINOLOGY, V143, P4886, DOI 10.1210/en.2002-220570; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Piantoni P, 2010, BIOINFORM BIOL INSIG, V4, P85; Pond AC, 2013, STEM CELLS, V31, P178, DOI 10.1002/stem.1266; POVEY RC, 1969, PATHOL VET, V6, P502, DOI 10.1177/030098586900600603; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Rauner G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030113; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Rosenfield Sonia M, 2013, Cells, V2, P43, DOI 10.3390/cells2010043; Rowson AR, 2012, SEMIN CELL DEV BIOL, V23, P557, DOI 10.1016/j.semcdb.2012.03.018; RUDLAND PS, 1989, J HISTOCHEM CYTOCHEM, V37, P1087, DOI 10.1177/37.7.2471725; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; Schneider M, 1996, J BIOTECHNOL, V46, P161, DOI 10.1016/0168-1656(95)00196-4; SHEFFIELD LG, 1988, INT J CANCER, V41, P713, DOI 10.1002/ijc.2910410513; SHEFFIELD LG, 1986, J DAIRY SCI, V69, P1141, DOI 10.3168/jds.S0022-0302(86)80513-6; SHEFFIELD LG, 1988, J DAIRY SCI, V71, P2855, DOI 10.3168/jds.S0022-0302(88)79881-1; Silva LFP, 2008, J DAIRY SCI, V91, P3034, DOI 10.3168/jds.2007-0761; Silva LFP, 2002, J DAIRY SCI, V85, P3277, DOI 10.3168/jds.S0022-0302(02)74416-0; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Stingl John, 2011, Hormones & Cancer, V2, P85, DOI 10.1007/s12672-010-0055-1; SUD SC, 1968, J DAIRY SCI, V51, P210, DOI 10.3168/jds.S0022-0302(68)86954-1; Visvader JE, 2010, COLD SPRING HARB PER, P3; Wiesen JF, 1999, DEVELOPMENT, V126, P335; Wilson CL, 2006, ENDOCR-RELAT CANCER, V13, P617, DOI 10.1677/erc.1.01165; WOODWARD TL, 1993, J ENDOCRINOL, V136, P149, DOI 10.1677/joe.0.1360149; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Yamaji D, 2007, JPN J VET RES, V54, P183; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	81	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68637	10.1371/journal.pone.0068637	http://dx.doi.org/10.1371/journal.pone.0068637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825700	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400199
J	Tourniaire, F; Romier-Crouzet, B; Lee, JH; Marcotorchino, J; Gouranton, E; Salles, J; Malezet, C; Astier, J; Darmon, P; Blouin, E; Walrand, S; Ye, JP; Landrier, JF				Tourniaire, Franck; Romier-Crouzet, Beatrice; Lee, Jong Han; Marcotorchino, Julie; Gouranton, Erwan; Salles, Jerome; Malezet, Christiane; Astier, Julien; Darmon, Patrice; Blouin, Eric; Walrand, Stephane; Ye, Jianping; Landrier, Jean-Francois			Chemokine Expression in Inflamed Adipose Tissue Is Mainly Mediated by NF-kappa B	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; UP-REGULATION; OBESITY; INFLAMMATION; ACCUMULATION; ADIPOCYTES; METABOLISM	Immune cell infiltration of expanding adipose tissue during obesity and its role in insulin resistance has been described and involves chemokines. However, studies so far have focused on a single chemokine or its receptor (especially CCL2 and CCL5) whereas redundant functions of chemokines have been described. The objective of this work was to explore the expression of chemokines in inflamed adipose tissue in obesity. Human and mouse adipocytes were analyzed for expression of chemokines in response to inflammatory signal (TNF-alpha) using microarrays and gene set enrichment analysis. Gene expression was verified by qRT-PCR. Chemokine protein was determined in culture medium with ELISA. Chemokine expression was investigated in human subcutaneous adipose tissue biopsies and mechanism of chemokine expression was investigated using chemical inhibitors and cellular and animal transgenic models. Chemokine encoding genes were the most responsive genes in TNF-alpha treated human and mouse adipocytes. mRNA and protein of 34 chemokine genes were induced in a dose-dependent manner in the culture system. Furthermore, expression of those chemokines was elevated in human obese adipose tissue. Finally, chemokine expression was reduced by NF-kappa B inactivation and elevated by NF-kappa B activation. Our data indicate that besides CCL2 and CCL5, numerous other chemokines such as CCL19 are expressed by adipocytes under obesity-associated chronic inflammation. Their expression is regulated predominantly by NF-kappa B. Those chemokines could be involved in the initiation of infiltration of leukocytes into obese adipose tissue.	[Tourniaire, Franck; Romier-Crouzet, Beatrice; Marcotorchino, Julie; Gouranton, Erwan; Malezet, Christiane; Astier, Julien; Darmon, Patrice; Landrier, Jean-Francois] INRA, UMR 1260, Marseille, France; [Tourniaire, Franck; Romier-Crouzet, Beatrice; Marcotorchino, Julie; Gouranton, Erwan; Malezet, Christiane; Astier, Julien; Darmon, Patrice; Landrier, Jean-Francois] INSERM, UMR Nutr Obes & Risque Thrombot 1062, F-13258 Marseille, France; [Tourniaire, Franck; Romier-Crouzet, Beatrice; Marcotorchino, Julie; Gouranton, Erwan; Malezet, Christiane; Astier, Julien; Darmon, Patrice; Landrier, Jean-Francois] Univ Aix Marseille, Fac Med, Marseille, France; [Lee, Jong Han; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Salles, Jerome; Walrand, Stephane] Ctr Rech INRA Clermont Ferrand Theix, UMR INRA Unite Nutr Humaine 1019, St Genes Champanelle, France; [Blouin, Eric] Lab Labcatal, Montrouge, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; INRAE	Landrier, JF (corresponding author), INRA, UMR 1260, Marseille, France.	jean-francois.landrier@univ-amu.fr	Tourniaire, Franck/K-9131-2017; Ye, Jianping/N-1998-2017; Landrier, Jean-Francois/AAH-2757-2019	Tourniaire, Franck/0000-0002-6394-7045; Ye, Jianping/0000-0003-3875-365X; Landrier, Jean-Francois/0000-0002-8690-8014; Walrand, Stephane/0000-0002-4349-3664; Salles, Jerome/0000-0002-1787-5802; Darmon, Patrice/0000-0003-1726-2296	NIH [DK068036, DK085495]; INRA; INSERM; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK068036, R01DK068036, R01DK085495] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INRA; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was partially supported by NIH grant (DK068036 and DK085495) to JY, and funding from INRA and INSERM to JFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Foster MT, 2010, PHYSIOL BEHAV, V101, P282, DOI 10.1016/j.physbeh.2010.05.014; Gouranton E, 2011, J NUTR BIOCHEM, V22, P642, DOI 10.1016/j.jnutbio.2010.04.016; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Landrier JF, 2008, FREE RADICAL RES, V42, P523, DOI 10.1080/10715760802098859; Landrier JF, 2010, J NUTR BIOCHEM, V21, P1207, DOI 10.1016/j.jnutbio.2009.10.008; Landrier JF, 2009, ENDOCRINOLOGY, V150, P5318, DOI 10.1210/en.2009-0506; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Nikolajczyk BS, 2011, GENES IMMUN, V12, P239, DOI 10.1038/gene.2011.14; O'Hara A, 2009, PFLUG ARCH EUR J PHY, V458, P1103, DOI 10.1007/s00424-009-0693-8; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Surmi BK, 2010, VASC PHARMACOL, V52, P27, DOI 10.1016/j.vph.2009.12.004; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Taylor R, 2008, DIABETOLOGIA, V51, P1781, DOI 10.1007/s00125-008-1116-7; Tsigos C, 1999, METABOLISM, V48, P1332, DOI 10.1016/S0026-0495(99)90277-9; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229	44	94	97	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66515	10.1371/journal.pone.0066515	http://dx.doi.org/10.1371/journal.pone.0066515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824685	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400120
J	Wang, YX; Marshall, KL; Baba, Y; Gerling, GJ; Lumpkin, EA				Wang, Yuxiang; Marshall, Kara L.; Baba, Yoshichika; Gerling, Gregory J.; Lumpkin, Ellen A.			Hyperelastic Material Properties of Mouse Skin under Compression	PLOS ONE			English	Article							AGE-RELATED-CHANGES; MECHANICAL-PROPERTIES; THICKNESS; POPULATIONS; PATTERNS	The skin is a dynamic organ whose complex material properties are capable of withstanding continuous mechanical stress while accommodating insults and organism growth. Moreover, synchronized hair cycles, comprising waves of hair growth, regression and rest, are accompanied by dramatic fluctuations in skin thickness in mice. Whether such structural changes alter skin mechanics is unknown. Mouse models are extensively used to study skin biology and pathophysiology, including aging, UV-induced skin damage and somatosensory signaling. As the skin serves a pivotal role in the transfer function from sensory stimuli to neuronal signaling, we sought to define the mechanical properties of mouse skin over a range of normal physiological states. Skin thickness, stiffness and modulus were quantitatively surveyed in adult, female mice (Mus musculus). These measures were analyzed under uniaxial compression, which is relevant for touch reception and compression injuries, rather than tension, which is typically used to analyze skin mechanics. Compression tests were performed with 105 full-thickness, freshly isolated specimens from the hairy skin of the hind limb. Physiological variables included body weight, hair-cycle stage, maturity level, skin site and individual animal differences. Skin thickness and stiffness were dominated by hair-cycle stage at young (6-10 weeks) and intermediate (13-19 weeks) adult ages but by body weight in mature mice (26-34 weeks). Interestingly, stiffness varied inversely with thickness so that hyperelastic modulus was consistent across hair-cycle stages and body weights. By contrast, the mechanics of hairy skin differs markedly with anatomical location. In particular, skin containing fascial structures such as nerves and blood vessels showed significantly greater modulus than adjacent sites. Collectively, this systematic survey indicates that, although its structure changes dramatically throughout adult life, mouse skin at a given location maintains a constant elastic modulus to compression throughout normal physiological stages.	[Wang, Yuxiang; Gerling, Gregory J.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22903 USA; [Marshall, Kara L.; Baba, Yoshichika; Lumpkin, Ellen A.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Lumpkin, Ellen A.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	University of Virginia; Columbia University; Columbia University	Gerling, GJ (corresponding author), Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22903 USA.	gregory-gerling@virginia.edu; eal2166@columbia.edu		Lumpkin, Ellen/0000-0002-1166-3374	National Institutes of Neurological Disorders and Stroke through the CRCNS program [NINDS R01NS073119]; Columbia University Skin Disease Research Center Tissue Culture and Histology and Advanced Imaging Cores [NIAMS P30AR044535]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073119] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke through the CRCNS program; Columbia University Skin Disease Research Center Tissue Culture and Histology and Advanced Imaging Cores; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Neurological Disorders and Stroke through the CRCNS program (NINDS R01NS073119 to EAL and GJG). Histology was performed with support from the Columbia University Skin Disease Research Center Tissue Culture and Histology and Advanced Imaging Cores (NIAMS P30AR044535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NINDS: http://www.ninds.nih.gov NIAMS:http://www.niams.nih.gov.	Ananthaswamy HN, 1997, NAT MED, V3, P510, DOI 10.1038/nm0597-510; Battaglia TC, 2005, J DERMATOL SCI, V39, P192, DOI 10.1016/j.jdermsci.2005.07.002; Crichton ML, 2013, BIOMATERIALS, V34, P2087, DOI 10.1016/j.biomaterials.2012.11.035; Crichton ML, 2011, BIOMATERIALS, V32, P4670, DOI 10.1016/j.biomaterials.2011.03.012; DALY CH, 1982, J INVEST DERMATOL, V79, pS17, DOI 10.1111/1523-1747.ep12544620; DALY CH, 1979, J INVEST DERMATOL, V73, P84, DOI 10.1111/1523-1747.ep12532770; ESCOFFIER C, 1989, J INVEST DERMATOL, V93, P353, DOI 10.1111/1523-1747.ep12280259; Eshel H, 2001, ANN BIOMED ENG, V29, P164, DOI 10.1114/1.1349697; FOSTER CA, 1987, ANAT REC, V218, P355, DOI 10.1002/ar.1092180317; Holzapfel G., 2000, NONLINEAR SOLID MECH; Kang GZ, 2011, J MECH BEHAV BIOMED, V4, P498, DOI 10.1016/j.jmbbm.2010.12.015; Kent RW, 2009, J BIOMECH, V42, P1656, DOI 10.1016/j.jbiomech.2009.04.027; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Krueger N, 2011, SKIN RES TECHNOL, V17, P141, DOI 10.1111/j.1600-0846.2010.00486.x; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; LANIR Y, 1974, J BIOMECH, V7, P171, DOI 10.1016/0021-9290(74)90058-X; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Martin PG., 2000, PROPERTIES HUMAN SKI; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; OOMENS CWJ, 1987, J BIOMECH, V20, P877, DOI 10.1016/0021-9290(87)90147-3; Plikus MV, 2008, J INVEST DERMATOL, V128, P1071, DOI 10.1038/sj.jid.5701180; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Plikus MV, 2009, INT J DEV BIOL, V53, P857, DOI 10.1387/ijdb.072564mp; Serrat MA, 2007, CONNECT TISSUE RES, V48, P19, DOI 10.1080/03008200601021373; Smalls LK, 2006, SKIN RES TECHNOL, V12, P43, DOI 10.1111/j.0909-725X.2006.00135.x; Wang Y, 2013, IEEE INT WORKS INFOR, P49, DOI 10.1109/WIFS.2013.6707793; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; WHITTON JT, 1973, HEALTH PHYS, V24, P1, DOI 10.1097/00004032-197301000-00001; Wolnicka-Glubisz A, 2013, EXP DERMATOL, V22, P226, DOI 10.1111/exd.12100; Wu JZ, 2003, BIO-MED MATER ENG, V13, P373; Zaidi Z, 2010, DERMATOLOGY IN CLINICAL PRACTICE, P1, DOI 10.1007/978-1-84882-862-9_1; Zimmermann K, 2009, NAT PROTOC, V4, P174, DOI 10.1038/nprot.2008.223	33	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67439	10.1371/journal.pone.0067439	http://dx.doi.org/10.1371/journal.pone.0067439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825661	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400185
J	Ferguson, LR; Dominguez, JM; Balaiya, S; Grover, S; Chalam, KV				Ferguson, Lee R.; Dominguez, James M., II; Balaiya, Sankarathi; Grover, Sandeep; Chalam, Kakarla V.			Retinal Thickness Normative Data in Wild-Type Mice Using Customized Miniature SD-OCT	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MOUSE MODEL; DEGENERATION; RETINOPATHY; GENE	Objective: To report normative data for retinal thickness in wild-type C57BL/6 mouse utilizing a miniature SD-OCT system. Methods: Thirty adult mice (range: 3-5 months) were anesthetized and secured into the Bioptigen Spectral Domain Ophthalmic Imaging System. Right eye SD-OCT images were standardized by centralizing the optic nerve head (ONH) prior to image acquisition. Global and quadrant total retinal thickness (TRT) values were measured from retinal nerve fiber layer to retinal pigment epithelial layer. Posterior segment analyses also included the outer retinal layer (ORL) and inner retinal layer (IRL). Further sublayer analyses of four layers from the ORL and three layers comprising the IRL were also performed. Results: The overall mean +/- SD global TRT in a C57BL/6 mouse model was 204.41 +/- 5.19 mu m. Quadrant mean TRT values were 204.85 +/- 5.81 mu m inferiorly, 204.97 +/- 6.71 mu m nasally, 205.08 +/- 5.44 mu m temporally, and 202.74 +/- 4.85 mu m superiorly. Mean +/- SD thickness for ORL, and IRL were 126.37 +/- 10.01 mu m, and 107.03 +/- 10.98 mu m respectively. The mean +/- SD estimates for the four layers of the ORL were 18.23 +/- 2.73 mu m, 26.04 +/- 4.21 mu m, 63.8 +/- 6.23 mu m, and 19.22 +/- 4.34 mu m. Mean +/- SD values for the three IRL sublayers were 27.82 +/- 4.04 mu m, 59.62 +/- 6.66 mu m and 19.12 +/- 3.71 mu m. Conclusion: This study established normative values for the total retinal thickness and sublayer thickness for the wild-type C57BL/6 mice. Moreover, it provides a standard of retinal morphology, in a commonly used animal model, for evaluating therapeutic interventions and retinal disease pathophysiology.	[Ferguson, Lee R.; Balaiya, Sankarathi; Grover, Sandeep; Chalam, Kakarla V.] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL USA; [Dominguez, James M., II] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chalam, KV (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL USA.	Kakarla.Chalam@jax.ufl.edu	Chalam, kakarla/K-7507-2019	Chalam, kakarla/0000-0001-9325-8665; Chalam, K V/0000-0002-0004-9416; Grover, Sandeep/0000-0002-3771-7510				Aguilar E, 2008, METHOD ENZYMOL, V444, P115, DOI 10.1016/S0076-6879(08)02806-1; Alam S, 2006, OPHTHALMOLOGY, V113, P1425, DOI 10.1016/j.ophtha.2006.03.020; Cebulla CM, 2010, EXP EYE RES, V90, P521, DOI 10.1016/j.exer.2010.01.008; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Dyer MA, 2004, MOL BRAIN RES, V132, P208, DOI 10.1016/j.molbrainres.2004.10.011; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Fukuchi T, 2001, GRAEF ARCH CLIN EXP, V239, P41, DOI 10.1007/s004170000205; Gabriele ML, 2010, INVEST OPHTH VIS SCI, V51, P6519, DOI 10.1167/iovs.10-5662; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Kern TS, 1996, ARCH OPHTHALMOL-CHIC, V114, P986, DOI 10.1001/archopht.1996.01100140194013; Li QH, 2001, INVEST OPHTH VIS SCI, V42, P2981; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morrow EM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-5; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Pang JJ, 2005, MOL VIS, V11, P152; Pignatelli V, 2004, J COMP NEUROL, V469, P351, DOI 10.1002/cne.11019; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Sabates FN, 2011, RETINA-J RET VIT DIS, V31, P1294, DOI 10.1097/IAE.0b013e3182019be2; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Weber BHF, 2002, P NATL ACAD SCI USA, V99, P6222, DOI 10.1073/pnas.092528599; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	31	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67265	10.1371/journal.pone.0067265	http://dx.doi.org/10.1371/journal.pone.0067265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826252	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000052
J	He, MH; Zhang, LL; Wang, XC; Huo, LH; Sun, L; Feng, CY; Jing, XT; Du, DY; Liang, HB; Liu, M; Hong, ZY; Zhou, J				He, Minghao; Zhang, Linlin; Wang, Xincheng; Huo, Lihong; Sun, Lei; Feng, Chengye; Jing, Xutian; Du, Danyao; Liang, Huabin; Liu, Min; Hong, Zhangyong; Zhou, Jun			Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHROMATIN-REMODELING COMPLEX; HIV-1 TAT; PROTEIN; TRANSACTIVATION; TRANSCRIPTION; BINDING; LOOP; ACETYLTRANSFERASE; PROLIFERATION	The Tat protein of HIV-1 has several well-known properties, such as nucleocytoplasmic trafficking, transactivation of transcription, interaction with tubulin, regulation of mitotic progression, and induction of apoptosis. Previous studies have identified a couple of lysine residues in Tat that are essential for its functions. In order to analyze the functions of all the lysine residues in Tat, we mutated them individually to alanine, glutamine, and arginine. Through systematic analysis of the lysine mutants, we discovered several previously unidentified characteristics of Tat. We found that lysine acetylation could modulate the subcellular localization of Tat, in addition to the regulation of its transactivation activity. Our data also revealed that lysine mutations had distinct effects on microtubule assembly and Tat binding to bromodomain proteins. By correlation analysis, we further found that the effects of Tat on apoptosis and mitotic progression were not entirely attributed to its effect on microtubule assembly. Our findings suggest that Tat may regulate diverse cellular activities through binding to different proteins and that the acetylation of distinct lysine residues in Tat may modulate its interaction with various partners.	[He, Minghao; Zhang, Linlin; Wang, Xincheng; Huo, Lihong; Feng, Chengye; Jing, Xutian; Du, Danyao; Liang, Huabin; Hong, Zhangyong; Zhou, Jun] Nankai Univ, Coll Life Sci, Ctr AIDS Res, Tianjin 300071, Peoples R China; [Sun, Lei; Liu, Min] Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin, Peoples R China	Nankai University; Tianjin Medical University	Hong, ZY (corresponding author), Nankai Univ, Coll Life Sci, Ctr AIDS Res, Tianjin 300071, Peoples R China.	hongzy@nankai.edu.cn; junzhou@nankai.edu.cn	Huo, Lihong/ABI-4909-2020; Sun, Lei/N-4783-2018; Zhang, Linlin/J-6639-2019	Zhang, Linlin/0000-0003-3240-1215; Feng, Chengye/0000-0001-7330-4273; Huo, Lihong/0000-0001-7901-6758	National Science and Technology [2012ZX10001-006]; National Natural Science Foundation of China [31170820, 31171334]; National Undergraduate Training Program for Innovation [111005521]; National Basic Science Personnel Training Fund [J1103503]; 111 project [B08011]	National Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Undergraduate Training Program for Innovation; National Basic Science Personnel Training Fund; 111 project(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Science and Technology Major Project (2012ZX10001-006), the National Natural Science Foundation of China (31170820 and 31171334), the National Undergraduate Training Program for Innovation (111005521), the National Basic Science Personnel Training Fund (J1103503), and the 111 project (B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Bukrinsky M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-49; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Chen D, 2002, EMBO J, V21, P6801, DOI 10.1093/emboj/cdf683; Col E, 2001, J BIOL CHEM, V276, P28179, DOI 10.1074/jbc.M101385200; D'Orso I, 2009, P NATL ACAD SCI USA, V106, P3101, DOI 10.1073/pnas.0900012106; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Dormeyer W, 2005, MOL CELL PROTEOMICS, V4, P1226, DOI 10.1074/mcp.M500047-MCP200; Dorr A, 2002, EMBO J, V21, P2715, DOI 10.1093/emboj/21.11.2715; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; Gibellini D, 2005, NEW MICROBIOL, V28, P95; Hetzer C, 2005, MICROBES INFECT, V7, P1364, DOI 10.1016/j.micinf.2005.06.003; Huo L, 2010, J PATHOL; Huo LH, 2011, J BIOL CHEM, V286, P9280, DOI 10.1074/jbc.M110.208884; JEANG KT, 1993, J BIOL CHEM, V268, P24940; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Neuveut C, 1996, J VIROL, V70, P5572, DOI 10.1128/JVI.70.8.5572-5581.1996; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Peruzzi F, 2006, FRONT BIOSCI-LANDMRK, V11, P708, DOI 10.2741/1829; Pugliese A, 2005, CELL BIOCHEM FUNCT, V23, P223, DOI 10.1002/cbf.1147; RAPPAPORT J, 1989, New Biologist, V1, P101; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Stauber RH, 1998, VIROLOGY, V252, P126, DOI 10.1006/viro.1998.9400; TILEY LS, 1990, VIROLOGY, V178, P560, DOI 10.1016/0042-6822(90)90354-T; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Truant R, 1999, MOL CELL BIOL, V19, P1210; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055833	34	15	15	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67186	10.1371/journal.pone.0067186	http://dx.doi.org/10.1371/journal.pone.0067186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826228	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000040
J	Hu, XQ; Yuan, P; Yan, J; Feng, F; Li, XL; Liu, WH; Yang, YF				Hu, Xiaoqin; Yuan, Ping; Yan, Jin; Feng, Fei; Li, Xiaoling; Liu, Wenhui; Yang, Yanfang			Gene Polymorphisms of ADIPOQ+45T > G, UCP2-866G > A, and FABP2 Ala54Thr on the Risk of Colorectal Cancer: A Matched Case-Control Study	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; ADIPONECTIN GENE; PLASMA ADIPONECTIN; CELL-PROLIFERATION; PROTEIN-2 GENE; ASSOCIATION; OBESITY; ENVIRONMENT; VARIANTS	As insulin resistance (IR) is an established risk factor for colorectal cancer (CRC), we explored the association between each of the IR-related gene polymorphisms of adiponectin (ADIPOQ) rs2241766, uncoupling protein 2 (UCP2) rs659366, and fatty acid-binding protein (FABP2) rs1799883 and CRC risk. Genotyping of blood samples and collection of lifestyle and dietary habits were performed for 400 case-control pairs. Unconditional logistic regression (ULR) was applied to assess the effects of the three single nucleotide polymorphisms (SNP), environmental factors. Both ULR and generalized multifactor dimensionality reduction (GMDR) were used to test the gene-gene and gene-environment interactions on CRC risk. Subjects carrying the ADIPOQ rs2241766 TG+GG genotype had a higher CRC risk than those carrying the TT genotype (OR = 1.429, 95% CI 1.069-1.909). The additive and multiplicative interactions between ADIPOQ rs2241766 and FABP2 rs1799883 on CRC were found by ULR (RERI = 0.764, 95%CI 0.218 similar to 1.311, AP = 0.514, 95%CI 0.165 similar to 0.864, S = -1.745, 95%CI is unachievable, and P-multi = 0.017, respectively). Furthermore, the high order gene-gene interaction of the three SNPs were found by GMDR (P = 0.0107). A significant dosage effect with an increasing number of risk genotypes was observed as the risk of CRC increased (P-trend = 0.037). In GMDR, the gene-environment interaction among the three SNPs and red meat consumption on CRC risk was significant (P = 0.0107). Compared with subjects with low red meat consumption and null risk genotypes, those with high-red meat consumption and three risk genotypes had 3.439-fold CRC risk (95% CI 1.410-8.385). In conclusion, the results showed that the ADIPOQ rs2241766 TG+GG genotype increased CRC risk. Given the complexity of the carcinogen for CRC, ADIPOQ rs2241766, UCP2 rs659366, FABP2 rs1799883 and red meat consumption potentially worked together in affecting CRC risk.	[Hu, Xiaoqin; Yuan, Ping; Feng, Fei; Li, Xiaoling; Liu, Wenhui; Yang, Yanfang] Sichuan Univ, Dept Epidemiol, West China Sch Publ Hlth, Chengdu 610064, Sichuan, Peoples R China; [Yan, Jin] Sichuan Canc Hosp, Dept Intestinal Surg, Chengdu, Sichuan, Peoples R China	Sichuan University	Yang, YF (corresponding author), Sichuan Univ, Dept Epidemiol, West China Sch Publ Hlth, Chengdu 610064, Sichuan, Peoples R China.	yangyanfang2000@yahoo.com.cn			Ministry of Education of China [20090181120019]; National Natural Science Foundation of China [81102196]	Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Doctoral Fund of Ministry of Education of China (Grant Number 20090181120019) and the National Natural Science Foundation of China (Grant Number 81102196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harithy RN, 2012, ONCOL LETT, V3, P176, DOI 10.3892/ol.2011.443; Albala C, 2006, REV MED CHILE, V134, P372; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Barnea M, 2006, OBESITY, V14, P2145, DOI 10.1038/oby.2006.251; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chamberlain AM, 2009, METABOLISM, V58, P1222, DOI 10.1016/j.metabol.2009.04.007; Chaolu H, 2011, EXP THER MED, V2, P369, DOI 10.3892/etm.2011.199; Chen MW, 2012, MED ONCOL, V29, P3129, DOI 10.1007/s12032-012-0280-2; Chung HK, 2009, DIABETES CARE, V32, P552, DOI 10.2337/dc08-1605; Cowey SL, 2005, CANCER-AM CANCER SOC, V103, P2643, DOI 10.1002/cncr.21094; D'Adamo M, 2004, DIABETES, V53, P1905, DOI 10.2337/diabetes.53.7.1905; D'Apolito M, 2010, J CLIN INVEST, V120, P203, DOI 10.1172/JCI37672; Daimon Makoto, 2012, Nihon Rinsho, V70 Suppl 3, P256; Djiogue S, 2013, ENDOCR-RELAT CANCER, V20, pR1, DOI 10.1530/ERC-12-0324; Ferlay J, 2010, GLOBOCAN 2008 V1 2, V1.2; Georgopoulos A, 2002, J CLIN ENDOCR METAB, V87, P3735, DOI 10.1210/jc.87.8.3735; Gingras D, 2011, CANCER MICROENVIRON, V4, P133, DOI 10.1007/s12307-010-0060-5; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Harano Y, 2001, Nihon Rinsho, V59 Suppl 2, P726; He BS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-94; Heidari J, 2010, ARCH IRAN MED, V13, P384, DOI 010135/AIM.004; Kahn R, 1998, DIABETES CARE, V21, P310; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Knize M G, 1999, Adv Exp Med Biol, V459, P179; Komninou D, 2003, EXP BIOL MED, V228, P396, DOI 10.1177/153537020322800410; Kotnis A, 2005, J BIOSCIENCES, V30, P93, DOI 10.1007/BF02705154; Leng SL, 2001, CARCINOGENESIS, V22, P1625, DOI 10.1093/carcin/22.10.1625; Li YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019686; Limburg PJ, 2006, CLIN GASTROENTEROL H, V4, P1514, DOI 10.1016/j.cgh.2006.09.014; Liu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027301; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; MCKEOWNEYSSEN G, 1994, CANCER EPIDEM BIOMAR, V3, P687; Melistas L, 2009, EUR J ENDOCRINOL, V161, P845, DOI 10.1530/EJE-09-0492; Michael M, 2007, FOOD NUTR PHYS ACT P; Noto H, 2011, ENDOCR PRACT, V17, P616, DOI 10.4158/EP10357.RA; Ochoa MC, 2007, MOL GENET METAB, V92, P351, DOI 10.1016/j.ymgme.2007.07.011; Ortiz AP, 2012, CANCER-AM CANCER SOC, V118, P1774, DOI 10.1002/cncr.26454; Otake S, 2010, WORLD J GASTROENTERO, V16, P1252, DOI 10.3748/wjg.v16.i10.1252; Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143; Partida-Perez M, 2010, CANCER BIOMARK, V7, P117, DOI 10.3233/CBM-2010-0154; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Saxena A, 2012, BBA-MOL BASIS DIS, V1822, P527, DOI 10.1016/j.bbadis.2011.12.006; Schechter S, 1995, R I Med, V78, P161; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Sugiyama M, 2009, INT J ONCOL, V34, P339, DOI 10.3892/ijo_00000156; Tang FY, 2012, J NUTR BIOCHEM, V23, P1302, DOI 10.1016/j.jnutbio.2011.07.011; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Von Eynatten M, 2006, CLIN CHEM, V52, P853, DOI 10.1373/clinchem.2005.060509; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Weiss EP, 2002, PHYSIOL GENOMICS, V10, P145, DOI 10.1152/physiolgenomics.00070.2001; Wilkin TJ, 2009, INT J OBESITY, V33, P716, DOI 10.1038/ijo.2009.97; Xita N, 2005, CLIN CHEM, V51, P416, DOI 10.1373/clinchem.2004.043109; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zeyda M, 2009, GERONTOLOGY, V55, P379, DOI 10.1159/000212758; Zhao P, 2011, CHINESE TUMOR REGIST; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	63	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67275	10.1371/journal.pone.0067275	http://dx.doi.org/10.1371/journal.pone.0067275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826253	gold, Green Submitted, Green Published			2022-12-27	WOS:000321150000053
J	Li, ZQ; Zhang, S; Ma, Y; Luo, JY; Wang, CY; Lv, LM; Dong, SL; Cui, JJ				Li, Zhao-Qun; Zhang, Shuai; Ma, Yan; Luo, Jun-Yu; Wang, Chun-Yi; Lv, Li-Min; Dong, Shuang-Lin; Cui, Jin-Jie			First Transcriptome and Digital Gene Expression Analysis in Neuroptera with an Emphasis on Chemoreception Genes in Chrysopa pallens (Rambur)	PLOS ONE			English	Article							BINDING-PROTEINS; CHEMOSENSORY PROTEINS; LACEWINGS NEUROPTERA; PHEROMONE DETECTION; CARNEA NEUROPTERA; CIRCADIAN CLOCK; SEX-PHEROMONE; MOTH; ANTENNAE; INSECT	Background: Chrysopa pallens (Rambur) are the most important natural enemies and predators of various agricultural pests. Understanding the sophisticated olfactory system in insect antennae is crucial for studying the physiological bases of olfaction and also could lead to effective applications of C. pallens in integrated pest management. However no transcriptome information is available for Neuroptera, and sequence data for C. pallens are scarce, so obtaining more sequence data is a priority for researchers on this species. Results: To facilitate identifying sets of genes involved in olfaction, a normalized transcriptome of C. pallens was sequenced. A total of 104,603 contigs were obtained and assembled into 10,662 clusters and 39,734 singletons; 20,524 were annotated based on BLASTX analyses. A large number of candidate chemosensory genes were identified, including 14 odorant-binding proteins (OBPs), 22 chemosensory proteins (CSPs), 16 ionotropic receptors, 14 odorant receptors, and genes potentially involved in olfactory modulation. To better understand the OBPs, CSPs and cytochrome P450s, phylogenetic trees were constructed. In addition, 10 digital gene expression libraries of different tissues were constructed and gene expression profiles were compared among different tissues in males and females. Conclusions: Our results provide a basis for exploring the mechanisms of chemoreception in C. pallens, as well as other insects. The evolutionary analyses in our study provide new insights into the differentiation and evolution of insect OBPs and CSPs. Our study provided large-scale sequence information for further studies in C. pallens.	[Li, Zhao-Qun; Zhang, Shuai; Ma, Yan; Luo, Jun-Yu; Wang, Chun-Yi; Lv, Li-Min; Cui, Jin-Jie] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Li, Zhao-Qun; Dong, Shuang-Lin] Nanjing Agr Univ, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University	Dong, SL (corresponding author), Nanjing Agr Univ, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	sldong@njau.edu.cn; cuijinjie@126.com		Zhang, Shuai/0000-0003-3646-1522; Ma, Yan/0000-0001-6897-5064	Ministry of Agricultural [2011ZX08011-002]; Ministry of Science and Technology [2012BAD19B05]; National Natural Science Foundation of China [31071978]	Ministry of Agricultural; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Agricultural (2011ZX08011-002), the Ministry of Science and Technology (2012BAD19B05), and the National Natural Science Foundation of China (31071978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JW, 2011, GENE, V480, P42, DOI 10.1016/j.gene.2011.03.002; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Athhan R, 2004, J PEST SCI, V77, P17, DOI 10.1007/s10340-003-0021-6; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Boo KS, 1998, J CHEM ECOL, V24, P631, DOI 10.1023/A:1022386001722; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; Doroszuk A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-167; Durand N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029147; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FLINT HM, 1979, ENVIRON ENTOMOL, V8, P1123, DOI 10.1093/ee/8.6.1123; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hoen PAC, 2008, NUCL ACIDS RES, V36; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Ito C, 2008, P NATL ACAD SCI USA, V105, P8446, DOI 10.1073/pnas.0800145105; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Ferreiro MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-483; Koczor S, 2010, PEST MANAG SCI, V66, P1374, DOI 10.1002/ps.2030; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Maibeche-Coisne M, 2004, CHEM SENSES, V29, P381, DOI 10.1093/chemse/bjh039; Maibeche-Coisne M, 2002, INSECT MOL BIOL, V11, P273, DOI 10.1046/j.1365-2583.2002.00335.x; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Medina P, 2003, ENVIRON ENTOMOL, V32, P196, DOI 10.1603/0046-225X-32.1.196; Merlin C, 2007, J BIOL RHYTHM, V22, P502, DOI 10.1177/0748730407307737; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; New TR, 2002, ACTA ZOOL ACAD SCI H, V48, P209; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Pottier MA, 2012, INSECT MOL BIOL, V21, P568, DOI 10.1111/j.1365-2583.2012.01160.x; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; RYBCZYNSKI R, 1989, J NEUROSCI, V9, P1341; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toth M, 2009, J CHEM ECOL, V35, P449, DOI 10.1007/s10886-009-9614-8; Vogt R.G., 2004, MOL BASIS PHEROMONE; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047954; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winterton S, 2006, AUST J ENTOMOL, V45, P235, DOI 10.1111/j.1440-6055.2006.00537.x; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang QH, 2004, J CHEM ECOL, V30, P1849, DOI 10.1023/B:JOEC.0000042406.76705.ab; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhu J, 2005, NATURWISSENSCHAFTEN, V92, P277, DOI 10.1007/s00114-005-0624-2; Zhu JW, 1999, J CHEM ECOL, V25, P1163, DOI 10.1023/A:1020846212465	67	25	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67151	10.1371/journal.pone.0067151	http://dx.doi.org/10.1371/journal.pone.0067151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826220	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000036
J	Shah, GA; Groot, JCJ; Shah, GM; Lantinga, EA				Shah, Ghulam Abbas; Groot, Jeroen C. J.; Shah, Ghulam Mustafa; Lantinga, Egbert A.			Simulation of Long-Term Carbon and Nitrogen Dynamics in Grassland-Based Dairy Farming Systems to Evaluate Mitigation Strategies for Nutrient Losses	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; AMMONIA EMISSION; CATTLE SLURRY; MODEL; MANAGEMENT; MANURE; STORAGE; GROWTH; LEVEL; DIGESTIBILITY	Many measures have been proposed to mitigate gaseous emissions and other nutrient losses from agroecosystems, which can have large detrimental effects for the quality of soils, water and air, and contribute to eutrophication and global warming. Due to complexities in farm management, biological interactions and emission measurements, most experiments focus on analysis of short-term effects of isolated mitigation practices. Here we present a model that allows simulating long-term effects at the whole-farm level of combined measures related to grassland management, animal housing and manure handling after excretion, during storage and after field application. The model describes the dynamics of pools of organic carbon and nitrogen (N), and of inorganic N, as affected by farm management in grassland-based dairy systems. We assessed the long-term effects of delayed grass mowing, housing type (cubicle and sloping floor barns, resulting in production of slurry and solid cattle manure, respectively), manure additives, contrasting manure storage methods and irrigation after application of covered manure. Simulations demonstrated that individually applied practices often result in compensatory loss pathways. For instance, methods to reduce ammonia emissions during storage like roofing or covering of manure led to larger losses through ammonia volatilization, nitrate leaching or denitrification after application, unless extra measures like irrigation were used. A strategy of combined management practices of delayed mowing and fertilization with solid cattle manure that is treated with zeolite, stored under an impermeable sheet and irrigated after application was effective to increase soil carbon stocks, increase feed self-sufficiency and reduce losses by ammonia volatilization and soil N losses. Although long-term datasets (>25 years) of farm nutrient dynamics and loss flows are not available to validate the model, the model is firmly based on knowledge of processes and measured effects of individual practices, and allows the integrated exploration of effective emission mitigation strategies.	[Shah, Ghulam Abbas; Groot, Jeroen C. J.; Shah, Ghulam Mustafa; Lantinga, Egbert A.] Wageningen Univ, Farming Syst Ecol Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Groot, JCJ (corresponding author), Wageningen Univ, Farming Syst Ecol Grp, NL-6700 AP Wageningen, Netherlands.	Jeroen.Groot@wur.nl	Shah, Ghulam Abbas/AAY-4883-2020; Lantinga, Egbert/AAR-2928-2020; Shah, Dr. Ghulam Mustafa/AAZ-1981-2021	Shah, Ghulam Mustafa/0000-0003-1230-7029; Groot, Jeroen/0000-0001-6516-5170; Shah, Ghulam Abbas/0000-0002-6992-4602	Higher Education Commission of Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	The funding of this study provided by the Higher Education Commission of Pakistan (www.hec.gov.pk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon B, 2006, AGR ECOSYST ENVIRON, V112, P153, DOI 10.1016/j.agee.2005.08.030; Astrup R, 2008, FOREST ECOL MANAG, V256, P1659, DOI 10.1016/j.foreco.2008.07.016; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Brooks RJ, 1996, MATH COMPUT MODEL, V24, P1, DOI 10.1016/0895-7177(96)00103-3; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Dammgen U, 2008, ENVIRON POLLUT, V154, P488, DOI 10.1016/j.envpol.2007.03.017; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Foereid B, 2004, NUTR CYCL AGROECOSYS, V68, P13, DOI 10.1023/B:FRES.0000012231.89516.80; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; GOUDRIAAN J, 1990, ANN BOT-LONDON, V66, P695, DOI 10.1093/oxfordjournals.aob.a088084; Gouttenoire L, 2011, MODELLING TOOL REDES, P1; Grace PR, 2006, SOIL BIOL BIOCHEM, V38, P1172, DOI 10.1016/j.soilbio.2005.09.013; Groot JCJ, 2006, LIVEST SCI, V100, P99, DOI 10.1016/j.livprodsci.2005.08.008; Groot JCJ, 1997, J SCI FOOD AGR, V75, P227, DOI 10.1002/(SICI)1097-0010(199710)75:2&lt;227::AID-JSFA869&gt;3.0.CO;2-F; Groot JCJ, 2004, ECOL MODEL, V177, P297, DOI 10.1016/j.ecolmodel.2004.02.008; Groot JCJ, 2003, NJAS-WAGEN J LIFE SC, V51, P165, DOI 10.1016/S1573-5214(03)80032-5; Groot JCJ, 2012, AGR SYST, V110, P63, DOI 10.1016/j.agsy.2012.03.012; Hansen MN, 2006, ATMOS ENVIRON, V40, P4172, DOI 10.1016/j.atmosenv.2006.02.013; Hansen MN, 2003, J ENVIRON QUAL, V32, P1099, DOI 10.2134/jeq2003.1099; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Henkens PLCM, 2001, NETH J AGR SCI, V49, P117, DOI 10.1016/S1573-5214(01)80002-6; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; JACKMAN R. H., 1964, NEW ZEAL J AGR RES, V7, P445; Johnston AE, 2009, ADV AGRON, V101, P1, DOI 10.1016/S0065-2113(08)00801-8; Kemanian AR, 2010, EUR J AGRON, V32, P22, DOI 10.1016/j.eja.2009.08.003; KIRCHMANN H, 1989, PLANT SOIL, V115, P35, DOI 10.1007/BF02220692; Kirchmann H., 1985, ACTA AGR SCAND     S, V24, P1; Kustermann B, 2010, AGR ECOSYST ENVIRON, V135, P70, DOI 10.1016/j.agee.2009.08.014; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; Misselbrook TH, 2002, BIOSYST ENG, V81, P313, DOI 10.1006/bioe.2001.0017; Mosquera J., 2006, INT C SERIES, V1293, P291, DOI DOI 10.1016/J.ICS.2006.02.041; MUMPTON FA, 1977, J ANIM SCI, V45, P1188, DOI 10.2527/jas1977.4551188x; Ndegwa PM, 2008, BIOSYST ENG, V100, P453, DOI 10.1016/j.biosystemseng.2008.05.010; Ondersteijn CJM, 2003, LIVEST PROD SCI, V84, P171, DOI 10.1016/j.livprodsci.2003.09.013; Rashid MI, 2013, ECOL APPL IN PRESS; Reijs JW, 2007, AGR ECOSYST ENVIRON, V118, P65, DOI 10.1016/j.agee.2006.04.013; Romera AJ, 2010, COMPUT ELECTRON AGR, V74, P66, DOI 10.1016/j.compag.2010.06.006; Rotz CA, 2006, APPL ENG AGRIC, V22, P773; Rotz C A, 2004, J Anim Sci, V82 E-Suppl, pE119; Rotz CA, 2005, CROP SCI, V45, P2139, DOI 10.2135/cropsci2004.0523; Rougoor CW, 1997, LIVEST PROD SCI, V47, P235, DOI 10.1016/S0301-6226(96)01408-X; Rufino MC, 2009, NUTR CYCL AGROECOSYS, V84, P229, DOI 10.1007/s10705-008-9239-2; Saffih-Hdadi K, 2008, SOIL BIOL BIOCHEM, V40, P594, DOI 10.1016/j.soilbio.2007.08.022; Schils RLM, 2005, NUTR CYCL AGROECOSYS, V71, P163, DOI 10.1007/s10705-004-2212-9; SCHOLEFIELD D, 1991, PLANT SOIL, V132, P165, DOI 10.1007/BF00010397; Shah GM, 2012, NUTR CYCL AGROECOSYS, V94, P299, DOI 10.1007/s10705-012-9543-8; Shah GM, 2012, AGR ECOSYST ENVIRON, V160, P59, DOI 10.1016/j.agee.2011.07.017; Shah GA, 2013, J AGR SCI IN PRESS; Shah GM, 2013, NUTR CYCL A IN PRESS; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; TAMMINGA S, 1994, LIVEST PROD SCI, V40, P139, DOI 10.1016/0301-6226(94)90043-4; Thomsen IK, 2000, J AGR SCI, V135, P151, DOI 10.1017/S0021859699008096; Thornton PK, 2001, AGR SYST, V70, P581, DOI 10.1016/S0308-521X(01)00060-9; Tipping E, 2012, ECOL MODEL, V247, P11, DOI 10.1016/j.ecolmodel.2012.08.002; van Apeldoorn DF, 2011, ECOL SOC, V16; van der Werf W, 2007, ECOL ENG, V29, P419, DOI 10.1016/j.ecoleng.2006.09.017; Van Es A.J.H., 1975, LIVEST PROD SCI, V2, P95, DOI DOI 10.1016/0301-6226(75)90029-9; Watson CA, 2005, SOIL USE MANAGE, V21, P132, DOI [10.1079/SUM2005304, 10.1079/SUM2005299]; Watson CA, 2002, SOIL USE MANAGE, V18, P239, DOI 10.1079/SUM2002131; Whitehead DC, 1995, GRASSLAND NITROGEN C; WITTER E, 1988, BIOL WASTE, V23, P279, DOI 10.1016/0269-7483(88)90016-X	61	12	12	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67279	10.1371/journal.pone.0067279	http://dx.doi.org/10.1371/journal.pone.0067279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826255	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000055
J	Huang, T; Cai, YD				Huang, Tao; Cai, Yu-Dong			An Information-Theoretic Machine Learning Approach to Expression QTL Analysis	PLOS ONE			English	Article							INTERACTION NETWORKS; STATISTICAL-METHODS; MUTUAL INFORMATION; FEATURE-SELECTION; GENE-REGULATION; PREDICTION; MOUSE	Expression Quantitative Trait Locus (eQTL) analysis is a powerful tool to study the biological mechanisms linking the genotype with gene expression. Such analyses can identify genomic locations where genotypic variants influence the expression of genes, both in close proximity to the variant (cis-eQTL), and on other chromosomes (trans-eQTL). Many traditional eQTL methods are based on a linear regression model. In this study, we propose a novel method by which to identify eQTL associations with information theory and machine learning approaches. Mutual Information (MI) is used to describe the association between genetic marker and gene expression. MI can detect both linear and non-linear associations. What's more, it can capture the heterogeneity of the population. Advanced feature selection methods, Maximum Relevance Minimum Redundancy (mRMR) and Incremental Feature Selection (IFS), were applied to optimize the selection of the affected genes by the genetic marker. When we applied our method to a study of apoE-deficient mice, it was found that the cis-acting eQTLs are stronger than trans-acting eQTLs but there are more trans-acting eQTLs than cis-acting eQTLs. We compared our results (mRMR. eQTL) with R/qtl, and MatrixEQTL (modelLINEAR and modelANOVA). In female mice, 67.9% of mRMR. eQTL results can be confirmed by at least two other methods while only 14.4% of R/qtl result can be confirmed by at least two other methods. In male mice, 74.1% of mRMR. eQTL results can be confirmed by at least two other methods while only 18.2% of R/qtl result can be confirmed by at least two other methods. Our methods provide a new way to identify the association between genetic markers and gene expression. Our software is available from supporting information.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Shanghai University; Icahn School of Medicine at Mount Sinai	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101, 2011CB910200, 2010CB912702]; National Natural Science Foundation of China [90913009]; Chinese Academy of Sciences [KSCX2-EW-R-04]; Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from the National Basic Research Program of China (2011CB510102, 2011CB510101, 2011CB910200 and 2010CB912702), the National Natural Science Foundation of China (90913009), Research Program of the Chinese Academy of Sciences (KSCX2-EW-R-04) and the Innovation Program of the Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040916; Batina L, 2011, J CRYPTOL, V24, P269, DOI 10.1007/s00145-010-9084-8; Bhasin JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001435; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cai Y., 2011, AMINO ACIDS; CHAITIN GJ, 1975, J ACM, V22, P329, DOI 10.1145/321892.321894; Chen L, 2010, MOLECULES, V15, P8177, DOI 10.3390/molecules15118177; Chen M, 2007, GENETICS, V177, P761, DOI 10.1534/genetics.107.071407; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Geng HM, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-32; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Huang T, 2012, BIOCHIMIE; Huang T, 2011, PROTEIN CELL; Huang T., 2010, P 1 ACM INT C BIOINF, P502; Huang T, 2011, PROTEIN PEPT LETT; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, NEUROCOMPUTING, V74, P3677, DOI 10.1016/j.neucom.2011.07.019; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang Tao, 2011, International Journal of Computational Biology and Drug Design, V4, P5, DOI 10.1504/IJCBDD.2011.038654; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang Tao, 2010, BMC Res Notes, V3, P142, DOI 10.1186/1756-0500-3-142; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Kendziorski C, 2006, MAMM GENOME, V17, P509, DOI 10.1007/s00335-005-0189-6; Kendziorski CM, 2006, BIOMETRICS, V62, P19, DOI 10.1111/j.1541-0420.2005.00437.x; Kojadinovic I, 2005, APPL STOCH MOD DAT A; Kumar PTK, 2011, COMPUT BIOL MED, V41, P357, DOI 10.1016/j.compbiomed.2011.03.013; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pinna A, 2011, BIOINFORMATICS, V27, P2459, DOI 10.1093/bioinformatics/btr407; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038845; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thomas MC, 2006, ELEMENTS INFORM THEO; Yi XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012495; Zhang W, 2010, FRONTIERS COMPUTATIO	53	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67899	10.1371/journal.pone.0067899	http://dx.doi.org/10.1371/journal.pone.0067899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825689	Green Submitted, gold, Green Published			2022-12-27	WOS:000321223000123
J	Leong, HT; Ng, GYF; Leung, VYF; Fu, SN				Leong, Hio-Teng; Ng, Gabriel Yin-fat; Leung, Vivian Yee-fong; Fu, Siu Ngor			Quantitative Estimation of Muscle Shear Elastic Modulus of the Upper Trapezius with Supersonic Shear Imaging during Arm Positioning	PLOS ONE			English	Article							SHOULDER; ELASTOGRAPHY; PATTERNS	Pain and tenderness of the upper trapezius are the major complaints among people with chronic neck and shoulder disorders. Hyper-activation and increased muscle tension of the upper trapezius during arm elevation will cause imbalance of the scapular muscle force and contribute to neck and shoulder disorders. Assessing the elasticity of the upper trapezius in different arm positions is therefore important for identifying people at risk so as to give preventive programmes or for monitoring the effectiveness of the intervention programmes for these disorders. This study aimed to establish the reliability of supersonic shear imaging (SSI) in quantifying upper trapezius elasticity/shear elastic modulus and its ability to measure the modulation of muscle elasticity during arm elevation. Twenty-eight healthy adults (15 males, 13 females; mean age = 29.6 years) were recruited to participate in the study. In each participant, the shear elastic modulus of the upper trapezius while the arm was at rest and at 30 degrees abduction was measured by two operators and twice by operator 1 with a time interval between the measurements. The results showed excellent within-and between-session intra-operator (ICC = 0.87-0.97) and inter-observer (ICC = 0.78-0.83) reliability for the upper trapezius elasticity with the arm at rest and at 30 degrees abduction. An increase of 55.23% of shear elastic modulus from resting to 30 degrees abduction was observed. Our findings demonstrate the possibilities for using SSI to quantify muscle elasticity and its potential role in delineating the modulation of upper trapezius elasticity, which is essential for future studies to compare the differences in shear elastic modulus between normal elasticity and that of individuals with neck and shoulder disorders.	[Leong, Hio-Teng; Ng, Gabriel Yin-fat; Fu, Siu Ngor] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Leung, Vivian Yee-fong] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Chinese University of Hong Kong; Prince of Wales Hospital	Fu, SN (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	rsamyfu@inet.polyu.edu.hk		FU, Amy/0000-0003-4405-015X; Leong, Hio Teng/0000-0003-4185-4814				Antony NT, 2010, J ELECTROMYOGR KINES, V20, P191, DOI 10.1016/j.jelekin.2009.04.010; Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Chen Q, 2007, ARCH PHYS MED REHAB, V88, P1658, DOI 10.1016/j.apmr.2007.07.020; Chester R, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-45; Cools AM, 2003, AM J SPORT MED, V31, P542, DOI 10.1177/03635465030310041101; Cram J, 1998, INTRO SURFACE ELECTR; Drakonaki EE, 2009, CLIN RADIOL, V64, P1196, DOI 10.1016/j.crad.2009.08.006; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623; Klauser AS, 2010, SEMIN MUSCULOSKEL R, V14, P323, DOI 10.1055/s-0030-1254521; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lin JJ, 2011, J ORTHOP RES, V29, P653, DOI 10.1002/jor.21300; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Lv FQ, 2012, ULTRASOUND MED BIOL, V38, P795, DOI 10.1016/j.ultrasmedbio.2012.01.010; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Strom V, 2009, PAIN, V144, P147, DOI 10.1016/j.pain.2009.04.002; Viir R, 2007, SCAND J WORK ENV HEA, P76; Wickham J, 2010, J ELECTROMYOGR KINES, V20, P212, DOI 10.1016/j.jelekin.2009.06.004; Wu CH, 2011, RADIOLOGY, V259, P502, DOI 10.1148/radiol.11101665	26	41	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67199	10.1371/journal.pone.0067199	http://dx.doi.org/10.1371/journal.pone.0067199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825641	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000089
J	Ma, QQ; Pan, XH; Cai, GF; Yan, JH; Xu, Y; Ono-Kihara, M; Kihara, M				Ma, Qiaoqin; Pan, Xiaohong; Cai, Gaofeng; Yan, Jiezhe; Xu, Yun; Ono-Kihara, Masako; Kihara, Masahiro			The Characteristics of Heterosexual STD Clinic Attendees Who Practice Oral Sex in Zhejiang Province, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HIV TRANSMISSION; RISK; BEHAVIORS; STIS	Background: The characteristics of heterosexual attendees who visit sexually transmitted disease (STD) clinics and practice oral sex have not been revealed in China. This information is important for the development of targeted STD prevention programmes for this population. Study Design: A self-administered questionnaire survey with a cross-sectional design was administered to consecutive attendees at four STD clinics in Zhejiang Province, China, between October and December in 2007. Demographic, psychosocial, and behavioural factors associated with oral sex over a lifetime were identified using univariate and multivariate analyses. Results: Of the 872 attendees, 6.9% engaged in oral sex over their lifetimes. Of the oral-sex group, 96.6% also engaged in vaginal sex. The correlates for oral sex over a lifetime as determined by the multivariate analysis were high income (odds ratio [OR] = 2.53, 95% confidence interval [CI] 1.39-4.59), high human immunodeficiency virus (HIV)-related knowledge (OR = 2.71, 95% CI 1.26-5.81), early sex initiation (OR = 2.42, 95% CI 1.37-4.27), multiple sexual partners (OR = 3.09, 95% CI 1.58-6.06), and sexually active in the previous 6 months (OR = 7.73, 95% CI 1.04-57.39). Conclusions: Though the prevalence of oral sex is low, the heterosexual STD clinic attendees practicing oral sex was found to have higher risks associated with STD/HIV transmission than those not. Behavioural and medical interventions conducted by clinicians in Chinese STD clinics should take into account the characteristics and related risks of those who practice oral sex.	[Ma, Qiaoqin; Pan, Xiaohong; Cai, Gaofeng; Yan, Jiezhe; Xu, Yun] Ctr Dis Control & Prevent Zhejiang Prov, Dept HIV STD Control, Hangzhou, Zhejiang, Peoples R China; [Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan	Kyoto University	Ma, QQ (corresponding author), Ctr Dis Control & Prevent Zhejiang Prov, Dept HIV STD Control, Hangzhou, Zhejiang, Peoples R China.	qiaoqinma@gamail.com			Zhejiang provincial center for disease prevention and control,China	Zhejiang provincial center for disease prevention and control,China	This research was supported by a grant from Zhejiang provincial center for disease prevention and control,China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral SO, 2005, SEX TRANSM DIS, V32, P710, DOI 10.1097/01.olq.0000175370.08709.72; Ballini A, 2012, J SEX MED, V9, P372, DOI 10.1111/j.1743-6109.2011.02515.x; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P966; Davis P, 1999, J SEX RES, V36, P135, DOI 10.1080/00224499909551978; Edwards S, 1998, SEX TRANSM INFECT, V74, P6, DOI 10.1136/sti.74.1.6; Edwards S, 1998, SEX TRANSM INFECT, V74, P95, DOI 10.1136/sti.74.2.95; Gilbart VL, 2006, SEX TRANSM INFECT, V82, P15, DOI 10.1136/sti.2004.014191; Gindi RM, 2008, J ADOLESCENT HEALTH, V42, P307, DOI 10.1016/j.jadohealth.2007.09.015; Gong X, 2012, B STI PREVENTION CON, V26, P9; Harrison A, 2005, SEX TRANSM INFECT, V81, P259, DOI 10.1136/sti.2004.011486; Hawkins DA, 2001, SEX TRANSM INFECT, V77, P307, DOI 10.1136/sti.77.5.307; Hu Q, 2006, CHINESE J HLTH ED, V22, P647; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Leichliter JS, 2007, J INFECT DIS, V196, P1852, DOI 10.1086/522867; Ma QQ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-44; Ma QQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-111; Mosher William D, 2005, Adv Data, P1; Ono-Kihara M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-106; Prinstein MJ, 2003, J PEDIATR PSYCHOL, V28, P243, DOI 10.1093/jpepsy/jsg012; Robinson EK, 1999, AIDS, V13, P737, DOI 10.1097/00002030-199904160-00021; Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004; Teng F, 2011, B STI PREVENTION CON, V25, P1; Wong ML, 1999, AIDS, V13, P1981, DOI 10.1097/00002030-199910010-00024; Wu M, CHINA SEXUAL SCI, V3, P4; Xu J, 2007, DERMATOLOGY VENEREAL, Vl29, P54; Xu Yi, 2005, Zhonghua Yufang Yixue Zazhi, V39, P37; Zhang Bei-chuan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P32; Zhi H, 2001, WORLD J INFECT, V1, P255	29	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67092	10.1371/journal.pone.0067092	http://dx.doi.org/10.1371/journal.pone.0067092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825627	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000078
J	Oda, M; Oxley, D; Dean, W; Reik, W				Oda, Masaaki; Oxley, David; Dean, Wendy; Reik, Wolf			Regulation of Lineage Specific DNA Hypomethylation in Mouse Trophectoderm	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HISTONE MODIFICATIONS; METHYLATION; DNMT3A; EXPRESSION; METHYLTRANSFERASES; CHROMATIN; PROMOTER; UNDERMETHYLATION; TARGETS	Background: DNA methylation is reprogrammed during early embryogenesis by active and passive mechanisms in advance of the first differentiation event producing the embryonic and extraembryonic lineage cells which contribute to the future embryo proper and to the placenta respectively. Embryonic lineage cells re-acquire a highly methylated genome dependent on the DNA methyltransferases (DNMTs) Dnmt3a and Dnmt3b that are required for de novo methylation. By contrast, extraembryonic lineage cells remain globally hypomethylated but the mechanisms that underlie this hypomethylation remain unknown. Methodology/Principal Findings: We have employed an inducible system that supports differentiation between these two lineages and recapitulates the DNA methylation asymmetry generated in vivo. We find that in vitro down-regulation of Oct3/4 in ES cells recapitulates the decline in global DNA methylation associated with trophoblast. The de novo DNMTs Dnmt3a2 and Dnmt3b are down-regulated during trophoblast differentiation. Dnmt1, which is responsible for maintenance methylation, is expressed comparably in embryonic and trophoblast lineages, however importantly in trophoblast giant cells Dnmt1fails to be attracted to replication foci, thus allowing loss of DNA methylation while implicating a passive demethylation mechanism. Interestingly, Dnmt1 localization was restored by exogenous Np95/Uhrf1, a Dnmt1 chaperone required for Dnmt1-targeting to replication foci, yet DNA methylation levels remained low. Over-expression of de novo DNMTs also failed to increase DNA methylation in target sequences. Conclusions/Significance: We propose that induced trophoblast cells may have a mechanism to resist genome-wide increases of DNA methylation, thus reinforcing the genome-wide epigenetic distinctions between the embryonic and extraembryonic lineages in the mouse. This resistance may be based on transcription factors or on global differences in chromatin structure.	[Oda, Masaaki; Dean, Wendy; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge, England; [Oxley, David] Babraham Inst, Cambridge, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Reik, W (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	wolf.reik@babraham.ac.uk	Dean, Wendy/GSE-3948-2022; Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881; Dean, Wendy/0000-0001-9441-5044	BBSRC [BB/H088071/1]; MRC [G0700760]; EU EpiGenesys; EU BLUEPRINT; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H334] Funding Source: researchfish; Medical Research Council [G0700760, G0700098] Funding Source: researchfish; BBSRC [BBS/E/B/0000H334] Funding Source: UKRI; MRC [G0700098] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU EpiGenesys; EU BLUEPRINT; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BBSRC; grant BB/H088071/1 (www.bbsrc.ac.uk), MRC; grant G0700760 (www.mrc.ac.uk), EU EpiGenesys; (www.epigenesys.eu), EU BLUEPRINT; Blueprint (www.blueprint-epigenome.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001764; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kotini AG, 2011, MOL CELL BIOL, V31, P1577, DOI 10.1128/MCB.01093-10; Lee HJ, 2011, STEM CELLS, V29, P1611, DOI 10.1002/stem.706; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lees-Murdock DJ, 2005, DEV DYNAM, V232, P992, DOI 10.1002/dvdy.20288; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; ROSSANT J, 1986, DEV BIOL, V117, P567, DOI 10.1016/0012-1606(86)90325-8; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	42	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e68846	10.1371/journal.pone.0068846	http://dx.doi.org/10.1371/journal.pone.0068846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825703	Green Published, gold			2022-12-27	WOS:000321223000131
J	Piatkov, K; Graciet, E; Varshavsky, A				Piatkov, Konstantin; Graciet, Emmanuelle; Varshavsky, Alexander			Ubiquitin Reference Technique and Its Use in Ubiquitin-Lacking Prokaryotes	PLOS ONE			English	Article							N-END RULE; PROTEIN; PATHWAY; RESTRICTION; DISSECTION; PLASMIDS; SEQUENCE; CLONING; FUSION; SYSTEM	In a pulse-chase assay, the in vivo degradation of a protein is measured through a brief labeling of cells with, for example, a radioactive amino acid, followed by cessation of labeling and analysis of cell extracts prepared at different times afterward ("chase"), using immunoprecipitation, electrophoresis and autoradiography of a labeled protein of interest. A conventional pulse-chase assay is fraught with sources of data scatter, as the efficacy of labeling and immunoprecipitation can vary, and sample volumes can vary as well. The ubiquitin reference technique (URT), introduced in 1996, addresses these problems. In eukaryotes, a DNA-encoded linear fusion of ubiquitin to another protein is cleaved by deubiquitylases at the ubiquitin-protein junction. A URT assay uses a fusion in which the ubiquitin moiety is located between a downstream polypeptide (test protein) and an upstream polypeptide (a long-lived reference protein). The cotranslational cleavage of a URT fusion by deubiquitylases after the last residue of ubiquitin produces, at the initially equimolar ratio, a test protein with a desired N-terminal residue and a reference protein containing C-terminal ubiquitin moiety. In addition to being more accurate than pulse-chases without a reference, URT makes it possible to detect and measure the degradation of a test protein during the pulse (before the chase). Because prokaryotes, including Gram-negative bacteria such as, for example, Escherichia coli and Vibrio vulnificus, lack the ubiquitin system, the use of URT in such cells requires ectopic expression of a deubiquitylase. We describe designs and applications of plasmid vectors that coexpress, in bacteria, both a URT-type fusion and Ubp1, a deubiquitylase of the yeast Saccharomyces cerevisiae. This single-plasmid approach extends the accuracy-enhancing URT assay to studies of protein degradation in prokaryotes.	[Piatkov, Konstantin; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Graciet, Emmanuelle] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland	California Institute of Technology; Trinity College Dublin	Piatkov, K (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	piatkov@caltech.edu; avarsh@caltech.edu		Graciet, Emmanuelle/0000-0003-3548-8213	National Institutes of Health [DK039520, GM031530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039520, R01DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by grants to AV from the National Institutes of Health (DK039520 and GM031530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 2010, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Catic A, 2007, EMBO J, V26, P3474, DOI 10.1038/sj.emboj.7601772; Davison J, 2002, BIOTECHNIQUES, V32, P386, DOI 10.2144/02322rv02; DAVISON J, 1987, GENE, V51, P275, DOI 10.1016/0378-1119(87)90316-7; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Dougan D. A., 2011, BIOCHIM BIOPHYS ACTA, V1823, P83; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Hochhut B, 2000, J BACTERIOL, V182, P2043, DOI 10.1128/JB.182.7.2043-2047.2000; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; O'Sullivan LE, 2010, J MICROBIOL BIOTECHN, V20, P871, DOI 10.4014/jmb.0912.12017; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Piatkov KI, 2012, MOL CELL, V48, P926, DOI 10.1016/j.molcel.2012.10.012; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Sheng J, 2002, EMBO J, V21, P6061, DOI 10.1093/emboj/cdf626; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Thomas CM, 1989, PROMISCUOUS PLASMIDS; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200	39	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67952	10.1371/journal.pone.0067952	http://dx.doi.org/10.1371/journal.pone.0067952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825692	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000126
J	Roman de Mettelinge, T; Cambier, D; Calders, P; Van den Noortgate, N; Delbaere, K				Roman de Mettelinge, Tine; Cambier, Dirk; Calders, Patrick; Van den Noortgate, Nele; Delbaere, Kim			Understanding the Relationship between Type 2 Diabetes Mellitus and Falls in Older Adults: A Prospective Cohort Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RISK-FACTORS; GAIT VARIABILITY; PEOPLE; DYSFUNCTION; STRENGTH; RELIABILITY; PREVENTION; PREDICTOR; HEALTH	Background: Older adults with type 2 Diabetes Mellitus are at increased risk of falling. The current study aims to identify risk factors that mediate the relationship between diabetes and falls. Methods: 199 older adults (104 with diabetes and 95 healthy controls) underwent a medical screening. Gait (GAITRite (R)), balance (AccuGait (R) force plate), grip strength (Jamar (R)), and cognitive status (Mini-Mental State Examination and Clock Drawing Test) were assessed. Falls were prospectively recorded during a 12-month follow-up period using monthly calendars. Results: Compared to controls, diabetes participants scored worse on all physical and cognitive measures. Sixty-four participants (42 diabetes vs. 22 controls) reported at least one injurious fall or two non-injurious falls ("fallers"). Univariate logistic regression identified diabetes as a risk factor for future falls (Odds Ratio 2.25, 95%CI 1.21-4.15, p = 0.010). Stepwise multiple regressions defined diabetes and poor balance as independent risk factors for falling. Taking more medications, slower walking speed, shorter stride length and poor cognitive performance were mediators that reduced the Odds Ratio of the relationship between diabetes and faller status relationship the most followed by reduced grip strength and increased stride length variability. Conclusions: Diabetes is a major risk factor for falling, even after controlling for poor balance. Taking more medications, poorer walking performance and reduced cognitive functioning were mediators of the relationship between diabetes and falls. Tailored preventive programs including systematic medication reviews, specific balance exercises and cognitive training might be beneficial in reducing fall risk in older adults suffering from diabetes.	[Roman de Mettelinge, Tine; Cambier, Dirk; Calders, Patrick] Univ Ghent, Fac Med & Hlth Sci, Dept Rehabil Sci & Physiotherapy, B-9000 Ghent, Belgium; [Van den Noortgate, Nele] Ghent Univ Hosp, Dept Internal Med, Div Geriatr & Gerontol, Ghent, Belgium; [Delbaere, Kim] Neurosci Res Australia, Falls & Balance Res Grp, Sydney, NSW, Australia	Ghent University; Ghent University; Ghent University Hospital; Neuroscience Research Australia	Roman de Mettelinge, T (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Rehabil Sci & Physiotherapy, B-9000 Ghent, Belgium.	Tine.RomandeMettelinge@Ugent.be	Roman de Mettelinge, Tine/ABC-6840-2020; Delbaere, Kim/D-6370-2011	Roman de Mettelinge, Tine/0000-0001-5338-0463; Delbaere, Kim/0000-0002-5655-0234	Special Research Fund, Bijzonder Onderzoeks Fonds (BOF), of the Ghent University [05v00608]	Special Research Fund, Bijzonder Onderzoeks Fonds (BOF), of the Ghent University	This study was funded by Special Research Fund, Bijzonder Onderzoeks Fonds (BOF), of the Ghent University (05v00608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2010, OTOL NEUROTOL; Allet L, 2008, DIABETES-METAB RES, V24, P173, DOI 10.1002/dmrr.809; Allet L, 2010, DIABETOLOGIA, V53, P458, DOI 10.1007/s00125-009-1592-4; Baloh RW, 2003, ARCH NEUROL-CHICAGO, V60, P835, DOI 10.1001/archneur.60.6.835; Bonnet C, 2009, J MOTOR BEHAV, V41, P172, DOI 10.3200/JMBR.41.2.172-192; Cetinus E, 2005, DIABETES RES CLIN PR, V70, P278, DOI 10.1016/j.diabres.2005.03.028; Delbaere K, 2012, AM J GERIAT PSYCHIAT, V20, P845, DOI 10.1097/JGP.0b013e31824afbc4; Delbaere K, 2012, AGE AGEING, V41, P404, DOI 10.1093/ageing/afs004; Delbaere K, 2010, J AM GERIATR SOC, V58, P1679, DOI 10.1111/j.1532-5415.2010.03017.x; Fess E. E., 1992, GRIP STRENGTH; Foley AL, 2012, AGE AGEING, V41, P35, DOI 10.1093/ageing/afr125; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeland KN, 2012, ANN PHARMACOTHER, V46, P1188, DOI 10.1345/aph.1Q689; Garrow AP, 2006, DIABETES-METAB RES, V22, P411, DOI 10.1002/dmrr.657; Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Holtzer R, 2012, J AM GERIATR SOC, V60, P2093, DOI 10.1111/j.1532-5415.2012.04193.x; Kwan MMS, 2012, AGE AGEING, V41, P606, DOI 10.1093/ageing/afs065; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Lim JY, 2012, PM&R, V4, P945, DOI 10.1016/j.pmrj.2012.07.005; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Maurer MS, 2005, J GERONTOL A-BIOL, V60, P1157, DOI 10.1093/gerona/60.9.1157; Menz HB, 2004, GAIT POSTURE, V20, P20, DOI 10.1016/S0966-6362(03)00068-7; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866, DOI 10.1093/gerona/61.8.866; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; Reijmer YD, 2011, DIABETES-METAB RES, V27, P195, DOI 10.1002/dmrr.1163; Reijmer YD, 2010, DIABETES-METAB RES, V26, P507, DOI 10.1002/dmrr.1112; Richardson JK, 1996, POSTGRAD MED, V99, P161, DOI 10.1080/00325481.1996.11946142; Salonen L, 2012, CURR GERONTOL GERIAT, V2012; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Strotmeyer ES, 2005, ARCH INTERN MED, V165, P1612, DOI 10.1001/archinte.165.14.1612; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; THALMANN B, 2002, BRAIN AGING, V2, P36, DOI DOI 10.1093/AGEING/AFU157; Tiedemann A, 2005, GERONTOLOGY, V51, P390, DOI 10.1159/000088703; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	39	68	68	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67055	10.1371/journal.pone.0067055	http://dx.doi.org/10.1371/journal.pone.0067055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175IB	23825617	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000069
J	Sinkko, H; Lukkari, K; Sihvonen, LM; Sivonen, K; Leivuori, M; Rantanen, M; Paulin, L; Lyra, C				Sinkko, Hanna; Lukkari, Kaarina; Sihvonen, Leila M.; Sivonen, Kaarina; Leivuori, Mirja; Rantanen, Matias; Paulin, Lars; Lyra, Christina			Bacteria Contribute to Sediment Nutrient Release and Reflect Progressed Eutrophication-Driven Hypoxia in an Organic-Rich Continental Sea	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; CHLOROFLEXI SUBPHYLUM-I; BALTIC SEA; MARINE-SEDIMENTS; SP-NOV.; GEN. NOV.; DISSOLVED SUBSTANCES; COMMUNITY STRUCTURE; PHYLUM CHLOROFLEXI; CHEMICAL CHARACTER	In the sedimental organic matter of eutrophic continental seas, such as the largest dead zone in the world, the Baltic Sea, bacteria may directly participate in nutrient release by mineralizing organic matter or indirectly by altering the sediment's ability to retain nutrients. Here, we present a case study of a hypoxic sea, which receives riverine nutrient loading and in which microbe-mediated vicious cycles of nutrients prevail. We showed that bacterial communities changed along the horizontal loading and vertical mineralization gradients in the Gulf of Finland of the Baltic Sea, using multivariate statistics of terminal restriction fragments and sediment chemical, spatial and other properties of the sampling sites. The change was mainly explained by concentrations of organic carbon, nitrogen and phosphorus, which showed strong positive correlation with Flavobacteria, Sphingobacteria, Alphaproteobacteria and Gammaproteobacteria. These bacteria predominated in the most organic-rich coastal surface sediments overlain by oxic bottom water, whereas sulphate-reducing bacteria, particularly the genus Desulfobacula, prevailed in the reduced organic-rich surface sediments in the open sea. They correlated positively with organic nitrogen and phosphorus, as well as manganese oxides. These relationships suggest that the bacterial groups participated in the aerobic and anaerobic degradation of organic matter and contributed to nutrient cycling. The high abundance of sulphate reducers in the surficial sediment layers reflects the persistence of eutrophication-induced hypoxia causing ecosystem-level changes in the Baltic Sea. The sulphate reducers began to decrease below depths of 20 cm, where members of the family Anaerolineaceae (phylum Chloroflexi) increased, possibly taking part in terminal mineralization processes. Our study provides valuable information on how organic loading affects sediment bacterial community compositions, which consequently may maintain active nutrient recycling. This information is needed to improve our understanding on nutrient cycling in shallow seas where the dead zones are continuously spreading worldwide.	[Sinkko, Hanna; Sihvonen, Leila M.; Sivonen, Kaarina; Lyra, Christina] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Lukkari, Kaarina] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [Sihvonen, Leila M.] Natl Inst Hlth & Welf, Helsinki, Finland; [Leivuori, Mirja] Finnish Environm Inst, Reference Lab, Helsinki, Finland; [Rantanen, Matias; Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; Finnish Environment Institute; Finland National Institute for Health & Welfare; Finnish Environment Institute; University of Helsinki	Sivonen, K (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	kaarina.sivonen@helsinki.fi		Sivonen, Kaarina/0000-0002-2904-0458; Sinkko, Hanna/0000-0002-4003-0429	Maj and Tor Nessling Foundation [202441]; Centre of Excellence [53305, 118637]	Maj and Tor Nessling Foundation; Centre of Excellence	This work was supported by Maj and Tor Nessling Foundation, Baltic Sea Research Program (BIREME, 202441), the Centre of Excellence (53305, 118637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Arnosti C, 2004, MAR CHEM, V92, P263, DOI 10.1016/j.marchem.2004.06.030; Arnosti C, 2000, LIMNOL OCEANOGR, V45, P1112, DOI 10.4319/lo.2000.45.5.1112; Arnosti C, 2008, FEMS MICROBIOL ECOL, V66, P343, DOI 10.1111/j.1574-6941.2008.00587.x; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Beardsley C, 2011, FEMS MICROBIOL ECOL, V77, P134, DOI 10.1111/j.1574-6941.2011.01094.x; BERNER RA, 1970, AM J SCI, V268, P1, DOI 10.2475/ajs.268.1.1; Bissett A, 2006, FEMS MICROBIOL ECOL, V55, P48, DOI 10.1111/j.1574-6941.2005.00012.x; Bissett A, 2008, AQUAT MICROB ECOL, V51, P31, DOI 10.3354/ame01174; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; CANFIELD DE, 1989, DEEP-SEA RES, V36, P121, DOI 10.1016/0198-0149(89)90022-8; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Carman R, 1998, VIE MILIEU, V48, P229; Choi JH, 2010, INT J SYST EVOL MICR, V60, P1488, DOI 10.1099/ijs.0.013557-0; Christensen KK, 1997, BIOGEOCHEMISTRY, V38, P149, DOI 10.1023/A:1005736930062; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Conley DJ, 1997, ESTUAR COAST SHELF S, V45, P591, DOI 10.1006/ecss.1997.0246; Conley DJ, 1999, HYDROBIOLOGIA, V410, P87, DOI 10.1023/A:1003784504005; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Edlund A, 2006, APPL ENVIRON MICROB, V72, P6800, DOI 10.1128/AEM.00971-06; GACHTER R, 1988, LIMNOL OCEANOGR, V33, P1542; Gomez-Pereira PR, 2012, ENVIRON MICROBIOL, V14, P52, DOI 10.1111/j.1462-2920.2011.02555.x; Helcom, 2004, BALT SEA ENV P, P93; Helcom, 1998, BALTIC SEA ENV P; Heyer J, 2000, ESTUAR COAST SHELF S, V51, P13, DOI 10.1006/ecss.2000.0616; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; Ivanova EP, 2001, MICROBIOLOGY+, V70, P10, DOI 10.1023/A:1004876301036; Jantti H, 2012, AMBIO, V41, P161, DOI 10.1007/s13280-011-0233-6; JENSEN HS, 1993, HYDROBIOLOGIA, V253, P47, DOI 10.1007/BF00050721; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kindt R., 2005, WORLD; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kondo R, 2012, MICROBES ENVIRON, V27, P193, DOI 10.1264/jsme2.ME11278; KROM MD, 1981, GEOCHIM COSMOCHIM AC, V45, P207; Kuever J, 2001, INT J SYST EVOL MICR, V51, P171, DOI 10.1099/00207713-51-1-171; Kunihiro T, 2011, ISME J, V5, P1818, DOI 10.1038/ismej.2011.57; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P2394, DOI 10.1128/AEM.60.7.2394-2399.1994; Lukkari K, 2008, BIOGEOCHEMISTRY, V90, P171, DOI 10.1007/s10533-008-9243-2; Lukkari K, 2009, BIOGEOCHEMISTRY, V96, P25, DOI 10.1007/s10533-009-9343-7; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P433, DOI 10.4319/lom.2007.5.433; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P445, DOI 10.4319/lom.2007.5.445; Lukkari K, 2009, BIOGEOCHEMISTRY, V94, P141, DOI 10.1007/s10533-009-9315-y; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; Mortimer CH, 1942, J ECOL, V30, P147, DOI 10.2307/2256691; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; MORTIMER CH, 1971, LIMNOL OCEANOGR, V16, P387, DOI 10.4319/lo.1971.16.2.0387; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Oksanen J., 2016, R PACKAG; Pallud C, 2006, GEOCHIM COSMOCHIM AC, V70, P1148, DOI 10.1016/j.gca.2005.11.002; Pimenov NV, 2012, MICROBIOLOGY+, V81, P79, DOI 10.1134/S0026261712010122; Pimenov NV, 2010, GEO-MAR LETT, V30, P439, DOI 10.1007/s00367-010-0200-4; Pitkanen H, 2001, AMBIO, V30, P195, DOI 10.1639/0044-7447(2001)030[0195:INFCDI]2.0.CO;2; R Development Core Team, 2011, R LANG ENV STAT COMP; Raber T, 1998, CURR MICROBIOL, V37, P172, DOI 10.1007/s002849900359; Rocker D, 2012, FEMS MICROBIOL ECOL, V80, P45, DOI 10.1111/j.1574-6941.2011.01269.x; Ruttenberg KC, 1997, MAR GEOL, V139, P123, DOI 10.1016/S0025-3227(96)00107-7; SCHNITZER M, 1969, SOIL SCI SOC AM PRO, V33, P75, DOI 10.2136/sssaj1969.03615995003300010022x; Sinkko H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021555; Spiro TG, 2010, ACCOUNTS CHEM RES, V43, P2, DOI 10.1021/ar800232a; Steenbergh AK, 2011, LIMNOL OCEANOGR, V56, P2018, DOI 10.4319/lo.2011.56.6.2018; SUZUMURA M, 1995, GEOCHIM COSMOCHIM AC, V59, P1021, DOI 10.1016/0016-7037(95)00006-2; Thamdrup B, 2000, APPL ENVIRON MICROB, V66, P2888, DOI 10.1128/AEM.66.7.2888-2897.2000; Thiessen O, 2006, CONT SHELF RES, V26, P2469, DOI 10.1016/j.csr.2006.07.020; Urios L, 2008, INT J SYST EVOL MICR, V58, P1233, DOI 10.1099/ijs.0.65470-0; van der Zee C, 2001, J MAR RES, V59, P133, DOI 10.1357/002224001321237407; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whiticar MJ, 2002, MAR GEOL, V182, P29, DOI 10.1016/S0025-3227(01)00227-4; WINTERHALTER B, 1981, BALTIC SEA ELSEVIER, P00001; Wong MT, 2004, MICROBIOL-SGM, V150, P3741, DOI 10.1099/mic.0.27291-0; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yamada T, 2005, APPL ENVIRON MICROB, V71, P7493, DOI 10.1128/AEM.71.11.7493-7503.2005; Yamada T, 2007, INT J SYST EVOL MICR, V57, P2299, DOI 10.1099/ijs.0.65098-0; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yamada T, 2009, MICROBES ENVIRON, V24, P205, DOI 10.1264/jsme2.ME09151S	89	71	80	8	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67061	10.1371/journal.pone.0067061	http://dx.doi.org/10.1371/journal.pone.0067061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825619	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000071
J	Wiens, MO; Pawluk, S; Kissoon, N; Kumbakumba, E; Ansermino, JM; Singer, J; Ndamira, A; Larson, C				Wiens, Matthew O.; Pawluk, Shane; Kissoon, Niranjan; Kumbakumba, Elias; Ansermino, J. Mark; Singer, Joel; Ndamira, Andrew; Larson, Charles			Pediatric Post-Discharge Mortality in Resource Poor Countries: A Systematic Review	PLOS ONE			English	Review							CONTROLLED-TRIAL; AFTER-DISCHARGE; CHILD-MORTALITY; SEVERE ANEMIA; MALARIA; MANAGEMENT; BANGLADESH; INFECTION; COHORT; KENYA	Objectives: Mortality following hospital discharge is an important and under-recognized contributor to overall child mortality in developing countries. The primary objective of this systematic review was to identify all studies reporting post-discharge mortality in children, estimate likelihood of death, and determine the most important risk factors for death. Search Strategy: MEDLINE and EMBASE were systematically searched using MeSH terms and keywords from the inception date to October, 2012. Key word searches using Google Scholar (TM) and hand searching of references of retrieved articles was also performed. Studies from developing countries reporting mortality following hospital discharge among a pediatric population were considered for inclusion. Results: Thirteen studies that reported mortality rates following discharge were identified. Studies varied significantly according to design, underlying characteristics of study population and duration of follow-up. Mortality rates following discharge varied significantly between studies (1%-18%). When reported, post-discharge mortality rates often exceeded in-hospital mortality rates. The most important baseline variables associated with post-discharge mortality were young age, malnutrition, multiple previous hospitalizations, HIV infection and pneumonia. Most post-discharge deaths occurred early during the post-discharge period. Follow-up care was examined in only one study examining malaria prophylaxis in children discharged following an admission secondary to malaria, which showed no significant benefit on post-discharge mortality. Conclusions: The months following hospital discharge carry significant risk for morbidity and mortality. While several characteristics are strongly associated with post-discharge mortality, no validated tools are available to aid health workers or policy makers in the systematic identification of children at high risk of post-discharge mortality. Future research must focus on both the creation of tools to aid in defining groups of children most likely to benefit from post-discharge interventions, and formal assessment of the effectiveness of such interventions in reducing morbidity and mortality in the first few months following hospital discharge.	[Wiens, Matthew O.; Kumbakumba, Elias; Ndamira, Andrew] Mbarara Univ Sci & Technol, Dept Pediat, Mbarara, Uganda; [Wiens, Matthew O.; Singer, Joel; Larson, Charles] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Wiens, Matthew O.; Pawluk, Shane] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Kissoon, Niranjan; Larson, Charles] BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada; [Kissoon, Niranjan; Ansermino, J. Mark; Larson, Charles] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Ansermino, J. Mark] BC Childrens Hosp, Dept Anesthesia, Vancouver, BC, Canada; [Kissoon, Niranjan; Larson, Charles] BC Childrens Hosp, Ctr Int Child Hlth, Child & Family Res Inst, Vancouver, BC, Canada	Mbarara University of Science & Technology; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia	Wiens, MO (corresponding author), Mbarara Univ Sci & Technol, Dept Pediat, Mbarara, Uganda.	mowiens@outlook.com	Wiens, Matthew/J-9249-2019; Kissoon, Niranjan/AAC-6140-2021	Kissoon, Niranjan/0000-0001-8847-9973; Ansermino, J Mark/0000-0001-8427-2035; Wiens, Matthew/0000-0002-3287-5181	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Canadian Child Health Clinician Scientist Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Child Health Clinician Scientist Program	This study received no external funding. Matthew O Wiens is supported by a fellowship from the Canadian Institutes of Health Research, The Michael Smith Foundation for Health Research and the Canadian Child Health Clinician Scientist Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, REC MAN COMM CHILDH; Ashraf H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000961; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; HENNART P, 1987, J TROP PEDIATRICS, V33, P10, DOI 10.1093/tropej/33.1.10; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Islam MA, 1996, J TROP PEDIATRICS, V42, P342, DOI 10.1093/tropej/42.6.342; Klugman J., 2011, HUMAN DEV REPORT 201; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Mangia CMF, 2009, J PEDIAT INF DIS-GER, V4, P71, DOI 10.3233/JPI-2009-0157; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P725, DOI 10.2471/BLT.11.089235; Phiri K, 2012, LANCET INFECT DIS, V12, P191, DOI 10.1016/S1473-3099(11)70320-6; Phiri KS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002903; ROY SK, 1983, BRIT MED J, V287, P1097, DOI 10.1136/bmj.287.6399.1097; Stanton B, 1986, TROPICAL GEOGRAPHICA, P113; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; United Nations General Assembly 56th session, 2001, UN GEN ASS 56 SESS; Veirum JE, 2007, ACTA PAEDIATR, V96, P1832, DOI 10.1111/j.1651-2227.2007.00562.x; Villamor E, 2005, INT J EPIDEMIOL, V34, P61, DOI 10.1093/ije/dyh378; Watson R Scott, 2005, Pediatr Crit Care Med, V6, pS3; West TE, 1999, B WORLD HEALTH ORGAN, V77, P144; Wiens Matthew O, 2012, Clin Epidemiol, V4, P319, DOI 10.2147/CLEP.S35693; Zucker JR, 1996, AM J TROP MED HYG, V55, P655, DOI 10.4269/ajtmh.1996.55.655	23	71	72	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66698	10.1371/journal.pone.0066698	http://dx.doi.org/10.1371/journal.pone.0066698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825556	Green Submitted, gold, Green Published			2022-12-27	WOS:000321223000022
J	Zan, JD; Heindl, JE; Liu, Y; Fuqua, C; Hill, RT				Zan, Jindong; Heindl, Jason E.; Liu, Yue; Fuqua, Clay; Hill, Russell T.			The CckA-ChpT-CtrA Phosphorelay System Is Regulated by Quorum Sensing and Controls Flagellar Motility in the Marine Sponge Symbiont Ruegeria sp KLH11	PLOS ONE			English	Article							GENE-TRANSFER AGENT; BACTERIAL-CELL-CYCLE; AGROBACTERIUM-TUMEFACIENS; TRANSCRIPTIONAL ACTIVATOR; HISTIDINE KINASE; MASTER REGULATOR; GENOME SEQUENCE; TI PLASMID; PROTEOBACTERIA; TRANSFORMATION	Bacteria respond to their environment via signal transduction pathways, often two-component type systems that function through phosphotransfer to control expression of specific genes. Phosphorelays are derived from two-component systems but are comprised of additional components. The essential cckA-chpT-ctrA phosphorelay in Caulobacter crescentus has been well studied and is important in orchestrating the cell cycle, polar development and flagellar biogenesis. Although cckA, chpT and ctrA homologues are widespread among the Alphaproteobacteria, relatively few is known about their function in the large and ecologically significant Roseobacter clade of the Rhodobacterales. In this study the cckA-chpT-ctrA system of the marine sponge symbiont Ruegeria sp. KLH11 was investigated. Our results reveal that the cckA, chpT and ctrA genes positively control flagellar biosynthesis. In contrast to C. crescentus, the cckA, chpT and ctrA genes in Ruegeria sp. KLH11 are non-essential and do not affect bacterial growth. Gene fusion and transcript analyses provide evidence for ctrA autoregulation and the control of motility-related genes. In KLH11, flagellar motility is controlled by the SsaRI system and acylhomoserine lactone (AHL) quorum sensing. SsaR and long chain AHLs are required for cckA, chpT and ctrA gene expression, providing a regulatory link between flagellar locomotion and population density in KLH11.	[Zan, Jindong; Liu, Yue; Hill, Russell T.] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA; [Heindl, Jason E.; Fuqua, Clay] Indiana Univ, Dept Biol, Bloomington, IN USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Indiana University System; Indiana University Bloomington	Hill, RT (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	hill@umces.edu	Hill, Russell/AAF-4190-2019; Liu, Yue/D-8816-2015	Hill, Russell/0000-0002-9832-1851; Heindl, Jason/0000-0003-3919-8045	National Science Foundation Microbial Interactions and Processes Program (MCB) [0703467, 6166]; BIO/IOS Program [IOS-0919728]; Ruth L. Kirschstein National Research Service [1 F32 GM100601-01A1]; Indiana University METACyt; Lilly Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100601] Funding Source: NIH RePORTER	National Science Foundation Microbial Interactions and Processes Program (MCB); BIO/IOS Program; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University METACyt; Lilly Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Science Foundation Microbial Interactions and Processes Program to CF (MCB #0703467, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 6166) and the BIO/IOS Program to RTH (#IOS-0919728, http://www.nsf.gov/bio/ios/about.jsp). This project was also supported by Ruth L. Kirschstein National Research Service Award 1 F32 GM100601-01A1 (JEH) and through a grant from the Indiana University METACyt program funded in part by a major endowment from the Lilly Foundation (CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura R, 2002, J BIOL CHEM, V277, P15773, DOI 10.1074/jbc.M200109200; Arora SK, 1997, J BACTERIOL, V179, P5574, DOI 10.1128/jb.179.17.5574-5581.1997; Barnett MJ, 2001, J BACTERIOL, V183, P3204, DOI 10.1128/JB.183.10.3204-3210.2001; Belas R, 2009, J BACTERIOL, V191, P4502, DOI 10.1128/JB.00429-09; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bird TH, 2011, ARCH MICROBIOL, V193, P451, DOI 10.1007/s00203-011-0676-y; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; Cheng ZH, 2011, MOL MICROBIOL, V82, P1217, DOI 10.1111/j.1365-2958.2011.07885.x; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gora KG, 2010, MOL CELL, V39, P455, DOI 10.1016/j.molcel.2010.06.024; Greene SE, 2012, J BACTERIOL, V194, P2973, DOI 10.1128/JB.00170-12; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Jacobs C, 2003, MOL MICROBIOL, V47, P1279, DOI 10.1046/j.1365-2958.2003.03379.x; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kanbe M, 2007, J BACTERIOL, V189, P1083, DOI 10.1128/JB.01405-06; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056682; Klose KE, 1998, MOL MICROBIOL, V28, P501, DOI 10.1046/j.1365-2958.1998.00809.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; Lang AS, 2000, P NATL ACAD SCI USA, V97, P859, DOI 10.1073/pnas.97.2.859; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Leung MM, 2010, CTRA GTAR 2 SYSTEMS; Leung MM, 2013, MICROBIOL-SGM, V159, P96, DOI 10.1099/mic.0.062349-0; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; MAYFIELD CI, 1977, CAN J MICROBIOL, V23, P1311, DOI 10.1139/m77-198; Mercer RG, 2012, FEMS MICROBIOL LETT, V331, P53, DOI 10.1111/j.1574-6968.2012.02553.x; Mercer RG, 2010, J BACTERIOL, V192, P2701, DOI 10.1128/JB.00160-10; Merritt PM, 2007, J BACTERIOL, V189, P8005, DOI 10.1128/JB.00566-07; MERSEREAU M, 1990, GENE, V90, P149, DOI 10.1016/0378-1119(90)90452-W; Miller TR, 2006, ENVIRON MICROBIOL, V8, P1648, DOI 10.1111/j.1462-2920.2006.01071.x; Mohamed NM, 2008, APPL ENVIRON MICROB, V74, P1209, DOI 10.1128/AEM.02047-07; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P75, DOI 10.1111/j.1462-2920.2007.01431.x; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Robertson GT, 2000, J BACTERIOL, V182, P3482, DOI 10.1128/JB.182.12.3482-3489.2000; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaefer AL, 2002, J BACTERIOL, V184, P6515, DOI 10.1128/JB.184.23.6515-6521.2002; Slightom RN, 2009, APPL ENVIRON MICROB, V75, P6027, DOI 10.1128/AEM.01508-09; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; TEMPE J, 1977, P NATL ACAD SCI USA, V74, P2848, DOI 10.1073/pnas.74.7.2848; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Zan JD, 2012, MOL MICROBIOL, V85, P916, DOI 10.1111/j.1365-2958.2012.08149.x; Zan JD, 2011, J BACTERIOL, V193, P5011, DOI 10.1128/JB.05556-11	50	27	27	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66346	10.1371/journal.pone.0066346	http://dx.doi.org/10.1371/journal.pone.0066346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825536	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000015
J	Kawano, Y; Neeley, S; Adachi, K; Nakai, H				Kawano, Yasuhiro; Neeley, Shane; Adachi, Kei; Nakai, Hiroyuki			An Experimental and Computational Evolution-Based Method to Study a Mode of Co-evolution of Overlapping Open Reading Frames in the AAV2 Viral Genome	PLOS ONE			English	Article							ASSEMBLY-ACTIVATING PROTEIN; GENE-THERAPY; ADENOASSOCIATED VIRUSES; DIRECTED EVOLUTION; IDENTIFICATION; PREDICTION; VECTORS; INFORMATION; HEMOPHILIA; SEQUENCES	Overlapping open reading frames (ORFs) in viral genomes undergo co-evolution; however, how individual amino acids coded by overlapping ORFs are structurally, functionally, and co-evolutionarily constrained remains difficult to address by conventional homologous sequence alignment approaches. We report here a new experimental and computational evolution-based methodology to address this question and report its preliminary application to elucidating a mode of co-evolution of the frame-shifted overlapping ORFs in the adeno-associated virus (AAV) serotype 2 viral genome. These ORFs encode both capsid VP protein and non-structural assembly-activating protein (AAP). To show proof of principle of the new method, we focused on the evolutionarily conserved QVKEVTQ and KSKRSRR motifs, a pair of overlapping heptapeptides in VP and AAP, respectively. In the new method, we first identified a large number of capsid-forming VP3 mutants and functionally competent AAP mutants of these motifs from mutant libraries by experimental directed evolution under no co-evolutionary constraints. We used Illumina sequencing to obtain a large dataset and then statistically assessed the viability of VP and AAP heptapeptide mutants. The obtained heptapeptide information was then integrated into an evolutionary algorithm, with which VP and AAP were co-evolved from random or native nucleotide sequences in silico. As a result, we demonstrate that these two heptapeptide motifs could exhibit high degeneracy if coded by separate nucleotide sequences, and elucidate how overlap-evoked co-evolutionary constraints play a role in making the VP and AAP heptapeptide sequences into the present shape. Specifically, we demonstrate that two valine (V) residues and beta-strand propensity in QVKEVTQ are structurally important, the strongly negative and hydrophilic nature of KSKRSRR is functionally important, and overlap-evoked co-evolution imposes strong constraints on serine (S) residues in KSKRSRR, despite high degeneracy of the motifs in the absence of co-evolutionary constraints.	[Kawano, Yasuhiro; Neeley, Shane; Adachi, Kei; Nakai, Hiroyuki] Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97201 USA; [Kawano, Yasuhiro] Takara Bio Inc, Otsu, Shiga, Japan	Oregon Health & Science University; Takara Bio Inc.	Nakai, H (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97201 USA.	nakaih@ohsu.edu			Public Health Service grant [R01 DK078388]; Sponsored Research Fund from Takara Bio Inc; National Institutes of Health; Takara Bio Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078388] Funding Source: NIH RePORTER	Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); Sponsored Research Fund from Takara Bio Inc; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara Bio Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Public Health Service grant (R01 DK078388) and a Sponsored Research Fund from Takara Bio Inc, and in part by the National Institutes of Health through resources provided by the National Resource for Biomedical Supercomputing (P41 RR06009), which is part of the Pittsburgh Supercomputing Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following inerests: This project was in part supported by a sponsored research fund obtained from Takara Bio Inc. Co-author Yasuhiro Kawano is an employee of Takara Bio Inc. The authors confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Adachi Kei, 2010, Gene Ther Regul, V5, P31, DOI 10.1142/S1568558610000197; Baker J.E., P INT C GEN ALG THEI, P101; Bartel MA, 2012, GENE THER, V19, P694, DOI 10.1038/gt.2012.20; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bruni R, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-48; Burton M, 1999, P NATL ACAD SCI USA, V96, P12725, DOI 10.1073/pnas.96.22.12725; Chirico N, 2010, P ROY SOC B-BIOL SCI, V277, P3809, DOI 10.1098/rspb.2010.1052; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Firth AE, 2005, BIOINFORMATICS, V21, P282, DOI 10.1093/bioinformatics/bti007; Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033; Foster JA, 2001, NAT REV GENET, V2, P428, DOI 10.1038/35076523; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Kalinina OV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042468; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Naumer M, 2012, J VIROL, V86, P13038, DOI 10.1128/JVI.01675-12; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Pavesi A, 2006, J GEN VIROL, V87, P1013, DOI 10.1099/vir.0.81375-0; Pavesi A, 1997, J MOL EVOL, V44, P625, DOI 10.1007/PL00006185; Pavesi A, 2000, J MOL EVOL, V50, P284, DOI 10.1007/s002399910033; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Sabath N, 2012, MOL BIOL EVOL, V29, P3767, DOI 10.1093/molbev/mss179; Sabath N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-144; Sonntag F, 2011, J VIROL, V85, P12686, DOI 10.1128/JVI.05359-11; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Travers SAA, 2007, MOL BIOL EVOL, V24, P2787, DOI 10.1093/molbev/msm213; Um HN, 2010, ANN NY ACAD SCI, V1200, P67, DOI 10.1111/j.1749-6632.2010.05508.x; Wu P, 2000, J VIROL, V74, P8635, DOI 10.1128/JVI.74.18.8635-8647.2000; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Yuen CM, 2007, NAT METHODS, V4, P995, DOI 10.1038/nmeth1207-995	40	12	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66211	10.1371/journal.pone.0066211	http://dx.doi.org/10.1371/journal.pone.0066211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826091	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400013
J	Riau, AK; Angunawela, RI; Chaurasia, SS; Lee, WS; Tan, DT; Mehta, JS				Riau, Andri K.; Angunawela, Romesh I.; Chaurasia, Shyam S.; Lee, Wing S.; Tan, Donald T.; Mehta, Jodhbir S.			Reversible Femtosecond Laser-Assisted Myopia Correction: A Non-Human Primate Study of Lenticule Re-Implantation after Refractive Lenticule Extraction	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; COLLAGEN CROSS-LINKING; EXCIMER LASER; PHOTOREFRACTIVE KERATECTOMY; PATIENT-SATISFACTION; SURGERY; CORNEA; ECTASIA; RELEX; EPIKERATOPHAKIA	LASIK (laser-assisted in situ keratomileusis) is a common laser refractive procedure for myopia and astigmatism, involving permanent removal of anterior corneal stromal tissue by excimer ablation beneath a hinged flap. Correction of refractive error is achieved by the resulting change in the curvature of the cornea and is limited by central corneal thickness, as a thin residual stromal bed may result in biomechanical instability of the cornea. A recently developed alternative to LASIK called Refractive Lenticule Extraction (ReLEx) utilizes solely a femtosecond laser (FSL) to incise an intrastromal refractive lenticule (RL), which results in reshaping the corneal curvature and correcting the myopia and/or astigmatism. As the RL is extracted intact in the ReLEx, we hypothesized that it could be cryopreserved and re-implanted at a later date to restore corneal stromal volume, in the event of keratectasia, making ReLEx a potentially reversible procedure, unlike LASIK. In this study, we re-implanted cryopreserved RLs in a non-human primate model of ReLEx. Mild intrastromal haze, noted during the first 2 weeks after re-implantation, subsided after 8 weeks. Refractive parameters including corneal thickness, anterior curvature and refractive error indices were restored to near pre-operative values after the re-implantation. Immunohistochemistry revealed no myofibroblast formation or abnormal collagen type I expression after 8 weeks, and a significant attenuation of fibronectin and tenascin expression from week 8 to 16 after re-implantation. In addition, keratocyte re-population could be found along the implanted RL interfaces. Our findings suggest that RL cryopreservation and re-implantation after ReLEx appears feasible, suggesting the possibility of potential reversibility of the procedure, and possible future uses of RLs in treating other corneal disorders and refractive errors.	[Riau, Andri K.; Angunawela, Romesh I.; Chaurasia, Shyam S.; Lee, Wing S.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Angunawela, Romesh I.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Chaurasia, Shyam S.] Duke NUS Grad Med Sch, SRP Neurosci & Behav Disorder Program, Singapore, Singapore; [Chaurasia, Shyam S.; Tan, Donald T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Tan, Donald T.; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore; [Tan, Donald T.; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Riau, AK (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.	andri_riau@yahoo.com; jodmehta@gmail.com	Chaurasia, Shyam/AAB-4709-2019; Mehta, Jodhbir/O-6192-2015; Riau, Andri/P-9693-2019	Chaurasia, Shyam/0000-0001-8725-676X; Riau, Andri/0000-0002-5105-0484; Angunawela, Romesh/0000-0001-6635-5283	National Research Foundation of Singapore-Funded Translational and Clinical Research [NMRC/TCR/002-SERI/2008, NMRC/CG/SERI/2010]	National Research Foundation of Singapore-Funded Translational and Clinical Research	Funding came from a National Research Foundation of Singapore-Funded Translational and Clinical Research Programme Grant (NMRC/TCR/002-SERI/2008) and Centre Grant (NMRC/CG/SERI/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Ophthalmology, 2008, IS LASIK ME PAT GUID; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P1414, DOI 10.1167/iovs.11-8808; Angunawela RI, 2012, INVEST OPHTH VIS SCI, V53, P4975, DOI 10.1167/iovs.12-10170; Bailey MD, 2003, OPHTHALMOLOGY, V110, P1371, DOI 10.1016/S0161-6420(03)00455-X; Battat L, 2001, OPHTHALMOLOGY, V108, P1230, DOI 10.1016/S0161-6420(01)00623-6; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Bromley JG, 2010, CURR OPIN OPHTHALMOL, V21, P255, DOI 10.1097/ICU.0b013e32833a8bfe; Dexl AK, 2011, J REFRACT SURG, V27, P876, DOI 10.3928/1081597X-20110802-02; Mulet ME, 2009, OPHTHALMOLOGY, V116, P1455, DOI 10.1016/j.ophtha.2009.05.019; Evans MDM, 2011, BIOMATERIALS, V32, P3158, DOI 10.1016/j.biomaterials.2011.01.047; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Goldberg DB, 2001, J CATARACT REFR SURG, V27, P1449, DOI 10.1016/S0886-3350(01)01001-X; HENDRIX MJC, 1982, INVEST OPHTH VIS SCI, V22, P359; Ivarsen A, 2003, BRIT J OPHTHALMOL, V87, P1272, DOI 10.1136/bjo.87.10.1272; Knorz Michael C, 2002, Curr Opin Ophthalmol, V13, P242, DOI 10.1097/00055735-200208000-00010; Kymionis GD, 2012, J CATARACT REFR SURG, V38, P713, DOI 10.1016/j.jcrs.2012.01.009; Kymionis GD, 2010, J CATARACT REFR SURG, V36, P1783, DOI 10.1016/j.jcrs.2010.06.044; Lee GA, 2003, BRIT J OPHTHALMOL, V87, P432, DOI 10.1136/bjo.87.4.432; MARSHALL J, 1985, OPHTHALMOLOGY, V92, P749; MCDONALD MB, 1986, ARCH OPHTHALMOL-CHIC, V104, P1294, DOI 10.1001/archopht.1986.01050210048024; Meltendorf C, 2002, CRYOBIOLOGY, V44, P170, DOI 10.1016/S0011-2240(02)00022-6; Meltendorf C, 2007, INVEST OPHTH VIS SCI, V48, P2068, DOI 10.1167/iovs.06-1150; Mitka M, 2009, JAMA-J AM MED ASSOC, V302, P2420, DOI 10.1001/jama.2009.1763; Mohamed-Noriega K, 2011, MOL VIS, V17, P3437; Pallikaris IG, 2001, J CATARACT REFR SURG, V27, P1796, DOI 10.1016/S0886-3350(01)01090-2; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Petrescu MS, 2007, INVEST OPHTH VIS SCI, V48, P5023, DOI 10.1167/iovs.07-0562; Rad AS, 2004, J REFRACT SURG, V20, pS718, DOI 10.3928/1081-597X-20040903-18; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI 10.1016/j.ophtha.2010.09.025; Randleman JB, 2008, OPHTHALMOLOGY, V115, P37, DOI 10.1016/j.ophtha.2007.03.073; Riau AK, 2012, J CATARACT REFR SURG, V38, P1467, DOI 10.1016/j.jcrs.2012.03.037; Riau AK, 2011, INVEST OPHTH VIS SCI, V52, P6213, DOI 10.1167/iovs.11-7439; Richter E, 1998, BONE MARROW TRANSPL, V22, pS16; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Solomon KD, 2009, OPHTHALMOLOGY, V116, P691, DOI 10.1016/j.ophtha.2008.12.037; Suri K, 2012, CURR OPIN OPHTHALMOL, V23, P280, DOI 10.1097/ICU.0b013e328354865e; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; VANSETTEN GB, 1992, GRAEF ARCH CLIN EXP, V230, P178, DOI 10.1007/BF00164660; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; VOGEL A, 1994, LASER SURG MED, V15, P32, DOI 10.1002/lsm.1900150106; Vrana NE, 2007, BIOMATERIALS, V28, P4303, DOI 10.1016/j.biomaterials.2007.06.013; WERBLIN TP, 1982, CURR EYE RES, V1, P591; WILSON DR, 1990, SURV OPHTHALMOL, V34, P294, DOI 10.1016/0039-6257(90)90028-T; Wilson SE, 1999, PROG RETIN EYE RES, V18, P293, DOI 10.1016/S1350-9462(98)00017-2; Wilson SE, 2004, NEW ENGL J MED, V351, P470, DOI 10.1056/NEJMcp033210; Wilson SE, 1998, INVEST OPHTH VIS SCI, V39, P220; Wusteman MC, 2008, CRYOBIOLOGY, V56, P62, DOI 10.1016/j.cryobiol.2007.10.177; Xiao JH, 2012, CHIN J TRAUMATOL, V15, P77, DOI 10.3760/cma.j.issn.1008-1275.2012.02.002; Zhu HY, 2010, MOL VIS, V16, P2215	51	43	50	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67058	10.1371/journal.pone.0067058	http://dx.doi.org/10.1371/journal.pone.0067058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826194	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400099
J	Graf, D; Seifert, S; Jaudszus, A; Bub, A; Watzl, B				Graf, Daniela; Seifert, Stephanie; Jaudszus, Anke; Bub, Achim; Watzl, Bernhard			Anthocyanin-Rich Juice Lowers Serum Cholesterol, Leptin, and Resistin and Improves Plasma Fatty Acid Composition in Fischer Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; GLUCOSE-INTOLERANCE; BERRY ANTHOCYANINS; OBESITY; MICE; INFLAMMATION; RISK; OVERWEIGHT; HEALTH	Obesity and obesity-associated diseases e.g. cardiovascular diseases and type 2 diabetes are spread worldwide. Anthocyanins are supposed to have health-promoting properties, although convincing evidence is lacking. The aim of the present study was to investigate the effect of anthocyanins on several risk factors for obesity-associated diseases. Therefore, Fischer rats were fed anthocyanin-rich grape-bilberry juice or an anthocyanin-depleted control juice for 10 weeks. Intervention with anthocyanin-rich grape-bilberry juice reduced serum cholesterol and tended to decrease serum triglycerides. No effects were seen for serum non-esterified fatty acids, glucose, and insulin. Anthocyanin-rich grape-bilberry juice intervention reduced serum leptin and resistin, but showed no influence on serum adiponectin and secretion of adipokines from mesenteric adipose tissue. Furthermore, anthocyanin-rich grape-bilberry juice increased the proportion of polyunsaturated fatty acids and decreased the amount of saturated fatty acids in plasma. These results indicate that anthocyanins possess a preventive potential for obesity-associated diseases.	[Graf, Daniela; Seifert, Stephanie; Jaudszus, Anke; Bub, Achim; Watzl, Bernhard] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Physiol & Biochem Nutr, Karlsruhe, Germany		Watzl, B (corresponding author), Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Physiol & Biochem Nutr, Karlsruhe, Germany.	bernhard.watzl@mri.bund.de		Graf, Daniela/0000-0002-1746-1415	German Federal Ministry of Research and Education [0315379G]	German Federal Ministry of Research and Education	This study has been financially supported by the German Federal Ministry of Research and Education (0315379G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Boullart ACI, 2012, BBA-MOL CELL BIOL L, V1821, P867, DOI 10.1016/j.bbalip.2011.10.002; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460; Espin JC, 2007, PHYTOCHEMISTRY, V68, P2986, DOI 10.1016/j.phytochem.2007.09.014; Catalano KJ, 2010, DIABETES, V59, P1416, DOI 10.2337/db08-0675; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; di Giuseppe R, 2009, AM J CLIN NUTR, V89, P354, DOI 10.3945/ajcn.2008.26661; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Graf D, 2013, MOL NUTR FOOD RES, V57, P1753, DOI 10.1002/mnfr.201300022; Guo HH, 2012, J NUTR BIOCHEM, V23, P349, DOI 10.1016/j.jnutbio.2010.12.013; Guo HH, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-10; Jaudszus A, 2013, J LIPID RES, V54, P923, DOI 10.1194/jlr.P031260; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Kanamoto Y, 2011, J AGR FOOD CHEM, V59, P8985, DOI 10.1021/jf201471p; Karlsen A, 2010, EUR J NUTR, V49, P345, DOI 10.1007/s00394-010-0092-0; Lecerf JM, 2011, BRIT J NUTR, V106, P6, DOI 10.1017/S0007114511000237; Lehtonen HM, 2011, EUR J CLIN NUTR, V65, P394, DOI 10.1038/ejcn.2010.268; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; Qi Y, 2006, DIABETES, V55, P3083, DOI 10.2337/db05-0615; Sackmann-Sala L, 2012, OBESITY, V20, P101, DOI 10.1038/oby.2011.235; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Toufektsian MC, 2011, J NUTR, V141, P37, DOI 10.3945/jn.110.127225; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vafeiadou K, 2012, BRIT J NUTR, V107, P303, DOI 10.1017/S0007114511004764; Wang QQ, 2012, ATHEROSCLEROSIS, V221, P536, DOI 10.1016/j.atherosclerosis.2012.01.006; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002	36	52	52	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66690	10.1371/journal.pone.0066690	http://dx.doi.org/10.1371/journal.pone.0066690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825152	Green Published, gold			2022-12-27	WOS:000320576400148
J	Han, DW; Tapia, N; Arauzo-Bravo, MJ; Lim, KT; Kim, KP; Ko, K; Lee, HT; Scholer, HR				Han, Dong Wook; Tapia, Natalia; Arauzo-Bravo, Marcos J.; Lim, Kyung Tae; Kim, Kee Pyo; Ko, Kinarm; Lee, Hoon Taek; Schoeler, Hans R.			Sox2 Level Is a Determinant of Cellular Reprogramming Potential	PLOS ONE			English	Article							NANOG; DIFFERENTIATION; PLURIPOTENCY; CELLS	Epiblast stem cells (EpiSCs) and embryonic stem cells (ESCs) differ in their in vivo differentiation potential. While ESCs form teratomas and efficiently contribute to the development of chimeras, EpiSCs form teratomas but very rarely chimeras. In contrast to their differentiation potential, the reprogramming potential of EpiSCs has not yet been investigated. Here we demonstrate that the epiblast-derived pluripotent stem cells EpiSCs and P19 embryonal carcinoma cells (ECCs) exhibit a lower reprogramming potential than ESCs and F9 ECCs. In addition, we show that the low reprogramming ability is due to the lower levels of Sox2 in epiblast-derived stem cells. Consistent with this observation, overexpression of Sox2 enhances reprogramming efficiency. In summary, these findings suggest that a low reprogramming potential is a general feature of epiblast-derived stem cells and that the Sox2 level is a determinant of the cellular reprogramming potential.	[Han, Dong Wook; Lim, Kyung Tae; Ko, Kinarm; Lee, Hoon Taek] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea; [Han, Dong Wook; Ko, Kinarm] Konkuk Univ, Inst Funct Genom, Seoul, South Korea; [Tapia, Natalia; Arauzo-Bravo, Marcos J.; Kim, Kee Pyo; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Konkuk University; Konkuk University Medical Center; Konkuk University; Max Planck Society; University of Munster	Han, DW (corresponding author), Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea.	dwhan@konkuk.ac.kr	Marcos, Arauzo-Bravo/A-1706-2011; Lim, Kyungtae/GYU-3532-2022; , HS/AAB-4434-2019; Tapia, Natalia/H-5500-2012	Marcos, Arauzo-Bravo/0000-0002-3264-464X; Lim, Kyungtae/0000-0001-6044-2191; , HS/0000-0003-2643-5136; Tapia, Natalia/0000-0003-0226-1952				Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Do JT, 2009, J CELL SCI, V122, P4122, DOI 10.1242/jcs.056119; Do JT, 2008, STEM CELLS, V26, P2821, DOI 10.1634/stemcells.2008-0482; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; MCBURNEY MW, 1988, J NEUROSCI, V8, P1063; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67594	10.1371/journal.pone.0067594	http://dx.doi.org/10.1371/journal.pone.0067594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825671	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400189
J	Kluk, MJ; Ashworth, T; Wang, HF; Knoechel, B; Mason, EF; Morgan, EA; Dorfman, D; Pinkus, G; Weigert, O; Hornick, JL; Chirieac, LR; Hirsch, M; Oh, DJ; South, AP; Leigh, IM; Pourreyron, C; Cassidy, AJ; DeAngelo, DJ; Weinstock, DM; Krop, IE; Dillon, D; Brock, JE; Lazar, AJF; Peto, M; Cho, RJ; Stoeck, A; Haines, BB; Sathayanrayanan, S; Rodig, S; Aster, JC				Kluk, Michael J.; Ashworth, Todd; Wang, Hongfang; Knoechel, Birgit; Mason, Emily F.; Morgan, Elizabeth A.; Dorfman, David; Pinkus, Geraldine; Weigert, Oliver; Hornick, Jason L.; Chirieac, Lucian R.; Hirsch, Michelle; Oh, David J.; South, Andrew P.; Leigh, Irene M.; Pourreyron, Celine; Cassidy, Andrew J.; DeAngelo, Daniel J.; Weinstock, David M.; Krop, Ian E.; Dillon, Deborah; Brock, Jane E.; Lazar, Alexander J. F.; Peto, Myron; Cho, Raymond J.; Stoeck, Alexander; Haines, Brian B.; Sathayanrayanan, Sriram; Rodig, Scott; Aster, Jon C.			Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry	PLOS ONE			English	Article							GENE AMPLIFICATION; CODING GENOME; B-CLL; MUTATIONS; TUMOR; REVEALS; PATHWAY; OVEREXPRESSION; ANGIOGENESIS; MECHANISMS	Fixed, paraffin-embedded (FPE) tissues are a potentially rich resource for studying the role of NOTCH1 in cancer and other pathologies, but tests that reliably detect activated NOTCH1 (NICD1) in FPE samples have been lacking. Here, we bridge this gap by developing an immunohistochemical (IHC) stain that detects a neoepitope created by the proteolytic cleavage event that activates NOTCH1. Following validation using xenografted cancers and normal tissues with known patterns of NOTCH1 activation, we applied this test to tumors linked to dysregulated Notch signaling by mutational studies. As expected, frequent NICD1 staining was observed in T lymphoblastic leukemia/lymphoma, a tumor in which activating NOTCH1 mutations are common. However, when IHC was used to gauge NOTCH1 activation in other human cancers, several unexpected findings emerged. Among B cell tumors, NICD1 staining was much more frequent in chronic lymphocytic leukemia than would be predicted based on the frequency of NOTCH1 mutations, while mantle cell lymphoma and diffuse large B cell lymphoma showed no evidence of NOTCH1 activation. NICD1 was also detected in 38% of peripheral T cell lymphomas. Of interest, NICD1 staining in chronic lymphocytic leukemia cells and in angioimmunoblastic lymphoma was consistently more pronounced in lymph nodes than in surrounding soft tissues, implicating factors in the nodal microenvironment in NOTCH1 activation in these diseases. Among carcinomas, diffuse strong NICD1 staining was observed in 3.8% of cases of triple negative breast cancer (3 of 78 tumors), but was absent from 151 non-small cell lung carcinomas and 147 ovarian carcinomas. Frequent staining of normal endothelium was also observed; in line with this observation, strong NICD1 staining was also seen in 77% of angiosarcomas. These findings complement insights from genomic sequencing studies and suggest that IHC staining is a valuable experimental tool that may be useful in selection of patients for clinical trials.	[Kluk, Michael J.; Ashworth, Todd; Wang, Hongfang; Mason, Emily F.; Morgan, Elizabeth A.; Dorfman, David; Pinkus, Geraldine; Hornick, Jason L.; Chirieac, Lucian R.; Hirsch, Michelle; Oh, David J.; Dillon, Deborah; Brock, Jane E.; Rodig, Scott; Aster, Jon C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kluk, Michael J.; Ashworth, Todd; Wang, Hongfang; Mason, Emily F.; Morgan, Elizabeth A.; Dorfman, David; Pinkus, Geraldine; Hornick, Jason L.; Chirieac, Lucian R.; Hirsch, Michelle; Oh, David J.; Dillon, Deborah; Brock, Jane E.; Rodig, Scott; Aster, Jon C.] Harvard Univ, Sch Med, Boston, MA USA; [Knoechel, Birgit; Weigert, Oliver; DeAngelo, Daniel J.; Weinstock, David M.; Krop, Ian E.] Dana Farber Canc Inst, Dept Pediat Hematol, Boston, MA 02115 USA; [Knoechel, Birgit; Weigert, Oliver; DeAngelo, Daniel J.; Weinstock, David M.; Krop, Ian E.] Dana Farber Canc Inst, Dept Oncol & Med Oncol, Boston, MA 02115 USA; [South, Andrew P.; Leigh, Irene M.; Pourreyron, Celine; Cassidy, Andrew J.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Canc Res, Dundee DD1 9SY, Scotland; [South, Andrew P.; Leigh, Irene M.; Pourreyron, Celine; Cassidy, Andrew J.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Genet Core Serv Unit, Dundee DD1 9SY, Scotland; [Lazar, Alexander J. F.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Peto, Myron] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Cho, Raymond J.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Stoeck, Alexander; Haines, Brian B.; Sathayanrayanan, Sriram] Merck Oncol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Dundee; University of Dundee; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; University of California System; University of California San Francisco	Aster, JC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	jaster@rics.bwh.harvard.edu	Lazar, Alexander J/A-3416-2008; Cho, Raymond/AAO-8125-2020; Pourreyron, Celine/AAE-7362-2020; Rodig, Scott/Y-3889-2019; Chirieac, Lucian R./AAD-2030-2019	Lazar, Alexander J/0000-0002-6395-4499; Cho, Raymond/0000-0001-6090-6603; Morgan, Elizabeth/0000-0001-5880-9337; Hornick, Jason/0000-0001-6475-8345; Cassidy, Andrew/0000-0003-4309-6981	NIH; Leukemia and Lymphoma Society; BWH Department of Pathology Robbins Award; Cancer Research UK [13044] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K08CA169865] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); BWH Department of Pathology Robbins Award; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the NIH and Leukemia and Lymphoma Society (JCA) and the BWH Department of Pathology Robbins Award (MJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Aster JC, 2012, J CLIN ONCOL, V30, P2418, DOI 10.1200/JCO.2012.42.0992; Balatti V, 2012, BLOOD, V119, P329, DOI 10.1182/blood-2011-10-386144; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bogusz AM, 2012, CLIN CANCER RES, V18, P6122, DOI 10.1158/1078-0432.CCR-12-0397; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; Deangelo DJ, 2006, J CLIN ONCOL, V24, p357S; Del Giudice I, 2012, HAEMATOL-HEMATOL J, V97, P437, DOI 10.3324/haematol.2011.060129; Di Ianni M, 2009, BRIT J HAEMATOL, V146, P689, DOI 10.1111/j.1365-2141.2009.07816.x; Dill MT, 2012, GASTROENTEROLOGY, V142, P967, DOI 10.1053/j.gastro.2011.12.052; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hubmann R, 2002, BLOOD, V99, P3742, DOI 10.1182/blood.V99.10.3742; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kridel R, 2012, BLOOD, V119, P1963, DOI 10.1182/blood-2011-11-391474; Lahat G, 2010, ANN SURG, V251, P1098, DOI 10.1097/SLA.0b013e3181dbb75a; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Liu JF, 2009, GYNECOL ONCOL, V115, P401, DOI 10.1016/j.ygyno.2009.08.023; Liu ZY, 2011, J CLIN INVEST, V121, P800, DOI 10.1172/JCI43114; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Pancewicz J, 2010, P NATL ACAD SCI USA, V107, P16619, DOI 10.1073/pnas.1010722107; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Simmons MJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3321; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Troen G, 2008, HAEMATOL-HEMATOL J, V93, P1107, DOI 10.3324/haematol.11635; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yashiro-Ohtani Y, 2010, SEMIN IMMUNOL, V22, P261, DOI 10.1016/j.smim.2010.04.015; Yen WC, 2012, CLIN CANCER RES, V18, P5374, DOI 10.1158/1078-0432.CCR-12-0736	57	78	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67306	10.1371/journal.pone.0067306	http://dx.doi.org/10.1371/journal.pone.0067306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825651	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400182
J	Mishra, V; Cline, R; Noel, P; Karlsson, J; Baty, CJ; Orlichenko, L; Patel, K; Trivedi, RN; Husain, SZ; Acharya, C; Durgampudi, C; Stolz, DB; Navina, S; Singh, VP				Mishra, Vivek; Cline, Rachel; Noel, Pawan; Karlsson, Jenny; Baty, Catherine J.; Orlichenko, Lidiya; Patel, Krutika; Trivedi, Ram Narayan; Husain, Sohail Z.; Acharya, Chathur; Durgampudi, Chandra; Stolz, Donna B.; Navina, Sarah; Singh, Vijay P.			Src Dependent Pancreatic Acinar Injury Can Be Initiated Independent of an Increase in Cytosolic Calcium	PLOS ONE			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; ZYMOGEN ACTIVATION; GASTROINTESTINAL HORMONES/NEUROTRANSMITTERS; TRYPSINOGEN ACTIVATION; GROWTH-FACTORS; CELL INJURY; CHOLECYSTOKININ; SECRETION; ASSOCIATION	Several deleterious intra-acinar phenomena are simultaneously triggered on initiating acute pancreatitis. These culminate in acinar injury or inflammatory mediator generation in vitro and parenchymal damage in vivo. Supraphysiologic caerulein is one such initiator which simultaneously activates numerous signaling pathways including non-receptor tyrosine kinases such as of the Src family. It also causes a sustained increase in cytosolic calcium-a player thought to be crucial in regulating deleterious phenomena. We have shown Src to be involved in caerulein induced actin remodeling, and caerulein induced changes in the Golgi and post-Golgi trafficking to be involved in trypsinogen activation, which initiates acinar cell injury. However, it remains unclear whether an increase in cytosolic calcium is necessary to initiate acinar injury or if injury can be initiated at basal cytosolic calcium levels by an alternate pathway. To study the interplay between tyrosine kinase signaling and calcium, we treated mouse pancreatic acinar cells with the tyrosine phosphatase inhibitor pervanadate. We studied the effect of the clinically used Src inhibitor Dasatinib (BMS-354825) on pervanadate or caerulein induced changes in Src activation, trypsinogen activation, cell injury, upstream cytosolic calcium, actin and Golgi morphology. Pervanadate, like supraphysiologic caerulein, induced Src activation, redistribution of the F-actin from its normal location in the sub-apical area to the basolateral areas, and caused antegrade fragmentation of the Golgi. These changes, like those induced by supraphysiologic caerulein, were associated with trypsinogen activation and acinar injury, all of which were prevented by Dasatinib. Interestingly, however, pervanadate did not cause an increase in cytosolic calcium, and the caerulein induced increase in cytosolic calcium was not affected by Dasatinib. These findings suggest that intra-acinar deleterious phenomena may be initiated independent of an increase in cytosolic calcium. Other players resulting in acinar injury along with the Src family of tyrosine kinases remain to be explored.	[Mishra, Vivek; Cline, Rachel; Noel, Pawan; Orlichenko, Lidiya; Patel, Krutika; Trivedi, Ram Narayan; Singh, Vijay P.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Karlsson, Jenny; Baty, Catherine J.; Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Husain, Sohail Z.] Univ Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15260 USA; [Acharya, Chathur; Durgampudi, Chandra] Univ Pittsburgh, Med Ctr, Dept Med, Passavant, PA USA; [Navina, Sarah] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, VP (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	singhv2@upmc.edu	Patel, Krutika/AAA-1302-2022	Singh, Vijay/0000-0001-6611-1908; Husain, Sohail Z/0000-0003-3012-1308	National Pancreas Foundation (NPF) [PR110417]; Department of Army (DOA) [UL1 RR024153]; National Center for Research Resources (NCRR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK092460]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093491, T32DK007017, R01DK092460] Funding Source: NIH RePORTER	National Pancreas Foundation (NPF); Department of Army (DOA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Pancreas Foundation (NPF) Research Award 2010 (Role of Src in Antegrade Golgi Expansion and Autophagic Acinar Cell Death) to V.P.S., Grant number PR110417 from the Department of Army (DOA) (V.P.S.), grant number UL1 RR024153 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research (S.N. and V.P.S.), and award number R01DK092460 (V.P.S.) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; DUAN RD, 1994, AM J PHYSIOL, V267, pG401, DOI 10.1152/ajpgi.1994.267.3.G401; El Alaoui-Talibi Z, 1997, AM J PHYSL, V272, pH1615; Eley T, 2009, J CLIN PHARMACOL, V49, P700, DOI 10.1177/0091270009333854; Fischer L, 2007, AM J PHYSIOL-GASTR L, V292, pG875, DOI 10.1152/ajpgi.00558.2005; Gerasimenko JV, 2011, P NATL ACAD SCI USA, V108, P5873, DOI 10.1073/pnas.1016534108; Gnoni A, 2011, CURR DRUG TARGETS, V12, P563, DOI 10.2174/138945011794751591; Gorelick F, 2008, J GASTROEN HEPATOL, V23, pS37, DOI 10.1111/j.1440-1746.2007.05282.x; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Han B, 2000, AM J PHYSIOL-CELL PH, V278, pC344, DOI 10.1152/ajpcell.2000.278.2.C344; Han B, 2001, AM J PHYSIOL-CELL PH, V280, pC465, DOI 10.1152/ajpcell.2001.280.3.C465; Hietaranta AJ, 2001, J BIOL CHEM, V276, P18742, DOI 10.1074/jbc.M009721200; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Husain SZ, 2012, AM J PHYSIOL-GASTR L, V302, pG1423, DOI 10.1152/ajpgi.00546.2011; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lynch G, 2004, PFLUG ARCH EUR J PHY, V447, P445, DOI 10.1007/s00424-003-1188-7; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Muili KA, 2012, AM J PHYSIOL-GASTR L, V302, pG898, DOI 10.1152/ajpgi.00545.2011; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Nozu F, 1999, AM J PHYSIOL-GASTR L, V276, pG915, DOI 10.1152/ajpgi.1999.276.4.G915; OKONSKI MS, 1993, PANCREAS, V8, P638, DOI 10.1097/00006676-199309000-00018; Orlichenko L, 2012, J BIOL CHEM, V287, P24284, DOI 10.1074/jbc.M111.328815; Orlichenko LS, 2010, AM J PHYSIOL-GASTR L, V299, pG867, DOI 10.1152/ajpgi.00177.2010; Pace A, 2006, BBA-MOL CELL RES, V1763, P356, DOI 10.1016/j.bbamcr.2006.03.004; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Parker EM, 2000, PANCREAS, V21, P219, DOI 10.1097/00006676-200010000-00001; Petersen OH, 2006, TRENDS PHARMACOL SCI, V27, P113, DOI 10.1016/j.tips.2005.12.006; Redondo PC, 2003, BIOCHEM J, V370, P255, DOI 10.1042/BJ20021505; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; SALUJA AK, 1989, P NATL ACAD SCI USA, V86, P8968, DOI 10.1073/pnas.86.22.8968; Samuel I, 2006, J GASTROINTEST SURG, V10, P1376, DOI 10.1016/j.gassur.2006.09.003; Sancho V, 2012, BBA-MOL CELL RES, V1823, P1285, DOI 10.1016/j.bbamcr.2012.05.015; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Sharma A, 2005, AM J PHYSIOL-GASTR L, V288, pG388, DOI 10.1152/ajpgi.00341.2004; Singh VP, 2008, MOL BIOL CELL, V19, P2339, DOI 10.1091/mbc.E07-11-1130; Singh VP, 2007, GUT, V56, P958, DOI 10.1136/gut.2006.094268; Singh VP, 2001, J CLIN INVEST, V108, P1387, DOI 10.1172/JCI200112874; Singh VP, 2001, GASTROENTEROLOGY, V120, P1818, DOI 10.1053/gast.2001.24883; Tapia JA, 1999, J BIOL CHEM, V274, P31261, DOI 10.1074/jbc.274.44.31261; Thrower EC, 2009, PANCREAS, V38, P930, DOI 10.1097/MPA.0b013e3181b8476a; Torgerson RR, 1998, J CELL SCI, V111, P2911; Torgerson RR, 2000, J CELL PHYSIOL, V182, P438, DOI 10.1002/(SICI)1097-4652(200003)182:3<438::AID-JCP15>3.0.CO;2-N; Tsunoda Y, 2004, BIOCHEM BIOPH RES CO, V314, P916, DOI 10.1016/j.bbrc.2003.11.186; Waterford SD, 2005, J BIOL CHEM, V280, P5430, DOI 10.1074/jbc.M413513200; Weber H, 2005, BIOCHEM PHARMACOL, V70, P1241, DOI 10.1016/j.bcp.2005.06.028; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66471	10.1371/journal.pone.0066471	http://dx.doi.org/10.1371/journal.pone.0066471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824669	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000320576400114
J	Ayieko, C; Maue, AC; Jura, WGZO; Noland, GS; Ayodo, G; Rochford, R; John, CC				Ayieko, Cyrus; Maue, Alexander C.; Jura, Walter G. Z. O.; Noland, Gregory S.; Ayodo, George; Rochford, Rosemary; John, Chandy C.			Changes in B Cell Populations and Merozoite Surface Protein-1-Specific Memory B Cell Responses after Prolonged Absence of Detectable P. falciparum Infection	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; GERMINAL CENTER; ANTIBODY-RESPONSES; MALARIA INFECTION; BONE-MARROW; ANTIGEN; INDIVIDUALS; CHILDREN; TERM; IGM	Clinical immunity to malaria declines in the absence of repeated parasite exposure. However, little is known about how B cell populations and antigen-specific memory B cells change in the absence of P. falciparum infection. A successful indoor residual insecticide spraying campaign in a highland area of western Kenya, led to an absence of blood-stage P. falciparum infection between March 2007 and April 2008. We assessed memory B cell responses in 45 adults at the beginning (April 2008) and end (April 2009) of a subsequent 12-month period during which none of the adults had evidence of asymptomatic parasitemia or clinical disease. Antibodies and memory B cells to the 42-kDa portion of the merozoite surface protein-1 (MSP-1(42)) were measured using ELISA and ELISPOT assays, respectively. B cell populations were characterized by flow cytometry. From 2008 to 2009, the prevalence of MSP-1(42)-specific memory B cells (45% vs. 55%, respectively, P = 0.32) or antibodies (91% vs. 82%, respectively, P = 0.32) did not differ significantly, although specific individuals did change from positive to negative and vice versa, particularly for memory B cells, suggesting possible low-level undetected parasitemia may have occurred in some individuals. The magnitude of MSP-1(42)-specific memory B cells and levels of antibodies to MSP-1(42) also did not differ from 2008 to 2009 (P > 0.10 for both). However, from 2008 to 2009 the proportions of both class-switched atypical (CD19+IgD-CD27-CD21-IgM-) and class-switched activated (CD19+IgD-CD27+CD21-IgM-) memory B cells decreased (both P < 0.001). In contrast, class-switched resting classical memory B cells (CD19+IgD-CD27+CD21+IgM-) increased (P < 0.001). In this area of seasonal malaria transmission, a one-year absence of detectable P. falciparum infection was not associated with changes in the prevalence or level of MSP-1(42) specific memory B cells, but was associated with major changes in overall memory B cell subsets.	[Ayieko, Cyrus; Jura, Walter G. Z. O.] Maseno Univ, Maseno, Kenya; [Maue, Alexander C.; Rochford, Rosemary] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Noland, Gregory S.; John, Chandy C.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Ayodo, George] Kenya Govt Med Res Ctr, Kisian, Kenya	Maseno University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Kenya Medical Research Institute	Ayieko, C (corresponding author), Maseno Univ, Maseno, Kenya.	cxayk@yahoo.com	John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411; Noland, Gregory/0000-0003-1332-4832	National Institute of Allergy and Infectious Diseases [U01 AI067854]; NIH/FIC [D43 TW008085]; FOGARTY INTERNATIONAL CENTER [D43TW008085] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA102667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	1. National Institute of Allergy and Infectious Diseases Grant U01 AI067854; 2. NIH/FIC D43 TW008085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asito AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-362; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Bockstal Viki, 2011, J Parasitol Res, V2011, P534697, DOI 10.1155/2011/534697; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; Carvalho LJM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-59; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Donati D, 2006, J IMMUNOL, V177, P3035, DOI 10.4049/jimmunol.177.5.3035; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; FACCHETTI F, 1995, J IMMUNOL, V154, P6624; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Gatto D, 2007, J IMMUNOL, V178, P67, DOI 10.4049/jimmunol.178.1.67; GREENWOOD BM, 1974, LANCET, V1, P435; Hirunpetcharat C, 1998, P NATL ACAD SCI USA, V95, P1715, DOI 10.1073/pnas.95.4.1715; Hui G, 2007, VACCINE, V25, P948, DOI 10.1016/j.vaccine.2006.08.041; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; John CC, 2005, T ROY SOC TROP MED H, V99, P780, DOI 10.1016/j.trstmh.2005.04.012; John CC, 2009, EMERG INFECT DIS, V15, P1917, DOI 10.3201/eid1512.090627; Kassa D, 2006, CLIN VACCINE IMMUNOL, V13, P376, DOI 10.1128/CVI.13.3.376-379.2006; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Korir JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-66; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Lang B, 2005, J INFECT DIS, V191, P117, DOI 10.1086/426512; Menge DM, 2008, AM J TROP MED HYG, V79, P173, DOI 10.4269/ajtmh.2008.79.173; Migot F, 1995, CLIN EXP IMMUNOL, V102, P529; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Ndungu FM, 2012, P NATL ACAD SCI USA, V109, P8247, DOI 10.1073/pnas.1200472109; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Stephens R, 2009, PARASITE IMMUNOL, V31, P20, DOI 10.1111/j.1365-3024.2008.01066.x; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Weiss GE, 2012, J IMMUNOL METHODS, V375, P68, DOI 10.1016/j.jim.2011.09.006; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Weller S, 2008, J EXP MED, V205, P1331, DOI 10.1084/jem.20071555; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510	51	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67230	10.1371/journal.pone.0067230	http://dx.doi.org/10.1371/journal.pone.0067230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826242	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000046
J	Garcia-Arriaza, J; Arnaez, P; Gomez, CE; Sorzano, COS; Esteban, M				Garcia-Arriaza, Juan; Arnaez, Pilar; Gomez, Carmen E.; Sorzano, Carlos Oscar S.; Esteban, Mariano			Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways	PLOS ONE			English	Article							T-CELL RESPONSES; HEALTHY HIV-1-UNINFECTED VOLUNTEERS; POXVIRUS VECTORS MVA; RNA HELICASE DDX3; HIV-1 INFECTION; PHASE-1 SAFETY; ANKARA; IMMUNOGENICITY; NYVAC; DNA	Poxvirus vector Modified Vaccinia Virus Ankara (MVA) expressing HIV-1 Env, Gag, Pol and Nef antigens from clade B (termed MVA-B) is a promising HIV/AIDS vaccine candidate, as confirmed from results obtained in a prophylactic phase I clinical trial in humans. To improve the immunogenicity elicited by MVA-B, we have generated and characterized the innate immune sensing and the in vivo immunogenicity profile of a vector with a double deletion in two vaccinia virus (VACV) genes (C6L and K7R) coding for inhibitors of interferon (IFN) signaling pathways. The innate immune signals elicited by MVA-B deletion mutants (MVA-B DC6L and MVA-B DC6L/K7R) in human macrophages and monocyte-derived dendritic cells (moDCs) showed an up-regulation of the expression of IFN-beta, IFN-alpha/beta-inducible genes, TNF-alpha, and other cytokines and chemokines. A DNA prime/MVA boost immunization protocol in mice revealed that these MVA-B deletion mutants were able to improve the magnitude and quality of HIV-1-specific CD4(+) and CD8(+) T cell adaptive and memory immune responses, which were mostly mediated by CD8(+) T cells of an effector phenotype, with MVA-B DC6L/K7R being the most immunogenic virus recombinant. CD4(+) T cell responses were mainly directed against Env, while GPN-specific CD8(+) T cell responses were induced preferentially by the MVA-B deletion mutants. Furthermore, antibody levels to Env in the memory phase were slightly enhanced by the MVA-B deletion mutants compared to the parental MVA-B. These findings revealed that double deletion of VACV genes that act blocking intracellularly the IFN signaling pathway confers an immunological benefit, inducing innate immune responses and increases in the magnitude, quality and durability of the HIV-1-specific T cell immune responses. Our observations highlighted the immunomodulatory role of the VACV genes C6L and K7R, and that targeting common pathways, like IRF3/IFN-beta signaling, could be a general strategy to improve the immunogenicity of poxvirus-based vaccine candidates.	[Garcia-Arriaza, Juan; Arnaez, Pilar; Gomez, Carmen E.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Esteban, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	S. Sorzano, Carlos Oscar/ABE-4884-2021; GARCIA-ARRIAZA, JUAN/Q-6243-2017; Esteban, Mariano/ABG-5375-2020; Gomez, Carmen Elena/K-1940-2014; Sorzano, Carlos Oscar S S./F-2639-2016	S. Sorzano, Carlos Oscar/0000-0002-9473-283X; GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Esteban, Mariano/0000-0003-0846-2827; Gomez, Carmen Elena/0000-0002-5414-7935; Sorzano, Carlos Oscar S S./0000-0002-9473-283X	 [SAF2008-02036];  [FIPSE-360731/09];  [Red Sida RD12/0017/0038]	; ; 	This investigation was supported by grants from Spain, SAF2008-02036, FIPSE-360731/09 and Red Sida RD12/0017/0038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Agy MB, 1995, VIROLOGY, V214, P379, DOI 10.1006/viro.1995.0047; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alcami A, 2002, J GEN VIROL, V83, P545, DOI 10.1099/0022-1317-83-3-545; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; BACAREGEN L, 1994, J VIROL, V68, P7559, DOI 10.1128/JVI.68.11.7559-7565.1994; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Cebere I, 2006, VACCINE, V24, P417, DOI 10.1016/j.vaccine.2005.08.041; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Climent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019644; COCCIA EM, 1994, J BIOL CHEM, V269, P23087; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Gomez CE, 2012, HUM VACC IMMUNOTHER, V8, P1192, DOI 10.4161/hv.20778; Gomez CE, 2012, J VIROL, V86, P5026, DOI 10.1128/JVI.06684-11; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; FERNIE BF, 1991, J VIROL, V65, P3968, DOI 10.1128/JVI.65.7.3968-3971.1991; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Garber DA, 2012, J VIROL, V86, P12605, DOI 10.1128/JVI.00246-12; Garber DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005445; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Gonzalez JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-59; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; HANSEN MB, 1992, CLIN EXP IMMUNOL, V88, P559; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Hughes R, 2012, REV MED VIROL, V22, P257, DOI 10.1002/rmv.1708; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674; Kutscher S, 2010, GENE THER, V17, P1372, DOI 10.1038/gt.2010.90; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; Northfield JW, 2007, J VIROL, V81, P5759, DOI 10.1128/JVI.00045-07; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Perdiguero B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048524; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Quakkelaar ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016819; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Sato Y, 2000, JPN CIRC J, V64, P321, DOI 10.1253/jcj.64.321; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; SHIRAZI Y, 1992, J VIROL, V66, P1321, DOI 10.1128/JVI.66.3.1321-1328.1992; Sumner RP, 2013, J GEN VIROL; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099	69	52	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66894	10.1371/journal.pone.0066894	http://dx.doi.org/10.1371/journal.pone.0066894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826170	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000017
J	Bhadra, T; Bhattacharyya, M; Feuerbach, L; Lengauer, T; Bandyopadhyay, S				Bhadra, Tapas; Bhattacharyya, Malay; Feuerbach, Lars; Lengauer, Thomas; Bandyopadhyay, Sanghamitra			DNA Methylation Patterns Facilitate the Identification of MicroRNA Transcription Start Sites: A Brain-Specific Study	PLOS ONE			English	Article							CPG-ISLANDS; TARGET RECOGNITION; MUTUAL INFORMATION; DATABASE; FEATURES; GENES	Predicting the transcription start sites (TSSs) of microRNAs (miRNAs) is important for understanding how these small RNA molecules, known to regulate translation and stability of protein-coding genes, are regulated themselves. Previous approaches are primarily based on genetic features, trained on TSSs of protein-coding genes, and have low prediction accuracy. Recently, a support vector machine based technique has been proposed for miRNA TSS prediction that uses known miRNA TSS for training the classifier along with a set of existing and novel CpG island based features. Current progress in epigenetics research has provided genomewide and tissue-specific reports about various phenotypic traits. We hypothesize that incorporating epigenetic characteristics into statistical models may lead to better prediction of primary transcripts of human miRNAs. In this paper, we have tested our hypothesis on brain-specific miRNAs by using epigenetic as well as genetic features to predict the primary transcripts. For this, we have used a sophisticated feature selection technique and a robust classification model. Our prediction model achieves an accuracy of more than 80% and establishes the potential of epigenetic analysis for in silico prediction of TSSs.	[Bhadra, Tapas; Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India; [Bhattacharyya, Malay] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India; [Feuerbach, Lars] German Canc Res Ctr, Eils Labs, Heidelberg, Germany; [Lengauer, Thomas] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, D-66123 Saarbrucken, Germany	Indian Statistical Institute; Indian Statistical Institute Kolkata; Kalyani University; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Bandyopadhyay, S (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, India.	sanghami@isical.ac.in	Bandyopadhyay, Sanghamitra/AAO-7010-2020; Bandyopadhyay, Sanghamitra/A-6597-2010; Bhadra, Tapas/ABG-5818-2021; Bhattacharyya, Malay/AAF-5036-2020; Bandyopadhyay, Sanghamitra/AAP-4578-2020	Bhadra, Tapas/0000-0001-8421-1072; Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; Bhattacharyya, Malay/0000-0001-7781-1264	Department of Science and Technology, India; Swarnajayanti project of the Department of Science and Technology, Government of India [DST/SJF/ET-02/2006-07]	Department of Science and Technology, India(Department of Science & Technology (India)); Swarnajayanti project of the Department of Science and Technology, Government of India	TB gratefully acknowledges Department of Science and Technology, India, for awarding him the INSPIRE Fellowship to carry out his PhD. research work. SB gratefully acknowledges the financial support from the Swarnajayanti project grant no. DST/SJF/ET-02/2006-07 of the Department of Science and Technology, Government of India. Part of the work was conducted when SB visited the Max Planck Institute for Informatics, Saarbrucken, Germany, in 2011-12 on a Humboldt Fellowship for Experienced Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Anand A, 2010, PATTERN RECOGN LETT, V31, P2097, DOI 10.1016/j.patrec.2009.10.008; Baer C, 2012, CANCER RES, V72, P3775, DOI 10.1158/0008-5472.CAN-12-0803; Bandyopadhyay S, COMMUNICATED; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya Malay, 2012, Genomics Proteomics & Bioinformatics, V10, P310, DOI 10.1016/j.gpb.2012.08.005; Bhattacharyya M, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1743; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Duda R.O., 2000, PATTERN CLASSIFICATI; Estevez PA, 2009, IEEE T NEURAL NETWOR, V20, P189, DOI 10.1109/TNN.2008.2005601; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; La The Vinh, 2010, 2010 10th IEEE/IPSJ International Symposium on Applications and the Internet (SAINT), P395, DOI 10.1109/SAINT.2010.50; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Novik K. L., 2002, Current Issues in Molecular Biology, V4, P111; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schaefer U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013934; Schubeler D, 2012, SCIENCE, V338, P756, DOI 10.1126/science.1227243; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; Vapnik V. N., 1995, NATURE STAT LAERNING; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Xin YR, 2012, NUCLEIC ACIDS RES, V40, pD1245, DOI 10.1093/nar/gkr1193; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhao ZM, 2009, BIOCHEM BIOPH RES CO, V382, P643, DOI 10.1016/j.bbrc.2009.03.076	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66722	10.1371/journal.pone.0066722	http://dx.doi.org/10.1371/journal.pone.0066722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826117	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400037
J	Oberbach, A; Jehmlich, N; Schlichting, N; Heinrich, M; Lehmann, S; Wirth, H; Till, H; Stolzenburg, JU; Volker, U; Adams, V; Neuhaus, J				Oberbach, Andreas; Jehmlich, Nico; Schlichting, Nadine; Heinrich, Marco; Lehmann, Stefanie; Wirth, Henry; Till, Holger; Stolzenburg, Jens-Uwe; Voelker, Uwe; Adams, Volker; Neuhaus, Jochen			Molecular Fingerprint of High Fat Diet Induced Urinary Bladder Metabolic Dysfunction in a Rat Model	PLOS ONE			English	Article							INSULIN-RESISTANCE; SIGNALING PATHWAYS; 14-3-3 PROTEINS; CALPAIN; HYPOXIA; MUSCLE; DEGRADATION; INVOLVEMENT; MECHANISMS; PROTEOMICS	Aims/hypothesis: Diabetic voiding dysfunction has been reported in epidemiological dimension of individuals with diabetes mellitus. Animal models might provide new insights into the molecular mechanisms of this dysfunction to facilitate early diagnosis and to identify new drug targets for therapeutic interventions. Methods: Thirty male Sprague-Dawley rats received either chow or high-fat diet for eleven weeks. Proteomic alterations were comparatively monitored in both groups to discover a molecular fingerprinting of the urinary bladder remodelling/dysfunction. Results were validated by ELISA, Western blotting and immunohistology. Results: In the proteome analysis 383 proteins were identified and canonical pathway analysis revealed a significant up-regulation of acute phase reaction, hypoxia, glycolysis, beta-oxidation, and proteins related to mitochondrial dysfunction in high-fat diet rats. In contrast, calcium signalling, cytoskeletal proteins, calpain, 14-3-3 eta and eNOS signalling were down-regulated in this group. Interestingly, we found increased ubiquitin proteasome activity in the high-fat diet group that might explain the significant down-regulation of eNOS, 14-3-3 eta and calpain. Conclusions/interpretation: Thus, high-fat diet is sufficient to induce significant remodelling of the urinary bladder and alterations of the molecular fingerprint. Our findings give new insights into obesity related bladder dysfunction and identified proteins that may indicate novel pathophysiological mechanisms and therefore constitute new drug targets.	[Oberbach, Andreas; Heinrich, Marco] Univ Leipzig, Dept Cardiac Surg, Ctr Heart, D-04109 Leipzig, Germany; [Oberbach, Andreas; Schlichting, Nadine; Heinrich, Marco; Lehmann, Stefanie] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany; [Jehmlich, Nico; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Dept Funct Gen, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Schlichting, Nadine] Univ Leipzig, Dept Pediat Surg, D-04109 Leipzig, Germany; [Wirth, Henry] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany; [Till, Holger] Graz Univ, Sch Med, Dept Pediat Surg, Graz, Austria; [Stolzenburg, Jens-Uwe; Neuhaus, Jochen] Univ Leipzig, Dept Urol, D-04109 Leipzig, Germany; [Adams, Volker] Univ Leipzig, Heart Ctr Leipzig, Dept Cardiol, D-04109 Leipzig, Germany	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; Ernst Moritz Arndt Universitat Greifswald; Leipzig University; Leipzig University; University of Graz; Leipzig University; Heart Center Leipzig GMBH; Leipzig University	Neuhaus, J (corresponding author), Univ Leipzig, Dept Urol, D-04109 Leipzig, Germany.	jochen.neuhaus@medizin.uni-leipzig.de	Jehmlich, Nico/D-9041-2015; Jehmlich, Nico/B-5403-2009	Jehmlich, Nico/0000-0002-5638-6868; Jehmlich, Nico/0000-0002-5638-6868; Loeffler-Wirth, Henry/0000-0001-8239-440X; Volker, Uwe/0000-0002-5689-3448	Bundesministerium fur Bildung und Forschung; IFB-Adipositas (University of Leipzig)	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); IFB-Adipositas (University of Leipzig)	Financial support was provided within the framework of the Bundesministerium fur Bildung und Forschung-funded GANI_MED project to NJ and UV and IFB-Adipositas (University of Leipzig) to AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa N, 2013, J UROLOGY, V189, P1580, DOI 10.1016/j.juro.2012.10.060; [Anonymous], 2012, ING PATHW AN IPA; ARAGON JJ, 1980, EUR J BIOCHEM, V110, P371, DOI 10.1111/j.1432-1033.1980.tb04877.x; Barendrecht MM, 2007, J PHARMACOL EXP THER, V322, P117, DOI 10.1124/jpet.106.119115; Birder LA, 2007, NAT CLIN PRACT UROL, V4, P46, DOI 10.1038/ncpuro0672; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; BURNETT AL, 1995, UROLOGY, V45, P1071, DOI 10.1016/S0090-4295(99)80136-8; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Christiaansen CE, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.12.041; Daneshgari F, 2006, SEMIN NEPHROL, V26, P182, DOI 10.1016/j.semnephrol.2005.09.009; Daneshgari F, 2009, J UROLOGY, V182, pS18, DOI 10.1016/j.juro.2009.08.070; Delobel J, 2012, J PROTEOMICS, V76, P181, DOI 10.1016/j.jprot.2012.05.004; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gasbarro G, 2010, AM J PHYSIOL-RENAL, V298, pF72, DOI 10.1152/ajprenal.00309.2009; Gomez Christopher S, 2011, Curr Urol Rep, V12, P419, DOI 10.1007/s11934-011-0214-0; Hagen Thilo, 2012, Biochem Res Int, V2012, P436981, DOI 10.1155/2012/436981; Hammarsten J, 2011, NAT REV UROL, V8, P483, DOI 10.1038/nrurol.2011.112; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Ho MH, 2007, CURR OPIN OBSTET GYN, V19, P469, DOI 10.1097/GCO.0b013e3282efe3b5; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jaskille A, 2004, J TRAUMA, V57, P262, DOI 10.1097/01.TA.0000133841.95455.73; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; KAPLAN SA, 1995, J UROLOGY, V153, P342, DOI 10.1097/00005392-199502000-00013; Kleppe R, 2011, SEMIN CELL DEV BIOL, V22, P713, DOI 10.1016/j.semcdb.2011.08.008; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lee WC, 2008, J UROLOGY, V179, P2470, DOI 10.1016/j.juro.2008.01.086; Lee WC, 2011, J UROLOGY, V186, P318, DOI 10.1016/j.juro.2011.03.037; Lee WC, 2009, J UROLOGY, V181, P198, DOI 10.1016/j.juro.2008.09.021; Leiria LO, 2013, J PHYSL, V9, P2259; Lin TL, 2012, TAIWAN J OBSTET GYNE, V51, P381, DOI 10.1016/j.tjog.2012.07.011; McGrother CW, 2006, AGE AGEING, V35, P16, DOI 10.1093/ageing/afi205; Oberbach A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041026; Oberbach A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010882; Poladia DP, 2003, DIABETES-METAB RES, V19, P313, DOI 10.1002/dmrr.385; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rahman NU, 2007, BJU INT, V100, P658, DOI 10.1111/j.1464-410X.2007.07069.x; Rasband W.S., 1997, IMAGEJ; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932; Romeis B, 1989, MIKROSKOPISCHE TECHN, P1; San Martin A, 2010, ANTIOXID REDOX SIGN, V12, P625, DOI 10.1089/ars.2009.2852; Smith IJ, 2007, EXP PHYSIOL, V92, P561, DOI 10.1113/expphysiol.2006.035790; Su YC, 2000, AM J PHYSIOL-LUNG C, V278, pL1204, DOI 10.1152/ajplung.2000.278.6.L1204; Thandavarayan RA, 2011, CELL PHYSIOL BIOCHEM, V28, P911, DOI 10.1159/000335805; Trayhurn Paul, 2008, Archives of Physiology and Biochemistry, V114, P267, DOI [10.1080/13813450802306602, 10.1080/13813450802306602 ]; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; Wang XM, 2010, J DIABETES COMPLICAT, V24, P121, DOI 10.1016/j.jdiacomp.2009.06.002; Wein Alan J, 2005, J Urol, V173, P910; Whitbeck C, 1999, PHARMACOLOGY, V59, P156, DOI 10.1159/000028316; Yohannes E, 2008, MOL CELL PROTEOMICS, V7, P1270, DOI 10.1074/mcp.M700563-MCP200; Yoon BC, 2012, DEV NEUROBIOL, V72, P600, DOI 10.1002/dneu.20955; Zhao Y, 1997, UROLOGY, V49, P293, DOI 10.1016/S0090-4295(96)00452-9	53	16	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66636	10.1371/journal.pone.0066636	http://dx.doi.org/10.1371/journal.pone.0066636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826106	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400026
J	Beckmann, N; Schafferer, L; Schrettl, M; Binder, U; Talasz, H; Lindner, H; Haas, H				Beckmann, Nicola; Schafferer, Lukas; Schrettl, Markus; Binder, Ulrike; Talasz, Heribert; Lindner, Herbert; Haas, Hubertus			Characterization of the Link between Ornithine, Arginine, Polyamine and Siderophore Metabolism in Aspergillus fumigatus	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; IRON-METABOLISM; NIDULANS; BIOSYNTHESIS; VIRULENCE; GENE; PATHOGENICITY; ACTIVATION; DEFICIENT	The opportunistic fungal pathogen Aspergillus fumigatus produces siderophores for uptake and storage of iron, which is essential for its virulence. The main precursor of siderophore biosynthesis (SB), ornithine, can be produced from glutamate in the mitochondria or by cytosolic hydrolysis of ornithine-derived arginine. Here, we studied the impact of mitochondrial versus cytosolic ornithine biosynthesis on SB by comparison of the arginine auxotrophic mutants Delta argEF and Delta argB, which lack and possess mitochondrial ornithine production, respectively. Deficiency in argEF (encoding acetylglutamate kinase and acetylglutamyl-phosphate-reductase), but not argB (encoding ornithine transcarbamoyl transferase) decreased (i) the cellular ornithine content, (ii) extra-and intracellular SB, (iii) growth under harsh iron starvation, (iv) resistance to the ornithine decarboxylase inhibitor eflornithine, and (v) virulence in the Galleria mellonella larvae model. These lines of evidence indicate that SB is mainly fueled by mitochondrial rather than cytosolic ornithine production and underline the role of SB in virulence. Ornithine content and SB of Delta argB increased with declining arginine supplementation indicating feedback-inhibition of mitochondrial ornithine biosynthesis by arginine. In contrast to SB, the arginine and polyamine contents were only mildly affected in Delta argEF, indicating prioritization of the latter two ornithine-consuming pathways over SB. These data highlight the metabolic differences between the two arginine auxotrophic mutants DargEF and Delta argB and demonstrate that supplementation of an auxotrophic mutant does not restore the wild type metabolism at the molecular level, a fact to be considered when working with auxotrophic mutants. Moreover, cross pathway control-mediating CpcA was found to influence the ornithine pool as well as biosynthesis of siderophores and polyamines.	[Beckmann, Nicola; Schafferer, Lukas; Schrettl, Markus; Haas, Hubertus] Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria; [Binder, Ulrike] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria; [Talasz, Heribert; Lindner, Herbert] Med Univ Innsbruck, Div Clin Biochem, Bioctr, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Haas, H (corresponding author), Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria.	hubertus.haas@i-med.ac.at	Binder, Ulrike/AAN-8364-2021	Binder, Ulrike/0000-0002-2160-2903; Beckmann, Nicola/0000-0003-4010-4384	Austrian Science Foundation (FWF) [P21643-B11]; Tyrolian Science Foundation [UNI-0404/752]; Austrian Science Fund (FWF) [P 21643] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Tyrolian Science Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation (FWF P21643-B11 to HH) and the Tyrolian Science Foundation (UNI-0404/752 to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ami R, 2010, ANTIMICROB AGENTS CH, V54, P1848, DOI 10.1128/AAC.01504-09; Berger H, 2008, MOL MICROBIOL, V69, P1385, DOI 10.1111/j.1365-2958.2008.06359.x; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Blatzer M, 2011, FUNGAL GENET BIOL, V48, P1027, DOI 10.1016/j.fgb.2011.07.009; BOONCHIRD C, 1991, MOL GEN GENET, V226, P154, DOI 10.1007/BF00273599; Brock M, 2010, EUKARYOT CELL; Chamilos G, 2010, MED MYCOL, V48, P506, DOI 10.3109/13693780903225813; COHN MS, 1980, J BACTERIOL, V142, P791, DOI 10.1128/JB.142.3.791-799.1980; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Frederick RE, 2011, J AM CHEM SOC, V133, P12338, DOI 10.1021/ja203397s; Haas H, 2003, APPL MICROBIOL BIOT, V62, P316, DOI 10.1007/s00253-003-1335-2; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HILGER F, 1973, J GEN MICROBIOL, V75, P33, DOI 10.1099/00221287-75-1-33; HINDE RW, 1986, J BIOL CHEM, V261, P5848; Hu RH, 1997, BIOCHEM J, V328, P307, DOI 10.1042/bj3280307; Jadoun J, 2004, CURR GENET, V45, P235, DOI 10.1007/s00294-003-0480-6; Jin Y, 2002, MOL MICROBIOL, V46, P801, DOI 10.1046/j.1365-2958.2002.03201.x; Joo YJ, 2011, EMBO J, V30, P859, DOI 10.1038/emboj.2010.332; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Klein RD, 1999, MICROBIOL-UK, V145, P301, DOI 10.1099/13500872-145-2-301; Krappmann S, 2004, MOL MICROBIOL, V52, P785, DOI 10.1111/j.1365-2958.2004.04015.x; MCDOUGALL KJ, 1977, A VAN LEEUW J MICROB, V43, P143, DOI 10.1007/BF00395669; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Ramot Y, 2010, EXP DERMATOL, V19, P784, DOI 10.1111/j.1600-0625.2010.01111.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Raymond-Bouchard I, 2012, EUKARYOT CELL, V11, P1333, DOI 10.1128/EC.00159-12; Sambrook J., 2002, MOL CLONING LAB MANU; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2010, PLOS PATHOG, V6, DOI DOI E1001124; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Wallner A, 2009, APPL ENVIRON MICROB, V75, P4194, DOI 10.1128/AEM.00479-09; WOLF EC, 1980, J BIOL CHEM, V255, P9189; WONGYAI S, 1989, J LIQ CHROMATOGR, V12, P2249	47	26	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67426	10.1371/journal.pone.0067426	http://dx.doi.org/10.1371/journal.pone.0067426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825660	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400184
J	Heine-Broring, RC; Winkels, RM; Botma, A; van Duijnhoven, FJB; Jung, AY; Kleibeuker, JH; Nagengast, FM; Vasen, HFA; Kampman, E				Heine-Broring, Renate C.; Winkels, Renate M.; Botma, Akke; van Duijnhoven, Franzel J. B.; Jung, Audrey Y.; Kleibeuker, Jan H.; Nagengast, Fokko M.; Vasen, Hans F. A.; Kampman, Ellen			Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study	PLOS ONE			English	Article							CANCER; VALIDITY; FAMILIES; VITAMIN; GENE; OMEGA-3-FATTY-ACIDS; QUESTIONNAIRE; POPULATION; PREVENTION; CARRIERS	Background and Aims: Individuals with Lynch syndrome have a high lifetime risk of developing colorectal tumors. In this prospective cohort study of individuals with Lynch syndrome, we examined associations between use of dietary supplements and occurrence of colorectal adenomas. Materials and Methods: Using data of 470 individuals with Lynch syndrome in a prospective cohort study, associations between dietary supplement use and colorectal adenoma risk were evaluated by calculating hazard ratios (HR) and 95% confidence intervals (CI) using cox regression models adjusted for age, sex, and number of colonoscopies during person time. Robust sandwich covariance estimation was used to account for dependency within families. Results: Of the 470 mismatch repair gene mutation carriers, 122 (26.0%) developed a colorectal adenoma during an overall median person time of 39.1 months. 40% of the study population used a dietary supplement. Use of any dietary supplement was not statistically significantly associated with colorectal adenoma risk (HR = 1.18; 95% CI 0.80-1.73). Multivitamin supplement use (HR = 1.15; 95% CI 0.72-1.84), vitamin C supplement use (HR = 1.57; 95% CI 0.93-2.63), calcium supplement use (HR = 0.69; 95% CI 0.25-1.92), and supplements containing fish oil (HR = 1.60; 95% CI 0.79-3.23) were also not associated with occurrence of colorectal adenomas. Conclusion: This prospective cohort study does not show inverse associations between dietary supplement use and occurrence of colorectal adenomas among individuals with Lynch syndrome. Further research is warranted to determine whether or not dietary supplement use is associated to colorectal adenoma and colorectal cancer risk in MMR gene mutation carriers.	[Heine-Broring, Renate C.; Winkels, Renate M.; Botma, Akke; van Duijnhoven, Franzel J. B.; Kampman, Ellen] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [van Duijnhoven, Franzel J. B.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Jung, Audrey Y.; Kampman, Ellen] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Kleibeuker, Jan H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol, Groningen, Netherlands; [Nagengast, Fokko M.] Radboud Univ Nijmegen, Dept Gastroenterol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vasen, Hans F. A.] Netherlands Fdn Detect Hereditary Tumours, Leiden, Netherlands; [Kampman, Ellen] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; University of Groningen; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Kampman, E (corresponding author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.	Ellen.Kampman@wur.nl	Winkels, Renate M./AAB-2619-2019; Kampman, E./H-8057-2014; van Duijnhoven, Fränzel/GWC-0059-2022	Winkels, Renate M./0000-0002-0376-8811; Vasen, Hans/0000-0003-2682-2603; Jung, Audrey/0000-0003-0875-6673	Dutch Cancer Society [UW-2005-3275]; Wereld Kanker Onderzoek Fonds; World Cancer Research Fund International (WCRF International)	Dutch Cancer Society(KWF Kankerbestrijding); Wereld Kanker Onderzoek Fonds; World Cancer Research Fund International (WCRF International)	This work was financially supported by the Dutch Cancer Society (grant UW-2005-3275); Wereld Kanker Onderzoek Fonds (WCRF NL); and World Cancer Research Fund International (WCRF International). Websites: (http://dcs.kwfkankerbestrijding.nl/Pages/Home.aspx.) (http://www.wcrf.nl/). (http://www.wcrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2008, COL CANC FACTS FIG 2; [Anonymous], 2008, ERF DARMK LAND RICHT; Barrow E, 2008, CLIN GENET, V74, P233, DOI 10.1111/j.1399-0004.2008.01035.x; Bjelakovic G, 2006, ALIMENT PHARM THER, V24, P281, DOI 10.1111/j.1365-2036.2006.02970.x; BLOCK G, 1994, AM J CLIN NUTR, V59, p232S, DOI 10.1093/ajcn/59.1.232S; Botma A, 2011, GASTROENTEROLOGY; Botma A, 2013, CANCER-AM CANCER SOC, V119, P512, DOI 10.1002/cncr.27726; Botma A, 2010, J CLIN ONCOL, V28, P4346, DOI 10.1200/JCO.2010.28.0453; Calviello G, 2007, CURR MED CHEM, V14, P3059, DOI 10.2174/092986707782793934; Carroll C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-29; CATS A, 1995, JNCI-J NATL CANCER I, V87, P598, DOI 10.1093/jnci/87.8.598; De Jong AE, 2004, GASTROENTEROLOGY, V126, P42, DOI 10.1053/j.gastro.2003.10.043; de la Chapelle A, 2005, FAM CANCER, V4, P233, DOI 10.1007/s10689-004-5811-3; Diergaarde B, 2007, CLIN GASTROENTEROL H, V5, P736, DOI 10.1016/j.cgh.2007.02.019; Ervin RB, 1999, VITAL HLTH STAT, V11, p[i, 1]; FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489; Figueiredo JC, 2011, INT J CANCER, V129, P192, DOI 10.1002/ijc.25872; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Kempers MJE, 2011, LANCET ONCOL, V12, P49, DOI 10.1016/S1470-2045(10)70265-5; Kuiper RP, 2011, HUM MUTAT, V32, P407, DOI 10.1002/humu.21446; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; McGinnis JM, 2007, AM J CLIN NUTR, V85, p257S; Neugut AI, 1996, CANCER-AM CANCER SOC, V78, P723, DOI 10.1002/(SICI)1097-0142(19960815)78:4<723::AID-CNCR5>3.0.CO;2-F; Papaioannou D, 2011, COLORECTAL DIS, V13, P1085, DOI 10.1111/j.1463-1318.2010.02289.x; Patterson RE, 1998, AM J EPIDEMIOL, V148, P643, DOI 10.1093/aje/148.7.643; POLS MA, 1995, INT J EPIDEMIOL, V24, P381, DOI 10.1093/ije/24.2.381; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; Reddy BS, 2004, INT J CANCER, V112, P1, DOI 10.1002/ijc.20320; Rijcken FEM, 2002, GUT, V50, P382, DOI 10.1136/gut.50.3.382; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Satia-Abouta J, 2003, AM J EPIDEMIOL, V157, P944, DOI 10.1093/aje/kwg039; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Signaleringscommissie Kanker van KWF Kankerbestrijding, 2007, SIGN KANS KANK BEW C; van Rossum CTM., 2011, 3500500062011 NAT I; Vasen HFA, 2010, GASTROENTEROLOGY, V138, P2300, DOI 10.1053/j.gastro.2010.02.053; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Weingarten MA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003548.pub3	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66819	10.1371/journal.pone.0066819	http://dx.doi.org/10.1371/journal.pone.0066819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825568	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400161
J	Liu, S; Ma, CY; Ren, WD; Yang, J; Zhang, Y; Li, S; Cheng, YB				Liu, Shuang; Ma, Chunyan; Ren, Weidong; Yang, Jun; Zhang, Yan; Li, Sha; Cheng, Yanbin			Left Atrial Systolic and Diastolic Dysfunction in Patients with Chronic Constrictive Pericarditis: A Study Using Speckle Tracking and Conventional Echocardiography	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; TISSUE CHARACTERIZATION; MYOCARDIAL-INFARCTION; FILLING PRESSURES; PUMP FUNCTION; STRAIN-RATE; SIZE; FIBRILLATION; RELAXATION; RECOMMENDATIONS	Background: Left atrial (LA) function plays an important role in the maintenance of cardiac output, however, in patients with constrictive pericarditis (CP), whether pericardial restriction and adhesion can lead to LA dysfunction, and the characteristics of LA function remain unclear. The aim of the study is to compare the left atrial (LA) function of patients with CP to that of healthy study participants using speckle tracking echocardiography (STE) and conventional echocardiography. Methods and Results: Thirty patients with CP and 30 healthy volunteers (controls) were enrolled in the study. The underlying cause of CP was viral pericarditis in 24 (80%) patients and unknown in 6 (20%) patients. The LA maximum volume (Vmax), LA minimal volume (Vmin), and LA volume before atrial contraction (Vpre-a) were measured using biplane modified Simpson's method. The LA expansion index (LA reservoir function) was determined as follows: ([LAVmax - LAVmin]/LAVmin) x 100. The passive emptying index (LA conduit function) was calculated as follows: ([LAVmax - LAVpre-a]/LAVmax) x 100, and the active emptying index (booster pump function) was calculated as follows: ([LAVpre-a - LAVmin]/LAVpre-a) x 100. All the patients underwent two-dimensional STE. The LA global systolic strain (S), systolic strain rate (SrS), early diastolic strain rate (SrE) and late diastolic strain rate (SrA) were measured. The LA expansion index, passive emptying index, the active emptying index and the LA global S, SrS, SrE, SrA were found to be significantly lower in patients with CP than in the control participants (P < 0.001). LA function was correlated with the early diastolic velocity of the lateral mitral annulus (P < 0.05). Conclusions: Although left ventricular systolic function was preserved in patients with CP, the LA reservoir, conduit, and booster functions were impaired. Pericardial restriction and impairment of the LA myocardium may play an important role in the reduction of LA function in patients with CP.	[Liu, Shuang; Ren, Weidong] China Med Univ, Dept Ultrasound, Shengjing Hosp, Shenyang, Peoples R China; [Liu, Shuang; Ma, Chunyan; Yang, Jun; Zhang, Yan; Li, Sha; Cheng, Yanbin] China Med Univ, Dept Cardiovasc Funct, Affiliated Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University	Ren, WD (corresponding author), China Med Univ, Dept Ultrasound, Shengjing Hosp, Shenyang, Peoples R China.	renweidong01@yahoo.com.cn	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454				Antoni ML, 2011, J AM SOC ECHOCARDIOG, V24, P1126, DOI 10.1016/j.echo.2011.06.017; Anwar AM, 2007, HEART, V93, P1393, DOI 10.1136/hrt.2006.099366; Barbier P, 1999, CIRCULATION, V100, P427, DOI 10.1161/01.CIR.100.4.427; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Bertini M, 2010, CIRC-CARDIOVASC IMAG, V3, P86, DOI 10.1161/CIRCIMAGING.109.882324; Blondheim DS, 2005, AM J CARDIOL, V96, P457, DOI 10.1016/j.amjcard.2005.03.101; Cameli M, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-6; D'Andrea A, 2008, BRIT J SPORT MED, V42, P696, DOI 10.1136/bjsm.2007.041210; Dernellis JM, 1996, J HUM HYPERTENS, V10, P789; Dernellis JM, 1998, AM J CARDIOL, V81, P1138, DOI 10.1016/S0002-9149(98)00134-9; Di Salvo G, 2009, EUR J ECHOCARDIOGR, V10, P256, DOI 10.1093/ejechocard/jen218; Dittrich HC, 1999, AM HEART J, V137, P494, DOI 10.1016/S0002-8703(99)70498-9; Gabrielli L, 2011, ECHOCARDIOGR-J CARD, V28, P1104, DOI 10.1111/j.1540-8175.2011.01518.x; Ha JW, 2001, CIRCULATION, V104, P976, DOI 10.1161/hc3401.095705; Hiroyama N, 1982, J Cardiogr, V12, P415; Kizer JR, 2006, AM HEART J, V151, P412, DOI 10.1016/j.ahj.2005.04.031; Kosmala W, 2013, HEART, V99, P320, DOI 10.1136/heartjnl-2012-303329; Kuppahally SS, 2010, CIRC-CARDIOVASC IMAG, V3, P231, DOI 10.1161/CIRCIMAGING.109.865683; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee HH, 2013, ULTRASOUND MED BIOL, V39, P54, DOI 10.1016/j.ultrasmedbio.2012.08.023; Leung DY, 2008, AM HEART J, V156, P1056, DOI 10.1016/j.ahj.2008.07.021; MATSUZAKI M, 1991, AM J CARDIOL, V67, P1121, DOI 10.1016/0002-9149(91)90876-M; Mizuno R, 2001, CARDIOLOGY, V96, P16, DOI 10.1159/000047381; Mondillo S, 2011, J AM SOC ECHOCARDIOG, V24, P898, DOI 10.1016/j.echo.2011.04.014; Morris DA, 2011, J AM SOC ECHOCARDIOG, V24, P651, DOI 10.1016/j.echo.2011.02.004; Nagueh SF, 1998, CIRCULATION, V98, P1644, DOI 10.1161/01.CIR.98.16.1644; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nikitin N P, 2003, Eur J Echocardiogr, V4, P36, DOI 10.1053/euje.2002.0611; Okamatsu K, 2009, J AM SOC ECHOCARDIOG, V22, P70, DOI 10.1016/j.echo.2008.11.006; Ommen SR, 2000, CIRCULATION, V102, P1788; Paraskevaidis IA, 2012, INT J CARDIOL, V157, P31, DOI 10.1016/j.ijcard.2010.11.007; PICANO E, 1990, CIRCULATION, V81, P58, DOI 10.1161/01.CIR.81.1.58; Qirko S, 1996, ARCH MAL COEUR VAISS, V89, P1003; Quinones MA, 2000, J AM COLL CARDIOL, V35, P1237, DOI 10.1016/S0735-1097(00)00511-8; Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P29, DOI 10.1016/j.jcmg.2007.10.006; Spencer KT, 2001, HEART, V85, P272, DOI 10.1136/heart.85.3.272; Vianna-Pinton R, 2009, J AM SOC ECHOCARDIOG, V22, P299, DOI 10.1016/j.echo.2008.12.017; Yan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051204; Yiu KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036115; Yu CM, 2007, J AM COLL CARDIOL, V49, P1903, DOI 10.1016/j.jacc.2007.01.078	41	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68718	10.1371/journal.pone.0068718	http://dx.doi.org/10.1371/journal.pone.0068718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825701	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400200
J	Pavlidi, N; Dermauw, W; Rombauts, S; Chrisargiris, A; Van Leeuwen, T; Vontas, J				Pavlidi, Nena; Dermauw, Wannes; Rombauts, Stephane; Chrisargiris, Antonis; Van Leeuwen, Thomas; Vontas, John			Analysis of the Olive Fruit Fly Bactrocera oleae Transcriptome and Phylogenetic Classification of the Major Detoxification Gene Families	PLOS ONE			English	Article							RESISTANCE; ANNOTATION; ABC; ACETYLCHOLINESTERASE; IDENTIFICATION; EXPRESSION; ENZYMES	The olive fruit fly Bactrocera oleae has a unique ability to cope with olive flesh, and is the most destructive pest of olives worldwide. Its control has been largely based on the use of chemical insecticides, however, the selection of insecticide resistance against several insecticides has evolved. The study of detoxification mechanisms, which allow the olive fruit fly to defend against insecticides, and/or phytotoxins possibly present in the mesocarp, has been hampered by the lack of genomic information in this species. In the NCBI database less than 1,000 nucleotide sequences have been deposited, with less than 10 detoxification gene homologues in total. We used 454 pyrosequencing to produce, for the first time, a large transcriptome dataset for B. oleae. A total of 482,790 reads were assembled into 14,204 contigs. More than 60% of those contigs (8,630) were larger than 500 base pairs, and almost half of them matched with genes of the order of the Diptera. Analysis of the Gene Ontology (GO) distribution of unique contigs, suggests that, compared to other insects, the assembly is broadly representative for the B. oleae transcriptome. Furthermore, the transcriptome was found to contain 55 P450, 43 GST-, 15 CCE- and 18 ABC transporter-genes. Several of those detoxification genes, may putatively be involved in the ability of the olive fruit fly to deal with xenobiotics, such as plant phytotoxins and insecticides. In summary, our study has generated new data and genomic resources, which will substantially facilitate molecular studies in B. oleae, including elucidation of detoxification mechanisms of xenobiotic, as well as other important aspects of olive fruit fly biology.	[Pavlidi, Nena; Chrisargiris, Antonis; Vontas, John] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Dermauw, Wannes; Van Leeuwen, Thomas] Univ Ghent, Dept Crop Protect, B-9000 Ghent, Belgium; [Rombauts, Stephane] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	University of Crete; Ghent University; Ghent University	Vontas, J (corresponding author), Univ Crete, Dept Biol, Iraklion, Crete, Greece.	vontas@biology.uoc.gr	Rombauts, Stephane M/D-7640-2014; Vontas, John/X-5112-2018; Rombauts, Stephane/P-2420-2019; Van Leeuwen, Thomas/H-5036-2013; Dermauw, Wannes/H-1583-2015	Rombauts, Stephane M/0000-0002-3985-4981; Vontas, John/0000-0002-8704-2574; Rombauts, Stephane/0000-0002-3985-4981; Dermauw, Wannes/0000-0003-4612-8969; Van Leeuwen, Thomas/0000-0003-4651-830X; Chrysargyris, Antonios/0000-0002-1067-7977	'HRAKLEITOS II' project; Operational Programme 'Education and Life Long Learning'; European Social Found and National Resources; Greek Ministry of Rural Development and Food	'HRAKLEITOS II' project; Operational Programme 'Education and Life Long Learning'; European Social Found and National Resources; Greek Ministry of Rural Development and Food	Part of this research was supported by 'HRAKLEITOS II' project, Operational Programme 'Education and Life Long Learning', which is co-funded by the European Social Found and National Resources and by the Greek Ministry of Rural Development and Food. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ant T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-51; Berenbaum MR, 2002, J CHEM ECOL, V28, P873, DOI 10.1023/A:1015260931034; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corrado G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-86; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dermauw W, 2012, P NATL ACAD SCI USA, V110, P393; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; HAGEN KS, 1966, NATURE, V209, P423, DOI 10.1038/209423a0; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Hsu JC, 2012, INSECT BIOCHEM MOLEC, V42, P806, DOI 10.1016/j.ibmb.2012.07.010; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kakani EG, 2008, INSECT BIOCHEM MOLEC, V38, P781, DOI 10.1016/j.ibmb.2008.05.004; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu FS, 2012, MOL BIOL REP, V39, P1927, DOI 10.1007/s11033-011-0939-3; Liu SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-491; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Oakeshott J.G., 2005, COMPREHENSIVE MOL IN, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Snyder MJ, 1996, METHOD ENZYMOL, V272, P304, DOI 10.1016/S0076-6879(96)72036-0; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tsoumani KT, 2011, MOL GENET GENOMICS, V285, P33, DOI 10.1007/s00438-010-0583-y; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Vontas JG, 2002, INSECT MOL BIOL, V11, P329, DOI 10.1046/j.1365-2583.2002.00343.x; Vontas J, 2011, PESTIC BIOCHEM PHYS, V100, P199, DOI 10.1016/j.pestbp.2011.04.004	43	34	38	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66533	10.1371/journal.pone.0066533	http://dx.doi.org/10.1371/journal.pone.0066533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824998	Green Published, gold			2022-12-27	WOS:000320576400123
J	Hijbeek, R; Koedam, N; Khan, MNI; Kairo, JG; Schoukens, J; Dahdouh-Guebas, F				Hijbeek, Renske; Koedam, Nico; Khan, Md Nabiul Islam; Kairo, James Gitundu; Schoukens, Johan; Dahdouh-Guebas, Farid			An Evaluation of Plotless Sampling Using Vegetation Simulations and Field Data from a Mangrove Forest	PLOS ONE			English	Article							MONTE-CARLO-SIMULATION; DENSITY ESTIMATORS	In vegetation science and forest management, tree density is often used as a variable. To determine the value of this variable, reliable field methods are necessary. When vegetation is sparse or not easily accessible, the use of sample plots is not feasible in the field. Therefore, plotless methods, like the Point Centred Quarter Method, are often used as an alternative. In this study we investigate the accuracy of different plotless sampling methods. To this end, tree densities of a mangrove forest were determined and compared with estimates provided by several plotless methods. None of these methods proved accurate across all field sites with mean underestimations up to 97% and mean overestimations up to 53% in the field. Applying the methods to different vegetation patterns shows that when random spatial distributions were used the true density was included within the 95% confidence limits of all the plotless methods tested. It was also found that, besides aggregation and regularity, density trends often found in mangroves contribute to the unreliability. This outcome raises questions about the use of plotless sampling in forest monitoring and management, as well as for estimates of density-based carbon sequestration. We give recommendations to minimize errors in vegetation surveys and recommendations for further in-depth research.	[Hijbeek, Renske; Koedam, Nico; Khan, Md Nabiul Islam; Dahdouh-Guebas, Farid] Vrije Univ Brussel, Lab Plant Biol & Nat Management, Brussels, Belgium; [Hijbeek, Renske] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Kairo, James Gitundu] Mombasa Res Ctr, Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Schoukens, Johan] Vrije Univ Brussel, Dept Fundamental Elect & Instrumentat, Brussels, Belgium; [Khan, Md Nabiul Islam; Dahdouh-Guebas, Farid] Univ Libre Brussels, Lab Syst Ecol & Resource Management, Brussels, Belgium	Vrije Universiteit Brussel; Wageningen University & Research; Vrije Universiteit Brussel; Universite Libre de Bruxelles	Hijbeek, R (corresponding author), Vrije Univ Brussel, Lab Plant Biol & Nat Management, Brussels, Belgium.	renske.hijbeek@wur.nl	Khan, Nabiul I/O-6775-2015; Khan, Md Nabiul Islam Islam/AAW-7861-2021; Khan, Nabiul Islam/K-3799-2015	Khan, Md Nabiul Islam Islam/0000-0002-1536-8954; DAHDOUH-GUEBAS, Farid/0000-0002-5906-8996; Schoukens, Johan/0000-0003-0492-6137; James, Kairo/0000-0001-8325-2550	Vlaamse Interuniversitaire Raad (VLIR-UOS); Fonds Nationales de la Recherche Scientifique	Vlaamse Interuniversitaire Raad (VLIR-UOS); Fonds Nationales de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	This study was financially supported by the Vlaamse Interuniversitaire Raad (VLIR-UOS) and Fonds Nationales de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman SM, 2010, MANGROVE REFERENCE D; Bouldin J, 2008, J BIOGEOGR, V35, P2000, DOI 10.1111/j.1365-2699.2008.01940.x; BYTH K, 1982, BIOMETRICS, V38, P127, DOI 10.2307/2530295; Cho-Ricketts L, 2011, TECHNICAL REPORT VAL; Cintron G., 1984, MANGROVE ECOSYSTEM R; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Dahdouh-Guebas F, 2011, J EXP MAR BIOL ECOL, V399, P188, DOI 10.1016/j.jembe.2010.11.012; Dahdouh-Guebas F, 2004, HUMAN IMPACTED MANGR; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; ENGEMAN RM, 1994, ECOLOGY, V75, P1769, DOI 10.2307/1939636; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; Hijbeek R, 2013, ADDITIONAL SUPORTING; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Matthijs S., 1999, Mangroves and Salt Marshes, V3, P243, DOI 10.1023/A:1009971023277; Minang P.A., 2010, REDD COPENHAGEN WAY; Mitchell K., 2007, QUANTITATIVE ANAL PO; Nagendra H, 2012, ECOL INDIC; PARKER KR, 1979, J WILDLIFE MANAGE, V43, P484, DOI 10.2307/3800359; Piou C, 2006, BIOTROPICA, V38, P365, DOI 10.1111/j.1744-7429.2006.00156.x; POLLARD JH, 1971, BIOMETRICS, V27, P991, DOI 10.2307/2528833; Saenger P, 2013, MANGROVE ECOLOGY SIL; Sales JBL., 2009, B MUSEU PARAENSE EM, V4, P27, DOI [10.46357/bcnaturais.v4i1.668, DOI 10.46357/BCNATURAIS.V4I1.668]; Satyanarayana B., 2001, 22 AS C REM SENS SIN; Steinke I, 2006, CAN J BOT, V84, P421, DOI 10.1139/B05-135; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Unifiji, 2019, FIJ MANGR EXT UPD; Verheyden A, 2002, HIGH RESOLUTION VEGE, V4, P113; White Neil A., 2008, BMC Ecology, V8, P6, DOI 10.1186/1472-6785-8-6	31	16	17	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67201	10.1371/journal.pone.0067201	http://dx.doi.org/10.1371/journal.pone.0067201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826233	Green Submitted, gold, Green Published			2022-12-27	WOS:000321150000043
J	Mitani, Y; Roberts, DB; Fatani, H; Weber, RS; Kies, MS; Lippman, SM; El-Naggar, AK				Mitani, Yoshitsugu; Roberts, Dianna B.; Fatani, Hanadi; Weber, Randal S.; Kies, Merrill S.; Lippman, Scott M.; El-Naggar, Adel K.			MicroRNA Profiling of Salivary Adenoid Cystic Carcinoma: Association of miR-17-92 Upregulation with Poor Outcome	PLOS ONE			English	Article							BREAST-CANCER; C-MYB; EXPRESSION; GENES; CELL; CLUSTER; HEAD; NECK; FUSION; MICROARRAYS	Background: Salivary adenoid cystic carcinoma (ACC) is a rare relentlessly progressive malignant tumor. The molecular events associated with ACC tumorigenesis are poorly understood. Variable microRNAs (miRNA) have been correlated with tumorigenesis of several solid tumors but not in ACC. To investigate the association of miRNAs with the development and/or progression of ACC, we performed a comparative analysis of primary ACC specimens and matched normal samples and a pooled salivary gland standard and correlated the results with clinicopathologic factors and validated selected miRNAs in a separate set of 30 tumors. Methods: MiRNA array platform was used for the identification of target miRNAs and the data was subjected to informatics and statistical interrelations. The results were also collected with the MYB-NFIB fusion status and the clinicopathologic features. Results: Differentially dysregulated miRNAs in ACC were characterized in comparison to normal expression. No significant differences in miRNA expression were found between the MYB-NFIB fusion positive and -negative ACCs. Of the highly dysregulated miRNA in ACC, overexpression of the miR-17 and miR-20a were significantly associated with poor outcome in the screening and validation sets. Conclusion: Our study indicates that the upregulation of miR-17-92 may play a role in the biology of ACC and could be potentially targeted in future therapeutic studies.	[Mitani, Yoshitsugu; Fatani, Hanadi; El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Roberts, Dianna B.; Weber, Randal S.; El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Kies, Merrill S.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Lippman, Scott M.] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	El-Naggar, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	anaggar@mdanderson.org	Mitani, Yoshitsugu/ABA-2736-2021	Mitani, Yoshitsugu/0000-0002-8661-4702	NIH National Institute of Dental and Craniofacial Research; NIH Office of Rare Diseases Research [U01DE019765]; Head and Neck SPORE program [P50 CA097007]; Kenneth D. Muller professorship; NCI [CA-16672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA097007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE019765] Funding Source: NIH RePORTER	NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH Office of Rare Diseases Research; Head and Neck SPORE program; Kenneth D. Muller professorship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study is supported in part by the NIH National Institute of Dental and Craniofacial Research and the NIH Office of Rare Diseases Research grant number U01DE019765, the Head and Neck SPORE program grant number P50 CA097007, The Kenneth D. Muller professorship and an NCI CA-16672 grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2011, CLIN CANCER RES, V17, P4772, DOI 10.1158/1078-0432.CCR-11-0242; Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BATSAKIS JG, 1990, ANN OTO RHINOL LARYN, V99, P1007, DOI 10.1177/000348949009901215; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; CHOMETTE G, 1982, VIRCHOWS ARCH A, V395, P289, DOI 10.1007/BF00429355; De Preter K, 2011, CLIN CANCER RES, V17, P7684, DOI 10.1158/1078-0432.CCR-11-0610; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; El Naggar AK, 2005, WHO CLASSIFICATION T, P221; Fordice J, 1999, ARCH OTOLARYNGOL, V125, P149, DOI 10.1001/archotol.125.2.149; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Haflidadottir BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011574; HARPER ME, 1983, NATURE, V304, P169, DOI 10.1038/304169a0; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Huang GX, 2012, CANCER RES, V72, P908, DOI 10.1158/0008-5472.CAN-11-1460; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jevnaker AM, 2011, J CELL PHYSIOL, V226, P2257, DOI 10.1002/jcp.22562; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mi SL, 2010, P NATL ACAD SCI USA, V107, P3710, DOI 10.1073/pnas.0914900107; Mitani Y, 2011, CLIN CANCER RES, V17, P7003, DOI 10.1158/1078-0432.CCR-11-1870; Mitani Y, 2010, CLIN CANCER RES, V16, P4722, DOI 10.1158/1078-0432.CCR-10-0463; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rao PH, 2008, CLIN CANCER RES, V14, P5181, DOI 10.1158/1078-0432.CCR-08-0158; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saito M, 2011, CLIN CANCER RES, V17, P1875, DOI 10.1158/1078-0432.CCR-10-2961; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; SPIRO RH, 1986, HEAD NECK SURG, V8, P177, DOI 10.1002/hed.2890080309; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tran N, 2010, HEAD NECK-J SCI SPEC, V32, P1099, DOI 10.1002/hed.21356; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ujifuku K, 2010, CANCER LETT, V296, P241, DOI 10.1016/j.canlet.2010.04.013; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wald AI, 2011, HEAD NECK-J SCI SPEC, V33, P504, DOI 10.1002/hed.21475; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298	55	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66778	10.1371/journal.pone.0066778	http://dx.doi.org/10.1371/journal.pone.0066778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825564	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000026
J	Ng, TFF; Kondov, NO; Hayashimoto, N; Uchida, R; Cha, Y; Beyer, AI; Wong, W; Pesavento, PA; Suemizu, H; Muench, MO; Delwart, E				Ng, Terry Fei Fan; Kondov, Nikola O.; Hayashimoto, Nobuhito; Uchida, Ritsuki; Cha, Yunhee; Beyer, Ashley I.; Wong, Walt; Pesavento, Patricia A.; Suemizu, Hiroshi; Muench, Marcus O.; Delwart, Eric			Identification of an Astrovirus Commonly Infecting Laboratory Mice in the US and Japan	PLOS ONE			English	Article							SCID-HU MOUSE; ENTERIC VIRUSES; IMMUNE-SYSTEM; HIV-INFECTION; CORD BLOOD; CELLS; ENGRAFTMENT; MODEL; TRANSPLANTATION; REPOPULATION	Mice (Mus musculus) are the most commonly used laboratory animals. Viral metagenomics on tissues of immunodeficient mice revealed sequences of a novel mammalian astrovirus. Using PCR, we screened mice from 4 breeders, 4 pharmaceutical companies, 14 research institutes and 30 universities in the US and Japan. Mice from one US breeder tested positive while none from Japanese breeders were positive for MuAstV. Mice in over half of the universities (19/30), institutes (7/14) and pharmaceutical animal facilities (2/4) investigated revealed the presence of MuAstV. Nine mice strains tested positive including both immunodeficient strains (NSG, NOD-SCID, NSG-3GS, C57BL6-Timp-3(-/-), and uPA-NOG) and immunocompetent strains (B6J, ICR, Bash2, BALB/c). Our data indicates that MuAstV has a wide geographical, institutional and host strain distribution. Comparison of the MuAstV RdRp sequences showed numerous mutations indicating ongoing viral divergence in different facilities. This study demonstrates the need for metagenomic screening of laboratory animals to identify adventitious infections that may affect experimental outcomes.	[Ng, Terry Fei Fan; Kondov, Nikola O.; Cha, Yunhee; Beyer, Ashley I.; Wong, Walt; Muench, Marcus O.; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Ng, Terry Fei Fan; Muench, Marcus O.; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Hayashimoto, Nobuhito; Uchida, Ritsuki] Cent Inst Expt Anim, ICLAS Monitoring Ctr, Kawasaki, Kanagawa, Japan; [Pesavento, Patricia A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Suemizu, Hiroshi] Cent Inst Expt Anim, Biomed Res Dept, Kawasaki, Kanagawa, Japan	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California Davis	Muench, MO (corresponding author), Blood Syst Res Inst, San Francisco, CA USA.	mmuench@bloodsystems.org; edelwart@bloodsystems.org	Muench, Marcus O./C-5025-2009; Ng, Terry Fei Fan/H-5305-2019	Muench, Marcus O./0000-0001-8946-6605; Ng, Terry Fei Fan/0000-0002-4815-8697; Delwart, Eric/0000-0002-6296-4484	Blood Systems Inc.; National Institutes of Health [R01HL105770, P01DK088760]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK088760] Funding Source: NIH RePORTER	Blood Systems Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Blood Systems Inc., and grants from the National Institutes of Health: R01HL105770 (ED) and P01DK088760 (MOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani M, 2012, INVEST NEW DRUG, V30, P1331, DOI 10.1007/s10637-011-9692-7; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Baumans V., 2007, WELFARE LAB ANIMALS, P119; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Cohen-Haguenauer O, 2006, P NATL ACAD SCI USA, V103, P2340, DOI 10.1073/pnas.0510613103; Coppo P, 2000, ANN HEMATOL, V79, P43, DOI 10.1007/s002770050008; Cunliffe NA, 2002, J MED VIROL, V67, P563, DOI 10.1002/jmv.10139; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Dennehy PH, 2001, J INFECT DIS, V184, P10, DOI 10.1086/321007; Farkas T, 2012, VIRUS GENES, V45, P518, DOI 10.1007/s11262-012-0803-0; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Gray J, 2005, J MED VIROL, V23, P377; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; Jiang HB, 2013, VIROLOGY, V436, P8, DOI 10.1016/j.virol.2012.09.040; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawano N, 2005, LEUKEMIA, V19, P1384, DOI 10.1038/sj.leu.2403829; Lapenta C, 2005, INT IMMUNOL, V17, P469, DOI 10.1093/intimm/dxh226; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; MCCUNE J, 1991, ANNU REV IMMUNOL, V9, P399, DOI 10.1146/annurev.iy.09.040191.002151; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Ng TFF, 2009, J GEN VIROL, V90, P1256, DOI 10.1099/vir.0.008987-0; Ng TFF, 2012, J VIROLOGY; Padalino MA, 2012, EUR J CARDIO-THORAC, V42, pE128, DOI 10.1093/ejcts/ezs462; Peters V, 2012, EXP CLIN ENDOCR DIAB, V120, P191, DOI 10.1055/s-0032-1304569; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Rozen S, 2000, Methods Mol Biol, V132, P365; Schoeberlein A, 2004, STEM CELLS DEV, V13, P677, DOI 10.1089/scd.2004.13.677; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12	44	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66937	10.1371/journal.pone.0066937	http://dx.doi.org/10.1371/journal.pone.0066937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825590	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000047
J	Long, C; Jiang, L; Wei, F; Ma, C; Zhou, H; Yang, SM; Liu, XG; Liu, ZJ				Long, Cheng; Jiang, Liang; Wei, Feng; Ma, Chuan; Zhou, Hua; Yang, Shaomin; Liu, Xiaoguang; Liu, Zhongjun			Integrated miRNA-mRNA Analysis Revealing the Potential Roles of miRNAs in Chordomas	PLOS ONE			English	Article							NUCLEUS PULPOSUS; GROWTH-FACTOR; EXPRESSION; MICRORNAS; SIGNATURES; CARCINOMA; NOTOCHORD; GENES; CELLS	Introduction: Emerging evidence suggests that microRNAs (miRNAs) are crucially involved in tumorigenesis and that paired expression profiles of miRNAs and mRNAs can be used to identify functional miRNA-target relationships with high precision. However, no studies have applied integrated analysis to miRNA and mRNA profiles in chordomas. The purpose of this study was to provide insights into the pathogenesis of chordomas by using this integrated analysis method. Methods: Differentially expressed miRNAs and mRNAs of chordomas (n = 3) and notochord tissues (n = 3) were analyzed by using microarrays with hierarchical clustering analysis. Subsequently, the target genes of the differentially expressed miRNAs were predicted and overlapped with the differentially expressed mRNAs. Then, GO and pathway analyses were performed for the intersecting genes. Results: The microarray analysis indicated that 33 miRNAs and 2,791 mRNAs were significantly dysregulated between the two groups. Among the 2,791 mRNAs, 911 overlapped with putative miRNA target genes. A pathway analysis showed that the MAPK pathway was consistently enriched in the chordoma tissue and that miR-149-3p, miR-663a, miR-1908, miR-2861 and miR-3185 likely play important roles in the regulation of MAPK pathways. Furthermore, the Notch signaling pathway and the loss of the calcification or ossification capacity of the notochord may also be involved in chordoma pathogenesis. Conclusion: This study provides an integrated dataset of the miRNA and mRNA profiles in chordomas, and the results demonstrate that not only the MAPK pathway and its related miRNAs but also the Notch pathway may be involved in chordoma development. The occurrence of chordoma may be associated with dysfunctional calcification or ossification of the notochord.	[Long, Cheng; Jiang, Liang; Wei, Feng; Zhou, Hua; Liu, Xiaoguang; Liu, Zhongjun] Peking Univ, Hosp 3, Dept Orthoped, Beijing 100871, Peoples R China; [Ma, Chuan] Peking Univ, Hosp 3, Spine Tumor Ctr, Beijing 100871, Peoples R China; [Yang, Shaomin] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Liu, ZJ (corresponding author), Peking Univ, Hosp 3, Dept Orthoped, Beijing 100871, Peoples R China.	liuzjpkth@163.com	, 姜亮/AAH-4981-2020; Zhou, Hua/HGC-9504-2022	Zhou, hua/0000-0002-2718-4108	Ministry of Health Funded Key Projects for Clinical Medicine [WSB08-6-15]	Ministry of Health Funded Key Projects for Clinical Medicine	Grant sponsor: Ministry of Health Funded Key Projects for Clinical Medicine; Grant number: WSB08-6-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruederlein Silke, 2010, Sarcoma, V2010, P630129, DOI 10.1155/2010/630129; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Deniz ML, 2002, NEUROSURGERY, V51, P753, DOI 10.1097/00006123-200209000-00026; Duan ZF, 2010, J ORTHOP RES, V28, P746, DOI 10.1002/jor.21055; Gui T, 2012, LAB INVEST, V92, P1250, DOI 10.1038/labinvest.2012.85; Guilmeau S, 2012, ADV EXP MED BIOL, V727, P272, DOI 10.1007/978-1-4614-0899-4_21; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HO KL, 1985, CLIN NEUROPATHOL, V4, P77; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; Jian P, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-20; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li D, 2011, OMICS, V15, P673, DOI 10.1089/omi.2011.0064; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Lisse TS, 2013, J BONE MINER RES; MEIS JM, 1988, ARCH PATHOL LAB MED, V112, P553; MIETTINEN M, 1984, ARCH PATHOL LAB MED, V108, P891; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; ROSENBERG AE, 1994, AM J CLIN PATHOL, V101, P36, DOI 10.1093/ajcp/101.1.36; SALISBURY JR, 1993, J PATHOL, V171, P253, DOI 10.1002/path.1711710404; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Shao HW, 2012, ADV PHARMACOL, V65, P191, DOI 10.1016/B978-0-12-397927-8.00007-5; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Sommer J, 2010, J PATHOL, V220, P608, DOI 10.1002/path.2679; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Stockhausen MT, 2012, ADV EXP MED BIOL, V727, P289, DOI 10.1007/978-1-4614-0899-4_22; Tamborini E, 2010, NEURO-ONCOLOGY, V12, P776, DOI 10.1093/neuonc/noq003; Torres A, 2013, INT J CANCER, V132, P1633, DOI 10.1002/ijc.27840; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693; Whelan JT, 2012, J CELL PHYSIOL, V227, P1235, DOI 10.1002/jcp.22899; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yan B, 2012, APOPTOSIS, V17, P717, DOI 10.1007/s10495-012-0710-9; Zhou H, 2010, J SURG ONCOL, V102, P720, DOI 10.1002/jso.21674	48	50	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66676	10.1371/journal.pone.0066676	http://dx.doi.org/10.1371/journal.pone.0066676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826111	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400031
J	Marques, PI; Ferreira, Z; Martins, M; Figueiredo, J; Silva, DI; Castro, P; Morales-Hojas, R; Simoes-Correia, J; Seixas, S				Marques, Patricia Isabel; Ferreira, Zelia; Martins, Manuella; Figueiredo, Joana; Silva, Diana Isabel; Castro, Patricia; Morales-Hojas, Ramiro; Simoes-Correia, Joana; Seixas, Susana			SERPINA2 Is a Novel Gene with a Divergent Function from SERPINA1	PLOS ONE			English	Article							MUTANT ALPHA(1)-ANTITRYPSIN Z; DETECTING POSITIVE SELECTION; ENDOPLASMIC-RETICULUM; INCLUSION-BODIES; MOLECULAR-BASIS; ALPHA-1-ANTITRYPSIN; DEGRADATION; GLYCOPROTEIN; ORGANIZATION; DEFICIENCY	Serine protease inhibitors (SERPINs) are a superfamily of highly conserved proteins that play a key role in controlling the activity of proteases in diverse biological processes. The SERPIN cluster located at the 14q32.1 region includes the gene coding for SERPINA1, and a highly homologous sequence, SERPINA2, which was originally thought to be a pseudogene. We have previously shown that SERPINA2 is expressed in different tissues, namely leukocytes and testes, suggesting that it is a functional SERPIN. To investigate the function of SERPINA2, we used HeLa cells stably transduced with the different variants of SERPINA2 and SERPINA1 (M1, S and Z) and leukocytes as the in vivo model. We identified SERPINA2 as a 52 kDa intracellular glycoprotein, which is localized at the endoplasmic reticulum (ER), independently of the variant analyzed. SERPINA2 is not significantly regulated by proteasome, proposing that ER localization is not due to misfolding. Specific features of SERPINA2 include the absence of insoluble aggregates and the insignificant response to cell stress, suggesting that it is a non-polymerogenic protein with divergent activity of SERPINA1. Using phylogenetic analysis, we propose an origin of SERPINA2 in the crown of primates, and we unveiled the overall conservation of SERPINA2 and A1. Nonetheless, few SERPINA2 residues seem to have evolved faster, contributing to the emergence of a new advantageous function, possibly as a chymotrypsin-like SERPIN. Herein, we present evidences that SERPINA2 is an active gene, coding for an ER-resident protein, which may act as substrate or adjuvant of ER-chaperones.	[Marques, Patricia Isabel; Ferreira, Zelia; Martins, Manuella; Figueiredo, Joana; Silva, Diana Isabel; Castro, Patricia; Simoes-Correia, Joana; Seixas, Susana] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Marques, Patricia Isabel] Univ Porto, Inst Biomed Sci Abel Salazar, P-4100 Oporto, Portugal; [Ferreira, Zelia] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal; [Figueiredo, Joana] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Morales-Hojas, Ramiro] Univ Porto, Inst Mol & Cell Biol, P-4100 Oporto, Portugal; [Simoes-Correia, Joana] Univ Coimbra, Fac Med, Inst Biomed Res Light & Image, Coimbra, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade de Coimbra	Seixas, S (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sseixas@ipatimup.pt	Seixas, Susana/I-5084-2013; Castro, Patricia/J-8537-2013; Marques, Patricia Isabel/J-9983-2019; Simões Correia, Joana/C-8755-2012; Figueiredo, Joana/J-7305-2013	Seixas, Susana/0000-0002-7035-7422; Marques, Patricia Isabel/0000-0001-6050-628X; Simões Correia, Joana/0000-0003-2623-5628; Figueiredo, Joana/0000-0002-1590-1974; Morales Hojas, Ramiro/0000-0002-4120-5964; MARTINS, Manuella/0000-0003-4490-7125; Castro, Patricia/0000-0001-9588-9065; Worman, Zelia/0000-0002-7619-7466	Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU-GMG/64043/2006, SFRH/BD/68940/2010, SFRH/BD/45907/2008, SFRH/BD/43763/2008, SFRH/BPD/26553/2006, SFRH/BPD/48765/2008]; POPH-QREN - Promotion of scientific employment; European Social Fund; Ministry of Education and Science	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); POPH-QREN - Promotion of scientific employment; European Social Fund(European Social Fund (ESF)); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Portuguese Foundation for Science and Technology (FCT), project grant to SS - PTDC/SAU-GMG/64043/2006. PIM (SFRH/BD/68940/2010), ZF (SFRH/BD/45907/2008), JF (SFRH/BD/43763/2008), PC (SFRH/BPD/26553/2006), and JSC (SFRH/BPD/48765/2008) are supported by FCT fellowships and funded by POPH-QREN - Promotion of scientific employment, supported by the European Social Fund and national funds of the Ministry of Education and Science. SS and RMH are supported by the programme "Ciencia 2007", financed by the POPH-QREN - Promotion of scientific employment, co-financed by the European Social Fund and national funds of the Ministry of Education and Science. Institute of Molecular Pathology and Immunology of the University of Porto is an Associate Laboratory of the Portuguese Ministry of Education and Science and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; [Anonymous], 1997, B WORLD HEALTH ORGAN, V75, P397; Askew DJ, 2007, J BIOL CHEM, V282, P24948, DOI 10.1074/jbc.M703182200; Atchley WR, 2001, MOL BIOL EVOL, V18, P1502, DOI 10.1093/oxfordjournals.molbev.a003936; BAO J-J, 1988, Genomics, V2, P165, DOI 10.1016/0888-7543(88)90099-7; Cabral CM, 2002, MOL BIOL CELL, V13, P2639, DOI 10.1091/mbc.E02-02-0068; Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; Chevet E, 2010, SEMIN CELL DEV BIOL, V21, P486, DOI 10.1016/j.semcdb.2009.12.005; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Dahl M, 2005, EUR RESPIR J, V26, P67, DOI 10.1183/09031936.05.00135704; Davies MJ, 2008, INT J BIOCHEM CELL B, V40, P1273, DOI 10.1016/j.biocel.2007.12.017; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elliott PR, 1996, NAT STRUCT BIOL, V3, P910, DOI 10.1038/nsb1196-910; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; Futamura A, 1998, BIOCHEMISTRY-US, V37, P13110, DOI 10.1021/bi981234m; Granell S, 2008, MOL BIOL CELL, V19, P572, DOI 10.1091/mbc.E07-06-0587; Granell S, 2008, AUTOPHAGY, V4, P375, DOI 10.4161/auto.5605; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOFKER MH, 1988, BIOCHEM BIOPH RES CO, V155, P634, DOI 10.1016/S0006-291X(88)80542-4; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Irving JA, 2007, MOL CELLULAR ASPECTS, P1; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Janciauskiene S, 2001, ATHEROSCLEROSIS, V158, P41, DOI 10.1016/S0021-9150(00)00767-X; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024; Marsden MD, 2005, FRONT BIOSCI-LANDMRK, V10, P1768; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Namciu SJ, 2004, MAMM GENOME, V15, P162, DOI 10.1007/s00335-003-2311-y; Papp E, 2006, FASEB J, V20, P1018, DOI 10.1096/fj.05-5065fje; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Seixas S, 2007, MOL BIOL EVOL, V24, P587, DOI 10.1093/molbev/msl187; Seixas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032518; Seo EJ, 2002, J BIOL CHEM, V277, P14216, DOI 10.1074/jbc.M110272200; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stepensky D, 2007, TRAFFIC, V8, P1530, DOI 10.1111/j.1600-0854.2007.00639.x; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V278, pG39, DOI 10.1152/ajpgi.2000.278.1.G39; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	54	4	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66889	10.1371/journal.pone.0066889	http://dx.doi.org/10.1371/journal.pone.0066889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826168	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400079
J	Menchaca, AC; Visi, DK; Strey, OF; Teel, PD; Kalinowski, K; Allen, MS; Williamson, PC				Menchaca, Arturo C.; Visi, David K.; Strey, Otto F.; Teel, Pete D.; Kalinowski, Kevin; Allen, Michael S.; Williamson, Phillip C.			Preliminary Assessment of Microbiome Changes Following Blood-Feeding and Survivorship in the Amblyomma americanum Nymph-to-Adult Transition using Semiconductor Sequencing	PLOS ONE			English	Article							LONE STAR TICK; BACTERIAL DIVERSITY; COMMUNITY; HUMANS; ACARI; TAG	The physiology of ticks supports a diverse community of non-pathogenic and pathogenic organisms. This study aims to initially characterize the microbial community present within colony-reared Amblyomma americanum using PCR of the variable region 5 of the 16S rRNA gene followed by semiconductor sequencing and classification of sequence data using the Ribosomal Database Project and MG-RAST analysis tools. Comparison of amplicon library datasets revealed changes in the microbiomes in newly engorged nymphs, newly-molted adults, and aged adults, as well as ticks exposed to different environmental conditions. These preliminary data support the concept that microbe survivorship and diversity are partially dependent upon environmental variables and the sequence of blood feeding, molting, and aging. The maintenance and/or emergence of pathogens in ticks may be dependent in part on temporal changes in the microbial community of the tick microbiome.	[Visi, David K.; Allen, Michael S.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Visi, David K.; Allen, Michael S.] Univ N Texas, Hlth Sci Ctr, Dept Forens & Investigat Genet, Ft Worth, TX USA; [Strey, Otto F.; Teel, Pete D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Kalinowski, Kevin; Allen, Michael S.] Univ N Texas, Texas Hlth Sci, Ctr Learning & Dev, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Health Science Center; Texas A&M University System; Texas A&M University College Station; University of North Texas System; University of North Texas Health Science Center	Allen, MS (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Forens & Investigat Genet, Ft Worth, TX USA.	Michael.Allen@unthsc.edu		Allen, Michael/0000-0003-2293-8078	State of Texas	State of Texas	This work was supported by the State of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Balashov Y. S., 1972, BLOODSUCKING TICKS I; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; CDC, TICK BORN DIS NIOSH; CDC, DISTR STARI; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clay K, 2008, MOL ECOL, V17, P4371, DOI 10.1111/j.1365-294X.2008.03914.x; Clay K., 2010, TICK MICROBIOME DIVE; Drummond R. O., 1987, EC IMPACT PARASITISM; Dykstra EA, 1997, J AM VET MED ASSOC, V210, P360; Felz MW, 1996, J PARASITOL, V82, P505, DOI 10.2307/3284095; Hair JA, 1986, MORPHOLOGY PHYSL BEH; Heise SR, 2010, J MED ENTOMOL, V47, P258, DOI 10.1603/ME09197; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Jiang J, 2010, VECTOR-BORNE ZOONOT, V10, P329, DOI 10.1089/vbz.2009.0061; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; KOCH HG, 1981, J MED ENTOMOL, V18, P93, DOI 10.1093/jmedent/18.2.93; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Luo YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-386; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Romoser William S., 1996, P298; Shi WB, 2010, INSECT SCI, V17, P199, DOI 10.1111/j.1744-7917.2010.01340.x; Sonenshine DE, 1991, BIOL TICKS, V1, P159; Uchiyama T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00230; Vishnivetskaya TA, 2012, AM SOC MICR 112 GEN; Visi DK, 2013, J IND MICROBIOL BIOT, V40, P465, DOI 10.1007/s10295-013-1242-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Williamson PC, 2010, EMERG INFECT DIS; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12	37	59	59	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67129	10.1371/journal.pone.0067129	http://dx.doi.org/10.1371/journal.pone.0067129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826210	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400107
J	Salces-Ortiz, J; Gonzalez, C; Moreno-Sanchez, N; Calvo, JH; Perez-Guzman, MD; Serrano, MM				Salces-Ortiz, Judit; Gonzalez, Carmen; Moreno-Sanchez, Natalia; Calvo, Jorge H.; Dolores Perez-Guzman, M.; Serrano, Magdalena M.			Ovine HSP90AA1 Expression Rate Is Affected by Several SNPs at the Promoter under Both Basal and Heat Stress Conditions	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; SHOCK PROTEINS; SHEEP; POLYMORPHISMS; EVOLUTIONARY; LINEAGES; TRAITS; DNA	The aim of this work was to investigate the association between polymorphisms located at the HSP90AA1 ovine gene promoter and gene expression rate under different environmental conditions, using a mixed model approach. Blood samples from 120 unrelated rams of the Manchega sheep breed were collected at three time points differing in environmental conditions. Rams were selected on the basis of their genotype for the transversion G/C located 660 base pairs upstream the gene transcription initiation site. Animals were also genotyped for another set of 6 SNPs located at the gene promoter. Two SNPs, G/C-660 and A/G(-444), were associated with gene overexpression resulting from heat stress. The composed genotype CC-660-AG(-444) was the genotype having the highest expression rates with fold changes ranging from 2.2 to 3.0. The genotype AG(-522) showed the highest expression levels under control conditions with a fold change of 1.4. Under these conditions, the composed genotype CC-601-TT-524-AG(-522)-TT-468 is expected to be correlated with higher basal expression of the gene according to genotype frequencies and linkage disequilibrium values. Some putative transcription factors were predicted for binding sites where the SNPs considered are located. Since the expression rate of the gene under alternative environmental conditions seems to depend on the composed genotype of several SNPs located at its promoter, a cooperative regulation of the transcription of the HSP90AA1 gene could be hypothesized. Nevertheless epigenetic regulation mechanisms cannot be discarded.	[Salces-Ortiz, Judit; Gonzalez, Carmen; Moreno-Sanchez, Natalia; Serrano, Magdalena M.] Inst Nac Invest Agr & Alimentarias, Dpto Mejora Genet Anim, Madrid, Spain; [Calvo, Jorge H.] ARAID, Zaragoza, Spain; [Dolores Perez-Guzman, M.] CERSYRA, Valdepenas, Spain		Salces-Ortiz, J (corresponding author), Inst Nac Invest Agr & Alimentarias, Dpto Mejora Genet Anim, Madrid, Spain.	malena@inia.es	Serrano, Malena/GXH-8219-2022; Serrano, Magdalena M/R-5716-2017; Calvo, Jorge H/E-5240-2016	Serrano, Magdalena M/0000-0002-1621-3102; Calvo, Jorge H/0000-0001-9513-0219; Gonzalez Verdejo, Carmen/0000-0001-8757-9147; Salces-Ortiz, Judit/0000-0002-3572-4020	INIA project (Subprograma de Investigacion Fundamental orientada a los Recursos y Tecnologias Agrarias) [RTA2009-00098-00-00]; FEDER (Fondo Europeo de Desarrollo Regional)	INIA project (Subprograma de Investigacion Fundamental orientada a los Recursos y Tecnologias Agrarias); FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	RTA2009-00098-00-00 INIA project (Subprograma de Investigacion Fundamental orientada a los Recursos y Tecnologias Agrarias) and FEDER (Fondo Europeo de Desarrollo Regional) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2009, J DAIRY SCI, V92, P5702, DOI 10.3168/jds.2008-1928; [Anonymous], 2006, SAS MIXED MODELS; Arceo ME, 2012, FRONTIERS GENETICS, V3; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Basu N, 2002, GENE, V295, P173, DOI 10.1016/S0378-1119(02)00687-X; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Blau J, 1996, MOL CELL BIOL, V16, P2044; Bustin SA, 2009, GENET ENG BIOTECHN N, V29, P40; Charoensook R, 2012, TROP ANIM HEALTH PRO, V44, P921, DOI 10.1007/s11250-011-9989-8; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Curtis SE, 1983, ENV MANAGEMENT ANIMA; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fanger O, 1970, THERMAL COMFORT; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Favatier F, 1997, CELL STRESS CHAPERON, V2, P141, DOI 10.1379/1466-1268(1997)002<0141:VIHGEA>2.3.CO;2; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Finocchiaro R, 2005, J DAIRY SCI, V88, P1855, DOI 10.3168/jds.S0022-0302(05)72860-5; Fleige S, 2006, MOL ASPECTS MED, V27; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang LH, 2008, CELL RES, V18, P1074, DOI 10.1038/cr.2008.283; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; KRONE PH, 1994, BIOCHEM BIOPH RES CO, V204, P746, DOI 10.1006/bbrc.1994.2522; Kumari D, 2001, J BIOL CHEM, V276, P4357, DOI 10.1074/jbc.M009629200; Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Lim A, 2012, VET MED INT; Maijala K., 1997, P13; Marai IFM, 2007, SMALL RUMINANT RES, V71, P1, DOI 10.1016/j.smallrumres.2006.10.003; Marai I. F. M., 2008, TROPICAL SUBTROPICAL, V8, P209; Marai IFM, 2001, TROP ANIM HEALTH PRO, V33, P451, DOI 10.1023/A:1012772311177; Marcos-Carcavilla A, 2008, CELL STRESS CHAPERON, V13, P19, DOI 10.1007/s12192-007-0004-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P343, DOI 10.1007/s12192-009-0149-2; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P67, DOI 10.1007/s12192-009-0123-z; Mendelson KG, 1996, P NATL ACAD SCI USA, V93, P12908, DOI 10.1073/pnas.93.23.12908; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morton JM, 2007, J DAIRY SCI, V90, P2271, DOI 10.3168/jds.2006-574; Oner Y, 2012, LIVEST SCI, V150, P381, DOI 10.1016/j.livsci.2012.07.028; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramon M, 2012, EFFECT ENV TEMPERATU; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Sanchez JP, 2009, J DAIRY SCI, V92, P4035, DOI 10.3168/jds.2008-1626; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Serrano M, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-36; Sevi A, 2012, SMALL RUMINANT RES, V107, P1, DOI 10.1016/j.smallrumres.2012.07.012; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Stephanou A, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/238601; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Thepot D, 2000, DEVELOPMENT, V127, P143; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Wadekar SA, 2001, MOL ENDOCRINOL, V15, P1396, DOI 10.1210/me.15.8.1396; Wood MA, 2009, BIOL REPROD, V80, P24, DOI 10.1095/biolreprod.108.070037; Yan B, 2002, BIOCHEM BIOPH RES CO, V291, P582, DOI 10.1006/bbrc.2002.6483	64	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66641	10.1371/journal.pone.0066641	http://dx.doi.org/10.1371/journal.pone.0066641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826107	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400027
J	Tao, Y; Gao, L; Wu, XS; Wang, HM; Yang, G; Zhan, FH; Shi, JM				Tao, Yi; Gao, Lu; Wu, Xiaosong; Wang, Hongmei; Yang, Guang; Zhan, Fenghuang; Shi, Jumei			Down-Regulation of 11 beta-Hydroxysteroid Dehydrogenase Type 2 by Bortezomib Sensitizes Jurkat Leukemia T Cells against Glucocorticoid-Induced Apoptosis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CARCINOMA-CELLS; HUMAN PITUITARY; EXPRESSION; RECEPTOR; RESISTANCE; PROLIFERATION; MODULATION; INHIBITOR; DETERMINANT	11 beta-hydroxysteroid dehydrogenases type 2 (11 beta-HSD2), a key regulator for pre-receptor metabolism of glucocorticoids (GCs) by converting active GC, cortisol, to inactive cortisone, has been shown to be present in a variety of tumors. But its expression and roles have rarely been discussed in hematological malignancies. Proteasome inhibitor bortezomib has been shown to not only possess antitumor effects but also potentiate the activity of other chemotherapeutics. In this study, we demonstrated that 11 beta-HSD2 was highly expressed in two GC-resistant T-cell leukemic cell lines Jurkat and Molt4. In contrast, no 11 beta-HSD2 expression was found in two GC-sensitive non-hodgkin lymphoma cell lines Daudi and Raji as well as normal peripheral blood T cells. Inhibition of 11 beta-HSD2 by 11 beta-HSD inhibitor 18 beta-glycyrrhetinic acid or 11 beta-HSD2 shRNA significantly increased cortisol-induced apoptosis in Jurkat cells. Additionally, pretreatment of Jurkat cells with low-dose bortezomib resulted in increased cellular sensitivity to GC as shown by elevated induction of apoptosis, more cells arrested at G1 stage and up-regulation of GC-induced leucine zipper which is an important mediator of GC action. Furthermore, we clarified that bortezomib could dose-dependently inhibit 11 beta-HSD2 messenger RNA and protein levels as well as activity (cortisol-cortisone conversion) through p38 mitogen-activated protein kinase signaling pathway. Therefore, we suggest 11 beta-HSD2 is, at least partially if not all, responsible for impaired GC suppression in Jurkat cells and also indicate a novel mechanism by which proteasome inhibitor bortezomib may influence GC action.	[Tao, Yi; Wu, Xiaosong; Wang, Hongmei; Yang, Guang; Shi, Jumei] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Hematol, Shanghai 200092, Peoples R China; [Gao, Lu] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Zhan, Fenghuang] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	Tongji University; Naval Medical University; University of Iowa	Shi, JM (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Hematol, Shanghai 200092, Peoples R China.	shijumei@hotmail.com		Tao, Yi/0000-0002-7361-6063; Zhan, Fenghuang/0000-0001-6208-1676; Tao, Yi/0000-0002-0749-6614	National Natural Science Foundation of China [81071856, 30973450]; Joint Research Fund for Overseas, Hong Kong and Macao Scholars [81228016]; Shanghai Pujiang Program [11PJ1407900]; Shanghai Tenth People's Hospital Funds [12RQ112, 10RD103, 11SC103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Research Fund for Overseas, Hong Kong and Macao Scholars; Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Tenth People's Hospital Funds	1. National Natural Science Foundation of China (No. 81071856 and 30973450 to JS), (http://www.nsfc.gov.cn/). 2. Joint Research Fund for Overseas, Hong Kong and Macao Scholars(No. 81228016 to FZ and JS), (http://www.nsfc.gov.cn/). 3. Shanghai Pujiang Program (No. 11PJ1407900 to JS), (http://www.stcsm.gov.cn). 4. Shanghai Tenth People's Hospital Funds (No. 12RQ112 to YT, No. 10RD103 and 11SC103 to JS), (http://www.shdsyy.com.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYROLDI E, 2009, FASEB J; Beesley AH, 2009, LEUKEMIA RES, V33, P321, DOI 10.1016/j.leukres.2008.08.007; Dasmahapatra G, 2006, LEUKEMIA RES, V30, P1263, DOI 10.1016/j.leukres.2006.01.005; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Eyre LJ, 2001, J CELL BIOCHEM, V81, P453, DOI 10.1002/1097-4644(20010601)81:3<453::AID-JCB1059>3.0.CO;2-Z; Fiskus W, 2011, CLIN CANCER RES, V17, P7347, DOI 10.1158/1078-0432.CCR-11-1541; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Goecke IA, 2007, MOL IMMUNOL, V44, P2115, DOI 10.1016/j.molimm.2006.07.303; Hennebold JD, 1996, AM J PHYSIOL-REG I, V270, pR1296, DOI 10.1152/ajpregu.1996.270.6.R1296; Kashkar H, 2007, BLOOD, V109, P3982, DOI 10.1182/blood-2006-10-053959; Kleinschnitz C, 2011, STROKE, V42, P1081, DOI 10.1161/STROKEAHA.110.592238; Korbonits M, 2001, J CLIN ENDOCR METAB, V86, P2728, DOI 10.1210/jc.86.6.2728; Koyama K, 2001, J STEROID BIOCHEM, V76, P153, DOI 10.1016/S0960-0760(00)00157-6; Lauten M, 2003, HAEMATOLOGICA, V88, P1253; Leung DYM, 1997, ANN ALLERG ASTHMA IM, V79, P197, DOI 10.1016/S1081-1206(10)63003-7; Lioni M, 2008, MOL CANCER THER, V7, P2866, DOI 10.1158/1535-7163.MCT-08-0391; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Nigawara T, 2006, ENDOCRINOLOGY, V147, P769, DOI 10.1210/en.2005-0544; Pacha J, 2002, STEROIDS, V67, P119, DOI 10.1016/S0039-128X(01)00143-X; Rabbitt E, 2003, ONCOGENE, V22, P1663, DOI 10.1038/sj.onc.1206293; Rabbitt EH, 2003, J STEROID BIOCHEM, V85, P415, DOI 10.1016/S0960-0760(03)00224-3; Rabbitt EH, 2002, FASEB J, V16, P36, DOI 10.1096/fj.01-0582com; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Riml S, 2004, CELL DEATH DIFFER, V11, pS65, DOI 10.1038/sj.cdd.4401413; Sai S, 2011, LEUKEMIA RES, V35, P1644, DOI 10.1016/j.leukres.2011.07.002; Schmidt S, 2006, FASEB J, V20, P2600, DOI 10.1096/fj.06-6214fje; Shang YL, 2012, AMINO ACIDS, V42, P1879, DOI 10.1007/s00726-011-0907-1; Sharma A, 2009, ENDOCRINOLOGY, V150, P4278, DOI 10.1210/en.2009-0479; Stewart PM, 1999, VITAM HORM, V57, P249; Tanaka T, 2006, EXP HEMATOL, V34, P1542, DOI 10.1016/j.exphem.2006.06.018; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Yang F, 2012, CANCER BIOL THER, V13, P349, DOI 10.4161/cbt.19239; Zhou X, 2011, MOL CARCINOG	34	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67067	10.1371/journal.pone.0067067	http://dx.doi.org/10.1371/journal.pone.0067067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826195	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400100
J	Zheng, Q; Hou, R; Zhang, JY; Ma, JW; Wu, ZS; Wang, GH; Wang, CF; Xu, JR				Zheng, Qian; Hou, Rui; Zhang, Juanyu; Ma, Jiwen; Wu, Zhongshou; Wang, Guanghui; Wang, Chenfang; Xu, Jin-Rong			The MAT Locus Genes Play Different Roles in Sexual Reproduction and Pathogenesis in Fusarium graminearum	PLOS ONE			English	Article							NEUROSPORA-CRASSA; FUNCTIONAL ANALYSES; SIGNALING PATHWAY; CELL-TYPE; GIBBERELLA; PROTEIN; ORGANIZATION; EVOLUTION; FUSION; KINASE	Sexual reproduction plays a critical role in the infection cycle of Fusarium graminearum because ascospores are the primary inoculum. As a homothallic ascomycete, F. graminearum contains both the MAT1-1 and MAT1-2-1 loci in the genome. To better understand their functions and regulations in sexual reproduction and pathogenesis, in this study we assayed the expression, interactions, and mutant phenotypes of individual MAT locus genes. Whereas the expression of MAT1-1-1 and MAT12-1 rapidly increased after perithecial induction and began to decline after 1 day post-perithecial induction (dpi), the expression of MAT1-1-2 and MAT1-1-3 peaked at 4 dpi. MAT1-1-2 and MAT1-1-3 had a similar expression profile and likely are controlled by a bidirectional promoter. Although none of the MAT locus genes were essential for perithecium formation, all of them were required for ascosporogenesis in self-crosses. In outcrosses, the mat11-1-2 and mat11-1-3 mutants were fertile but the mat1-1-1 and mat1-2-1 mutants displayed male-and female-specific defects, respectively. The mat1-2-1 mutant was reduced in FgSO expression and hyphal fusion. Mat1-1-2 interacted with all other MAT locus transcription factors, suggesting that they may form a protein complex during sexual reproduction. Mat1-1-1 also interacted with FgMcm1, which may play a role in controlling cell identity and sexual development. Interestingly, the mat1-1-1 and mat1-2-1 mutants were reduced in virulence in corn stalk rot assays although none of the MAT locus genes was important for wheat infection. The MAT1-1-1 and MAT1-2-1 genes may play a host-specific role in colonization of corn stalks.	[Zheng, Qian; Hou, Rui; Zhang, Juanyu; Ma, Jiwen; Wu, Zhongshou; Wang, Guanghui; Wang, Chenfang] Northwest Agr & Forestry Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Hou, Rui; Wang, Guanghui; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xu, JR (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	jinrong@purdue.edu		Wu, Zhongshou/0000-0001-6687-1675	National Major Project of Breeding for New Transgenic Organisms [2012ZX08009003]; National Basic Research Program of China [2012CB114002, 2013CB127703]; USDA-NIFA [2010 65110 20439]	National Major Project of Breeding for New Transgenic Organisms; National Basic Research Program of China(National Basic Research Program of China); USDA-NIFA(United States Department of Agriculture (USDA))	This work was supported the National Major Project of Breeding for New Transgenic Organisms (2012ZX08009003), the National Basic Research Program of China (2012CB114002; 2013CB127703), and a grant from the USDA-NIFA (2010 65110 20439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Badgett TC, 1999, P FUNGAL GENET C, V20, P127; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Choi YE, 2010, MOL PLANT MICROBE IN, V23, P522, DOI 10.1094/MPMI-23-4-0522; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; da Silva CC, 2009, GENET MOL BIOL, V32, P354, DOI 10.1590/S1415-47572009000200023; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Desjardins AE, 2003, ANNU REV PHYTOPATHOL, V41, P177, DOI 10.1146/annurev.phyto.41.011703.115501; Ding SL, 2009, EUKARYOT CELL, V8, P867, DOI 10.1128/EC.00048-09; Ferreira AVB, 1996, MOL GEN GENET, V250, P767, DOI 10.1007/BF02172989; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2007, EUKARYOT CELL, V6, P84, DOI 10.1128/EC.00268-06; Gale LR, 2002, PHYTOPATHOLOGY, V92, P1315, DOI 10.1094/PHYTO.2002.92.12.1315; Gelli A, 2002, MOL MICROBIOL, V46, P845, DOI 10.1046/j.1365-2958.2002.03213.x; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; HAMER JE, 1987, MOL CELL BIOL, V7, P2352, DOI 10.1128/MCB.7.7.2352; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jacobsen S, 2002, CURR GENET, V41, P150, DOI 10.1007/s00294-002-0276-0; Jenczmionka NJ, 2005, CURR GENET, V47, P29, DOI 10.1007/s00294-004-0547-z; Kim HK, 2008, FUNGAL GENET BIOL, V45, P1188, DOI 10.1016/j.fgb.2008.05.008; Kim HK, 2012, FEMS MICROBIOL LETT, V337, P89, DOI 10.1111/1574-6968.12012; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee JK, 2008, EUKARYOT CELL, V7, P1211, DOI 10.1128/EC.00272-07; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Li YM, 2011, MOL PLANT MICROBE IN, V24, P487, DOI 10.1094/MPMI-10-10-0233; Martin SH, 2011, FUNGAL GENET BIOL, V48, P731, DOI 10.1016/j.fgb.2011.03.005; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; Morohashi N, 2006, EUKARYOT CELL, V5, P1925, DOI 10.1128/EC.00105-06; Nolting N, 2006, EUKARYOT CELL, V5, P1043, DOI 10.1128/EC.00086-06; Park G, 2006, PLANT CELL, V18, P2822, DOI 10.1105/tpc.105.038422; PHILLEY ML, 1994, GENETICS, V137, P715; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Schmelz EA, 2011, P NATL ACAD SCI USA, V108, P5455, DOI 10.1073/pnas.1014714108; Seong K, 2006, FUNGAL GENET BIOL, V43, P34, DOI 10.1016/j.fgb.2005.10.002; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Trail F, 2009, PLANT PHYSIOL, V149, P103, DOI 10.1104/pp.108.129684; Tsong Annie E., 2007, P75; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Wang G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039700, 10.1371/journal.pone.0051764, 10.1371/journal.pone.0047051]; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; Zhao XH, 2007, MOL MICROBIOL, V63, P881, DOI 10.1111/j.1365-2958.2006.05548.x; Zheng DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049495; Zhong HL, 1999, GENOME RES, V9, P1040, DOI 10.1101/gr.9.11.1040; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001	52	60	64	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66980	10.1371/journal.pone.0066980	http://dx.doi.org/10.1371/journal.pone.0066980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826182	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400091
J	Jackson, BL; Blackwood, EM; Blum, J; Carruthers, SP; Nemorin, S; Pryor, BA; Sceneay, SD; Bevan, S; Crewther, DP				Jackson, Brianna L.; Blackwood, Ellie M.; Blum, Julieanne; Carruthers, Sean P.; Nemorin, Sabrina; Pryor, Brett A.; Sceneay, Shannon D.; Bevan, Stephanie; Crewther, David P.			Magno- and Parvocellular Contrast Responses in Varying Degrees of Autistic Trait	PLOS ONE			English	Article							GANGLION-CELLS; SPECTRUM DISORDERS; COGNITIVE-STYLE; VISUAL-SYSTEM; HUMAN RETINA; PERCEPTION; COHERENCE; CHILDREN; SENSITIVITY; CHANNELS	Autistic tendency has been associated with altered visual perception, especially impaired visual motion sensitivity and global/local integration, as well as enhanced visual search and local shape recognition. However, the neurophysiological mechanisms underlying these abnormalities remain poorly defined. The current study recruited 29 young adults displaying low, middle or high autistic trait as measured by Baron-Cohen's Autism spectrum Quotient (AQ), and measured motion coherence thresholds psychophysically, with manipulation of dot lifetime and stimulus contrast, as well as nonlinear cortical visual evoked potentials (VEPs) over a range of temporal luminance contrast levels from 10% to 95%. Contrast response functions extracted from the major first order and second order Wiener kernel peaks of the VEPs showed consistent variation with AQ group, and Naka-Rushton fits enabled contrast gain and semi-saturation contrasts to be elicited for each peak. A short latency second order response (previously associated with magnocellular processing) with high contrast gain and a saturating contrast response function showed higher amplitude for the High AQ (compared with Mid and Low groups) indicating poorer neural recovery after rapid stimulation. A non-linearity evoked at longer interaction times (previously associated with parvocellular processing) with no evidence of contrast saturation and lower contrast gain showed no difference between autism quotient groups across the full range of stimulus contrasts. In addition, the short latency first order response and a small, early second order second slice response showed gain and semi-saturation parameters indicative of magnocellular origin, while the longer latency first order response probably reflects a mixture of inputs (including feedback from higher cortical areas). Significant motion coherence (AQ group) * (dot lifetime) interactions with higher coherence threshold for limited dot lifetime stimuli is consistent with atypical magnocellular functioning, however psychophysical performance for those with High AQ is not explained fully, suggesting that other factors may be involved.	[Jackson, Brianna L.; Blackwood, Ellie M.; Blum, Julieanne; Carruthers, Sean P.; Nemorin, Sabrina; Pryor, Brett A.; Sceneay, Shannon D.; Bevan, Stephanie; Crewther, David P.] Swinburne Univ Technol, Ctr Human Psychopharmacol, Melbourne, Vic, Australia	Swinburne University of Technology	Crewther, DP (corresponding author), Swinburne Univ Technol, Ctr Human Psychopharmacol, Melbourne, Vic, Australia.	dcrewther@swin.edu.au			NHMRC (Australia) [1004740]	NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	The authors wish to acknowledge support from a NHMRC (Australia) project grant #1004740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashwin E, 2009, BIOL PSYCHIAT, V65, P17, DOI 10.1016/j.biopsych.2008.06.012; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baseler HA, 1997, VISION RES, V37, P675, DOI 10.1016/S0042-6989(96)00209-X; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Bertone A, 2003, J COGNITIVE NEUROSCI, V15, P218, DOI 10.1162/089892903321208150; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Camp AJ, 2009, J NEUROSCI, V29, P5009, DOI 10.1523/JNEUROSCI.0219-09.2009; Court, 1998, RAVENS ADV PROGR MAT; Crewther David P, 2009, Biol Psychiatry, V66, pe21, DOI 10.1016/j.biopsych.2009.02.036; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Grinter EJ, 2009, J AUTISM DEV DISORD, V39, P1278, DOI 10.1007/s10803-009-0740-5; Hamel R, 2006, EDUC PSYCHOL MEAS, V66, P1039, DOI 10.1177/0013164406288169; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Iarocci G, 2006, J AUTISM DEV DISORD, V36, P117, DOI 10.1007/s10803-005-0045-2; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Klistorner A, 1997, VISION RES, V37, P2161, DOI 10.1016/S0042-6989(97)00003-5; Koh HC, 2010, J AUTISM DEV DISORD, V40, P978, DOI 10.1007/s10803-010-0953-7; Laycock R, 2007, NEUROSCI BIOBEHAV R, V31, P363, DOI 10.1016/j.neubiorev.2006.10.003; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; McCleery JP, 2007, BIOL PSYCHIAT, V62, P1007, DOI 10.1016/j.biopsych.2007.02.009; MERIGAN WH, 1990, VISUAL NEUROSCI, V5, P347, DOI 10.1017/S0952523800000432; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Milne E, 2002, J CHILD PSYCHOL PSYC, V43, P255, DOI 10.1111/1469-7610.00018; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2001, DEVELOPMENT OF AUTISM: PERSPECTIVES FROM THEORY AND RESEARCH, P131; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Pellicano E, 2005, J CHILD PSYCHOL PSYC, V46, P533, DOI 10.1111/j.1469-7610.2004.00380.x; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; Schiller PH, 2010, P NATL ACAD SCI USA, V107, P17087, DOI 10.1073/pnas.1011782107; SCHILLER PH, 1992, TRENDS NEUROSCI, V15, P86, DOI 10.1016/0166-2236(92)90017-3; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; Stewart ME, 2009, AUTISM, V13, P133, DOI 10.1177/1362361308098515; Stuart GW, 2001, VISION RES, V41, P3205, DOI 10.1016/S0042-6989(01)00176-6; Super H, 2007, NEUROPSYCHOLOGIA, V45, P3329, DOI 10.1016/j.neuropsychologia.2007.07.001; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; SUTTER EE, 1992, VISION RES, V32, P433, DOI 10.1016/0042-6989(92)90235-B; Sutter Erich, 2000, Documenta Ophthalmologica, V100, P49, DOI 10.1023/A:1002702917233; Tavassoli T, 2011, VISION RES, V51, P1778, DOI 10.1016/j.visres.2011.06.004; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10	53	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66797	10.1371/journal.pone.0066797	http://dx.doi.org/10.1371/journal.pone.0066797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824955	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400159
J	Kim, JH; Song, HN; Austin, JL; Cheng, W				Kim, Jin H.; Song, Hanna; Austin, Jamie L.; Cheng, Wei			Optimized Infectivity of the Cell-Free Single-Cycle Human Immunodeficiency Viruses Type 1 (HIV-1) and Its Restriction by Host Cells	PLOS ONE			English	Article							FUSION INHIBITOR T-20; REPLICATION-COMPETENT; REVERSE-TRANSCRIPTASE; VPR ARRESTS; IN-VITRO; VIRIONS; GENE; EXPRESSION; LEVEL; DNA	The infectivity of retroviruses such as HIV-1 in plasma or cultured media is less than 0.1% in general, the mechanisms of which are not yet fully understood. One possible explanation among others is the potential presence of large numbers of defective virions in a virus pool, which limits the apparent infectivity of HIV virions. To test this hypothesis, we have varied the culture conditions used to generate single-cycle HIV-1 virions. Among these culture variables, virion harvest time, media change after transfection, and envelope plasmid input can all improve HIV-1 infectivity by reducing the number of defective virions. A harvest time of 18-24 hours post transfection as opposed to 48 hours, and a media change six hours post transfection both improve viral infectivity. An optimal quantity of envelope plasmid input during transfection was also found. Collectively, these conditions increased the infectivity of HIV-1 virions by sevenfold compared to normally reported values in TZM-bl indicator cell lines. These conditions also increased the infectivity of HIV-1 in CD4(+) T cells, suggesting that these conditions work by increasing the intrinsic infectivity of a virus pool. Nevertheless, these improvements on virion infectivity were marginal compared to the impact of host cells on HIV infection, which can decrease the apparent infectivity by 19-fold even for the most optimized viruses. These results suggest that the infectivity of HIV-1 virions can be optimized by reducing the number of defective virions; however, viral-cell interactions may pose a major barrier for HIV-1 infectivity.	[Kim, Jin H.; Song, Hanna; Austin, Jamie L.; Cheng, Wei] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cheng, W (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.	chengwe@umich.edu			NIH [1DP2OD008693-01]; March of Dimes Foundation [5-FY10-490]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008693] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant 1DP2OD008693-01 to WC and also in part by Research Grant No. 5-FY10-490 to WC from the March of Dimes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; An WF, 2001, VIROLOGY, V286, P475, DOI 10.1006/viro.2001.1025; Berkhout B, 2006, FEBS LETT, V580, P2896, DOI 10.1016/j.febslet.2006.02.070; BERNIER R, 1995, J VIROL, V69, P291, DOI 10.1128/JVI.69.1.291-300.1995; Binley J, 2009, CURR OPIN HIV AIDS, V4, P364, DOI 10.1097/COH.0b013e32832e06fe; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Cavrois Marielle, 2004, Methods Mol Biol, V263, P333; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; ENGLUND G, 1995, J VIROL, V69, P3216, DOI 10.1128/JVI.69.5.3216-3219.1995; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Haim H, 2005, J VIROL, V79, P622, DOI 10.1128/JVI.79.1.622-625.2005; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Kingston RE, 2003, CURR PROTOC MOL BIOL, V63, DOI DOI 10.1002/0471142727.MB0901S63; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; KONIG R, 1989, P NATL ACAD SCI USA, V86, P9188, DOI 10.1073/pnas.86.23.9188; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Kwon YJ, 2003, J VIROL, V77, P5712, DOI 10.1128/JVI.77.10.5712-5720.2003; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; McMahon MA, 2009, CURR OPIN INFECT DIS, V22, P574, DOI 10.1097/QCO.0b013e328332c54d; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Montefiori DC, 2004, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1211S64; Munk C, 2003, CURR PROTOC PHARM; Ono A, 2009, FUTURE VIROL, V4, P241, DOI 10.2217/FVL.09.4; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Padow M, 2003, J VIROL, V77, P11050, DOI 10.1128/JVI.77.20.11050-11059.2003; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Poon B, 2005, J VIROL, V79, P10210, DOI 10.1128/JVI.79.16.10210-10217.2005; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; RICHARDS KH, 2006, CURR PROTOC MICROBIO, pCH15; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Schaeffer E, 2001, J VIROL, V75, P2993, DOI 10.1128/JVI.75.6.2993-3000.2001; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Thali M, 2011, BIOCHEM SOC T, V39, P529, DOI 10.1042/BST0390529; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-12; Wu Y, 2007, CURR HIV RES, V5, P394; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004	64	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67170	10.1371/journal.pone.0067170	http://dx.doi.org/10.1371/journal.pone.0067170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825637	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400178
J	Luo, XC; Wang, SS; Zhang, J; Qian, DD; Wang, SM; Li, LL				Luo, Xiao-Chun; Wang, Shan-Shan; Zhang, Jie; Qian, Duo-Duo; Wang, Si-Min; Li, Lu-Lin			Effects of Early or Overexpression of the Autographa californica Multiple Nucleopolyhedrovirus orf94 (ODV-e25) on Virus Replication	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; OCCLUSION-DERIVED VIRUS; SPODOPTERA-FRUGIPERDA CELLS; MESSENGER-RNA INITIATION; IN-VITRO TRANSCRIPTION; EARLY GENES; BACULOVIRUS; PROTEIN; IDENTIFICATION; INSECT	odv-e25(e25) is one of the core genes of baculoviruses. To investigate how it functions in the replication cycle of a baculovirus, a number of Autographa californica multiple nucleopolyhedrovirus recombinants with e25 under control of the promoter of immediate early gene ie1, or the promoter of the very late hyperexpressed gene p10, were constructed using a bacmid system, and the effects of early expression or overexpression of e25 on replication of the virus were evaluated. Microscopy and titration assays demonstrated that bacmids with e25 under control of ie1 promoter were unable to produce budded viruses; and that the recombinant viruses with e25 under control of p10 promoter generated budded virus normally, but formation of occlusion bodies were dramatically reduced and delayed in the infected cells. Electron microscopy showed that there were no mature virions or intact nucleocapsids present in the cells transfected with a recombinant bacmid with e25 under control of ie1 promoter. Quantitative real-time PCR analysis demonstrated that alteration of the e25 promoter did not affect viral DNA synthesis. The reporter gene expression from the promoter of the major capsid protein gene vp39 was reduced 63% by early expression of e25. Confocal microscopy revealed that E25 was predominantly localized in nuclei by 24 hours post infection with wild-type virus, but it remained in the cytoplasm in the cells transfected with a recombinant bacmid with e25 under control of the ie1 promoter, suggesting that the transport of E25 into nuclei was regulated in a specific and strict time dependent manner.	[Luo, Xiao-Chun; Wang, Shan-Shan; Zhang, Jie; Qian, Duo-Duo; Wang, Si-Min; Li, Lu-Lin] Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China	Central China Normal University	Li, LL (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China.	lilulin@mail.ccnu.edu.cn	LULIN, LI/W-3785-2019		National Natural Science Foundation of China [31170145]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by National Natural Science Foundation of China (31170145) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Beniya H, 1996, VIROLOGY, V216, P12, DOI 10.1006/viro.1996.0029; Beniya H, 1998, VIROLOGY, V240, P64, DOI 10.1006/viro.1997.8903; Braunagel SC, 2004, P NATL ACAD SCI USA, V101, P8372, DOI 10.1073/pnas.0402727101; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 1999, J VIROL, V73, P8559, DOI 10.1128/JVI.73.10.8559-8570.1999; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; Braunagel SC, 2009, J VIROL, V83, P1280, DOI 10.1128/JVI.01661-08; CHAABIHI H, 1993, J VIROL, V67, P2664, DOI 10.1128/JVI.67.5.2664-2671.1993; Chen L, 2012, ARCH VIROL, V157, P617, DOI 10.1007/s00705-011-1211-9; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng F, 2007, J VIROL, V81, P9377, DOI 10.1128/JVI.00632-07; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; GLOCKER B, 1992, J VIROL, V66, P3476, DOI 10.1128/JVI.66.6.3476-3484.1992; GLOCKER B, 1993, J VIROL, V67, P3771, DOI 10.1128/JVI.67.7.3771-3776.1993; GRANADOS RR, 1981, VIROLOGY, V108, P297, DOI 10.1016/0042-6822(81)90438-4; GUARINO LA, 1986, J VIROL, V57, P563, DOI 10.1128/JVI.57.2.563-571.1986; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Hefferon KL, 1999, VIROLOGY, V258, P455, DOI 10.1006/viro.1999.9758; Hong T, 1997, P NATL ACAD SCI USA, V94, P4050, DOI 10.1073/pnas.94.8.4050; HOOPES RR, 1991, P NATL ACAD SCI USA, V88, P4513, DOI 10.1073/pnas.88.10.4513; Hou D, 2012, J VIROL, V67, P4566; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; King A.M., 2012, VIRUS TAXONOMY, V9; KOVACS GR, 1991, VIROLOGY, V185, P633, DOI 10.1016/0042-6822(91)90534-I; KUZIO J, 1984, VIROLOGY, V139, P414, DOI 10.1016/0042-6822(84)90388-X; Li LL, 1999, VIROLOGY, V255, P9, DOI 10.1006/viro.1998.9546; Li ZF, 2006, VIRUS GENES, V32, P13, DOI 10.1007/s11262-005-5840-5; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; RUSSELL RLQ, 1993, VIROLOGY, V195, P532, DOI 10.1006/viro.1993.1404; Saksena S, 2004, P NATL ACAD SCI USA, V101, P12537, DOI 10.1073/pnas.0404934101; Sambrook J., 2001, MOL CLONING LAB MANU; Simon O, 2012, J INVERTEBR PATHOL, V109, P117, DOI 10.1016/j.jip.2011.10.010; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; THIEM SM, 1989, J VIROL, V63, P2008, DOI 10.1128/JVI.63.5.2008-2018.1989; Vanarsdall AL, 2004, VIROLOGY, V326, P191, DOI 10.1016/j.virol.2004.06.003; VANLENT JWM, 1990, ARCH VIROL, V111, P103, DOI 10.1007/BF01310508; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Xu F, 2011, VIRUS RES, V158, P1, DOI 10.1016/j.virusres.2011.02.014; Yuan MJ, 2011, J VIROL, V85, P11664, DOI 10.1128/JVI.05275-11; Zhang JH, 2005, J GEN VIROL, V86, P1619, DOI 10.1099/vir.0.80930-0	46	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65635	10.1371/journal.pone.0065635	http://dx.doi.org/10.1371/journal.pone.0065635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825525	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400014
J	Ha, DA; Goldberg, RJ; Allison, JJ; Chu, TH; Nguyen, HL				Duc Anh Ha; Goldberg, Robert J.; Allison, Jeroan J.; Thang Hong Chu; Nguyen, Hoa L.			Prevalence, Awareness, Treatment, and Control of High Blood Pressure: A Population-Based Survey in Thai Nguyen, Vietnam	PLOS ONE			English	Article							HYPERTENSION PREVALENCE; RISK-FACTORS; ADULTS; DISEASE; PROJECT; TRENDS; URBAN	Background: Cardiovascular disease (CVD) is one of the leading causes of morbidity and mortality in Vietnam and hypertension (HTN) is an important and prevalent risk factor for CVD in the adult Vietnamese population. Despite an increasing prevalence of HTN in this country, information about the awareness, treatment, and control of HTN is limited. The objectives of this study were to describe the prevalence, awareness, treatment, and control of HTN, and factors associated with these endpoints, in residents of a mountainous province in Vietnam. Methods: Data from 2,368 adults (age >= 25 years) participating in a population-based survey conducted in 2011 in Thai Nguyen province were analyzed. All eligible participants completed a structured questionnaire and were examined by community health workers using a standardized protocol. Results: The overall prevalence of HTN in this population was 23%. Older age, male sex, and being overweight were associated with a higher odds of having HTN, while higher educational level was associated with a lower odds of having HTN. Among those with HTN, only 34% were aware of their condition, 43% of those who were aware they had HTN received treatment and, of these, 39% had their HTN controlled. Conclusions: Nearly one in four adults in Thai Nguyen is hypertensive, but far fewer are aware of this condition and even fewer have their blood pressure adequately controlled. Public health strategies increasing awareness of HTN in the community, as well as improvements in the treatment and control of HTN, remain needed to reduce the prevalence of HTN and related morbidity and mortality.	[Duc Anh Ha] Minist Hlth, Hanoi, Vietnam; [Goldberg, Robert J.; Allison, Jeroan J.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Thang Hong Chu] Thai Nguyen Dept Hlth, Thai Nguyen, Vietnam; [Nguyen, Hoa L.] Inst Populat Hlth & Dev, Hanoi, Vietnam; [Nguyen, Hoa L.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Massachusetts System; University of Massachusetts Worcester; University of Oxford	Ha, DA (corresponding author), Minist Hlth, Hanoi, Vietnam.	ddha04@gmail.com	Nguyen, Hoa/AAA-5685-2020	Nguyen, Hoa/0000-0002-4998-8510; Allison, Jeroan/0000-0003-4472-2112	FIC NIH HHS [R21 TW009740] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R21TW009740] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Aekplakorn W, 2012, J HYPERTENS, V30, P1734, DOI 10.1097/HJH.0b013e3283568158; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Altun L, 2005, J HYPERTENS, V23, P1817; [Anonymous], 2011, VIETNAM BURDEN DIS I; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; Bovet P, 2003, J HYPERTENS, V21, P509, DOI 10.1097/00004872-200303000-00016; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; FARQUHAR JW, 1990, JAMA-J AM MED ASSOC, V264, P359, DOI 10.1001/jama.264.3.359; Gee ME, 2012, CAN J CARDIOL, V28, P375, DOI 10.1016/j.cjca.2011.12.012; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Houston TK, 2011, ANN INTERN MED, V154, P77, DOI 10.7326/0003-4819-154-2-201101180-00004; IBRAHIM MM, 1995, HYPERTENSION, V26, P886, DOI 10.1161/01.HYP.26.6.886; Jaddou HY, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/828797; Kaur P, 2012, INT J PUBLIC HEALTH, V57, P87, DOI 10.1007/s00038-011-0303-3; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Ministry of Health, 2011, HLTH STAT YB 2010; MOH, 2003, REP RES VIETN NAT HT; Muntner P, 2004, HYPERTENSION, V43, P578, DOI 10.1161/01.HYP.0000116302.08484.14; Nissinen A, 2004, J HUM HYPERTENS, V18, P553, DOI 10.1038/sj.jhh.1001696; Nissinen A, 2001, B WORLD HEALTH ORGAN, V79, P963; PUSKA P, 1983, BRIT MED J, V287, P1840, DOI 10.1136/bmj.287.6408.1840; Nguyen N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-325; Saeed AA, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/174135; Scheltens T, 2007, J HUM HYPERTENS, V21, P99, DOI 10.1038/sj.jhh.1002123; Son PT, 2012, J HUM HYPERTENS, V26, P268, DOI 10.1038/jhh.2011.18; Tunstall-Pedoe H, 2006, BRIT MED J, V332, P629, DOI 10.1136/bmj.38753.779005.BE; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; WILBER JA, 1972, AM J MED, V52, P653, DOI 10.1016/0002-9343(72)90055-1; WILBER JA, 1973, B NEW YORK ACAD MED, V49, P510; World Health Organization, 2007, RED SALT INT POP REP; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Wu Y, 2009, J HYPERTENS, V27, P190, DOI 10.1097/HJH.0b013e328317c8c3	34	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66792	10.1371/journal.pone.0066792	http://dx.doi.org/10.1371/journal.pone.0066792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826134	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000009
J	Gopal, K; Nagarajan, P; Jedy, J; Raj, AT; Gnanaselvi, SK; Jahan, P; Sharma, Y; Shankar, EM; Kumar, JM				Gopal, Kaliappan; Nagarajan, Perumal; Jedy, Jose; Raj, Avinash T.; Gnanaselvi, S. Kalai; Jahan, Parveen; Sharma, Yogendra; Shankar, Esaki M.; Kumar, Jerald M.			beta-Carotene Attenuates Angiotensin II-Induced Aortic Aneurysm by Alleviating Macrophage Recruitment in Apoe(-/-) Mice	PLOS ONE			English	Article							ALPHA-TOCOPHEROL; VITAMIN-E; ATHEROSCLEROTIC LESIONS; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE-9; ANTIOXIDANTS; RECEPTOR; INHIBIT	Abdominal aortic aneurysm (AAA) is a common chronic degenerative disease characterized by progressive aortic dilation and rupture. The mechanisms underlying the role of alpha-tocopherol and beta-carotene on AAA have not been comprehensively assessed. We investigated if alpha-tocopherol and beta-carotene supplementation could attenuate AAA, and studied the underlying mechanisms utilized by the antioxidants to alleviate AAA. Four-months-old Apoe(-/-) mice were used in the induction of aneurysm by infusion of angiotensin II (Ang II), and were orally administered with alpha-tocopherol and beta-carotene enriched diet for 60 days. Significant increase of LDL, cholesterol, triglycerides and circulating inflammatory cells was observed in the Ang II-treated animals, and gene expression studies showed that ICAM-1, VCAM-1, MCP-1, M-CSF, MMP-2, MMP-9 and MMP-12 were upregulated in the aorta of aneurysm-induced mice. Extensive plaques, aneurysm and diffusion of inflammatory cells into the tunica intima were also noticed. The size of aorta was significantly (P = 0.0002) increased (2.24 +/- 0.20 mm) in the aneurysm-induced animals as compared to control mice (1.17 +/- 0.06 mm). Interestingly, beta-carotene dramatically controlled the diffusion of macrophages into the aortic tunica intima, and circulation. It also dissolved the formation of atheromatous plaque. Further, beta-carotene significantly decreased the aortic diameter (1.33 +/- 0.12 mm) in the aneurysm-induced mice (beta-carotene, P = 0.0002). It also downregulated ICAM-1, VCAM-1, MCP-1, M-CSF, MMP-2, MMP-9, MMP-12, PPAR-alpha and PPAR-gamma following treatment. Hence, dietary supplementation of beta-carotene may have a protective function against Ang II-induced AAA by ameliorating macrophage recruitment in Apoe(-/-) mice.	[Gopal, Kaliappan; Jedy, Jose; Raj, Avinash T.; Gnanaselvi, S. Kalai; Sharma, Yogendra; Kumar, Jerald M.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Nagarajan, Perumal] Natl Inst Immunol, New Delhi 110067, India; [Jahan, Parveen] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Gopal, Kaliappan] Univ Malaya, Fac Med, Dept Orthoped, Natl Orthopaed Ctr Excellence Res & Learning, Kuala Lumpur, Malaysia; [Shankar, Esaki M.] Univ Malaya, Fac Med, Dept Med Microbiol, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur, Malaysia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Osmania University; Universiti Malaya; Universiti Malaya	Kumar, JM (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	mahesh73@ccmb.res.in	Shankar, EM/G-6444-2011; Perumal, Nagarajan/B-8736-2017; Muthu, Shankar Esaki/B-3132-2019; K, Gopal/D-6751-2012; Nagarajan, Perumal/AAJ-8599-2021; jahan, parveen/AAW-8428-2021	Perumal, Nagarajan/0000-0003-4557-4633; Muthu, Shankar Esaki/0000-0002-7866-9818; Nagarajan, Perumal/0000-0003-4557-4633; Parveen Jahan, DR/0000-0003-3203-1816	Indian Council of Medical Research, Government of India [IRIS ID. 2005-04430]	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, Government of India (Project IRIS ID. 2005-04430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alija AJ, 2010, ACTA BIOCHIM POL, V57, P1968; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Browatzki M, 2005, J VASC RES, V42, P415, DOI 10.1159/000087451; Carrell TWG, 1999, BRIT J SURG, V86, P305, DOI 10.1046/j.1365-2168.1999.01092.x; Chinetti G, 2001, NAT MED, V7, P33; Coll T, 2008, CURR MOL PHARM, V2, P46; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Gopal K, 2010, J THROMB THROMBOLYS, V30, P154, DOI 10.1007/s11239-010-0446-8; Grimaldi PA, 2007, CELL MOL LIFE SCI, V64, P2459, DOI 10.1007/s00018-007-7278-5; Jiang F, 2007, BRIT J PHARMACOL, V152, P880, DOI 10.1038/sj.bjp.0707449; Kaipainen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000260; Kaliappan G, 2012, J THROMB THROMBOLYSI; Koul A, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-14; Leeper NJ, 2009, AM J PHYSIOL-HEART C, V296, pH1329, DOI 10.1152/ajpheart.01341.2008; Manning MW, 2002, VASC MED, V7, P45, DOI 10.1191/1358863x02vm413ra; Meli DN, 2003, J INFECT DIS, V187, P1411, DOI 10.1086/374644; Munday JS, 1998, ARTERIOSCL THROM VAS, V18, P114, DOI 10.1161/01.ATV.18.1.114; Nakahashi TK, 2002, ARTERIOSCL THROM VAS, V22, P2017, DOI 10.1161/01.ATV.0000042082.38014.EA; PHONPANICHRASAMEE C, 1990, INT J VITAM NUTR RES, V60, P240; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; REAVEN PD, 1993, ARTERIOSCLER THROMB, V13, P590, DOI 10.1161/01.ATV.13.4.590; Reed A, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-32; Sadek M, 2008, SURGERY, V144, P252, DOI 10.1016/j.surg.2008.04.007; Shaish A, 1999, ARTERIOSCL THROM VAS, V19, P1470, DOI 10.1161/01.ATV.19.6.1470; SHAISH A, 1995, J CLIN INVEST, V96, P2075, DOI 10.1172/JCI118256; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sun JD, 1997, INT J VITAM NUTR RES, V67, P155; Takada T, 2010, MOL NUTR FOOD RES, V54, P616, DOI 10.1002/mnfr.200900481; Xiong WF, 2009, ATHEROSCLEROSIS, V202, P128, DOI 10.1016/j.atherosclerosis.2008.03.029; Ziegelstein RC, 2004, BIOCHEM BIOPH RES CO, V322, P68, DOI 10.1016/j.bbrc.2004.07.080; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	33	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67098	10.1371/journal.pone.0067098	http://dx.doi.org/10.1371/journal.pone.0067098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826202	Green Submitted, gold, Green Published			2022-12-27	WOS:000321150000026
J	Lowther, KM; Uliasz, TF; Gotz, KR; Nikolaev, VO; Mehlmann, LM				Lowther, Katie M.; Uliasz, Tracy F.; Goetz, Konrad R.; Nikolaev, Viacheslav O.; Mehlmann, Lisa M.			Regulation of Constitutive GPR3 Signaling and Surface Localization by GRK2 and beta-arrestin-2 Overexpression in HEK293 Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; 3RD INTRACELLULAR LOOP; MEIOTIC ARREST; MOLECULAR-CLONING; BETA-ARRESTINS; ALPHA(2)-ADRENERGIC RECEPTORS; INDEPENDENT REGULATION; CAMP CONCENTRATIONS; ENDOCYTIC VESICLES; LAEVIS OOCYTES	G protein-coupled receptor 3 (GPR3) is a constitutively active receptor that maintains high 3'-5'-cyclic adenosine monophosphate (cAMP) levels required for meiotic arrest in oocytes and CNS function. Ligand-activated G protein-coupled receptors (GPCRs) signal at the cell surface and are silenced by phosphorylation and beta-arrestin recruitment upon endocytosis. Some GPCRs can also signal from endosomes following internalization. Little is known about the localization, signaling, and regulation of constitutively active GPCRs. We demonstrate herein that exogenously-expressed GPR3 localizes to the cell membrane and undergoes internalization in HEK293 cells. Inhibition of endocytosis increased cell surface-localized GPR3 and cAMP levels while overexpression of GPCR-Kinase 2 (GRK2) and beta-arrestin-2 decreased cell surface-localized GPR3 and cAMP levels. GRK2 by itself is sufficient to decrease cAMP production but both GRK2 and beta-arrestin-2 are required to decrease cell surface GPR3. GRK2 regulates GPR3 independently of its kinase activity since a kinase inactive GRK2-K220R mutant significantly decreased cAMP levels. However, GRK2-K220R and beta-arrestin-2 do not diminish cell surface GPR3, suggesting that phosphorylation is required to induce GPR3 internalization. To understand which residues are targeted for desensitization, we mutated potential phosphorylation sites in the third intracellular loop and C-terminus and examined the effect on cAMP and receptor surface localization. Mutation of residues in the third intracellular loop dramatically increased cAMP levels whereas mutation of residues in the C-terminus produced cAMP levels comparable to GPR3 wild type. Interestingly, both mutations significantly reduced cell surface expression of GPR3. These results demonstrate that GPR3 signals at the plasma membrane and can be silenced by GRK2/beta-arrestin overexpression. These results also strongly implicate the serine and/or threonine residues in the third intracellular loop in the regulation of GPR3 activity.	[Lowther, Katie M.; Uliasz, Tracy F.; Mehlmann, Lisa M.] Univ Connecticut Hlth Ctr, Dept Cell Biol, Farmington, CT 06030 USA; [Goetz, Konrad R.; Nikolaev, Viacheslav O.] Univ Gottingen, Med Ctr, Heart Res Ctr Gottingen, European Heart Res Inst Gottingen,Dept Cardiol &, D-37073 Gottingen, Lower Saxony, Germany	University of Connecticut; University of Gottingen	Mehlmann, LM (corresponding author), Univ Connecticut Hlth Ctr, Dept Cell Biol, Farmington, CT 06030 USA.	lmehlman@neuron.uchc.edu	Nikolaev, Vyacheslav/AAT-7746-2020		National Institutes of Health [HD056366]; Deutsche Forschungsgemeinschaft [NI 1301/1-1]; University of Gottingen Medical Center "pro futura" grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Gottingen Medical Center "pro futura" grant	National Institutes of Health HD056366 to LMM, the Deutsche Forschungsgemeinschaft grant NI 1301/1-1 and the University of Gottingen Medical Center "pro futura" grant to VON. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Chee MJS, 2008, J BIOL CHEM, V283, P33337, DOI 10.1074/jbc.M804671200; Damaj BB, 1996, FASEB J, V10, P1426, DOI 10.1096/fasebj.10.12.8903513; Deng J, 2008, MOL ENDOCRINOL, V22, P1853, DOI 10.1210/me.2008-0124; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; DiLuigi A, 2008, BIOL REPROD, V78, P667, DOI 10.1095/biolreprod.107.066019; Droese J, 2004, BIOCHEM BIOPH RES CO, V322, P42, DOI 10.1016/j.bbrc.2004.07.076; Dupre DJ, 2007, CELL SIGNAL, V19, P481, DOI 10.1016/j.cellsig.2006.07.021; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; El-Jouni W, 2007, DEVELOPMENT, V134, P3307, DOI 10.1242/dev.005454; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Fernandez N, 2011, J BIOL CHEM, V286, P28697, DOI 10.1074/jbc.M111.269613; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Fraile-Ramos A, 2003, TRAFFIC, V4, P243, DOI 10.1034/j.1600-0854.2003.00079.x; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Iancu RV, 2008, AM J PHYSIOL-CELL PH, V295, pC414, DOI 10.1152/ajpcell.00038.2008; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Kovanci E, 2008, FERTIL STERIL, V90, P1269, DOI 10.1016/j.fertnstert.2007.07.1373; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leurs R, 1998, TRENDS BIOCHEM SCI, V23, P418, DOI 10.1016/S0968-0004(98)01287-0; Lowther KM, 2011, REPRODUCTION, V141, P737, DOI 10.1530/REP-10-0461; MAENHAUT C, 1990, BIOCHEM BIOPH RES CO, V173, P1169, DOI 10.1016/S0006-291X(05)80909-X; Mehlmann LM, 1998, DEV BIOL, V203, P221, DOI 10.1006/dbio.1998.9051; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Mokros T, 2002, J BIOL CHEM, V277, P45122, DOI 10.1074/jbc.M208214200; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Padmanabhan S, 2009, FEBS LETT, V583, P107, DOI 10.1016/j.febslet.2008.11.033; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Prezeau L, 1999, J BIOL CHEM, V274, P13462, DOI 10.1074/jbc.274.19.13462; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Rios-Cardona D, 2008, DEV BIOL, V317, P380, DOI 10.1016/j.ydbio.2008.02.047; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ruiz-Medina J, 2011, NEUROPHARMACOLOGY, V61, P43, DOI 10.1016/j.neuropharm.2011.02.014; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; SONG ZH, 1994, FEBS LETT, V351, P375, DOI 10.1016/0014-5793(94)00888-4; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Tanaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005922; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tourino C, 2012, BR J PHARM; Valverde O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004704; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Wade SM, 1999, MOL PHARMACOL, V56, P1005, DOI 10.1124/mol.56.5.1005; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Yang CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038807; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Zhang BL, 2012, J ZHEJIANG UNIV-SC B, V13, P555, DOI 10.1631/jzus.B1100353; Zhou SR, 2010, REPROD BIOMED ONLINE, V20, P53, DOI 10.1016/j.rbmo.2009.10.013	68	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e65365	10.1371/journal.pone.0065365	http://dx.doi.org/10.1371/journal.pone.0065365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826079	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000003
J	Massicot, F; Hache, G; David, L; Chen, D; Leuxe, C; Garnier-Legrand, L; Rat, P; Laprevote, O; Coudore, F				Massicot, France; Hache, Guillaume; David, Ludivine; Chen, Dominique; Leuxe, Charlotte; Garnier-Legrand, Laure; Rat, Patrice; Laprevote, Olivier; Coudore, Francois			P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo Approach	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; OXIDATIVE STRESS; NEUROPATHIC PAIN; RESAZURIN METABOLISM; P2X(7) PURINOCEPTOR; CHANNEL EXPRESSION; N-ACETYLCYSTEINE; DNA-ADDUCTS; CISPLATIN; ASSAY	Limited information is available regarding the cellular mechanisms of oxaliplatin-induced painful neuropathy during exposure of patients to this drug. We therefore determined oxidative stress in cultured cells and evaluated its occurrence in C57BL/ 6 mice. Using both cultured neuroblastoma (SH-SY5Y) and macrophage (RAW 264.7) cell lines and also brain tissues of oxaliplatin-treated mice, we investigated whether oxaliplatin (OXA) induces oxidative stress and apoptosis. Cultured cells were treated with 2-200 mu M OXA for 24 h. The effects of pharmacological inhibitors of oxidative stress or inflammation (N-acetyl cysteine, ibuprofen, acetaminophen) were also tested. Inhibitors were added 30 min before OXA treatment and then in combination with OXA for 24 h. In SH-SY5Y cells, OXA caused a significant dose-dependent decrease in viability, a large increase in ROS and NO production, lipid peroxidation and mitochondrial impairment as assessed by a drop in mitochondrial membrane potential, which are deleterious for the cell. An increase in levels of negatively charged phospholipids such as cardiolipin but also phosphatidylserine and phosphatidylinositol, was also observed. Additionally, OXA caused concentration-dependent P2X7 receptor activation, increased chromatin condensation and caspase-3 activation associated with TNF-alpha and IL-6 release. The majority of these toxic effects were equally observed in Raw 264.7 which also presented high levels of PGE2. Pretreatment of SH-SY5Y cells with pharmacological inhibitors significantly reduced or blocked all the neurotoxic OXA effects. In OXA-treated mice (28 mg/kg cumulated dose) significant cold hyperalgesia and oxidative stress in the tested brain areas were shown. Our study suggests that targeting P2X7 receptor activation and mitochondrial impairment might be a potential therapeutic strategy against OXA-induced neuropathic pain.	[Massicot, France; David, Ludivine; Chen, Dominique; Leuxe, Charlotte; Garnier-Legrand, Laure; Rat, Patrice; Laprevote, Olivier] Univ Paris 05, PRES Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Lab Chim Toxicol Analyt & Cellulaire,EA4463, Paris, France; [Hache, Guillaume; Coudore, Francois] Univ Paris 11, Fac Pharm, Lab NeuroPharmacol, EA3544,PRES Paris Saclay, F-92290 Chatenay Malabry, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Massicot, F (corresponding author), Univ Paris 05, PRES Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Lab Chim Toxicol Analyt & Cellulaire,EA4463, Paris, France.	france.massicot@parisdescartes.fr		Hache, Guillaume/0000-0002-6474-8101	Adebiopharm [ER67]	Adebiopharm	This work was supported by Adebiopharm ER67. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BH, 2010, BASIC CLIN PHARMACOL, V106, P272, DOI 10.1111/j.1742-7843.2009.00512.x; Anand U, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-82; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Baron JA, 2009, RECENT RESULTS CANC, V181, P223; Barriere DA, 2012, PAIN, V153, P553, DOI 10.1016/j.pain.2011.11.019; Basha Riyaz, 2011, Front Biosci (Schol Ed), V3, P797, DOI 10.2741/s188; Bernabucci M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-77; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Camu F, 2003, DRUGS, V63, P1, DOI 10.2165/00003495-200363001-00002; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Choucroun P, 2001, MUTAT RES-FUND MOL M, V478, P89, DOI 10.1016/S0027-5107(01)00123-3; Cunha TM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-63; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P2525; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dickey DT, 2005, J PHARMACOL EXP THER, V314, P1052, DOI 10.1124/jpet.105.087601; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Donzelli E, 2004, J NEURO-ONCOL, V67, P65, DOI 10.1023/B:NEON.0000021787.70029.ce; Du F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004593; Dunlap Beth, 2006, J Support Oncol, V4, P398; Dutot M, 2008, EUR J PHARM SCI, V33, P138, DOI 10.1016/j.ejps.2007.10.006; Dzagnidze A, 2007, J NEUROSCI, V27, P9451, DOI 10.1523/JNEUROSCI.0523-07.2007; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Eltom SE, 2011, J HEALTH CARE POOR U, V22, P3, DOI 10.1353/hpu.2011.0167; Fernandez MG, 2002, CELL GROWTH DIFFER, V13, P449; Ghazi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048351; Goodisman J, 2006, CANCER CHEMOTH PHARM, V57, P257, DOI 10.1007/s00280-005-0041-4; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Greco A, 2003, J NEUROSCI RES, V71, P844, DOI 10.1002/jnr.10543; Hache G, 2012, NEUROREPORT, V23, P525, DOI 10.1097/WNR.0b013e328353d70a; Hochberg MC, 2001, BEST PRACT RES CL RH, V15, P583, DOI 10.1053/berh.2001.0175; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Ibrahim A, 2004, ONCOLOGIST, V9, P8, DOI 10.1634/theoncologist.9-1-8; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Inoue K, 2012, EXP NEUROL, V234, P293, DOI 10.1016/j.expneurol.2011.09.016; Jamieson SMF, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-66; Jarvis MF, 2001, BRIT J PHARMACOL, V132, P259, DOI 10.1038/sj.bjp.0703793; Jerremalm E, 2009, J PHARM SCI-US, V98, P3879, DOI 10.1002/jps.21732; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Joseph EK, 2006, PAIN, V121, P105, DOI 10.1016/j.pain.2005.12.010; Joseph EK, 2008, J PAIN, V9, P463, DOI 10.1016/j.jpain.2008.01.335; Joseph EK, 2009, J PAIN, V10, P534, DOI 10.1016/j.jpain.2008.12.003; Kasseckert SA, 2012, NEUROSURGER IN PRESS; Kern W, 1999, CLIN CANCER RES, V5, P761; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929; Larsson KP, 2002, J NEUROCHEM, V83, P285; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; Ma W, 2003, NEUROSCIENCE, V121, P691, DOI 10.1016/S0306-4522(03)00495-0; Maciorowski Z, 1998, CYTOMETRY, V32, P44, DOI 10.1002/(SICI)1097-0320(19980501)32:1<44::AID-CYTO6>3.0.CO;2-F; Mannelli LD, 2012, J PAIN, V13, P276, DOI 10.1016/j.jpain.2011.11.009; MCCAFFREY TA, 1988, IN VITRO CELL DEV B, V24, P247; Mihara Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-8; Nakano A, 2011, INT J HEMATOL, V93, P727, DOI 10.1007/s12185-011-0850-7; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Neuwelt EA, 2004, J PHARMACOL EXP THER, V309, P594, DOI 10.1124/jpet.103.063347; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nishida K, 2012, J NEUROCHEM, V122, P1118, DOI 10.1111/j.1471-4159.2012.07868.x; Norcini M, 2009, PAIN, V146, P141, DOI 10.1016/j.pain.2009.07.017; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; PALMER DK, 1991, CELL IMMUNOL, V138, P473, DOI 10.1016/0008-8749(91)90170-G; Parada CA, 2003, EUR J NEUROSCI, V17, P1847, DOI 10.1046/j.1460-9568.2003.02626.x; Park SB, 2011, EXP NEUROL, V227, P120, DOI 10.1016/j.expneurol.2010.10.002; PENDYALA L, 1995, CANCER LETT, V97, P177, DOI 10.1016/0304-3835(95)03974-2; Perez-Medrano A, 2009, J MED CHEM, V52, P3366, DOI 10.1021/jm8015848; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Perrot S, 2003, TOXICOL SCI, V72, P122, DOI 10.1093/toxsci/kfg014; Perrot SB, 2003, CYTOM PART A, V55A, P7, DOI 10.1002/cyto.a.10067; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Piga R, 2007, NEUROTOXICOLOGY, V28, P67, DOI 10.1016/j.neuro.2006.07.006; Rainer Q, 2011, INT J NEUROPSYCHOPH, V8, P1; RAT P, 1994, CELL BIOL TOXICOL, V10, P329, DOI 10.1007/BF00755779; RAT P, 1995, METHOD ENZYMOL, V252, P331; Saris CP, 1996, CARCINOGENESIS, V17, P2763, DOI 10.1093/carcin/17.12.2763; Sarti P., 2002, Cell Death and Differentiation, V9, P1160, DOI 10.1038/sj.cdd.4401099; Schafers M, 2004, EXP NEUROL, V185, P160, DOI 10.1016/j.expneurol.2003.09.015; Scheuren N, 1998, BRIT J PHARMACOL, V123, P645, DOI 10.1038/sj.bjp.0701652; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Schwartz ES, 2009, J NEUROSCI, V29, P159, DOI 10.1523/JNEUROSCI.3792-08.2009; Sergeeva MG, 1997, BIOCHEMISTRY-MOSCOW+, V62, P269; Sittl R, 2012, P NATL ACAD SCI USA, V109, P6704, DOI 10.1073/pnas.1118058109; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; St-Jacques B, 2011, J NEUROCHEM, V118, P841, DOI 10.1111/j.1471-4159.2011.07230.x; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Ta LE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-9; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; Theile D, 2012, J PHARMACOL EXP THER, V341, P51, DOI 10.1124/jpet.111.189621; Thibault K, 2012, PAIN, V153, P1636, DOI 10.1016/j.pain.2012.04.016; Tonini G, 2002, J BIOL REG HOMEOS AG, V16, P105; Toulme E, 2010, TRANSLATIONAL PAIN R; Tripathy D, 2009, MICROVASC RES, V77, P289, DOI 10.1016/j.mvr.2009.02.002; Ushio S, 2012, EUR J CANCER, V48, P1407, DOI 10.1016/j.ejca.2011.08.009; van Leeuwen JS, 2012, TOXICOL IN VITRO, V26, P197, DOI 10.1016/j.tiv.2011.11.013; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Woynarowski JM, 2000, MOL PHARMACOL, V58, P920, DOI 10.1124/mol.58.5.920; Wu YJ, 2005, J PHARMACOL EXP THER, V312, P424, DOI 10.1124/jpet.104.075119; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; Zhang WJ, 2008, J CHROMATOGR B, V876, P277, DOI 10.1016/j.jchromb.2008.10.055	103	40	43	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66830	10.1371/journal.pone.0066830	http://dx.doi.org/10.1371/journal.pone.0066830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826152	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000015
J	Chan, BT; Abu Osman, NA; Lim, E; Chee, KH; Aziz, YFA; Al Abed, A; Lovell, NH; Dokos, S				Chan, Bee Ting; Abu Osman, Noor Azuan; Lim, Einly; Chee, Kok Han; Aziz, Yang Faridah Abdul; Al Abed, Amr; Lovell, Nigel H.; Dokos, Socrates			Sensitivity Analysis of Left Ventricle with Dilated Cardiomyopathy in Fluid Structure Simulation	PLOS ONE			English	Article							STRAIN-RATE; MYOCARDIAL-INFARCTION; WALL STRESS; DIASTOLIC FUNCTION; HEART-DISEASE; BLOOD-FLOW; DOPPLER; DYNAMICS; VORTEX; ECHOCARDIOGRAPHY	Dilated cardiomyopathy (DCM) is the most common myocardial disease. It not only leads to systolic dysfunction but also diastolic deficiency. We sought to investigate the effect of idiopathic and ischemic DCM on the intraventricular fluid dynamics and myocardial wall mechanics using a 2D axisymmetrical fluid structure interaction model. In addition, we also studied the individual effect of parameters related to DCM, i.e. peak E-wave velocity, end systolic volume, wall compliance and sphericity index on several important fluid dynamics and myocardial wall mechanics variables during ventricular filling. Intraventricular fluid dynamics and myocardial wall deformation are significantly impaired under DCM conditions, being demonstrated by low vortex intensity, low flow propagation velocity, low intraventricular pressure difference (IVPD) and strain rates, and high-end diastolic pressure and wall stress. Our sensitivity analysis results showed that flow propagation velocity substantially decreases with an increase in wall stiffness, and is relatively independent of preload at low-peak E-wave velocity. Early IVPD is mainly affected by the rate of change of the early filling velocity and end systolic volume which changes the ventriculo: annular ratio. Regional strain rate, on the other hand, is significantly correlated with regional stiffness, and therefore forms a useful indicator for myocardial regional ischemia. The sensitivity analysis results enhance our understanding of the mechanisms leading to clinically observable changes in patients with DCM.	[Chan, Bee Ting; Abu Osman, Noor Azuan; Lim, Einly] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia; [Chee, Kok Han] Univ Malaya, Dept Med, Fac Med Bldg, Kuala Lumpur, Malaysia; [Aziz, Yang Faridah Abdul] Univ Malaya, Fac Med, Dept Biomed Imaging, Res Imaging Ctr, Kuala Lumpur, Malaysia; [Al Abed, Amr; Lovell, Nigel H.; Dokos, Socrates] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of New South Wales Sydney	Chan, BT (corresponding author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia.	beetn_chan@yahoo.com	LIM, EINLY/B-8861-2010; Aziz, Yang Faridah Abdul/C-7945-2012; ABDUL AZIZ, YANG FARIDAH/C-1063-2010; Chan, Bee Ting/K-5202-2015; ABU OSMAN, NOOR AZUAN/B-9265-2010; Lovell, Nigel H/AGF-6679-2022; Chee, Kok Han/I-2138-2013	LIM, EINLY/0000-0003-2037-4213; Aziz, Yang Faridah Abdul/0000-0002-0869-1972; Chan, Bee Ting/0000-0002-6625-1430; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Lovell, Nigel H/0000-0003-1637-1079; Chee, Kok Han/0000-0002-4485-0504; Dokos, Socrates/0000-0002-7399-2712	University of Malaya/Ministry of Higher Education/High Impact Research (UM/MOHE/HIR) [D000014-16001]	University of Malaya/Ministry of Higher Education/High Impact Research (UM/MOHE/HIR)	This study was supported by University of Malaya/Ministry of Higher Education/High Impact Research (UM/MOHE/HIR) grant (Project number D000014-16001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alben S, 2011, INT J NONLIN MECH, V46, P586, DOI 10.1016/j.ijnonlinmec.2010.12.011; Baccani B, 2002, J BIOMECH, V35, P665, DOI 10.1016/S0021-9290(02)00005-2; Buakhamsri A, 2009, EUR HEART J, V30, P1213, DOI 10.1093/eurheartj/ehp084; Choi HF, 2010, J BIOMECH, V43, P1745, DOI 10.1016/j.jbiomech.2010.02.022; De Boeck BWL, 2005, EUR J HEART FAIL, V7, P19, DOI 10.1016/j.ejheart.2004.03.010; DOUGLAS PS, 1989, J AM COLL CARDIOL, V13, P311, DOI 10.1016/0735-1097(89)90504-4; Duan FX, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-8; Eriksson J, 2012, EUROPEAN HEART J CAR; FALK RH, 1992, AM HEART J, V123, P136, DOI 10.1016/0002-8703(92)90757-M; Firstenberg MS, 2000, J AM COLL CARDIOL, V36, P1942, DOI 10.1016/S0735-1097(00)00963-3; Firstenberg MS, 2001, CIRCULATION, V104, pI330; Garcia MJ, 1998, J AM COLL CARDIOL, V32, P865, DOI 10.1016/S0735-1097(98)00345-3; Garcia MJ, 1996, J AM COLL CARDIOL, V27, P108, DOI 10.1016/0735-1097(95)00434-3; Gjesdal O, 2008, CIRC-CARDIOVASC IMAG, V1, P189, DOI 10.1161/CIRCIMAGING.108.784900; GunjaSmith Z, 1996, AM J PATHOL, V148, P1639; Hanc J, 2004, AM J PHYS, V72, P514, DOI 10.1119/1.1645282; HAYASHIDA W, 1990, CIRCULATION, V82, P2075, DOI 10.1161/01.CIR.82.6.2075; Hong GR, 2008, JACC-CARDIOVASC IMAG, V1, P705, DOI 10.1016/j.jcmg.2008.06.008; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Jackson BM, 2003, AM J PHYSIOL-HEART C, V284, pH475, DOI 10.1152/ajpheart.00360.2002; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Khalafvand SS, 2011, COMPUT METHOD BIOMEC, V14, P113, DOI 10.1080/10255842.2010.493515; Loerakker S, 2008, COMPUT METHOD BIOMEC, V11, P649, DOI 10.1080/10255840802469379; MacGowan GA, 1997, CIRCULATION, V96, P535; MAZE SS, 1989, J AM COLL CARDIOL, V13, P873, DOI 10.1016/0735-1097(89)90230-1; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Ogden R.W., 2004, COMPUTATIONAL MECH; OHNO M, 1994, CIRCULATION, V89, P2241, DOI 10.1161/01.CIR.89.5.2241; Park TH, 2006, AM J PHYSIOL-HEART C, V290, pH724, DOI 10.1152/ajpheart.00714.2005; PARODI O, 1993, CIRCULATION, V88, P509, DOI 10.1161/01.CIR.88.2.509; Pasipoularides A, 2003, AM J PHYSIOL-HEART C, V284, pH1064, DOI 10.1152/ajpheart.00804.2002; Pislaru C, 2004, CIRCULATION, V109, P2905, DOI 10.1161/01.CIR.0000129311.73402.EF; Rodriguez L, 1996, AM HEART J, V131, P982, DOI 10.1016/S0002-8703(96)90183-0; Stoylen A, 2001, J AM SOC ECHOCARDIOG, V14, P264, DOI 10.1067/mje.2001.110375; Tibayan FA, 2003, J HEART VALVE DIS, V12, P292; Tulner SAF, 2006, J THORAC CARDIOV SUR, V132, P610, DOI 10.1016/j.jtcvs.2005.12.016; Veress AI, 2005, J BIOMECHANICAL ENG, V127; Voigt JU, 2002, J AM SOC ECHOCARDIOG, V15, P13, DOI 10.1067/mje.2002.116536; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882; Watanabe H, 2004, JSME INT J C-MECH SY, V47, P1019, DOI 10.1299/jsmec.47.1019; Yotti R, 2005, CIRCULATION, V112, P2921, DOI 10.1161/CIRCULATIONAHA.105.561340; Zabalgoitia M, 2001, AM J CARDIOL, V88, P521, DOI 10.1016/S0002-9149(01)01730-1; Zeng S, 2009, ECHOCARDIOGR-J CARD, V26, P163, DOI 10.1111/j.1540-8175.2008.00797.x; Zhang Y, 2005, J AM COLL CARDIOL, V46, P864, DOI 10.1016/j.jacc.2005.05.054	46	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67097	10.1371/journal.pone.0067097	http://dx.doi.org/10.1371/journal.pone.0067097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825628	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000079
J	Fetterman, JL; Pompilius, M; Westbrook, DG; Uyeminami, D; Brown, J; Pinkerton, KE; Ballinger, SW				Fetterman, Jessica L.; Pompilius, Melissa; Westbrook, David G.; Uyeminami, Dale; Brown, Jamelle; Pinkerton, Kent E.; Ballinger, Scott W.			Developmental Exposure to Second-Hand Smoke Increases Adult Atherogenesis and Alters Mitochondrial DNA Copy Number and Deletions in apoE(-/-) Mice	PLOS ONE			English	Article							TOBACCO-SMOKE; OXIDATIVE STRESS; MATERNAL HYPERCHOLESTEROLEMIA; ATHEROSCLEROTIC LESIONS; VITAL-STATISTICS; PASSIVE SMOKING; CARBON-MONOXIDE; HEART-DISEASE; FREE-RADICALS; DAMAGE	Cardiovascular disease is a major cause of morbidity and mortality in the United States. While many studies have focused upon the effects of adult second-hand smoke exposure on cardiovascular disease development, disease development occurs over decades and is likely influenced by childhood exposure. The impacts of in utero versus neonatal second-hand smoke exposure on adult atherosclerotic disease development are not known. The objective of the current study was to determine the effects of in utero versus neonatal exposure to a low dose (1 mg/m(3) total suspended particulate) of second-hand smoke on adult atherosclerotic lesion development using the apolipoprotein E null mouse model. Consequently, apolipoprotein E null mice were exposed to either filtered air or second-hand smoke: (i) in utero from gestation days 1-19, or (ii) from birth until 3 weeks of age (neonatal). Subsequently, all animals were exposed to filtered air and sacrificed at 12-14 weeks of age. Oil red-O staining of whole aortas, measures of mitochondrial damage, and oxidative stress were performed. Results show that both in utero and neonatal second-hand smoke exposure significantly increased adult atherogenesis in mice compared to filtered air controls. These changes were associated with changes in aconitase and mitochondrial superoxide dismutase activities consistent with increased oxidative stress in the aorta, changes in mitochondrial DNA copy number and deletion levels. These studies show that in utero or neonatal exposure to second-hand smoke significantly influences adult atherosclerotic lesion development and results in significant alterations to the mitochondrion and its genome that may contribute to atherogenesis.	[Fetterman, Jessica L.; Pompilius, Melissa; Westbrook, David G.; Brown, Jamelle; Ballinger, Scott W.] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Uyeminami, Dale; Pinkerton, Kent E.] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA; [Ballinger, Scott W.] Dept Pathol, Div Mol & Cellular Pathol, Birmingham, England	University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis	Ballinger, SW (corresponding author), Univ Alabama Birmingham, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA.	sballing@uab.edu		Brown, Jamelle/0000-0002-2040-0488; Pompilius, Melissa/0000-0002-3006-7930; Fetterman, Jessica/0000-0002-9286-7538	National Institutes of Health (NIH) [HL77419, HL94518, P60 DK079626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918, R01HL094518, R01HL077419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants HL77419 and HL94518 (SWB) and by the NIH funded Diabetes Research Training Center (P60 DK079626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, 2006, CIRCULATION, V105, P1; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Ballinger SW, 1996, CANCER RES, V56, P5692; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Bouhours-Nouet N, 2005, AM J PHYSIOL-ENDOC M, V288, pE171, DOI 10.1152/ajpendo.00260.2003; Cakir Y, 2007, FREE RADICAL BIO MED, V43, P1279, DOI 10.1016/j.freeradbiomed.2007.07.015; Coffman JA, 2007, DEV BIOL, V308, P266, DOI 10.1016/j.ydbio.2007.05.042; Coffman JA, 2009, SEMIN CELL DEV BIOL, V20, P321, DOI 10.1016/j.semcdb.2009.02.002; Coffman JA, 2009, DEV BIOL, V330, P123, DOI 10.1016/j.ydbio.2009.03.017; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; Freeman B A, 1995, Adv Pharmacol, V34, P45; Gairola CG, 2001, ATHEROSCLEROSIS, V156, P49, DOI 10.1016/S0021-9150(00)00621-3; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; GVOZDJAKOVA A, 1992, CARDIOLOGY, V81, P81, DOI 10.1159/000175780; GVOZDJAKOVA A, 1984, CARDIOVASC RES, V18, P229, DOI 10.1093/cvr/18.4.229; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; Harrison CM, 2011, ENVIRON HEALTH PERSP, V119, P676, DOI 10.1289/ehp.1002857; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Heron M, 2010, PEDIATRICS, V125, P4, DOI 10.1542/peds.2009-2416; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; KJELDSEN K, 1974, CIRC RES, V34, P339, DOI 10.1161/01.RES.34.3.339; Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977; Knudsen Thomas B, 2004, Birth Defects Res C Embryo Today, V72, P313, DOI 10.1002/bdrc.20028; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; MASSAELI H, 1995, CARDIOVASC RES, V29, P597; May-Panloup P, 2007, CURR TOP DEV BIOL, V77, P51, DOI 10.1016/S0070-2153(06)77003-X; McMahan CA, 2005, ARCH INTERN MED, V165, P883, DOI 10.1001/archinte.165.8.883; Miro O, 1999, CARCINOGENESIS, V20, P1331, DOI 10.1093/carcin/20.7.1331; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; THOMSEN HK, 1974, ARCH ENVIRON HEALTH, V29, P73, DOI 10.1080/00039896.1974.10666536; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Westbrook DG, 2010, CARDIOVASC TOXICOL, V10, P216, DOI 10.1007/s12012-010-9085-8; Witschi H, 1997, ANNU REV PHARMACOL, V37, P29, DOI 10.1146/annurev.pharmtox.37.1.29; Yang Z, 2004, CIRCULATION, V110, P3715, DOI 10.1161/01.CIR.0000149747.82157.01; Yang Z, 2007, MUTAT RES-FUND MOL M, V621, P61, DOI 10.1016/j.mrfmmm.2007.02.010; Yuan Hongwei, 2007, BMC Cardiovasc Disord, V7, P1, DOI 10.1186/1471-2261-7-1; Zieske AW, 2005, ATHEROSCLEROSIS, V180, P87, DOI 10.1016/j.atherosclerosis.2004.10.039; Zieske AW, 2002, PEDIATR PATHOL MOL M, V21, P213, DOI 10.1080/15227950252852104	53	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66835	10.1371/journal.pone.0066835	http://dx.doi.org/10.1371/journal.pone.0066835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825571	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000032
J	Heo, H; Park, JW; Park, SW				Heo, Hwan; Park, Jung Won; Park, Sang Woo			Light Transmission and Preference of Eye Patches for Occlusion Treatment	PLOS ONE			English	Article							RANDOMIZED-TRIAL; MODERATE AMBLYOPIA; CHILDREN; ATROPINE; THERAPY; PENALIZATION; EFFICACY	Purpose: To investigate light transmission and preference for six eye patches for occlusion therapy. Methods: Six patches were examined, including; Ortopad Fun Pack, Ortopad Flesh, Kawamoto A-1, Kawamoto A-2, 3M Opticlude, and Everade Eye Guard. The size and the presence of a light blocking pad of patches were investigated. The amount of light transmitted through the patches was evaluated, using a digital light meter and a model eye, in three different environments; indoors with fluorescent light, outdoors on a sunny day, and strong light from illuminator. After patching the normal eye, the flash visual evoked potential (VEP) was measured. Thirty patients with amblyopia or horizontal strabismus, who received occlusion therapy as initial treatment, were included. After using all six patches, patients completed a 7-item questionnaire regarding the patch preference for size, color and shape, adhesive power, pain with removal, skin irritation after removing patch, parent's preference and overall opinion. Results: All patches had a light-blocking pad, except the 3M Nexcare. Ortopad had the strongest light blocking power in the three environments, and the 3M Nexcare had the weakest power. In flash VEP, Ortopad and Kawamoto patches showed flat, but 3M Nexcare and Everade Eye Guard showed normal response. There were significant preferential differences among the patches in all the items of the questionnaire (P<0.05). In comparison between the patches respectively, 3M Nexcare received the lowest satisfaction in pain when removing a patch and skin irritation after removing a patch. Kawamoto A-2 received the lowest score in the overall satisfaction. Conclusions: We found differences in the light-blocking power and in the preference of the various patches for the occlusion treatment. This is a pilot study regarding only characteristics and preferences of patches. Further clinical studies regarding the relationship between characteristics or preferences of patches and outcomes of occlusion treatment are needed.	[Heo, Hwan; Park, Jung Won; Park, Sang Woo] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Kwangju, South Korea	Chonnam National University	Park, SW (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Kwangju, South Korea.	intereye@empal.com	HEO, HWAN/ABF-9441-2020; Heo, Hwan/G-7096-2015	HEO, HWAN/0000-0003-2169-8770; Heo, Hwan/0000-0003-2169-8770	Chonnam National University Hospital Research Institute of Clinical Medicine [CRI11071-1]	Chonnam National University Hospital Research Institute of Clinical Medicine	This study was supported by a grant (CRI11071-1) of the Chonnam National University Hospital Research Institute of Clinical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attebo K, 1998, OPHTHALMOLOGY, V105, P154, DOI 10.1016/S0161-6420(98)91862-0; Beardsell R, 1999, J PEDIAT OPHTH STRAB, V36, P19; Beneish RG, 2009, CAN J OPHTHALMOL, V44, P523, DOI 10.3129/i09-122; Cleary M, 2000, BRIT J OPHTHALMOL, V84, P572, DOI 10.1136/bjo.84.6.572; FIELDER AR, 1995, BRIT J OPHTHALMOL, V79, P585, DOI 10.1136/bjo.79.6.585; Figueira EC, 2006, CLIN EXP OPHTHALMOL, V34, P245, DOI 10.1111/j.1442-9071.2006.01199.x; FoleyNolan A, 1997, BRIT J OPHTHALMOL, V81, P54, DOI 10.1136/bjo.81.1.54; France TD, 1999, J AAPOS, V3, P341, DOI 10.1016/S1091-8531(99)70042-X; Goransson A, 1998, PATIENT EDUC COUNS, V34, P213, DOI 10.1016/S0738-3991(97)00111-0; HISCOX F, 1992, EYE, V6, P300, DOI 10.1038/eye.1992.59; Kowal Lionel, 2002, Binocul Vis Strabismus Q, V17, P275; Loudon S E, 2002, Strabismus, V10, P79, DOI 10.1076/stra.10.2.79.8143; NUCCI P, 1992, ACTA OPHTHALMOL, V70, P128; OLIVER M, 1986, AM J OPHTHALMOL, V102, P340, DOI 10.1016/0002-9394(86)90008-5; Repka MX, 2009, J AAPOS, V13, P258, DOI 10.1016/j.jaapos.2009.03.002; Repka MX, 2005, ARCH OPHTHALMOL-CHIC, V123, P149; REPKA MX, 1993, OPHTHALMOLOGY, V100, P769; Roefs AMJ, 2012, STRABISMUS, V20, P3, DOI 10.3109/09273972.2012.655837; Rutstein RP, 2010, OPHTHALMOLOGY, V117, P998, DOI 10.1016/j.ophtha.2009.10.014; Scheiman MM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1634, DOI 10.1001/archophthalmol.2008.107; Simons K, 1999, BRIT J OPHTHALMOL, V83, P582, DOI 10.1136/bjo.83.5.582; Simons K, 2005, SURV OPHTHALMOL, V50, P123, DOI 10.1016/j.survophthal.2004.12.005; SMITH LK, 1995, J PEDIATR OPHTHALMOL, V32, P98; SPOOR DK, 1979, OPHTHALMOLOGY, V86, P2152; WOODRUFF G, 1994, EYE, V8, P627, DOI 10.1038/eye.1994.157	25	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e68079	10.1371/journal.pone.0068079	http://dx.doi.org/10.1371/journal.pone.0068079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825695	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000129
J	Jia, LL; Li, XD; Shao, C; Wei, LL; Li, ML; Guo, ZG; Liu, ZH; Gao, YH				Jia, Lulu; Li, Xundou; Shao, Chen; Wei, Lilong; Li, Menglin; Guo, Zhengguang; Liu, Zhihong; Gao, Youhe			Using an Isolated Rat Kidney Model to Identify Kidney Origin Proteins in Urine	PLOS ONE			English	Article							TARGETED PROTEOMICS; BIOMARKERS; ORTHOLOGS; PARALOGS	The use of targeted proteomics to identify urinary biomarkers of kidney disease in urine can avoid the interference of serum proteins. It may provide better sample throughput, higher sensitivity, and specificity. Knowing which urinary proteins to target is essential. By analyzing the urine from perfused isolated rat kidneys, 990 kidney origin proteins with human analogs were identified in urine. Of these proteins, 128 were not found in normal human urine and may become biomarkers with zero background. A total of 297 proteins were not found in normal human plasma. These proteins will not be influenced by other normal organs and will be kidney specific. The levels of 33 proteins increased during perfusion with an oxygen-deficient solution compared to those perfused with oxygen. The 75 proteins in the perfusion-driven urine have a significantly increased abundance ranking compared to their ranking in normal human urine. When compared with existing candidate biomarkers, over ninety percent of the kidney origin proteins in urine identified in this study have not been examined as candidate biomarkers of kidney diseases.	[Jia, Lulu; Li, Xundou; Shao, Chen; Wei, Lilong; Li, Menglin; Guo, Zhengguang; Gao, Youhe] Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Dept Physiol & Pathophy, Beijing 100021, Peoples R China; [Liu, Zhihong] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing 210008, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Nanjing University	Gao, YH (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Dept Physiol & Pathophy, Beijing 100021, Peoples R China.	gaoyouhe@pumc.edu.cn	meng, li/GVT-2063-2022	Liu, Zhi-Hong/0000-0001-6093-0726	National Basic Research Program of China [2012CB517606, 2013CB530805, 2011CB964901]; National High Technology Research and Development Program of China [2011AA020116]; Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT [IRT0909]; 111 Project [B08007]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (2012CB517606, 2013CB530805, 2011CB964901), the National High Technology Research and Development Program of China (2011AA020116), Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT (IRT0909), and 111 Project (B08007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Decramer S, 2008, MOL CELL PROTEOMICS, V7, P1850, DOI 10.1074/mcp.R800001-MCP200; EPSTEIN FH, 1982, AM J PHYSIOL, V243, pF284, DOI 10.1152/ajprenal.1982.243.3.F284; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gutman S, 2006, NAT REV CANCER, V6, P565, DOI 10.1038/nrc1911; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Li QR, 2010, RAPID COMMUN MASS SP, V24, P823, DOI 10.1002/rcm.4441; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marimuthu A, 2011, J PROTEOME RES, V10, P2734, DOI 10.1021/pr2003038; Moon PG, 2011, PROTEOMICS, V11, P2459, DOI 10.1002/pmic.201000443; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pan S, 2005, MOL CELL PROTEOMICS, V4, P182, DOI 10.1074/mcp.M400161-MCP200; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Poola NR, 2002, J PHARM PHARM SCI, V5, P135; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Saha S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-12; Shao C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010975; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Taft David R, 2004, Curr Drug Discov Technol, V1, P97, DOI 10.2174/1570163043484824; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang Y, 2008, BIOCHEM BIOPH RES CO, V371, P385, DOI 10.1016/j.bbrc.2008.04.082; Wang Z, 2011, PROTEOMICS; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Ye Xiaoying, 2009, Briefings in Functional Genomics & Proteomics, V8, P126, DOI 10.1093/bfgp/eln050	30	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66911	10.1371/journal.pone.0066911	http://dx.doi.org/10.1371/journal.pone.0066911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825584	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000041
J	Praveen, BB; Mazilu, M; Marchington, RF; Herrington, CS; Riches, A; Dholakia, K				Praveen, Bavishna B.; Mazilu, Michael; Marchington, Robert F.; Herrington, C. Simon; Riches, Andrew; Dholakia, Kishan			Optimisation of Wavelength Modulated Raman Spectroscopy: Towards High Throughput Cell Screening	PLOS ONE			English	Article							FLUORESCENCE SUPPRESSION; SPECTRA; STRETCH	In the field of biomedicine, Raman spectroscopy is a powerful technique to discriminate between normal and cancerous cells. However the strong background signal from the sample and the instrumentation affects the efficiency of this discrimination technique. Wavelength Modulated Raman spectroscopy (WMRS) may suppress the background from the Raman spectra. In this study we demonstrate a systematic approach for optimizing the various parameters of WMRS to achieve a reduction in the acquisition time for potential applications such as higher throughput cell screening. The Signal to Noise Ratio (SNR) of the Raman bands depends on the modulation amplitude, time constant and total acquisition time. It was observed that the sampling rate does not influence the signal to noise ratio of the Raman bands if three or more wavelengths are sampled. With these optimised WMRS parameters, we increased the throughput in the binary classification of normal human urothelial cells and bladder cancer cells by reducing the total acquisition time to 6 s which is significantly lower in comparison to previous acquisition times required for the discrimination between similar cell types.	[Praveen, Bavishna B.; Mazilu, Michael; Marchington, Robert F.; Dholakia, Kishan] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews, Fife, Scotland; [Herrington, C. Simon; Riches, Andrew] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Herrington, C. Simon] Univ Dundee, Ninewells Hosp, Jacqui Wood Canc Ctr, Dundee, Scotland	University of St Andrews; University of St Andrews; University of Dundee	Praveen, BB (corresponding author), Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews, Fife, Scotland.	bb295@st-andrews.ac.uk	Herrington, C Simon/I-4895-2014; Mazilu, Michael/B-1852-2009; Herrington, C Simon/O-4688-2017; Marchington, Robert F/A-4863-2011	Herrington, C Simon/0000-0001-9177-8165; Mazilu, Michael/0000-0002-4758-3528; Herrington, C Simon/0000-0001-9177-8165; Dholakia, Kishan/0000-0001-6534-9009	CRUK/EPSRC/MRC/DoH (England) imaging Programme; Cancer Research UK [10329] Funding Source: researchfish	CRUK/EPSRC/MRC/DoH (England) imaging Programme; Cancer Research UK(Cancer Research UK)	The work was funded by CRUK/EPSRC/MRC/DoH (England) imaging Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGLEY RF, 1974, APPL PHYS LETT, V25, P387, DOI 10.1063/1.1655519; BRADLEY MS, 1992, J PHYS CHEM-US, V96, P75, DOI 10.1021/j100180a017; BRADLEY MS, 1993, J PHYS CHEM-US, V97, P575, DOI 10.1021/j100105a009; Bridges TE, 2004, ANAL CHEM, V76, P576, DOI 10.1021/ac034969s; BRUCKNER S, 1984, CHEM PHYS LETT, V105, P218, DOI 10.1016/0009-2614(84)85654-7; Carey PR, 1999, J BIOL CHEM, V274, P26625, DOI 10.1074/jbc.274.38.26625; Chan J, 2008, LASER PHOTONICS REV, V2, P325, DOI 10.1002/lpor.200810012; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; Cormack IG, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2756311; De Luca AC, 2010, ANAL CHEM, V82, P738, DOI 10.1021/ac9026737; Dochow S, 2011, LAB CHIP, V11, P1484, DOI 10.1039/c0lc00612b; FUNFSCHILLING J, 1976, APPL SPECTROSC, V30, P443, DOI 10.1366/000370276774457128; GALEENER FL, 1977, CHEM PHYS LETT, V48, P7, DOI 10.1016/0009-2614(77)80201-7; Harvey TJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2999609; HOCHMUTH RM, 1982, ANNU REV BIOPHYS BIO, V11, P43, DOI 10.1146/annurev.bb.11.060182.000355; Jess PRT, 2006, OPT EXPRESS, V14, P5779, DOI 10.1364/OE.14.005779; LEVIN KH, 1978, APPL PHYS LETT, V33, P817, DOI 10.1063/1.90539; MASTERS JRW, 1986, BRIT J CANCER, V54, P131, DOI 10.1038/bjc.1986.163; Matousek P, 1999, APPL SPECTROSC, V53, P1485, DOI 10.1366/0003702991945993; Mazilu M, 2010, OPT EXPRESS, V18, P11382, DOI 10.1364/OE.18.011382; McCain ST, 2008, OPT EXPRESS, V16, P10975, DOI 10.1364/OE.16.010975; Nijssen A, 2002, J INVEST DERMATOL, V119, P64, DOI 10.1046/j.1523-1747.2002.01807.x; Nijsssen A, 2009, J BIOPHOTONICS, V2, P29, DOI 10.1002/jbio.200810055; Praveen BB, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077006; Rusciano G, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2424674; Rusciano G, 2007, ANAL CHEM, V79, P3708, DOI 10.1021/ac070050n	26	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67211	10.1371/journal.pone.0067211	http://dx.doi.org/10.1371/journal.pone.0067211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825643	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000091
J	Renz, AJ; Meyer, A; Kuraku, S				Renz, Adina J.; Meyer, Axel; Kuraku, Shigehiro			Revealing Less Derived Nature of Cartilaginous Fish Genomes with Their Evolutionary Time Scale Inferred with Nuclear Genes	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; METABOLIC-RATE; CHONDRICHTHYES; SHARKS; GENERATION; ELASMOBRANCHS; PHYLOGENOMICS; HOLOCEPHALI; POSITION	Cartilaginous fishes, divided into Holocephali (chimaeras) and Elasmoblanchii (sharks, rays and skates), occupy a key phylogenetic position among extant vertebrates in reconstructing their evolutionary processes. Their accurate evolutionary time scale is indispensable for better understanding of the relationship between phenotypic and molecular evolution of cartilaginous fishes. However, our current knowledge on the time scale of cartilaginous fish evolution largely relies on estimates using mitochondrial DNA sequences. In this study, making the best use of the still partial, but large-scale sequencing data of cartilaginous fish species, we estimate the divergence times between the major cartilaginous fish lineages employing nuclear genes. By rigorous orthology assessment based on available genomic and transcriptomic sequence resources for cartilaginous fishes, we selected 20 protein-coding genes in the nuclear genome, spanning 2973 amino acid residues. Our analysis based on the Bayesian inference resulted in the mean divergence time of 421 Ma, the late Silurian, for the Holocephali-Elasmobranchii split, and 306 Ma, the late Carboniferous, for the split between sharks and rays/skates. By applying these results and other documented divergence times, we measured the relative evolutionary rate of the Hox A cluster sequences in the cartilaginous fish lineages, which resulted in a lower substitution rate with a factor of at least 2.4 in comparison to tetrapod lineages. The obtained time scale enables mapping phenotypic and molecular changes in a quantitative framework. It is of great interest to corroborate the less derived nature of cartilaginous fish at the molecular level as a genome-wide phenomenon.	[Renz, Adina J.; Meyer, Axel; Kuraku, Shigehiro] Univ Konstanz, Dept Biol, Chair Zool & Evolutionary Biol, Constance, Germany	University of Konstanz	Kuraku, S (corresponding author), RIKEN Ctr Dev Biol, Genome Resource & Anal Unit, Kobe, Hyogo, Japan.	shigehiro-kuraku@cdb.riken.jp	Meyer, Axel/C-9826-2009; Kuraku, Shigehiro/B-2801-2009	Meyer, Axel/0000-0002-0888-8193; Kuraku, Shigehiro/0000-0003-1464-8388	University of Konstanz; Deutsche Forschungsgemeinschaft (DFG) [KU2669/1-1]	University of Konstanz; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Young Scholar Fund of the University of Konstanz and the research grant (KU2669/1-1) from the Deutsche Forschungsgemeinschaft (DFG) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amemiya CT, 2010, P NATL ACAD SCI USA, V107, P3622, DOI 10.1073/pnas.0914312107; Arnason U, 2001, ZOOL SCR, V30, P249, DOI 10.1046/j.1463-6409.2001.00067.x; Aschliman NC, 2012, MOL PHYLOGENET EVOL, V63, P28, DOI 10.1016/j.ympev.2011.12.012; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Benton M, 2009, TIMETREE LIFE, P35; Bigelow H. B., 1954, Memoirs Sears Foundation for Marine Research, V1, P1; BIGELOW H. B., 1948, MEM SEARS FOUND MARINE RES [NEW HAVEN], V1, P1; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Casane D, 2013, BIOESSAYS, V35, P332, DOI 10.1002/bies.201200145; Coates MI, 2001, SYST ASSOC SPEC VOL, V61, P241; Compagno Leonard J.V., 2005, P4; Daubin V, 2001, Genome Inform, V12, P155; de Carvalho Marcelo R., 1996, P35, DOI 10.1016/B978-012670950-6/50004-7; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dessimoz C, 2011, BRIEF BIOINFORM, V12, P474, DOI 10.1093/bib/bbr038; Didier Dominique A, 1998, J Morphol, V236, P25, DOI 10.1002/(SICI)1097-4687(199804)236:1<25::AID-JMOR2>3.0.CO;2-N; Douady CJ, 2003, MOL PHYLOGENET EVOL, V26, P215, DOI 10.1016/S1055-7903(02)00333-0; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Grogan ED, 2004, CRC MAR BIOL SER, P3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hay JM, 2008, TRENDS GENET, V24, P106, DOI 10.1016/j.tig.2007.12.002; Hedges S. Blair, 2009, P383; Heinicke Matthew P., 2009, P320; Iglesias SP, 2005, MOL PHYLOGENET EVOL, V34, P569, DOI 10.1016/j.ympev.2004.10.022; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Ivanov Alexander, 2005, Revista Brasileira de Paleontologia, V8, P127; Janvier P., 1996, EARLY VERTEBRATES; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; King BL, 2011, SCIENCE, V334, P1517, DOI 10.1126/science.1210912; Klug S, 2010, ZOOL SCR, V39, P37, DOI 10.1111/j.1463-6409.2009.00399.x; Kuraku S, 2010, INTEGR COMP BIOL, V50, P124, DOI 10.1093/icb/icq044; Kuraku S, 2009, INT J DEV BIOL, V53, P765, DOI 10.1387/ijdb.072533km; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Li CH, 2012, MOL PHYLOGENET EVOL, V63, P365, DOI 10.1016/j.ympev.2012.01.013; Luer CA, 2007, ENVIRON BIOL FISH, V80, P239, DOI 10.1007/s10641-007-9219-4; MAISEY J G, 1986, Cladistics, V2, P201, DOI 10.1111/j.1096-0031.1986.tb00462.x; MAISEY JG, 1984, ZOOL J LINN SOC-LOND, V82, P33, DOI 10.1111/j.1096-3642.1984.tb00534.x; MAISEY JG, 2004, MESOZOIC FISHES, V3, P17; Mallatt J, 2007, MOL PHYLOGENET EVOL, V43, P1005, DOI 10.1016/j.ympev.2006.11.023; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN AP, 1992, NATURE, V357, P153, DOI 10.1038/357153a0; Martin AP, 1999, MOL BIOL EVOL, V16, P996, DOI 10.1093/oxfordjournals.molbev.a026189; Miller HC, 2009, TRENDS GENET, V25, P13, DOI 10.1016/j.tig.2008.09.007; Mulley JF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-218; NELSON J S, 1976, P416; Parton A, 2003, COMP BIOCHEM PHYS D, V5, P199; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Shirai S., 1992, SQUALEAN PHYLOGENY N; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Wang JL, 2009, MOL BIOL EVOL, V26, P487, DOI 10.1093/molbev/msn278; Winchell CJ, 2004, MOL PHYLOGENET EVOL, V31, P214, DOI 10.1016/j.ympev.2003.07.010; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	68	22	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66400	10.1371/journal.pone.0066400	http://dx.doi.org/10.1371/journal.pone.0066400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825540	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000018
J	Ramirez-Zamora, S; Mendez-Rodriguez, ML; Olguin-Martinez, M; Sanchez-Sevilla, L; Quintana-Quintana, M; Garcia-Garcia, N; Hernandez-Munoz, R				Ramirez-Zamora, Serafin; Mendez-Rodriguez, Miguel L.; Olguin-Martinez, Marisela; Sanchez-Sevilla, Lourdes; Quintana-Quintana, Miguel; Garcia-Garcia, Norberto; Hernandez-Munoz, Rolando			Increased Erythrocytes By-Products of Arginine Catabolism Are Associated with Hyperglycemia and Could Be Involved in the Pathogenesis of Type 2 Diabetes Mellitus	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; AMINO-ACID-TRANSPORT; OXIDATIVE STRESS; LIPID-PEROXIDATION; BLOOD-CELLS; METABOLISM; INSULIN; BIOENERGETICS; DYSFUNCTION; CITRULLINE	Diabetes mellitus (DM) is a worldwide disease characterized by metabolic disturbances, frequently associated with high risk of atherosclerosis and renal and nervous system damage. Here, we assessed whether metabolites reflecting oxidative redox state, arginine and nitric oxide metabolism, are differentially distributed between serum and red blood cells (RBC), and whether significant metabolism of arginine exists in RBC. In 90 patients with type 2 DM without regular treatment for diabetes and 90 healthy controls, paired by age and gender, we measured serum and RBC levels of malondialdehyde (MDA), nitrites, ornithine, citrulline, and urea. In isolated RBC, metabolism of L-[C-14]-arginine was also determined. In both groups, nitrites were equally distributed in serum and RBC; citrulline predominated in serum, whereas urea, arginine, and ornithine were found mainly in RBC. DM patients showed hyperglycemia and increased blood HbA(1C), and increased levels of these metabolites, except for arginine, significantly correlating with blood glucose levels. RBC were observed to be capable of catabolizing arginine to ornithine, citrulline and urea, which was increased in RBC from DM patients, and correlated with an increased affinity for arginine in the activities of putative RBC arginase (Km = 0.23 +/- 0.06 vs. 0.50 +/- 0.13 mM, in controls) and nitric oxide synthase (Km = 0.28 +/- 0.06 vs. 0.43 +/- 0.09 mM, in controls). In conclusion, our results suggest that DM alters metabolite distribution between serum and RBC, demonstrating that RBC regulate serum levels of metabolites which affect nitrogen metabolism, not only by transporting them but also by metabolizing amino acids such as arginine. Moreover, we confirmed that urea can be produced also by human RBC besides hepatocytes, being much more evident in RBC from patients with type 2 DM. These events are probably involved in the specific physiopathology of this disease, i.e., endothelial damage and dysfunction.	[Ramirez-Zamora, Serafin; Olguin-Martinez, Marisela; Sanchez-Sevilla, Lourdes; Garcia-Garcia, Norberto; Hernandez-Munoz, Rolando] Univ Nacl Autonoma Mexico, Depto Biol Celular, Inst Fisiol Celular, Mexico City, DF, Mexico; [Mendez-Rodriguez, Miguel L.] Escuela Medico Naval, Secretaria Marina Navy, Mexico City, DF, Mexico; [Quintana-Quintana, Miguel] Hosp Naval Alta Especialidad, Secretaria Marina Navy, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Hernandez-Munoz, R (corresponding author), Univ Nacl Autonoma Mexico, Depto Biol Celular, Inst Fisiol Celular, Mexico City, DF, Mexico.	rhernand@ifc.unam.mx			CONACYT [45352-Q]; PAPIIT-DGAPA, UNAM [IN 229703-3]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-DGAPA, UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by Institutional (Mexico) funding grants: from CONACYT (45352-Q) and from PAPIIT-DGAPA, UNAM (IN 229703-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuja PM, 2001, CLIN CHIM ACTA, V306, P1, DOI 10.1016/S0009-8981(01)00393-X; Agli AN, 1998, EUR J APPL PHYSIOL O, V78, P502, DOI 10.1007/s004210050452; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BEAUMIER L, 1995, AM J PHYSIOL-ENDOC M, V269, pE884, DOI 10.1152/ajpendo.1995.269.5.E884; CHRISTENSEN HN, 1982, PHYSIOL REV, V62, P1193, DOI 10.1152/physrev.1982.62.4.1193; Cosentino F, 1998, J CARDIOVASC PHARM, V32, pS54; CRANDALL EA, 1983, DIABETES, V32, P222, DOI 10.2337/diabetes.32.3.222; FAURE P, 1993, CLIN CHEM, V39, P789; FELIG P, 1973, P NATL ACAD SCI USA, V70, P1775, DOI 10.1073/pnas.70.6.1775; FERVENZA FC, 1990, NEPHROL DIAL TRANSPL, V5, P594, DOI 10.1093/ndt/5.8.594; FITZGIBBONS JF, 1976, J CLIN INVEST, V58, P820, DOI 10.1172/JCI108534; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; GERICH JE, 1974, J CLIN INVEST, V54, P833, DOI 10.1172/JCI107823; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GRIESMACHER A, 1995, AM J MED, V98, P469, DOI 10.1016/S0002-9343(99)80347-7; Hayashi T, 2005, P NATL ACAD SCI USA, V102, P13681, DOI 10.1073/pnas.0506595102; HECKER M, 1990, P NATL ACAD SCI USA, V87, P8612, DOI 10.1073/pnas.87.21.8612; HERNANDEZMUNOZ R, 1984, BIOCHEM PHARMACOL, V33, P2599, DOI 10.1016/0006-2952(84)90631-2; Hoeldtke RD, 2003, J CLIN ENDOCR METAB, V88, P1624, DOI 10.1210/jc.2002-021525; HUNT JV, 1990, DIABETES, V39, P1420, DOI 10.2337/diabetes.39.11.1420; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Kohli R, 2004, J NUTR, V134, P600, DOI 10.1093/jn/134.3.600; KRAFFCZYK F, 1971, CLIN CHIM ACTA, V31, P489, DOI 10.1016/0009-8981(71)90427-X; Li H, 2002, AM J PHYSIOL-REG I, V282, pR64, DOI 10.1152/ajpregu.2002.282.1.R64; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Lucotti P, 2006, AM J PHYSIOL-ENDOC M, V291, pE906, DOI 10.1152/ajpendo.00002.2006; Maeda T, 2006, BIOL PHARM BULL, V29, P234, DOI 10.1248/bpb.29.234; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; MOORE WT, 1964, CLIN CHEM, V10, P1059; MORGAN DML, 1994, BIOCHEM SOC T, V22, pS387, DOI 10.1042/bst022387s; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; OHTSUKA Y, 1988, BIOCHEM BIOPH RES CO, V155, P160, DOI 10.1016/S0006-291X(88)81063-5; OLIVES B, 1995, J BIOL CHEM, V270, P15607, DOI 10.1074/jbc.270.26.15607; Omodeo-Sale F, 2010, AM J PHYSIOL-CELL PH, V299, pC148, DOI 10.1152/ajpcell.00405.2009; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Paroni R, 2007, CLIN BIOCHEM, V40, P1398, DOI 10.1016/j.clinbiochem.2007.08.001; Remor AP, 2011, BBA-MOL BASIS DIS, V1812, P1460, DOI 10.1016/j.bbadis.2011.06.017; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Shab-Bidar S, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-125; Srinivasan S, 2004, DIABETOLOGIA, V47, P1727, DOI 10.1007/s00125-004-1525-1; Taysi S, 2002, RHEUMATOL INT, V21, P200, DOI 10.1007/s00296-001-0163-x; TUCKER EM, 1980, BIOCHEM J, V192, P33, DOI 10.1042/bj1920033; VANBROECKHOVEN CL, 1982, CLIN CHIM ACTA, V126, P209, DOI 10.1016/0009-8981(82)90294-7; VELAZQUEZ E, 1991, DIABETIC MED, V8, P752, DOI 10.1111/j.1464-5491.1991.tb01695.x; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Waugh WH, 2001, J NATL MED ASSOC, V93, P363; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Wu GY, 2000, J NUTR, V130, P2626, DOI 10.1093/jn/130.11.2626; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xu B, 2005, CLIN SCI, V109, P439, DOI 10.1042/CS20050183; YOUNG JD, 1980, PROC R SOC SER B-BIO, V209, P355, DOI 10.1098/rspb.1980.0100; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	58	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66823	10.1371/journal.pone.0066823	http://dx.doi.org/10.1371/journal.pone.0066823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826148	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400062
J	Rich, C; Geraci, M; Griffiths, L; Sera, F; Dezateux, C; Cortina-Borja, M				Rich, Carly; Geraci, Marco; Griffiths, Lucy; Sera, Francesco; Dezateux, Carol; Cortina-Borja, Mario			Quality Control Methods in Accelerometer Data Processing: Defining Minimum Wear Time	PLOS ONE			English	Article							PHYSICAL-ACTIVITY ASSESSMENT; EUROPEAN CHILDREN; PATTERNS; INACTIVITY; VALIDITY; SCHOOL; GIRLS	Background: When using accelerometers to measure physical activity, researchers need to determine whether subjects have worn their device for a sufficient period to be included in analyses. We propose a minimum wear criterion using population-based accelerometer data, and explore the influence of gender and the purposeful inclusion of children with weekend data on reliability. Methods: Accelerometer data obtained during the age seven sweep of the UK Millennium Cohort Study were analysed. Children were asked to wear an ActiGraph GT1M accelerometer for seven days. Reliability coefficients(r) of mean daily counts/minute were calculated using the Spearman-Brown formula based on the intraclass correlation coefficient. An r of 1.0 indicates that all the variation is between- rather than within-children and that measurement is 100% reliable. An r of 0.8 is often regarded as acceptable reliability. Analyses were repeated on data from children who met different minimum daily wear times (one to 10 hours) and wear days (one to seven days). Analyses were conducted for all children, separately for boys and girls, and separately for children with and without weekend data. Results: At least one hour of wear time data was obtained from 7,704 singletons. Reliability increased as the minimum number of days and the daily wear time increased. A high reliability (r = 0.86) and sample size (n = 6,528) was achieved when children with >= two days lasting >= 10 hours/day were included in analyses. Reliability coefficients were similar for both genders. Purposeful sampling of children with weekend data resulted in comparable reliabilities to those calculated independent of weekend wear. Conclusion: Quality control procedures should be undertaken before analysing accelerometer data in large-scale studies. Using data from children with >= two days lasting >= 10 hours/day should provide reliable estimates of physical activity. It's unnecessary to include only children with accelerometer data collected during weekends in analyses.	[Rich, Carly; Geraci, Marco; Griffiths, Lucy; Sera, Francesco; Dezateux, Carol; Cortina-Borja, Mario] UCL, Med Res Ctr Epidemiol Child Hlth, London, England	University of London; University College London	Rich, C (corresponding author), UCL, Med Res Ctr Epidemiol Child Hlth, London, England.	c.rich@ucl.ac.uk	Borja, Mario Cortina/A-3847-2009; Sera, Francesco/C-8176-2011; Geraci, Marco/B-9588-2009	Borja, Mario Cortina/0000-0003-0627-2624; Geraci, Marco/0000-0002-6311-8685; Sera, Francesco/0000-0002-8890-6848; Rich, Carly/0000-0003-4717-5855; Griffiths, Lucy/0000-0001-9230-624X; Dezateux, Carol/0000-0001-9787-6276	Wellcome Trust [084686/Z/08/A]; United Kingdom Medical Research Council [G0400546]; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Economic and Social Research Council; MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The MCS accelerometer project was funded by the Wellcome Trust (grant 084686/Z/08/A). The Medical Research Council Centre of Epidemiology for Child Health is supported by funds from the United Kingdom Medical Research Council (grant G0400546). Research at the University College London Institute of Child Health & Great Ormond Street Hospital for Children receives a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The Millennium Cohort Study is funded by grants to Centre for Longitudinal Studies at the Institute of Education from the Economic and Social Research Council and a consortium of government departments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Baranowski T, 2008, MED SCI SPORT EXER, V40, pS544, DOI 10.1249/MSS.0b013e31817c6651; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Escobar, 1998, STAT METHODS RELIABI; Esliger DW, 2010, MED SCI SPORT EXER, V42, P296, DOI 10.1249/MSS.0b013e3181b3afd2; ESLIGER DW, 2005, J PHYS ACT HEALTH, V3, P366; Fau Hinkley T, ASSESSING VOLUME ACC; Fletcher TD, 2012, R PACKAGE ICC1 LME I; Gidlow C, 2008, J SPORT SCI, V26, P1411, DOI 10.1080/02640410802277445; JANZ KF, 1994, MED SCI SPORT EXER, V26, P369; JANZ KF, 1995, MED SCI SPORT EXER, V27, P1326; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; McClain JJ, 2010, AM COLL SPORTS MED A; Murray DM, 2006, MED SCI SPORT EXER, V38, P926, DOI 10.1249/01.mss.0000218188.57274.91; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nilsson A, 2009, SCAND J MED SCI SPOR, V19, P10, DOI 10.1111/j.1600-0838.2007.00762.x; Owen CG, 2009, INT J EPIDEMIOL, V38, P1082, DOI 10.1093/ije/dyp176; Penpraze V, 2006, PEDIATR EXERC SCI, V18, P483, DOI 10.1123/pes.18.4.483; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Plewis I., 2007, MILLENNIUM COHORT ST; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Rowlands AV, 2008, PREV MED, V46, P317, DOI 10.1016/j.ypmed.2007.11.004; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Spearman CE, 1904, AM J PSYCHOL, V5, P201; Taylor RW, 2009, MED SCI SPORT EXER, V41, P96, DOI 10.1249/MSS.0b013e3181849d81; Team RDC, 2010, R LANG ENV STAT COMP; Thompson AM, 2009, INT J PEDIATR OBES, V4, P28, DOI 10.1080/17477160802170050; Treuth MS, 2003, MED SCI SPORT EXER, V35, P532, DOI 10.1249/01.MSS.0000053702.03884.3F; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2006, MED SCI SPORT EXER, V38, P380, DOI 10.1249/01.mss.0000183848.25845.e0; Tucker J, 2010, AM COLL SPORTS MED 2; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Venables WN., 2002, MODERN APPL STAT S 4	42	173	176	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67206	10.1371/journal.pone.0067206	http://dx.doi.org/10.1371/journal.pone.0067206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826236	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400119
J	Rong, MQ; Duan, ZG; Chen, JL; Li, JL; Xiao, YC; Liang, SP				Rong, Mingqiang; Duan, Zhigui; Chen, Juliang; Li, Jianglin; Xiao, Yuchen; Liang, Songping			Native Pyroglutamation of Huwentoxin-IV: A Post-Translational Modification that Increases the Trapping Ability to the Sodium Channel	PLOS ONE			English	Article							CHINESE BIRD SPIDER; TARANTULA CHILOBRACHYS-JINGZHAO; II VOLTAGE SENSOR; D-AMINO-ACID; SELENOCOSMIA-HUWENA; VENOM; CONOTOXINS; PEPTIDE; INHIBITION; NEUROTOXIN	Huwentoxin-IV (HWTX-IV), a tetrodotoxin-sensitive (TTX-s) sodium channel antagonist, is found in the venom of the Chinese spider Ornithoctonus huwena. A naturally modified HWTX-IV (mHWTX-IV), having a molecular mass 18 Da lower than HWTX-IV, has also been isolated from the venom of the same spider. By a combination of enzymatic fragmentation and MS/MS de novo sequencing, mHWTX-IV has been shown to have the same amino acid sequence as that of HWTX-IV, except that the N-terminal glutamic acid replaced by pyroglutamic acid. mHWTX-IV inhibited tetrodotoxin-sensitive voltage-gated sodium channels of dorsal root ganglion neurons with an IC50 nearly equal to native HWTX-IV. mHWTX-IV showed the same activation and inactivation kinetics seen for native HWTX-IV. In contrast with HWTX-IV, which dissociates at moderate voltage depolarization voltages (+50 mV, 180000 ms), mHWTX-IV inhibition of TTX-sensitive sodium channels is not reversed by strong depolarization voltages (+200 mV, 500 ms). Recovery of Nav1.7current was voltage-dependent and was induced by extreme depolarization in the presence of HWTX-IV, but no obvious current was elicited after application of mHWTX-IV. Our data indicate that the N-terminal modification of HWTX-IV gives the peptide toxin a greater ability to trap the voltage sensor in the sodium channel. Loss of a negative charge, caused by cyclization at the N-terminus, is a possible reason why the modified toxin binds much stronger. To our knowledge, this is the first report of a pyroglutamic acid residue in a spider toxin; this modification seems to increase the trapping ability of the voltage sensor in the sodium channel.	[Rong, Mingqiang; Duan, Zhigui; Chen, Juliang; Li, Jianglin; Xiao, Yuchen; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Rong, Mingqiang] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Yunnan, Peoples R China	Hunan Normal University; Chinese Academy of Sciences; Kunming Institute of Zoology	Liang, SP (corresponding author), Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China.	liangsp@hunnu.edu.cn			National 973 Project of China [2010CB529801, 2009BC526510]; Science Research Fund of the Hunan Provincial Education Department [10B049]; National Natural Science Foundation of China [31200590, 30900242, 3100047]; Hunan Education Department of Science and Technology Research Project [10C0961]	National 973 Project of China(National Basic Research Program of China); Science Research Fund of the Hunan Provincial Education Department(Hunan Provincial Education Department); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Education Department of Science and Technology Research Project	This work was supported by grants from the National 973 Project of China (2010CB529801, 2009BC526510), the Science Research Fund of the Hunan Provincial Education Department (10B049), the National Natural Science Foundation of China (31200590, 30900242), the National Natural Science Foundation of China (grant 3100047), the Hunan Education Department of Science and Technology Research Project (10C0961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Buczek O, 2005, FEBS J, V272, P4178, DOI 10.1111/j.1742-4658.2005.04830.x; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; Chen JJ, 2009, PEPTIDES, V30, P1042, DOI 10.1016/j.peptides.2009.02.018; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; Craig AG, 1997, J BIOL CHEM, V272, P4689, DOI 10.1074/jbc.272.8.4689; Deng MC, 2009, NEUROPHARMACOLOGY, V57, P77, DOI 10.1016/j.neuropharm.2009.04.009; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; GOREN HJ, 1977, MOL PHARMACOL, V13, P606; Jakubowski JA, 2004, ANAL CHEM, V76, P6541, DOI 10.1021/ac0494376; Li ZH, 2006, J BIOL CHEM, V281, P8628, DOI 10.1074/jbc.M513542200; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Morty RE, 2006, BIOCHEM J, V394, P635, DOI 10.1042/BJ20051593; Nillni EA, 1999, ENDOCRINE, V10, P185, DOI 10.1007/BF02738618; Nillni EA, 2007, ENDOCRINOLOGY, V148, P4191, DOI 10.1210/en.2007-0173; Peng K, 2001, TOXICON, V39, P491, DOI 10.1016/S0041-0101(00)00150-1; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Rigby AC, 1999, P NATL ACAD SCI USA, V96, P5758, DOI 10.1073/pnas.96.10.5758; Rong MQ, 2011, FASEB J, V25, P3177, DOI 10.1096/fj.10-178848; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Shu Q, 1999, J PEPT RES, V53, P486, DOI 10.1034/j.1399-3011.1999.00039.x; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Witt KA, 2001, PEPTIDES, V22, P2329, DOI 10.1016/S0196-9781(01)00537-X; Xiao YC, 2004, J BIOL CHEM, V279, P26220, DOI 10.1074/jbc.M401387200; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Yuan CH, 2007, J PROTEOME RES, V6, P2792, DOI 10.1021/pr0700192; Zhang PF, 2003, TOXICON, V42, P15, DOI 10.1016/S0041-0101(03)00095-3	36	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65984	10.1371/journal.pone.0065984	http://dx.doi.org/10.1371/journal.pone.0065984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826086	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400008
J	Yin, YW; Sun, QQ; Zhang, BB; Hu, AM; Liu, HL; Wang, Q; Hou, ZZ				Yin, Yan-Wei; Sun, Qian-Qian; Zhang, Bei-Bei; Hu, Ai-Min; Liu, Hong-Li; Wang, Qi; Hou, Zhi-Zhen			Association between Apolipoprotein E Gene Polymorphism and the Risk of Coronary Artery Disease in Chinese Population: Evidence from a Meta-Analysis of 40 Studies	PLOS ONE			English	Article							APOE; CLUSTER	Background: Epidemiological studies have evaluated the association between apolipoprotein E (ApoE) gene polymorphism and coronary artery disease (CAD) risk which developed inconsistent conclusions. To derive a more precise estimation of the relationship in Chinese population, we performed this meta-analysis. Methods: Databases, including PubMed, EMbase, Web of Science, CBMdisc and CNKI, were searched to get the genetic association studies. Additionally, hand searching of the references of identified articles were performed. All the statistical tests were performed using Review Manager 5.1.2 and Stata 11.0. Results: We identified a total of 40 studies, including 4,564 CAD cases and 3,985 controls. The results showed evidence for significant association between ApoE epsilon 4 allele and CAD risk (for epsilon 2/epsilon 4 vs. epsilon 3/epsilon 3: OR = 1.86, 95% CI = 1.42-2.43, p<0.00001; for epsilon 3/epsilon 4 vs. epsilon 3/epsilon 3: OR = 2.34, 95% CI = 2.07- 2.65, p<0.00001; for epsilon 4/epsilon 4 vs. epsilon 3/epsilon 3: OR = 2.89, 95% CI = 1.87-4.47, p<0.00001; for epsilon 4 allele vs. epsilon 3 allele: OR = 2.11, 95% CI = 1.91-2.35, p<0.00001). Conclusions: The present meta-analysis suggests an association between ApoE epsilon 4 allele and increased risk of CAD in Chinese population. However, due to the small sample size in most of the included studies and the selection bias existed in some studies, the results should be interpreted with caution.	[Yin, Yan-Wei; Hu, Ai-Min; Liu, Hong-Li; Wang, Qi; Hou, Zhi-Zhen] Chinese PLA AF Gen Hosp, Dept Emergency, Beijing, Peoples R China; [Sun, Qian-Qian] Jinsong Sanat Beijing AF, Beijing, Peoples R China; [Zhang, Bei-Bei] Gen Hosp PLA Chengdu Mil Area Command, Dept Med Affairs, Chengdu, Peoples R China		Yin, YW (corresponding author), Chinese PLA AF Gen Hosp, Dept Emergency, Beijing, Peoples R China.	shuaishuaijita@sohu.com						Bai X, 2001, Zhonghua Yi Xue Za Zhi, V81, P340; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Cao LC, 2003, J CHINESE PHYS, V5, P741; Cao W, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P249; Chu YR, 2007, PROG MOD BIOMED, V7, P244; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Feng SZ, 2005, GERIATR HLTH CARE, V11, P174; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong YD, 2009, J NEW CHINESE MED, V41, P42; [胡迎富 HU Ying-Fu], 2009, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V17, P765; [黄跃斌 HUANG Yue-Bin], 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P2864; Ji WD, 2009, CHINESE MENTAL HLTH, V15, P1; Lahiri DK, 2004, NEUROBIOL AGING, V25, P651, DOI 10.1016/j.neurobiolaging.2003.12.024; Li HM, 2003, CHIN J MOD MED, V13, P35; Li WH, 2000, CHIN J ARTERIOSCI, V8, P54; Liao MZ, 2004, PRACT PREV MED, V11, P691; [刘晓春 Liu Xiaochun], 2003, [上海医学检验杂志, Shanghai Journal of Medical Laboratory Sciences], V18, P36; Ma HS, 2006, BMC J, V29, P257; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Ordovas JM, 2000, BRIT J NUTR, V83, pS127; Ouyang Tao, 2005, Zhong Xi Yi Jie He Xue Bao, V3, P438; Pan JH, 2005, MED PHARM YUNNAN, V26, P500; Pan YY, 2001, J CLIN INTERN MED, V18, P267; Peng DQ, 2003, INT J CARDIOL, V92, P257, DOI 10.1016/S0167-5273(03)00101-3; Peng S, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P375; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pollin TI, 2004, ATHEROSCLEROSIS, V173, P89, DOI 10.1016/j.atherosclerosis.2003.11.012; [戚厚兴 QI Hou-Xing], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P329; [石玉荣 SHI Yu-rong], 2009, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V30, P85; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Sun HX, 2004, J BEIHUA U NATURAL S, V5, P534; Sun Z, 2008, MED J LIAONING, V22, P7; Wang CH, 2006, INT J HYG ENVIR HEAL, V209, P265, DOI 10.1016/j.ijheh.2005.12.005; Wang XC, 2008, J JILIN MED COLL, V29, P187; Wang XM, 2007, J CHANGSHA MED COLL, V6, P8; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Wu QP, 2005, CHIN J CLIN REHABILI, V9, P82; Wu XL, 2000, J NAVY MED, V21, P32; Xiang GD, 2005, CLIN MED CHINA, V21, P13; [Yang Shengli 杨胜利], 2003, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V11, P429; Zhang DW, 2004, MED J QILU, V19, P230; Zhang GB, 2001, CHIN J ARTERIOSCL, V9, P310; Zhang L, 2008, ACTA ACAD MED CPAF, V17, P572; Zhang WH, 2000, MED J CHINESE CIVIL, V12, P206; Zhang YL, 1998, CHIN J CARDIOL, V26, P443; Zhu DM, 1997, CHIN CIRC J, V12, P347; Zhu JY, 2002, CLIN MED J CHIN, V9, P224; Zhu TB, 2003, J NANJING MED U, V17, P82; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011; 李伟, 2003, [中华老年医学杂志, Chinese Journal of Geriatrics], V22, P214; 张少敏, 2001, 中国实用内科杂志, V21, P18	55	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66924	10.1371/journal.pone.0066924	http://dx.doi.org/10.1371/journal.pone.0066924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826174	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400084
J	Dixit, P; Dwivedi, LK; Ram, F				Dixit, Priyanka; Dwivedi, Laxmi Kant; Ram, Faujdar			Strategies to Improve Child Immunization via Antenatal Care Visits in India: A Propensity Score Matching Analysis	PLOS ONE			English	Article							AGED 12-23 MONTHS; NEONATAL-MORTALITY; PRENATAL-CARE; HEALTH-CARE; DETERMINANTS; COVERAGE; DISTRICT; PROGRAMS; URBAN	Numerous studies have examined the empirical evidence concerning the influence of demographic and socio-economic factors influencing child immunization, but no documentation is available which shows the actual impact of antenatal care (ANC) visits on subsequent child immunization. Therefore, this paper aims to examine the net impact of ANC visits on subsequent utilization of child immunization after removing the presence of selection bias. Nationwide data from India's latest National Family Health Survey conducted during 2005-06 is used for the present study. The analysis has been carried out in the two separate models, in the first model 1-2 ANC visit and in the second model three or more ANC visits has been compared with no visit. We have used propensity score matching method with a counterfactual model that assesses the actual ANC visits effect on treated (ANC visits) and untreated groups (no ANC visit), and have employed Mantel-Haenszel bounds to examine whether result would be free from hidden bias or not. Using matched sample analysis result shows that child immunization among the groups of women who have completed 1-2 ANC visits and those who had more than two visits was about 13 percent and 19 percent respectively, higher than the group of women who have not made any ANC visit. Findings of nearest neighbor matching with replacement method, which completely eliminated the bias, indicate that selection bias present in data set leads to overestimates the positive effects of ANC visits on child immunization. Result based on Mantel-Haenszel bounds method suggest that if around 19 percent bias would be involved in the result then also we could observe the true positive effect of 1-2 ANC visits on child immunization. This also indicates that antenatal clinics are the conventional platforms for educating pregnant women on the benefits of child immunization.	[Dixit, Priyanka; Ram, Faujdar] Int Inst Populat Sci, Bombay, Maharashtra, India; [Dwivedi, Laxmi Kant] Int Inst Populat Sci, Dept Math Demog & Stat, Bombay, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences	Dixit, P (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	dixit15bhu@gmail.com	Dwivedi, Laxmi Kant/ABC-8045-2020; Dwivedi, Laxmi Kant/GRX-4421-2022	Dwivedi, Laxmi Kant/0000-0001-9737-2844; Dwivedi, Laxmi Kant/0000-0001-9737-2844				Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; AHMAD J, 2010, J FAMILY WELFARE, V56; Ahmed S, 2002, DEMOGRAPHY, V39, P75, DOI 10.1353/dem.2002.0001; [Anonymous], 2012, UNICEF PROGR REPORT; Antai D, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.238; BALRAJ V, 1993, INT J EPIDEMIOL, V22, P1146, DOI 10.1093/ije/22.6.1146; BHATTACHARYYA S, 2012, QUAL CAR CHILDB CONT, V1, DOI DOI 10.3823/1101; Bondy JN, 2009, VACCINE, V27, P169, DOI 10.1016/j.vaccine.2008.08.042; Burns Ilene Timko, 2005, J Fam Pract, V54, pS58; Chen XK, 2007, AUST NZ J OBSTET GYN, V47, P122, DOI 10.1111/j.1479-828X.2007.00697.x; Choi JY, 2006, SOC SCI MED, V63, P107, DOI 10.1016/j.socscimed.2005.11.063; Conniffe D, 2000, ECON SOC REV, V31, P283; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Etana B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-566; Fatiregun AA, 2012, VACCINE, V30, P730, DOI 10.1016/j.vaccine.2011.11.082; Guo S.Y., 2014, PROPENSITY SCORE ANA; HARAHAP J, 2000, FACTORS AFFECTING CH; IIPS and ORC Macro, 2007, NAT FAM HLTH SURV 20; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Kusuma YS, 2010, TROP MED INT HEALTH, V15, P1326, DOI 10.1111/j.1365-3156.2010.02628.x; Lechner M, 2002, J R STAT SOC A STAT, V165, P59, DOI 10.1111/1467-985X.0asp2; Mathew JL, 2002, TROP DOCT, V32, P135, DOI 10.1177/004947550203200305; Matthews Z, 1997, J BIOSOC SCI, V29, P327, DOI 10.1017/S0021932097003271; Mavalankar DV, 2009, J HEALTH POPUL NUTR, V27, P235; Nath Bhola, 2007, Indian J Med Sci, V61, P598; Ozawa S, 2011, HEALTH POLICY PLANN, V26, pi20, DOI 10.1093/heapol/czr045; PANDEY S, 2011, HLTH ED J, DOI DOI 10.1177/0017896911419343.ACCESSED; Petrou S, 2003, EUR J OBSTET GYN R B, V106, P40, DOI 10.1016/S0301-2115(02)00215-4; Phathammavong O, 2010, SE ASIAN J TROP MED, V41, P705; Raatikainen K, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-268; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rowe R, 2006, EUR J PUBLIC HEALTH, V16, P4, DOI 10.1093/eurpub/ckl004; Roy SG., 2010, RISK FACTORS CHILDHO; Sanou A, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S10; SHARMA S, 2007, WORKING PAPER SERIES; Smith JA, 2005, J ECONOMETRICS, V125, P305, DOI 10.1016/j.jeconom.2004.04.011; Statacorp, 2007, STAT STAT SOFTW REL; Steele F, 1996, J ROY STAT SOC A STA, V159, P289, DOI 10.2307/2983175; Sullivan MC, 2010, J COMMUN HEALTH, V35, P53, DOI 10.1007/s10900-009-9192-2; Teklay Kidane, 2003, Ethiopian Journal of Health Development, V17, P105; Titaley CR, 2010, B WORLD HEALTH ORGAN, V88, P500, DOI 10.2471/BLT.09.065813; Titaley CR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-232; *UNICEF, 2012, UN INT AG GROUP CHIL; UNICEF, 2011, LEV TRENDS CHILD MOR; UNICEF World Health Organization, 2011, IMM SUMM STAT REF CO; Wadgave HV, 2012, ANN TROP MED PUBLIC, V5, P436, DOI 10.4103/1755-6783.105126; *WHO, 1994, WHO ANTENATAL CARE R; *WHO TWG, 1999, POSTP CAR MOTH NEWB, V26; Xie JP, 2005, SOC SCI MED, V61, P601, DOI 10.1016/j.socscimed.2004.12.016; Yanovitzky I, 2005, EVAL PROGRAM PLANN, V28, P209, DOI 10.1016/j.evalprogplan.2005.01.004; [No title captured]; [No title captured]	53	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66175	10.1371/journal.pone.0066175	http://dx.doi.org/10.1371/journal.pone.0066175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23824555	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400063
J	Jia, HP; Wang, CY; Wang, GB; Qu, L; Chen, WB; Chan, Q; Zhao, B				Jia, Haipeng; Wang, Cuiyan; Wang, Guangbin; Qu, Lei; Chen, Weibo; Chan, Queenie; Zhao, Bin			Impact of 3.0 T Cardiac MR Imaging Using Dual-Source Parallel Radiofrequency Transmission with Patient-Adaptive B1 Shimming	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; RF TRANSMISSION; BODY; PRECESSION; HEART; COIL	Objectives: To prospectively evaluate the impact of 3.0 T Cardiac MR imaging using dual-source parallel radiofrequency (RF) transmission with patient-adaptive B1 shimming compared with single-source RF transmission in the RF homogeneity, image contrast and image quality. Methods: The study was approved by the local institutional review board, and all subjects provided written informed consent. Fourteen healthy volunteers were examined at 3.0 T MR, with both the conventional single-source and the new dual-source RF transmission. B1 calibrations (RF shimming) of the heart region were performed to acquire a percent of the prescribed flip angle (FA) of B1 maps, which were used for quantitative assessment of RF homogeneity. Contrast ratios (CRs) between ventricular blood pool and septum were calculated on balanced-turbo field echo (B-TFE) cine images. The off-resonance artifacts of cine images were blindly assessed by two radiologists according to a 4-point grading-scale. Results: A significantly lower mean coefficients of variance of the achieved FA with dual-source revealed better RF homogeneity compared to single-source (P = 0.0094). Dual-source RF shimming significantly increased the CRs (P<0.05) and reduced the off-resonance artifacts of B-TFE cine images (P<0.05). Inter-observer agreement for the off-resonance artifacts of B-TFE cine images was good to excellent (k >0.65). Conclusions: Dual-source parallel RF transmission significantly improves the RF homogeneity, increases image contrast and reduces image artifacts of cardiac B-TFE images compared to single-source mode. This may be of value in reducing the observer-dependence of cardiac MR images and enhancing diagnostic confidence for clinical practice using CMR at 3.0 T.	[Jia, Haipeng; Wang, Cuiyan; Wang, Guangbin; Qu, Lei; Zhao, Bin] Shandong Univ, Shandong Med Imaging Res Inst, Jinan 250100, Peoples R China; [Chen, Weibo; Chan, Queenie] Philips Ltd China, MR Res Collaborat, Shanghai, Peoples R China	Shandong University; Philips	Zhao, B (corresponding author), Shandong Univ, Shandong Med Imaging Res Inst, Jinan 250100, Peoples R China.	cjr.zhaobin@vip.163.com	jia, haipeng/ABB-2498-2020	Jia, Haipeng/0000-0003-0186-5703	Provincial Natural Science Foundation of Shandong [ZR2012HM042]	Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	This study was supported by Provincial Natural Science Foundation of Shandong (ZR2012HM042); http://www.sdnsf.gov.cn/portal/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhausen J, 2001, RADIOLOGY, V219, P264, DOI 10.1148/radiology.219.1.r01ap12264; Caudron J, 2011, EUR RADIOL, V21, P2111, DOI 10.1007/s00330-011-2152-0; Childs AS, 2013, MAGN RESON MATER PHY, V26, P401, DOI 10.1007/s10334-012-0360-5; Cunningham CH, 2006, MAGN RESON MED, V55, P1326, DOI 10.1002/mrm.20896; Franklin KM, 2008, J MAGN RESON IMAGING, V27, P1443, DOI 10.1002/jmri.21164; Hussain S, 2011, J CARDIOVASC MAGN S1, V13, pO10; Katscher U, 2006, NMR BIOMED, V19, P393, DOI 10.1002/nbm.1049; Krishnamurthy R, 2011, P 19 ANN M ISMRM MON; Kubach MR, 2009, PHYS MED BIOL, V54, pN467, DOI 10.1088/0031-9155/54/20/N01; Kuhl CK, 2008, RADIOLOGY, V246, P675, DOI 10.1148/radiol.2463060881; Lee VS, 2007, RADIOLOGY, V244, P692, DOI 10.1148/radiol.2443060582; Mihara H, 1998, MAGN RESON MATER PHY, V7, P115; Mueller A, 2012, RADIOLOGY, V263, P77, DOI 10.1148/radiol.11110347; Nelles M, 2010, RADIOLOGY, V257, P743, DOI 10.1148/radiol.10092146; Oshinski JN, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-55; Plein S, 2001, J MAGN RESON IMAGING, V14, P230, DOI 10.1002/jmri.1178; Ridgway JP, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-71; Saremi F, 2008, RADIOGRAPHICS, V28, P1161, DOI 10.1148/rg.284065718; Schar M, 2004, MAGN RESON MED, V51, P799, DOI 10.1002/mrm.20024; Setsompop K, 2006, MAGN RESON MED, V56, P1163, DOI 10.1002/mrm.21042; Vernickel P, 2007, MAGN RESON MED, V58, P381, DOI 10.1002/mrm.21294; Weisser-Thomas J, 2010, J CARDIOVASC MAGN S1, pO72; Wieben O, 2008, EUR J RADIOL, V65, P15, DOI 10.1016/j.ejrad.2007.10.022; Willinek WA, 2007, EUR RADIOL, V17, P618, DOI 10.1007/s00330-006-0406-z; Willinek WA, 2010, RADIOLOGY, V256, P966, DOI 10.1148/radiol.10092127; Wong KKL, 2012, COMPUT MED IMAG GRAP, V36, P527, DOI 10.1016/j.compmedimag.2012.04.003; Wong KKL, 2009, J MECH MED BIOL, V9, P1, DOI 10.1142/S0219519409002894; Wong KKL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005688; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Zhai Z, 2007, MR involving high speed coil mode switching between I-channel linear, Q-channel linear, quadrature and anti-quadrature modes, Patent No. [WO2007/124246, 2007124246]	30	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66946	10.1371/journal.pone.0066946	http://dx.doi.org/10.1371/journal.pone.0066946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825592	Green Submitted, gold, Green Published			2022-12-27	WOS:000320576400170
J	Najumudeen, AK; Kohnke, M; Solman, M; Alexandrov, K; Abankwa, D				Najumudeen, Arafath Kaja; Kohnke, Monika; Solman, Maja; Alexandrov, Kirill; Abankwa, Daniel			Cellular FRET-Biosensors to Detect Membrane Targeting Inhibitors of N-Myristoylated Proteins	PLOS ONE			English	Article							H-RAS; PLASMA-MEMBRANE; METHIONINE AMINOPEPTIDASE; CANCER-THERAPY; IN-VIVO; MYRISTOYLTRANSFERASE; NANOCLUSTERS; TRANSFORMATION; SEQUENCE; PALMITOYLATION	Hundreds of eukaryotic signaling proteins require myristoylation to functionally associate with intracellular membranes. N-myristoyl transferases (NMT) responsible for this modification are established drug targets in cancer and infectious diseases. Here we describe NANOMS (NANOclustering and Myristoylation Sensors), biosensors that exploit the FRET resulting from plasma membrane nanoclustering of myristoylated membrane targeting sequences of G alpha(12), Yes- or Src-kinases fused to fluorescent proteins. When expressed in mammalian cells, NANOMS report on loss of membrane anchorage due to chemical or genetic inhibition of myristoylation e. g. by blocking NMT and methionine-aminopeptidase (Met-AP). We used Yes-NANOMS to assess inhibitors of NMT and a cherry-picked compound library of putative Met-AP inhibitors. Thus we successfully confirmed the activity of DDD85646 and fumagillin in our cellular assay. The developed assay is unique in its ability to identify modulators of signaling protein nanoclustering, and is amenable to high throughput screening for chemical or genetic inhibitors of functional membrane anchorage of myristoylated proteins in mammalian cells.	[Najumudeen, Arafath Kaja; Solman, Maja; Abankwa, Daniel] Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland; [Kohnke, Monika; Alexandrov, Kirill; Abankwa, Daniel] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Abo Akademi University; University of Turku; University of Queensland	Alexandrov, K (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	k.alexandrov@uq.edu.au; daniel.abankwa@btk.fi	Najumudeen, Arafath/AAH-2250-2020; Alexandrov, Kirill/A-5830-2013	Najumudeen, Arafath/0000-0002-3764-5721; Alexandrov, Kirill/0000-0002-0957-6511; Abankwa, Daniel/0000-0003-2769-0745	National Health and Medical Research Council, Australia [569652]; ARC, Australia [DP1094080]; Academy of Finland fellowship [252381]; Sigrid Juselius Foundation; Cancer Society of Finland; Marie-Curie Reintegration [268271]; graduate school, National Doctoral Programme in Informational and Structural Biology (ISB); Cancer Foundation Finland sr [100073] Funding Source: researchfish	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); ARC, Australia(Australian Research Council); Academy of Finland fellowship; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Marie-Curie Reintegration(European Commission); graduate school, National Doctoral Programme in Informational and Structural Biology (ISB); Cancer Foundation Finland sr	This work was supported National Health and Medical Research Council grant 569652 (Australia), ARC grant DP1094080 (Australia) (www.nhmrc.gov. au/www.arc.gov.au/). Additional support was provided by the Academy of Finland fellowship grant (252381), the Sigrid Juselius Foundation, the Cancer Society of Finland and the Marie-Curie Reintegration Grant to DA (268271). AKN is grateful for support by the graduate school, National Doctoral Programme in Informational and Structural Biology (ISB) (http://web.abo.fi/isb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bhandarkar SS, 2008, CLIN CANCER RES, V14, P5743, DOI 10.1158/1078-0432.CCR-08-0405; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Draper JM, 2009, MOL MEMBR BIOL, V26, P5, DOI 10.1080/09687680802683839; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gelb MH, 2003, MOL BIOCHEM PARASIT, V126, P155, DOI 10.1016/S0166-6851(02)00282-7; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Goncalves V, 2012, ANAL BIOCHEM, V421, P342, DOI 10.1016/j.ab.2011.10.013; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Harrington JM, 2010, J BIOL CHEM, V285, P28659, DOI 10.1074/jbc.M110.151886; Hedberg C, 2011, ANGEW CHEM INT EDIT, V50, P9832, DOI 10.1002/anie.201102965; Hu X, 2007, CHEM BIOL, V14, P764, DOI 10.1016/j.chembiol.2007.05.010; Hu XY, 2006, P NATL ACAD SCI USA, V103, P18148, DOI 10.1073/pnas.0608389103; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Kinder FR, 2001, J MED CHEM, V44, P3692; Kohnke M, 2012, CHEM BIOL, V19, P866, DOI 10.1016/j.chembiol.2012.05.019; Li ZL, 2012, J AM CHEM SOC, V134, P17278, DOI 10.1021/ja307716z; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Maurer-Stroh S, 2004, TRENDS MICROBIOL, V12, P178, DOI 10.1016/j.tim.2004.02.006; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Mugler A, 2013, P NATL ACAD SCI USA, V110, P5927, DOI 10.1073/pnas.1218301110; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rampoldi F, 2012, J LIPID RES, V53, P2459, DOI 10.1194/jlr.D026997; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; ROCQUE WJ, 1993, J BIOL CHEM, V268, P9964; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Selvakumar P, 2007, PROG LIPID RES, V46, P1, DOI 10.1016/j.plipres.2006.05.002; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Thale Z, 2001, J ORG CHEM, V66, P1733, DOI 10.1021/jo001380+; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wedegaertner PB, 1998, BIOL SIGNAL RECEPT, V7, P125; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Yang SH, 2005, J BIOL CHEM, V280, P18990, DOI 10.1074/jbc.M412917200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	58	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66425	10.1371/journal.pone.0066425	http://dx.doi.org/10.1371/journal.pone.0066425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824448	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400108
J	Nakaya, T; Ishiguro, K; Belzil, C; Rietsch, AM; Yu, QY; Mizuno, S; Bronson, RT; Geng, Y; Nguyen, MD; Akashi, K; Sicinski, P; Nakatani, Y				Nakaya, Takeo; Ishiguro, Kei-ichiro; Belzil, Camille; Rietsch, Anna M.; Yu, Qunyan; Mizuno, Shin-ichi; Bronson, Roderick T.; Geng, Yan; Minh Dang Nguyen; Akashi, Koichi; Sicinski, Piotr; Nakatani, Yoshihiro			p600 Plays Essential Roles in Fetal Development	PLOS ONE			English	Article							END RULE PATHWAY; FOCAL ADHESION KINASE; AUXIN TRANSPORT; PROTEIN; IDENTIFICATION; GENES	p600 is a multifunctional protein implicated in cytoskeletal organization, integrin-mediated survival signaling, calcium-calmodulin signaling and the N-end rule pathway of ubiquitin-proteasome-mediated proteolysis. While push, the Drosophila counterpart of p600, is dispensable for development up to adult stage, the role of p600 has not been studied during mouse development. Here we generated p600 knockout mice to investigate the in vivo functions of p600. Interestingly, we found that homozygous deletion of p600 results in lethality between embryonic days 11.5 and 13.5 with severe defects in both embryo and placenta. Since p600 is required for placental development, we performed conditional disruption of p600, which deletes selectively p600 in the embryo but not in the placenta. The conditional mutant embryos survive longer than knockout embryos but ultimately die before embryonic day 14.5. The mutant embryos display severe cardiac problems characterized by ventricular septal defects and thin ventricular walls. These anomalies are associated with reduced activation of FAK and decreased expression of MEF2, which is regulated by FAK and plays a crucial role in cardiac development. Moreover, we observed pleiotropic defects in the liver and brain. In sum, our study sheds light on the essential roles of p600 in fetal development.	[Nakaya, Takeo; Ishiguro, Kei-ichiro; Rietsch, Anna M.; Yu, Qunyan; Geng, Yan; Sicinski, Piotr; Nakatani, Yoshihiro] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Nakaya, Takeo; Ishiguro, Kei-ichiro; Rietsch, Anna M.; Yu, Qunyan; Mizuno, Shin-ichi; Geng, Yan; Akashi, Koichi; Sicinski, Piotr; Nakatani, Yoshihiro] Harvard Univ, Sch Med, Boston, MA USA; [Nakaya, Takeo] Tokyo Med Univ, Translat Res Unit, Shinjuku Ku, Tokyo 1608402, Japan; [Nakaya, Takeo] Tokyo Med Univ, Dept Mol Pathol, Shinjuku Ku, Tokyo 1608402, Japan; [Ishiguro, Kei-ichiro] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; [Belzil, Camille; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Mizuno, Shin-ichi; Akashi, Koichi] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Mizuno, Shin-ichi; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Bronson, Roderick T.] Harvard Univ, Sch Med, Dana Farber Harvard Canc Ctr, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Tokyo Medical University; Tokyo Medical University; University of Tokyo; University of Calgary; Harvard University; Dana-Farber Cancer Institute; Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Nakatani, Y (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	yoshihiro_nakatani@dfci.harvard.edu	Ishiguro, Kei-ichiro/K-3340-2019	Ishiguro, Kei-ichiro/0000-0002-7515-1511	National Institutes of Health [R01CA138866, R01CA108950]; Uehara foundation; Japan Society for the Promotion of Science; AIHS; NATIONAL CANCER INSTITUTE [R01CA138866, R01CA108950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AIHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants (R01CA138866 to YN and R01CA108950 to PS). TN was supported by Uehara foundation fellowship for research abroad. KI was supported by Japan Society for the Promotion of Science fellowship for research abroad, the Grant-in-Aid for Scientific Research on Priority Areas, a Grant in-Aid for Scientific Research on Innovative Areas and Grant in-Aid for Young Scientists. CB was supported by an AIHS doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; DeMasi J, 2005, P NATL ACAD SCI USA, V102, P11486, DOI 10.1073/pnas.0505322102; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakatani Y, 2005, P NATL ACAD SCI USA, V102, P15093, DOI 10.1073/pnas.0507458102; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Richards S, 1996, GENETICS, V142, P1215; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sakai H, 2011, ANN SURG ONCOL, V18, P2057, DOI 10.1245/s10434-010-1523-0; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sekelsky JJ, 1999, GENETICS, V152, P529; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Sun GF, 2002, BBA-MOL BASIS DIS, V1588, P241, DOI 10.1016/S0925-4439(02)00171-0; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2013, P NATL ACAD SCI USA, V110, P3800, DOI 10.1073/pnas.1217358110; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Webb S, 1998, CIRC RES, V82, P645, DOI 10.1161/01.RES.82.6.645; White EA, 2012, P NATL ACAD SCI USA, V109, pE260, DOI 10.1073/pnas.1116776109; Yager J, 2001, P NATL ACAD SCI USA, V98, P10445, DOI 10.1073/pnas.191107698	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66269	10.1371/journal.pone.0066269	http://dx.doi.org/10.1371/journal.pone.0066269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824717	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400075
J	Shigeta, K; Hayashida, T; Hoshino, Y; Okabayashi, K; Endo, T; Ishii, Y; Hasegawa, H; Kitagawa, Y				Shigeta, Kohei; Hayashida, Tetsu; Hoshino, Yoshinori; Okabayashi, Koji; Endo, Takashi; Ishii, Yoshiyuki; Hasegawa, Hirotoshi; Kitagawa, Yuko			Expression of Epidermal Growth Factor Receptor Detected by Cetuximab Indicates Its Efficacy to Inhibit In Vitro and In Vivo Proliferation of Colorectal Cancer Cells	PLOS ONE			English	Article							GENE COPY NUMBER; EGFR EXPRESSION; MONOCLONAL-ANTIBODIES; PLUS IRINOTECAN; RAS MUTATIONS; THERAPY; CHEMOTHERAPY; PROGNOSIS; ADENOCARCINOMA; ACTIVATION	Cetuximab is a chimeric mouse-human monoclonal antibody that targets the human epidermal growth factor receptor (EGFR). However, EGFR expression determined by immunohistochemistry does not predict clinical outcomes of colorectal cancer (CRC) patients treated with cetuximab. Therefore, we evaluated the correlation between EGFR levels detected by cetuximab and drug sensitivities of CRC cell lines (Caco-2, WiDR, SW480, and HCT116) and the A431 epidermoid carcinoma cell line. We used flow cytometry (FCM) to detect EGFR-binding of biotinylated cetuximab on the cell surface. Subcloned cell lines showing the highest and lowest EGFR expression levels were chosen for further study. Cytotoxic assays were used to determine differential responses to cetuximab. Xenograft models treated with cetuximab intraperitoneally to assess sensitivity to cetuximab. Strong responses to cetuximab were specifically exhibited by subcloned cells with high EGFR expression levels. Furthermore, cetuximab inhibited the growth of tumors in xenograft models with high or low EGFR expression levels by 35% and 10%-20%, respectively. We conclude that detection of EGFR expression by cetuximab promises to provide a novel, sensitive, and specific method for predicting the sensitivity of CRC to cetuximab.	[Shigeta, Kohei; Hayashida, Tetsu; Hoshino, Yoshinori; Okabayashi, Koji; Endo, Takashi; Ishii, Yoshiyuki; Hasegawa, Hirotoshi; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan	Keio University	Hayashida, T (corresponding author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan.	tetsu@z7.keio.jp	Shigeta, Kohei/H-3451-2019	Shigeta, Kohei/0000-0003-1596-4200	Japanese Ministry of Education, Culture, Sports, Science and Technology [23791559, 23791499, 25293292]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research ( B) (#23791559 K.S., #23791499 T.H. and #25293292 Y.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 1999, J CLIN PATHOL, V52, P75, DOI 10.1136/jcp.52.1.75; Aerts HJWL, 2009, J NUCL MED, V50, P123, DOI 10.2967/jnumed.108.054312; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Boughdady I S, 1992, Surg Oncol, V1, P275, DOI 10.1016/0960-7404(92)90088-3; Castillo L, 2004, ANN ONCOL, V15, P1007, DOI 10.1093/annonc/mdh257; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO;2-N; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Hebbar M, 2006, ANTI-CANCER DRUG, V17, P855, DOI 10.1097/01.cad.0000217425.44584.9f; Huether A, 2005, BIOCHEM PHARMACOL, V70, P1568, DOI 10.1016/j.bcp.2005.09.007; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Matsuo Teppei, 2011, BMC Res Notes, V4, P140, DOI 10.1186/1756-0500-4-140; Mellstedt H, 2003, DRUG TODAY, V39, P1; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Scartozzi M, 2004, J CLIN ONCOL, V22, P4772, DOI 10.1200/JCO.2004.00.117; Scartozzi M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-303; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wierzbicki R, 2011, INVEST NEW DRUG, V29, P167, DOI 10.1007/s10637-009-9341-6; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zlobec I, 2007, BRIT J CANCER, V96, P793, DOI 10.1038/sj.bjc.6603619	40	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66302	10.1371/journal.pone.0066302	http://dx.doi.org/10.1371/journal.pone.0066302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824671	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400080
J	Sun, JF; Huang, Y; Huang, HQ; Liang, P; Wang, XY; Mao, Q; Men, JT; Chen, WJ; Deng, CH; Zhou, CH; Lv, XL; Zhou, JJ; Zhang, F; Li, R; Tian, YL; Lei, HL; Liang, C; Hu, XC; Xu, J; Li, XR; XinbingYu				Sun, Jiufeng; Huang, Yan; Huang, Huaiqiu; Liang, Pei; Wang, Xiaoyun; Mao, Qiang; Men, Jingtao; Chen, Wenjun; Deng, Chuanhuan; Zhou, Chenhui; Lv, Xiaoli; Zhou, Juanjuan; Zhang, Fan; Li, Ran; Tian, Yanli; Lei, Huali; Liang, Chi; Hu, Xuchu; Xu, Jin; Li, Xuerong; XinbingYu			Low Divergence of Clonorchis sinensis in China Based on Multilocus Analysis	PLOS ONE			English	Article							PARAGONIMUS-WESTERMANI; DNA; OPISTHORCHIASIS	Clonorchis sinensis, an ancient parasite that infects a number of piscivorous mammals, attracts significant public health interest due to zoonotic exposure risks in Asia. The available studies are insufficient to reflect the prevalence, geographic distribution, and intraspecific genetic diversity of C. sinensis in endemic areas. Here, a multilocus analysis based on eight genes (ITS1, act, tub, ef-1 alpha, cox1, cox3, nad4 and nad5 [4.986 kb]) was employed to explore the intra-species genetic construction of C. sinensis in China. Two hundred and fifty-six C. sinensis isolates were obtained from environmental reservoirs from 17 provinces of China. A total of 254 recognized Multilocus Types (MSTs) showed high diversity among these isolates using multilocus analysis. The comparison analysis of nuclear and mitochondrial phylogeny supports separate clusters in a nuclear dendrogram. Genetic differentiation analysis of three clusters (A, B, and C) showed low divergence within populations. Most isolates from clusters B and C are geographically limited to central China, while cluster A is extraordinarily genetically diverse. Further genetic analyses between different geographic distributions, water bodies and hosts support the low population divergence. The latter haplotype analyses were consistent with the phylogenetic and genetic differentiation results. A recombination network based on concatenated sequences showed a concentrated linkage recombination population in cox1, cox3, nad4 and nad5, with spatial structuring in ITS1. Coupled with the history record and archaeological evidence of C. sinensis infection in mummified desiccated feces, these data point to an ancient origin of C. sinensis in China. In conclusion, we present a likely phylogenetic structure of the C. sinensis population in mainland China, highlighting its possible tendency for biogeographic expansion. Meanwhile, ITS1 was found to be an effective marker for tracking C. sinensis infection worldwide. Thus, the present study improves our understanding of the global epidemiology and evolution of C. sinensis.	[Sun, Jiufeng] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Sun, Jiufeng; Huang, Yan; Liang, Pei; Wang, Xiaoyun; Mao, Qiang; Men, Jingtao; Chen, Wenjun; Deng, Chuanhuan; Zhou, Chenhui; Lv, Xiaoli; Zhou, Juanjuan; Zhang, Fan; Li, Ran; Tian, Yanli; Lei, Huali; Liang, Chi; Hu, Xuchu; Xu, Jin; Li, Xuerong; XinbingYu] Sun Yat Sen Univ, Dept Parasitol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Jiufeng; Huang, Yan; Liang, Pei; Wang, Xiaoyun; Mao, Qiang; Men, Jingtao; Chen, Wenjun; Deng, Chuanhuan; Zhou, Chenhui; Lv, Xiaoli; Zhou, Juanjuan; Zhang, Fan; Li, Ran; Tian, Yanli; Lei, Huali; Liang, Chi; Hu, Xuchu; Xu, Jin; Li, Xuerong; XinbingYu] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Huaiqiu] Sun Yat Sen Univ, Dept Dermatol & Venereol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, XR (corresponding author), Sun Yat Sen Univ, Dept Parasitol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	xuerongli@hotmail.com; yuhxteam@163.com	Wang, Xiaoyun/F-1212-2015; sun, Jiufeng/CAG-6546-2022	sun, jiufeng/0000-0003-1047-929X; liang, pei/0000-0003-1674-8745; huaiqiu, HUANG/0000-0002-6320-8031	National S & T Major Program [2008ZX10004-011, 2012ZX10004-220]; National Key Basic Research and Development Project of China (973 project) [2010CB530000]; China Postdoctoral Science Foundation [20110490952]	National S & T Major Program; National Key Basic Research and Development Project of China (973 project)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by the National S & T Major Program (Grant No. 2008ZX10004-011; 2012ZX10004-220), National Key Basic Research and Development Project of China (973 project; No. 2010CB530000) and China Postdoctoral Science Foundation (No. 20110490952). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, World Health Organ Tech Rep Ser, V849, P1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blair D, 1997, MOL BIOCHEM PARASIT, V85, P259, DOI 10.1016/S0166-6851(96)02827-7; Blair D, 1997, PARASITOLOGY, V115, P411, DOI 10.1017/S0031182097001534; BOWLES J, 1994, AM J TROP MED HYG, V50, P33, DOI 10.4269/ajtmh.1994.50.1.TM0500010033; BOWLES J, 1995, MOL PHYLOGENET EVOL, V4, P103, DOI 10.1006/mpev.1995.1011; Chen XQ, 1993, CHIN J ZOONOSIS S, V9, P36; Choi BI, 2004, CLIN MICROBIOL REV, V17, P540, DOI 10.1128/CMR.17.3.540-552.2004; CHOI DW, 1984, ARZNEIMITTELFORSCH, V34-2, P1145; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1985, GENETICS, V111, P147; Iwagami M, 2000, J HELMINTHOL, V74, P315; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Lai DH, 2008, ACTA TROP, V107, P213, DOI 10.1016/j.actatropica.2008.05.003; Lee Soo-Ung, 2004, Korean Journal of Parasitology, V42, P145, DOI 10.3347/kjp.2004.42.3.145; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu GH, J HELMINTHOL, P1; Liu WQ, 2007, ACTA TROP, V101, P91, DOI 10.1016/j.actatropica.2006.08.010; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Morgan JAT, 1998, INT J PARASITOL, V28, P493, DOI 10.1016/S0020-7519(97)00204-X; Nei M., 1987, MOL EVOLUTIONARY GEN; Pan B, 2000, ANN B SOC PARASITOL, V22, P85; Park G M, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P12; Park Gab-Man, 2000, Korean Journal of Parasitology, V38, P201, DOI 10.3347/kjp.2000.38.3.201; Park Gab-Man, 2000, Korean Journal of Parasitology, V38, P45, DOI 10.3347/kjp.2000.38.1.45; Rim HJ, 2005, J HELMINTHOL, V79, P269, DOI 10.1079/JOH2005300; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sithiathaworn P, 2009, MANSONS TROPICAL DIS, P1461; Sithithaworn P, 2003, ACTA TROP, V88, P187, DOI 10.1016/j.actatropica.2003.02.001; Stauffer WM, 2004, J TRAVEL MED, V11, P157; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatonova YV, 2012, PARASITOL INT, V61, P664, DOI 10.1016/j.parint.2012.07.005; Wang XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r107; Wang XY, 2009, PARASITOL RES, V106, P15, DOI 10.1007/s00436-009-1622-7; Wang YZ, 1983, HUMAN PARASITOLOGY, P451; Wei DX, 1980, J WUHAN MED COLL, V9, P1; Wu De, 2002, Journal of Tropical Medicine (Guangzhou), V2, P277; Yossepowitch O, 2004, EMERG INFECT DIS, V10, P2122, DOI 10.3201/eid1012.040410; Zou H, 1994, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V12, P294	42	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67006	10.1371/journal.pone.0067006	http://dx.doi.org/10.1371/journal.pone.0067006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825605	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400174
J	Wang, Z; Li, P; Xu, QH; Xu, J; Li, XQ; Zhang, XF; Ma, QY; Wu, Z				Wang, Zheng; Li, Pei; Xu, Qinhong; Xu, Jun; Li, Xuqi; Zhang, Xufeng; Ma, Qingyong; Wu, Zheng			Potent Antitumor Activity Generated by a Novel Tumor Specific Cytotoxic T Cell	PLOS ONE			English	Article							PHASE-I TRIAL; CD40 LIGAND; LOW-AVIDITY; E-CADHERIN; ANTIGENS; PEPTIDE; AGONIST	Hepatocellular carcinoma is one of the most common malignant neoplasms in the world and is the main cause of death in patients with liver cirrhosis. Surgical intervention is not suitable for majority of hepatocellular carcinoma. Investigation of the effective targeting to the tumor cells is essential for both primary tumors and metastases. Tumor specific cytotoxic T lymphocytes (CTL) have been considered to be the attractive vehicles for delivering therapeutic agents toward various tumor diseases. This study was to explore the distribution pattern of CTL carrying the lentiviral vectors with the characteristic of adenoviral E1 gene under the control of the cell activation-dependent CD40 ligand promoter (Lenti/hCD40L/E1AB). Following transduction with adenoviral vectors containing chimeric type 5 and type 35 fiber proteins (Ad5/35-TRAIL), these CTLs produced infectious virus when exposed to HepG2 cells. We assessed the therapeutic ability of CTLs using MTT, Western blot and colony formation assay. The novel CTL harboring Lenti/hCD40L/E1AB and Ad5/35-TRAIL caused proliferation inhibition and significant apoptosis in hepatocellular carcinoma cell lines. Thus, the novel CTL may be useful for the development of gene therapy approaches to hepatocellular carcinoma.	[Wang, Zheng; Li, Pei; Xu, Qinhong; Xu, Jun; Li, Xuqi; Zhang, Xufeng; Ma, Qingyong; Wu, Zheng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Wu, Z (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China.	wuzheng@126.com	zhang, xian/GYA-0290-2022; Li, Xuqi/B-3090-2014; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022	Li, Xuqi/0000-0002-2497-020X; 	National Nature Science Foundation of China [81071877]; Fundamental Research Funds for the Central University in Xi'an Jiaotong University [2011-05]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University in Xi'an Jiaotong University	The work was supported by National Nature Science Foundation of China (No. 81071877) and the Fundamental Research Funds for the Central University in Xi'an Jiaotong University (No. 2011-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger F, 2001, GENE THER, V8, P687, DOI 10.1038/sj.gt.3301455; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Clark HP, 2005, RADIOGRAPHICS, V25, pS3, DOI 10.1148/rg.25si055507; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; FELTKAMP MCW, 1995, EUR J IMMUNOL, V25, P2638, DOI 10.1002/eji.1830250935; Gao W, 2003, GENE THER, V10, P1941, DOI 10.1038/sj.gt.3302097; Hou YF, 2008, J IMMUNOL, V180, P1526, DOI 10.4049/jimmunol.180.3.1526; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; KAST WM, 1989, CELL, V59, P603, DOI 10.1016/0092-8674(89)90006-8; Kazansky DB, 2007, ADV EXP MED BIOL, V601, P133; KNUTH A, 1989, P NATL ACAD SCI USA, V86, P2804, DOI 10.1073/pnas.86.8.2804; Lindgren H, 2001, J IMMUNOL, V166, P4578, DOI 10.4049/jimmunol.166.7.4578; McMahan RH, 2007, SEMIN CANCER BIOL, V17, P317, DOI 10.1016/j.semcancer.2007.06.006; Osada T, 1996, HEPATOLOGY, V24, P1460, DOI 10.1002/hep.510240627; Overwijk WW, 2001, TRENDS IMMUNOL, V22, P5, DOI 10.1016/S1471-4906(00)01793-2; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Segerman A, 2000, J VIROL, V74, P1457, DOI 10.1128/JVI.74.3.1457-1467.2000; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Siddiqa A, 2001, NATURE, V410, P383, DOI 10.1038/35066602; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Visonneau S, 2000, CLIN CANCER RES, V6, P1744; Wolchok JD, 2002, J CLIN ONCOL, V20, P3176, DOI 10.1200/JCO.2002.20.14.3176; Yotnda P, 2001, GENE THER, V8, P930, DOI 10.1038/sj.gt.3301488; Zaremba S, 1997, CANCER RES, V57, P4570; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	28	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66659	10.1371/journal.pone.0066659	http://dx.doi.org/10.1371/journal.pone.0066659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825554	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400143
J	Zhao, XW; Wu, HY; Lu, HR; Li, GD; Huang, QS				Zhao, Xiaowei; Wu, Hongyu; Lu, Hairong; Li, Guodong; Huang, Qingshan			LAMP: A Database Linking Antimicrobial Peptides	PLOS ONE			English	Article							DEFENSE PEPTIDES; STRATEGIES; DISCOVERY; SEQUENCES; DESIGN; TOOL	The frequent emergence of drug-resistant bacteria has created an urgent demand for new antimicrobial agents. Traditional methods of novel antibiotic development are almost obsolete. Antimicrobial peptides (AMPs) are now regarded as a potential solution to revive the traditional methods of antibiotic development, although, until now, many AMPs have failed in clinical trials. A comprehensive database of AMPs with information about their antimicrobial activity and cytotoxicity will help promote the process of finding novel AMPs with improved antimicrobial activity and reduced cytotoxicity and eventually accelerate the speed of translating the discovery of new AMPs into clinical or preclinical trials. LAMP, a database linking AMPs, serves as a tool to aid the discovery and design of AMPs as new antimicrobial agents. The current version of LAMP has 5,547 entries, comprising 3,904 natural AMPs and 1,643 synthetic peptides. The database can be queried using either simply keywords or combinatorial conditions searches. Equipped with the detailed antimicrobial activity and cytotoxicity data, the cross-linking and top similar AMPs functions implemented in LAMP will help enhance our current understanding of AMPs and this may speed up the development of new AMPs for medical applications. LAMP is freely available at: http://biotechlab.fudan.edu.cn/database/lamp.	[Zhao, Xiaowei; Lu, Hairong; Huang, Qingshan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Xiaowei] Shanghai High Tech Bioengn Co Ltd, Shanghai, Peoples R China; [Wu, Hongyu; Lu, Hairong; Li, Guodong; Huang, Qingshan] Shanghai High Tech United Biotechnol R&D Co Ltd, Shanghai, Peoples R China	Fudan University	Huang, QS (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	qshuang@fudan.edu.cn			Shanghai Science and Technology Innovation Action Plan of China [12DE1940500]; 'Yangtze River Delta' joint scientific and technological project of China [10495810600]; SHUB	Shanghai Science and Technology Innovation Action Plan of China; 'Yangtze River Delta' joint scientific and technological project of China; SHUB	This work was supported in part by the Shanghai Science and Technology Innovation Action Plan (2012) of China (Grant 12DE1940500) and the 'Yangtze River Delta' joint scientific and technological project of China (Grant 10495810600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Shanghai High-Tech Bioengineering Co., Ltd (SHB) and Shanghai High-Tech United Bio-Technological R&D Co. Ltd (SHUB) are independent member companies of Yingtai Group, which is dedicated to researching, producing and selling products related to bio-disinfectant. Xiaowei Zhao is affiliated SHB and currently major in Master of Engineering at the State Key Laboratory of Genetic Engineering (SKLGE) at Fudan University. The program of Master of Engineering in China set two mentors from University and Industry respectively. Her two mentors are Guodong Li and Qingshan Huang, from SHUB and SKLGE separately. Hongyu Wu is affiliated SHUB as a paid employee. Hairong Lu is affiliated SHUB as a paid employee and currently major in Genetics as a PhD student at SKLGE. Guodong Li is the CTO at SHUB. Qingshan Huang is affiliated Fudan University and as a paid consultant at SHUB. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Eckert R, 2011, FUTURE MICROBIOL, V6, P635, DOI [10.2217/fmb.11.27, 10.2217/FMB.11.27]; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Gueguen Y, 2006, DEV COMP IMMUNOL, V30, P283, DOI 10.1016/j.dci.2005.04.003; Guo-Dong L, 2012, J MICROBIOLOGY, V2012; Hammami R, 2010, DRUG DISCOV TODAY, V15, P540, DOI 10.1016/j.drudis.2010.05.002; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; Hammami R, 2009, NUCLEIC ACIDS RES, V37, pD963, DOI 10.1093/nar/gkn655; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jiang ZQ, 2011, CHEM BIOL DRUG DES, V77, P225, DOI 10.1111/j.1747-0285.2011.01086.x; Li YF, 2008, FEMS MICROBIOL LETT, V289, P126, DOI 10.1111/j.1574-6968.2008.01357.x; Novkovic M, 2012, BIOINFORMATICS, V28, P1406, DOI 10.1093/bioinformatics/bts141; Pag U, 2008, J ANTIMICROB CHEMOTH, V61, P341, DOI 10.1093/jac/dkm479; Seebah S, 2007, NUCLEIC ACIDS RES, V35, pD265, DOI 10.1093/nar/gkl866; Sundararajan VS, 2012, NUCLEIC ACIDS RES, V40, pD1108, DOI 10.1093/nar/gkr1063; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475; Wade D, 2002, PROTEIN PEPTIDE LETT, V9, P53, DOI 10.2174/0929866023408986; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; Wu HY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-54; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	31	187	199	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66557	10.1371/journal.pone.0066557	http://dx.doi.org/10.1371/journal.pone.0066557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825543	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400129
J	Lee, SY; Chen, SL; Chang, YH; Chen, PS; Huang, SY; Tzeng, NS; Wang, YS; Wang, LJ; Lee, IH; Wang, TY; Yeh, TL; Yang, YK; Hong, JS; Lu, RB				Lee, Sheng-Yu; Chen, Shiou-Lan; Chang, Yun-Hsuan; Chen, Po See; Huang, San-Yuan; Tzeng, Nian-Sheng; Wang, Yu-Shan; Wang, Liang-Jen; Lee, I. Hui; Wang, Tzu-Yun; Yeh, Tzung Lieh; Yang, Yen Kuang; Hong, Jau-Shyong; Lu, Ru-Band			Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naive Patients with Bipolar II Disorder	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR-BETA; INSULIN-RESISTANCE; MAJOR DEPRESSION; ADIPOSE-TISSUE; FACTOR-ALPHA; LITHIUM TREATMENT; RATING-SCALE; DOUBLE-BLIND	Inflammation is thought to be involved in the pathophysiology of bipolar disorder (BP) and metabolic syndrome. Prior studies evaluated the association between metabolic profiles and cytokines only during certain mood states instead of their changes during treatment. We enrolled drug-naive patients with BP-II and investigated the correlation between changes in mood symptoms and metabolic indices with changes in plasma cytokine levels after 12 weeks of pharmacological treatment. Drug-naive patients (n = 117) diagnosed with BP-II according to DSM-IV criteria were recruited. Metabolic profiles (cholesterol, triglyceride, HbA1C, fasting serum glucose, body mass index (BMI) and plasma cytokines (TNF-alpha, CRP, IL-6, and TGF-beta) were measured at baseline and 2, 8, and 12 weeks post-treatment. To adjust within-subject dependence over repeated assessments, multiple linear regressions with generalized estimating equation methods were used. Seventy-six (65.0%) patients completed the intervention. Changes in plasma CRP were significantly associated with changes in BMI (P = 1.7E-7) and triglyceride (P = 0.005) levels. Changes in plasma TGF-beta 1 were significantly associated with changes in BMI (P = 8.2E-6), cholesterol (P = 0.004), and triglyceride (P = 0.006) levels. However, changes in plasma TNF-alpha and IL-6 were not associated with changes in any of the metabolic indices. Changes in Hamilton Depression Rating Scale scores were significantly associated with changes in IL-6 (P = 0.003) levels; changes in Young Mania Rating Scale scores were significantly associated with changes in CRP (P = 0.006) and TNF-alpha (P = 0.039) levels. Plasma CRP and TGF-beta 1 levels were positively correlated with several metabolic indices in BP-II after 12 weeks of pharmacological intervention. We also hypothesize that clinical symptoms are correlated with certain cytokines. These new findings might be important evidence that inflammation is the pathophysiology of clinical symptoms and metabolic disturbance in BP-II.	[Lee, Sheng-Yu; Chen, Shiou-Lan; Chen, Po See; Lee, I. Hui; Yeh, Tzung Lieh; Yang, Yen Kuang; Lu, Ru-Band] Natl Cheng Kung Univ, Dept Psychiat, Tainan 70101, Taiwan; [Chen, Shiou-Lan; Wang, Yu-Shan; Lu, Ru-Band] Natl Cheng Kung Univ, Inst Behav Med, Tainan 70101, Taiwan; [Chang, Yun-Hsuan; Lu, Ru-Band] Natl Cheng Kung Univ, Coll Med & Hosp, Inst Allied Hlth Sci, Tainan 70101, Taiwan; [Huang, San-Yuan; Tzeng, Nian-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Psychiat, Taipei, Taiwan; [Wang, Liang-Jen] Kaohsiung Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan; [Wang, Liang-Jen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Addict Res Ctr, Tainan 70101, Taiwan; [Wang, Tzu-Yun] Tainan Hosp, Dept Hlth, Dept Psychiat, Tainan, Taiwan; [Hong, Jau-Shyong] NIEHS, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Lu, RB (corresponding author), Natl Cheng Kung Univ, Dept Psychiat, Tainan 70101, Taiwan.	rblu@mail.ncku.edu.tw	Wang, Liang-Jen/AAR-1089-2020; Hong, Jau-shyong/F-1920-2019; Chen, Po See/AAA-6492-2021; Tzeng, Nian-Sheng/AAU-4945-2021	Wang, Liang-Jen/0000-0002-5320-1151; Hong, Jau-shyong/0000-0002-3056-8401; Chen, Shiou Lan/0000-0003-3995-0276	Taiwan National Science Council [NSC98-2314-B-006-022-MY3]; Taiwan Department of Health [DOH 95-TD-M-113-055]; Taiwan National Health Research Institute [NHRI-EX-97-9738NI]; National Cheng Kung University Project for Promoting Academic Excellence and Developing World Class Research Centers; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090082] Funding Source: NIH RePORTER	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Department of Health; Taiwan National Health Research Institute; National Cheng Kung University Project for Promoting Academic Excellence and Developing World Class Research Centers; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grant NSC98-2314-B-006-022-MY3 (to RBL) and NSC98-2314-B-006-022-MY3 (to SYL) from the Taiwan National Science Council, grant DOH 95-TD-M-113-055 (to RBL) from the Taiwan Department of Health, grant NHRI-EX-97-9738NI (to RBL) from the Taiwan National Health Research Institute, and the National Cheng Kung University Project for Promoting Academic Excellence and Developing World Class Research Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKISKAL HS, 1977, AM J PSYCHIAT, V134, P1227; Akiskal HS, 1999, PSYCHIAT CLIN N AM, V22, P517, DOI 10.1016/S0193-953X(05)70093-9; AKISKAL HS, 1979, ARCH GEN PSYCHIAT, V36, P635; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angst J, 1998, J AFFECT DISORDERS, V50, P143, DOI 10.1016/S0165-0327(98)00142-6; Angst J, 2003, EUR ARCH PSY CLIN N, V253, P236, DOI 10.1007/s00406-003-0437-2; Angst J, 2007, BRIT J PSYCHIAT, V190, P189, DOI 10.1192/bjp.bp.106.030957; Benazzi F, 2003, J AFFECT DISORDERS, V73, P33, DOI 10.1016/S0165-0327(02)00327-0; Benazzi F, 2001, J AFFECT DISORDERS, V66, P13, DOI 10.1016/S0165-0327(99)00038-5; Benazzi F, 2001, EUR ARCH PSY CLIN N, V251, P32, DOI 10.1007/s004060170065; Bermudez Edmund A, 2002, Prev Cardiol, V5, P42, DOI 10.1111/j.1520-037X.2002.1032.x; Bornstein SR, 2006, MOL PSYCHIATR, V11, P892, DOI 10.1038/sj.mp.4001873; Boufidou F, 2004, J AFFECT DISORDERS, V82, P309, DOI 10.1016/j.jad.2004.01.007; Bowden CL, 2000, ARCH GEN PSYCHIAT, V57, P481, DOI 10.1001/archpsyc.57.5.481; Brietzke E, 2008, PROG NEURO-PSYCHOPH, V32, P1355, DOI 10.1016/j.pnpbp.2008.01.006; Brietzke E, 2009, J AFFECT DISORDERS, V116, P214, DOI 10.1016/j.jad.2008.12.001; BUCHNER A, 1996, G POWER PRIORI POSTH; Bullo M, 2003, OBES RES, V11, P525, DOI 10.1038/oby.2003.74; Chang HH, 2010, J AFFECT DISORDERS, V124, P319, DOI 10.1016/j.jad.2009.12.011; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Dickerson F, 2007, PROG NEURO-PSYCHOPH, V31, P952, DOI 10.1016/j.pnpbp.2007.02.018; Elmslie JL, 2009, AUST NZ J PSYCHIAT, V43, P53, DOI 10.1080/00048670802534341; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Fagiolini A, 2005, BIPOLAR DISORD, V7, P424, DOI 10.1111/j.1399-5618.2005.00234.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferguson JM, 2007, CLIN NEUROPHARMACOL, V30, P136, DOI 10.1097/WNF.0B013E3180314AE7; Ghaemi SN, 2000, COMPR PSYCHIAT, V41, P167, DOI 10.1016/S0010-440X(00)90043-9; Goldberg JF, 2009, AM J PSYCHIAT, V166, P173, DOI 10.1176/appi.ajp.2008.08050746; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; Grundy SM, 1999, AM J CARDIOL, V83, p25F; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hsuchou H, 2012, CELL PHYSIOL BIOCHEM, V30, P1109, DOI 10.1159/000343302; Huang SY, 2004, ALCOHOL CLIN EXP RES, V28, P374, DOI 10.1097/01.ALC.0000117832.62901.61; Judd LL, 2003, J AFFECT DISORDERS, V73, P19, DOI 10.1016/S0165-0327(02)00324-5; Karalis KP, 2009, FEBS J, V276, P5747, DOI 10.1111/j.1742-4658.2009.07304.x; Kenna HA, 2009, HARVARD REV PSYCHIAT, V17, P138, DOI 10.1080/10673220902899722; Kim YK, 2007, J AFFECT DISORDERS, V104, P91, DOI 10.1016/j.jad.2007.02.018; Knijff EM, 2006, BIOL PSYCHIAT, V59, P317, DOI 10.1016/j.biopsych.2005.06.041; Knijff EM, 2007, BIPOLAR DISORD, V9, P743, DOI 10.1111/j.1399-5618.2007.00444.x; Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x; MacQueen GM, 2001, PSYCHIAT SERV, V52, P358, DOI 10.1176/appi.ps.52.3.358; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Marques-Vidal P, 2012, EUR J CLIN NUTR, V66, P426, DOI 10.1038/ejcn.2011.170; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moon YS, 2004, METABOLISM, V53, P863, DOI 10.1016/j.metabol.2004.02.007; Nery FG, 2008, HUM PSYCHOPHARM CLIN, V23, P87, DOI 10.1002/hup.912; O'Brien SM, 2006, J AFFECT DISORDERS, V90, P263, DOI 10.1016/j.jad.2005.11.015; Pallanti S, 1999, AM J PSYCHIAT, V156, P1094; Pan WH, 1999, ADV DRUG DELIVER REV, V36, P291, DOI 10.1016/S0169-409X(98)00086-6; Porreca E, 2002, AM J HYPERTENS, V15, P759, DOI 10.1016/S0895-7061(02)02978-3; Reynolds MF, 2007, CURR MED CHEM, V14, P2799, DOI 10.2174/092986707782360088; Rihmer Z, 1999, PSYCHIAT CLIN N AM, V22, P667, DOI 10.1016/S0193-953X(05)70101-5; Saltevo Juha, 2007, Diab Vasc Dis Res, V4, P328, DOI 10.3132/dvdr.2007.060; Shen CW, 2012, BIOMETRICS, V68, P1046, DOI 10.1111/j.1541-0420.2012.01758.x; Soderlund J, 2011, J PSYCHIATR NEUROSCI, V36, P114, DOI 10.1503/jpn.100080; Steen NE, 2011, J CLIN PSYCHIAT, V72, P1515, DOI 10.4088/JCP.10m06068yel; Taylor V, 2006, J CLIN PSYCHIAT, V67, P1034, DOI 10.4088/JCP.v67n0704; Verma S, 2003, AM J PHYSIOL-REG I, V285, pR1253, DOI 10.1152/ajpregu.00170.2003; Vieta E, 1997, COMPR PSYCHIAT, V38, P98, DOI 10.1016/S0010-440X(97)90088-2; Vieta E, 2008, BIPOLAR DISORD, V10, P163, DOI 10.1111/j.1399-5618.2007.00561.x; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Vogelzangs N, 2011, Tijdschr Psychiatr, V53, P613; Vuksan-Cusa B, 2010, PSYCHIAT DANUB, V22, P275; Wang XL, 1997, CARDIOVASC RES, V34, P404, DOI 10.1016/S0008-6363(97)00033-3; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zarate CA, 2006, AM J PSYCHIAT, V163, P153, DOI 10.1176/appi.ajp.163.1.153; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zhou XH, 2009, ATHEROSCLEROSIS, V204, P381, DOI 10.1016/j.atherosclerosis.2008.10.017; Zhu CB, 2006, NEUROPSYCHOPHARMACOL, V31, P2121, DOI 10.1038/sj.npp.1301029; Zimmet P, 1999, ANN NY ACAD SCI, V892, P25, DOI 10.1111/j.1749-6632.1999.tb07783.x	75	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66847	10.1371/journal.pone.0066847	http://dx.doi.org/10.1371/journal.pone.0066847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826157	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000016
J	Ling, ZQ; Lv, P; Lu, XX; Yu, JL; Han, J; Ying, LS; Zhu, X; Zhu, WY; Fang, XH; Wang, S; Wu, YC				Ling, Zhi-Qiang; Lv, Ping; Lu, Xiao-Xiao; Yu, Jiang-Liu; Han, Jing; Ying, Li-Sha; Zhu, Xin; Zhu, Wang-Yu; Fang, Xian-Hua; Wang, Shi; Wu, Yi-Chen			Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; MODULATED DOWN-REGULATION; TUMOR DNA; ESOPHAGEAL CANCER; EXPRESSION; HYPERMETHYLATION; PLASMA; GENE; PROGRESSION; CARCINOMA	Background: Methylated DNA in fluids may be a suitable biomarker for cancer patients. XAF1 has been shown to be frequently down-regulated in human gastric cancer (GC). Here, we investigated if XAF1 methylation in GC could be a useful biomarker. Methods: Real-time RT-PCR was used to detect XAF1 mRNA expression; immunohistochemistry and western blot were used to examine XAF1 protein expression in GC tissues (n = 202) and their corresponding para-cancerous histological normal tissues (PCHNTs). Real-time methylation specific-PCR was used to investigate XAF1 promoter methylation in the same panel of GC tissues, their PCHNTs and sera. Results: We confirmed frequent XAF1 down-regulation in both mRNA and protein levels in GC tissues as compared to normal controls and PCHNTs. XAF1 hypermethylation was evidenced in 83.2% (168/202) of GC tissues and 27.2% (55/202) of PCHNTs, while no methylation was detected in the 88 normal controls. The methylation level in GC tissues was significantly higher than that in PCHNTs (p < 0.05). The hypermethylation of XAF1 significantly correlated with the down-regulation of XAF1 in GC tissues in both mRNA and protein levels (p < 0.001 each). Moreover, we detected high frequency of XAF1 methylation (69.8%, 141 out of 202) in the sera DNAs from the same patients, while the sera DNAs from 88 non-tumor controls were negative for XAF1 methylation. The XAF1 methylation in both GC tissues and in the sera could be a good biomarker for diagnosis of GC (AUC = 0.85 for tissue and AUC = 0.91 for sera) and significantly correlated with poorer prognosis (p < 0.001). In addition, after-surgery negative-to-positive transition of XAF1 methylation in sera strongly associated with tumor recurrence. Conclusions: 1) Dysfunction of XAF1 is frequent and is regulated through XAF1 promoter hypermethylation; 2) Detection of circulating methylated XAF1 DNAs in the serum may be a useful biomarker in diagnosis, evaluating patient's outcome (prognosis and recurrence) for GC patients.	[Ling, Zhi-Qiang; Lv, Ping; Lu, Xiao-Xiao; Yu, Jiang-Liu; Han, Jing; Ying, Li-Sha; Zhu, Xin; Zhu, Wang-Yu; Wu, Yi-Chen] Zhejiang Prov Canc Hosp, Zhejiang Canc Ctr, Zhejiang Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Fang, Xian-Hua] Zhejiang Prov Canc Hosp, Dept Pathol, Zhejiang Canc Ctr, Hangzhou, Zhejiang, Peoples R China; [Wang, Shi] Zhejiang Prov Canc Hosp, Dept Endoscopy, Zhejiang Canc Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Ling, ZQ (corresponding author), Zhejiang Prov Canc Hosp, Zhejiang Canc Ctr, Zhejiang Canc Res Inst, Hangzhou, Zhejiang, Peoples R China.	lingzq@hotmail.com			Science and Technology General Project of Zhejiang Province [2009C33143]; Backbone Talent of Zhejiang Provincial Medicine and Hygiene Platform Programs [2011RCA009]	Science and Technology General Project of Zhejiang Province; Backbone Talent of Zhejiang Provincial Medicine and Hygiene Platform Programs	This research was supported by a grant from the Science and Technology General Project of Zhejiang Province (no. 2009C33143), and partly by a grant from the Backbone Talent of Zhejiang Provincial Medicine and Hygiene Platform Programs (no. 2011RCA009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byun DS, 2003, CANCER RES, V63, P7068; Charlet J, 2012, BIOCHEM PHARMACOL, V83, P858, DOI 10.1016/j.bcp.2012.01.009; David S, 2011, CANCER BIOMARK, V9, P493, DOI 10.3233/CBM-2011-0169; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Ge MH, 2011, HUM PATHOL, V42, P1862, DOI 10.1016/j.humpath.2011.02.003; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hashemi MR, 2008, CYTOPATHOLOGY, V19, P179, DOI 10.1111/j.1365-2303.2007.00417.x; He J, 2011, ONCOTARGET, V2, P178; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kempkensteffen C, 2007, CANCER LETT, V254, P227, DOI 10.1016/j.canlet.2007.03.006; Lee MG, 2006, ONCOGENE, V25, P5807, DOI 10.1038/sj.onc.1209867; Ling ZQ, 2012, EJSO-EUR J SURG ONC, V38, P326, DOI 10.1016/j.ejso.2012.01.008; Ling ZQ, 2011, DIGEST DIS SCI, V56, P2992, DOI 10.1007/s10620-011-1774-z; Ling ZQ, 2011, INT J MOL MED, V27, P625, DOI 10.3892/ijmm.2011.640; Ling ZQ, 2010, CANCER LETT, V297, P244, DOI 10.1016/j.canlet.2010.05.017; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Lu XX, 2012, CANCER-AM CANCER SOC, V118, P5507, DOI 10.1002/cncr.27604; Luebke T, 2005, WORLD J SURG, V29, P1422, DOI 10.1007/s00268-005-7795-z; Mao WM, 2011, ARCH MED RES, V42, P182, DOI 10.1016/j.arcmed.2011.04.002; Muller I, 2006, ANN NY ACAD SCI, V1075, P222, DOI 10.1196/annals.1368.030; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; Plenchette S, 2007, CURR OPIN INVEST DR, V8, P469; Sincic N, 2011, CURR OPIN ONCOL, V23, P69, DOI 10.1097/CCO.0b013e3283412eb4; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Spindler KLG, 2012, CLIN CANCER RES, V18, P1177, DOI 10.1158/1078-0432.CCR-11-0564; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Tian XY, 2012, J CLIN GASTROENTEROL, V46, P285, DOI 10.1097/MCG.0b013e318249c4cd; Tu SP, 2009, INT J CANCER, V125, P688, DOI 10.1002/ijc.24282; Vinayanuwattikun C, 2011, J THORAC ONCOL, V6, P1818, DOI 10.1097/JTO.0b013e318226b46f; Yu M, 2012, MITOCHONDR DNA, V23, P329, DOI 10.3109/19401736.2012.696625; Yu QM, 2012, J SURG ONCOL, V106, P765, DOI 10.1002/jso.23116; Zhang H, 2011, WORLD J GASTROENTERO, V17, P3257, DOI 10.3748/wjg.v17.i27.3257; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050	34	48	54	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67195	10.1371/journal.pone.0067195	http://dx.doi.org/10.1371/journal.pone.0067195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826230	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000041
J	Ambigapathy, G; Zheng, ZQ; Li, W; Keifer, J				Ambigapathy, Ganesh; Zheng, Zhaoqing; Li, Wei; Keifer, Joyce			Identification of a Functionally Distinct Truncated BDNF mRNA Splice Variant and Protein in Trachemys scripta elegans	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SYNAPTIC DELIVERY; TRANSCRIPTION; ACQUISITION; TRAFFICKING; BOUTONS; GENES	Brain-derived neurotrophic factor (BDNF) has a diverse functional role and complex pattern of gene expression. Alternative splicing of mRNA transcripts leads to further diversity of mRNAs and protein isoforms. Here, we describe the regulation of BDNF mRNA transcripts in an in vitro model of eyeblink classical conditioning and a unique transcript that forms a functionally distinct truncated BDNF protein isoform. Nine different mRNA transcripts from the BDNF gene of the pond turtle Trachemys scripta elegans (tBDNF) are selectively regulated during classical conditioning: exon I mRNA transcripts show no change, exon II transcripts are downregulated, while exon III transcripts are upregulated. One unique transcript that codes from exon II, tBDNF2a, contains a 40 base pair deletion in the protein coding exon that generates a truncated tBDNF protein. The truncated transcript and protein are expressed in the naive untrained state and are fully repressed during conditioning when full-length mature tBDNF is expressed, thereby having an alternate pattern of expression in conditioning. Truncated BDNF is not restricted to turtles as a truncated mRNA splice variant has been described for the human BDNF gene. Further studies are required to determine the ubiquity of truncated BDNF alternative splice variants across species and the mechanisms of regulation and function of this newly recognized BDNF protein.	[Ambigapathy, Ganesh; Zheng, Zhaoqing; Li, Wei; Keifer, Joyce] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Neurosci Grp, Vermillion, SD 57069 USA	University of South Dakota	Keifer, J (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Neurosci Grp, Vermillion, SD 57069 USA.	jkeifer@usd.edu		Keifer, Joyce/0000-0002-5900-0414	NIH INBRE; NIH [NS051187]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051187] Funding Source: NIH RePORTER	NIH INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Callegari was supported by the NIH INBRE Program. This study was supported by NIH Grant NS051187 (to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Ambigapathy G, 2012, IDENTIFICATION NOVEL; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Branciamore S, 2010, P NATL ACAD SCI USA, V107, P15485, DOI 10.1073/pnas.1010506107; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; Keifer J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00009; Keifer J, 2009, J NEUROSCI, V29, P14956, DOI 10.1523/JNEUROSCI.3649-09.2009; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li W, 2008, NEUROSCIENCE, V155, P686, DOI 10.1016/j.neuroscience.2008.06.043; Li W, 2012, NEUROSCIENCE, V203, P50, DOI 10.1016/j.neuroscience.2011.12.015; Li W, 2011, J NEUROSCI, V31, P8441, DOI 10.1523/JNEUROSCI.6343-10.2011; Li W, 2009, NEUROBIOL LEARN MEM, V91, P243, DOI 10.1016/j.nlm.2008.10.002; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Mauk MD, 2004, LEARN MEMORY, V11, P566, DOI 10.1101/lm.83504; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yu Y, 2009, BRAIN RES, V1269, P1, DOI 10.1016/j.brainres.2009.01.071; Zheng ZQ, 2012, J NEUROPHYSIOL, V108, P101, DOI 10.1152/jn.01097.2011; Zheng ZQ, 2009, J NEUROPHYSIOL, V101, P2539, DOI 10.1152/jn.91282.2008	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67141	10.1371/journal.pone.0067141	http://dx.doi.org/10.1371/journal.pone.0067141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825634	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000084
J	Jimenez-Diaz, MB; Viera, S; Ibanez, J; Mulet, T; Magan-Marchal, N; Garuti, H; Gomez, V; Cortes-Gil, L; Martinez, A; Ferrer, S; Fraile, MT; Calderon, F; Fernandez, E; Shultz, LD; Leroy, D; Wilson, DM; Garcia-Bustos, JF; Gamo, FJ; Angulo-Barturen, I				Belen Jimenez-Diaz, Maria; Viera, Sara; Ibanez, Javier; Mulet, Teresa; Magan-Marchal, Noemi; Garuti, Helen; Gomez, Vanessa; Cortes-Gil, Lorena; Martinez, Antonio; Ferrer, Santiago; Teresa Fraile, Maria; Calderon, Felix; Fernandez, Esther; Shultz, Leonard D.; Leroy, Didier; Wilson, David M.; Francisco Garcia-Bustos, Jose; Javier Gamo, Francisco; Angulo-Barturen, Inigo			A New In Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery	PLOS ONE			English	Article							FALCIPARUM-MALARIA; CYCLOPROPYL CARBOXAMIDES; ARTEMISININ RESISTANCE; PLASMODIUM-BERGHEI; STARTING POINTS; AZITHROMYCIN; CANDIDATE; EFFICACY; MODELS	The emergence of resistance to available antimalarials requires the urgent development of new medicines. The recent disclosure of several thousand compounds active in vitro against the erythrocyte stage of Plasmodium falciparum has been a major breakthrough, though converting these hits into new medicines challenges current strategies. A new in vivo screening concept was evaluated as a strategy to increase the speed and efficiency of drug discovery projects in malaria. The new in vivo screening concept was developed based on human disease parameters, i.e. parasitemia in the peripheral blood of patients on hospital admission and parasite reduction ratio (PRR), which were allometrically down-scaled into P. berghei-infected mice. Mice with an initial parasitemia (P-0) of 1.5% were treated orally for two consecutive days and parasitemia measured 24 h after the second dose. The assay was optimized for detection of compounds able to stop parasite replication (PRR = 1) or induce parasite clearance (PRR >1) with statistical power >99% using only two mice per experimental group. In the P. berghei in vivo screening assay, the PRR of a set of eleven antimalarials with different mechanisms of action correlated with human-equivalent data. Subsequently, 590 compounds from the Tres Cantos Antimalarial Set with activity in vitro against P. falciparum were tested at 50 mg/kg (orally) in an assay format that allowed the evaluation of hundreds of compounds per month. The rate of compounds with detectable efficacy was 11.2% and about one third of active compounds showed in vivo efficacy comparable with the most potent antimalarials used clinically. High-throughput, high-content in vivo screening could rapidly select new compounds, dramatically speeding up the discovery of new antimalarial medicines. A global multilateral collaborative project aimed at screening the significant chemical diversity within the antimalarial in vitro hits described in the literature is a feasible task.	[Belen Jimenez-Diaz, Maria; Viera, Sara; Ibanez, Javier; Mulet, Teresa; Magan-Marchal, Noemi; Garuti, Helen; Gomez, Vanessa; Cortes-Gil, Lorena; Martinez, Antonio; Ferrer, Santiago; Teresa Fraile, Maria; Calderon, Felix; Fernandez, Esther; Wilson, David M.; Francisco Garcia-Bustos, Jose; Javier Gamo, Francisco; Angulo-Barturen, Inigo] GlaxoSmithKline, Tres Cantos, Spain; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA	GlaxoSmithKline; Jackson Laboratory	Angulo-Barturen, I (corresponding author), GlaxoSmithKline, Tres Cantos Med Dev Campus, Tres Cantos, Spain.	inigo.x.angulo@gsk.com	Ferrer-Bazaga, Santiago/AAA-7749-2021	Ferrer-Bazaga, Santiago/0000-0002-6672-551X; Garcia-Bustos, Jose/0000-0002-6310-796X; Ibanez, Javier/0000-0001-6215-6332	Medicines for Malaria Venture; GlaxoSmithKline, Diseases of the Developing World, Tres Cantos Medicines Development Campus	Medicines for Malaria Venture; GlaxoSmithKline, Diseases of the Developing World, Tres Cantos Medicines Development Campus	The study was funded in part under a Miniportfolio Agreement between the Medicines for Malaria Venture and GlaxoSmithKline, Diseases of the Developing World, Tres Cantos Medicines Development Campus. The funders had no role on study design, data collection and analysis.	Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; ANDERSEN SL, 1995, AM J TROP MED HYG, V52, P159, DOI 10.4269/ajtmh.1995.52.159; Angulo-Barturen Inigo, 2013, Drug Discov Today Technol, V10, pe351, DOI 10.1016/j.ddtec.2012.07.003; Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Anvikar AR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-97; Apte SH, 2011, INT J PARASITOL, V41, P1285, DOI 10.1016/j.ijpara.2011.07.010; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Barker RH, 2011, ANTIMICROB AGENTS CH, V55, P2612, DOI 10.1128/AAC.01714-10; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH, V53, P4533, DOI 10.1128/AAC.00519-09; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Calderon F, 2012, ACS MED CHEM LETT, V3, P373, DOI 10.1021/ml300008j; Calderon F, 2011, ACS MED CHEM LETT, V2, P741, DOI 10.1021/ml200135p; Cao Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006894; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Empfield JR, 2010, IDRUGS, V13, P869; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; GINGRAS BA, 1993, AM J TROP MED HYG, V49, P101, DOI 10.4269/ajtmh.1993.49.101; Gleeson MP, 2011, CURR TOP MED CHEM, V11, P358; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hou T, 2008, EXPERT OPIN DRUG MET, V4, P759, DOI 10.1517/17425255.4.6.759 ; Jimenez-Diaz MB, 2005, CYTOM PART A, V67A, P27, DOI 10.1002/cyto.a.20169; KINNAMON KE, 1975, AM J TROP MED HYG, V24, P174, DOI 10.4269/ajtmh.1975.24.174; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Madden JC, 2012, REGUL TOXICOL PHARM, V63, P140, DOI 10.1016/j.yrtph.2012.03.010; Mahmood I., 2005, INTERSPECIES PHARMAC; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MMV, 2008, COMP PROGR CRIT; MMV, 2010, NEW MED MAL CONTR ER; Moore BR, 2011, ANTIMICROB AGENTS CH, V55, P3899, DOI 10.1128/AAC.00067-11; Nilsen A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005029; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Ockenhouse Christian F, 2005, Mil Med, V170, P12; Olliaro P, 2009, CLIN PHARMACOL THER, V85, P584, DOI 10.1038/clpt.2009.51; Peters W, 1999, HDB ANIMAL MODELS IN, P757; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P2395, DOI 10.1128/AAC.44.9.2395-2398.2000; Ricklefs RE, 2010, SCIENCE, V329, P226, DOI 10.1126/science.1188954; Rueda L, 2011, ACS MED CHEM LETT, V2, P840, DOI 10.1021/ml2001517; Sanz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030949; Sanz LM, 2011, ANTIMICROB AGENTS CH, V55, P5740, DOI 10.1128/AAC.05188-11; Slater LB, 2005, B HIST MED, V79, P261, DOI 10.1353/bhm.2005.0092; Tamimi NAM, 2009, NEPHRON CLIN PRACT, V113, pC125, DOI 10.1159/000232592; Thompson PE, 1972, ANTIMALARIAL AGENTS; van Eijk AM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006688.pub2; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2020, REP ANT DRUG EFF RES; Yeramian P, 2005, J INFECT DIS, V192, P319, DOI 10.1086/430928	61	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66967	10.1371/journal.pone.0066967	http://dx.doi.org/10.1371/journal.pone.0066967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825598	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000052
J	Eraso, P; Portillo, F; Mazon, MJ				Eraso, Pilar; Portillo, Francisco; Mazon, Maria J.			Characterization of Two Second-Site Mutations Preventing Wild Type Protein Aggregation Caused by a Dominant Negative PMA1 Mutant	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; ER QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PHOSPHORYLATION DOMAIN; SURFACE TRANSPORT; MISFOLDED MUTANTS; RAFT ASSOCIATION; LETHAL MUTATIONS; BINDING-SITE	The correct biogenesis and localization of Pma1 at the plasma membrane is essential for yeast growth. A subset of PMA1 mutations behave as dominant negative because they produce aberrantly folded proteins that form protein aggregates, which in turn provoke the aggregation of the wild type protein. One approach to understand this dominant negative effect is to identify second-site mutations able to suppress the dominant lethal phenotype caused by those mutant alleles. We isolated and characterized two intragenic second-site suppressors of the PMA1-D378T dominant negative mutation. We present here the analysis of these new mutations that are located along the amino-terminal half of the protein and include a missense mutation, L151F, and an in-frame 12bp deletion that eliminates four residues from Cys409 to Ala412. The results show that the suppressor mutations disrupt the interaction between the mutant and wild type enzymes, and this enables the wild type Pma1 to reach the plasma membrane.	[Eraso, Pilar; Portillo, Francisco] Univ Autonoma Madrid, Dept Bioquim, Consejo Super Invest Cient, Madrid, Spain; [Eraso, Pilar; Portillo, Francisco; Mazon, Maria J.] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Consejo Super Invest Cient, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Mazon, MJ (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Consejo Super Invest Cient, Madrid, Spain.	mjmazon@iib.uam.es	Mazmela, Pilar Eraso/E-9248-2016; Calpena, María Jesús Mazón/E-9168-2016	Mazmela, Pilar Eraso/0000-0002-6928-3219; Calpena, María Jesús Mazón/0000-0003-4151-4051; Portillo Perez, Francisco/0000-0003-4922-346X	Spanish Ministerio de Ciencia e Innovacion [BFU2008-04285]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion Grant BFU2008-04285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Almeida WI, 2006, BBA-BIOMEMBRANES, V1758, P1768, DOI 10.1016/j.bbamem.2006.08.018; Ambesi A, 2000, J EXP BIOL, V203, P155; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bukrinsky JT, 2001, FEBS LETT, V494, P6, DOI 10.1016/S0014-5793(01)02301-8; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; DeWitt ND, 1998, J BIOL CHEM, V273, P21744, DOI 10.1074/jbc.273.34.21744; dExaerde AD, 1996, YEAST, V12, P907; ERASO P, 1987, FEBS LETT, V224, P193, DOI 10.1016/0014-5793(87)80446-5; Eraso P, 2011, MOL MICROBIOL, V79, P1339, DOI 10.1111/j.1365-2958.2010.07528.x; Eraso P, 2010, TRAFFIC, V11, P37, DOI 10.1111/j.1600-0854.2009.01005.x; Ferreira T, 2002, J BIOL CHEM, V277, P21027, DOI 10.1074/jbc.M112281200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HARRIS SL, 1994, P NATL ACAD SCI USA, V91, P10531, DOI 10.1073/pnas.91.22.10531; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Maldonado AM, 1998, GENETICS, V150, P11; MALDONADO AM, 1995, J BIOL CHEM, V270, P8655, DOI 10.1074/jbc.270.15.8655; Mason AB, 2006, J BIOL CHEM, V281, P23887, DOI 10.1074/jbc.M601818200; Mazon MJ, 2007, MOL MICROBIOL, V63, P1069, DOI 10.1111/j.1365-2958.2006.05580.x; MONK BC, 1994, J BIOENERG BIOMEMBR, V26, P101, DOI 10.1007/BF00763222; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Nakamoto RK, 1998, J BIOL CHEM, V273, P7338, DOI 10.1074/jbc.273.13.7338; Pagant S, 2010, J BIOL CHEM, V285, P36304, DOI 10.1074/jbc.M110.142760; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Petrov VV, 1997, J BIOL CHEM, V272, P1688, DOI 10.1074/jbc.272.3.1688; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Portillo F, 1997, FEBS LETT, V402, P136, DOI 10.1016/S0014-5793(96)01515-3; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SERRANO R, 1993, EUR J BIOCHEM, V212, P737, DOI 10.1111/j.1432-1033.1993.tb17712.x; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Serrano R, 1991, MOL CELLULAR BIOL YE, P523; SetoYoung D, 1996, J BIOL CHEM, V271, P581, DOI 10.1074/jbc.271.1.581; SIKORSKI RS, 1989, GENETICS, V122, P19; Toulmay A, 2007, BIOCHIMIE, V89, P249, DOI 10.1016/j.biochi.2006.07.020; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67080	10.1371/journal.pone.0067080	http://dx.doi.org/10.1371/journal.pone.0067080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825623	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000075
J	Fang, YF; Zhong, LK; Lin, MH; Zhou, XL; Jing, H; Ying, MD; Luo, PH; Yang, B; He, QJ				Fang, Yanfen; Zhong, Like; Lin, Meihua; Zhou, Xinglu; Jing, Hui; Ying, Meidan; Luo, Peihua; Yang, Bo; He, Qiaojun			MEK/ERK Dependent Activation of STAT1 Mediates Dasatinib-Induced Differentiation of Acute Myeloid Leukemia	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; PHOSPHORYLATION; INHIBITORS; THERAPY; TRANSCRIPTION; PATHWAYS; CELLS; RAF	Dasatinib (BMS-354825) is a FDA-approved multitargeted kinase inhibitor of BCR/ABL and Src kinases. It is now used in the treatment of chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapies, including imatinib. Here we report a novel effect of dasatinib on inducing the differentiation of acute myeloid leukemia (AML) cells through MEK/ERK-dependent activation of signal transducer and activator of transcription 1 (STAT1). We found that dasatinib could induce the differentiation of AML cells as demonstrated by the expression of differentiation marker CD11b, G0/G1 phase arrest and decreased ratio of nucleus to cytoplasm. Of note, dasatinib induced robust phosphorylation of STAT1 both at Tyr701 and Ser727 as well as the redistribution of STAT1 from the cytoplasm to the nucleus, thus leading to the transcription of STAT1-targeted genes. Knocking down STAT1 expression by shRNA significantly attenuated dasatinib-induced differentiation, indicating an important role of STAT1 in myeloid maturation. We further found that dasatinib-induced activation of STAT1 was regulated by the MEK/ERK kinases. The phosporylation of MEK and ERK occurred rapidly upon dasatinib treatment and increased progressively as differentiation was induced. MEK inhibitors PD98059 and U0216 not only inhibited the phosphorylation of STAT1, but also abrogated dasatinib-induced myeloid differentiation, suggesting that MEK/ERK dependent phosphorylation of STAT1 might be indispensable for the differentiating effect of dasatinib in AML cells. Taken together, our study suggests that STAT1 is an important mediator in dasatinib-induced differentiation of AML cells, whose activation requires the activation of MEK/ERK cascades.	[Fang, Yanfen; Zhong, Like; Lin, Meihua; Zhou, Xinglu; Jing, Hui; Ying, Meidan; Luo, Peihua; Yang, Bo; He, Qiaojun] Zhejiang Univ, Sch Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310027, Zhejiang, Peoples R China; [Fang, Yanfen] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Zhejiang University; University of Michigan System; University of Michigan	Yang, B (corresponding author), Zhejiang Univ, Sch Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310027, Zhejiang, Peoples R China.	yang924@zju.edu.cn; qiaojunhe@zju.edu.cn	Jing, Hui/GXM-4109-2022; Jing, Hui/AAL-7810-2020	Jing, Hui/0000-0002-8389-8252; Jing, Hui/0000-0002-2129-7937	Zhejiang Provincial Program for the Cultivation of High-Level Innovative Heath Talents; Natural Science Foundation of Zhejiang Province [Y12H310029]; Research Foundation of Education Bureau of Zhejiang Province [Y201121007]; Science Foundation of Chinese University	Zhejiang Provincial Program for the Cultivation of High-Level Innovative Heath Talents; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Research Foundation of Education Bureau of Zhejiang Province; Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Zhejiang Provincial Program for the Cultivation of High-Level Innovative Heath Talents, Natural Science Foundation of Zhejiang Province (number Y12H310029), Research Foundation of Education Bureau of Zhejiang Province (Y201121007), and Science Foundation of Chinese University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Borriello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028555; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Chevalier N, 2010, LEUKEMIA, V24, P1779, DOI 10.1038/leu.2010.151; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; Dimberg A, 2000, BLOOD, V96, P2870; Fang YF, 2011, MOL CARCINOGEN, V50, P24, DOI 10.1002/mc.20687; Fang YF, 2010, CANCER BIOL THER, V10, P1158, DOI 10.4161/cbt.10.11.13556; Fey A, 2004, APPL ENVIRON MICROB, V70, P3618, DOI 10.1128/aem.70.6.3618-3623.2004; Gianni M, 1997, BLOOD, V89, P1001, DOI 10.1182/blood.V89.3.1001; Gianni' M, 2001, BLOOD, V97, P3234, DOI 10.1182/blood.V97.10.3234; Gu ZM, 2011, FEBS LETT, V585, P375, DOI 10.1016/j.febslet.2010.12.021; Guerrouahen BS, 2010, CLIN CANCER RES, V16, P1149, DOI 10.1158/1078-0432.CCR-09-2416; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Johnson DE, 2008, ADV ENZYME REGUL, V48, P98, DOI 10.1016/j.advenzreg.2007.11.002; Kolb EA, 2008, PEDIATR BLOOD CANCER, V50, P1198, DOI 10.1002/pbc.21368; Kropf PL, 2010, LEUKEMIA, V24, P663, DOI 10.1038/leu.2009.267; Lainey E, 2011, BIOCHEM PHARMACOL, V82, P1457, DOI 10.1016/j.bcp.2011.05.011; Li SW, 2011, J GEN VIROL, V92, P1127, DOI 10.1099/vir.0.028936-0; Luo PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027298; Miranda MB, 2008, LEUKEMIA, V22, P1624, DOI 10.1038/leu.2008.28; Miranda MB, 2007, LEUKEMIA, V21, P1363, DOI 10.1038/sj.leu.2404690; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Rivieccio MA, 2005, J IMMUNOL, V174, P3719, DOI 10.4049/jimmunol.174.6.3719; Rosenzweig SA, 2012, BIOCHEM PHARMACOL, V83, P1041, DOI 10.1016/j.bcp.2011.12.025; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schuringa JJ, 2000, BLOOD, V95, P3765, DOI 10.1182/blood.V95.12.3765; Shami PJ, 2012, LEUKEMIA, V26, P214, DOI 10.1038/leu.2011.217; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Sullivan C, 2010, BIOCHEM PHARMACOL, V80, P584, DOI 10.1016/j.bcp.2010.05.001; Vera J, 2011, PROG BIOPHYS MOL BIO, V106, P426, DOI 10.1016/j.pbiomolbio.2011.06.013; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Weber S, 2009, GENE DEV, V23, P118, DOI 10.1101/gad.489409; Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Zhang YG, 2004, CARCINOGENESIS, V25, P1165, DOI 10.1093/carcin/bgh115	42	27	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66915	10.1371/journal.pone.0066915	http://dx.doi.org/10.1371/journal.pone.0066915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825585	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000042
J	Zamora, L; Fernandez-Garayzabal, JF; Sanchez-Porro, C; Palacios, MA; Moore, ERB; Dominguez, L; Ventosa, A; Vela, AI				Zamora, Leydis; Fernandez-Garayzabal, Jose F.; Sanchez-Porro, Cristina; Angel Palacios, Mari; Moore, Edward R. B.; Dominguez, Lucas; Ventosa, Antonio; Vela, Ana I.			Flavobacterium plurextorum sp nov Isolated from Farmed Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							EMENDED DESCRIPTION; LIPID-COMPOSITION; FAMILY	Five strains (1126-1H-08(T), 51B-09, 986-08, 1084B-08 and 424-08) were isolated from diseased rainbow trout. Cells were Gram-negative rods, 0.7 mu m wide and 3 mu m long, non-endospore-forming, catalase and oxidase positive. Colonies were circular, yellow-pigmented, smooth and entire on TGE agar after 72 hours incubation at 25 degrees C. They grew in a temperature range between 15 degrees C to 30 degrees C, but they did not grow at 37 degrees Cor 42 degrees C. Based on 16S rRNA gene sequence analysis, the isolates belonged to the genus Flavobacterium. Strain 1126-1H-08(T) exhibited the highest levels of similarity with Flavobacterium oncorhynchi CECT 7678(T) and Flavobacterium pectinovorum DSM 6368(T) (98.5% and 97.9% sequence similarity, respectively). DNA-DNA hybridization values were 87 to 99% among the five isolates and ranged from 21 to 48% between strain 1126-1H-08(T), selected as a representative isolate, and the type strains of Flavobacterium oncorhynchi CECT 7678(T) and other phylogenetic related Flavobacterium species. The DNA G+C content of strain 1126-1H-08(T) was 33.2 mol%. The predominant respiratory quinone was MK-6 and the major fatty acids were iso-C-15:0 and C-15:0. These data were similar to those reported for Flavobacterium species. Several physiological and biochemical tests differentiated the novel bacterial strains from related Flavobacterium species. Phylogenetic, genetic and phenotypic data indicate that these strains represent a new species of the genus Flavobacterium, for which the name Flavobacterium plurextorum sp. nov. was proposed. The type strain is 1126-1H-08(T) (=CECT 7844(T) = CCUG 60112(T)).	[Zamora, Leydis; Fernandez-Garayzabal, Jose F.; Dominguez, Lucas; Vela, Ana I.] Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, E-28040 Madrid, Spain; [Fernandez-Garayzabal, Jose F.; Vela, Ana I.] Univ Complutense, Fac Vet, Dept Sanidad Anim, E-28040 Madrid, Spain; [Angel Palacios, Mari] Piszolla SL, Salamanca, Spain; [Sanchez-Porro, Cristina; Ventosa, Antonio] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain; [Moore, Edward R. B.] Univ Gothenburg, CCUG, Gothenburg, Sweden; [Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden	Complutense University of Madrid; Complutense University of Madrid; University of Sevilla; University of Gothenburg; University of Gothenburg	Fernandez-Garayzabal, JF (corresponding author), Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, E-28040 Madrid, Spain.	garayzab@vet.ucm.es	Vela, Ana I/K-8015-2014; Ventosa, Antonio/K-8239-2017; Zamora Morales, Leydis/F-4790-2016; Rodríguez, Lucas Domínguez/B-9668-2014; FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/K-9611-2014; Sanchez, Cristina/K-8027-2017; studies, IT VISAVET Account for bibliometric/C-3115-2014	Vela, Ana I/0000-0001-5004-3103; Ventosa, Antonio/0000-0002-7573-0556; Zamora Morales, Leydis/0000-0003-4068-0584; Rodríguez, Lucas Domínguez/0000-0001-8843-0010; FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/0000-0003-1597-0643; Sanchez, Cristina/0000-0002-1834-1239; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Moore, Edward/0000-0001-7693-924X	Spanish Office for Science and Technology (CDETI); Spanish Ministry of Science and Innovation [CGL2010-19303]; Junta de Andalucia [P10-CVI-6226]; Vastra Gotaland Region [VGFOUREG-30781, 83080, 157801]	Spanish Office for Science and Technology (CDETI); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Vastra Gotaland Region	This work was funded by projects CENIT 2007-2010 (ACUISOST) of the Spanish Office for Science and Technology (CDETI), CGL2010-19303 of the Spanish Ministry of Science and Innovation and P10-CVI-6226 from the Junta de Andalucia. ERBM was supported by funding of Vastra Gotaland Region projects VGFOUREG-30781, 83080 and 157801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arahal DR, 2001, INT J SYST EVOL MICR, V51, P1443, DOI 10.1099/00207713-51-4-1443; Bernardet J.F., 2011, BERGEYS MANUAL SYSTE, V4, P112; Bernardet J.-F., 2006, PROKARYOTES, P481, DOI [10.1007/0-387-30747-8_17, DOI 10.1007/0-387-30747-8_17]; Bernardet J-F, 2006, PROKARYOTES HDB BIOL, V7, P455, DOI [DOI 10.1007/0-387-30747-8_16, DOI 10.1007/0-387-30747-8]; Bernardet JF, 1996, INT J SYST BACTERIOL, V46, P128, DOI 10.1099/00207713-46-1-128; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/00207713-52-3-1049; Bowman JP, 1996, INT J SYST BACTERIOL, V46, P841, DOI 10.1099/00207713-46-4-841; Chen WM, 2013, INT J SYST EVOL MICR, V63, P827, DOI 10.1099/ijs.0.041178-0; Chen YC, 2008, J FISH DIS, V31, P765, DOI 10.1111/j.1365-2761.2008.00950.x; DELEY J, 1970, ANTON VAN LEE J M S, V36, P461, DOI 10.1007/BF02069048; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Flemming L, 2007, RES MICROBIOL, V158, P18, DOI 10.1016/j.resmic.2006.09.001; Georgiadis MP, 2001, PREV VET MED, V48, P287, DOI 10.1016/S0167-5877(00)00202-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ilardi P, 2008, B EUR ASSOC FISH PAT, V28, P176; Johnson John L., 1994, P655; Kampfer P, 2012, INT J SYST EVOL MICR, V62, P1402, DOI 10.1099/ijs.0.033431-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lim CS, 2011, INT J SYST EVOL MICR, V61, P2734, DOI 10.1099/ijs.0.028563-0; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Rasmussen S. W., 2002, SEQTOOLS SOFTWARE PA; Roberts R.J., 2012, FISH PATHOL, P339, DOI [10.1111/j.1751-0813.2002.tb14791.x, DOI 10.1111/J.1751-0813.2002.TB14791.X, DOI 10.1002/9781118222942.CH8]; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASSER M, 2001, 101 MIDI INC; Sheu SY, 2013, INT J SYST EVOL MICR, V63, P2239, DOI 10.1099/ijs.0.046425-0; Sheu SY, 2011, INT J SYST EVOL MICR, V61, P1402, DOI 10.1099/ijs.0.025403-0; Smibert Robert M., 1994, P607; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Starliper C. E., 2012, FISH DIS DISORDERS, V3, P606; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TINDALL BJ, 1990, FEMS MICROBIOL LETT, V66, P199; TINDALL BJ, 1990, SYST APPL MICROBIOL, V13, P128, DOI 10.1016/S0723-2020(11)80158-X; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Xu MS, 2011, INT J SYST EVOL MICR, V61, P20, DOI 10.1099/ijs.0.014126-0; Yoon JH, 2011, INT J SYST EVOL MICR, V61, P81, DOI 10.1099/ijs.0.017582-0; Zamora L, 2012, SYST APPL MICROBIOL, V35, P86, DOI 10.1016/j.syapm.2011.11.007	38	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67741	10.1371/journal.pone.0067741	http://dx.doi.org/10.1371/journal.pone.0067741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825681	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000321223000115
J	Auclair, Y; Konig, B; Lindholm, AK				Auclair, Yannick; Koenig, Barbara; Lindholm, Anna K.			A Selfish Genetic Element Influencing Longevity Correlates with Reactive Behavioural Traits in Female House Mice (Mus domesticus)	PLOS ONE			English	Article							AMERICAN RED SQUIRRELS; FALSE DISCOVERY RATE; LIFE-HISTORY; INDIVIDUAL-DIFFERENCES; GASTEROSTEUS-ACULEATUS; REPRODUCTIVE SUCCESS; AVIAN PERSONALITIES; ANIMAL PERSONALITY; MOUSE-POPULATION; RISK-ASSESSMENT	According to theory in life-history and animal personality, individuals with high fitness expectations should be risk-averse, while individuals with low fitness expectations should be more bold. In female house mice, a selfish genetic element, the t haplotype, is associated with increased longevity under natural conditions, representing an appropriate case study to investigate this recent theory empirically. Following theory, females heterozygous for the t haplotype (+/t) are hypothesised to express more reactive personality traits and be more shy, less explorative and less active compared to the shorter-lived homozygous wildtype females (+/+). As males of different haplotype do not differ in survival, no similar pattern is expected. We tested these predictions by quantifying boldness, exploration, activity, and energetic intake in both +/t and +/+ mice. +/t females, unlike +/+ ones, expressed some reactive-like personality traits: +/t females were less active, less prone to form an exploratory routine and tended to ingest less food. Taken together these results suggest that differences in animal personality may contribute to the survival advantage observed in +/t females but fail to provide full empirical support for recent theory.	[Auclair, Yannick; Koenig, Barbara; Lindholm, Anna K.] Univ Zurich, Inst Evolutionary Biol & Environm Studios Anim Be, Zurich, Switzerland	University of Zurich	Auclair, Y (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studios Anim Be, Zurich, Switzerland.	yannick.auclair@ieu.uzh.ch	Lindholm, Anna K/E-5207-2012; Koenig, Barbara/M-9214-2013	Lindholm, Anna K/0000-0001-8460-9769; Konig, Barbara/0000-0001-7696-4736	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This project was funded by the Swiss National Science Foundation and the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENUS RF, 1990, BEHAVIOUR, V112, P176, DOI 10.1163/156853990X00185; BENUS RF, 1987, BEHAVIOUR, V100, P105, DOI 10.1163/156853987X00099; BERRY R J, 1970, Field Studies, V3, P219; BERRY RJ, 1971, EXP GERONTOL, V6, P187, DOI 10.1016/S0531-5565(71)80018-9; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Boon AK, 2008, OIKOS, V117, P1321, DOI 10.1111/j.0030-1299.2008.16567.x; Boon AK, 2007, ECOL LETT, V10, P1094, DOI 10.1111/j.1461-0248.2007.01106.x; Both C, 2005, J ANIM ECOL, V74, P667, DOI 10.1111/j.1365-2656.2005.00962.x; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Careau V, 2009, FUNCT ECOL, V23, P150, DOI 10.1111/j.1365-2435.2008.01468.x; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Cote J, 2008, P ROY SOC B-BIOL SCI, V275, P2851, DOI 10.1098/rspb.2008.0783; Crawley MJ, 2007, J ANIM ECOL; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; David M, 2012, ETHOLOGY, V118, P932, DOI 10.1111/j.1439-0310.2012.02085.x; David M, 2011, ANIM BEHAV, V81, P219, DOI 10.1016/j.anbehav.2010.10.008; DICKMAN CR, 1984, J ZOOL, V204, P521, DOI 10.1111/j.1469-7998.1984.tb02384.x; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Exnerova A, 2010, P ROY SOC B-BIOL SCI, V277, P723, DOI 10.1098/rspb.2009.1673; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; Gray SJ, 2000, ANIM BEHAV, V60, P765, DOI 10.1006/anbe.2000.1527; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Guillette LM, 2009, BEHAV PROCESS, V82, P265, DOI 10.1016/j.beproc.2009.07.005; HAMMER MF, 1989, P NATL ACAD SCI USA, V86, P3261, DOI 10.1073/pnas.86.9.3261; HAMMERBERG C, 1975, NATURE, V258, P296, DOI 10.1038/258296a0; HURST JL, 1989, ANIM BEHAV, V37, P705, DOI 10.1016/0003-3472(89)90057-2; JEDRZEJEWSKI W, 1993, OIKOS, V68, P251, DOI 10.2307/3544837; KONIG B, 1988, J ZOOL, V216, P195; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kraus C, 2005, J ANIM ECOL, V74, P171, DOI 10.1111/j.1365-2656.2004.00910.x; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; LENINGTON S, 1988, BEHAV GENET, V18, P549, DOI 10.1007/BF01065521; LENINGTON S, 1991, ADV STUD BEHAV, V20, P51; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindholm AK, 2013, ECOL EVOL, V3, P1231, DOI 10.1002/ece3.534; Lyon MF, 2003, ANNU REV GENET, V37, P393, DOI 10.1146/annurev.genet.37.110801.143030; Manser A, 2009, INFLUENCE SELFISH GE; Manser A, 2011, EVOLUTION, V65, P2435, DOI 10.1111/j.1558-5646.2011.01336.x; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Marques JM, 2008, PHYSIOL BEHAV, V93, P139, DOI 10.1016/j.physbeh.2007.08.006; Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526; MORITA T, 1992, P NATL ACAD SCI USA, V89, P6851, DOI 10.1073/pnas.89.15.6851; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nunes AC, 2009, BEHAV ECOL, V20, P1252, DOI 10.1093/beheco/arp122; PENNYCUIK PR, 1986, J ANIM ECOL, V55, P371, DOI 10.2307/4715; PERRIGO G, 1990, BEHAVIOUR, V114, P191, DOI 10.1163/156853990X00112; Pillay N, 2003, BEHAVIOUR, V140, P125, DOI 10.1163/156853903763999944; Quinn JL, 2005, BEHAVIOUR, V142, P1377, DOI 10.1163/156853905774539391; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2009, J EVOLUTION BIOL, V22, P1599, DOI 10.1111/j.1420-9101.2009.01781.x; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Ricklefs RE, 1996, AM NAT, V147, P1047, DOI 10.1086/285892; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Wilson ADM, 2010, BEHAV ECOL SOCIOBIOL, V64, P703, DOI 10.1007/s00265-009-0888-1; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	72	15	15	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67130	10.1371/journal.pone.0067130	http://dx.doi.org/10.1371/journal.pone.0067130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826211	gold, Green Published, Green Accepted			2022-12-27	WOS:000321738400108
J	Markina-Inarrairaegui, A; Pantazopoulou, A; Espeso, EA; Penalva, MA				Markina-Inarrairaegui, Ane; Pantazopoulou, Areti; Espeso, Eduardo A.; Penalva, Miguel A.			The Aspergillus nidulans Peripheral ER: Disorganization by ER Stress and Persistence during Mitosis	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM MEMBRANE; FILAMENTOUS FUNGI; SEC PROTEINS; TIP GROWTH; IN-VIVO; TRANSLOCATION; COMPLEX; YEAST; LOCALIZATION	The genetically amenable fungus Aspergillus nidulans is well suited for cell biology studies involving the secretory pathway and its relationship with hyphal tip growth by apical extension. We exploited live-cell epifluorescence microscopy of the ER labeled with the translocon component Sec63, endogenously tagged with GFP, to study the organization of 'secretory' ER domains. The Sec63 A. nidulans ER network includes brightly fluorescent peripheral strands and more faintly labeled nuclear envelopes. In hyphae, the most abundant peripheral ER structures correspond to plasma membrane-associated strands that are polarized, but do not invade the hyphal tip dome, at least in part because the subapical collar of endocytic actin patches constrict the cortical strands in this region. Thus the subapical endocytic ring might provide an attachment for ER strands, thereby ensuring that the growing tip remains 'loaded' with secretory ER. Acute disruption of secretory ER function by reductive stress-mediated induction of the unfolded protein response results in the reversible aggregation of ER strands, cessation of exocytosis and swelling of the hyphal tips. The secretory ER is insensitive to brefeldin A treatment and does not undergo changes during mitosis, in agreement with the reports that apical extension continues at normal rates during this period.	[Markina-Inarrairaegui, Ane; Pantazopoulou, Areti; Espeso, Eduardo A.; Penalva, Miguel A.] CSIC, Ctr Invest Biol, Dept Biol Celular & Mol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Penalva, MA (corresponding author), CSIC, Ctr Invest Biol, Dept Biol Celular & Mol, Madrid, Spain.	penalva@cib.csic.es	Espeso, Eduardo A/AAC-7238-2022; Espeso, Eduardo A/C-5259-2011; Pantazopoulou, Areti/G-7381-2015; Penalva, Miguel A/G-2295-2015	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Penalva, Miguel A/0000-0002-3102-2806; Pantazopoulou, Areti/0000-0002-1985-6525	Subdireccion General de Proyectos de Investigacion, Ministerio de Economia y Competitividad, Spain; Direccion General de Universidades e Investigacion de la Comunidad de Madrid, Spain	Subdireccion General de Proyectos de Investigacion, Ministerio de Economia y Competitividad, Spain; Direccion General de Universidades e Investigacion de la Comunidad de Madrid, Spain	Funding provided by Subdireccion General de Proyectos de Investigacion, Ministerio de Economia y Competitividad, Spain (http://www.idi.mineco.gob.es) Direccion General de Universidades e Investigacion de la Comunidad de Madrid, Spain (http://www.madrimasd.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Breakspear A, 2007, FEMS MICROBIOL LETT, V277, P90, DOI 10.1111/j.1574-6968.2007.00945.x; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Gladfelter AS, 2010, CURR OPIN MICROBIOL, V13, P720, DOI 10.1016/j.mib.2010.09.012; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Hernandez-Rodriguez Y, 2012, EUKARYOT CELL, V11, P311, DOI 10.1128/EC.05164-11; Hohmann-Marriott MF, 2006, NEW PHYTOL, V172, P208, DOI 10.1111/j.1469-8137.2006.01868.x; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Kimura S, 2010, FUNGAL GENET BIOL, V47, P1044, DOI 10.1016/j.fgb.2010.09.003; Koehli M, 2008, J CELL SCI, V121, P3878, DOI 10.1242/jcs.033852; Lee SC, 2008, FEMS MICROBIOL LETT, V283, P216, DOI 10.1111/j.1574-6968.2008.01174.x; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; Pantazopoulou A, 2011, TRAFFIC, V12, P386, DOI 10.1111/j.1600-0854.2011.01164.x; Pantazopoulou A, 2009, MOL BIOL CELL, V20, P4335, DOI 10.1091/mbc.E09-03-0254; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Penalva Miguel A, 2012, Cell Logist, V2, P2; Prescott AR, 2001, TRAFFIC, V2, P321, DOI 10.1034/j.1600-0854.2001.002005321.x; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Riquelme M, 2003, PROTOPLASMA, V222, P211, DOI 10.1007/s00709-003-0020-8; Saloheimo M, 2003, MOL MICROBIOL, V47, P1149, DOI 10.1046/j.1365-2958.2003.03363.x; Sims AH, 2005, APPL ENVIRON MICROB, V71, P2737, DOI 10.1128/AEM.71.5.2737-2747.2005; Straube A, 2005, EMBO J, V24, P1674, DOI 10.1038/sj.emboj.7600644; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Taheri-Talesh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031218; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Ukil L, 2009, MOL BIOL CELL, V20, P2132, DOI 10.1091/mbc.E08-10-1046; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Verdin J, 2009, MOL MICROBIOL, V74, P1044, DOI 10.1111/j.1365-2958.2009.06917.x; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	49	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67154	10.1371/journal.pone.0067154	http://dx.doi.org/10.1371/journal.pone.0067154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826221	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400112
J	Wang, PH; Lee, TH; Ismail, W; Tsai, CY; Lin, CW; Tsai, YW; Chiang, YR				Wang, Po-Hsiang; Lee, Tzong-Huei; Ismail, Wael; Tsai, Ching-Yen; Lin, Ching-Wen; Tsai, Yu-Wen; Chiang, Yin-Ru			An Oxygenase-Independent Cholesterol Catabolic Pathway Operates under Oxic Conditions	PLOS ONE			English	Article							SIDE-CHAIN DEGRADATION; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; STEROLIBACTERIUM-DENITRIFICANS; MICROBIAL TRANSFORMATION; MYCOBACTERIUM-TUBERCULOSIS; ANAEROBIC DEGRADATION; AROMATIC-COMPOUNDS; STEROID OXIDATION; GENE-CLUSTER; SP-NOV.	Cholesterol is one of the most ubiquitous compounds in nature. The 9,10-seco-pathway for the aerobic degradation of cholesterol was established thirty years ago. This pathway is characterized by the extensive use of oxygen and oxygenases for substrate activation and ring fission. The classical pathway was the only catabolic pathway adopted by all studies on cholesterol-degrading bacteria. Sterolibacterium denitrificans can degrade cholesterol regardless of the presence of oxygen. Here, we aerobically grew the model organism with C-13-labeled cholesterol, and substrate consumption and intermediate production were monitored over time. Based on the detected C-13-labeled intermediates, this study proposes an alternative cholesterol catabolic pathway. This alternative pathway differs from the classical 9,10-seco-pathway in numerous important aspects. First, substrate activation proceeds through anaerobic C-25 hydroxylation and subsequent isomerization to form 26-hydroxycholest-4-en-3-one. Second, after the side chain degradation, the resulting androgen intermediate is activated by adding water to the C-1/C-2 double bond. Third, the cleavage of the core ring structure starts at the A-ring via a hydrolytic mechanism. The O-18-incorporation experiments confirmed that water is the sole oxygen donor in this catabolic pathway.	[Wang, Po-Hsiang; Tsai, Ching-Yen; Lin, Ching-Wen; Tsai, Yu-Wen; Chiang, Yin-Ru] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Lee, Tzong-Huei] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Ismail, Wael] Arabian Gulf Univ, Coll Grad Studies, Biotechnol Program, Manama, Bahrain	Academia Sinica - Taiwan; Taipei Medical University; Arabian Gulf University	Chiang, YR (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	yinru915@gate.sinica.edu.tw	Chiang, Yin-Ru/L-7727-2019; Ismail, Wael/X-5336-2019	Chiang, Yin-Ru/0000-0001-6899-3166; Lee, Tzong-Huei/0000-0001-8036-7563; Ahmed Ismail El Moslimany, Wael/0000-0002-3027-928X	National Science Council [NSC 100-2311-B-182-005-MY3]; Chang-Gung Memorial Hospital of Taiwan [CMRPD1A0072]; Genomics Research Center, Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Chang-Gung Memorial Hospital of Taiwan; Genomics Research Center, Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This study was funded by the National Science Council (NSC 100-2311-B-182-005-MY3) and Chang-Gung Memorial Hospital (CMRPD1A0072) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Small Molecule Metabolomics Core Facility sponsored by the Institute of Plant and Microbial Biology, Academia Sinica for UPLCMS analyses. NMR analysis was performed by the NMR Laboratory sponsored by the Genomics Research Center, Academia Sinica, Taiwan.	ARIMA K, 1969, AGR BIOL CHEM TOKYO, V33, P1636, DOI 10.1080/00021369.1969.10859516; Brodkorb D, 2010, J BIOL CHEM, V285, P30436, DOI 10.1074/jbc.M109.084244; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chiang YR, 2008, J BACTERIOL, V190, P905, DOI 10.1128/JB.01525-07; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Dermer J, 2012, J BIOL CHEM, V287, P36905, DOI 10.1074/jbc.M112.407304; Doukyu N, 2009, APPL MICROBIOL BIOT, V83, P825, DOI 10.1007/s00253-009-2059-8; Drzyzga O, 2011, APPL ENVIRON MICROB, V77, P4802, DOI 10.1128/AEM.05149-11; Fahrbach M, 2006, INT J SYST EVOL MICR, V56, P1547, DOI 10.1099/ijs.0.63672-0; Fernandes P, 2003, ENZYME MICROB TECH, V32, P688, DOI 10.1016/S0141-0229(03)00029-2; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Heyen U, 2000, APPL ENVIRON MICROB, V66, P3004, DOI 10.1128/AEM.66.7.3004-3009.2000; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P4421, DOI 10.1128/AEM.69.8.4421-4430.2003; Horinouchi M, 2012, J STEROID BIOCHEM, V129, P4, DOI 10.1016/j.jsbmb.2010.10.008; Hylemon PB, 1998, FEMS MICROBIOL REV, V22, P475, DOI 10.1111/j.1574-6976.1998.tb00382.x; Ismail W., 2011, J BIOREMED BIODEGR S, DOI [10.4172/2155-6199, DOI 10.4172/2155-6199]; Ismail W, 2012, APPL ENVIRON MICROB, V78, P5043, DOI 10.1128/AEM.00633-12; JOHNSON DF, 1963, SCIENCE, V140, P198, DOI 10.1126/science.140.3563.198; KIESLICH K, 1985, J BASIC MICROB, V25, P461, DOI 10.1002/jobm.3620250713; KOCHHAR SP, 1983, PROG LIPID RES, V22, P161, DOI 10.1016/0163-7827(83)90008-5; Leu YL, 2011, J BACTERIOL, V193, P4447, DOI 10.1128/JB.00331-11; NAGASAWA M, 1970, AGR BIOL CHEM TOKYO, V34, P838, DOI 10.1080/00021369.1970.10859703; NAGASAWA M, 1969, AGR BIOL CHEM TOKYO, V33, P1644; OWEN RW, 1983, J LIPID RES, V24, P1500; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Petrusma M, 2009, APPL ENVIRON MICROB, V75, P5300, DOI 10.1128/AEM.00066-09; PFENNIG N, 1978, INT J SYST BACTERIOL, V28, P283, DOI 10.1099/00207713-28-2-283; RABUS R, 1995, ARCH MICROBIOL, V163, P96, DOI 10.1007/BF00381782; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; SIH CJ, 1967, J AM CHEM SOC, V89, P1957, DOI 10.1021/ja00984a039; SIH CJ, 1968, BIOCHEMISTRY-US, V7, P808, DOI 10.1021/bi00842a039; SIH CJ, 1965, J AM CHEM SOC, V87, P1386, DOI 10.1021/ja01084a043; SIH CJ, 1966, J BIOL CHEM, V241, P540; Sih CJ, 1965, J AM CHEM SOC, V87, P1385, DOI [10.1021/ja01084a042, DOI 10.1021/JA01084A042]; Tak J. D., 1942, ANTON LEEUW INT J G, V8, P32, DOI DOI 10.1007/BF02272764; Tarlera S, 2003, INT J SYST EVOL MICR, V53, P1085, DOI 10.1099/ijs.0.02039-0; TSCHECH A, 1984, ARCH MICROBIOL, V137, P163, DOI 10.1007/BF00414460; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Wang PH, 2013, J LIPID RES, V54, P1493, DOI 10.1194/jlr.M034223; Weete JD, 1989, ADV LIPID RES, V23, P484; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Whitmarsh J. M., 1964, BIOCHEM J, V90, P23	44	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66675	10.1371/journal.pone.0066675	http://dx.doi.org/10.1371/journal.pone.0066675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826110	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400030
J	Goldeck, D; Larbi, A; Pellicano, M; Alam, I; Zerr, I; Schmidt, C; Fulop, T; Pawelec, G				Goldeck, David; Larbi, Anis; Pellicano, Mariavaleria; Alam, Iftikhar; Zerr, Inga; Schmidt, Christian; Fulop, Tamas; Pawelec, Graham			Enhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's Disease	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; T-CELLS; AMYLOID-BETA; TRANSENDOTHELIAL MIGRATION; TRANSPORTER EXPRESSION; FUNCTIONAL EXPRESSION; ACCUMULATION; RECRUITMENT; MACROPHAGES	Although primarily a neurological complaint, systemic inflammation is present in Alzheimer's Disease, with higher than normal levels of proinflammatory cytokines and chemokines in the periphery as well as the brain. A gradient of these factors may enhance recruitment of activated immune cells into the brain via chemotaxis. Here, we investigated the phenotypes of circulating immune cells in AD patients with multi-colour flow cytometry to determine whether their expression of chemokine receptors is consistent with this hypothesis. In this study, we confirmed our previously reported data on the shift of early-to late-differentiated CD4+ T-cells in AD patients. The percentage of cells expressing CD25, a marker of acute T-cell activation, was higher in patients than in age-matched controls, and percentages of CCR6+ cells were elevated. This chemokine receptor is primarily expressed on pro-inflammatory memory cells and Th17 cells. The proportion of cells expressing CCR4 (expressed on Th2 cells) and CCR5 (Th1 cells and dendritic cells) was also greater in patients, and was more pronounced on CD4+ than CD8+ T-cells. These findings allow a more detailed insight into the systemic immune status of patients with Alzheimer's disease and suggest possible novel targets for immune therapy.	[Goldeck, David; Pellicano, Mariavaleria; Alam, Iftikhar; Pawelec, Graham] Univ Tubingen, Med Res Ctr, Tubingen Ageing & Tumour Immunol Grp, Tubingen, Germany; [Larbi, Anis] Agcy Sci Technol & Res, Singapore Immunol Network SIgN, Singapore, Singapore; [Alam, Iftikhar] Abdul Wali Khan Univ, Mardan, Pakistan; [Zerr, Inga; Schmidt, Christian] Univ Gottingen, Univ Med Sch, Dept Neurol, Clin Dementia Ctr, D-37073 Gottingen, Germany; [Fulop, Tamas] Univ Sherbrooke, Res Ctr Aging, Fac Med, Immunol Program,Geriatr Div, Sherbrooke, PQ J1K 2R1, Canada	Eberhard Karls University of Tubingen; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Abdul Wali Khan University; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Sherbrooke	Goldeck, D (corresponding author), Univ Tubingen, Med Res Ctr, Tubingen Ageing & Tumour Immunol Grp, Tubingen, Germany.	david.goldeck@medizin.uni-tuebingen.de	Larbi, Anis/ABE-5868-2020; Pawelec, Graham/H-2713-2019	Pawelec, Graham/0000-0002-3600-0163; alam, iftikhar/0000-0002-9014-4002	Tubingen University Medical School Fortune Program [1732-0-0]; Deutsche Forschungsgemeinschaft (Graduate School) [GK 794, PA 361-14/1]; Canadian Institutes of Health Research (CIHR) [106634]; Bundesministerium fur Bildung und Forschung grant within the German Network for Degenerative Dementia [KNDD-2, 2012-2015, 01GI1010C]	Tubingen University Medical School Fortune Program; Deutsche Forschungsgemeinschaft (Graduate School)(German Research Foundation (DFG)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Bundesministerium fur Bildung und Forschung grant within the German Network for Degenerative Dementia	This work was supported by the Tubingen University Medical School Fortune Program (grant no. 1732-0-0), the Deutsche Forschungsgemeinschaft (Graduate School GK 794; PA 361-14/1), and grants from the Canadian Institutes of Health Research (CIHR, grant No. 106634). The recruitment of clinical study patients was supported by a Bundesministerium fur Bildung und Forschung grant within the German Network for Degenerative Dementia (KNDD-2, 2012-2015, determinants for disease progression in AD, grant No. 01GI1010C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM I, 2012, AGE; Alam I, 2012, J IMMUNOASS IMMUNOCH, V33, P128, DOI 10.1080/15321819.2011.604370; Alt C, 2002, EUR J IMMUNOL, V32, P2133, DOI 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W; Alter A, 2003, J IMMUNOL, V170, P4497, DOI 10.4049/jimmunol.170.9.4497; Buffa S, 2011, J NEUROIMMUNOL, V242, P52; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Correa JD, 2011, ARQ NEURO-PSIQUIAT, V69, P455, DOI 10.1590/S0004-282X2011000400009; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fiala M, 1998, MOL MED, V4, P480, DOI 10.1007/BF03401753; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Glass WG, 2003, J VIROL, V77, P191, DOI 10.1128/JVI.77.1.191-198.2003; Kovac A, 2009, J ALZHEIMERS DIS, V18, P897, DOI 10.3233/JAD-2009-1197; Larbi A, 2009, J ALZHEIMERS DIS, V17, P91, DOI 10.3233/JAD-2009-1015; Lee KS, 2009, DEMENT GERIATR COGN, V28, P281, DOI 10.1159/000245156; Lee YK, 2009, NEUROBIOL LEARN MEM, V92, P356, DOI 10.1016/j.nlm.2009.04.003; Li M, 2009, J IMMUNOL, V182, P5778, DOI 10.4049/jimmunol.0803013; Liu YJ, 2010, NEUROBIOL AGING, V31, P175, DOI 10.1016/j.neurobiolaging.2008.03.024; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Man SM, 2007, NEUROBIOL AGING, V28, P485, DOI 10.1016/j.neurobiolaging.2006.02.013; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Noda Mariko, 2012, Int J Alzheimers Dis, V2012, P891087, DOI 10.1155/2012/891087; Pellicano M, 2010, J ALZHEIMERS DIS, V21, P181, DOI 10.3233/JAD-2010-091714; Reale M, 2008, J ALZHEIMERS DIS, V14, P147; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sallusto F, 2012, IMMUNOL REV, V248, P216, DOI 10.1111/j.1600-065X.2012.01140.x; Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P1034, DOI 10.1097/NEN.0b013e3181f46e25; Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P98, DOI 10.1097/NEN.0b013e3181c8ad2f; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sorce S, 2011, PROG NEUROBIOL, V93, P297, DOI 10.1016/j.pneurobio.2010.12.003; Subramanian S, 2010, J ALZHEIMERS DIS, V22, P619, DOI 10.3233/JAD-2010-100852; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Westermann J, 1996, IMMUNOL TODAY, V17, P278, DOI 10.1016/0167-5699(96)80545-7; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0	41	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66664	10.1371/journal.pone.0066664	http://dx.doi.org/10.1371/journal.pone.0066664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824053	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400144
J	Karlep, L; Reintamm, T; Kelve, M				Karlep, Liisi; Reintamm, Tonu; Kelve, Merike			Intragenomic Profiling Using Multicopy Genes: The rDNA Internal Transcribed Spacer Sequences of the Freshwater Sponge Ephydatia fluviatilis	PLOS ONE			English	Article							VERTICAL TRANSMISSION; CELL-ADHESION; DNA; EVOLUTION; PORIFERA; MUTATION; GENOME; RANGE	Multicopy genes, like ribosomal RNA genes (rDNA), are widely used to describe and distinguish individuals. Despite concerted evolution that homogenizes a large number of rDNA gene copies, the presence of different gene variants within a genome has been reported. Characterization of an organism by defining every single variant of tens to thousands of rDNA repeat units present in a eukaryotic genome would be quite unreasonable. Here we provide an alternative approach for the characterization of a set of internal transcribed spacer sequences found within every rDNA repeat unit by implementing direct sequencing methodology. The prominent allelic variants and their relative amounts characterizing an individual can be described by a single sequencing electropherogram of the mixed amplicon containing the variants present within the genome. We propose a method for rational analysis of heterogeneity of multicopy genes by compiling a profile based on quantification of different sequence variants of the internal transcribed spacers of the freshwater sponge Ephydatia fluviatilis as an example. In addition to using conventional substitution analysis, we have developed a mathematical method, the proportion model method, to quantify the relative amounts of allelic variants of different length using data from direct sequencing of the heterogeneous amplicon. This method is based on determining the expected signal intensity values (corresponding to peak heights from the sequencing electropherogram) by sequencing clones from the same or highly similar amplicon and comparing hypothesized combinations against the values obtained by direct sequencing of the heterogeneous amplicon. This method allowed to differentiate between all specimens analysed.	[Karlep, Liisi; Reintamm, Tonu; Kelve, Merike] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	Tallinn University of Technology	Kelve, M (corresponding author), Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia.	merike.kelve@ttu.ee			Estonian Ministry of Education and Research [0140108]; Estonian Science Foundation [9185]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation	This work was supported by the Estonian Ministry of Education and Research (Grant No. 0140108) and the Estonian Science Foundation (Grant No. 9185) (www.etis.ee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amos CI, 2000, AM J HUM GENET, V66, P1689, DOI 10.1086/302894; Andreakis N, 2012, ZOOL J LINN SOC-LOND, V166, P225, DOI 10.1111/j.1096-3642.2012.00848.x; Applied Biosystems, 1998, AUT DNA SEQ CHEM GUI; Blanquer A, 2011, MOL BIOL EVOL, V28, P2435, DOI 10.1093/molbev/msr096; BOND C, 1992, J EXP ZOOL, V263, P284, DOI 10.1002/jez.1402630308; Buckler ES, 1997, GENETICS, V145, P821; BUSCEMA M, 1980, ROUX ARCH DEV BIOL, V188, P45, DOI 10.1007/BF00848609; Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105; Cazaux B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-124; Costa R, 2013, MICROB ECOL, V65, P232, DOI 10.1007/s00248-012-0102-2; CURTIS ASG, 1971, J EMBRYOL EXP MORPH, V26, P295; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Fernandez-Busquets X, 1999, MICROSC RES TECHNIQ, V44, P204, DOI 10.1002/(SICI)1097-0029(19990215)44:4<204::AID-JEMT2>3.0.CO;2-I; Funayama N, 2005, DEV GROWTH DIFFER, V47, P243; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Gigliarelli L, 2008, HYDROBIOLOGIA, V605, P265, DOI 10.1007/s10750-008-9327-y; Gonzalez IL, 2001, GENOMICS, V73, P255, DOI 10.1006/geno.2001.6540; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Ishijima J, 2008, ZOOL SCI, V25, P480, DOI 10.2108/zsj.25.480; Itskovich V, 2008, J MOL EVOL, V67, P608, DOI 10.1007/s00239-008-9158-5; Lee OO, 2009, APPL ENVIRON MICROB, V75, P6147, DOI 10.1128/AEM.00023-09; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lopp A, 2007, FUND APPL LIMNOL, V168, P93, DOI 10.1127/1863-9135/2007/0168-0093; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Queiroz CD, 2011, MOL PHYLOGENET EVOL, V59, P293, DOI 10.1016/j.ympev.2011.01.013; Rasmont R, 1961, ANN SOC ROY ZOOL BEL, V91, P147; RUTHMANN A, 1965, Q J MICROSC SCI, V106, P99; Schmitt S, 2007, APPL ENVIRON MICROB, V73, P2067, DOI 10.1128/AEM.01944-06; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Simpson TL, 1984, CELL BIOL SPONGES, P662; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; van de Vyver G., 1970, Annls Embryol. Morphogen., V3, P251; WAGNER A, 1994, SYST BIOL, V43, P250, DOI 10.2307/2413465; Wilkening S, 2005, BIOTECHNIQUES, V39, P853, DOI 10.2144/000112027; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; [No title captured]	40	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66601	10.1371/journal.pone.0066601	http://dx.doi.org/10.1371/journal.pone.0066601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825547	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400134
J	Zager, RA; Johnson, ACM; Becker, K				Zager, Richard A.; Johnson, Ali C. M.; Becker, Kirsten			Renal Cortical Lactate Dehydrogenase: A Useful, Accurate, Quantitative Marker of In Vivo Tubular Injury and Acute Renal Failure	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; HEME OXYGENASE-1; MORTALITY; EXPRESSION; NEPHROTOXICITY; MECHANISMS; INFARCTION; INCREASES; OUTCOMES; DEATH	Studies of experimental acute kidney injury (AKI) are critically dependent on having precise methods for assessing the extent of tubular cell death. However, the most widely used techniques either provide indirect assessments (e.g., BUN, creatinine), suffer from the need for semi-quantitative grading (renal histology), or reflect the status of residual viable, not the number of lost, renal tubular cells (e.g., NGAL content). Lactate dehydrogenase (LDH) release is a highly reliable test for assessing degrees of in vitro cell death. However, its utility as an in vivo AKI marker has not been defined. Towards this end, CD-1 mice were subjected to graded renal ischemia (0, 15, 22, 30, 40, or 60 min) or to nephrotoxic (glycerol; maleate) AKI. Sham operated mice, or mice with AKI in the absence of acute tubular necrosis (ureteral obstruction; endotoxemia), served as negative controls. Renal cortical LDH or NGAL levels were assayed 2 or 24 hrs later. Ischemic, glycerol, and maleate-induced AKI were each associated with striking, steep, inverse correlations (r, -0.89) between renal injury severity and renal LDH content. With severe AKI, >65% LDH declines were observed. Corresponding prompt plasma and urinary LDH increases were observed. These observations, coupled with the maintenance of normal cortical LDH mRNA levels, indicated the renal LDH efflux, not decreased LDH synthesis, caused the falling cortical LDH levels. Renal LDH content was well maintained with sham surgery, ureteral obstruction or endotoxemic AKI. In contrast to LDH, renal cortical NGAL levels did not correlate with AKI severity. In sum, the above results indicate that renal cortical LDH assay is a highly accurate quantitative technique for gauging the extent of experimental acute ischemic and toxic renal injury. That it avoids the limitations of more traditional AKI markers implies great potential utility in experimental studies that require precise quantitation of tubule cell death.	[Zager, Richard A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Zager, Richard A.; Johnson, Ali C. M.; Becker, Kirsten] Fred Hutchinson Canc Res Ctr, Clin Div, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Zager, RA (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	dzager@fhcrc.org			National Institutes of Health [DK-38432, DK083310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health (DK-38432; DK083310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Huang CC, 2007, AM J EMERG MED, V25, P164, DOI 10.1016/j.ajem.2006.06.010; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jarmi T, 2009, CURR HYPERTENS REP, V11, P56, DOI 10.1007/s11906-009-0011-z; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Liu NN, 2000, GENE, V241, P175, DOI 10.1016/S0378-1119(99)00439-4; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nath KA, 2013, AM J PHYSIOL-RENAL, V304, pF317, DOI 10.1152/ajprenal.00606.2012; Rudnick MR, 1997, SEMIN NEPHROL, V17, P15; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Seta F, 2006, AM J PATHOL, V169, P1612, DOI 10.2353/ajpath.2006.060555; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; WEINBERG JM, 1994, J AM SOC NEPHROL, V5, P1314; Weisbord SD, 2006, J AM SOC NEPHROL, V17, P2871, DOI 10.1681/ASN.2006030301; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zager RA, 2002, AM J KIDNEY DIS, V40, P90, DOI 10.1053/ajkd.2002.33917; Zager RA, 2006, KIDNEY INT, V69, P1181, DOI 10.1038/sj.ki.5000022; ZAGER RA, 1989, LAB INVEST, V61, P290; Zager RA, 2008, KIDNEY INT, V74, P674, DOI 10.1038/ki.2008.251; Zager RA, 2008, AM J PHYSIOL-RENAL, V294, pF187, DOI 10.1152/ajprenal.00434.2007; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147; Zager RA, 2009, AM J PHYSIOL-RENAL, V296, pF362, DOI 10.1152/ajprenal.90645.2008	25	49	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66776	10.1371/journal.pone.0066776	http://dx.doi.org/10.1371/journal.pone.0066776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825563	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400158
J	Chen, Y; Yang, L; Ding, YF; Zhang, SY; He, T; Mao, FL; Zhang, CY; Zhang, HN; Huo, CX; Liu, PS				Chen, Yong; Yang, Li; Ding, Yunfeng; Zhang, Shuyan; He, Tong; Mao, Fenglou; Zhang, Congyan; Zhang, Huina; Huo, Chaoxing; Liu, Pingsheng			Tracing Evolutionary Footprints to Identify Novel Gene Functional Linkages	PLOS ONE			English	Article							LIPID DROPLETS; COMPARATIVE GENOMICS; IDENTIFICATION; PROTEIN; FUSION; SNARE; ANNOTATION; CHROMOSOME; INSIGHTS; DNA	Systematic determination of gene function is an essential step in fully understanding the precise contribution of each gene for the proper execution of molecular functions in the cell. Gene functional linkage is defined as to describe the relationship of a group of genes with similar functions. With thousands of genomes sequenced, there arises a great opportunity to utilize gene evolutionary information to identify gene functional linkages. To this end, we established a computational method (called TRACE) to trace gene footprints through a gene functional network constructed from 341 prokaryotic genomes. TRACE performance was validated and successfully tested to predict enzyme functions as well as components of pathway. A so far undescribed chromosome partitioning-like protein ro03654 of an oleaginous bacteria Rhodococcus sp. RHA1 (RHA1) was predicted and verified experimentally with its deletion mutant showing growth inhibition compared to RHA1 wild type. In addition, four proteins were predicted to act as prokaryotic SNARE-like proteins, and two of them were shown to be localized at the plasma membrane. Thus, we believe that TRACE is an effective new method to infer prokaryotic gene functional linkages by tracing evolutionary events.	[Chen, Yong; Yang, Li; Ding, Yunfeng; Zhang, Shuyan; Zhang, Congyan; Zhang, Huina; Huo, Chaoxing; Liu, Pingsheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Yang, Li; Zhang, Congyan; Huo, Chaoxing] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Tong] Cent Univ Finance & Econ, Sch Appl Math, Beijing, Peoples R China; [Mao, Fenglou] Univ Georgia, Inst Bioinformat, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Central University of Finance & Economics; University System of Georgia; University of Georgia	Chen, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	yongchen@tsinghua.edu.cn; pliu@ibp.ac.cn	Zhang, Congyan/HHC-8442-2022; Zhang, Hui/HHN-8494-2022		Ministry of Science and Technology of China [2009CB919000, 2011CBA00906]; National Natural Science Foundation of China [30971431, 31100068, 61273228]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology of China (2009CB919000, 2011CBA00906), and the National Natural Science Foundation of China (30971431, 31100068, 61273228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonacid DE, 2011, CURR OPIN CHEM BIOL, V15, P435, DOI 10.1016/j.cbpa.2011.03.008; Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brouwer RW, 2008, BRIEF BIOINFORM; Chen Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S1; Chuang LY, 2010, BIOINFORMATICS, V26, P3127, DOI 10.1093/bioinformatics/btq601; Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; DEAZEVEDO JA, 1994, EUR J OPER RES, V73, P188, DOI 10.1016/0377-2217(94)90162-7; Ding YF, 2013, NAT PROTOC, V8, P43, DOI 10.1038/nprot.2012.142; Ding YF, 2012, J LIPID RES, V53, P399, DOI 10.1194/jlr.M021899; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Egan AN, 2010, SYST BIOL, V59, P534, DOI 10.1093/sysbio/syq041; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ferrer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-493; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Ghosh SK, 2006, ANNU REV BIOCHEM, V75, P211, DOI 10.1146/annurev.biochem.75.101304.124037; Hernandez MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-600; Hindre T, 2012, NAT REV MICROBIOL, V10, P352, DOI 10.1038/nrmicro2750; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karimpour-Fard A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-397; Kellis M, 2004, J COMPUT BIOL, V11, P319, DOI 10.1089/1066527041410319; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Kuroda Makoto, 2004, Methods Mol Biol, V266, P29; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Moscoso M, 1997, J MOL BIOL, V268, P840, DOI 10.1006/jmbi.1997.1012; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; Pejaver VR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S2; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Powell BC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-31; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Risselada HJ, 2012, CURR OPIN STRUC BIOL, V22, P187, DOI 10.1016/j.sbi.2012.01.007; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Ta HX, 2011, BIOINFORMATICS, V27, P700, DOI 10.1093/bioinformatics/btq705; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wu J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-80; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Yang Y, 2010, BIOINFORMATICS, V26, P22, DOI 10.1093/bioinformatics/btp613; Yelton AP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002230	54	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66817	10.1371/journal.pone.0066817	http://dx.doi.org/10.1371/journal.pone.0066817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825567	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000029
J	Desestret, V; Riou, A; Chauveau, F; Cho, TH; Devillard, E; Marinescu, M; Ferrera, R; Rey, C; Chanal, M; Angoulvant, D; Honnorat, J; Nighoghossian, N; Berthezene, Y; Nataf, S; Wiart, M				Desestret, Virginie; Riou, Adrien; Chauveau, Fabien; Cho, Tae-Hee; Devillard, Emilie; Marinescu, Marilena; Ferrera, Rene; Rey, Catherine; Chanal, Marie; Angoulvant, Denis; Honnorat, Jerome; Nighoghossian, Norbert; Berthezene, Yves; Nataf, Serge; Wiart, Marlene			In Vitro and In Vivo Models of Cerebral Ischemia Show Discrepancy in Therapeutic Effects of M2 Macrophages	PLOS ONE			English	Article							CELLS; POLARIZATION; STROKE; ACTIVATION; EXPRESSION; MICROGLIA; MECHANISM; DYNAMICS; INJURY	The inflammatory response following ischemic stroke is dominated by innate immune cells: resident microglia and blood-derived macrophages. The ambivalent role of these cells in stroke outcome might be explained in part by the acquisition of distinct functional phenotypes: classically (M1) and alternatively activated (M2) macrophages. To shed light on the crosstalk between hypoxic neurons and macrophages, an in vitro model was set up in which bone marrow-derived macrophages were co-cultured with hippocampal slices subjected to oxygen and glucose deprivation. The results showed that macrophages provided potent protection against neuron cell loss through a paracrine mechanism, and that they expressed M2-type alternative polarization. These findings raised the possibility of using bone marrow-derived M2 macrophages in cellular therapy for stroke. Therefore, 2 million M2 macrophages (or vehicle) were intravenously administered during the subacute stage of ischemia (D4) in a model of transient middle cerebral artery occlusion. Functional neuroscores and magnetic resonance imaging endpoints (infarct volumes, blood-brain barrier integrity, phagocytic activity assessed by iron oxide uptake) were longitudinally monitored for 2 weeks. This cell-based treatment did not significantly improve any outcome measure compared with vehicle, suggesting that this strategy is not relevant to stroke therapy.	[Desestret, Virginie; Riou, Adrien; Chauveau, Fabien; Cho, Tae-Hee; Marinescu, Marilena; Nighoghossian, Norbert; Berthezene, Yves; Wiart, Marlene] CREATIS, INSA Lyon, INSERM, CNRS,UMR 5220, Lyon, France; [Desestret, Virginie; Cho, Tae-Hee; Angoulvant, Denis; Honnorat, Jerome; Nighoghossian, Norbert; Berthezene, Yves; Nataf, Serge] Lyon Univ Hosp, Hosp Civils Lyon, Lyon, France; [Desestret, Virginie; Cho, Tae-Hee; Ferrera, Rene; Angoulvant, Denis; Honnorat, Jerome; Nighoghossian, Norbert; Berthezene, Yves; Nataf, Serge] Univ Lyon, Lyon, France; [Devillard, Emilie; Honnorat, Jerome; Nataf, Serge] CRNL, INSERM, U1028, CNRS,UMR 5292, Lyon, France; [Ferrera, Rene; Angoulvant, Denis] INSERM, U886, F-69008 Lyon, France; [Rey, Catherine] ProfilXpert, Univ INSERM US7, UMS CNRS 3453, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm)	Wiart, M (corresponding author), CREATIS, INSA Lyon, INSERM, CNRS,UMR 5220, Lyon, France.	marlene.wiart@creatis.insa-lyon.fr	Nighoghossian, Norbert/H-7492-2014; Cho, Tae-Hee/GOJ-9942-2022; Desestret, Virginie/H-9056-2017; Cho, Tae-Hee/I-5491-2014; Wiart, Marlene/K-3839-2014; Honnorat, jerome/G-6394-2017; Angoulvant, Denis/Q-9743-2019; Berthezene, yves/I-5689-2014; Chauveau, Fabien/T-4295-2019; Chauveau, Fabien/I-9722-2014	Cho, Tae-Hee/0000-0001-8677-2447; Wiart, Marlene/0000-0003-0326-7002; Honnorat, jerome/0000-0002-4721-5952; Angoulvant, Denis/0000-0003-0788-8092; Chauveau, Fabien/0000-0002-4177-741X; Chauveau, Fabien/0000-0002-4177-741X	ANR; Fondation pour la Recherche pour le Cerveau (FRC); Rhone-Alpes Region [11]	ANR(French National Research Agency (ANR)); Fondation pour la Recherche pour le Cerveau (FRC); Rhone-Alpes Region(Region Auvergne-Rhone-Alpes)	This work was supported by the ANR "INFLAM" and a grant from the Fondation pour la Recherche pour le Cerveau (FRC). AR was supported by a grant from the Rhone-Alpes Region (Cluster 11). MRI experiments were performed on the "Animage" platform of Centre d'Exploration et de Recherche Medicale par Emission de Positons (CERMEP) -Imagerie du Vivant, Lyon, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUMONT M, 2009, J CEREB BLOOD FLOW M, V8, P8; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Hicks A, 2009, CELL STEM CELL, V5, P139, DOI 10.1016/j.stem.2009.07.009; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Riou A, 2013, NMR BIOMED, V26, P115, DOI 10.1002/nbm.2826; Rizk NN, 2007, ENDOCRINE, V31, P66, DOI 10.1007/s12020-007-0012-0; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tei N, 2013, J NEUROSCI RES, V91, P681, DOI 10.1002/jnr.23202; Wagner DC, 2012, NEUROIMAGE, V61, P780, DOI 10.1016/j.neuroimage.2012.04.023; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863	29	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67063	10.1371/journal.pone.0067063	http://dx.doi.org/10.1371/journal.pone.0067063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825621	gold, Green Published			2022-12-27	WOS:000321223000073
J	Hu, XJ; Zhao, DZ; Strotmann, A				Hu, Xiaojun; Zhao, Dangzhi; Strotmann, Andreas			Mapping Molecular Association Networks of Nervous System Diseases via Large-Scale Analysis of Published Research	PLOS ONE			English	Article							PARKINSONS-DISEASE; INFORMATION-SCIENCE; PROTEIN; MEDICINE; AUTHOR; GENOTYPE	Network medicine has been applied successfully to elicit the structure of large-scale molecular interaction networks. Its main proponents have claimed that this approach to integrative medical investigation should make it possible to identify functional modules of interacting molecular biological units as well as interactions themselves. This paper takes a significant step in this direction. Based on a large-scale analysis of the nervous system molecular medicine literature, this study analyzes and visualizes the complex structure of associations between diseases on the one hand and all types of molecular substances on the other. From this analysis it then identifies functional co-association groups consisting of several types of molecular substances, each consisting of substances that exhibit a pattern of frequent co-association with similar diseases. These groups in turn exhibit interlinking in a complex pattern, suggesting that such complex interactions between functional molecular modules may play a role in disease etiology. We find that the patterns exhibited by the networks of disease - molecular substance associations studied here correspond well to a number of recently published research results, and that the groups of molecular substances identified by statistical analysis of these networks do appear to be interesting groups of molecular substances that are interconnected in identifiable and interpretable ways. Our results not only demonstrate that networks are a convenient framework to analyze and visualize large-scale, complex relationships among molecular networks and diseases, but may also provide a conceptual basis for bridging gaps in experimental and theoretical knowledge.	[Hu, Xiaojun] Zhejiang Univ, Sch Med, Med Informat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Dangzhi] Univ Alberta, Sch Lib & Informat Studies, Edmonton, AB, Canada; [Strotmann, Andreas] GESIS Leibniz Inst Social Sci, Cologne, Germany	Zhejiang University; University of Alberta; Leibniz Institut fur Sozialwissenschaften (GESIS)	Hu, XJ (corresponding author), Zhejiang Univ, Sch Med, Med Informat Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	xihu@zju.edi.cn	Strotmann, Andreas/P-5891-2017	Strotmann, Andreas/0000-0002-0679-6498				Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; ALS, 2012, STRUCT 3 MEMBR TRANS; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barbosa-Silva A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-435; Batagelj V., 2003, PAJEK ANAL VISUALIZA; Brown DR, 2000, BIOCHEM J, V352, P511, DOI 10.1042/0264-6021:3520511; Chava KR, 2012, BLOOD, V119, P308, DOI 10.1182/blood-2011-02-339473; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Cohen S, 2008, SCIENCE, V320, P1172, DOI 10.1126/science.1159146; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; DAVIDOFF F, 1995, BRIT MED J, V310, P1085, DOI 10.1136/bmj.310.6987.1085; Dias N, 2002, MOL CANCER THER, V1, P347; Farmer C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041750; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goedert M, 1991, BRAIN PATHOL, V1, P279, DOI 10.1111/j.1750-3639.1991.tb00671.x; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hair J.F., 1998, MULTIVARIATE DATA AN, V5, P207; Hirschman L, 2002, BIOINFORMATICS, V18, P1553, DOI 10.1093/bioinformatics/18.12.1553; Hoffmann R, 2005, BIOINFORMATICS, V21, P252, DOI 10.1093/bioinformatics/bti1142; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Isserlin R, 2007, PROTEOM CLIN APPL, V1, P1156, DOI 10.1002/prca.200700146; Komotar RJ, 2011, NEUROSURGERY, V68, pN14, DOI 10.1227/01.neu.0000398206.71573.50; Larner AJ, 2009, J ALZHEIMERS DIS, V17, P259, DOI 10.3233/JAD-2009-1042; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Margineanu DG, 2012, EPILEPSY RES, V98, P104, DOI 10.1016/j.eplepsyres.2011.10.006; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Mueller Wolf C, 2009, Recent Results Cancer Res, V171, P217, DOI 10.1007/978-3-540-31206-2_13; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Olanow CW, 2011, MOVEMENT DISORD, V26, P1056, DOI 10.1002/mds.23767; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Poston KL, 2012, NEUROLOGY, V78, P1237, DOI 10.1212/WNL.0b013e318250d7fd; Riemenschneider MJ, 2010, TARGET ONCOL, V5, P161, DOI 10.1007/s11523-010-0153-6; Saiki S, 2012, J NEUROL NEUROSUR PS, V83, P430, DOI 10.1136/jnnp-2011-301205; Sakoguchi Tetsuhiko, 2012, Hiroshima Journal of Medical Sciences, V61, P1; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wolk DA, 2010, P NATL ACAD SCI USA, V107, P10256, DOI 10.1073/pnas.1001412107; Yates D, 2012, NAT REV NEUROSCI, V13, P290, DOI [10.1038/nrn3235, 10.1038/nrn3248, 10.1038/nrd3731]; Zhao DZ, 2008, J AM SOC INF SCI TEC, V59, P2070, DOI 10.1002/asi.20910; Zhao DZ, 2008, J INFORMETR, V2, P229, DOI 10.1016/j.joi.2008.05.004; Zhao DZ, 2008, J AM SOC INF SCI TEC, V59, P916, DOI 10.1002/asi.20799; Zhao DZ, 2011, J AM SOC INF SCI TEC, V62, P654, DOI 10.1002/asi.21495; Zhao ZM, 2012, CHEM BIODIVERS, V9, P841, DOI 10.1002/cbdv.201100396; Zhou JH, 2005, MOL MICROBIOL, V58, P349, DOI 10.1111/j.1365-2958.2005.04842.x	48	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67121	10.1371/journal.pone.0067121	http://dx.doi.org/10.1371/journal.pone.0067121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825632	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000082
J	Olsen, KS; Fenton, C; Froyland, L; Waaseth, M; Paulssen, RH; Lund, E				Olsen, Karina Standahl; Fenton, Christopher; Froyland, Livar; Waaseth, Marit; Paulssen, Ruth H.; Lund, Eiliv			Plasma Fatty Acid Ratios Affect Blood Gene Expression Profiles - A Cross-Sectional Study of the Norwegian Women and Cancer Post-Genome Cohort	PLOS ONE			English	Article							GROWTH-FACTOR; CARDIOVASCULAR-DISEASE; RISK; N-3; AUTOPHAGY; FISH; EPIDEMIOLOGY; MODULATION; RECEPTOR; MIR-296	High blood concentrations of n-6 fatty acids (FAs) relative to n-3 FAs may lead to a "physiological switch" towards permanent low-grade inflammation, potentially influencing the onset of cardiovascular and inflammatory diseases, as well as cancer. To explore the potential effects of FA ratios prior to disease onset, we measured blood gene expression profiles and plasma FA ratios (linoleic acid/alpha-linolenic acid, LA/ALA; arachidonic acid/eicosapentaenoic acid, AA/EPA; and total n-6/n-3) in a cross-section of middle-aged Norwegian women (n = 227). After arranging samples from the highest values to the lowest for all three FA ratios (LA/ALA, AA/EPA and total n-6/n-3), the highest and lowest deciles of samples were compared. Differences in gene expression profiles were assessed by single-gene and pathway-level analyses. The LA/ALA ratio had the largest impact on gene expression profiles, with 135 differentially expressed genes, followed by the total n-6/n-3 ratio (125 genes) and the AA/EPA ratio (72 genes). All FA ratios were associated with genes related to immune processes, with a tendency for increased pro-inflammatory signaling in the highest FA ratio deciles. Lipid metabolism related to peroxisome proliferator-activated receptor gamma (PPAR gamma) signaling was modified, with possible implications for foam cell formation and development of cardiovascular diseases. We identified higher expression levels of several autophagy marker genes, mainly in the lowest LA/ALA decile. This finding may point to the regulation of autophagy as a novel aspect of FA biology which warrants further study. Lastly, all FA ratios were associated with gene sets that included targets of specific microRNAs, and gene sets containing common promoter motifs that did not match any known transcription factors. We conclude that plasma FA ratios are associated with differences in blood gene expression profiles in this free-living population, and that affected genes and pathways may influence the onset and progression of disease.	[Olsen, Karina Standahl; Lund, Eiliv] Univ Tromso, Dept Community Med, Tromso, Norway; [Fenton, Christopher; Paulssen, Ruth H.] Univ Tromso, Dept Clin Med, Tromso, Norway; [Froyland, Livar] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Waaseth, Marit] Univ Tromso, Dept Pharm, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Olsen, KS (corresponding author), Univ Tromso, Dept Community Med, Tromso, Norway.	karina.s.olsen@uit.no	Waaseth, Marit/W-6711-2019	Waaseth, Marit/0000-0002-1318-3972; Lund, Eiliv/0000-0002-8071-8711	Norwegian Research Council; University of Tromso	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Tromso	The study was funded by grants from the Norwegian Research Council and the University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman LA, 2012, PROG LIPID RES, V51, P63, DOI 10.1016/j.plipres.2011.11.005; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Ambring A, 2006, AM J CLIN NUTR, V83, P575, DOI 10.1093/ajcn.83.3.575; Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Araujo P, 2008, J CHROMATOGR A, V1212, P106, DOI 10.1016/j.chroma.2008.10.006; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouwens M, 2009, AM J CLIN NUTR AJCN, V2009, P28586; Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Brea D, 2011, CLIN IMMUNOL, V139, P193, DOI 10.1016/j.clim.2011.02.001; Brustad M, 2004, EUR J CLIN NUTR, V58, P128, DOI 10.1038/sj.ejcn.1601759; Burdge GC, 2006, BRIT J NUTR, V96, P489, DOI 10.1079/BJN20061877; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Cazzola M, 2011, EUR RESPIR J, V38, P42, DOI 10.1183/09031936.00140310; Chapkin RS, 2009, PROSTAG LEUKOTR ESS, V81, P187, DOI 10.1016/j.plefa.2009.05.010; de Aloysio D, 1999, ATHEROSCLEROSIS, V147, P147, DOI 10.1016/S0021-9150(99)00315-9; Dumeaux V, 2008, BIOMARK MED, V2, P11, DOI 10.2217/17520363.2.1.11; Dumeaux V, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1859; Dumeaux V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000873; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Goodstine SL, 2003, J NUTR, V133, P1409; Griffin BA, 2008, CURR OPIN LIPIDOL, V19, P57, DOI 10.1097/MOL.0b013e3282f2e2a8; GUEBREEGZIABHER F, 2007, EUR J CLIN NUTR; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyson Dianne, 2003, Curr Atheroscler Rep, V5, P437, DOI 10.1007/s11883-003-0033-y; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Juhn YJ, 2012, ALLERGY ASTHMA IMMUN, V4, P122, DOI 10.4168/aair.2012.4.3.122; Kalogeropoulos N, 2010, CLIN CHIM ACTA, V411, P584, DOI 10.1016/j.cca.2010.01.023; Knaevelsrud H, 2012, BBA-MOL CELL BIOL L, V1821, P1133, DOI 10.1016/j.bbalip.2012.01.001; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lund E, 2008, INT J EPIDEMIOL, V37, P36, DOI 10.1093/ije/dym137; Mauldin JP, 2008, CIRCULATION, V117, P2785, DOI 10.1161/CIRCULATIONAHA.107.741314; Myhrstad MCW, 2011, INFLAMM RES, V60, P309, DOI 10.1007/s00011-010-0302-5; Plourde M, 2007, APPL PHYSIOL NUTR ME, V32, P619, DOI 10.1139/H07-034; Rovito D, 2013, J CELL PHYSIOL, V228, P1314, DOI 10.1002/jcp.24288; Sebastiani G, 2011, DIABETES-METAB RES, V27, P862, DOI 10.1002/dmrr.1262; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Waaseth Marit, 2008, BMC Womens Health, V8, P1, DOI 10.1186/1472-6874-8-1; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wan JB, 2010, ARTERIOSCL THROM VAS, V30, P2487, DOI 10.1161/ATVBAHA.110.210054; Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861; Welch AA, 2002, PUBLIC HEALTH NUTR, V5, P1273, DOI 10.1079/PHN2002404; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005	53	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67270	10.1371/journal.pone.0067270	http://dx.doi.org/10.1371/journal.pone.0067270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825649	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000094
J	Sun, J; Zhao, Y; Hu, JH				Sun, Jun; Zhao, Yi; Hu, Jinhong			Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice	PLOS ONE			English	Article							SUPPRESSES CONSTITUTIVE ACTIVATION; CYTOKINE GENE-EXPRESSION; TOPICAL IMMUNOMODULATOR; INTERLEUKIN-17 FAMILY; SKIN INFLAMMATION; 5-PERCENT CREAM; DOUBLE-BLIND; T-CELLS; KAPPA-B; KERATINOCYTES	Curcumin, a selective phosphorylase kinase inhibitor, is a naturally occurring phytochemical present in turmeric. Curcumin has been confirmed to have anti-inflammatory properties in addition to the ability to decrease the expression of pro-inflammatory cytokines in keratinocytes. The interleukin-23 (IL-23)/IL-17A cytokine axis plays a critical role in the pathogenesis of psoriasis. Here, we report that topical use of a curcumin gel formulation strongly inhibited imiquimod (IMQ)-induced psoriasis-like inflammation, the development of which was based on the IL-23/IL-17A axis. IMQ-induced epidermal hyperplasia and inflammation in BALB/c mouse ear was significantly inhibited following curcumin treatment. Real-time PCR showed that mRNA levels of IL-17A, IL-17F, IL-22, IL-1 beta, IL-6 and TNF-alpha cytokines were decreased significantly by curcumin in ear skin, an effect similar to that of clobetasol. In addition, we found that curcumin may enhance the proliferation of epidermis gamma delta T cells but inhibit dermal gamma delta T cell proliferation. We inferred that curcumin was capable of impacting the IL-23/IL-17A axis by inhibiting IL-1 beta/IL-6 and then indirectly down-regulating IL-17A/IL-22 production. In conclusion, curcumin can relieve the IMQ-induced psoriasis-like inflammation in a mouse model, similar to the effects of clobetasol. Therefore, we have every reason to expect that curcumin will be used in the treatment of psoriasis in the future.	[Sun, Jun; Zhao, Yi; Hu, Jinhong] Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China	Naval Medical University	Hu, JH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China.	tudou_2000@yahoo.com.cn			National Natural Science Foundation of China [30873128]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported financially by Grant 30873128 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Beutner Karl R., 1997, American Journal of Medicine, V102, P9; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cho JW, 2007, INT J MOL MED, V19, P469; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Farahani SS, 2010, PATHOL RES PRACT, V206, P151, DOI 10.1016/j.prp.2009.10.006; Fujisawa H, 1996, J INTERF CYTOK RES, V16, P555, DOI 10.1089/jir.1996.16.555; Geisse JK, 2002, J AM ACAD DERMATOL, V47, P390, DOI 10.1067/mjd.2002.126215; Hidaka H, 2002, CANCER-AM CANCER SOC, V95, P1206, DOI 10.1002/cncr.10812; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KONO T, 1994, LYMPHOKINE CYTOK RES, V13, P71; Leverkus M, 1997, EXP CELL RES, V232, P255, DOI 10.1006/excr.1997.3514; Mahaisavariya P, 2000, INT J DERMATOL, V39, P274, DOI 10.1046/j.1365-4362.2000.00908.x; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Natarajan C, 2002, J IMMUNOL, V168, P6506, DOI 10.4049/jimmunol.168.12.6506; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Patel NA, 2009, PHARM DEV TECHNOL, V14, P80, DOI 10.1080/10837450802409438; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Saydmohammed M, 2010, J CELL BIOCHEM, V110, P447, DOI 10.1002/jcb.22558; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; Szeimies RM, 2004, J AM ACAD DERMATOL, V51, P547, DOI 10.1016/j.jaad.2004.02.022; Tsuruta D, 2009, RECENT PATENTS INFLA, V3, P40, DOI 10.2174/187221309787158399; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194	38	118	124	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67078	10.1371/journal.pone.0067078	http://dx.doi.org/10.1371/journal.pone.0067078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825622	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000074
J	Tong, JF; Sydorskyy, Y; St-Germain, JR; Taylor, P; Tsao, MS; Moran, MF				Tong, Jiefei; Sydorskyy, Yaroslav; St-Germain, Jonathan R.; Taylor, Paul; Tsao, Ming S.; Moran, Michael F.			Odin (ANKS1A) Modulates EGF Receptor Recycling and Stability	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SIGNAL-TRANSDUCTION; PHOSPHORYLATION DYNAMICS; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; ERBB RECEPTORS; PROTEIN GRB2; HUMAN CANCER; ENDOCYTOSIS; DOMAIN	The ANKS1A gene product, also known as Odin, was first identified as a tyrosine-phosphorylated component of the epidermal growth factor receptor network. Here we show that Odin functions as an effector of EGFR recycling. In EGF-stimulated HEK293 cells tyrosine phosphorylation of Odin was induced prior to EGFR internalization and independent of EGFR-to-ERK signaling. Over-expression of Odin increased EGF-induced EGFR trafficking to recycling endosomes and recycling back to the cell surface, and decreased trafficking to lysosomes and degradation. Conversely, Odin knockdown in both HEK293 and the non-small cell lung carcinoma line RVH6849, which expresses roughly 10-fold more EGF receptors than HEK293, caused decreased EGFR recycling and accelerated trafficking to the lysosome and degradation. By governing the endocytic fate of internalized receptors, Odin may provide a layer of regulation that enables cells to contend with receptor cell densities and ligand concentration gradients that are physiologically and pathologically highly variable.	[Tong, Jiefei; Sydorskyy, Yaroslav; St-Germain, Jonathan R.; Taylor, Paul; Moran, Michael F.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [St-Germain, Jonathan R.; Moran, Michael F.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Tsao, Ming S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Tsao, Ming S.] Univ Toronto, Toronto, ON, Canada; [Tsao, Ming S.; Moran, Michael F.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Moran, MF (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	m.moran@utoronto.ca	Tsao, Ming Sound/AFQ-7332-2022; Moran, Michael/GYD-3631-2022; Tsao, Ming-Sound/M-3503-2017	Tsao, Ming Sound/0000-0002-9160-5405; 	Canadian Institutes of Health Research; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This research was supported by the Canadian Institutes of Health Research, and Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; Emaduddin Muhammad, 2008, Cell Commun Signal, V6, P7, DOI 10.1186/1478-811X-6-7; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Imamura H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-232; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kajiho H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030575; Kharchenko MV, 2007, CELL BIOL INT, V31, P349, DOI 10.1016/j.cellbi.2007.01.020; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Kristiansen TZ, 2004, DNA RES, V11, P285; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Mercurio FA, 2012, BIOCHEMISTRY-US, V51, P2136, DOI 10.1021/bi300141h; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pandey A, 2002, ONCOGENE, V21, P8029, DOI 10.1038/sj.onc.1205988; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shin J, 2007, MOL CELL BIOL, V27, P8113, DOI 10.1128/MCB.00794-07; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; STEIN BS, 1984, J BIOL CHEM, V259, P4762; STOVER DR, 2004, CLIN PROTEOM, V1, P69; Teis D, 2003, CELL MOL LIFE SCI, V60, P2020, DOI 10.1007/s00018-003-3010-2; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tong J, 2008, J PROTEOME RES, V7, P1067, DOI 10.1021/pr7006363; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; WILLINGHAM MC, 1983, EXP CELL RES, V146, P163, DOI 10.1016/0014-4827(83)90334-8; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Woodman P, 2009, BIOCHEM SOC T, V37, P146, DOI 10.1042/BST0370146; Wu SL, 2006, MOL CELL PROTEOMICS, V5, P1610, DOI 10.1074/mcp.M600105-MCP200; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhong J, 2011, J PROTEOMICS, V74, P294, DOI 10.1016/j.jprot.2010.11.006; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	59	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e64817	10.1371/journal.pone.0064817	http://dx.doi.org/10.1371/journal.pone.0064817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825523	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000003
J	Aghcheh, RK; Druzhinina, IS; Kubicek, CP				Aghcheh, Razieh Karimi; Druzhinina, Irina S.; Kubicek, Christian P.			The Putative Protein Methyltransferase LAE1 of Trichoderma atroviride Is a Key Regulator of Asexual Development and Mycoparasitism	PLOS ONE			English	Article							VELVET-LIKE COMPLEX; SECONDARY METABOLISM; CONIDIATION; EXPRESSION; REESEI; PHOTOSTIMULATION; MORPHOGENESIS; COMPONENTS; VIRULENCE; GROWTH	In Ascomycota the protein methyltransferase LaeA is a global regulator that affects the expression of secondary metabolite gene clusters, and controls sexual and asexual development. The common mycoparasitic fungus Trichoderma atroviride is one of the most widely studied agents of biological control of plant-pathogenic fungi that also serves as a model for the research on regulation of asexual sporulation (conidiation) by environmental stimuli such as light and/or mechanical injury. In order to learn the possible involvement of LAE1 in these two traits, we assessed the effect of deletion and overexpression of lae1 gene on conidiation and mycoparasitic interaction. In the presence of light, conidiation was 50% decreased in a Delta lae1 and 30-50% increased in lae1-overexpressing (OElae1) strains. In darkness, Delta lae1 strains did not sporulate, and the OElae1 strains produced as much spores as the parent strain. Loss-of-function of lae1 also abolished sporulation triggered by mechanical injury of the mycelia. Deletion of lae1 also increased the sensitivity of T. atroviride to oxidative stress, abolished its ability to defend against other fungi and led to a loss of mycoparasitic behaviour, whereas the OElae1 strains displayed enhanced mycoparasitic vigor. The loss of mycoparasitic activity in the Dlae1 strain correlated with a significant underexpressionn of several genes normally upregulated during mycoparasitic interaction (proteases, GH16 beta-glucanases, polyketide synthases and small cystein-rich secreted proteins), which in turn was reflected in the partial reduction of formation of fungicidal water soluble metabolites and volatile compounds. Our study shows T. atroviride LAE1 is essential for asexual reproduction in the dark and for defense and parasitism on other fungi.	[Aghcheh, Razieh Karimi; Druzhinina, Irina S.; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, Microbiol Grp, A-1040 Vienna, Austria; [Druzhinina, Irina S.; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, Austrian Ctr Ind Biotechnol, A-1040 Vienna, Austria	Technische Universitat Wien; Austrian Centre of Industrial Biotechnology; Technische Universitat Wien	Kubicek, CP (corresponding author), Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, Microbiol Grp, A-1040 Vienna, Austria.	ckubicek@mail.zserv.tuwien.ac.at	Druzhinina, Irina S./AAK-7054-2021	Druzhinina, Irina S./0000-0003-2821-5268; Karimi Aghcheh, Razieh/0000-0003-0027-1030	Austrian Science Fund [P 21266]; Austrian Science Fund (FWF) [P 21266] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by a grant of the Austrian Science Fund to CPK:P 21266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akel E, 2009, EUKARYOT CELL, V8, P1837, DOI 10.1128/EC.00162-09; Atanasova L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-121; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Butchko RAE, 2012, FUNGAL GENET BIOL, V49, P602, DOI 10.1016/j.fgb.2012.06.003; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Carreras-Villasenor N, 2012, MICROBIOL-SGM, V158, P3, DOI 10.1099/mic.0.052688-0; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Chang PK, 2012, FUNGAL BIOL-UK, V116, P298, DOI 10.1016/j.funbio.2011.12.003; CLAYDON N, 1987, T BRIT MYCOL SOC, V88, P503, DOI 10.1016/S0007-1536(87)80034-7; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Druzhinina IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009191; Friedl MA, 2008, MICROBIOL-SGM, V154, P1229, DOI 10.1099/mic.0.2007/014175-0; Friedl MA, 2008, APPL ENVIRON MICROB, V74, P245, DOI 10.1128/AEM.02068-07; Guangtao Z, 2009, J BIOTECHNOL, V139, P146, DOI 10.1016/j.jbiotec.2008.10.007; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hernandez-Onate MA, 2012, P NATL ACAD SCI USA, V109, P14918, DOI 10.1073/pnas.1209396109; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Karimi-Aghcheh R, 2013, G3-GENES GENOM GENET, V3, P369, DOI 10.1534/g3.112.005140; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kullnig CM, 2001, MYCOL RES, V105, P770, DOI 10.1017/S0953756201229967; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Nemcovic M, 2008, FEMS MICROBIOL LETT, V284, P231, DOI 10.1111/j.1574-6968.2008.01202.x; Omann M, 2010, J SIGNAL TRANSDUCT, P123; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Roze LV, 2010, BMC BIOCH, V24, p[11, 33]; Schrey AW, 2012, MOL ECOL, V21, P2559, DOI 10.1111/j.1365-294X.2012.05487.x; Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x; Steyaert JM, 2010, MICROBIOL-SGM, V156, P2887, DOI 10.1099/mic.0.041715-0; Sugui JA, 2007, EUKARYOT CELL, V6, P1552, DOI 10.1128/EC.00140-07; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542	40	29	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67144	10.1371/journal.pone.0067144	http://dx.doi.org/10.1371/journal.pone.0067144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826217	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400111
J	Hsiao, SC; Liu, H; Holstlaw, TA; Liu, C; Francis, CY; Francis, MB				Hsiao, Sonny C.; Liu, Hong; Holstlaw, Taylor A.; Liu, Cheng; Francis, Catherine Y.; Francis, Matthew B.			Real Time Assays for Quantifying Cytotoxicity with Single Cell Resolution	PLOS ONE			English	Article							ANTI-CD20 ANTIBODY IDEC-C2B8; NATURAL-KILLER-CELL; IN-VITRO; RITUXIMAB; COMPLEMENT; LYMPHOMA; THERAPY; DNA; RESISTANCE; ADHESION	A new live cell-based assay platform has been developed for the determination of complement dependent cytotoxicity (CDC), antibody dependent cellular cytotoxicity (ADCC), and overall cytotoxicity in human whole blood. In these assays, the targeted tumor cell populations are first labeled with fluorescent Cell Tracker dyes and immobilized using a DNA-based adhesion technique. This allows the facile generation of live cell arrays that are arranged arbitrarily or in ordered rectilinear patterns. Following the addition of antibodies in combination with serum, PBMCs, or whole blood, cell death within the targeted population can be assessed by the addition of propidium iodide (PI) as a viability probe. The array is then analyzed with an automated microscopic imager. The extent of cytotoxicity can be quantified accurately by comparing the number of surviving target cells to the number of dead cells labeled with both Cell Tracker and PI. Excellent batch-to-batch reproducibility has been achieved using this method. In addition to allowing cytotoxicity analysis to be conducted in real time on a single cell basis, this new assay overcomes the need for hazardous radiochemicals. Fluorescently-labeled antibodies can be used to identify individual cells that bear the targeted receptors, but yet resist the CDC and ADCC mechanisms. This new approach also allows the use of whole blood in cytotoxicity assays, providing an assessment of antibody efficacy in a highly relevant biological mixture. Given the rapid development of new antibody-based therapeutic agents, this convenient assay platform is well-poised to streamline the drug discovery process significantly.	[Hsiao, Sonny C.; Holstlaw, Taylor A.; Francis, Catherine Y.] Adheren Inc, Berkeley, CA USA; [Liu, Hong; Liu, Cheng] Eureka Therapeut, Emeryville, CA USA; [Francis, Matthew B.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Francis, Matthew B.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hsiao, SC (corresponding author), Adheren Inc, Berkeley, CA USA.	sonny@adheren.com						Amoroso A, 2011, FRONT BIOSCI-LANDMRK, V16, P770, DOI 10.2741/3719; Anderson DR, 1997, BIOCHEM SOC T, V25, P705, DOI 10.1042/bst0250705; Bannerji R, 2003, J CLIN ONCOL, V21, P1466, DOI 10.1200/JCO.2003.06.012; Bornstein GG, 2010, INVEST NEW DRUG, V28, P561, DOI 10.1007/s10637-009-9291-z; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; BRUNNER KT, 1968, IMMUNOLOGY, V14, P181; Chandra RA, 2006, ANGEW CHEM INT EDIT, V45, P896, DOI 10.1002/ANIE.200502421; Chow KU, 2002, HAEMATOLOGICA, V87, P33; Dalle S, 2008, ANTI-CANCER AGENT ME, V8, P523, DOI 10.2174/187152008784533071; Douglas ES, 2009, LAB CHIP, V9, P2010, DOI 10.1039/b821690h; Gancz D, 2009, MOL IMMUNOL, V46, P2794, DOI 10.1016/j.molimm.2009.05.009; GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2; Gupta P, 2012, BLOOD, V119, P3767, DOI 10.1182/blood-2011-09-381988; Harjunpaa A, 2000, SCAND J IMMUNOL, V51, P634; Hsiao SC, 2008, ANGEW CHEM INT EDIT, V47, P8473, DOI 10.1002/anie.200802525; Hsiao SC, 2009, LANGMUIR, V25, P6985, DOI 10.1021/la900150n; JOHANN S, 1995, J IMMUNOL METHODS, V185, P209, DOI 10.1016/0022-1759(95)00116-R; Khattak SF, 2006, BIOTECHNOL LETT, V28, P1361, DOI 10.1007/s10529-006-9104-9; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Kosits C, 2000, Oncol Nurs Forum, V27, P51; Liadi I, 2013, JOVE-J VIS EXP, DOI 10.3791/50058; Lv M, 2010, CANCER LETT, V294, P66, DOI 10.1016/j.canlet.2010.01.023; Onoe H, 2012, LANGMUIR, V28, P8120, DOI 10.1021/la204863s; Plosker GL, 2003, DRUGS, V63, P803, DOI 10.2165/00003495-200363080-00005; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Vugmeyster Y, 2003, CYTOM PART A, V52A, P101, DOI 10.1002/cyto.a.10030; Wang SY, 2008, EXPERT OPIN BIOL TH, V8, P759, DOI [10.1517/14712598.8.6.759, 10.1517/14712598.8.6.759 ]; Wu L, 2010, CANCER LETT, V292, P208, DOI 10.1016/j.canlet.2009.12.004; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405	29	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66739	10.1371/journal.pone.0066739	http://dx.doi.org/10.1371/journal.pone.0066739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826123	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400043
J	Lachnit, H; Thorwart, A; Schultheis, H; Lotz, A; Koenig, S; Uengoer, M				Lachnit, Harald; Thorwart, Anna; Schultheis, Holger; Lotz, Anja; Koenig, Stephan; Uengoer, Metin			Indicators of Early and Late Processing Reveal the Importance of Within-Trial-Time for Theories of Associative Learning	PLOS ONE			English	Article							MATLAB SIMULATOR; PARTIAL-REINFORCEMENT; PREDICTIVE ACCURACY; SKIN-CONDUCTANCE; DISCRIMINATION; SUMMATION; MODEL; SIMILARITY; STIMULI; REPRESENTATIONS	In four human learning experiments (Pavlovian skin conductance, causal learning, speeded classification task), we evaluated several associative learning theories that assume either an elemental (modified unique cue model and Harris' model) or a configural (Pearce's configural theory and an extension of it) form of stimulus processing. The experiments used two modified patterning problems (A/B/C+, AB/BC/AC+ vs. ABC-; A+, BC+ vs. ABC-). Pearce's configural theory successfully predicted all of our data reflecting early stimulus processing, while the predictions of the elemental theories were in accord with all of our data reflecting later stages of stimulus processing. Our results suggest that the form of stimulus representation depends on the amount of time available for stimulus processing. Our findings highlight the necessity to investigate stimulus processing during conditioning on a finer time scale than usually done in contemporary research.	[Lachnit, Harald; Thorwart, Anna; Lotz, Anja; Koenig, Stephan; Uengoer, Metin] Univ Marburg, Fachbereich Psychol, D-35032 Marburg, Germany; [Schultheis, Holger] Univ Bremen, Fachbereich Informat, D-28359 Bremen, Germany	Philipps University Marburg; University of Bremen	Lachnit, H (corresponding author), Univ Marburg, Fachbereich Psychol, Gutenbergstr 18, D-35032 Marburg, Germany.	lachnit@uni-marburg.de	Thorwart, Anna/E-1237-2017; Lachnit, Harald/A-9640-2008	Thorwart, Anna/0000-0002-7620-4427; Lachnit, Harald/0000-0003-0182-838X; Koenig, Stephan/0000-0001-8083-4184; Schultheis, Holger/0000-0001-6892-1656; Uengoer, Metin/0000-0001-5453-2860	German Science Foundation (Deutsche Forschungsgemeinschaft) [DFG LA 564/10-4, LA 564/19-1]	German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The research reported in this article was supported by research grants DFG LA 564/10-4 and LA 564/19-1 from the German Science Foundation (Deutsche Forschungsgemeinschaft) to Harald Lachnit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandon SE, 2000, BEHAV BRAIN RES, V110, P67, DOI 10.1016/S0166-4328(99)00185-0; COLLINS L, 1985, J EXP PSYCHOL ANIM B, V11, P548; Deisig N, 2003, LEARN MEMORY, V10, P199, DOI 10.1101/lm.55803; Glautier S, 2004, Q J EXP PSYCHOL-B, V57, P315, DOI 10.1080/02724990344000169; Harris JA, 2006, PSYCHOL REV, V113, P584, DOI 10.1037/0033-295X.113.3.584; HONEY RC, 1987, LEARN MOTIV, V18, P288, DOI 10.1016/0023-9690(87)90016-6; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; KAYE H, 1984, J EXP PSYCHOL ANIM B, V10, P90, DOI 10.1037/0097-7403.10.1.90; KEHOE EJ, 1994, ANIM LEARN BEHAV, V22, P19, DOI 10.3758/BF03199952; Killeen PR, 2003, J EXP PSYCHOL-ANIM B, V29, P49, DOI 10.1037//0097-7403.29.1.49; KIMMEL HD, 1980, BEHAV RES METH INSTR, V12, P605, DOI 10.3758/BF03201851; Kinder A, 2003, PSYCHOPHYSIOLOGY, V40, P226, DOI 10.1111/1469-8986.00024; LACHNIT H, 1988, J EXP PSYCHOL HUMAN, V14, P143, DOI 10.1037/0096-1523.14.1.143; Lachnit H, 2001, BIOL PSYCHOL, V56, P45, DOI 10.1016/S0301-0511(00)00087-9; Lachnit H, 2008, J EXP PSYCHOL-ANIM B, V34, P303, DOI 10.1037/0097-7403.34.2.303; Lamberts K, 1998, J EXP PSYCHOL LEARN, V24, P695, DOI 10.1037/0278-7393.24.3.695; LOCKHEAD GR, 1972, PSYCHOL REV, V79, P410, DOI 10.1037/h0033129; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Melchers KG, 2008, BEHAV PROCESS, V77, P413, DOI 10.1016/j.beproc.2007.09.013; Myers KM, 2001, ANIM LEARN BEHAV, V29, P36, DOI 10.3758/BF03192814; OHMAN A, 1972, PSYCHOPHYSIOLOGY, V9, P199, DOI 10.1111/j.1469-8986.1972.tb00754.x; Pearce JM, 1997, J EXP PSYCHOL ANIM B, V23, P84; PEARCE JM, 1994, PSYCHOL REV, V101, P587, DOI 10.1037/0033-295X.101.4.587; PEARCE JM, 1993, J EXP PSYCHOL ANIM B, V19, P180, DOI 10.1037/0097-7403.19.2.180; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; REDHEAD ES, 1995, Q J EXP PSYCHOL-B, V48, P46; RESCORLA RA, 1995, ANIM LEARN BEHAV, V23, P314, DOI 10.3758/BF03198928; Schultheis H, 2008, BEHAV RES METHODS, V40, P442, DOI 10.3758/BRM.40.2.442; Schultheis H, 2008, BEHAV RES METHODS, V40, P435, DOI 10.3758/BRM.40.2.435; Shanks DR, 2008, BEHAV PROCESS, V77, P451, DOI 10.1016/j.beproc.2007.09.005; SWAN JA, 1987, J EXP PSYCHOL ANIM B, V13, P407, DOI 10.1037/0097-7403.13.4.407; Thorwart A, 2009, BEHAV RES METHODS, V41, P29, DOI 10.3758/BRM.41.1.29; Venables Peter H, 1980, TECHNIQUES PSYCHOPHY, V54, P3; Wagner AR, 2003, Q J EXP PSYCHOL-B, V56, P7, DOI 10.1080/02724990244000133; WARD TB, 1983, J EXP PSYCHOL HUMAN, V9, P103, DOI 10.1037/0096-1523.9.1.103; WOLTER J, 1993, INTEGR PHYS BEH SCI, V28, P163, DOI 10.1007/BF02691221	36	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66291	10.1371/journal.pone.0066291	http://dx.doi.org/10.1371/journal.pone.0066291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23826092	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400014
J	Nagai, K; Miyoshi, M; Kake, T; Fukushima, N; Matsuura, M; Shibata, E; Yamada, S; Yoshikawa, K; Kanayama, H; Fukawa, T; Yamaguchi, K; Izaki, H; Mima, A; Abe, N; Araoka, T; Murakami, T; Kishi, F; Kishi, S; Tominaga, T; Moriya, T; Abe, H; Doi, T				Nagai, Kojiro; Miyoshi, Masashi; Kake, Takei; Fukushima, Naoshi; Matsuura, Motokazu; Shibata, Eriko; Yamada, Satoshi; Yoshikawa, Kazuhiro; Kanayama, Hiro-omi; Fukawa, Tomoya; Yamaguchi, Kunihisa; Izaki, Hirofumi; Mima, Akira; Abe, Naoko; Araoka, Toshikazu; Murakami, Taichi; Kishi, Fumi; Kishi, Seiji; Tominaga, Tatsuya; Moriya, Tatsumi; Abe, Hideharu; Doi, Toshio			Dual Involvement of Growth Arrest-Specific Gene 6 in the Early Phase of Human IgA Nephropathy	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; MESANGIAL CELL-PROLIFERATION; KIDNEY INJURY MOLECULE-1; OXFORD CLASSIFICATION; DIABETIC-NEPHROPATHY; GAS6; EXPRESSION; DISEASE; LIGAND; GLOMERULONEPHRITIS	Background: Gas6 is a growth factor that causes proliferation of mesangial cells in the development of glomerulonephritis. Gas6 can bind to three kinds of receptors; Axl, Dtk, and Mer. However, their expression and functions are not entirely clear in the different glomerular cell types. Meanwhile, representative cell cycle regulatory protein p27 has been reported to be expressed in podocytes in normal glomeruli with decreased expression in proliferating glomeruli, which inversely correlated with mesangial proliferation in human IgA nephropathy (IgAN). Methods: The aim of this study is to clarify Gas6 involvement in the progression of IgAN. Expression of Gas6/Axl/Dtk was examined in 31 biopsy proven IgAN cases. We compared the expression levels with histological severity or clinical data. Moreover, we investigated the expression of Gas6 and its receptors in cultured podocytes. Results: In 28 of 31 cases, Gas6 was upregulated mainly in podocytes. In the other 3 cases, Gas6 expression was induced in endothelial and mesangial cells, which was similar to animal nephritis models. Among 28 podocyte type cases, the expression level of Gas6 correlated with the mesangial hypercellularity score of IgAN Oxford classification and urine protein excretion. It also inversely correlated with p27 expression in glomeruli. As for the receptors, Axl was mainly expressed in endothelial and mesangial cells, while Dtk was expressed in podocytes. In vitro, Dtk was expressed in cultured murine podocytes, and the expression of p27 was decreased by Gas6 stimulation. Conclusions: Gas6 was uniquely upregulated in either endothelial/mesangial cells or podocytes in IgAN. The expression pattern can be used as a marker to classify IgAN. Gas6 has a possibility to be involved in not only mesangial proliferation via Axl, but also podocyte injury via Dtk in IgAN.	[Nagai, Kojiro; Miyoshi, Masashi; Matsuura, Motokazu; Shibata, Eriko; Yamada, Satoshi; Yoshikawa, Kazuhiro; Mima, Akira; Abe, Naoko; Araoka, Toshikazu; Murakami, Taichi; Kishi, Fumi; Kishi, Seiji; Tominaga, Tatsuya; Abe, Hideharu; Doi, Toshio] Univ Tokushima, Grad Sch Med, Dept Nephrol, Tokushima 770, Japan; [Kake, Takei; Fukushima, Naoshi] Chugai Res Inst Med Sci Inc, Shizuoka, Japan; [Kanayama, Hiro-omi; Fukawa, Tomoya; Yamaguchi, Kunihisa; Izaki, Hirofumi] Univ Tokushima, Grad Sch Med, Dept Urol, Tokushima 770, Japan; [Tominaga, Tatsuya] Kitasato Univ, Sch Med, Dept Endocrinol Diabet & Metab, Kanagawa, Japan	Tokushima University; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Tokushima University; Kitasato University	Nagai, K (corresponding author), Univ Tokushima, Grad Sch Med, Dept Nephrol, Tokushima 770, Japan.	knagai@clin.med.tokushima-u.ac.jp	Fukawa, Tomoya/AFV-7106-2022		Ministry of Health, Labour and Welfare of Japan [24591202]; Japan Science and Technology Agency	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Grants-in-aid for Scientific Research 24591202, Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research, from the Ministry of Health, Labour and Welfare of Japan and Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asao R, 2012, CLIN J AM SOC NEPHRO, V7, P1385, DOI 10.2215/CJN.08110811; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; CROSIER KE, 1994, GROWTH FACTORS, V11, P137, DOI 10.3109/08977199409001055; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Ding HL, 2007, CLIN IMMUNOL, V123, P227, DOI 10.1016/j.clim.2007.01.010; Ebefors K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018575; Funakoshi H, 2002, J NEUROSCI RES, V68, P150, DOI 10.1002/jnr.10211; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; Liu LL, 2012, CLIN EXP IMMUNOL, V169, P148, DOI 10.1111/j.1365-2249.2012.04604.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Murakami T, 2010, AM J NEPHROL, V32, P505, DOI 10.1159/000321366; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nystrom J, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-13; O'Donnell K, 1999, AM J PATHOL, V154, P1171, DOI 10.1016/S0002-9440(10)65369-2; Onda K, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-64; Peters HPE, 2011, NEPHROL DIAL TRANSPL, V26, P3581, DOI 10.1093/ndt/gfr135; Qiu LQ, 2004, LAB INVEST, V84, P1112, DOI 10.1038/labinvest.3700144; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shankland SJ, 1996, KIDNEY INT, V50, P1230, DOI 10.1038/ki.1996.432; Tominaga T, 2011, J BIOL CHEM, V286, P20109, DOI 10.1074/jbc.M110.179382; Tumlin JA, 2007, CLIN J AM SOC NEPHRO, V2, P1054, DOI 10.2215/CJN.04351206; Xu PC, 2011, NEPHROL DIAL TRANSPL, V26, P3229, DOI 10.1093/ndt/gfr023; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yanagita M, 1999, J AM SOC NEPHROL, V10, P2503; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	30	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66759	10.1371/journal.pone.0066759	http://dx.doi.org/10.1371/journal.pone.0066759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826128	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400046
J	Van Der Velden, J; Sum, G; Barker, D; Koumoundouros, E; Barcham, G; Wulff, H; Castle, N; Bradding, P; Snibson, K				Van Der Velden, Joanne; Sum, Grace; Barker, Donna; Koumoundouros, Emmanuel; Barcham, Garry; Wulff, Heike; Castle, Neil; Bradding, Peter; Snibson, Kenneth			K(Ca)3.1 Channel-Blockade Attenuates Airway Pathophysiology in a Sheep Model of Chronic Asthma	PLOS ONE			English	Article							K+ CHANNELS; CELLS; EXACERBATIONS; PROLIFERATION; ANGIOGENESIS; INFLAMMATION; ACTIVATION; CHALLENGE; LUNGS	Background: The Ca2+-activated K+ channel K(Ca)3.1 is expressed in several structural and inflammatory airway cell types and is proposed to play an important role in the pathophysiology of asthma. The aim of the current study was to determine whether inhibition of K(Ca)3.1 modifies experimental asthma in sheep. Methodology and Principal Findings: Atopic sheep were administered either 30 mg/kg Senicapoc (ICA-17073), a selective inhibitor of the K(Ca)3.1-channel, or vehicle alone (0.5% methylcellulose) twice daily (orally). Both groups received fortnightly aerosol challenges with house dust mite allergen for fourteen weeks. A separate sheep group received no allergen challenges or drug treatment. In the vehicle-control group, twelve weeks of allergen challenges resulted in a 60 +/- 19% increase in resting airway resistance, and this was completely attenuated by treatment with Senicapoc (0.25 +/- 12%; n = 10, P = 0.0147). The vehicle-control group had a peak-early phase increase in lung resistance of 82 +/- 21%, and this was reduced by 58% with Senicapoc treatment (24 +/- 14%; n = 10, P = 0.0288). Senicapoc-treated sheep also demonstrated reduced airway hyperresponsiveness, requiring a significantly higher dose of carbachol to increase resistance by 100% compared to allergen-challenged vehicle-control sheep (20 +/- 5 vs. 52 +/- 18 breath-units of carbachol; n = 10, P = 0.0340). Senicapoc also significantly reduced eosinophil numbers in bronchoalveolar lavage taken 48 hours post-allergen challenge, and reduced vascular remodelling. Conclusions: These findings suggest that K(Ca)3.1-activity contributes to allergen-induced airway responses, inflammation and vascular remodelling in a sheep model of asthma, and that inhibition of K(Ca)3.1 may be an effective strategy for blocking allergen-induced airway inflammation and hyperresponsiveness in humans.	[Van Der Velden, Joanne; Sum, Grace; Barker, Donna; Koumoundouros, Emmanuel; Barcham, Garry; Snibson, Kenneth] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Van Der Velden, Joanne] Univ Melbourne, Dept Pharmacol, Lung Hlth Res Ctr, Parkville, Vic 3052, Australia; [Koumoundouros, Emmanuel] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3052, Australia; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Castle, Neil] Icagen Inc, Durham, NC USA; [Bradding, Peter] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England	University of Melbourne; University of Melbourne; University of Melbourne; University of California System; University of California Davis; University of Leicester	Snibson, K (corresponding author), Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia.	ksnibson@unimelb.edu.au	wulff, Heike/Z-2056-2019; Sum, Grace/C-7349-2015; KOUMOUNDOUROS, EMMANUEL/H-5766-2016	Sum, Grace/0000-0001-8503-8523; Barker, Donna/0000-0003-2005-5239; Bradding, Peter/0000-0001-8403-0319; Snibson, Kenneth/0000-0003-4772-9408; KOUMOUNDOUROS, EMMANUEL/0000-0002-6419-329X	National Health and Medical Research Council (NHMRC) of Australia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by the National Health and Medical Research Council (NHMRC) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Cruse G, 2011, J ALLERGY CLIN IMMUN, V128, P1303, DOI 10.1016/j.jaci.2011.07.047; Duffy SM, 2004, J ALLERGY CLIN IMMUN, V114, P66, DOI 10.1016/j.jaci.2004.04.005; Duffy SM, 2001, J IMMUNOL, V167, P4261, DOI 10.4049/jimmunol.167.8.4261; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Jensen BS, 1999, P NATL ACAD SCI USA, V96, P10917, DOI 10.1073/pnas.96.19.10917; KOHN EC, 1995, P NATL ACAD SCI USA, V92, P1307, DOI 10.1073/pnas.92.5.1307; Koumoundouros E, 2006, EXP LUNG RES, V32, P321, DOI 10.1080/01902140600916960; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Molinari JF, 1995, J APPL PHYSIOL, V79, P1966, DOI 10.1152/jappl.1995.79.6.1966; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Siddiqui S, 2007, J ALLERGY CLIN IMMUN, V120, P813, DOI 10.1016/j.jaci.2007.05.028; Snibson KJ, 2005, CLIN EXP ALLERGY, V35, P146, DOI 10.1111/j.1365-2222.2005.02137.x; Van der Velden J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037161; Van der Velden J, 2012, EXP LUNG RES, V38, P307, DOI 10.3109/01902148.2012.697975; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11	24	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66886	10.1371/journal.pone.0066886	http://dx.doi.org/10.1371/journal.pone.0066886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826167	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400078
J	Hua, RH; Liu, LK; Chen, ZS; Li, YN; Bu, ZG				Hua, Rong-Hong; Liu, Li-Ke; Chen, Zhen-Shi; Li, Ye-Nan; Bu, Zhi-Gao			Comprehensive Mapping Antigenic Epitopes of NS1 Protein of Japanese Encephalitis Virus with Monoclonal Antibodies	PLOS ONE			English	Article							WEST-NILE-VIRUS; RECOMBINANT VACCINIA VIRUS; LINKED-IMMUNOSORBENT-ASSAY; CROSS-REACTIVE EPITOPES; B-CELL EPITOPES; NONSTRUCTURAL-1 PROTEIN; PROTECTIVE IMMUNITY; ENVELOPE; MICE; IDENTIFICATION	Japanese encephalitis virus (JEV) non-structural protein 1 (NS1) contributes to virus replication and elicits protective immune responses during infection. JEV NS1-specific antibody responses could be a target in the differential diagnosis of different flavivirus infections. However, the epitopes on JEV NS1 are poorly characterized. The present study describes the full mapping of linear B-cell epitopes in JEV NS1. We generated eleven NS1-specific monoclonal antibodies from mice immunized with recombinant NS1. For epitope mapping of monoclonal antibodies, a set of 51 partially-overlapping peptides covering the entire NS1 protein were expressed with a GST-tag and then screened using monoclonal antibodies. Through enzyme-linked immunosorbent assay (ELISA), five linear epitope-containing peptides were identified. By sequentially removing amino acid residues from the carboxy and amino terminal of peptides, the minimal units of the five linear epitopes were identified and confirmed using monoclonal antibodies. Five linear epitopes are located in amino acids residues (5)AIDITRK(11), (RDELNVL78)-R-72, (251)KSKHNRREGY(260), (269)DENGIVLD(276), and (DETTLVRS348)-D-341. Furthermore, it was found that the epitopes are highly conserved among JEV strains through sequence alignment. Notably, none of the homologous regions on NS1 proteins from other flaviviruses reacted with the MAbs when they were tested for cross-reactivity, and all five epitope peptides were not recognized by sera against West Nile virus or Dengue virus. These novel virus-specific linear B-cell epitopes of JEV NS1 would benefit the development of new vaccines and diagnostic assays.	[Hua, Rong-Hong; Liu, Li-Ke; Chen, Zhen-Shi; Li, Ye-Nan; Bu, Zhi-Gao] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Hua, RH (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China.	huaronghong@163.com		Hua, Rong-Hong/0000-0001-7034-5766	Special Fund for Agro-scientific Research in the Public Interest of China [201203082]; Basic Scientific Research Fund of Central Research Academies and Institutes [ZGKJ201106, 1610302013011]	Special Fund for Agro-scientific Research in the Public Interest of China; Basic Scientific Research Fund of Central Research Academies and Institutes	This work was supported by grants from the Special Fund for Agro-scientific Research in the Public Interest of China (201203082) and the Basic Scientific Research Fund of Central Research Academies and Institutes (ZGKJ201106, 1610302013011). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin SE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-45; Wang B, 2009, VIRUS RES, V141, P90, DOI 10.1016/j.virusres.2009.01.004; Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07; Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Hall RA, 2001, ANN NY ACAD SCI, V951, P153; HALL RA, 1990, J GEN VIROL, V71, P2923, DOI 10.1099/0022-1317-71-12-2923; Hua RH, 2004, BIOCHEM BIOPH RES CO, V319, P929, DOI 10.1016/j.bbrc.2004.05.066; Huang JL, 2001, J MED VIROL, V65, P553, DOI 10.1002/jmv.2072; Khoretonenko MV, 2003, IMMUNOL LETT, V90, P161, DOI 10.1016/j.imlet.2003.09.002; KIMURAKURODA J, 1986, J GEN VIROL, V67, P2663, DOI 10.1099/0022-1317-67-12-2663; Kitai Y, 2007, CLIN VACCINE IMMUNOL, V14, P1024, DOI 10.1128/CVI.00051-07; Kitai Y, 2011, J VIROL METHODS, V171, P123, DOI 10.1016/j.jviromet.2010.10.012; Konishi E, 2004, J CLIN MICROBIOL, V42, P5087, DOI 10.1128/JCM.42.11.5087-5093.2004; Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7; Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314; Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8; Lee TH, 2012, J GEN VIROL, V93, P20, DOI 10.1099/vir.0.036640-0; Lin CW, 2008, BIOTECHNOL LETT, V30, P205, DOI 10.1007/s10529-007-9529-9; Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998; Lindahl J, 2012, TROP ANIM HEALTH PRO, V44, P239, DOI 10.1007/s11250-011-0005-0; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mathew A, 1998, J VIROL, V72, P3999, DOI 10.1128/JVI.72.5.3999-4004.1998; Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; Shu PY, 2004, J CLIN MICROBIOL, V42, P2489, DOI 10.1128/JCM.42.6.2489-2494.2004; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Sun EC, 2012, J GEN VIROL, V93, P50, DOI 10.1099/vir.0.034900-0; Sun EC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-160; Sun EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031434; Thakare J. P., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P801; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510	36	21	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67553	10.1371/journal.pone.0067553	http://dx.doi.org/10.1371/journal.pone.0067553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825668	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400187
J	Xie, T; Sun, C; Uslu, K; Auth, RD; Fang, H; Ouyang, WM; Frucht, DM				Xie, Tao; Sun, Chen; Uslu, Kadriye; Auth, Roger D.; Fang, Hui; Ouyang, Weiming; Frucht, David M.			A New Murine Model for Gastrointestinal Anthrax Infection	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; BACILLUS-ANTHRACIS; LETHAL TOXIN; PATHOLOGY; HISTOPATHOLOGY; SUSCEPTIBILITY; DISSEMINATION	The scientific community has been restricted by the lack of a practical and informative animal model of gastrointestinal infection with vegetative Bacillus anthracis. We herein report the development of a murine model of gastrointestinal anthrax infection by gavage of vegetative Sterne strain of Bacillus anthracis into the complement-deficient A/J mouse strain. Mice infected in this manner developed lethal infections in a dose-dependent manner and died 30 h-5 d following gavage. Histological findings were consistent with penetration and growth of the bacilli within the intestinal villi, with subsequent dissemination into major organs including the spleen, liver, kidney and lung. Blood cultures confirmed anthrax bacteremia in all moribund animals, with approximately 1/3 showing co-infection with commensal enteric organisms. However, no evidence of immune activation was observed during infection. Time-course experiments revealed early compromise of the intestinal epithelium, characterized by villus blunting and ulceration in the ileum and jejunum. A decrease in body temperature was most predictive of near-term lethality. Antibiotic treatment of infected animals 24 h following high-dose bacterial gavage protected all animals, demonstrating the utility of this animal model in evaluating potential therapeutics.	[Xie, Tao; Sun, Chen; Uslu, Kadriye; Auth, Roger D.; Fang, Hui; Ouyang, Weiming; Frucht, David M.] US FDA, Cell Biol Lab, Div Monoclonal Antibodies, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Frucht, DM (corresponding author), US FDA, Cell Biol Lab, Div Monoclonal Antibodies, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	david.frucht@fda.hhs.gov			Federal Drug Administration Medical Countermeasures Initiative	Federal Drug Administration Medical Countermeasures Initiative	This project was supported by the Federal Drug Administration Medical Countermeasures Initiative. No external funding sources were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEBY JC, 1955, J GEN MICROBIOL, V12, P526, DOI 10.1099/00221287-12-3-526; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; DRUETT HA, 1953, J HYG-CAMBRIDGE, V51, P359, DOI 10.1017/S0022172400015795; Duong S, 2006, INT J EXP PATHOL, V87, P131, DOI 10.1111/j.0959-9673.2006.00473.x; Fang H, 2010, J IMMUNOL, V185, P5463, DOI 10.4049/jimmunol.1002471; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; LINCOLN RE, 1965, J INFECT DIS, V115, P481, DOI 10.1093/infdis/115.5.481; Lovchik JA, 2012, INFECT IMMUN, V80, P2414, DOI 10.1128/IAI.06340-11; Loving CL, 2007, INFECT IMMUN, V75, P2689, DOI 10.1128/IAI.01875-06; Lyons CR, 2004, INFECT IMMUN, V72, P4801, DOI 10.1128/IAI.72.8.4801-4809.2004; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Plaut RD, 2012, INFECT IMMUN, V80, P3189, DOI 10.1128/IAI.00515-12; Popov SG, 2012, MICROBES INFECT; Sun C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033583; Twenhafel NA, 2010, VET PATHOL, V47, P819, DOI 10.1177/0300985810378112; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; WHO, 2008, ANTHRAX HUMANS ANIMA; YOUNG GA, 1946, J INFECT DIS, V79, P233, DOI 10.1093/infdis/79.3.233; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	23	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66943	10.1371/journal.pone.0066943	http://dx.doi.org/10.1371/journal.pone.0066943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825096	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400169
J	Cardoso, EC; Pereira, NZ; Mitsunari, GE; Oliveira, LMD; Ruocco, RMSA; Francisco, RPV; Zugaib, M; Duarte, AJD; Sato, MN				Cardoso, Elaine Cristina; Pereira, Natalli Zanete; Mitsunari, Gabrielle Eimi; da Silva Oliveira, Luanda Mara; Ruocco, Rosa Maria S. A.; Vieira Francisco, Rossana Pulcineli; Zugaib, Marcelo; da Silva Duarte, Alberto Jose; Sato, Maria Notomi			TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CELLULAR IMMUNE-RESPONSES; INNATE IMMUNITY; MICROBIAL TRANSLOCATION; UNINFECTED INFANTS; TYPE-1 INFECTION; EARLY-LIFE; IN-UTERO; BLOOD; EXPRESSION	Mother-to-child transmission (MTCT) of HIV-1 has been significantly reduced with the use of antiretroviral therapies, resulting in an increased number of HIV-exposed uninfected infants. The consequences of HIV infection on the innate immune system of both mother-newborn are not well understood. In this study, we analyzed peripheral blood and umbilical cord blood (CB) collected from HIV-1-infected and uninfected pregnant women. We measured TNF-alpha, IL-10 and IFN-alpha secretion after the stimulation of the cells with agonists of both extracellular Toll-like receptors (TLRs) (TLR2, TLR4 and TLR5) and intracellular TLRs (TLR7, TLR7/8 and TLR9). Moreover, as an indicator of the innate immune response, we evaluated the responsiveness of myeloid dendritic cells (mDCs) and plasmacytoid DCs (pDCs) to TLRs that are associated with the antiviral response. Our results showed that peripheral blood mononuclear cells (PBMCs) from HIV-1-infected mothers and CB were defective in TNF-alpha production after activation by TLR2, TLR5, TLR3 and TLR7. However, the TNF-alpha response was preserved after TLR7/8 (CL097) stimulation, mainly in the neonatal cells. Furthermore, only CL097 activation was able to induce IL-10 and IFN-alpha secretion in both maternal and CB cells in the infected group. An increase in IFN-alpha secretion was observed in CL097-treated CB from HIV-infected mothers compared with control mothers. The effectiveness of CL097 stimulation was confirmed by observation of similar mRNA levels of interferon regulatory factor-7 (IRF-7), IFN-alpha and TNF-alpha in PBMCs of both groups. The function of both mDCs and pDCs was markedly compromised in the HIV-infected group, and although TLR7/TLR8 activation overcame the impairment in TNF-alpha secretion by mDCs, such stimulation was unable to reverse the dysfunctional type I IFN response by pDCs in the HIV-infected samples. Our findings highlight the dysfunction of innate immunity in HIV-infected mother-newborn pairs. The activation of the TLR7/8 pathway could function as an adjuvant to improve maternal-neonatal innate immunity.	[Cardoso, Elaine Cristina; Pereira, Natalli Zanete; Mitsunari, Gabrielle Eimi; da Silva Oliveira, Luanda Mara; da Silva Duarte, Alberto Jose; Sato, Maria Notomi] Univ Sao Paulo, Sch Med, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil; [Ruocco, Rosa Maria S. A.; Vieira Francisco, Rossana Pulcineli; Zugaib, Marcelo] Univ Sao Paulo, Sch Med, Dept Obstet & Gynecol, Hosp Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Sato, MN (corresponding author), Univ Sao Paulo, Sch Med, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil.	marisato@usp.br	Duarte, Alberto J S/D-4382-2012; Sato, Maria N/C-1196-2012; Francisco, Rossana Pulcineli Vieira/AAG-7461-2020; Sato, Maria N/C-2853-2012; Francisco, Rossana PV/C-5648-2012; Pereira, Nátalli Zanete/U-7291-2019; Zugaib, Marcelo/A-5724-2013; da Silva Oliveira, Luanda Mara/E-7273-2013	Sato, Maria N/0000-0002-7911-1824; Francisco, Rossana Pulcineli Vieira/0000-0002-9981-8069; Francisco, Rossana PV/0000-0002-9981-8069; Pereira, Nátalli Zanete/0000-0002-8875-9470; Zugaib, Marcelo/0000-0003-1155-2671; da Silva Oliveira, Luanda Mara/0000-0003-0903-8219	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/55962-3]; Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2008/55962-3) and the Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; [Anonymous], 2012, BJOG, P1; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; Boasso A, 2011, BLOOD, V118, P5152, DOI 10.1182/blood-2011-03-344218; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burlingham WJ, 2009, NEW ENGL J MED, V360, P1355, DOI 10.1056/NEJMcibr0810752; Caron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165; Charrier E, 2012, CELL IMMUNOL, V276, P114, DOI 10.1016/j.cellimm.2012.04.010; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3; de Brito CA, 2009, IMMUNOTHERAPY-UK, V1, P883, DOI 10.2217/IMT.09.38; Desai S, 2007, JAIDS-J ACQ IMM DEF, V45, P501, DOI 10.1097/QAI.0b013e3180654811; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dolcini G, 2003, AIDS RES HUM RETROV, V19, P857, DOI 10.1089/088922203322493021; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Futata EA, 2012, EXPERT REV ANTI-INFE, V10, P289, DOI [10.1586/eri.12.9, 10.1586/ERI.12.9]; Giaquinto C, 2005, BJOG-INT J OBSTET GY, V112, P881, DOI 10.1111/j.1471-0528.2005.00569.x; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kamga I, 2005, J INFECT DIS, V192, P303, DOI 10.1086/430931; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kuhn L, 2002, CLIN INFECT DIS, V34, P267, DOI 10.1086/338153; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohman-Payne B, 2010, CLIN PERINATOL, V37, P787, DOI 10.1016/j.clp.2010.08.005; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Meier A, 2007, EXPERT REV ANTI-INFE, V5, P323, DOI 10.1586/14787210.5.3.323; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Morgado JM, 2008, TRANSPL IMMUNOL, V19, P55, DOI 10.1016/j.trim.2007.11.002; Mussi-Pinhata MM, 2007, PEDIATR INFECT DIS J, V26, P1032, DOI 10.1097/INF.0b013e31812f56ed; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Rosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Velilla PA, 2008, CLIN IMMUNOL, V126, P243, DOI 10.1016/j.clim.2007.11.004; Villacres MC, 2012, J INFECT DIS, V206, P780, DOI 10.1093/infdis/jis380; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391	53	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67036	10.1371/journal.pone.0067036	http://dx.doi.org/10.1371/journal.pone.0067036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826189	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000021
J	Dituri, F; Mazzocca, A; Peidro, FJ; Papappicco, P; Fabregat, I; De Santis, F; Paradiso, A; Sabba, C; Giannelli, G				Dituri, Francesco; Mazzocca, Antonio; Juan Peidro, Fernando; Papappicco, Patrizia; Fabregat, Isabel; De Santis, Flavia; Paradiso, Angelo; Sabba, Carlo; Giannelli, Gianluigi			Differential Inhibition of the TGF-beta Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-beta Receptor Type II	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA GROWTH; TRANSFORMING GROWTH-FACTOR-BETA-1; VASCULAR INVASION; CANCER; BLOCKS; METASTASIS; STROMA	We investigated blocking the TGF-beta signaling pathway in HCC using two small molecule inhibitors (LY2157299, LY2109761) and a neutralizing humanized antibody (D10) against TGF-beta RII. LY2157299 and LY2109761 inhibited HCC cell migration on Laminin-5, Fibronectin, Vitronectin, Fibrinogen and Collagen-I and de novo phosphorylation of pSMAD2. LY2157299 inhibited HCC migration and cell growth independently of the expression levels of TGF-beta RII. In contrast to LY2157299, D10 showed a reduction in pSMAD2 only after a short exposure. This study supports the use of LY2157299 in clinical trials, and presents new insights into TGF-beta receptor cycling in cancer cells.	[Dituri, Francesco; Mazzocca, Antonio; Papappicco, Patrizia; De Santis, Flavia; Giannelli, Gianluigi] Univ Bari, Sch Med, Dept Emergency & Organ Transplantat, Sect Internal Med Allergol & Immunol, Bari, Italy; [Juan Peidro, Fernando; Fabregat, Isabel] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain; [Paradiso, Angelo] Natl Canc Inst, Clin Expt Oncol Lab, Bari, Italy; [Sabba, Carlo] Univ Bari, Sch Med, Dept Interdisciplinary Med, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); IRCCS Istituto Tumori Bari Giovanni Paolo II; Universita degli Studi di Bari Aldo Moro	Giannelli, G (corresponding author), Univ Bari, Sch Med, Dept Emergency & Organ Transplantat, Sect Internal Med Allergol & Immunol, Bari, Italy.	g.giannelli@intmed.uniba.it	paradiso, angelo V/J-9457-2018; Dituri, Francesco/K-5819-2016; Fabregat, Isabel/H-7038-2015; Giannelli, Gianluigi/K-5123-2016	MAZZOCCA, Antonio/0000-0003-0940-7352; Sabba', Carlo/0000-0002-9874-8740; Fabregat, Isabel/0000-0003-0136-8440; Giannelli, Gianluigi/0000-0002-5140-8060	Italian Association of Cancer Research (AIRC) [IG11389]	Italian Association of Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association of Cancer Research (AIRC) (grant number IG11389 to G.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Bergamini C, 2007, HEPATOLOGY, V46, P1801, DOI 10.1002/hep.21936; Bissell DM, 2001, EXP MOL MED, V33, P179, DOI 10.1038/emm.2001.31; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Colombo M, 1999, J HEPATOL, V31, P25, DOI 10.1016/S0168-8278(99)80370-5; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Fransvea E, 2009, HEPATOLOGY, V49, P839, DOI 10.1002/hep.22731; Giannelli G, 2002, AM J PATHOL, V161, P183, DOI 10.1016/S0002-9440(10)64170-3; Giannelli G, 2011, BBA-REV CANCER, V1815, P214, DOI 10.1016/j.bbcan.2010.11.004; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; ITO N, 1991, CANCER RES, V51, P4080; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mamiya T, 2010, LAB INVEST, V90, P1339, DOI 10.1038/labinvest.2010.105; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Mazzocca A, 2009, HEPATOLOGY, V50, P1140, DOI 10.1002/hep.23118; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; SHIRAI Y, 1994, CANCER, V73, P2275, DOI 10.1002/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Zhong ZJ, 2010, CLIN CANCER RES, V16, P1191, DOI 10.1158/1078-0432.CCR-09-1634	24	80	88	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67109	10.1371/journal.pone.0067109	http://dx.doi.org/10.1371/journal.pone.0067109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826206	Green Submitted, gold, Green Published			2022-12-27	WOS:000321150000029
J	Fang, DD; Zhang, CC; Gu, Y; Jani, JP; Cao, J; Tsaparikos, K; Yuan, J; Thiel, M; Jackson-Fisher, A; Zong, Q; Lappin, PB; Hayashi, T; Schwab, RB; Wong, A; John-Baptiste, A; Bagrodia, S; Los, G; Bender, S; Christensen, J; VanArsdale, T				Fang, Douglas D.; Zhang, Cathy C.; Gu, Yin; Jani, Jitesh P.; Cao, Joan; Tsaparikos, Konstantinos; Yuan, Jing; Thiel, Melissa; Jackson-Fisher, Amy; Zong, Qing; Lappin, Patrick B.; Hayashi, Tomoko; Schwab, Richard B.; Wong, Anthony; John-Baptiste, Annette; Bagrodia, Shubha; Los, Geritt; Bender, Steve; Christensen, James; VanArsdale, Todd			Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation	PLOS ONE			English	Article							PI3K; PATHWAY; GROWTH; BREAST; GENE; SUBPOPULATION; PROMOTES; SURVIVAL; OVARIAN; TARGET	PIK3CA (phosphoinositide-3-kinase, catalytic, alpha polypeptide) mutations can help predict the antitumor activity of phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathway inhibitors in both preclinical and clinical settings. In light of the recent discovery of tumor-initiating cancer stem cells (CSCs) in various tumor types, we developed an in vitro CSC model from xenograft tumors established in mice from a colorectal cancer patient tumor in which the CD133+/EpCAM+ population represented tumor-initiating cells. CD133+/EpCAM+ CSCs were enriched under stem cell culture conditions and formed 3-dimensional tumor spheroids. Tumor spheroid cells exhibited CSC properties, including the capability for differentiation and self-renewal, higher tumorigenic potential and chemo-resistance. Genetic analysis using an OncoCarta (TM) panel revealed a PIK3CA (H1047R) mutation in these cells. Using a dual PI3K/mTOR inhibitor, PF-04691502, we then showed that blockage of the PI3K/mTOR pathway inhibited the in vitro proliferation of CSCs and in vivo xenograft tumor growth with manageable toxicity. Tumor growth inhibition in mice was accompanied by a significant reduction of phosphorylated Akt (pAKT) (S473), a well-established surrogate biomarker of PI3K/mTOR signaling pathway inhibition. Collectively, our data suggest that PF-04691502 exhibits potent anticancer activity in colorectal cancer by targeting both PIK3CA (H1047R) mutant CSCs and their derivatives. These results may assist in the clinical development of PF-04691502 for the treatment of a subpopulation of colorectal cancer patients with poor outcomes.	[Fang, Douglas D.; Zhang, Cathy C.; Gu, Yin; Jani, Jitesh P.; Cao, Joan; Tsaparikos, Konstantinos; Yuan, Jing; Thiel, Melissa; Jackson-Fisher, Amy; Bagrodia, Shubha; Los, Geritt; Bender, Steve; Christensen, James; VanArsdale, Todd] Pfizer Global Res & Dev, Oncol Res Unit, San Diego, CA 92121 USA; [Zong, Qing; Lappin, Patrick B.; Wong, Anthony; John-Baptiste, Annette] Pfizer Global Res & Dev, Drug Safety Res & Dev, San Diego, CA USA; [Hayashi, Tomoko; Schwab, Richard B.] Univ Calif San Diego, Moores UCSD Canc Ctr, San Diego, CA 92103 USA	Pfizer; Pfizer; University of California System; University of California San Diego	Zhang, CC (corresponding author), Pfizer Global Res & Dev, Oncol Res Unit, San Diego, CA 92121 USA.	cathy.zhang@pfizer.com	Schwab, Richard/AAX-9262-2020		Pfizer	Pfizer(Pfizer)	The authors have the following interests. All authors are either current or former employees of Pfizer, the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bander AG, 2006, P NATL ACAD SCI USA, V103, P1475; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Don ASA, 2011, REV RECENT CLIN TRIA, V6, P24, DOI 10.2174/157488711793980147; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Hong ZY, 2011, CARCINOGENESIS, V32, P1550, DOI 10.1093/carcin/bgr176; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kato S, 2007, INT J CANCER, V121, P1771, DOI 10.1002/ijc.22890; Kinross KM, 2011, MOL CANCER THER, V10, P1440, DOI 10.1158/1535-7163.MCT-11-0240; Krishnamurthy S, 2010, CANCER RES, V70, P9969, DOI 10.1158/0008-5472.CAN-10-1712; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Martelli AM, 2011, CURR MED CHEM, V18, P2715; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ong CW, 2010, MODERN PATHOL, V23, P450, DOI 10.1038/modpathol.2009.181; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2010, FASEB J, V24, P4291, DOI 10.1096/fj.10-159970; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yuan J, 2011, MOL CANCER THER, V10, P2189, DOI 10.1158/1535-7163.MCT-11-0185	47	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67258	10.1371/journal.pone.0067258	http://dx.doi.org/10.1371/journal.pone.0067258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826249	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000050
J	Leow, MKS; Griva, K; Choo, R; Wee, HL; Thumboo, J; Tai, ES; Newman, S				Leow, Melvin Khee-Shing; Griva, Konstadina; Choo, Robin; Wee, Hwee-Lin; Thumboo, Julian; Tai, E. Shyong; Newman, Stanton			Determinants of Health-Related Quality of Life (HRQoL) in the Multiethnic Singapore Population - A National Cohort Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; SELF-RATED HEALTH; BODY-MASS INDEX; 12-COUNTRY RELIABILITY; RISK-FACTORS; ETHNICITY; OUTCOMES; SENSITIVITY; MORTALITY; SURVIVAL	Background: HRQoL is an important outcome to guide and promote healthcare. Clinical and socioeconomic factors may influence HRQoL according to ethnicity. Methodology: A multiethnic cross-sectional national cohort (N = 7198) of the Singapore general population consisting of Chinese (N = 4873), Malay (N = 1167) and Indian (N = 1158) adults were evaluated using measures of HRQoL (SF-36 version 2), family functioning, health behaviours and clinical/laboratory assessments. Multiple regression analyses were performed to identify determinants of physical and mental HRQoL in the overall population and their potential differential effects by ethnicity. No a priori hypotheses were formulated so all interaction effects were explored. Principal Findings: HRQoL levels differed between ethnic groups. Chinese respondents had higher physical HRQoL (PCS) than Indian and Malay participants (p < 0.001) whereas mental HRQoL (MCS) was higher in Malay relative to Chinese participants (p < 0.001). Regressions models explained 17.1% and 14.6% of variance in PCS and MCS respectively with comorbid burden, income and employment being associated with lower HRQoL. Age and family were associated only with MCS. The effects of gender, stroke and musculoskeletal conditions on PCS varied by ethnicity, suggesting non-uniform patterns of association for Chinese, Malay and Indian individuals. Conclusions: Differences in HRQoL levels and determinants of HRQoL among ethnic groups underscore the need to better or differentially target population segments to promote well-being. More work is needed to explore HRQoL and wellness in relation to ethnicity.	[Leow, Melvin Khee-Shing] Tan Tock Seng Hosp, Dept Endocrinol, Singapore, Singapore; [Leow, Melvin Khee-Shing; Choo, Robin] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Leow, Melvin Khee-Shing; Thumboo, Julian] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Leow, Melvin Khee-Shing; Thumboo, Julian] Duke NUS Grad Sch Med, Off Clin Sci, Singapore, Singapore; [Griva, Konstadina] Natl Univ Singapore, Fac Sci, Dept Psychol, Singapore 117548, Singapore; [Wee, Hwee-Lin; Thumboo, Julian] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Wee, Hwee-Lin] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Div Endocrinol, Singapore 117548, Singapore; [Newman, Stanton] City Univ London, Sch Community & Hlth Sci, London EC1V 0HB, England	Tan Tock Seng Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; National University of Singapore; National University of Singapore; City University London	Newman, S (corresponding author), City Univ London, Sch Community & Hlth Sci, London EC1V 0HB, England.	Stanton.Newman.1@city.ac.uk	Leow, Melvin/AAJ-1168-2020; Tai, E Shyong/J-9831-2013; Leow, Melvin/H-3129-2019; Griva, Konstadina/A-6549-2018; Wee, Hwee Lin/D-4126-2012	Leow, Melvin/0000-0002-2837-5889; Wee, Hwee Lin/0000-0002-7150-1801; GRIVA, KONSTADINA/0000-0001-8173-5663; Choo, Robin/0000-0002-3240-3029; Tai, E Shyong/0000-0003-2929-8966; Newman, Stanton/0000-0001-6712-6079				ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; [Anonymous], 2009, GUIDANCE ROUTINE COL; Ashing-Giwa KT, 2010, QUAL LIFE RES, V19, P789, DOI 10.1007/s11136-010-9642-4; Bassett DR, 2003, MED SCI SPORT EXER, V35, P1396, DOI 10.1249/01.MSS.0000078923.96621.1D; Bhalla V, 2006, SMJ Singapore Medical Journal, V47, P841; Bowling A., 2005, AGEING WELL QUALITY; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Chang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038079; Cheung P, 2001, SINGAPORE CENSUS POP; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dalan R, 2010, DIABETES METAB SYNDR, V3, P187, DOI 10.2147/DMSO.S10721; Dawson J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c186; Diehl M, 1996, PSYCHOL AGING, V11, P127, DOI 10.1037/0882-7974.11.1.127; Dixon D, 2007, PAIN, V130, P249, DOI 10.1016/j.pain.2006.12.004; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Giedzinska AS, 2004, ANN BEHAV MED, V28, P39, DOI 10.1207/s15324796abm2801_6; GOVE WR, 1983, J HEALTH SOC BEHAV, V24, P122, DOI 10.2307/2136639; Greenhalgh J, 2009, QUAL LIFE RES, V18, P115, DOI 10.1007/s11136-008-9430-6; Hudson M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1112, DOI 10.1002/art.24676; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Khoo CM, 2007, OBESITY, V15, P262, DOI 10.1038/oby.2007.559; Kutner N G, 1994, Adv Ren Replace Ther, V1, P210; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Liew CF, 2003, INT J OBESITY, V27, P784, DOI 10.1038/sj.ijo.0802307; Lim WY, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-184; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Maruish M, 2007, USERS MANUAL SF 36V2; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meyerowitz BE, 1998, PSYCHOL BULL, V123, P47, DOI 10.1037/0033-2909.123.1.47; Mineau GP, 2002, SOC SCI MED, V54, P245, DOI 10.1016/S0277-9536(01)00024-7; Netuveli G, 2005, BRIT MED J, V331, P1382, DOI 10.1136/bmj.331.7529.1382; Ng TP, 2005, QUAL LIFE RES, V14, P1755, DOI 10.1007/s11136-005-1741-2; OTTEN MW, 1990, JAMA-J AM MED ASSOC, V263, P845, DOI 10.1001/jama.263.6.845; Pappa E, 2009, INT J PUBLIC HEALTH, V54, P241, DOI 10.1007/s00038-009-8057-x; Pekmezovic T, 2011, QUAL LIFE RES, V20, P391, DOI 10.1007/s11136-010-9754-x; PROMIS, 2012, DYN TOOLS MEAS HLTH; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Ramachandran V, PLOS ONE, V7; Revicki DA, 2000, QUAL LIFE RES, V9, P887, DOI 10.1023/A:1008996223999; Sherbourne CD, 1992, SOCIAL FUNCTIONING F, P193; Singapore Department of Statistics, 2011, KEY DEM IND 1970 201; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Thumboo J, 2003, SOC SCI MED, V56, P1761, DOI 10.1016/S0277-9536(02)00171-5; Thumboo J, 1999, LUPUS, V8, P514, DOI 10.1191/096120399678840747; Unruh M, 2004, KIDNEY INT, V65, P1482, DOI 10.1111/j.1523-1755.2004.00529.x; Vathesatogkit P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049921; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; Ware Jr JE, 1994, SF 36 PHYS MENTAL HL; Wee HL, 2010, INT J OBESITY, V34, P1034, DOI 10.1038/ijo.2010.24; Wee HL, 2006, J DIABETES COMPLICAT, V20, P170, DOI 10.1016/j.jdiacomp.2005.06.010; Wilcox S, 2003, HEALTH PSYCHOL, V22, P513, DOI 10.1037/0278-6133.22.5.513	54	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67138	10.1371/journal.pone.0067138	http://dx.doi.org/10.1371/journal.pone.0067138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IX	23826215	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000033
J	Liu, H; Ma, YN; Fang, F; Zhang, Y; Zou, LP; Yang, YL; Zhu, SN; Wang, ST; Zheng, XF; Pei, P; Li, L; Wu, HR; Xiao, Y; Xu, YF; Wang, LW; Cao, YY; Pan, H; Qi, Y				Liu, Hui; Ma, Yinan; Fang, Fang; Zhang, Ying; Zou, Liping; Yang, Yanling; Zhu, Sainan; Wang, Songtao; Zheng, Xuefei; Pei, Pei; Li, Lin; Wu, Hairong; Xiao, Yang; Xu, Yufeng; Wang, Liwen; Cao, Yanyan; Pan, Hong; Qi, Yu			Wild-Type Mitochondrial DNA Copy Number in Urinary Cells as a Useful Marker for Diagnosing Severity of the Mitochondrial Diseases	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; A3243G MUTATION; MTDNA; MELAS; PHENOTYPE; POPULATION; DEAFNESS; GENE; LOAD	The genotype-phenotype relationship in diseases with mtDNA point mutations is still elusive. The maintenance of wild-type mtDNA copy number is essential to the normal mitochondrial oxidative function. This study examined the relationship between mtDNA copy number in blood and urine and disease severity of the patients harboring A3243G mutation. We recruited 115 A3243G patients, in which 28 were asymptomatic, 42 were oligo-symptomatic, and 45 were poly-symptomatic. Increase of total mtDNA copy number without correlation to the proportion of mutant mtDNA was found in the A3243G patients. Correlation analyses revealed that wild-type mtDNA copy number in urine was the most important factor correlated to disease severity, followed by proportion of mutant mtDNA in urine and proportion of mutant mtDNA in blood. Wild-type copy number in urine negatively correlated to the frequencies of several major symptoms including seizures, myopathy, learning disability, headache and stroke, but positively correlated to the frequencies of hearing loss and diabetes. Besides proportion of mutant mtDNA in urine, wild-type copy number in urine is also an important marker for disease severity of A3243G patients.	[Liu, Hui; Ma, Yinan; Zhang, Ying; Wang, Songtao; Zheng, Xuefei; Pei, Pei; Li, Lin; Wu, Hairong; Xiao, Yang; Xu, Yufeng; Pan, Hong; Qi, Yu] Peking Univ, Hosp 1, Cent Lab, Beijing 100871, Peoples R China; [Fang, Fang] Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China; [Zou, Liping] Beijing 301 Hosp, Dept Pediat, Beijing, Peoples R China; [Yang, Yanling] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Zhu, Sainan] Peking Univ, Hosp 1, Dept Biostat, Beijing 100871, Peoples R China; [Wang, Liwen; Cao, Yanyan] Capital Inst Pediat, Dept Neurol, Beijing, Peoples R China	Peking University; Capital Medical University; Peking University; Peking University; Capital Institute of Pediatrics (CIP)	Ma, YN (corresponding author), Peking Univ, Hosp 1, Cent Lab, Beijing 100871, Peoples R China.	mayinan1014@163.com; qiyu0724@163.com			National Natural Science Foundation of China [81271256]; Capital Medical Development Foundation of China [2009-2022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Medical Development Foundation of China	This work was supported by the National Natural Science Foundation of China (grant number 81271256); the Capital Medical Development Foundation of China (grant number 2009-2022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197; BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Francisci S, 1998, CURR GENET, V33, P110, DOI 10.1007/s002940050315; Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2; Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008; Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701; Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005; Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x; Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004; Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004; Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Oka T, 1996, DIABETIC MED, V13, pS98; Rinaldi T, 2003, GENE, V303, P63, DOI 10.1016/S0378-1119(02)01154-X; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209	21	11	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67146	10.1371/journal.pone.0067146	http://dx.doi.org/10.1371/journal.pone.0067146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826218	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000034
J	Shaikh, AG; Zee, DS; Mandir, AS; Lederman, HM; Crawford, TO				Shaikh, Aasef G.; Zee, David S.; Mandir, Allen S.; Lederman, Howard M.; Crawford, Thomas O.			Disorders of Upper Limb Movements in Ataxia-Telangiectasia	PLOS ONE			English	Article							ESSENTIAL TREMOR; BASAL GANGLIA; DYSTONIA; MODEL; DIAGNOSIS; DOPAMINE; NEURONS; DISEASE; MICE	Ataxia-telangiectasia is known for cerebellar degeneration, but clinical descriptions of abnormal tone, posture, and movements suggest involvement of the network between cerebellum and basal ganglia. We quantitatively assessed the nature of upper-limb movement disorders in ataxia-telangiectasia. We used a three-axis accelerometer to assess the natural history and severity of abnormal upper-limb movements in 80 ataxia-telangiectasia and 19 healthy subjects. Recordings were made during goal-directed movements of upper limb (kinetic task), while arms were outstretched (postural task), and at rest. Almost all ataxia-telangiectasia subjects (79/80) had abnormal involuntary movements, such as rhythmic oscillations (tremor), slow drifts (dystonia or athetosis), and isolated rapid movements (dystonic jerks or myoclonus). All patients with involuntary movements had both kinetic and postural tremor, while 48 (61%) also had resting tremor. The tremor was present in transient episodes lasting several seconds during two-minute recording sessions of all three conditions. Percent time during which episodic tremor was present was greater for postural and kinetic tasks compared to rest. Resting tremor had higher frequency but smaller amplitude than postural and kinetic tremor. Rapid non-rhythmic movements were minimal during rest, but were triggered during sustained arm postures and goal directed arm movements suggesting they are best considered a form of dystonic jerks or action myoclonus. Advancing age did not correlate with the severity of involuntary limb movements. Abnormal upper-limb movements in ataxia-telangiectasia feature classic cerebellar impairment, but also suggest involvement of the network between the cerebellum and basal ganglia.	[Shaikh, Aasef G.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Zee, David S.; Crawford, Thomas O.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Mandir, Allen S.] Georgetown Univ, Dept Neurol, Washington, DC USA; [Lederman, Howard M.; Crawford, Thomas O.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Lederman, Howard M.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Case Western Reserve University; Johns Hopkins University; Georgetown University; Johns Hopkins University; Johns Hopkins University	Shaikh, AG (corresponding author), Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA.	aasefshaikh@gmail.com			Ataxia-Telangiectasia Children's Project; Gustavus Louise Pfeiffer Foundation; Allen Leavy Foundation	Ataxia-Telangiectasia Children's Project; Gustavus Louise Pfeiffer Foundation; Allen Leavy Foundation	The study was supported by grants from Ataxia-Telangiectasia Children's Project, Gustavus Louise Pfeiffer Foundation, and Allen Leavy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR MJ, 1968, J NEUROPATH EXP NEUR, V27, P659; Boder E, 1970, Psychiatr Neurol Med Psychol Beih, V13-14, P8; Cabana MD, 1998, PEDIATRICS, V102, P98, DOI 10.1542/peds.102.1.98; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Crawford TO, 2000, NEUROLOGY, V54, P1505, DOI 10.1212/WNL.54.7.1505; Deuschl G, 2001, MUSCLE NERVE, V24, P716, DOI 10.1002/mus.1063; Deuschl G, 1999, J NEURAL TRANSM-SUPP, P211; Eilam R, 1998, P NATL ACAD SCI USA, V95, P12653, DOI 10.1073/pnas.95.21.12653; Elble RJ, 2005, CLIN NEUROPHYSIOL, V116, P1638, DOI 10.1016/j.clinph.2005.03.014; Gernert M, 2002, J NEUROSCI, V22, P7244; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; LeDoux M S, 1998, Adv Neurol, V78, P63; LEDOUX MS, 1993, EXP NEUROL, V120, P302, DOI 10.1006/exnr.1993.1064; Lewis RF, 1999, ANN NEUROL, V46, P287, DOI 10.1002/1531-8249(199909)46:3<287::AID-ANA3>3.0.CO;2-0; McAuley JH, 1998, NEUROLOGY, V50, P1882, DOI 10.1212/WNL.50.6.1882; Mount HTJ, 2004, J NEUROCHEM, V88, P1449, DOI 10.1046/j.1471-4159.2003.02278.x; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; Ni Z, 2010, ANN NEUROL, V68, P816, DOI 10.1002/ana.22221; OBESO JA, 1983, NEUROLOGY, V33, P825, DOI 10.1212/WNL.33.7.825; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pizoli CE, 2002, J NEUROSCI, V22, P7825; Saunders-Pullman R, 2012, NEUROLOGY, V78, P649, DOI 10.1212/WNL.0b013e3182494d51; SEDGWICK RP, 1960, NEUROLOGY, V10, P705, DOI 10.1212/WNL.10.7.705; Shaikh AG, 2008, J NEUROL NEUROSUR PS, V79, P187, DOI 10.1136/jnnp.2007.131110; Shaikh AG, 2009, J NEUROL NEUROSUR PS, V80, P858, DOI 10.1136/jnnp.2008.170522; Shaikh AG, 2011, J NEUROPHYSIOL, V105, P3034, DOI 10.1152/jn.00721.2010; Shaikh AG, 2006, NOVEL SOFTWARE ALGOR; Shibasaki H, 2011, MOVEMENT DISORD, V26, P1142, DOI 10.1002/mds.23673; Syllaba L, 1926, REV NEUROLOGIA, V1, P541; Tabbal SD, 2006, NEUROSCIENCE, V141, P1281, DOI 10.1016/j.neuroscience.2006.04.072; Vaillancourt DE, 2003, NEUROLOGY, V61, P919, DOI 10.1212/01.WNL.0000086371.78447.D2; WELLS CE, 1957, J NEUROL NEUROSUR PS, V20, P98, DOI 10.1136/jnnp.20.2.98; Worth PF, 2012, MOV DISORD	33	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67042	10.1371/journal.pone.0067042	http://dx.doi.org/10.1371/journal.pone.0067042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826191	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000022
J	Sterratt, DC				Sterratt, David C.			On the Importance of Countergradients for the Development of Retinotopy: Insights from a Generalised Gierer Model	PLOS ONE			English	Article							HALF RETINAL PROJECTION; RETINOTECTAL PROJECTION; EPHRIN-AS; OPPOSING GRADIENTS; TOPOGRAPHIC MAPS; DRIVING-FORCE; OPTIC TECTUM; COMPETITION; MECHANISMS; RECEPTORS	During the development of the topographic map from vertebrate retina to superior colliculus (SC), EphA receptors are expressed in a gradient along the nasotemporal retinal axis. Their ligands, ephrin-As, are expressed in a gradient along the rostrocaudal axis of the SC. Countergradients of ephrin-As in the retina and EphAs in the SC are also expressed. Disruption of any of these gradients leads to mapping errors. Gierer's (1981) model, which uses well-matched pairs of gradients and countergradients to establish the mapping, can account for the formation of wild type maps, but not the double maps found in EphA knock-in experiments. I show that these maps can be explained by models, such as Gierer's (1983), which have gradients and no countergradients, together with a powerful compensatory mechanism that helps to distribute connections evenly over the target region. However, this type of model cannot explain mapping errors found when the countergradients are knocked out partially. I examine the relative importance of countergradients as against compensatory mechanisms by generalising Gierer's (1983) model so that the strength of compensation is adjustable. Either matching gradients and countergradients alone or poorly matching gradients and countergradients together with a strong compensatory mechanism are sufficient to establish an ordered mapping. With a weaker compensatory mechanism, gradients without countergradients lead to a poorer map, but the addition of countergradients improves the mapping. This model produces the double maps in simulated EphA knock-in experiments and a map consistent with the Math5 knock-out phenotype. Simulations of a set of phenotypes from the literature substantiate the finding that countergradients and compensation can be traded off against each other to give similar maps. I conclude that a successful model of retinotopy should contain countergradients and some form of compensation mechanism, but not in the strong form put forward by Gierer.	Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland	University of Edinburgh	Sterratt, DC (corresponding author), Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland.	david.c.sterratt@ed.ac.uk		Sterratt, David C/0000-0001-9092-9099	Wellcome Trust [083205/B/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	DCS was supported by The Wellcome Trust (grant number 083205/B/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2010, 2010, COLD SPRING HARB PER, V2.; ATTARDI DG, 1963, EXP NEUROL, V7, P46, DOI 10.1016/0014-4886(63)90093-1; Bevins N, 2011, J NEUROSCI, V31, P10302, DOI 10.1523/JNEUROSCI.1652-11.2011; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Donoghue MJ, 1996, MOL CELL NEUROSCI, V8, P185, DOI 10.1006/mcne.1996.0056; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; GAZE R M, 1970, Experimental Brain Research, V10, P171; Gebhardt C, 2012, DEVELOPMENT, V139, P335, DOI 10.1242/dev.070474; GIERER A, 1983, PROC R SOC SER B-BIO, V218, P77, DOI 10.1098/rspb.1983.0027; GIERER A, 1981, BIOL CYBERN, V42, P69, DOI 10.1007/BF00335161; GIERER A, 1987, DEVELOPMENT, V101, P479; Godfrey KB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000600; Goodhill GJ, 2005, NETWORK-COMP NEURAL, V16, P5, DOI 10.1080/09548980500254654; Gosse NJ, 2008, NATURE, V452, P892, DOI 10.1038/nature06816; Grimbert F, 2012, J NEUROSCI, V32, P9755, DOI 10.1523/JNEUROSCI.6180-11.2012; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; Hayfield T, 2008, J STAT SOFTW, V27, P1; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Koulakov AA, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-30; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Nissenbaum D, 2010, THESIS U CAMBRIDGE; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; PRESTIGE MC, 1975, PROC R SOC SER B-BIO, V190, P77, DOI 10.1098/rspb.1975.0080; R Core Team, 2012, R LANG ENV STAT COMP; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; SCHMIDT JT, 1978, J COMP NEUROL, V177, P257, DOI 10.1002/cne.901770206; SCHMIDT JT, 1978, J COMP NEUROL, V177, P279, DOI 10.1002/cne.901770207; Simpson HD, 2011, BIOL CYBERN, V104, P9, DOI 10.1007/s00422-011-0417-y; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sterratt D, 2011, PRINCIPLES COMPUTATI; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Suetterlin P, 2012, SEMIN CELL DEV BIOL, V23, P1, DOI 10.1016/j.semcdb.2011.10.015; Triplett JW, 2011, P NATL ACAD SCI USA, V108, P19060, DOI 10.1073/pnas.1102834108; Tsigankov D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-155; Tsigankov DN, 2006, J COMPUT NEUROSCI, V21, P101, DOI 10.1007/s10827-006-9575-7; VONDERMALSBURG C, 1977, P NATL ACAD SCI USA, V74, P5176, DOI 10.1073/pnas.74.11.5176; WHITELAW VA, 1981, J NEUROSCI, V1, P1369; Willshaw D, 2006, DEVELOPMENT, V133, P2705, DOI 10.1242/dev.02430; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; YOON M, 1971, EXP NEUROL, V33, P395, DOI 10.1016/0014-4886(71)90031-8; YOON M, 1972, AM ZOOL, V12, pR22	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67096	10.1371/journal.pone.0067096	http://dx.doi.org/10.1371/journal.pone.0067096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826201	Green Published, gold			2022-12-27	WOS:000321150000025
J	Farrell, JJ; Sampath, R; Ecker, DJ; Bonomo, RA				Farrell, John J.; Sampath, Rangarajan; Ecker, David J.; Bonomo, Robert A.			"Salvage Microbiology": Detection of Bacteria Directly from Clinical Specimens following Initiation of Antimicrobial Treatment	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; RAPID IDENTIFICATION; PCR; MENINGITIS; PATHOGENS; DIAGNOSIS	Background: PCR coupled with electrospray ionization mass spectrometry (ESI-MS) is a diagnostic approach that has demonstrated the capacity to detect pathogenic organisms from culture negative clinical samples after antibiotic treatment has been initiated. [1] We describe the application of PCR/ESI-MS for detection of bacteria in original patient specimens that were obtained after administration of antibiotic treatment in an open investigation analysis. Methods: We prospectively identified cases of suspected bacterial infection in which cultures were not obtained until after the initiation of antimicrobial treatment. PCR/ESI-MS was performed on 76 clinical specimens that were submitted for conventional microbiology testing from 47 patients receiving antimicrobial treatment. Findings: In our series, 72% (55/76) of cultures obtained following initiation of antimicrobial treatment were non-diagnostic (45 negative cultures; and 10 respiratory specimens with normal flora (5), yeast (4), or coagulase-negative staphylococcus (1)). PCR/ESR-MS detected organisms in 83% (39/47) of cases and 76% (58/76) of the specimens. Bacterial pathogens were detected by PCR/ESI-MS in 60% (27/45) of the specimens in which cultures were negative. Notably, in two cases of relapse of prosthetic knee infections in patients on chronic suppressive antibiotics, the previous organism was not recovered in tissue cultures taken during extraction of the infected knee prostheses, but was detected by PCR/ESI-MS. Conclusion: Molecular methods that rely on nucleic acid amplification may offer a unique advantage in the detection of pathogens collected after initiation of antimicrobial treatment and may provide an opportunity to target antimicrobial therapy and "salvage" both individual treatment regimens as well as, in select cases, institutional antimicrobial stewardship efforts.	[Farrell, John J.] Univ Illinois, Sch Med, Dept Med, Peoria, IL USA; [Sampath, Rangarajan; Ecker, David J.] Ibis Biosci, Carlsbad, CA USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Microbiol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland, OH USA	University of Illinois System; University of Illinois Peoria; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Farrell, JJ (corresponding author), Univ Illinois, Sch Med, Dept Med, Peoria, IL USA.	jjf@uic.edu		Ecker, David/0000-0003-4350-9037	Veterans Affairs Merit Review Program; National Institutes of Health [AI072219-05, AI063517-07]; Geriatric Research Education and Clinical Center VISN 10; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072219, R01AI063517] Funding Source: NIH RePORTER	Veterans Affairs Merit Review Program(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geriatric Research Education and Clinical Center VISN 10; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Veterans Affairs Merit Review Program, the National Institutes of Health (Grant AI072219-05 and AI063517-07), and the Geriatric Research Education and Clinical Center VISN 10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; Bhatia NS, 2012, J CLIN MICROBIOL, V50, P4160, DOI 10.1128/JCM.01296-12; Caliendo AM, 2011, CLIN INFECT DIS, V52, pS326, DOI 10.1093/cid/cir047; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Fitch MT, 2007, LANCET INFECT DIS, V7, P191, DOI 10.1016/S1473-3099(07)70050-6; Houck PM, 2002, ARCH INTERN MED, V162, P843, DOI 10.1001/archinte.162.7.843-a; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; McGarvey R N, 1993, QRB Qual Rev Bull, V19, P124; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; Puskarich MA, 2011, CRIT CARE MED, V39, P2066, DOI 10.1097/CCM.0b013e31821e87ab; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008	11	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66349	10.1371/journal.pone.0066349	http://dx.doi.org/10.1371/journal.pone.0066349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825537	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000016
J	Mulherkar, S; Liu, F; Chen, Q; Narayanan, A; Couvillon, AD; Shine, HD; Tolias, KF				Mulherkar, Shalaka; Liu, Feng; Chen, Qin; Narayanan, Anjana; Couvillon, Anthony D.; Shine, H. David; Tolias, Kimberley F.			The Small GTPase RhoA Is Required for Proper Locomotor Circuit Assembly	PLOS ONE			English	Article							GROWTH CONE COLLAPSE; SPINAL-CORD; AXON GUIDANCE; CORTICOSPINAL TRACT; IN-VIVO; EPHA4; RECEPTORS; KINASE; ORGANIZATION; PLASTICITY	The assembly of neuronal circuits during development requires the precise navigation of axons, which is controlled by attractive and repulsive guidance cues. In the developing spinal cord, ephrinB3 functions as a short-range repulsive cue that prevents EphA4 receptor-expressing corticospinal tract and spinal interneuron axons from crossing the midline, ensuring proper formation of locomotor circuits. Here we report that the small GTPase RhoA, a key regulator of cytoskeletal dynamics, is also required for ephrinB3/EphA4-dependent locomotor circuit formation. Deletion of RhoA from neural progenitor cells results in mice that exhibit a rabbit-like hopping gait, which phenocopies mice lacking ephrinB3 or EphA4. Consistent with this locomotor defect, we found that corticospinal tract axons and spinal interneuron projections from RhoA-deficient mice aberrantly cross the spinal cord midline. Furthermore, we determined that loss of RhoA blocks ephrinB3-induced growth cone collapse of cortical axons and disrupts ephrinB3 expression at the spinal cord midline. Collectively, our results demonstrate that RhoA is essential for the ephrinB3/EphA4-dependent assembly of cortical and spinal motor circuits that control normal locomotor behavior.	[Mulherkar, Shalaka; Liu, Feng; Chen, Qin; Shine, H. David; Tolias, Kimberley F.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Chen, Qin; Shine, H. David] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Narayanan, Anjana] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Shine, H. David] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Couvillon, Anthony D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tolias, KF (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.			Tolias, Kimberley/0000-0002-2092-920X	NINDS NIH HHS [R01 NS062829] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062829] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Chen Q, 2008, EXP NEUROL, V209, P497, DOI 10.1016/j.expneurol.2007.11.025; Chen Q, 2006, J NEUROTRAUM, V23, P1254, DOI 10.1089/neu.2006.23.1254; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; Imondi R, 2000, DEVELOPMENT, V127, P1397; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Katayama KI, 2012, J NEUROSCI, V32, P10396, DOI 10.1523/JNEUROSCI.6474-11.2012; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Leslie JR, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00067; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038	36	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67015	10.1371/journal.pone.0067015	http://dx.doi.org/10.1371/journal.pone.0067015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825607	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000059
J	Ribeiro, E; Ganzinelli, M; Andreis, D; Bertoni, R; Giardini, R; Fox, SB; Broggini, M; Bottini, A; Zanoni, V; Bazzola, L; Foroni, C; Generali, D; Damia, G				Ribeiro, Enilze; Ganzinelli, Monica; Andreis, Daniele; Bertoni, Ramona; Giardini, Roberto; Fox, Stephen B.; Broggini, Massimo; Bottini, Alberto; Zanoni, Vanessa; Bazzola, Letizia; Foroni, Chiara; Generali, Daniele; Damia, Giovanna			Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; CELL LUNG-CANCER; THERAPEUTIC STRATEGIES; POLY(ADP-RIBOSE) POLYMERASE; SUBTYPES; CHEMOTHERAPY; SENSITIVITY; PHENOTYPE; DEFECTS; ERCC1	DNA repair is a key determinant in the cellular response to therapy and tumor repair status could play an important role in tailoring patient therapy. Our goal was to evaluate the mRNA of 13 genes involved in different DNA repair pathways (base excision, nucleotide excision, homologous recombination, and Fanconi anemia) in paraffin embedded samples of triple negative breast cancer (TNBC) compared to luminal A breast cancer (LABC). Most of the genes involved in nucleotide excision repair and Fanconi Anemia pathways, and CHK1 gene were significantly less expressed in TNBC than in LABC. PARP1 levels were higher in TNBC than in LABC. In univariate analysis high level of FANCA correlated with an increased overall survival and event free survival in TNBC; however multivariate analyses using Cox regression did not confirm FANCA as independent prognostic factor. These data support the evidence that TNBCs compared to LABCs harbour DNA repair defects.	[Ribeiro, Enilze] UFPR, Dept Genet, Lab Citogenet Humana & Oncogenet, Curitiba, Parana, Brazil; [Ganzinelli, Monica; Broggini, Massimo; Damia, Giovanna] IRCCS Ist Ric Farmacol Mario Negri, Mol Pharmacol Lab, Milan, Italy; [Andreis, Daniele; Bottini, Alberto; Zanoni, Vanessa; Bazzola, Letizia; Foroni, Chiara; Generali, Daniele] AO Ist Ospitalieri Cremona, UO Multidisciplinare Patol Mammaria, Lab Oncol Mol Senol, Cremona, Italy; [Bertoni, Ramona; Giardini, Roberto] AO Ist Ospitalieri Cremona, UO Anat Patol, Cremona, Italy; [Fox, Stephen B.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Universidade Federal do Parana; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Peter Maccallum Cancer Center	Generali, D (corresponding author), AO Ist Ospitalieri Cremona, UO Multidisciplinare Patol Mammaria, Lab Oncol Mol Senol, Cremona, Italy.	daniele.generali@gmail.com; giovanna.damia@marionegri.it	broggini, massimo/AAA-6460-2020; Andreis, Daniele/J-8333-2016; damia, giovanna/AAB-1428-2020; Ganzinelli, Monica/K-4548-2016; Ribeiro, Enilze MSF/K-7319-2012; Fox, Stephen/G-9719-2016	Andreis, Daniele/0000-0001-6686-5662; damia, giovanna/0000-0001-9749-434X; Ganzinelli, Monica/0000-0002-0526-0835; GENERALI, DANIELE/0000-0003-2480-3855; BROGGINI, MASSIMO/0000-0002-8138-9358; Fox, Stephen/0000-0002-7648-8896	Italian Association for Cancer Research (AIRC); Associazione Ricerca in Campo Oncologico (ARCO); Victorian Breast Cancer Research Consortium of Australia	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Ricerca in Campo Oncologico (ARCO); Victorian Breast Cancer Research Consortium of Australia	The work was supported by the Italian Association for Cancer Research (AIRC), Associazione Ricerca in Campo Oncologico (ARCO) and the Victorian Breast Cancer Research Consortium of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BM, 2010, CLIN CANCER RES, V16, P5796, DOI 10.1158/1078-0432.CCR-10-0292; Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; Carrassa L, 2011, CELL CYCLE, V10, P2121, DOI 10.4161/cc.10.13.16398; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Damia G, 2010, CURR DRUG TARGETS, V11, P1317, DOI 10.2174/1389450111007011317; Damia G, 1996, INT J CANCER, V66, P779, DOI 10.1002/(SICI)1097-0215(19960611)66:6<779::AID-IJC12>3.0.CO;2-Z; Damia G, 2007, EUR J CANCER, V43, P1791, DOI 10.1016/j.ejca.2007.05.003; de Bruin PC, 2011, MOD PATHOL; de Ruijter TC, 2011, J CANCER RES CLIN, V137, P183, DOI 10.1007/s00432-010-0957-x; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dienstmann R, 2011, CANCER J, V17, P114, DOI 10.1097/PPO.0b013e318212f844; Domagala P, 2011, BREAST CANCER RES TR, V127, P861, DOI 10.1007/s10549-011-1441-2; Friboulet L, 2011, CLIN CANCER RES, V17, P5562, DOI 10.1158/1078-0432.CCR-11-0790; Fumagalli C, 2012, BREAST CANC RES TREA; Generali D, 2009, J CLIN ONCOL, V27, P227, DOI 10.1200/JCO.2007.13.7083; Gossage L, 2007, CANCER TREAT REV, V33, P565, DOI 10.1016/j.ctrv.2007.07.001; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Kaplan HG, 2008, BREAST J, V14, P456, DOI 10.1111/j.1524-4741.2008.00622.x; Karihtala P, 2012, BRIT J CANCER, V106, P344, DOI 10.1038/bjc.2011.518; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Keimling M, 2008, INT J CANCER, V123, P730, DOI 10.1002/ijc.23551; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; Latimer JJ, 2010, P NATL ACAD SCI USA, V107, P21725, DOI 10.1073/pnas.0914772107; Lips EH, 2011, ANN ONCOL, V22, P870, DOI 10.1093/annonc/mdq468; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Nishimura R, 2008, BREAST CANCER-TOKYO, V15, P303, DOI 10.1007/s12282-008-0042-3; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rhee JY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-307; Rothschild SI, 2011, CURR OPIN ONCOL, V23, P150, DOI 10.1097/CCO.0b013e328341ee38; Rowe BP, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2566; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Wang Shu, 2009, Gan To Kagaku Ryoho, V36, P255; Weigman VJ, 2011, BREAST CANC RES TREA; Willers H, 2009, MOL CANCER RES, V7, P1304, DOI 10.1158/1541-7786.MCR-09-0149; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192	56	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66243	10.1371/journal.pone.0066243	http://dx.doi.org/10.1371/journal.pone.0066243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825533	Green Published, gold			2022-12-27	WOS:000321223000012
J	Weide, B; Faller, C; Elsasser, M; Buttner, P; Pflugfelder, A; Leiter, U; Eigentler, TK; Bauer, J; Meier, F; Garbe, C				Weide, Benjamin; Faller, Christine; Elsaesser, Margrit; Buettner, Petra; Pflugfelder, Annette; Leiter, Ulrike; Eigentler, Thomas Kurt; Bauer, Juergen; Meier, Friedegund; Garbe, Claus			Melanoma Patients with Unknown Primary Site or Nodal Recurrence after Initial Diagnosis Have a Favourable Survival Compared to Those with Synchronous Lymph Node Metastasis and Primary Tumour	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; AMERICAN JOINT COMMITTEE; PROGNOSTIC-FACTORS; DISTANT RECURRENCE; SURGICAL-TREATMENT; IMMUNE-RESPONSE; STAGE-II; DISSECTION; REGRESSION	Background: A direct comparison of prognosis between patients with regional lymph node metastases (LNM) detected synchronously with the primary melanoma (primary LNM), patients who developed their first LNM subsequently (secondary LNM) and those with initial LNM in melanoma with unknown primary site (MUP) is missing thus far. Patients and Methods: Survival of 498 patients was calculated from the time point of the first macroscopic LNM using Kaplan Meier and multivariate Cox hazard regression analysis. Results: Patients with secondary LNM (HR = 0.67; p = 0.009) and those with initial LNM in MUP (HR = 0.45; p = 0.008) had a better prognosis compared to patients with primary LNM (median survival time 52 and 65 vs. 24 months, respectively). A high number of involved nodes, the presence of in-transit/satellite metastases and male gender had an additional independent unfavourable effect. Conclusions: Survival of patients with LNM in MUP and with secondary LNM is similar and considerably more favourable compared to those with primary LNM. This difference needs to be considered during patient counselling and for stratification purposes in clinical trials. The assumption of an immune privilege of patients with MUP which is responsible for rejection of the primary melanoma, and results in a favourable prognosis is not supported by our data.	[Weide, Benjamin; Faller, Christine; Elsaesser, Margrit; Pflugfelder, Annette; Leiter, Ulrike; Eigentler, Thomas Kurt; Bauer, Juergen; Meier, Friedegund; Garbe, Claus] Univ Med Ctr, Ctr Dermatooncol, Dept Dermatol, Tubingen, Germany; [Buettner, Petra; Garbe, Claus] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Skin Canc Res Grp, Townsville, Qld 4811, Australia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; James Cook University	Weide, B (corresponding author), Univ Med Ctr, Ctr Dermatooncol, Dept Dermatol, Tubingen, Germany.	benjamin.weide@med.uni-tuebingen.de	Pflugfelder, Annette/Q-2659-2016; Weide, Benjamin/N-3698-2013; Garbe, Claus/ABH-2128-2021; Eigentler, Thomas/K-8570-2015; Bauer, Jurgen/B-4656-2008	Garbe, Claus/0000-0001-8530-780X; Eigentler, Thomas/0000-0003-0019-2770; Leiter, Ulrike/0000-0002-8019-1577; Bauer, Jurgen/0000-0001-8789-1536				Anbari KK, 1997, CANCER-AM CANCER SOC, V79, P1816, DOI 10.1002/(SICI)1097-0142(19970501)79:9<1816::AID-CNCR26>3.0.CO;2-#; [Anonymous], ASCO M; Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; BALCH CM, 1981, ANN SURG, V193, P377, DOI 10.1097/00000658-198103000-00023; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Brand CU, 1997, CANCER, V79, P2345; Buzzell RA, 1996, J AM ACAD DERMATOL, V34, P798, DOI 10.1016/S0190-9622(96)90017-1; Callender GG, 2012, J AM COLL SURGEONS, V214, P608, DOI 10.1016/j.jamcollsurg.2011.12.027; Carlson JA, 2003, AM J DERMATOPATH, V25, P291, DOI 10.1097/00000372-200308000-00003; CHANG P, 1982, CANCER-AM CANCER SOC, V49, P1106, DOI 10.1002/1097-0142(19820315)49:6<1106::AID-CNCR2820490607>3.0.CO;2-0; Cohn-Cedermark G, 1999, ACTA ONCOL, V38, P549; Cormier JN, 2006, CANCER-AM CANCER SOC, V106, P2012, DOI 10.1002/cncr.21835; Elsaesser O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029791; Essner R, 2004, ARCH SURG-CHICAGO, V139, P961, DOI 10.1001/archsurg.139.9.961; Francken AB, 2008, ANN SURG ONCOL, V15, P1476, DOI 10.1245/s10434-007-9717-9; GIULIANO AE, 1982, SEMIN ONCOL, V9, P442; Herman K, 2009, WORLD J SURG, V33, P469, DOI 10.1007/s00268-008-9895-z; Katz KA, 2005, MELANOMA RES, V15, P77, DOI 10.1097/00008390-200502000-00013; Konstadoulakis MM, 2002, MELANOMA RES, V12, P357, DOI 10.1097/00008390-200208000-00008; Kretschmer L, 2000, MELANOMA RES, V10, P483, DOI 10.1097/00008390-200010000-00011; Lee CC, 2008, J CLIN ONCOL, V26, P535, DOI 10.1200/JCO.2007.14.0285; Leiter U, 2010, MELANOMA RES, V20, P240, DOI 10.1097/CMR.0b013e32833716f9; MARKOWITZ JS, 1991, ARCH SURG-CHICAGO, V126, P703; Menzies SW, 1997, ARCH SURG-CHICAGO, V132, P553; Messeguer F, 2012, J EUR ACAD DERMATOL; Mihm MC, 1996, LAB INVEST, V74, P43; NORMAN J, 1992, ANN PLAS SURG, V28, P81, DOI 10.1097/00000637-199201000-00021; Nowecki ZI, 2008, ANN SURG ONCOL, V15, P2223, DOI 10.1245/s10434-008-9965-3; Prens SP, 2011, ANN SURG ONCOL; REINTGEN DS, 1983, SURG GYNECOL OBSTET, V156, P335; Ribero S, 2012, J EUR ACAD DERMATOL, P10; ROSES DF, 1991, SURG GYNECOL OBSTET, V172, P262; Rutkowski P, 2010, DERMATOL SURG, V36, P868, DOI 10.1111/j.1524-4725.2010.01562.x; Saleh FH, 2001, INT J CANCER, V94, P551, DOI 10.1002/ijc.1491; Schlagenhauff B, 1997, CANCER-AM CANCER SOC, V80, P60, DOI 10.1002/(SICI)1097-0142(19970701)80:1<60::AID-CNCR8>3.0.CO;2-J; SHAW HM, 1989, HISTOPATHOLOGY, V15, P257, DOI 10.1111/j.1365-2559.1989.tb03076.x; Soong SJ, 2010, ANN SURG ONCOL, V17, P2006, DOI 10.1245/s10434-010-1050-z; Soong SJ, 1998, J SURG ONCOL, V67, P228, DOI 10.1002/(SICI)1096-9098(199804)67:4<228::AID-JSO4>3.0.CO;2-A; van Akkooi ACJ, 2007, EJSO-EUR J SURG ONC, V33, P102, DOI 10.1016/j.ejso.2006.10.032; Weide B, 2012, BRIT J CANCER, V107, P422, DOI 10.1038/bjc.2012.306; WONG JH, 1987, ARCH SURG-CHICAGO, V122, P1380	43	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66953	10.1371/journal.pone.0066953	http://dx.doi.org/10.1371/journal.pone.0066953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825594	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000321223000050
J	Woodell, A; Coughlin, B; Kunchithapautham, K; Casey, S; Williamson, T; Ferrell, WD; Atkinson, C; Jones, BW; Rohrer, B				Woodell, Alex; Coughlin, Beth; Kunchithapautham, Kannan; Casey, Sarah; Williamson, Tucker; Ferrell, W. Drew; Atkinson, Carl; Jones, Bryan W.; Rohrer, Baerbel			Alternative Complement Pathway Deficiency Ameliorates Chronic Smoke-Induced Functional and Morphological Ocular Injury	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; AGE-RELATED MACULOPATHY; FACTOR-H POLYMORPHISM; CAUSES OXIDATIVE DAMAGE; MACULAR DEGENERATION; CIGARETTE-SMOKE; BRUCHS MEMBRANE; FACTOR-B; CHOROIDAL NEOVASCULARIZATION; MITOCHONDRIAL DYSFUNCTION	Background: Age-related macular degeneration (AMD), a complex disease involving genetic variants and environmental insults, is among the leading causes of blindness in Western populations. Genetic and histologic evidence implicate the complement system in AMD pathogenesis; and smoking is the major environmental risk factor associated with increased disease risk. Although previous studies have demonstrated that cigarette smoke exposure (CE) causes retinal pigment epithelium (RPE) defects in mice, and smoking leads to complement activation in patients, it is unknown whether complement activation is causative in the development of CE pathology; and if so, which complement pathway is required. Methods: Mice were exposed to cigarette smoke or clean, filtered air for 6 months. The effects of CE were analyzed in wildtype (WT) mice or mice without a functional complement alternative pathway (AP; CFB-/-) using molecular, histological, electrophysiological, and behavioral outcomes. Results: CE in WT mice exhibited a significant reduction in function of both rods and cones as determined by electroretinography and contrast sensitivity measurements, concomitant with a thinning of the nuclear layers as measured by SD-OCT imaging and histology. Gene expression analyses suggested that alterations in both photoreceptors and RPE/choroid might contribute to the observed loss of function, and visualization of complement C3d deposition implies the RPE/Bruch's membrane (BrM) complex as the target of AP activity. RPE/BrM alterations include an increase in mitochondrial size concomitant with an apical shift in mitochondrial distribution within the RPE and a thickening of BrM. CFB-/- mice were protected from developing these CE-mediated alterations. Conclusions: Taken together, these findings provide clear evidence that ocular pathology generated in CE mice is dependent on complement activation and requires the AP. Identifying animal models with RPE/BrM damage and verifying which aspects of pathology are dependent upon complement activation is essential for developing novel complement-based treatment approaches for the treatment of AMD.	[Woodell, Alex; Rohrer, Baerbel] Med Univ S Carolina, Dept Neurosci, Div Res, Charleston, SC 29425 USA; [Coughlin, Beth; Kunchithapautham, Kannan; Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Casey, Sarah; Williamson, Tucker; Atkinson, Carl] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Ferrell, W. Drew; Jones, Bryan W.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA; [Rohrer, Baerbel] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Rohrer, B (corresponding author), Med Univ S Carolina, Dept Neurosci, Div Res, Charleston, SC 29425 USA.	rohrer@musc.edu		Jones, Bryan/0000-0001-5527-6643	Department for Veterans Affairs [RX000444]; Research to Prevent Blindness (RPB), New York, NY; Foundation Fighting Blindness, Columbia, MD; NIH NHLBI [RO1 091944]; NIH [C06RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091944] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	Department for Veterans Affairs(US Department of Veterans Affairs); Research to Prevent Blindness (RPB), New York, NY(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness, Columbia, MD; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by a Department for Veterans Affairs merit award RX000444 (BR), unrestricted grant to MUSC from Research to Prevent Blindness (RPB), New York, NY and Foundation Fighting Blindness, Columbia, MD, and NIH NHLBI RO1 091944 (CA). Animal studies were conducted in a facility constructed with support from the NIH (C06RR015455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2002, TOXICOLOGY, V180, P121, DOI 10.1016/S0300-483X(02)00386-4; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Appel GB, 2005, J AM SOC NEPHROL, V16, P1392, DOI 10.1681/ASN.2005010078; Atkinson C, 2010, J IMMUNOL, V185, P7007, DOI 10.4049/jimmunol.1001504; Barot M, 2011, CURR EYE RES, V36, P1069, DOI 10.3109/02713683.2011.607536; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; BROWN B, 1986, OPHTHAL PHYSL OPT, V6, P81, DOI 10.1111/j.1475-1313.1986.tb00704.x; BROWN B, 1986, AM J OPTOM PHYS OPT, V63, P450; Brown MM, 2005, CAN J OPHTHALMOL, V40, P277, DOI 10.1016/S0008-4182(05)80070-5; Bruno Richard S, 2006, Pathophysiology, V13, P143, DOI 10.1016/j.pathophys.2006.05.003; Burke JM, 2009, INVEST OPHTH VIS SCI, V50, P1940, DOI 10.1167/iovs.08-2671; Cankova Z, 2011, EXP EYE RES, V93, P947, DOI 10.1016/j.exer.2011.10.016; Chakravarthy U, 2007, OPHTHALMOLOGY, V114, P1157, DOI 10.1016/j.ophtha.2006.09.022; CHEN JC, 1992, INVEST OPHTH VIS SCI, V33, P334; CHOW CK, 1986, J AM COLL NUTR, V5, P305; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; CRONIN VB, 1990, BIOCHEM SOC T, V18, P256, DOI 10.1042/bst0180256; Curcio CA, 2001, EYE, V15, P376, DOI 10.1038/eye.2001.140; Droz I, 2008, BRIT J OPHTHALMOL, V92, P513, DOI 10.1136/bjo.2007.127811; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; Freund KB, 2010, RETINA-J RET VIT DIS, V30, P1333, DOI 10.1097/IAE.0b013e3181e7976b; FRIEDMAN E, 1995, OPHTHALMOLOGY, V102, P640, DOI 10.1016/S0161-6420(95)30974-8; Friedman E, 2004, BRIT J OPHTHALMOL, V88, P161, DOI 10.1136/bjo.2003.036277; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Guymer R, 1999, PROG RETIN EYE RES, V18, P59, DOI 10.1016/S1350-9462(98)00012-3; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Harboe M, 2006, CLIN EXP IMMUNOL, V144, P512, DOI 10.1111/j.1365-2249.2006.03072.x; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; He Y, 2010, ADV EXP MED BIOL, V664, P165, DOI 10.1007/978-1-4419-1399-9_20; Hecker LA, 2010, ADV EXP MED BIOL, V703, P49, DOI 10.1007/978-1-4419-5635-4_4; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; Huang JD, 2007, EXP EYE RES, V85, P202, DOI 10.1016/j.exer.2007.03.011; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Jia LH, 2007, INVEST OPHTH VIS SCI, V48, P339, DOI 10.1167/iovs.06-0248; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; KEW RR, 1985, J CLIN INVEST, V75, P1000, DOI 10.1172/JCI111760; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; LILES MR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1285, DOI 10.1001/archopht.1991.01080090111033; Liu CH, 2012, APPL IMMUNOHISTOCHEM; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Lois N, 2008, BRIT J OPHTHALMOL, V92, P1304, DOI 10.1136/bjo.2008.141168; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Mantel I, 2013, OPHTHALMIC GENET; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Marshall J., 1998, RETINAL PIGMENT EPIT, P669; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Mettu PS, 2012, MOL ASPECTS MED, V33, P376, DOI 10.1016/j.mam.2012.04.006; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; Montes T, 2009, P NATL ACAD SCI USA, V106, P4366, DOI 10.1073/pnas.0812584106; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P1310, DOI 10.1167/iovs.05-1292; Panda K, 1999, FREE RADICAL BIO MED, V27, P1064, DOI 10.1016/S0891-5849(99)00154-9; Pappuru RR, 2011, INVEST OPHTH VIS SCI, V52, P6743, DOI 10.1167/iovs.10-6723; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Pu ML, 2006, INVEST OPHTH VIS SCI, V47, P3579, DOI 10.1167/iovs.05-1450; Pugh EN, 1998, PHOTOSTASIS AND RELATED PHENOMENA, P93, DOI 10.1007/978-1-4899-1549-8_7; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Sanai M, 2011, AFR J BIOTECHNOL, V10, P19211, DOI 10.5897/AJB11.254; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P586, DOI 10.1167/iovs.08-2514; Shaw PX, 2012, P NATL ACAD SCI USA, V109, P13757, DOI 10.1073/pnas.1121309109; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Stoppelkamp S, 2010, J NEUROSCI METH, V194, P132, DOI 10.1016/j.jneumeth.2010.10.008; TATE DJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P963, DOI 10.1001/archopht.1993.01090070083023; Thomas BB, 2010, NEUROSCI LETT, V479, P92, DOI 10.1016/j.neulet.2010.05.031; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005304; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yin W, 2008, THROMB RES, V122, P221, DOI 10.1016/j.thromres.2007.11.005; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; ZHU BQ, 1995, AM HEART J, V130, P1270, DOI 10.1016/0002-8703(95)90154-X	93	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67894	10.1371/journal.pone.0067894	http://dx.doi.org/10.1371/journal.pone.0067894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825688	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000122
J	Gutierrez, A; Beltran, G; Warringer, J; Guillamon, JM				Gutierrez, Alicia; Beltran, Gemma; Warringer, Jonas; Guillamon, Jose M.			Genetic Basis of Variations in Nitrogen Source Utilization in Four Wine Commercial Yeast Strains	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; METHIONINE SALVAGE PATHWAY; ALCOHOLIC FERMENTATION; CATABOLITE REPRESSION; ENOLOGICAL CONDITIONS; ASSIMILABLE NITROGEN; SYNTHETIC GRAPE; BUDDING YEAST; TRAIT; METABOLISM	The capacity of wine yeast to utilize the nitrogen available in grape must directly correlates with the fermentation and growth rates of all wine yeast fermentation stages and is, thus, of critical importance for wine production. Here we precisely quantified the ability of low complexity nitrogen compounds to support fast, efficient and rapidly initiated growth of four commercially important wine strains. Nitrogen substrate abundance in grape must failed to correlate with the rate or the efficiency of nitrogen source utilization, but well predicted lag phase length. Thus, human domestication of yeast for grape must growth has had, at the most, a marginal impact on wine yeast growth rates and efficiencies, but may have left a surprising imprint on the time required to adjust metabolism from non growth to growth. Wine yeast nitrogen source utilization deviated from that of the lab strain experimentation, but also varied between wine strains. Each wine yeast lineage harbored nitrogen source utilization defects that were private to that strain. By a massive hemizygote analysis, we traced the genetic basis of the most glaring of these defects, near inability of the PDM wine strain to utilize methionine, as consequence of mutations in its ARO8, ADE5,7 and VBA3 alleles. We also identified candidate causative mutations in these genes. The methionine defect of PDM is potentially very interesting as the strain can, in some circumstances, overproduce foul tasting H2S, a trait which likely stems from insufficient methionine catabolization. The poor adaptation of wine yeast to the grape must nitrogen environment, and the presence of defects in each lineage, open up wine strain optimization through biotechnological endeavors.	[Gutierrez, Alicia; Guillamon, Jose M.] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, Paterna, Valencia, Spain; [Beltran, Gemma; Guillamon, Jose M.] Univ Rovira & Virgili, Fac Enol, Dept Bioquim & Biotecnol, E-43007 Tarragona, Spain; [Warringer, Jonas] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universitat Rovira i Virgili; University of Gothenburg	Guillamon, JM (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, Paterna, Valencia, Spain.	guillamon@iata.csic.es	Guillamon, Jose/AAB-4251-2019; Beltran, Gemma/C-6416-2015; Guillamon, Jose/I-2040-2015	Guillamon, Jose/0000-0001-5414-0787; Beltran, Gemma/0000-0002-7071-205X; Guillamon, Jose/0000-0001-5414-0787	AGROVIN Company; "Centro para el Desarrollo Tecnologico Industrial (CDTI) in the context of the Project CENIT DEMETER; Spanish government [AGL2010-22001-C02-01, AGL2009-07331]; CSIC	AGROVIN Company; "Centro para el Desarrollo Tecnologico Industrial (CDTI) in the context of the Project CENIT DEMETER; Spanish government(Spanish GovernmentEuropean Commission); CSIC	This work has been financially supported by AGROVIN Company (http://www.agrovin.com/) and "Centro para el Desarrollo Tecnologico Industrial (CDTI; http://www.cdti.es/) in the context of the Project CENIT DEMETER and by the grants AGL2010-22001-C02-01 and AGL2009-07331, from the Spanish government, awarded to JMG and GB respectively. AG also wants to thank to CSIC for her "JAE-PRE" grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As required by the journal, the authors can state that, in spite of the partial funding from a commercial source (AGROVIN Company), this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; Beltran G, 2005, J AGR FOOD CHEM, V53, P996, DOI 10.1021/jf0487001; Beltran G, 2004, FEMS YEAST RES, V4, P625, DOI 10.1016/j.femsyr.2003.12.004; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; Bisson L F., 1999, AM J ENOL VITICULT, V150, P1; Cooper T., 1982, MOL BIOL YEAST SACCH, P399; Cordente AG, 2009, FEMS YEAST RES, V9, P446, DOI 10.1111/j.1567-1364.2009.00489.x; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Guillamon JM, 1998, ARCH MICROBIOL, V169, P387, DOI 10.1007/s002030050587; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gutierrez A, 2012, FOOD MICROBIOL, V31, P25, DOI 10.1016/j.fm.2012.02.012; Henschke P. A., 1993, WINE MICROBIOLOGY BI, P77, DOI DOI 10.1089/END.2014.0018; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; JIRANEK V, 1995, APPL ENVIRON MICROB, V61, P461, DOI 10.1128/AEM.61.2.461-467.1995; Katou T, 2008, YEAST, V25, P799, DOI 10.1002/yea.1634; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Liti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000659; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Magasanik B., 1992, MOL BIOL YEAST SACCH, P238; Martinez-Moreno R, 2012, FEMS YEAST RES, V12, P477, DOI 10.1111/j.1567-1364.2012.00802.x; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; Nogami S, 2007, PLOS GENET, V3, P305, DOI 10.1371/journal.pgen.0030031; Novo MT, 2003, INT J FOOD MICROBIOL, V86, P153, DOI 10.1016/S0168-1605(03)00253-8; Ottosson LG, 2010, EUKARYOT CELL, V9, P1635, DOI 10.1128/EC.00078-10; OUGH CS, 1991, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON NITROGEN IN GRAPES AND WINE, P165; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x; Riou C, 1997, YEAST, V13, P903, DOI 10.1002/(SICI)1097-0061(199708)13:10<903::AID-YEA145>3.3.CO;2-T; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; Salmon JM, 1998, APPL ENVIRON MICROB, V64, P3831; Shimazu M, 2005, J BIOL CHEM, V280, P4851, DOI 10.1074/jbc.M412617200; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Thomas D, 2000, J BIOL CHEM, V275, P40718, DOI 10.1074/jbc.M005967200; Varela C, 2004, APPL ENVIRON MICROB, V70, P3392, DOI 10.1128/AEM.70.6.3392-3400.2004; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Zorgo E, 2012, MOL BIOL EVOL, V29, P1781, DOI 10.1093/molbev/mss019	51	45	45	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67166	10.1371/journal.pone.0067166	http://dx.doi.org/10.1371/journal.pone.0067166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826223	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400113
J	Lin, CC; Lee, CH; Fuh, CS; Juan, HF; Huang, HC				Lin, Chen-Ching; Lee, Chia-Hsien; Fuh, Chiou-Shann; Juan, Hsueh-Fen; Huang, Hsuan-Cheng			Link Clustering Reveals Structural Characteristics and Biological Contexts in Signed Molecular Networks	PLOS ONE			English	Article							GENETIC INTERACTIONS; YEAST; PROTEINS; BALANCE; ORGANIZATION; COMMUNITIES; PATHWAY; COMPLEX; CELLS	Many biological networks are signed molecular networks which consist of positive and negative links. To reveal the distinct features between links with different signs, we proposed signed link-clustering coefficients that assess the similarity of interaction profiles between linked molecules. We found that positive links tended to cluster together, while negative links usually behaved like bridges between positive clusters. Positive links with higher adhesiveness tended to share protein domains, be associated with protein-protein interactions and make intra-connections within protein complexes. Negative links that were more bridge-like tended to make interconnections between protein complexes. Utilizing the proposed measures to group positive links, we observed hierarchical modules that could be well characterized by functional annotations or known protein complexes. Our results imply that the proposed sign-specific measures can help reveal the network structural characteristics and the embedded biological contexts of signed links, as well as the functional organization of signed molecular networks.	[Lin, Chen-Ching; Huang, Hsuan-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Inst Biomed Informat, Taipei 112, Taiwan; [Lin, Chen-Ching; Lee, Chia-Hsien; Fuh, Chiou-Shann; Juan, Hsueh-Fen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Ctr Syst Biol, Dept Life Sci, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Juan, HF (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	yukijuan@ntu.edu.tw; hsuancheng@ym.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; Fuh, Chiou-Shann/0000-0002-6174-2556; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council of Taiwan [99-2621-B-010-001-MY3, 99-2621-B-002-005-MY3]; National Taiwan University Frontier an Innovative Research Projects [99R70437]; National Health Research Institutes [NHRI-EX101-9819PI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Frontier an Innovative Research Projects; National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by grants from the National Science Council of Taiwan (99-2621-B-010-001-MY3 and 99-2621-B-002-005-MY3), National Taiwan University Frontier an Innovative Research Projects (99R70437), and National Health Research Institutes (NHRI-EX101-9819PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bateson William, 1905, REPORTS EVOLUTION CO, V2, P1; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2011, CURR OPIN BIOTECH, V22, P66, DOI 10.1016/j.copbio.2010.11.001; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DAVIS JA, 1967, HUM RELAT, V20, P181, DOI 10.1177/001872676702000206; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; DOBZHANSKY T, 1946, GENETICS, V31, P269; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Faucher D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001082; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Gurley KE, 2001, CURR BIOL, V11, P191, DOI 10.1016/S0960-9822(01)00048-3; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hummon NP, 2003, SOC NETWORKS, V25, P17, DOI 10.1016/S0378-8733(02)00019-9; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lin CC, 2009, J PROTEOME RES, V8, P1925, DOI 10.1021/pr8008786; Madi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017445; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Roth D, 2011, BIOCOMMUNICATION SOI; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharifpoor S, 2012, GENOME RES, V22, P791, DOI 10.1101/gr.129213.111; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Solava RW, 2012, BIOINFORMATICS, V28, pI480, DOI 10.1093/bioinformatics/bts376; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	51	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67089	10.1371/journal.pone.0067089	http://dx.doi.org/10.1371/journal.pone.0067089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826198	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400102
J	Nunez, MA; Hayward, J; Horton, TR; Amico, GC; Dimarco, RD; Barrios-Garcia, MN; Simberloff, D				Nunez, Martin A.; Hayward, Jeremy; Horton, Thomas R.; Amico, Guillermo C.; Dimarco, Romina D.; Barrios-Garcia, M. Noelia; Simberloff, Daniel			Exotic Mammals Disperse Exotic Fungi That Promote Invasion by Exotic Trees	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BOAR SUS-SCROFA; MOUNT-ST-HELENS; WILD BOAR; ECTOMYCORRHIZAL FUNGI; SOUTHERN-HEMISPHERE; SEQUENCE ALIGNMENT; SPORE DISPERSAL; PINE INVASIONS; IDENTIFICATION	Biological invasions are often complex phenomena because many factors influence their outcome. One key aspect is how non-natives interact with the local biota. Interaction with local species may be especially important for exotic species that require an obligatory mutualist, such as Pinaceae species that need ectomycorrhizal (EM) fungi. EM fungi and seeds of Pinaceae disperse independently, so they may use different vectors. We studied the role of exotic mammals as dispersal agents of EM fungi on Isla Victoria, Argentina, where many Pinaceae species have been introduced. Only a few of these tree species have become invasive, and they are found in high densities only near plantations, partly because these Pinaceae trees lack proper EM fungi when their seeds land far from plantations. Native mammals (a dwarf deer and rodents) are rare around plantations and do not appear to play a role in these invasions. With greenhouse experiments using animal feces as inoculum, plus observational and molecular studies, we found that wild boar and deer, both non-native, are dispersing EM fungi. Approximately 30% of the Pinaceae seedlings growing with feces of wild boar and 15% of the seedlings growing with deer feces were colonized by non-native EM fungi. Seedlings growing in control pots were not colonized by EM fungi. We found a low diversity of fungi colonizing the seedlings, with the hypogeous Rhizopogon as the most abundant genus. Wild boar, a recent introduction to the island, appear to be the main animal dispersing the fungi and may be playing a key role in facilitating the invasion of pine trees and even triggering their spread. These results show that interactions among non-natives help explain pine invasions in our study area.	[Nunez, Martin A.; Dimarco, Romina D.; Barrios-Garcia, M. Noelia; Simberloff, Daniel] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Nunez, Martin A.; Amico, Guillermo C.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Hayward, Jeremy; Horton, Thomas R.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	University of Tennessee System; University of Tennessee Knoxville; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Nunez, MA (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	mnunez@utk.edu	Nuñez, Martin A./B-2735-2010; Amico, Guillermo C c/HGD-9402-2022	Nuñez, Martin A./0000-0003-0324-5479; Dimarco, Romina D./0000-0002-1751-0643; Amico, Guillermo/0000-0002-3709-3111; Horton, Tom/0000-0002-2112-9618	National Science Foundation [DEB 949175, DEB 948930]; Division Of Environmental Biology [0949175, 0948930] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by funding from the National Science Foundation, awards #DEB 949175 and #DEB 948930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MF, 1987, T BRIT MYCOL SOC, V88, P413, DOI 10.1016/S0007-1536(87)80019-0; ALLEN MF, 1992, MYCOL RES, V96, P447, DOI 10.1016/S0953-7562(09)81089-7; Relva MA, 2010, BIOL INVASIONS, V12, P303, DOI 10.1007/s10530-009-9623-0; Ashkannejhad S, 2006, NEW PHYTOL, V169, P345, DOI 10.1111/j.1469-8137.2005.01593.x; Aylor DE, 2003, ECOLOGY, V84, P1989, DOI 10.1890/01-0619; Baar J, 1999, NEW PHYTOL, V143, P409, DOI 10.1046/j.1469-8137.1999.00452.x; Barroetavena C, 2005, NOVA HEDWIGIA, V80, P453, DOI 10.1127/0029-5035/2005/0080-0453; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Buller A. H. R., 1922, RES FUNGI; Caley P, 1997, WILDLIFE RES, V24, P77, DOI 10.1071/WR94075; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; CAZARES E, 1994, MYCOLOGIA, V86, P507, DOI 10.2307/3760743; Chapela IH, 2001, SOIL BIOL BIOCHEM, V33, P1733, DOI 10.1016/S0038-0717(01)00098-0; CHUCHOU M, 1990, SOIL BIOL BIOCHEM, V22, P959; CHUCHOU M, 1981, SOIL BIOL BIOCHEM, V13, P247, DOI 10.1016/0038-0717(81)90029-8; Collier FA, 2009, J ECOL, V97, P950, DOI 10.1111/j.1365-2745.2009.01544.x; DARDAILLON M, 1986, BEHAV PROCESS, V13, P251, DOI 10.1016/0376-6357(86)90088-4; Davis M. R., 1996, New Zealand Journal of Forestry Science, V26, P380; Dickie IA, 2008, NEW PHYTOL, V180, P263, DOI 10.1111/j.1469-8137.2008.02635.x; Dickie IA, 2010, NEW PHYTOL, V187, P475, DOI 10.1111/j.1469-8137.2010.03277.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galante TE, 2011, MYCOLOGIA, V103, P1175, DOI 10.3852/10-388; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gardes M, 1996, Methods Mol Biol, V50, P177; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gehring CA, 2002, ECOL LETT, V5, P540, DOI 10.1046/j.1461-0248.2002.00353.x; GENARD M, 1988, CAN J ZOOL, V66, P2324, DOI 10.1139/z88-347; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; James TY, 2001, MOL ECOL, V10, P471, DOI 10.1046/j.1365-294x.2001.01224.x; JANOS DP, 1995, ECOLOGY, V76, P1852, DOI 10.2307/1940717; KLIEJUNAS JT, 1976, PHYTOPATHOLOGY, V66, P457, DOI 10.1094/Phyto-66-457; Kretzer A, 1996, MYCOLOGIA, V88, P776, DOI 10.2307/3760972; LAMB RJ, 1979, AUST FOREST RES, V9, P25; Li A, 2010, 5 IUFRO PHYTOPHTHORA; Li DW, 2005, MYCOL RES, V109, P1235, DOI 10.1017/S0953756205003953; Lilleskov EA, 2005, MYCOLOGIA, V97, P762, DOI 10.3852/mycologia.97.4.762; Malloch D., 1992, FUNGAL COMMUNITY ITS, V2nd ed, P147; Mangan SA, 2002, OECOLOGIA, V131, P587, DOI 10.1007/s00442-002-0907-7; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Martin VL, 2012, 25 REUN ARG EC LUJ; MASER C, 1978, ECOLOGY, V59, P799, DOI 10.2307/1938784; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MIKOLA P., 1970, Mycorrhizal inoculation in afforestation, P123; Mikola P, 1953, KARSTENIA, V2, P33; Molina R, 1992, SPECIFICITY PHENOMEN, P357; Nguyen NH, 2012, FUNGAL ECOL, V5, P741, DOI 10.1016/j.funeco.2012.05.006; Nunez MA, 2008, BIOL INVASIONS, V10, P1389, DOI 10.1007/s10530-007-9214-x; Nunez MA, 2008, AUSTRAL ECOL, V33, P317, DOI 10.1111/j.1442-9993.2007.01819.x; Nunez MA, 2011, OIKOS, V120, P1311, DOI 10.1111/j.1600-0706.2011.19504.x; Nunez MA, 2011, DIVERS DISTRIB, V17, P703, DOI 10.1111/j.1472-4642.2011.00772.x; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Richardson DM, 2006, PRESLIA, V78, P375; Richardson David M., 1998, P450; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Richardson DM, 2004, DIVERS DISTRIB, V10, P321, DOI 10.1111/j.1366-9516.2004.00096.x; RICHARDSON DM, 1994, J BIOGEOGR, V21, P511, DOI 10.2307/2845655; Richardson DM, 1998, CONSERV BIOL, V12, P18, DOI 10.1046/j.1523-1739.1998.96392.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simberloff D, 2003, ENVIRON MANAGE, V31, P263, DOI 10.1007/s00267-002-2794-4; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Simberloff Daniel, 2002, Biological Invasions, V4, P35, DOI 10.1023/A:1020576408884; Simberloff D, 2010, AUSTRAL ECOL, V35, P489, DOI 10.1111/j.1442-9993.2009.02058.x; SINGER FJ, 1981, J WILDLIFE MANAGE, V45, P343, DOI 10.2307/3807917; Smith AH, 1966, PRELIMINARY ACCOUNT; Sodeikat G, 2002, Z JAGDWISS, V48, P161, DOI 10.1007/BF02192404; TRAPPE JM, 1976, MYCOLOGIA, V68, P433, DOI 10.2307/3759016; Vazquez Diego P., 2002, Biological Invasions, V4, P175, DOI 10.1023/A:1020522923905; Vellinga EC, 2009, NEW PHYTOL, V181, P960, DOI 10.1111/j.1469-8137.2008.02728.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zenni RD, 2013, OIKOS, V122, P801, DOI 10.1111/j.1600-0706.2012.00254.x	72	71	75	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66832	10.1371/journal.pone.0066832	http://dx.doi.org/10.1371/journal.pone.0066832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826154	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400065
J	Singer, CF; Klinglmuller, F; Stratmann, R; Staudigl, C; Fink-Retter, A; Gschwantler, D; Helmy, S; Pfeiler, G; Dressler, AC; Sartori, C; Bilban, M				Singer, Christian F.; Klinglmueller, Florian; Stratmann, Rembert; Staudigl, Christine; Fink-Retter, Anneliese; Gschwantler, Daphne; Helmy, Samir; Pfeiler, Georg; Dressler, Anne Catharina; Sartori, Christian; Bilban, Martin			Response Prediction to Neoadjuvant Chemotherapy: Comparison between Pre-Therapeutic Gene Expression Profiles and In Vitro Chemosensitivity Assay	PLOS ONE			English	Article							BREAST-CANCER; DIRECTED CHEMOTHERAPY; PATHOLOGICAL RESPONSE; SYSTEMIC THERAPY; OVARIAN-CANCER; SURVIVAL; KI67; REDUCTION; PATTERNS; MARKER	Although the use of (neo-)adjuvant chemotherapy in breast cancer patients has resulted in improved outcome, not all patients benefit equally. We have evaluated the utility of an in vitro chemosensitivity assay in predicting response to neoadjuvant chemotherapy. Pre-therapeutic biopsies were obtained from 30 breast cancer patients assigned to neoadjuvant epirubicin 75 mg/m2 and docetaxel 75 mg/m2 (Epi/Doc) in a prospectively randomized clinical trial. Biopsies were subjected to a standardized ATP-based Epi/Doc chemosensitivity assay, and to gene expression profiling. Patients then received 3 cycles of chemotherapy, and response was evaluated by changes in tumor diameter and Ki67 expression. The efficacy of Epi/Doc in vitro was correlated with differential changes in tumor cell proliferation in response to Epi/Doc in vivo (p = 0.0011; r = 0.73670, Spearmans rho), but did not predict for changes in tumor size. While a pre-therapeutic gene expression signature identified tumors with a clinical response to Epi/Doc, no such signature could be found for tumors that responded to Epi/Doc in vitro, or tumors in which Epi/Doc exerted an antiproliferative effect in vivo. This is the first prospective clinical trial to demonstrate the utility of a standardized in vitro chemosensitivity assay in predicting the individual biological response to chemotherapy in breast cancer.	[Singer, Christian F.; Staudigl, Christine; Fink-Retter, Anneliese; Gschwantler, Daphne; Helmy, Samir; Pfeiler, Georg; Dressler, Anne Catharina] Med Univ Vienna, Dept Gynecol & Obstet, Vienna, Austria; [Singer, Christian F.; Staudigl, Christine; Fink-Retter, Anneliese; Gschwantler, Daphne; Helmy, Samir; Pfeiler, Georg; Dressler, Anne Catharina] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Klinglmueller, Florian] Med Univ Vienna, Inst Med Stat & Informat, Vienna, Austria; [Stratmann, Rembert; Sartori, Christian] DCS Innovat Diagnost Syst GmbH, Hamburg, Germany; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Singer, CF (corresponding author), Med Univ Vienna, Dept Gynecol & Obstet, Vienna, Austria.	christian.singer@meduniwien.ac.at		Bilban, Martin/0000-0001-7043-7142; Klinglmueller, Florian/0000-0002-7346-3669	Privatstiftung fur Brustgesundheit; Jubilaumsfonds des Burgermeisters der Stadt Wien; Austrian Society of Senology	Privatstiftung fur Brustgesundheit; Jubilaumsfonds des Burgermeisters der Stadt Wien; Austrian Society of Senology	This work was supported by the Privatstiftung fur Brustgesundheit, by the Jubilaumsfonds des Burgermeisters der Stadt Wien, and by a research grant of the Austrian Society of Senology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assersohn L, 2003, BREAST CANCER RES TR, V82, P113, DOI 10.1023/B:BREA.0000003968.45511.3f; Bear HD, 2010, SURG ONCOL CLIN N AM, V19, P607, DOI 10.1016/j.soc.2010.04.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billgren AM, 1999, ACTA ONCOL, V38, P597; Bottini A, 2001, BRIT J CANCER, V85, P1106, DOI 10.1054/bjoc.2001.2048; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Cleator S, 2006, BREAST CANCER RES TR, V95, P229, DOI 10.1007/s10549-005-9009-7; Dowsett M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2434; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Glaysher S, 2010, BRIT J CANCER, V103, P656, DOI 10.1038/sj.bjc.6605817; Glaysher S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-300; Gralow JR, 2008, J CLIN ONCOL, V26, P814, DOI 10.1200/JCO.2007.15.3510; Groheux D, 2011, EUR J NUCL MED MOL I, V38, P426, DOI 10.1007/s00259-010-1640-9; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaffe N, 2006, NEW ALTERNATIVES J C, V24, P3245; Jones RL, 2009, BREAST CANCER RES TR, V116, P53, DOI 10.1007/s10549-008-0081-7; Keune JD, 2010, AM J SURG, V199, P477, DOI 10.1016/j.amjsurg.2009.03.012; Kurbacher CA, 2005, METH MOLEC MED, V110, P101; Kurbacher CM, 1997, CLIN CANCER RES, V3, P1527; Lee J, 2008, CANCER CHEMOTH PHARM, V61, P569, DOI 10.1007/s00280-007-0506-8; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Miller WR, 2010, J STEROID BIOCHEM, V118, P273, DOI 10.1016/j.jsbmb.2009.10.005; Montagna E, 2010, BREAST CANCER RES TR, V124, P689, DOI 10.1007/s10549-010-1027-4; Neubauer H, 2008, ANTICANCER RES, V28, P949; Sharma S, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-19; Smith IE, 2005, J CLIN ONCOL, V23, P5108, DOI 10.1200/JCO.2005.04.005; Takada M, 2004, INT J ONCOL, V25, P397; Ueda S, 2011, BREAST CANCER-TOKYO, V18, P299, DOI 10.1007/s12282-010-0212-y; Ueda S, 2010, BREAST J, V16, P660, DOI 10.1111/j.1524-4741.2010.01011.x; Ugurel S, 2006, CLIN CANCER RES, V12, P5454, DOI 10.1158/1078-0432.CCR-05-2763; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501	34	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66573	10.1371/journal.pone.0066573	http://dx.doi.org/10.1371/journal.pone.0066573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826101	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400022
J	Jeong, CW; Jung, JW; Cha, WH; Lee, BK; Lee, S; Jeong, SJ; Hong, SK; Byun, SS; Lee, SE				Jeong, Chang Wook; Jung, Jin-Woo; Cha, Woo Heon; Lee, Byung Ki; Lee, Sangchul; Jeong, Seong Jin; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun			Seoul National University Renal Stone Complexity Score for Predicting Stone-Free Rate after Percutaneous Nephrolithotomy	PLOS ONE			English	Article							DECISION CURVE ANALYSIS; CLINICAL-RESEARCH OFFICE; STAGHORN MORPHOMETRY; PROSTATE-CANCER; CLASSIFICATION; COMPLICATIONS; VALIDATION; MODELS; ATTENUATION; MONOTHERAPY	Objectives: Currently, no standardized method is available to predict success rate after percutaneous nephrolithotomy. We devised and validated the Seoul National University Renal Stone Complexity (S-ReSC) scoring system for predicting the stone-free rate after single-tract percutaneous nephrolithotomy (sPCNL). Patients and Methods: The data of 155 consecutive patients who underwent sPCNL were retrospectively analyzed. Preoperative computed tomography images were reviewed. The S-ReSC score was assigned from 1 to 9 based on the number of sites involved in the renal pelvis (#1), superior and inferior major calyceal groups (#2-3), and anterior and posterior minor calyceal groups of the superior (#4-5), middle (#6-7), and inferior calyx (#8-9). The inter-and intra-observer agreements were accessed using the weighted kappa (k). The stone-free rate and complication rate were evaluated according to the S-ReSC score. The predictive accuracy of the S-ReSC score was assessed using the area under the receiver operating characteristic curve (AUC). Results: The overall SFR was 72.3%. The mean S-ReSC score was 3.15 +/- 62.1. The weighted kappas for the inter-and intra-observer agreements were 0.832 and 0.982, respectively. The SFRs in low (1 and 2), medium (3 and 4), and high (5 or higher) S-ReSC scores were 96.0%, 69.0%, and 28.9%, respectively (p<0.001). The predictive accuracy was very high (AUC 0.860). After adjusting for other variables, the S-ReSC score was still a significant predictor of the SFR by multiple logistic regression. The complication rates were increased to low (18.7%), medium (28.6%), and high (34.2%) (p = 0.166). Conclusions: The S-ReSC scoring system is easy to use and reproducible. This score accurately predicts the stone-free rate after sPCNL. Furthermore, this score represents the complexity of surgery.	[Jeong, Chang Wook; Jung, Jin-Woo; Cha, Woo Heon; Lee, Byung Ki; Lee, Sangchul; Jeong, Seong Jin; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea; [Jeong, Chang Wook; Lee, Sangchul; Jeong, Seong Jin; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, SE (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	selee@snubh.org		Hong, Sung Kyu/0000-0002-8344-6774				Binbay M, 2011, UROLOGY, V78, P733, DOI 10.1016/j.urology.2011.03.058; de la Rosette J, 2011, J ENDOUROL, V25, P11, DOI 10.1089/end.2010.0424; de la Rosette JJMCH, 2008, EUR UROL, V54, P994, DOI 10.1016/j.eururo.2008.03.052; de la Rosette JJMCH, 2012, EUR UROL, V62, P246, DOI 10.1016/j.eururo.2012.03.055; Demehri S, 2011, RADIOLOGY, V258, P915, DOI 10.1148/radiol.10100333; Desai M, 2011, J ENDOUROL, V25, P1263, DOI [10.1089/end.2011.0055, 10.1590/S1677-55382011000500016]; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Duan XH, 2012, J UROLOGY, V188, P989, DOI 10.1016/j.juro.2012.04.098; Jeong CW, 2012, INT J UROL, V19, P846, DOI 10.1111/j.1442-2042.2012.03040.x; Mishra S, 2012, CURR OPIN UROL, V22, P148, DOI 10.1097/MOU.0b013e32834fc306; Mishra S, 2012, J ENDOUROL, V26, P6, DOI 10.1089/end.2011.0145; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Perks AE, 2008, UROLOGY, V72, P765, DOI 10.1016/j.urology.2008.05.046; Preminger GM, 2007, EUR UROL, V52, P1610, DOI 10.1016/j.eururo.2007.09.039; Preminger GM, 2005, J UROLOGY, V173, P1991, DOI 10.1097/01.ju.0000161171.67806.2a; Ramello A, 2000, J NEPHROL, V13, pS45; Sampaio FJB, 2012, SMITHS TXB ENDOUROLO, P68; Shahrour K, 2012, UROLOGY, V80, P19, DOI 10.1016/j.urology.2011.12.065; Shariat SF, 2008, CLIN CANCER RES, V14, P4400, DOI 10.1158/1078-0432.CCR-07-4713; Skolarikos A, 2005, EUR UROL, V47, P22, DOI 10.1016/j.eururo.2004.08.009; Steyerberg EW, 2008, MED DECIS MAKING, V28, P146, DOI 10.1177/0272989X07312725; Thomas K, 2011, UROLOGY, V78, P277, DOI 10.1016/j.urology.2010.12.026; Tiselius HG, 2003, EUR UROL, V43, P275, DOI 10.1016/S0302-2838(03)00006-X; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361	25	69	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65888	10.1371/journal.pone.0065888	http://dx.doi.org/10.1371/journal.pone.0065888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824752	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400030
J	Sun, RX; Kittichotirat, W; Wang, J; Jan, M; Chen, WZ; Asikainen, S; Bumgarner, R; Chen, C				Sun, Ruoxing; Kittichotirat, Weerayuth; Wang, Justin; Jan, Minnie; Chen, Weizhen; Asikainen, Sirkka; Bumgarner, Roger; Chen, Casey			Genomic Stability of Aggregatibacter actinomycetemcomitans during Persistent Oral Infection in Human	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; HELICOBACTER-PYLORI; PSEUDOMONAS-AERUGINOSA; INTRAFAMILIAL TRANSMISSION; PERIODONTAL PATHOGENS; SUBGINGIVAL PLAQUE; SEROTYPES; EVOLUTION; ANTIGEN; HYBRIDIZATION	The genome of periodontal pathogen Aggregatibacter actinomycetemcomitans exhibits substantial variations in gene content among unrelated strains primarily due to the presence or absence of genomic islands. This study examined the genomic stability of A. actinomycetemcomitans during its persistent infection in the same host. Four pairs of A. actinomycetemcomitans strains, each pair isolated from an individual over time (0-10 years), were examined for their gains/losses of genes by whole genome sequencing, comparative genomic hybridization by microarray and PCR analysis. Possible effects due to genomic changes were further assessed by comparative transcriptome analysis using microarrays. The results showed that each pair of strains was clonally identical based on phylogenetic analysis of 150 core genes. A novel 24.1-Kb plasmid found in strain S23A was apparently lost in the sibling strain I23C. A 353-bp inversion affecting two essential genes of the serotype-specific gene cluster was found in the serotype antigen-nonexpressing strain I23C, while the same gene cluster was intact in the serotype-expressing sibling strain S23A. A 2,293-bp deletion affecting a gene encoding oxaloacetate decarboxylase and its neighbor region was found in strain SCC2302 but not in the sibling strain AAS4a. However, no evidence of gains or losses of genomic islands was found in the paired strains. Transcriptome profiles showed little or no difference in the paired strains. In conclusion, the genome of A. actinomycetemcomitans appears to be relatively stable during short-term infection. Several types of genomic changes were observed in the paired strains of A. actinomycetemcomitans recovered from the same subjects, including a mutation in serotype-specific gene cluster that may allow the bacteria to evade host immune response.	[Sun, Ruoxing; Wang, Justin; Jan, Minnie; Chen, Weizhen; Chen, Casey] Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA 90089 USA; [Kittichotirat, Weerayuth; Bumgarner, Roger] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Kittichotirat, Weerayuth] King Mongkuts Univ Technol Thonburi, Pilot Plant Dev & Training Inst, Syst Biol & Bioinformat Res Grp, Bangkok, Thailand; [Asikainen, Sirkka] Umea Univ, Dept Oral Microbiol, Umea, Sweden	University of Southern California; University of Washington; University of Washington Seattle; King Mongkuts University of Technology Thonburi; Umea University	Chen, C (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA 90089 USA.	ccchen@usc.edu	Bumgarner, Roger/AAA-6846-2020; Bumgarner, Roger E/K-3531-2015; Jan, Minnie/ABC-3695-2021	Bumgarner, Roger E/0000-0002-8168-6985; Kittichotirat, Weerayuth/0000-0001-8397-633X	National Institutes of Health [RO1 DE012212]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study was supported by National Institutes of Health grant RO1 DE012212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALALUUSUA S, 1991, J PERIODONTOL, V62, P207, DOI 10.1902/jop.1991.62.3.207; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Asikainen S, 1997, J AM DENT ASSOC, V128, P1263, DOI 10.14219/jada.archive.1997.0403; ASIKAINEN S, 1991, J PERIODONTOL, V62, P203, DOI 10.1902/jop.1991.62.3.203; Asikainen S, 1999, PERIODONTOL 2000, V20, P65, DOI 10.1111/j.1600-0757.1999.tb00158.x; Asikainen S, 1996, ORAL MICROBIOL IMMUN, V11, P387, DOI 10.1111/j.1399-302X.1996.tb00200.x; ASIKAINEN S, 1995, ORAL MICROBIOL IMMUN, V10, P65, DOI 10.1111/j.1399-302X.1995.tb00120.x; Asikainen S, 1997, CLIN INFECT DIS, V25, pS227, DOI 10.1086/516211; ASIKAINEN S, 1991, ORAL MICROBIOL IMMUN, V6, P115, DOI 10.1111/j.1399-302X.1991.tb00462.x; Chen C, 2010, MOL ORAL MICROBIOL, V25, P207, DOI 10.1111/j.2041-1014.2010.00567.x; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Di Bonaventura MP, 2009, J BACTERIOL, V191, P4693, DOI 10.1128/JB.00447-09; Dogan B, 2008, J PERIODONTOL, V79, P307, DOI [10.1902/jop.2008.070270, 10.1902/jop.2008.070270 ]; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fujise O, 2008, ORAL MICROBIOL IMMUN, V23, P226, DOI 10.1111/j.1399-302X.2007.00416.x; Fujise O, 2004, ORAL MICROBIOL IMMUN, V19, P340, DOI 10.1111/j.1399-302x.2004.00157.x; Gu K, 1998, ORAL MICROBIOL IMMUN, V13, P150, DOI 10.1111/j.1399-302X.1998.tb00726.x; Haubek D, 2007, INFECT IMMUN, V75, P3080, DOI 10.1128/IAI.01734-06; Huang Y, 2013, MOL ORAL MICROBIOL, V28, P1, DOI 10.1111/omi.12005; Huse HK, 2010, MBIO, V1, DOI 10.1128/mBio.00199-10; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; Kanasi E, 2010, J DENT RES, V89, P292, DOI 10.1177/0022034509358865; Karched M, 2007, J MICROBIOL METH, V68, P46, DOI 10.1016/j.mimet.2006.06.004; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Kiewitz C, 2000, MICROBIOL-UK, V146, P2365, DOI 10.1099/00221287-146-10-2365; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; Kresse AU, 2003, MOL MICROBIOL, V47, P145, DOI 10.1046/j.1365-2958.2003.03261.x; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Maughan H, 2009, J BACTERIOL, V191, P428, DOI 10.1128/JB.01234-08; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; NOVAK KF, 1994, PLASMID, V31, P31, DOI 10.1006/plas.1994.1004; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; PAGE RC, 1991, INFECT IMMUN, V59, P3451, DOI 10.1128/IAI.59.10.3451-3462.1991; Paju S, 1998, J CLIN MICROBIOL, V36, P2019, DOI 10.1128/JCM.36.7.2019-2022.1998; Patra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043370; Rylev M, 2008, J CLIN PERIODONTOL, V35, P346, DOI 10.1111/j.1600-051X.2008.01280.x; SAARELA M, 1992, ORAL MICROBIOL IMMUN, V7, P277, DOI 10.1111/j.1399-302X.1992.tb00588.x; SAARELA M, 1993, ORAL MICROBIOL IMMUN, V8, P349, DOI 10.1111/j.1399-302X.1993.tb00610.x; Saarela MH, 1999, J PERIODONTOL, V70, P504, DOI 10.1902/jop.1999.70.5.504; Silva IN, 2011, MICROBIOL-SGM, V157, P3124, DOI 10.1099/mic.0.050989-0; Smeets LC, 2002, TRENDS MICROBIOL, V10, P159, DOI 10.1016/S0966-842X(02)02314-4; Takada K, 2010, MOL ORAL MICROBIOL, V25, P200, DOI 10.1111/j.2041-1014.2010.00572.x; Yakoob J, 2000, APMIS, V108, P482, DOI 10.1034/j.1600-0463.2000.d01-86.x; Yoshida Y, 1998, INFECT IMMUN, V66, P107, DOI 10.1128/IAI.66.1.107-114.1998	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66472	10.1371/journal.pone.0066472	http://dx.doi.org/10.1371/journal.pone.0066472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824402	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400115
J	Arning, L; Ocklenburg, S; Schulz, S; Ness, V; Gerding, WM; Hengstler, JG; Falkenstein, M; Epplen, JT; Gunturkun, O; Beste, C				Arning, Larissa; Ocklenburg, Sebastian; Schulz, Stefanie; Ness, Vanessa; Gerding, Wanda M.; Hengstler, Jan G.; Falkenstein, Michael; Epplen, Joerg T.; Guentuerkuen, Onur; Beste, Christian			PCSK6 VNTR Polymorphism Is Associated with Degree of Handedness but Not Direction of Handedness	PLOS ONE			English	Article							RELATIVE HAND SKILL; INCONSISTENT HANDEDNESS; LINKAGE ANALYSIS; LRRTM1; GENE; SCHIZOPHRENIA; HERITABILITY; EVOLUTION; MEMORY; TWINS	Although the left and right human cerebral hemispheres differ both functionally and anatomically, the mechanisms that underlie the establishment of these hemispheric specializations, as well as their physiological and behavioral implications, remain largely unknown. Since cerebral asymmetry is strongly correlated with handedness, and handedness is assumed to be influenced by a number of genetic and environmental factors, we performed an association study of LRRTM1 rs6733871 and a number of polymorphisms in PCSK6 and different aspects of handedness assessed with the Edinburgh handedness inventory in a sample of unrelated healthy adults (n = 1113). An intronic 33bp variable-number tandem repeat (VNTR) polymorphism in PCSK6 (rs10523972) shows a significant association (significance threshold: p < 0.0025, adjusted for multiple comparisons) with a handedness category comparison (P = 0.0005) and degree of handedness (P = 0.001). These results provide further evidence for the role of PCSK6 as candidate for involvement in the biological mechanisms that underlie the establishment of normal brain lateralization and thus handedness and support the assumption that the degree of handedness, instead the direction, may be the more appropriate indicator of cerebral organization.	[Arning, Larissa; Gerding, Wanda M.; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Ocklenburg, Sebastian; Schulz, Stefanie; Ness, Vanessa; Guentuerkuen, Onur; Beste, Christian] Ruhr Univ Bochum, Dept Psychol, Inst Cognit Neurosci, Bochum, Germany; [Hengstler, Jan G.; Falkenstein, Michael] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Ruhr University Bochum; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Arning, L (corresponding author), Ruhr Univ Bochum, Dept Human Genet, Univ Str 150, Bochum, Germany.	larissa.arning@rub.de	Hengstler, Jan G./O-1415-2013; Falkenstein, Michael/ABA-7497-2020; Ocklenburg, Sebastian/O-5867-2017	Ocklenburg, Sebastian/0000-0001-5882-3200; Hengstler, Jan/0000-0002-1427-5246; Gunturkun, Onur/0000-0003-4173-5233; Epplen, Joerg T./0000-0002-6087-3327	DFG [BE4045/10-1]; Ruhr-University of Bochum	DFG(German Research Foundation (DFG)); Ruhr-University of Bochum	This work was supported by a DFG Emmy-Noether grant [BE4045/10-1 to C.B.] and a Cutting-Edge Grant from the Ruhr-University of Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Constam DB, 2000, GENE DEV, V14, P1146; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Crow TJ, 2009, LATERALITY, V14, P3, DOI 10.1080/13576500802574984; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Francks C, 2003, AM J HUM GENET, V72, P499, DOI 10.1086/367548; Francks C, 2002, AM J HUM GENET, V70, P800, DOI 10.1086/339249; Gemayel R, 2012, GENES-BASEL, V3, P461, DOI 10.3390/genes3030461; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Kempe V, 2009, PSYCHON B REV, V16, P480, DOI 10.3758/PBR.16.3.480; Ludwig KU, 2009, MOL PSYCHIATR, V14, P743, DOI 10.1038/mp.2009.28; Lyle KB, 2012, J EXP PSYCHOL LEARN, V38, P187, DOI 10.1037/a0024831; Lyle KB, 2011, MEMORY, V19, P613, DOI 10.1080/09658211.2011.595418; Mcmanus C, 2009, LATERALITY, V14, P1, DOI 10.1080/13576500802542577; McManus IC, 2013, ANN NEW YOR IN PRESS; Medland SE, 2009, NEUROPSYCHOLOGIA, V47, P330, DOI 10.1016/j.neuropsychologia.2008.09.005; Medland SE, 2006, TWIN RES HUM GENET, V9, P46, DOI 10.1375/183242706776402885; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prichard E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00009; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Scerri TS, 2011, HUM MOL GENET, V20, P608, DOI 10.1093/hmg/ddq475; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Van Agtmael T, 2002, EUR J HUM GENET, V10, P623, DOI 10.1038/sj.ejhg.5200851; Warren DM, 2006, LATERALITY, V11, P508, DOI 10.1080/13576500600761056; Zhong M, 1996, FEBS LETT, V396, P31, DOI 10.1016/0014-5793(96)01059-9	27	67	67	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67251	10.1371/journal.pone.0067251	http://dx.doi.org/10.1371/journal.pone.0067251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826248	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000049
J	Wu, YT; Wubet, T; Trogisch, S; Both, S; Scholten, T; Bruelheide, H; Buscot, F				Wu, Yu Ting; Wubet, Tesfaye; Trogisch, Stefan; Both, Sabine; Scholten, Thomas; Bruelheide, Helge; Buscot, Francois			Forest Age and Plant Species Composition Determine the Soil Fungal Community Composition in a Chinese Subtropical Forest	PLOS ONE			English	Article							BROAD-LEAVED FOREST; ECTOMYCORRHIZAL FUNGI; MYCORRHIZAL FUNGI; QUERCUS SPP.; DIVERSITY; BIODIVERSITY; SPECIFICITY; SUCCESSION; DYNAMICS; GROWTH	Fungal diversity and community composition are mainly related to soil and vegetation factors. However, the relative contribution of the different drivers remains largely unexplored, especially in subtropical forest ecosystems. We studied the fungal diversity and community composition of soils sampled from 12 comparative study plots representing three forest age classes (Young: 10-40 yrs; Medium: 40-80 yrs; Old: >= 80 yrs) in Gutianshan National Nature Reserve in South-eastern China. Soil fungal communities were assessed employing ITS rDNA pyrotag sequencing. Members of Basidiomycota and Ascomycota dominated the fungal community, with 22 putative ectomycorrhizal fungal families, where Russulaceae and Thelephoraceae were the most abundant taxa. Analysis of similarity showed that the fungal community composition significantly differed among the three forest age classes. Forest age class, elevation of the study plots, and soil organic carbon (SOC) were the most important factors shaping the fungal community composition. We found a significant correlation between plant and fungal communities at different taxonomic and functional group levels, including a strong relationship between ectomycorrhizal fungal and non-ectomycorrhizal plant communities. Our results suggest that in subtropical forests, plant species community composition is the main driver of the soil fungal diversity and community composition.	[Wu, Yu Ting; Wubet, Tesfaye; Buscot, Francois] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Wu, Yu Ting; Buscot, Francois] Univ Leipzig, Inst Biol, Chair Soil Ecol, D-04109 Leipzig, Germany; [Wubet, Tesfaye; Bruelheide, Helge; Buscot, Francois] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Trogisch, Stefan] Univ Freiburg, Fac Biol, Dept Geobot, D-79106 Freiburg, Germany; [Trogisch, Stefan; Both, Sabine; Bruelheide, Helge] Univ Halle Wittenberg, Dept Biol & Geobot, D-06108 Halle, Saale, Germany; [Scholten, Thomas] Univ Tubingen, Chair Phys Geog & Soil Sci, Tubingen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; University of Freiburg; Martin Luther University Halle Wittenberg; Eberhard Karls University of Tubingen	Wubet, T (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany.	tesfaye.wubet@ufz.de	Bruelheide, Helge/G-3907-2013; Both, Sabine/GRO-4210-2022; Trogisch, Stefan/D-4358-2017; Buscot, Francois/A-4125-2016; Wubet, Tesfaye/C-6241-2012; Scholten, Thomas/E-4024-2012	Bruelheide, Helge/0000-0003-3135-0356; Buscot, Francois/0000-0002-2364-0006; Wubet, Tesfaye/0000-0001-8572-4486; Scholten, Thomas/0000-0002-4875-2602; Trogisch, Stefan/0000-0002-1426-1012; Both, Sabine/0000-0003-4437-5106	German Research Foundation (DFG) [BU 941/12-1, FOR 891/1]; Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary GRADuate School for Environmental Research (HIGRADE)	German Research Foundation (DFG)(German Research Foundation (DFG)); Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary GRADuate School for Environmental Research (HIGRADE)	The project was mainly supported by the German Research Foundation (DFG) (Grant BU 941/12-1 in the Research Unit FOR 891/1) and additionally by the Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary GRADuate School for Environmental Research (HIGRADE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; ALLEN EB, 1995, PLANT SOIL, V170, P47, DOI 10.1007/BF02183054; Aucina A, 2007, APPL ENVIRON MICROB, V73, P4867, DOI 10.1128/AEM.00584-07; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Baselga A, 2013, BETAPARRT PARTITIONI; Bolker B, 2012, GPLOTS VARIOUS VARIO; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Buee M, 2007, SOIL BIOL BIOCHEM, V39, P1947, DOI 10.1016/j.soilbio.2007.02.016; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burke DJ, 2009, APPL ENVIRON MICROB, V75, P7639, DOI 10.1128/AEM.01648-09; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Courty PE, 2010, SOIL BIOL BIOCHEM, V42, P679, DOI 10.1016/j.soilbio.2009.12.006; Curlevski NJA, 2010, J SOIL SEDIMENT, V10, P1278, DOI 10.1007/s11368-010-0239-x; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; DeBellis T, 2006, MICROB ECOL, V52, P114, DOI 10.1007/s00248-006-9038-8; Dickie IA, 2002, NEW PHYTOL, V156, P527, DOI 10.1046/j.1469-8137.2002.00535.x; Dickie IA, 2007, NEW PHYTOL, V174, P230, DOI 10.1111/j.1469-8137.2007.02055.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geissler C, 2012, CATENA, V91, P85, DOI 10.1016/j.catena.2010.10.009; Harrell FE, 2012, HMISC HARREL MISCELL; He JZ, 2005, FEMS MICROBIOL LETT, V247, P91, DOI 10.1016/j.femsle.2005.04.033; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; KEIZER PJ, 1994, MYCORRHIZA, V4, P147, DOI 10.1007/BF00203533; Kernaghan G, 2005, PEDOBIOLOGIA, V49, P511, DOI 10.1016/j.pedobi.2005.05.007; Kernaghan G, 2001, ECOGRAPHY, V24, P181, DOI 10.1034/j.1600-0587.2001.240208.x; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Lentendu G, 2011, FUNGAL DIVERS, V49, P113, DOI 10.1007/s13225-011-0101-5; Liang Y, 2007, MYCORRHIZA, V17, P271, DOI 10.1007/s00572-006-0096-z; LODGE DJ, 1995, CAN J BOT, V73, pS1391, DOI 10.1139/b95-402; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moora M, 2011, J BIOGEOGR, V38, P1305, DOI 10.1111/j.1365-2699.2011.02478.x; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Morris MH, 2008, NEW PHYTOL, V178, P167, DOI 10.1111/j.1469-8137.2007.02348.x; Morris S.J., 2005, LINKING FUNCTION SCA; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Osono T, 2006, SOIL BIOL BIOCHEM, V38, P2743, DOI 10.1016/j.soilbio.2006.04.028; Pandey Ram Vinay, 2010, BMC Res Notes, V3, P3, DOI 10.1186/1756-0500-3-3; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Peter M, 2001, NEW PHYTOL, V149, P311, DOI 10.1046/j.1469-8137.2001.00030.x; Qu L, 2010, ECOL STUD-ANAL SYNTH, V209, P413, DOI 10.1007/978-1-4020-9693-8_21; Revelle W., 2011, PSYCH PROCEDURES PSY; Richard F, 2005, NEW PHYTOL, V166, P1011, DOI 10.1111/j.1469-8137.2005.01382.x; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Riviere T, 2007, MYCORRHIZA, V17, P415, DOI 10.1007/s00572-007-0117-6; Roberts DW., 2012, LABDSV ORDINATION MU; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rosling A, 2003, NEW PHYTOL, V159, P775, DOI 10.1046/j.1469-8137.2003.00829.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith JE, 2002, CAN J BOT, V80, P186, DOI [10.1139/b02-003, 10.1139/B02-003]; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Team R. D. C, 2011, R LANG ENV STAT COMP; Tedersoo L, 2003, NEW PHYTOL, V159, P153, DOI 10.1046/j.1469-8137.2003.00792.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; Wang Q, 2012, MYCORRHIZA, V22, P461, DOI 10.1007/s00572-011-0423-x; Westover KM, 2001, ECOLOGY, V82, P3285, DOI 10.1890/0012-9658(2001)082[3285:MOPSCR]2.0.CO;2; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wu YT, 2012, ECOSYSTEMS, V15, P624, DOI 10.1007/s10021-012-9533-3; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zhu WZ, 2010, J MT SCI-ENGL, V7, P327, DOI 10.1007/s11629-010-1098-z	76	46	55	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66829	10.1371/journal.pone.0066829	http://dx.doi.org/10.1371/journal.pone.0066829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826151	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000014
J	Alam, MM; Khurshid, A; Shaukat, S; Suleman, RM; Sharif, S; Angez, M; Malik, SA; Ahmed, TM; Aamir, UB; Naeem, M; Zaidi, SSZ				Alam, Muhammad Masroor; Khurshid, Adnan; Shaukat, Shahzad; Suleman, Rana Muhammad; Sharif, Salmaan; Angez, Mehar; Malik, Salman Akbar; Ahmed, Tahir Masood; Aamir, Uzma Bashir; Naeem, Muhammad; Zaidi, Syed Sohail Zahoor			Epidemiology and Genetic Diversity of Rotavirus Strains in Children with Acute Gastroenteritis in Lahore, Pakistan	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; POLYMERASE-CHAIN-REACTION; UNITED-STATES; VIRAL GASTROENTERITIS; VACCINE-INTRODUCTION; DIARRHEAL DISEASE; SEROTYPE G9; VP7; SURVEILLANCE; EFFICACY	Pakistan harbors high disease burden of gastro-enteric infections with majority of these caused by rotavirus. Unfortunately, lack of proper surveillance programs and laboratory facilities have resulted in scarcity of available data on rotavirus associated disease burden and epidemiological information in the country. We investigated 1306 stool samples collected over two years (2008-2009) from hospitalized children under 5 years of age for the presence of rotavirus strains and its genotypic diversity in Lahore. The prevalence rate during 2008 and 2009 was found to be 34% (n = 447 out of 1306). No significant difference was found between different age groups positive for rotavirus (p>0.05). A subset of EIA positive samples was further screened for rotavirus RNA through RT-PCR and 44 (49.43%) samples, out of total 89 EIA positive samples, were found positive. G and P type prevalence was found as follows: G1P [4] = 3(6.81%); G1P [6] = 9(20.45%); G1P [8] = 1(2.27%); G2P [4] = 21(47.72%); G2P [8] = 1(2.27%); G9P [4] = 1(2.27%); G9P [6] = 1(2.27%) and G9P [8] = 7(15.90%). Phylogenetic analysis revealed that the VP7 and VP4 sequences clustered closely with the previously detected strains in the country as well as Belgian rotaviruses. Antigenic characterization was performed by analyzing major epitopes in the immunodominant VP7 and VP4 gene segments. Although the neutralization conferring motifs were found variable between the Pakistani strains and the two recommended vaccines strains (Rotarix (TM) and RotaTeq (TM)), we validate the use of rotavirus vaccine in Pakistan based on the proven and recognized vaccine efficacy across the globe. Our findings constitute the first report on rotavirus' genotype diversity, their phylogenetic relatedness and epidemiology during the pre-vaccination era in Lahore, Pakistan and support the immediate introduction of rotavirus vaccine in the routine immunization program of the country.	[Alam, Muhammad Masroor; Naeem, Muhammad] Quaid I Azam Univ, Dept Biotechnol, Islamabad, Pakistan; [Khurshid, Adnan; Shaukat, Shahzad; Suleman, Rana Muhammad; Sharif, Salmaan; Angez, Mehar; Aamir, Uzma Bashir; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan; [Malik, Salman Akbar] Quaid I Azam Univ, Dept Biochem, Islamabad, Pakistan; [Ahmed, Tahir Masood] Childrens Hosp Lahore, Dept Pediat, Lahore, Pakistan	Quaid I Azam University; Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	zaidis@pak.emro.who.int	Shaukat, Shahzad/HHZ-1088-2022; Zaidi, Syed Sohail Zahoor/F-7432-2015; Angez, Mehar/J-3792-2015; Naeem, Muhammad/F-4869-2011	Naeem, Muhammad/0000-0002-3894-3085				Alam MM, 2009, VIRUS RES, V144, P280, DOI 10.1016/j.virusres.2009.03.015; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1255; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; ANSARI SA, 1991, REV INFECT DIS, V13, P448; Aoki ST, 2009, SCIENCE, V324, P1444, DOI 10.1126/science.1170481; BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282; Bishop RF, 2001, J CLIN MICROBIOL, V39, P1085, DOI 10.1128/JCM.39.3.1085-1091.2001; Bishop RF, 1996, ARCH VIROL, P119; Block SL, 2007, PEDIATRICS, V119, P11, DOI 10.1542/peds.2006-2058; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Bresee J, 2004, EMERG INFECT DIS, V10, P988, DOI 10.3201/eid1006.030519; Clark HF, 2004, J CLIN MICROBIOL, V42, P1434, DOI 10.1128/JCM.42.4.1434-1438.2004; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; COULSON BS, 1991, J VIROL, V65, P5968, DOI 10.1128/JVI.65.11.5968-5974.1991; Das S, 2003, J CLIN MICROBIOL, V41, P2760, DOI 10.1128/JCM.41.6.2760-2762.2003; Dennehy PH, 2005, INFECT DIS CLIN N AM, V19, P585, DOI 10.1016/j.idc.2005.05.003; DUTTA SR, 1990, INT J EPIDEMIOL, V19, P722, DOI 10.1093/ije/19.3.722; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Giaquinto C, 2011, HUM VACCINES, V7, P734, DOI 10.4161/hv.7.7.15511; Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; Gomara MI, 2001, J CLIN MICROBIOL, V39, P3796, DOI 10.1128/JCM.39.10.3796-3798.2001; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; HIEBER JP, 1978, AM J DIS CHILD, V132, P853, DOI 10.1001/archpedi.1978.02120340029004; Hoshino Y, 2000, J HEALTH POPUL NUTR, V18, P5; Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78; do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024; Iturriza-Gomara M, 2000, J MED VIROL, V61, P510, DOI 10.1002/1096-9071(200008)61:4&lt;510::AID-JMV15&gt;3.0.CO;2-Q; Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P4394; Jin Q, 1996, ARCH VIROL, V141, P2057, DOI 10.1007/BF01718215; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90; KONNO T, 1983, J INFECT DIS, V147, P125, DOI 10.1093/infdis/147.1.125; Koopmans M, 1999, ACTA PAEDIATR, V88, P14, DOI 10.1111/j.1651-2227.1999.tb14320.x; Laird AR, 2003, J CLIN MICROBIOL, V41, P3100, DOI 10.1128/JCM.41.7.3100-3111.2003; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Logan C, 2006, J CLIN MICROBIOL, V44, P3189, DOI 10.1128/JCM.00915-06; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; McIver CJ, 2001, PATHOLOGY, V33, P353, DOI 10.1080/00313020120062983; Miles MG, 2012, VACCINE, V30, pA131, DOI 10.1016/j.vaccine.2011.10.002; Monnier N, 2006, J VIROL, V80, P1513, DOI 10.1128/JVI.80.3.1513-1523.2006; Nakagomi T, 2005, J INFECT DIS, V192, pS106, DOI 10.1086/431503; Nishio O, 2000, PEDIATR INT, V42, P425, DOI 10.1046/j.1442-200x.2000.01256.x; Oka T, 2000, MICROBIOL IMMUNOL, V44, P957, DOI 10.1111/j.1348-0421.2000.tb02590.x; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Patel MM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001330; Phan TG, 2007, J VIROL, V81, P4645, DOI 10.1128/JVI.02342-06; Qazi R, 2009, VACCINE, V27, pF25, DOI 10.1016/j.vaccine.2009.08.064; Rahman M, 2005, J CLIN MICROBIOL, V43, P3208, DOI 10.1128/JCM.43.7.3208-3212.2005; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Simpson R, 2003, J MED VIROL, V70, P258, DOI 10.1002/jmv.10386; Soares-Weiser K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008521; STOLL BJ, 1982, BRIT MED J, V285, P1185, DOI 10.1136/bmj.285.6349.1185; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2004, PEDIATR INFECT DIS J, V23, P937, DOI 10.1097/01.inf.0000141722.10130.50; WEN LY, 1995, MICROBIOL IMMUNOL, V39, P911, DOI 10.1111/j.1348-0421.1995.tb03277.x; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285; Zeller M, 2012, J CLIN MICROBIOL, V50, P966, DOI 10.1128/JCM.05590-11; Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004	67	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67998	10.1371/journal.pone.0067998	http://dx.doi.org/10.1371/journal.pone.0067998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825693	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000127
J	Mwau, M; Adungo, F; Kadima, S; Njagi, E; Kirwaye, C; Abubakr, NS; Okubi, LA; Waihenya, M; Lusike, J; Hungu, J				Mwau, Matilu; Adungo, Ferdinard; Kadima, Silvia; Njagi, Ephantus; Kirwaye, Carolyne; Abubakr, Najma Salim; Okubi, Lucy Atsieno; Waihenya, Mary; Lusike, Judi; Hungu, Jackson			Evaluation of PIMA (TM)(R) Point of Care Technology for CD4 T Cell Enumeration in Kenya	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; POTENT ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; PERFORMANCE EVALUATION; DIAGNOSING INFECTIONS; TOTAL LYMPHOCYTE; PIMA CD4; ANALYZER; COHORT; TESTS	CD4+ T cell enumeration is used to determine eligibility for antiretroviral therapy (ART) and to monitor the immune status of HIV-positive patients; however, many patients do not have access to this essential diagnostic test. Introducing point of care (POC) testing may improve access. We have evaluated Alere's PIMA (TM), one such POC device, against conventional CD4+ testing platforms to determine its performance and validity for use in Kenya. In our hands, Alere PIMA (TM) had a coefficient of variability of 10.3% and of repeatability of 175.6 cells/mu l. It differed from both the BD FACSCalibur (TM) (r(2) = 0.762, mean bias 264.8 cells/mu l), and the BD FACSCount (TM) (r(2) = 0.874, mean bias 7.8 cells/mu l). When compared to the FACSCalibur (TM) at a cutoff of 350 cells/mu l, it had a sensitivity of 89.6% and a specificity of 86.7% in those aged 5 years and over (Kw = 0.7566). With the BD FACSCount (TM), it had a sensitivity of 79.4% and a specificity of 83.4% in those aged 5 years and over (Kw = 0.7790). The device also differed from PARTEC Cyflow (TM) (r(2) = 0.781, mean bias -224.2 cells/mu l) and GUAVA (TM) (r(2) = 0.658, mean bias -0.3 cells/mu l) platforms, which are used in some facilities in Kenya. We conclude that with refinement, Alere PIMA (TM) technology has potential benefits for HIV-positive patients. This study highlights the difficulty in selecting the most appropriate reference technology for technical evaluations.	[Mwau, Matilu; Adungo, Ferdinard; Kadima, Silvia; Kirwaye, Carolyne; Abubakr, Najma Salim; Okubi, Lucy Atsieno; Waihenya, Mary] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Lusike, Judi; Hungu, Jackson] Clinton Hlth Access Initiat, Nairobi, Kenya; [Njagi, Ephantus] Deloitte Consulting LLC, Nairobi, Kenya	Kenya Medical Research Institute; Deloitte Touche Tohmatsu Limited	Mwau, M (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.	matilu.mwau@gmail.com		Hungu, Jackson/0000-0002-9058-5027; Njagi, Ephantus/0000-0002-1484-0241; Adungo, Ferdinard/0000-0002-0873-7993	Kenya Medical Research Institute; Clinton Health Access Initiative	Kenya Medical Research Institute; Clinton Health Access Initiative	Funding for this work was supported by the Kenya Medical Research Institute and the Clinton Health Access Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bissonnette L, 2010, CLIN MICROBIOL INFEC, V16, P1044, DOI 10.1111/j.1469-0691.2010.03282.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CDC, 1997, 1997 NAT C PUBL HLTH, p[1057, 1]; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Fox J, 2011, SEX TRANSM INFECT, V87, P178, DOI 10.1136/sti.2010.042564; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Herbert S, 2012, SEX TRANSM INFECT; Herbert S, 2012, SEX TRANSM INFECT, V88, P413, DOI 10.1136/sextrans-2012-050507; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Manasa J, 2007, CLIN VACCINE IMMUNOL, V14, P293, DOI 10.1128/CVI.00416-06; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Marinucci F, 2011, CYTOM PART A, V79A, P368, DOI 10.1002/cyto.a.21064; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Peter T, 2008, CYTOM PART B-CLIN CY, V74B, pS123, DOI 10.1002/cyto.b.20416; PRINCE HE, 1989, AM J CLIN PATHOL, V92, P206, DOI 10.1093/ajcp/92.2.206; Rouet F, 2006, J TROP PEDIATRICS, V52, P346, DOI 10.1093/tropej/fml024; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26; Usdin M, 2010, J INFECT DIS, V201, pS73, DOI 10.1086/650384; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x	26	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67612	10.1371/journal.pone.0067612	http://dx.doi.org/10.1371/journal.pone.0067612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825674	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000110
J	Navarro-Mateu, F; Escamez, T; Koenen, KC; Alonso, J; Sanchez-Meca, J				Navarro-Mateu, Fernando; Escamez, Teresa; Koenen, Karestan C.; Alonso, Jordi; Sanchez-Meca, Julio			Meta-Analyses of the 5-HTTLPR Polymorphisms and Post-Traumatic Stress Disorder	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; EMOTIONAL REGULATION; CHILDHOOD ADVERSITY; SYSTEMATIC REVIEWS; OEF/OIF VETERANS; PROMOTER REGION; SOCIAL SUPPORT; LIFE EVENTS; ASSOCIATION; GENOTYPE	Objective: To conduct a meta-analysis of all published genetic association studies of 5-HTTLPR polymorphisms performed in PTSD cases Methods Data Sources: Potential studies were identified through PubMed/MEDLINE, EMBASE, Web of Science databases (Web of Knowledge, WoK), PsychINFO, PsychArticles and HuGeNet (Human Genome Epidemiology Network) up until December 2011. Study Selection: Published observational studies reporting genotype or allele frequencies of this genetic factor in PTSD cases and in non-PTSD controls were all considered eligible for inclusion in this systematic review. Data Extraction: Two reviewers selected studies for possible inclusion and extracted data independently following a standardized protocol. Statistical analysis: A biallelic and a triallelic meta-analysis, including the total S and S' frequencies, the dominant (S+/LL and S'+/L'L') and the recessive model (SS/L+ and S'S'/L'+), was performed with a random-effect model to calculate the pooled OR and its corresponding 95% CI. Forest plots and Cochran's Q-Statistic and I-2 index were calculated to check for heterogeneity. Subgroup analyses and meta-regression were carried out to analyze potential moderators. Publication bias and quality of reporting were also analyzed. Results: 13 studies met our inclusion criteria, providing a total sample of 1874 patients with PTSD and 7785 controls in the biallelic meta-analyses and 627 and 3524, respectively, in the triallelic. None of the meta-analyses showed evidence of an association between 5-HTTLPR and PTSD but several characteristics (exposure to the same principal stressor for PTSD cases and controls, adjustment for potential confounding variables, blind assessment, study design, type of PTSD, ethnic distribution and Total Quality Score) influenced the results in subgroup analyses and meta-regression. There was no evidence of potential publication bias. Conclusions: Current evidence does not support a direct effect of 5-HTTLPR polymorphisms on PTSD. Further analyses of gene-environment interactions, epigenetic modulation and new studies with large samples and/or meta-analyses are required.	[Navarro-Mateu, Fernando] Serv Murciano Salud, Subdirecc Gen Salud Mental & Asistencia Psiquiatr, Unidad Docencia Invest & Formac Salud Mental UDIF, Murcia, Spain; [Navarro-Mateu, Fernando] CIBER Epidemiol & Salud Publ CIBERESP, Murcia, Spain; [Escamez, Teresa] Fdn Formac & Invest Sanitarias FFIS Reg Murcia, IMIB BIOBANC MUR, Biobanco HUVA AECC FFIS, Murcia, Spain; [Koenen, Karestan C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Alonso, Jordi] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain; [Alonso, Jordi] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Sanchez-Meca, Julio] Univ Murcia, Fac Psicol, Dept Psicol Basica & Metodol, Murcia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Columbia University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Murcia	Navarro-Mateu, F (corresponding author), Serv Murciano Salud, Subdirecc Gen Salud Mental & Asistencia Psiquiatr, Unidad Docencia Invest & Formac Salud Mental UDIF, Murcia, Spain.	fernando.navarro@carm.es	Navarro-Mateu, Fernando/H-9055-2017; Sánchez-Meca, Julio/AAA-7807-2019; Alonso, Jordi/A-5514-2010	Navarro-Mateu, Fernando/0000-0002-3228-623X; Sánchez-Meca, Julio/0000-0002-8412-788X; Alonso, Jordi/0000-0001-8627-9636	Regional Health Authorities of Murcia (Consejeria de Sanidad y Politica Social and Servicio Murciano de Salud); Fundacion para la Formacion e Investigacion Sanitaria (FFIS) of the Murcia Region	Regional Health Authorities of Murcia (Consejeria de Sanidad y Politica Social and Servicio Murciano de Salud); Fundacion para la Formacion e Investigacion Sanitaria (FFIS) of the Murcia Region	This work has been financed by the Regional Health Authorities of Murcia (Consejeria de Sanidad y Politica Social and Servicio Murciano de Salud) and the Fundacion para la Formacion e Investigacion Sanitaria (FFIS) of the Murcia Region. The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Jim van Os	Beach SRH, 2010, AM J MED GENET B, V153B, P710, DOI 10.1002/ajmg.b.31028; Borenstein M., 2005, COMPREHENSIVE META A; Brugha TS, 2012, BRIT J PSYCHIAT, V200, P446, DOI 10.1192/bjp.bp.111.098103; Bryant RA, 2010, BIOL PSYCHIAT, V67, P1217, DOI 10.1016/j.biopsych.2010.03.016; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Cho HJ, 2005, MOL PSYCHIATR, V10, P771, DOI 10.1038/sj.mp.4001663; Clarke H, 2010, PSYCHOL MED, V40, P1767, DOI 10.1017/S0033291710000516; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Esteller M, 2006, CARCINOGENESIS, V27, P1121, DOI 10.1093/carcin/bgl033; Feinn R, 2005, AM J MED GENET B, V133B, P79, DOI 10.1002/ajmg.b.30132; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Grabe HJ, 2009, AM J PSYCHIAT, V166, P926, DOI 10.1176/appi.ajp.2009.08101542; GREEN BL, 1994, J TRAUMA STRESS, V7, P341, DOI 10.1007/BF02102782; Handwerger K L., 2010, THESIS PROQUEST INFO; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Holman EA, 2011, J TRAUMA STRESS, V24, P497, DOI 10.1002/jts.20671; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Kaufman J, 2009, BIOL PSYCHIAT, V65, p106S; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kilpatrick DG, 2007, AM J PSYCHIAT, V164, P1693, DOI 10.1176/appi.ajp.2007.06122007; King AP, 2011, BIOL PSYCHIAT, V69, p74S; King AP, 2010, BIOL PSYCHIAT, V67, p209S; King AP, 2009, BIOL PSYCHIAT, V65, p6S; Koenen KC, 2008, EUR ARCH PSY CLIN N, V258, P82, DOI 10.1007/s00406-007-0787-2; Koenen K, 2006, AM J MED GENET B, V141B, P742; Koenen KC, 2007, J TRAUMA STRESS, V20, P737, DOI 10.1002/jts.20205; Koenen KC, 2011, DEPRESS ANXIETY, V28, P639, DOI 10.1002/da.20825; Koenen KC, 2009, J TRAUMA STRESS, V22, P416, DOI 10.1002/jts.20435; Koenen KC, 2009, AM J EPIDEMIOL, V169, P704, DOI 10.1093/aje/kwn397; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li D, 2007, MOL PSYCHIATR, V12, P47, DOI 10.1038/sj.mp.4001890; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Little J, 2006, HUGENET HUGE REV HDB; Little J, 2009, ANN INTERN MED, V150, P206, DOI 10.7326/0003-4819-150-3-200902030-00011; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Valente NLM, 2011, J MOL NEUROSCI, V44, P59, DOI 10.1007/s12031-011-9513-7; Mellman TA, 2009, PSYCHOSOM MED, V71, P627, DOI 10.1097/PSY.0b013e3181a54341; Mercer KB, 2012, ARCH GEN PSYCHIAT, V69, P89, DOI 10.1001/archgenpsychiatry.2011.109; Morey RA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-76; Munafo MR, 2006, NEUROPSYCHOBIOLOGY, V53, P1, DOI 10.1159/000089915; Mushtaq D, 2012, J AFFECT DISORDERS, V136, P955, DOI 10.1016/j.jad.2011.08.033; Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698; Nugent NR, 2008, AM J MED GENET C, V148C, P127, DOI 10.1002/ajmg.c.30169; Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028; Sanchez-Meca J, 2008, PSYCHOL METHODS, V13, P31, DOI 10.1037/1082-989X.13.1.31; Sayin A, 2010, DNA CELL BIOL, V29, P71, DOI 10.1089/dna.2009.0936; Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P99; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takano A, 2007, BIOL PSYCHIAT, V62, P588, DOI 10.1016/j.biopsych.2006.11.007; Terracciano A, 2010, NEUROPSYCHOPHARMACOL, V35, P1083, DOI 10.1038/npp.2009.213; Thakur GA, 2009, J TRAUMA STRESS, V22, P240, DOI 10.1002/jts.20405; Toyokawa S, 2012, SOC SCI MED, V74, P67, DOI 10.1016/j.socscimed.2011.09.036; Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123; Vandenbroucke JP, 2007, LANCET, V4, P297; Wang ZW, 2011, DEPRESS ANXIETY, V28, P1067, DOI 10.1002/da.20872; Wang ZW, 2009, BIOL PSYCHIAT, V65, p119S; Xie PX, 2012, AM J MED GENET B, V159B, P644, DOI 10.1002/ajmg.b.32068; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588	65	43	43	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66227	10.1371/journal.pone.0066227	http://dx.doi.org/10.1371/journal.pone.0066227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825531	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000010
J	Ramsing, BGU; Arpi, M; Andersen, EA; Knabe, N; Mogensen, D; Buhl, D; Westh, H; Ostergaard, C				Ramsing, Benedicte Grenness Utke; Arpi, Magnus; Andersen, Erik Arthur; Knabe, Niels; Mogensen, Dorthe; Buhl, Dorte; Westh, Henrik; Ostergaard, Christian			First Outbreak with MRSA in a Danish Neonatal Intensive Care Unit: Risk Factors and Control Procedures	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; NOSOCOMIAL TRANSMISSION; STAPHYLOCLOCCUS-AUREUS; INFECTION; COLONIZATION; INFANTS; SURVEILLANCE; CARRIAGE; NURSERY	Introduction: The purpose of the study was to describe demographic and clinical characteristics and outbreak handling of a large methicillin-resistant Staphylococcus aureus (MRSA) outbreak in a neonatal intensive care unit (NICU) in Denmark June 25th-August 8th 2008, and to identify risk factors for MRSA transmission. Methods: Data were collected retrospectively from medical records and the Danish Neobase database. All MRSA isolates obtained from neonates, relatives and NICU health care workers (HCW) as well as environmental cultures were typed. Results: During the 46 day outbreak period, 102 neonates were admitted to the two neonatal wards. Ninety-nine neonates were subsequently sampled, and 32 neonates (32%) from 25 families were colonized with MRSA (spa-type t127, SCCmec V, PVL negative). Thirteen family members from 11 of those families (44%) and two of 161 HCWs (1%) were colonized with the same MRSA. No one was infected. Five environmental cultures were MRSA positive. In a multiple logistic regression analysis, nasal Continuous Positive Airway Pressure (nCPAP) treatment (p = 0.006) and Caesarean section (p = 0.016) were independent risk factors for MRSA acquisition, whereas days of exposure to MRSA was a risk factors in the unadjusted analysis (p = 0.04). Conclusions: MRSA transmission occurs with high frequency in the NICU during hospitalization with unidentified MRSA neonates. Caesarean section and nCPAP treatment were identified as risk factors for MRSA colonization. The MRSA outbreak was controlled through infection control procedures.	[Ramsing, Benedicte Grenness Utke; Andersen, Erik Arthur; Knabe, Niels] Copenhagen Univ Hosp, Dept Pediat, Glostrup, Denmark; [Arpi, Magnus; Mogensen, Dorthe; Buhl, Dorte; Ostergaard, Christian] Copenhagen Univ Hosp, Dept Clin Microbiol, Herlev, Denmark; [Westh, Henrik; Ostergaard, Christian] Copenhagen Univ Hosp, MRSA Knowledge Ctr, Dept Clin Microbiol, Hvidovre, Denmark; [Westh, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Ramsing, BGU (corresponding author), Copenhagen Univ Hosp, Dept Pediat, Glostrup, Denmark.	benedicte.ramsing@gmail.com		Westh, Henrik/0000-0001-5681-647X				Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128; Babazono A, 2008, ACTA MED OKAYAMA, V62, P261; Bartels MD, 2008, J HOSP INFECT, V70, P35, DOI 10.1016/j.jhin.2008.05.018; Bartels MD, 2007, EMERG INFECT DIS, V13, P1533, DOI 10.3201/eid1310.070503; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; Bratu S, 2005, EMERG INFECT DIS, V11, P808, DOI 10.3201/eid1106.040885; Carey AJ, 2010, J PERINATOL, V30, P135, DOI 10.1038/jp.2009.119; Chapman AK, 2012, J PERINATOL, V32, P4, DOI 10.1038/jp.2011.148; David MD, 2006, J HOSP INFECT, V64, P244, DOI 10.1016/j.jhin.2006.06.022; Gerber SI, 2006, INFECT CONT HOSP EP, V27, P139, DOI 10.1086/501216; Gould IM, 2009, EPIDEMIOL INFECT, V137, P1242, DOI 10.1017/S0950268809002234; Gregory ML, 2009, PEDIATRICS, V123, pE790, DOI 10.1542/peds.2008-1526; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hayakawa T, 2000, PEDIATR INT, V42, P67, DOI 10.1046/j.1442-200x.2000.01177.x; Heinrich N, 2011, EUR J CLIN MICROBIOL, V30, P909, DOI 10.1007/s10096-011-1175-4; Hetem DJ, 2012, J ANTIMICROB CHEMOTH, V67, P1775, DOI 10.1093/jac/dks125; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; Khoury J, 2005, INFECT CONT HOSP EP, V26, P616, DOI 10.1086/502590; Laing IA, 2009, ARCH DIS CHILD-FETAL, V94, pF307, DOI 10.1136/adc.2008.151290; Lebon A, 2010, J CLIN MICROBIOL, V48, P960, DOI 10.1128/JCM.01799-09; Lin Yu-Chen, 2007, Journal of Microbiology Immunology and Infection, V40, P325; Lindberg E, 2000, PEDIATR RES, V48, P741, DOI 10.1203/00006450-200012000-00007; Maraqa NF, 2011, AM J INFECT CONTROL, V39, P35, DOI 10.1016/j.ajic.2010.07.013; McDonald JR, 2007, PEDIATR INFECT DIS J, V26, P678, DOI 10.1097/INF.0b013e3180616ce4; Milstone AM, 2010, INFECT CONT HOSP EP, V31, P766, DOI 10.1086/653615; Milstone AM, 2010, INFECT CONT HOSP EP, V31, P558, DOI 10.1086/652449; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nambiar Sumathi, 2003, Pediatr Crit Care Med, V4, P220, DOI 10.1097/01.PCC.0000059736.20597.75; Otter JA, 2007, J HOSP INFECT, V67, P232, DOI 10.1016/j.jhin.2007.07.024; Peacock SJ, 2003, J CLIN MICROBIOL, V41, P5718, DOI 10.1128/JCM.41.12.5718-5725.2003; Pinter DM, 2009, AM J PERINAT, V26, P145, DOI 10.1055/s-0028-1095179; Regev-Yochay G, 2005, EMERG INFECT DIS, V11, P453, DOI 10.3201/eid1103.040470; Sakaki H, 2009, AM J INFECT CONTROL, V37, P580, DOI 10.1016/j.ajic.2009.02.008; Sax H, 2006, J HOSP INFECT, V63, P93, DOI 10.1016/j.jhin.2005.11.016; Stein M, 2006, PEDIATR INFECT DIS J, V25, P557, DOI 10.1097/01.inf.0000219407.31195.44	35	15	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66904	10.1371/journal.pone.0066904	http://dx.doi.org/10.1371/journal.pone.0066904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825581	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000039
J	Shan, D; Sun, JP; Yakusik, A; Chen, ZD; Yuan, JH; Li, T; Fu, J; Khoshnood, K; Yang, X; Wei, M; Duan, S; Bulterys, M; Sante, M; Ye, RH; Xiang, LF; Yang, YC				Shan, Duo; Sun, Jiangping; Yakusik, Anna; Chen, Zhongdan; Yuan, Jianhua; Li, Tao; Fu, Jeannia; Khoshnood, Kaveh; Yang, Xing; Wei, Mei; Duan, Song; Bulterys, Marc; Sante, Michael; Ye, Runhua; Xiang, Lifen; Yang, Yuecheng			Total HIV/AIDS Expenditures in Dehong Prefecture, Yunnan Province in 2010: The First Systematic Evaluation of Both Health and Non-Health Related HIV/AIDS Expenditures in China	PLOS ONE			English	Article							AREA	Objective: We assessed HIV/AIDS expenditures in Dehong Prefecture, Yunnan Province, one of the highest prevalence regions in China, and describe funding sources and spending for different categories of HIV-related interventions and at-risk populations. Methods: 2010 HIV/AIDS expenditures in Dehong Prefecture were evaluated based on UNAIDS' National AIDS Spending Assessment methodology. Results: Nearly 93% of total expenditures for HIV/AIDS was contributed by public sources. Of total expenditures, 52.7% was allocated to treatment and care, 24.5% to program management and administration and 19.8% to prevention. Spending on treatment and care was primarily allocated to the treatment of opportunistic infections. Most (40.4%) prevention spending was concentrated on most-at-risk populations, injection drug users (IDUs), sex workers, and men who have sex with men (MSM), with 5.5% allocated to voluntary counseling and testing. Prevention funding allocated for MSM, partners of people living with HIV and prisoners and other confined populations was low compared to the disproportionate burden of HIV/AIDS in these populations. Overall, people living with HIV accounted for 57.57% of total expenditures, while most-at-risk populations accounted for only 7.99%. Conclusions: Our study demonstrated the applicability of NASA for tracking and assessing HIV expenditure in the context of China, it proved to be a useful tool in understanding national HIV/AIDS response from financial aspect, and to assess the extent to which HIV expenditure matches epidemic patterns. Limited funding for primary prevention and prevention for MSM, prisoners and partners of people living with HIV, signal that resource allocation to these key areas must be strengthened. Comprehensive analyses of regional and national funding strategies are needed to inform more equitable, effective and cost-effective HIV/AIDS resource allocation.	[Shan, Duo; Sun, Jiangping; Sante, Michael] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Yakusik, Anna] UNAIDS Belarus Off, Minsk, BELARUS; [Chen, Zhongdan] UNAIDS China Off, Beijing, Peoples R China; [Yuan, Jianhua; Li, Tao] Beijing Informat & Control Inst, Beijing, Peoples R China; [Fu, Jeannia; Khoshnood, Kaveh] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Yang, Xing; Wei, Mei] Dehong Prefecture Hlth Bur, Dehong, Yunnan, Peoples R China; [Duan, Song; Ye, Runhua; Xiang, Lifen; Yang, Yuecheng] Dehong Prefecture Ctr Dis Control & Prevent, Dehong, Yunnan, Peoples R China; [Bulterys, Marc] Global AIDS Program China Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Yale University	Sun, JP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	jpsun@chinaaids.cn	Khoshnood, Kaveh/AAX-1402-2020; Yakusik, Anna/ABF-3984-2021	Khoshnood, Kaveh/0000-0003-2795-0447; Yakusik, Anna/0000-0001-7105-9120	UNAIDS; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	UNAIDS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by a grant from UNAIDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 27 CHIN INT INF CTR, P5; Aran-Matero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022373; Botswana National AIDS Coordinating Agency (NACA) Joint United Nations Program on AIDS (UNAIDS), 2007, BOTSW NAT AIDS SPEND; Council State AIDS Working Committee Office Disease Control Bureau of Ministry of Health National Center for Disease Prevention and Control, 2011, HIV AIDS PREV CONTR, P26; Country Coordinating Mechanism/National AIDS Council, 2006, ZAMB COORD MECH COUN; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Han MJ, 2010, INT J EPIDEMIOL, V39, pII47, DOI 10.1093/ije/dyq212; International Health Policy Program National Economics and Social Development Board Office of Prime Ministers, 2007, THAIL NAT AIDS SPEND; Jia YJ, 2008, INT J EPIDEMIOL, V37, P1287, DOI 10.1093/ije/dyn196; National Coordination Committeeto Combat HIV/AIDS Tuberculosis and Malaria in The Republic of Tajikistan Ministry of Health of The Republic of Tajikistan, 2011, TAJ NAT AIDS SPEND A; National HIV and AIDS/STI/TB Council, 2008, ZAMB NAT AIDS SPEND; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sun JP, 2010, INT J EPIDEMIOL, V39, pII14, DOI 10.1093/ije/dyq208; UNAIDS, 2009, NAT AIDS SPEND ASS N; UNAIDS, 2009, ZAMB NAT AIDS SPEND; Who UNAIDS UNICEF, 2013, UN ACC SCAL PRIOR HI, V8; Wu ZY, 2011, B WORLD HEALTH ORGAN, V89, P227, DOI 10.2471/BLT.10.082552; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	18	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e68006	10.1371/journal.pone.0068006	http://dx.doi.org/10.1371/journal.pone.0068006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825694	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000128
J	Zhang, XW; Tian, WX; Cai, XZ; Wang, XF; Dang, WQ; Tang, H; Cao, H; Wang, L; Chen, TM				Zhang, Xiwen; Tian, Wenxia; Cai, Xiaozhong; Wang, Xiaofei; Dang, Weiqi; Tang, Hao; Cao, Hong; Wang, Lin; Chen, Tingmei			Hydrazinocurcumin Encapsuled Nanoparticles "Re-Educate" Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							MOLECULAR TARGETS; PROGRESSION; CURCUMIN; POLARIZATION; POPULATION; INHIBITION; APOPTOSIS; CELLS	Tumor-associated macrophages (TAMs) are essential cellular components within tumor microenvironment (TME). TAMs are educated by TME to transform to M2 polarized population, showing a M2-like phenotype, IL-10(high), IL-12(low), TGF-beta(high). STAT3 signaling triggers crosstalk between tumor cells and TAMs, and is crucial for the regulation of malignant progression. In our study, legumain-targeting liposomal nanoparticles (NPs) encapsulating HC were employed to suppress STAT3 activity and "re-educate" TAMs, and to investigate the effects of suppression of tumor progression in vivo. The results showed that TAMs treated by HC encapsuled NPs could switch to M1-like phenotype, IL-10(low), IL-12(high), TGF-beta(low), and the "re-educated" macrophages (M1-like macrophages) considerably demonstrated opposite effect of M2-like macrophages, especially the induction of 4T1 cells migration and invasion in vitro, and suppression of tumor growth, angiogenesis and metastasis in vivo. These data indicated that inhibition of STAT3 activity of TAMs by HC-NPs was able to reverse their phenotype and could regulate their crosstalk between tumor cells and TAMs in order to suppress tumor progression.	[Zhang, Xiwen; Tian, Wenxia; Cai, Xiaozhong; Wang, Xiaofei; Dang, Weiqi; Tang, Hao; Cao, Hong; Wang, Lin; Chen, Tingmei] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China	Chongqing Medical University	Chen, TM (corresponding author), Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China.	chentingmei@sohu.com	Tian, Wenxi/M-4316-2016	Tian, Wenxi/0000-0001-6815-6974; Chen, Tingmei/0000-0003-4250-674X	National Natural Science Foundation of China [81272544, 30971131]; Key Laboratory of Diagnostic Medicine Designated by the Ministry of Education, Chongqing Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Diagnostic Medicine Designated by the Ministry of Education, Chongqing Medical University	This work was supported by a grant from National Natural Science Foundation of China (No. 81272544, 30971131) and was supported in part by Key Laboratory of Diagnostic Medicine Designated by the Ministry of Education, Chongqing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alas S, 2003, CLIN CANCER RES, V9, P316; Allavena P, 2005, CANCER RES, V65, P2964, DOI 10.1158/0008-5472.CAN-04-4037; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chiang CS, 2008, INT IMMUNOL, V20, P215, DOI 10.1093/intimm/dxm137; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; JOHN C, 2006, CELL, V124, P263, DOI DOI 10.1016/J.CELL.2006.01.007.PUBMED:16439202; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Liao D, 2011, NANOMED-NANOTECHNOL, V7, P665, DOI 10.1016/j.nano.2011.03.001; Liao D, 2011, CANCER RES, V71, P5688, DOI 10.1158/0008-5472.CAN-11-1264; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2004, EUR J CANCER, V40, P1660, DOI 10.1016/j.ejca.2004.03.016; Niu GL, 2001, CANCER RES, V61, P3276; Rathore R, 2008, J PHARMACEUT BIOMED, V46, P374, DOI 10.1016/j.jpba.2007.09.019; Robinson SC, 2003, CANCER RES, V63, P8360; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Turkson J, 2005, J BIOL CHEM, V280, P32979, DOI 10.1074/jbc.M502694200; Wang XF, 2012, INT J ONCOL, V40, P1189, DOI 10.3892/ijo.2011.1298; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	28	98	108	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e65896	10.1371/journal.pone.0065896	http://dx.doi.org/10.1371/journal.pone.0065896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825527	Green Published, gold			2022-12-27	WOS:000321223000006
J	Lim, CB; Prele, CM; Cheah, HM; Cheng, YY; Klebe, S; Reid, G; Watkins, DN; Baltic, S; Thompson, PJ; Mutsaers, SE				Lim, Chuan Bian; Prele, Cecilia M.; Cheah, Hui Min; Cheng, Yuen Yee; Klebe, Sonja; Reid, Glen; Watkins, D. Neil; Baltic, Svetlana; Thompson, Philip J.; Mutsaers, Steven E.			Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma	PLOS ONE			English	Article							BASAL-CELL CARCINOMAS; PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; HUMAN HOMOLOG; PTCH GENE; ODONTOGENIC KERATOCYSTS; SOMATIC MUTATIONS; PATCHED GENE; PLEURAL MESOTHELIOMA; MISSENSE MUTATIONS	Background: The Hedgehog (HH) signaling pathway is critical for embryonic development and adult homeostasis. Recent studies have identified regulatory roles for this pathway in certain cancers with mutations in the HH pathway genes. The extent to which mutations of the HH pathway genes are involved in the pathogenesis of malignant mesothelioma (MMe) is unknown. Methodology/Principal Findings: Real-time PCR analysis of HH pathway genes PTCH1, GLI1 and GLI2 were performed on 7 human MMe cell lines. Exon sequencing of 13 HH pathway genes was also performed in cell lines and human MMe tumors. In silico programs were used to predict the likelihood that an amino-acid substitution would have a functional effect. GLI1, GLI2 and PTCH1 were highly expressed in MMe cells, indicative of active HH signaling. PTCH1, SMO and SUFU mutations were found in 2 of 11 MMe cell lines examined. A non-synonymous missense SUFU mutation (p.T411M) was identified in LO68 cells. In silico characterization of the SUFU mutant suggested that the p.T411M mutation might alter protein function. However, we were unable to demonstrate any functional effect of this mutation on Gli activity. Deletion of exons of the PTCH1 gene was found in JU77 cells, resulting in loss of one of two extracellular loops implicated in HH ligand binding and the intracellular C-terminal domain. A 3-bp insertion (69_70insCTG) in SMO, predicting an additional leucine residue in the signal peptide segment of SMO protein was also identified in LO68 cells and a MMe tumour. Conclusions/Significance: We identified the first novel mutations in PTCH1, SUFU and SMO associated with MMe. Although HH pathway mutations are relatively rare in MMe, these data suggest a possible role for dysfunctional HH pathway in the pathogenesis of a subgroup of MMe and help rationalize the exploration of HH pathway inhibitors for MMe therapy.	[Lim, Chuan Bian; Prele, Cecilia M.; Cheah, Hui Min; Baltic, Svetlana; Thompson, Philip J.; Mutsaers, Steven E.] Univ Western Australia, Sch Med & Pharmacol, Lung Inst Western Australia, Crawley, WA, Australia; [Lim, Chuan Bian; Prele, Cecilia M.; Cheah, Hui Min; Baltic, Svetlana; Thompson, Philip J.; Mutsaers, Steven E.] Univ Western Australia, Sch Med & Pharmacol, Dept Med, Ctr Asthma Allergy & Resp Res, Crawley, WA, Australia; [Prele, Cecilia M.; Mutsaers, Steven E.] Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Crawley, WA, Australia; [Prele, Cecilia M.; Mutsaers, Steven E.] Univ Western Australia, Western Australian Inst Med Res, Crawley, WA, Australia; [Cheng, Yuen Yee; Reid, Glen] Univ Sydney, ADRI, Sydney, NSW 2006, Australia; [Klebe, Sonja] SA Pathol, Dept Anat Pathol, Adelaide, SA, Australia; [Klebe, Sonja] Flinders Univ S Australia, Flinders Med Ctr, Adelaide, SA 5001, Australia; [Watkins, D. Neil] Monash Univ, Monash Inst Med Res, Ctr Canc Res, Melbourne, Vic 3004, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Sydney; SA Pathology; Flinders Medical Centre; Flinders University South Australia; Monash University	Mutsaers, SE (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Lung Inst Western Australia, Crawley, WA, Australia.	steven.mutsaers@uwa.edu.au	Cheng, Yuen Yee/G-4406-2016; Cheng, Yuen/AAU-2402-2020; Prele, Cecilia/H-5664-2014; CHeah, Hui Min/AAU-3478-2020; Baltic, Svetlana/C-2313-2014	Cheng, Yuen Yee/0000-0001-7060-0624; Prele, Cecilia/0000-0002-9014-263X; Klebe, Sonja/0000-0002-8976-4714; Baltic, Svetlana/0000-0002-3428-940X; Cheah, Hui Min/0000-0003-1292-4561; Reid, Glen/0000-0001-6465-5223	National Health and Medical Research Council, Australia [572676]; Mesothelioma Applied Research Foundation, USA	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Mesothelioma Applied Research Foundation, USA	This study was supported by grants from the National Health and Medical Research Council, Australia (Project ID number 572676) and the Mesothelioma Applied Research Foundation, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Asplund A, 2005, BRIT J DERMATOL, V152, P868, DOI 10.1111/j.1365-2133.2005.06464.x; Barreto DC, 2000, J DENT RES, V79, P1418, DOI 10.1177/00220345000790061101; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chang-Claude J, 2003, INT J CANCER, V103, P779, DOI 10.1002/ijc.10889; Chen M, 2010, CANCER PREV RES, V3, P1235, DOI 10.1158/1940-6207.CAPR-10-0035; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Couve-Privat S, 2002, CANCER RES, V62, P7186; Evans T, 2000, HUM MUTAT, V16, P43, DOI 10.1002/1098-1004(200007)16:1<43::AID-HUMU8>3.3.CO;2-Z; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Hafner C, 2007, HUM PATHOL, V38, P1496, DOI 10.1016/j.humpath.2007.02.015; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Holloway AJ, 2006, CLIN CANCER RES, V12, P5129, DOI 10.1158/1078-0432.CCR-06-1027; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Johnson RL, 2000, MOL CELL, V6, P467, DOI 10.1016/S1097-2765(00)00045-9; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kagawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018638; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kao SCH, 2011, PATHOLOGY, V43, P128, DOI 10.1097/PAT.0b013e328342016c; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lam CW, 1999, ONCOGENE, V18, P833, DOI 10.1038/sj.onc.1202360; Lee AY, 2007, CANCER-AM CANCER SOC, V109, P1454, DOI 10.1002/cncr.22552; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lee Y, 2003, CANCER RES, V63, P5428; Lee Y, 2006, CANCER RES, V66, P6964, DOI 10.1158/0008-5472.CAN-06-0505; Li DH, 2012, CARCINOGENESIS, V33, P1384, DOI 10.1093/carcin/bgs151; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057346; Liboutet M, 2006, J INVEST DERMATOL, V126, P1510, DOI 10.1038/sj.jid.5700263; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Maesawa C, 1998, GENE CHROMOSOME CANC, V21, P276, DOI 10.1002/(SICI)1098-2264(199803)21:3<276::AID-GCC15>3.3.CO;2-H; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; McGarvey TW, 1998, ONCOGENE, V17, P1167, DOI 10.1038/sj.onc.1202045; Michimukai E, 2001, IN VITRO CELL DEV-AN, V37, P459; Moolgavkar SH, 2009, CANCER CAUSE CONTROL, V20, P935, DOI 10.1007/s10552-009-9328-9; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Musk AW, 2011, EUR RESPIR J, V38, P1420, DOI 10.1183/09031936.00000811; Musk AW, 2004, LUNG CANCER, V45, pS21, DOI 10.1016/j.lungcan.2004.04.010; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ohki K, 2004, INT J ORAL MAX SURG, V33, P584, DOI 10.1016/j.ijom.2004.01.013; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Ping XL, 2001, J INVEST DERMATOL, V116, P614, DOI 10.1046/j.1523-1747.2001.01301.x; Price B, 2004, AM J EPIDEMIOL, V159, P107, DOI 10.1093/aje/kwh025; Putoux A, NAT GENET, V43, P601; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Reifenberger J, 1998, CANCER RES, V58, P1798; Robinson BWS, 2002, MESOTHELIOMA, Vxiii; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Shi YD, 2012, CLIN CANCER RES, V18, P4646, DOI 10.1158/1078-0432.CCR-12-0599; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slade I, 2011, FAM CANCER, V10, P337, DOI 10.1007/s10689-010-9411-0; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Song YL, 2006, TUMOR BIOL, V27, P175, DOI 10.1159/000093054; Stone DM, 1999, J CELL SCI, V112, P4437; Sun LS, 2008, J DENT RES, V87, P575, DOI 10.1177/154405910808700616; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Vorechovsky I, 1997, CANCER RES, V57, P4677; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054415; Wolter M, 1997, CANCER RES, V57, P2581; Xie JW, 1997, CANCER RES, V57, P2369; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Zaphiropoulos PG, 1999, CANCER RES, V59, P787	76	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66685	10.1371/journal.pone.0066685	http://dx.doi.org/10.1371/journal.pone.0066685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826113	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400033
J	Liu, RY; Rao, HY; Wang, JH; Xie, XW; Jiang, D; Pan, XB; Zhao, P; Zhang, HH; Wei, L				Liu, Ruyu; Rao, Huiying; Wang, Jianghua; Xie, Xingwang; Jiang, Dong; Pan, Xiaoben; Zhao, Ping; Zhang, Henghui; Wei, Lai			Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313-327 and 432-443 of Hepatitis C Virus E1E2 Glycoproteins	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; VIRAL CLEARANCE; SINGLE-SOURCE; CELL ENTRY; INFECTION; PARTICLES; HCV; E2; ASSOCIATION; INDUCTION	It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potential to prevent hepatitis C virus (HCV) infection. The protective epitopes targeted by these MAbs have been mapped to the region sencompassing amino acids 313-327 and 432-443. In this study, we synthesized these two peptides and tested the reactivity of serum samples from 336 patients, 210 of which were from Chronic Hepatitis C (CHC) patients infected with diverse HCV genotypes. The remaining 126 samples were isolated from patients who had spontaneously cleared HCV infection. In the chronic HCV-infected group (CHC group), the prevalence of human serum antibodies reactive to epitopes 313-327 and 432-443 was 24.29% (51 of 210) and 4.76% (10 of 210), respectively. In the spontaneous clearance group (SC group), the prevalence was 0.79% (1 of 126) and 12.70% (16 of 126), respectively. The positive serum samples that contained antibodies reactive to epitope 313-327 neutralized HCV pseudo particles (HCVpp) bearing the envelope glycoproteins of genotypes 1a or 1b and/or 4, but genotypes 2a, 3a, 5 and 6 were not neutralized. The neutralizing activity of these serum samples could not be inhibited by peptide 313-327. Six samples (SC17, SC38, SC86, SC92, CHC75 and CHC198) containing antibodies reactive to epitope 432-443 had cross-genotype neutralizing activities. The neutralizing activity of SC38, SC86, SC92 and CHC75 was partially inhibited by peptide 432-443. However, the neutralizing activity of sample SC17 for genotype 4HCVpp and sample CHC198 for genotype 1b HCVppwere notinhibited by the peptide. This study identifies the neutralizing ability of endogenous anti-HCV antibodies and warrants the exploration of antibodies reactive to epitope 432-443 as sources for future antibody therapies.	[Liu, Ruyu; Rao, Huiying; Wang, Jianghua; Xie, Xingwang; Jiang, Dong; Pan, Xiaoben; Zhang, Henghui; Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China; [Liu, Ruyu; Rao, Huiying; Wang, Jianghua; Xie, Xingwang; Jiang, Dong; Pan, Xiaoben; Zhang, Henghui; Wei, Lai] Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing, Peoples R China; [Zhao, Ping] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China	Peking University; Naval Medical University	Wei, L (corresponding author), Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China.	weelai@163.com			National Science and Technology Major Project [2012ZX10002003]	National Science and Technology Major Project	The work was sponsored by National Science and Technology Major Project (2012ZX10002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Diamond MS, 2012, PLOS PATHOG, V8; DIETZSCHOLD B, 1990, J VIROL, V64, P3804, DOI 10.1128/JVI.64.8.3804-3809.1990; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Goulding C, 2005, GUT, V54, P1157, DOI 10.1136/gut.2004.055699; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Knapp S, 2003, IMMUNOGENETICS, V55, P362, DOI 10.1007/s00251-003-0594-5; Kopp M, 2009, VIROLOGY, V84, P1666; Lavillette D, 2005, J VIROL, V79, P6023, DOI 10.1128/JVI.79.10.6023-6034.2005; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Li Y, 2012, P NATL ACAD SCI US; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Morin TJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002895; Ndongo N, 2010, HEPATOLOGY, V52, P1531, DOI 10.1002/hep.23862; Ndongo N, 2009, J MED VIROL, V81, P1726, DOI 10.1002/jmv.21562; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rosnoblet C, 2012, J BIOL CHEM; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SIMMONDS P, 1993, J CLIN MICROBIOL, V31, P1493, DOI 10.1128/JCM.31.6.1493-1503.1993; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Song HS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-40; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tarr AW, 2007, J GEN VIROL, V88, P2991, DOI 10.1099/vir.0.83065-0; Tarr AW, 2012, J VIROL, V86, P2739, DOI 10.1128/JVI.06492-11; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Tong YM, 2011, J VIROL, V85, P2793, DOI 10.1128/JVI.01818-10; Torresi J, 2007, IMMUNOL CELL BIOL, V85, P169, DOI 10.1038/sj.icb.7100021; Watanabe T, 2012, GUT; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x; Zhang P, 2009, P NATL ACAD SCI USA, V106, P7537, DOI 10.1073/pnas.0902749106	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66872	10.1371/journal.pone.0066872	http://dx.doi.org/10.1371/journal.pone.0066872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826163	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400074
J	Lukasz, A; Beutel, G; Kumpers, P; Denecke, A; Westhoff-Bleck, M; Schieffer, B; Bauersachs, J; Kielstein, JT; Tutarel, O				Lukasz, Alexander; Beutel, Gernot; Kuempers, Philipp; Denecke, Agnieszka; Westhoff-Bleck, Mechthild; Schieffer, Bernhard; Bauersachs, Johann; Kielstein, Jan T.; Tutarel, Oktay			Angiopoietin-2 in Adults with Congenital Heart Disease and Heart Failure	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; NATRIURETIC PEPTIDE; EXERCISE; ANGIOGENESIS; INFLAMMATION; CIRCULATION; VENTRICLE; SEVERITY; SURVIVAL; PATHWAY	Background: Chronic heart failure is an important cause for morbidity and mortality in adults with congenital heart disease (ACHD). While NT-proBNP is an established biomarker for heart failure of non-congenital origin, its application in ACHD has limitations. The angiogenic factors Angiopoietin-1 and -2 (Ang-1, Ang-2), vascular endothelial growth factor (VEGF), and soluble receptor tyrosine kinase of the Tie family (sTie2) correlate with disease severity in heart failure of non-congenital origin. Their role in ACHD has not been studied. Methods: In 91 patients Ang-2 and NT-proBNP were measured and related to New York Heart Association class, systemic ventricular function and parameters of cardiopulmonary exercise testing. Ang-1, VEGF, and sTie2 were also measured. Results: Ang-2 correlates with NYHA class and ventricular dysfunction comparable to NT-proBNP. Further, Ang-2 showed a good correlation with parameters of cardiopulmonary exercise testing. Both, Ang-2 and NT-proBNP identified patients with severely limited cardiopulmonary exercise capacity. Additionally, Ang-2 is elevated in patients with a single ventricle physiology in contrast to NT-proBNP. VEGF, Ang-1, and sTie2 were not correlated with any clinical parameter. Conclusion: The performance of Ang-2 as a biomarker for heart failure in ACHD is comparable to NT-proBNP. Its significant elevation in patients with single ventricle physiology indicates potential in this patient group and warrants further studies.	[Lukasz, Alexander; Denecke, Agnieszka; Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany; [Lukasz, Alexander; Kuempers, Philipp] Univ Hosp Muenster, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany; [Beutel, Gernot] Hannover Med Sch, Dept Hematol & Oncol, Hannover, Germany; [Denecke, Agnieszka; Westhoff-Bleck, Mechthild; Schieffer, Bernhard; Bauersachs, Johann; Tutarel, Oktay] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany	Hannover Medical School; University of Munster; Hannover Medical School; Hannover Medical School	Tutarel, O (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany.	otutarel@hotmail.com	Kielstein, Jan T./I-2956-2019; Stefanadis, Christodoulos/ABH-2232-2020	Kielstein, Jan T./0000-0001-8110-9064; Tutarel, Oktay/0000-0002-5201-5509; Stefanadis, Christodoulos/0000-0001-5974-6454	DFG-Project "Open Access Publishing" by the German Research Council	DFG-Project "Open Access Publishing" by the German Research Council	The article processing charge was funded by means of the DFG-Project "Open Access Publishing" by the German Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolger AP, 2003, EUR HEART J, V24, P970, DOI 10.1016/S0195-668X(03)00005-8; Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Chong AY, 2004, J AM COLL CARDIOL, V43, P423, DOI 10.1016/j.jacc.2003.08.042; Chong AY, 2004, EUR J CLIN INVEST, V34, P9, DOI 10.1111/j.1365-2362.2004.01284.x; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Dimopoulos K, 2006, CIRCULATION, V113, P2796, DOI 10.1161/CIRCULATIONAHA.105.594218; Eindhoven JA, 2012, CARDIOL YOUNG, P1; Eindhoven JA, 2012, J AM COLL CARDIOL, V60, P2140, DOI 10.1016/j.jacc.2012.02.092; Eleuteri E, 2011, EUR J CARDIOV PREV R, V18, P607, DOI 10.1177/1741826710389410; Elsasser A, 1997, CIRCULATION, V96, P2920, DOI 10.1161/01.CIR.96.9.2920; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Garg R, 2008, PEDIATR CARDIOL, V29, P641, DOI 10.1007/s00246-007-9187-7; Gewillig M, 2010, INTERACT CARDIOV TH, V10, P428, DOI 10.1510/icvts.2009.218594; Giannakoulas G, 2010, AM J CARDIOL, V105, P869, DOI 10.1016/j.amjcard.2009.11.041; Kim HN, 2011, CIRCULATION, V123, P2015, DOI 10.1161/CIRCULATIONAHA.110.979500; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kumpers P, 2010, EUR HEART J, V31, P2291, DOI 10.1093/eurheartj/ehq226; Larsson DA, 2007, INT J CARDIOL, V114, P345, DOI 10.1016/j.ijcard.2006.01.023; Law YM, 2006, AM J CARDIOL, V98, P520, DOI 10.1016/j.amjcard.2006.02.058; Lukasz A, 2008, CRIT CARE, V12, DOI 10.1186/cc6966; Norozi K, 2007, CLIN RES CARDIOL, V96, P542, DOI 10.1007/s00392-007-0530-z; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Shaddy Robert E, 2008, Expert Rev Cardiovasc Ther, V6, P165, DOI 10.1586/14779072.6.2.165; Tousoulis D, 2005, INT J CARDIOL, V100, P347, DOI 10.1016/j.ijcard.2004.05.030; Tutarel O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033795; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	32	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66861	10.1371/journal.pone.0066861	http://dx.doi.org/10.1371/journal.pone.0066861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826161	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400071
J	Seraphim, TV; Alves, MM; Silva, IM; Gomes, FER; Silva, KP; Murta, SMF; Barbosa, LRS; Borges, JC				Seraphim, Thiago V.; Alves, Marina M.; Silva, Indjara M.; Gomes, Francisco E. R.; Silva, Kelly P.; Murta, Silvane M. F.; Barbosa, Leandro R. S.; Borges, Julio C.			Low Resolution Structural Studies Indicate that the Activator of Hsp90 ATPase 1 (Aha1) of Leishmania braziliensis Has an Elongated Shape Which Allows Its Interaction with Both N- and M-Domains of Hsp90	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; PROTEIN SECONDARY STRUCTURE; MOLECULAR CHAPERONE HSP90; HEAT-SHOCK PROTEINS; X-RAY-SCATTERING; COCHAPERONE AHA1; CLIENT PROTEIN; BIOLOGICAL MACROMOLECULES; CONFORMATIONAL DYNAMICS; PROTOZOAN PARASITES	The Hsp90 molecular chaperone is essential for protein homeostasis and in the maturation of proteins involved with cell-cycle control. The low ATPase activity of Hsp90 is critical to drive its functional cycle, which is dependent on the Hsp90 cochaperones. The Activator of Hsp90 ATPase-1 (Aha1) is a protein formed by two domains, N- and C-terminal, that stimulates the Hsp90 ATPase activity by several folds. Although the relevance of Aha1 for Hsp90 functions has been proved, as well as its involvement in the desensitization to inhibitors of the Hsp90, the knowledge on its overall structure and behavior in solution is limited. In this work we present the functional and structural characterization of Leishmania braziliensis Aha1 (LbAha1). This protozoan is the causative agent of cutaneous and mucocutaneous leishmaniasis, a neglected disease. The recombinant LbAha1 behaves as an elongated monomer and is organized into two folded domains interconnected by a flexible linker. Functional experiments showed that LbAha1 interacts with L. braziliensis Hsp90 (LbHsp90) with micromolar dissociation constant in a stoichiometry of 2 LbAha1 to 1 LbHsp90 dimer and stimulates 10-fold the LbHsp90 ATPase activity showing positive cooperativity. Furthermore, the LbHsp90:: LbAha1 complex is directed by enthalphy and opposed by entropy, probably due to the spatial freedom restrictions imposed by the proteins' interactions. Small-angle X-ray scattering data allowed the reconstruction of low resolution models and rigid body simulations of LbAha1, indicating its mode of action on LbHsp90. Western blot experiments allowed Aha1 identification (as well as Hsp90) in three Leishmania species at two temperatures, suggesting that Aha1 is a cognate protein. All these data shed light on the LbAha1 mechanism of action, showing that it has structural dimensions and flexibility that allow interacting with both N-terminal and middle domains of the LbHsp90.	[Seraphim, Thiago V.; Alves, Marina M.; Silva, Indjara M.; Gomes, Francisco E. R.; Silva, Kelly P.; Borges, Julio C.] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil; [Seraphim, Thiago V.] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, BR-13560 Sao Carlos, SP, Brazil; [Murta, Silvane M. F.] Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil; [Barbosa, Leandro R. S.] Univ Sao Paulo, Inst Fis, Dept Fis Geral, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Borges, JC (corresponding author), Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil.	borgesjc@iqsc.usp.br	Borges, Julio C/C-6160-2008; Barbosa, L. R. S./AAN-7787-2020; gomes, edvan/ABF-1792-2021; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Seraphim, Thiago V/J-9949-2013; Murta, Silvane Fonseca Murta/ABE-9410-2021; Barbosa, Leandro Ramos Souza/E-6577-2012	Borges, Julio C/0000-0003-4856-748X; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Murta, Silvane Fonseca Murta/0000-0002-8523-2155; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Vargas Seraphim, Thiago/0000-0002-8682-8962	Fundacao de Amparo a pesquisa do Estado de Sao Paulo [2007/05001-4, 2008/09025-8, 2010/19242-6, 2011/23110-0, 2012/50161-8, 2012/01953-9]; Conselho Nacional de Pesquisa e Desenvolvimento [303792/2009-4, 479229/2011-2]	Fundacao de Amparo a pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a pesquisa do Estado de Sao Paulo (http://www.fapesp.br/): grants #2007/05001-4; #2008/09025-8; #2010/19242-6; #2011/23110-0; #2012/50161-8; #2012/01953-9; and Conselho Nacional de Pesquisa e Desenvolvimento (http://www.cnpq.br): grants #303792/2009-4 and #479229/2011-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Borges JC, 2011, CURR MED CHEM, V18, P1276; Brown PH, 2009, EUR BIOPHYS J BIOPHY, V38, P1079, DOI 10.1007/s00249-009-0514-1; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Petersen ALDA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049496; Gonzalez U, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004834.pub2; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Laskowski R. A., 1994, PROCHECK V 3 0 PROGR; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Niedzwiecka A, 2002, BIOCHEMISTRY-US, V41, P12140, DOI 10.1021/bi0258142; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pullen L, 2011, J BIOL CHEM, V286, P11091, DOI 10.1074/jbc.M111.223131; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Roy N, 2012, BBA-MOL CELL RES, V1823, P707, DOI 10.1016/j.bbamcr.2011.12.003; Shonhai A, 2011, PROTEIN PEPTIDE LETT, V18, P143, DOI 10.2174/092986611794475002; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Silva JC, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-40; Silva KP, 2013, BBA-PROTEINS PROTEOM, V1834, P351, DOI 10.1016/j.bbapap.2012.08.004; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walker, 1955, SMALL ANGLE SCATTERI, P7; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WHO, 2007, WORLD HEALD ORG CONT; Wiesgigl M, 2001, MOL BIOL CELL, V12, P3307, DOI 10.1091/mbc.12.11.3307; Zhou YL, 2005, THERMOCHIM ACTA, V426, P173, DOI 10.1016/j.tca.2004.07.018; Zurawska A, 2010, BBA-MOL CELL RES, V1803, P575, DOI 10.1016/j.bbamcr.2010.03.002	48	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66822	10.1371/journal.pone.0066822	http://dx.doi.org/10.1371/journal.pone.0066822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826147	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400061
J	Ehya, F; Monavarfeshani, A; Fard, EM; Farsad, LK; Nekouei, MK; Mardi, M; Salekdeh, GH				Ehya, Farveh; Monavarfeshani, Aboozar; Fard, Ehsan Mohseni; Farsad, Laleh Karimi; Nekouei, Mojtaba Khayam; Mardi, Mohsen; Salekdeh, Ghasem Hosseini			Phytoplasma-Responsive microRNAs Modulate Hormonal, Nutritional, and Stress Signalling Pathways in Mexican Lime Trees	PLOS ONE			English	Article							WITCHES-BROOM DISEASE; ABIOTIC STRESS; ARABIDOPSIS; GENES; EXPRESSION; AUXIN; IDENTIFICATION; PROLIFERATION; TRANSDUCTION; DEFICIENCY	Background: Witches' broom disease of Mexican lime (Citrus aurantifolia L.), which is associated to the phytoplasma 'Candidatus Phytoplasma aurantifolia', is a devastating disease that results in significant economic losses. Plants adapt to biotic stresses by regulating gene expression at the transcriptional and post-transcriptional levels. MicroRNAs (miRNAs) are a recently identified family of molecules that regulate plant responses to environmental stresses through post-transcriptional gene silencing. Methods: Using a high-throughput approach to sequence small RNAs, we compared the expression profiles of miRNAs in healthy Mexican lime trees and in plants infected with 'Ca. P. aurantifolia'. Results: Our results demonstrated the involvement of different miRNAs in the response of Mexican lime trees to infection by 'Ca. P. aurantifolia'. We identified miRNA families that are expressed differentially upon infection with phytoplasmas. Most of the miRNAs had variants with small sequence variations (isomiRs), which are expressed differentially in response to pathogen infection. Conclusions: It is likely that the miRNAs that are expressed differentially in healthy and phytoplasma-infected Mexican lime trees are involved in coordinating the regulation of hormonal, nutritional, and stress signalling pathways, and the complex interactions between them. Future research to elucidate the roles of these miRNAs should improve our understanding of the level of diversity of specific plant responses to phytoplasmas.	[Ehya, Farveh; Monavarfeshani, Aboozar; Fard, Ehsan Mohseni; Farsad, Laleh Karimi; Nekouei, Mojtaba Khayam; Mardi, Mohsen; Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Genom, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Tehran, Iran; [Salekdeh, Ghasem Hosseini] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran	Academic Center for Education, Culture & Research (ACECR)	Mardi, M (corresponding author), Agr Biotechnol Res Inst Iran, Dept Genom, Tehran, Iran.	Mardi@abrii.ac.ir; h_salekdeh@abrii.ac.ir	Salekdeh, Ghasem Hosseini/E-4198-2012; Mardi, Mohsen/M-5829-2017; Monavarfeshani, Aboozar/ABI-4689-2020	Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Mardi, Mohsen/0000-0002-4718-7701; Monavarfeshani, Aboozar/0000-0001-8906-5115	Iranian Witches' Broom Disease of Lime Network (IWBDLN); Agricultural Biotechnology Research Institute of Iran	Iranian Witches' Broom Disease of Lime Network (IWBDLN); Agricultural Biotechnology Research Institute of Iran	The work was supported by grants from the Iranian Witches' Broom Disease of Lime Network (IWBDLN) and Agricultural Biotechnology Research Institute of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Blumwald E, 1998, TRENDS PLANT SCI, V3, P342, DOI 10.1016/S1360-1385(98)01289-8; BOVE J, 1988, P INT ORG CITR VIR, V10, P307; Bove J, 1993, WITCHES BROOM DIS LI, P342; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; DUNLAP JR, 1989, PLANT PHYSIOL, V90, P197, DOI 10.1104/pp.90.1.197; Feshani AM, 2012, GENE, V493, P253, DOI 10.1016/j.gene.2011.11.024; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gundersen D. E., 1996, Phytopathologia Mediterranea, V35, P144; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Huang SQ, 2010, PLANT BIOTECHNOL J, V8, P887, DOI 10.1111/j.1467-7652.2010.00517.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lang QL, 2011, J ZHEJIANG UNIV-SC B, V12, P116, DOI 10.1631/jzus.B1000278; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Liu Lei, 2008, Yichuan, V30, P1265, DOI 10.3724/SP.J.1005.2008.01265; Mardi M, 2011, B INSECTOL, V64, pS205; Meng YJ, 2010, PLANT SIGNAL BEHAV, V5, P252, DOI 10.4161/psb.5.3.10549; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Musetti R, 2005, EUR J PLANT PATHOL, V112, P53, DOI 10.1007/s10658-004-8233-z; Musetti R, 2004, PHYTOPATHOLOGY, V94, P203, DOI 10.1094/PHYTO.2004.94.2.203; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Sanchez-Rojo S, 2011, AM J POTATO RES, V88, P175, DOI 10.1007/s12230-010-9175-y; Shikata M, 2012, PLANTA, V236, P1027, DOI 10.1007/s00425-012-1649-3; Smart CD, 1996, APPL ENVIRON MICROB, V62, P2988, DOI 10.1128/AEM.62.8.2988-2993.1996; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Zamharir MG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-1; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhao Y, 2009, INT J SYST EVOL MICR, V59, P2582, DOI 10.1099/ijs.0.010249-0; ZREIK L, 1995, INT J SYST BACTERIOL, V45, P449, DOI 10.1099/00207713-45-3-449	54	42	43	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66372	10.1371/journal.pone.0066372	http://dx.doi.org/10.1371/journal.pone.0066372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824690	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400095
J	Skubisz, MM; Brown, JK; Tong, S; Kaitu'u-Lino, T; Horne, AW				Skubisz, Monika M.; Brown, Jeremy K.; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha; Horne, Andrew W.			Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MARKER; MIC-1; MISCARRIAGE	Background: Ectopic pregnancy (EP) occurs in 1-2% of pregnancies, but is over-represented as a leading cause of maternal death in early pregnancy. It remains a challenge to diagnose early and accurately. Women often present in early pregnancy with a `pregnancy of unknown location' (PUL) and the diagnosis and exclusion of EP is difficult due to a lack of reliable biomarkers. A serum biomarker able to clearly distinguish between EP and other pregnancy outcomes would greatly assist clinicians in diagnosing and safely managing PULs. This study evaluates the ability of maternal serum macrophage inhibitory cytokine-1 (MIC-1) levels to differentiate between EP and other pregnancy outcomes in women with a PUL. Methods: Sera were collected from 120 women with a PUL at first clinical presentation and assayed for MIC-1 by ELISA. Results were classified according to ultimate pregnancy outcome and the discriminatory ability of MIC-1 to diagnose EP was assessed. Results: Serum MIC-1 levels were lower in women with histologically confirmed (definite) EP (dEP) (median 552 ng/mL; interquartile range (IQR) 414-693 ng/mL) compared to women with definite viable intra-uterine pregnancies (dVIUPs) (722 ng/mL; IQR 412-1122 ng/mL), and higher when compared to women with definite non-viable intra-uterine pregnancies (dNVIUPs) (465 ng/mL; IQR 341-675 ng/mL). MIC-1 levels were significantly higher in women with dEP compared to women whose PULs resolved without medical intervention (srPUL) (401 ng/mL; IQR 315-475 ng/mL) (p<0.003). There were no women with an ectopic pregnancy where serum MIC-1>1000 ng/mL. Conclusion: Serum MIC-1 levels in PUL were not able to categorically diagnose EP, however, MIC-1 could distinguish women with an EP that required medical intervention and those women whose PULs spontaneously resolved. A single serum MIC-1 measurement also excluded EP at levels above 1000 ng/mL. MIC-1 may play a role in the development of a combined assay of biomarkers for the diagnosis of EP.	[Skubisz, Monika M.; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha] Univ Melbourne, Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia; [Skubisz, Monika M.] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia; [Brown, Jeremy K.; Horne, Andrew W.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Melbourne; Monash University; University of Edinburgh	Skubisz, MM (corresponding author), Univ Melbourne, Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia.	monika.skubisz@monash.edu		Horne, Andrew/0000-0002-9656-493X; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Tong, Stephen/0000-0002-2319-0586	Australian National Health and Medical Research Council [1008276, 606611]; United Kingdom Medical Research Council [MRC G0802808]; MRC [G1002033, G0802808] Funding Source: UKRI; Medical Research Council [G0802808, G1002033] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Australian National Health and Medical Research Council (# 1008276; # 606611) and by the United Kingdom Medical Research Council (MRC G0802808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart K, 2011, FERTIL STERIL, V95, P857, DOI 10.1016/j.fertnstert.2010.09.006; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Creanga AA, 2011, OBSTET GYNECOL, V117, P837, DOI 10.1097/AOG.0b013e3182113c10; Daniel Y, 1999, FERTIL STERIL, V72, P1013, DOI 10.1016/S0015-0282(99)00417-3; Daponte A, 2005, HUM REPROD, V20, P3163, DOI 10.1093/humrep/dei218; Daponte A, 2011, J CLIN ENDOCR METAB, V96, pE1444, DOI 10.1210/jc.2011-0037; Felemban A, 2002, HUM REPROD, V17, P490, DOI 10.1093/humrep/17.2.490; Horne AW, 2011, J CLIN ENDOCR METAB, V96, pE104, DOI 10.1210/jc.2010-1403; Jurkovic D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3397; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; Kirk E, 2009, BEST PRACT RES CL OB, V23, P493, DOI 10.1016/j.bpobgyn.2009.01.008; Lewis Ge, 2007, SAVING MOTHERS LIVES; Marjono AB, 2003, PLACENTA, V24, P100, DOI 10.1053/plac.2002.0881; Rausch ME, 2012, CLIN OBSTET GYNECOL, V55, P418, DOI 10.1097/GRF.0b013e31825109f6; Rausch ME, 2011, OBSTET GYNECOL, V117, P573, DOI 10.1097/AOG.0b013e31820b3c61; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Tong S, 2012, OBSTET GYNECOL, V119, P1000, DOI 10.1097/AOG.0b013e3182518fd3; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397; Wills GS, 2009, CLIN VACCINE IMMUNOL, V16, P835, DOI 10.1128/CVI.00021-09	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66339	10.1371/journal.pone.0066339	http://dx.doi.org/10.1371/journal.pone.0066339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824055	gold, Green Published			2022-12-27	WOS:000320576400088
J	Zhou, W; Quan, JH; Lee, YH; Shin, DW; Cha, GH				Zhou, Wei; Quan, Juan-Hua; Lee, Young-Ha; Shin, Dae-Whan; Cha, Guang-Ho			Toxoplasma gondii Proliferation Require Down-Regulation of Host Nox4 Expression via Activation of PI3 Kinase/Akt Signaling Pathway	PLOS ONE			English	Article							FACTOR-KAPPA-B; OCULAR TOXOPLASMOSIS; REACTIVE OXYGEN; PROTEIN-KINASE; INHIBITION; CELLS; ROS; LOCALIZATION; INJURY	Toxoplasma gondii results in ocular toxoplasmosis characterized by chorioretinitis with inflammation and necrosis of the neuroretina, pigment epithelium, and choroid. After invasion, T. gondii replicates in host cells before cell lysis, which releases the parasites to invade neighboring cells to repeat the life cycle and establish a chronic retinal infection. The mechanism by which T. gondii avoids innate immune defense, however, is unknown. Therefore, we determined whether PI3K/Akt signaling pathway activation by T. gondii is essential for subversion of host immunity and parasite proliferation. T. gondii infection or excretory/secretory protein (ESP) treatment of the human retinal pigment epithelium cell line ARPE-19 induced Akt phosphorylation, and PI3K inhibitors effectively reduced T. gondii proliferation in host cells. Furthermore, T. gondii reduced intracellular reactive oxygen species (ROS) while activating the PI3K/Akt signaling pathway. While searching for the main source of these ROS, we found that NADPH oxidase 4 (Nox4) was prominently expressed in ARPE-19 cells, and this expression was significantly reduced by T. gondii infection or ESP treatment along with decreased ROS levels. In addition, artificial reduction of host Nox4 levels with specific siRNA increased replication of intracellular T. gondii compared to controls. Interestingly, these T. gondii-induced effects were reversed by PI3K inhibitors, suggesting that activation of the PI3K/Akt signaling pathway is important for suppression of both Nox4 expression and ROS levels by T. gondii infection. These findings demonstrate that manipulation of the host PI3K/Akt signaling pathway and Nox4 gene expression is a novel mechanism involved in T. gondii survival and proliferation.	[Zhou, Wei; Quan, Juan-Hua; Lee, Young-Ha; Shin, Dae-Whan; Cha, Guang-Ho] Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon, South Korea; [Quan, Juan-Hua] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Guangdong, Peoples R China	Chungnam National University; Guangdong Medical University	Cha, GH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon, South Korea.	gcha@cnu.ac.kr		Cha, Guang-Ho/0000-0003-2639-1727	Basic Science Research Program through the National Research Foundation of Korea; Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea [A100876-1102-0000100]; Ministry of Education, Science, and Technology [2007-0054932, 2009-0068747, 2011-0006228, 2011-0023501]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2007-0054932, 2009-0068747, 2011-0006228, 2011-0023501) and Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea (A100876-1102-0000100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aline F, 2002, INFECT IMMUN, V70, P2368, DOI 10.1128/IAI.70.5.2368-2374.2002; Allen LAH, 2005, J IMMUNOL, V174, P3658, DOI 10.4049/jimmunol.174.6.3658; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; Coppens I, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002277; da Silva CV, 2009, BIOCHEM BIOPH RES CO, V378, P656, DOI 10.1016/j.bbrc.2008.11.108; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Faghiri Z, 2010, EXP EYE RES, V90, P718, DOI 10.1016/j.exer.2010.03.002; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Garcia-Garcia JC, 2009, INFECT IMMUN, V77, P2385, DOI 10.1128/IAI.00023-09; GRITZ DC, 1991, CURR EYE RES, V10, P927, DOI 10.3109/02713689109020328; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; JABS DA, 1990, INT OPHTHALMOL CLIN, V30, P264, DOI 10.1097/00004397-199030040-00009; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Kang KH, 2009, TRENDS MOL MED, V15, P191, DOI 10.1016/j.molmed.2009.03.005; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kim L, 2006, J CELL SCI, V119, P2119, DOI 10.1242/jcs.02934; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lee H, 2010, INT J BIOL MACROMOL, V47, P104, DOI 10.1016/j.ijbiomac.2010.05.014; Lin MQ, 2007, CELL MICROBIOL, V9, P861, DOI 10.1111/j.1462-5822.2006.00835.x; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; MacLaren A, 2004, VET PARASITOL, V125, P301, DOI 10.1016/j.vetpar.2004.07.006; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; MCMENAMIN PG, 1986, EXP EYE RES, V43, P529, DOI 10.1016/S0014-4835(86)80021-5; MICELI MV, 1994, EXP CELL RES, V214, P242, DOI 10.1006/excr.1994.1254; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; NICHOLSON DH, 1976, ARCH OPHTHALMOL-CHIC, V94, P248, DOI 10.1001/archopht.1976.03910030120009; PERKINS ES, 1973, BRIT J OPHTHALMOL, V57, P1, DOI 10.1136/bjo.57.1.1; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Qian JQ, 2011, J CELL BIOCHEM, V112, P2480, DOI 10.1002/jcb.23173; Quan JH, 2013, EXP PARASITOL, V133, P462, DOI 10.1016/j.exppara.2013.01.005; Shrestha SP, 2006, INT J PARASITOL, V36, P433, DOI 10.1016/j.ijpara.2006.01.006; Son Eui-Sun, 2001, Korean Journal of Parasitology, V39, P49, DOI 10.3347/kjp.2001.39.1.49; Streilein JW, 1996, INVEST OPHTH VIS SCI, V37, P413; TABBARA KF, 1974, ARCH OPHTHALMOL-CHIC, V92, P244; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Vallochi AL, 2002, SCAND J IMMUNOL, V55, P324, DOI 10.1046/j.1365-3083.2002.01052.x; Wang YB, 2010, MOL BIOCHEM PARASIT, V173, P142, DOI 10.1016/j.molbiopara.2010.05.020; Wang YB, 2010, J BIOL CHEM, V285, P15611, DOI 10.1074/jbc.M109.095778; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Zhang YD, 2004, CANCER RES, V64, P1902, DOI 10.1158/0008-5472.CAN-03-3361	47	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66306	10.1371/journal.pone.0066306	http://dx.doi.org/10.1371/journal.pone.0066306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824914	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400081
J	Collip, D; Geschwind, N; Peeters, F; Myin-Germeys, I; van Os, J; Wichers, M				Collip, Dina; Geschwind, Nicole; Peeters, Frenk; Myin-Germeys, Inez; van Os, Jim; Wichers, Marieke			Putting a Hold on the Downward Spiral of Paranoia in the Social World: A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Individuals with a History of Depression	PLOS ONE			English	Article							COMMITMENT THERAPY; PSYCHOTIC SYMPTOMS; ACCEPTANCE; SCHIZOPHRENIA; ENVIRONMENT; EXPERIENCE; DISORDERS; PREVENT; ANXIETY; RISK	Context: Paranoia embodies altered representation of the social environment, fuelling altered feelings of social acceptance leading to further mistrust. Mindfulness-based cognitive therapy (MBCT) may relieve paranoia and reduce its impact on social acceptance. Objective: To determine whether MBCT alters momentary feeling of paranoia and social acceptance in daily life. Design: Randomized controlled trial of daily-life repeated measures (up to 120 per participant) before and after allocation to MBCT or waiting list control. Participants: Volunteer sample of 130 eligible men and women with residual affective dysregulation after at least one episode of major depressive disorder. Interventions: Eight weeks of MBCT in groups of 10-15 participants in addition to participants' usual treatment. Outcome Measures: Daily-life ratings of paranoia and social acceptance. This manuscript concerns additional analyses of the original trial; hypotheses were developed after data collection (focus initially on depressive symptoms) but before data analysis. Results: Sixty-six participants were assigned to the waiting list control group and 64 to the MBCT intervention group, of whom 66 and 61 respectively were included in the per-protocol analyses. Intention-to-treat analyses revealed a significant group by time interaction in the model of momentary paranoia (b = -.18, p<0.001, d = -0.35) and social acceptance (b = .26, p<0.001, d = 0.41). Paranoia levels in the intervention group were significantly reduced (b = -.11, p<0.001) and feelings of social acceptance significantly increased (b = .18, p<0.001), whereas in the Control condition a significant increase in paranoia (b = .07, p = 0.008) and a decrease in social acceptance was apparent (b = 2.09, p = 0.013). The detrimental effect of paranoia on social acceptance was significantly reduced in the MBCT, but not the control group (group by time interaction: b = .12, p = 0.022). Conclusions: MBCT confers a substantial benefit on subclinical paranoia and may interrupt the social processes that maintain and foster paranoia in individuals with residual affective dysregulation.	[Collip, Dina; Geschwind, Nicole; Peeters, Frenk; Myin-Germeys, Inez; van Os, Jim; Wichers, Marieke] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands; [Geschwind, Nicole] Univ Leuven, Hlth Psychol Grp, CLEP, Louvain, Belgium; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London, England	Maastricht University; KU Leuven; University of London; King's College London	Collip, D (corresponding author), Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands.	d.collip@maastrichtuniversity.nl	Myin-Germeys, Inez/L-5106-2014; Geschwind, Nicole/J-4617-2019; van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; Wichers, Marieke/N-6667-2014; Myin Germeys, Inez/HIR-3364-2022	Geschwind, Nicole/0000-0001-7171-6426; van Os, Jim/0000-0002-7245-1586; Wichers, Marieke/0000-0001-5024-9064; Myin Germeys, Inez/0000-0002-3731-4930; Peeters, F/0000-0002-6167-8582	Dutch Organisation for Scientific Research (NWO, VENI Grant) [916.76.147]; Kootstra Talent Fellowship from Maastricht University; K.U. Leuven Center of Excellence on Generalization Research (GRIP*TT) [PF/10/005]	Dutch Organisation for Scientific Research (NWO, VENI Grant)(Netherlands Organization for Scientific Research (NWO)); Kootstra Talent Fellowship from Maastricht University; K.U. Leuven Center of Excellence on Generalization Research (GRIP*TT)	MW was supported by the Dutch Organisation for Scientific Research (NWO, VENI Grant Nr. 916.76.147). DC was supported by a Kootstra Talent Fellowship from Maastricht University. NG was supported by K.U. Leuven Center of Excellence on Generalization Research (GRIP*TT; PF/10/005). All above mentioned funding sources had no role in data collection, analysis, or interpretation, trial design, patient recruitment, or any aspect pertinent to the study nor in the writing of the manuscript or the decision to submit it for publication. None of the authors were paid to write this article by a pharmaceutical company or other agency. The authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Bach P, 2002, J CONSULT CLIN PSYCH, V70, P1129, DOI 10.1037//0022-006X.70.5.1129; Bach P, 2012, ACCEPTANCE COMMITMEN; Bach PA, 2006, ACCEPTANCE MINDFULNE; Bach P, 2012, BEHAV MODIF, V36, P165, DOI 10.1177/0145445511427193; Bentall RP, 2009, ARCH GEN PSYCHIAT, V66, P236, DOI 10.1001/archgenpsychiatry.2009.1; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Chadwick P, 2005, BEHAV COGN PSYCHOTH, V33, P351, DOI 10.1017/S1352465805002158; Chadwick P, 2009, BEHAV COGN PSYCHOTH, V37, P403, DOI 10.1017/S1352465809990166; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P101; Cramer AOJ, 2012, BEHAV BRAIN SCI, V35, P146, DOI 10.1017/S0140525X11001488; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Delespaul P., 1995, EXPERIENCE SAMPLING; Delespaul P.A.E.G., 1995, ASSESSING SCHIZOPHRE; First MB, 2002, STRUCTURED CLIN INTE; Fjorback L, 2011, ACTA PSYCHIAT SCANDI; Freeman D, 2003, BEHAV RES THER, V41, P923, DOI 10.1016/S0005-7967(02)00104-3; Freeman D, 2007, CLIN PSYCHOL REV, V27, P425, DOI 10.1016/j.cpr.2006.10.004; Gaudiano BA, 2006, BEHAV RES THER, V44, P415, DOI 10.1016/j.brat.2005.02.007; Gaudiano BA, 2010, BEHAV THER, V41, P543, DOI 10.1016/j.beth.2010.03.001; Geschwind N, 2012, BRIT J PSYCHIAT; Geschwind N, 2011, J CONSULT CLIN PSYCH, V79, P618, DOI 10.1037/a0024595; Green MJ, 2004, NEUROSCI BIOBEHAV R, V28, P333, DOI 10.1016/j.neubiorev.2004.03.006; Greeson J., 2009, CLIN HDB MINDFULNESS, P171; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HARVEY DM, 1981, J ABNORM PSYCHOL, V90, P134, DOI 10.1037/0021-843X.90.2.134; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Langer AI, 2012, BEHAV COGN PSYCHOTH, V40, P105, DOI 10.1017/S1352465811000464; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2009, PSYCHOL MED, P1; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Pankey J., 2003, INT J PSYCHOL PSYCHO, V3, P311; Segal Z. V., 2002, MINDFULNESS BASED CO; Shawyer F, 2011, BEHAV RES THERAPY; Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Taylor KN, 2009, BEHAV COGN PSYCHOTH, V37, P397, DOI 10.1017/S135246580999018X; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; TEASDALE JD, 1995, BEHAV RES THER, V33, P25, DOI 10.1016/0005-7967(94)E0011-7; Thewissen V, 2008, J ABNORM PSYCHOL, V117, P143, DOI 10.1037/0021-843X.117.1.143; van der Valk R, 2012, EARLY INTERVENTION P; van Os J, 2012, SCHIZOPHRENIA BULL, V38, P227, DOI 10.1093/schbul/sbr188; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101; White R, 2011, FEASIBILITY STUDY AC; Wigman JTW, 2012, SCHIZOPHRENIA BULL, V38, P247, DOI 10.1093/schbul/sbr196; Williams JMG, 2008, MINDFULNESS BASED CO	47	17	17	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66747	10.1371/journal.pone.0066747	http://dx.doi.org/10.1371/journal.pone.0066747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IX	23826125	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000008
J	Gandolfi, B; Alhaddad, H; Affolter, VK; Brockman, J; Haggstrom, J; Joslin, SEK; Koehne, AL; Mullikin, JC; Outerbridge, CA; Warren, WC; Lyons, LA				Gandolfi, Barbara; Alhaddad, Hasan; Affolter, Verena K.; Brockman, Jeffrey; Haggstrom, Jens; Joslin, Shannon E. K.; Koehne, Amanda L.; Mullikin, James C.; Outerbridge, Catherine A.; Warren, Wesley C.; Lyons, Leslie A.			To the Root of the Curl: A Signature of a Recent Selective Sweep Identifies a Mutation That Defines the Cornish Rex Cat Breed	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE HYPOTRICHOSIS; PROTEIN-COUPLED RECEPTOR; HYPOHIDROTIC ECTODERMAL DYSPLASIA; HAIR FOLLICLE DEVELOPMENT; WOOLLY HAIR; DOMESTIC CAT; COAT MUTANT; P2RY5 GENE; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC-ACID	The cat (Felis silvestris catus) shows significant variation in pelage, morphological, and behavioral phenotypes amongst its over 40 domesticated breeds. The majority of the breed specific phenotypic presentations originated through artificial selection, especially on desired novel phenotypic characteristics that arose only a few hundred years ago. Variations in coat texture and color of hair often delineate breeds amongst domestic animals. Although the genetic basis of several feline coat colors and hair lengths are characterized, less is known about the genes influencing variation in coat growth and texture, especially rexoid - curly coated types. Cornish Rex is a cat breed defined by a fixed recessive curly coat trait. Genome-wide analyses for selection (d(i), Tajima's D and nucleotide diversity) were performed in the Cornish Rex breed and in 11 phenotypically diverse breeds and two random bred populations. Approximately 63K SNPs were used in the analysis that aimed to localize the locus controlling the rexoid hair texture. A region with a strong signature of recent selective sweep was identified in the Cornish Rex breed on chromosome A1, as well as a consensus block of homozygosity that spans approximately 3 Mb. Inspection of the region for candidate genes led to the identification of the lysophosphatidic acid receptor 6 (LPAR6). A 4 bp deletion in exon 5, c.250_253_delTTTG, which induces a premature stop codon in the receptor, was identified via Sanger sequencing. The mutation is fixed in Cornish Rex, absent in all straight haired cats analyzed, and is also segregating in the German Rex breed. LPAR6 encodes a G protein-coupled receptor essential for maintaining the structural integrity of the hair shaft; and has mutations resulting in a wooly hair phenotype in humans.	[Gandolfi, Barbara; Alhaddad, Hasan; Joslin, Shannon E. K.; Lyons, Leslie A.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Affolter, Verena K.; Koehne, Amanda L.] Univ Calif Davis, Sch Vet Med, Dept Pathol, Davis, CA 95616 USA; [Brockman, Jeffrey] Hills Pet Nutr Ctr, Topeka, KS USA; [Haggstrom, Jens] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden; [Mullikin, James C.] NHGRI, Comparat Genom Unit, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Outerbridge, Catherine A.] Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA; [Warren, Wesley C.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	University of California System; University of California Davis; University of California System; University of California Davis; Swedish University of Agricultural Sciences; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Davis; Washington University (WUSTL)	Gandolfi, B (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	bgandolfi@ucdavis.edu		Alhaddad, Hasan/0000-0001-7904-2913; Lyons, Leslie/0000-0002-1628-7726; /0000-0001-5470-1193; Haggstrom, Jens/0000-0003-3402-023X	National Center for Research Resources; Office of Research Infrastructure Programs of the National Institute of Health [R24 RR016094]; Winn Feline Foundation [W10-14, W11-041]; Center for Companion Animal Health at University of California Davis [2010-09-F]; George and Phyllis Miller Feline Health Fund of the San Francisco Foundation [2008-36-F]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the National Institute of Health; Winn Feline Foundation; Center for Companion Animal Health at University of California Davis; George and Phyllis Miller Feline Health Fund of the San Francisco Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by the National Center for Research Resources and the Office of Research Infrastructure Programs of the National Institute of Health through Grant Number R24 RR016094, the Winn Feline Foundation (W10-14, W11-041), the Center for Companion Animal Health at University of California Davis (2010-09-F) (http://www.vetmed.ucdavis.edu/ccah/index.cfm), and the George and Phyllis Miller Feline Health Fund of the San Francisco Foundation (2008-36-F). Support for the development of the Illumina Infinium Feline 63K iSelect DNA array was provided by the Morris Animal Foundation (http://www.morrisanimalfoundation.org)via a donation from Hill's Pet Food, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Alhaddad H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053537; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Azeem Z, 2008, HUM GENET, V123, P515, DOI 10.1007/s00439-008-0507-7; Bach LH, 2012, CYTOGENET GENOME RES, V137, P7, DOI 10.1159/000339416; Bal E, 2007, HUM MUTAT, V28, P703, DOI 10.1002/humu.20500; Baumer A, 2000, EUR J HUM GENET, V8, P443, DOI 10.1038/sj.ejhg.5200506; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Bazzi H, 2007, DEV BIOL, V305, P498, DOI 10.1016/j.ydbio.2007.02.035; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Chien AJ, 2006, J AM ACAD DERMATOL, V54, pS35, DOI 10.1016/j.jaad.2005.01.092; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Cooper MP, 2006, ANIM GENET, V37, P163, DOI 10.1111/j.1365-2052.2005.01389.x; Diribarne M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019281; Farooq M, 2013, HUM MUTAT; Filler S, 2012, J HERED, V103, P727, DOI 10.1093/jhered/ess039; Fujimoto A, 2012, J INVEST DERMATOL, V132, P2342, DOI 10.1038/jid.2012.154; Gandolfi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053173; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Harada K, 2013, INT J DERMATOL, V52, P572, DOI 10.1111/j.1365-4632.2012.05775.x; HARDEN TK, 1995, ANNU REV PHARMACOL, V35, P541, DOI 10.1146/annurev.pharmtox.35.1.541; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Herzog H, 1996, GENOME RES, V6, P858, DOI 10.1101/gr.6.9.858; Horev L, 2010, J EUR ACAD DERMATOL, V24, P858, DOI 10.1111/j.1468-3083.2009.03514.x; Ishida Y, 2006, GENOMICS, V88, P698, DOI 10.1016/j.ygeno.2006.06.006; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; JUDE AC, 1953, NATURE, V172, P81, DOI 10.1038/172081b0; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kikkawa Y, 2003, GENETICS, V165, P721; Kuramoto T, 2010, J VET MED SCI; Kurban M, 2012, J EUR ACAD DERMATOL; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Langbein L, 2006, J INVEST DERMATOL, V126, P2377, DOI 10.1038/sj.jid.5700494; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Mullikin JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-406; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pasternack SM, 2009, ARCH DERMATOL RES, V301, P621, DOI 10.1007/s00403-009-0971-5; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Petukhova L, 2008, GENOMICS, V92, P273, DOI 10.1016/j.ygeno.2008.06.009; Petukhova L, 2009, HUM HERED, V68, P117, DOI 10.1159/000212504; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROBINSON R, 1969, GENETICA, V40, P597, DOI 10.1007/BF01787384; ROBINSON R, 1973, J HERED, V64, P47, DOI 10.1093/oxfordjournals.jhered.a108339; ROBINSON R, 1971, GENETICA, V42, P466, DOI 10.1007/BF00122078; ROBINSON R, 1972, GENETICA, V43, P236, DOI 10.1007/BF00123630; ROBINSON R, 1968, GENETICA, V39, P351, DOI 10.1007/BF02324474; Searle A. G., 1956, Journal of Genetics, V54, P506, DOI 10.1007/BF02982964; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Shimomura Y, 2012, J DERMATOL, V39, P3, DOI 10.1111/j.1346-8138.2011.01395.x; Shimomura Y, 2010, ANNU REV GENOM HUM G, V11, P109, DOI 10.1146/annurev-genom-021610-131501; Shimomura Y, 2010, AM J HUM GENET, V86, P632, DOI 10.1016/j.ajhg.2010.02.025; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Shimomura Y, 2010, J INVEST DERMATOL, V130, P892, DOI 10.1038/jid.2009.341; Shimomura Y, 2009, EXP DERMATOL, V18, P218, DOI 10.1111/j.1600-0625.2008.00788.x; Shinkuma S, 2010, HUM MUTAT, V31, P602, DOI 10.1002/humu.21235; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Sprecher E, 2001, NAT GENET, V29, P134, DOI 10.1038/ng716; Takahashi T, 2003, J INVEST DERMATOL, V121, P448, DOI 10.1046/j.1523-1747.2003.12426.x; Tanahashi K, 2012, J EUR ACAD DERMATOL; Tariq M, 2009, BRIT J DERMATOL, V160, P1006, DOI 10.1111/j.1365-2133.2009.09046.x; Tariq M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00730; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; TORIBIO J, 1974, BRIT J DERMATOL, V91, P687, DOI 10.1111/j.1365-2133.1974.tb12455.x; van Steensel MAM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.021030; Wasif N, 2011, HUM GENET, V129, P419, DOI 10.1007/s00439-010-0938-9; Whiting PW, 1919, AM NAT, V53, P473, DOI 10.1086/279726; Winter H, 1997, NAT GENET, V16, P372, DOI 10.1038/ng0897-372; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Zhigachev A. I., 2000, Genetika, V36, P538	75	23	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67105	10.1371/journal.pone.0067105	http://dx.doi.org/10.1371/journal.pone.0067105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826204	gold, Green Submitted, Green Published			2022-12-27	WOS:000321150000027
J	Kiertiburanakul, S; Chaiwarith, R; Sirivichayakul, S; Ditangco, R; Jiamsakul, A; Li, PCK; Kantipong, P; Lee, C; Ratanasuwan, W; Kamarulzaman, A; Sohn, AH; Sungkanuparph, S				Kiertiburanakul, Sasisopin; Chaiwarith, Romanee; Sirivichayakul, Sunee; Ditangco, Rossana; Jiamsakul, Awachana; Li, Patrick C. K.; Kantipong, Pacharee; Lee, Christopher; Ratanasuwan, Winai; Kamarulzaman, Adeeba; Sohn, Annette H.; Sungkanuparph, Somnuek		TREAT Asia Studies Evaluate Resist	Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients	PLOS ONE			English	Article							ANTIRETROVIRAL-NAIVE INDIVIDUALS; SUB-SAHARAN AFRICA; GENOTYPIC RESISTANCE; TREAT ASIA; THRESHOLD SURVEY; HIGH-LEVEL; MUTATIONS; SURVEILLANCE; TRANSMISSION; EPIDEMIOLOGY	Background: The emergence and transmission of HIV-1 drug resistance (HIVDR) has raised concerns after rapid global antiretroviral therapy (ART) scale-up. There are limited data on the epidemiology of primary HIVDR in resource-limited settings in Asia. We aimed to determine the prevalence and compare the distribution of HIVDR in a cohort of ART-naive Asian patients with recent and chronic HIV-1 infection. Methods: Multicenter prospective study was conducted in ART-naive patients between 2007 and 2010. Resistance-associated mutations (RAMs) were assessed using the World Health Organization 2009 list for surveillance of primary HIVDR. Results: A total of 458 patients with recent and 1,340 patients with chronic HIV-1 infection were included in the analysis. The overall prevalence of primary HIVDR was 4.6%. Recently infected patients had a higher prevalence of primary HIVDR (6.1% vs. 4.0%, p = 0.065) and frequencies of RAMs to protease inhibitors (PIs; 3.9% vs. 1.0%, p<0.001). Among those with recent infection, the most common RAMs to nucleoside reverse transcriptase inhibitors (NRTIs) were M184I/V and T215D/E/F/I/S/Y (1.1%), to non-NRTIs was Y181C (1.3%), and to PIs was M46I (1.5%). Of patients with chronic infection, T215D/E/F/I/S/Y (0.8%; NRTI), Y181C (0.5%; non-NRTI), and M46I (0.4%; PI) were the most common RAMs. K70R (p = 0.016) and M46I (p = 0.026) were found more frequently among recently infected patients. In multivariate logistic regression analysis in patients with chronic infection, heterosexual contact as a risk factor for HIV-1 infection was less likely to be associated with primary HIVDR compared to other risk categories (odds ratio 0.34, 95% confidence interval 0.20-0.59, p<0.001). Conclusions: The prevalence of primary HIVDR was higher among patients with recent than chronic HIV-1 infection in our cohort, but of borderline statistical significance. Chronically infected patients with non-heterosexual risks for HIV were more likely to have primary HIVDR.	[Kiertiburanakul, Sasisopin; Sungkanuparph, Somnuek] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Chaiwarith, Romanee] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Sirivichayakul, Sunee] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Sirivichayakul, Sunee] HIV NAT Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Ditangco, Rossana] Res Inst Trop Med, Manila, Philippines; [Jiamsakul, Awachana] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Li, Patrick C. K.] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China; [Kantipong, Pacharee] Chiang Rai Reg Hosp, Chiang Rai, Thailand; [Lee, Christopher] Hosp Sungai Buloh, Kuala Lumpur, Malaysia; [Ratanasuwan, Winai] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand; [Kamarulzaman, Adeeba] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Sohn, Annette H.] amfAR Fdn AIDS Res, TREAT Asia, Bangkok, Thailand	Mahidol University; Chiang Mai University; Chulalongkorn University; Thai Red Cross Society; Research Institute for Tropical Medicine - Philippines; University of New South Wales Sydney; Kirby Institute; Mahidol University; Universiti Malaya	Kiertiburanakul, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand.	sasisopin.kie@mahidol.ac.th	KAMARULZAMAN, ADEEBA/B-5216-2010	Chaiwarith, Romanee/0000-0002-1241-5954	Dutch Ministry of Foreign Affairs; Stichting Aids Fonds; amfAR; National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH); National Cancer Institute (NCI) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) [U01AI069907]; Hong Kong Council for AIDS Trust Fund; Australian Government Department of Health and Ageing; Faculty of Medicine, The University of New South Wales; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	Dutch Ministry of Foreign Affairs; Stichting Aids Fonds; amfAR; National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA); Hong Kong Council for AIDS Trust Fund; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Faculty of Medicine, The University of New South Wales; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The TREAT Asia Studies to Evaluate Resistance is an initiative of TREAT Asia, a program of amfAR, The Foundation for AIDS Research, with major support provided by the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds, and with additional support from amfAR and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) and the National Cancer Institute (NCI) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no. U01AI069907). Queen Elizabeth Hospital and the Integrated Treatment Centre are supported by the Hong Kong Council for AIDS Trust Fund. The Kirby Institute is funded by the Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, The University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammaranond P, 2003, J CLIN VIROL, V26, P153, DOI 10.1016/S1386-6532(02)00114-2; Apisarnthanarak A, 2008, HIV MED, V9, P322, DOI 10.1111/j.1468-1293.2008.00562.x; Apisarnthanarak A, 2008, CLIN INFECT DIS, V46, P1630, DOI 10.1086/587753; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Charpentier C, 2011, ANTIVIR THER, V16, P429, DOI 10.3851/IMP1754; DHHS, 2012, GUID US ANT AG HIV 1; Division of HIV/AIDS Epidemiology and Surveillance National HIV and Retrovirology Laboratories Centre for Infectious Disease Prevention and Control Public Health Agency of Canada Health Canada, 2006, HIV 1 STRAIN PRIM DR; Eiros JM, 2002, EUR J CLIN MICROBIOL, V21, P310, DOI 10.1007/s10096-002-0711-7; Gagliani LH, 2011, AIDS RES HUM RETROV, V27, P251, DOI 10.1089/aid.2010.0150; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Haidara A, 2010, HIV MED, V11, P404, DOI 10.1111/j.1468-1293.2009.00806.x; Hamers RL, 2012, INT J EPIDEMIOL, V41, P43, DOI 10.1093/ije/dyq192; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Johansson KA, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-3; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Jongwutiwes U, 2008, JPN J INFECT DIS, V61, P111; Kiertiburanakul S, 2009, CURR HIV RES, V7, P273, DOI 10.2174/157016209788347976; Kuritzkes DR, 2004, AIDS PATIENT CARE ST, V18, P259, DOI 10.1089/108729104323076007; Land S, 2009, J VIROL METHODS, V159, P185, DOI 10.1016/j.jviromet.2009.03.016; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Lee CC, 2009, HIV MED, V10, P370, DOI 10.1111/j.1468-1293.2009.00698.x; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Maphalala G, 2008, ANTIVIR THER, V13, P95; Nguyen HT, 2008, ANTIVIR THER, V13, P115; Picard V, 2001, J INFECT DIS, V184, P781, DOI 10.1086/323088; Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004; Riva C, 2002, ANTIVIR THER, V7, pS136; Sirivichayakul S, 2011, 6 IAS C HIV PATH TRE; Sirivichoyaku S, 2008, ANTIVIR THER, V13, P109; Sungkanuparph S, 2012, JAIDS-J ACQ IMM DEF, V59, pE3, DOI 10.1097/QAI.0b013e31823ac978; Sungkanuparph S, 2011, CLIN INFECT DIS, V52, P1053, DOI 10.1093/cid/cir107; UNAIDS, 2010, REP GLOB AIDS EP; Vergne L, 2006, ANTIVIR THER, V11, P575; Violin M, 2004, AIDS, V18, P227, DOI 10.1097/00002030-200401230-00012; World Health Organization, 2000, REP WHO CONS ORG COL; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]	39	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e62057	10.1371/journal.pone.0062057	http://dx.doi.org/10.1371/journal.pone.0062057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826076	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000001
J	Snitker, S; Xie, KM; Ryan, KA; Yu, DZ; Shuldiner, AR; Mitchell, BD; Gong, DW				Snitker, Soren; Xie, Keming; Ryan, Kathleen A.; Yu, Daozhan; Shuldiner, Alan R.; Mitchell, Braxton D.; Gong, Da-Wei			Correlation of Circulating MMP-9 with White Blood Cell Count in Humans: Effect of Smoking	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; OBSTRUCTIVE PULMONARY-DISEASE; LEFT-VENTRICULAR MEASURES; MATRIX METALLOPROTEINASES; METABOLIC SYNDROME; EXTRACELLULAR-MATRIX; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; INFLAMMATORY MARKERS; SERUM MMP-9	Background: Matrix metalloproteinase-9 (MMP-9) is an emerging biomarker for several disease conditions, where white blood cell (WBC) count is also elevated. In this study, we examined the relationship between MMP-9 and WBC levels in apparently healthy smoking and non-smoking human subjects. Methods: We conducted a cross-sectional study to assess the relationship of serum MMP-9 with WBC in 383 men and 356 women. Next, we divided the male population (women do not smoke in this population) into three groups: never (n = 243), current (n = 76) and former (n = 64) smokers and compared the group differences in MMP-9 and WBC levels and their correlations within each group. Results: Circulating MMP-9 and WBC count are significantly correlated in men (R-2 = 0.13, p<0.001) and women (R-2 = 0.19, p<0.001). After stratification by smoking status, MMP-9 level was significantly higher in current smokers (mean 6 SE; 663.3 +/- 43.4 ng/ml), compared to never (529.7 +/- 20.6) and former smokers (568 +/- 39.3). WBC count was changed in a similar pattern. Meanwhile, the relationship became stronger in current smokers with increased correlation coefficient of r = 0.45 or R-2 = 0.21 (p<0.001) and steeper slope of beta = 1.16 +/- 0.30 (p<0.001) in current smokers, compared to r = 0.26 or R-2 = 0.07 (p<0.001) and beta = 0.34 +/- 0.10 (p<0.001) in never smokers. Conclusions: WBC count accounts for 13% and 19% of MMP-9 variance in men and women, respectively. In non-smoking men, WBC count accounts for 7% of MMP-9 variance, but in smoking subjects, it accounts for up to 21% of MMP-9 variance. Thus, we have discovered a previously unrecognized correlation between the circulating MMP-9 and WBC levels in humans.	[Snitker, Soren; Xie, Keming; Ryan, Kathleen A.; Yu, Daozhan; Shuldiner, Alan R.; Mitchell, Braxton D.; Gong, Da-Wei] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Xie, Keming] Soochow Univ, Coll Med, Dept Pathophysiol, Suzhou, Peoples R China; [Shuldiner, Alan R.; Gong, Da-Wei] Baltimore Vet Affairs Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Soochow University - China; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Gong, DW (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	dgong@medicine.umaryland.edu	Gong, Dawei/AAB-4283-2020; Mitchell, Braxton/CAF-0876-2022	Shuldiner, Alan/0000-0001-9921-4305; Mitchell, Braxton/0000-0003-4920-4744	Maryland Clinical Nutrition Research Unit [DK072488]; Baltimore Diabetes Research and Training Center from the National Institutes of Health [U01 HL072512, U01GM074518]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER	Maryland Clinical Nutrition Research Unit; Baltimore Diabetes Research and Training Center from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was partially supported by grants from Maryland Clinical Nutrition Research Unit (DK072488), the Baltimore Diabetes Research and Training Center, U01 HL072512, and U01GM074518 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Arunachalam G, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-34; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Batlle M, 2007, TRANSPL P, V39, P2344, DOI 10.1016/j.transproceed.2007.06.046; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bolton C E, 2009, Chron Respir Dis, V6, P81, DOI 10.1177/1479972309103131; Brajer B, 2008, J PHYSIOL PHARMACOL, V59, P145; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Busti C, 2010, INTERN EMERG MED, V5, P13, DOI 10.1007/s11739-009-0283-y; Chambaut-Guerin AM, 2000, J NEUROCHEM, V74, P508, DOI 10.1046/j.1471-4159.2000.740508.x; Dogan A, 2008, CORONARY ARTERY DIS, V19, P559, DOI 10.1097/MCA.0b013e3283109079; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Fang L, 2010, CLIN SCI, V119, P175, DOI 10.1042/CS20100011; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; Genersch E, 2000, J CELL SCI, V113, P4319; Giannelli G, 2004, CLIN EXP RHEUMATOL, V22, P335; Goncalves FM, 2009, CLIN CHIM ACTA, V403, P173, DOI 10.1016/j.cca.2009.02.013; Grodin JL, 2011, VASC MED, V16, P339, DOI 10.1177/1358863X11422110; Gruber BL, 1996, CLIN IMMUNOL IMMUNOP, V78, P161, DOI 10.1006/clin.1996.0025; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Hansson J, 2009, EUR J CARDIOV PREV R, V16, P297, DOI 10.1097/HJR.0b013e3283213108; Hwang JJ, 2009, ATHEROSCLEROSIS, V204, P293, DOI 10.1016/j.atherosclerosis.2008.08.019; Jacob MP, 2003, BIOMED PHARMACOTHER, V57, P195, DOI 10.1016/S0753-3322(03)00065-9; Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340; Jouneau S, 2011, RESPIROLOGY, V16, P705, DOI 10.1111/j.1440-1843.2011.01960.x; Kato R, 2005, AM J CARDIOL, V95, P90, DOI 10.1016/j.amjcard.2004.08.066; Kim KC, 2005, ARCH PHARM RES, V28, P1257, DOI 10.1007/BF02978209; KOOLWIJK P, 1995, J RHEUMATOL, V22, P385; Lagente V, 2010, J MOL CELL CARDIOL, V48, P440, DOI 10.1016/j.yjmcc.2009.09.017; Li XM, 1999, VET IMMUNOL IMMUNOP, V67, P247, DOI 10.1016/S0165-2427(98)00228-1; Li YY, 2000, P NATL ACAD SCI USA, V97, P12746, DOI 10.1073/pnas.97.23.12746; Lim HS, 2008, J INTERN MED, V263, P620, DOI 10.1111/j.1365-2796.2008.01937.x; Muzzio ML, 2009, ARCH MED RES, V40, P48, DOI 10.1016/j.arcmed.2008.10.011; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Muroski ME, 2008, CURR PHARM BIOTECHNO, V9, P34; Oda E, 2009, INTERNAL MED, V48, P1127, DOI 10.2169/internalmedicine.48.2138; Odagiri K, 2011, INTERNAL MED, V50, P2491, DOI 10.2169/internalmedicine.50.5877; Omachi TA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-35; Overbeek SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055612; Pugin J, 1999, AM J RESP CELL MOL, V20, P458, DOI 10.1165/ajrcmb.20.3.3311; Ramos-Fernandez M, 2011, J STROKE CEREBROVASC, V20, P47, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.008; Roberts CK, 2006, J APPL PHYSIOL, V100, P1657, DOI 10.1152/japplphysiol.01292.2005; Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358; Rydlova M, 2008, ANTICANCER RES, V28, P1389; Sands MF, 2012, IMMUNOL INVEST, V41, P87, DOI 10.3109/08820139.2011.584600; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Takagi Hisato, 2009, Interact Cardiovasc Thorac Surg, V9, P437, DOI 10.1510/icvts.2009.208835; Velthove KJ, 2009, BIOMARKERS, V14, P523, DOI 10.3109/13547500903150763; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Welsh P, 2008, QJM-INT J MED, V101, P785, DOI 10.1093/qjmed/hcn088; Wu YW, 2008, J FORMOS MED ASSOC, V107, P93, DOI 10.1016/S0929-6646(08)60015-7; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x; ZYSSET T, 1985, HEPATOLOGY, V5, P531, DOI 10.1002/hep.1840050402	57	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66277	10.1371/journal.pone.0066277	http://dx.doi.org/10.1371/journal.pone.0066277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825535	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000014
J	Hoobler, EK; Rai, G; Warrilow, AGS; Perry, SC; Smyrniotis, CJ; Jadhav, A; Simeonov, A; Parker, JE; Kelly, DE; Maloney, DJ; Kelly, SL; Holman, TR				Hoobler, Eric K.; Rai, Ganesha; Warrilow, Andrew G. S.; Perry, Steven C.; Smyrniotis, Christopher J.; Jadhav, Ajit; Simeonov, Anton; Parker, Josie E.; Kelly, Diane E.; Maloney, David J.; Kelly, S. L.; Holman, Theodore R.			Discovery of a Novel Dual Fungal CYP51/Human 5-Lipoxygenase Inhibitor: Implications for Anti-Fungal Therapy	PLOS ONE			English	Article							MONOXIDE-BINDING PIGMENT; SELECTIVE INHIBITORS; CANDIDA-ALBICANS; PHENYLENEDIAMINE DERIVATIVES; NORDIHYDROGUAIARETIC ACID; SEBORRHEIC DERMATITIS; LIVER MICROSOMES; ACCURATE DOCKING; WHOLE-BLOOD; LIPOXYGENASE	We report the discovery of a novel dual inhibitor targeting fungal sterol 14 alpha-demethylase (CYP51 or Erg11) and human 5-lipoxygenase (5-LOX) with improved potency against 5-LOX due to its reduction of the iron center by its phenylenediamine core. A series of potent 5-LOX inhibitors containing a phenylenediamine core, were synthesized that exhibit nanomolar potency and >30-fold selectivity against the LOX paralogs, platelet-type 12-human lipoxygenase, reticulocyte 15-human lipoxygenase type-1, and epithelial 15-human lipoxygenase type-2, and >100-fold selectivity against ovine cyclooxygenase-1 and human cyclooxygnease-2. The phenylenediamine core was then translated into the structure of ketoconazole, a highly effective anti-fungal medication for seborrheic dermatitis, to generate a novel compound, ketaminazole. Ketaminazole was found to be a potent dual inhibitor against human 5-LOX (IC50 = 700 nM) and CYP51 (IC50 = 43 nM) in vitro. It was tested in whole blood and found to down-regulate LTB4 synthesis, displaying 45% inhibition at 10 mu M. In addition, ketaminazole selectively inhibited yeast CYP51 relative to human CYP51 by 17-fold, which is greater selectivity than that of ketoconazole and could confer a therapeutic advantage. This novel dual anti-fungal/anti-inflammatory inhibitor could potentially have therapeutic uses against fungal infections that have an anti-inflammatory component.	[Hoobler, Eric K.; Perry, Steven C.; Smyrniotis, Christopher J.; Holman, Theodore R.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Rai, Ganesha; Jadhav, Ajit; Simeonov, Anton; Maloney, David J.] NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Warrilow, Andrew G. S.; Parker, Josie E.; Kelly, Diane E.; Kelly, S. L.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales	University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Swansea University	Maloney, DJ (corresponding author), NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	maloneyd@mail.nih.gov; s.l.kelly@swansea.ac.uk; holman@ucsc.edu		Parker, Josie/0000-0002-3855-4194; Perry, Steven/0000-0003-4428-5338; Warrilow, Andrew/0000-0003-0183-8334; Jadhav, Ajit/0000-0001-7955-1451	National Institutes of Health [GM56062, S10-RR20939]; Welsh Government (SLK); ERDF, via the Beacon project; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056062, R01GM056062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welsh Government (SLK); ERDF, via the Beacon project; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM56062 (TRH) S10-RR20939 (UCSC MS Equipment grant), the Welsh Government (SLK) and the ERDF, via the Beacon project (SLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagata T, 2003, J NAT PROD, V66, P230, DOI 10.1021/np020462l; BEETENS JR, 1986, BIOCHEM PHARMACOL, V35, P883, DOI 10.1016/0006-2952(86)90072-9; BELL RL, 1992, INT J IMMUNOPHARMACO, V14, P505, DOI 10.1016/0192-0561(92)90182-K; Borgers M, 2007, CUTIS, V80, P359; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Deschamps JD, 2007, BIOORGAN MED CHEM, V15, P6900, DOI 10.1016/j.bmc.2007.08.015; Ducharme Y, 2010, ACS MED CHEM LETT, V1, P170, DOI 10.1021/ml100029k; Estabrook RW., 1972, METHODS PHARM, Vvol 2, P303; Faergemann J, 2000, Am J Clin Dermatol, V1, P75, DOI 10.2165/00128071-200001020-00001; Faergemann J, 2007, EXPERT OPIN PHARMACO, V8, P1365, DOI 10.1517/14656566.8.9.1365; FALGUEYRET JP, 1993, BIOCHEM PHARMACOL, V45, P978, DOI 10.1016/0006-2952(93)90185-Y; FOGH J, 1992, J PHARMACOL TOXICOL, V28, P185, DOI 10.1016/1056-8719(92)90002-I; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hutchinson JH, 2009, J MED CHEM, V52, P5803, DOI 10.1021/jm900945d; Ito S, 2005, J ORG CHEM, V70, P2285, DOI 10.1021/jo048489s; Itoh T, 2004, TETRAHEDRON, V60, P6649, DOI 10.1016/j.tet.2004.05.096; Jefcoate C R, 1978, Methods Enzymol, V52, P258; JEFCOATE CR, 1969, BIOCHEMISTRY-US, V8, P3455, DOI 10.1021/bi00836a049; KEMAL C, 1987, BIOCHEMISTRY-US, V26, P7064, DOI 10.1021/bi00396a031; Kenyon V, 2011, J MED CHEM, V54, P5485, DOI 10.1021/jm2005089; Koeberle A, 2008, J MED CHEM, V51, P8068, DOI 10.1021/jm801085s; Lamb DC, 1999, YEAST, V15, P755, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;755::AID-YEA417&gt;3.0.CO;2-8; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lewis ER, 1999, J AM CHEM SOC, V121, P1395, DOI 10.1021/ja983083g; Lo HY, 2010, BIOORG MED CHEM LETT, V20, P6379, DOI 10.1016/j.bmcl.2010.09.095; Lutz JD, 2009, BIOCHEM PHARMACOL, V77, P258, DOI 10.1016/j.bcp.2008.10.012; Masferrer JL, J PHARM EXP THER, V334, P294; McGill KA, 1996, LANCET, V348, P519, DOI 10.1016/S0140-6736(95)12297-4; MCMILLAN RM, 1992, TRENDS PHARMACOL SCI, V13, P323, DOI 10.1016/0165-6147(92)90100-K; MUSSER JH, 1992, J MED CHEM, V35, P2501, DOI 10.1021/jm00092a001; NELSON MJ, 1994, BIOCHEMISTRY-US, V33, P4966, DOI 10.1021/bi00182a027; OByrne PM, 1997, ANN INTERN MED, V127, P472, DOI 10.7326/0003-4819-127-6-199709150-00009; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pergola C, 2010, EXPERT OPIN THER PAT, V20, P355, DOI 10.1517/13543771003602012; Pham C, 1998, BIOCHEMISTRY-US, V37, P17952, DOI 10.1021/bi981989t; Radmark OP, 2000, AM J RESP CRIT CARE, V161, pS11, DOI 10.1164/ajrccm.161.supplement_1.ltta-3; Rai G, 2010, J MED CHEM, V53, P7392, DOI 10.1021/jm1008852; Robert NY, 1999, EUR J MED CHEM, V34, P671; Robinson SJ, 2009, J NAT PROD, V72, P1857, DOI 10.1021/np900465e; Rubin P, 2007, PROSTAG OTH LIPID M, V83, P188, DOI 10.1016/j.prostaglandins.2007.01.005; Sakurai H, 2005, J ORG CHEM, V70, P2754, DOI 10.1021/jo048324j; Scheinfeld N, 2008, DRUG TODAY, V44, P369, DOI 10.1358/dot.2008.44.5.1216598; Segraves EN, 2003, BIOCHEMISTRY-US, V42, P5236, DOI 10.1021/bi0273462; SPAETHE SM, 1992, BIOCHEM PHARMACOL, V43, P377, DOI 10.1016/0006-2952(92)90302-Y; Steel HC, 2007, CLIN EXP IMMUNOL, V150, P144, DOI 10.1111/j.1365-2249.2007.03470.x; Stewart AO, 1997, J MED CHEM, V40, P1955, DOI 10.1021/jm9700474; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Vasquez-Martinez Y, 2007, BIOORGAN MED CHEM, V15, P7408, DOI 10.1016/j.bmc.2007.07.036; VENKATESWARLU K, 1995, FEMS MICROBIOL LETT, V131, P337, DOI 10.1111/j.1574-6968.1995.tb07797.x; VOUROS P, 1969, ORG MASS SPECTROM, V2, P375, DOI 10.1002/oms.1210020406; WALENGA RW, 1980, LIFE SCI, V27, P1047, DOI 10.1016/0024-3205(80)90028-4; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4235, DOI 10.1128/AAC.00587-10; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; Whitman S, 2002, J MED CHEM, V45, P2659, DOI 10.1021/jm0201262; Zouboulis CC, 2005, DERMATOLOGY, V210, P36, DOI 10.1159/000081481	61	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65928	10.1371/journal.pone.0065928	http://dx.doi.org/10.1371/journal.pone.0065928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826084	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400006
J	Steigen, A; Nylund, A; Karlsbakk, E; Akoll, P; Fiksdal, IU; Nylund, S; Odong, R; Plarre, H; Semyalo, R; Skar, C; Watanabe, K				Steigen, Andreas; Nylund, Are; Karlsbakk, Egil; Akoll, Peter; Fiksdal, Ingrid U.; Nylund, Stian; Odong, Robinson; Plarre, Heidrun; Semyalo, Ronald; Skar, Cecilie; Watanabe, Kuninori			'Cand. Actinochlamydia clariae' gen. nov., sp. nov., a Unique Intracellular Bacterium Causing Epitheliocystis in Catfish (Clarias gariepinus) in Uganda	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CANDIDATUS-CLAVOCHLAMYDIA-SALMONICOLA; CHLAMYDIA-PSITTACI; ATLANTIC SALMON; PROTOCHLAMYDIA-AMOEBOPHILA; PISCICHLAMYDIA SALMONIS; ACANTHAMOEBA-POLYPHAGA; SURFACE PROJECTIONS; ORDER CHLAMYDIALES; CELL	Background and Objectives: Epitheliocystis, caused by bacteria infecting gill epithelial cells in fish, is common among a large range of fish species in both fresh-and seawater. The aquaculture industry considers epitheliocystis an important problem. It affects the welfare of the fish and the resulting gill disease may lead to mortalities. In a culture facility in Kampala, Uganda, juveniles of the African sharptooth catfish (Clarias gariepinus) was observed swimming in the surface, sometimes belly up, showing signs of respiratory problems. Histological examination of gill tissues from this fish revealed large amounts of epitheliocysts, and also presence of a few Ichthyobodo sp. and Trichodina sp. Methods and Results: Sequencing of the epitheliocystis bacterium 16S rRNA gene shows 86.3% similarity with Candidatus Piscichlamydia salmonis causing epitheliocystis in Atlantic salmon (Salmo salar). Transmission electron microscopy showed that the morphology of the developmental stages of the bacterium is similar to that of members of the family Chlamydiaceae. The similarity of the bacterium rRNA gene sequences compared with other chlamydia-like bacteria ranged between 80.5% and 86.3%. Inclusions containing this new bacterium have tubules/channels (termed actinae) that are radiating from the inclusion membrane and opening on the cell surface or in neighbouring cells. Conclusions: Radiation of tubules/channels (actinae) from the inclusion membrane has never been described in any of the other members of Chlamydiales. It seems to be a completely new character and an apomorphy. We propose the name Candidatus Actinochlamydia clariae gen. nov., sp. nov. (Actinochlamydiaceae fam. nov., order Chlamydiales, phylum Chlamydiae) for this new agent causing epitheliocystis in African sharptooth catfish.	[Steigen, Andreas; Nylund, Are; Nylund, Stian; Plarre, Heidrun; Watanabe, Kuninori] Univ Bergen, Dept Biol, Bergen, Norway; [Karlsbakk, Egil; Fiksdal, Ingrid U.; Skar, Cecilie] Inst Marine Res, N-5024 Bergen, Norway; [Akoll, Peter; Odong, Robinson] Makerere Univ, Dept Zool, Kampala, Uganda; [Semyalo, Ronald] Kampala Univ, Dept Biol, Kampala, Uganda	University of Bergen; Institute of Marine Research - Norway; Makerere University	Steigen, A (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	andreas.steigen@bio.uib.no	Akoll, Peter/AAW-9968-2021; Odong, Robinson/AAX-4173-2020		University of Bergen, Bergen, Norway	University of Bergen, Bergen, Norway	The study has been funded by the University of Bergen, Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADLEY TM, 1988, DIS AQUAT ORGAN, V4, P9, DOI 10.3354/dao004009; Collingro A, 2005, INT J SYST EVOL MICR, V55, P1863, DOI 10.1099/ijs.0.63572-0; Corsaro D, 2010, EUR J PROTISTOL, V46, P86, DOI 10.1016/j.ejop.2009.11.002; Crespo S, 1999, DIS AQUAT ORGAN, V37, P61, DOI 10.3354/dao037061; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Devold M, 2000, DIS AQUAT ORGAN, V40, P9, DOI 10.3354/dao040009; Draghi A, 2004, J CLIN MICROBIOL, V42, P5286, DOI 10.1128/JCM.42.11.5286-5297.2004; Draghi A, 2007, DIS AQUAT ORGAN, V76, P27, DOI 10.3354/dao076027; Draghi A, 2010, DIS AQUAT ORGAN, V89, P39, DOI 10.3354/dao02171; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Garritya G. M., 2001, BERGEYS MANUAL SYSTE, P119, DOI DOI 10.1002/9781118960608.BM00031; Greub G, 2002, APPL ENVIRON MICROB, V68, P3076, DOI 10.1128/AEM.68.6.3076-3084.2002; Groff JM, 1996, J VET DIAGN INVEST, V8, P172, DOI 10.1177/104063879600800206; Heinz E, 2010, J BACTERIOL, V192, P5093, DOI 10.1128/JB.00605-10; HODINKA RL, 1986, INFECT IMMUN, V54, P855, DOI 10.1128/IAI.54.3.855-863.1986; HOFFMAN GL, 1969, ANTON VAN LEE J M S, V35, P146, DOI 10.1007/BF02219125; Horn M, 2000, MICROBIOL-SGM, V146, P1231, DOI 10.1099/00221287-146-5-1231; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Isaksen TE, 2012, PARASITOL INT, V61, P675, DOI 10.1016/j.parint.2012.07.006; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Kahane S, 2001, APPL ENVIRON MICROB, V67, P4789, DOI 10.1128/AEM.67.10.4789-4795.2001; Karlsen M, 2008, ENVIRON MICROBIOL, V10, P208, DOI 10.1111/j.1462-2920.2007.01445.x; Kostanjsek R, 2004, INT J SYST EVOL MICR, V54, P543, DOI 10.1099/ijs.0.02802-0; KUO CC, 1988, INFECT IMMUN, V56, P1668, DOI 10.1128/IAI.56.6.1668-1672.1988; Kuo CC, 2011, BERGEYS MANUAL SYSTE, V4, P846; MATSUMOTO A, 1973, J BACTERIOL, V116, P1355, DOI 10.1128/JB.116.3.1355-1363.1973; MATSUMOTO A, 1982, J BACTERIOL, V151, P1040, DOI 10.1128/JB.151.2.1040-1042.1982; MATSUMOTO A, 1976, J ELECTRON MICROSC, V25, P169; Meijer A, 2006, APPL ENVIRON MICROB, V72, P284, DOI 10.1128/AEM.72.1.284-290.2006; Mitchell SO, 2010, J FISH DIS, V33, P665, DOI 10.1111/j.1365-2761.2010.01171.x; Moelleken K, 2008, MOL MICROBIOL, V67, P403, DOI 10.1111/j.1365-2958.2007.06050.x; MOULDER JW, 1964, PSITTACOSIS GROUP BA; Nowak BF, 2006, J FISH DIS, V29, P573, DOI 10.1111/j.1365-2761.2006.00747.x; Nylund A, 1998, J AQUAT ANIM HEALTH, V10, P43, DOI 10.1577/1548-8667(1998)010&lt;0043:AMSOTE&gt;2.0.CO;2; Nylund A, 2008, ARCH VIROL, V153, P1299, DOI 10.1007/s00705-008-0117-7; Nylund S, CHARACTERIZATI UNPUB; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; PLEHN M, 1920, ZBL BAKT PARASITE 1, V85, P275; Polkinghorne A, 2010, DIS AQUAT ORGAN, V91, P75, DOI 10.3354/dao02255; Repstad O, 2011, THESIS U BERGEN, P86; Rockey DD, 1996, INFECT IMMUN, V64, P4269, DOI 10.1128/IAI.64.10.4269-4278.1996; Schmidt-Posthaus H, 2012, ENVIRON MICROBIOL, V14, P2048, DOI 10.1111/j.1462-2920.2011.02670.x; STORZ J, 1971, International Journal of Systematic Bacteriology, V21, P332; Stride MC, 2013, APPL ENVIRON MICROB, V79, P1590, DOI 10.1128/AEM.02899-12; SU H, 1990, INFECT IMMUN, V58, P1017, DOI 10.1128/IAI.58.4.1017-1025.1990; Suchland RJ, 2005, INFECT IMMUN, V73, P3954, DOI 10.1128/IAI.73.7.3954-3962.2005; SWANSON AF, 1994, INFECT IMMUN, V62, P24, DOI 10.1128/IAI.62.1.24-28.1994; Thomas V, 2006, ENVIRON MICROBIOL, V8, P2125, DOI 10.1111/j.1462-2920.2006.01094.x; Toenshoff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032696; Vilinn Tolas I, 2012, DIS AQUAT ORGAN, P72	52	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66840	10.1371/journal.pone.0066840	http://dx.doi.org/10.1371/journal.pone.0066840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826156	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400067
J	Yang, PF; Chen, YY; Chen, DY; Hu, JW; Chen, JH; Yen, CT				Yang, Pai-Feng; Chen, You-Yin; Chen, Der-Yow; Hu, James W.; Chen, Jyh-Horng; Yen, Chen-Tung			Comparison of fMRI BOLD Response Patterns by Electrical Stimulation of the Ventroposterior Complex and Medial Thalamus of the Rat	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; RESONANCE-IMAGING SIGNALS; DEEP BRAIN-STIMULATION; CENTRAL-NERVOUS-SYSTEM; SHORT-TERM PLASTICITY; SOMATOSENSORY CORTEX; FUNCTIONAL MRI; BLOOD OXYGENATION; NEURONAL-ACTIVITY; NEGATIVE BOLD	The objective of this study was to compare the functional connectivity of the lateral and medial thalamocortical pain pathways by investigating the blood oxygen level-dependent (BOLD) activation patterns in the forebrain elicited by direct electrical stimulation of the ventroposterior (VP) and medial (MT) thalamus. An MRI-compatible stimulation electrode was implanted in the VP or MT of alpha-chloralose-anesthetized rats. Electrical stimulation was applied to the VP or MT at various intensities (50 mu A to 300 mA) and frequencies (1 Hz to 12 Hz). BOLD responses were analyzed in the ipsilateral forelimb region of the primary somatosensory cortex (iS1FL) after VP stimulation and in the ipsilateral cingulate cortex (iCC) after MT stimulation. When stimulating the VP, the strongest activation occurred at 3 Hz. The stimulation intensity threshold was 50 mA and the response rapidly peaked at 100 mu A. When stimulating the MT, The optimal frequency for stimulation was 9 Hz or 12 Hz, the stimulation intensity threshold was 100 mu A and we observed a graded increase in the BOLD response following the application of higher intensity stimuli. We also evaluated c-Fos expression following the application of a 200-mu A stimulus. Ventroposterior thalamic stimulation elicited c-Fos-positivity in few cells in the iS1FL and caudate putamen (iCPu). Medial thalamic stimulation, however, produced numerous c-Fos-positive cells in the iCC and iCPu. The differential BOLD responses and c-Fos expressions elicited by VP and MT stimulation indicate differences in stimulus-response properties of the medial and lateral thalamic pain pathways.	[Yang, Pai-Feng; Chen, Jyh-Horng] Natl Taiwan Univ, Interdisciplinary MRI MRI Lab, Dept Elect Engn, Taipei 10764, Taiwan; [Chen, You-Yin] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 112, Taiwan; [Chen, Der-Yow] Natl Cheng Kung Univ, Dept Psychol, Tainan 70101, Taiwan; [Hu, James W.] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Yang, Pai-Feng; Chen, Jyh-Horng; Yen, Chen-Tung] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Yen, Chen-Tung] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; National Cheng Kung University; University of Toronto; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University	Chen, JH (corresponding author), Natl Taiwan Univ, Interdisciplinary MRI MRI Lab, Dept Elect Engn, Taipei 10764, Taiwan.	Jhchen@ntu.edu.tw; ctyen@ntu.edu.tw		Yen, Chen-Tung/0000-0002-0076-4487	National Science Council, Taiwan [NSC100-2311-B002-002-MY3]; National Health Research Institutes, Taiwan [NHRI-EX101-10104NI]; National Taiwan University [101R892102]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Taiwan University(National Taiwan University)	This work was supported by grants from National Science Council, Taiwan (NSC100-2311-B002-002-MY3), from National Health Research Institutes, Taiwan (NHRI-EX101-10104NI), and from National Taiwan University (101R892102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APKARIAN AV, 1994, J NEUROSCI, V14, P6779; BERKLEY KJ, 1995, BRAIN RES, V695, P92, DOI 10.1016/0006-8993(95)00828-E; Bol CJJG, 1997, J PHARMACOL EXP THER, V283, P1051; Canals S, 2008, MAGN RESON IMAGING, V26, P978, DOI 10.1016/j.mri.2008.02.018; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; CastroAlamancos MA, 1996, J NEUROSCI, V16, P2767; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; Chang C, 2001, BRAIN RES, V897, P71, DOI 10.1016/S0006-8993(01)02094-7; Chen YY, 2009, J NEUROSCI METH, V182, P6, DOI 10.1016/j.jneumeth.2009.05.010; DADO RJ, 1994, J NEUROPHYSIOL, V71, P981, DOI 10.1152/jn.1994.71.3.981; Alonso BD, 2008, CEREB CORTEX, V18, P1314, DOI 10.1093/cercor/bhm163; DOSTROVSKY JO, 1990, PAIN, V40, P93, DOI 10.1016/0304-3959(90)91056-O; Ergenzinger ER, 1998, NAT NEUROSCI, V1, P226, DOI 10.1038/673; GUILBAUD G, 1980, PAIN, V8, P303, DOI 10.1016/0304-3959(80)90076-7; Gyngell ML, 1996, MAGNET RESON MED, V36, P13, DOI 10.1002/mrm.1910360104; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Huttunen JK, 2008, NEUROIMAGE, V39, P775, DOI 10.1016/j.neuroimage.2007.06.042; Jasmin L, 2004, J COMP NEUROL, V468, P425, DOI 10.1002/cne.10978; Jasper HH, 1960, HDB PHYSL 1, P1307; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Just N, 2010, MAGN RESON IMAGING, V28, P1143, DOI 10.1016/j.mri.2010.02.002; Keilholz SD, 2004, MAGN RESON MED, V52, P89, DOI 10.1002/mrm.20114; Kida I, 2008, NEUROSCI RES, V62, P25, DOI 10.1016/j.neures.2008.05.006; KRETTEK JE, 1977, J COMP NEUROL, V171, P157, DOI 10.1002/cne.901710204; Kung JC, 2002, BRAIN RES, V953, P37, DOI 10.1016/S0006-8993(02)03265-1; Kuo CC, 2005, CHINESE J PHYSIOL, V48, P200; Kuo CC, 2005, J NEUROPHYSIOL, V94, P1825, DOI 10.1152/jn.00294.2005; Kuo CC, 2009, J NEUROPHYSIOL, V101, P1201, DOI 10.1152/jn.90347.2008; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lai HY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036001; Morrison RS, 1942, AM J PHYSIOL, V135, P281; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PESCHANSKI M, 1980, BRAIN RES, V197, P401, DOI 10.1016/0006-8993(80)91125-7; Phillips MD, 2006, RADIOLOGY, V239, P209, DOI 10.1148/radiol.2391041990; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Sanganahalli BG, 2008, NMR BIOMED, V21, P410, DOI 10.1002/nbm.1259; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Shih YYI, 2009, J NEUROSCI, V29, P3036, DOI 10.1523/JNEUROSCI.3447-08.2009; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shyu BC, 2004, MAGN RESON MED, V52, P47, DOI 10.1002/mrm.20111; Stefurak T, 2003, MOVEMENT DISORD, V18, P1508, DOI 10.1002/mds.10593; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tuor UI, 2000, PAIN, V87, P315, DOI 10.1016/S0304-3959(00)00293-1; Vertes RP, 2002, J COMP NEUROL, V442, P163, DOI 10.1002/cne.10083; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Yang PF, 2011, PAIN, V152, P194, DOI 10.1016/j.pain.2010.10.027; Yang SW, 1998, BRAIN RES, V779, P41, DOI 10.1016/S0006-8993(97)01053-6; Yen CT, 2003, BRAIN RES, V968, P179, DOI 10.1016/S0006-8993(03)02235-2; Zhang ZG, 2012, J NEUROSCI, V32, P7429, DOI 10.1523/JNEUROSCI.5877-11.2012	57	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66821	10.1371/journal.pone.0066821	http://dx.doi.org/10.1371/journal.pone.0066821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826146	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400060
J	Almunia, C; Bretaudeau, M; Held, G; Babon, A; Marchetti, C; Castelli, FA; Menez, A; Maillere, B; Gillet, D				Almunia, Christine; Bretaudeau, Marie; Held, Gerhard; Babon, Aurelie; Marchetti, Charles; Castelli, Florence Anne; Menez, Andre; Maillere, Bernard; Gillet, Daniel			Bee Venom Phospholipase A2, a Good "Chauffeur" for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1	PLOS ONE			English	Article							CROSS-PRESENTATION; EXOGENOUS ANTIGENS; IMMUNE-RESPONSES; SIPULEUCEL-T; PROTEIN; EPITOPE; VACCINATION; COMPLEX; IMMUNOTHERAPY; PROTEASOMES	Bee venom phospholipase A2 (bvPLA2) is a small, 15kDa enzyme which hydrolyses many phospholipids through interfacial binding. The mutated bvPLA2H34Q (bvPLA2m), in which histidine-34 is replaced by glutamine, is not catalytically active. This protein has been shown to be a suitable membrane anchor and has been suggested as a suitable tumor-antigen vector for the development of novel dendritic cell-based vaccines. To confirm this feature, in this study the fusion protein PNY, composed of NY-ESO-1(NY(s)) fused to the C-terminus of bvPLA2m, was engineered. bvPLA2m enhanced the binding of NY(s) to the membrane of human monocyte-derived dendritic cells (DCs) and, once taken up by the cells, the antigen fused to the vector was directed to both MHC I and MHC II peptide-loading compartments. bvPLA2m was shown to increase the cross-presentation of the NY(s)-derived, restricted HLA-A*02 peptide, NY-ESO-1(157-165)(NY157-165), at the T1 cell surface. DCs loaded with the fusion protein induced cross-priming of NY(s)-specific CD8 + T-cells with greater efficiency than DCs loaded with NY( s). Sixty-five percent of these NY(s)-specific CD8+ T-cell lines could also be activated with the DCs pulsed with the peptide, NY157-165. Of these CD8+ T-cell lines, two were able to recognize the human melanoma cell line, SK-MEL-37, in a context of HLA-A*02. Only a small number of bvPLA2m CD8+ T-cell lines were induced, indicating the low immunogenicity of the protein. It was concluded that bvPLA2m can be used as a membrane-binding vector to promote MHC class II peptide presentation and MHC class I peptide cross-presentation. Such a system can, therefore, be tested for the preparation of cell-based vaccines.	[Almunia, Christine; Babon, Aurelie; Castelli, Florence Anne; Menez, Andre; Maillere, Bernard; Gillet, Daniel] Commissariat Energie Atom & Energies Alternat, Serv Ingn Mol Prot, Inst Biol & Technol Saclay, Gif Sur Yvette, France; [Held, Gerhard] Univ Klin Saarlandes, Med Klin 1, Homburg, Germany; [Almunia, Christine; Bretaudeau, Marie; Marchetti, Charles] Commissariat Energie Atom & Energies Alternat, Serv Biochim & Toxicol Nucl, Inst Biol Environm & Biotechnol, Bagnols Sur Ceze, France; [Menez, Andre] Museum Natl Hist Nat, F-75231 Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Universitatsklinikum des Saarlandes; CEA; Museum National d'Histoire Naturelle (MNHN)	Almunia, C (corresponding author), Commissariat Energie Atom & Energies Alternat, Serv Ingn Mol Prot, Inst Biol & Technol Saclay, Gif Sur Yvette, France.	christine.almunia@cea.fr	Gillet, Daniel/C-5592-2008	Gillet, Daniel/0000-0003-0477-3599	CEA; Association pour la Recherche sur le Cancer [5876]	CEA(French Atomic Energy Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by the CEA and grant #5876 from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Annand RR, 1996, BIOCHEMISTRY-US, V35, P4591, DOI 10.1021/bi9528412; Babon A, 2005, FEBS LETT, V579, P1658, DOI 10.1016/j.febslet.2005.02.019; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Beinart Garth, 2005, Clin Prostate Cancer, V4, P55, DOI 10.3816/CGC.2005.n.013; Bioley G, 2009, J IMMUNOTHER, V32, P161, DOI 10.1097/CJI.0b013e31819302f6; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buhot C, 2004, PROTEIN SCI, V13, P2970, DOI 10.1110/ps.04885404; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chen YT, 1997, CYTOGENET CELL GENET, V79, P237, DOI 10.1159/000134734; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chenal A, 2002, J BIOL CHEM, V277, P43425, DOI 10.1074/jbc.M204148200; De Luca A, 2012, J CLIN INVEST, V122, P1816, DOI 10.1172/JCI60862; den Brok MHMGM, 2005, EXPERT REV VACCINES, V4, P699, DOI 10.1586/14760584.4.5.699; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Held G, 2004, EUR J IMMUNOL, V34, P2919, DOI 10.1002/eji.200425297; Higano CS, 2009, CANCER-AM CANCER SOC, V115, P3670, DOI 10.1002/cncr.24429; ILLINGER D, 1991, BIOL CELL, V73, P131, DOI 10.1016/0248-4900(91)90095-5; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7306, DOI 10.1021/bi00243a036; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kreer Christoph, 2011, Front Immunol, V2, P87, DOI 10.3389/fimmu.2011.00087; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Luckey CJ, 1998, J IMMUNOL, V161, P112; MAILLERE B, 1995, TOXICON, V33, P475, DOI 10.1016/0041-0101(94)00186-C; Mandic M, 2005, J IMMUNOL, V174, P1751, DOI 10.4049/jimmunol.174.3.1751; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Palucka AK, 2008, J IMMUNOTHER, V31, P793, DOI 10.1097/CJI.0b013e31818403bc; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; ROCK KL, 1993, J IMMUNOL, V150, P438; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x; Tavallaie M, 2004, FEBS LETT, V572, P299, DOI 10.1016/j.febslet.2004.06.094; Villunger A, 1999, NAT MED, V5, P874, DOI 10.1038/11311; Yewdell JW, 2001, J CELL SCI, V114, P845; Zarei S, 2009, BLOOD, V113, P6658, DOI 10.1182/blood-2008-06-161075; Zarour HM, 2000, P NATL ACAD SCI USA, V97, P400, DOI 10.1073/pnas.97.1.400; Zeng G, 2006, J IMMUNOL, V177, P3582, DOI 10.4049/jimmunol.177.6.3582	44	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67645	10.1371/journal.pone.0067645	http://dx.doi.org/10.1371/journal.pone.0067645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825678	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400191
J	Gong, HL; Shi, Y; Zhou, L; Wu, CP; Cao, PY; Tao, L; Xu, C; Hou, DS; Wang, YZ				Gong, Hong-Li; Shi, Yi; Zhou, Liang; Wu, Chun-Ping; Cao, Peng-Yu; Tao, Lei; Xu, Chen; Hou, Dong-Sheng; Wang, Yue-Zhu			The Composition of Microbiome in Larynx and the Throat Biodiversity between Laryngeal Squamous Cell Carcinoma Patients and Control Population	PLOS ONE			English	Article							DIVERSITY; GUT; INFECTIONS; NUTRITION; COMMENSAL	The throat is an ecological assemblage involved human cells and microbiota, and the colonizing bacteria are important factors in balancing this environment. However, this bacterial community profile has thus been poorly investigated. The purpose of this study was to investigate the microbial biology of the larynx and to analyze the throat biodiversity in laryngeal carcinoma patients compared to a control population in a case-control study. Barcoded pyrosequencing analysis of the 16S rRNA gene was used. We collected tissue samples from 29 patients with laryngeal carcinoma and 31 control patients with vocal cord polyps. The findings of high-quality sequence datasets revealed 218 genera from 13 phyla in the laryngeal mucosa. The predominant communities of phyla in the larynx were Firmicutes (54%), Fusobacteria (17%), Bacteroidetes (15%), Proteobacteria (11%), and Actinobacteria (3%). The leading genera were Streptococcus (36%), Fusobacterium (15%), Prevotella (12%), Neisseria (6%), and Gemella (4%). The throat bacterial compositions were highly different between laryngeal carcinoma subjects and control population (p = 0.006). The abundance of the 26 genera was significantly different between the laryngeal cancer and control groups by metastats analysis (p < 0.05). Fifteen genera may be associated with laryngeal carcinoma by partial least squares discriminant analysis (p < 0.001). In summary, this study revealed the microbiota profiles in laryngeal mucosa from tissue specimens. The compositions of bacteria community in throat were different between laryngeal cancer patients and controls, and probably were related with this carcinoma. The disruption of this bio-ecological niche might be a risk factor for laryngeal carcinoma.	[Gong, Hong-Li; Zhou, Liang; Wu, Chun-Ping; Cao, Peng-Yu; Tao, Lei] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China; [Shi, Yi] Fudan Univ, Dept Clin Lab, Shanghai Pudong Hosp, Pudong Med Ctr, Shanghai 200433, Peoples R China; [Xu, Chen; Hou, Dong-Sheng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med, Dept Histol & Embryol, Shanghai 200030, Peoples R China; [Wang, Yue-Zhu] Chinese Natl Human Genome Sequencing Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Shi, Y (corresponding author), Fudan Univ, Dept Clin Lab, Shanghai Pudong Hosp, Pudong Med Ctr, Shanghai 200433, Peoples R China.	yishi750@163.com; zhoulent@126.com	Zhou, Liang/AAJ-4024-2020		National Natural Science Foundation of China [81001203]; Academic Leaders Training Program of Pudong Health Bureau of Shanghai [PWRd2012-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Leaders Training Program of Pudong Health Bureau of Shanghai	This work was supported by National Natural Science Foundation of China, No. 81001203, and was funded by the Academic Leaders Training Program of Pudong Health Bureau of Shanghai (Grant No. PWRd2012-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; El-Sharif A, 2012, FUTURE MICROBIOL, V7, P1423, DOI [10.2217/fmb.12.125, 10.2217/FMB.12.125]; Gale N, 2009, HISTOPATHOLOGY, V54, P639, DOI 10.1111/j.1365-2559.2008.03111.x; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Gong HL, 2012, CLIN TRANSL ONCOL, V14, P905, DOI 10.1007/s12094-012-0879-y; Hand D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053115; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; James WPT, 2012, NUTR REV, V70, pS87, DOI 10.1111/j.1753-4887.2012.00497.x; Kahrstrom CT, 2012, NAT REV MICROBIOL, V10, DOI 10.1038/nrmicro2878; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kelly D, 2012, NUTR REV, V70, pS18, DOI 10.1111/j.1753-4887.2012.00498.x; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Peyyala R, 2013, J DENT RES; Peyyala R, 2012, CYTOKINE, V58, P65, DOI 10.1016/j.cyto.2011.12.016; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rudolph E, 2011, EUR ARCH OTO-RHINO-L, V268, P165, DOI 10.1007/s00405-010-1395-8; Santos AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028088; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siqueira JF, 2008, J ENDODONT, V34, P1457, DOI 10.1016/j.joen.2008.08.037; Sobin LH, 2002, INT UN CANC UICC TNM; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tirandaz H, 2013, MED HYPOTHESES, V80, P675, DOI 10.1016/j.mehy.2013.01.024; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; Walker A, 2007, NAT REV MICROBIOL, V5, P572, DOI 10.1038/nrmicro1720; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Widdicombe J, 2004, DRUG AGING, V21, P243, DOI 10.2165/00002512-200421040-00003; Yamanaka W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042806; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhuo XL, 2008, ARCH MED RES, V39, P625, DOI 10.1016/j.arcmed.2008.04.008	49	55	56	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66476	10.1371/journal.pone.0066476	http://dx.doi.org/10.1371/journal.pone.0066476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824228	Green Submitted, gold, Green Published			2022-12-27	WOS:000320576400116
J	Kalliokoski, S; Sulic, AM; Korponay-Szabo, IR; Szondy, Z; Frias, R; Perez, MA; Martucciello, S; Roivainen, A; Pelliniemi, LJ; Esposito, C; Griffin, M; Sblattero, D; Maki, M; Kaukinen, K; Lindfors, K; Caja, S				Kalliokoski, Suvi; Sulic, Ana-Marija; Korponay-Szabo, Ilma R.; Szondy, Zsuzsa; Frias, Rafael; Perez, Mileidys Alea; Martucciello, Stefania; Roivainen, Anne; Pelliniemi, Lauri J.; Esposito, Carla; Griffin, Martin; Sblattero, Daniele; Maki, Markku; Kaukinen, Katri; Lindfors, Katri; Caja, Sergio			Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; NEOVASCULARIZATION; ERYTHROPOIETIN; GROWTH	A characteristic feature of celiac disease is the presence of circulating autoantibodies targeted against transglutaminase 2 (TG2), reputed to have a function in angiogenesis. In this study we investigated whether TG2-specific autoantibodies derived from celiac patients inhibit angiogenesis in both ex vivo and in vivo models and sought to clarify the mechanism behind this phenomenon. We used the ex vivo murine aorta-ring and the in vivo mouse matrigel-plug assays to address aforementioned issues. We found angiogenesis to be impaired as a result of celiac disease antibody supplementation in both systems. Our results also showed the dynamics of endothelial cells was affected in the presence of celiac antibodies. In the in vivo angiogenesis assays, the vessels formed were able to transport blood despite impairment of functionality after treatment with celiac autoantibodies, as revealed by positron emission tomography. We conclude that celiac autoantibodies inhibit angiogenesis ex vivo and in vivo and impair vascular functionality. Our data suggest that the anti-angiogenic mechanism of the celiac disease-specific autoantibodies involves extracellular TG2 and inhibited endothelial cell mobility.	[Kalliokoski, Suvi; Sulic, Ana-Marija; Korponay-Szabo, Ilma R.; Martucciello, Stefania; Maki, Markku; Lindfors, Katri; Caja, Sergio] Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Kalliokoski, Suvi; Sulic, Ana-Marija; Korponay-Szabo, Ilma R.; Martucciello, Stefania; Maki, Markku; Lindfors, Katri; Caja, Sergio] Tampere Univ Hosp, Tampere, Finland; [Korponay-Szabo, Ilma R.] Heim Pal Childrens Hosp, Celiac Dis Ctr, Budapest, Hungary; [Korponay-Szabo, Ilma R.] Univ Debrecen, Dept Paediat, Med & Hlth Sci Ctr, Debrecen, Hungary; [Szondy, Zsuzsa] Univ Debrecen, Dept Biochem & Mol Biol, Med & Hlth Sci Ctr, Debrecen, Hungary; [Frias, Rafael] Univ Turku, Cent Anim Lab, Turku, Finland; [Perez, Mileidys Alea; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Martucciello, Stefania; Esposito, Carla] Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy; [Roivainen, Anne] Turku Univ Hosp, Turku PET Ctr, FIN-20520 Turku, Finland; [Roivainen, Anne] Univ Turku, Turku, Finland; [Roivainen, Anne] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Pelliniemi, Lauri J.] Univ Turku, Lab Electron Microscopy, Turku, Finland; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Kaukinen, Katri] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kaukinen, Katri] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, Tampere, Finland; [Kaukinen, Katri] Seinajoki Cent Hosp, Dept Med, Seinajoki, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Debrecen; University of Debrecen; University of Turku; Aston University; University of Salerno; University of Turku; University of Turku; University of Turku; University of Turku; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Tampere University; Tampere University; Tampere University Hospital; Seinajoki Central Hospital	Caja, S (corresponding author), Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland.	sergio.caja@uta.fi	Korponay-Szabó, Ilma/AFK-1690-2022; Korponay-Szabó, Ilma/AAF-9048-2022; Frías, Rafael/AAE-5664-2020; Caja, Sergio/H-5947-2015	Griffin, Martin/0000-0003-3824-306X; Kalliokoski, Suvi/0000-0003-2934-3077; Roivainen, Anne/0000-0002-4006-7977; MARTUCCIELLO, STEFANIA/0000-0002-3720-1442; Caja, Sergio/0000-0003-2662-3145; Caja Galan, Sergio/0000-0002-5161-880X; Sblattero, Daniele/0000-0003-4309-242X	Academy of Finland; Sigrid Juselius Foundation; Pediatric Research Foundation; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital [9P033, 9P020]; Finnish Coeliac Society; Elna Kaarina Savolainen's fund; Hungarian Scientific Research Fund [OTKA K101788]; European Commission [PIA-GA-2010-251506, PERG08-GA-2010-277049]; University of Turku; Turku University Hospital; Abo Akademi University; EC Marie Curie Research Training Network [MRTN-CT-20010-289964]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Pediatric Research Foundation; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Finnish Coeliac Society; Elna Kaarina Savolainen's fund; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Commission(European CommissionEuropean Commission Joint Research Centre); University of Turku; Turku University Hospital; Abo Akademi University; EC Marie Curie Research Training Network(European Commission)	This work was supported by grants to Celiac Disease Study Group from the Academy of Finland, the Sigrid Juselius Foundation, the Pediatric Research Foundation, the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (grants 9P033 and 9P020), the Research Fund of the Finnish Coeliac Society, Elna Kaarina Savolainen's fund allocated for the development of cancer treatment, the Hungarian Scientific Research Fund (OTKA K101788), and the European Commission (contract numbers PIA-GA-2010-251506 and PERG08-GA-2010-277049). PET studies were conducted within the Finnish Center of Excellence in Molecular Imaging in Cardiovascular and Metabolic Research supported by the Academy of Finland, the University of Turku, Turku University Hospital, and Abo Akademi University. This work was supported by EC Marie Curie Research Training Network (MRTN-CT-20010-289964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alkim C, 2012, LIBYAN J MED, V7, DOI 10.3402/ljm.v7i0.8942; Caja S, 2010, SCAND J GASTROENTERO, V45, P421, DOI 10.3109/00365520903540822; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheng XW, 2011, HYPERTENSION, V57, P981, DOI 10.1161/HYPERTENSIONAHA.110.168385; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Figg WD, 2008, ANGIOGENESIS INTEGRA, P55; FROJDMAN K, 1992, DIFFERENTIATION, V50, P113, DOI 10.1111/j.1432-0436.1992.tb00492.x; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Jones RA, 2006, CELL DEATH DIFFER, V13, P1442, DOI 10.1038/sj.cdd.4401816; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Malinda Katherine M., 2009, V467, P287, DOI 10.1007/978-1-59745-241-0_17; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Myrsky E, 2009, CELL MOL LIFE SCI, V66, P3375, DOI 10.1007/s00018-009-0116-1; Myrsky E, 2009, SCAND J GASTROENTERO, V44, P162, DOI 10.1080/00365520802400875; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Pagonopoulou O, 2008, IN VIVO, V22, P587; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Rubio-Tapia A, 2012, MAYO CLIN PROC, V87, P732, DOI 10.1016/j.mayocp.2012.06.003; Simon-Vecsei Z, 2012, P NATL ACAD SCI USA, V109, P431, DOI 10.1073/pnas.1107811108; SMITH KA, 1988, BRIT J CANCER, V57, P247, DOI 10.1038/bjc.1988.54; [No title captured]	30	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65887	10.1371/journal.pone.0065887	http://dx.doi.org/10.1371/journal.pone.0065887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824706	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400029
J	Ku, C; Chung, WC; Chen, LL; Kuo, CH				Ku, Chuan; Chung, Wan-Chia; Chen, Ling-Ling; Kuo, Chih-Horng			The Complete Plastid Genome Sequence of Madagascar Periwinkle Catharanthus roseus (L.) G. Don: Plastid Genome Evolution, Molecular Marker Identification, and Phylogenetic Implications in Asterids	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; TRANSFER-RNA; HIGHER-PLANTS; GENES; GENERATION; DNA; MICROSATELLITES; DIVERSIFICATION; ANGIOSPERM; AMBORELLA	The Madagascar periwinkle (Catharanthus roseus in the family Apocynaceae) is an important medicinal plant and is the source of several widely marketed chemotherapeutic drugs. It is also commonly grown for its ornamental values and, due to ease of infection and distinctiveness of symptoms, is often used as the host for studies on phytoplasmas, an important group of uncultivated plant pathogens. To gain insights into the characteristics of apocynaceous plastid genomes (plastomes), we used a reference-assisted approach to assemble the complete plastome of C. roseus, which could be applied to other C. roseus-related studies. The C. roseus plastome is the second completely sequenced plastome in the asterid order Gentianales. We performed comparative analyses with two other representative sequences in the same order, including the complete plastome of Coffea arabica (from the basal Gentianales family Rubiaceae) and the nearly complete plastome of Asclepias syriaca (Apocynaceae). The results demonstrated considerable variations in gene content and plastome organization within Apocynaceae, including the presence/absence of three essential genes (i.e., accD, clpP, and ycf1) and large size changes in non-coding regions (e. g., rps2-rpoC2 and IRb-ndhF). To find plastome markers of potential utility for Catharanthus breeding and phylogenetic analyses, we identified 41 C. roseus-specific simple sequence repeats. Furthermore, five intergenic regions with high divergence between C. roseus and three other euasterids I taxa were identified as candidate markers. To resolve the euasterids I interordinal relationships, 82 plastome genes were used for phylogenetic inference. With the addition of representatives from Apocynaceae and sampling of most other asterid orders, a sister relationship between Gentianales and Solanales is supported.	[Ku, Chuan; Chung, Wan-Chia; Chen, Ling-Ling; Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Mol & Biol Agr Sci Program, Taiwan Int Grad Program, Taipei, Taiwan; [Kuo, Chih-Horng] Acad Sinica, Taipei 115, Taiwan; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University	Kuo, CH (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	chk@gate.sinica.edu.tw	Chen, Ling-Ling/AAY-3547-2021; Kuo, Chih-Horng/E-2045-2013; Ku, Chuan/N-3093-2013	Kuo, Chih-Horng/0000-0002-2857-0529; Ku, Chuan/0000-0001-6414-4423	National Science Council of Taiwan [NSC 99-2313-B-001-006-MY2]; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	Funding for this work was provided by research grants from the National Science Council of Taiwan (NSC 99-2313-B-001-006-MY2) and Academia Sinica to CHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albach DC, 2001, ANN MO BOT GARD, V88, P163, DOI 10.2307/2666224; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backlund M, 2000, AM J BOT, V87, P1029, DOI 10.2307/2657003; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Contin A, 1998, FEBS LETT, V434, P413, DOI 10.1016/S0014-5793(98)01022-9; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hatch SB, 2004, MUTAT RES-FUND MOL M, V545, P117, DOI 10.1016/j.mrfmmm.2003.09.015; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; KANNO A, 1993, CURR GENET, V23, P166, DOI 10.1007/BF00352017; Kim SW, 2007, BIOTECHNOL BIOPROC E, V12, P646, DOI 10.1007/BF02931081; Kim SW, 2009, J PLANT BIOL, V52, P462, DOI 10.1007/s12374-009-9059-1; Kode V, 2005, PLANT J, V44, P237, DOI 10.1111/j.1365-313X.2005.02533.x; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lian CL, 2006, J PLANT RES, V119, P415, DOI 10.1007/s10265-006-0274-2; Lo WS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-22; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marcone C, 1997, EUR J FOREST PATHOL, V27, P347; Martin W, 2005, TRENDS PLANT SCI, V10, P203, DOI 10.1016/j.tplants.2005.03.007; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; MORENO PRH, 1993, PLANT CELL REP, V12, P702, DOI 10.1007/BF00233423; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Pribylova Jaroslava, 2013, Methods Mol Biol, V938, P41, DOI 10.1007/978-1-62703-089-2_4; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roepke J, 2010, P NATL ACAD SCI USA, V107, P15287, DOI 10.1073/pnas.0911451107; Samson N, 2007, PLANT BIOTECHNOL J, V5, P339, DOI 10.1111/j.1467-7652.2007.00245.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Simoes AO, 2007, ANN MO BOT GARD, V94, P268, DOI 10.3417/0026-6493(2007)94[268:PASOTR]2.0.CO;2; Soltis DE, 2004, AM J BOT, V91, P997, DOI 10.3732/ajb.91.6.997; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Straub SCK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-211; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Swofford DL., 2003, PAUP PHYLOGENETIC AN; THURSTON MI, 2005, MSATFINDER DETECTION; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Winkworth RC, 2008, TAXON, V57, P53, DOI 10.2307/25065948; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yi DK, 2012, MOL CELLS, V33, P497, DOI 10.1007/s10059-012-2281-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	68	44	47	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68518	10.1371/journal.pone.0068518	http://dx.doi.org/10.1371/journal.pone.0068518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825699	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400198
J	Wuriyanghan, H; Falk, BW				Wuriyanghan, Hada; Falk, Bryce W.			RNA Interference towards the Potato Psyllid, Bactericera cockerelli, Is Induced in Plants Infected with Recombinant Tobacco mosaic virus (TMV)	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GENE KNOCKDOWN; EXPRESSION; RESISTANCE; TOMATO; VECTOR; SYSTEM; HOST	The potato/tomato psyllid, Bactericera cockerelli (B. cockerelli), is an important plant pest and the vector of the phloem-limited bacterium Candidatus Liberibacter psyllaurous (solanacearum), which is associated with the zebra chip disease of potatoes. Previously, we reported induction of RNA interference effects in B. cockerelli via in vitro-prepared dsRNA/siRNAs after intrathoracic injection, and after feeding of artificial diets containing these effector RNAs. In order to deliver RNAi effectors via plant hosts and to rapidly identify effective target sequences in plant-feeding B. cockerelli, here we developed a plant virus vector-based in planta system for evaluating candidate sequences. We show that recombinant Tobacco mosaic virus (TMV) containing B. cockerelli sequences can efficiently infect and generate small interfering RNAs in tomato (Solanum lycopersicum), tomatillo (Physalis philadelphica) and tobacco (Nicotiana tabacum) plants, and more importantly delivery of interfering sequences via TMV induces RNAi effects, as measured by actin and V-ATPase mRNA reductions, in B. cockerelli feeding on these plants. RNAi effects were primarily detected in the B. cockerelli guts. In contrast to our results with TMV, recombinant Potato virus X (PVX) and Tobacco rattle virus (TRV) did not give robust infections in all plants and did not induce detectable RNAi effects in B. cockerelli. The greatest RNA interference effects were observed when B. cockerelli nymphs were allowed to feed on leaf discs collected from inoculated or lower expanded leaves from corresponding TMV-infected plants. Tomatillo plants infected with recombinant TMV containing B. cockerelli actin or V-ATPase sequences also showed phenotypic effects resulting in decreased B. cockerelli progeny production as compared to plants infected by recombinant TMV containing GFP. These results showed that RNAi effects can be achieved in plants against the phloem feeder, B. cockerelli, and the TMV-plant system will provide a faster and more convenient method for screening of suitable RNAi target sequences in planta.	[Wuriyanghan, Hada; Falk, Bryce W.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Wuriyanghan, Hada] Inner Mongolia Univ, Life Sci Coll, Hohhot, Inner Mongolia, Peoples R China	University of California System; University of California Davis; Inner Mongolia University	Falk, BW (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	bwfalk@ucdavis.edu		Yan, Zhiyong/0000-0001-8253-0694	Florida Citrus Research and Development Foundation (FDACS) [NAS ID 122]; University of California	Florida Citrus Research and Development Foundation (FDACS); University of California(University of California System)	This work was funded in part by a grant from the Florida Citrus Research and Development Foundation (FDACS Contract Number NAS ID 122) and the University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Becker A, 2010, TRENDS PLANT SCI, V15, P1, DOI 10.1016/j.tplants.2009.09.002; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Casteel CL, 2006, ENTOMOL EXP APPL, V121, P67, DOI 10.1111/j.1570-8703.2006.00458.x; CHAPMAN S, 1992, PLANT J, V2, P549; Ding SW, 2011, CURR OPIN VIROL, V1, P533, DOI 10.1016/j.coviro.2011.10.028; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Escobar MA, 2001, P NATL ACAD SCI USA, V98, P13437, DOI 10.1073/pnas.241276898; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Lindbo JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-52; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; PALUKAITIS P, 1983, VIROLOGY, V131, P533, DOI 10.1016/0042-6822(83)90518-4; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Rosa C, 2012, PEST MANAG SCI; Roy G, 2006, PHYTOPATHOLOGY, V96, P819, DOI 10.1094/PHYTO-96-0819; Stewart LR, 2009, VIROLOGY, V388, P212, DOI 10.1016/j.virol.2009.03.016; Tomilov AA, 2008, PLANT J, V56, P389, DOI 10.1111/j.1365-313X.2008.03613.x; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Valentine TA, 2007, PLANT BIOTECHNOL J, V5, P827, DOI 10.1111/j.1467-7652.2007.00289.x; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Yin CT, 2011, MOL PLANT MICROBE IN, V24, P554, DOI 10.1094/MPMI-10-10-0229; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504	42	57	63	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66050	10.1371/journal.pone.0066050	http://dx.doi.org/10.1371/journal.pone.0066050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824081	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400050
J	Kamiya, K; Shimizu, K; Saito, A; Igarashi, A; Kobashi, H				Kamiya, Kazutaka; Shimizu, Kimiya; Saito, Aya; Igarashi, Akihito; Kobashi, Hidenaga			Comparison of Optical Quality and Intraocular Scattering after Posterior Chamber Phakic Intraocular Lens with and without a Central Hole (Hole ICL and Conventional ICL) Implantation Using the Double-Pass Instrument	PLOS ONE			English	Article							HIGH MYOPIC ASTIGMATISM; ADMINISTRATION CLINICAL-TRIAL; FOLLOW-UP; COLLAMER LENS; CONTACT-LENS; IOL ICL; MODERATE	Purpose: To objectively compare the optical quality and the intraocular scattering after implantation of the posterior chamber phakic implantable collamer lens (Visian ICL (TM), STAAR Surgical) with and without a central artificial hole for moderate to high ametropia. Methods: This retrospective study comprised 28 eyes of 28 consecutive patients undergoing Hole ICL implantation (mean age +/- standard deviation, 30.3 +/- 5.8 years), and 24 age-matched eyes of 24 patients undergoing conventional ICL implantation (age, 30.4 +/- 6.1 years). We quantitatively assessed the postoperative values of MTF cutoff frequency, Strehl ratio, objective scattering index (OSI), and OQAS values (OVs), using an Optical Quality Analysis System (TM). We compared these postoperative variables between the two groups. Results: The mean MTF cutoff frequency, Strehl ratio, OSI, OV100%, OV 20%, and OV9%, were 26.21 +/- 8.32 cycles/degree, 0.16 +/- 0.04, 1.16 +/- 0.57, 0.87 +/- 0.28, 0.80 +/- 0.35, and 0.80 +/- 0.33, respectively, 3 months after Hole ICL implantation. We found no significant differences in the MTF cutoff frequency (Mann Whitney U test, p = 0.59), the Strehl ratio (p = 0.82), the OSI (p = 0.63), or the OVs at contrasts of 100% (p = 0.58), 20% (p = 0.40), and 9% (p = 0.87), between the two groups. Conclusions: Both Hole ICL and conventional ICL implantation provides an excellent optical performance including intraocular scattering. Newly developed Hole ICL implantation appears to be essentially equivalent in the optical quality variables to conventional ICL implantation, suggesting that the presence of the central artificial hole does not significantly affect the optical quality and the intraocular scattering after surgery.	[Kamiya, Kazutaka; Shimizu, Kimiya; Saito, Aya; Igarashi, Akihito; Kobashi, Hidenaga] Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan.	kamiyak-tky@umin.ac.jp						Alfonso JF, 2011, J CATARACT REFR SURG, V37, P873, DOI 10.1016/j.jcrs.2010.11.040; Alfonso JF, 2010, J CATARACT REFR SURG, V36, P568, DOI 10.1016/j.jcrs.2009.10.052; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Bhikoo R, 2010, CLIN EXP OPHTHALMOL, V38, P467, DOI 10.1111/j.1442-9071.2010.02273.x; Bloomenstein Marc R, 2002, Optometry, V73, P435; Fujisawa K, 2007, GRAEF ARCH CLIN EXP, V245, P114, DOI 10.1007/s00417-006-0338-y; Ieong A, 2010, OPHTHALMOLOGY, V117, P2295, DOI 10.1016/j.ophtha.2010.03.055; Jimenez-Alfaro I, 2001, J REFRACT SURG, V17, P641; Kamiya K, 2008, J CATARACT REFR SURG, V34, P1687, DOI 10.1016/j.jcrs.2008.06.030; Kamiya K, 2012, INVEST OPHTH VIS SCI, V53, P3161, DOI 10.1167/iovs.12-9650; Kamiya K, 2010, OPHTHALMOLOGY, V117, P2287, DOI 10.1016/j.ophtha.2010.03.054; Kamiya K, 2009, J CATARACT REFR SURG, V35, P1582, DOI 10.1016/j.jcrs.2009.03.052; Kamiya K, 2009, ARCH OPHTHALMOL-CHIC, V127, P845, DOI 10.1001/archophthalmol.2009.67; Lackner B, 2003, OPHTHALMOLOGY, V110, P2153, DOI 10.1016/S0161-6420(03)00830-3; Pineda-Fernandez A, 2004, J CATARACT REFR SURG, V30, P2277, DOI 10.1016/j.jcrs.2004.03.035; Sanders DR, 2007, OPHTHALMOLOGY, V114, P54, DOI 10.1016/j.ophtha.2006.08.049; Sanders DR, 2004, OPHTHALMOLOGY, V111, P1683, DOI 10.1016/j.ophtha.2004.03.026; Sanders DR, 1998, J CATARACT REFR SURG, V24, P607, DOI 10.1016/S0886-3350(98)80254-X; Schallhorn S, 2007, J REFRACT SURG, V23, P853, DOI 10.3928/1081-597X-20071101-01; Shimizu K, 2012, AM J OPHTHALMOL, V154, P486, DOI 10.1016/j.ajo.2012.04.001; Shimizu K, 2012, BRIT J OPHTHALMOL, V96, P409, DOI 10.1136/bjophthalmol-2011-300148; Shiratani T, 2008, GRAEF ARCH CLIN EXP, V246, P719, DOI 10.1007/s00417-007-0759-2; Uozato H, 2011, GRAEF ARCH CLIN EXP, V249, P1081, DOI 10.1007/s00417-010-1602-8; Uusitalo RJ, 2002, J CATARACT REFR SURG, V28, P29, DOI 10.1016/S0886-3350(01)01218-4; Vukich JA, 2003, OPHTHALMOLOGY, V110, P255, DOI 10.1016/S0161-6420(02)01771-2; Zaldivar R, 1998, J REFRACT SURG, V14, P294	26	42	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66846	10.1371/journal.pone.0066846	http://dx.doi.org/10.1371/journal.pone.0066846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825575	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000036
J	Wei, XZ; Meng, HJ; Jiang, MX				Wei, Xinzeng; Meng, Hongjie; Jiang, Mingxi			Landscape Genetic Structure of a Streamside Tree Species Euptelea pleiospermum (Eupteleaceae): Contrasting Roles of River Valley and Mountain Ridge	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; SCALE PATTERNS; RIPARIAN; DIVERSITY; SOFTWARE; INFERENCE; PLANT; FLOW; DIFFERENTIATION	We used landscape genetics and statistical models to test how landscape features influence connectivity or create barriers to dispersal for a mountain riparian tree species, Euptelea pleiospermum. Young leaves from 1078 individuals belonging to 36 populations at elevations of 900-2000 m along upper reaches of four rivers were genotyped using eight nuclear microsatellite markers. We found no evidence for the unidirectional dispersal hypothesis in E. pleiospermum within each river. The linear dispersal pattern along each river valley is mostly consistent with the "classical metapopulaton'' model. Mountain ridges separating rivers were genetic barriers for this wind-pollinated tree species with anemochorous seeds, whereas river valleys provided important corridors for dispersal. Gene flow among populations along elevational gradients within each river prevails over gene flow among populations at similar elevations but from different rivers. This pattern of gene flow is likely to promote elevational range shifts of plant populations and to hinder local adaptation along elevational gradients. This study provides a paradigm to determine which of the two strategies (migration or adaptation) will be adopted by mountain riparian plants under climate warming.	[Wei, Xinzeng; Meng, Hongjie; Jiang, Mingxi] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China; [Meng, Hongjie] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, MX (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China.	mxjiang@wbgcas.cn	Xinzeng, Wei/AAL-4076-2020	Wei, Xinzeng/0000-0002-5084-9390	National Natural Science Foundation of China [31070465, 31100344]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Nos. 31070465 and 31100344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; Beerli Peter, 2009, V17, P42; Belkhir K, 1996, GENETIX 4 05 LOGICIE; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fer T, 2008, FRESHWATER BIOL, V53, P1409, DOI 10.1111/j.1365-2427.2008.01973.x; Freckleton RP, 2002, J ECOL, V90, P419, DOI 10.1046/j.1365-2745.2002.00692.x; Fu L.K., 1992, CHINA PLANT RED DATA; Garcia-Fernandez A, 2012, ANN BOT-LONDON, V110, P1221, DOI 10.1093/aob/mcs195; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hahn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041608; Hampe A, 2002, BIOL CONSERV, V107, P263, DOI 10.1016/S0006-3207(02)00061-7; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Honnay O, 2010, J BIOGEOGR, V37, P1730, DOI 10.1111/j.1365-2699.2010.02331.x; Hu LJ, 2010, CONSERV GENET, V11, P77, DOI 10.1007/s10592-009-0004-0; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Imbert E, 2003, J ECOL, V91, P447, DOI 10.1046/j.1365-2745.2003.00772.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kikuchi S, 2011, CONSERV GENET, V12, P79, DOI 10.1007/s10592-009-9992-z; Li JX, 2008, THESIS GRADUATE U CH; Liu YF, 2006, AM J BOT, V93, P206, DOI 10.3732/ajb.93.2.206; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Markwith SH, 2007, AM J BOT, V94, P151, DOI 10.3732/ajb.94.2.151; Mejias JA, 2007, J BIOGEOGR, V34, P456, DOI 10.1111/j.1365-2699.2006.01627.x; Mitsui Y, 2010, AM J BOT, V97, P101, DOI 10.3732/ajb.0800220; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pan KY, 1991, ACTA PHYTOTAXON SIN, V29, P439; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pollux BJA, 2009, FRESHWATER BIOL, V54, P64, DOI 10.1111/j.1365-2427.2008.02100.x; Prentis PJ, 2008, FRESHWATER BIOL, V53, P973, DOI 10.1111/j.1365-2427.2008.01953.x; Prentis PJ, 2004, AUST J BOT, V52, P201, DOI 10.1071/BT03064; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK., 2010, DOCUMENTATION STRUCT; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RITLAND K, 1989, CAN J BOT, V67, P2017, DOI 10.1139/b89-255; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shi MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021302; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Suzuki W, 2002, FOREST ECOL MANAG, V157, P285, DOI 10.1016/S0378-1127(00)00667-8; Tero N, 2003, MOL ECOL, V12, P2073, DOI 10.1046/j.1365-294X.2003.01898.x; Tsuda Y, 2010, TREE GENET GENOMES, V6, P377, DOI 10.1007/s11295-009-0256-3; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wei XZ, 2010, SEED SCI TECHNOL, V38, P1; Wei XZ, 2010, FLORA, V205, P841, DOI 10.1016/j.flora.2010.04.003; Wei Xin-Zeng, 2008, Zhiwu Shengtai Xuebao, V32, P825, DOI 10.3773/j.issn.1005-264x.2008.04.011; Wei XZ, 2012, PLANT ECOL, V213, P909, DOI 10.1007/s11258-012-0052-2; Wei XZ, 2012, NEW PHYTOL, V193, P779, DOI 10.1111/j.1469-8137.2011.03957.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1943, GENETICS, V28, P114; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhang J, 2008, MOL ECOL RESOUR, V8, P314, DOI 10.1111/j.1471-8286.2007.01939.x; Zhu Z., 1999, SCI SURVEY SHENNONGJ	63	16	17	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66928	10.1371/journal.pone.0066928	http://dx.doi.org/10.1371/journal.pone.0066928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825588	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000045
J	Du, WG; Tu, MC; Radder, RS; Shine, R				Du, Wei-Guo; Tu, Ming-Chung; Radder, Rajkumar S.; Shine, Richard			Can Reptile Embryos Influence Their Own Rates of Heating and Cooling?	PLOS ONE			English	Article							WATER; EGG; THERMOREGULATION; EVOLUTION; EXCHANGE; PYTHONS	Previous investigations have assumed that embryos lack the capacity of physiological thermoregulation until they are large enough for their own metabolic heat production to influence nest temperatures. Contrary to intuition, reptile embryos may be capable of physiological thermoregulation. In our experiments, egg-sized objects (dead or infertile eggs, water-filled balloons, glass jars) cooled down more rapidly than they heated up, whereas live snake eggs heated more rapidly than they cooled. In a nest with diel thermal fluctuations, that hysteresis could increase the embryo's effective incubation temperature. The mechanisms for controlling rates of thermal exchange are unclear, but may involve facultative adjustment of blood flow. Heart rates of snake embryos were higher during cooling than during heating, the opposite pattern to that seen in adult reptiles. Our data challenge the view of reptile eggs as thermally passive, and suggest that embryos of reptile species with large eggs can influence their own rates of heating and cooling.	[Du, Wei-Guo; Tu, Ming-Chung; Radder, Rajkumar S.; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Du, Wei-Guo] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Tu, Ming-Chung] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	University of Sydney; Chinese Academy of Sciences; Institute of Zoology, CAS; National Taiwan Normal University	Shine, R (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	rick.shine@sydney.edu.au	Du, Wei-Guo/K-1071-2014		Australian Research Council; Taiwan National Science Council; Chinese Academy of Sciences	Australian Research Council(Australian Research Council); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Chinese Academy of Sciences(Chinese Academy of Sciences)	The Australian Research Council, the Taiwan National Science Council and "One Hundred Talent Programme'' of the Chinese Academy of Sciences supported this work financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RA, 1985, COPEIA, P703, DOI 10.2307/1444764; Bartholomew G.A., 1982, Biology of Reptilia, V12, P167; Boughner JC, 2007, ZOOLOGY, V110, P212, DOI 10.1016/j.zool.2007.01.005; Denny MW, 1993, AIR WATER BIOL PHYS, P145; Du WG, 2011, P NATL ACAD SCI USA, V108, P9513, DOI 10.1073/pnas.1102965108; Du WG, 2009, J EXP BIOL, V212, P1302, DOI 10.1242/jeb.027425; Dzialowski EM, 2001, J THERM BIOL, V26, P231, DOI 10.1016/S0306-4565(00)00050-4; Ewert MA, 2003, J THERM BIOL, V28, P159, DOI 10.1016/S0306-4565(02)00053-0; Gans C, 1982, BIOL REPTILIA, P1; GRIGG GC, 1979, J THERM BIOL, V4, P95, DOI 10.1016/0306-4565(79)90052-4; Huey R.B., 1982, Biology of Reptilia, V12, P25; McCue Marshall D., 2004, P71; PACKARD GC, 1980, AM ZOOL, V20, P351; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R., 2004, P187; Shine R., 1988, BIOL REPTILIA, P275; SLIP DJ, 1988, J ZOOL, V216, P367; Somma L. A., 2003, PARENTAL BEHAV LEPID; Stahlschmidt ZR, 2008, ETHOLOGY, V114, P1113, DOI 10.1111/j.1439-0310.2008.01553.x; Tattersall GJ, 2006, RESP PHYSIOL NEUROBI, V154, P302, DOI 10.1016/j.resp.2006.02.011; TURNER JS, 1990, J THERM BIOL, V15, P211, DOI 10.1016/0306-4565(90)90004-2; Valenzuela N., 2004, P211; Zaar M, 2004, COMP BIOCHEM PHYS A, V137, P675, DOI 10.1016/j.cbpb.2004.01.028; Zbinden JA, 2006, J EXP MAR BIOL ECOL, V334, P151, DOI 10.1016/j.jembe.2006.01.021	24	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67095	10.1371/journal.pone.0067095	http://dx.doi.org/10.1371/journal.pone.0067095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826200	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400103
J	Gallos, LK; Potiguar, FQ; Andrade, JS; Makse, HA				Gallos, Lazaros K.; Potiguar, Fabricio Q.; Andrade, Jose S., Jr.; Makse, Hernan A.			IMDB Network Revisited: Unveiling Fractal and Modular Properties from a Typical Small-World Network	PLOS ONE			English	Article							COMPLEX; SPREAD	We study a subset of the movie collaboration network, http://www.imdb.com, where only adult movies are included. We show that there are many benefits in using such a network, which can serve as a prototype for studying social interactions. We find that the strength of links, i.e., how many times two actors have collaborated with each other, is an important factor that can significantly influence the network topology. We see that when we link all actors in the same movie with each other, the network becomes small-world, lacking a proper modular structure. On the other hand, by imposing a threshold on the minimum number of links two actors should have to be in our studied subset, the network topology becomes naturally fractal. This occurs due to a large number of meaningless links, namely, links connecting actors that did not actually interact. We focus our analysis on the fractal and modular properties of this resulting network, and show that the renormalization group analysis can characterize the self-similar structure of these networks.	[Gallos, Lazaros K.; Makse, Hernan A.] CUNY City Coll, Levich Inst, New York, NY 10031 USA; [Potiguar, Fabricio Q.] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Andrade, Jose S., Jr.] Fed Univ Para, ICEN, Fac Fis, BR-66059 Belem, Para, Brazil; Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Universidade Federal do Para; Universidade Federal do Ceara	Makse, HA (corresponding author), CUNY City Coll, Levich Inst, New York, NY 10031 USA.	hmakse@lev.ccny.cuny.edu	Andrade, José S/C-5451-2013; Potiguar, Fabricio Q./AAL-2329-2020	Andrade, José S/0000-0002-5571-7610; Potiguar, Fabricio Q./0000-0002-4922-9151; Gallos, Lazaros/0000-0002-2713-7934	CNPq; CAPES; FUNCAP; FUNCAP/Cnpq Pronex grant; National Institute of Science and Technology for Complex Systems in Brazil	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FUNCAP(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); FUNCAP/Cnpq Pronex grant; National Institute of Science and Technology for Complex Systems in Brazil	The authors acknowledge support from Brazilian agencies CNPq, CAPES, and FUNCAP, the FUNCAP/Cnpq Pronex grant, and the National Institute of Science and Technology for Complex Systems in Brazil for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; [Anonymous], 2012, AIRP COUNC INT ANN W; [Anonymous], 2012, INTERNET MAPPING PRO; [Anonymous], 2012, DATABASE INTERACTING; [Anonymous], 2009, INTERNET MOVIE DATAB; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERNARD HR, 1988, ETHNOLOGY, V27, P155, DOI 10.2307/3773626; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Davis GF, 1997, AM J SOCIOL, V103, P1, DOI 10.1086/231170; Fararo T, 1964, STUDY BIASED FRIENDS; Gallos LK, 2007, P NATL ACAD SCI USA, V104, P7746, DOI 10.1073/pnas.0700250104; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Galvao V, 2010, P NATL ACAD SCI USA, V107, P5750, DOI 10.1073/pnas.0914748107; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Kretzschmar M, 1996, MATH BIOSCI, V133, P165, DOI 10.1016/0025-5564(95)00093-3; Li G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018701; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rozenfeld HD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.025701; SATTENSPIEL L, 1988, MATH BIOSCI, V90, P341, DOI 10.1016/0025-5564(88)90074-0; Song CM, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/03/P03006; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; VANRAAN AFJ, 1990, NATURE, V347, P626, DOI 10.1038/347626a0; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	30	21	24	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66443	10.1371/journal.pone.0066443	http://dx.doi.org/10.1371/journal.pone.0066443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826098	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400020
J	Goldsworthy, M; Absalom, NL; Schroter, D; Matthews, HC; Bogani, D; Moir, L; Long, A; Church, C; Hugill, A; Anstee, QM; Goldin, R; Thursz, M; Hollfelder, F; Cox, RD				Goldsworthy, Michelle; Absalom, Nathan L.; Schroeter, David; Matthews, Helen C.; Bogani, Debora; Moir, Lee; Long, Anna; Church, Christopher; Hugill, Alison; Anstee, Quentin M.; Goldin, Rob; Thursz, Mark; Hollfelder, Florian; Cox, Roger D.			Mutations in Mll2, an H3K4 Methyltransferase, Result in Insulin Resistance and Impaired Glucose Tolerance in Mice	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FATTY LIVER-DISEASE; TYPE-2 DIABETES RISK; SUSCEPTIBILITY LOCI; PANCREATIC-ISLETS; GENETIC-VARIANTS; BETA-CELLS; MOUSE; EXPRESSION; SECRETION	We employed a random mutagenesis approach to identify novel monogenic determinants of type 2 diabetes. Here we show that haplo-insufficiency of the histone methyltransferase myeloid-lineage leukemia (Mll2/Wbp7) gene causes type 2 diabetes in the mouse. We have shown that mice heterozygous for two separate mutations in the SET domain of Mll2 or heterozygous Mll2 knockout mice were hyperglycaemic, hyperinsulinaemic and developed non-alcoholic fatty liver disease. Consistent with previous Mll2 knockout studies, mice homozygous for either ENU mutation (or compound heterozygotes) died during embryonic development at 9.5-14.5 days post coitum. Heterozygous deletion of Mll2 induced in the adult mouse results in a normal phenotype suggesting that changes in chromatin methylation during development result in the adult phenotype. Mll2 has been shown to regulate a small subset of genes, a number of which Neurod1, Enpp1, Slc27a2, and Plcxd1 are downregulated in adult mutant mice. Our results demonstrate that histone H3K4 methyltransferase Mll2 is a component of the genetic regulation necessary for glucose homeostasis, resulting in a specific disease pattern linking chromatin modification with causes and progression of type 2 diabetes, providing a basis for its further understanding at the molecular level.	[Goldsworthy, Michelle; Absalom, Nathan L.; Matthews, Helen C.; Bogani, Debora; Moir, Lee; Long, Anna; Church, Christopher; Hugill, Alison; Anstee, Quentin M.; Cox, Roger D.] MRC Harwell, Diabet Grp, Oxford, England; [Schroeter, David; Hollfelder, Florian] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Matthews, Helen C.; Thursz, Mark] Univ London Imperial Coll Sci Technol & Med, Acad Dept Med, London, England; [Anstee, Quentin M.] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Goldin, Rob] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England	MRC Harwell; University of Cambridge; Imperial College London; Newcastle University - UK; Imperial College London	Goldsworthy, M (corresponding author), MRC Harwell, Diabet Grp, Harwell Sci & Innovat Campus, Oxford, England.	m.goldsworthy@har.mrc.ac.uk	Anstee, Quentin M./L-2981-2013	Anstee, Quentin M./0000-0002-9518-0088; Cox, Roger/0000-0001-7170-5014; Moir, Lee/0000-0003-4829-3597; Thursz, Mark/0000-0002-8218-192X; Hollfelder, Florian/0000-0002-1367-6312; Goldin, Robert/0000-0001-5184-4519; Goldsworthy, Michelle/0000-0003-1354-7737	Higher Education Funding Council for England (HEFCE); Wellcome Trust Research Training Fellowship (OXION); Diabetes UK [BDA:RD07/0003447]; Medical Research Council [G84/6233, MC_U142661184] Funding Source: researchfish; National Institute for Health Research [CL-2007-21-007] Funding Source: researchfish; MRC [G84/6233, MC_U142661184] Funding Source: UKRI	Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Wellcome Trust Research Training Fellowship (OXION); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	QMA is the recipient of a Clinical Senior Lectureship Award from the Higher Education Funding Council for England (HEFCE). NLA was supported by a Wellcome Trust Research Training Fellowship (OXION) and by a Diabetes UK grant BDA:RD07/0003447. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Anstee QM, 2011, BBA-MOL BASIS DIS, V1812, P1557, DOI 10.1016/j.bbadis.2011.07.017; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Ghanaat-Pour H, 2007, J MOL ENDOCRINOL, V39, P135, DOI 10.1677/JME-07-0002; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Goldsworthy M, 2008, DIABETES, V57, P2234, DOI 10.2337/db07-0337; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hough TA, 2002, MAMM GENOME, V13, P595, DOI 10.1007/s00335-002-2188-1; Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Raychaudhuri N, 2008, J BIOL CHEM, V283, P13611, DOI 10.1074/jbc.M800128200; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shimomura K, 2009, METHOD ENZYMOL, V457, P451, DOI 10.1016/S0076-6879(09)05025-3; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Suh YH, 2005, BIOCHEM BIOPH RES CO, V337, P481, DOI 10.1016/j.bbrc.2005.09.078; Suh YH, 2005, J MOL ENDOCRINOL, V34, P299, DOI 10.1677/jme.1.01679; Toye AA, 2004, DIABETES, V53, P1577, DOI 10.2337/diabetes.53.6.1577; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Vrang N, 2010, OBESITY, V18, P1289, DOI 10.1038/oby.2009.361; Walker JN, 2011, DIABETES OBES METAB, V13, P95, DOI 10.1111/j.1463-1326.2011.01450.x; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Young EH, 2007, INT J OBESITY, V31, P1437, DOI 10.1038/sj.ijo.0803609; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	51	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e61870	10.1371/journal.pone.0061870	http://dx.doi.org/10.1371/journal.pone.0061870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826075	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400001
J	Arora, N; Sachdev, B; Gupta, R; Vimala, Y; Bhatnagar, RK				Arora, Naresh; Sachdev, Bindiya; Gupta, Rani; Vimala, Y.; Bhatnagar, Raj K.			Characterization of a Chitin-Binding Protein from Bacillus thuringiensis HD-1	PLOS ONE			English	Article							CRY1AC TOXIN; RESIDUES; MODULE; GENE	Strains of Bacillus thuringiensis produce insecticidal proteins. These strains have been isolated from diverse ecological niches, such as soil, phylloplane, insect cadavers and grain dust. To effectively propagate, these strains produce a range of molecules that facilitate its multiplication in a competing environment. In this report, we have examined synthesis of a chitin-binding protein and evaluated its effect on fungi encountered in environment and its interaction with insecticidal proteins synthesized by B. thuringiensis. The gene encoding chitin-binding protein has been cloned and expressed. The purified protein has been demonstrated to interact with Cry insecticidal protein, Cry1Ac by Circular Dichrosim spectroscopy (CD) and in vitro pull down assays. The chitin-binding protein potentiates insecticidal activity of bacillar insecticidal protein, Cry1Ac. Further, chitin-binding protein was fungistatic against several soil fungi. The chitin binding protein is expressed in spore mother cell and deposited along with insecticidal protein, Cry1Ac. It interacts with Cry1Ac to potentiate its insecticidal activity and facilitate propagation of Bacillus strain in environment by inhibiting growth of certain fungi.	[Arora, Naresh; Sachdev, Bindiya; Bhatnagar, Raj K.] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Gupta, Rani] Univ Delhi, Dept Microbiol, New Delhi, India; [Vimala, Y.] Ch Charan Singh Univ, Dept Bot, Meerut, Uttar Pradesh, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Delhi; Chaudhary Charan Singh University	Bhatnagar, RK (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi, India.	raj@icgeb.res.in	Sachdev, Bindiya/AAR-7156-2020	Arora, Naresh/0000-0003-2131-735X	"International Center for Genetic Engineering and Biotechnology'' (ICGEB), New Delhi, India	"International Center for Genetic Engineering and Biotechnology'' (ICGEB), New Delhi, India	This work was supported by research grant of "International Center for Genetic Engineering and Biotechnology'' (ICGEB), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2008, INT J PEPT RES THER, V14, P21, DOI 10.1007/s10989-007-9095-y; Ahmad T, 2003, BIOCHEM BIOPH RES CO, V310, P188, DOI 10.1016/j.bbrc.2003.08.136; Arora N, 2003, BIOCHEM BIOPH RES CO, V307, P620, DOI 10.1016/S0006-291X(03)01228-2; CHARNEY J, 1947, J BIOL CHEM, V171, P501; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; HJELMELAND K, 1982, COMP BIOCHEM PHYS B, V71, P557, DOI 10.1016/0305-0491(82)90462-X; Lee MK, 1999, APPL ENVIRON MICROB, V65, P4513; Liu Y, 2002, ANTIMICROB AGENTS CH, V46, P1455, DOI 10.1128/AAC.46.5.1455-1461.2002; Mishra RN, 2002, BIOTECHNIQUES, V33, P830, DOI 10.2144/02334st07; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Neeraja C, 2010, CRIT REV BIOTECHNOL, V30, P231, DOI 10.3109/07388551.2010.487258; Neeraja C, 2010, BIORESOURCE TECHNOL, V101, P3635, DOI 10.1016/j.biortech.2009.12.118; Pena G, 2006, APPL ENVIRON MICROB, V72, P353, DOI 10.1128/AEM.72.1.353-360.2006; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Purushotham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036714; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; Rajagopal R, 2009, BIOCHEM J, V419, P309, DOI 10.1042/BJ20081152; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHNELLMANN J, 1994, MOL MICROBIOL, V13, P807, DOI 10.1111/j.1365-2958.1994.tb00473.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; SHARPE ES, 1975, APPL MICROBIOL, V30, P1052, DOI 10.1128/AEM.30.6.1052-1053.1975; SHIMAHARA K, 1988, METHOD ENZYMOL, V161, P417; SPURLINO JC, 1992, J MOL BIOL, V226, P15, DOI 10.1016/0022-2836(92)90119-5; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Tunnicliffe RB, 2005, J MOL BIOL, V347, P287, DOI 10.1016/j.jmb.2005.01.038; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; WU D, 1991, FEMS MICROBIOL LETT, V81, P31, DOI 10.1016/0378-1097(91)90466-N	30	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66603	10.1371/journal.pone.0066603	http://dx.doi.org/10.1371/journal.pone.0066603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824872	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400136
J	Maher, RL; Morrical, SW				Maher, Robyn L.; Morrical, Scott W.			Coordinated Binding of Single-Stranded and Double-Stranded DNA by UvsX Recombinase	PLOS ONE			English	Article							ESCHERICHIA-COLI RECA; HOMOLOGOUS RECOMBINATION; BACTERIOPHAGE-T4 UVSX; HUMAN RAD51; SACCHAROMYCES-CEREVISIAE; MEDIATOR PROTEIN; ATP HYDROLYSIS; DYNAMICS; REPLICATION; BREAKS	Homologous recombination is important for the error-free repair of DNA double-strand breaks and for replication fork restart. Recombinases of the RecA/Rad51 family perform the central catalytic role in this process. UvsX recombinase is the RecA/Rad51 ortholog of bacteriophage T4. UvsX and other recombinases form presynaptic filaments on ssDNA that are activated to search for homology in dsDNA and to perform DNA strand exchange. To effectively initiate recombination, UvsX must find and bind to ssDNA within an excess of dsDNA. Here we examine the binding of UvsX to ssDNA and dsDNA in the presence and absence of nucleotide cofactor, ATP. We also examine how the binding of one DNA substrate is affected by simultaneous binding of the other to determine how UvsX might selectively assemble on ssDNA. We show that the two DNA binding sites of UvsX are regulated by the nucleotide cofactor ATP and are coordinated with each other such that in the presence of ssDNA, dsDNA binding is significantly reduced and correlated with its homology to the ssDNA bound to the enzyme. UvsX has high affinity for dsDNA in the absence of ssDNA, which may allow for sequestration of the enzyme in an inactive form prior to ssDNA generation.	[Maher, Robyn L.; Morrical, Scott W.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Morrical, SW (corresponding author), Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA.	smorrica@uvm.edu			National Institutes of Health research [R01GM48847]; American Cancer Society [PF-09-254-01-DMC]	National Institutes of Health research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society)	This work was supported by National Institutes of Health research grant no. R01GM48847 to SWM and by American Cancer Society postdoctoral fellowship no. PF-09-254-01-DMC to RLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2008, METHOD ENZYMOL, V450, P253, DOI 10.1016/S0076-6879(08)03412-5; Ando RA, 1998, J MOL BIOL, V283, P785, DOI 10.1006/jmbi.1998.2124; Bar-Ziv R, 2001, P NATL ACAD SCI USA, V98, P9068, DOI 10.1073/pnas.151242898; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; CAZENAVE C, 1983, EMBO J, V2, P2247, DOI 10.1002/j.1460-2075.1983.tb01730.x; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Eisen JA, 1995, J MOL EVOL, V41, P1105; Farb JN, 2009, J MOL BIOL, V385, P393, DOI 10.1016/j.jmb.2008.11.003; FORMOSA T, 1986, J BIOL CHEM, V261, P6107; Gajewski S, 2011, J MOL BIOL, V405, P65, DOI 10.1016/j.jmb.2010.10.004; Goddard NL, 2000, PHYS REV LETT, V85, P2400, DOI 10.1103/PhysRevLett.85.2400; GRIFFITH J, 1985, J BIOL CHEM, V260, P4484; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KODADEK T, 1990, J BIOL CHEM, V265, P20966; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Lieber MR, 1998, AM J PATHOL, V153, P1323, DOI 10.1016/S0002-9440(10)65716-1; Liu J, 2006, BIOCHEMISTRY-US, V45, P5493, DOI 10.1021/bi0525167; Liu J, 2006, J BIOL CHEM, V281, P26308, DOI 10.1074/jbc.M604349200; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; Liu J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-357; LLOYD AT, 1993, J MOL EVOL, V37, P399; Maher RL, 2011, J CELL BIOCH; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Mishra G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031930; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; Sandler SJ, 1996, NUCLEIC ACIDS RES, V24, P2125, DOI 10.1093/nar/24.11.2125; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sweezy MA, 1997, J MOL BIOL, V266, P927, DOI 10.1006/jmbi.1996.0829; Xu H, 2010, NUCLEIC ACIDS RES, V38, P4821, DOI 10.1093/nar/gkq219; Yang SX, 2001, J MOL BIOL, V312, P999, DOI 10.1006/jmbi.2001.5025; YONESAKI T, 1985, EMBO J, V4, P3321, DOI 10.1002/j.1460-2075.1985.tb04083.x; YU X, 1993, J MOL BIOL, V232, P1, DOI 10.1006/jmbi.1993.1363; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	41	9	10	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66654	10.1371/journal.pone.0066654	http://dx.doi.org/10.1371/journal.pone.0066654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824136	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400141
J	Perez-Montarelo, D; Fernandez, A; Barragan, C; Noguera, JL; Folch, JM; Rodriguez, MC; Ovilo, C; Silio, L; Fernandez, AI				Perez-Montarelo, Dafne; Fernandez, Almudena; Barragan, Carmen; Noguera, Jose L.; Folch, Josep M.; Carmen Rodriguez, M.; Ovilo, Cristina; Silio, Luis; Fernandez, Ana I.			Transcriptional Characterization of Porcine Leptin and Leptin Receptor Genes	PLOS ONE			English	Article							RT-PCR; RELATIVE QUANTIFICATION; EARLY-PREGNANCY; MESSENGER-RNA; FAT TISSUE; LONG FORM; EXPRESSION; LOCALIZATION; PROMOTER; ISOFORMS	The leptin (LEP) and its receptor (LEPR) regulate food intake and energy balance through hypothalamic signaling. However, the LEP-LEPR axis seems to be more complex and its expression regulation has not been well described. In pigs, LEP and LEPR genes have been widely studied due to their relevance. Previous studies reported significant effects of SNPs located in both genes on growth and fatness traits. The aim of this study was to determine the expression profiles of LEP and LEPR across hypothalamic, adipose, hepatic and muscle tissues in Iberian x Landrace backcrossed pigs and to analyze the effects of gene variants on transcript abundance. To our knowledge, non porcine LEPR isoforms have been described rather than LEPRb. A short porcine LEPR isoform (LEPRa), that encodes a protein lacking the intracellular residues responsible of signal transduction, has been identified for the first time. The LEPRb isoform was only quantifiable in hypothalamus while LEPRa appeared widely expressed across tissues, but at higher levels in liver, suggesting that both isoforms would develop different roles. The unique LEP transcript showed expression in backfat and muscle. The effects of gene variants on transcript expression revealed interesting results. The LEPRc. 1987C> T polymorphism showed opposite effects on LEPRb and LEPRa hypothalamic expression. In addition, one out of the 16 polymorphisms identified in the LEPR promoter region revealed high differential expression in hepatic LEPRa. These results suggest a LEPR isoform-specific regulation at tissue level. Conversely, non-differential expression of LEP conditional on the analyzed polymorphisms could be detected, indicating that its regulation is likely affected by other mechanisms rather than gene sequence variants. The present study has allowed a transcriptional characterization of LEP and LEPR isoforms on a range of tissues. Their expression patterns seem to indicate that both molecules develop peripheral roles apart from their known hypothalamic signal transduction function.	[Perez-Montarelo, Dafne; Fernandez, Almudena; Barragan, Carmen; Carmen Rodriguez, M.; Ovilo, Cristina; Silio, Luis; Fernandez, Ana I.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Mejora Genet Anim, Madrid, Spain; [Noguera, Jose L.] Inst Recerca Tecnol Agroalimentaries, Lleida, Spain; [Folch, Josep M.] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Aliments, Bellaterra, Spain; [Folch, Josep M.] Ctr Recerca Agrigen, Bellaterra, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Perez-Montarelo, D (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Mejora Genet Anim, Madrid, Spain.	dafne.perez@inia.es	Fernández, Ana Isabel/J-3265-2012; Silio, Luis/R-6439-2019; Muñoz, Almudena Fernández/AAB-4608-2019; Ovilo, Cristina/N-9931-2014; Folch, Josep M/I-4738-2015	Fernández, Ana Isabel/0000-0002-1509-5191; Muñoz, Almudena Fernández/0000-0002-4495-9366; Ovilo, Cristina/0000-0002-5738-8435; Folch, Josep M/0000-0003-3689-1303	Ministerio de Ciencia e Innovacion (MICINN) [AGL2008-04818-C03, AGL2011-29821-C02-02]; Spanish Ministerio de Ciencia e Innovacion [BES-2009-025417]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by Ministerio de Ciencia e Innovacion (MICINN) projects AGL2008-04818-C03 and AGL2011-29821-C02-02. D. Perez-Montarelo was funded by a Formacion de Personal Investigador (FPI) PhD grant from the Spanish Ministerio de Ciencia e Innovacion (BES-2009-025417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bacart J, 2010, FEBS LETT, V584, P2213, DOI 10.1016/j.febslet.2010.03.033; Barb CR, 2001, DOMEST ANIM ENDOCRIN, V21, P297, DOI 10.1016/S0739-7240(01)00123-0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bogacka I, 2006, J PHYSIOL PHARMACOL, V57, P479; Brown DE, 2012, J DAIRY SCI, V95, P6384, DOI 10.3168/jds.2012-5593; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Cumin F, 1996, INT J OBESITY, V20, P1120; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Erkens T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-41; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Galve A, 2012, LIVEST SCI, V145, P145, DOI 10.1016/j.livsci.2012.01.010; Garibotto G, 1998, BIOCHEM BIOPH RES CO, V247, P504, DOI 10.1006/bbrc.1998.8819; Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308; Gu YR, 2011, ANIM SCI J, V82, P722, DOI 10.1111/j.1740-0929.2011.00908.x; Houseknecht KL, 1998, J ANIM SCI, V76, P1405; Hu XX, 2001, CHINESE SCI BULL, V46, P396, DOI 10.1007/BF03183273; Jensen MD, 1999, AM J CLIN NUTR, V69, P18; Kaminski T, 2006, J PHYSIOL PHARMACOL, V57, P95; Kin JH, 2008, C INT SOC AN GEN 200; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu DJ, 2011, MOL BIOL REP, V38, P2051, DOI 10.1007/s11033-010-0330-9; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Manavella PA, 2007, BIOCHEM BIOPH RES CO, V360, P621, DOI 10.1016/j.bbrc.2007.06.088; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Meyer C, 1997, AM J PHYSIOL-ENDOC M, V273, pE903, DOI 10.1152/ajpendo.1997.273.5.E903; Munoz G, 2011, MEAT SCI, V88, P169, DOI 10.1016/j.meatsci.2010.12.018; Munoz G, 2009, J ANIM SCI, V87, P459, DOI 10.2527/jas.2008-1127; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Oczkowicz M, 2010, DOMEST ANIM ENDOCRIN, V40, P147; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ovilo C, 2000, MAMM GENOME, V11, P344, DOI 10.1007/s003350010065; Ovilo C, 2010, MAMM GENOME, V21, P583, DOI 10.1007/s00335-010-9307-1; Perez-Montarelo D, 2012, ANIM GENET, V43, P805, DOI 10.1111/j.1365-2052.2012.02338.x; Pinson J, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-25; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rezamand P, 2012, J DAIRY SCI, V95, P7097, DOI 10.3168/jds.2012-5613; Rodriguez MC, 2010, P 9 WORLD C GEN APPL; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Stachowiak M, 2007, BIOCHEM GENET, V45, P245, DOI 10.1007/s10528-006-9070-x; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Stenger C, 2010, FASEB J, V24, P4218, DOI 10.1096/fj.10-160440; Svobodova K, 2008, J APPL GENET, V49, P263, DOI 10.1007/BF03195623; Switonski M, 2010, J APPL GENET, V51, P153, DOI 10.1007/BF03195724; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanPatten S, 2001, AM J PHYSIOL-GASTR L, V281, pG393, DOI 10.1152/ajpgi.2001.281.2.G393; Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335; Wrann CD, 2012, ADIPOCYTE, V1, P168, DOI 10.4161/adip.20574; Wylie ARG, 2011, ANIMAL, V5, P246, DOI 10.1017/S1751731110001540; Yadav VK, 2011, J EXP MED, V208, P41, DOI 10.1084/jem.20101940; Zeng JB, 1997, AM J PHYSIOL-ENDOC M, V273, pE1102, DOI 10.1152/ajpendo.1997.273.6.E1102	59	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66398	10.1371/journal.pone.0066398	http://dx.doi.org/10.1371/journal.pone.0066398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824082	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400103
J	Sykes, A; Edwards, MR; Macintyre, J; del Rosario, A; Gielen, V; Haas, J; Kon, OM; McHale, M; Johnston, SL				Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Kon, Onn Min; McHale, Mark; Johnston, Sebastian L.			TLR3, TLR4 and TLRs7-9 Induced Interferons Are Not Impaired in Airway and Blood Cells in Well Controlled Asthma	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; BRONCHIAL EPITHELIAL-CELLS; MONONUCLEAR-CELLS; RHINOVIRUS; INFECTION; DEFICIENT; RESPONSES; CHILDREN; AGONISTS; ALPHA	Defective Rhinovirus induced interferon-beta and interferon-lambda production has been reported in bronchial epithelial cells from asthmatics but the mechanisms of defective interferon induction in asthma are unknown. Virus infection can induce interferon through Toll like Receptors (TLR) 3, TLR7 and TLR8. The role of these TLRs in interferon induction in asthma is unclear. This objective of this study was to measure the type I and III interferon response to TLR in bronchial epithelial cells and peripheral blood cells from atopic asthmatics and non-atopic non-asthmatics. Bronchial epithelial cells and peripheral blood mononuclear cells from atopic asthmatic and non-atopic non-asthmatic subjects were stimulated with agonists to TLR3, TLR4 & TLRs7-9 and type I and III interferon and pro-inflammatory cytokine, interleukin(IL)-6 and IL-8, responses assessed. mRNA expression was analysed by qPCR. Interferon proteins were analysed by ELISA. Pro-inflammatory cytokines were induced by each TLR ligand in both cell types. Ligands to TLR3 and TLR7/8, but not other TLRs, induced interferon-beta and interferon-lambda in bronchial epithelial cells. The ligand to TLR7/8, but not those to other TLRs, induced only type I interferons in peripheral blood mononuclear cells. No difference was observed in TLR induced interferon or pro-inflammatory cytokine production between asthmatic and non-asthmatic subjects from either cell type. TLR3 and TLR7/8,, stimulation induced interferon in bronchial epithelial cells and peripheral blood mononuclear cells. Interferon induction to TLR agonists was not observed to be different in asthmatics and non-asthmatics.	[Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Johnston, Sebastian L.] MRC, London, England; [Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Johnston, Sebastian L.] Asthma UK Ctr Allerg Mech Asthma, London, England; [Sykes, Annemarie; Edwards, Michael R.; Macintyre, Jonathan; del Rosario, Ajerico; Gielen, Vera; Haas, Jennifer; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, London, England; [Sykes, Annemarie; Macintyre, Jonathan; del Rosario, Ajerico; Kon, Onn Min; Johnston, Sebastian L.] Imperial Coll Healthcare NHS Trust, London, England; [McHale, Mark] AstraZeneca R&D Charnwood, Resp & Inflammat Res Area, Loughborough, Leics, England	Imperial College London; University of London; King's College London; Imperial College London; Imperial College London; AstraZeneca	Sykes, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	annemarie.sykes@imperial.ac.uk	Johnston, Sebastian Lennox/I-2423-2012	Johnston, Sebastian Lennox/0000-0003-3009-9200; Edwards, Michael Robert/0000-0001-6837-0532; Kon, Onn Min/0000-0003-2647-4688	Medical Research Council (MRC) [G0601236, 100758]; MRC Clinical Research Fellowship; British Lung Foundation [P06/3]; Wellcome Trust [083567/Z/07/Z]; Asthma UK [05/067, 08/048]; Asthma UK Fellowship [RF07/04]; Asthma UK Clinical Chair [CH11SJ]; ERC [233015]; AstraZeneca; National Institute of Health Research Biomedical Research Centre and Clinical Lecturer funding schemes; Medical Research Council [G0601236, G0700552, G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [RF07/04, MRC-Asthma UK Centre] Funding Source: researchfish; MRC [G0601236, G0700552] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Clinical Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; Asthma UK Fellowship; Asthma UK Clinical Chair; ERC(European Research Council (ERC)European Commission); AstraZeneca(AstraZeneca); National Institute of Health Research Biomedical Research Centre and Clinical Lecturer funding schemes; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (MRC project grant G0601236 and Centre grant 100758, and a MRC Clinical Research Fellowship (to AS)), the British Lung Foundation (Grant P06/3), the Wellcome Trust (Grant 083567/Z/07/Z for the Centre for Respiratory Infection), Asthma UK (grants 05/067 and 08/048), an Asthma UK Fellowship RF07/04 (to MRE), the Asthma UK Clinical Chair (CH11SJ to SLJ), ERC FP7 Advanced grant 233015 (to SLJ), AstraZeneca and the National Institute of Health Research Biomedical Research Centre and Clinical Lecturer funding schemes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, BIOCHEM SOC T, V35, P1461, DOI 10.1042/BST0351461; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Biscione GL, 2004, EUR RESPIR J, V24, P745, DOI 10.1183/09031936.04.00049004; Bufe A, 2002, INT ARCH ALLERGY IMM, V127, P82, DOI 10.1159/000048173; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708; Gehlhar K, 2006, CLIN EXP ALLERGY, V36, P331, DOI 10.1111/j.1365-2222.2006.02450.x; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Iikura K, 2011, INT ARCH ALLERGY IMM, V155, P27, DOI 10.1159/000327262; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Klemets P, 2010, THORAX, V65, P698, DOI 10.1136/thx.2009.132670; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Montville DJ, 2012, J ALLERGY CLIN IMMUN; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; Pilishvili T, 2010, PEDIATRICS, V126, pE9, DOI 10.1542/peds.2009-2150; Roponen M, 2010, EUR RESPIR J, V35, P64, DOI 10.1183/09031936.00172008; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Thomas A, 2007, ANTIMICROB AGENTS CH, V51, P2969, DOI 10.1128/AAC.00268-07; Vissers M, 2012, EUR J IMMUNOL; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	32	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65921	10.1371/journal.pone.0065921	http://dx.doi.org/10.1371/journal.pone.0065921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824215	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400032
J	Bueno, D; Palacios-Gimenez, OM; Cabral-de-Mello, DC				Bueno, Danilo; Palacios-Gimenez, Octavio Manuel; Cabral-de-Mello, Diogo Cavalcanti			Chromosomal Mapping of Repetitive DNAs in the Grasshopper Abracris flavolineata Reveal Possible Ancestry of the B Chromosome and H3 Histone Spreading	PLOS ONE			English	Article							PROCHILODUS-LINEATUS CHARACIFORMES; MYRMELEOTETTIX-MACULATUS THUNB; EXTRACHROMOSOMAL CIRCULAR DNA; REPEATED GENOMIC SEQUENCES; NUCLEAR-RNA GENES; 5S RIBOSOMAL DNA; EVOLUTIONARY DYNAMICS; A-CHROMOSOME; EYPREPOCNEMIS-PLORANS; ASTYANAX-SCABRIPINNIS	Supernumerary chromosomes (B chromosomes) occur in approximately 15% of eukaryote species. Although these chromosomes have been extensively studied, knowledge concerning their specific molecular composition is lacking in most cases. The accumulation of repetitive DNAs is one remarkable characteristic of B chromosomes, and the occurrence of distinct types of multigene families, satellite DNAs and some transposable elements have been reported. Here, we describe the organization of repetitive DNAs in the A complement and B chromosome system in the grasshopper species Abracris flavolineata using classical cytogenetic techniques and FISH analysis using probes for five multigene families, telomeric repeats and repetitive C(0)t-1 DNA fractions. The 18S rRNA and H3 histone multigene families are highly variable and well distributed in A. flavolineata chromosomes, which contrasts with the conservation of U snRNA genes and less variable distribution of 5S rDNA sequences. The H3 histone gene was an extensively distributed with clusters occurring in all chromosomes. Repetitive DNAs were concentrated in C-positive regions, including the pericentromeric region and small chromosomal arms, with some occurrence in C-negative regions, but abundance was low in the B chromosome. Finally, the first demonstration of the U2 snRNA gene in B chromosomes in A. flavolineata may shed light on its possible origin. These results provide new information regarding chromosomal variability for repetitive DNAs in grasshoppers and the specific molecular composition of B chromosomes.	[Bueno, Danilo; Palacios-Gimenez, Octavio Manuel; Cabral-de-Mello, Diogo Cavalcanti] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Biol, Rio Claro, SP, Brazil	Universidade Estadual Paulista	Cabral-de-Mello, DC (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Biol, Rio Claro, SP, Brazil.	mellodc@rc.unesp.br	Bueno, Danilo/J-6154-2018; Cabral-de-Mello, Diogo C/F-5328-2010; Bueno, Danilo/GLT-0793-2022; Cabral-de-Mello, Diogo Cavalcanti/E-7656-2012	Bueno, Danilo/0000-0002-8788-9695; Bueno, Danilo/0000-0002-8788-9695; Cabral-de-Mello, Diogo Cavalcanti/0000-0002-4721-2655	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2011/19481-3, 2011/18028-3]; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [475308/2011-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (2011/19481-3, 2011/18028-3), Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior-CAPES and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (475308/2011-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artoni RF, 2006, GENETICA, V127, P277, DOI 10.1007/s10709-005-4846-1; Barzotti R, 2003, CHROMOSOME RES, V11, P365, DOI 10.1023/A:1024048108918; Bidau CJ, 2004, CYTOGENET GENOME RES, V106, P295, DOI 10.1159/000079302; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bugrov AG, 2004, CYTOGENET GENOME RES, V106, P284, DOI 10.1159/000079300; Bugrov AG, 2007, CHROMOSOME RES, V15, P315, DOI 10.1007/s10577-007-1128-z; Cabral-de-Mello DC, 2012, CHROMOSOME RES, V20, P279, DOI 10.1007/s10577-011-9271-y; Cabral-De-Mello DC, 2011, CYTOGENET GENOME RES, V132, P89, DOI 10.1159/000317476; Cabral-de-Mello DC, 2010, HEREDITY, V104, P393, DOI 10.1038/hdy.2009.126; Cabral-de-Mello DC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-88; Cabral-de-Mello DC, 2011, GENETICA, V139, P921, DOI 10.1007/s10709-011-9596-7; Cabral-de-Mello DC, 2011, GENETICA, V139, P315, DOI 10.1007/s10709-011-9551-7; Cabrero J, 2007, CYTOGENET GENOME RES, V119, P135, DOI 10.1159/000109630; Cabrero J, 2003, CHROMOSOMA, V112, P207, DOI 10.1007/s00412-003-0264-2; Cabrero J, 2003, CHROMOSOME RES, V11, P375, DOI 10.1023/A:1024127525756; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Cabrero J, 2009, CHROMOSOME RES, V17, P397, DOI 10.1007/s10577-009-9030-5; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Castillo E.R.D., 2011, REV CIENC TECNOL, V16, P31; CELLA DM, 1991, REV BRAS GENET, V14, P315; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; Cohen S, 2008, PLANT J, V53, P1027, DOI 10.1111/j.1365-313X.2007.03394.x; Cohen S, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-11; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; CONFALONIERI VA, 1986, GENETICA, V68, P87, DOI 10.1007/BF02424404; Dhar MK, 2002, CHROMOSOMA, V111, P332, DOI 10.1007/s00412-002-0214-4; Ferreira IA, 2008, MICRON, V39, P411, DOI 10.1016/j.micron.2007.02.010; GALLAGHER A, 1973, CHROMOSOMA, V40, P167; Grieco ML, 2000, HEREDITY, V84, P639, DOI 10.1046/j.1365-2540.2000.00688.x; Hanson RE, 1996, CHROMOSOMA, V105, P55, DOI 10.1007/BF02510039; Hewitt G.M., 1979, Animal Cytogenetics, V3, P1; Munoz-Pajares A, 2011, GENETICS, V187, P853, DOI 10.1534/genetics.110.122713; JOHN B, 1965, CHROMOSOMA, V16, P548, DOI 10.1007/BF00326973; Jones N, 2003, TRENDS PLANT SCI, V8, P417, DOI 10.1016/S1360-1385(03)00187-0; Jones RN, 2008, CYTOGENET GENOME RES, V120, P265, DOI 10.1159/000121076; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Jones RN, 1993, FRONT PLANT SCI, P81; LONG EO, 1980, J MOL BIOL, V138, P873, DOI 10.1016/0022-2836(80)90070-4; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lopez-Leon MD, 1994, CHROMOSOME RES, V2, P87, DOI 10.1007/BF01553487; Loreto V, 2008, CHROMOSOME RES, V16, P233, DOI 10.1007/s10577-007-1188-0; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Merlo MA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-201; Mestriner CA, 2000, HEREDITY, V85, P1, DOI 10.1046/j.1365-2540.2000.00702.x; Nakajima RT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-198; Nguyen P, 2010, GENETICA, V138, P343, DOI 10.1007/s10709-009-9424-5; Oliveira NL, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-24; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; Pelliccia F, 2001, GENOME, V44, P331, DOI 10.1139/gen-44-3-331; PENDAS AM, 1994, CHROMOSOMA, V103, P147, DOI 10.1007/BF00352324; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Raskina O, 2004, CHROMOSOME RES, V12, P153, DOI 10.1023/B:CHRO.0000013168.61359.43; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; Rubtsov NB, 2004, CYTOGENET GENOME RES, V106, P289, DOI 10.1159/000079301; Ruiz-Estevez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036600; Ruiz-Ruano FJ, 2011, CYTOGENET GENOME RES, V134, P120, DOI 10.1159/000324690; Sambrook J., 2001, MOL CLONING LAB MANU; SCHUBERT I, 1984, PLANT SYST EVOL, V144, P291, DOI 10.1007/BF00984139; SCHWEIZER D, 1983, CHROMOSOMA, V88, P227, DOI 10.1007/BF00285625; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Teruel M, 2011, CYTOGENET GENOME RES, V132, P94, DOI 10.1159/000319621; Teruel M, 2009, CYTOGENET GENOME RES, V125, P286, DOI 10.1159/000235935; Teruel M, 2010, CHROMOSOMA, V119, P217, DOI 10.1007/s00412-009-0251-3; Teruel M, 2009, CHROMOSOMA, V118, P291, DOI 10.1007/s00412-008-0197-x; Teruel M, 2009, CHROMOSOME RES, V17, P11, DOI 10.1007/s10577-008-9001-2; Ubeda-Manzanaro M, 2010, GENETICA, V138, P787, DOI 10.1007/s10709-010-9460-1; Vicari MR, 2011, GENETICA, V139, P1073, DOI 10.1007/s10709-011-9611-z; VILARDI JC, 1986, MENDELIANA, V7, P125; Voltolin TA, 2010, GENETICA, V138, P1133, DOI 10.1007/s10709-010-9502-8; Wilson E, 1907, SCIENCE, V26, P870, DOI [10.1126/science.26.677.870-a, DOI 10.1126/SCIENCE.26.660.258]; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; Zhang LL, 2007, GENETICA, V130, P193, DOI 10.1007/s10709-006-9006-8; Zwick MS, 1997, GENOME, V40, P138, DOI 10.1139/g97-020	77	78	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66532	10.1371/journal.pone.0066532	http://dx.doi.org/10.1371/journal.pone.0066532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826099	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000005
J	Kolahdooz, F; Spearing, K; Sharma, S				Kolahdooz, Fariba; Spearing, Kerry; Sharma, Sangita			Dietary Adequacies among South African Adults in Rural KwaZulu-Natal	PLOS ONE			English	Article							NUTRITION TRANSITION; OBESITY; FOOD; ZINC; DEFICIENCY; CARBOHYDRATE; POPULATION; COUNTRIES; IRON	Background: Food quality, determined by micronutrient content, is a stronger determinant of nutritional status than food quantity. Health concerns resulting from the co-existence of over-nutrition and under-nutrition in low income populations in South Africa have been fully recognized in the last two decades. This study aimed to further investigate dietary adequacy amongst adults in rural KwaZulu-Natal, by determining daily energy and nutrient intakes, and identifying the degree of satisfaction of dietary requirements. Methods: Cross-sectional study assessing dietary adequacy from 24-hour dietary recalls of randomly selected 136 adults in Empangeni, KwaZulu-Natal, South Africa. Results: Results are presented for men (n = 52) and women (n = 84) 19-50 and >50 years old. Mean energy intake was greatest in women >50 years (2852 kcal/day) and exceeded Dietary Reference Intake's for both men and women, regardless of age. Mean daily energy intake from carbohydrates was 69% for men and 67% for women, above the Dietary Reference Intake range of 45-65%. Sodium was also consumed in excess, and the Dietary Reference Intakes of vitamins A, B12, C, D, and E, calcium, zinc and pantothenic acid were not met by the majority of the population. Conclusion: Despite mandatory fortification of staple South African foods, micronutrient inadequacies are evident among adults in rural South African communities. Given the excess caloric intake and the rising prevalence of obesity and other non-communicable diseases in South Africa, a focus on diet quality may be a more effective approach to influence micronutrient status than a focus on diet quantity.	[Kolahdooz, Fariba; Spearing, Kerry; Sharma, Sangita] Univ Alberta, Dept Med, Aboriginal & Global Hlth Res Grp, Edmonton, AB, Canada	University of Alberta	Sharma, S (corresponding author), Univ Alberta, Dept Med, Aboriginal & Global Hlth Res Grp, Edmonton, AB, Canada.	gita.sharma@ualberta.ca		Sharma, Sangita/0000-0002-4995-0010	Aboriginal and Global Health Research Group, Department of Medicine, University of Alberta	Aboriginal and Global Health Research Group, Department of Medicine, University of Alberta	Funding was provided by the Aboriginal and Global Health Research Group, Department of Medicine, University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; ALLEN LH, 1993, NUTR REV, V51, P255, DOI 10.1111/j.1753-4887.1993.tb03117.x; Bourne LT, 2002, PUBLIC HEALTH NUTR, V5, P157, DOI 10.1079/PHN2001288; Buyken AE, 2010, AM J CLIN NUTR, V92, P634, DOI 10.3945/ajcn.2010.29390; Campbell NC, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/860954; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Gautam S, 2011, INT J FOOD SCI NUTR, V62, P826, DOI 10.3109/09637486.2011.584861; Hattingh Z, 2008, W INDIAN MED J, V57, P431; Hunt JR, 2002, NUTR REV, V60, P127, DOI 10.1301/00296640260093788; Institute of Medicine of the National Academies, 2005, DIET REF INT EN CARB; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Labadarios D, 2005, PUBLIC HEALTH NUTR, V8, P533, DOI 10.1079/PHN2005816; MacIntyre UE, 2002, NUTR RES, V22, P239, DOI 10.1016/S0271-5317(01)00392-X; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Merchant AT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-2; Mocchegiani E, 2013, AGE, V35, P839, DOI 10.1007/s11357-011-9377-3; Mohan S, 2009, CLIN SCI, V117, P1, DOI 10.1042/CS20080207; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Muscogiuri G, 2012, NUTR METAB CARDIOVAS, V22, P81, DOI 10.1016/j.numecd.2011.11.001; Neumann CG, 2003, J NUTR, V133, p3941S, DOI 10.1093/jn/133.11.3941S; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Prasad AS, 2009, J AM COLL NUTR, V28, P257, DOI 10.1080/07315724.2009.10719780; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Prentice A, 2009, CLIN REV BONE MINER, V7, P94, DOI 10.1007/s12018-009-9038-6; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Sanchez-Castillo CP, 2005, SODIUM SALT INTAKE H; Sharma S, 2011, P NUTR SOC, V70, P232, DOI 10.1017/S0029665110004775; Shikany JM, 2010, NUTRITION, V26, P641, DOI 10.1016/j.nut.2009.08.014; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285; South African Medical Research Council, 2012, SAFOODS S AFR FOOD D; Spearing K, 2013, J HUM NUTR DIET, V26, P222, DOI 10.1111/jhn.12001; Statistics South Africa, 2011, STATS BRIEF 2010; Statistics South Africa, 2011, MID YEAR POP EST; Steyn NP, 2008, PUBLIC HEALTH NUTR, V11, P307, DOI 10.1017/S136898000700033X; Temple NJ, 2011, NUTRITION, V27, P55, DOI 10.1016/j.nut.2009.12.004; Tremblay A, 2011, J AM COLL NUTR, V30, p449S, DOI 10.1080/07315724.2011.10719989; Venti CA, 2002, J NUTR, V132, P1050, DOI 10.1093/jn/132.5.1050; Wolmarans P., 2010, CONDENSED FOOD COMPO; World Health Organization, 2011, WHO GLOB INF DAT SAV; Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144	42	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67184	10.1371/journal.pone.0067184	http://dx.doi.org/10.1371/journal.pone.0067184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825639	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000087
J	Almeida-Souza, L; Asselbergh, B; De Winter, V; Goethals, S; Timmerman, V; Janssens, S				Almeida-Souza, Leonardo; Asselbergh, Bob; De Winter, Vicky; Goethals, Sofie; Timmerman, Vincent; Janssens, Sophie			HSPB1 Facilitates the Formation of Non-Centrosomal Microtubules	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GAMMA-TUBULIN COMPLEXES; MARIE-TOOTH NEUROPATHY; PROTEASOMAL DEGRADATION; ACTIN POLYMERIZATION; IN-VITRO; F-ACTIN; HSP27; NUCLEATION; CELLS	The remodeling capacity of microtubules (MT) is essential for their proper function. In mammals, MTs are predominantly formed at the centrosome, but can also originate from non-centrosomal sites, a process that is still poorly understood. We here show that the small heat shock protein HSPB1 plays a role in the control of non-centrosomal MT formation. The HSPB1 expression level regulates the balance between centrosomal and non-centrosomal MTs. The HSPB1 protein can be detected specifically at sites of de novo forming non-centrosomal MTs, while it is absent from the centrosomes. In addition, we show that HSPB1 binds preferentially to the lattice of newly formed MTs in vitro, suggesting that its function occurs by stabilizing MT seeds. Our findings open new avenues for the understanding of the role of HSPB1 in the development, maintenance and protection of cells with specialized non-centrosomal MT arrays.	[Almeida-Souza, Leonardo; Asselbergh, Bob; De Winter, Vicky; Goethals, Sofie; Timmerman, Vincent; Janssens, Sophie] VIB, Dept Mol Genet, Antwerp, Belgium; [Almeida-Souza, Leonardo; Asselbergh, Bob; De Winter, Vicky; Goethals, Sofie; Timmerman, Vincent; Janssens, Sophie] Univ Antwerp, B-2020 Antwerp, Belgium; [Almeida-Souza, Leonardo; Asselbergh, Bob; De Winter, Vicky; Goethals, Sofie; Timmerman, Vincent] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium; [Janssens, Sophie] Univ Ghent, Lab Immunoregulat & Mucosal Immunol, GROUP ID Consortium, B-9000 Ghent, Belgium; [Janssens, Sophie] VIB, Dept Mol Biomed Res, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Ghent University; Flanders Institute for Biotechnology (VIB)	Timmerman, V (corresponding author), VIB, Dept Mol Genet, Antwerp, Belgium.	vincent.timmerman@molgen.vib-ua.be; sophie.janssens@dmbr.vib-ugent.be	Almeida-Souza, Leonardo/C-3437-2011; Timmerman, Vincent/O-7283-2019; Janssens, Sophie/HHN-1756-2022	Almeida-Souza, Leonardo/0000-0002-7169-1238; Timmerman, Vincent/0000-0002-2162-0933; Asselbergh, Bob/0000-0003-2784-2470	University of Antwerp; Fund for Scientific Research (FWO-Flanders); Medical Foundation Queen Elisabeth (GSKE); "Association Belge contre les Maladies Neuromusculaires'' (ABMM); American Muscular Dystrophy Association (MDA); Hercules foundation	University of Antwerp; Fund for Scientific Research (FWO-Flanders)(FWO); Medical Foundation Queen Elisabeth (GSKE); "Association Belge contre les Maladies Neuromusculaires'' (ABMM); American Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Hercules foundation	This work was supported in part by the special research fund and the Methusalem program of the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), the Medical Foundation Queen Elisabeth (GSKE), the "Association Belge contre les Maladies Neuromusculaires'' (ABMM), the American Muscular Dystrophy Association (MDA). We thank the Hercules foundation providing funding for the transmission electron and spinning disk microscopes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Almeida-Souza L, 2011, J NEUROSCI, V31, P15320, DOI 10.1523/JNEUROSCI.3266-11.2011; Almeida-Souza L, 2010, J BIOL CHEM, V285, P12778, DOI 10.1074/jbc.M109.082644; Barron DM, 2003, ANAL BIOCHEM, V315, P49, DOI 10.1016/S0003-2697(02)00691-7; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Brown DD, 2007, GENESIS, V45, P667, DOI 10.1002/dvg.20340; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chen L, 2012, P NATL ACAD SCI USA, V109, P11842, DOI 10.1073/pnas.1121180109; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Ferns G, 2006, INT J EXP PATHOL, V87, P253, DOI 10.1111/j.1365-2613.2006.00484.x; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Gibert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029719; Hino M, 2000, BIOCHEM BIOPH RES CO, V271, P164, DOI 10.1006/bbrc.2000.2553; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HUOT J, 1991, CANCER RES, V51, P5245; Jonak C, 2011, J DERMATOL SCI, V61, P32, DOI 10.1016/j.jdermsci.2010.10.009; Knapinska AM, 2011, MOL CELL BIOL, V31, P1419, DOI 10.1128/MCB.00907-10; Knowlton AA, 1998, J MOL CELL CARDIOL, V30, P811, DOI 10.1006/jmcc.1998.0646; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Komarova YA, 2002, J CELL SCI, V115, P3527; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Macurek L, 2008, BIOCHEM J, V416, P421, DOI 10.1042/BJ20080909; Mehlen P, 1999, CELL DEATH DIFFER, V6, P227, DOI 10.1038/sj.cdd.4400483; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; MIRON T, 1988, J MUSCLE RES CELL M, V9, P91; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Pivovarova AV, 2007, FEBS J, V274, P5937, DOI 10.1111/j.1742-4658.2007.06117.x; Pivovarova AV, 2005, BIOCHEM BIOPH RES CO, V331, P1548, DOI 10.1016/j.bbrc.2005.04.077; Reilein A, 2005, NAT CELL BIOL, V7, P463, DOI 10.1038/ncb1248; Rios RM, 2004, CELL, V118, P323; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Salmon P., 2006, CURR PROTOC NEUROSCI; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stetler RA, 2009, CURR MOL MED, V9, P863, DOI 10.2174/156652409789105561; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Vinogradova T, 2009, CELL CYCLE, V8, P2168, DOI 10.4161/cc.8.14.9074; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Xiao JJ, 2010, PHARMACOLOGY, V85, P301, DOI 10.1159/000292948	56	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66541	10.1371/journal.pone.0066541	http://dx.doi.org/10.1371/journal.pone.0066541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826100	Green Published, gold			2022-12-27	WOS:000321738400021
J	Bond, WS; Akinfenwa, PY; Perlaky, L; Hurwitz, MY; Hurwitz, RL; Chevez-Barrios, P				Bond, Wesley S.; Akinfenwa, Patricia Y.; Perlaky, Laszlo; Hurwitz, Mary Y.; Hurwitz, Richard L.; Chevez-Barrios, Patricia			Tumorspheres but Not Adherent Cells Derived from Retinoblastoma Tumors Are of Malignant Origin	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; GENE; IDENTIFICATION; EXPRESSION; LINES; MISIDENTIFICATION; PRECURSORS; CULTURE; BRAIN	Verification that cell lines used for cancer research are derived from malignant cells in primary tumors is imperative to avoid invalidation of study results. Retinoblastoma is a childhood ocular tumor that develops from loss of functional retinoblastoma protein (pRb) as a result of genetic or epigenetic changes that affect both alleles of the RB1 gene. These patients contain unique identifiable genetic signatures specifically present in malignant cells. Primary cultures derived from retinoblastoma tumors can be established as non-adherent tumorspheres when grown in defined media or as attached monolayers when grown in serum-containing media. While the RB1 genotypes of tumorspheres match those of the primary tumor, adherent cultures have the germline RB1 genotype. Tumorspheres derived from pRb-negative tumors do not express pRb and express the neuroendocrine tumor markers synaptophysin and microtubule-associated protein 2 (MAP2). Adherent cells are synaptophysin-negative and express pRb, the epithelial cell marker cytokeratin that is expressed in the retinal pigmented epithelium and the vascular endothelial cell marker CD34. While tumorspheres are of malignant origin, our results cast doubt on the assumption that adherent tumor-derived cultures are always valid in vitro models of malignant cells and emphasize the need for validation of primary tumor cultures.	[Bond, Wesley S.; Akinfenwa, Patricia Y.; Hurwitz, Richard L.; Chevez-Barrios, Patricia] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bond, Wesley S.; Akinfenwa, Patricia Y.; Perlaky, Laszlo; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Bond, Wesley S.; Akinfenwa, Patricia Y.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Ctr Cell & Gene Therapy, Houston, TX USA; [Bond, Wesley S.; Akinfenwa, Patricia Y.; Perlaky, Laszlo; Hurwitz, Mary Y.; Hurwitz, Richard L.] Texas Childrens Canc & Hematol Cts, Houston, TX USA; [Chevez-Barrios, Patricia] Methodist Hosp, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Hurwitz, Richard L.; Chevez-Barrios, Patricia] Retinoblastoma Ctr Houston, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston	Chevez-Barrios, P (corresponding author), Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA.	pchevez-barrios@tmhs.org			Retina Research Foundation; Golfers Against Cancer; National Institutes of Health grant [T32 EY007001-37]; NATIONAL EYE INSTITUTE [T32EY007001] Funding Source: NIH RePORTER	Retina Research Foundation; Golfers Against Cancer; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Retina Research Foundation (RLH), Golfers Against Cancer (RLH) and National Institutes of Health grant T32 EY007001-37 (PYA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond WS, 2011, JOVE-J VIS EXP, DOI 10.3791/2644; Chatterjee R, 2007, SCIENCE, V315, P928, DOI 10.1126/science.315.5814.928; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; FINA L, 1990, BLOOD, V75, P2417; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GOULD VE, 1987, AM J PATHOL, V126, P243; HERMAN MM, 1989, AM J PATHOL, V134, P115; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P708, DOI 10.1136/bjo.68.10.708; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P698, DOI 10.1136/bjo.68.10.698; HURWITZ RL, 1990, J CLIN INVEST, V85, P1872, DOI 10.1172/JCI114648; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; Liscovitch M, 2007, CANCER LETT, V245, P350, DOI 10.1016/j.canlet.2006.01.013; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; McCallum HM, 1996, BREAST CANCER RES TR, V39, P247, DOI 10.1007/BF01806153; Nardone RM, 2008, BIOTECHNIQUES, V45, P221, DOI 10.2144/000112925; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Singh SK, 2003, CANCER RES, V63, P5821; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; TUCKER RP, 1988, DEV BIOL, V130, P423, DOI 10.1016/0012-1606(88)90338-7; Valverde JR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-53; Wadhwa L, 2012, INVEST OPHTH VIS SCI, V53, P3454, DOI 10.1167/iovs.12-9549; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880	29	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e63519	10.1371/journal.pone.0063519	http://dx.doi.org/10.1371/journal.pone.0063519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826078	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400002
J	Bonnet, MP; Basso, O; Bouvier-Colle, MH; Dupont, C; Rudigoz, RC; Fuhrer, R; Deneux-Tharaux, C				Bonnet, Marie-Pierre; Basso, Olga; Bouvier-Colle, Marie-Helene; Dupont, Corinne; Rudigoz, Rene-Charles; Fuhrer, Rebecca; Deneux-Tharaux, Catherine			Postpartum Haemorrhage in Canada and France: A Population-Based Comparison	PLOS ONE			English	Article							RISK-FACTORS; FETAL GROWTH; TRENDS; EPIDEMIOLOGY; MACROSOMIA; DELIVERIES; PREVALENCE; COUNTRIES; COHORT	Objective: Maternal mortality ratio due to postpartum haemorrhage (PPH) is higher in France than in Canada. We explored this difference by comparing PPH features between these two countries. Methods: Using data between 2004 and 2006, we compared the incidence, risk factors, causes and use of second-line treatments, of PPH between France (N = 6,660 PPH) and Canada (N = 9,838 PPH). We assessed factors associated with PPH through multivariate logistic models. Results: PPH incidence, overall (4.8% (95% CI 4.7-4.9) in Canada and 4.5% (95% CI 4.4-4.7) in France), and after vaginal delivery (5.3% (95% CI 5.2-5.4) in Canada and 4.8 (95% CI 4.7-4.9) in France), were significantly higher in Canada than in France, but not after caesarean delivery. Women delivering without PPH were similar between the two populations, except for macrosomia (11% in Canada, 7% in France, p<0.001), caesarean delivery (27% in Canada, 18% in France, p<0.001), and episiotomy (17% in Canada, 34% in France, p<0.001). After vaginal delivery, factors strongly associated with PPH were multiple pregnancy, operative delivery and macrosomia in both populations, and episiotomy only in France (Odds Ratio 1.39 (95% CI 1.23-1.57)). The use of second-line treatments for PPH management was significantly more frequent in France than in Canada after both vaginal and caesarean delivery. Conclusion: PPH incidence was not higher in France than in Canada and there was no substantial difference in PPH risk factors between the 2 countries. Greater use of second-line treatments in PPH management in France suggests a more frequent failure of first-line treatments and a higher rate of severe PPH, which may be involved in the higher maternal mortality ratio due to PPH.	[Bonnet, Marie-Pierre; Bouvier-Colle, Marie-Helene; Deneux-Tharaux, Catherine] Univ Paris 06, INSERM, Epidemiol Res Unit Perinatal Hlth, U953, Paris, France; [Bonnet, Marie-Pierre; Bouvier-Colle, Marie-Helene; Deneux-Tharaux, Catherine] Univ Paris 06, Womens & Childrens Hlth, Paris, France; [Bonnet, Marie-Pierre] Hop Univ Paris Ctr, Hop Cochin, AP HP, Anaesthesia & Crit Care Dept, Paris, France; [Bonnet, Marie-Pierre; Basso, Olga; Fuhrer, Rebecca] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Basso, Olga] McGill Univ, Royal Victoria Hosp, Dept Obstet & Gynaecol, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Dupont, Corinne; Rudigoz, Rene-Charles] Univ Lyon 1, EA 4129, Hosp Civiles Lyon, Aurore Perinatal Network,Hop Croix Rousse, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; McGill University; McGill University; Royal Victoria Hospital; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bonnet, MP (corresponding author), Univ Paris 06, INSERM, Epidemiol Res Unit Perinatal Hlth, U953, Paris, France.	marie-pierre.bonnet@inserm.fr	DUPONT, Corinne/ABD-5045-2020; Basso, Olga/E-5384-2010; deneux-tharaux, catherine/R-1111-2016	Basso, Olga/0000-0001-9298-4921; deneux-tharaux, catherine/0000-0002-6561-3321	French Ministry of Health [27-35]; AXA Research Funds; French Society of Anesthesiology (SFAR); Assistance Publique-Hopitaux de Paris (AP-HP)	French Ministry of Health; AXA Research Funds(AXA Research Fund); French Society of Anesthesiology (SFAR); Assistance Publique-Hopitaux de Paris (AP-HP)	The Pithagore6 project was funded by the French Ministry of Health under its Clinical Research program (contract no27-35). This study was supported by doctoral grants from the AXA Research Funds, the French Society of Anesthesiology (SFAR) and the Assistance Publique-Hopitaux de Paris (AP-HP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Al-Zirqi I, 2009, AM J OBSTET GYNECOL, V201; Allen VM, 2006, OBSTET GYNECOL, V108, P286, DOI 10.1097/01.AOG.0000215988.23224.e4; Ananth CV, 2002, SEMIN PERINATOL, V26, P260, DOI 10.1053/sper.2002.34772; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Belghiti J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000514; Blondel B, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P373; Blondel B, 2012, J Gynecol Obstet Biol Reprod (Paris), V41, pe1, DOI 10.1016/j.jgyn.2012.04.014; Bonnet MP, 2011, EUR J OBSTET GYN R B, V158, P183, DOI 10.1016/j.ejogrb.2011.04.042; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Calvert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041114; Carroli G, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub2; Confidential Enquiry into Maternal and Child Health, 2007, SAV MOTH LIV REV MAT; Deneux-Tharaux C, 2010, BJOG-INT J OBSTET GY, V117, P1278, DOI 10.1111/j.1471-0528.2010.02648.x; Driessen M, 2011, OBSTET GYNECOL, V117, P21, DOI 10.1097/AOG.0b013e318202c845; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Institut de Veille Sanitaire, 2010, REP NAT COMM EXP MAT; Jolly MC, 2003, EUR J OBSTET GYN R B, V111, P9, DOI 10.1016/S0301-2115(03)00154-4; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Kayem G, 2011, BJOG-INT J OBSTET GY, V118, P856, DOI 10.1111/j.1471-0528.2011.02921.x; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kramer MS, 2002, J PEDIATR-US, V141, P538, DOI 10.1067/mpd.2002.128029; Lousquy R, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.10.003; Lutomski JE, 2012, BJOG-INT J OBSTET GY, V119, P306, DOI 10.1111/j.1471-0528.2011.03198.x; Mocanu EV, 2000, EUR J OBSTET GYN R B, V92, P229, DOI 10.1016/S0301-2115(99)00280-8; Murtha A, 2011, AM J OBSTET GYNECOL, V204, pS27, DOI 10.1016/j.ajog.2010.10.057; Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d; Public Health Agency of Canada, 2008, CAN PER HLTH REP; Rossi AC, 2012, ARCH GYNECOL OBSTET, V285, P1499, DOI 10.1007/s00404-012-2301-y; Schuurmans N, 2000, SOGC CLIN PRACTICE G; Sosa CG, 2009, OBSTET GYNECOL, V113, P1313, DOI 10.1097/AOG.0b013e3181a66b05; Wen S W, 1997, Chronic Dis Can, V18, P113; World Health Organization, GLOB DAT BOD MASS IN; World Health Organization (WHO), 2007, WHO REC PREV POSTP H	35	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66882	10.1371/journal.pone.0066882	http://dx.doi.org/10.1371/journal.pone.0066882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826165	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400076
J	Caponnetto, P; Campagna, D; Cibella, F; Morjaria, JB; Caruso, M; Russo, C; Polosa, R				Caponnetto, Pasquale; Campagna, Davide; Cibella, Fabio; Morjaria, Jaymin B.; Caruso, Massimo; Russo, Cristina; Polosa, Riccardo			EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study	PLOS ONE			English	Article							DEVICE E-CIGARETTE; SMOKING-CESSATION; NICOTINE; TRIAL; COTININE; QUESTIONNAIRE; WITHDRAWAL; DEPENDENCE; REDUCTION; SYMPTOMS	Background: Electronic cigarettes (e-cigarettes) are becoming increasingly popular with smokers worldwide. Users report buying them to help quit smoking, to reduce cigarette consumption, to relieve tobacco withdrawal symptoms, and to continue having a 'smoking' experience, but with reduced health risks. Research on e-cigarettes is urgently needed in order to ensure that the decisions of regulators, healthcare providers and consumers are based on science. Methods ECLAT is a prospective 12-month randomized, controlled trial that evaluates smoking reduction/abstinence in 300 smokers not intending to quit experimenting two different nicotine strengths of a popular e-cigarette model ('Categoria'; Arbi Group Srl, Italy) compared to its non-nicotine choice. GroupA (n = 100) received 7.2 mg nicotine cartridges for 12 weeks; GroupB (n = 100), a 6-week 7.2 mg nicotine cartridges followed by a further 6-week 5.4 mg nicotine cartridges; GroupC (n = 100) received no-nicotine cartridges for 12 weeks. The study consisted of nine visits during which cig/day use and exhaled carbon monoxide (eCO) levels were measured. Smoking reduction and abstinence rates were calculated. Adverse events and product preferences were also reviewed. Results: Declines in cig/day use and eCO levels were observed at each study visits in all three study groups (p<0.001 vs baseline), with no consistent differences among study groups. Smoking reduction was documented in 22.3% and 10.3% at week-12 and week-52 respectively. Complete abstinence from tobacco smoking was documented in 10.7% and 8.7% at week-12 and week-52 respectively. A substantial decrease in adverse events from baseline was observed and withdrawal symptoms were infrequently reported during the study. Participants' perception and acceptance of the product under investigation was satisfactory. Conclusion: In smokers not intending to quit, the use of e-cigarettes, with or without nicotine, decreased cigarette consumption and elicited enduring tobacco abstinence without causing significant side effects.	[Caponnetto, Pasquale; Campagna, Davide; Russo, Cristina; Polosa, Riccardo] Univ Catania, Azienda Osped Univ Policlin V Emanuele, Ctr Prevenz & Cura Tabagismo, Catania, Italy; [Caponnetto, Pasquale; Campagna, Davide; Caruso, Massimo; Russo, Cristina; Polosa, Riccardo] Univ Catania, Azienda Osped Univ Policlin V Emanuele, S Marta Hosp, Inst Internal Med, Catania, Italy; [Cibella, Fabio] Natl Res Council Italy, Inst Biomed & Mol Immunol, Palermo, Italy; [Morjaria, Jaymin B.] Univ Hull, Castle Hill Hosp, Hull York Med Sch, Div Cardiovasc & Resp Studies, Cottingham, England	University of Catania; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Hull; University of York - UK	Polosa, R (corresponding author), Univ Catania, Azienda Osped Univ Policlin V Emanuele, Ctr Prevenz & Cura Tabagismo, Catania, Italy.	polosa@unict.it	Cibella, Fabio/AAH-6982-2019; Caruso, Massimo/G-6604-2012; Caruso, Massimo/P-4161-2016	Cibella, Fabio/0000-0003-1674-2263; Caruso, Massimo/0000-0002-4412-2080; Caruso, Massimo/0000-0002-4412-2080	Lega Italiana AntiFumo; University of Catania, Italy; Pfizer; GlaxoSmithKline	Lega Italiana AntiFumo; University of Catania, Italy; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline)	This research was supported by a grant-in-aid from Lega Italiana AntiFumo. The study sponsor had no involvement in the study design, collection, analysis, and interpretation of data, the writing of the manuscript or the decision to submit the manuscript for publication. RP and PC are currently funded by the University of Catania, Italy. The e-cigarette supplier had no involvement in the study design, collection, analysis, and interpretation of data, the writing of the manuscript or the decision to submit the manuscript for publication.; RP has received lecture fees and research funding from Pfizer and GlaxoSmithKline, manufacturers of stop smoking medications. He has served as a consultant for Pfizer and Arbi Group Srl, the distributor of the Categoria (TM) e-Cigarette. The other authors have no relevant conflict of interest to declare in relation to this work. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2008, REP GLOB TOB EP; Aubin HJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4439; Beck A.T., 1987, MANUAL BECK DEPRESSI; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bolliger CT, 2000, BMJ-BRIT MED J, V321, P329, DOI 10.1136/bmj.321.7257.329; Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Cahn Z, 2011, J PUBLIC HEALTH POL, V32, P16, DOI 10.1057/jphp.2010.41; Caponnetto P, 2011, EUR RESPIR J, V38, P1005, DOI 10.1183/09031936.00109610; Caponnetto P, 2011, INT J CLIN MED, V2, P281, DOI DOI 10.4236/ijcm.2011.23046; Caponnetto P, 2013, INTERN EMERG MED, V8, P7, DOI 10.1007/s11739-012-0864-z; Caponnetto Pasquale, 2011, J Med Case Rep, V5, P585, DOI 10.1186/1752-1947-5-585; Caponnetto P, 2012, EXPERT REV RESP MED, V6, P63, DOI [10.1586/ers.11.92, 10.1586/ERS.11.92]; CARROLL KM, 1997, NIDA RES MONOGRAPH S, V165; Casella G, 2010, THER ADV CHRONIC DIS, V1, P95, DOI 10.1177/2040622310374896; Dawkins L, 2012, ADDICT BEHAV, V37, P970, DOI 10.1016/j.addbeh.2012.03.004; Etter JF, 2011, EUR RESPIR J, V38, P1219, DOI 10.1183/09031936.00066011; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Etter JF, 2011, TOB CONTROL, V20, P243, DOI 10.1136/tc.2010.042168; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P75, DOI 10.1093/ntr/ntr137; Fagerstrom KO, 2000, TOB CONTROL, V9, P327, DOI 10.1136/tc.9.3.327; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Fiore MC, 2008, TREATING TOBACCO USE; Glover ED, 2005, AM J HEALTH BEHAV, V29, P443, DOI 10.5993/AJHB.29.5.7; Goniewicz M.L., 2012, NICOTINE TOB RES; Hon L, 2005, Patent, Patent No. [CA 2518174, 2518174]; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; JACOB P, 1981, J CHROMATOGR, V222, P61, DOI 10.1016/S0378-4347(00)81033-6; Miura K., 2011, SEIKATSU EISEI, V55, P59; Nides M, 2006, ARCH INTERN MED, V166, P1561, DOI 10.1001/archinte.166.15.1561; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; Services UDoHaH, 1990, HLTH BEN SMOK CESS; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Smith SS, 2009, ARCH INTERN MED, V169, P2148, DOI 10.1001/archinternmed.2009.426; Tobacco Advisory Group of the Royal College of Physicians, 2007, HARM RED NIC ADD HEL; Vansickel AR, 2010, CANCER EPIDEM BIOMAR, V19, P1945, DOI 10.1158/1055-9965.EPI-10-0288; WALL MA, 1988, AM J PUBLIC HEALTH, V78, P699, DOI 10.2105/AJPH.78.6.699; WHO, 2009, WHO TECH REP SER, V955, P1; World Health Organization (WHO), WHO FRAM CONV TOB CO	39	522	525	16	219	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66317	10.1371/journal.pone.0066317	http://dx.doi.org/10.1371/journal.pone.0066317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826093	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400015
J	Denaro, G; Valenti, D; Spagnolo, B; Basilone, G; Mazzola, S; Zgozi, SW; Aronica, S; Bonanno, A				Denaro, Giovanni; Valenti, Davide; Spagnolo, Bernardo; Basilone, Gualtiero; Mazzola, Salvatore; Zgozi, Salem W.; Aronica, Salvatore; Bonanno, Angelo			Dynamics of Two Picophytoplankton Groups in Mediterranean Sea: Analysis of the Deep Chlorophyll Maximum by a Stochastic Advection-Reaction-Diffusion Model	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; NOISE; PHYTOPLANKTON; PROCHLOROCOCCUS; LIGHT; GROWTH; COMPETITION; ECOSYSTEM; STRAIT; FLUCTUATIONS	A stochastic advection-reaction-diffusion model with terms of multiplicative white Gaussian noise, valid for weakly mixed waters, is studied to obtain the vertical stationary spatial distributions of two groups of picophytoplankton, i.e., picoeukaryotes and Prochlorococcus, which account about for 60% of total chlorophyll on average in Mediterranean Sea. By numerically solving the equations of the model, we analyze the one-dimensional spatio-temporal dynamics of the total picophytoplankton biomass and nutrient concentration along the water column at different depths. In particular, we integrate the equations over a time interval long enough, obtaining the steady spatial distributions for the cell concentrations of the two picophytoplankton groups. The results are converted into chlorophyll a and divinil chlorophyll a concentrations and compared with experimental data collected in two different sites of the Sicily Channel (southern Mediterranean Sea). The comparison shows that real distributions are well reproduced by theoretical profiles. Specifically, position, shape and magnitude of the theoretical deep chlorophyll maximum exhibit a good agreement with the experimental values.	[Denaro, Giovanni; Valenti, Davide; Spagnolo, Bernardo] Univ Palermo, Dipartimento Fis & Chim, Grp Interdisciplinary Phys & Consorzio Nazl Inter, Unita Palermo, Palermo, Italy; [Basilone, Gualtiero; Mazzola, Salvatore; Aronica, Salvatore; Bonanno, Angelo] CNR, Ist Ambiente Marino Costiero, Unita Operat Supporto Capo Granitola, Trapani, Italy; [Zgozi, Salem W.] Marine Biol Res Ctr, Tajura, Libya	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Valenti, D (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Grp Interdisciplinary Phys & Consorzio Nazl Inter, Unita Palermo, Palermo, Italy.	davide.valenti@unipa.it; bernardo.spagnolo@unipa.it; angelo.bonanno@iamc.cnr.it	Valenti, Davide/K-9228-2015; Basilone, Gualtiero/D-2896-2017; Bonanno, Angelo/H-9025-2013; Spagnolo, Bernardo/F-6973-2014	Valenti, Davide/0000-0001-5496-1518; Basilone, Gualtiero/0000-0002-5732-5055; Bonanno, Angelo/0000-0002-3868-751X; Spagnolo, Bernardo/0000-0002-6625-3989; Mazzola, Salvatore/0000-0002-4622-8129; aronica, salvatore/0000-0003-3489-1473	Short visit grant, within ESF Scientific Programme "Exploring the Physics of Small Devices (EPSD)", Unit PESC [4933]; Italian Ministry of University and Research	Short visit grant, within ESF Scientific Programme "Exploring the Physics of Small Devices (EPSD)", Unit PESC; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	The work was supported by the following: 1) Short visit grant, ref. n. 4933 within ESF Scientific Programme "Exploring the Physics of Small Devices (EPSD)", Unit PESC, coordinated by Prof. Christian Van den Broeck (http://www.esf.org/activities/research-networking-programmes/physical-and-engineering-sciences-pesc/current-research-networking-programmes/exploring-the-physics-of-small-devices-epsd.html); 2) Italian Ministry of University and Research (no specific grant) (http://www.istruzione.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barale V, 2008, REMOTE SENS ENVIRON, V112, P3300, DOI 10.1016/j.rse.2007.10.014; BARRERA P, 1993, J PHYS A-MATH GEN, V26, pL559, DOI 10.1088/0305-4470/26/13/001; Basilone G, 2004, FISH RES, V68, P9, DOI 10.1016/j.fishres.2004.02.012; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Bougaran G, 2010, J THEOR BIOL, V265, P443, DOI 10.1016/j.jtbi.2010.04.018; Brunet C, 2003, J PLANKTON RES, V25, P1413, DOI 10.1093/plankt/fbg091; Brunet C, 2006, AQUAT MICROB ECOL, V44, P127, DOI 10.3354/ame044127; Brunet C, 2008, J PLANKTON RES, V30, P645, DOI 10.1093/plankt/fbn028; Brunet C, 2007, MAR ECOL PROG SER, V346, P15, DOI 10.3354/meps07017; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Caruso A, 2005, FLUCT NOISE LETT, V5, pL349, DOI 10.1142/S0219477505002768; Casotti R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001541; Casotti R, 2000, MAR ECOL PROG SER, V195, P15, DOI 10.3354/meps195015; Chichigina O, 2005, FLUCT NOISE LETT, V5, pL243, DOI 10.1142/S0219477505002616; Chichigina OA, 2008, EUR PHYS J B, V65, P347, DOI 10.1140/epjb/e2008-00226-6; Chichigina OA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021134; CIUCHI S, 1993, PHYS REV E, V47, P3915, DOI 10.1103/PhysRevE.47.3915; Ciuchi S, 1996, PHYS REV E, V54, P706, DOI 10.1103/PhysRevE.54.706; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; d'Alcala MR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001650; Denaro G, 2013, ACTA PHYS POL B, V44, P977, DOI 10.5506/APhysPolB.44.977; Denaro G, 2013, ECOL COMPLEX, V13, P21, DOI 10.1016/j.ecocom.2012.10.002; Dimier C, 2007, J PHYCOL, V43; Dimier C, 2009, PROTIST, V160, P397, DOI 10.1016/j.protis.2009.03.001; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; Ebeling W, 2005, FLUCT NOISE LETT, V5, pL159, DOI 10.1142/S0219477505002495; Estrada M, 1996, SCI MAR, V60, P55; Fennel K, 2003, LIMNOL OCEANOGR, V48, P1521, DOI 10.4319/lo.2003.48.4.1521; Fiasconaro A, 2006, EUR PHYS J B, V50, P189, DOI 10.1140/epjb/e2006-00058-4; FOGG GE, 1991, NEW PHYTOL, V118, P191, DOI 10.1111/j.1469-8137.1991.tb00974.x; Garc?a-Ojalvo J., 1999, NOISE SPATIALLY EXTE; Garczarek L, 2007, FEMS MICROBIOL ECOL, V60, P189, DOI 10.1111/j.1574-6941.2007.00297.x; Giuffrida A, 2009, EUR FOOD RES TECHNOL, V228, P767, DOI 10.1007/s00217-008-0988-6; Goryachev AB, 2005, PLOS COMPUT BIOL, V1, P265, DOI 10.1371/journal.pcbi.0010037; GRAHAM R, 1982, PHYS REV A, V25, P1731, DOI 10.1103/PhysRevA.25.1731; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Hickman AE, 2010, MAR ECOL PROG SER, V406, P1, DOI 10.3354/meps08588; Horsthemke W., 1984, NOISE INDUCED TRANSI; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Huppert A, 2005, J THEOR BIOL, V236, P276, DOI 10.1016/j.jtbi.2005.03.012; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032; Klausmeier CA, 2001, LIMNOL OCEANOGR, V46, P1998, DOI 10.4319/lo.2001.46.8.1998; La Barbera A, 2002, PHYSICA A, V314, P120, DOI 10.1016/S0378-4371(02)01173-1; La Cognata A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011121; LI WKW, 1995, MAR ECOL PROG SER, V122, P1, DOI 10.3354/meps122001; Liu QX, 2008, J STAT MECH THEORY E, V2008; Mann KH, 1996, DYNAMICS MARINE ECOS, P480, DOI 10.2307/2960585; Manor A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.030601; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Mei ZP, 2009, J THEOR BIOL, V259, P582, DOI 10.1016/j.jtbi.2009.04.018; Melbourne-Thomas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055093; Mendonca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029526; Mikhailov AS, 1996, SPRINGER SERIES SYNE; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Munoz MA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056102; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Patti B, 2010, SCI MAR, V74, P577, DOI 10.3989/scimar.2010.74n3577; PREZELIN BB, 1991, AQUAT SCI, V53, P136, DOI 10.1007/BF00877058; Provata A, 2008, EUR PHYS J B, V65, P307, DOI 10.1140/epjb/e2008-00380-9; Raven JA, 2005, VIE MILIEU, V55, P209; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; REDNER S, 1990, AM J PHYS, V58, P267, DOI 10.1119/1.16497; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Ryabov AB, 2012, THEOR ECOL-NETH, V5, P373, DOI 10.1007/s12080-012-0158-0; Ryabov AB, 2011, ECOL LETT, V14, P220, DOI 10.1111/j.1461-0248.2010.01574.x; Ryabov AB, 2010, J THEOR BIOL, V263, P120, DOI 10.1016/j.jtbi.2009.10.034; SCHENZLE A, 1979, PHYS REV A, V20, P1628, DOI 10.1103/PhysRevA.20.1628; SHIGESADA N, 1981, J MATH BIOL, V12, P311, DOI 10.1007/BF00276919; Somette D, 2000, SPRINGER SERIES SYNE, P178; Spagnolo B, 2005, PROG THEOR PHYS SUPP, P312, DOI 10.1143/PTPS.157.312; Spagnolo B, 2004, MATH BIOSCI ENG, V1, P185; Spagnolo B, 2003, FLUCT NOISE LETT, V3, pL177, DOI 10.1142/S0219477503001245; Spagnolo B, 2002, J PHYS-CONDENS MAT, V14, P2247, DOI 10.1088/0953-8984/14/9/313; Spagnolo B, 2002, PHYSICA A, V315, P114, DOI 10.1016/S0378-4371(02)01245-1; Spagnolo B, 2009, EUR PHYS J B, V69, P133, DOI 10.1140/epjb/e2009-00162-y; Spagnolo B, 2008, INT J BIFURCAT CHAOS, V18, P2643; THINGSTAD TF, 1995, MAR ECOL PROG SER, V117, P299, DOI 10.3354/meps117299; Turpin D.H., 1988, P316; Valenti D, 2008, ECOL MODEL, V213, P449, DOI 10.1016/j.ecolmodel.2008.01.023; Valenti D, 2006, EUR PHYS J B, V50, P199, DOI 10.1140/epjb/e2006-00102-5; Valenti D, 2004, ACTA PHYS POL B, V35, P1481; Valenti D, 2012, ACTA PHYS POL B, V43, P1227, DOI 10.5506/APhysPolB.43.1227; Valenti D, 2004, PHYSICA A, V331, P477, DOI 10.1016/j.physa.2003.09.036; Valenti D, 2007, PHYSICA A, V382, P311, DOI 10.1016/j.physa.2007.03.044; Veldhuis MJW, 2005, J SEA RES, V53, P7, DOI 10.1016/j.seares.2004.01.006; Weston K, 2005, J PLANKTON RES, V27, P909, DOI 10.1093/plankt/fbi064; Worden AZ, 2008, MICROBIAL ECOLOGY OC; Yeo SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056207; Yoshiyama K, 2009, AM NAT, V174, P190, DOI 10.1086/600113; Zimmer C, 1999, SCIENCE, V284, P83, DOI 10.1126/science.284.5411.83	99	101	101	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66765	10.1371/journal.pone.0066765	http://dx.doi.org/10.1371/journal.pone.0066765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826130	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400048
J	Dias, IHK; Chapple, ILC; Milward, M; Grant, MM; Hill, E; Brown, J; Griffiths, HR				Dias, Irundika H. K.; Chapple, Ian L. C.; Milward, Mike; Grant, Melissa M.; Hill, Eric; Brown, James; Griffiths, Helen R.			Sulforaphane Restores Cellular Glutathione Levels and Reduces Chronic Periodontitis Neutrophil Hyperactivity In Vitro	PLOS ONE			English	Article							LIPID RAFTS; RESPIRATORY BURST; REACTIVE OXYGEN; DNA-BINDING; REDOX; NRF2; CELLS; ACTIVATION; SPHINGOMYELINASE; MODEL	The production of high levels of reactive oxygen species by neutrophils is associated with the local and systemic destructive phenotype found in the chronic inflammatory disease periodontitis. In the present study, we investigated the ability of sulforaphane (SFN) to restore cellular glutathione levels and reduce the hyperactivity of circulating neutrophils associated with chronic periodontitis. Using differentiated HL60 cells as a neutrophil model, here we show that generation of extracellular O-2 center dot - by the nicotinamide adenine dinucleotide (NADPH) oxidase complex is increased by intracellular glutathione depletion. This may be attributed to the upregulation of thiol regulated acid sphingomyelinase driven lipid raft formation. Intracellular glutathione was also lower in primary neutrophils from periodontitis patients and, consistent with our previous findings, patients neutrophils were hyper-reactive to stimuli. The activity of nuclear factor erythroid-2-related factor 2 (Nrf2), a master regulator of the antioxidant response, is impaired in circulating neutrophils from chronic periodontitis patients. Although patients' neutrophils exhibit a low reduced glutathione (GSH)/oxidised glutathione (GSSG) ratio and a higher total Nrf2 level, the DNA-binding activity of nuclear Nrf2 remained unchanged relative to healthy controls and had reduced expression of glutamate cysteine ligase catalytic (GCLC), and modifier (GCLM) subunit mRNAs, compared to periodontally healthy subjects neutrophils. Pre-treatment with SFN increased expression of GCLC and GCM, improved intracellular GSH/GSSG ratios and reduced agonist-activated extracellular O-2 center dot - production in both dHL60 and primary neutrophils from patients with periodontitis and controls. These findings suggest that a deficiency in Nrf2-dependent pathways may underpin susceptibility to hyper-reactivity in circulating primary neutrophils during chronic periodontitis.	[Dias, Irundika H. K.; Hill, Eric; Brown, James; Griffiths, Helen R.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Chapple, Ian L. C.; Milward, Mike; Grant, Melissa M.] Univ Birmingham, Coll Med & Dent Sci, Sch Dent, Birmingham, W Midlands, England	Aston University; University of Birmingham	Griffiths, HR (corresponding author), Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England.	h.r.griffiths@aston.ac.uk	Griffiths, Helen R./E-3453-2013; Grant, Melissa/A-5590-2010; Dias, Irundika H.K./AAC-3838-2019; Brown, James E/A-7503-2012; Chapple, Iain L C/T-2986-2017	Griffiths, Helen R./0000-0002-2666-2147; Grant, Melissa/0000-0003-1154-7266; Chapple, Iain L C/0000-0003-2697-7082; Hill, Eric/0000-0002-9419-1500; Dias, Irundika/0000-0002-6620-8221	Dunhill Medical Trust [R92/1108]; COST [CM1001, BM1203]	Dunhill Medical Trust(Dunhill Medical Trust); COST(European Cooperation in Science and Technology (COST))	IHKD gratefully acknowledges funding from the Dunhill Medical Trust (R92/1108). HRG gratefully acknowledges funding by COST CM1001 and COST BM1203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EM, 2011, J CLIN PERIODONTOL, V38, P894, DOI 10.1111/j.1600-051X.2011.01764.x; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Chapple ILC, 2012, J CLIN PERIODONTOL, V39, P62, DOI 10.1111/j.1600-051X.2011.01793.x; Chapple IL., 2013, J CLIN PERIODONTOL, V40, pS106; Chapple ILC, 2002, J CLIN PATHOL-MOL PA, V55, P367; Cui WP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/821936; David A, 2005, EXP CELL RES, V308, P156, DOI 10.1016/j.yexcr.2005.03.034; Dias IHK, 2008, INFECT IMMUN, V76, P317, DOI 10.1128/IAI.00618-07; Dias IHK, 2011, J CLIN PERIODONTOL, V38, P1, DOI 10.1111/j.1600-051X.2010.01628.x; Evans WE, 2003, J ANDROL, V24, P812; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P1604, DOI 10.1016/j.jaci.2011.03.031; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gherghel D, 2005, INVEST OPHTH VIS SCI, V46, P877, DOI 10.1167/iovs.04-0777; Go YM, 2010, METHOD ENZYMOL, V474, P165, DOI 10.1016/S0076-6879(10)74010-6; Grant MM, 2010, J CLIN PERIODONTOL, V37, P17, DOI 10.1111/j.1600-051X.2009.01504.x; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Griffiths HR, 2005, REDOX REP, V10, P273, DOI 10.1179/135100005X83680; Griffiths HR, 2000, FREE RADICAL RES, V33, pS47; Guerra BA, 2012, DIABETES RES CLIN PR, V98, P108, DOI 10.1016/j.diabres.2012.07.004; Guichard C, 2005, J BIOL CHEM, V280, P37021, DOI 10.1074/jbc.M506594200; Hancock John T., 2008, V476, P1, DOI 10.1007/978-1-59745-129-1_1; Hancock JT, 2003, ANN NY ACAD SCI, V1010, P446, DOI 10.1196/annals.1299.081; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Holopainen JM, 1998, BIOCHEMISTRY-US, V37, P17562, DOI 10.1021/bi980915e; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Jacob C, 2002, INT IMMUNOPHARMACOL, V2, P1647, DOI 10.1016/S1567-5769(02)00141-8; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Li PL, 2007, ANTIOXID REDOX SIGN, V9, P1457, DOI 10.1089/ars.2007.1667; Martin SF, 2007, ARCH BIOCHEM BIOPHYS, V459, P295, DOI 10.1016/j.abb.2006.11.007; Matthews JB, 2007, CLIN EXP IMMUNOL, V147, P255, DOI 10.1111/j.1365-2249.2006.03276.x; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Panjamurthy K, 2005, CELL MOL BIOL LETT, V10, P255; Petri S, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/878030; Phillips DC, 2010, ANTIOXID REDOX SIGN, V12, P743, DOI 10.1089/ars.2009.2607; Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Seckin S, 1997, PHARMACOL RES, V36, P55, DOI 10.1006/phrs.1997.0204; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; Soeda S, 2004, NEUROCHEM INT, V45, P619, DOI 10.1016/j.neuint.2004.04.001; Starrett W, 2011, J IMMUNOTOXICOL, V8, P150, DOI 10.3109/1547691X.2011.558529; Sun XY, 2011, TOXICOL APPL PHARM, V255, P9, DOI 10.1016/j.taap.2011.05.011; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tonetti MS, 2013, J CLIN PERIODONTOL, V40; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Yeligar SM, 2010, J BIOL CHEM, V285, P35359, DOI 10.1074/jbc.M110.138636; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	51	53	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66407	10.1371/journal.pone.0066407	http://dx.doi.org/10.1371/journal.pone.0066407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826097	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000321738400019
J	Caldwell, W; McInnis, OA; McQuaid, RJ; Liu, G; Stead, JD; Anisman, H; Hayley, S				Caldwell, Warren; McInnis, Opal A.; McQuaid, Robyn J.; Liu, Gele; Stead, John D.; Anisman, Hymie; Hayley, Shawn			The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive Symptoms	PLOS ONE			English	Article							MAJOR DEPRESSION; LIFE STRESS; RISK-FACTOR; BDNF; VARIANT; ASSOCIATION; INVENTORY; SUSCEPTIBILITY; VULNERABILITY; RUMINATION	Disturbances of brain derived neurotrophic factor (BDNF) signalling have been implicated in the evolution of depression, which likely arises, in part, as a result of diminished synaptic plasticity. Predictably, given stressor involvement in depression, BDNF is affected by recent stressors as well as stressors such as neglect experienced in early life. The effects of early life maltreatment in altering BDNF signalling may be particularly apparent among those individuals with specific BDNF polymorphisms. We examined whether polymorphisms of the Val66Met genotype might be influential in moderating how early-life events play out with respect to later coping styles, cognitive flexibility and depressive features. Among male and female undergraduate students (N = 124), childhood neglect was highly related to subsequent depressive symptoms. This outcome was moderated by the BDNF polymorphism in the sense that depressive symptoms appeared higher in Met carriers who reported low levels of neglect than in those with the Val/Val allele. However, under conditions of high neglect depressive symptoms only increased in the Val/Val individuals. In effect, the Met polymorphism was associated with depressive features, but did not interact with early life neglect in predicting later depressive features. It was further observed that among the Val/Val individuals, the relationship between neglect and depression was mediated by emotion-focused styles and diminished perceived control, whereas this mediation was not apparent in Met carriers. In contrast to the more typical view regarding this polymorphism, the data are consistent with the perspective that in the presence of synaptic plasticity presumably associated with the Val/Val genotype, neglect allows for the emergence of specific appraisal and coping styles, which are tied to depression. In the case of the reduced degree of neuroplasticity expected in the Met carriers, early life adverse experiences are not tied to coping styles, and hence less likely to be translated into depressive states.	[Caldwell, Warren; McInnis, Opal A.; McQuaid, Robyn J.; Liu, Gele; Stead, John D.; Anisman, Hymie; Hayley, Shawn] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Hayley, S (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	shawn_hayley@carleton.ca	Stead, John/X-8500-2018; McQuaid, Robyn/ABB-4143-2021	Stead, John/0000-0002-5726-6809; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248; Barker-Collo Suzanne, 2003, Trauma Violence Abuse, V4, P95, DOI 10.1177/1524838002250760; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beevers CG, 2009, EMOTION, V9, P579, DOI 10.1037/a0016189; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Brougham RR, 2009, CURR PSYCHOL, V28, P85, DOI 10.1007/s12144-009-9047-0; Buchmann AF, 2012, EUR NEUROPS IN PRESS; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Channon S, 1996, J AFFECT DISORDERS, V39, P107, DOI 10.1016/0165-0327(96)00027-4; Chen L, 2008, AM J MED GENET B, V147B, P814, DOI 10.1002/ajmg.b.30686; Demare D, 1996, APA TOR CAN; Dennis JP, 2010, COGNITIVE THER RES, V34, P241, DOI 10.1007/s10608-009-9276-4; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elzinga BM, 2011, PSYCHOPHARMACOLOGY, V214, P319, DOI 10.1007/s00213-010-1961-1; Espejo EP, 2012, J ABNORM CHILD PSYCH, V40, P303, DOI 10.1007/s10802-011-9552-0; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Grabe HJ, 2012, PROG NEURO-PSYCHOPH, V36, P264, DOI 10.1016/j.pnpbp.2011.09.010; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003; Hilt LM, 2007, NEUROSCI LETT, V429, P12, DOI 10.1016/j.neulet.2007.09.053; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Karlovic D, 2013, J PSYCHIATR RES, V47, P162, DOI 10.1016/j.jpsychires.2012.09.017; Kato T, 2012, J COUNS PSYCHOL, V59, P262, DOI 10.1037/a0027770; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Kelly O, 2007, DEPRESS ANXIETY, V24, P233, DOI 10.1002/da.20236; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Kocabas NA, 2011, INT CLIN PSYCHOPHARM, V26, P1, DOI 10.1097/YIC.0b013e32833d18f8; Lavebratt C, 2010, J AFFECT DISORDERS, V125, P249, DOI 10.1016/j.jad.2010.02.113; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Matheson K, 2003, STRESS, V6, P223, DOI 10.1080/10253890310001594487; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; Meyer SE, 2001, DEV PSYCHOPATHOL, V13, P565, DOI 10.1017/S095457940100308X; Miranda R, 2007, BEHAV RES THER, V45, P3088, DOI 10.1016/j.brat.2007.07.015; Nolen-Hoeksema S., 1998, MOTIVATION SELF REGU, P237, DOI DOI 10.1017/CBO9780511527869; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Okamoto T, 2008, PROG NEURO-PSYCHOPH, V32, P1185, DOI 10.1016/j.pnpbp.2008.02.009; Perea CS, 2012, J AFFECT DISORDERS, V136, P767, DOI 10.1016/j.jad.2011.09.043; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Ravindran AV, 2002, J AFFECT DISORDERS, V71, P121, DOI 10.1016/S0165-0327(01)00389-5; Roelofs J, 2009, EUR CHILD ADOLES PSY, V18, P635, DOI 10.1007/s00787-009-0026-7; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Schmidt HD, 2010, NEUROPSYCHOPHARMACOL, V35, P2378, DOI 10.1038/npp.2010.114; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; STANTON AL, 1994, J PERS SOC PSYCHOL, V66, P350, DOI 10.1037/0022-3514.66.2.350; STANTON AL, 1999, COPING PSYCHOL WHAT; Surtees PG, 2007, J PSYCHIATR RES, V41, P404, DOI 10.1016/j.jpsychires.2006.01.004; Taylor WD, 2007, AM J GERIAT PSYCHIAT, V15, P850, DOI 10.1097/JGP.0b013e318050c9d5; Thompson M, 2011, J PSYCHIATR NEUROSCI, V36, P195, DOI 10.1503/jpn.100048; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Wolkowitz OM, 2011, PROG NEURO-PSYCHOPH, V35, P1623, DOI 10.1016/j.pnpbp.2011.06.013; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Zou YF, 2010, EUR NEUROPSYCHOPHARM, V20, P535, DOI 10.1016/j.euroneuro.2009.12.005	64	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65547	10.1371/journal.pone.0065547	http://dx.doi.org/10.1371/journal.pone.0065547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824678	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400009
J	da Silva, MV; Figueiredo, AA; Machado, JR; Castellano, LC; Alexandre, PBD; Oliveira, RF; Faria, GEL; Pereira, SAL; Rodrigues, DBR; Rodrigues, V				da Silva, Marcos Vinicius; Figueiredo, Amanda A.; Machado, Juliana R.; Castellano, Lucio C.; Alexandre, Patricia B. D.; Oliveira, Rafael F.; Faria, Gladstone E. L.; Pereira, Sanivia A. L.; Rodrigues, Denise B. R.; Rodrigues, Virmondes, Jr.			T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; INTERFERON-GAMMA RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; IMMUNE-RESPONSES; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; LUNG INFLAMMATION; LT-ALPHA; TGF-BETA	Background: Th1 cytokines are essential for the control of M. tuberculosis infection. The role of IL-10 in tuberculosis is controversial and there is an increasing body of evidence suggesting that the relationship between Th1 cytokines and IL-10 is not as antagonistic as it was first believed, and that these cytokines may complement each other in infectious diseases. Methods: The present study evaluated the activating capacity of CD4+ and CD8+ T cell repertoire in response to antigen stimulation through the expression of CD69 using Flow Cytometry, as well as the functionality of PBMCs by determining the cytokine profile in patients with active tuberculosis and in clinically cured patients after in vitro stimulation using ELISA. Treated patients were subdivided according to time after clinical cure (<12 months or >12 months post-treatment). Results: We observed that T cell activation was higher in TB-treated patients, especially CD8+ T cell activation in TB-Treated >1 year. Th1 cytokines were significantly higher in TB-Treated, and the levels of IFN-gamma and TNF-alpha increased continuously after clinical cure. Moreover, IL-10 production was significantly higher in cured patients and it was also enhanced in cured patients over time after treatment. Th17, Th2 and Th22 cytokines showed no statistically significant differences between Healthy Donors, Active-TB and TB-Treated. Conclusions: This study describes a scenario in which potentiation of CD4+ and CD8+ T cell activation and increased Th1 cytokine production are associated with the clinical cure of tuberculosis in the absence of significant changes in Th2 cytokine production and is accompanied by increased production of IL-10. In contrast to other infections with intracellular microorganisms, this response occurs later after the end of treatment.	[da Silva, Marcos Vinicius; Figueiredo, Amanda A.; Machado, Juliana R.; Oliveira, Rafael F.; Faria, Gladstone E. L.; Rodrigues, Virmondes, Jr.] Triangulo Mineiro Fed Univ, Dept Biol Sci, Immunol Lab, Uberaba, MG, Brazil; [Castellano, Lucio C.] Univ Fed Paraiba, Dept Tech Sch Hlth, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Pereira, Sanivia A. L.; Rodrigues, Denise B. R.] Univ Uberaba, Lab Biopathol & Mol Biol, Uberaba, MG, Brazil; [Alexandre, Patricia B. D.] Uberaba Municipal Dept Hlth, Uberaba, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal da Paraiba; Universidade de Uberaba (Uniube)	Rodrigues, V (corresponding author), Triangulo Mineiro Fed Univ, Dept Biol Sci, Immunol Lab, Uberaba, MG, Brazil.	vrodrigues@mednet.com.br	Silva, Marcos Vinicius/AAY-1986-2020; Machado, Juliana/AAY-1978-2020; Castellano, Lucio/D-8887-2015	Silva, Marcos Vinicius/0000-0002-2966-7621; Machado, Juliana/0000-0002-8673-7788; Castellano, Lucio/0000-0003-0851-5298; Rodrigues Jr, Virmondes/0000-0001-8706-4223	CAPES; Programa de Apoio a Planos de Reestruturacao e Expansao das Universidades Federais (Reuni); CNPq; FAPEMIG	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio a Planos de Reestruturacao e Expansao das Universidades Federais (Reuni); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by CAPES, Programa de Apoio a Planos de Reestruturacao e Expansao das Universidades Federais (Reuni), CNPq, and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah R, 2003, FEMS IMMUNOL MED MIC, V38, P249, DOI 10.1016/S0928-8244(03)00166-4; Avgustin B, 2005, CLIN DIAGN LAB IMMUN, V12, P101, DOI 10.1128/CDLI.12.1.101-106.2005; Baker KS, 1999, BONE MARROW TRANSPL, V23, P1123, DOI 10.1038/sj.bmt.1701780; Bean AGD, 1999, J IMMUNOL, V162, P3504; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bhattacharyya S, 1999, INFECT IMMUN, V67, P5597, DOI 10.1128/IAI.67.11.5597-5603.1999; Bold TD, 2012, J IMMUNOL, V189, P2530, DOI 10.4049/jimmunol.1200994; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Bopst M, 2001, EUR J IMMUNOL, V31, P1935, DOI 10.1002/1521-4141(200106)31:6&lt;1935::AID-IMMU1935&gt;3.0.CO;2-N; *BRAZ MIN HEALTH, 2013, TUBERCULOSIS CONF CA; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; Capo C, 1996, INFECT IMMUN, V64, P4143, DOI 10.1128/IAI.64.10.4143-4147.1996; Casanova JL, 2001, SWISS MED WKLY, V131, P445; Castellano LR, 2009, HUM IMMUNOL, V70, P383, DOI 10.1016/j.humimm.2009.01.007; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; De Miranda SS, 2012, REV MED CHILE, V140, P1022, DOI 10.4067/S0034-98872012000800008; Deckert M, 2001, INFECT IMMUN, V69, P4561, DOI 10.1128/IAI.69.7.4561-4571.2001; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Esnault S, 1996, CLIN EXP IMMUNOL, V103, P111, DOI 10.1046/j.1365-2249.1996.00911.x; Feng CG, 2005, J IMMUNOL, V174, P4185, DOI 10.4049/jimmunol.174.7.4185; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Harris J, 2009, VET IMMUNOL IMMUNOP, V128, P37, DOI 10.1016/j.vetimm.2008.10.293; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Hill PC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000068; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; Hunter CA, 1997, J IMMUNOL, V158, P3311; Jacobs M, 2000, CLIN IMMUNOL, V94, P192, DOI 10.1006/clim.2000.4835; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jason J, 2000, J INFECT DIS, V182, P474, DOI 10.1086/315740; Jason J, 2001, CLIN DIAGN LAB IMMUN, V8, P1097, DOI 10.1128/CDLI.8.6.1097-1103.2001; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kruisbeek A. M., 2004, CURR PROTOC IMMUNOL; Lee JS, 2002, CLIN EXP IMMUNOL, V128, P516, DOI 10.1046/j.1365-2249.2002.01858.x; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023700; Lin YG, 1996, INFECT IMMUN, V64, P1351, DOI 10.1128/IAI.64.4.1351-1356.1996; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Murray PJ, 1997, J IMMUNOL, V158, P315; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Ottenhoff THM, 1998, IMMUNOL TODAY, V19, P491, DOI 10.1016/S0167-5699(98)01321-8; Pereira CB, 2004, MICROBES INFECT, V6, P25, DOI 10.1016/j.micinf.2003.10.007; Petit-Bertron AF, 2003, J LEUKOCYTE BIOL, V73, P145, DOI 10.1189/jlb.0802388; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Sharma S, 2004, IMMUNOL CELL BIOL, V82, P377, DOI 10.1111/j.0818-9641.2004.01245.x; Smith SM, 2002, TUBERCULOSIS, V82, P7, DOI 10.1054/tube.2001.0317; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Tapaninen P, 2010, INT J TUBERC LUNG D, V14, P347; TESTI R, 1989, J IMMUNOL, V143, P1123; Vankayalapati R, 2003, CLIN INFECT DIS, V36, P24, DOI 10.1086/344903; Walker D, 2002, CLIN DIAGN LAB IMMUN, V9, P1049, DOI 10.1128/CDLI.9.5.1049-1056.2002; WHO Global Tuberculosis Control Report, 2010, CENT EUR J PUBL HEAL, V18, P237; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; ZHANG M, 1995, INFECT IMMUN, V63, P3231, DOI 10.1128/IAI.63.8.3231-3234.1995; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	72	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65492	10.1371/journal.pone.0065492	http://dx.doi.org/10.1371/journal.pone.0065492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824716	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400007
J	Faircloth, BC; Sorenson, L; Santini, F; Alfaro, ME				Faircloth, Brant C.; Sorenson, Laurie; Santini, Francesco; Alfaro, Michael E.			A Phylogenomic Perspective on the Radiation of Ray-Finned Fishes Based upon Targeted Sequencing of Ultraconserved Elements (UCEs)	PLOS ONE			English	Article							SPECIES TREES; SISTER-GROUP; EVOLUTION; GENOME; ALGORITHMS; RESOLUTION; MARKERS	Ray-finned fishes constitute the dominant radiation of vertebrates with over 32,000 species. Although molecular phylogenetics has begun to disentangle major evolutionary relationships within this vast section of the Tree of Life, there is no widely available approach for efficiently collecting phylogenomic data within fishes, leaving much of the enormous potential of massively parallel sequencing technologies for resolving major radiations in ray-finned fishes unrealized. Here, we provide a genomic perspective on longstanding questions regarding the diversification of major groups of ray-finned fishes through targeted enrichment of ultraconserved nuclear DNA elements (UCEs) and their flanking sequence. Our workflow efficiently and economically generates data sets that are orders of magnitude larger than those produced by traditional approaches and is well-suited to working with museum specimens. Analysis of the UCE data set recovers a well-supported phylogeny at both shallow and deep time-scales that supports a monophyletic relationship between Amia and Lepisosteus (Holostei) and reveals elopomorphs and then osteoglossomorphs to be the earliest diverging teleost lineages. Our approach additionally reveals that sequence capture of UCE regions and their flanking sequence offers enormous potential for resolving phylogenetic relationships within ray-finned fishes.	[Faircloth, Brant C.; Sorenson, Laurie; Santini, Francesco; Alfaro, Michael E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Alfaro, ME (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	michaelalfaro@ucla.edu	Faircloth, Brant C/Y-3978-2019; Alfaro, Michael/Q-2113-2017	Faircloth, Brant/0000-0002-1943-0217; Alfaro, Michael/0000-0002-8898-8230	National Science Foundation [DEB-6861953, DEB-6701648, DEB-1242260]; Amazon Web Services education; Direct For Biological Sciences [0918748] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Amazon Web Services education; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation grants DEB-6861953 and DEB-6701648 (to MEA) and DEB-1242260 (to BCF) provided partial support for this work. Funds from an Amazon Web Services education grant (to BCF) supported computational portions of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Arratia G, 2001, J VERTEBR PALEONTOL, V21, P767, DOI 10.1671/0272-4634(2001)021[0767:TSGOTC]2.0.CO;2; Arratia G, 2010, REV BIOL MAR OCEANOG, V45, P635, DOI 10.4067/S0718-19572010000400009; Arratia Gloria, 2004, P279; Bayzid MS, 2012, J COMPUT BIOL, V19, P591, DOI 10.1089/cmb.2012.0037; Broughton Richard E., 2010, P61; Castillo-Ramirez S, 2010, ESTIMATING SPECIES T; Cloutier R., 2004, RECENT ADV ORIGIN EA, P217; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; de Pinna Mario C.C., 1996, P147; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Grande L, 2010, COPEIA, P1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris R. S., 2007, THESIS PENNSYLVANIA; He S, 2012, INTEGRATING MULTIORI, V2; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Liu L, 2010, BIOINFORMATICS, V26, P962, DOI 10.1093/bioinformatics/btq062; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Mabuchi K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-10; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; Meynard CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036443; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nelson G, 1969, B AM MUS NAT HIST, V141, P465; Nylander J, 2004, MRAIC PL EVOLUTIONAR; Olsen PE., 1984, J VERTEBR PALEONTOL, V4, P481, DOI [10.1080/02724634.1984.10012024, DOI 10.1080/02724634.1984.10012024]; PATTERSON C, 1977, Bulletin of the American Museum of Natural History, V158, P83; Patterson C., 1973, INTERRELATIONSHIPS F, P207; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santini F, 2012, 12100120 ARXIV; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Smith WL, 2006, J HERED, V97, P206, DOI 10.1093/jhered/esj034; Smith WL, 2007, COPEIA, P35, DOI 10.1643/0045-8511(2007)7[35:CTPNWT]2.0.CO;2; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Zaragueta-Bagils R, 2002, CR BIOL, V325, P1191, DOI 10.1016/S1631-0691(02)01535-4; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	191	194	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65923	10.1371/journal.pone.0065923	http://dx.doi.org/10.1371/journal.pone.0065923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824177	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400033
J	Parmar, A; Greco, D; Venalainen, J; Gentile, M; Dukes, E; Saavalainen, P				Parmar, Amarjit; Greco, Dario; Venalainen, Jarkko; Gentile, Massimiliano; Dukes, Emma; Saavalainen, Paivi			Gene Expression Profiling of Gliadin Effects on Intestinal Epithelial Cells Suggests Novel Non-Enzymatic Functions of Pepsin and Trypsin	PLOS ONE			English	Article							NF-KAPPA-B; CELIAC-DISEASE; WHEAT GLIADIN; ALTERED EXPRESSION; T-CELLS; APOPTOSIS; PEPTIDES; PROLIFERATION; PREVALENCE; ACTIVATION	Gliadin triggers T-cell mediated immunity in celiac disease, and has cytotoxic effects on enterocytes mediated through obscure mechanisms. In addition, gliadin transport mechanisms, potential cell surface receptors and gliadin-activated downstream signaling pathways are not completely understood. In order to screen for novel downstream gliadin target genes we performed a systematic whole genome expression study on intestinal epithelial cells. Undifferentiated Caco-2 cells were exposed to pepsin-and trypsin-digested gliadin (PT-G), a blank pepsin-trypsin control (PT) and to a synthetic peptide corresponding to gliadin p31-43 peptide for six hours. RNA from four different experiments was used for hybridization on Agilent one color human whole genome DNA microarray chips. The microarray data were analyzed using the Bioconductor package LIMMA. Genes with nominal p<0.01 were considered statistically significant. Compared to the untreated cells 1705, 1755 and 211 probes were affected by PT-G, PT and p31-43 respectively. 46 probes were significantly different between PT and PT-G treated cells. Among the p31-43 peptide affected probes, 10 and 21 probes were affected by PT-G and PT respectively. Only PT-G affected genes could be validated by quantitative real-time polymerase chain reaction. All the genes were, nonetheless, also affected to a comparable level by PT treated negative controls. In conclusion, we could not replicate previously reported direct effects of gliadin peptides on enterocytes. The results rather suggest that certain epitopes derived from pepsin and trypsin may also affect epithelial cell gene transcription. Our study suggests novel nonenzymatic effects of pepsin and trypsin on cells and calls for proper controls in pepsin and trypsin digested gliadin experiments. It is conceivable that gliadin effects on enterocytes are secondary mediated through oxidative stress, NFkB activation and IL-15 up-regulation.	[Parmar, Amarjit; Dukes, Emma; Saavalainen, Paivi] Univ Helsinki, Dept Med Genet, Res Programs Unit, Immunobiol & Haartman Inst, Helsinki, Finland; [Greco, Dario] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Venalainen, Jarkko] Univ Eastern Finland, Dept Pharmacol & Toxicol, Kuopio, Finland; [Gentile, Massimiliano] Univ Helsinki, Genome Informat Unit, Helsinki, Finland	University of Helsinki; Karolinska Institutet; University of Eastern Finland; University of Helsinki	Saavalainen, P (corresponding author), Univ Helsinki, Dept Med Genet, Res Programs Unit, Immunobiol & Haartman Inst, Helsinki, Finland.	paivi.saavalainen@helsinki.fi	Saavalainen, Päivi M/E-8621-2011; Gentile, Massimo/R-3270-2016; Greco, Dario/T-7113-2019	Gentile, Massimo/0000-0002-5256-0726; Greco, Dario/0000-0001-9195-9003	European Union Commission by a Marie Curie Excellence [MEXT-CT-2005-025270]; Academy of Finland	European Union Commission by a Marie Curie Excellence; Academy of Finland(Academy of Finland)	This work was funded by the European Union Commission by a Marie Curie Excellence Grant (FP6 contract MEXT-CT-2005-025270) and by the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Barone MV, 2007, GUT, V56, P480, DOI 10.1136/gut.2005.086637; Barone MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012246; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bracken S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-377; Caputo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045209; Ciccocioppo R, 2006, AM J CLIN PATHOL, V125, P502, DOI 10.1309/DTYRA91G8R0KTM8M; Ciccocioppo R, 2005, CLIN EXP IMMUNOL, V140, P408, DOI 10.1111/j.1365-2249.2005.02783.x; Ciccocioppo R, 2001, AM J CLIN PATHOL, V115, P494; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gertz EM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-566; Giovannini C, 2003, FEBS LETT, V540, P117, DOI 10.1016/S0014-5793(03)00236-9; Giovannini C, 2000, TOXICOLOGY, V145, P63, DOI 10.1016/S0300-483X(99)00223-1; Green PHR, 2006, ANNU REV MED, V57, P207, DOI 10.1146/annurev.med.57.051804.122404; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Heyman M, 2009, ANN NY ACAD SCI, V1165, P274, DOI 10.1111/j.1749-6632.2009.04032.x; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Johnston N, 2012, LARYNGOSCOPE, V122, P1317, DOI 10.1002/lary.23307; Juuti-Uusitalo K, 2004, J AUTOIMMUN, V22, P249, DOI 10.1016/j.jaut.2003.12.001; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Laza-Stanca V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002114; Lindfors K, 2008, CLIN EXP IMMUNOL, V152, P552, DOI 10.1111/j.1365-2249.2008.03635.x; Lo WS, 2003, DIGEST DIS SCI, V48, P395, DOI 10.1023/A:1021956200382; Londei M, 2005, MOL IMMUNOL, V42, P913, DOI 10.1016/j.molimm.2004.12.005; LUCIANI A, 2009, GUT; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 1996, GASTROENTEROLOGY, V110, P1368, DOI 10.1053/gast.1996.v110.pm8613040; Maiuri L, 2001, GUT, V48, P418, DOI 10.1136/gut.48.3.418; Maiuri MC, 2003, J MOL MED-JMM, V81, P373, DOI 10.1007/s00109-003-0440-0; Malamut G, 2010, J CLIN INVEST, V120, P2131, DOI 10.1172/JCI41344; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mazzarella G, 2008, GASTROENTEROLOGY, V134, P1017, DOI 10.1053/j.gastro.2008.01.008; McGough N, 2005, P NUTR SOC, V64, P434, DOI 10.1079/PNS2005461; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Reinke Y, 2011, EXP CELL RES, V317, P2124, DOI 10.1016/j.yexcr.2011.05.022; Rivabene R, 1999, BBA-MOL BASIS DIS, V1453, P152, DOI 10.1016/S0925-4439(98)00095-7; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Schumann M, 2012, GUT, V61, P220, DOI 10.1136/gutjnl-2011-300123; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Suen JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013809; Team RDC, 2012, R LANG ENV STAT COMP; TIAN QS, 1995, J EXP MED, V182, P865, DOI 10.1084/jem.182.3.865; Tursi A, 2001, HEPATO-GASTROENTEROL, V48, P462; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; van den Berg R, 2001, BRIT J NUTR, V86, pS121, DOI 10.1079/BJN2001340; Washizu J, 1998, IMMUNOGENETICS, V48, P1, DOI 10.1007/s002510050393; Yeung KT, 2011, MOL CELL BIOL, V31, P2287, DOI 10.1128/MCB.01381-10; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142	54	11	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66307	10.1371/journal.pone.0066307	http://dx.doi.org/10.1371/journal.pone.0066307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824913	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400082
J	Rieg, AD; Rossaint, R; Verjans, E; Maihofer, NA; Uhlig, S; Martin, C				Rieg, Annette D.; Rossaint, Rolf; Verjans, Eva; Maihoefer, Nina A.; Uhlig, Stefan; Martin, Christian			Levosimendan Relaxes Pulmonary Arteries and Veins in Precision-Cut Lung Slices - The Role of K-ATP-Channels, cAMP and cGMP	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; POTASSIUM CHANNELS; SMOOTH-MUSCLE; PHYSIOLOGICAL ROLES; VASODILATING MECHANISMS; INDIVIDUAL AIRWAYS; HYPERTENSION; ACTIVATION; RECEPTOR; METHACHOLINE	Introduction: Levosimendan is approved for left heart failure and is also used in right heart failure to reduce right ventricular afterload. Despite the fact that pulmonary arteries (PAs) and pulmonary veins (PVs) contribute to cardiac load, their responses to levosimendan are largely unknown. Materials and Methods: Levosimendan-induced vasorelaxation of PAs and PVs was studied in precision-cut lung slices from guinea pigs by videomicroscopy; baseline luminal area was defined as 100%. Intracellular cAMP- and cGMP-levels were measured by ELISA and NO end products were determined by the Griess reaction. Results: Levosimendan relaxed control PVs (116%) and those pre-constricted with an endothelin(A)-receptor agonist (119%). PAs were only relaxed if pre-constricted (115%). Inhibition of K-ATP-channels (glibenclamide), adenyl cyclase (SQ 22536) and protein kinase G (KT 5823) largely attenuated the levosimendan-induced relaxation in control PVs, as well as in pre-constricted PAs and PVs. Inhibition of BKCa2+-channels (iberiotoxin) and K-v-channels (4-aminopyridine) only contributed to the relaxant effect of levosimendan in pre-constricted PAs. In both PAs and PVs, levosimendan increased intracellular cAMP- and cGMP-levels, whereas NO end products remained unchanged. Notably, basal NO-levels were higher in PVs. The K-ATP-channel activator levcromakalim relaxed PAs dependent on cAMP/PKA/PKG and increased cAMP-levels in PAs. Discussion: Levosimendan initiates complex and divergent signaling pathways in PAs and PVs. Levosimendan relaxes PAs and PVs primarily via KATP-channels and cAMP/cGMP; in PAs, BKCa2+- and K-v-channels are also involved. Our findings with levcromakalim do further suggest that in PAs the activation of KATP-channels leads to the production of cAMP/PKA/PKG. In conclusion, these results suggest that levosimendan might reduce right ventricular afterload by relaxation of PAs as well as pulmonary hydrostatic pressure and pulmonary edema by relaxation of PVs.	[Rieg, Annette D.; Verjans, Eva; Maihoefer, Nina A.; Uhlig, Stefan; Martin, Christian] Rhenish Westphalian Tech Univ, Med Fac Aachen, Inst Pharmacol & Toxicol, Aachen, Germany; [Rieg, Annette D.; Rossaint, Rolf] Rhenish Westphalian Tech Univ, Med Fac Aachen, Dept Anesthesiol, Aachen, Germany; [Verjans, Eva] Rhenish Westphalian Tech Univ, Med Fac Aachen, Dept Pediat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Rieg, AD (corresponding author), Rhenish Westphalian Tech Univ, Med Fac Aachen, Inst Pharmacol & Toxicol, Aachen, Germany.	arieg@ukaachen.de	Uhlig, Stefan/A-7290-2014	Uhlig, Stefan/0000-0003-2332-1280	START-program of the Medical Faculty Aachen, RWTH Aachen	START-program of the Medical Faculty Aachen, RWTH Aachen	This work was supported by the START-program of the Medical Faculty Aachen, RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bina S, 1998, EUR J PHARMACOL, V351, P253, DOI 10.1016/S0014-2999(98)00307-0; Bonnet S, 2007, PHARMACOL THERAPEUT, V115, P56, DOI 10.1016/j.pharmthera.2007.03.014; Bowman P, 1999, J PHARMACOL EXP THER, V288, P316; Cavusoglu Y, 2009, J CARDIOVASC MED, V10, P503, DOI 10.2459/JCM.0b013e32832aa873; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; Chong TJ, 2007, PEPTIDES, V28, P2036, DOI 10.1016/j.peptides.2007.07.018; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; DANDURAND RJ, 1993, J APPL PHYSIOL, V75, P364, DOI 10.1152/jappl.1993.75.1.364; De Witt BJ, 2002, ANESTH ANALG, V94, P1427; Evans AM, 2011, CURR OPIN ANESTHESIO, V24, P13, DOI 10.1097/ACO.0b013e3283421201; Forrest P, 2009, ANAESTH INTENS CARE, V37, P370, DOI 10.1177/0310057X0903700314; Gao YS, 2005, AM J PHYSIOL-LUNG C, V288, pL213, DOI 10.1152/ajplung.00103.2004; Gruhn N, 1998, J CARDIOVASC PHARM, V31, P741, DOI 10.1097/00005344-199805000-00013; Hou YL, 2003, J BIOL CHEM, V278, P16706, DOI 10.1074/jbc.M300045200; Hourani SMO, 2001, BRIT J PHARMACOL, V133, P833, DOI 10.1038/sj.bjp.0704140; JIANG H, 1992, J BIOL CHEM, V267, P1015; Kleber FX, 2009, J CLIN PHARMACOL, V49, P109, DOI 10.1177/0091270008325150; Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65; Kostic TS, 2002, J BIOL CHEM, V277, P16412, DOI 10.1074/jbc.M112439200; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Landoni G, 2012, CRIT CARE MED, V40, P634, DOI 10.1097/CCM.0b013e318232962a; Leather HA, 2003, CRIT CARE MED, V31, P2339, DOI 10.1097/01.CCM.0000084844.95073.C0; Lubomirov LT, 2006, BIOFIZIKA+, V51, P773; Martin C, 1996, EUR RESPIR J, V9, P2479, DOI 10.1183/09031936.96.09122479; Michelakis ED, 2001, AM J PHYSIOL-LUNG C, V280, pL1138, DOI 10.1152/ajplung.2001.280.6.L1138; Morgado M, 2012, CELL MOL LIFE SCI, V69, P247, DOI 10.1007/s00018-011-0815-2; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Nijhawan N, 1999, J CARDIOVASC PHARM, V34, P219, DOI 10.1097/00005344-199908000-00007; Norel X, 2004, BRIT J PHARMACOL, V142, P788, DOI 10.1038/sj.bjp.0705843; Park Won Sun, 2010, Journal of Smooth Muscle Research, V46, P89; Pataricza J, 2003, CARDIOVASC DRUG THER, V17, P115, DOI 10.1023/A:1025331617233; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Poelzl G, 2008, HERZ, V33, P368, DOI 10.1007/s00059-008-3051-2; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; Revermann M, 2011, INTENS CARE MED, V37, P1368, DOI 10.1007/s00134-011-2254-9; Rieg AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029698; Rossi P, 2008, INTENS CARE MED, V34, P873, DOI 10.1007/s00134-007-0980-9; Schleputz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047344; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Shi WB, 1998, BRIT J PHARMACOL, V123, P1525, DOI 10.1038/sj.bjp.0701759; Usta C, 2006, EUR J CARDIO-THORAC, V30, P329, DOI 10.1016/j.ejcts.2006.05.019; Yildiz O, 2006, ANN THORAC SURG, V81, P1715, DOI 10.1016/j.athoracsur.2005.12.057; Yildiz O, 2007, J PHARMACOL SCI, V104, P1, DOI 10.1254/jphs.CP0060010; Yokoshiki H, 2003, CARDIOVASC DRUG THER, V17, P111, DOI 10.1023/A:1025379400395	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66195	10.1371/journal.pone.0066195	http://dx.doi.org/10.1371/journal.pone.0066195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824760	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400067
J	Sriwai, W; Mahavadi, S; Al-Shboul, O; Grider, JR; Murthy, KS				Sriwai, Wimolpak; Mahavadi, Sunila; Al-Shboul, Othman; Grider, John R.; Murthy, Karnam S.			Distinctive G Protein-Dependent Signaling by Protease-Activated Receptor 2 (PAR2) in Smooth Muscle: Feedback Inhibition of RhoA by cAMP-Independent PKA	PLOS ONE			English	Article							MYOSIN PHOSPHATASE; MYENTERIC NEURONS; MOLECULAR-CLONING; EPITHELIAL-CELLS; IN-VIVO; PHOSPHORYLATION; CONTRACTION; RELAXATION; EXPRESSION; THROMBIN	We examined expression of protease-activated receptors 2 (PAR2) and characterized their signaling pathways in rabbit gastric muscle cells. The PAR2 activating peptide SLIGRL (PAR2-AP) stimulated G(q), G(13), G(i1), PI hydrolysis, and Rho kinase activity, and inhibited cAMP formation. Stimulation of PI hydrolysis was partly inhibited in cells expressing PAR2 siRNA, Ga-q or Ga-i minigene and in cells treated with pertussis toxin, and augmented by expression of dominant negative regulator of G protein signaling (RGS4(N88S)). Stimulation of Rho kinase activity was abolished by PAR-2 or Ga-13 siRNA, and by Ga-13 minigene. PAR2-AP induced a biphasic contraction; initial contraction was selectively blocked by the inhibitor of PI hydrolysis (U73122) or MLC kinase (ML-9), whereas sustained contraction was selectively blocked by the Rho kinase inhibitor (Y27632). PAR2-AP induced phosphorylation of MLC20, MYPT1 but not CPI-17. PAR2-AP also caused a decrease in the association of NF-kappa B and PKA catalytic subunit: the effect of PAR2-AP was blocked by PAR2 siRNA or phosphorylation-deficient RhoA (RhoA(S188A)). PAR2-AP-induced degradation of IkBa and activation of NF-kappa B were abolished by the blockade of RhoA activity by Clostridium botulinum C3 exoenzyme suggesting RhoA-dependent activation of NF-kappa B. PAR2-AP- stimulated Rho kinase activity was significantly augmented by the inhibitors of PKA (myristoylated PKI), IKK2 (IKKIV) or NF-kappa B (MG132), and in cells expressing dominant negative mutants of IKK (IKK(K44A), IkBa (IkBa (S32A/S36A)) or RhoA(S188A), suggesting feedback inhibition of Rho kinase activity via PKA derived from NF-kappa B pathway. PAR2-AP induced phosphorylation of RhoA and the phosphorylation was attenuated in cells expressing phosphorylation-deficient RhoA(S188A). Our results identified signaling pathways activated by PAR2 to mediate smooth muscle contraction and a novel pathway for feedback inhibition of PAR2-stimulated RhoA. The pathway involves activation of the NF-kappa B to release catalytic subunit of PKA from its binding to IkBa and phosphorylation of RhoA at Ser(188).	[Sriwai, Wimolpak; Mahavadi, Sunila; Al-Shboul, Othman; Grider, John R.; Murthy, Karnam S.] Virginia Commonwealth Univ, Dept Physiol, VCU Program Enter Neuromuscular Sci, Richmond, VA 23284 USA	Virginia Commonwealth University	Murthy, KS (corresponding author), Virginia Commonwealth Univ, Dept Physiol, VCU Program Enter Neuromuscular Sci, Richmond, VA 23284 USA.	skarnam@vcu.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK28300, DK15564]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015564] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grants (DK28300 and DK15564 to KSM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Bohm SK, 1996, BIOCHEM J, V314, P1009; Bunnett NW, 2006, SEMIN THROMB HEMOST, V32, P39, DOI 10.1055/s-2006-939553; Cocks TM, 1999, GASTROENTEROLOGY, V116, P586, DOI 10.1016/S0016-5085(99)70180-0; Corvera CU, 1999, J PHYSIOL-LONDON, V517, P741, DOI 10.1111/j.1469-7793.1999.0741s.x; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; D'Andrea MR, 1998, J HISTOCHEM CYTOCHEM, V46, P157; de Godoy MAF, 2011, TRENDS PHARMACOL SCI, V32, P384, DOI 10.1016/j.tips.2011.03.005; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Gao CY, 2002, GASTROENTEROLOGY, V123, P1554, DOI 10.1053/gast.2002.36581; Garrido R, 2002, J NEUROCHEM, V83, P556, DOI 10.1046/j.1471-4159.2002.01119.x; Gilchrist A, 1999, J BIOL CHEM, V274, P6610, DOI 10.1074/jbc.274.10.6610; Gilchrist A, 2001, J BIOL CHEM, V276, P25672, DOI 10.1074/jbc.M100914200; Hu WH, 2008, BIOCHEM J, V412, P35, DOI 10.1042/BJ20080042; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Kawabata A, 2008, BRIT J PHARMACOL, V153, pS230, DOI 10.1038/sj.bjp.0707491; Kawabata A, 2001, BRIT J PHARMACOL, V133, P1213, DOI 10.1038/sj.bjp.0704211; Kawabata A, 1999, BRIT J PHARMACOL, V128, P865, DOI 10.1038/sj.bjp.0702755; Kawabata A, 2003, NIPPON YAKURIGAKU ZA, V121, P411; Kunzelmann K, 2002, CELL BIOCHEM BIOPHYS, V36, P209, DOI 10.1385/CBB:36:2-3:209; Mule F, 2002, BRIT J PHARMACOL, V136, P367, DOI 10.1038/sj.bjp.0704746; MURTHY KS, 1991, AM J PHYSIOL, V261, pG945, DOI 10.1152/ajpgi.1991.261.6.G945; Murthy KS, 1996, MOL PHARMACOL, V50, P870; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG1006, DOI 10.1152/ajpgi.00465.2002; Nishikawa H, 2002, EUR J PHARMACOL, V447, P87, DOI 10.1016/S0014-2999(02)01892-7; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; OKAMOTO T, 1992, FEBS LETT, V305, P125, DOI 10.1016/0014-5793(92)80878-K; Profirovic J, 2005, J BIOL CHEM, V280, P32866, DOI 10.1074/jbc.M501361200; Salinthone S, 2004, AM J PHYSIOL-GASTR L, V287, pG627, DOI 10.1152/ajpgi.00462.2003; Schmidlin F, 2001, AM J RESP CRIT CARE, V164, P1276, DOI 10.1164/ajrccm.164.7.2101157; Shea-Donohue T, 2010, NEUROGASTROENT MOTIL, V22, P1138, DOI 10.1111/j.1365-2982.2010.01557.x; Shi XZ, 2005, AM J PHYSIOL-GASTR L, V289, pG274, DOI 10.1152/ajpgi.00512.2004; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Singer CA, 2004, BIOESSAYS, V26, P646, DOI 10.1002/bies.20041; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Ubl JJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1339, DOI 10.1152/ajplung.00392.2001; Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zhou HP, 2004, AM J PHYSIOL-CELL PH, V286, pC1130, DOI 10.1152/ajpcell.00429.2003	43	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66743	10.1371/journal.pone.0066743	http://dx.doi.org/10.1371/journal.pone.0066743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825105	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400156
J	Sun, HL; Zhang, SH; Zhong, K; Xu, ZH; Feng, B; Yu, J; Fang, Q; Wang, S; Wu, DC; Zhang, JM; Chen, Z				Sun, Hong-Liu; Zhang, Shi-Hong; Zhong, Kai; Xu, Zheng-Hao; Feng, Bo; Yu, Jie; Fang, Qi; Wang, Shuang; Wu, Deng-Chang; Zhang, Jian-Min; Chen, Zhong			A Transient Upregulation of Glutamine Synthetase in the Dentate Gyrus Is Involved in Epileptogenesis Induced by Amygdala Kindling in the Rat	PLOS ONE			English	Article							LOW-FREQUENCY STIMULATION; TEMPORAL-LOBE EPILEPSY; THERAPEUTIC TIME-WINDOW; SPRAGUE-DAWLEY RATS; EPILEPTIFORM ACTIVITY; EXTRACELLULAR GLUTAMATE; SEIZURE DEVELOPMENT; MODEL; HIPPOCAMPUS; SUSCEPTIBILITY	Reduction of glutamine synthetase (GS) function is closely related to established epilepsy, but little is known regarding its role in epileptogenesis. The present study aimed to elucidate the functional changes of GS in the brain and its involvement in epileptogenesis using the amygdala kindling model of epilepsy induced by daily electrical stimulation of basolateral amygdala in rats. Both expression and activity of GS in the ipsilateral dentate gyrus (DG) were upregulated when kindled seizures progressed to stage 4. A single dose of L-methionine sulfoximine (MSO, in 2 mu l), a selective GS inhibitor, was administered into the ipsilateral DG on the third day following the first stage 3 seizure (just before GS was upregulated). It was found that low doses of MSO (5 or 10 mu g) significantly and dose-dependently reduced the severity of and susceptibility to evoked seizures, whereas MSO at a high dose (20 mu g) aggravated kindled seizures. In animals that seizure acquisition had been successfully suppressed with 10 mu g MSO, GS upregulation reoccurred when seizures re-progressed to stage 4 and re-administration of 10 mu g MSO consistently reduced the seizures. GLN at a dose of 1.5 mu g abolished the alleviative effect of 10 mu g MSO and deleterious effect of 20 mu g MSO on kindled seizures. Moreover, appropriate artificial microRNA interference (1 and 1.5x10(6) TU/2 mu l) of GS expression in the ipsilateral DG also inhibited seizure progression. In addition, a transient increase of GS expression and activity in the cortex was also observed during epileptogenesis evoked by pentylenetetrazole kindling. These results strongly suggest that a transient and region-specific upregulation of GS function occurs when epilepsy develops into a certain stage and eventually promotes the process of epileptogenesis. Inhibition of GS to an adequate degree and at an appropriate timing may be a potential therapeutic approach to interrupting epileptogenesis.	[Sun, Hong-Liu; Zhang, Shi-Hong; Zhong, Kai; Xu, Zheng-Hao; Feng, Bo; Yu, Jie; Fang, Qi; Wu, Deng-Chang; Chen, Zhong] Zhejiang Univ, Sch Med, Dept Pharmacol,Coll Pharmaceut Sci, Key Lab Med Neurobiol,Minist Hlth China,Zhejiang, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Shuang; Zhang, Jian-Min; Chen, Zhong] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Epilepsy Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Hong-Liu] Binzhou Med Univ, Dept Pharmacol, Yantai, Peoples R China	Zhejiang University; Zhejiang University; Binzhou Medical University	Chen, Z (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol,Coll Pharmaceut Sci, Key Lab Med Neurobiol,Minist Hlth China,Zhejiang, Hangzhou 310003, Zhejiang, Peoples R China.	chenzhong@zju.edu.cn		Xu, Zhenghao/0000-0003-0033-525X	National Natural Science Foundation of China [81030061, 81273506, 81221003, 81173042, 81202516, 81273492]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundation of China (81030061, 81273506, 81221003, 81173042, 81202516, 81273492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarpour B, 2012, NEUROSCI BULL, V28, P729, DOI 10.1007/s12264-012-1279-6; Amaral David G., 1995, P443; Bacci A, 2002, J NEUROPHYSIOL, V88, P2302, DOI 10.1152/jn.00665.2001; Bidmon HJ, 2008, EPILEPSIA, V49, P1733, DOI 10.1111/j.1528-1167.2008.01642.x; Broman J, 2000, HAND CHEM N, V18, P1; Bryant AS, 2009, J NEUROPHYSIOL, V102, P2880, DOI 10.1152/jn.00476.2009; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; DURING MJ, 1993, LANCET, V341, P1607; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Eid T, 2008, BRAIN, V131, P2061, DOI 10.1093/brain/awn133; Gorg B, 2007, FEBS LETT, V581, P84, DOI 10.1016/j.febslet.2006.11.081; HAMBERGER AC, 1979, BRAIN RES, V168, P513, DOI 10.1016/0006-8993(79)90306-8; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; HEINEMANN U, 1992, EPILEPSY RES, P273; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; Hu WW, 2012, CNS NEUROSCI THER, V18, P683, DOI 10.1111/j.1755-5949.2012.00356.x; Itoh K, 2009, NEUROSCIENCE, V159, P735, DOI 10.1016/j.neuroscience.2008.12.040; Kang TC, 2006, GLIA, V54, P258, DOI 10.1002/glia.20380; LEPPIK IE, 1992, EPILEPSY RES, P7; LOTHMAN EW, 1987, EPILEPSY RES, V1, P313, DOI 10.1016/0920-1211(87)90055-6; LOTHMAN EW, 1992, EPILEPSY RES, P301; Olney J W, 1986, Adv Neurol, V44, P857; OLNEY JW, 1978, KAINIC ACID TOOL NEU, P37; Perez EL, 2012, NEUROBIOL DIS, V47, P331, DOI 10.1016/j.nbd.2012.05.010; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; STRINGER JL, 1992, NEUROSCIENCE, V46, P309, DOI 10.1016/0306-4522(92)90053-5; Tani H, 2007, NEUROBIOL DIS, V25, P230, DOI 10.1016/j.nbd.2006.08.025; UEDA Y, 1995, EPILEPSY RES, V20, P213, DOI 10.1016/0920-1211(94)00081-7; van Gassen KLI, 2009, GENES BRAIN BEHAV, V8, P290, DOI 10.1111/j.1601-183X.2008.00471.x; VANDENBE.CJ, 1971, BIOCHEM J, V123, P211, DOI 10.1042/bj1230211; Wang S, 2008, NEUROBIOL DIS, V29, P52, DOI 10.1016/j.nbd.2007.07.027; WILLIAMSON A, 1994, CLIN NEUROSCI, V2, P47; Wu DC, 2008, NEUROBIOL DIS, V32, P151, DOI 10.1016/j.nbd.2008.07.002; Wu DC, 2008, NEUROBIOL DIS, V31, P74, DOI 10.1016/j.nbd.2008.03.007; Xu ZH, 2010, EPILEPSIA, V51, P1861, DOI 10.1111/j.1528-1167.2010.02663.x; Yang LX, 2006, NEUROSCIENCE, V138, P1089, DOI 10.1016/j.neuroscience.2005.12.006; Zhang LS, 2003, PHARMACOLOGY, V69, P27, DOI 10.1159/000071263; Zhang SH, 2009, NEUROSCI LETT, V455, P51, DOI 10.1016/j.neulet.2009.03.041; Zhong K, 2012, NEUROBIOL DIS, V48, P20, DOI 10.1016/j.nbd.2012.05.011	41	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66885	10.1371/journal.pone.0066885	http://dx.doi.org/10.1371/journal.pone.0066885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825580	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400166
J	Cai, XQ; Yu, HQ; Ruan, ZX; Yang, LL; Bai, JS; Qiu, DY; Jian, ZH; Xiao, YQ; Yang, JY; Le, TH; Zhu, XQ				Cai, Xian-Quan; Yu, Hai-Qiong; Ruan, Zhou-Xi; Yang, Lei-Liang; Bai, Jian-Shan; Qiu, De-Yi; Jian, Zhi-Hua; Xiao, Yi-Qian; Yang, Jie-Yang; Thanh Hoa Le; Zhu, Xing-Quan			Rapid Detection and Simultaneous Genotyping of Cronobacter spp. (formerly Enterobacter sakazakii) in Powdered Infant Formula Using Real-time PCR and High Resolution Melting (HRM) Analysis	PLOS ONE			English	Article							DUBLINENSIS SP-NOV; IDENTIFICATION; STRAINS; GENUS; PROPOSAL; ASSAY	Cronobacter spp. is an emerging pathogen that causes meningitis, sepsis, bacteremia, and necrotizing enterocolitis in neonates and children. The present study developed an assay integrating real-time PCR and high resolution melting (HRM) analysis targeting the OmpA gene for the specific detection and rapid identification of Cronobacter spp. (formerly Enterobacter sakazakii) in powdered infant formula. Eleven Cronobacter field isolates and 25 reference strains were examined using one pair of primers, having the accuracy of 100% in reference to conventional methods. The assay was proved to be highly sensitive with a detection limit of 10(2) CFU/ml without pre-enrichment, and highly concordant (100%) when compared with ISO-IDF 22964 in 89 actual samples. The method performed for Cronobacter spp. detection was less than 24 h, drastically shortened, compared to several days using standard culturing method, it is probe-free and reduces a risk of PCR carryover. Moreover, all Cronobacter strains examined in this study were genotyped into two species according to their HRM profiles. The established method should provide a molecular tool for direct detection and simultaneous genotyping of Cronobacter spp. in powdered infant formula.	[Cai, Xian-Quan; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Cai, Xian-Quan; Yang, Lei-Liang; Qiu, De-Yi; Jian, Zhi-Hua; Xiao, Yi-Qian; Yang, Jie-Yang] Zhongshan Entry Exit Inspect & Quarantine Bur, Ctr Tech, Zhongshan, Guangdong, Peoples R China; [Yu, Hai-Qiong] Guangdong Entry Exit Inspect & Quarantine Bur, Ctr Tech, Guangzhou, Guangdong, Peoples R China; [Ruan, Zhou-Xi] Shenzhen Entry Exit Inspect & Quarantine Bur, Anim & Plant Inspect & Quarantine Tech Ctr, Shenzhen, Guangdong, Peoples R China; [Yang, Jie-Yang] Guangzhou Airport Entry Exit Inspect & Quarantine, Guangzhou, Guangdong, Peoples R China; [Thanh Hoa Le] Vietnam Acad Sci & Technol, Dept Immunol, Inst Biotechnol, Hanoi, Vietnam	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Vietnam Academy of Science & Technology (VAST)	Zhu, XQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	xingquanzhu1@hotmail.com	Le, Thanh/GRY-4094-2022	LE, THANH HOA/0000-0003-3841-368X	Science & Technology Program of Zhongshan [20123A299]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]; Science & Technology Program of The General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China [2008IK007]	Science & Technology Program of Zhongshan; Science Fund for Creative Research Groups of Gansu Province(Science Fund for Creative Research Groups); Science & Technology Program of The General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China	This work was supported by The Science & Technology Program of Zhongshan (Grant No. 20123A299) to XQC, The Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006) to XQZ, and the Science & Technology Program of The General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (Grant No. 2008IK007) to HQY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; Cousins MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051359; Douarre PE, 2012, J MICROBIOL METH, V88, P172, DOI 10.1016/j.mimet.2011.10.009; Druggan P, 2009, INT J FOOD MICROBIOL, V136, P169, DOI 10.1016/j.ijfoodmicro.2009.09.008; Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; Gori A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030199; Hoque A, 2010, INT J FOOD MICROBIOL, V142, P375, DOI 10.1016/j.ijfoodmicro.2010.07.019; Hunter CJ, 2008, SURG INFECT, V9, P533, DOI 10.1089/sur.2008.006; International Organization for Standardization, 2006, 22964 ISOIDF; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; Iversen C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-64; Jaradat ZW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-225; Jin DZ, 2012, FEMS MICROBIOL LETT, V330, P72, DOI 10.1111/j.1574-6968.2012.02535.x; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Kandhai MC, 2010, FOOD CONTROL, V21, P1127, DOI 10.1016/j.foodcont.2010.01.007; Lehner A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-43; Liu X, 2012, WORLD J MICROB BIOT, V28, P1013, DOI 10.1007/s11274-011-0899-8; Liu Y, 2006, J MICROBIOL METH, V65, P21, DOI 10.1016/j.mimet.2005.06.007; Miled-Bennour R, 2010, INT J FOOD MICROBIOL, V139, P116, DOI 10.1016/j.ijfoodmicro.2010.01.045; Mittal R, 2009, LAB INVEST, V89, P263, DOI 10.1038/labinvest.2008.164; Nair MKM, 2006, APPL ENVIRON MICROB, V72, P2539, DOI 10.1128/AEM.72.4.2539-2546.2006; Ngui R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041996; O'Brien S, 2009, LETT APPL MICROBIOL, V48, P536, DOI 10.1111/j.1472-765X.2009.02562.x; Seo KH, 2005, J FOOD PROTECT, V68, P59, DOI 10.4315/0362-028X-68.1.59; Stoop B, 2009, INT J FOOD MICROBIOL, V136, P165, DOI 10.1016/j.ijfoodmicro.2009.04.023; Strydom A, 2012, CURR MICROBIOL, V64, P251, DOI 10.1007/s00284-011-0061-8; Strydom A, 2011, FOOD MICROBIOL, V28, P1472, DOI 10.1016/j.fm.2011.08.015; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Terragno R, 2009, INT J FOOD MICROBIOL, V136, P193, DOI 10.1016/j.ijfoodmicro.2009.10.013; Turcovsky I, 2011, ANTON LEEUW INT J G, V99, P257, DOI 10.1007/s10482-010-9484-7; World Health Organization, 2007, GUID SAF PREP STOR H; Ye Y, 2010, J DAIRY SCI, V93, P2315, DOI 10.3168/jds.2009-2662; Zeinzinger J, 2012, APPL ENVIRON MICROB, V78, P3352, DOI 10.1128/AEM.07668-11	33	30	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67082	10.1371/journal.pone.0067082	http://dx.doi.org/10.1371/journal.pone.0067082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825624	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000076
J	Heister, D; Diwakar, M; Nichols, S; Robb, A; Angeles, AM; Tal, O; Harrington, DL; Song, T; Lee, RR; Huang, MX				Heister, David; Diwakar, Mithun; Nichols, Sharon; Robb, Ashley; Angeles, Anne Marie; Tal, Omer; Harrington, Deborah L.; Song, Tao; Lee, Roland R.; Huang, Mingxiong			Resting-State Neuronal Oscillatory Correlates of Working Memory Performance	PLOS ONE			English	Article							SIGNAL SPACE SEPARATION; INDIVIDUAL-DIFFERENCES; FUNCTIONAL CONNECTIVITY; PRINCIPAL COMPONENT; EEG DIFFERENCES; ATTENTION; ALPHA; TASK; NETWORK; AROUSAL	Purpose: Working memory (WM) represents the brain's ability to maintain information in a readily available state for short periods of time. This study examines the resting-state cortical activity patterns that are most associated with performance on a difficult working-memory task. Methods: Magnetoencephalographic (MEG) band-passed (delta/theta (1-7 Hz), alpha (8-13 Hz), beta (14-30 Hz)) and sensor based regional power was collected in a population of adult men (18-28 yrs, n = 24) in both an eyes-closed and eyes-open resting state. The normalized power within each resting state condition as well as the normalized change in power between eyes closed and open (zECO) were correlated with performance on a WM task. The regional and band-limited measures that were most associated with performance were then combined using singular value decomposition (SVD) to determine the degree to which zECO power was associated with performance on the three-back verbal WM task. Results: Changes in power from eyes closed to open revealed a significant decrease in power in all band-widths that was most pronounced in the posterior brain regions (delta/theta band). zECO right posterior frontal and parietal cortex delta/theta power were found to be inversely correlated with three-back working memory performance. The SVD evaluation of the most correlated zECO metrics then provided a singular measure that was highly correlated with three-back performance (r = 20.73, p<0.0001). Conclusion: Our results indicate that there is an association between WM performance and changes in resting-state power (right posterior frontal and parietal delta/theta power). Moreover, an SVD of the most associated zECO measures produces a composite resting-state metric of regional neural oscillatory power that has an improved association with WM performance. To our knowledge, this is the first investigation that has found that changes in resting state electromagnetic neural patterns are highly associated with verbal working memory performance.	[Heister, David; Diwakar, Mithun; Tal, Omer; Harrington, Deborah L.; Lee, Roland R.; Huang, Mingxiong] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Nichols, Sharon; Song, Tao] Univ Calif San Diego, San Diego, CA 92103 USA; [Robb, Ashley; Angeles, Anne Marie; Harrington, Deborah L.; Lee, Roland R.; Huang, Mingxiong] Vet Affairs San Diego Healthcare Syst, Serv Radiol, San Diego, CA USA; [Robb, Ashley; Angeles, Anne Marie; Harrington, Deborah L.; Lee, Roland R.; Huang, Mingxiong] Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Heister, D (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.	dheister@ucsd.edu		Harrington, Deborah/0000-0001-9658-9080	National Institutes of Health-The National Institute of Biomedical Imaging and Bioengineering [T32 EB005970]; Department of Veterans Affairs; National Football League; McDonnell Foundation via the Brain Trauma Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health-The National Institute of Biomedical Imaging and Bioengineering; Department of Veterans Affairs(US Department of Veterans Affairs); National Football League; McDonnell Foundation via the Brain Trauma Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health-The National Institute of Biomedical Imaging and Bioengineering T32 EB005970 (DH). Merit Review Grants from the Department of Veterans Affairs (two for MX Huang, one for RR Lee), National Football League (MX Huang and RR Lee), and McDonnell Foundation via the Brain Trauma Foundation (PI: J Ghajar, site PIs: RR Lee and MX Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These supporting sources do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arruda JE, 2009, APPL PSYCHOPHYS BIOF, V34, P7, DOI 10.1007/s10484-008-9071-0; Arruda JE, 1999, INT J PSYCHOPHYSIOL, V32, P119, DOI 10.1016/S0167-8760(99)00006-9; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Barry RJ, 2005, J PSYCHOPHYSIOL, V19, P91, DOI 10.1027/0269-8803.19.2.91; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P402, DOI 10.1016/S1388-2457(03)00343-2; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Clark CR, 2004, INT J PSYCHOPHYSIOL, V53, P1, DOI 10.1016/j.ijpsycho.2003.12.011; Cohen D., 2002, P 13 INT C BIOMAGNET, P919; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; del Rio D, 2012, INT J PSYCHOPHYSIOL, V86, P160, DOI 10.1016/j.ijpsycho.2012.08.011; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Esposito F, 2009, ARCH ITAL BIOL, V147, P11; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P1083, DOI 10.1111/j.1469-8986.2010.01173.x; Foucher JR, 2004, NEUROIMAGE, V22, P688, DOI 10.1016/j.neuroimage.2004.01.048; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Goldman-Rakic PS, 1995, CELL, V14, P477; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Klimesch W, 1999, INTELLIGENCE, V27, P347, DOI 10.1016/S0160-2896(99)00027-6; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Levy F, 2001, CURR DRUG TARGETS, V2, P347, DOI 10.2174/1389450013348155; Macmillan NA, 2005, DETECTION THEORY USE; Makeig S, 1996, COGNITIVE BRAIN RES, V4, P15, DOI 10.1016/0926-6410(95)00042-9; Makeig S, 1995, NEUROREPORT, V7, P213, DOI 10.1097/00001756-199512000-00051; Makeig S, 2000, CAN J EXP PSYCHOL, V54, P266, DOI 10.1037/h0087346; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; O'Hearn K, 2008, DEV PSYCHOPATHOL, V20, P1103, DOI 10.1017/S0954579408000527; Perin B, 2010, BRAIN COGNITION, V72, P271, DOI 10.1016/j.bandc.2009.09.010; Petersen S. E., 2012, ANN REV NEUROSCIENCE, DOI 10.1146/annurev-neuro062111-150525; Pyka M, 2013, HUM BRAIN MAPP, V34, P3010, DOI 10.1002/hbm.22121; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Sala-Llonch R, 2011, CORTEX, P1; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Sturm W, 2006, EXP BRAIN RES, V171, P16, DOI 10.1007/s00221-005-0253-1; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; VaezMousavi SM, 2009, PHYSIOL BEHAV, V98, P326, DOI 10.1016/j.physbeh.2009.06.007; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Zou Q, 2012, HUMAN BRAIN IN PRESS	49	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66820	10.1371/journal.pone.0066820	http://dx.doi.org/10.1371/journal.pone.0066820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825569	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000030
J	Ma, JB; Zhang, MR; Xiao, XL; You, JJ; Wang, JR; Wang, T; Yao, YN; Tian, CY				Ma, Jinbiao; Zhang, Meiru; Xiao, Xinlong; You, Jinjin; Wang, Junru; Wang, Tao; Yao, Yinan; Tian, Changyan			Global Transcriptome Profiling of Salicornia europaea L. Shoots under NaCl Treatment	PLOS ONE			English	Article							CONFERRED SALT TOLERANCE; SALINITY TOLERANCE; ARABIDOPSIS-THALIANA; REGULATES EXPRESSION; SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; NA+/H+ ANTIPORTER; SEED-GERMINATION; STRESS RESPONSES; ION ACCUMULATION	Background: Soil salinity is a major abiotic stress that limits agriculture productivity worldwide. Salicornia europaea is well adapted to extreme saline environments with more than 1,000 mM NaCl in the soil, so it could serve as an important model species for studying halophilic mechanisms in euhalophytes. To obtain insights into the molecular basis of salt tolerance, we present here the first extensive transcriptome analysis of this species using the Illumina HiSeq (TM) 2000. Principal Findings: A total of 41 and 39 million clean reads from the salt-treated (Se200S) and salt-free (SeCKS) tissues of S. europaea shoots were obtained, and de novo assembly produced 97,865 and 101,751 unigenes, respectively. Upon further assembly with EST data from both Se200S and SeCKS, 109,712 high-quality non-redundant unigenes were generated with a mean unigene size of 639 bp. Additionally, a total of 3,979 differentially expressed genes (DEGs) were detected between the Se200S and SeCKS libraries, with 348 unigenes solely expressed in Se200S and 460 unigenes solely expressed in SeCKS. Furthermore, we identified a large number of genes that are involved in ion homeostasis and osmotic adjustment, including cation transporters and proteins for the synthesis of low-molecular compounds. All unigenes were functionally annotated within the COG, GO and KEGG pathways, and 10 genes were validated by qRT-PCR. Conclusion: Our data contains the extensive sequencing and gene-annotation analysis of S. europaea. This genetic knowledge will be very useful for future studies on the molecular adaptation to abiotic stress in euhalophytes and will facilitate the genetic manipulation of other economically important crops.	[Ma, Jinbiao; Zhang, Meiru; Xiao, Xinlong; You, Jinjin; Wang, Junru; Yao, Yinan; Tian, Changyan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China; [Zhang, Meiru; Xiao, Xinlong; Wang, Junru] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Tao] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xinjiang University	Yao, YN (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China.	yaoya@ms.xjb.ac.cn; tiancy@ms.xjb.ac.cn	Xiao, Xinlong/I-6330-2012		programme of 100 Distinguished Young Scientists in the Chinese Academy of Sciences; Natural Science Foundation in China [31270660]; Youth Science Foundation of Xinjiang Uygur Autonomous Region of China [2011211B47]; Open Fund of the State Key Laboratory of Crop Stress Biology for Arid Areas [CSBAA2011-04]; Doctor Western [XBBS 201201]	programme of 100 Distinguished Young Scientists in the Chinese Academy of Sciences; Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Xinjiang Uygur Autonomous Region of China; Open Fund of the State Key Laboratory of Crop Stress Biology for Arid Areas; Doctor Western	This work was supported by the programme of 100 Distinguished Young Scientists in the Chinese Academy of Sciences, Natural Science Foundation in China (Grant No. 31270660), the Youth Science Foundation of Xinjiang Uygur Autonomous Region of China (Grant No. 2011211B47), the Open Fund of the State Key Laboratory of Crop Stress Biology for Arid Areas (CSBAA2011-04), and the Doctor Western-funded Projects of Chinese Academy of Sciences (XBBS 201201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaleh M, 2009, BIOL PLANTARUM, V53, P243, DOI 10.1007/s10535-009-0046-7; Aghaleh M, 2011, ACTA PHYSIOL PLANT, V33, P1261, DOI 10.1007/s11738-010-0656-x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Ardie SW, 2009, J EXP BOT, V60, P3491, DOI 10.1093/jxb/erp184; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Barkla BJ, 2011, PLANT CELL MONOGR, V19, P457, DOI 10.1007/978-3-642-13431-9_21; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Berthomieu P, 2003, EMBO J, V22, P2004, DOI 10.1093/emboj/cdg207; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Chen SH, 2007, DNA SEQUENCE, V18, P61, DOI 10.1080/10425170601108555; Chen XY, 2011, PLANT CELL PHYSIOL, V52, P909, DOI 10.1093/pcp/pcr043; Chinnusamy Viswanathan, 2006, Genet Eng (N Y), V27, P141, DOI 10.1007/0-387-25856-6_9; Cockburn W, 1996, J EXP BOT, V47, P647, DOI 10.1093/jxb/47.5.647; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; FOYER C, 1991, PLANT PHYSIOL, V97, P863, DOI 10.1104/pp.97.3.863; Fukuda A, 1998, PLANT CELL PHYSIOL, V39, P196, DOI 10.1093/oxfordjournals.pcp.a029357; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo YH, 2012, ACTA PHYSIOL PLANT, V34, P1287, DOI 10.1007/s11738-012-0925-y; Halfter Ursula, 1999, Plant Biology (Rockville), V1999, P123; Han HP, 2008, BIOTECHNOL LETT, V30, P1501, DOI 10.1007/s10529-008-9705-6; Horie T, 2001, PLANT J, V27, P129, DOI 10.1046/j.1365-313x.2001.01077.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kachout SS, 2012, J SCI FOOD AGR, V92, P336, DOI 10.1002/jsfa.4581; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kore-eda S, 2004, GENE, V341, P83, DOI 10.1016/j.gene.2004.06.037; Kyndt T, 2012, J EXP BOT, V63, P2141, DOI 10.1093/jxb/err435; Li HT, 2009, BIOCHEM BIOPH RES CO, V382, P637, DOI 10.1016/j.bbrc.2009.03.091; Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438; Lv SL, 2012, ACTA PHYSIOL PLANT, V34, P503, DOI 10.1007/s11738-011-0847-0; Lv SL, 2012, PLANT PHYSIOL BIOCH, V51, P47, DOI 10.1016/j.plaphy.2011.10.015; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mazel A, 2004, PLANT PHYSIOL, V134, P118, DOI 10.1104/pp.103.025379; Moghaieb REA, 2004, PLANT SCI, V166, P1345, DOI 10.1016/j.plantsci.2004.01.016; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozawa T, 2007, SOIL SCI PLANT NUTR, V53, P12, DOI 10.1111/j.1747-0765.2007.00098.x; Pardo JM, 1998, P NATL ACAD SCI USA, V95, P9681, DOI 10.1073/pnas.95.16.9681; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; RIEHL TE, 1982, OECOLOGIA, V54, P193, DOI 10.1007/BF00378392; Roy SJ, 2011, CURR OPIN PLANT BIOL, V14, P232, DOI 10.1016/j.pbi.2011.03.002; Rus A, 2001, P NATL ACAD SCI USA, V98, P14150, DOI 10.1073/pnas.241501798; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Sokhansanj A, 2006, RUSS J PLANT PHYSL+, V53, P110, DOI 10.1134/S1021443706010146; Su H, 2003, PLANT MOL BIOL, V52, P967, DOI 10.1023/A:1025445612244; Subramanyam K, 2012, PLANTA, V236, P1909, DOI 10.1007/s00425-012-1733-8; Subramanyam K, 2011, PLANT CELL TISS ORG, V105, P181, DOI 10.1007/s11240-010-9850-1; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Taji T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-115; Torabi S, 2011, IN VITRO CELL DEV-PL, V47, P734, DOI 10.1007/s11627-011-9371-6; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Ueda A, 2001, PLANT CELL PHYSIOL, V42, P1282, DOI 10.1093/pcp/pce166; Ungar IA, 1996, AM J BOT, V83, P604, DOI 10.2307/2445919; Ushakova SA, 2005, ADV SPACE RES-SERIES, V36, P1349, DOI 10.1016/j.asr.2004.09.017; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Waditee R, 2002, J BIOL CHEM, V277, P18373, DOI 10.1074/jbc.M112012200; Wang DY, 2012, PLANT PHYSIOL BIOCH, V51, P53, DOI 10.1016/j.plaphy.2011.10.009; Wang XC, 2009, J PROTEOME RES, V8, P3331, DOI 10.1021/pr801083a; Winicov I, 1999, PLANT PHYSIOL, V120, P473, DOI 10.1104/pp.120.2.473; Wu S, 2010, ISOLATION CHOLINE MO; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yang XL, 2011, AFR J BIOTECHNOL, V10, P16452, DOI 10.5897/AJB11.1092; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang JS, 1999, THEOR APPL GENET, V99, P1006, DOI 10.1007/s001220051408; Zhou SF, 2008, BIOTECHNOL LETT, V30, P369, DOI 10.1007/s10529-007-9548-6; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	73	28	34	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e65877	10.1371/journal.pone.0065877	http://dx.doi.org/10.1371/journal.pone.0065877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825526	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000005
J	Zhong, XC; Zhang, H; Zhao, Y; Sun, QW; Hu, YF; Peng, H; Zhou, DX				Zhong, Xiaochao; Zhang, Hua; Zhao, Yu; Sun, Qianwen; Hu, Yongfeng; Peng, Hai; Zhou, Dao-Xiu			The Rice NAD(+)-Dependent Histone Deacetylase OsSRT1 Targets Preferentially to Stress- and Metabolism-Related Genes and Transposable Elements	PLOS ONE			English	Article							EXPRESSION; ACETYLATION; ARABIDOPSIS; SIRT6	Histone acetylation/deacetylation is an important chromatin modification for epigenetic regulation of gene expression. Silent information regulation2 (Sir2)-related sirtuins are nicotinamide-adenine dinucleotide (NAD(+))-dependent histone deacetylases (HDAC). The mammalian sirtuin family comprises 7 members (SIRT1-7) that act in different cellular compartments to regulate metabolism and aging. The rice genome contains only two Sir2-related genes: OsSRT1 (or SRT701) and OsSRT2 (orSRT702). OsSRT1 is closely related to the mammalian SIRT6, while OsSRT2 is homologous to SIRT4. Previous work has shown that OsSRT1 is required for the safeguard against genome instability and cell damage in rice plant. In this work we investigated the role of OsSRT1 on genome-wide acetylation of histone H3 lysine 9 (H3K9ac) and studied the genome-wide binding targets of OsSRT1. The study reveals that OsSRT1 binds to loci with relatively low levels of H3K9ac and directly regulates H3K9ac and expression of many genes that are related to stress and metabolism, indicating that OsSRT1 is an important site-specific histone deacetylase for gene regulation in rice. In addition, OsSRT1 is found to also target to several families of transposable elements, suggesting that OsSRT1 is directly involved in transposable element repression.	[Zhong, Xiaochao; Zhang, Hua; Zhao, Yu; Sun, Qianwen] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hu, Yongfeng; Zhou, Dao-Xiu] Univ Paris 11, Inst Biol Plantes, Orsay, France; [Peng, Hai] Jianghan Univ, Inst Interdisciplinary Sci, Res Inst, Wuhan, Peoples R China	Huazhong Agricultural University; UDICE-French Research Universities; Universite Paris Saclay; Jianghan University	Zhou, DX (corresponding author), Univ Paris 11, Inst Biol Plantes, Orsay, France.	dao-xiu.zhou@u-psud.fr		Zhou, Dao-Xiu/0000-0002-1540-0598	Chinese Ministry of Science and Technology "863" project [2012AA10A303]; Fundamental Research Funds for the Central Universities [2011PY051, 2012ZYTS057]; French Agence Nationale de la Recherche (ANR) program Blanc (NERDPATH)	Chinese Ministry of Science and Technology "863" project(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); French Agence Nationale de la Recherche (ANR) program Blanc (NERDPATH)(French National Research Agency (ANR))	This work was supported by the Chinese Ministry of Science and Technology "863" project (2012AA10A303); the Fundamental Research Funds for the Central Universities ("2011PY051" and "2012ZYTS057"); and the French Agence Nationale de la Recherche (ANR) program Blanc (NERDPATH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Chung PJ, 2009, FEBS LETT, V583, P2249, DOI 10.1016/j.febslet.2009.06.003; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Earley KW, 2007, PLANT J, V52, P615, DOI 10.1111/j.1365-313X.2007.03264.x; Greiss S, 2009, MOL CELLS, V28, P407, DOI 10.1007/s10059-009-0169-x; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu YF, 2012, P NATL ACAD SCI USA, V109, P5773, DOI 10.1073/pnas.1203148109; Hu YF, 2009, BIOCHEM BIOPH RES CO, V388, P266, DOI 10.1016/j.bbrc.2009.07.162; Huang LM, 2007, PLANT PHYSIOL, V144, P1508, DOI 10.1104/pp.107.099473; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Servet C, 2010, MOL PLANT, V3, P670, DOI 10.1093/mp/ssq018; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	20	31	37	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66807	10.1371/journal.pone.0066807	http://dx.doi.org/10.1371/journal.pone.0066807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825566	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000028
J	Lasko, TA; Denny, JC; Levy, MA				Lasko, Thomas A.; Denny, Joshua C.; Levy, Mia A.			Computational Phenotype Discovery Using Unsupervised Feature Learning over Noisy, Sparse, and Irregular Clinical Data	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; RISK STRATIFICATION; HEART-FAILURE; MODELS; REGULARIZATION; TIME	Inferring precise phenotypic patterns from population-scale clinical data is a core computational task in the development of precision, personalized medicine. The traditional approach uses supervised learning, in which an expert designates which patterns to look for (by specifying the learning task and the class labels), and where to look for them (by specifying the input variables). While appropriate for individual tasks, this approach scales poorly and misses the patterns that we don't think to look for. Unsupervised feature learning overcomes these limitations by identifying patterns (or features) that collectively form a compact and expressive representation of the source data, with no need for expert input or labeled examples. Its rising popularity is driven by new deep learning methods, which have produced high-profile successes on difficult standardized problems of object recognition in images. Here we introduce its use for phenotype discovery in clinical data. This use is challenging because the largest source of clinical data - Electronic Medical Records - typically contains noisy, sparse, and irregularly timed observations, rendering them poor substrates for deep learning methods. Our approach couples dirty clinical data to deep learning architecture via longitudinal probability densities inferred using Gaussian process regression. From episodic, longitudinal sequences of serum uric acid measurements in 4368 individuals we produced continuous phenotypic features that suggest multiple population subtypes, and that accurately distinguished (0.97 AUC) the uric-acid signatures of gout vs. acute leukemia despite not being optimized for the task. The unsupervised features were as accurate as gold-standard features engineered by an expert with complete knowledge of the domain, the classification task, and the class labels. Our findings demonstrate the potential for achieving computational phenotype discovery at population scale. We expect such data-driven phenotypes to expose unknown disease variants and subtypes and to provide rich targets for genetic association studies.	[Lasko, Thomas A.; Denny, Joshua C.; Levy, Mia A.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Denny, Joshua C.; Levy, Mia A.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Levy, Mia A.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Lasko, TA (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	tom.lasko@vanderbilt.edu	Denny, Josh/AAL-3359-2021	Denny, Josh/0000-0002-3049-7332	Edward Mallinckrodt, Jr. Foundation; Vanderbilt University Medical Center; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER	Edward Mallinckrodt, Jr. Foundation; Vanderbilt University Medical Center; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded in part by a grant from the Edward Mallinckrodt, Jr. Foundation, and Vanderbilt University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lario B, 2011, QJM-INT J MED, V104, P1015, DOI 10.1093/qjmed/hcr159; Arel I, 2010, IEEE COMPUT INTELL M, V5, P13, DOI 10.1109/MCI.2010.938364; Batal I, 2011, IEEE INT C BIOINFORM, P358, DOI 10.1109/BIBM.2011.39; Bengio Y., 2012, P ICML WORKSH UNS TR, V27, P17; Bengio Y., 2007, LARGE SCALE KERNEL M; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bishop C. M, 2006, PATTERN RECOGNITION; Carroll Robert J, 2011, AMIA Annu Symp Proc, V2011, P189; Conway Mike, 2011, AMIA Annu Symp Proc, V2011, P274; Cover T. M., 1991, ELEMENTS INFORM THEO; De Keulenaer GW, 2011, CIRCULATION, V123, P1996, DOI 10.1161/CIRCULATIONAHA.110.981431; De Keulenaer GW, 2009, CIRCULATION, V119, P3044, DOI 10.1161/CIRCULATIONAHA.109.870006; Dean BB, 2009, MED CARE RES REV, V66, P611, DOI 10.1177/1077558709332440; Denny JC, 2009, J AM MED INFORM ASSN, V16, P806, DOI 10.1197/jamia.M3037; DIETTERICH TG, 1981, ARTIF INTELL, V16, P257, DOI 10.1016/0004-3702(81)90002-3; Fawcett TE, 1992, P 9 INT C MACH LEARN, P144; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howard SC, 2011, NEW ENGL J MED, V364, P1844, DOI 10.1056/NEJMra0904569; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Klompas M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002626; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Le Q., 2012, P INT C MACH LEARN; Lee H., 2008, ADV NEURAL INFORM PR; Lee H, 2009, NIPS 2009 WORKSH DEE; Lee H, 2011, COMMUN ACM, V54, P95, DOI 10.1145/2001269.2001295; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; MacKay D. J. C., 1998, Neural Networks and Machine Learning. Proceedings, P133; MacKay D. J. C., 2003, INFORM THEORY INFERE; Markovitch S, 2002, MACH LEARN, V49, P59, DOI 10.1023/A:1014046307775; Matheny ME, 2010, MED DECIS MAKING, V30, P639, DOI 10.1177/0272989X10364246; Moskovitch Robert, 2009, AMIA Annu Symp Proc, V2009, P452; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Ng A, 2011, UFLDL TUTORIAL; Ngiam J., 2011, P 28 INT C INT C MAC, P265; Ngiam J., 2011, P INT C MACH LEARN; Noren GN, 2010, DATA MIN KNOWL DISC, V20, P361, DOI 10.1007/s10618-009-0152-3; O'Sullivan F., 1986, STAT SCI, V1, P502, DOI DOI 10.1214/ss/1177013525; Paciorek C.J., 2004, ADV NEURAL INFORM PR; Poggio Tomaso, 2003, NOTICES AM MATH SOC, V50, P537; R Core Team, 2012, R LANG ENV STAT COMP; Raina R, 2007, 24 ANN INT C MACH LE, V227, P759, DOI [10.1145/1273496.1273592, DOI 10.1145/1273496.1273592]; Rasmussen C. E., 2011, GPML TOOLBOX VERSION; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roque FS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002141; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.441.0206; Saria S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001304; Schmidt AM, 2003, J R STAT SOC B, V65, P743, DOI 10.1111/1467-9868.00413; Stacey M, 2007, ARTIF INTELL MED, V39, P1, DOI 10.1016/j.artmed.2006.08.002; Syed Z, 2011, J MACH LEARN RES, V12, P999; Tikhonov A., 1977, SOLUTION ILL POSED P; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang F., 2012, P 18 ACM SIGKDD INT, P453, DOI DOI 10.1145/2339530.2339605; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wilcox WD, 1996, J PEDIATR-US, V128, P731, DOI 10.1016/S0022-3476(96)70322-0; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	63	162	165	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66341	10.1371/journal.pone.0066341	http://dx.doi.org/10.1371/journal.pone.0066341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826094	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400016
J	Liu, YC; Ferguson, JF; Xue, CY; Silverman, IM; Gregory, B; Reilly, MP; Li, MY				Liu, Yichuan; Ferguson, Jane F.; Xue, Chenyi; Silverman, Ian M.; Gregory, Brian; Reilly, Muredach P.; Li, Mingyao			Evaluating the Impact of Sequencing Depth on Transcriptome Profiling in Human Adipose	PLOS ONE			English	Article							RNA-SEQ; GENE-EXPRESSION; INFLAMMATION; ENDOTOXIN; DISEASE; BIOMARKERS	Recent advances in RNA sequencing (RNA-Seq) have enabled the discovery of novel transcriptomic variations that are not possible with traditional microarray-based methods. Tissue and cell specific transcriptome changes during pathophysiological stress in disease cases versus controls and in response to therapies are of particular interest to investigators studying cardiometabolic diseases. Thus, knowledge on the relationships between sequencing depth and detection of transcriptomic variation is needed for designing RNA-Seq experiments and for interpreting results of analyses. Using deeply sequenced Illumina HiSeq 2000 101 bp paired-end RNA-Seq data derived from adipose of a healthy individual before and after systemic administration of endotoxin (LPS), we investigated the sequencing depths needed for studies of gene expression and alternative splicing (AS). In order to detect expressed genes and AS events, we found that similar to 100 to 150 million (M) filtered reads were needed. However, the requirement on sequencing depth for the detection of LPS modulated differential expression (DE) and differential alternative splicing (DAS) was much higher. To detect 80% of events, similar to 300 M filtered reads were needed for DE analysis whereas at least 400 M filtered reads were necessary for detecting DAS. Although the majority of expressed genes and AS events can be detected with modest sequencing depths (similar to 100 M filtered reads), the estimated gene expression levels and exon/intron inclusion levels were less accurate. We report the first study that evaluates the relationship between RNA-Seq depth and the ability to detect DE and DAS in human adipose. Our results suggest that a much higher sequencing depth is needed to reliably identify DAS events than for DE genes.	[Liu, Yichuan; Li, Mingyao] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Ferguson, Jane F.; Xue, Chenyi; Reilly, Muredach P.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Silverman, Ian M.; Gregory, Brian] Univ Penn, Perelman Sch Med, Dept Biol, Philadelphia, PA 19104 USA; [Silverman, Ian M.; Gregory, Brian] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Reilly, MP (corresponding author), Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.	muredach@mail.med.upenn.edu; mingyao@mail.med.upenn.edu	Ferguson, Jane/C-7154-2011; Gregory, Brian D/G-2890-2010; Liu, Yichuan/AAF-3893-2021	Ferguson, Jane/0000-0001-6896-1025; Reilly, Muredach/0000-0002-3035-9386; LIU, YICHUAN/0000-0003-2023-072X; Silverman, Ian/0000-0003-3819-6726	pilot grant from Penn Genomes Frontiers Institute [R01-HL-113147]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000003]; NIH-NHLBI SCCOR Project grant [P50-HL-083799];  [R01-HG-004517];  [R01-HG-005854];  [R01-HL-111694];  [R01-DK-090505];  [U01-HL-108636];  [K24-HL-107643]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113147, K24HL107643, R01HL111694, P50HL083799, U01HL108636] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005854, R01HG004517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER	pilot grant from Penn Genomes Frontiers Institute; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH-NHLBI SCCOR Project grant; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a pilot grant from Penn Genomes Frontiers Institute and R01-HL-113147 (ML and MPR) as well as by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000003 and a NIH-NHLBI SCCOR Project grant (P50-HL-083799) to MPR. ML is also supported by R01-HG-004517 and R01-HG-005854. MPR is also supported by R01-HL-111694, R01-DK-090505, U01-HL-108636, and K24-HL-107643. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ferguson JF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-63; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Hudgins LC, 2003, J LIPID RES, V44, P1489, DOI 10.1194/jlr.M200440-JLR200; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Pedrotty DM, 2012, PROG CARDIOVASC DIS, V55, P64, DOI 10.1016/j.pcad.2012.06.003; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shah R, 2009, DIABETES, V58, P2211, DOI 10.2337/db09-0256; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016	30	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66883	10.1371/journal.pone.0066883	http://dx.doi.org/10.1371/journal.pone.0066883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826166	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400077
J	Nydam, ML; Netuschil, N; Sanders, E; Langenbacher, A; Lewis, DD; Taketa, DA; Marimuthu, A; Gracey, AY; De Tomaso, AW				Nydam, Marie L.; Netuschil, Nikolai; Sanders, Erin; Langenbacher, Adam; Lewis, Daniel D.; Taketa, Daryl A.; Marimuthu, Arumugapradeep; Gracey, Andrew Y.; De Tomaso, Anthony W.			The Candidate Histocompatibility Locus of a Basal Chordate Encodes Two Highly Polymorphic Proteins	PLOS ONE			English	Article							PROTOCHORDATE ALLORECOGNITION; EVOLUTION; GENE; REJECTION; GENOME; FESTER	The basal chordate Botryllus schlosseri undergoes a natural transplantation reaction governed by a single, highly polymorphic locus called the fuhc. Our initial characterization of this locus suggested it encoded a single gene alternatively spliced into two transcripts: a 555 amino acid-secreted form containing the first half of the gene, and a full-length, 1008 amino acid transmembrane form, with polymorphisms throughout the ectodomain determining outcome. We have now found that the locus encodes two highly polymorphic genes which are separated by a 227 bp intergenic region: first, the secreted form as previously described, and a second gene encoding a 531 amino acid membrane-bound gene containing three extracellular immunoglobulin domains. While northern blotting revealed only these two mRNAs, both PCR and mRNA-seq detect a single capped and polyadenylated transcript that encodes processed forms of both genes linked by the intergenic region, as well as other transcripts in which exons of the two genes are spliced together. These results might suggest that the two genes are expressed as an operon, during which both genes are co-transcribed and then trans-spliced into two separate messages. This type of transcriptional regulation has been described in tunicates previously; however, the membrane-bound gene does not encode a typical Splice Leader (SL) sequence at the 59 terminus that usually accompanies trans-splicing. Thus, the presence of stable transcripts encoding both genes may suggest a novel mechanism of regulation, or conversely may be rare but stable transcripts in which the two mRNAs are linked due to a small amount of read-through by RNA polymerase. Both genes are highly polymorphic and co-expressed on tissues involved in histocompatibility. In addition, polymorphisms on both genes correlate with outcome, although we have found a case in which it appears that the secreted form may be major allorecognition determinant.	[Nydam, Marie L.; Netuschil, Nikolai; Sanders, Erin; Langenbacher, Adam; Lewis, Daniel D.; Taketa, Daryl A.; Marimuthu, Arumugapradeep; De Tomaso, Anthony W.] Univ Calif Santa Barbara, Dept MCD Biol, Santa Barbara, CA 93106 USA; [Gracey, Andrew Y.] Univ So Calif, Dept Marine Environm Biol, Los Angeles, CA USA	University of California System; University of California Santa Barbara; University of Southern California	De Tomaso, AW (corresponding author), Univ Calif Santa Barbara, Dept MCD Biol, Santa Barbara, CA 93106 USA.	detomaso@lifesci.ucsb.edu		Sanders, Erin/0000-0003-2312-6346	National Institutes of Health [NIH R01 AI041588, NIH R01 AG037966, NSF IOS-08421387]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by the National Institutes of Health grants NIH R01 AI041588, NIH R01 AG037966, and NSF IOS-08421387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Blumenthal Thomas, 2012, WormBook, P1, DOI 10.1895/wormbook.1.5.2; Brown FD, 2009, DEVELOPMENT, V136, P3485, DOI 10.1242/dev.037754; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; De Tomaso AW, 2006, TRENDS GENET, V22, P485, DOI 10.1016/j.tig.2006.07.001; De Tomaso AW, 2009, DIS MODEL MECH, V2, P440, DOI 10.1242/dmm.001156; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; De Tomaso AW, 1998, GENETICS, V149, P277; De Tomaso AW, 2004, SCIENCE, V303, P977, DOI 10.1126/science.1094952; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Gasparini F, 2011, DEV GENES EVOL, V220, P329, DOI 10.1007/s00427-011-0351-y; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; Harada Y, 2008, SCIENCE, V320, P548, DOI 10.1126/science.1152488; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Matsumoto J, 2010, GENOME RES, V20, P636, DOI 10.1101/gr.100271.109; McKitrick TR, 2011, IMMUNITY, V34, P616, DOI 10.1016/j.immuni.2011.01.019; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Nydam ML, 2013, DEV COMP IMMUNOL, V41, P128, DOI 10.1016/j.dci.2013.03.004; Nydam ML, 2013, EVOLUTION, V67, P487, DOI 10.1111/j.1558-5646.2012.01787.x; Nydam ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-249; Nydam ML, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00079; Nyholm SV, 2006, IMMUNITY, V25, P163, DOI 10.1016/j.immuni.2006.04.011; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rinkevich B, 2012, DEV COMP IMMUNOL, V36, P718, DOI 10.1016/j.dci.2011.10.015; Rosa SFP, 2010, CURR BIOL, V20, P1122, DOI 10.1016/j.cub.2010.04.050; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; Sabbadin A, 1962, ATTI ACCAD NAZ LINCE, V32; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCOFIELD VL, 1983, BIOL BULL, V165, P733, DOI 10.2307/1541475; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65980	10.1371/journal.pone.0065980	http://dx.doi.org/10.1371/journal.pone.0065980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826085	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400007
J	Rohban, R; Reinisch, A; Etchart, N; Schallmoser, K; Hofmann, NA; Szoke, K; Brinchmann, JE; Rad, EB; Rohde, E; Strunk, D				Rohban, Rokhsareh; Reinisch, Andreas; Etchart, Nathalie; Schallmoser, Katharina; Hofmann, Nicole A.; Szoke, Krisztina; Brinchmann, Jan E.; Rad, Ehsan Bonyadi; Rohde, Eva; Strunk, Dirk			Identification of an Effective Early Signaling Signature during Neo-Vasculogenesis In Vivo by Ex Vivo Proteomic Profiling	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; HUMAN-ENDOTHELIAL-CELLS; Q-VD-OPH; INFLAMMATORY CASPASES; CORD BLOOD; GENE-EXPRESSION; STEM-CELLS; APOPTOSIS; VITRO; ANGIOGENESIS	Therapeutic neo-vasculogenesis in vivo can be achieved by the co-transplantation of human endothelial colony-forming progenitor cells (ECFCs) with mesenchymal stem/progenitor cells (MSPCs). The underlying mechanism is not completely understood thus hampering the development of novel stem cell therapies. We hypothesized that proteomic profiling could be used to retrieve the in vivo signaling signature during the initial phase of human neo-vasculogenesis. ECFCs and MSPCs were therefore either transplanted alone or co-transplanted subcutaneously into immune deficient mice. Early cell signaling, occurring within the first 24 hours in vivo, was analyzed using antibody microarray proteomic profiling. Vessel formation and persistence were verified in parallel transplants for up to 24 weeks. Proteomic analysis revealed significant alteration of regulatory components including caspases, calcium/calmodulin-dependent protein kinase, DNA protein kinase, human ErbB2 receptor-tyrosine kinase as well as mitogen-activated protein kinases. Caspase-4 was selected from array results as one therapeutic candidate for targeting vascular network formation in vitro as well as modulating therapeutic vasculogenesis in vivo. As a proof-of-principle, caspase-4 and general caspase-blocking led to diminished endothelial network formation in vitro and significantly decreased vasculogenesis in vivo. Proteomic profiling ex vivo thus unraveled a signaling signature which can be used for target selection to modulate neo-vasculogenesis in vivo.	[Rohban, Rokhsareh; Reinisch, Andreas; Etchart, Nathalie; Schallmoser, Katharina; Hofmann, Nicole A.; Strunk, Dirk] Med Univ Graz, Stem Cell Res Unit, Graz, Austria; [Reinisch, Andreas; Etchart, Nathalie; Strunk, Dirk] Med Univ Graz, Div Hematol & Stem Cell Transplantat, Graz, Austria; [Etchart, Nathalie; Schallmoser, Katharina] Med Univ Graz, Dept Blood Grp Serol & Transfus Med, Graz, Austria; [Schallmoser, Katharina; Rohde, Eva] Paracelsus Med Univ, Dept Blood Grp Serol & Transfus Med, Salzburg, Austria; [Szoke, Krisztina; Brinchmann, Jan E.] Univ Oslo, Inst Basic Med Sci, Norwegian Ctr Stem Cell Res, Oslo, Norway; [Rad, Ehsan Bonyadi] Med Univ Graz, Dept Dermatol, Canc Biol Unit, Graz, Austria; [Rad, Ehsan Bonyadi] Med Univ Graz, Dept Pediat & Adolescence Surg, Graz, Austria; [Strunk, Dirk] Paracelsus Med Univ, Inst Expt & Clin Cell Therapy, Salzburg, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Paracelsus Private Medical University; University of Oslo; Medical University of Graz; Medical University of Graz; Paracelsus Private Medical University	Strunk, D (corresponding author), Med Univ Graz, Stem Cell Res Unit, Graz, Austria.	dirk.strunk@pmu.ac.at	Schallmoser, Katharina/V-4734-2017; Strunk, Dirk/V-4598-2017; Rohde, Eva/V-5766-2017	Schallmoser, Katharina/0000-0002-7204-0058; Strunk, Dirk/0000-0003-1810-867X; Rohde, Eva/0000-0001-8692-886X; Reinisch, Andreas/0000-0001-9333-7689	Austrian Research Foundation (FFG) [N211-NAN]; Adult Stem Cell Research Foundation; Medical University of Graz	Austrian Research Foundation (FFG)(Austrian Science Fund (FWF)); Adult Stem Cell Research Foundation; Medical University of Graz	This work was supported by the Austrian Research Foundation (FFG, grant N211-NAN; DS), the Adult Stem Cell Research Foundation and a young investigator starting grant of the Medical University of Graz (AR). RR and NAH are fellows of the PhD program Molecular Medicine at the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Bian ZM, 2009, INVEST OPHTH VIS SCI, V50, P6006, DOI 10.1167/iovs.09-3628; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Das SB, 2005, ONCOL REP, V14, P1059; Dasari VR, 2010, AGING-US, V2, P791, DOI 10.18632/aging.100217; DAVIS GE, 1995, EXP CELL RES, V216, P113, DOI 10.1006/excr.1995.1015; DUMONT DJ, 1992, ONCOGENE, V7, P1471; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hofmann NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044468; Hofmann Nicole A, 2012, Methods Mol Biol, V879, P381, DOI 10.1007/978-1-61779-815-3_23; Kersse K, 2007, BIOCHEM SOC T, V35, P1508, DOI 10.1042/BST0351508; Kim KW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002275; Kuzelova K, 2011, J CELL BIOCHEM, V112, P3334, DOI 10.1002/jcb.23263; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Mead LE, 2008, CURR PROTOC STEM CEL; MEANS AR, 1980, NATURE, V285, P73, DOI 10.1038/285073a0; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Moretti L, 2009, MOL CANCER THER, V8, P1270, DOI 10.1158/1535-7163.MCT-08-0893; Mukhopadhyay D, 1996, BIOCHEM BIOPH RES CO, V229, P733, DOI 10.1006/bbrc.1996.1873; Nadiri A, 2006, J IMMUNOL, V177, P4239, DOI 10.4049/jimmunol.177.7.4239; Reinisch A, 2009, J VIS EXP; Reinisch A, 2007, REGEN MED, V2, P371, DOI 10.2217/17460751.2.4.371; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Rohde E, 2007, STEM CELLS, V25, P1746, DOI 10.1634/stemcells.2006-0833; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Scharner D, 2009, ARTERIOSCL THROM VAS, V29, P571, DOI 10.1161/ATVBAHA.108.182006; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Segura I, 2002, FASEB J, V16, DOI 10.1096/fj.01-0819com; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Szoke K, 2012, CELL TRANSPLANT, V21, P235, DOI 10.3727/096368911X580518; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105	42	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66909	10.1371/journal.pone.0066909	http://dx.doi.org/10.1371/journal.pone.0066909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826172	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400082
J	Baumann, H; Doherty, O				Baumann, Hannes; Doherty, Owen			Decadal Changes in the World's Coastal Latitudinal Temperature Gradients	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; COUNTERGRADIENT VARIATION; CONTRASTING PATTERNS; GEOGRAPHIC-VARIATION; MARINE GASTROPOD; RANGE SHIFTS; GROWTH-RATE; VARIABILITY; IMPACTS	Most of the world's living marine resources inhabit coastal environments, where average thermal conditions change predictably with latitude. These coastal latitudinal temperature gradients (CLTG) coincide with important ecological clines,e.g., in marine species diversity or adaptive genetic variations, but how tightly thermal and ecological gradients are linked remains unclear. A first step is to consistently characterize the world's CLTGs. We extracted coastal cells from a global 1 degrees x 1 degrees dataset of weekly sea surface temperatures (SST, 1982-2012) to quantify spatial and temporal variability of the world's 11 major CLTGs. Gradient strength, i.e., the slope of the linear mean-SST/latitude relationship, varied 3-fold between the steepest (North-American Atlantic and Asian Pacific gradients: -0.91 degrees C and -0.68 degrees C lat(-1), respectively) and weakest CLTGs (African Indian Ocean and the South- and North-American Pacific gradients: -0.28, -0.29, -0.32 degrees C lat(-1), respectively). Analyzing CLTG strength by year revealed that seven gradients have weakened by 3-10% over the past three decades due to increased warming at high compared to low latitudes. Almost the entire South- American Pacific gradient (6-47 degrees S), however, has considerably cooled over the study period (-0.3 to -1.7 degrees C, 31 years), and the substantial weakening of the North-American Atlantic gradient (-10%) was due to warming at high latitudes (42-60 degrees N, +0.8 to +1.6 degrees C, 31 years) and significant mid-latitude cooling ( Florida to Cape Hatteras 26-35 degrees N, -0.5 to -2.2 degrees C, 31 years). Average SST trends rarely resulted from uniform shifts throughout the year; instead individual seasonal warming or cooling patterns elicited the observed changes in annual means. This is consistent with our finding of increased seasonality (i.e., summer-winter SST amplitude) in three quarters of all coastal cells (331 of 433). Our study highlights the regionally variable footprint of global climate change, while emphasizing ecological implications of changing CLTGs, which are likely driving observed spatial and temporal clines in coastal marine life.	[Baumann, Hannes] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Doherty, Owen] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego; Scripps Institution of Oceanography	Baumann, H (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	hannes.baumann@stonybrook.edu	Baumann, Hannes/D-1435-2010	Baumann, Hannes/0000-0002-4039-4230				[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BAKUN A, 1991, J PHYS OCEANOGR, V21, P1815, DOI 10.1175/1520-0485(1991)021<1815:TSCOWS>2.0.CO;2; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Baumann H, 2012, COPEIA, P341, DOI 10.1643/CG-10-189; Baumann H, 2011, P ROY SOC B-BIOL SCI, V278, P2265, DOI 10.1098/rspb.2010.2479; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Beninger PG, 2012, J EXP MAR BIOL ECOL, V426, P97, DOI 10.1016/j.jembe.2012.05.020; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Bograd SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035933; Brown JJ, 1998, T AM FISH SOC, V127, P598, DOI 10.1577/1548-8659(1998)127<0598:VILGRA>2.0.CO;2; Bryden HL, 2005, J OCEANOGR, V61, P479, DOI 10.1007/s10872-005-0057-8; Bryden HL, 2005, NATURE, V438, P655, DOI 10.1038/nature04385; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1987, NATURE, V326, P496, DOI 10.1038/326496a0; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; CONOVER DO, 1992, J FISH BIOL, V41, P161, DOI 10.1111/j.1095-8649.1992.tb03876.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dengler M., 2006, GEOPHYS RES LETT, P33; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ezer T, 2013, J GEOPHYS RES-OCEANS, V118, P685, DOI 10.1002/jgrc.20091; Folland CK, 1990, CLIMATE CHANGE: THE IPCC SCIENTIFIC ASSESSMENT, P195; Gomez-Gesteira M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004315; Goreau T.J., 2005, WORLD RESOURCE REV, V17, P350; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Jonassen TM, 2000, J FISH BIOL, V56, P279, DOI 10.1111/j.1095-8649.2000.tb02106.x; Jordan D. S., 1891, Proceedings of the United States National Museum, Vxiv, P107; Lemos RT, 2004, INT J CLIMATOL, V24, P511, DOI 10.1002/joc.1009; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Lima FP, 2006, J BIOGEOGR, V33, P812, DOI 10.1111/j.1365-2699.2006.01457.x; McDowall RM, 2008, J BIOGEOGR, V35, P501, DOI 10.1111/j.1365-2699.2007.01823.x; Munch SB, 2003, EVOLUTION, V57, P2119, DOI 10.1554/02-711; Munch SB, 2003, ECOLOGY, V84, P2168, DOI 10.1890/02-0137; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; NOAA, 2012, EARTH SYST RES LAB N; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; PALTRIDGE G, 1981, MON WEATHER REV, V109, P2427, DOI 10.1175/1520-0493(1981)109<2427:CIGSTF>2.0.CO;2; Pardo PC, 2011, CLIM RES, V48, P231, DOI 10.3354/cr00989; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parsons KE, 1997, EVOLUTION, V51, P784, DOI 10.1111/j.1558-5646.1997.tb03661.x; PAULY D, 1980, J CONSEIL, V39, P175; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Portner H.-O., 2022, SUMMARY POLICYMAKERS; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rossby T, 1996, REV GEOPHYS, V34, P463, DOI 10.1029/96RG02214; Roughan M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001833; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Salinas S, 2012, ECOL LETT, V15, P159, DOI 10.1111/j.1461-0248.2011.01721.x; Sanford E, 2006, ECOLOGY, V87, P2882, DOI 10.1890/0012-9658(2006)87[2882:LTGFAT]2.0.CO;2; Santos F, 2012, CONT SHELF RES, V47, P1, DOI 10.1016/j.csr.2012.07.023; Santos F, 2011, CONT SHELF RES, V31, P2012, DOI 10.1016/j.csr.2011.10.005; Santos F, 2012, CONT SHELF RES, V34, P79, DOI 10.1016/j.csr.2011.12.004; SCHROEDER EH, 1966, B MAR SCI, V16, P302; Schultz ET, 1996, FUNCT ECOL, V10, P366, DOI 10.2307/2390285; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Strong AE, 2000, GEOPHYS RES LETT, V27, P1667, DOI 10.1029/1999GL002392; ter Hofstede R, 2010, MAR ECOL PROG SER, V414, P1, DOI 10.3354/meps08753; Yasuhara M, 2012, ECOL LETT, V15, P1174, DOI 10.1111/j.1461-0248.2012.01828.x; Zacherl D, 2003, J BIOGEOGR, V30, P913, DOI 10.1046/j.1365-2699.2003.00899.x	68	39	39	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67596	10.1371/journal.pone.0067596	http://dx.doi.org/10.1371/journal.pone.0067596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825672	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400190
J	Boeykens, N; Ponsaerts, P; Ysebaert, D; De Greef, K				Boeykens, Nele; Ponsaerts, Peter; Ysebaert, Dirk; De Greef, Kathleen			Biochemical Parameters for Longitudinal Monitoring of Liver Function in Rat Models of Partial Hepatectomy Following Liver Injury	PLOS ONE			English	Article							CHOLINE-DEFICIENT DIET; COLORECTAL METASTASES; HEPATIC STEATOSIS; MAJOR HEPATECTOMY; FATTY LIVER; RISK-FACTOR; CHEMOTHERAPY; REGENERATION; RESECTION; SURGERY	Background: While evaluation of liver function in preclinical animal studies is commonly performed at selected time-points by invasive determination of the liver/body weight ratio and histological analyses, the validation of longitudinal measurement tools for monitoring liver function are of major interest. Aims: To longitudinally evaluate serum cholinesterase (CHE) and total serum bilirubin (TSB) levels as non-invasive markers to determine injury-and partial hepatectomy (PHx)-induced alterations of liver function in rats. Methods: Male and female Lewis rats were subjected to either methionine/choline deficient (MCD) diet or treatment with FOLFOX chemotherapy prior to PHx. Body weight and CHE/TSB levels are determined weekly. Following PHx and at the study end, histological analyses of liver tissue are performed. Results: Following MCD diet, but not after FOLFOX chemotherapy treatment, results indicate gender-specific alterations in serum CHE levels and gender-independent alterations in TSB levels. Likewise, histological analyses of resected liver parts indicate significant liver injury following MCD-diet, but not following FOLFOX treatment. While TSB levels rapidly recover following MCD diet/FOLFOX treatment combined with a PHx, serum CHE levels are subject to significant model-and gender-specific differences, despite full histopathological recovery of liver tissue. Conclusions: Longitudinal measurements of serum CHE levels and TSB levels in rats are highly complementary as non-invasive parameters for evaluation of liver injury and/or recovery.	[Boeykens, Nele; Ysebaert, Dirk; De Greef, Kathleen] Univ Antwerp, Univ Antwerp Hosp, Antwerp Surg Training & Res Ctr, Expt Surg Lab, B-2020 Antwerp, Belgium; [Ponsaerts, Peter] Univ Antwerp, Vaccine & Infect Dis Inst Vaxinfectio, Lab Expt Hematol, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Ysebaert, D (corresponding author), Univ Antwerp, Univ Antwerp Hosp, Antwerp Surg Training & Res Ctr, Expt Surg Lab, B-2020 Antwerp, Belgium.	dirk.ysebaert@ua.ac.be	Ponsaerts, Peter/B-6213-2017; Ysebaert, Dirk/J-6800-2013	Ponsaerts, Peter/0000-0002-1892-6499; Ysebaert, Dirk/0000-0002-3350-6994	University of Antwerp; Flemish Institute for Science and Technology (IWT-Vlaanderen)	University of Antwerp; Flemish Institute for Science and Technology (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by a BOF-NOI 2009 research grant from the University of Antwerp (granted to DY and KDG). NB holds a PhD-studentship from the Flemish Institute for Science and Technology (IWT-Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beveridge JMR, 1941, SCIENCE, V93, P356, DOI 10.1126/science.93.2415.356; Brahmer JR, 2011, J THORAC ONCOL, V6, P103, DOI 10.1097/JTO.0b013e3181fa8efd; Cakmak GK, 2012, INT J SURG; Chansky K, 2005, CANCER-AM CANCER SOC, V103, P1165, DOI 10.1002/cncr.20878; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Gomez D, 2007, BRIT J SURG, V94, P1395, DOI 10.1002/bjs.5820; Kandutsch S, 2008, EJSO-EUR J SURG ONC, V34, P1231, DOI 10.1016/j.ejso.2008.01.001; Karoui M, 2006, ANN SURG, V243, P1, DOI 10.1097/01.sla.0000193603.26265.c3; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; McCormack L, 2007, ANN SURG, V245, P923, DOI 10.1097/01.sla.0000251747.80025.b7; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Nordlinger B, 2007, EUR J CANCER, V43, P2037, DOI 10.1016/j.ejca.2007.07.017; Pelz S, 2012, EXP CELL RES, V318, P276, DOI 10.1016/j.yexcr.2011.11.005; Rickenbacher A, 2011, LIVER INT, V31, P313, DOI 10.1111/j.1478-3231.2010.02446.x; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Robinson S, 2011, SURG ONCOL, V20, P57, DOI 10.1016/j.suronc.2009.10.002; Schmetzer Oliver, 2012, Handb Exp Pharmacol, P411, DOI 10.1007/978-3-642-30726-3_19; Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933; van der Jagt EJ, 2012, LIVER INT; Vauthey JN, 2006, J CLIN ONCOL, V24, P2065, DOI 10.1200/JCO.2005.05.3074; Vetelainen R, 2007, ANN SURG, V245, P20, DOI 10.1097/01.sla.0000225113.88433.cf; Vetelainen R, 2007, ANN SURG, V245, P44, DOI 10.1097/01.sla.0000225253.84501.0e; Yamamoto H, 2008, ONCOLOGY-BASEL, V75, P169, DOI 10.1159/000159268; Ysebaert DK, 2003, KIDNEY INT, V64, P864, DOI 10.1046/j.1523-1755.2003.00150.x; Zafiriou G, 2002, CHEMOTHERAPY, V48, P298, DOI 10.1159/000069711	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66383	10.1371/journal.pone.0066383	http://dx.doi.org/10.1371/journal.pone.0066383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824267	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400099
J	Rai, S; Mahapatra, B; Sircar, S; Raj, PY; Venkatesh, S; Shaukat, M; Rewari, BB				Rai, Sandeep; Mahapatra, Bidhubhusan; Sircar, Subhashish; Raj, Pinnamaneni Yujwal; Venkatesh, Srinivasan; Shaukat, Mohammed; Rewari, Bharat Bhusan			Adherence to Antiretroviral Therapy and Its Effect on Survival of HIV-Infected Individuals in Jharkhand, India	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; MORTALITY; ADULTS; CARE; OUTCOMES; PREDICTORS; RETENTION; BARRIERS; FAILURE; PROGRAM	Introduction: Research in India has extensively examined the factors associated with non-adherence to antiretroviral therapy (ART) with limited focus on examining the relationship between adherence to ART regimen and survival status of HIV infected patients. This study examines the effect of optimal adherence to ART on survival status of HIV infected patients attending ART centers in Jharkhand, India. Materials and Methods: Data from a cohort of 239 HIV infected individuals who were initiated ART in 2007 were compiled from medical records retrospectively for 36 months. Socio-demographic characteristics, CD4 T cell count, presence of opportunistic infections at the time of ART initiation and ART regimen intake and survival status was collected periodically. Optimal adherence was assessed using pill count methods; patients who took <95% of the specified regimens were identified as non-adherent. Cox-proportional hazard model was used to determine the relative hazards of mortality. Results: More than three-fourths of the patients were male, on an average 34 year old and median CD4 T cell count was 118 cells/cmm at the time of ART registration. About 57% of the patients registered for ART were found to be adherent to ART. A total of 104 patients died in 358.5 patient-years of observation resulting in a mortality rate of 29 per 100 patient-years (95% confidence interval (CI): 23.9-35.2) and median survival time of 6.5 months (CI: 2.7-10.9). The mortality rate was higher among patients who were non-adherent to ART (64.5, CI: 50.5-82.4) than who were adherent (15.4, CI: 11.3-21.0). The risk of mortality was fourfold higher among individuals who were non-adherent to ART than who were adherent (Adjusted hazard ratio: 3.9, CI: 2.6-6.0). Conclusion: Adherence to ART is associated with a higher chance of survival of HIV infected patients, ascertaining the need for interventions to improve the ART adherence and early initiation of ART.	[Rai, Sandeep; Sircar, Subhashish] Jharkhand & Bihar State AIDS Control Soc, Ranchi, Bihar, India; [Mahapatra, Bidhubhusan] Populat Council, HIV & AIDS Program, New Delhi, India; [Raj, Pinnamaneni Yujwal; Venkatesh, Srinivasan; Shaukat, Mohammed; Rewari, Bharat Bhusan] Govt India, Natl AIDS Control Org, Dept AIDS Control, Minist Hlth & Family Welf, New Delhi, India		Mahapatra, B (corresponding author), Populat Council, HIV & AIDS Program, New Delhi, India.	bbmahapatra@popcouncil.org	RAJ, PROFESSORDES/AAA-1007-2020; Mahapatra, Bidhubhusan/M-1411-2019; Rai, Dr Sandeep/AAX-3363-2021	RAJ, PROFESSORDES/0000-0002-4050-4778; Mahapatra, Bidhubhusan/0000-0003-0240-7026; 	Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative	Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative(Bill & Melinda Gates FoundationGates Foundation India)	This paper was written as part of the Knowledge Network project of the Population Council, which is a grantee of the Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation and Avahan. We are also thankful to the national AIDS control organization (NACO) and Jharkhand state AIDS control society (JSACS) for providing the necessary approval to use of the patients medical records. The views expressed in this publication are those of the authors and do not necessarily reflect those of the NACO and JSACS.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Arrivillaga M, 2009, REV PANAM SALUD PUBL, V26, P502, DOI 10.1590/S1020-49892009001200005; Bachani D, 2010, NATL MED J INDIA, V23, P7; Batavia AS, 2010, AIDS BEHAV, V14, P794, DOI 10.1007/s10461-009-9663-6; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; Chan KCW, 2002, AIDS, V16, P1693, DOI 10.1097/00002030-200208160-00020; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Ghate M, 2011, INDIAN J MED RES, V133, P414; Gonzalez MA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-605; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Joglekar N, 2011, INDIAN J MED RES, V134, P954, DOI 10.4103/0971-5916.92642; Kumarasamy N, 2005, CLIN INFECT DIS, V41, P1525, DOI 10.1086/497267; Kunutsor S, 2010, JAIDS-J ACQ IMM DEF, V55, P221, DOI 10.1097/QAI.0b013e3181e255ec; Lal Vivek, 2010, Indian J Public Health, V54, P179, DOI 10.4103/0019-557X.77256; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Minzi O M S, 2008, Tanzan J Health Res, V10, P84; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; National AIDS Control Organisation (NACO), 2011, NAT AIDS CONTR PROGR; Rajasekaran S, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000279706.24428.78; Reda AA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/574656; Sahay S, 2011, INDIAN J MED RES, V134, P835, DOI 10.4103/0971-5916.92629; Sogarwal Ruchi, 2009, J Indian Med Assoc, V107, P276; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; Teja Vijay Dharma, 2007, Indian J Med Sci, V61, P555; Venkatesh KK, 2010, AIDS PATIENT CARE ST, V24, P795, DOI 10.1089/apc.2010.0153; Wagner JH, 2001, J CLIN EPIDEMIOL, V54, pS91, DOI 10.1016/S0895-4356(01)00450-4; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	36	32	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66860	10.1371/journal.pone.0066860	http://dx.doi.org/10.1371/journal.pone.0066860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825577	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400162
J	Tang, XY; Oishi, K; Faria, AV; Hillis, AE; Albert, MS; Mori, S; Miller, MI				Tang, Xiaoying; Oishi, Kenichi; Faria, Andreia V.; Hillis, Argye E.; Albert, Marilyn S.; Mori, Susumu; Miller, Michael I.			Bayesian Parameter Estimation and Segmentation in the Multi-Atlas Random Orbit Model	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; IMAGE SEGMENTATION; WHITE-MATTER; HUMAN BRAIN; MR-IMAGES; ANATOMICAL STRUCTURES; PROBABILISTIC ATLAS; SHAPE MODEL; HIPPOCAMPAL; FRAMEWORK	This paper examines the multiple atlas random diffeomorphic orbit model in Computational Anatomy (CA) for parameter estimation and segmentation of subcortical and ventricular neuroanatomy in magnetic resonance imagery. We assume that there exist multiple magnetic resonance image (MRI) atlases, each atlas containing a collection of locally-defined charts in the brain generated via manual delineation of the structures of interest. We focus on maximum a posteriori estimation of high dimensional segmentations of MR within the class of generative models representing the observed MRI as a conditionally Gaussian random field, conditioned on the atlas charts and the diffeomorphic change of coordinates of each chart that generates it. The charts and their diffeomorphic correspondences are unknown and viewed as latent or hidden variables. We demonstrate that the expectation-maximization (EM) algorithm arises naturally, yielding the likelihood-fusion equation which the a posteriori estimator of the segmentation labels maximizes. The likelihoods being fused are modeled as conditionally Gaussian random fields with mean fields a function of each atlas chart under its diffeomorphic change of coordinates onto the target. The conditional-mean in the EM algorithm specifies the convex weights with which the chartspecific likelihoods are fused. The multiple atlases with the associated convex weights imply that the posterior distribution is a multi-modal representation of the measured MRI. Segmentation results for subcortical and ventricular structures of subjects, within populations of demented subjects, are demonstrated, including the use of multiple atlases across multiple diseased groups.	[Tang, Xiaoying; Miller, Michael I.] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD 21218 USA; [Oishi, Kenichi; Faria, Andreia V.; Mori, Susumu] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Hillis, Argye E.; Albert, Marilyn S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Hillis, Argye E.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Hillis, Argye E.] Johns Hopkins Univ, Sch Med, Dept Cognit Sci, Baltimore, MD USA; [Albert, Marilyn S.] Johns Hopkins Alzheimers Dis Res Ctr, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Miller, MI (corresponding author), Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD 21218 USA.	mim@cis.jhu.edu	Oishi, Kenichi/H-1371-2013	Oishi, Kenichi/0000-0002-1200-8611	National Institutes of Health (NIH) [RO1AG020012]; NIBIB/NIH [R01 DC011317, R01 EB000975, P41 EB015909, R01 EB008171, R01 HD065955, R21AG033774, U01 AG033655, R03EB04357]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065955] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017638, P41EB015909, R03EB014357, R01EB000975, R01EB008171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033774, U01AG033655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011317, R01DC003681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIBIB/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is partially supported by National Institutes of Health (NIH) RO1AG020012, R03EB04357 from NIBIB/NIH, R01 DC011317, R01 EB000975, P41 EB015909, R01 EB008171, R01 HD065955, R21AG033774, and U01 AG033655. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Allassonniere S, 2007, J R STAT SOC B, V69, P3; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Asman AJ, 2012, IEEE T MED IMAGING, V31, P1326, DOI 10.1109/TMI.2012.2190992; Awate SP, 2007, LECT NOTES COMPUT SC, V4584, P296; Baillard C, 2000, LECT NOTES COMPUT SC, V1935, P236; Baillard C, 2001, MED IMAGE ANAL, V5, P185, DOI 10.1016/S1361-8415(01)00039-1; BAJCSY R, 1983, J COMPUT ASSIST TOMO, V7, P618, DOI 10.1097/00004728-198308000-00008; BAJCSY R, 1989, COMPUT VISION GRAPH, V46, P1, DOI 10.1016/S0734-189X(89)80014-3; Beg MF, 2005, INT J COMPUT VISION, V61, P139, DOI 10.1023/B:VISI.0000043755.93987.aa; Boothby W. M., 1986, INTRO DIFFERENTIABLE; Carmichael OT, 2005, NEUROIMAGE, V27, P979, DOI 10.1016/j.neuroimage.2005.05.005; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Christensen GE, 1997, IEEE T MED IMAGING, V16, P864, DOI 10.1109/42.650882; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; COOTES TF, 1994, IMAGE VISION COMPUT, V12, P355, DOI 10.1016/0262-8856(94)90060-4; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; Crum WR, 2001, NEUROIMAGE, V13, P847, DOI 10.1006/nimg.2001.0744; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Drury HA, 1996, J COGNITIVE NEUROSCI, V8, P1, DOI 10.1162/jocn.1996.8.1.1; Dubes R. C., 1990, Proceedings. 10th International Conference on Pattern Recognition (Cat. No.90CH2898-5), P808, DOI 10.1109/ICPR.1990.118221; Dupuis P, 1998, Q APPL MATH, V56, P587, DOI 10.1090/qam/1632326; Duta N, 1998, IEEE T MED IMAGING, V17, P1049, DOI 10.1109/42.746716; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Glaunes J, 2005, SURFACE MATCHING VIA, V3565, P1; Grenander U, 1998, Q APPL MATH, V56, P617, DOI 10.1090/qam/1668732; Grenander U., 1993, GEN PATTERN THEORY; Haller JW, 1997, RADIOLOGY, V202, P504, DOI 10.1148/radiology.202.2.9015081; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Han X, 2003, IEEE T PATTERN ANAL, V25, P755, DOI 10.1109/TPAMI.2003.1201824; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883; Hogan RE, 2000, RADIOLOGY, V216, P291, DOI 10.1148/radiology.216.1.r00jl41291; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kittler J, 2003, IEEE T PATTERN ANAL, V25, P110, DOI 10.1109/TPAMI.2003.1159950; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Lotjonen J, 2011, NEUROIMAGE, V56, P185, DOI 10.1016/j.neuroimage.2011.01.062; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Ma J, 2008, NEUROIMAGE, V42, P252, DOI 10.1016/j.neuroimage.2008.03.056; Ma J, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/974957; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Miller MI, 2006, J MATH IMAGING VIS, V24, P209, DOI 10.1007/s10851-005-3624-0; MILLER MI, 1993, P NATL ACAD SCI USA, V90, P11944, DOI 10.1073/pnas.90.24.11944; Miller MI, 2002, ANNU REV BIOMED ENG, V4, P375, DOI 10.1146/annurev.bioeng.4.092101.125733; Miller MI, 2001, INT J COMPUT VISION, V41, P61, DOI 10.1023/A:1011161132514; Mitchell SC, 2001, IEEE T MED IMAGING, V20, P415, DOI 10.1109/42.925294; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Paragios N, 2003, IEEE T MED IMAGING, V22, P773, DOI 10.1109/TMI.2003.814785; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pham DL, 1999, IEEE T MED IMAGING, V18, P737, DOI 10.1109/42.802752; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Priebe CE, 2006, COMPUT STAT DATA AN, V50, P551, DOI 10.1016/j.csda.2004.09.003; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Sabuncu MR, 2010, IEEE T MED IMAGING, V29, P1714, DOI 10.1109/TMI.2010.2050897; Shen DG, 2001, IEEE T MED IMAGING, V20, P257, DOI 10.1109/42.921475; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang Xu, 2012, Microcomputer Information, P123; Trouve A, 1995, INFINITE DI IN PRESS; Tu Z, 2008, IEEE T MED IMAGING, V27, P495, DOI 10.1109/TMI.2007.908121; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; van Ginneken B, 2002, IEEE T MED IMAGING, V21, P924, DOI 10.1109/TMI.2002.803121; van Rikxoort EM, 2010, MED IMAGE ANAL, V14, P39, DOI 10.1016/j.media.2009.10.001; VANCAMPENHOUT JM, 1981, IEEE T INFORM THEORY, V27, P483, DOI 10.1109/TIT.1981.1056374; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Warfield S, 1999, BRAIN WARPING, V4, P67; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yang J, 2004, MED IMAGE ANAL, V8, P285, DOI 10.1016/j.media.2004.06.008; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	89	111	113	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65591	10.1371/journal.pone.0065591	http://dx.doi.org/10.1371/journal.pone.0065591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824159	gold, Green Published			2022-12-27	WOS:000320576400012
J	Van Horn, DJ; Van Horn, ML; Barrett, JE; Gooseff, MN; Altrichter, AE; Geyer, KM; Zeglin, LH; Takacs-Vesbach, CD				Van Horn, David J.; Van Horn, M. Lee; Barrett, John E.; Gooseff, Michael N.; Altrichter, Adam E.; Geyer, Kevin M.; Zeglin, Lydia H.; Takacs-Vesbach, Cristina D.			Factors Controlling Soil Microbial Biomass and Bacterial Diversity and Community Composition in a Cold Desert Ecosystem: Role of Geographic Scale	PLOS ONE			English	Article							MCMURDO DRY VALLEYS; WRIGHT VALLEY; TAYLOR VALLEY; FUNGAL COMMUNITIES; GLOBAL PATTERNS; VICTORIA LAND; BIODIVERSITY; CLASSIFICATION; BIOGEOCHEMISTRY; GEOMORPHOLOGY	Understanding controls over the distribution of soil bacteria is a fundamental step toward describing soil ecosystems, understanding their functional capabilities, and predicting their responses to environmental change. This study investigated the controls on the biomass, species richness, and community structure and composition of soil bacterial communities in the McMurdo Dry Valleys, Antarctica, at local and regional scales. The goals of the study were to describe the relationships between abiotic characteristics and soil bacteria in this unique, microbially dominated environment, and to test the scale dependence of these relationships in a low complexity ecosystem. Samples were collected from dry mineral soils associated with snow patches, which are a significant source of water in this desert environment, at six sites located in the major basins of the Taylor and Wright Valleys. Samples were analyzed for a suite of characteristics including soil moisture, pH, electrical conductivity, soil organic matter, major nutrients and ions, microbial biomass, 16 S rRNA gene richness, and bacterial community structure and composition. Snow patches created local biogeochemical gradients while inter-basin comparisons encompassed landscape scale gradients enabling comparisons of microbial controls at two distinct spatial scales. At the organic carbon rich, mesic, low elevation sites Acidobacteria and Actinobacteria were prevalent, while Firmicutes and Proteobacteria were dominant at the high elevation, low moisture and biomass sites. Microbial parameters were significantly related with soil water content and edaphic characteristics including soil pH, organic matter, and sulfate. However, the magnitude and even the direction of these relationships varied across basins and the application of mixed effects models revealed evidence of significant contextual effects at local and regional scales. The results highlight the importance of the geographic scale of sampling when determining the controls on soil microbial community characteristics.	[Van Horn, David J.; Takacs-Vesbach, Cristina D.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Van Horn, M. Lee] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Barrett, John E.; Altrichter, Adam E.; Geyer, Kevin M.] Virginia Technol Inst, Dept Biol Sci, Blacksburg, VA USA; [Gooseff, Michael N.] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA; [Zeglin, Lydia H.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA	University of New Mexico; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Oregon State University	Takacs-Vesbach, CD (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	cvesbach@unm.edu	Barrett, John/D-5851-2016; Gooseff, Michael N/N-6087-2015	Barrett, John/0000-0002-7610-0505; Gooseff, Michael N/0000-0003-4322-8315; Geyer, Kevin/0000-0002-5218-2745; Altrichter, Adam/0000-0002-8201-0346	NSF [0838879]; McMurdo LTER, NSF [1115245]; Office of Polar Programs (OPP) [0838850] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); McMurdo LTER, NSF; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by NSF OPP grant 0838879 to JEB, MNG, and CTV. Additional support was provided by the McMurdo LTER, NSF grant 1115245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Aislabie JM, 2008, GEODERMA, V144, P9, DOI 10.1016/j.geoderma.2007.10.006; Aislabie JM, 2006, SOIL BIOL BIOCHEM, V38, P3041, DOI 10.1016/j.soilbio.2006.02.018; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Babalola OO, 2009, ENVIRON MICROBIOL, V11, P566, DOI 10.1111/j.1462-2920.2008.01809.x; Bamforth SS, 2005, POLAR BIOL, V28, P756, DOI 10.1007/s00300-005-0006-4; Barrett JE, 2004, ECOLOGY, V85, P3105, DOI 10.1890/03-0213; Bockheim JG, 2008, ARCT ANTARCT ALP RES, V40, P279, DOI 10.1657/1523-0430(06-057)[BOCKHEIM]2.0.CO;2; Bockheim JG, 1997, SOIL SCI SOC AM J, V61, P224, DOI 10.2136/sssaj1997.03615995006100010031x; Burkins MB, 2001, GLOB CHANGE BIOL, V7, P113, DOI 10.1046/j.1365-2486.2001.00393.x; Burkins MB, 2000, ECOLOGY, V81, P2377, DOI 10.1890/0012-9658(2000)081[2377:OADOSO]2.0.CO;2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cary SC, 2010, NAT REV MICROBIOL, V8, P129, DOI 10.1038/nrmicro2281; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Clow GD, 1988, J CLIMATE, V1, P715, DOI 10.1175/1520-0442(1988)001<0715:COAPSR>2.0.CO;2; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Dequiedt S, 2009, ENV MICROBIOL REP, V1, P251, DOI 10.1111/j.1758-2229.2009.00040.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon JC, 2005, GEOMORPHOLOGY, V67, P127, DOI 10.1016/j.geomorph.2004.07.009; Doran PT, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD002045; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elberling B, 2006, SOIL BIOL BIOCHEM, V38, P3095, DOI 10.1016/j.soilbio.2005.12.011; Fell JW, 2006, SOIL BIOL BIOCHEM, V38, P3107, DOI 10.1016/j.soilbio.2006.01.014; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fountain AG, 2010, INT J CLIMATOL, V30, P633, DOI 10.1002/joc.1933; Freckman DW, 1998, ANTARCT RES SER, V72, P323; Freckman DW, 1997, ECOLOGY, V78, P363, DOI 10.1890/0012-9658(1997)078[0363:LDASNC]2.0.CO;2; GIOVANNONI SJ, 1990, APPL ENVIRON MICROB, V56, P2572, DOI 10.1128/AEM.56.8.2572-2575.1990; Gooseff MN, 2003, ARCT ANTARCT ALP RES, V35, P91, DOI 10.1657/1523-0430(2003)035[0091:SPIOSB]2.0.CO;2; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hall BL, 2005, GEOMORPHOLOGY, V64, P25, DOI 10.1016/j.geomorph.2004.05.002; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee CK, 2012, ISME J, V6, P1046, DOI 10.1038/ismej.2011.170; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; McLeod M, 2008, GEODERMA, V144, P93, DOI 10.1016/j.geoderma.2007.10.017; McLeod M, 2009, ANTARCT SCI, V21, P355, DOI 10.1017/S0954102009001965; Mitchell KR, 2008, J IND MICROBIOL BIOT, V35, P1139, DOI 10.1007/s10295-008-0393-y; Moorhead DL, 2007, ECOSYSTEMS, V10, P86, DOI 10.1007/s10021-006-9005-8; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Niederberger TD, 2008, ENVIRON MICROBIOL, V10, P1713, DOI 10.1111/j.1462-2920.2008.01593.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Onyenwoke RU, 2004, ARCH MICROBIOL, V182, P182, DOI 10.1007/s00203-004-0696-y; Poage MA, 2008, ARCT ANTARCT ALP RES, V40, P119, DOI 10.1657/1523-0430(06-051)[POAGE]2.0.CO;2; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Porazinska DL, 2004, ARCT ANTARCT ALP RES, V36, P84, DOI 10.1657/1523-0430(2004)036[0084:TBABOC]2.0.CO;2; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2021, R LANGUAGE ENV STAT; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127; Smith JJ, 2006, MICROB ECOL, V51, P413, DOI 10.1007/s00248-006-9022-3; Smith JL, 2010, ANTARCT SCI, V22, P673, DOI 10.1017/S0954102010000763; Soininen J, 2012, ENV MICROBIOL REP, V4, P10, DOI 10.1111/j.1758-2229.2011.00308.x; Szekely AJ, 2013, ISME J, V7, P61, DOI 10.1038/ismej.2012.80; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Tiao G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1645; Treonis AM, 1999, ECOSYSTEMS, V2, P482, DOI 10.1007/s100219900096; Ugolini FC, 2008, GEODERMA, V144, P1, DOI 10.1016/j.geoderma.2007.10.005; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Wood SA, 2008, ISME J, V2, P308, DOI 10.1038/ismej.2007.104; Zeglin LH, 2011, MICROB ECOL, V61, P543, DOI 10.1007/s00248-010-9782-7; Zeglin LH, 2009, ECOSYSTEMS, V12, P562, DOI 10.1007/s10021-009-9242-8	81	74	75	1	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66103	10.1371/journal.pone.0066103	http://dx.doi.org/10.1371/journal.pone.0066103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824063	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400053
J	Wang, LS; Zang, WD; Sang, YX; Xie, DL; Wei, L; Ji, WD; Pan, YS; Li, ZQ; Shen, JW; Shi, YY				Wang, Lishan; Zang, Weidong; Sang, Yunxia; Xie, Dongli; Wei, Li; Ji, Weidong; Pan, Yaosheng; Li, Zhiqiang; Shen, Jiawei; Shi, Yongyong			RETRACTED: Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis (Retracted article. See vol. 11, e0160298, 2016)	PLOS ONE			English	Article; Retracted Publication							ANTIGEN; RISK; MARKERS; FAMILY; HK2	Objectives: To assess the association of polymorphism rs198977 in the human kallikrein-2 gene (KLK2) and risk of prostate cancer (PCa). Methods: Two investigators independently searched the PubMed, Elsevier, EMBASE, Web of Science, Wiley Online Library and Chinese National Knowledge Infrastructure (CNKI). Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) for rs198977 and PCa were calculated in a fixed-effects model (the Mantel-Haenszel method) and a random-effects model (the DerSimonian and Laird method) when appropriate. Results: Six studies met the inclusion criteria in this meta-analysis, which included 5859 PCa cases and 4867 controls. Overall, rs198977 was associated with the PCa risk (TT+CT vs. CC, pooled OR = 1.163, 95% CI = 1.076-1.258, P-value <0.0001). When stratified by ethnicity, significant association was observed in Caucasian samples under both allele comparison (T vs. C, pooled OR = 1.152, 95% CI = 1.079-1.229, P-value <0.0001) and dominant model (TT+CT vs. CC, pooled OR = 1.197, 95% CI = 1.104-1.297, P-value <0.0001). In the overall analysis, a comparably significant increase in the frequency of allele T for rs198977 was detected between cases and controls in Caucasian. Conclusion: This meta-analysis suggests that rs198977 of KLK2 was associated with susceptibility of PCa in Caucasian and the allele T might increase the risk of PCa in Caucasian.	[Wang, Lishan; Ji, Weidong; Pan, Yaosheng; Li, Zhiqiang; Shen, Jiawei; Shi, Yongyong] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Wang, Lishan; Zang, Weidong; Xie, Dongli; Wei, Li] FengHe ShangHai Informat Technol Co Ltd, Shanghai, Peoples R China; [Sang, Yunxia] Shanghai Jiao Tong Univ, Coll Pharm, Shanghai 200030, Peoples R China; [Ji, Weidong; Pan, Yaosheng; Shi, Yongyong] Shanghai Changning Mental Hlth Ctr, Shanghai, Peoples R China; [Ji, Weidong; Pan, Yaosheng; Shi, Yongyong] Shanghai Jiao Tong Univ, Inst Neuropsychiat Sci & Syst Biol Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shi, YY (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	shiyongysyysyy@hotmail.com			Fenghe (ShangHai) Information Technology Co.	Fenghe (ShangHai) Information Technology Co.	The authors named Lishan Wang, Weidong Zang, Dongli Xie and Li Wei are employed by Fenghe (ShangHai) Information Technology Co., whose company provided funding towards this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahn J, 2008, NAT GENET, V40, P1032, DOI 10.1038/ng0908-1032; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; CATALONA WJ, 1994, J UROLOGY, V152, P2031, DOI 10.1016/S0022-5347(17)32299-1; Chiang CH, 2005, J UROLOGY, V173, P429, DOI 10.1097/01.ju.0000148964.92943.39; Diamandis EP, 2000, TRENDS ENDOCRIN MET, V11, P54, DOI 10.1016/S1043-2760(99)00225-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Klein RJ, 2010, CANCER PREV RES, V3, P611, DOI 10.1158/1940-6207.CAPR-09-0206; Langeberg WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4101, DOI 10.2741/2374; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Light R.J., 1984, SUMMING SCI REV RES; Lintula S, 2005, PROSTATE, V63, P324, DOI 10.1002/pros.20194; Mikolajczyk SD, 1999, INT J CANCER, V81, P438, DOI 10.1002/(SICI)1097-0215(19990505)81:3<438::AID-IJC18>3.3.CO;2-L; Mittal RD, 2007, STEROIDS, V72, P335, DOI 10.1016/j.steroids.2006.12.004; Nam RK, 2005, CLIN CANCER RES, V11, P8391, DOI 10.1158/1078-0432.CCR-05-1226; Nam RK, 2003, J CLIN ONCOL, V21, P2312, DOI 10.1200/JCO.2003.11.007; Nam RK, 2006, CLIN CANCER RES, V12, P6452, DOI 10.1158/1078-0432.CCR-06-1485; Nogueira L, 2010, BJU INT, V105, P166, DOI 10.1111/j.1464-410X.2009.09088.x; Partin AW, 1999, UROLOGY, V54, P839, DOI 10.1016/S0090-4295(99)00270-8; REIGMAN PHJ, 1989, BIOCHEM BIOPH RES CO, V159, P95, DOI 10.1016/0006-291X(89)92409-1; Shariat SF, 2011, ACTA ONCOL, V50, P61, DOI 10.3109/0284186X.2010.542174; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tremblay RR, 1997, AM J PATHOL, V150, P455; Williams SA, 2010, PROSTATE, V70, P788, DOI 10.1002/pros.21111; Yousef GM, 1999, ANTICANCER RES, V19, P2843; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	27	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65651	10.1371/journal.pone.0065651	http://dx.doi.org/10.1371/journal.pone.0065651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824286	Green Published, gold			2022-12-27	WOS:000320576400017
J	van der Kooi-Pol, MM; Sadabad, MS; Duipmans, JC; Sabat, AJ; Stobernack, T; Omansen, TF; Westerhout-Pluister, GN; Jonkman, MF; Harmsen, HJM; van Dijl, JM				van der Kooi-Pol, Magdalena M.; Sadabad, Mehdi Sadaghian; Duipmans, Jose C.; Sabat, Artur J.; Stobernack, Tim; Omansen, Till F.; Westerhout-Pluister, Gerlinde N.; Jonkman, Marcel F.; Harmsen, Hermie J. M.; van Dijl, Jan Maarten			Topography of Distinct Staphylococcus aureus Types in Chronic Wounds of Patients with Epidermolysis Bullosa	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; NASAL CARRIAGE; DIVERSITY	The opportunistic pathogen Staphylococcus aureus is known to interfere with wound healing and represents a significant risk factor for wound infections and invasive disease. It is generally assumed that one individual is predominantly colonized by one S. aureus type. Nevertheless, patients with the genetic blistering disease epidermolysis bullosa (EB) often carry multiple S. aureus types. We therefore investigated whether different S. aureus types are present in individual wounds of EB patients and, if so, how they are spatially distributed. The staphylococcal topography in chronic wounds was mapped by replica-plating of used bandages and subsequent typing of S. aureus isolates. Individual chronic wounds of five patients contained up to six different S. aureus types. Unexpectedly, distinct S. aureus types formed micro-colonies that were located in close proximity and sometimes even overlapped. While some adjacent S. aureus isolates were closely related, others belonged to distinct molecular complexes. We conclude that the general assumption that one individual is predominantly colonized by one type of S. aureus does not apply to chronic wounds of EB patients. We consider this observation important, not only for EB patients, but also for other patients with chronic wounds in view of the potential risk for severe staphylococcal infections.	[van der Kooi-Pol, Magdalena M.; Sadabad, Mehdi Sadaghian; Sabat, Artur J.; Stobernack, Tim; Omansen, Till F.; Harmsen, Hermie J. M.; van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, Groningen, Netherlands; [van der Kooi-Pol, Magdalena M.; Sadabad, Mehdi Sadaghian; Duipmans, Jose C.; Sabat, Artur J.; Stobernack, Tim; Omansen, Till F.; Jonkman, Marcel F.; Harmsen, Hermie J. M.; van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Duipmans, Jose C.; Jonkman, Marcel F.] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Groningen, Netherlands; [Westerhout-Pluister, Gerlinde N.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands	University of Groningen; University of Groningen; University of Groningen; Netherlands National Institute for Public Health & the Environment	van Dijl, JM (corresponding author), Univ Groningen, Dept Med Microbiol, Groningen, Netherlands.	M.van.Dijl01@umcg.nl		Omansen, Till Frederik/0000-0003-0645-9683	Commission of the European Union [LSHG-CT-2006-037469]; Top Institute Pharma [T4-213]; Dutch Butterfly Child Foundation	Commission of the European Union(European Commission); Top Institute Pharma; Dutch Butterfly Child Foundation	This work was supported by the Commission of the European Union (grant LSHG-CT-2006-037469), the Top Institute Pharma (project T4-213), and the Dutch Butterfly Child Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Coen PG, 2006, J THEOR BIOL, V240, P98, DOI 10.1016/j.jtbi.2005.08.031; Deurenberg RH, 2009, EMERG INFECT DIS, V15, P727, DOI 10.3201/eid1505.071618; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Friedrich A W, 2008, Euro Surveill, V13; Glasner C, 2013, INT J MED MICROBIOL, V303, P124, DOI 10.1016/j.ijmm.2013.02.015; Glasner C, 2013, INT J MED MICROBIOL, V303, P70, DOI 10.1016/j.ijmm.2012.12.005; Goerke C, 2007, ENVIRON MICROBIOL, V9, P3134, DOI 10.1111/j.1462-2920.2007.01423.x; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hallin M, 2007, J CLIN MICROBIOL, V45, P127, DOI 10.1128/JCM.01866-06; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Jansen GJ, 2000, J CLIN MICROBIOL, V38, P814, DOI 10.1128/JCM.38.2.814-817.2000; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kock R, 2009, J HOSP INFECT, V71, P320, DOI 10.1016/j.jhin.2008.12.001; Lomholt H, 2005, J INVEST DERMATOL, V125, P977, DOI 10.1111/j.0022-202X.2005.23916.x; Madsen SM, 1996, APMIS, V104, P895, DOI 10.1111/j.1699-0463.1996.tb04955.x; Mongkolrattanothai K, 2011, J MED MICROBIOL, V60, P317, DOI 10.1099/jmm.0.025841-0; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Sabat AJ, 2012, J CLIN MICROBIOL, V50, P2255, DOI 10.1128/JCM.00056-12; van der Kooi-Pol MM, 2013, J INVEST DERMATOL, V133, P847, DOI 10.1038/jid.2012.347; van der Kooi-Pol MM, 2012, EXP DERMATOL, V21, P463, DOI 10.1111/j.1600-0625.2012.01502.x; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966	23	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67272	10.1371/journal.pone.0067272	http://dx.doi.org/10.1371/journal.pone.0067272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825650	Green Published, gold			2022-12-27	WOS:000321223000095
J	Zhang, Y; Whitfield-Gabrieli, S; Christodoulou, JA; Gabrieli, JDE				Zhang, Ying; Whitfield-Gabrieli, Susan; Christodoulou, Joanna A.; Gabrieli, John D. E.			Atypical Balance between Occipital and Fronto-Parietal Activation for Visual Shape Extraction in Dyslexia	PLOS ONE			English	Article							HUMAN PARIETAL OPERCULUM; TOP-DOWN; DIRECTED ATTENTION; CYTOARCHITECTONIC AREAS; VISUOSPATIAL ATTENTION; DEVELOPMENTAL DYSLEXIA; CONTRAST SENSITIVITY; PERCEPTION DEFICITS; NEURAL MECHANISMS; BRAIN ACTIVITY	Reading requires the extraction of letter shapes from a complex background of text, and an impairment in visual shape extraction would cause difficulty in reading. To investigate the neural mechanisms of visual shape extraction in dyslexia, we used functional magnetic resonance imaging (fMRI) to examine brain activation while adults with or without dyslexia responded to the change of an arrow's direction in a complex, relative to a simple, visual background. In comparison to adults with typical reading ability, adults with dyslexia exhibited opposite patterns of atypical activation: decreased activation in occipital visual areas associated with visual perception, and increased activation in frontal and parietal regions associated with visual attention. These findings indicate that dyslexia involves atypical brain organization for fundamental processes of visual shape extraction even when reading is not involved. Overengagement in higher-order association cortices, required to compensate for underengagment in lower-order visual cortices, may result in competition for top-down attentional resources helpful for fluent reading.	[Zhang, Ying; Whitfield-Gabrieli, Susan; Christodoulou, Joanna A.; Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Zhang, Ying] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Massachusetts Institute of Technology (MIT); Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, Y (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	yzhang00@mit.edu	Gabrieli, John/AAJ-2869-2020; Christodoulou, Joanna/AFV-2648-2022	Christodoulou, Joanna/0000-0001-8167-8021	Ellison Medical Foundation; MIT; Martin Richmond Memorial Fund; NIH [UL1RR025758, F32EY014750-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY014750] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); MIT; Martin Richmond Memorial Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Ellison Medical Foundation; MIT Class of 1976 Funds for Dyslexia Research; Bard and Julie Richmond through the Martin Richmond Memorial Fund; and NIH grants UL1RR025758 and F32EY014750-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitay S, 2002, BRAIN, V125, P2272, DOI 10.1093/brain/awf231; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; [Anonymous], 2002, READING WRITING INTE, DOI DOI 10.1023/A:1013872422108; Barnard N, 1998, OPTOMETRY VISION SCI, V75, P62, DOI 10.1097/00006324-199801000-00026; Beattie RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027893; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Brown JM, 2009, PROG BRAIN RES, V176, P47, DOI 10.1016/S0079-6123(09)17604-5; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Callaway EM, 2005, J PHYSIOL-LONDON, V566, P13, DOI 10.1113/jphysiol.2005.088047; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Chandrasekaran B, 2009, NEURON, V64, P311, DOI 10.1016/j.neuron.2009.10.006; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; Cieslik EC, 2010, J NEUROPHYSIOL, V104, P1472, DOI 10.1152/jn.00261.2010; Cohen L, 2008, NEUROIMAGE, V40, P353, DOI 10.1016/j.neuroimage.2007.11.036; Conlon EG, 2012, NEUROPSYCHOLOGIA, V50, P1672, DOI 10.1016/j.neuropsychologia.2012.03.023; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Demb JB, 1998, J NEUROSCI, V18, P6939; Demb JB, 1997, P NATL ACAD SCI USA, V94, P13363, DOI 10.1073/pnas.94.24.13363; Dole M, 2012, NEUROPSYCHOLOGIA, V50, P1543, DOI 10.1016/j.neuropsychologia.2012.03.007; Durrwachter U, 2010, ANN DYSLEXIA, V60, P86, DOI 10.1007/s11881-010-0034-9; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, CEREB CORTEX, V17, P1800, DOI 10.1093/cercor/bhl090; EVANS BJW, 1994, VISION RES, V34, P1913, DOI 10.1016/0042-6989(94)90315-8; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Facoetti A, 2003, COGNITIVE BRAIN RES, V16, P185, DOI 10.1016/S0926-6410(02)00270-7; Facoetti A, 2001, EXP BRAIN RES, V138, P46, DOI 10.1007/s002210100700; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Gaab N, 2007, RESTOR NEUROL NEUROS, V25, P295; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Glantz SA, 1992, PRIMER BIOSTATISTICS, P309; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Iles J, 2000, Dyslexia, V6, P163, DOI 10.1002/1099-0909(200007/09)6:3<163::AID-DYS150>3.0.CO;2-U; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kaufman A. S., 1997, KAUFMAN BRIEF INTELL; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; Lobier M, 2011, CORTEX; LOVEGROVE W, 1982, NEUROPSYCHOLOGIA, V20, P309, DOI 10.1016/0028-3932(82)90105-1; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malikovic A, 2007, CEREB CORTEX, V17, P562, DOI 10.1093/cercor/bhj181; Marinus E, 2010, CORTEX, V46, P1259, DOI 10.1016/j.cortex.2010.06.005; McMains S, 2011, J NEUROSCI, V31, P587, DOI 10.1523/JNEUROSCI.3766-10.2011; McMains SA, 2007, J NEUROPHYSIOL, V98, P2110, DOI 10.1152/jn.00538.2007; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mody M, 1997, J EXP CHILD PSYCHOL, V64, P199, DOI 10.1006/jecp.1996.2343; Moores E, 2011, NEUROPSYCHOLOGIA, V49, P3881, DOI 10.1016/j.neuropsychologia.2011.10.005; Nassi JJ, 2006, NEURON, V50, P319, DOI 10.1016/j.neuron.2006.03.019; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Oleksiak A, 2011, BRAIN RES REV, V67, P56, DOI 10.1016/j.brainresrev.2010.11.002; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peyrin C, 2011, BRAIN LANG, V118, P128, DOI 10.1016/j.bandl.2010.06.005; Reynolds M, 2006, J EXP PSYCHOL HUMAN, V32, P1303, DOI 10.1037/0096-1523.32.6.1303; Reynolds MG, 2011, Q J EXP PSYCHOL, V64, P2405, DOI 10.1080/17470218.2011.614352; Roach NW, 2008, VISION RES, V48, P193, DOI 10.1016/j.visres.2007.11.001; Roach NW, 2004, PSYCHOL SCI, V15, P650, DOI 10.1111/j.0956-7976.2004.00735.x; Rottschy C, 2007, HUM BRAIN MAPP, V28, P1045, DOI 10.1002/hbm.20348; RUMSEY JM, 1992, JAMA-J AM MED ASSOC, V268, P912, DOI 10.1001/jama.268.7.912; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Scheperjans F, 2008, CEREB CORTEX, V18, P2141, DOI 10.1093/cercor/bhm241; Scheperjans F, 2008, CEREB CORTEX, V18, P846, DOI 10.1093/cercor/bhm116; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Skottun BC, 2000, VISION RES, V40, P111, DOI 10.1016/S0042-6989(99)00170-4; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2006, PSYCHOL SCI, V17, P1047, DOI 10.1111/j.1467-9280.2006.01825.x; Spinelli D, 2002, CORTEX, V38, P179, DOI 10.1016/S0010-9452(08)70649-X; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Szlyk JP, 2009, INVEST OPHTH VIS SCI, V50, P4487, DOI 10.1167/iovs.08-2258; TALLAL P, 1973, NATURE, V241, P468, DOI 10.1038/241468a0; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Torgesen Wagner, 1999, COMPREHENSIVE TEST P; Twomey T, 2011, NEUROIMAGE, V55, P1242, DOI 10.1016/j.neuroimage.2011.01.001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Ingelghem M, 2001, NEUROREPORT, V12, P3603, DOI 10.1097/00001756-200111160-00046; Vidyasagar TR, 1999, NEUROREPORT, V10, P1283, DOI 10.1097/00001756-199904260-00024; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Waldie KE, 2010, NEUROPSYCHOLOGIA, V48, P3650, DOI 10.1016/j.neuropsychologia.2010.08.023; Walker KMM, 2006, BRAIN RES, V1124, P126, DOI 10.1016/j.brainres.2006.09.080; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wilms M, 2005, ANAT EMBRYOL, V210, P485, DOI 10.1007/s00429-005-0064-y; Wilms M, 2010, NEUROIMAGE, V49, P1171, DOI 10.1016/j.neuroimage.2009.09.063; Woodcock R.W., 2011, WOODCOCK READING MAS; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	106	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67331	10.1371/journal.pone.0067331	http://dx.doi.org/10.1371/journal.pone.0067331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825653	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000096
J	Hauer, M; Baker, J; Brown, W				Hauer, Matt; Baker, Jack; Brown, Warren			Indirect Estimates of Total Fertility Rate Using Child Woman/Ratio: A Comparison with the Bogue-Palmore Method	PLOS ONE			English	Article							POPULATION; AGE	Indirect estimation methodologies of the total fertility rate (TFR) have a long history within demography and have provided important techniques applied demographers can use when data is sparse or lacking. However new methodologies for approximating the total fertility rate have not been proposed in nearly 30 years. This study presents a novel method for indirectly approximating the total fertility rate using an algebraic rearrangement of the general fertility rate (GFR) through the known relationship between GFR and TFR. It then compares the proposed method to the well-known Bogue-Palmore method. These methods are compared in 196 countries and include overall errors as well as characteristics of the countries that contribute to fertility behavior. Additionally, these methods were compared geographically to find any geographical patterns. We find this novel method is not only simpler than the Bogue-Palmore method, requiring fewer data inputs, but also has reduced algebraic and absolute errors when compared with the Bogue-Palmore method and specifically outperforms the Bogue-Palmore method in developing countries. We find that our novel method may be useful estimation procedure for demographers.	[Hauer, Matt] Univ Georgia, Carl Vinson Inst Govt, Athens, GA 30602 USA; [Baker, Jack] Univ New Mexico, UNM Geospatial & Populat Studies, Albuquerque, NM 87131 USA; [Brown, Warren] Cornell Univ, Cornell Inst Social & Econ Res, Ithaca, NY USA	University System of Georgia; University of Georgia; University of New Mexico; Cornell University	Hauer, M (corresponding author), Univ Georgia, Carl Vinson Inst Govt, Athens, GA 30602 USA.	hauer@cviog.uga.edu		Hauer, Mathew/0000-0001-9390-5308				Abraham B., 1983, STAT METHODS FORECAS, DOI [10.1002/9780470316610, DOI 10.1002/9780470316610]; [Anonymous], 1968, DEMOGRAPHY TROPICAL; [Anonymous], 2012, SUBNATIONAL POPULATI; Arriaga A, 1994, POPULATION ANAL MICR; Arriaga E.E., 1994, POPULATION ANAL MICR; Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023222; BOGUE DJ, 1964, DEMOGRAPHY, V1, P316, DOI 10.2307/2060056; Bongaarts J, 1983, FERTILITY BIOL BEHAV; Brass W, 1965, WPCWP409 UN; Brass W., 1975, LAB POPULATION STAT; Brass W, 1964, ECN14CAS7 UN; Caswell, 2000, MATRIX POPULATION MO; Cavanaugh F, 1981, SERIES GE, V41; Christensen R, 1996, LOGISTIC REGRESSION; COALE AJ, 1974, POPUL INDEX, V40, P185, DOI 10.2307/2733910; Fisher RA, 1930, GENETICAL THEORY NAT; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gunasekaran S, 1984, ASIAN PACIFIC CE MAY; Haining R., 2003, SPATIAL DATA ANAL TH; Hanenberg R, 1983, Asian Pac Cens Forum, V10, P5; Hollander M., 1973, NONPARAMETRIC STAT M; Human Fertility Database,, HUM FERT DAT; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; Lam D, 2011, DEMOGRAPHY, V48, P1231, DOI 10.1007/s13524-011-0070-z; Levinson N, 1947, J AM STAT ASS; NETER J, 1999, APPL LINEAR STAT MOD; Palmore J, 1978, PAPERS E W POPULATIO; Preston S, 2003, DEMOGRAPHY MEASURING; RELE JR, 1987, POPUL DEV REV, V13, P513, DOI 10.2307/1973137; Rele JR, 1967, POPULATION MONOGRAPH, V2; Samuels ML, 1998, STAT LIFE SCI; Shahidullah M, 2005, POPUL RES POLICY REV, V24, P215, DOI 10.1007/s11113-004-5313-x; Shyrock H. S., 1980, METHODS MAT DEMOGRAP; Smith S., 2001, STATE LOCAL POPULATI; SMITH SK, 1990, J AM STAT ASSOC, V85, P367, DOI 10.2307/2289772; Swanson DA, 2010, POPUL RES POLICY REV, V29, P47, DOI 10.1007/s11113-009-9144-7; TUCHFELD BS, 1974, DEMOGRAPHY, V11, P195, DOI 10.2307/2060558; United Nations, 1983, MAN 10 IND TECHN EST; United Nations Population Division, 2011, WORLD POP PROSP 2010; Wachter K, 2012, ESSENTIAL DEMOGRAPHI; Welsch R, 1980, REGRESSION DIAGNOSTI; Wilson E. O., 1971, PRIMER POPULATION BI	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67226	10.1371/journal.pone.0067226	http://dx.doi.org/10.1371/journal.pone.0067226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826239	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400121
J	Vincent, EE; Elder, DJE; Curwen, J; Kilgour, E; Hers, I; Tavare, JM				Vincent, Emma E.; Elder, Douglas J. E.; Curwen, Jon; Kilgour, Elaine; Hers, Ingeborg; Tavare, Jeremy M.			Targeting Non-Small Cell Lung Cancer Cells by Dual Inhibition of the Insulin Receptor and the Insulin-Like Growth Factor-1 Receptor	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; IGF-I; MONOCLONAL-ANTIBODIES; CLINICAL DEVELOPMENT; BINDING PROTEIN-3; HYBRID RECEPTORS; PROSTATE-CANCER; PLASMA-LEVELS; EXPRESSION; LINES	Phase III trials of the anti-insulin-like growth factor-1 receptor (IGF1R) antibody figitumumab in non-small cell lung cancer (NSCLC) patients have been discontinued owing to lack of survival benefit. We investigated whether inhibition of the highly homologous insulin receptor (IR) in addition to the IGF1R would be more effective than inhibition of the IGF1R alone at preventing the proliferation of NSCLC cells. Signalling through IGF1R and IR in the NSCLC cell lines A549 and Hcc193 was stimulated by a combination of IGF1, IGF2 and insulin. It was inhibited by antibodies that block ligand binding, alpha IR3 (IGF1R) and IR47-9 (IR), and by the ATP-competitive small molecule tyrosine kinase inhibitors AZ12253801 and NVPAWD742 which inhibit both IGF1R and IR tyrosine kinases. The effect of inhibitors was determined by an anchorage-independent proliferation assay and by analysis of Akt phosphorylation. In Hcc193 cells the reduction in cell proliferation and Akt phosphorylation due to anti-IGF1R antibody was enhanced by antibody-mediated inhibition of the IR whereas in A549 cells, with a relatively low IR: IGF1R expression ratio, it was not. In each cell line proliferation and Akt phosphorylation were more effectively inhibited by AZ12253801 and NVPAWD742 than by combined alpha IR3 and IR47-9. When the IGF1R alone is inhibited, unencumbered signalling through the IR can contribute to continued NSCLC cell proliferation. We conclude that small molecule inhibitors targeting both the IR and IGF1R more effectively reduce NSCLC cell proliferation in a manner independent of the IR: IGF1R expression ratio, providing a therapeutic rationale for the treatment of this disease.	[Vincent, Emma E.; Elder, Douglas J. E.; Tavare, Jeremy M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Curwen, Jon; Kilgour, Elaine] AstraZeneca, CIRA Discovery, Macclesfield, Cheshire, England; [Hers, Ingeborg] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol; AstraZeneca; University of Bristol	Tavare, JM (corresponding author), Univ Bristol, Sch Biochem, Med Sci Bldg, Bristol, Avon, England.	j.tavare@bristol.ac.uk	Hers, Ingeborg/ABG-3357-2020	Vincent, Emma/0000-0002-8917-7384; Hers, Ingeborg/0000-0002-6467-5715	Medical Research Council; AstraZeneca; British Heart Foundation [PG/10/100/28658, FS/12/3/29232] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); British Heart Foundation(British Heart Foundation)	The work described was funded by grants from the Medical Research Council and AstraZeneca to JMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnet S, 2009, CANCER RES, V69, P2443, DOI 10.1158/0008-5472.CAN-08-2645; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Basu B, 2011, BRIT J CANCER, V104, P1, DOI 10.1038/sj.bjc.6606023; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Cappuzzo F, 2010, ANN ONCOL, V21, P562, DOI 10.1093/annonc/mdp357; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Dalby AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050253; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Dent P, 2005, BIOCHEM PHARMACOL, V70, P1685, DOI 10.1016/j.bcp.2005.08.020; Dong JY, 2010, MOL CANCER THER, V9, P2593, DOI 10.1158/1535-7163.MCT-09-1018; Dziadziuszko R, 2008, J THORAC ONCOL, V3, P815, DOI 10.1097/JTO.0b013e31818180f5; FAVONI RE, 1994, INT J CANCER, V56, P858, DOI 10.1002/ijc.2910560618; Feng Y, 2006, MOL CANCER THER, V5, P114, DOI 10.1158/1535-7163.MCT-05-0252; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; Goya M, 2004, CANCER RES, V64, P6252, DOI 10.1158/0008-5472.CAN-04-0919; Gridelli C, 2010, EXPERT OPIN INV DRUG, V19, P631, DOI 10.1517/13543781003767434; Gualberto A, 2011, BRIT J CANCER, V104, P68, DOI 10.1038/sj.bjc.6605972; Gualberto A, 2010, CLIN CANCER RES, V16, P4654, DOI 10.1158/1078-0432.CCR-10-0089; Gualberto A, 2009, CURR DRUG TARGETS, V10, P923, DOI 10.2174/138945009789577945; Hakam A, 1999, HUM PATHOL, V30, P1128, DOI 10.1016/S0046-8177(99)90027-8; Hellawell GO, 2002, CANCER RES, V62, P2942; Jassem J, 2010, J CLIN ONCOL S, V28; KAISER U, 1993, J CANCER RES CLIN, V119, P665, DOI 10.1007/BF01215985; KAREY KP, 1988, CANCER RES, V48, P4083; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Kornprat P, 2006, J CLIN PATHOL, V59, P202, DOI 10.1136/jcp.2005.028480; KULL FC, 1983, J BIOL CHEM, V258, P6561; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Ludovini V, 2009, ANN ONCOL, V20, P842, DOI 10.1093/annonc/mdn727; Massoner P, 2010, BRIT J CANCER, V103, P1479, DOI 10.1038/sj.bjc.6605932; Meng JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014124; MILAZZO G, 1992, CANCER RES, V52, P3924; NAKANISHI Y, 1988, J CLIN INVEST, V82, P354, DOI 10.1172/JCI113594; Neal JW, 2010, CURR TREAT OPTION ON, V11, P36, DOI 10.1007/s11864-010-0120-6; OSBORNE CK, 1976, P NATL ACAD SCI USA, V73, P4536, DOI 10.1073/pnas.73.12.4536; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; PAPA V, 1993, CANCER RES, V53, P3736; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petridou E, 2003, ONCOLOGY-BASEL, V64, P341, DOI 10.1159/000070291; PILLEMER G, 1992, INT J CANCER, V50, P80, DOI 10.1002/ijc.2910500117; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prince SN, 2007, MOL CANCER THER, V6, P607, DOI 10.1158/1535-7163.MCT-06-0509; Quinn KA, 1996, J BIOL CHEM, V271, P11477, DOI 10.1074/jbc.271.19.11477; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Sachdev D, 2003, CANCER RES, V63, P627; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SOOS MA, 1990, BIOCHEM J, V270, P383, DOI 10.1042/bj2700383; Ulanet DB, 2010, P NATL ACAD SCI US; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Vincent EE, 2011, BR J CANC; Vincent EE, 2011, ANTICANCER RES, V31, P1577; Warshamana-Greene GS, 2004, MOL CANCER THER, V3, P527; Werner H, 1996, ADV CANCER RES, V68, P183, DOI 10.1016/S0065-230X(08)60354-1; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yeh J, 2008, LUNG CANCER, V60, P166, DOI 10.1016/j.lungcan.2007.09.023; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zhang H, 2010, ONCOGENE, V29, P2517, DOI 10.1038/onc.2010.17; Zhao H, 2003, J UROLOGY, V169, P714, DOI 10.1016/S0022-5347(05)63999-7; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104	64	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66963	10.1371/journal.pone.0066963	http://dx.doi.org/10.1371/journal.pone.0066963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826179	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400088
J	Chong, G; Kimyon, O; Manefield, M				Chong, Grace; Kimyon, Oender; Manefield, Mike			Quorum Sensing Signal Synthesis May Represent a Selective Advantage Independent of Its Role in Regulation of Bioluminescence in Vibrio fischeri	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; LUMINESCENCE; POPULATIONS; COOPERATION; MUTAGENESIS; INDUCTION; DIFFUSION; BIOFILMS; FITNESS	The evolution of biological signalling systems and apparently altruistic or cooperative traits in diverse organisms has required selection against the subversive tendencies of self-interested biological entities. The bacterial signalling and response system known as quorum sensing or Acylated Homoserine Lactone (AHL) mediated gene expression is thought to have evolved through kin selection. In this in vitro study on the model quorum sensing bioluminescent marine symbiont Vibrio fischeri, competition and long-term sub culturing experiments suggest that selection for AHL synthesis (encoded by the AHL synthase gene luxI) is independent of the quorum sensing regulated phenotype (bioluminescence encoded by luxCDABE). Whilst results support the hypothesis that signal response (AHL binding and transcriptional activation encoded by the luxR gene) is maintained through indirect fitness benefits (kin selection), signal synthesis is maintained in the V. fischeri genome over evolutionary time through direct fitness benefits at the individual level from an unknown function.	[Chong, Grace; Kimyon, Oender; Manefield, Mike] UNSW, CMB, Sch Biotechnol & Biomol Sci BABS, Sydney, NSW, Australia	University of New South Wales Sydney	Manefield, M (corresponding author), UNSW, CMB, Sch Biotechnol & Biomol Sci BABS, Sydney, NSW, Australia.	manefield@unsw.edu.au	Kimyon, Onder/J-8852-2014	Kimyon, Onder/0000-0001-9222-7672	Centre for Marine Bio-Innovation; Environmental Biotechnology Cooperative Research Centre; Australian Research Council Future Fellowship [FT100100078]	Centre for Marine Bio-Innovation; Environmental Biotechnology Cooperative Research Centre; Australian Research Council Future Fellowship(Australian Research Council)	This work was partially supported by grants from the Centre for Marine Bio-Innovation, the Environmental Biotechnology Cooperative Research Centre and an Australian Research Council Future Fellowship (FT100100078) awarded to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2001, APPL ENVIRON MICROB, V67, P575, DOI 10.1128/AEM.67.2.575-585.2001; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Bose JL, 2011, APPL ENVIRON MICROB, V77, P2445, DOI 10.1128/AEM.02643-10; Brookfield JEY, 1998, EVOLUTION, V52, P1263, DOI 10.1111/j.1558-5646.1998.tb02007.x; Brown SP, 2001, P ROY SOC B-BIOL SCI, V268, P961, DOI 10.1098/rspb.2001.1609; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Heurlier K, 2006, INT J MED MICROBIOL, V296, P93, DOI 10.1016/j.ijmm.2006.01.043; KUO A, 1994, J BACTERIOL, V176, P7558, DOI 10.1128/JB.176.24.7558-7565.1994; Manefield M, 2007, PHILOS T R SOC B, V362, P1235, DOI 10.1098/rstb.2007.2048; Miyashiro T, 2012, MOL MICROBIOL, V84, P795, DOI 10.1111/j.1365-2958.2012.08065.x; Nasser W, 2007, ANAL BIOANAL CHEM, V387, P381, DOI 10.1007/s00216-006-0702-0; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; Rumbaugh KP, 2012, P ROY SOC B-BIOL SCI, V279, P3584, DOI 10.1098/rspb.2012.0843; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Schuster BM, 2010, SYMBIOSIS, V51, P85, DOI 10.1007/s13199-010-0074-2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stabb EV, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P233; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Szathmary E, 1995, MAJOR TRANSITIONS EV; Trott AE, 2001, J BACTERIOL, V183, P387, DOI 10.1128/JB.183.1.387-392.2001; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143; Visick KL, 1997, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P119; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904	38	11	13	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67443	10.1371/journal.pone.0067443	http://dx.doi.org/10.1371/journal.pone.0067443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825662	Green Submitted, gold, Green Published			2022-12-27	WOS:000320576400186
J	de Vienne, DM; Giraud, T; Gouyon, PH				de Vienne, Damien M.; Giraud, Tatiana; Gouyon, Pierre-Henri			Lineage Selection and the Maintenance of Sex	PLOS ONE			English	Article							SPECIES SELECTION; PLURALIST APPROACH; EVOLUTION; COMPETITION; SPECIATION; RECOMBINATION; REPRODUCTION; POPULATIONS; PATTERNS; SYSTEMS	Sex predominates in eukaryotes, despite its short-term disadvantage when compared to asexuality. Myriad models have suggested that short-term advantages of sex may be sufficient to counterbalance its twofold costs. However, despite decades of experimental work seeking such evidence, no evolutionary mechanism has yet achieved broad recognition as explanation for the maintenance of sex. We explore here, through lineage-selection models, the conditions favouring the maintenance of sex. In the first model, we allowed the rate of transition to asexuality to evolve, to determine whether lineage selection favoured species with the strongest constraints preventing the loss of sex. In the second model, we simulated more explicitly the mechanisms underlying the higher extinction rates of asexual lineages than of their sexual counterparts. We linked extinction rates to the ecological and/ or genetic features of lineages, thereby providing a formalisation of the only figure included in Darwin's "The origin of species". Our results reinforce the view that the long-term advantages of sex and lineage selection may provide the most satisfactory explanations for the maintenance of sex in eukaryotes, which is still poorly recognized, and provide figures and a simulation website for training and educational purposes. Short-term benefits may play a role, but it is also essential to take into account the selection of lineages for a thorough understanding of the maintenance of sex.	[de Vienne, Damien M.] CRG, Bionformat & Genom Programme, Barcelona, Spain; [de Vienne, Damien M.] Univ Pompeu Fabra, Bionformat & Genom Programme, Barcelona, Spain; [Giraud, Tatiana] CNRS, UMR 8079, F-91405 Orsay, France; [Giraud, Tatiana] Univ Paris 11, Orsay, France; [Gouyon, Pierre-Henri] Museum Natl Hist Nat, CNRS, Dept Systemat & Evolut, UMR 7205, Paris, France	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	de Vienne, DM (corresponding author), CRG, Bionformat & Genom Programme, Barcelona, Spain.	damien.de-vienne@crg.es	Gouyon, Pierre-Henri/A-9603-2013	de Vienne, Damien/0000-0001-9532-5251; Giraud, Tatiana/0000-0002-2685-6478	FungiSex [ANR-09-0064-01]; Chaire Modelisation Mathematique et Biodiversite (MMB) of Veolia Environnement-Ecole Polytechnique-Museum national d'Histoire naturelle-Fondation X	FungiSex; Chaire Modelisation Mathematique et Biodiversite (MMB) of Veolia Environnement-Ecole Polytechnique-Museum national d'Histoire naturelle-Fondation X	TG received funding from the FungiSex ANR-09-0064-01 grant (http://urgi.versailles.inra.fr/Projects/FungiSex). DDV received a postdoctoral grant from the Chaire Modelisation Mathematique et Biodiversite (MMB) of Veolia Environnement-Ecole Polytechnique-Museum national d'Histoire naturelle-Fondation X (http://www.cmap.polytechnique.fr/chaire-mmb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen Duur K., 2007, P527; Agnarsson I, 2006, EVOLUTION, V60, P2342; Barton NH, 2010, PHILOS T R SOC B, V365, P2559, DOI 10.1098/rstb.2010.0106; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Becerra M, 1999, EVOL ECOL RES, V1, P567; Bell G, 1982, MASTERPIECE NATURE E; Bruggeman J, 2004, FUNGAL GENET BIOL, V41, P181, DOI 10.1016/j.fgb.2003.10.007; Burt A, 2000, EVOLUTION, V54, P337; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Darwin C., 1859, ORIGINS SPECIES MEAN; Davy A, 1988, PLANT POPULATION ECO; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Fisher RA, 1930, GENETICAL THEORY NAT; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Getz WM, 2001, ANN ZOOL FENN, V38, P315; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; GLIDDON CJ, 1989, TRENDS ECOL EVOL, V4, P204, DOI 10.1016/0169-5347(89)90074-8; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Gouyon PH, 1999, J EVOLUTION BIOL, V12, P1029; Gray MM, 2001, CAN J FISH AQUAT SCI, V58, P1313, DOI 10.1139/cjfas-58-7-1313; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Janko K, 2008, EVOLUTION, V62, P1264, DOI 10.1111/j.1558-5646.2008.00359.x; Johnson MTJ, 2011, EVOLUTION, V65, P3230, DOI 10.1111/j.1558-5646.2011.01378.x; Jokela J, 1997, EVOLUTION, V51, P1120, DOI 10.1111/j.1558-5646.1997.tb03959.x; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Kono T, 2006, CYTOGENET GENOME RES, V113, P31, DOI 10.1159/000090812; Krisko A, 2012, P NATL ACAD SCI USA, V109, P2354, DOI 10.1073/pnas.1119762109; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Lopez-Villacencio M, 2013, J EVOL BIOL IN PRESS; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Maynard Smith J., 1971, GROUP SELECTION, P163; Neiman M, 2009, ANN NY ACAD SCI, V1168, P185, DOI 10.1111/j.1749-6632.2009.04572.x; Normark BB, 2003, ANNU REV ENTOMOL, V48, P397, DOI 10.1146/annurev.ento.48.091801.112703; NUNNEY L, 1989, EVOLUTION, V43, P245, DOI 10.1111/j.1558-5646.1989.tb04225.x; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Rice WR, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P75, DOI 10.1007/978-90-481-2770-2_5; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Rispe C, 1998, J EVOLUTION BIOL, V11, P685, DOI 10.1007/s000360050113; Schwander T, 2009, MOL ECOL, V18, P28, DOI 10.1111/j.1365-294X.2008.03992.x; Silliker ME, 1997, CURR GENET, V32, P281, DOI 10.1007/s002940050278; SLATKIN M, 1981, PALEOBIOLOGY, V7, P421, DOI 10.1017/S0094837300025471; SMITH JM, 1978, EVOLUTION SEX; STANLEY SM, 1975, SCIENCE, V190, P382, DOI 10.1126/science.1179215; Stireman JO, 2005, J EVOLUTION BIOL, V18, P325, DOI 10.1111/j.1420-9101.2004.00850.x; Tagg N, 2005, BIOL J LINN SOC, V85, P111, DOI 10.1111/j.1095-8312.2005.00475.x; Templeton A.R., 1982, P75; van Diepeningen AD, 2008, ASPERGILLUS IN THE GENOMIC ERA, P133; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Wilson CG, 2011, BIOL J LINN SOC, V104, P564, DOI 10.1111/j.1095-8312.2011.01737.x; Zhang XS, 2007, EVOLUTION, V61, P1532, DOI 10.1111/j.1558-5646.2007.00147.x	53	22	22	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66906	10.1371/journal.pone.0066906	http://dx.doi.org/10.1371/journal.pone.0066906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825582	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400167
J	Shanks, RMQ; Davra, VR; Romanowski, EG; Brothers, KM; Stella, NA; Godboley, D; Kadouri, DE				Shanks, Robert M. Q.; Davra, Viral R.; Romanowski, Eric G.; Brothers, Kimberly M.; Stella, Nicholas A.; Godboley, Dipti; Kadouri, Daniel E.			An Eye to a Kill: Using Predatory Bacteria to Control Gram-Negative Pathogens Associated with Ocular Infections	PLOS ONE			English	Article							BDELLOVIBRIO-BACTERIOVORUS; GALLERIA-MELLONELLA; STAPHYLOCOCCUS-AUREUS; MICAVIBRIO-AERUGINOSAVORUS; CONTACT-LENS; MODEL; HOST; CIPROFLOXACIN; BIOFILMS; THERAPY	Ocular infections are a leading cause of vision loss. It has been previously suggested that predatory prokaryotes might be used as live antibiotics to control infections. In this study, Pseudomonas aeruginosa and Serratia marcescens ocular isolates were exposed to the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus. All tested S. marcescens isolates were susceptible to predation by B. bacteriovorus strains 109J and HD100. Seven of the 10 P. aeruginosa isolates were susceptible to predation by B. bacteriovorus 109J with 80% being attacked by M. aeruginosavorus. All of the 19 tested isolates were found to be sensitive to at least one predator. To further investigate the effect of the predators on eukaryotic cells, human corneal-limbal epithelial (HCLE) cells were exposed to high concentrations of the predators. Cytotoxicity assays demonstrated that predatory bacteria do not damage ocular surface cells in vitro whereas the P. aeruginosa used as a positive control was highly toxic. Furthermore, no increase in the production of the proinflammatory cytokines IL-8 and TNF-alpha was measured in HCLE cells after exposure to the predators. Finally, injection of high concentration of predatory bacteria into the hemocoel of Galleria mellonella, an established model system used to study microbial pathogenesis, did not result in any measurable negative effect to the host. Our results suggest that predatory bacteria could be considered in the near future as a safe topical bio-control agent to treat ocular infections.	[Shanks, Robert M. Q.; Romanowski, Eric G.; Brothers, Kimberly M.; Stella, Nicholas A.] Univ Pittsburgh, Dept Ophthalmol, Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA; [Davra, Viral R.; Godboley, Dipti; Kadouri, Daniel E.] Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kadouri, DE (corresponding author), Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA.	kadourde@umdnj.edu	Shanks, Robert M. Q./AFO-0831-2022	Shanks, Robert M. Q./0000-0002-7699-5396; Brothers, Kimberly/0000-0003-2055-9760	Department of the ARMY USAMRAA [W81XWH-12-2-0067]; UMDNJ departmental start-up fund; National Institutes of Health (NIH) [AI085570]; Research to Prevent Blindness Career Development award; NIH [EY08098]; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570] Funding Source: NIH RePORTER	Department of the ARMY USAMRAA; UMDNJ departmental start-up fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development award(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the Department of the ARMY USAMRAA #W81XWH-12-2-0067 and by UMDNJ departmental start-up fund to DEK and RMQS was supported by National Institutes of Health (NIH) grant AI085570 and a Research to Prevent Blindness Career Development award. The authors thank the NIH EY08098 grant sponsored hybridoma module for providing HCLE cells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejko M, 2009, COMP BIOCHEM PHYS B, V152, P118, DOI 10.1016/j.cbpb.2008.10.008; Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Boileau MJ, 2011, CAN J VET RES, V75, P285; Das S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1182, DOI 10.1001/archopht.125.9.1182; Dashiff A, 2011, MOL ORAL MICROBIOL, V26, P19, DOI 10.1111/j.2041-1014.2010.00592.x; Dashiff A, 2011, J APPL MICROBIOL, V110, P431, DOI 10.1111/j.1365-2672.2010.04900.x; Dubovskiy IM, 2008, J INVERTEBR PATHOL, V98, P360, DOI 10.1016/j.jip.2008.03.011; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; FRATAMICO PM, 1995, J FOOD PROTECT, V58, P160, DOI 10.4315/0362-028X-58.2.160; Fratamico PM, 1996, J FOOD SAFETY, V16, P161, DOI 10.1111/j.1745-4565.1996.tb00157.x; Fukuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047742; Garcia-Lara J, 2005, FEMS IMMUNOL MED MIC, V43, P311, DOI 10.1016/j.femsim.2004.11.003; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gorski A, 2009, OPHTHALMOLOGICA, V223, P162, DOI 10.1159/000193293; Hazlett LD, 2005, OCUL IMMUNOL INFLAMM, V13, P133, DOI 10.1080/09273940490912362; Hume E, 2004, Arch Soc Esp Oftalmol, V79, P475; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jurkevitch E, 2000, APPL ENVIRON MICROB, V66, P2365, DOI 10.1128/AEM.66.6.2365-2371.2000; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri D, 2007, APPL ENVIRON MICROB, V73, P605, DOI 10.1128/AEM.01893-06; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kowalski RP, 2001, OPHTHALMOLOGY, V108, P1826, DOI 10.1016/S0161-6420(01)00724-2; LAMBINA V A, 1983, Mikrobiologiya, V52, P777; LENZ RW, 1978, ARCH MICROBIOL, V119, P245, DOI 10.1007/BF00405402; Lu F, 2010, LETT APPL MICROBIOL, V51, P625, DOI 10.1111/j.1472-765X.2010.02943.x; Markelova NY, 2010, INT J HYG ENVIR HEAL, V213, P428, DOI 10.1016/j.ijheh.2010.08.004; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; NAKAMURA M, 1972, AM J CLIN NUTR, V25, P1441; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Ramirez JC, 2012, INVEST OPHTH VIS SCI, V53, P448, DOI 10.1167/iovs.11-8999; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Rhee MK, 2004, AM J OPHTHALMOL, V138, P226, DOI 10.1016/j.ajo.2004.03.016; Rogosky AM, 2006, CURR MICROBIOL, V52, P81, DOI 10.1007/s00284-005-0038-6; Santos TMA, 2011, AM J VET RES, V72, P1079, DOI 10.2460/ajvr.72.8.1079; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; SHILO M, 1965, J GEN MICROBIOL, V40, P317, DOI 10.1099/00221287-40-3-317; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Van Essche M, 2011, MOL ORAL MICROBIOL, V26, P52, DOI 10.1111/j.2041-1014.2010.00595.x; Van Essche M, 2009, J DENT RES, V88, P182, DOI 10.1177/0022034508329693; Varaprasathan G, 2004, CORNEA, V23, P360, DOI 10.1097/00003226-200405000-00009; VERKLOVA Z S, 1973, Gigiena i Sanitariya, V38, P10; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453; WESTERGAARD JM, 1977, APPL ENVIRON MICROB, V34, P506, DOI 10.1128/AEM.34.5.506-511.1977; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Wingard JB, 2011, ANTIMICROB AGENTS CH, V55, P3788, DOI 10.1128/AAC.01828-10; Zhang J, 2005, CURR EYE RES, V30, P527, DOI 10.1080/02713680590968150	47	58	59	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66723	10.1371/journal.pone.0066723	http://dx.doi.org/10.1371/journal.pone.0066723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824756	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400154
J	Zhu, YM; Zhou, PP; Hu, JR; Zhang, RJ; Ren, L; Li, MT; Ning, F; Chen, W; Yu, LJ				Zhu, Yuanmin; Zhou, Pengpeng; Hu, Jingrong; Zhang, Ruijiao; Ren, Liang; Li, Maoteng; Ning, Fan; Chen, Wei; Yu, Longjiang			Characterization of Pythium Transcriptome and Gene Expression Analysis at Different Stages of Fermentation	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; EICOSAPENTAENOIC ACID; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; FISH CONSUMPTION; OMEGA-3-FATTY-ACIDS; GLYCEROL; BENEFITS; REVEALS; HEALTH	Background: The Pythium splendens is a potentially useful organism for the synthesis of large amounts of eicosapentaenoic acid. Peak biomass and lipid accumulation do not occur at the same time and growth temperature has an effect on the fatty acid composition. Little is known about the pathway or the genes involved in growth, lipid synthesis or temperature resistance in P. splendens. Analysis of the transcriptome and expression profile data for P. splendensRBB-5 were used to extend genetic information for this strain and to contribute to a comprehensive understanding of the molecular mechanisms involved in specific biological processes. Methodology/Principal Findings: This study used transcriptome assembly and gene expression analysis with short-read sequencing technology combined with a tag-based digital gene expression (DGE) system. Assembled sequences were annotated with gene descriptions, such as gene ontology (GO), clusters of orthologous group (COG) terms and KEGG orthology (KO) to generate 23,796 unigenes. In addition, we obtained a larger number of genes at different stages of fermentation (48, 100 and 148 h). The genes related to growth characteristics and lipid biosynthesis were analyzed in detail. Some genes associated with lipid and fatty acid biosynthesis were selected to confirm the digital gene expression (DGE) results by quantitative real-time PCR (qRT-PCR). Conclusion/Significance: The transcriptome improves our genetic understanding of P. splendensRBB-5 greatly and makes a large number of gene sequences available for further study. Notably, the transcriptome and DGE profiling data of P. splendensRBB-5 provide a comprehensive insight into gene expression profiles at different stages of fermentation and lay the foundation for the study of optimizing lipid content and growth speed at the molecular level.	[Zhu, Yuanmin; Zhou, Pengpeng; Hu, Jingrong; Zhang, Ruijiao; Ren, Liang; Li, Maoteng; Ning, Fan; Chen, Wei; Yu, Longjiang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Resource Biol & Biotechnol, Dept Biotechnol, Wuhan 430074, Peoples R China; [Zhu, Yuanmin; Zhou, Pengpeng; Hu, Jingrong; Zhang, Ruijiao; Ren, Liang; Li, Maoteng; Ning, Fan; Chen, Wei; Yu, Longjiang] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Peoples R China; [Zhu, Yuanmin; Zhou, Pengpeng; Zhang, Ruijiao; Ren, Liang; Li, Maoteng; Ning, Fan; Chen, Wei; Yu, Longjiang] Wuhan Inst Biotechnol, Wuhan, Peoples R China; [Ren, Liang] Wuhan Vocat Coll Software & Engn, Dept Environm & Biochem Engn, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yu, LJ (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Resource Biol & Biotechnol, Dept Biotechnol, Wuhan 430074, Peoples R China.	yulongjiang@hust.edu.cn	zhu, yuanmin/AAF-6339-2019		National Natural Science Foundation of China [20976065]; National High-Tech Research and Development Plan [2007AA100402]; Key technologies research and development program of Wuhan [201020622246]; New Century Talents Support Program by the Ministry of Education of China [NCET110172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Plan(National High Technology Research and Development Program of China); Key technologies research and development program of Wuhan; New Century Talents Support Program by the Ministry of Education of China	This work was supported by National Natural Science Foundation of China (Grant No. 20976065), National High-Tech Research and Development Plan (Grant No. 2007AA100402), Key technologies research and development program of Wuhan (201020622246) and New Century Talents Support Program by the Ministry of Education of China (NCET110172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Athalye SK, 2009, J AGR FOOD CHEM, V57, P2739, DOI 10.1021/jf803922w; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Bock AK, 1999, J BACTERIOL, V181, P1861, DOI 10.1128/JB.181.6.1861-1867.1999; Cantrell KB, 2009, J AM OIL CHEM SOC, V86, P791, DOI 10.1007/s11746-009-1409-0; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Cronwright GR, 2002, APPL ENVIRON MICROB, V68, P4448, DOI 10.1128/AEM.68.9.4448-4456.2002; Das UN, 2002, NUTRITION, V18, P178, DOI 10.1016/S0899-9007(01)00719-5; Domingo JL, 2007, ENVIRON INT, V33, P993, DOI 10.1016/j.envint.2007.05.001; Domingo JL, 2007, TOXICOLOGY, V230, P219, DOI 10.1016/j.tox.2006.11.054; Eticha D, 2010, ANN BOT-LONDON, V105, P1119, DOI 10.1093/aob/mcq049; GANDHI SR, 1991, J GEN MICROBIOL, V137, P1825, DOI 10.1099/00221287-137-8-1825; Gill I, 1997, TRENDS BIOTECHNOL, V15, P401, DOI 10.1016/S0167-7799(97)01076-7; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hites RA, 2004, SCIENCE, V303, P226, DOI 10.1126/science.1091447; Ho SY, 2008, J AGR FOOD CHEM, V56, P7903, DOI 10.1021/jf801404y; Hong H, 2002, PLANT PHYSIOL, V129, P354, DOI 10.1104/pp.001495; Hong HP, 2002, LIPIDS, V37, P863, DOI 10.1007/s11745-002-0972-5; Hu JR, 2011, Z NATURFORSCH C, V66, P429, DOI 10.5560/ZNC.2011.66c0429; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liang Y, 2012, BIORESOURCE TECHNOL, V111, P404, DOI 10.1016/j.biortech.2012.02.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nakayama N, 1996, J BIOCHEM-TOKYO, V119, P435; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Park J, 2008, NUCLEIC ACIDS RES, V36, pD562, DOI 10.1093/nar/gkm758; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Remize F, 2001, METAB ENG, V3, P301, DOI 10.1006/mben.2001.0197; ROSE DP, 1995, JNCI-J NATL CANCER I, V87, P587, DOI 10.1093/jnci/87.8.587; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; Sakuradani E, 2009, J BIOTECHNOL, V144, P31, DOI 10.1016/j.jbiotec.2009.04.012; Sayanova OV, 2004, PHYTOCHEMISTRY, V65, P147, DOI 10.1016/j.phytochem.2003.10.017; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; SHIMIZU S, 1988, BIOCHEM BIOPH RES CO, V150, P335, DOI 10.1016/0006-291X(88)90525-6; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; STINSON EE, 1991, J IND MICROBIOL, V8, P171, DOI 10.1007/BF01575850; Sydenham E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005379.pub3; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang L., 2011, PLOS ONE, V6; Wen ZY, 2003, BIOTECHNOL ADV, V21, P273, DOI 10.1016/S0734-9750(03)00051-X; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xue ZX, 2013, APPL MICROBIOL BIOT, V97, P1973, DOI 10.1007/s00253-012-4068-2; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zhang Y, 2007, MICROBIOL-SGM, V153, P2013, DOI 10.1099/mic.0.2006/002683-0	62	8	8	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65552	10.1371/journal.pone.0065552	http://dx.doi.org/10.1371/journal.pone.0065552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824586	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400010
J	Qu, J; Jakobs, TC				Qu, Juan; Jakobs, Tatjana C.			The Time Course of Gene Expression during Reactive Gliosis in the Optic Nerve	PLOS ONE			English	Article							ELEVATED INTRAOCULAR-PRESSURE; AXONAL-TRANSPORT; RAT GLAUCOMA; MOUSE RETINA; ASTROCYTES; HEAD; INJURY; MODEL; BRAIN; NEURONS	Reactive gliosis is a complex process that involves changes in gene expression and morphological remodeling. The mouse optic nerve, where astrocytes, microglia and oligodendrocytes interact with retinal ganglion cell axons and each other, is a particularly suitable model for studying the molecular mechanisms of reactive gliosis. We triggered gliosis at the mouse optic nerve head by retro orbital nerve crush. We followed the expression profiles of 14,000 genes from 1 day to 3 months, as the optic nerve formed a glial scar. The transcriptome showed profound changes. These were greatest shortly after injury; the numbers of differentially regulated genes then dropped, returning nearly to resting levels by 3 months. Different genes were modulated with very different time courses, and functionally distinct groups of genes responded in partially overlapping waves. These correspond roughly to two quick waves of inflammation and cell proliferation, a slow wave of tissue remodeling and debris removal, and a final stationary phase that primarily reflects permanent structural changes in the axons. Responses from astrocytes, microglia and oligodendrocytes were distinctively different, both molecularly and morphologically. Comparisons to other models of brain injury and to glaucoma indicated that the glial responses depended on both the tissue and the injury. Attempts to modulate glial function after axonal injuries should consider different mechanistic targets at different times following the insult.	[Qu, Juan; Jakobs, Tatjana C.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Jakobs, TC (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02138 USA.	tatjana_jakobs@meei.harvard.edu		Jakobs, Tatjana/0000-0002-8104-9206	National Institutes of Health (NIH) [EY019703, EY14104]; Research to Prevent Blindness; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R01EY019703] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was funded by National Institutes of Health (NIH) grant EY019703, core grant EY14104, and grants from Research to Prevent Blindness and the Massachusetts Lions Eye Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Frank M, 1996, GLIA, V16, P227, DOI 10.1002/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z; Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ito U, 2007, STROKE, V38, P2577, DOI 10.1161/STROKEAHA.107.484394; Jakobs TC, 2007, MOL VIS, V13, P933; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jakobs TC, 2003, J COMP NEUROL, V465, P361, DOI 10.1002/cne.10845; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Kalmar B, 2001, NEUROCHEM INT, V38, P453, DOI 10.1016/S0197-0186(00)00090-5; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Moore DL, 2011, MOL CELL NEUROSCI, V47, P233, DOI 10.1016/j.mcn.2011.05.005; Morcos Y, 2000, J NEUROCYTOL, V29, P665, DOI 10.1023/A:1010835404754; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Nolte C, 2001, GLIA, V33, P72; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Pena JDO, 1999, EXP EYE RES, V68, P29, DOI 10.1006/exer.1998.0577; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soto I, 2011, INVEST OPHTH VIS SCI, V52, P434, DOI 10.1167/iovs.10-5856; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; Yanagi M, 2008, SCHIZOPHR RES, V100, P291, DOI 10.1016/j.schres.2007.11.042; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	47	78	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67094	10.1371/journal.pone.0067094	http://dx.doi.org/10.1371/journal.pone.0067094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826199	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000024
J	Prie, D; Forand, A; Francoz, C; Elie, C; Cohen, I; Courbebaisse, M; Eladari, D; Lebrec, D; Durand, F; Friedlander, G				Prie, Dominique; Forand, Anne; Francoz, Claire; Elie, Caroline; Cohen, Isabelle; Courbebaisse, Marie; Eladari, Dominique; Lebrec, Didier; Durand, Francois; Friedlander, Gerard			Plasma Fibroblast Growth Factor 23 Concentration Is Increased and Predicts Mortality in Patients on the Liver-Transplant Waiting List	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM SODIUM; MELD SCORE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; DIETARY PHOSPHATE; GENE-EXPRESSION; FGF-23; FGF23; MODEL; CIRRHOSIS	High plasma fibroblast growth factor-23 (FGF23) concentration predicts the risk of death and poor outcomes in patients with chronic kidney disease or chronic heart failure. We checked if FGF23 concentration could be modified in patients with end stage liver disease (ESLD) and predict mortality. We measured plasma FGF23 in 200 patients with ESLD registered on a liver transplant waiting list between January 2005 and October 2008. We found that median plasma FGF23 concentration was above normal values in 63% of the patients. Increased FGF23 concentration was not explained by its classical determinants: hyperphosphataemia, increased calcitriol concentration or decreased renal function. FGF23 concentration correlated with the MELD score, serum sodium concentration, and GFR. Forty-six patients died before being transplanted and 135 underwent liver transplantation. We analyzed the prognostic value of FGF23 levels. Mortality was significantly associated with FGF23 levels, the MELD score, serum sodium concentration and glomerular filtration rate. On multivariate analyses only FGF23 concentration was associated with mortality. FGF23 levels were independent of the cause of the liver disease. To determine if the damaged liver can produce FGF23 we measured plasma FGF23 concentration and liver FGF23 mRNA expression in control and diethyl-nitrosamine (DEN)-treated mice. FGF23 plasma levels increased with the apparition of liver lesions in DEN-treated mice and that FGF23 mRNA expression, which was undetectable in the liver of control mice, markedly increased with the development of liver lesions. The correlation between FGF23 plasma concentration and FGF23 mRNA expression in DEN-treated mice suggests that FGF23 production by the liver accounts for the increased plasma FGF23 concentration. In conclusion chronic liver lesions can induce expression of FGF23 mRNA leading to increased FGF23 concentration, which is associated with a higher mortality in patients on a liver-transplant waiting list. In these patients FGF23 concentration was the best predictor of mortality.	[Prie, Dominique; Courbebaisse, Marie] Univ Paris 05, INSERM, Hop Necker Enfants Malad, AP HP,Fac Med,U845, Paris, France; [Forand, Anne; Cohen, Isabelle] INSERM, U845, Paris, France; [Francoz, Claire; Lebrec, Didier; Durand, Francois] Hop Beaujon, INSERM, AP HP, Unite Soins Intensifs,Serv Hepatol, Clichy, France; [Elie, Caroline] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Biostat & Informat Med,Fac Med,EA 4472, Paris, France; [Eladari, Dominique] Univ Paris 05, INSERM, Hop Europe Georges Pompidou, AP HP,Fac Med,INSERM,UMRS 872,Serv Explorat Fonct, Paris, France; [Friedlander, Gerard] Univ Paris 05, INSERM, Hop Europe Georges Pompidou, AP HP,Fac Med,Serv Explorat Fonct & Radio Isotope, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Prie, D (corresponding author), Univ Paris 05, INSERM, Hop Necker Enfants Malad, AP HP,Fac Med,U845, Paris, France.	dominique.prie@inserm.fr		Forand, Anne/0000-0003-4970-2372; Durand, Francois/0000-0002-0357-1090; Friedlander, Gerard/0000-0002-6854-4261; Eladari, Dominique/0000-0003-1067-0844; Francoz, Claire/0000-0001-7391-8507	INSERM; Universite Paris Descartes; Association Laboratoire de Recherches Physiologiques; Agence Nationale pour la Recherche [ANR-07-PHYSIO-017-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; Association Laboratoire de Recherches Physiologiques; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants from INSERM, Universite Paris Descartes, Association Laboratoire de Recherches Physiologiques, and l'Agence Nationale pour la Recherche (ANR-07-PHYSIO-017-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Arnlov J, 2012, KIDNEY INT; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Biggins SW, 2005, HEPATOLOGY, V41, P32, DOI 10.1002/hep.20517; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; COX DR, 1972, J R STAT SOC B, V34, P187; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gauglhofer C, 2011, HEPATOLOGY, V53, P854, DOI 10.1002/hep.24099; Gotthardt D, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-72; Gruson D, 2012, PEPTIDES, V37, P258, DOI 10.1016/j.peptides.2012.08.003; Gupta A, 2004, J CLIN ENDOCR METAB, V89, P4489, DOI 10.1210/jc.2004-0724; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Heuman DM, 2004, HEPATOLOGY, V40, P802, DOI 10.1002/hep.20405; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; JinNo K, 1997, J GASTROENTEROL, V32, P119; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Lang PO, 2012, OSTEOPOROS INT; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Londono MC, 2007, GUT, V56, P1283, DOI 10.1136/gut.2006.102764; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; Mirams M, 2004, BONE, V35, P1192, DOI 10.1016/j.bone.2004.06.014; NAGASAKI T, 1991, HEPATOLOGY, V13, P6, DOI 10.1002/hep.1840130103; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Northup PG, 2005, ANN SURG, V242, P244, DOI 10.1097/01.sla.0000171327.29262.e0; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Plischke M, 2011, EUROPEAN J CLIN INVE; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Raimann A, 2013, CONNECT TISSUE RES, V54, P108, DOI 10.3109/03008207.2012.753879; Ruf AE, 2005, LIVER TRANSPLANT, V11, P336, DOI 10.1002/lt.20329; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Seiler S, 2011, EUROPEAN HEART J; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Uematsu S, 2005, J GASTROEN HEPATOL, V20, P583, DOI 10.1111/j.1440-1746.2005.03726.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105; Yamazaki Y, 2008, J BONE MINER RES, V23, P1509, DOI 10.1359/JBMR.080417; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Zittermann A, 2009, CLIN CHEM, V55, P1163, DOI 10.1373/clinchem.2008.120006	56	39	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66182	10.1371/journal.pone.0066182	http://dx.doi.org/10.1371/journal.pone.0066182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825530	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000009
J	Shun-Shin, MJ; Francis, DP				Shun-Shin, Matthew James; Francis, Darrel P.			Why Even More Clinical Research Studies May Be False: Effect of Asymmetrical Handling of Clinically Unexpected Values	PLOS ONE			English	Article								Background: In medical practice, clinically unexpected measurements might be quite properly handled by the remeasurement, removal, or reclassification of patients. If these habits are not prevented during clinical research, how much of each is needed to sway an entire study? Methods and Results: Believing there is a difference between groups, a well-intentioned clinician researcher addresses unexpected values. We tested how much removal, remeasurement, or reclassification of patients would be needed in most cases to turn an otherwise-neutral study positive. Remeasurement of 19 patients out of 200 per group was required to make most studies positive. Removal was more powerful: just 9 out of 200 was enough. Reclassification was most powerful, with 5 out of 200 enough. The larger the study, the smaller the proportion of patients needing to be manipulated to make the study positive: the percentages needed to be remeasured, removed, or reclassified fell from 45%, 20%, and 10% respectively for a 20 patient-per-group study, to 4%, 2%, and 1% for an 800 patient-per-group study. Dot-plots, but not bar-charts, make the perhaps-inadvertent manipulations visible. Detection is possible using statistical methods such as the Tadpole test. Conclusions: Behaviours necessary for clinical practice are destructive to clinical research. Even small amounts of selective remeasurement, removal, or reclassification can produce false positive results. Size matters: larger studies are proportionately more vulnerable. If observational studies permit selective unblinded enrolment, malleable classification, or selective remeasurement, then results are not credible. Clinical research is very vulnerable to "remeasurement, removal, and reclassification", the 3 evil R's.	[Shun-Shin, Matthew James; Francis, Darrel P.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England	Imperial College London	Shun-Shin, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England.	m@shun-shin.com		Shun-Shin, Matthew/0000-0002-1179-0867	British Heart Foundation [FS/10/038]; British Heart Foundation [FS/10/38/28268] Funding Source: researchfish; National Institute for Health Research [ACF-2011-21-003] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	DPF is supported by the British Heart Foundation (FS/10/038) which kindly funds this article to be Open Access. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Committee for Practice Guidelines of the European Society of Cardiology, 2010, REC GUID PROD EUR SO, P1; DAGOSTIN.RB, 1970, BIOMETRIKA, V57, P679, DOI 10.1093/biomet/57.3.679; Deeks J J, 2003, Health Technol Assess, V7, piii; Hodge VJ, 2004, ARTIF INTELL REV, V22, P85, DOI 10.1023/B:AIRE.0000045502.10941.a9; Huwaldt JA, PLOT DIGITIZER GPL; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; R Core Team, 2021, R LANGUAGE ENV STAT; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; The Document Foundation, 2013, LIBR 4 0 2; Tzoulaki I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6829; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Wilkinson L, 1999, AM STAT, V53, P276, DOI 10.2307/2686111; Wilmshurst Peter, 2007, Med Leg J, V75, P3	15	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e65323	10.1371/journal.pone.0065323	http://dx.doi.org/10.1371/journal.pone.0065323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825524	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000004
J	Stefos, GC; Soppa, U; Dierssen, M; Becker, W				Stefos, Georgios C.; Soppa, Ulf; Dierssen, Mara; Becker, Walter			NGF Upregulates the Plasminogen Activation Inhibitor-1 in Neurons via the Calcineurin/NFAT Pathway and the Down Syndrome-Related Proteins DYRK1A and RCAN1 Attenuate This Effect	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; DOWN-SYNDROME; GENE-EXPRESSION; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; HUMAN HOMOLOG; KINASE; MINIBRAIN; ROLES	Background: Plasminogen activator inhibitor 1 (PAI-1) is a key regulator of the plasminogen activation system. Although several lines of evidence support a significant role of PAI-1 in the brain, the regulation of its expression in neurons is poorly understood. In the present study we tested the hypothesis that NGF induces the upregulation of PAI-1 via the calcineurin/nuclear factor of activated T cells (NFAT) pathway and analysed whether the overexpression of the Down syndrome-related proteins DYRK1A and RCAN1 modulated the effect of NGF on PAI-1 expression. Results: NGF upregulated PAI-1 mRNA levels in primary mouse hippocampal neurons cultured for 3 days in vitro and in the rat pheochromocytoma cell line PC12. Reporter gene assays revealed that NGF activated the calcineurin/NFAT pathway in PC12 cells. Induction of PAI-1 by NGF was sensitive to the calcineurin inhibitor FK506 and the specific inhibition of NFAT activation by the cell permeable VIVIT peptide. Activation of calcineurin/NFAT signalling through other stimuli resulted in a much weaker induction of PAI-1 expression, suggesting that other NGF-induced pathways are involved in PAI-1 upregulation. Overexpression of either DYRK1A or RCAN1 negatively regulated NFAT-dependent transcriptional activity and reduced the upregulation of PAI-1 levels by NGF. Conclusion: The present results show that the calcineurin/NFAT pathway mediates the upregulation of PAI-1 by NGF. The negative effect of DYRK1A and RCAN1 overexpression on NGF signal transduction in neural cells may contribute to the altered neurodevelopment and brain function in Down syndrome.	[Stefos, Georgios C.; Soppa, Ulf; Becker, Walter] Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany; [Stefos, Georgios C.; Dierssen, Mara] Pompeu Fabra Univ, Ctr Genom Regulat, Syst Biol Programme, Barcelona, Spain; [Stefos, Georgios C.; Dierssen, Mara] Ctr Invest Biomed Red Enfermedades Raras, Barcelona, Spain	RWTH Aachen University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Stefos, GC (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany.	stegi121@yahoo.gr	Becker, Walter/B-8889-2008; Dierssen, Mara/G-3552-2015	Becker, Walter/0000-0002-0347-4768; Dierssen, Mara/0000-0003-0853-6865; Stefos, Georgios/0000-0001-7832-6965	Alexander von Humboldt Stiftung, Germany; Jerome Lejeune Foundation, France; Spanish Ministry of Science and Innovation [SAF2010-16427]; European Union [PS09102673]; Friedrich-Naumann-Foundation, Germany	Alexander von Humboldt Stiftung, Germany(Alexander von Humboldt Foundation); Jerome Lejeune Foundation, France; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Friedrich-Naumann-Foundation, Germany	This work was supported by grants from the Alexander von Humboldt Stiftung, Germany (GCS), the Jerome Lejeune Foundation, France (WB), the Spanish Ministry of Science and Innovation SAF2010-16427 (MD), the European Union CureFXS ERare- FIS PS09102673 (MD) and the Friedrich-Naumann-Foundation, Germany (US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukawa H, 2009, MOL VIS, V15, P451; Ahamed J, 2004, J IMMUNOL, V172, P6961, DOI 10.4049/jimmunol.172.11.6961; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Arque G, 2009, NEUROBIOL DIS, V36, P312, DOI 10.1016/j.nbd.2009.07.027; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; BANKER G, 1998, CULTURING NERVE CELL; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Corbit KC, 1999, MOL CELL BIOL, V19, P4209; Czekay RP, 2004, EXP BIOL MED, V229, P1090, DOI 10.1177/153537020422901102; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de la Luna S, 2006, TRENDS MOL MED, V12, P451, DOI 10.1016/j.molmed.2006.08.001; Dierssen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017010; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Goldberg HJ, 2002, J BIOL CHEM, V277, P33833, DOI 10.1074/jbc.M112331200; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Harslund J, 2007, AM J PHYSIOL-REG I, V293, pR1630, DOI 10.1152/ajpregu.00380.2007; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hopkins WE, 2000, AM J CARDIOL, V85, P784, DOI 10.1016/S0002-9149(99)00864-4; Jankun J, 2009, POL ARCH MED WEWN, V119, P410, DOI 10.20452/pamw.729; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kelly PA, 2005, MOL BIOL CELL, V16, P3562, DOI 10.1091/mbc.E04-12-1085; Lee MH, 2010, J LIPID RES, V51, P2619, DOI 10.1194/jlr.M003988; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Lopez S, 1999, THROMB HAEMOSTASIS, V81, P415, DOI 10.1055/s-0037-1614488; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Minneman KP, 2000, J NEUROCHEM, V74, P2392, DOI 10.1046/j.1471-4159.2000.0742392.x; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nguyen T, 2009, J BIOL CHEM, V284, P18816, DOI 10.1074/jbc.M109.015719; Nico B, 2008, MICROVASC RES, V75, P135, DOI 10.1016/j.mvr.2007.07.004; Pandey M, 2005, FASEB J, V19, P1317, DOI 10.1096/fj.04-3459fje; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Papadopoulos C, 2011, J BIOL CHEM, V286, P5494, DOI 10.1074/jbc.M110.157909; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Peiretti F, 1996, BLOOD, V87, P162; Prasai P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-90; Rahmani Z, 1998, BIOCHEM BIOPH RES CO, V253, P514, DOI 10.1006/bbrc.1998.9803; Ren S, 2000, AM J PHYSIOL-ENDOC M, V278, pE656, DOI 10.1152/ajpendo.2000.278.4.E656; Ryeom S, 2009, J CRANIOFAC SURG, V20, P595, DOI 10.1097/SCS.0b013e3181927f47; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440; Shin SY, 2011, J CELL SCI, V124, P82, DOI 10.1242/jcs.076034; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Soeda S, 2006, NEUROSCIENCE, V141, P101, DOI 10.1016/j.neuroscience.2006.03.026; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Takahashi H, 2000, NEUROREPORT, V11, P1111, DOI 10.1097/00001756-200004070-00040; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vician L, 1997, J NEUROSCI RES, V50, P32, DOI 10.1002/(SICI)1097-4547(19971001)50:1<32::AID-JNR4>3.0.CO;2-M; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Yeh CC, 2009, ARTHRITIS RHEUM-US, V60, P2350, DOI 10.1002/art.24680; Zhao J, 2008, CELL RES, V18, P803, DOI 10.1038/cr.2008.89	72	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67470	10.1371/journal.pone.0067470	http://dx.doi.org/10.1371/journal.pone.0067470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825664	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000104
J	Wu, LP; Li, YC; Zhao, JL; Zheng, C; Chen, JH; Hong, J; Lin, JX; Li, J; Li, J; Ji, KT; Lin, JF				Wu Lian-Pin; Li Yue-Chun; Zhao Jing-Lin; Zheng Cheng; Chen Jun-Hua; Hong Jun; Lin Jia-Xuan; Li Jin; Li Jia; Ji Kang-Ting; Lin Jia-Feng			Catheter Ablation of Idiopathic Premature Ventricular Contractions and Ventricular Tachycardias Originating from Right Ventricular Septum	PLOS ONE			English	Article							ELECTROCARDIOGRAPHIC CHARACTERISTICS	Background: Idiopathic premature ventricular contractions (PVCs) and ventricular tachycardias (IVTs) originating from the subtricuspid septum and near the His bundle have been reported. However, little is known about the prevalence, distribution, electrocardiographic characteristics and the efficacy of radiofrequency catheter ablation (RFCA) for the ventricular arrhythmias arising from the right ventricular (RV) septum. This study aimed to investigate electrocardiographic characteristics and effects of RFCA for patients with symptomatic PVCs/IVTs, originating from the different portions of the RV septum. Methodology/Principal Findings: Characteristics of body surface electrocardiogram and electrophysiologic recordings were analyzed in 29 patients with symptomatic PVCs/IVTs originating from the RV septum. Among 581 patients with PVCs/IVTs, the incidence of ventricular arrhythmias originating from the RV septum was 5%. Twenty (69%) had PVCs/IVTs from the septal portion of the tricuspid valvular RV region (3 from superoseptum, 15 from midseptum, 2 from inferoseptum), and 9 (31%) from the septal portion of the basal RV (1 from superoseptum, 4 from midseptum, 4 from inferoseptum). There were different characteristics of ECG of PVCs/VT originating from the different portions of the RV septum. Twenty-seven of 29 patients with PVCs/IVTs arising from the RV septum were successfully ablated (93.1% acute success). Conclusions/Significance: ECG characteristics of PVCs/VTs originating from the different portions of the RV septum are different, and can help regionalize the origin of these arrhythmias. The septal portion of the tricuspid valvular RV region was the preferential site of origin. RFCA was effective and safe for the PVCs/IVTs arising from the RV septum.	[Wu Lian-Pin; Li Yue-Chun; Zhao Jing-Lin; Zheng Cheng; Chen Jun-Hua; Hong Jun; Lin Jia-Xuan; Li Jin; Li Jia; Ji Kang-Ting; Lin Jia-Feng] Wenzhou Med Coll, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Peoples R China	Wenzhou Medical University	Lin, JF (corresponding author), Wenzhou Med Coll, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Peoples R China.	linjiafeng_wzmcfey@163.com			Wenzhou Municipal Science and Technology Commission [Y2008086]; Electrophysiology and Cardiac Pacing Association of Zhejiang Medical Association, China [2011ZYC-A27]	Wenzhou Municipal Science and Technology Commission; Electrophysiology and Cardiac Pacing Association of Zhejiang Medical Association, China	This study is supported by Wenzhou Municipal Science and Technology Commission (Grant No. Y2008086) and Electrophysiology and Cardiac Pacing Association of Zhejiang Medical Association (Grant No. 2011ZYC-A27), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan V, 2006, HEART RHYTHM, V3, P1132, DOI 10.1016/j.hrthm.2006.06.024; Ceresnak SR, 2012, J ELECTROCARDIOL, V45, P385, DOI 10.1016/j.jelectrocard.2012.03.009; COGGINS DL, 1994, J AM COLL CARDIOL, V23, P1333, DOI 10.1016/0735-1097(94)90375-1; Li YC, 2013, INT J CARDIOL, V167, P2673, DOI 10.1016/j.ijcard.2012.06.119; Navarrete A, 2008, EUROPACE, V10, P1343, DOI 10.1093/europace/eun239; Satish OS, 2005, EUROPACE, V7, P348, DOI 10.1016/j.eupc.2005.02.122; Tada H, 2007, HEART RHYTHM, V4, P7, DOI 10.1016/j.hrthm.2006.09.025; Tsai CF, 1997, INT J CARDIOL, V62, P143, DOI 10.1016/S0167-5273(97)00198-8; Van Herendael H, 2011, HEART RHYTHM, V8, P511, DOI 10.1016/j.hrthm.2010.11.044; Yamauchi Y, 2005, J CARDIOVASC ELECTR, V16, P1041, DOI 10.1111/j.1540-8167.2005.40787.x; Yue-Chun Li, 2012, BMC Cardiovasc Disord, V12, P32, DOI 10.1186/1471-2261-12-32	11	8	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67038	10.1371/journal.pone.0067038	http://dx.doi.org/10.1371/journal.pone.0067038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825610	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000062
J	Yoon, Y; Yoon, J; Jang, MY; Na, Y; Ko, Y; Choi, JH; Seok, SH				Yoon, Yina; Yoon, Jihye; Jang, Man-Young; Na, Yirang; Ko, Youngho; Choi, Jae-Hoon; Seok, Seung Hyeok			High Cholesterol Diet Induces IL-1 beta Expression in Adult but Not Larval Zebrafish	PLOS ONE			English	Article							TARGETED GENE DISRUPTION; ZINC-FINGER NUCLEASES; MOUSE MODELS; HYPERCHOLESTEROLEMIC ZEBRAFISH; LIPID-ACCUMULATION; TNF-ALPHA; ATHEROSCLEROSIS; DISEASE; INTERLEUKIN-1-BETA; TALENS	Recently, it has been demonstrated that high cholesterol diet induced hypercholesterolemia and vascular lipid oxidation and accumulation in zebrafish larvae, suggesting that zebrafish is a new promising atherosclerosis model in addition to mouse models. However, up to date, there was no report regarding inflammatory cytokine expression during the lipid accumulation in zebrafish larva and adult fish. In this study, we first demonstrated the expression levels of IL-1 beta and TNF-alpha in high cholesterol diet (HCD)-fed zebrafish larvae, and found that although HCD induced vascular lipid accumulation, the cytokine expressions in the larvae were not changed by HCD. Furthermore, there was no significant difference in leukocyte accumulation in vessels between control and HCD fed group. But prolonged HCD induced IL-1 beta expression in spleen and liver compared to those of control zebrafish, and produced very early stage of fatty streak lesion in dorsal aorta of 19 week HCD-fed zebrafish. These results indicate that HCD induced hypercholesterolemia and atherosclerotic changes in zebrafish are very early stage, and suggest the necessity of the generation of mutant zebrafish having a disruption in a lipid metabolism-related gene leading to severe hypercholesterolemia and advanced atherosclerosis.	[Yoon, Yina; Na, Yirang; Ko, Youngho; Seok, Seung Hyeok] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Yoon, Yina; Na, Yirang; Ko, Youngho; Seok, Seung Hyeok] Seoul Natl Univ, Coll Med, Inst Endem Dis, Seoul, South Korea; [Yoon, Jihye; Jang, Man-Young; Choi, Jae-Hoon] Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South Korea; [Yoon, Jihye; Jang, Man-Young; Choi, Jae-Hoon] Hanyang Univ, Res Inst Nat Sci, Seoul 133791, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Hanyang University	Choi, JH (corresponding author), Hanyang Univ, Coll Nat Sci, Dept Life Sci, Seoul 133791, South Korea.	jchoi75@hanyang.ac.kr; lamseok@snu.ac.kr	Choi, Jae-Hoon/R-6224-2016; Seok, Seung Hyeok/J-3279-2012	Choi, Jae-Hoon/0000-0002-5265-3463; Seok, Seung Hyeok/0000-0002-4315-0688	Ministry of Education, Science and Technology, Korea [2011-0005843]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology, South Korea [2011-0013669]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was funded by the Ministry of Education, Science and Technology, Korea (2011-0005843) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, South Korea (2011-0013669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alestrom P, 2006, TRENDS BIOTECHNOL, V24, P15, DOI 10.1016/j.tibtech.2005.11.004; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fang LH, 2011, J CLIN INVEST, V121, P4861, DOI 10.1172/JCI57755; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Lei L, 2009, J LIPID RES, V50, P1057, DOI 10.1194/jlr.M800484-JLR200; Lewis JD, 2005, CANCER RES, V65, P2938, DOI 10.1158/0008-5472.CAN-04-2874; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Ozeren A, 2003, MEDIAT INFLAMM, V12, P361, DOI 10.1080/09629350310001633360; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Schonbeck U, 2002, CIRCULATION, V106, P2888, DOI 10.1161/01.CIR.0000043029.52803.7B; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	28	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66970	10.1371/journal.pone.0066970	http://dx.doi.org/10.1371/journal.pone.0066970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825600	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000054
J	Zheng, ZJ; Hong, L; Huang, XD; Yang, PR; Li, J; Ding, Y; Yao, RE; Geng, J; Shen, YN; Shen, YP; Fu, QH; Yu, YG				Zheng, Zhaojing; Hong, Li; Huang, Xiaodong; Yang, Peirong; Li, Juan; Ding, Yu; Yao, Ru-en; Geng, Juan; Shen, Yongnian; Shen, Yiping; Fu, Qihua; Yu, Yongguo			Screening for Coding Variants in FTO and SH2B1 Genes in Chinese Patients with Obesity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; CHILDHOOD OBESITY; FAT MASS; RNA; PREVALENCE; OVERWEIGHT; SUBSTRATE; DELETIONS; CHILDREN	Objective: To investigate potential functional variants in FTO and SH2B1 genes among Chinese children with obesity. Methods: Sanger sequencing of PCR products of all FTO and SH2B1 exons and their flanking regions were performed in 338 Chinese Han children with obesity and 221 age- and sex-matched lean controls. Results: A total of seven and five rare non-synonymous variants were identified in FTO and SH2B1, respectively. The overall frequencies of FTO and SH2B1 rare non-synonymous variants were similar in obese and lean children (2.37% and 0.90% vs. 1.81% and 1.36%, P>0.05). However, four out of the seven variants in FTO were novel and all were unique to obese children (p>0.05). None of the novel variants was consistently being predicted to be deleterious. Four out of five variants in SH2B1 were novel and one was unique to obese children (p>0.05). One variant (L293R) that was consistently being predicted as deleterious in SH2B1 gene was unique to lean control. While rare missense mutations were more frequently detected in girls from obesity as well as lean control than boys, the difference was not statistically significant. In addition, it's shown that the prevalence of rare missense mutations of FTO as well as SH2B1 was similar across different ethnic groups. Conclusion: The rare missense mutations of FTO and SH2B1 did not confer risks of obesity in Chinese Han children in our cohort.	[Zheng, Zhaojing; Yao, Ru-en; Geng, Juan; Shen, Yiping; Fu, Qihua] Shanghai Jiao Tong Univ, Dept Lab Med, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200030, Peoples R China; [Hong, Li] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Nutr, Shanghai 200030, Peoples R China; [Huang, Xiaodong; Yang, Peirong; Li, Juan; Ding, Yu; Shen, Yongnian; Yu, Yongguo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Internal Med, Shanghai 200030, Peoples R China; [Shen, Yiping] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Boston Children's Hospital	Fu, QH (corresponding author), Shanghai Jiao Tong Univ, Dept Lab Med, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200030, Peoples R China.	qfu@shsmu.edu.cn; yuyongguo@shsmu.edu.cn	Fu, Qihua/AAW-9989-2020	yu, yongguo/0000-0002-4472-0910	Project HOPE "The Abbott Fund Institute of Nutrition Science" [AFINS-HOPE-2013-05]; Shanghai Jiaotong University Cross Biomedical Engineering [YG-2011-MS28]; National Natural Science Foundation of China [81000346]; Shanghai Science & Technology Commission Major Project [11dz1950300]	Project HOPE "The Abbott Fund Institute of Nutrition Science"; Shanghai Jiaotong University Cross Biomedical Engineering; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science & Technology Commission Major Project	This work was supported by Project HOPE "The Abbott Fund Institute of Nutrition Science (AFINS-HOPE-2013-05, to YGY)", the other is Shanghai Jiaotong University Cross Biomedical Engineering (YG-2011-MS28, to YGY). This study is further supported by grant from the National Natural Science Foundation of China (No. 81000346, to YGY), and grant from Shanghai Science & Technology Commission Major Project (No. 11dz1950300, to YGY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Deliard S, 2013, OBESITY, V21, P159, DOI 10.1002/oby.20147; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Ji CY, 2008, OBES REV, V9, P78, DOI 10.1111/j.1467-789X.2007.00443.x; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Loos RJF, 2003, J INTERN MED, V254, P401, DOI 10.1046/j.1365-2796.2003.01242.x; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Sallman Almen M, 2012, INT J OBESITY, DOI [10.1038/ijo.2012.57, DOI 10.1038/IJ0.2012.57.[]; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang H, 2011, PROTECTING PRIVACY IN CHINA: A RESEARCH ON CHINAS PRIVACY STANDARDS AND THE POSSIBILITY OF ESTABLISHING THE RIGHT TO PRIVACY AND THE INFORMATION PRIVACY PROTECTION LEGISLATION IN MODERN CHINA, P1, DOI 10.1007/978-3-642-21750-0_1; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	38	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67039	10.1371/journal.pone.0067039	http://dx.doi.org/10.1371/journal.pone.0067039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825611	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000063
J	Kling, RC; Lanig, H; Clark, T; Gmeiner, P				Kling, Ralf C.; Lanig, Harald; Clark, Timothy; Gmeiner, Peter			Active-State Models of Ternary GPCR Complexes: Determinants of Selective Receptor-G-Protein Coupling	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DOPAMINE-D-2 RECEPTOR; SYNTHETIC PEPTIDES; STRUCTURAL BASIS; AMINO-TERMINUS; BINDING; ACTIVATION; AGONIST; SPECIFICITY; G-ALPHA(I1)	Based on the recently described crystal structure of the beta(2) adrenergic receptor - G(s)-protein complex, we report the first molecular-dynamics simulations of ternary GPCR complexes designed to identify the selectivity determinants for receptor-G-protein binding. Long-term molecular dynamics simulations of agonist-bound beta 2AR-G alpha s and D2R-G alpha, complexes embedded in a hydrated bilayer environment and computational alanine-scanning mutagenesis identified distinct residues of the N-terminal region of intracellular loop 3 to be crucial for coupling selectivity. Within the G-protein, specific amino acids of the alpha 5-helix, the C-terminus of the G alpha-subunit and the regions around alpha N-beta 1 and alpha 4-beta 6 were found to determine receptor recognition. Knowledge of these determinants of receptor-G-protein binding selectivity is essential for designing drugs that target specific receptor/G-protein combinations.	[Kling, Ralf C.; Gmeiner, Peter] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Kling, Ralf C.; Lanig, Harald; Clark, Timothy] Univ Erlangen Nurnberg, Comp Chem Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Clark, Timothy] Univ Portsmouth, Ctr Mol Design, Portsmouth, Hants, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Portsmouth	Gmeiner, P (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany.	peter.gmeiner@fau.de	Gmeiner, Peter/N-5275-2015	Gmeiner, Peter/0000-0002-4127-197X; Clark, Timothy/0000-0001-7931-4659; Lanig, Harald/0000-0003-1593-5557				Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Babin V., 2008, AMBER; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bradshaw RT, 2011, PROTEIN ENG DES SEL, V24, P197, DOI 10.1093/protein/gzq047; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Coley C, 2000, J NEUROCHEM, V74, P358, DOI 10.1046/j.1471-4159.2000.0740358.x; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Deupi X, 2012, BIOCHEM SOC T, V40, P383, DOI 10.1042/BST20120001; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; EASON MG, 1995, J BIOL CHEM, V270, P24753, DOI 10.1074/jbc.270.42.24753; Ehrlich K, 2009, J MED CHEM, V52, P4923, DOI 10.1021/jm900690y; Fowler JC, 2012, MOL PHARM; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frisch G. W., 2013, GAUSSIAN 09; Gazi L, 2003, BRIT J PHARMACOL, V138, P775, DOI 10.1038/sj.bjp.0705116; Goetz A, 2011, J MOL BIOL; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Katritch V, 2012, ANN REV PHARM TOXICO; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Miller III B. R., 2012, J CHEM THEORY COMPUT; MORO O, 1993, J BIOL CHEM, V268, P22273; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Nickolls SA, 2003, BIOCHEM PHARMACOL, V65, P1139, DOI 10.1016/S0006-2952(03)00040-6; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Romanelli RJ, 2010, RECEPT SER, P137, DOI 10.1007/978-1-60327-333-6_6; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; RUBENSTEIN RC, 1987, J BIOL CHEM, V262, P16655; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Tschammer N, 2011, J MED CHEM, V54, P2477, DOI 10.1021/jm101639t; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; VOSS T, 1993, J BIOL CHEM, V268, P4637; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108	65	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67244	10.1371/journal.pone.0067244	http://dx.doi.org/10.1371/journal.pone.0067244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826246	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400126
J	Kocarek, P; John, V; Hulva, P				Kocarek, Petr; John, Vaclav; Hulva, Pavel			When the Body Hides the Ancestry: Phylogeny of Morphologically Modified Epizoic Earwigs Based on Molecular Evidence	PLOS ONE			English	Article							DERMAPTERA; EVOLUTION; INSECTA; SUBSTITUTION; CHROMOSOMES; FORFICULINA; INFERENCE; OVARIES; MODEL	Here, we present a study regarding the phylogenetic positions of two enigmatic earwig lineages whose unique phenotypic traits evolved in connection with ectoparasitic relationships with mammals. Extant earwigs (Dermaptera) have traditionally been divided into three suborders: the Hemimerina, Arixeniina, and Forficulina. While the Forficulina are typical, well-known, free-living earwigs, the Hemimerina and Arixeniina are unusual epizoic groups living on molossid bats (Arixeniina) or murid rodents (Hemimerina). The monophyly of both epizoic lineages is well established, but their relationship to the remainder of the Dermaptera is controversial because of their extremely modified morphology with paedomorphic features. We present phylogenetic analyses that include molecular data (18S and 28S ribosomal DNA and histone-3) for both Arixeniina and Hemimerina for the first time. This data set enabled us to apply a rigorous cladistics approach and to test competing hypotheses that were previously scattered in the literature. Our results demonstrate that Arixeniidae and Hemimeridae belong in the dermapteran suborder Neodermaptera, infraorder Epidermaptera, and superfamily Forficuloidea. The results support the sister group relationships of Arixeniidae+Chelisochidae and Hemimeridae+Forficulidae. This study demonstrates the potential for rapid and substantial macroevolutionary changes at the morphological level as related to adaptive evolution, in this case linked to the utilization of a novel trophic niche based on an epizoic life strategy. Our results also indicate that the evolutionary consequences of the transition to an ectoparazitic mode of living, which is extremely rare in earwigs, have biased previous morphology-based hypotheses regarding the phylogeny of this insect group.	[Kocarek, Petr] Univ Ostrava, Fac Sci, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic; [John, Vaclav; Hulva, Pavel] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Hulva, Pavel] Univ Ostrava, Fac Sci, Life Sci Res Ctr, CZ-70103 Ostrava, Czech Republic	University of Ostrava; Charles University Prague; University of Ostrava	Kocarek, P (corresponding author), Univ Ostrava, Fac Sci, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic.	petr.kocarek@osu.cz	Kocarek, Petr/C-2989-2011	Kocarek, Petr/0000-0002-1739-0143	Charles University in Prague [SVV-2012-265 206]; University of Ostrava [SGS21/PrF/2013]	Charles University in Prague; University of Ostrava	The funding was provided by an Institutional Research Support grant from the Charles University in Prague (reg. no. SVV-2012-265 206) and an Institutional Research Support grant from the University of Ostrava (reg. no. SGS21/PrF/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J, 2004, MOL MARKERS NATURAL; Burr M, 1911, GENERA INSECTORUM FA, V122; Colgan DJ, 2003, INSECT SYST EVOL, V34, P65, DOI 10.1163/187631203788964935; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Deem LS, 2012, DERMAPTERA SPECIES F; DERIJK P, 1994, NUCLEIC ACIDS RES, V22, P3495; DERIJK P, 1992, NUCLEIC ACIDS RES, V20, P2075, DOI 10.1093/nar/20.suppl.2075; Engel Michael S., 2003, Transactions of the Kansas Academy of Science, V106, P115, DOI 10.1660/0022-8443(2003)106[0115:TEOKWA]2.0.CO;2; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)539[1:FNFED]2.0.CO;2; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Giles E. T., 1963, Transactions of the Royal Entomological Society of London, V115, P95; Grimaldi David, 2005, pi; Guillet S, 2001, EVOL ECOL RES, V3, P441; HAAS F, 1995, SYST ENTOMOL, V20, P85, DOI 10.1111/j.1365-3113.1995.tb00085.x; Haas F, 2001, EUR J ENTOMOL, V98, P445, DOI 10.14411/eje.2001.065; Haas F, 2000, ARTHROPOD STRUCT DEV, V29, P137, DOI 10.1016/S1467-8039(00)00025-6; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hanson H. J., 1933, Entomologiske Meddelelser, V18, P349; HEDGES SB, 1990, MOL BIOL EVOL, V7, P607; Hendlirsch A, 1925, HDB ENTOMOLOGIE, V3, P472; Heymons Richard, 1911, Deutsche Entomologische Zeitschrift, V1911; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jarvis KJ, 2005, SYST ENTOMOL, V30, P442, DOI 10.1111/j.1365-3113.2004.00276.x; Jordan K., 1909, Novitates Zoologicae Tring, V16; Kamimura Y, 2004, ANN ENTOMOL SOC AM, V97, P903, DOI 10.1603/0013-8746(2004)097[0903:ISOTOO]2.0.CO;2; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Klass KD, 2001, ZOOL J LINN SOC-LOND, V131, P251, DOI 10.1111/j.1096-3642.2001.tb02239.x; Kocarek P, 2009, TROP ZOOL, V22, P237; Lecointre G, 2005, ZOOL SCR, V34, P101, DOI 10.1111/j.1463-6409.2005.00168.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; NAKATA S, 1974, PAC INSECTS, V16, P307; Page RDM, 2000, MOL EVOLUTION PHYLOG; Patterson C., 1987, MOL MORPHOLOGY EVOLU; Popham E. J., 1962, Proceedings of the Zoological Society of London, V139, P429; Popham E. J., 1961, Proceedings of the Royal Entomological Society of London (B), V30, P19; POPHAM EDWARD J., 1965, PROC ZOOL SOC LONDON, V146, P1; POPHAM EJ, 1985, Z ZOOL SYST EVOL, V23, P199; Popham EJ, 2000, J NAT HIST, V34, P2007, DOI 10.1080/00222930050144837; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Rehn J. A. G., 1935, Proceedings of the Academy of Natural Sciences of Philadelphia, V87, P457; REHN JAMES A. G., 1937, PROC ACAD NAT SCI PHILADELPHIA, V89, P331; Rentz D.C.F., 1991, P360; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sakai S., 1982, Dermapterorum Catalogus, V14, P1; Sakai S., 1987, P496; Sakai S, 1988, INT C ENT 18, P62; Saussure H, 1879, MEM SOC HIST NAT GEN, V26, P399; Sharp D, 1892, ENTOMOL MON MAG, V28, P212; Sharp D, 1895, CAMBRIDGE NATURAL HI, V5, P217; STEINMANN H, 1973, Folia Entomologica Hungarica, V26, P145; Steinmann H, 1989, DERMAPTERA CATADERMA, V108; Steinmann H, 1993, DERMAPTERA EUDERMAPT, V108; Steinmann H, 1990, DERMAPTERA EUDERMAPT, V106; Steinmann H, 1986, DERMAPTERA CATADERMA, V102; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tworzydlo W, 2013, ZOOL ANZ, V252, P410, DOI 10.1016/j.jcz.2012.11.002; Tworzydlo W, 2010, ACTA BIOL CRACOV BOT, V52, P95; Tworzydlo W, 2010, ARTHROPOD STRUCT DEV, V39, P360, DOI 10.1016/j.asd.2010.05.004; von Reumont BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-119; Walker F, 1871, CATALOGUE SPECIMEN 5; Warnow T, 2012, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1308; WHITE MJD, 1972, CHROMOSOMA, V36, P338, DOI 10.1007/BF00336792; WHITE MJD, 1971, CHROMOSOMA, V34, P183; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Wirth T, 1999, MOL BIOL EVOL, V16, P1645, DOI 10.1093/oxfordjournals.molbev.a026078	68	34	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66900	10.1371/journal.pone.0066900	http://dx.doi.org/10.1371/journal.pone.0066900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826171	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400081
J	Kuo, LT; Tsai, SY; Chang, CC; Kuo, KT; Huang, APH; Tsai, JC; Tseng, HM; Kuo, MF; Tu, YK				Kuo, Lu-Ting; Tsai, Shao-Yu; Chang, Cheng-Chi; Kuo, Kuang-Ting; Huang, Abel Po-Hao; Tsai, Jui-Chang; Tseng, Ham-Min; Kuo, Meng-Fai; Tu, Yong-Kwang			Genetic and Epigenetic Alterations in Primary-Progressive Paired Oligodendroglial Tumors	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE 1; IDH2 MUTATIONS; PROMOTER METHYLATION; SURVIVAL; 19Q; GLIOMAS; 10Q; HYBRIDIZATION; ASTROCYTOMAS; TEMOZOLOMIDE	The aim of the present study was to identify genetic and epigenetic alterations involved in the progression of oligodendroglial tumors. We characterized 21 paired, World Health Organization (WHO) grade II and III oligodendroglial tumors from patients who received craniotomies for the partial or complete resection of primary and secondary oligodendroglial tumors. Tumor DNA was analyzed for alterations in selected genetic loci (1p36, 9p22, 10q23-24, 17p13, 19q13, 22q12), isocitrate dehydrogenase 1 (IDH1), isocitrate dehydrogenase 2 (IDH2) and the CpG island methylation status of critical tumor-related genes (MGMT, P16, DAPK, PTEN, RASSF1A, Rb1). Alterations of these markers were common early in the tumorigenesis. In the primary tumors we identified 12 patients (57.1%) with 1p36 deletions, 17 (81.0%) with 19q13 deletions, 9 (42.9%) with 1p36/19q13 codeletions, 11 (52.3%) with 9p22 deletions, and 12 (57.1%) with IDH1 mutation. Epigenetic analysis detected promoter methylation of the MGMT, P16, DAPK, PTEN, RASSF1A, and Rb1 genes in 38.1%, 19.0%, 38.1%, 33.3%, 66.7%, and 14.3% of primary tumors, respectively. After progression, additional losses of 1p, 9p, 10q, 17p, 19q and 22q were observed in 3 (14.3%), 1 (4.8%), 3 (14.3%), 2 (9.5%), 1 (4.8%) and 3 (14.3%) cases, respectively. Additional methylations of the MGMT, P16, DAPK, PTEN, RASSF1A, and RB1 promoters was observed in 4 (19.0%), 2 (9.5%), 0 (0%), 6 (28.6%), 2(9.5%) and 3 (14.3%) cases, respectively. The status of IDH1 mutation remained unchanged in all tumors after progression. The primary tumors of three patients with subsequent progression to high-grade astrocytomas, all had 9p deletion, intact 1p, intact 10q and unmethylated MGMT. Whether this may represent a molecular signature of patients at-risk for the development of aggressive astrocytomas needs further investigation.	[Kuo, Lu-Ting] Natl Taiwan Univ Hosp, Yun Lin branch, Dept Surg, Div Neurosurg, Yun Lin Cty, Taiwan; [Tsai, Shao-Yu] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan; [Chang, Cheng-Chi] Natl Taiwan Univ, Sch Dent, Grad Inst Oral Biol, Taipei 10764, Taiwan; [Kuo, Kuang-Ting] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Huang, Abel Po-Hao; Tsai, Jui-Chang; Tseng, Ham-Min; Kuo, Meng-Fai; Tu, Yong-Kwang] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Kuo, MF (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan.	Y01951@ms1.ylh.gov.tw	Kuo, Lu-Ting/AAU-3205-2021	TSAI, JUI-CHANG/0000-0003-2723-6841; Tu, Yong-kwang/0000-0003-2113-1176; TSAI, SHAO-YU/0000-0002-2874-5202; KUO, MENG-FAI/0000-0002-1803-2719; Kuo, Lu-Ting/0000-0002-1405-8700; HUANG, ABEL PO-HAO/0000-0002-5689-6761; KUO, KUAN-TING/0000-0002-3657-1652	National Taiwan University Hospital [NTUH95A18, NTUH96N018]; National Science Council [98-2314-B-002-045-MY2]	National Taiwan University Hospital(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants from National Taiwan University Hospital (NTUH95A18, NTUH96N018)(L. Kuo) and the National Science Council (98-2314-B-002-045-MY2)(L. Kuo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso ME, 2003, CANCER GENET CYTOGEN, V144, P134, DOI 10.1016/S0165-4608(02)00928-7; Barker FG, 1997, J NEURO-ONCOL, V31, P17, DOI 10.1023/A:1005768910871; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Brat DJ, 2004, NEURO-ONCOLOGY, V6, P96, DOI 10.1215/S1152851703000231; Burton EC, 2002, CANCER RES, V62, P6205; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Campbell BA, 2008, J NEURO-ONCOL, V89, P37, DOI 10.1007/s11060-008-9597-2; Dehais C, 2006, CANCER-AM CANCER SOC, V107, P1891, DOI 10.1002/cncr.22211; Fallon KB, 2004, J NEUROPATH EXP NEUR, V63, P314, DOI 10.1093/jnen/63.4.314; Ferrer-Luna R, 2011, J NEURO-ONCOL, V103, P71, DOI 10.1007/s11060-010-0369-4; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Ichimura K, 1996, ONCOGENE, V13, P1065; Ino Y, 2001, CLIN CANCER RES, V7, P839; Jeuken JWM, 2011, BRAIN PATHOL, V21, P308, DOI 10.1111/j.1750-3639.2010.00447.x; Jha P, 2010, NEUROSURGERY, V67, P1681, DOI 10.1227/NEU.0b013e3181f743f5; Kloosterhof NK, 2011, LANCET ONCOL, V12, P83, DOI 10.1016/S1470-2045(10)70053-X; Kuo LT, 2009, INT J CANCER, V124, P2872, DOI 10.1002/ijc.24303; Lass U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041298; Lavon I, 2007, CLIN CANCER RES, V13, P1429, DOI 10.1158/1078-0432.CCR-06-2050; NARAHARA K, 1985, HUM GENET, V71, P37, DOI 10.1007/BF00295665; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; PEGG AE, 1990, CANCER RES, V50, P6119; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Sasaki H, 2001, AM J PATHOL, V159, P359, DOI 10.1016/S0002-9440(10)61702-6; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Schmidt MC, 2002, J NEUROPATH EXP NEUR, V61, P321, DOI 10.1093/jnen/61.4.321; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Trost D, 2007, INT J CANCER, V120, P2368, DOI 10.1002/ijc.22574; Walker C, 2006, NEUROLOGY, V66, P1661, DOI 10.1212/01.wnl.0000218270.12495.9a; Wolter M, 2001, J NEUROPATH EXP NEUR, V60, P1170, DOI 10.1093/jnen/60.12.1170; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67139	10.1371/journal.pone.0067139	http://dx.doi.org/10.1371/journal.pone.0067139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826216	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400110
J	Spotorno, N; Cheylus, A; Van Der Henst, JB; Noveck, IA				Spotorno, Nicola; Cheylus, Anne; Van Der Henst, Jean-Baptiste; Noveck, Ira A.			What's behind a P600? Integration Operations during Irony Processing	PLOS ONE			English	Article							ERP EVIDENCE; LANGUAGE COMPREHENSION; BRAIN OSCILLATIONS; EEG ALPHA; MEMORY; DISCOURSE; SENTENCE; SYNCHRONIZATION; POTENTIALS; RETRIEVAL	The combined knowledge of word meanings and grammatical rules does not allow a listener to grasp the intended meaning of a speaker's utterance. Pragmatic inferences on the part of the listener are also required. The present work focuses on the processing of ironic utterances (imagine a slow day being described as "really productive'') because these clearly require the listener to go beyond the linguistic code. Such utterances are advantageous experimentally because they can serve as their own controls in the form of literal sentences (now imagine an active day being described as "really productive'') as we employ techniques from electrophysiology (EEG). Importantly, the results confirm previous ERP findings showing that irony processing elicits an enhancement of the P600 component (Regel et al., 2011). More original are the findings drawn from Time Frequency Analysis (TFA) and especially the increase of power in the gamma band in the 280-400 time-window, which points to an integration among different streams of information relatively early in the comprehension of an irony. This represents a departure from traditional accounts of language processing which generally view pragmatic inferences as late-arriving. We propose that these results indicate that unification operations between the linguistic code and contextual information play a critical role throughout the course of irony processing and earlier than previously thought.	[Spotorno, Nicola; Cheylus, Anne; Van Der Henst, Jean-Baptiste; Noveck, Ira A.] Univ Lyon, Lab Langage Cerveau & Cognit L2C2, Ctr Natl Rech Sci, Bron, France; [Noveck, Ira A.] CRFJ, Jerusalem, Israel	Centre National de la Recherche Scientifique (CNRS)	Spotorno, N (corresponding author), Univ Lyon, Lab Langage Cerveau & Cognit L2C2, Ctr Natl Rech Sci, Bron, France.	nicola.spotorno@isc.cnrs.fr	Cheylus, Anne/GSD-3809-2022	Cheylus, Anne/0000-0002-4243-3686	CNRS, Universite de Lyon; Centre de recherche francais a Jerusalem (CRFJ)	CNRS, Universite de Lyon(Centre National de la Recherche Scientifique (CNRS)); Centre de recherche francais a Jerusalem (CRFJ)	Work was supported by CNRS, Universite de Lyon and Centre de recherche francais a Jerusalem (CRFJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera PE, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/158970; Amenta S, 2008, NEUROPSYCHOL TRENDS, P7, DOI 10.7358/neur-2008-003-amen; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Bastiaansen M., 2012, OXFORD HDB EVENT REL, P31, DOI [10.1093/oxfordhb/9780195374148.013.0024, DOI 10.1093/OXFORDHB/9780195374148.013.0024, DOI 10.1371/journal.pone.0018993]; Bastiaansen MCM, 2008, BRAIN LANG, V106, P15, DOI 10.1016/j.bandl.2007.10.006; Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; Bianchi C., 2004, SEMANTICS PRAGMATICS; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; CLARK HH, 1984, J EXP PSYCHOL GEN, V113, P121, DOI 10.1037/0096-3445.113.1.121; Cornejo C, 2007, J PSYCHOLINGUIST RES, V36, P411, DOI 10.1007/s10936-007-9052-0; Coulson S, 2010, ITAL J LINGUIST, V22, P107; De Grauwe S, 2010, NEUROPSYCHOLOGIA, V48, P1965, DOI 10.1016/j.neuropsychologia.2010.03.017; Filik R, 2010, COGNITION, V116, P421, DOI 10.1016/j.cognition.2010.06.005; Fischler I, 2006, PROGR BRAIN RES UNDE, V156; Friederici AD, 2004, NEUROREPORT, V15, P165, DOI 10.1097/00001756-200401190-00032; Friederici AD, 2004, BRAIN RES, V1000, P72, DOI 10.1016/j.brainres.2003.10.057; Friederici AD, 2007, BRAIN RES, V1146, P50, DOI 10.1016/j.brainres.2006.08.038; Geangu E, 2012, SOCIAL COGNITIVE AFF; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; Giora R, 1997, COGN LINGUIST, V8, P183, DOI 10.1515/cogl.1997.8.3.183; Giora R., 1999, METAPHOR SYMBOL, V14, P241, DOI [10.1207/S15327868MS1404_1, DOI 10.1207/S15327868MS1404_, DOI 10.1207/S15327868MS1404_1]; Giora R, 2009, APPL COGN LINGUIST, V10, P383; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Grice P., 1989, STUDIES WAY WORDS; Grossmann T, 2008, P ROY SOC B-BIOL SCI, V275, P2803, DOI 10.1098/rspb.2008.0986; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P., 1999, NEUROCOGNITION LANGU, P273, DOI DOI 10.1093/ACPROF:OSO/9780198507932.001.0001; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Katz AN, 2004, CURR DIR PSYCHOL SCI, V13, P186, DOI 10.1111/j.0963-7214.2004.00304.x; Katz AN, 2003, DISCOURSE PROCESS, V36, P19, DOI 10.1207/S15326950DP3601_2; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1997, NEUROSCI LETT, V238, P9, DOI 10.1016/S0304-3940(97)00771-4; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch Wolfgang, 1994, STRUCTURE LONG TERM; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lattner S, 2003, NEUROSCI LETT, V339, P191, DOI 10.1016/S0304-3940(03)00027-2; Meinhardt J, 2012, NEUROIMAGE, V63, P623, DOI 10.1016/j.neuroimage.2012.07.019; Meinhardt J, 2011, DEV COGN NEUROS-NETH, V1, P67, DOI 10.1016/j.dcn.2010.08.001; Nieuwand MS, 2005, COGNITIVE BRAIN RES, V24, P691, DOI 10.1016/j.cogbrainres.2005.04.003; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; Nieuwland MS, 2010, J MEM LANG, V63, P324, DOI 10.1016/j.jml.2010.06.005; Noveck IA, 2003, BRAIN LANG, V85, P203, DOI 10.1016/S0093-934X(03)00053-1; Pexman PM, 2008, CURR DIR PSYCHOL SCI, V17, P286, DOI 10.1111/j.1467-8721.2008.00591.x; Pexman PM, 2000, DISCOURSE PROCESS, V29, P201, DOI 10.1207/S15326950dp2903_2; Pfurtscheller G., 1999, HDB ELECTROENCEPHALO, V6; Recanati F, 2004, LITERAL MEANING; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Regel S, 2010, BRAIN RES, V1311, P121, DOI 10.1016/j.brainres.2009.10.077; Sabbagh MA, 2000, PSYCHOL SCI, V11, P46, DOI 10.1111/1467-9280.00213; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Spotorno N, 2012, NEUROIMAGE, V63, P25, DOI 10.1016/j.neuroimage.2012.06.046; Sterman MB, 1996, BRAIN TOPOGR, V9, P21, DOI 10.1007/BF01191639; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tarski A., 1943, PHILOS PHENOMEN RES, V4, P341, DOI [10.2307/2102968, DOI 10.2307/2102968]; Turner K, 2005, SEMANTICS MEETS PRAG; van Berkum J. J., 2004, ANN M COGN NEUR SOC; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; van den Brink D, 2012, SOC COGN AFFECT NEUR, V7, P173, DOI 10.1093/scan/nsq094; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Varela F., 2001, NATURE REV NEUROSCIE, V2; Weiss S, 2003, NEUROKOGNITION SPRAC; Wilson D., 2012, MEANING RELEVANCE	74	72	74	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66839	10.1371/journal.pone.0066839	http://dx.doi.org/10.1371/journal.pone.0066839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826155	Green Published, gold			2022-12-27	WOS:000321738400066
J	Vasluian, E; de Jong, IGM; Janssen, WGM; Poelma, MJ; van Wijk, I; Reinders-Messelink, HA; van der Sluis, CK				Vasluian, Ecaterina; de Jong, Ingrid G. M.; Janssen, Wim G. M.; Poelma, Margriet J.; van Wijk, Iris; Reinders-Messelink, Heleen A.; van der Sluis, Corry K.			Opinions of Youngsters with Congenital Below-Elbow Deficiency, and Those of Their Parents and Professionals Concerning Prosthetic Use and Rehabilitation Treatment	PLOS ONE			English	Article							UPPER-LIMB DEFICIENCY; ONLINE FOCUS GROUPS; QUALITY-OF-LIFE; HEALTH-CARE; CHILDREN; MANAGEMENT; AMPUTEES; ADULTS; EPIDEMIOLOGY; PRESCRIPTION	Background: Youngsters with unilateral congenital below-elbow deficiency (UCBED) seem to function well with or without a prosthesis. Reasons for rejecting prostheses have been reported earlier, but unfortunately not those of the children themselves. Furthermore, reasons for acceptance are underexplored in the literature. Objectives: To investigate opinions of children and early and late adolescents with UCBED, and those of their parents and healthcare professionals, concerning (1) reasons to wear or not to wear prostheses and (2) about rehabilitation care. Methods: During one week of online focus group interviews, 42 children of 8-12 y/o, early and late adolescents of 13-16 and 17-20 y/o, 17 parents, and 19 healthcare professionals provided their opinions on various topics. This study addresses prosthetic use or non-use of prosthetics and rehabilitation care. Data were analyzed using the framework approach. Results: Cosmesis was considered to be the prime factor for choosing and wearing a prosthesis, since this was deemed especially useful in avoiding stares from others. Although participants functioned well without prostheses, they agreed that it was an adjuvant in daily-life activities and sports. Weight and limited functionality constituted rejection reasons for a prosthesis. Children and adolescents who had accepted that they were different no longer needed the prosthesis to avoid being stared at. The majority of participants highly valued the peer-to-peer contact provided by the healthcare professionals. Conclusions: For children and adolescents with UCBED, prostheses appeared particularly important for social integration, but much less so for functionality. Peer-to-peer contact seemed to provide support during the process of achieving social integration and should be embedded in the healthcare process.	[Vasluian, Ecaterina; de Jong, Ingrid G. M.; Reinders-Messelink, Heleen A.; van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Janssen, Wim G. M.] Erasmus MC, Dept Rehabil Med, Rotterdam, Netherlands; [Poelma, Margriet J.] Rehabil Ctr De Sint Maartensklin, Nijmegen, Netherlands; [van Wijk, Iris] Rehabil Ctr De Hoogstraat, Utrecht, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC; Sint Maartens Clinic	Vasluian, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.	e.golea.vasluian@umcg.nl			OIM Foundation; Beatrixoord Foundation; Orthopedietechniek De Hoogstraat Foundation; Gratama Foundation	OIM Foundation; Beatrixoord Foundation; Orthopedietechniek De Hoogstraat Foundation; Gratama Foundation	This study was financed by grants from national foundations: the OIM Foundation, Beatrixoord Foundation, Orthopedietechniek De Hoogstraat Foundation and the Gratama Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no further financial relationships relevant to this article to disclose.	Atkins DJ., 1996, J PROSTHET ORTHOT, V8, P2, DOI DOI 10.1097/00008526-199600810-00003; Biddiss E, 2007, DISABIL REHABIL-ASSI, V2, P71, DOI 10.1080/17483100601138959; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Biddiss EA, 2008, DISABIL REHABIL-ASSI, V3, P181, DOI 10.1080/17483100701869826; Buffart LM, 2007, J REHABIL MED, V39, P379, DOI 10.2340/16501977-0068; BURGER H, 1994, PROSTHET ORTHOT INT, V18, P25; CURRAN B, 1991, PROSTHET ORTHOT INT, V15, P82; Datta D, 2004, CLIN REHABIL, V18, P172, DOI 10.1191/0269215504cr716oa; Davids JR, 2006, J BONE JOINT SURG AM, V88A, P1294, DOI 10.2106/JBJS.E.00982; Davidson Judith, 2002, J Hand Ther, V15, P62, DOI 10.1016/S0894-1130(02)50011-9; de Jong IGM, 2012, J REHABIL MED, V44, P885, DOI 10.2340/16501977-1027; de Jong IGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037099; DIMDI, 2005, INT CLASS FUNCT DIS; Donkervoort M, 2009, DEV MED CHILD NEUROL, V51, P53, DOI 10.1111/j.1469-8749.2008.03115.x; Ekblom AG, 2010, J HAND SURG-AM, V35A, P1742, DOI 10.1016/j.jhsa.2010.07.007; Endacott Ruth, 2007, Accid Emerg Nurs, V15, P234; Ephraim PL, 2006, ARCH PHYS MED REHAB, V87, P328, DOI 10.1016/j.apmr.2005.11.010; Fraser CM, 1998, PROSTHET ORTHOT INT, V22, P216; Gaiser TJ, 1997, SOC SCI COMPUT REV, V15, P135, DOI 10.1177/089443939701500202; Giele H, 2001, J HAND SURG-AM, V26A, P628, DOI 10.1053/jhsu.2001.26121; Gill P, 2008, BRIT DENT J, V204, P291, DOI 10.1038/bdj.2008.192; Hadders-Algra M, 2013, EARLY HUM DEV, V89, P49, DOI 10.1016/j.earlhumdev.2012.07.011; Huizing K, 2010, PROSTHET ORTHOT INT, V34, P166, DOI 10.3109/03093640903584993; Jain S, 1996, ARCH PHYS MED REHAB, V77, pS9, DOI 10.1016/S0003-9993(96)90237-3; James MA, 2006, J BONE JOINT SURG AM, V88A, P2356, DOI 10.2106/JBJS.E.01146; Jang CH, 2011, ANN REHABIL MED-ARM, V35, P907, DOI 10.5535/arm.2011.35.6.907; Kanas JL, 2009, J PEDIATR REHAB MED, V2, P181, DOI 10.3233/PRM-2009-0082; KEJLAA GH, 1993, PROSTHET ORTHOT INT, V17, P157; Koskimies E, 2011, J HAND SURG-AM, V36A, P1058, DOI 10.1016/j.jhsa.2011.03.015; KREBS DE, 1991, PHYS THER, V71, P920, DOI 10.1093/ptj/71.12.920; Kreitner C, 1994, Rehab Manag, V7, P25; Kuyper MA, 2001, PROSTHET ORTHOT INT, V25, P228, DOI 10.1080/03093640108726606; Mathiesen AM, 2012, J GENET COUNS, V21, P862, DOI 10.1007/s10897-012-9518-6; Metzger AJ, 2012, ARCH PHYS MED REHAB, V93, P2029, DOI 10.1016/j.apmr.2012.03.011; Meurs M, 2006, PROSTHET ORTHOT INT, V30, P165, DOI 10.1080/03093640600731710; Montoya-Weiss M.M., 1998, EUR J MARKETING, V32, P713, DOI DOI 10.1108/03090569810224100; Mundhenke L, 2010, SCAND J OCCUP THER, V17, P130, DOI [10.3109/11038120903114386, 10.1080/11038120903114386]; Murray CD, 2009, DISABIL REHABIL, V31, P573, DOI 10.1080/09638280802240290; Nelson VS, 2006, ARCH PHYS MED REHAB, V87, pS3, DOI 10.1016/j.apmr.2005.11.022; Ping L.C., 2001, J EDUC ENQ, V2, P50, DOI [10.1016/j.msard.2021.103473, DOI 10.1016/J.MSARD.2021.103473]; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Pope C, 2006, QUALITATIVE RES HLTH, P153; Postema K, 1999, CLIN REHABIL, V13, P243, DOI 10.1191/026921599668801945; Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68; Ritchie S, 2011, PROSTHET ORTHOT INT, V35, P332, DOI 10.1177/0309364611420326; Romkema S, 2013, PHYS THER, V93, P22, DOI 10.2522/ptj.20120058; Saradjan A, 2008, DISABIL REHABIL, V30, P871, DOI 10.1080/09638280701427386; SCHOR EL, 1986, PEDIATRICS, V77, P834; Sheffler LC, 2009, J BONE JOINT SURG AM, V91A, P2852, DOI 10.2106/JBJS.H.01108; SILCOX DH, 1993, J BONE JOINT SURG AM, V75A, P1781, DOI 10.2106/00004623-199312000-00007; Tates K, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-15; Wagner L.V., 2007, JPO J PROSTHETICS OR, V19, P51, DOI [10.1097/JPO.0b013e3180421539, DOI 10.1097/JPO.0B013E3180421539]; Zinchiak M, 2001, ONLINE FOCUS GROUP F; Zwaanswijk Marieke, 2007, BMC Pediatr, V7, P35, DOI 10.1186/1471-2431-7-35	55	26	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67101	10.1371/journal.pone.0067101	http://dx.doi.org/10.1371/journal.pone.0067101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826203	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400104
J	Liu, M; Wang, JH; Jiang, B; Sun, DL; Wu, L; Yang, SS; Wang, YY; Li, XY; He, Y				Liu, Miao; Wang, Jianhua; Jiang, Bin; Sun, Dongling; Wu, Lei; Yang, Shanshan; Wang, Yiyan; Li, Xiaoying; He, Yao			Increasing Prevalence of Metabolic Syndrome in a Chinese Elderly Population: 2001-2010	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METAANALYSIS; RISK; TRENDS; DETERMINANTS; CHOLESTEROL; OBESITY; ADULTS; HEALTH; DIET	Objective: The information on the changes of prevalence of MetS in China is limited. Our objective was to assess a 10-year's change of the prevalence of MetS in a Chinese elderly population between 2001 and 2010. Methods: We conducted two cross-sectional surveys in a representative sample of elderly population aged 60 to 95 years in Beijing in 2001 and 2010 respectively. MetS was defined according to the 2009 harmonizing definition. Results: A total of 2,334 participants (943 male, 1,391 female) in 2001 and 2,102 participants (848 male, 1,254 female) in 2010 completed the survey. The prevalence of MetS was 50.4% (95% CI: 48.4%-52.4%) in 2001 and 58.1% (95% CI: 56.0%-60.2%) in 2010. The absolute change of prevalence of MetS was 7.7% over the 10-year's period (p<0.001). The syndrome was more common in female than male in both survey years. Among the five components, hypertriglyceridemia and low HDL-C had increased most, with an increase of 14.8% (from 29.4% to 44.2%) and 9.9% (from 28.3% to 38.2%) respectively. The adjusted ORs of MetS for CHD, stroke and CVD were 1.67(95% CI: 1.39-1.99), 1.50(95% CI: 1.19-1.88) and 1.70(95% CI: 1.43-2.01) respectively in 2001, and were 1.74(95% CI: 1.40-2.17), 1.25(95% CI: 0.95-1.63) and 1.52(95% CI: 1.25-1.86) respectively in 2010. Conclusion: The prevalence of MetS is high and increasing rapidly in this Chinese elderly population. Participants with Mets and its individual components are at significantly elevated ORs for CVD. Urgent public health actions are needed to control MetS and its components, especially for dislipidemia.	[Liu, Miao; Wang, Jianhua; Sun, Dongling; Wu, Lei; Yang, Shanshan; Wang, Yiyan; He, Yao] Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing, Peoples R China; [Liu, Miao; Wang, Jianhua; Wu, Lei; Yang, Shanshan; Wang, Yiyan; He, Yao] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Aging & Geriatr, Beijing, Peoples R China; [Jiang, Bin] Chinese Peoples Liberat Army Gen Hosp, Dept Chinese Tradit Med & Acupuncture, Beijing, Peoples R China; [Li, Xiaoying] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	He, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing, Peoples R China.	yhe301@sina.com	刘, 淼/X-1216-2019	Liu, Miao/0000-0002-7975-6702; He, Yao/0000-0001-6205-7895	National Natural Science Foundation of China [81072355]; Beijing Municipal Science and Technology Commission [D121100004912003]; National Public Benefit Research Foundation by the Ministry of Health of China [201002011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Public Benefit Research Foundation by the Ministry of Health of China	This study is supported by research grants from the National Natural Science Foundation of China (81072355), Beijing Municipal Science and Technology Commission (D121100004912003) and National Public Benefit Research Foundation by the Ministry of Health of China (201002011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Cai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036936; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hu G, 2008, J CLIN ENDOCR METAB, V93, P832, DOI 10.1210/jc.2007-1883; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lorenzo C, 2005, DIABETES CARE, V28, P2480, DOI 10.2337/diacare.28.10.2480; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Villegas R, 2009, METAB SYNDR RELAT D, V7, P37, DOI 10.1089/met.2008.0042; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wu ZS, 2001, CIRCULATION, V103, P462; Zhao J, 2011, J ENDOCRINOL INVEST, V34, P444, DOI [10.1007/BF03346711, 10.3275/7482]	21	52	60	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66233	10.1371/journal.pone.0066233	http://dx.doi.org/10.1371/journal.pone.0066233			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824753	gold, Green Published			2022-12-27	WOS:000320576400070
J	Ordonez, C; Moreno-Murciano, P; Hernandez, M; Di Caudo, C; Carril-Mundinano, I; Vazquez, N; Garcia-Verdugo, JM; Sanchez-Pernaute, R; Luquin, MR				Ordonez, Cristina; Moreno-Murciano, Paz; Hernandez, Maria; Di Caudo, Carla; Carril-Mundinano, Inaki; Vazquez, Nerea; Manuel Garcia-Verdugo, Jose; Sanchez-Pernaute, Rosario; Luquin, Maria-Rosario			Sox-2 Positive Neural Progenitors in the Primate Striatum Undergo Dynamic Changes after Dopamine Denervation	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; NEWLY GENERATED NEURONS; MAMMALIAN SPINAL-CORD; SUBVENTRICULAR ZONE; STEM-CELLS; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; EXPRESSION DEFINES; ADULT HIPPOCAMPUS; NEUROGENESIS	existence of endogenous neural progenitors in the nigrostriatal system could represent a powerful tool for restorative therapies in Parkinson's disease. Sox-2 is a transcription factor expressed in pluripotent and adult stem cells, including neural progenitors. In the adult brain Sox-2 is expressed in the neurogenic niches. There is also widespread expression of Sox-2 in other brain regions, although the neurogenic potential outside the niches is uncertain. Here, we analyzed the presence of Sox-2(+) cells in the adult primate (Macaca fascicularis) brain in naive animals (N = 3) and in animals exposed to systemic administration of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine to render them parkinsonian (N = 8). Animals received bromodeoxyuridine (100 mg/kg once a day during five consecutive days) to label proliferating cells and their progeny. Using confocal and electron microscopy we analyzed the Sox-2(+) cell population in the nigrostriatal system and investigated changes in the number, proliferation and neurogenic potential of Sox-2(+) cells, in control conditions and at two time points after MPTP administration. We found Sox-2(+) cells with self-renewal capacity in both the striatum and the substantia nigra. Importantly, only in the striatum Sox-2(+) was expressed in some calretinin(+) neurons. MPTP administration led to an increase in the proliferation of striatal Sox-2(+) cells and to an acute, concomitant decrease in the percentage of Sox-2(+)/calretinin(+) neurons, which recovered by 18 months. Given their potential capacity to differentiate into neurons and their responsiveness to dopamine neurotoxic insults, striatal Sox-2(+) cells represent good candidates to harness endogenous repair mechanisms for regenerative approaches in Parkinson's disease.	[Ordonez, Cristina; Hernandez, Maria; Di Caudo, Carla; Carril-Mundinano, Inaki; Luquin, Maria-Rosario] Univ Navarra Clin, Ctr Invest Med Aplicada, Div Neurosci, Lab Regenerat Therapy, Pamplona, Spain; [Ordonez, Cristina; Moreno-Murciano, Paz; Hernandez, Maria; Di Caudo, Carla; Carril-Mundinano, Inaki; Luquin, Maria-Rosario] Univ Navarra Clin, Dept Neurol, Pamplona, Spain; [Moreno-Murciano, Paz] CIBERNED, Ctr Invest Principe Felipe, Lab Cellular Morphol, Valencia, Spain; [Vazquez, Nerea; Sanchez-Pernaute, Rosario] Fdn Inbiomed, Lab Stem Cells & Neural Repair, San Sebastian, Spain; [Manuel Garcia-Verdugo, Jose] Univ Valencia, CIBERNED, Inst Cavanilles, Lab Comparat Neurobiol, Paterna, Spain	University of Navarra; University of Navarra; CIBERNED; Prince Felipe Research Center; CIBERNED; University of Valencia	Sanchez-Pernaute, R (corresponding author), Fdn Inbiomed, Lab Stem Cells & Neural Repair, San Sebastian, Spain.	rpernaute@inbiomed.org; rluquin@unav.es	Luquin, M R/T-5546-2017; Sanchez-Pernaute, Rosario/ABD-8661-2021; Moreno-Murciano, Paz/D-7871-2018; Sanchez-Pernaute, Rosario/AAZ-9566-2021; García-Verdugo, José Manuel/L-8421-2017	Luquin, M R/0000-0002-5594-1794; Sanchez-Pernaute, Rosario/0000-0003-1144-9025; García-Verdugo, José Manuel/0000-0001-9872-6499; Mundinano, Inaki-Carril/0000-0003-1063-7550	Foundation Kutxa Obra; UTE-project/Foundation for Applied Medical Research (F.I.M.A.); Spanish Ministry of Science and Innovation; European Social Fund	Foundation Kutxa Obra; UTE-project/Foundation for Applied Medical Research (F.I.M.A.); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Social Fund(European Social Fund (ESF))	This study was supported by funding from Foundation Kutxa Obra social to RSP for a collaborative network to advance translational stem cell research for neurodegenerative disorders (Inbiomed, CIMA, UV), PD research network and by the UTE-project/Foundation for Applied Medical Research (F.I.M.A.) to MRL. CO and I-CM were supported by a Torres Quevedo grant awarded by the Spanish Ministry of Science and Innovation, and by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2011, NEUROBIOL AGING, V32, P140, DOI 10.1016/j.neurobiolaging.2008.12.011; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bankiewicz KS, 2001, CURR PROTOC NEUROSCI; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Betarbet R, 1997, J NEUROSCI, V17, P6761; Bihel E, 2010, J CEREBR BLOOD F MET, V30, P273, DOI 10.1038/jcbfm.2009.209; Bjorklund A, 2010, PROG BRAIN RES, V184, P265, DOI 10.1016/S0079-6123(10)84014-2; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Coronas V, 2004, J NEUROCHEM, V91, P1292, DOI 10.1111/j.1471-4159.2004.02823.x; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Ganz J, 2011, EXPERT REV NEUROTHER, V11, P1325, DOI [10.1586/ERN.11.74, 10.1586/ern.11.74]; Goritz C, 2012, CELL STEM CELL, V10, P657, DOI 10.1016/j.stem.2012.04.005; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; Jiang M, 1997, NEUROSCIENCE, V81, P1137, DOI 10.1016/S0306-4522(97)00231-5; Kato T, 1999, NEUROREPORT, V10, P2769, DOI 10.1097/00001756-199909090-00013; Kay JN, 2000, DEV NEUROSCI-BASEL, V22, P56, DOI 10.1159/000017427; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Komitova M, 2005, EUR J NEUROSCI, V21, P2397, DOI 10.1111/j.1460-9568.2005.04072.x; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Lie DC, 2002, J NEUROSCI, V22, P6639; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Luzzati F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025088; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mao LM, 2001, DEV BRAIN RES, V131, P57, DOI 10.1016/S0165-3806(01)00260-7; Martin RF, 1996, NEUROIMAGE, V4, P119, DOI 10.1006/nimg.1996.0036; Merlo S, 2011, NEUROPHARMACOLOGY, V60, P892, DOI 10.1016/j.neuropharm.2011.01.026; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Ngwenya LB, 2006, J COMP NEUROL, V498, P204, DOI 10.1002/cne.21045; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parent A, 1996, NEUROSCI RES, V25, P309; Politis M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-80; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sirerol-Piquer MS, 2012, MICRON, V43, P589, DOI 10.1016/j.micron.2011.10.008; San Sebastian W, 2007, BRAIN, V130, P1306, DOI 10.1093/brain/awm061; Shi SR, 2006, J HISTOCHEM CYTOCHEM, V54, P739, DOI 10.1369/jhc.5B6851.2006; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tande D, 2006, BRAIN, V129, P1194, DOI 10.1093/brain/awl041; Tonchev AB, 2006, NEUROSCIENCE, V139, P1355, DOI 10.1016/j.neuroscience.2006.01.053; Ulfig N, 2002, ADV ANAT EMBRYOL CEL, V165, P1; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Weiss S, 1996, J NEUROSCI, V16, P7599; Yang ZG, 2008, J COMP NEUROL, V511, P19, DOI 10.1002/cne.21819; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	61	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66377	10.1371/journal.pone.0066377	http://dx.doi.org/10.1371/journal.pone.0066377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824751	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400097
J	Tian, LX; Kong, YZ; Ren, JJ; Varoquaux, G; Zang, YF; Smith, SM				Tian, Lixia; Kong, Yazhuo; Ren, Juejing; Varoquaux, Gael; Zang, Yufeng; Smith, Stephen M.			Spatial vs. Temporal Features in ICA of Resting-State fMRI - A Quantitative and Qualitative Investigation in the Context of Response Inhibition	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL-CONNECTIVITY; HUMAN BRAIN; ALZHEIMERS-DISEASE; CINGULATE CORTEX; MOTOR CORTEX; SIGNAL; STOP; ATTENTION	Independent component analysis (ICA) can identify covarying functional networks in the resting brain. Despite its relatively widespread use, the potential of the temporal information (unlike spatial information) obtained by ICA from resting state fMRI (RS-fMRI) data is not always fully utilized. In this study, we systematically investigated which features in ICA of resting-state fMRI relate to behaviour, with stop signal reaction time (SSRT) in a stop-signal task taken as a test case. We did this by correlating SSRT with the following three kinds of measure obtained from RS-fMRI data: (1) the amplitude of each resting state network (RSN) (evaluated by the standard deviation of the RSN timeseries), (2) the temporal correlation between every pair of RSN timeseries, and (3) the spatial map of each RSN. For multiple networks, we found significant correlations not only between SSRT and spatial maps, but also between SSRT and network activity amplitude. Most of these correlations are of functional interpretability. The temporal correlations between RSN pairs were of functional significance, but these correlations did not appear to be very sensitive to finding SSRT correlations. In addition, we also investigated the effects of the decomposition dimension, spatial smoothing and Z-transformation of the spatial maps, as well as the techniques for evaluating the temporal correlation between RSN timeseries. Overall, the temporal information acquired by ICA enabled us to investigate brain function from a complementary perspective to the information provided by spatial maps.	[Tian, Lixia] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Dept Biomed Engn, Beijing, Peoples R China; [Tian, Lixia; Kong, Yazhuo; Smith, Stephen M.] Univ Oxford, Nuffield Dept Clin Neurosci, FMRIB, Ctr Funct MRI Brain, Oxford, England; [Ren, Juejing] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Varoquaux, Gael] INRIA Saclay Ile de France, Parietal Team, Saclay, France; [Zang, Yufeng] Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China	Beijing Jiaotong University; University of Oxford; Beijing Normal University; Hangzhou Normal University	Tian, LX (corresponding author), Beijing Jiaotong Univ, Sch Comp & Informat Technol, Dept Biomed Engn, Beijing, Peoples R China.	tian.bme@gmail.com	ZANG, Yu-Feng/J-1558-2012	ZANG, Yu-Feng/0000-0003-1833-8010; Varoquaux, Gael/0000-0003-1076-5122; Smith, Stephen/0000-0001-8166-069X; Tian, Lixia/0000-0002-8952-5158	National Natural Science Foundation of China [30800249, 61272356]; Beijing Natural Science Foundation [3123040]; Fundamental Research Funds for the Central Universities [2011JBM021, 2011JBM220, 2013JBZ003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 30800249, 61272356), the Beijing Natural Science Foundation (Grant No. 3123040), and the Fundamental Research Funds for the Central Universities (Grant No. 2011JBM021, 2011JBM220, 2013JBZ003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Banerjee O., 2006, P 23 INT C MACH LEAR, P96; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/s1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3]; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dawson DA, 2013, NEUROIMAGE, V67, P331, DOI 10.1016/j.neuroimage.2012.11.006; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim MJ, 2011, CEREB CORTEX, V21, P1667, DOI 10.1093/cercor/bhq237; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Li R, 2012, HUM BRAIN MAPP, V33, P1076, DOI 10.1002/hbm.21269; Littow H, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00032; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKeown MJ, 2003, CURR OPIN NEUROBIOL, V13, P620, DOI 10.1016/j.conb.2003.09.012; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Varoquaux G, 2010, LECT NOTES COMPUT SC, V6361, P200; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wu CWW, 2011, BRAIN CONNECT, V1, P401, DOI 10.1089/brain.2011.0018; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	61	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66572	10.1371/journal.pone.0066572	http://dx.doi.org/10.1371/journal.pone.0066572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825545	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400132
J	Wong, SZH; Ching, BY; Chng, YR; Wong, WP; Chew, SF; Ip, YK				Wong, Samuel Z. H.; Ching, Biyun; Chng, You R.; Wong, Wai P.; Chew, Shit F.; Ip, Yuen K.			Ascorbic Acid Biosynthesis and Brackish Water Acclimation in the Euryhaline Freshwater White-Rimmed Stingray, Himantura signifer	PLOS ONE			English	Article							GAMMA-LACTONE OXIDASE; L-GULONOLACTONE-OXIDASE; DIETARY VITAMIN-C; KEY ENZYME; BIOLOGICAL SYNTHESIS; ANIMAL-TISSUES; GLUTATHIONE; FISH; STRESS; EXPRESSION	L-gulono-gamma-lactone oxidase (Gulo) catalyzes the last step of ascorbic acid biosynthesis, which occurs in the kidney of elasmobranchs. This study aimed to clone and sequence gulonolactone oxidase (gulo) from the kidney of the euryhaline freshwater stingray, Himantura signifer, and to determine the effects of acclimation from freshwater to brackish water (salinity 20) on its renal gulo mRNA expression and Gulo activity. We also examined the effects of brackish water acclimation on concentrations of ascorbate, dehydroascorbate and ascorbate + dehydroascorbate in the kidney, brain and gill. The complete cDNA coding sequence of gulo from the kidney of H. signifer contained 1323 bp coding for 440 amino acids. The expression of gulo was kidney-specific, and renal gulo expression decreased significantly by 67% and 50% in fish acclimated to brackish water for 1 day and 6 days, respectively. There was also a significant decrease in renal Gulo activity after 6 days of acclimation to brackish water. Hence, brackish water acclimation led to a decrease in the ascorbic acid synthetic capacity in the kidney of H. signifer. However, there were significant increases in concentrations of ascorbate and ascorbate + dehydroascorbate in the gills (after 1 or 6 days), and a significant increase in the concentration of ascorbate and a significant decrease in the concentration of dehydroascorbate in the brain (after 1 day) of fish acclimated to brackish water. Taken together, our results indicate that H. signifer might experience greater salinity-induced oxidative stress in freshwater than in brackish water, possibly related to its short history of freshwater invasion. These results also suggest for the first time a possible relationship between the successful invasion of the freshwater environment by some euryhaline marine elasmobranchs and the ability of these elasmobranchs to increase the capacity of ascorbic acid synthesis in response to hyposalinity stress.	[Wong, Samuel Z. H.; Ching, Biyun; Chng, You R.; Wong, Wai P.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsipyk@nus.edu.sg	Chew, Shit Fun/I-2248-2012; Ip, Yuen Kwong/H-8041-2012	Chew, Shit Fun/0000-0003-4599-5817; Ip, Yuen Kwong/0000-0001-9124-7911	Singapore Ministry of Education [R154-000-470-112]; Singapore Ministry of Defence [R-347-000-188-232]	Singapore Ministry of Education(Ministry of Education, Singapore); Singapore Ministry of Defence(Ministry of Defence, Singapore)	This study was supported in part by the Singapore Ministry of Education through grant R154-000-470-112 and the Singapore Ministry of Defence through grant R-347-000-188-232 to Y. K. Ip. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 1997, J CLIN INVEST, V100, P2842, DOI 10.1172/JCI119832; Ballantyne JS, 2010, J COMP PHYSIOL B, V180, P475, DOI 10.1007/s00360-010-0447-0; BISBY RH, 1995, ARCH BIOCHEM BIOPHYS, V317, P170, DOI 10.1006/abbi.1995.1150; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BODANNES RS, 1979, FEBS LETT, V105, P195, DOI 10.1016/0014-5793(79)80609-2; Braun L, 1999, FEBS LETT, V463, P345, DOI 10.1016/S0014-5793(99)01649-X; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; CHATTERJEE IB, 1960, BIOCHEM J, V74, P193, DOI 10.1042/bj0740193; CHATTERJEE IB, 1960, BIOCHEM J, V76, P279, DOI 10.1042/bj0760279; Chew SF, 2006, J EXP BIOL, V209, P484, DOI 10.1242/jeb.02002; Ching BY, 2009, AQUAT TOXICOL, V95, P203, DOI 10.1016/j.aquatox.2009.09.004; Cho YS, 2007, COMP BIOCHEM PHYS B, V147, P178, DOI 10.1016/j.cbpb.2007.01.001; Choi CY, 2008, COMP BIOCHEM PHYS A, V149, P330, DOI 10.1016/j.cbpa.2008.01.013; COHEN G, 1994, ANN NY ACAD SCI, V738, P8; DABROWSKA H, 1990, MAGNESIUM TRACE ELEM, V9, P101; DABROWSKI K, 1990, BIOL CHEM H-S, V371, P207, DOI 10.1515/bchm3.1990.371.1.207; DABROWSKI K, 1990, J COMP PHYSIOL B, V160, P549; DAVIES MB, 1991, VITAMIN C ITS CHEM B, V154; Drouin G, 2011, CURR GENOMICS, V12, P371, DOI 10.2174/138920211796429736; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fornai F, 1999, NEUROSCIENCE, V94, P937, DOI 10.1016/S0306-4522(99)00349-8; Fracalossi DM, 2001, AQUACULTURE, V192, P321, DOI 10.1016/S0044-8486(00)00455-5; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Gong X, 2011, FISHERIES SCI, V77, P547, DOI 10.1007/s12562-011-0370-7; GUPTA R, 2001, THESIS TU DENMARK; Gupta R., 2003, PAC S BIOCOMPUT, V7, P310; Gupta R, 2004, PREDICTION N GLYCOSY; Ha MN, 2004, GENOMICS, V83, P482, DOI 10.1016/j.ygeno.2003.08.018; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HORIO F, 1993, J NUTR, V123, P2075; Horio F, 1997, BIOSCI BIOTECH BIOCH, V61, P109, DOI 10.1271/bbb.61.109; Jenner AM, 2002, ARTERIOSCL THROM VAS, V22, P574, DOI 10.1161/01.ATV.0000013785.03265.5C; KIUCHI K, 1982, BIOCHEMISTRY-US, V21, P5076, DOI 10.1021/bi00263a035; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; KOSHIZAKA T, 1988, J BIOL CHEM, V263, P1619; Liu Y, 2007, AQUACULTURE, V265, P351, DOI 10.1016/j.aquaculture.2007.02.010; Lushchak VI, 2005, INT J BIOCHEM CELL B, V37, P1670, DOI 10.1016/j.biocel.2005.02.024; MACHLIN LJ, 1987, FASEB J, V1, P441, DOI 10.1096/fasebj.1.6.3315807; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Martinez-Alvarez RM, 2002, J EXP BIOL, V205, P3699; MEISTER A, 1994, J BIOL CHEM, V269, P9397; Moreau R, 1999, AQUACULTURE, V180, P359, DOI 10.1016/S0044-8486(99)00211-2; Moreau R, 2003, FREE RADICAL BIO MED, V34, P1326, DOI 10.1016/S0891-5849(03)00148-5; Nam YK, 2002, AQUACULTURE, V209, P271, DOI 10.1016/S0044-8486(01)00731-1; Nandi A, 1997, FREE RADICAL BIO MED, V22, P1047, DOI 10.1016/S0891-5849(96)00491-1; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; NISHIKIMI M, 1975, BIOCHEM BIOPH RES CO, V63, P463, DOI 10.1016/0006-291X(75)90710-X; NISHIKIMI M, 1991, AM J CLIN NUTR, V54, pS1203, DOI 10.1093/ajcn/54.6.1203s; OTAKE T, 1999, REPORT STUDIES ADAPT, P79; Otake Tsuguo, 2005, Coastal Marine Science, V29, P147; Paital B, 2010, COMP BIOCHEM PHYS C, V151, P142, DOI 10.1016/j.cbpc.2009.09.007; Papp G, 1999, J APPL ICHTHYOL, V15, P258; Ramos-Vasconcelos GR, 2003, J EXP BIOL, V206, P675, DOI 10.1242/jeb.00124; Ren T, 2005, J WORLD AQUACULT SOC, V36, P437, DOI 10.1111/j.1749-7345.2005.tb00391.x; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Roche H, 1996, MAR ENVIRON RES, V41, P27, DOI 10.1016/0141-1136(95)00015-1; ROSE RC, 1993, BRAIN RES, V628, P49, DOI 10.1016/0006-8993(93)90936-H; Sarma K, 2013, AQUACULT INT, V21, P183, DOI 10.1007/s10499-012-9544-2; SATO P, 1976, BIOCHEM BIOPH RES CO, V71, P293, DOI 10.1016/0006-291X(76)90281-3; Sezaki K, 1999, FISHERIES SCI, V65, P563, DOI 10.2331/fishsci.65.563; Tam WL, 2003, J EXP BIOL, V206, P2931, DOI 10.1242/jeb.00510; TSAO CS, 1989, LIFE SCI, V45, P1553, DOI 10.1016/0024-3205(89)90421-9; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Wang XJ, 2003, AQUACULTURE, V215, P203, DOI 10.1016/S0044-8486(02)00042-X; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; Zhou XQ, 2005, AQUACULT NUTR, V11, P169, DOI 10.1111/j.1365-2095.2005.00343.x; Zhou XQ, 2003, COMP BIOCHEM PHYS A, V135, P263, DOI 10.1016/S1095-6433(03)00066-7	71	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66691	10.1371/journal.pone.0066691	http://dx.doi.org/10.1371/journal.pone.0066691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825042	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400149
J	Xu, B; Chotewutmontri, S; Wolf, S; Klos, U; Schmitz, M; Durst, M; Schwarz, E				Xu, Bo; Chotewutmontri, Sasithorn; Wolf, Stephan; Klos, Ursula; Schmitz, Martina; Duerst, Matthias; Schwarz, Elisabeth			Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas	PLOS ONE			English	Article							CELLULAR FUSION TRANSCRIPTS; VIRAL INTEGRATION; TYPE-16 DNA; INTRAEPITHELIAL NEOPLASIA; READ ALIGNMENT; E6 VARIANTS; MYC LOCUS; E2 GENE; CANCER; SEQUENCES	Cervical cancer is caused by high-risk human papillomaviruses (HPV), in more than half of the worldwide cases by HPV16. Viral DNA integration into the host genome is a frequent mutation in cervical carcinogenesis. Because integration occurs into different genomic locations, it creates unique viral-cellular DNA junctions in every single case. This singularity complicates the precise identification of HPV integration sites enormously. We report here the development of a novel multiplex strategy for sequence determination of HPV16 DNA integration sites. It includes DNA fragmentation and adapter tagging, PCR enrichment of the HPV16 early region, Illumina next-generation sequencing, data processing, and validation of candidate integration sites by junction-PCR. This strategy was performed with 51 cervical cancer samples (47 primary tumors and 4 cell lines). Altogether 75 HPV16 integration sites (3'-junctions) were identified and assigned to the individual samples. By comparing the DNA junctions with the presence of viral oncogene fusion transcripts, 44 tumors could be classified into four groups: Tumors with one transcriptionally active HPV16 integrate (n = 12), tumors with transcribed and silent DNA junctions (n = 8), tumors carrying episomal HPV16 DNA (n = 10), and tumors with one to six DNA junctions, but without fusion transcripts (n = 14). The 39-breakpoints of integrated HPV16 DNA show a statistically significant (p<0.05) preferential distribution within the early region segment upstream of the major splice acceptor underscoring the importance of deregulated viral oncogene expression for carcinogenesis. Half of the mapped HPV16 integration sites target cellular genes pointing to a direct influence of HPV integration on host genes (insertional mutagenesis). In summary, the multiplex strategy for HPV16 integration site determination worked very efficiently. It will open new avenues for comprehensive mapping of HPV integration sites and for the possible use of HPV integration sites as individualized biomarkers after cancer treatment of patients for the early diagnosis of residual and recurrent disease.	[Xu, Bo; Chotewutmontri, Sasithorn; Klos, Ursula; Schwarz, Elisabeth] DKFZ, Res Program Infect & Canc, Heidelberg, Germany; [Wolf, Stephan] DKFZ, Genom & Prote Core Facil, Heidelberg, Germany; [Schmitz, Martina; Duerst, Matthias] Jena Univ Hosp, Dept Gynecol, Jena, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Friedrich Schiller University of Jena	Schwarz, E (corresponding author), DKFZ, Res Program Infect & Canc, Heidelberg, Germany.	e.schwarz@dkfz.de			BMBF/HGF-Canceropole Grand-Est (BMBF) [01KX0908]; Deutsche Forschungsgemeinschaft [DR780/3-1]	BMBF/HGF-Canceropole Grand-Est (BMBF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from BMBF/HGF-Canceropole Grand-Est (BMBF grant number 01KX0908; www.bmbf.de) granted to ES, and in part by funds of the Deutsche Forschungsgemeinschaft (DR780/3-1; www dfg.de) granted to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Badaracco G, 2002, J MED VIROL, V67, P574, DOI 10.1002/jmv.10141; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; Bechtold V, 2003, J VIROL, V77, P2021, DOI 10.1128/JVI.77.3.2021-2028.2003; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Campitelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043393; Caruccio N, 2011, METHODS MOL BIOL, V733, P241, DOI 10.1007/978-1-61779-089-8_17; Casas L, 1999, INT J CANCER, V83, P449, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt;449::AID-IJC3&gt;3.0.CO;2-0; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Corden SA, 1999, J CLIN PATHOL-MOL PA, V52, P275, DOI 10.1136/mp.52.5.275; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; COUTURIER J, 1991, J VIROL, V65, P4534, DOI 10.1128/JVI.65.8.4534-4538.1991; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DURST M, 1987, P NATL ACAD SCI USA, V84, P1070, DOI 10.1073/pnas.84.4.1070; Einstein MH, 2002, CLIN CANCER RES, V8, P549; ELAWADY MK, 1987, VIROLOGY, V159, P389, DOI 10.1016/0042-6822(87)90478-8; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Ferber MJ, 2003, ONCOGENE, V22, P3813, DOI 10.1038/sj.onc.1206528; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gadducci A, 2013, CRIT REV ONCOL HEMAT, V86, P104, DOI 10.1016/j.critrevonc.2012.09.003; Gray E, 2010, CANCER RES, V70, P4081, DOI 10.1158/0008-5472.CAN-09-3335; Grodzki M, 2006, CANCER EPIDEM BIOMAR, V15, P820, DOI 10.1158/1055-9965.EPI-05-0864; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Kalantari M, 2001, DIAGN MOL PATHOL, V10, P46, DOI 10.1097/00019606-200103000-00008; Klaes R, 1999, CANCER RES, V59, P6132; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; MINCHEVA A, 1987, MED MICROBIOL IMMUN, V176, P245, DOI 10.1007/bf00190531; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; POPESCU NC, 1989, CANCER GENET CYTOGEN, V42, P157, DOI 10.1016/0165-4608(89)90084-8; Reuter S, 1998, EMBO J, V17, P215, DOI 10.1093/emboj/17.1.215; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; SMITS HL, 1991, VIROLOGY, V182, P870, DOI 10.1016/0042-6822(91)90632-L; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Swan DC, 2005, GYNECOL ONCOL, V96, P695, DOI 10.1016/j.ygyno.2004.11.045; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Thorland EC, 2000, CANCER RES, V60, P5916; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Vernon SD, 1997, INT J CANCER, V74, P50, DOI 10.1002/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.3.CO;2-P; WAGATSUMA M, 1990, J VIROL, V64, P813, DOI 10.1128/JVI.64.2.813-821.1990; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; YEE C, 1985, AM J PATHOL, V119, P361; Yu TX, 2005, CANCER GENET CYTOGEN, V158, P27, DOI 10.1016/j.cancergencyto.2004.08.021; Zehbe I, 1998, CANCER RES, V58, P829; Zhao X, 2012, NUCLEIC ACIDS RES, V40, pD1041, DOI 10.1093/nar/gkr1142; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629	76	80	85	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66693	10.1371/journal.pone.0066693	http://dx.doi.org/10.1371/journal.pone.0066693			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824673	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400150
J	Doyle, SR; Kasinadhuni, NRP; Chan, CK; Grant, WN				Doyle, Stephen R.; Kasinadhuni, Naga R. P.; Chan, Chee Kai; Grant, Warwick N.			Evidence of Evolutionary Constraints That Influences the Sequence Composition and Diversity of Mitochondrial Matrix Targeting Signals	PLOS ONE			English	Article							PROTEIN-IMPORT; PRECURSOR PROTEINS; PREPROTEIN IMPORT; INNER MEMBRANE; PRESEQUENCE; IDENTIFICATION; TRANSLOCATION; PREDICTION; PEPTIDES; CLEAVAGE	Mitochondrial targeting signals (MTSs) are responsible for trafficking nuclear encoded proteins to their final destination within mitochondria. These sequences are diverse, sharing little amino acid homology and vary significantly in length, and although the formation of a positively-charged amphiphilic alpha helix within the MTS is considered to be necessary and sufficient to mediate import, such a feature does not explain their diversity, nor how such diversity influences target sequence function, nor how such dissimilar signals interact with a single, evolutionarily conserved import mechanism. An in silico analysis of 296 N-terminal, matrix destined MTSs from Homo sapiens, Mus musculus, Saccharomyces cerevisiae, Arabidopsis thaliana, and Oryza sativa was undertaken to investigate relationships between MTSs, and/or, relationships between an individual targeting signal sequence and the protein that it imports. We present evidence that suggests MTS diversity is influenced in part by physiochemical and N-terminal characteristics of their mature sequences, and that some of these correlated characteristics are evolutionarily maintained across a number of taxa. Importantly, some of these associations begin to explain the variation in MTS length and composition.	[Doyle, Stephen R.; Kasinadhuni, Naga R. P.; Chan, Chee Kai; Grant, Warwick N.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	La Trobe University	Doyle, SR (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia.	s.doyle@latrobe.edu.au	Grant, Warwick/AAF-5854-2020; Doyle, Stephen/GRJ-3949-2022; Doyle, Stephen/AAS-8224-2021	Grant, Warwick/0000-0002-1187-5270; Doyle, Stephen/0000-0001-9167-7532; Doyle, Stephen/0000-0001-9167-7532; Kasinadhuni, Naga/0000-0001-6924-1476	La Trobe University	La Trobe University	SRD was supported by an Early Career Development Fellowship from La Trobe University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Braun HP, 1999, PLANTA, V209, P267, DOI 10.1007/s004250050632; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; Emanuelsson O, 2001, METHOD CELL BIOL, V65, P175, DOI 10.1016/S0091-679X(01)65011-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Geissler A, 2001, MOL CELL BIOL, V21, P7097, DOI 10.1128/MCB.21.20.7097-7104.2001; Gonzalez-Halphen D, 2004, ANN NY ACAD SCI, V1019, P232, DOI 10.1196/annals.1297.039; Hammen PK, 2000, FEBS LETT, V468, P101, DOI 10.1016/S0014-5793(00)01160-1; HARTMANN C, 1991, NATURE, V352, P762, DOI 10.1038/352762b0; HARTMANN CM, 1991, BIOCHEM BIOPH RES CO, V174, P1232, DOI 10.1016/0006-291X(91)91553-O; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; Huang SB, 2009, PLANT PHYSIOL, V150, P1272, DOI 10.1104/pp.109.137885; Krayl M, 2007, MOL CELL BIOL, V27, P411, DOI 10.1128/MCB.01391-06; Lim JH, 2001, EMBO J, V20, P941, DOI 10.1093/emboj/20.5.941; Lister R, 2006, CURR BIOL, V16, pR197, DOI 10.1016/j.cub.2006.02.024; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; MARTIN J, 1991, J BIOL CHEM, V266, P18051; Matouschek A, 2003, CURR OPIN STRUC BIOL, V13, P98, DOI 10.1016/S0959-440X(03)00010-1; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Meier S, 2005, J BIOL CHEM, V280, P7777, DOI 10.1074/jbc.M412158200; Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021; Muto T, 2001, J MOL BIOL, V306, P137, DOI 10.1006/jmbi.2000.4397; Perry AJ, 2006, CURR BIOL, V16, P221, DOI 10.1016/j.cub.2005.12.034; Peterson EL, 2009, BIOINFORMATICS, V25, P1356, DOI 10.1093/bioinformatics/btp164; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Schleiff E, 1999, FEBS LETT, V461, P9, DOI 10.1016/S0014-5793(99)01415-5; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schneider G, 1998, PROTEINS, V30, P49, DOI 10.1002/(SICI)1097-0134(19980101)30:1<49::AID-PROT5>3.3.CO;2-P; Schwartz MP, 1999, J BIOL CHEM, V274, P12759, DOI 10.1074/jbc.274.18.12759; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; VERNER K, 1989, EMBO J, V8, P1491, DOI 10.1002/j.1460-2075.1989.tb03533.x; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Waltner M, 1996, J BIOL CHEM, V271, P21226, DOI 10.1074/jbc.271.35.21226; Werhahn W, 2003, PLANT PHYSIOL BIOCH, V41, P407, DOI 10.1016/S0981-9428(03)00047-0; Werhahn W, 2001, PLANT PHYSIOL, V125, P943, DOI 10.1104/pp.125.2.943; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Yano M, 2000, MOL CELL BIOL, V20, P7205, DOI 10.1128/MCB.20.19.7205-7213.2000	50	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67938	10.1371/journal.pone.0067938	http://dx.doi.org/10.1371/journal.pone.0067938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825690	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000124
J	Wang, R; Hsu, HK; Blattler, A; Wang, YS; Lan, X; Wang, Y; Hsu, PY; Leu, YW; Huang, THM; Farnham, PJ; Jin, VX				Wang, Rui; Hsu, Hang-Kai; Blattler, Adam; Wang, Yisong; Lan, Xun; Wang, Yao; Hsu, Pei-Yin; Leu, Yu-Wei; Huang, Tim H. -M.; Farnham, Peggy J.; Jin, Victor X.			LOcating Non-Unique matched Tags (LONUT) to Improve the Detection of the Enriched Regions for ChIP-seq Data	PLOS ONE			English	Article							WEB APPLICATION TOOL; DNA BINDING-SITES; BREAST-CANCER; HUMAN GENOME; RNA-SEQ; HI-C; IDENTIFICATION; REVEALS; ALPHA; MODEL	One big limitation of computational tools for analyzing ChIP-seq data is that most of them ignore non-unique tags (NUTs) that match the human genome even though NUTs comprise up to 60% of all raw tags in ChIP-seq data. Effectively utilizing these NUTs would increase the sequencing depth and allow a more accurate detection of enriched binding sites, which in turn could lead to more precise and significant biological interpretations. In this study, we have developed a computational tool, LOcating Non-Unique matched Tags (LONUT), to improve the detection of enriched regions from ChIP-seq data. Our LONUT algorithm applies a linear and polynomial regression model to establish an empirical score (ES) formula by considering two influential factors, the distance of NUTs to peaks identified using uniquely matched tags (UMTs) and the enrichment score for those peaks resulting in each NUT being assigned to a unique location on the reference genome. The newly located tags from the set of NUTs are combined with the original UMTs to produce a final set of combined matched tags (CMTs). LONUT was tested on many different datasets representing three different characteristics of biological data types. The detected sites were validated using de novo motif discovery and ChIP-PCR. We demonstrate the specificity and accuracy of LONUT and show that our program not only improves the detection of binding sites for ChIP-seq, but also identifies additional binding sites.	[Wang, Rui] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Wang, Rui; Wang, Yisong; Lan, Xun; Wang, Yao; Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Hsu, Hang-Kai; Hsu, Pei-Yin; Huang, Tim H. -M.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78229 USA; [Blattler, Adam; Farnham, Peggy J.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Blattler, Adam] Univ Calif Davis, Genet Grad Grp, Davis, CA 95616 USA; [Leu, Yu-Wei] Natl Chung Cheng Univ, Inst Mol Biol, Dept Life Sci, Human Epigen Ctr, Chiayi, Taiwan; [Leu, Yu-Wei] Natl Chung Cheng Univ, Inst Biomed Sci, Chiayi, Taiwan	Lanzhou University; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health San Antonio; University of Southern California; University of California System; University of California Davis; National Chung Cheng University; National Chung Cheng University	Jin, VX (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.	Victor.Jin@osumc.edu		Lan, Xun/0000-0002-6523-046X; Farnham, Peggy/0000-0003-4469-7914; Blattler, Adam/0000-0002-4682-7201				Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bonneville R, 2013, BIOINFORMATICS, V29, P22, DOI 10.1093/bioinformatics/bts639; Chung DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002111; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gu F, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-170; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jin VX, 2009, BIOINFORMATICS, V25, P3191, DOI 10.1093/bioinformatics/btp570; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Lan X, 2012, NUCLEIC ACIDS RES, V40, P7690, DOI 10.1093/nar/gks501; Lan X, 2011, BIOINFORMATICS, V27, P428, DOI 10.1093/bioinformatics/btq669; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Narlikar L, 2012, METHODS MOL BIOL, V802, P305, DOI 10.1007/978-1-61779-400-1_20; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenfeld JA, 2009, EPIGENETICS-US, V4, P476, DOI 10.4161/epi.4.7.9809; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Shen CY, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-67; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Wu J, 2011, BIOINFORMATICS, V27, P3010, DOI 10.1093/bioinformatics/btr508; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang XK, 2011, BIOMETRICS, V67, P151, DOI 10.1111/j.1541-0420.2010.01441.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67788	10.1371/journal.pone.0067788	http://dx.doi.org/10.1371/journal.pone.0067788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825685	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000119
J	Zorko, DJ; Choong, K; Gilleland, J; Agar, B; Baker, S; Brennan, C; Pullenayegum, E				Zorko, David J.; Choong, Karen; Gilleland, Jonathan; Agar, Barbara; Baker, Shawn; Brennan, Cindy; Pullenayegum, Eleanor			Urgent Ultrasound Guided Hemodynamic Assessments by a Pediatric Medical Emergency Team: A Pilot Study	PLOS ONE			English	Article							CARDIAC-OUTPUT MONITOR; CLINICAL-PRACTICE PARAMETERS; SEPTIC SHOCK; CHILDREN; MANAGEMENT; SUPPORT; UPDATE	Purpose: To determine the feasibility of using the Ultrasound Cardiac Output Monitor (USCOM) as an adjunct during hemodynamic assessments by a pediatric medical emergency team (PMET). Methods: Pediatric in-patients at McMaster Children's Hospital aged under 18 years requiring urgent PMET consultation, were eligible. Patients with known cardiac outflow valve defects, Pediatric Critical Care Unit in-patients, and those in cardiorespiratory arrest, were excluded. The primary outcome was feasibility, and the ease of USCOM transport and application as assessed by a self-administered user questionnaire. Secondary outcomes included the quality of USCOM measurements, and agreement in clinical versus USCOM-derived assessments. Results: Forty-one patients from 85 eligible PMET consultations were enrolled between March and August 2011. A total of 55 USCOM assessments were performed on 36 of 41 (87.8%) participants. USCOM could not be completed in 5 (12.2%) participants due to patient agitation (n = 4) and emergent care (n = 1). USCOM was reported as easy to transport and apply by 97.4% and 94.7% of respondents respectively, not obstructive to patient care by 94.7%, and yielded timely measurements by 84.2% respondents. USCOM tracings were of good quality in 41 (75.9%) assessments. Agreement between clinical and USCOM-derived hemodynamic assessments by two independent raters was poor (Rater 1: kappa = 0.094; Rater 2: kappa = 0.146). Conclusion: USCOM can be applied by a PMET during urgent hemodynamic assessments in children. While USCOM has been validated in stable children, its role in guiding hemodynamic resuscitation and informing therapeutic goals in a hemodynamically unstable pediatric population requires further investigation.	[Zorko, David J.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Choong, Karen; Gilleland, Jonathan] McMaster Univ, Fac Hlth Sci, Dept Pediat, Hamilton, ON, Canada; [Choong, Karen; Gilleland, Jonathan; Agar, Barbara; Baker, Shawn; Brennan, Cindy] McMaster Univ, Fac Hlth Sci, Dept Crit Care, Hamilton, ON, Canada; [Pullenayegum, Eleanor] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Ottawa; McMaster University; McMaster University; McMaster University	Choong, K (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Pediat, Hamilton, ON, Canada.	choongk@mcmaster.ca	Zorko, David/AAA-3748-2021; Choong, Karen/ABB-7867-2021; Pullenayegum, Eleanor/AAT-1712-2020	Choong, Karen/0000-0002-4608-4508; Pullenayegum, Eleanor/0000-0003-4265-1330	USCOM Limited	USCOM Limited	With respect to funding received from USCOM Limited, the authors declare that USCOM Limited provided the ultrasound cardiac output monitory device on loan to McMaster University for the duration of this specific research project. The authors did not receive any other funding from USCOM Limited or other sources to support this study. USCOM Limited has no intellectual property of the design, execution, analysis, interpretation, and reporting of the results, or manuscript preparation for this study. As such, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arnold DM, 2009, CRIT CARE MED, V37, pS69, DOI 10.1097/CCM.0b013e3181920e33; Bonanno Fabrizio Giuseppe, 2011, J Emerg Trauma Shock, V4, P233, DOI 10.4103/0974-2700.82211; Brierley J, 2008, PEDIATRICS, V122, P752, DOI 10.1542/peds.2007-1979; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040; Carcillo JA, 2009, PEDIATRICS, V124, P500, DOI 10.1542/peds.2008-1967; Cattermole GN, 2010, CRIT CARE MED, V38, P1875, DOI 10.1097/CCM.0b013e3181e8adee; Ceneviva G, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e19; Chand R, 2006, J CARDIOTHOR VASC AN, V20, P315, DOI 10.1053/j.jvca.2005.05.024; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dhanani S, 2011, PEDIATR ANESTH, V21, P858, DOI 10.1111/j.1460-9592.2010.03480.x; Duchateau FX, 2011, EUR J EMERG MED, V18, P357, DOI 10.1097/MEJ.0b013e32834777b6; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; He SR, 2012, EARLY HUM DEV, DOI [10.1016/j.bbr.2011.03.031, DOI 10.1016/J.BBR.2011.03.031]; Ho GYL, 2013, PEDIAT CRIT IN PRESS; Holmes CL, 2003, CLIN CHEST MED, V24, P775, DOI 10.1016/S0272-5231(03)00107-2; Inwald DP, 2009, ARCH DIS CHILD, V94, P348, DOI 10.1136/adc.2008.153064; Jain S, 2008, AM J SURG, V196, P961, DOI 10.1016/j.amjsurg.2008.07.039; Jenkins SD, 2010, CLIN NURSE SPEC, V24, P24, DOI 10.1097/NUR.0b013e3181c4abe9; Knirsch W, 2008, INTENS CARE MED, V34, P1060, DOI 10.1007/s00134-008-1030-y; Likes ML, 2010, J HEART LUNG TRANSPL, V29, pS172, DOI 10.1016/j.healun.2009.11.546; On Tang C, 2009, SCI S EM MED HONG KO; Oren-Grinberg A, 2010, INT ANESTHESIOL CLIN, V48, P57, DOI 10.1097/AIA.0b013e3181c3dc11; Phillips R., 2006, CRIT CARE, V10, pP343, DOI [10.1186/cc4690, DOI 10.1186/CC4690]; Rainer TH, 2013, ANESTH ANAL IN PRESS; Ranjit Suchitra, 2005, Pediatr Crit Care Med, V6, P412, DOI 10.1097/01.PCC.0000163676.75693.BF; Scherr K, 2012, AACN ADV CRIT CARE, V23, P32, DOI 10.1097/NCI.0b013e318240e2f9; Tan HL, 2005, BRIT J ANAESTH, V94, P287, DOI 10.1093/bja/aei054; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; Tibby SM, 1997, ARCH DIS CHILD, V77, P516, DOI 10.1136/adc.77.6.516; USCOM Ltd, 2009, USCOM BAS TRAIN MOD; van Lelyveld-Haas LEM, 2008, EUR J ANAESTH, V25, P917, DOI 10.1017/S0265021508004882; Vincent JL, 2011, CRIT CARE, V15, DOI 10.1186/cc10291; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012	36	2	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66951	10.1371/journal.pone.0066951	http://dx.doi.org/10.1371/journal.pone.0066951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825593	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000049
J	Bryan, C; Rice, C; Harkisheimer, M; Schultz, DC; Skordalakes, E				Bryan, Christopher; Rice, Cory; Harkisheimer, Michael; Schultz, David C.; Skordalakes, Emmanuel			Structure of the Human Telomeric Stn1-Ten1 Capping Complex	PLOS ONE			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; BINDING-PROTEIN; END-PROTECTION; POLYMERASE-ALPHA; CHROMOSOME ENDS; CDC13; STN1; RPA; PROMOTES	The identification of the human homologue of the yeast CST in 2009 posed a new challenge in our understanding of the mechanism of telomere capping in higher eukaryotes. The high-resolution structure of the human Stn1-Ten1 (hStn1-Ten1) complex presented here reveals that hStn1 consists of an OB domain and tandem C-terminal wHTH motifs, while hTen1 consists of a single OB fold. Contacts between the OB domains facilitate formation of a complex that is strikingly similar to the replication protein A (RPA) and yeast Stn1-Ten1 (Ten1) complexes. The hStn1-Ten1 complex exhibits non-specific single-stranded DNA activity that is primarily dependent on hStn1. Cells expressing hStn1 mutants defective for dimerization with hTen1 display elongated telomeres and telomere defects associated with telomere uncapping, suggesting that the telomeric function of hCST is hTen1 dependent. Taken together the data presented here show that the structure of the hStn1-Ten1 subcomplex is conserved across species. Cell based assays indicate that hTen1 is critical for the telomeric function of hCST, both in telomere protection and downregulation of telomerase function.	[Bryan, Christopher; Rice, Cory; Harkisheimer, Michael; Schultz, David C.; Skordalakes, Emmanuel] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA USA; [Bryan, Christopher; Skordalakes, Emmanuel] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Rice, Cory; Skordalakes, Emmanuel] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Skordalakes, E (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA USA.	skorda@wistar.org	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833; Rice, Cory/0000-0003-2270-030X	National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [5 R01 GM088332-03]; Wistar Cancer Center Support Grant [P30 CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815, T32CA009171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088332] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wistar Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) (5 R01 GM088332-03) and The Wistar Cancer Center Support Grant (P30 CA10815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; DeZwaan DC, 2009, NAT STRUCT MOL BIOL, V16, P711, DOI 10.1038/nsmb.1616; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gelinas AD, 2009, P NATL ACAD SCI USA, V106, P19298, DOI 10.1073/pnas.0909203106; Grandin N, 2001, EMBO J, V20, P6127, DOI 10.1093/emboj/20.21.6127; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CH, 2012, CELL RES, V22, P1681, DOI 10.1038/cr.2012.132; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakaoka H, 2012, J BIOL CHEM, V287, P619, DOI 10.1074/jbc.M111.263723; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Otwinowski Z, 1991, ISOMORPHOUS SCATTERI; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Puglisi A, 2008, EMBO J, V27, P2328, DOI 10.1038/emboj.2008.158; Qian W, 2010, PROTEIN EXPRES PURIF, V73, P107, DOI 10.1016/j.pep.2010.05.006; Qian W, 2009, CELL RES, V19, P849, DOI 10.1038/cr.2009.67; Song XY, 2008, P NATL ACAD SCI USA, V105, P19815, DOI 10.1073/pnas.0807867105; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Wellinger RJ, 2009, MOL CELL, V36, P168, DOI 10.1016/j.molcel.2009.10.001; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Xu L, 2009, GENETICS, V183, P793, DOI 10.1534/genetics.109.108894	57	54	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66756	10.1371/journal.pone.0066756	http://dx.doi.org/10.1371/journal.pone.0066756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826127	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400045
J	Sheen, P; Couvin, D; Grandjean, L; Zimic, M; Dominguez, M; Luna, G; Gilman, RH; Rastogi, N; Moore, DAJ				Sheen, Patricia; Couvin, David; Grandjean, Louis; Zimic, Mirko; Dominguez, Maria; Luna, Giannina; Gilman, Robert H.; Rastogi, Nalin; Moore, David A. J.			Genetic Diversity of Mycobacterium tuberculosis in Peru and Exploration of Phylogenetic Associations with Drug Resistance	PLOS ONE			English	Article							SUSCEPTIBILITY ASSAY; EPIDEMIOLOGY; SPOLIGOTYPES	Background: There is limited available data on the strain diversity of M tuberculosis in Peru, though there may be interesting lessons to learn from a setting where multidrug resistant TB has emerged as a major problem despite an apparently well-functioning DOTS control programme. Methods: Spoligotyping was undertaken on 794 strains of M tuberculosis collected between 1999 and 2005 from 553 community-based patients and 241 hospital-based HIV co-infected patients with pulmonary tuberculosis in Lima, Peru. Phylogenetic and epidemiologic analyses permitted identification of clusters and exploration of spoligotype associations with drug resistance. Results: Mean patient age was 31.9 years, 63% were male and 30.4% were known to be HIV+. Rifampicin mono-resistance, isoniazid mono-resistance and multidrug resistance (MDR) were identified in 4.7%, 8.7% and 17.3% of strains respectively. Of 794 strains from 794 patients there were 149 different spoligotypes. Of these there were 27 strains (3.4%) with novel, unique orphan spoligotypes. 498 strains (62.7%) were clustered in the nine most common spoligotypes: 16.4% SIT 50 (clade H3), 12.3% SIT 53 (clade T1), 8.3% SIT 33 (LAM3), 7.4% SIT 42 (LAM9), 5.5% SIT 1 (Beijing), 3.9% SIT 47 (H1), 3.0% SIT 222 (clade unknown), 3.0% SIT1355 (LAM), and 2.8% SIT 92 (X3). Amongst HIV-negative community-based TB patients no associations were seen between drug resistance and specific spoligotypes; in contrast HIV-associated MDRTB, but not isoniazid or rifampicin mono-resistance, was associated with SIT42 and SIT53 strains. Conclusion: Two spoligotypes were associated with MDR particularly amongst patients with HIV. The MDR-HIV association was significantly reduced after controlling for SIT42 and SIT53 status; residual confounding may explain the remaining apparent association. These data are suggestive of a prolonged, clonal, hospital-based outbreak of MDR disease amongst HIV patients but do not support a hypothesis of strain-specific propensity for the acquisition of resistance-conferring mutations.	[Sheen, Patricia; Grandjean, Louis; Zimic, Mirko; Dominguez, Maria; Luna, Giannina; Gilman, Robert H.; Moore, David A. J.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Labs Invest & Desarrollo, Lab Enfermedades Infecciosas, Lima, Peru; [Grandjean, Louis; Moore, David A. J.] Univ London London Sch Hyg & Trop Med, LSHTM TB Ctr, London WC1E 7HT, England; [Grandjean, Louis; Moore, David A. J.] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Grandjean, Louis; Gilman, Robert H.; Moore, David A. J.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Gilman, Robert H.; Moore, David A. J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moore, DAJ (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Labs Invest & Desarrollo, Lab Enfermedades Infecciosas, Lima, Peru.	david.moore@lshtm.ac.uk	RASTOGI, NALIN/AAP-1958-2020	RASTOGI, NALIN/0000-0002-7199-7747; Grandjean, Louis/0000-0002-1457-8327; Couvin, David/0000-0002-7897-9023	Wellcome Trust Fellowships [064672/Z/01/Z, 078067/Z/05/Z]; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Wellcome Trust Fellowships(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DAJM was supported by Wellcome Trust Fellowships (064672/Z/01/Z and 078067/Z/05/Z; www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Ellson J, 2002, LECT NOTES COMPUT SC, V2265, P483; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Svensson E, 2011, CLIN MICROBIOL INFEC, V17, P881, DOI 10.1111/j.1469-0691.2010.03358.x; Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	12	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65873	10.1371/journal.pone.0065873	http://dx.doi.org/10.1371/journal.pone.0065873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826083	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000321738400005
J	Fiebig, T; Figueiredo, G; Boll, H; Kerl, HU; Noelte, IS; Forster, A; Groden, C; Kramer, M; Brockmann, MA				Fiebig, Teresa; Figueiredo, Giovanna; Boll, Hanne; Kerl, Hans Ulrich; Noelte, Ingo S.; Forster, Alex; Groden, Christoph; Kramer, Martin; Brockmann, Marc A.			A Low Cost Metal-Free Vascular Access Mini-Port for Artifact Free Imaging and Repeated Injections in Mice	PLOS ONE			English	Article							JUGULAR-VEIN; CATHETERIZATION; INFUSION; PATENCY; SYSTEM; DRUGS; RATS	Purpose: Small injection ports for mice are increasingly used for drug testing or when administering contrast agents. Commercially available mini-ports are expensive single-use items that cause imaging-artifacts. We developed and tested an artifact-free, low-cost, vascular access mini-port (VAMP) for mice. Procedures: Leakage testing of the VAMP was conducted with high speed bolus injections of different contrast agents. VAMP-induced artifacts were assessed using a micro-CT and a small animal MRI (9.4T) scanner ex vivo. Repeated contrast administration was performed in vivo. Results: With the VAMP there was no evidence of leakage with repeated punctures, high speed bolus contrast injections, and drawing of blood samples. In contrast to the tested commercially available ports, the VAMP did not cause artifacts with MRI or CT imaging. Conclusions: The VAMP is an alternative to commercially available mini-ports and has useful applications in animal research involving imaging procedures and contrast agent testing.	[Fiebig, Teresa; Figueiredo, Giovanna; Boll, Hanne; Kerl, Hans Ulrich; Noelte, Ingo S.; Forster, Alex; Groden, Christoph] Heidelberg Univ, Dept Neuroradiol, Univ Med Ctr Mannheim, Mannheim, Germany; [Kramer, Martin] Univ Giessen, Dept Vet Clin Sci, Small Anim Clin, D-35390 Giessen, Germany; [Brockmann, Marc A.] Rhein Westfal TH Aachen, Univ Hosp, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany	Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; RWTH Aachen University; RWTH Aachen University Hospital	Brockmann, MA (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany.	brockmann@gmx.de			Federal Ministry of Education and Research; Land Baden-Wurttemberg (HBFG) [125-648]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Land Baden-Wurttemberg (HBFG)	The acquisition of the micro-CT (Yxlon Y. Fox) was funded by the Federal Ministry of Education and Research and the Land Baden-Wurttemberg (HBFG grant # 125-648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR JL, 1987, J CANCER RES CLIN, V113, P27, DOI 10.1007/BF00389963; Bardelmeijer HA, 2003, LAB ANIM-UK, V37, P181, DOI 10.1258/002367703766453010; BARR J E, 1979, Pharmacology Biochemistry and Behavior, V11, P115, DOI 10.1016/0091-3057(79)90307-1; Boll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025692; Brockmann MA, 2012, AJNR AM J NEURORADIO; Chen L, 2009, J NEUROSCI RES, V87, P1718, DOI 10.1002/jnr.21973; Chistyakov Vladimir S., 2006, Journal of Pharmacological and Toxicological Methods, V53, P117, DOI 10.1016/j.vascn.2005.03.009; Foley PL, 2002, COMPARATIVE MED, V52, P243; Fonseca UNK, 2010, LAB ANIM-UK, V44, P46, DOI 10.1258/la.2009.008122; Gabra P, 2010, PHYSIOL MEAS, V31, P249, DOI 10.1088/0967-3334/31/2/010; Groman EV, 2004, CONTEMP TOP LAB ANIM, V43, P35; Kelley BM, 1997, PHYSIOL BEHAV, V62, P163, DOI 10.1016/S0031-9384(97)00029-2; Kim H, 2011, MOL IMAGING BIOL, V13, P94, DOI 10.1007/s11307-010-0320-2; Luo YS, 2000, 51 ANN M AM ASS LAB, P4; MACLEOD JN, 1988, LAB ANIM SCI, V38, P603; Madoiwa S, 2012, HAEMOPHILIA, V18, pe323, DOI 10.1111/j.1365-2516.2011.02686.x; MARKS MJ, 1981, J PHARMACOL EXP THER, V218, P337; MOKHTARIAN A, 1993, PHYSIOL BEHAV, V54, P895, DOI 10.1016/0031-9384(93)90298-T; MUCHA RF, 1979, J PHARM PHARMACOL, V31, P191, DOI 10.1111/j.2042-7158.1979.tb13473.x; Nolan Thomas E, 2002, ILAR J, V43, P175; Ruiter M, 2011, ALN MAGZINE, P4; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schambach SJ, 2009, STROKE, V40, P1444, DOI 10.1161/STROKEAHA.108.521740; Schambach SJ, 2011, CLIN NEURORADIOLOGY; Solomon I, 2011, 2011 CAT PLYM M INST; Tesche S, 2002, ONKOLOGIE, V25, P178, DOI 10.1159/000055229; THOMSEN M, 2005, CURR PROTOC NEUROSCI, pCH9, DOI DOI 10.1002/0471142301.NS0920S32	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65939	10.1371/journal.pone.0065939	http://dx.doi.org/10.1371/journal.pone.0065939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824056	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400035
J	Jung, TW; Choi, HY; Lee, SY; Hong, HC; Yang, SJ; Yoo, HJ; Youn, BS; Baik, SH; Choi, KM				Jung, Tae Woo; Choi, Hae Yoon; Lee, So Young; Hong, Ho Cheol; Yang, Sae Jeong; Yoo, Hye Jin; Youn, Byung-Soo; Baik, Sei Hyun; Choi, Kyung Mook			Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1 alpha Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; TARGET INFLAMMATION; KAPPA-B; BETA	Selenoprotein P (SeP) was recently identified as a hepatokine that induces insulin resistance (IR) in rodents and humans. Recent clinical trials have shown that salsalate, a prodrug of salicylate, significantly lowers blood glucose levels and increases adiponectin concentrations. We examined the effects of salsalate and full length-adiponectin (fAd) on the expression of SeP under hyperlipidemic conditions and explored their regulatory mechanism on SeP. In palmitate-treated HepG2 cells as well as high fat diet (HFD)-fed male Spraque Dawley (SD) rats and male db/db mice, SeP expression and its regulatory pathway, including AMPK-FOXO1 alpha, were evaluated after administration of salsalate and salicylate. Palmitate treatment significantly increased SeP expression and aggravated IR, while knock-down of SeP by siRNA restored these changes in HepG2 cells. Palmitate-induced SeP expression was inhibited by both salsalate and salicylate, which was mediated by AMPK activation, and was blocked by AMPK siRNA or an inhibitor of AMPK. Chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift (EMSA) assay showed that salsalate suppressed SeP expression by AMPK-mediated phosphorylation of FOXO1 alpha. Moreover, fAd also reduced palmitate-induced SeP expression through the activation of AMPK, which results in improved IR. Both salsalate and salicylate treatment significantly improved glucose intolerance and insulin sensitivity, accompanied by reduced SeP mRNA and protein expression in HFD-fed rats and db/db mice, respectively. Taken together, we found that salsalate and adiponectin ameliorated palmitate-induced IR in hepatocytes via SeP inhibition through the AMPK-FOXO1 alpha pathway. The regulation of SeP might be a novel mechanism mediating the anti-diabetic effects of salsalate and adiponectin.	[Jung, Tae Woo; Choi, Hae Yoon; Lee, So Young; Hong, Ho Cheol; Yang, Sae Jeong; Yoo, Hye Jin; Baik, Sei Hyun; Choi, Kyung Mook] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea; [Youn, Byung-Soo] AdipoGen Inc, Inchon, South Korea	Korea University; Korea University Medicine (KU Medicine)	Choi, KM (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea.	medica7@gmail.com	Choi, Kyung Mook/C-4195-2018	Choi, Kyung Mook/0000-0001-6175-0225	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012006363]; Ministry of Education and Human Resources Development, Republic of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education and Human Resources Development, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012006363) (by K.M.C.) and by the Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea. (by K.M.C. and S.H.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2009, INFLAMMATION, V32, P296, DOI 10.1007/s10753-009-9135-1; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Goldfine AB, 2011, CLIN CHEM, V57, P162, DOI 10.1373/clinchem.2010.148833; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hawley SA, 2012, SCIENCE; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Kim NH, 2012, DIABETES METAB J, V36, P268, DOI [10.4093/dmj.2012.36.4.268, 10.4093/dmj.2012.36.1.26]; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lesniewski LA, 2011, J GERONTOL A-BIOL, V66, P409, DOI 10.1093/gerona/glq233; MALOFF BL, 1986, DIABETOLOGIA, V29, P295, DOI 10.1007/BF00452066; Misu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034952; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Polyzos SA, 2010, DIABETES OBES METAB, V12, P365, DOI 10.1111/j.1463-1326.2009.01176.x; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Su DM, 2009, DIABETES, V58, P2624, DOI 10.2337/db09-0232; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	25	31	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66529	10.1371/journal.pone.0066529	http://dx.doi.org/10.1371/journal.pone.0066529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825542	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400122
J	Reetz, J; Genz, B; Meier, C; Kowtharapu, BS; Timm, F; Vollmar, B; Herchenroder, O; Abshagen, K; Putzer, BM				Reetz, Julia; Genz, Berit; Meier, Claudia; Kowtharapu, Bhavani S.; Timm, Franziska; Vollmar, Brigitte; Herchenroeder, Ottmar; Abshagen, Kerstin; Puetzer, Brigitte M.			Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo	PLOS ONE			English	Article							LIVER FIBROSIS; GENE DELIVERY; RECEPTOR EXPRESSION; UNDERGO APOPTOSIS; VECTORS; TROPISM; TOXICITY; BINDING; STRATEGIES; CIRRHOSIS	Hepatic stellate cells (HSCs) are known as initiator cells that induce liver fibrosis upon intoxication or other noxes. Deactivation of this ongoing remodeling process of liver parenchyma into fibrotic tissue induced by HSCs is an interesting goal to be achieved by targeted genetic modification of HSCs. The most widely applied approach in gene therapy is the utilization of specifically targeted vectors based on Adenovirus (Ad) serotype 5. To narrow down the otherwise ubiquitous tropism of parental Ad, two modifications are required: a) ablating the native tropism and b) redirecting the vector particles towards a specific entity solely present on the cells of interest. Therefore, we designed a peptide of the nerve growth factor (NGF(p)) with specific affinity for the p75 neurotrophin receptor (p75NTR) present on HSCs. Coupling of this NGF(p) to vector particles was done either via chemical conjugation using bifunctional polyethylene glycol (PEG) or, alternatively, by molecular bridging with a fusion protein specific for viral fiber knob and p75NTR. Both Ad vectors transmit the gene for the green fluorescent protein (GFP). GFP expression was monitored in vitro on primary murine HSCs as well as after systemic administration in mice with healthy and fibrotic livers using intravital fluorescence microscopy. Coupling of NGF(p) to Ad via S11 and/or PEGylation resulted in markedly reduced liver tropism and an enhanced adenoviral-mediated gene transfer to HSCs. Transduction efficiency of both specific Ads was uniformly higher in fibrotic livers, whereas Ad. GFP-S11-NGF(p) transduce activated HSCs better than Ad. GFP-PEG-NGF(p). These experiments contribute to the development of a targeted gene transfer system to specifically deliver antifibrotic compounds into activated HSCs by systemically applied adenoviral vector modified with NGF(p).	[Reetz, Julia; Meier, Claudia; Kowtharapu, Bhavani S.; Herchenroeder, Ottmar; Puetzer, Brigitte M.] Univ Rostock, Inst Expt Gene Therapy & Canc Res, Sch Med, D-18055 Rostock, Germany; [Genz, Berit; Timm, Franziska; Vollmar, Brigitte; Abshagen, Kerstin] Univ Rostock, Inst Expt Surg, Sch Med, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Abshagen, K (corresponding author), Univ Rostock, Inst Expt Surg, Sch Med, D-18055 Rostock, Germany.	kerstin.abshagen@uni-rostock.de	Genz, Berit/AAZ-4230-2020; Kowtharapu, Bhavani S./AAQ-7603-2020	Kowtharapu, Bhavani S./0000-0002-2336-5729	FORUN, University of Rostock [889036]; Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany [AB 453/1-1, PU 188/9-1]	FORUN, University of Rostock; Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany(German Research Foundation (DFG))	This work was supported by FORUN, University of Rostock (No. 889036) and by the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany (AB 453/1-1, PU 188/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Armendariz-Borunda J, 2011, J BIOSCI BIOENG, V112, P415, DOI 10.1016/j.jbiosc.2011.07.018; Asai K, 2006, LIVER INT, V26, P595, DOI 10.1111/j.1478-3231.2006.01267.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beljaars L, 2002, FRONT BIOSCI-LANDMRK, V7, pE214, DOI 10.2741/beljaars; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Coughlan L, 2010, VIRUSES-BASEL, V2, P2290, DOI 10.3390/v2102290; Curiel DT, 1999, ANN NY ACAD SCI, V886, P158, DOI 10.1111/j.1749-6632.1999.tb09409.x; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; Douglas Joanne T, 2004, Methods Mol Biol, V246, P29; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; Gonzalo T, 2007, J PHARMACOL EXP THER, V321, P856, DOI 10.1124/jpet.106.114496; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Haisma HJ, 2010, INT J PHARMACEUT, V391, P155, DOI 10.1016/j.ijpharm.2010.02.032; Haisma HJ, 2000, CANCER GENE THER, V7, P901, DOI 10.1038/sj.cgt.7700198; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; Kawakami Y, 2009, COLD SPRING HARB PRO, V2009; Kim PH, 2011, BIOMATERIALS, V32, P2314, DOI 10.1016/j.biomaterials.2010.10.031; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; LOMENHOERTH C, 1995, J NEUROCHEM, V64, P1780; Lyle C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-148; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Myhre S, 2007, GENE THER, V14, P376, DOI 10.1038/sj.gt.3302875; Nettelbeck DM, 2004, INT J CANCER, V108, P136, DOI 10.1002/ijc.11563; O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021; Ogawa S, 2010, HEPATOL RES, V40, P1128, DOI 10.1111/j.1872-034X.2010.00718.x; Ogawara KI, 2004, HUM GENE THER, V15, P433, DOI 10.1089/10430340460745766; Perez-Perez M, 2003, ANAT REC PART A, V270A, P117, DOI 10.1002/ar.a.10010; RAIVICH G, 1987, J COMP NEUROL, V256, P229, DOI 10.1002/cne.902560204; RAIVICH G, 1987, J NEUROCYTOL, V16, P689, DOI 10.1007/BF01637660; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Romanczuk H, 1999, HUM GENE THER, V10, P2615, DOI 10.1089/10430349950016654; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Schachtrup C, 2011, CELL CYCLE, V10, P1764, DOI 10.4161/cc.10.11.15828; Schmidt A, 2011, GENE THER, V18, P418, DOI 10.1038/gt.2010.165; Schmidt A, 2007, STEM CELLS, V25, P2910, DOI 10.1634/stemcells.2007-0238; Schoemaker MH, 2008, MOL PHARM, V5, P399, DOI 10.1021/mp700118p; SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4; Shayakhmetov DM, 2004, J VIROL, V78, P5368, DOI 10.1128/JVI.78.10.5368-5381.2004; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Vollmar B, 1998, HEPATOLOGY, V27, P1544, DOI 10.1002/hep.510270612; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wonganan P, 2010, VIRUSES-BASEL, V2, P468, DOI 10.3390/v2020468; Zhang XY, 2000, MICROVASC RES, V60, P232, DOI 10.1006/mvre.2000.2264	54	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67091	10.1371/journal.pone.0067091	http://dx.doi.org/10.1371/journal.pone.0067091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825626	Green Submitted, gold, Green Published			2022-12-27	WOS:000320576400175
J	Schee, K; Lorenz, S; Worren, MM; Gunther, CC; Holden, M; Hovig, E; Fodstad, O; Meza-Zepeda, LA; Flatmark, K				Schee, Kristina; Lorenz, Susanne; Worren, Merete Molton; Gunther, Clara-Cecilie; Holden, Marit; Hovig, Eivind; Fodstad, Oystein; Meza-Zepeda, Leonardo A.; Flatmark, Kjersti			Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer	PLOS ONE			English	Article							EXPRESSION; BIOMARKERS; TARGETS; KRAS; DIAGNOSIS; SURVIVAL; PCR	Colorectal cancer (CRC) is one of the leading causes of cancer related deaths and the search for prognostic biomarkers that might improve treatment decisions is warranted. MicroRNAs (miRNAs) are short non-coding RNA molecules involved in regulating gene expression and have been proposed as possible biomarkers in CRC. In order to characterize the miRNA transcriptome, a large cohort including 88 CRC tumors with long-term follow-up was deep sequenced. 523 mature miRNAs were expressed in our cohort, and they exhibited largely uniform expression patterns across tumor samples. Few associations were found between clinical parameters and miRNA expression, among them, low expression of miR-592 and high expression of miR-10b-5p and miR-615-3p were associated with tumors located in the right colon relative to the left colon and rectum. High expression of miR-615-3p was also associated with poorly differentiated tumors. No prognostic biomarker candidates for overall and metastasis-free survival were identified by applying the LASSO method in a Cox proportional hazards model or univariate Cox. Examination of the five most abundantly expressed miRNAs in the cohort (miR-10a-5p, miR-21-5p, miR-22-3p, miR-143-3p and miR-192-5p) revealed that their collective expression represented 54% of the detected miRNA sequences. Pathway analysis of the target genes regulated by the five most highly expressed miRNAs uncovered a significant number of genes involved in the CRC pathway, including APC, TGF beta and PI3K, thus suggesting that these miRNAs are relevant in CRC.	[Schee, Kristina; Lorenz, Susanne; Hovig, Eivind; Fodstad, Oystein; Meza-Zepeda, Leonardo A.; Flatmark, Kjersti] Oslo Univ Hosp, Norwegian Radium Hosp, Clin Canc Surg & Transplantat, Inst Canc Res,Dept Tumor Biol, Oslo, Norway; [Lorenz, Susanne; Meza-Zepeda, Leonardo A.] Univ Oslo, Inst Mol Biosci, Genom Core Facil, Oslo, Norway; [Worren, Merete Molton; Hovig, Eivind] Univ Oslo, Inst Informat, Oslo, Norway; [Gunther, Clara-Cecilie; Holden, Marit] Norwegian Comp Ctr, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Med Informat, Bioinformat Core Facil, Oslo, Norway; [Flatmark, Kjersti] Oslo Univ Hosp, Norwegian Radium Hosp, Clin Canc Surg & Transplantat, Dept Surg Gastroenterol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Flatmark, K (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Clin Canc Surg & Transplantat, Inst Canc Res,Dept Tumor Biol, Oslo, Norway.	kjersti.flatmark-@rr-research.no	Hovig, Eivind/H-2474-2011; Meza-Zepeda, Leonardo Andres/CAG-5229-2022	Hovig, Eivind/0000-0002-9103-1077; Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X	South-Eastern Norway Regional Health Authority; Norwegian Cancer Society	South-Eastern Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from South-Eastern Norway Regional Health Authority and from the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Benjamini Y, 2008, BIOMETRICS, V64, P1215, DOI 10.1111/j.1541-0420.2007.00984.x; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Chang KH, 2011, INT J COLORECTAL DIS, V26, P1415, DOI 10.1007/s00384-011-1279-4; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Flatmark K, 2011, BRIT J CANCER, V104, P1434, DOI 10.1038/bjc.2011.97; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Giovannucci E, 2003, J WOMEN HEALTH GEN-B, V12, P173, DOI 10.1089/154099903321576574; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Han L, 2007, CANCER BIOL THER, V6, P1284; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ju JF, 2010, BIOANALYSIS, V2, P901, DOI [10.4155/bio.10.45, 10.4155/BIO.10.45]; Kulda V, 2010, CANCER GENET CYTOGEN, V200, P154, DOI 10.1016/j.cancergencyto.2010.04.015; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lin MS, 2011, ONCOL REP, V25, P739, DOI 10.3892/or.2010.1112; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Migliore L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/792362; Mori Y, ENDOCR RELAT CANC, V18, P465; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mosakhani N, 2012, CANCER GENET-NY, V205, P545, DOI 10.1016/j.cancergen.2012.08.003; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schee K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-505; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Tang JT, 2009, MINI-REV MED CHEM, V9, P921, DOI 10.2174/138955709788681672; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Toth E, 2011, ROM J MORPHOL EMBRYO, V52, P767; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Vergoulis T., NUCL ACIDS RES, V40, pD222; Wu Y, 2012, GENE; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113	48	117	125	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66165	10.1371/journal.pone.0066165	http://dx.doi.org/10.1371/journal.pone.0066165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824282	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400062
J	Simkova, A; Civanova, K; Gettova, L; Gilles, A				Simkova, Andrea; Civanova, Kristina; Gettova, Lenka; Gilles, Andre			Genomic Porosity between Invasive Chondrostoma nasus and Endangered Endemic Parachondrostoma toxostoma (Cyprinidae): The Evolution of MHC IIB Genes	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TRANSSPECIES POLYMORPHISM; POPULATION-STRUCTURE; INTROGRESSIVE HYBRIDIZATION; SEXUAL SELECTION; CLASS-I; DIVERSITY; MICROSATELLITE; PATTERNS; LOCI	Two cyprinid species, Parachondrostoma toxostoma, an endemic threatened species, and Chondrostoma nasus, an invasive species, live in sympatry in southern France and form two sympatric zones where the presence of intergeneric hybrids is reported. To estimate the potential threat to endemic species linked to the introduction of invasive species, we focused on the DAB genes (functional MHC IIB genes) because of their adaptive significance and role in parasite resistance. More specifically, we investigated (1) the variability of MHC IIB genes, (2) the selection pattern shaping MHC polymorphism, and (3) the extent to which trans-species evolution and intergeneric hybridization affect MHC polymorphism. In sympatric areas, the native species has more diversified MHC IIB genes when compared to the invasive species, probably resulting from the different origins and dispersal of both species. A similar level of MHC polymorphism was found at population level in both species, suggesting similar mechanisms generating MHC diversity. In contrast, a higher number of DAB-like alleles per specimen were found in invasive species. Invasive species tended to express the alleles of two DAB lineages, whilst native species tended to express the alleles of only the DAB3 lineage. Hybrids have a pattern of MHC expression intermediate between both species. Whilst positive selection acting on peptide binding sites (PBS) was demonstrated in both species, a slightly higher number of positively selected sites were identified in C. nasus, which could result from parasite-mediated selection. Bayesian clustering analysis revealed a similar pattern of structuring for the genetic variation when using microsatellites or the MHC approach. We confirmed the importance of trans-species evolution for MHC polymorphism. In addition, we demonstrated bidirectional gene flow for MHC IIB genes in sympatric areas. The positive significant correlation between MHC and microsatellites suggests that demographic factors may contribute to MHC variation on a short time scale.	[Simkova, Andrea; Civanova, Kristina; Gettova, Lenka] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Gilles, Andre] Aix Marseille Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, UMR 7263, CNRS, Marseille, France	Masaryk University Brno; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Simkova, A (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.	simkova@sci.muni.cz	Civanova, Kristina/G-1182-2014; Simkova, Andrea/F-7636-2019	Civanova, Kristina/0000-0001-5690-3637; Simkova, Andrea/0000-0002-5995-6766	Czech Science Foundation [P505/10/1138]; European Centre of Excellence [P505/12/G112]	Czech Science Foundation(Grant Agency of the Czech Republic); European Centre of Excellence	This study (from 2010 to 2012) was funded by the Czech Science Foundation, Project No. P505/10/1138. A part of analyses performed in 2013 was funded by the Czech Science Foundation, European Centre of Excellence, Project No. P505/12/G112. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2008, MOL ECOL, V17, P2652, DOI 10.1111/j.1365-294X.2008.03791.x; Anderson EC, 2002, GENETICS, V160, P1217; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biedrzycka A, 2008, MOL ECOL, V17, P4801, DOI 10.1111/j.1365-294X.2008.03955.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Chatterji S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r29; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Cohen S, 2002, MOL BIOL EVOL, V19, P1870, DOI 10.1093/oxfordjournals.molbev.a004011; Corse E, 2010, THESIS U PROVENCE MA; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Corse E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-26; Costedoat C, 2005, BIOL J LINN SOC, V85, P135, DOI 10.1111/j.1095-8312.2005.00478.x; Costedoat C, 2004, CYBIUM, V28, P51; Costedoat C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000357; Dixon B, 1996, IMMUNOGENETICS, V44, P419, DOI 10.1007/s002510050148; Doherty P C, 1975, Nature, V256, P50; DOWLING TE, 1993, NATURE, V362, P444, DOI 10.1038/362444a0; Dubut Vincent, 2010, BMC Res Notes, V3, P135, DOI 10.1186/1756-0500-3-135; Eizaguirre C, 2009, ECOL LETT, V12, P5, DOI 10.1111/j.1461-0248.2008.01247.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Figueroa F, 2000, IMMUNOGENETICS, V51, P556, DOI 10.1007/s002510000181; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graser R, 1996, IMMUNOGENETICS, V44, P36, DOI 10.1007/BF02602655; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hansson B, 2005, ANIM CONSERV, V8, P83, DOI 10.1017/S1367943004001878; Hedrick PW, 2001, MOL ECOL, V10, P1399, DOI 10.1046/j.1365-294X.2001.01289.x; HUGHES AL, 1992, NATURE, V355, P402, DOI 10.1038/355402b0; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JUKES T H, 1969, P21; KLEIN J, 1994, PHILOS T R SOC B, V346, P351, DOI 10.1098/rstb.1994.0152; KLEIN J, 1986, CRC CR REV IMMUNOL, V6, P295; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Landry C, 2001, MOL ECOL, V10, P2525, DOI 10.1046/j.1365-294X.2001.01383.x; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Longeri M, 2002, EUR J IMMUNOGENET, V29, P517, DOI 10.1046/j.1365-2370.2002.00356.x; Marsden CD, 2012, MOL ECOL, V21, P1379, DOI 10.1111/j.1365-294X.2012.05477.x; Marsden CD, 2009, J HERED, V100, pS54, DOI 10.1093/jhered/esp031; Mason RAB, 2011, CONSERV GENET, V12, P91, DOI 10.1007/s10592-009-9993-y; Meglecz E, 2011, BIOINFORMATICS, V27, P277, DOI 10.1093/bioinformatics/btq641; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Miller HC, 2010, MOL ECOL, V19, P3894, DOI 10.1111/j.1365-294X.2010.04771.x; Moutou KA, 2011, CONSERV GENET, V12, P1159, DOI 10.1007/s10592-011-0217-x; Nadachowska-Brzyska K, 2012, MOL ECOL, V21, P887, DOI 10.1111/j.1365-294X.2011.05347.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ottova E, 2005, FISH SHELLFISH IMMUN, V18, P199, DOI 10.1016/j.fsi.2004.07.004; Ottova E, 2007, BIOL J LINN SOC, V90, P525, DOI 10.1111/j.1095-8312.2007.00743.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026; Rakus KL, 2003, AQUAT LIVING RESOUR, V16, P432, DOI 10.1016/S0990-7440(03)00057-3; Rakus KL, 2009, AQUACULTURE, V288, P44, DOI 10.1016/j.aquaculture.2008.11.016; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; Ricanova S, 2011, CONSERV GENET, V12, P1115, DOI 10.1007/s10592-011-0213-1; Sawyer S, 1999, GENECONV COMPUTER PA; Seifertova M, 2011, IMMUNOGENETICS, V63, P167, DOI 10.1007/s00251-010-0495-3; Simkova A, 2006, EVOL ECOL, V20, P465, DOI 10.1007/s10682-006-0014-z; Simkova A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-200; Smith S, 2010, CONSERV GENET, V11, P269, DOI 10.1007/s10592-009-0029-4; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; vanErp SHM, 1996, IMMUNOGENETICS, V44, P192, DOI 10.1007/BF02602585; Wegner KM, 2012, MOL ECOL, V21, P779, DOI 10.1111/j.1365-294X.2011.05401.x; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395	74	8	8	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65883	10.1371/journal.pone.0065883	http://dx.doi.org/10.1371/journal.pone.0065883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824831	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400028
J	Tuladhar, AM; Snaphaan, L; Shumskaya, E; Rijpkema, M; Fernandez, G; Norris, DG; de Leeuw, FE				Tuladhar, Anil Man; Snaphaan, Liselore; Shumskaya, Elena; Rijpkema, Mark; Fernandez, Guillen; Norris, David G.; de Leeuw, Frank-Erik			Default Mode Network Connectivity in Stroke Patients	PLOS ONE			English	Article							RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; BRAIN; MEMORY; FMRI; FLUCTUATIONS; DEFICITS; LESIONS; MRI	The pathophysiology of episodic memory dysfunction after infarction is not completely understood. It has been suggested that infarctions located anywhere in the brain can induce widespread effects causing disruption of functional networks of the cortical regions. The default mode network, which includes the medial temporal lobe, is a functional network that is associated with episodic memory processing. We investigated whether the default mode network activity is reduced in stroke patients compared to healthy control subjects in the resting state condition. We assessed the whole brain network properties during resting state functional MRI in 21 control subjects and 20 'first-ever' stroke patients. Patients were scanned 9-12 weeks after stroke onset. Stroke lesions were located in various parts of the brain. Independent component analyses were conducted to identify the default mode network and to compare the group differences of the default mode network. Furthermore, region-of-interest based analysis was performed to explore the functional connectivity between the regions of the default mode network. Stroke patients performed significantly worse than control subjects on the delayed recall score on California verbal learning test. We found decreased functional connectivity in the left medial temporal lobe, posterior cingulate and medial prefrontal cortical areas within the default mode network and reduced functional connectivity between these regions in stroke patients compared with controls. There were no significant volumetric differences between the groups. These results demonstrate that connectivity within the default mode network is reduced in `first-ever' stroke patients compared to control subjects. This phenomenon might explain the occurrence of post-stroke cognitive dysfunction in stroke patients.	[Tuladhar, Anil Man; Snaphaan, Liselore; Fernandez, Guillen; Norris, David G.; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, Dept Neurol,Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands; [Tuladhar, Anil Man; Shumskaya, Elena; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Shumskaya, Elena] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit, NL-6525 ED Nijmegen, Netherlands; [Rijpkema, Mark] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6525 ED Nijmegen, Netherlands; [Norris, David G.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Norris, David G.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Duisburg Essen; University of Twente	de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, Dept Neurol,Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands.	H.deLeeuw@neuro.umcn.nl	Tuladhar, Anil/G-8214-2016; de Leeuw, H.F./L-4479-2015; Fernandez, Guillen/B-3771-2009; Norris, David G/A-1937-2010; de Leeuw, Frank-Erik/E-4795-2012; Rijpkema, Mark/D-1974-2010	Tuladhar, Anil/0000-0002-4815-2834; Fernandez, Guillen/0000-0002-5522-0604; Norris, David G/0000-0002-3699-6917; Rijpkema, Mark/0000-0002-8495-4703	Dutch Brain foundation [H04-12]; Netherlands Organization for Scientific Research [40-00703-97-07197]	Dutch Brain foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Dr. De Leeuw received a personal fellowship from the Dutch Brain foundation (H04-12) and a clinical fellowship from the Netherlands Organization for Scientific Research (project number: 40-00703-97-07197). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Damasio H, 1989, LESION ANAL NEUROPSY; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Jonghe J F, 1997, Tijdschr Gerontol Geriatr, V28, P224; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Delis DC., 2000, CALIFORNIA VERBAL LE; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; FOLSTEIN M, 1973, BIOL PSYCHIAT, V7, P147; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Golestani AM, 2013, NEUROREHAB NEURAL RE, V27, P153, DOI 10.1177/1545968312457827; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Lassalle-Lagadec S, 2012, RADIOLOGY, V264, P218, DOI 10.1148/radiol.12111718; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; MAHONEY F I, 1965, Md State Med J, V14, P61; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; Pineiro R, 2002, STROKE, V33, P103, DOI 10.1161/hs0102.100482; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raj D, 2001, PHYS MED BIOL, V46, P3331, DOI 10.1088/0031-9155/46/12/318; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Snaphaan L, 2007, STROKE, V38, P198, DOI 10.1161/01.STR.0000251842.34322.8f; Snaphaan L, 2009, BRAIN, V132, P1882, DOI 10.1093/brain/awp133; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Squire LR, 2009, NEURON, V61, P6, DOI 10.1016/j.neuron.2008.12.023; Tuladhar AM, 2010, NAT REV NEUROL, V6, P63, DOI 10.1038/nrneurol.2009.229; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Young MP, 2000, PHILOS T R SOC B, V355, P147, DOI 10.1098/rstb.2000.0555; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	53	69	74	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66556	10.1371/journal.pone.0066556	http://dx.doi.org/10.1371/journal.pone.0066556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824302	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400128
J	Liu, XY; Hu, Q; Liu, S; Tallo, LJ; Sadzewicz, L; Schettine, CA; Nikiforov, M; Klyushnenkova, EN; Ionov, Y				Liu, Xinyue; Hu, Qiang; Liu, Song; Tallo, Luke J.; Sadzewicz, Lisa; Schettine, Cassandra A.; Nikiforov, Mikhail; Klyushnenkova, Elena N.; Ionov, Yurij			Serum Antibody Repertoire Profiling Using In Silico Antigen Screen	PLOS ONE			English	Article							T-CELL EPITOPES; IDENTIFICATION; LIBRARIES	Serum antibodies are valuable source of information on the health state of an organism. The profiles of serum antibody reactivity can be generated by using a high throughput sequencing of peptide-coding DNA from combinatorial random peptide phage display libraries selected for binding to serum antibodies. Here we demonstrate that the targets of immune response, which are recognized by serum antibodies directed against sequential epitopes, can be identified using the serum antibody repertoire profiles generated by high throughput sequencing. We developed an algorithm to filter the results of the protein database BLAST search for selected peptides to distinguish real antigens recognized by serum antibodies from irrelevant proteins retrieved randomly. When we used this algorithm to analyze serum antibodies from mice immunized with human protein, we were able to identify the protein used for immunizations among the top candidate antigens. When we analyzed human serum sample from the metastatic melanoma patient, the recombinant protein, corresponding to the top candidate from the list generated using the algorithm, was recognized by antibodies from metastatic melanoma serum on the western blot, thus confirming that the method can identify autoantigens recognized by serum antibodies. We demonstrated also that our unbiased method of looking at the repertoire of serum antibodies reveals quantitative information on the epitope composition of the targets of immune response. A method for deciphering information contained in the serum antibody repertoire profiles may help to identify autoantibodies that can be used for diagnosing and monitoring autoimmune diseases or malignancies.	[Liu, Xinyue; Tallo, Luke J.; Sadzewicz, Lisa] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Hu, Qiang; Liu, Song] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; [Schettine, Cassandra A.; Ionov, Yurij] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Nikiforov, Mikhail] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Klyushnenkova, Elena N.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; University System of Maryland; University of Maryland Baltimore	Ionov, Y (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	yurij.ionov@roswellpark.org			Hubbel Family foundation; NCI [P30CA016056]; UMGCC Paul Calabresi Award [KCA126849A]; UMGCC Pilot;  [IRG-0197-07]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA120244] Funding Source: NIH RePORTER	Hubbel Family foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UMGCC Paul Calabresi Award; UMGCC Pilot; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the gift from the Hubbel Family foundation, the IRG-0197-07 grant, the NCI grant P30CA016056, the KCA126849A UMGCC Paul Calabresi Award for Clinical Oncology and UMGCC Pilot and Grant Program to Support Developing Shared Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastas G, 2008, MOL CELL PROTEOMICS, V7, P247, DOI 10.1074/mcp.M700107-MCP200; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; Ionov Y, 2010, ONCOTARGET, V1, P148, DOI 10.18632/oncotarget.118; Klyushnenkova EN, 2007, PROSTATE, V67, P1019, DOI 10.1002/pros.20575; Klyushnenkova EN, 2005, CLIN CANCER RES, V11, P2853, DOI 10.1158/1078-0432.CCR-04-1927; Mennuni C, 1997, J MOL BIOL, V268, P599, DOI 10.1006/jmbi.1997.0946; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Ryvkin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041469; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028	11	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67181	10.1371/journal.pone.0067181	http://dx.doi.org/10.1371/journal.pone.0067181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826227	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000039
J	Gay, L; Siol, M; Ronfort, J				Gay, Laurene; Siol, Mathieu; Ronfort, Joelle			Pedigree-Free Estimates of Heritability in the Wild: Promising Prospects for Selfing Populations	PLOS ONE			English	Article							QUANTITATIVE GENETIC-PARAMETERS; ESTIMATING VARIANCE-COMPONENTS; PAIRWISE RELATEDNESS; INBREEDING DEPRESSION; NATURAL-POPULATIONS; BREEDING VALUES; SPATIAL AUTOCORRELATION; INFERRED RELATEDNESS; RELATIONSHIP MATRIX; GENOMIC SELECTION	Estimating the genetic variance available for traits informs us about a population's ability to evolve in response to novel selective challenges. In selfing species, theory predicts a loss of genetic diversity that could lead to an evolutionary dead-end, but empirical support remains scarce. Genetic variability in a trait is estimated by correlating the phenotypic resemblance with the proportion of the genome that two relatives share identical by descent ('realized relatedness'). The latter is traditionally predicted from pedigrees (Phi(A): expected value) but can also be estimated using molecular markers (average number of alleles shared). Nevertheless, evolutionary biologists, unlike animal breeders, remain cautious about using marker-based relatedness coefficients to study complex phenotypic traits in populations. In this paper, we review published results comparing five different pedigree-free methods and use simulations to test individual-based models (hereafter called animal models) using marker-based relatedness coefficients, with a special focus on the influence of mating systems. Our literature review confirms that Ritland's regression method is unreliable, but suggests that animal models with marker-based estimates of relatedness and genomic selection are promising and that more testing is required. Our simulations show that using molecular markers instead of pedigrees in animal models seriously worsens the estimation of heritability in outcrossing populations, unless a very large number of loci is available. In selfing populations the results are less biased. More generally, populations with high identity disequilibrium (consanguineous or bottlenecked populations) could be propitious for using marker-based animal models, but are also more likely to deviate from the standard assumptions of quantitative genetics models (non-additive variance).	[Gay, Laurene; Siol, Mathieu; Ronfort, Joelle] UMR AGAP 1334, Montpellier, France; [Siol, Mathieu] UMR Agroecol 1347, Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne	Gay, L (corresponding author), UMR AGAP 1334, Montpellier, France.	Laurene.Gay@supagro.inra.fr	Gay, Laurene/K-6644-2014		French Research Institute INRA	French Research Institute INRA	This work was funded by the French Research Institute INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2010, P ROY SOC B-BIOL SCI, V277, P2531, DOI 10.1098/rspb.2010.0196; Andrew RL, 2005, GENETICS, V171, P1989, DOI 10.1534/genetics.105.042952; Baird NA, 2008, PLOS ONE, V3; Barton NH, 2004, EVOLUTION, V58, P2111; Bessega C, 2009, AM J BOT, V96, P458, DOI 10.3732/ajb.0800074; Blonk RJW, 2010, GENETICS, V184, P213, DOI 10.1534/genetics.109.110536; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Bouvet JM, 2008, GENET RESOUR CROP EV, V55, P1291, DOI 10.1007/s10722-008-9328-8; Brookfield JFY, 2009, BIOL LETTERS, V5, P44, DOI 10.1098/rsbl.2008.0639; Bulmer MG, 1980, MATH THEORY QUANTITA; Byers DL, 1999, ANNU REV ECOL SYST, V30, P479, DOI 10.1146/annurev.ecolsys.30.1.479; Calus MPL, 2007, J ANIM BREED GENET, V124, P362, DOI 10.1111/j.1439-0388.2007.00691.x; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; CHARLESWORTH D, 1995, EVOLUTION, V49, P911, DOI 10.2307/2410413; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; COCKERHAM CC, 1985, CROP SCI, V25, P483, DOI 10.2135/cropsci1985.0011183X002500030012x; COCKERHAM CC, 1983, THEOR POPUL BIOL, V23, P85, DOI 10.1016/0040-5809(83)90006-0; COCKERHAM CC, 1971, GENETICS, V69, P235; Coltman DW, 2005, MOL ECOL, V14, P2593, DOI 10.1111/j.1365-294X.2005.02600.x; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; DiBattista JD, 2009, EVOLUTION, V63, P1051, DOI 10.1111/j.1558-5646.2008.00605.x; Doran J. C., 1994, New Forests, V8, P155, DOI 10.1007/BF00028191; Duchesne P, 2002, MOL ECOL NOTES, V2, P191, DOI 10.1046/j.1471-8286.2002.00164.x; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frentiu FD, 2008, P R SOC B, V275, P639, DOI 10.1098/rspb.2007.1032; Garant D, 2005, MOL ECOL, V14, P1843, DOI 10.1111/j.1365-294X.2005.02561.x; Geber MA, 2003, INT J PLANT SCI, V164, pS21, DOI 10.1086/368233; Gilmore AR, 2006, ASREML USER GUIDE RE; Glemin S, 2003, GENETICS, V165, P2193; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Goldringer I, 1997, HEREDITY, V79, P60, DOI 10.1038/hdy.1997.123; Guo S-W, 1998, HUM HERED, V46, P61; Hamrick JL, 1997, CROP SCI, V37, P26, DOI 10.2135/cropsci1997.0011183X003700010004x; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Hardy OJ, 2003, MOL ECOL, V12, P1577, DOI 10.1046/j.1365-294X.2003.01835.x; Hardy OJ, 1999, HEREDITY, V83, P145, DOI 10.1046/j.1365-2540.1999.00558.x; HARRIS DL, 1964, GENETICS, V50, P1319; Hayes BJ, 2008, J ANIM SCI, V86, P2089, DOI 10.2527/jas.2007-0733; HEATH DD, 1994, HEREDITY, V72, P146, DOI 10.1038/hdy.1994.21; HEDRICK PW, 1980, GENETICS, V94, P791; Henderson C. R, 1984, APPL LINEAR MODELS A; HILL WG, 1993, HEREDITY, V71, P652, DOI 10.1038/hdy.1993.190; Hill WG, 2012, CURR GENOMICS, V13, P196, DOI 10.2174/138920212800543110; Holland J. B., 2010, ESTIMATING INTERPRET, P9; Holland JB, 2010, EPISTASIS PLANT BREE, P27; HOULE D, 1992, GENETICS, V130, P195; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; Igic B, 2006, EVOLUTION, V60, P1098, DOI 10.1111/j.0014-3820.2006.tb01186.x; Jarne P, 2006, EVOLUTION, V60, P1816; Jensen J, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-44; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Kelly JK, 1999, EVOLUTION, V53, P336, DOI 10.1111/j.1558-5646.1999.tb03770.x; Kelly JK, 2000, J THEOR BIOL, V207, P37, DOI 10.1006/jtbi.2000.2154; Klaper R, 2001, J HERED, V92, P421, DOI 10.1093/jhered/92.5.421; Kruuk LEB, 2008, P ROY SOC B-BIOL SCI, V275, P593, DOI 10.1098/rspb.2007.1689; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2008, ANNU REV ECOL EVOL S, V39, P525, DOI 10.1146/annurev.ecolsys.39.110707.173542; Kumar S, 2005, MOL BREEDING, V15, P55, DOI 10.1007/s11032-004-2059-4; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lee SH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-22; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Leroy G, 2012, ANIM GENET, V43, P309, DOI 10.1111/j.1365-2052.2011.02253.x; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lynch M, 1999, GENETICS, V152, P1753; Lynch M., 1998, GENETICS ANAL QUANTI; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Milner JM, 2000, J EVOLUTION BIOL, V13, P804, DOI 10.1046/j.1420-9101.2000.00222.x; Mousseau TA, 1998, HEREDITY, V80, P218, DOI 10.1046/j.1365-2540.1998.00269.x; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Nordborg M, 1997, GENETICS, V146, P1185; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Oliehoek PA, 2006, GENETICS, V173, P483, DOI 10.1534/genetics.105.049940; PEDERSON DG, 1969, AUST J BIOL SCI, V22, P117, DOI 10.1071/BI9690117; Pemberton JM, 2008, P ROY SOC B-BIOL SCI, V275, P613, DOI 10.1098/rspb.2007.1531; Peterson BK, 2012, PLOS ONE, P7; POLLAK E, 1987, GENETICS, V117, P353; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reid JM, 2010, EVOLUTION, V64, P973, DOI 10.1111/j.1558-5646.2009.00865.x; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Ritland K, 1996, EVOLUTION, V50, P1062, DOI [10.2307/2410647, 10.1111/j.1558-5646.1996.tb02347.x]; Ritland K, 2000, DETECTING INHERITANC; Rodriguez-Ramilo ST, 2007, CONSERV GENET, V8, P1189, DOI 10.1007/s10592-006-9273-z; Rolf MM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-24; SCHOEN DJ, 1991, P NATL ACAD SCI USA, V88, P4494, DOI 10.1073/pnas.88.10.4494; Shaw RG, 1998, GENETICS, V150, P1649; Shikano T, 2008, J HERED, V99, P94, DOI 10.1093/jhered/esm105; Sillanpaa MJ, 2011, MOL ECOL, V20, P1324, DOI 10.1111/j.1365-294X.2011.05021.x; Smith BR, 2001, GENETICS, V158, P1329; Sorensen A, 2002, GENET SEL EVOL, V34, P1; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stopher KV, 2012, EVOLUTION, V66, P2411, DOI 10.1111/j.1558-5646.2012.01620.x; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; Thomas SC, 2000, HEREDITY, V84, P427, DOI 10.1046/j.1365-2540.2000.00681.x; Thomas SC, 2000, GENETICS, V155, P1961; Thomas SC, 2002, J EVOLUTION BIOL, V15, P92, DOI 10.1046/j.1420-9101.2002.00372.x; Toro M, 2002, CONSERV GENET, V3, P309, DOI 10.1023/A:1019921131171; Usai MG, 2009, GENET RES, V91, P427, DOI 10.1017/S0016672309990334; Van Buskirk J, 2006, EVOLUTION, V60, P2428, DOI 10.1111/j.0014-3820.2006.tb01879.x; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; van Kleunen M, 2005, J HERED, V96, P368, DOI 10.1093/jhered/esi039; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Veerkamp RF, 2011, J DAIRY SCI, V94, P4189, DOI 10.3168/jds.2011-4223; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Villanueva B, 2005, J ANIM SCI, V83, P1747; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2009, GENETICA, V136, P351, DOI 10.1007/s10709-008-9301-7; Vogler DW, 2001, EVOLUTION, V55, P202, DOI 10.1111/j.0014-3820.2001.tb01285.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wang JL, 2002, GENETICS, V160, P1203; WEIR BS, 1973, GENET RES, V21, P247, DOI 10.1017/S0016672300013446; Wilson AJ, 2003, GENET RES, V81, P145, DOI 10.1017/S0016672302006055; Wright A J, 1985, SELECTION PARTIAL SE; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	134	17	17	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66983	10.1371/journal.pone.0066983	http://dx.doi.org/10.1371/journal.pone.0066983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825602	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000056
J	Heerwagen, MJR; Stewart, MS; de la Houssaye, BA; Janssen, RC; Friedman, JE				Heerwagen, Margaret J. R.; Stewart, Michael S.; de la Houssaye, Becky A.; Janssen, Rachel C.; Friedman, Jacob E.			Transgenic Increase in N-3/N-6 Fatty Acid Ratio Reduces Maternal Obesity-Associated Inflammation and Limits Adverse Developmental Programming in Mice	PLOS ONE			English	Article							BODY-MASS INDEX; ADIPOSE-TISSUE; INSULIN-RESISTANCE; EARLY-CHILDHOOD; LIPOPROTEIN-LIPASE; GROWTH RESTRICTION; GLUCOSE-TOLERANCE; FETAL-GROWTH; RISK-FACTORS; FAT-1 MOUSE	Maternal and pediatric obesity has risen dramatically over recent years, and is a known predictor of adverse long-term metabolic outcomes in offspring. However, which particular aspects of obese pregnancy promote such outcomes is less clear. While maternal obesity increases both maternal and placental inflammation, it is still unknown whether this is a dominant mechanism in fetal metabolic programming. In this study, we utilized the Fat-1 transgenic mouse to test whether increasing the maternal n-3/n-6 tissue fatty acid ratio could reduce the consequences of maternal obesity-associated inflammation and thereby mitigate downstream developmental programming. Eight-week-old WT or hemizygous Fat-1 C57BL/6J female mice were placed on a high-fat diet (HFD) or control diet (CD) for 8 weeks prior to mating with WT chowfed males. Only WT offspring from Fat-1 mothers were analyzed. WT-HFD mothers demonstrated increased markers of infiltrating adipose tissue macrophages (P<0.02), and a striking increase in 12 serum pro-inflammatory cytokines (P<0.05), while Fat1-HFD mothers remained similar to WT-CD mothers, despite equal weight gain. E18.5 Fetuses from WT-HFD mothers had larger placentas (P<0.02), as well as increased placenta and fetal liver TG deposition (P<0.01 and P<0.02, respectively) and increased placental LPL TG-hydrolase activity (P<0.02), which correlated with degree of maternal insulin resistance (r = 0.59, P<0.02). The placentas and fetal livers from Fat1-HFD mothers were protected from this excess placental growth and fetal-placental lipid deposition. Importantly, maternal protection from excess inflammation corresponded with improved metabolic outcomes in adult WT offspring. While the offspring from WT-HFD mothers weaned onto CD demonstrated increased weight gain (P<0.05), body and liver fat (P<0.05 and P<0.001, respectively), and whole body insulin resistance (P<0.05), these were prevented in WT offspring from Fat1-HFD mothers. Our results suggest that reducing excess maternal inflammation may be a promising target for preventing adverse fetal metabolic outcomes in pregnancies complicated by maternal obesity.	[Heerwagen, Margaret J. R.; Stewart, Michael S.; de la Houssaye, Becky A.; Janssen, Rachel C.; Friedman, Jacob E.] Univ Colorado, Sch Med, Dept Pediat, Div Neonatol, Aurora, CO USA; [Friedman, Jacob E.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Friedman, JE (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Div Neonatol, Aurora, CO USA.	jed.friedman@ucdenver.edu			National Institutes of Health [DK-5R01DK062155]; Colorado Nutrition and Obesity Research (NORC) NIH [P30 DK048520]; American Heart Association [AHA-11PRE5020014]; Colorado Clinical Translational Science Institute [TL1-RR-025778]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001081] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R24DK090964, R01DK062155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Nutrition and Obesity Research (NORC) NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Colorado Clinical Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge support for this study from the National Institutes of Health DK-5R01DK062155, the Colorado Nutrition and Obesity Research (NORC) NIH P30 DK048520, the American Heart Association Predoctoral Fellowship AHA-11PRE5020014, and the Colorado Clinical Translational Science Institute T32 Grant TL1-RR-025778. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzamendi Ana, 2012, ISRN Endocrinol, V2012, P757913, DOI 10.5402/2012/757913; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Aviram A, 2011, INT J GYNECOL OBSTET, V115, pS6, DOI 10.1016/S0020-7292(11)60004-0; Baranowski M, 2012, CYTOKINE, V59, P382, DOI 10.1016/j.cyto.2012.04.004; Barroso CS, 2012, CHILD OBES, V8, P449, DOI 10.1089/chi.2011.0094; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Bilal S, 2011, BBA-MOL BASIS DIS, V1812, P1164, DOI 10.1016/j.bbadis.2011.05.002; Birbilis M, 2013, EUR J CLIN NUTR, V67, P115, DOI 10.1038/ejcn.2012.176; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Brumbaugh DE, 2012, J PEDIAT; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Cole BK, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/851798; Cordero P, 2012, J ENDOCRINOL INVEST, V35, P981, DOI 10.1007/BF03346741; Crawford MA, 2000, AM J CLIN NUTR, V71, p275S, DOI 10.1093/ajcn/71.1.275S; Cunningham P, 2009, J NUTR, V139, P636, DOI 10.3945/jn.108.098608; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; DuBois BN, 2012, PLACENTA, V33, P1045, DOI 10.1016/j.placenta.2012.09.008; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Durnwald C, 2004, AM J OBSTET GYNECOL, V191, P804, DOI 10.1016/j.ajog.2003.11.033; ECKEL RH, 1995, INT J OBESITY, V19, pS16; Eckel RH, 1986, METHODS DIABETES RES, V2, P259; Ehrenthal DB, 2013, OBSTET GYNECOL, V121, P115, DOI [10.1097/AOG.0b013e318278f56a, http://10.1097/AOG.0b013e318278f56a]; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Gil-Sanchez Alfonso, 2011, Frontiers in Genetics, V2, P57, DOI 10.3389/fgene.2011.00057; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; Gravaghi C, 2011, J NUTR BIOCHEM, V22, P360, DOI 10.1016/j.jnutbio.2010.03.003; Haggarty P, 2002, PLACENTA, V23, pS28, DOI 10.1053/plac.2002.0791; Hagopian K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012696; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Jones ML, 2012, BIOL REPROD; Jungheim ES, 2011, BIOL REPROD, V85, P678, DOI 10.1095/biolreprod.111.092148; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kappen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038445; Kim EH, 2012, BIOCHEM PHARMACOL, V84, P1359, DOI 10.1016/j.bcp.2012.08.029; Krasnow SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1243, DOI 10.1152/ajpendo.00261.2011; Burgueno AL, 2013, J NUTR BIOCHEM, V24, P6, DOI 10.1016/j.jnutbio.2011.12.008; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026656; Long NM, 2012, J ANIM SCI, V90, P2201, DOI 10.2527/jas.2011-4343; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Monk JM, 2012, J NUTR, V142, P117, DOI 10.3945/jn.111.147058; Moon RJ, 2013, J CLIN ENDOCR METAB, V98, P299, DOI 10.1210/jc.2012-2482; Mouralidarane A, 2013, HEPATOLOGY; Much D, 2013, EUR J CLIN NUTR, V67, P282, DOI 10.1038/ejcn.2013.2; Muhlhausler BS, 2011, PROSTAG LEUKOTR ESS, V85, P83, DOI 10.1016/j.plefa.2011.04.027; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Niculescu MD, 2009, INT J DEV NEUROSCI, V27, P627, DOI 10.1016/j.ijdevneu.2009.08.005; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Orr SK, 2010, NEUROCHEM RES, V35, P811, DOI 10.1007/s11064-010-0139-x; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023; Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301; Shankar K, 2011, ENDOCRINOLOGY, V152, P4158, DOI 10.1210/en.2010-1078; Smith BK, 2010, APPL PHYSIOL NUTR ME, V35, P699, DOI 10.1139/H10-066; Strakovsky RS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094482; Torres-Rovira L, 2013, J STEROID BIOCHEM; Turdi S, 2012, J MOL CELL CARDIOL; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vonnahme KA, 2013, J ANIM SCI; Wadhwani NS, 2013, PROSTAG LEUKOTR ESS, V88, P235, DOI 10.1016/j.plefa.2012.12.002; Wallace JM, 2012, PLACENTA, V33, P611, DOI 10.1016/j.placenta.2012.05.006; Wallace JM, 2004, BIOL REPROD, V71, P1055, DOI 10.1095/biolreprod.104.030965; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005; Weylandt KH, 2008, BBA-MOL BASIS DIS, V1782, P634, DOI 10.1016/j.bbadis.2008.08.011; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhu MJ, 2010, PLACENTA, V31, P387, DOI 10.1016/j.placenta.2010.02.002	85	87	88	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67791	10.1371/journal.pone.0067791	http://dx.doi.org/10.1371/journal.pone.0067791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825686	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000120
J	Oosterkamp, MJ; Veuskens, T; Saia, FT; Weelink, SAB; Goodwin, LA; Daligault, HE; Bruce, DC; Detter, JC; Tapia, R; Han, CS; Land, ML; Hauser, LJ; Langenhoff, AAM; Gerritse, J; van Berkel, WJH; Pieper, DH; Junca, H; Smidt, H; Schraa, G; Davids, M; Schaap, PJ; Plugge, CM; Stams, AJM				Oosterkamp, Margreet J.; Veuskens, Teun; Saia, Flavia Talarico; Weelink, Sander A. B.; Goodwin, Lynne A.; Daligault, Hajnalka E.; Bruce, David C.; Detter, John C.; Tapia, Roxanne; Han, Cliff S.; Land, Miriam L.; Hauser, Loren J.; Langenhoff, Alette A. M.; Gerritse, Jan; van Berkel, Willem J. H.; Pieper, Dietmar H.; Junca, Howard; Smidt, Hauke; Schraa, Gosse; Davids, Mark; Schaap, Peter J.; Plugge, Caroline M.; Stams, Alfons J. M.			Genome Analysis and Physiological Comparison of Alicycliphilus denitrificans Strains BC and K601(T)	PLOS ONE			English	Article							PERIPLASMIC NITRATE REDUCTASE; ANAEROBIC BENZENE DEGRADATION; CYTOCHROME-C-OXIDASE; AROMATIC-COMPOUNDS; PERCHLORATE REDUCTION; CHLORITE DISMUTASE; 1ST STEP; CYCLOHEXANOL; METABOLISM; BIODEGRADATION	The genomes of the Betaproteobacteria Alicycliphilus denitrificans strains BC and K601(T) have been sequenced to get insight into the physiology of the two strains. Strain BC degrades benzene with chlorate as electron acceptor. The cyclohexanol-degrading denitrifying strain K601(T) is not able to use chlorate as electron acceptor, while strain BC cannot degrade cyclohexanol. The 16S rRNA sequences of strains BC and K601(T) are identical and the fatty acid methyl ester patterns of the strains are similar. Basic Local Alignment Search Tool (BLAST) analysis of predicted open reading frames of both strains showed most hits with Acidovorax sp. JS42, a bacterium that degrades nitro-aromatics. The genomes include strain-specific plasmids (pAlide201 in strain K601(T) and pAlide01 and pAlide02 in strain BC). Key genes of chlorate reduction in strain BC were located on a 120 kb megaplasmid (pAlide01), which was absent in strain K601(T). Genes involved in cyclohexanol degradation were only found in strain K601(T). Benzene and toluene are degraded via oxygenase-mediated pathways in both strains. Genes involved in the meta-cleavage pathway of catechol are present in the genomes of both strains. Strain BC also contains all genes of the ortho-cleavage pathway. The large number of mono-and dioxygenase genes in the genomes suggests that the two strains have a broader substrate range than known thus far.	[Oosterkamp, Margreet J.; Veuskens, Teun; Saia, Flavia Talarico; Weelink, Sander A. B.; Smidt, Hauke; Schraa, Gosse; Plugge, Caroline M.; Stams, Alfons J. M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Goodwin, Lynne A.; Daligault, Hajnalka E.; Bruce, David C.; Detter, John C.; Tapia, Roxanne; Han, Cliff S.] Los Alamos Natl Lab, Joint Genome Inst, Los Alamos, NM USA; [Land, Miriam L.; Hauser, Loren J.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA; [Land, Miriam L.; Hauser, Loren J.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Langenhoff, Alette A. M.; Gerritse, Jan] Deltares, Utrecht, Netherlands; [van Berkel, Willem J. H.] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands; [Pieper, Dietmar H.] Helmholz Ctr Infect Res, Microbial Interact & Proc Res Grp, Braunschweig, Germany; [Junca, Howard] CorpoGen, Res Grp Microbial Ecol Metab Genom & Evolut Commu, Bogota, Colombia; [Davids, Mark; Schaap, Peter J.] Wageningen Univ, Lab Syst & Synth Biol, NL-6700 AP Wageningen, Netherlands; [Stams, Alfons J. M.] Univ Minho, Ctr Biol Engn, Braga, Portugal	Wageningen University & Research; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); United States Department of Energy (DOE); Oak Ridge National Laboratory; Deltares; Wageningen University & Research; Wageningen University & Research; Universidade do Minho	Stams, AJM (corresponding author), Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands.	fons.stams@wur.nl	Saia, Flávia/AFU-8666-2022; Junca, Howard/K-5525-2014; Land, Miriam L/A-6200-2011; Smidt, Hauke/D-7054-2014; van Berkel, Willem J.H./O-2431-2014; Langenhoff, Alette/J-5795-2012; Stams, Alfons/C-8167-2014	Junca, Howard/0000-0003-4546-6229; Land, Miriam L/0000-0001-7102-0031; Smidt, Hauke/0000-0002-6138-5026; van Berkel, Willem J.H./0000-0002-6551-2782; Langenhoff, Alette/0000-0002-9622-007X; Gerritse, Jan/0000-0003-2184-6630; Stams, Alfons/0000-0001-7840-6500; Schaap, Peter/0000-0002-4346-6084	Technology Foundation; Applied Science Division (STW) of the Netherlands Organization for Scientific Research (NWO) [08053]; graduate school WIMEK (Wageningen Institute for Environment and Climate Research, which is part of SENSE Research School for Socio-Economic and Natural Sciences of the Environment); SKB (Dutch Centre for Soil Quality Management and Knowledge Transfer); Consolider project [CSD-2007-00055]; FAPESP (the State of Sao Paulo Research Foundation) [2006-01997/ 5]; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; ERC (European Research Counsil) [323009]	Technology Foundation; Applied Science Division (STW) of the Netherlands Organization for Scientific Research (NWO)(Technologiestichting STWNetherlands Organization for Scientific Research (NWO)); graduate school WIMEK (Wageningen Institute for Environment and Climate Research, which is part of SENSE Research School for Socio-Economic and Natural Sciences of the Environment); SKB (Dutch Centre for Soil Quality Management and Knowledge Transfer); Consolider project(Spanish Government); FAPESP (the State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); ERC (European Research Counsil)	This research was supported by the Technology Foundation, the Applied Science Division (STW) of the Netherlands Organization for Scientific Research (NWO), project number 08053, the graduate school WIMEK (Wageningen Institute for Environment and Climate Research, which is part of SENSE Research School for Socio-Economic and Natural Sciences of the Environment, www.wimek-new.wur.nl and www.sense.nl), SKB (Dutch Centre for Soil Quality Management and Knowledge Transfer, www.skbodem.nl) and the Consolider project CSD-2007-00055. The research was incorporated in the TRIAS (TRIpartite Approaches 469 toward Soil systems processes) program (http://www.nwo.nl/en/research-and-results/programmes/alw/trias-tripartite-approach-to-soil-system-processes/index.html). Flavia Talarico Saia was supported by a FAPESP (the State of Sao Paulo Research Foundation) scholarship (2006-01997/ 5). The work conducted by the DOE JGI is supported by the Office of Science of the United States Department of Energy under contract number DE-AC02-05CH11231. Alfons Stams acknowledges support by an ERC (European Research Counsil) advanced grant (project 323009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Laban N, 2009, FEMS MICROBIOL ECOL, V68, P300, DOI 10.1111/j.1574-6941.2009.00672.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade SLA, 2000, EUR J BIOCHEM, V267, P2054, DOI 10.1046/j.1432-1327.2000.01209.x; Bedzyk L, 1999, J BACTERIOL, V181, P2802, DOI 10.1128/JB.181.9.2802-2806.1999; BELL LC, 1990, FEBS LETT, V265, P85, DOI 10.1016/0014-5793(90)80889-Q; Bender KS, 2005, J BACTERIOL, V187, P5090, DOI 10.1128/JB.187.15.5090-5096.2005; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Boll M, 2002, CURR OPIN CHEM BIOL, V6, P604, DOI 10.1016/S1367-5931(02)00375-7; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; Cafaro V, 2004, APPL ENVIRON MICROB, V70, P2211, DOI 10.1128/AEM.70.4.2211-2219.2004; Cao B, 2009, APPL MICROBIOL BIOT, V85, P207, DOI 10.1007/s00253-009-2192-4; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Chakraborty R, 2005, APPL ENVIRON MICROB, V71, P5427, DOI 10.1128/AEM.71.9.5427-5432.2005; Coates J. D., 1999, BIOREMEDIAT J, V3, P323, DOI [10.1080/10889869991219415, DOI 10.1080/10889869991219415]; Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926; DANGEL W, 1989, ARCH MICROBIOL, V152, P273, DOI 10.1007/BF00409663; DANGEL W, 1988, ARCH MICROBIOL, V150, P358, DOI 10.1007/BF00408307; Danielsson H, 2003, APPL ENVIRON MICROB, V69, P5585, DOI 10.1128/AEM.69.9.5585-5592.2003; Di Gennaro P, 2011, APPL MICROBIOL BIOT, V90, P1817, DOI 10.1007/s00253-011-3285-4; Dou JF, 2010, J ENVIRON SCI-CHINA, V22, P709, DOI 10.1016/S1001-0742(09)60167-4; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Han C., 2006, P 2006 INT C BIOINF, P141; HARAYAMA S, 1987, J BACTERIOL, V169, P558, DOI 10.1128/jb.169.2.558-564.1987; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Holmes DE, 2011, APPL ENVIRON MICROB, V77, P5926, DOI 10.1128/AEM.05452-11; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jin JF, 2011, APPL MICROBIOL BIOT, V89, P1831, DOI 10.1007/s00253-010-2996-2; Kasai Y, 2006, APPL ENVIRON MICROB, V72, P3586, DOI 10.1128/AEM.72.5.3586-3592.2006; Kivisaar M, 2009, MOL MICROBIOL, V74, P777, DOI 10.1111/j.1365-2958.2009.06905.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; Logan B. E. A., 1998, BIOREMEDIAT J, V2, P69, DOI DOI 10.1080/10889869891214222; Logan Bruce E., 2002, Bioremediation Journal, V6, P87, DOI 10.1080/10588330208951205; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mechichi T, 2003, INT J SYST EVOL MICR, V53, P147, DOI 10.1099/ijs.0.02276-0; Melnyk RA, 2011, APPL ENVIRON MICROB, V77, P7401, DOI 10.1128/AEM.05758-11; Morikawa M, 2010, APPL MICROBIOL BIOT, V87, P1595, DOI 10.1007/s00253-010-2715-z; Mukherjee AK, 2012, ENVIRON SCI POLLUT R, V19, P3380, DOI 10.1007/s11356-012-0862-8; Musat F, 2008, ENVIRON MICROBIOL, V10, P10, DOI 10.1111/j.1462-2920.2007.01425.x; NEWMAN LM, 1995, BIOCHEMISTRY-US, V34, P14066, DOI 10.1021/bi00043a012; NORRIS DB, 1971, BIOCHEM J, V121, P363, DOI 10.1042/bj1210363; Oosterkamp MJ, 2011, BIOCHEM SOC T, V39, P230, DOI 10.1042/BST0390230; Oosterkamp MJ, 2011, GENOME SEQUENCES ALI; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Perez-Pantoja D, 2010, HDB HYDROCARBON LIPI, P799, DOI DOI 10.1007/978-3-540-77587-4_60; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rikken GB, 1996, APPL MICROBIOL BIOT, V45, P420, DOI 10.1007/s002530050707; Rusmana I, 2004, FEMS MICROBIOL ECOL, V48, P379, DOI 10.1016/j.femsec.2004.02.010; Salinero KK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-351; SHINGLER V, 1994, J BACTERIOL, V176, P1555, DOI 10.1128/jb.176.6.1555-1560.1994; Stolz JF, 2002, CHEMBIOCHEM, V3, P198, DOI 10.1002/1439-7633(20020301)3:2/3<198::AID-CBIC198>3.0.CO;2-C; Suenaga H, 2009, ISME J, V3, P1335, DOI 10.1038/ismej.2009.76; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Thorell HD, 2002, BBA-GENE STRUCT EXPR, V1577, P445, DOI 10.1016/S0167-4781(02)00446-3; Trudgill PW, 1984, MICROBIAL DEGRADATIO; vanGlinkel CG, 1996, ARCH MICROBIOL, V166, P321, DOI 10.1007/s002030050390; Vogt C, 2011, MICROB BIOTECHNOL, V4, P710, DOI 10.1111/j.1751-7915.2011.00260.x; Weelink SAB, 2008, APPL ENVIRON MICROB, V74, P6672, DOI 10.1128/AEM.00835-08; Weelink SAB, 2007, FEMS MICROBIOL ECOL, V60, P312, DOI 10.1111/j.1574-6941.2007.00289.x; Weelink SAB, 2010, REV ENVIRON SCI BIO, V9, P359, DOI 10.1007/s11157-010-9219-2; Wu ML, 2011, BIOCHEM SOC T, V39, P243, DOI 10.1042/BST0390243; Zedelius J, 2011, ENV MICROBIOL REP, V3, P125, DOI 10.1111/j.1758-2229.2010.00198.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	75	23	23	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66971	10.1371/journal.pone.0066971	http://dx.doi.org/10.1371/journal.pone.0066971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825601	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000055
J	Tzeng, ST; Tsai, MH; Chen, CL; Lee, JX; Jao, TM; Yu, SL; Yen, SJ; Yang, YC				Tzeng, Sheng-Tai; Tsai, Ming-Hong; Chen, Chi-Long; Lee, Jing-Xing; Jao, Tzu-Ming; Yu, Sung-Liang; Yen, Sou-Jhy; Yang, Ya-Chien			NDST4 Is a Novel Candidate Tumor Suppressor Gene at Chromosome 4q26 and Its Genetic Loss Predicts Adverse Prognosis in Colorectal Cancer	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MOLECULAR MARKERS; SULFOTRANSFERASE; CARCINOMA; DELETIONS; BIOSYNTHESIS; PATHOGENESIS; INSTABILITY; ISOZYMES; PATTERNS	Background: Genomic deletion at tumor suppressor loci is a common genetic aberration in human cancers. The study aimed to explore candidate tumor suppressor genes at chromosome 4q25-q28.2 and to delineate novel prognostic biomarkers associated with colorectal cancer (CRC). Methods: Deletion mapping of chromosome 4q25-q28.2 was conducted in 114 sporadic CRC by loss of heterozygosity study with 11 microsatellite markers. A novel candidate tumor suppressor gene, namely NDST4, was identified at 4q26. Gene expression of NDST4 was investigated in 52 pairs of primary CRC tissues by quantitative reverse transcription-polymerase chain reaction. Allelic loss of NDST4 gene was further determined in 174 colorectal carcinomas by loss of heterozygosity analysis, and then was assessed for clinical relevance. Results: One minimal deletion region was delineated between D4S2297 and D4S2303 loci at 4q26, where NDST4 was the only gene that had markedly been downregulated in CRC tumors. By laser capture microdissection, NDST4 RNA expression was demonstrated in colonic epithelial cells, but was undetectable in tumor cells. In total, 30 (57.7%) of 52 colorectal carcinomas showed a dramatic reduction in NDST4 gene expression compared with matched normal mucosae. The genetic loss of NDST4 was significantly associated with advanced pathological stage (P = 0.039) and poorer overall survival of patients (P = 0.036). Conclusions: NDST4 gene is a novel candidate tumor suppressor gene in human cancer, and the loss of its function might be involved in CRC progression. In addition, the loss of heterozygosity assay, which was established to determine the allelic loss of NDST4 gene, could be a cost-effective tool for providing a useful biomarker of adverse prognosis in CRC.	[Tzeng, Sheng-Tai; Lee, Jing-Xing; Jao, Tzu-Ming; Yu, Sung-Liang; Yang, Ya-Chien] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Tsai, Ming-Hong; Yen, Sou-Jhy] Cardinal Tien Hosp, Dept Surg, New Taipei City, Taiwan; [Tsai, Ming-Hong] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Chen, Chi-Long] Taipei Municipal Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Chen, Chi-Long] Taipei Med Univ, Taipei, Taiwan; [Yu, Sung-Liang; Yang, Ya-Chien] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; Cardinal Tien Hospital; Fu Jen Catholic University; Taipei Municipal WanFang Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital	Yang, YC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	ycyangntu@ntu.edu.tw	Jao, Tzu-Ming/GQB-1940-2022; Jao, Tzu-Ming/L-3490-2019	Jao, Tzu-Ming/0000-0003-2676-292X; YANG, YA-CHIEN/0000-0002-9981-210X; Tzeng, Sheng-Tai/0000-0002-0089-0512; YU, SUNG-LIANG/0000-0003-4535-9036	National Science Council, Executive Yuan [NSC99-2320-B-002-020-MY3]; Cardinal Tien Hospital [CTH-93-1-2A01]; National Health Research Institutes, Taiwan [NHRI-EX101-10136BI]	National Science Council, Executive Yuan(Ministry of Science and Technology, Taiwan); Cardinal Tien Hospital; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	The study was supported by grants from the National Science Council, Executive Yuan (NSC99-2320-B-002-020-MY3), the Cardinal Tien Hospital (CTH-93-1-2A01), and the National Health Research Institutes (NHRI-EX101-10136BI), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Arai Y, 2010, GENE CHROMOSOME CANC, V49, P596, DOI 10.1002/gcc.20770; Arribas R, 1999, CLIN CANCER RES, V5, P3454; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bendardaf R, 2004, ANTICANCER RES, V24, P2519; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Duffy MJ, 2011, CANCER TREAT REV, V37, P151, DOI 10.1016/j.ctrv.2010.07.004; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fernandez-Vega I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-24; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Harrison S, 2011, SURG-J R COLL SURG E, V9, P200, DOI 10.1016/j.surge.2011.01.011; Jones AM, 2007, J PATHOL, V213, P249, DOI 10.1002/path.2234; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kjellen L, 2003, BIOCHEM SOC T, V31, P340, DOI 10.1042/BST0310340; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LASKO D, 1991, ANNU REV GENET, V25, P281, DOI 10.1146/annurev.ge.25.120191.001433; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurje G, 2007, CLIN COLORECTAL CANC, V6, P683, DOI 10.3816/CCC.2007.n.037; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Perea J, 2011, REV ESP ENFERM DIG, V103, P29, DOI 10.4321/s1130-01082011000100006; Raman Karthik, 2010, Curr Chem Biol, V4, P20; Raman K, 2011, FEBS LETT, V585, P3420, DOI 10.1016/j.febslet.2011.09.030; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Sarrazin S, 2011, COLD SPRING HARB PER, V3; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Shivapurkar N, 2001, HUM PATHOL, V32, P169, DOI 10.1053/hupa.2001.21560; Singh RK, 2007, HUM GENET, V122, P71, DOI 10.1007/s00439-007-0375-6; Tsai MH, 2002, HEPATO-GASTROENTEROL, V49, P672; van Engeland M, 2011, J CLIN ONCOL, V29, P1382, DOI 10.1200/JCO.2010.28.2319; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67040	10.1371/journal.pone.0067040	http://dx.doi.org/10.1371/journal.pone.0067040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825612	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000064
J	Anderson, LN; Cotterchio, M; Knight, JA; Borgida, A; Gallinger, S; Cleary, SP				Anderson, Laura N.; Cotterchio, Michelle; Knight, Julia A.; Borgida, Ayelet; Gallinger, Steven; Cleary, Sean P.			Genetic Variants in Vitamin D Pathway Genes and Risk of Pancreas Cancer; Results from a Population-Based Case-Control Study in Ontario, Canada	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; 25-HYDROXYVITAMIN D; PROLIFERATION; DIETARY; BREAST	Recent studies of 25-hydroxyvitamin D (25(OH)D) levels and pancreas cancer have suggested a potential role of the vitamin D pathway in the etiology of this fatal disease. Variants in vitamin-D related genes are known to affect 25(OH)D levels and function and it is unknown if these variants may influence pancreatic cancer risk. The association between 87 single nucleotide polymorphisms (SNPs) in 11 genes was evaluated within the Ontario Pancreas Cancer Study, a population-based case-control study. Pancreatic cancer cases with pathology confirmed adenocarcinoma were identified from the Ontario Cancer Registry (n = 628) and controls were identified through random digit dialing (n = 1193). Age and sex adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated by multivariate logistic regression. SNPs in the CYP24A1, CYP2R1, calcium sensing receptor (CASR), vitamin D binding protein (GC), retinoid X receptor-alpha (RXRA) and megalin (LRP2) genes were significantly associated with pancreas cancer risk. For example, pancreas cancer risk was inversely associated with CYP2R1 rs10741657 (AA versus GG, OR = 0.70; 95%CI: 0.51-0.95) and positively with CYP24A1 rs6127119 (TT versus CC. OR = 1.94; 95%CI: 1.28-2.94). None of the associations were statistically significant after adjustment for multiple comparisons. Vitamin D pathway gene variants may be associated with pancreas cancer risk and future studies are needed to understand the possible role of vitamin D in tumorigenesis and may have implications for cancer-prevention strategies.	[Anderson, Laura N.; Knight, Julia A.; Gallinger, Steven; Cleary, Sean P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Cotterchio, Michelle; Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cotterchio, Michelle] Canc Care Ontario, Canc Prevent & Control, Toronto, ON, Canada; [Borgida, Ayelet] Mt Sinai Hosp, Zane Cohen Digest Dis Clin Res Ctr, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven; Cleary, Sean P.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Cleary, SP (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sean.cleary@uhn.on.ca	Knight, Julia/A-6843-2012; Anderson, Laura/K-4707-2019; Knight, Julia/R-5617-2019; Gallinger, Steven/E-4575-2013	Anderson, Laura/0000-0002-6106-5073; Knight, Julia/0000-0002-7610-7635; Cleary, Sean/0000-0002-5274-9983	Robert Elliott and Paul Wilson Fund; Canadian Institute for Health Research [MOP119412]; National Institutes of Health (as part of the PACGENE consortium) [R01 CA97075]; National Cancer Institute, National Institutes of Health under RFA [CA-95-011]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; Colon Cancer Family Registry (CFRs) and Principle Investigators; National Cancer Institute of Canada [13304]; NATIONAL CANCER INSTITUTE [R01CA097075, U01CA074783, UM1CA167551, U24CA074783, K22CA095011] Funding Source: NIH RePORTER	Robert Elliott and Paul Wilson Fund; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (as part of the PACGENE consortium)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ontario Registry for Studies of Familial Colorectal Cancer; Colon Cancer Family Registry (CFRs) and Principle Investigators; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by funding from the Robert Elliott and Paul Wilson Fund, the Canadian Institute for Health Research (MOP119412), the National Institutes of Health (R01 CA97075, as part of the PACGENE consortium), and the National Cancer Institute, National Institutes of Health under RFA number CA-95-011, the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), and through cooperative agreements with members of the Colon Cancer Family Registry (CFRs) and Principle Investigators, and the National Cancer Institute of Canada (grant number 13304). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government or the CFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Anderson LN, 2009, CANCER CAUSE CONTROL, V20, P825, DOI 10.1007/s10552-009-9303-5; Andreassen TK, 2006, HORM METAB RES, V38, P279, DOI 10.1055/s-2006-925348; Bao Y, 2010, BRIT J CANCER, V102, P1422, DOI 10.1038/sj.bjc.6605658; Chlebowski RT, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2846; Ding EL, 2008, INT J CANCER, V122, P1690, DOI 10.1002/ijc.23311; Dong LM, 2008, CANCER EPIDEM BIOMAR, V17, P2755, DOI 10.1158/1055-9965.EPI-08-0388; Fleet JC, 2012, BIOCHEM J, V441, P61, DOI 10.1042/BJ20110744; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Hibler EA, 2012, CANCER EPIDEM BIOMAR, V21, P368, DOI 10.1158/1055-9965.EPI-11-0916; Holt SK, 2008, CLIN CANCER RES, V14, P3823, DOI 10.1158/1078-0432.CCR-07-4566; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Jacobs ET, 2010, CARCINOGENESIS, V31, P1412, DOI 10.1093/carcin/bgq127; Jang JH, 2012, CARCINOGENESIS, V33, P818, DOI 10.1093/carcin/bgs028; Maisonneuve P, 2010, DIGEST DIS, V28, P645, DOI 10.1159/000320068; McCullough ML, 2009, ANNU REV NUTR, V29, P111, DOI 10.1146/annurev-nutr-080508-141248; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; Persons KS, 2010, ANTICANCER RES, V30, P1875; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Sanchez GV, 2012, MOL CARCINOGEN, V51, P119, DOI 10.1002/mc.20833; Schwartz GG, 2008, CANCER BIOL THER, V7, P430, DOI 10.4161/cbt.7.3.5418; Schwartz GG, 2004, CARCINOGENESIS, V25, P1015, DOI 10.1093/carcin/bgh086; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Skinner HG, 2006, CANCER EPIDEM BIOMAR, V15, P1688, DOI 10.1158/1055-9965.EPI-06-0206; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Warnes G., 2008, GENETICS POPULATION; Wolpin BM, 2012, CANCER EPIDEM BIOMAR, V21, P82, DOI 10.1158/1055-9965.EPI-11-0836; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Zablotska LB, 2011, CANCER CAUSE CONTROL, V22, P91, DOI 10.1007/s10552-010-9678-3; Zavoral M, 2011, WORLD J GASTROENTERO, V17, P2897, DOI 10.3748/wjg.v17.i24.2897; Zhang XH, 2011, BEST PRACT RES CL GA, V25, P485, DOI 10.1016/j.bpg.2011.10.001	33	29	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66768	10.1371/journal.pone.0066768	http://dx.doi.org/10.1371/journal.pone.0066768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826131	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400049
J	Bjorndal, B; Brattelid, T; Strand, E; Vigerust, NF; Frodahl, G; Svingen, T; Svardal, A; Nygard, O; Berge, RK				Bjorndal, Bodil; Brattelid, Trond; Strand, Elin; Vigerust, Natalya Filipchuk; Frodahl, Gard; Svingen, Tveitevag; Svardal, Asbjorn; Nygard, Ottar; Berge, Rolf Kristian			Fish Oil and the Pan-PPAR Agonist Tetradecylthioacetic Acid Affect the Amino Acid and Carnitine Metabolism in Rats	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; SKELETAL-MUSCLE; FATTY-ACIDS; ALPHA-ACTIVATION; BETA-OXIDATION; PEROXISOME; ACYLCARNITINES; GENE; FENOFIBRATE; INDUCTION	Peroxisome proliferator-activated receptors (PPARs) are important in the regulation of lipid and glucose metabolism. Recent studies have shown that PPAR alpha-activation by WY 14,643 regulates the metabolism of amino acids. We investigated the effect of PPAR activation on plasma amino acid levels using two PPAR alpha activators with different ligand binding properties, tetradecylthioacetic acid (TTA) and fish oil, where the pan-PPAR agonist TTA is a more potent ligand than omega-3 polyunsaturated fatty acids. In addition, plasma L-carnitine esters were investigated to reflect cellular fatty acid catabolism. Male Wistar rats (Rattus norvegicus) were fed a high-fat (25% w/w) diet including TTA (0.375%, w/w), fish oil (10%, w/w) or a combination of both. The rats were fed for 50 weeks, and although TTA and fish oil had hypotriglyceridemic effects in these animals, only TTA lowered the body weight gain compared to high fat control animals. Distinct dietary effects of fish oil and TTA were observed on plasma amino acid composition. Administration of TTA led to increased plasma levels of the majority of amino acids, except arginine and lysine, which were reduced. Fish oil however, increased plasma levels of only a few amino acids, and the combination showed an intermediate or TTA-dominated effect. On the other hand, TTA and fish oil additively reduced plasma levels of the L-carnitine precursor gamma-butyrobetaine, as well as the carnitine esters acetylcarnitine, propionylcarnitine, valeryl/isovalerylcarnitine, and octanoylcarnitine. These data suggest that while both fish oil and TTA affect lipid metabolism, strong PPAR alpha activation is required to obtain effects on amino acid plasma levels. TTA and fish oil may influence amino acid metabolism through different metabolic mechanisms.	[Bjorndal, Bodil; Strand, Elin; Vigerust, Natalya Filipchuk; Frodahl, Gard; Svingen, Tveitevag; Svardal, Asbjorn; Nygard, Ottar; Berge, Rolf Kristian] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Brattelid, Trond] Natl Inst Nutr & Seafood Res, NIFES, Bergen, Norway; [Nygard, Ottar; Berge, Rolf Kristian] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Bjorndal, B (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	Bodil.Bjorndal@k2.uib.no	Bjørndal, Bodil/HDN-4287-2022; Bjørndal, Bodil/H-6143-2017	Bjørndal, Bodil/0000-0001-9718-5117	NordForsk [070010]; Research Council of Norway [190287/110]; European Community's Seventh Framework Program (FP7) [201668]; Western Norway Regional Health Authority	NordForsk; Research Council of Norway(Research Council of Norway); European Community's Seventh Framework Program (FP7); Western Norway Regional Health Authority	This study was financially supported by grants from NordForsk, grant 070010, MitoHealth; the Research Council of Norway, grant 190287/110; and the European Community's Seventh Framework Program (FP7/2007-2013), grant 201668, AtheroRemo. The Western Norway Regional Health Authority also supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerschlaeger M, 2004, TOXICOL SCI, V78, P229, DOI 10.1093/toxsci/kfh071; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Benetti Elisa, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P273; Berge RK, 2005, BIOCHIMIE, V87, P15, DOI 10.1016/j.biochi.2004.11.011; Bjorndal B, 2011, EUR J NUTR, V46, P679; Blaak EE, 2005, BEST PRACT RES CL EN, V19, P391, DOI 10.1016/j.beem.2005.04.001; Burri L, 2011, FRONT NUTRIGENOMICS, V2, P1, DOI DOI 10.3389/FGENE.2011.0004522303341; Burri L, 2011, LIPIDS, V46, P679, DOI 10.1007/s11745-011-3536-2; Chaput E, 2000, BIOCHEM BIOPH RES CO, V271, P445, DOI 10.1006/bbrc.2000.2647; ENGLARD S, 1985, BIOCHEMISTRY-US, V24, P1110, DOI 10.1021/bi00326a007; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Hagland HR, 2013, BIOCHEM BIOPH RES CO, V430, P573, DOI 10.1016/j.bbrc.2012.11.111; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; HOPPEL CL, 1986, BIOCHEM SOC T, V14, P673, DOI 10.1042/bst0140673; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2011, J BIOL CHEM, V286, P28382, DOI 10.1074/jbc.M111.234732; Lopez-Huertas E, 2012, BRIT J NUTR, V107, pS185, DOI 10.1017/S0007114512001572; Lovas K, 2009, DIABETES OBES METAB, V11, P304, DOI 10.1111/j.1463-1326.2008.00958.x; Lu Y, 2011, PHYSIOL GENOMICS, V43, P1307, DOI 10.1152/physiolgenomics.00100.2011; Madsen L, 2002, J LIPID RES, V43, P742; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114; PAIK WK, 1975, ADV ENZYMOL RAMB, V42, P227; Pyper S.R., 2010, NUCL RECEPT SIGNAL, V8; REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Schoonjans K, 1996, J LIPID RES, V37, P907; Sheikh K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1157, DOI 10.1152/ajpendo.00254.2006; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; SPYDEVOLD O, 1989, BIOCHIM BIOPHYS ACTA, V1003, P72, DOI 10.1016/0005-2760(89)90101-X; STEIN R, 1982, ARCH BIOCHEM BIOPHYS, V217, P324, DOI 10.1016/0003-9861(82)90508-2; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Ueland T, 2013, INT J CARDIOL, V167, P1892, DOI 10.1016/j.ijcard.2012.04.150; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; Vernez L, 2004, RAPID COMMUN MASS SP, V18, P1233, DOI 10.1002/rcm.1470; Vigerust NF, 2012, FERTIL STERIL, V98, P1620, DOI 10.1016/j.fertnstert.2012.08.024; Vigerust NF, 2012, J NUTR BIOCHEM, V23, P1384, DOI 10.1016/j.jnutbio.2011.08.006; Westergaard M, 2001, J INVEST DERMATOL, V116, P702, DOI 10.1046/j.1523-1747.2001.01329.x; Wrzesinski K, 2013, J PROTEOMICS, V84, P61, DOI 10.1016/j.jprot.2013.03.027; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	47	9	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66926	10.1371/journal.pone.0066926	http://dx.doi.org/10.1371/journal.pone.0066926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826175	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400085
J	Borries, C; Gordon, AD; Koenig, A				Borries, Carola; Gordon, Adam D.; Koenig, Andreas			Beware of Primate Life History Data: A Plea for Data Standards and a Repository	PLOS ONE			English	Article							LANGURS PRESBYTIS-ENTELLUS; FEMALE JAPANESE MACAQUES; RING-TAILED LEMURS; REPRODUCTIVE PARAMETERS; HANUMAN LANGURS; GESTATION LENGTH; METABOLIC-RATE; MATERNAL INVESTMENT; NATIONAL-PARK; BODY-WEIGHT	Life history variables such as the age at first reproduction and the interval between consecutive births are measures of investment in growth and reproduction in a particular population or species. As such they allow for meaningful comparisons of the speed of growth and reproduction between species and between larger taxa. Especially in primates such life history research has far reaching implications and has led for instance to the "grandmother hypothesis". Other links have been proposed with respect to dietary adaptations: Because protein is essential for growth and one of the primary sources of protein, leaves, occurs much less seasonally than fruits, it has been predicted that folivorous primates should grow faster compared to frugivorous ones. However, when comparing folivorous Asian colobines with frugivorous Asian macaques we recently documented a longer, instead of a shorter gestation length in folivores while age at first reproduction and interbirth interval did not differ. This supports earlier findings for Malagasy lemurs in which all life history variables tested were significantly longer in folivores compared to frugivores. Wondering why these trends were not apparent sooner, we tried to reconstruct our results for Asian primates with data from four popular life history compilations. However, this attempt failed; even the basic, allometric relationship with adult female body mass that is typical for life history variables could not be recovered. This negative result hints at severe problems with data quality. Here we show that data quality can be improved significantly by standardizing the variables and by controlling for factors such as nutritional conditions or infant mortality. Ideally, in the future, revised primate life history data should be collated in a central database accessible to everybody. In the long run such an initiative should be expanded to include all mammalian species.	[Borries, Carola; Koenig, Andreas] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Gordon, Adam D.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Borries, C (corresponding author), SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA.	carola.borries@stonybrook.edu	Koenig, Andreas/G-6705-2013; Borries, Carola/L-8517-2013; Gordon, Adam/AAB-9006-2019; Koenig, Andreas/AAE-6492-2020	Koenig, Andreas/0000-0003-1494-9156; Borries, Carola/0000-0001-5262-1405; Gordon, Adam/0000-0002-1807-4644; Koenig, Andreas/0000-0003-1494-9156	Hunt Postdoctoral Fellowship from The Wenner-Gren Foundation	Hunt Postdoctoral Fellowship from The Wenner-Gren Foundation	AD Gordon was partially supported in the writing of this manuscript by a Hunt Postdoctoral Fellowship from The Wenner-Gren Foundation (www.wennergren.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alfaro JWL, 2012, J BIOGEOGR, V39, P272, DOI 10.1111/j.1365-2699.2011.02609.x; Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; Altmann J, 2003, AM J HUM BIOL, V15, P401, DOI 10.1002/ajhb.10157; Alvarez HP, 2000, AM J PHYS ANTHROPOL, V113, P435, DOI 10.1002/1096-8644(200011)113:3<435::AID-AJPA11>3.0.CO;2-O; [Anonymous], 2012, LANG ENV STAT COMP; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; ASQUITH PJ, 1989, YEARB PHYS ANTHROPOL, V32, P129; Barelli C, 2007, HORM BEHAV, V51, P221, DOI 10.1016/j.yhbeh.2006.10.008; Barrickman NL, 2008, J HUM EVOL, V54, P568, DOI 10.1016/j.jhevol.2007.08.012; Barton RA, 2011, P NATL ACAD SCI USA, V108, P6169, DOI 10.1073/pnas.1019140108; Bau AM, 2009, EUR J ENDOCRINOL, V160, P107, DOI 10.1530/EJE-08-0594; Beehner JC, 2006, BEHAV ECOL, V17, P741, DOI 10.1093/beheco/arl006; Beehner JC, 2006, HORM BEHAV, V49, P688, DOI 10.1016/j.yhbeh.2005.12.016; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Borries C, 1997, BEHAV ECOL SOCIOBIOL, V41, P139, DOI 10.1007/s002650050373; Borries C, 2001, BEHAV ECOL SOCIOBIOL, V50, P391, DOI 10.1007/s002650100391; Borries C, 2011, AM J PHYS ANTHROPOL, V144, P286, DOI 10.1002/ajpa.21403; BRAMBLETT CA, 1975, J MAMMAL, V56, P940, DOI 10.2307/1379672; Bronson FH, 1989, MAMMALIAN REPROD BIO; Capellini I, 2011, AM NAT, V177, P86, DOI 10.1086/657435; Carbone C, 2005, AM NAT, V165, P290, DOI 10.1086/426790; Catlett KK, 2010, AM J PHYS ANTHROPOL, V142, P391, DOI 10.1002/ajpa.21236; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Cords M, 2010, INT J PRIMATOL, V31, P409, DOI [10.1007/s10764-010-9400-z, 10.1007/s10764-010-9405-7]; CosmanJD LoweKA, 2018, CURR BIOL, V28, P3, DOI 10.1016/j.cub.2018.11.007; Covert HH, 2012, EVOL ANTHROPOL, V21, P84, DOI 10.1002/evan.21301; CROCKETT CM, 1987, AM J PRIMATOL, V13, P369, DOI 10.1002/ajp.1350130403; Cross J.F., 1981, Dodo, P30; CZEKALA NM, 1983, BIOL REPROD, V28, P289, DOI 10.1095/biolreprod28.2.289; Delson E., 1980, P10; Delson Eric, 1994, P11; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dubman E, 2012, BIOL LETTERS, V8, P998, DOI 10.1098/rsbl.2012.0642; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; EISENBER.JF, 1973, J MAMMAL, V54, P954, DOI 10.2307/1379089; ELIAS MF, 1977, AM J CLIN NUTR, V30, P355, DOI 10.1093/ajcn/30.3.355; Ernest SKM, 2003, ECOLOGY, V84, P3402, DOI 10.1890/02-9002; EVANS CS, 1968, J ZOOL, V156, P181; Fedigan Linda M., 2012, P165; Fedigan LM, 2008, AM J PHYS ANTHROPOL, V137, P82, DOI 10.1002/ajpa.20848; FEDIGAN LM, 1995, AM J PRIMATOL, V37, P9, DOI 10.1002/ajp.1350370103; Fujita S, 2004, AM J PRIMATOL, V64, P367, DOI 10.1002/ajp.20086; GLANDER KE, 1980, AM J PHYS ANTHROPOL, V53, P25, DOI 10.1002/ajpa.1330530106; Godfrey LR, 2004, AM J PHYS ANTHROPOL, V123, P250, DOI 10.1002/ajpa.10315; Godfrey LR, 2001, AM J PHYS ANTHROPOL, V114, P192, DOI 10.1002/1096-8644(200103)114:3<192::AID-AJPA1020>3.0.CO;2-Q; Gordon AD, 2006, INT J PRIMATOL, V27, P27, DOI 10.1007/s10764-005-9003-2; Groves C.P., 2001, PRIMATE TAXONOMY; Guthrie EH, 2011, AM J PHYS ANTHROPOL, V145, P446, DOI 10.1002/ajpa.21525; Harvey P.H., 1989, Special Publication of the British Ecological Society, P305; Harvey P.H., 1987, P181; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Hawkes K., 2006, EVOLUTION HUMAN LIFE; Hawkes K, 2006, SCH AM RES, P45; Hearn J.P., 1982, International Zoo Yearbook, V22, P138, DOI 10.1111/j.1748-1090.1982.tb02022.x; Hendrickx A. G., 1995, NONHUMAN PRIMATES BI, P147; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hrdy S.B., 1987, P370; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; IZARD MK, 1988, AM J PRIMATOL, V16, P331, DOI 10.1002/ajp.1350160405; Janson Charles H., 1993, P57; Jin T, 2009, AM J PRIMATOL, V71, P558, DOI 10.1002/ajp.20688; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kamilar JM, 2010, BIOL LETTERS, V6, P736, DOI 10.1098/rsbl.2010.0348; Kappeler P M, 2003, PRIMATE LIFE HIST SO; Kappeler Peter M., 2012, P101; KIHLSTROM JE, 1972, COMP BIOCHEM PHYSIOL, V43, P673, DOI 10.1016/0300-9629(72)90254-X; Koenig A, 1997, J ZOOL, V243, P215, DOI 10.1111/j.1469-7998.1997.tb02778.x; Koenig A, 2001, EVOL ANTHROPOL, V10, P122, DOI 10.1002/evan.1026; KOYAMA N, 1992, PRIMATES, V33, P33, DOI 10.1007/BF02382761; Koyama N, 2001, PRIMATES, V42, P1, DOI 10.1007/BF02640684; KRIEWALDT FH, 1968, LAB ANIM CARE, V18, P361; Lee PC, 2012, INT J PRIMATOL, V33, P1309, DOI 10.1007/s10764-011-9536-5; Leigh S. R., 2011, PRIMATES PERSPECTIVE, P418; LEIGH SR, 1994, AM J PHYS ANTHROPOL, V94, P499, DOI 10.1002/ajpa.1330940406; LEIGH SR, 1994, ZOO BIOL, V13, P21, DOI 10.1002/zoo.1430130105; LITTLE BB, 1989, AM J PHYS ANTHROPOL, V80, P213, DOI 10.1002/ajpa.1330800209; Lu A, 2010, AM J PRIMATOL, V72, P1073, DOI 10.1002/ajp.20866; Lyons SK, 2010, PHILOS T R SOC B, V365, P3681, DOI 10.1098/rstb.2010.0263; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Matin R.D., 1992, P238; McNeilly AS, 2006, ANN NY ACAD SCI, V709, P145; Meyer D, 2011, MOL PHYLOGENET EVOL, V59, P311, DOI 10.1016/j.ympev.2011.02.015; MICHOD RE, 1979, AM NAT, V113, P531, DOI 10.1086/283411; Mumby H, 2008, EVOL BIOL, V35, P287, DOI 10.1007/s11692-008-9040-9; Mustoe AC, 2012, GEN COMP ENDOCR, V175, P519, DOI 10.1016/j.ygcen.2011.12.020; Nakamichi M, 2009, PRIMATES, V50, P153, DOI 10.1007/s10329-009-0134-5; National Research Council US, 1981, TECHN STUD PRIM POP; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; Nguyen N, 2006, THESIS PRINCETON U P; NIGI H, 1976, Primates, V17, P81, DOI 10.1007/BF02381568; ORME C. D. L., 2012, CAPER COMP ANAL PHYL; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Pochron ST, 2004, AM J PHYS ANTHROPOL, V125, P61, DOI 10.1002/ajpa.10266; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAJPUROHIT LS, 1991, PRIMATES, V32, P213, DOI 10.1007/BF02381178; Ramirez-Llorens P, 2008, AM J PRIMATOL, V70, P473, DOI 10.1002/ajp.20522; RASMUSSEN DT, 1988, AM J PHYS ANTHROPOL, V75, P357, DOI 10.1002/ajpa.1330750307; Reichard Ulrich H., 2012, P237; Robbins AM, 2009, BEHAVIOUR, V146, P525, DOI 10.1163/156853909X426354; Roberts EK, 2012, SCIENCE, V335, P1222, DOI 10.1126/science.1213600; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Roff Derek A., 1992; Ross C, 2000, FOLIA PRIMATOL, V71, P93, DOI 10.1159/000021733; ROSS C, 1992, PRIMATES, V33, P207, DOI 10.1007/BF02382750; Rowe N, 2011, ALL WORLDS PRIMATES; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Schwartz GT, 2005, J HUM EVOL, V49, P702, DOI 10.1016/j.jhevol.2005.08.006; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; SILK J, 1993, INT J PRIMATOL, V14, P95, DOI 10.1007/BF02196505; SILK JB, 1986, INT J PRIMATOL, V7, P583, DOI 10.1007/BF02736663; Skinner MM, 2006, SCH AM RES, P331; Smith R, 1999, J CLIN ENDOCR METAB, V84, P2820, DOI 10.1210/jc.84.8.2820; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; SMUTS B, 1989, AM J PRIMATOL, V19, P229, DOI 10.1002/ajp.1350190405; SOMMER V, 1992, AM J PRIMATOL, V28, P1, DOI 10.1002/ajp.1350280102; Stearns S.C., 1992, pi; Stewart K.J., 1988, P22; Strier KB, 2005, AM J PRIMATOL, V67, P1, DOI 10.1002/ajp.20165; STRUHSAKER TT, 1991, BEHAVIOUR, V117, P182, DOI 10.1163/156853991X00526; Struhsaker TT, 2010, RED COLOBUS MONKEYS: VARIATION IN DEMOGRAPHY, BEHAVIOR, AND ECOLOGY OF ENDANGERED SPECIES, P1, DOI 10.1093/acprof:oso/9780198529583.001.0001; Takahata Y, 1998, PRIMATES, V39, P339, DOI 10.1007/BF02573082; Terasawa E, 2012, ENDOCRINOLOGY, V153, P1696, DOI 10.1210/en.2011-1970; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; Van Belle S, 2009, AM J PRIMATOL, V71, P153, DOI 10.1002/ajp.20635; van Schaik Carel P., 2000, P61, DOI 10.1017/CBO9780511542312.005; van Schaik Carel P., 2000, P27, DOI 10.1017/CBO9780511542312.004; WATANABE K, 1992, PRIMATES, V33, P1, DOI 10.1007/BF02382760; WATTS DP, 1989, ETHOLOGY, V81, P1; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Wich SA, 2007, AM J PRIMATOL, V69, P641, DOI 10.1002/ajp.20386; Ziegler T, 2000, AM J PRIMATOL, V51, P119, DOI 10.1002/(SICI)1098-2345(200006)51:2<119::AID-AJP2>3.0.CO;2-O	135	24	24	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67200	10.1371/journal.pone.0067200	http://dx.doi.org/10.1371/journal.pone.0067200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826232	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400117
J	Cheng, H; Furnham, A				Cheng, Helen; Furnham, Adrian			Factors Influencing Adult Physical Health after Controlling for Current Health Conditions: Evidence from a British Cohort	PLOS ONE			English	Article							PERSONALITY-TRAITS; SOCIOECONOMIC POSITION; COGNITIVE-ABILITY; INCOME INEQUALITY; MENTAL-HEALTH; CONSCIENTIOUSNESS; METAANALYSIS; CHILDHOOD; BEHAVIORS; MORTALITY	This study explored a longitudinal data set of 6875 British adults examining the effects of parental social status (measured at birth), cognitive ability (at age 11 yrs), personality traits, education and occupational attainment on physical health and functioning (all measured at age 50 yrs), after taking account of current health conditions (number of illness). Correlation analysis showed that parental social class, childhood cognitive ability, education and occupation, and two personality traits (Emotional Stability/Neuroticism, and Conscientiousness) were all significantly associated with adult physical health variables. Structural equation modelling showed that health conditions and personality traits were significantly, and inversely, associated with physical health (indicated by good daily physical functioning, relative absence of pain, perceived health, and low level of limitations at work due to physical health). Parental social status, childhood intelligence, educational and occupational attainment were all modestly, but significantly and directly, associated with adult physical health. The effect of childhood intelligence on adult physical health was, in part, mediated through Emotional Stability and Conscientiousness. After controlling for health conditions Emotional Stability was the strongest predictor of physical health. Implications and limitations are discussed.	[Cheng, Helen; Furnham, Adrian] UCL, Dept Psychol, London, England	University of London; University College London	Furnham, A (corresponding author), UCL, Dept Psychol, London, England.	a.furnham@ucl.ac.uk	Furnham, Adrian/ABB-2072-2020					Arbuckle J. L, 2009, AMOS VERSION 18 0 US; Arbuckle JL., 1996, ADV STRUCTURAL EQUAT, P243, DOI DOI 10.4324/9781315827414; Argyle M., 2001, PSYCHOL HAPPINESS; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Brown G., 1978, SOCIAL ORIGINS DEPRE; Butler N., 1997, 1970 BRIT COHORT STU; Cheng H, 2003, PERS INDIV DIFFER, V34, P921, DOI 10.1016/S0191-8869(02)00078-8; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Craig TJ, 2008, EVID-BASED MENT HEAL, V11, P9, DOI 10.1136/ebmh.11.1.9; Davie R, 1972, BIRTH 7; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary Ian J, 2010, Psychol Sci Public Interest, V11, P53, DOI 10.1177/1529100610387081; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Douglas James W.B, 1964, HOME SCH; Duncan G.J., 1997, CONSEQUENCES GROWING; Duncan O. D., 1972, SEMINAR-J GER STUD; Feinstein L, 2004, CHILD DEV, V75, P1329, DOI 10.1111/j.1467-8624.2004.00743.x; Fergusson D.M., 2008, RES SOCIAL STRATIFIC, V26, P277, DOI [DOI 10.1016/J.RSSM.2008.05.001, 10.1016/j.rssm.2008.05.001]; Ferri E., 2003, CHANGING BRITAIN CHA; Fogelman K., 1976, BRITAINS 16 YEAR OLD; FRIEDMAN HS, 1993, J PERS SOC PSYCHOL, V65, P176, DOI 10.1037/0022-3514.65.1.176; FURNHAM A, 1990, PERS INDIV DIFFER, V11, P1093, DOI 10.1016/0191-8869(90)90138-H; Furnham A, 1997, PSYCHOL REP, V80, P761, DOI 10.2466/pr0.1997.80.3.761; Furnham A., 2008, PERSONALITY INTELLIG; Furnham A, 2013, J SOCIO-ECON, V44, P120, DOI 10.1016/j.socec.2013.02.008; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Goodwin RD, 2006, J HEALTH PSYCHOL, V11, P643, DOI 10.1177/1359105306066610; Hampson SE, 2006, HEALTH PSYCHOL, V25, P57, DOI 10.1037/0278-6133.25.1.57; Hill PL, 2011, HEALTH PSYCHOL, V30, P536, DOI 10.1037/a0023859; Kern ML, 2008, HEALTH PSYCHOL, V27, P505, DOI 10.1037/0278-6133.27.5.505; Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471; Kuh D, 2009, SOC SCI MED, V68, P1565, DOI 10.1016/j.socscimed.2009.02.006; Leete R, 1977, POPULATION TRENDS, V8, P1; Marmot M, 2004, STATUS SYNDROME; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; MARSH C, 1986, KEY VARIABLES SOCIAL; Martin LR, 2007, HLTH PSYCHOL; Matthews G., 2009, PERSONALITY TRAITS; MCCRAE RR, 1994, CURR DIR PSYCHOL SCI, V3, P173, DOI 10.1111/1467-8721.ep10770693; Mensah FK, 2010, SOC PSYCH PSYCH EPID, V45, P1023, DOI 10.1007/s00127-009-0137-y; Morgan Z, 2012, SOC PSYCH PSYCH EPID, V47, P1707, DOI 10.1007/s00127-012-0481-1; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Muris P, 2005, PERS INDIV DIFFER, V38, P1757, DOI 10.1016/j.paid.2004.11.018; O'Cleirigh C, 2007, HEALTH PSYCHOL, V26, P473, DOI 10.1037/0278-6133.26.4.473; Plewis I, 2004, NATL CHILD DEV STUDY; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schoon I, 2010, LONGITUD LIFE COURSE, V1, P241; Smith GD., 2005, BIOPSYCHOSOC MED; Spinath B, 2006, INTELLIGENCE, V34, P363, DOI 10.1016/j.intell.2005.11.004; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Strand BH, 2011, EUR J EPIDEMIOL, V26, P475, DOI 10.1007/s10654-011-9562-9; Takahashi Y, 2012, PSYCHOL HEALTH, V27, P1048, DOI 10.1080/08870446.2011.652110; Tolea MI, 2012, J GERONTOLOGY B; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036	59	5	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66204	10.1371/journal.pone.0066204	http://dx.doi.org/10.1371/journal.pone.0066204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23826090	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400012
J	Copeland, HE; Pocewicz, A; Naugle, DE; Griffiths, T; Keinath, D; Evans, J; Platt, J				Copeland, Holly E.; Pocewicz, Amy; Naugle, David E.; Griffiths, Tim; Keinath, Doug; Evans, Jeffrey; Platt, James			Measuring the Effectiveness of Conservation: A Novel Framework to Quantify the Benefits of Sage-Grouse Conservation Policy and Easements in Wyoming	PLOS ONE			English	Article							ENERGY DEVELOPMENT; POPULATIONS; SELECTION	Increasing energy and housing demands are impacting wildlife populations throughout western North America. Greater sage-grouse (Centrocercus urophasianus), a species known for its sensitivity to landscape-scale disturbance, inhabits the same low elevation sage-steppe in which much of this development is occurring. Wyoming has committed to maintain sage-grouse populations through conservation easements and policy changes that conserves high bird abundance "core'' habitat and encourages development in less sensitive landscapes. In this study, we built new predictive models of oil and gas, wind, and residential development and applied build-out scenarios to simulate future development and measure the efficacy of conservation actions for maintaining sage-grouse populations. Our approach predicts sage-grouse population losses averted through conservation action and quantifies return on investment for different conservation strategies. We estimate that without conservation, sage-grouse populations in Wyoming will decrease under our long-term scenario by 14-29% (95% CI: 4-46%). However, a conservation strategy that includes the "core area'' policy and $250 million in targeted easements could reduce these losses to 9-15% (95% CI: 3-32%), cutting anticipated losses by roughly half statewide and nearly two-thirds within sage-grouse core breeding areas. Core area policy is the single most important component, and targeted easements are complementary to the overall strategy. There is considerable uncertainty around the magnitude of our estimates; however, the relative benefit of different conservation scenarios remains comparable because potential biases and assumptions are consistently applied regardless of the strategy. There is early evidence based on a 40% reduction in leased hectares inside core areas that Wyoming policy is reducing potential for future fragmentation inside core areas. Our framework using build-out scenarios to anticipate species declines provides estimates that could be used by decision makers to determine if expected population losses warrant ESA listing.	[Copeland, Holly E.; Pocewicz, Amy] Nature Conservancy, Lander, WY USA; [Naugle, David E.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Griffiths, Tim] Nat Resources Conservat Serv, Bozeman, MT USA; [Keinath, Doug] Univ Wyoming, Laramie, WY 82071 USA; [Evans, Jeffrey] Nature Conservancy, Laramie, WY USA; [Platt, James] Nature Conservancy, Minneapolis, MN USA	Nature Conservancy; University of Montana System; University of Montana; University of Wyoming; Nature Conservancy	Copeland, HE (corresponding author), Nature Conservancy, Lander, WY USA.	hcopeland@tnc.org		Evans, Jeffrey/0000-0002-5533-7044	Natural Resources Conservation Service, Sage Grouse Initiaive Program	Natural Resources Conservation Service, Sage Grouse Initiaive Program	This study was funded by a grant from the Natural Resources Conservation Service, Sage Grouse Initiaive Program (http://www.sagegrouseinitiative.com/). One of the study authors, Tim Griffiths, had a coordinating role in the grant process. Tim played an advisory role in preparation of this manuscript and helped conceive the project, but otherwise had no role in study design, data collection and analysis, or decision to publish.	Bastian C, 2010, ESTIMATING MARKET VA; Beier P., 2007, CONCEPTUAL STEPS DES; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Bureau of Land Management, 2012, WY2012019 BUR LAND M; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Connelly JW, 1997, WILDLIFE BIOL, V3, P229, DOI 10.2981/wlb.1997.028; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Copeland Holly E., 2011, P7; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Doherty K, 2010, MAPPING BREEDING DEN, P1; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Doherty KE, 2011, STUD AVIAN BIOL, P505; Doherty KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010339; ESRI, 2011, ARCGIS DESKT REL 10; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; Fishburn IS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004996; Garton EO, 2011, STUD AVIAN BIOL, P293; Gude PH, 2006, LANDSCAPE URBAN PLAN, V77, P131, DOI 10.1016/j.landurbplan.2005.02.004; Hagen CA, 2011, STUD AVIAN BIOL, P95; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hansen AJ, 2002, BIOSCIENCE, V52, P151, DOI 10.1641/0006-3568(2002)052[0151:ECACOD]2.0.CO;2; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Holloran M., 2005, THESIS U WYOMING LAR; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Holloran MRJ, 2005, CONDOR, V107, P742, DOI 10.1650/7749.1; IHS Incorporated, 2007, OIL GAS WELL DAT; Johnson D. H., 2011, INFLUENCES ENV ANTHR; Kiesecker JM, 2007, FRONT ECOL ENVIRON, V5, P125, DOI 10.1890/1540-9295(2007)5[125:CEICAQ]2.0.CO;2; Knick ST, 2011, STUD AVIAN BIOL, P1; Love D, 2010, UPDATED GEOLOGIC MAP; Lyon AG, 2003, WILDLIFE SOC B, V31, P486; Mitchell M.W., 2011, OJS, V01, P205, DOI [10.4236/ojs.2011.13024, DOI 10.4236/OJS.2011.13024]; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; National Renewable Energy Laboratory, 2008, ANN AV WIND RES POT; Naugle DE, 2011, STUD AVIAN BIOL, P489; O'Donnell MS, 2010, SPATIAL MAPPING ATTR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pocewicz A, 2011, BIOL CONSERV, V144, P567, DOI 10.1016/j.biocon.2010.10.012; R Core Team, 2021, R LANGUAGE ENV STAT; Schneider RR, 2010, BIOL CONSERV, V143, P1603, DOI 10.1016/j.biocon.2010.04.002; Schrag A, 2011, GEOJOURNAL, V76, P561, DOI 10.1007/s10708-010-9369-3; State of Wyoming Executive Department, 2011, 20115 STAT WYOM EX D; Taylor RL, 2012, VIABILITY ANAL CONSE; *US DOE, 2008, 20 EN 2030 INCR WIND; US Energy Information Administration, 2013, WYOM STAT PROF EN ES; US Government Accountability Office, 2006, GAO06730; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Wilson RR, 2013, CONSERV LETT, V00, P1; Wisdom MJ, 2011, STUD AVIAN BIOL, P451; Wyoming Department of Revenue, 2012, CAMA DAT DOWNL; Wyoming Governor's Sage-Grouse Implementation Team, 2010, WYOM SAG GROUS COR A; Wyoming Housing Database Partnership, 2010, 2010 WYOM HOUS NEEDS; Wyoming Wildlife Consultants, 2007, IRR LANDS WYOM	58	41	42	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67261	10.1371/journal.pone.0067261	http://dx.doi.org/10.1371/journal.pone.0067261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826250	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400127
J	Figueroa, CM; Kuhn, ML; Falaschetti, CA; Solamen, L; Olsen, KW; Ballicora, MA; Iglesias, AA				Figueroa, Carlos M.; Kuhn, Misty L.; Falaschetti, Christine A.; Solamen, Ligin; Olsen, Kenneth W.; Ballicora, Miguel A.; Iglesias, Alberto A.			Unraveling the Activation Mechanism of the Potato Tuber ADP-Glucose Pyrophosphorylase	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; AGROBACTERIUM-TUMEFACIENS; MOLECULAR-DYNAMICS; REGULATORY ENZYME; ADPGLUCOSE PYROPHOSPHORYLASES; ALLOSTERIC REGULATION; SCANNING MUTAGENESIS; BINDING-SITES; N-TERMINUS	ADP-glucose pyrophosphorylase regulates the synthesis of glycogen in bacteria and of starch in plants. The enzyme from plants is mainly activated by 3-phosphoglycerate and is a heterotetramer comprising two small and two large subunits. Here, we found that two highly conserved residues are critical for triggering the activation of the potato tuber ADP-glucose pyrophosphorylase, as shown by site-directed mutagenesis. Mutations in the small subunit, which bears the catalytic function in this potato tuber form, had a more dramatic effect on disrupting the allosteric activation than those introduced in the large subunit, which is mainly modulatory. Our results strongly agree with a model where the modified residues are located in loops responsible for triggering the allosteric activation signal for this enzyme, and the sensitivity to this activation correlates with the dynamics of these loops. In addition, previous biochemical data indicates that the triggering mechanism is widespread in the enzyme family, even though the activator and the quaternary structure are not conserved.	[Figueroa, Carlos M.; Iglesias, Alberto A.] Univ Nacl Litoral, Inst Agrobiotecnol Litoral, Santa Fe, Argentina; [Figueroa, Carlos M.; Iglesias, Alberto A.] Consejo Nacl Invest Cient & Tecn, Santa Fe, Argentina; [Figueroa, Carlos M.; Kuhn, Misty L.; Falaschetti, Christine A.; Solamen, Ligin; Olsen, Kenneth W.; Ballicora, Miguel A.] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA	National University of the Littoral; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Loyola University Chicago	Iglesias, AA (corresponding author), Univ Nacl Litoral, Inst Agrobiotecnol Litoral, Santa Fe, Argentina.	iglesias@fbcb.unl.edu.ar		Figueroa, Carlos Maria/0000-0003-4047-0480; Iglesias, Alberto/0000-0001-9729-7338; Ballicora, Miguel/0000-0002-5324-0724	National Science Foundation [MCB 1024945]; ANPCyT [PICT'08 1754]; CONICET [NSF] [PIP 2519]; UNL [CAI+D Orientado]; Fulbright Fellowship; American Society of Plant Biologists; Carbon Scholar Fellowship (Loyola University Chicago); Mulcahy Scholarship (Loyola University Chicago); John Simon Guggenheim Memorial Foundation; Div Of Molecular and Cellular Bioscience [1024945] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ANPCyT(ANPCyT); CONICET [NSF](Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNL [CAI+D Orientado]; Fulbright Fellowship; American Society of Plant Biologists; Carbon Scholar Fellowship (Loyola University Chicago); Mulcahy Scholarship (Loyola University Chicago); John Simon Guggenheim Memorial Foundation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants to MAB from the National Science Foundation [MCB 1024945] and to AAI from ANPCyT [PICT'08 1754], CONICET [PIP 2519 and for collaboration with NSF], and UNL [CAI+D Orientado]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CMF was a recipient of a Fulbright Fellowship. CAF was recipient of the Summer Undergraduate Research Fellowship from the American Society of Plant Biologists and the Carbon Scholar Fellowship (Loyola University Chicago). LS is the recipient of a Mulcahy Scholarship (Loyola University Chicago). AAI received a Fellowship from The John Simon Guggenheim Memorial Foundation. CMF and AAI are members of the Researcher Career from CONICET.	BALL K, 1994, J BIOL CHEM, V269, P24706; Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Ballicora MA, 1998, PLANT PHYSIOL, V118, P265, DOI 10.1104/pp.118.1.265; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2002, BIOCHEMISTRY-US, V41, P9431, DOI 10.1021/bi025793b; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; BALLICORA MA, 1995, PLANT PHYSIOL, V109, P245, DOI 10.1104/pp.109.1.245; Ballicora MA, 2007, J BACTERIOL, V189, P5325, DOI 10.1128/JB.00481-07; Bejar CM, 2006, J BIOL CHEM, V281, P40473, DOI 10.1074/jbc.M607088200; Bejar CM, 2006, BIOCHEM BIOPH RES CO, V343, P216, DOI 10.1016/j.bbrc.2006.02.123; Bejar CM, 2004, FEBS LETT, V573, P99, DOI 10.1016/j.febslet.2004.07.060; Boehlein SK, 2010, PLANT PHYSIOL, V152, P85, DOI 10.1104/pp.109.146928; Boehlein SK, 2009, PLANT PHYSIOL, V149, P318, DOI 10.1104/pp.108.126862; CHARNG YY, 1994, J BIOL CHEM, V269, P24107; CHARNG YY, 1992, PLANT MOL BIOL, V20, P37, DOI 10.1007/BF00029147; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; Cupp-Vickery JR, 2008, BIOCHEMISTRY-US, V47, P4439, DOI 10.1021/bi701933q; Figueroa CM, 2011, BIOCHIMIE, V93, P1816, DOI 10.1016/j.biochi.2011.06.029; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; GARDIOL A, 1990, ARCH BIOCHEM BIOPHYS, V280, P175, DOI 10.1016/0003-9861(90)90533-5; GHOSH HP, 1965, BIOCHEMISTRY-US, V4, P1354, DOI 10.1021/bi00883a020; GHOSH HP, 1965, J BIOL CHEM, V240, pP960; GHOSH HP, 1966, J BIOL CHEM, V241, P4491; Gomez-Casati DF, 2001, BIOCHEMISTRY-US, V40, P10169, DOI 10.1021/bi002615e; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iglesias AA, 2006, PLANT CELL PHYSIOL, V47, P523, DOI 10.1093/pcp/pcj021; IGLESIAS AA, 1993, J BIOL CHEM, V268, P1081; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Kuhn ML, 2009, J BIOL CHEM, V284, P34092, DOI 10.1074/jbc.M109.037614; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MORELL M, 1988, J BIOL CHEM, V263, P633; Pessarakli A. A, 2005, HDB PHOTOSYNTHESIS, P525; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sheng J, 1996, BIOCHEMISTRY-US, V35, P3115, DOI 10.1021/bi952359j; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Vinson VJ, 2009, SCIENCE, V324, P197, DOI 10.1126/science.324.5924.197; Yep A, 2004, ANAL BIOCHEM, V324, P52, DOI 10.1016/j.ab.2003.09.024	42	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66824	10.1371/journal.pone.0066824	http://dx.doi.org/10.1371/journal.pone.0066824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826149	Green Published, gold			2022-12-27	WOS:000321738400063
J	Fischer, C; Koblmuller, S; Gully, C; Schlotterer, C; Sturmbauer, C; Thallinger, GG				Fischer, Christoph; Koblmueller, Stephan; Guelly, Christian; Schloetterer, Christian; Sturmbauer, Christian; Thallinger, Gerhard G.			Complete Mitochondrial DNA Sequences of the Threadfin Cichlid (Petrochromis trewavasae) and the Blunthead Cichlid (Tropheus moorii) and Patterns of Mitochondrial Genome Evolution in Cichlid Fishes	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; LAKE TANGANYIKA; SELECTION; ALIGNMENT; MODEL; SITES; ACCURACY; GENES; RATES; PHYLOGENETICS	The cichlid fishes of the East African Great Lakes represent a model especially suited to study adaptive radiation and speciation. With several African cichlid genome projects being in progress, a promising set of closely related genomes is emerging, which is expected to serve as a valuable data base to solve questions on genotype-phenotype relations. The mitochondrial (mt) genomes presented here are the first results of the assembly and annotation process for two closely related but eco-morphologically highly distinct Lake Tanganyika cichlids, Petrochromis trewavasae and Tropheus moorii. The genomic sequences comprise 16,588 bp (P. trewavasae) and 16,590 bp (T. moorii), and exhibit the typical mitochondrial structure, with 13 protein-coding genes, 2 rRNA genes, 22 tRNA genes, and a non-coding control region. Analyses confirmed that the two species are very closely related with an overall sequence similarity of 96%. We analyzed the newly generated sequences in the phylogenetic context of 21 published labroid fish mitochondrial genomes. Consistent with other vertebrates, the D-loop region was found to evolve faster than protein-coding genes, which in turn are followed by the rRNAs; the tRNAs vary greatly in the rate of sequence evolution, but on average evolve the slowest. Within the group of coding genes, ND6 evolves most rapidly. Codon usage is similar among examined cichlid tribes and labroid families; although a slight shift in usage patterns down the gene tree could be observed. Despite having a clearly different nucleotide composition, ND6 showed a similar codon usage. C-terminal ends of Cox1 exhibit variations, where the varying number of amino acids is related to the structure of the obtained phylogenetic tree. This variation may be of functional relevance for Cox1 synthesis.	[Fischer, Christoph; Thallinger, Gerhard G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; [Koblmueller, Stephan; Sturmbauer, Christian] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Guelly, Christian] Med Univ Graz, Med Res Ctr, Graz, Austria; [Schloetterer, Christian] Univ Vet Med Vienna, Inst Populat Genet, Vienna, Austria	Graz University of Technology; University of Graz; Medical University of Graz; University of Veterinary Medicine Vienna	Sturmbauer, C (corresponding author), Karl Franzens Univ Graz, Dept Zool, Graz, Austria.	Christian.Sturmbauer@uni-graz.at; Gerhard.Thallinger@tugraz.at	Schlötterer, Christian/G-6326-2010; Schlötterer, Christian/Q-5264-2019	Schlötterer, Christian/0000-0003-4710-6526; Schlötterer, Christian/0000-0003-4710-6526; Koblmuller, Stephan/0000-0002-1024-3220; Thallinger, Gerhard G./0000-0002-2864-5404	Austria Science Fund project Cichlid [FWF] [P22737]; EU [BM1006]; Austrian Ministry of Science and Research GEN-AU project BIN [FFG] [820962]; Austrian Science Fund (FWF) [P 22737] Funding Source: researchfish	Austria Science Fund project Cichlid [FWF]; EU(European Commission); Austrian Ministry of Science and Research GEN-AU project BIN [FFG]; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austria Science Fund project Cichlid [FWF Grant P22737], by the EU-FP7 COST Action SeqAhead [EC Grant BM1006] and by the Austrian Ministry of Science and Research GEN-AU project BIN [FFG Grant 820962]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Barlow G., 2002, CICHLID FISHES NATUR; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CANN RL, 1984, GENETICS, V106, P479; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; CHRISTIANSON TW, 1988, MOL CELL BIOL, V8, P4502, DOI 10.1128/MCB.8.10.4502; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; COHEN AS, 1993, GEOLOGY, V21, P511, DOI 10.1130/0091-7613(1993)021<0511:ETAOFO>2.3.CO;2; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FROESE R., 2012, FISHBASE; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Guderley H, 2002, J EXP BIOL, V205, P2237; Hardewig I, 1999, AM J PHYSIOL-REG I, V277, pR508, DOI 10.1152/ajpregu.1999.277.2.R508; He AY, 2011, MOL BIOL REP, V38, P2015, DOI 10.1007/s11033-010-0324-7; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Kartavtsev YP, 2007, GENE, V396, P13, DOI 10.1016/j.gene.2007.01.027; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kimura M, 1985, NEUTRAL THEORY MOL E; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Koonin EV, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100029; Kunstner A, 2011, GENOME BIOL EVOL, V3, P1381, DOI 10.1093/gbe/evr112; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; Mabuchi K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-10; Maddison W. P., 2012, MESQUITE MODULAR SYS; MADSEN CS, 1993, MOL CELL BIOL, V13, P2162, DOI 10.1128/MCB.13.4.2162; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Moola S, 2011, ANN M SOC MOL BIOL E, P1; MORGAN BJT, 1995, APPL STAT-J ROY ST C, V44, P117, DOI 10.2307/2986199; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Pages H, 2012, BIOSTRINGS STRING OB; Pamplona Reinald, 2011, J Aging Res, V2011, P807108, DOI 10.4061/2011/807108; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peng ZG, 2006, GENE, V376, P290, DOI 10.1016/j.gene.2006.04.014; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; POLL M, 1986, Academie Royale de Belgique Memoires de la Classe des Sciences Collection in Octavo, V45, P1; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2012, R LANG ENV STAT COMP; Rambaut A., 2011, TRACER 1 5; Rican O, 2008, MOL PHYLOGENET EVOL, V49, P941, DOI 10.1016/j.ympev.2008.07.022; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J., 2001, MOL CLONING LAB MANU; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sturmbauer C, 2003, HYDROBIOLOGIA, V500, P51, DOI 10.1023/A:1024680201436; Subramanian S, 2011, GENOME BIOL EVOL, V3, P1324, DOI 10.1093/gbe/evr108; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe A. S., 2011, MRBAYES5D; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Walker J. M, 2005, PROTEOMICS PROTOCOLS; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Warnow T., 2012, PLOS CURR, V4; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Widmann J, 2010, RNA, V16, P1469, DOI 10.1261/rna.726010; Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065; Zwickl DJ, 2004, SYST BIOL, V53, P877, DOI 10.1080/10635150490522584	85	28	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67048	10.1371/journal.pone.0067048	http://dx.doi.org/10.1371/journal.pone.0067048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826193	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400098
J	Kmet, M; Guo, C; Edmondson, C; Chen, B				Kmet, Muriel; Guo, Chao; Edmondson, Carina; Chen, Bin			Directed Differentiation of Human Embryonic Stem Cells into Corticofugal Neurons Uncovers Heterogeneous Fezf2-Expressing Subpopulations	PLOS ONE			English	Article							SUBCORTICAL PROJECTION NEURONS; EFFICIENT NEURAL CONVERSION; CEREBRAL-CORTEX; MOTOR-NEURONS; HEAD INDUCTION; DEVELOPING NEOCORTEX; EXPRESSION CLONING; SONIC HEDGEHOG; RADIAL GLIA; WNT	Understanding how neuronal diversity is achieved within the cerebral cortex remains a major challenge in neuroscience. The advent of human embryonic stem cells (hESCs) as a model system provides a unique opportunity to study human corticogenesis in vitro and to identify the mechanisms that promote neuronal differentiation to achieve neuronal diversity in human brain. The transcription factor Fezf2 is necessary and sufficient for the specification of subcerebral projection neurons in mouse. However, its function during human corticogenesis is poorly understood. This study reports the differentiation of a hFezf2-YFP hESC reporter line into corticofugal projection neurons capable of extending axons toward the spinal cord upon transplantation into neonatal mouse brains. Additionally, we show that triple inhibition of the TGF beta/BMP/Wnt-Shh pathway promotes the generation of hFezf2-expressing cells in vitro. Finally, this study unveils the isolation of two novel and distinct populations of hFezf2-YFP expressing cells reminiscent of the distinct Fezf2-expressing neuronal subtypes in the developing mouse brain. Overall our data suggest that the directed differentiation of hESCs into corticofugal neurons provides a useful model to identify the molecular mechanisms regulating human corticofugal differentiation and survival.	[Kmet, Muriel; Guo, Chao; Edmondson, Carina; Chen, Bin] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Chen, B (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	bchen@ucsc.edu	guo, chao/E-2849-2014		SEED grant from the California Institute of Regenerative Medicine (CIRM) [RS1-00170]; CIRM [TG2-01157]	SEED grant from the California Institute of Regenerative Medicine (CIRM); CIRM(California Institute for Regenerative Medicine)	This work was supported by a SEED grant from the California Institute of Regenerative Medicine (CIRM) RS1-00170 to BC and MK was a CIRM training grant TG2-01157 scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bedogni F, P NATL ACAD SCI US, V107, P13129; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cecchi C, 2002, GENE, V291, P1, DOI 10.1016/S0378-1119(02)00623-6; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiao E, 2008, METHOD CELL BIOL, V86, P1, DOI 10.1016/S0091-679X(08)00001-0; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Plachez C, 2008, J COMP NEUROL, V508, P385, DOI 10.1002/cne.21645; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Shu TZ, 2003, J NEUROSCI, V23, P203; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Verani R, 2007, J NEUROCHEM, V100, P242, DOI 10.1111/j.1471-4159.2006.04207.x; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Zhu H, 2010, NEUROSCI RES, V68, P73, DOI 10.1016/j.neures.2010.05.007	67	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67292	10.1371/journal.pone.0067292	http://dx.doi.org/10.1371/journal.pone.0067292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826257	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400128
J	Montgomery, P; Burton, JR; Sewell, RP; Spreckelsen, TF; Richardson, AJ				Montgomery, Paul; Burton, Jennifer R.; Sewell, Richard P.; Spreckelsen, Thees F.; Richardson, Alexandra J.			Low Blood Long Chain Omega-3 Fatty Acids in UK Children Are Associated with Poor Cognitive Performance and Behavior: A Cross-Sectional Analysis from the DOLAB Study	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; FATTY-ACIDS; OMEGA-3 INDEX; SUPPLEMENTATION	Background: Omega-3 long-chain polyunsaturated fatty acids (LC-PUFA), especially DHA (docosahexaenonic acid) are essential for brain development and physical health. Low blood Omega-3 LC-PUFA have been reported in children with ADHD and related behavior/learning difficulties, as have benefits from dietary supplementation. Little is known, however, about blood fatty acid status in the general child population. We therefore investigated this in relation to age-standardized measures of behavior and cognition in a representative sample of children from mainstream schools. Participants: 493 schoolchildren aged 7-9 years from mainstream Oxfordshire schools, selected for below average reading performance in national assessments at age seven. Method: Whole blood fatty acids were obtained via fingerstick samples. Reading and working memory were assessed using the British Ability Scales (II). Behaviour (ADHD-type symptoms) was rated using the revised Conners' rating scales (long parent and teacher versions). Associations were examined and adjusted for relevant demographic variables. Results: DHA and eicosapentaenoic acid (EPA), accounted for only 1.9% and 0.55% respectively of total blood fatty acids, with DHA showing more individual variation. Controlling for sex and socio-economic status, lower DHA concentrations were associated with poorer reading ability (std. OLS coeff. = 0.09, p = <.042) and working memory performance (0.14, p = <.001). Lower DHA was also associated with higher levels of parent rated oppositional behavior and emotional lability (-0.175, p= <.0001 and -0.178, p = <.0001). Conclusions: In these healthy UK children with below average reading ability, concentrations of DHA and other Omega-3 LC-PUFA were low relative to adult cardiovascular health recommendations, and directly related to measures of cognition and behavior. These findings require confirmation, but suggest that the benefits from dietary supplementation with Omega-3 LC-PUFA found for ADHD, Dyspraxia, Dyslexia, and related conditions might extend to the general school population.	[Montgomery, Paul; Burton, Jennifer R.; Sewell, Richard P.; Spreckelsen, Thees F.; Richardson, Alexandra J.] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England	University of Oxford	Montgomery, P (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford, England.	paul.montgomery@spi.ox.ac.uk	Spreckelsen, Thees/L-9281-2019	Spreckelsen, Thees/0000-0002-5043-2077; Richardson, Alex/0000-0001-5650-4409; Montgomery, Paul/0000-0001-8008-1370	Martek Biosciences Inc.	Martek Biosciences Inc.	The study was funded by Martek Biosciences Inc. (http://www.lifesdha.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Funding for the trial was provided by Martek Biosciences Inc., who also provided product and placebo. JRB, TFS and RPS declare that no other competing interests exist. AJR and PM acts as an occasional paid consultant (lectures and advisory work) for companies and organisations involved in producing, selling, or promoting foods or supplements containing omega-3. None of these issues alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bailey-Hall E, 2008, LIPIDS, V43, P181, DOI 10.1007/s11745-007-3140-7; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bloch MH, 2011, J AM ACAD CHILD PSY, V50, P991, DOI 10.1016/j.jaac.2011.06.008; BURGESS JR, 2003, PHOSPHOLIPID SPECTRU, P511; Chen JR, 2004, J NUTR BIOCHEM, V15, P467, DOI 10.1016/j.jnutbio.2004.01.008; Conners C.K., 1997, CONNERSRATING SCALES; Cyhlarova E, 2007, EUR NEUROPSYCHOPHARM, V17, P116, DOI 10.1016/j.euroneuro.2006.07.003; Decsi T, 2011, AM J CLIN NUTR, V94, p1914S, DOI 10.3945/ajcn.110.000893; Department of Education, 2001, DFES5812001 DEP ED; Elliott C. D., 1997, TECHNICAL MANUAL BRI; Food Standards Agency, 2010, EAT WELL YOUR GUID H; Galli C, 2010, 9 C INT SOC STUD FAT; Glaser C, 2010, J PEDIATR-US, V157, P826, DOI 10.1016/j.jpeds.2010.05.001; Harris WS, 2011, AM J CLIN NUTR, V93, P907, DOI 10.3945/ajcn.111.014365; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hobbs G, 2010, BRIT EDUC RES J, V36, P673, DOI 10.1080/01411920903083111; Kirby A, 2010, RES DEV DISABIL, V31, P718, DOI 10.1016/j.ridd.2010.01.014; Marangoni F, 2004, ANAL BIOCHEM, V326, P267, DOI 10.1016/j.ab.2003.12.016; Mathias RA, 2011, BMC GENET, V12, DOI [10.1186/1471-2156-1112-1150, DOI 10.1186/1471-2156-1112-1150]; MORRISON WR, 1964, J LIPID RES, V5, P600; Ramakrishnan U, 2009, AM J CLIN NUTR, V89, p958S, DOI 10.3945/ajcn.2008.26692F; Richardson AJ, 2005, PEDIATRICS, V115, P1360, DOI 10.1542/peds.2004-2164; Richardson AJ, 2006, INT REV PSYCHIATR, V18, P155, DOI 10.1080/09540260600583031; Richardson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043909; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Ryan AS, 2010, PROSTAG LEUKOTR ESS, V82, P305, DOI 10.1016/j.plefa.2010.02.007; Schuchardt JP, 2010, EUR J PEDIATR, V169, P149, DOI 10.1007/s00431-009-1035-8; Sinn N, 2008, PROSTAG LEUKOTR ESS, V78, P311, DOI 10.1016/j.plefa.2008.04.004; Standards and Testing Agency, 2012, NAT CURR ASS ASS REP; STEVENS LJ, 1995, AM J CLIN NUTR, V62, P761, DOI 10.1093/ajcn/62.4.761	30	63	66	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66697	10.1371/journal.pone.0066697	http://dx.doi.org/10.1371/journal.pone.0066697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826114	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400034
J	Simon, E; Caille, A; Perrotin, F; Giraudeau, B				Simon, Emmanuel; Caille, Agnes; Perrotin, Franck; Giraudeau, Bruno			Mixing Nulliparous and Multiparous Women in Randomised Controlled Trials of Preeclampsia Prevention Is Debatable: Evidence from a Systematic Review	PLOS ONE			English	Review							CLINICAL-TRIALS; PROSPECTIVE COHORT; RISK; PREGNANCY	Background: Nulliparity is a major risk factor of preeclampsia investigated in numerous trials of its prevention. Objective: We aimed to assess whether these trials considered nulliparity in subject selection or analysis of results. Search Strategy: 01 April 2013 search of MEDLINE via PubMed, EMBASE and the Cochrane Library. 01 April 2013 search of trials registered in Clinicaltrials.gov. Selection Criteria: Randomised controlled trials and metaanalyses of preeclampsia prevention with no restriction to period of publication or language. Metaanalyses were selected to fully identify relevant trials. Data Collection and Analysis: One reader appraised each selected article/registered protocol using a pretested, standardized data abstraction form developed in a pilot test. For each article, he recorded whether both nulliparous and multiparous were included and, in case of mixed populations, whether randomisation was stratified, and whether subgroup analyses had been reported. For registered protocols, he only assessed whether it was planned to include mixed populations. Main Results: 88 randomised controlled trials were identified, representing 83,396 included women. In 58 of the 88 articles identified (65.9%), preeclampsia was the primary outcome. In 31 of these (53.4%), the investigation combined nulliparous and multiparous women; only two reports in 31 (6.5%) stated that randomisation was stratified on parity and only four (12.9%) described a subgroup analysis by parity. Of the 30 registered trials, 20 (66.6%) planned to include both nulliparous and multiparous women. Conclusion: Parity is largely ignored in randomised controlled trials of preeclampsia prevention, which raises difficulties in interpreting the results.	[Simon, Emmanuel; Caille, Agnes; Giraudeau, Bruno] INSERM, UMR S 738, Paris, France; [Simon, Emmanuel; Perrotin, Franck] Univ Tours, CHRU Tours, Serv Obstet, Tours, France; [Caille, Agnes; Giraudeau, Bruno] INSERM, CIC 202, Tours, France; [Caille, Agnes; Giraudeau, Bruno] Univ Tours, Tours, France; [Caille, Agnes; Giraudeau, Bruno] CHRU Tours, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Giraudeau, B (corresponding author), INSERM, UMR S 738, Paris, France.	giraudeau@med.univ-tours.fr	Giraudeau, Bruno/L-9003-2015; caille, agnes/L-9011-2015; Perrotin, Franck/AAL-8833-2021	Giraudeau, Bruno/0000-0003-3031-8258; Perrotin, Franck/0000-0001-9694-6658; Simon, Emmanuel/0000-0001-6442-1013; Caille, Agnes/0000-0003-4715-6144				Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Gail MH., 2000, ENCY EPIDEMIOLOGIC M; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hernandez-Diaz S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2255; Hill CL, 2002, J CLIN EPIDEMIOL, V55, P783, DOI 10.1016/S0895-4356(02)00440-7; Hofmeyr GJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub3; Julian DG, 2004, J INTERN MED, V255, P309, DOI 10.1046/j.1365-2796.2003.01282.x; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Macdonald-Wallis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022115; Makrides M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub2; Meher S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006065; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Rumbold A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004227.pub3; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Steer P, 2005, BJOG-INT J OBSTET GY, V112, P1, DOI 10.1111/j.1471-0528.2005.00575.x; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Walter SD, 2000, J CLIN EPIDEMIOL, V53, P931, DOI 10.1016/S0895-4356(00)00210-9; Walter SD, 1997, STAT MED, V16, P2883, DOI 10.1002/(SICI)1097-0258(19971230)16:24<2883::AID-SIM825>3.0.CO;2-B	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66677	10.1371/journal.pone.0066677	http://dx.doi.org/10.1371/journal.pone.0066677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826112	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400032
J	Wallerstedt, SM; Fastbom, J; Johnell, K; Sjoberg, C; Landahl, S; Sundstrom, A				Wallerstedt, Susanna M.; Fastbom, Johan; Johnell, Kristina; Sjoberg, Christina; Landahl, Sten; Sundstrom, Anders			Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System-A Longitudinal Analysis	PLOS ONE			English	Article							MEDICATION ERRORS; ELDERLY-PATIENTS; NURSING-HOMES; HEALTH-CARE; QUALITY; PRESCRIPTION; DEMENTIA	Background: An association has been found between multi-dose drug dispensing (MDD) and use of many drugs. The aim of this study was to investigate the nature of this association, by performing a longitudinal analysis of the drug treatment before and after the transition to MDD. Methods: Inclusion critera in this register-based study were inhabitants in Region Vastra Gotaland, Sweden, who, at >= 65 years of age and between 1st July 2006 and 30th June 2010, filled their first MDD prescription. For each individual, prescribed drugs were estimated at three month intervals before and after (maximum 3 years, respectively) the first date of filling an MDD prescription (index date). Results: A total of 30,922 individuals matched the inclusion criteria (mean age: 83.2 years; 59.9% female). There was a temporal association between the transition to MDD and an increased number of drugs: 5.4 +/- 3.9 and 7.5 +/- 3.8 unique drugs three months before and after the index date, respectively, as well as worse outcomes on several indicators of prescribing quality. When either data before or after the index date were used, a multi-level regression analysis predicted the number of drugs at the index date at 5.76 (95% confidence limits: 5.71; 5.80) and 7.15 (7.10; 7.19), respectively, for an average female individual (83.2 years, 10.8 unique diagnoses, 2.4 healthcare contacts/three months). The predicted change in the number of drugs, from three months before the index date to the index date, was greater when data before this date was used as compared with data after this date: 0.12 (0.09; 0.14) versus 0.02 (-0.01; 0.05). Conclusions: After the patients entered the MDD system, they had an increased number of drugs, more often potentially harmful drug treatment, and fewer changes in drug treatment. These findings support a causal relationship between such a system and safety concerns as regards prescribing practices.	[Wallerstedt, Susanna M.] Sahlgrens Univ Hosp, Dept Clin Pharmacol, Gothenburg, Sweden; [Fastbom, Johan; Johnell, Kristina] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Fastbom, Johan; Johnell, Kristina] Stockholm Univ, S-10691 Stockholm, Sweden; [Sjoberg, Christina] Sahlgrenska Univ Hosp Molndal, Dept Geriatr, Molndal, Sweden; [Landahl, Sten] Sahlgrens Acad, Dept Geriatr, Molndal, Sweden; [Sundstrom, Anders] Karolinska Inst, Ctr Pharmacoepidemiol, Stockholm, Sweden	Sahlgrenska University Hospital; Karolinska Institutet; Stockholm University; Sahlgrenska University Hospital; Karolinska Institutet	Wallerstedt, SM (corresponding author), Sahlgrens Univ Hosp, Dept Clin Pharmacol, Gothenburg, Sweden.	susanna.wallerstedt@pharm.gu.se	Wallerstedt, Susanna/AAE-5607-2020	Wallerstedt, Susanna/0000-0001-7238-1680; Landahl, Sten/0000-0001-7251-9192	Swedish Medical Products Agency	Swedish Medical Products Agency	The study was funded by the Swedish Medical Products Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alassaad A, 2013, J EVAL CLIN PRACT, V19, P185, DOI 10.1111/j.1365-2753.2011.01798.x; Bakken Toril, 2003, Tidsskr Nor Laegeforen, V123, P3595; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; Bergkvist A, 2009, EUR J CLIN PHARMACOL, V65, P1037, DOI 10.1007/s00228-009-0680-1; Bergman A, 2007, SCAND J PRIM HEALTH, V25, P9, DOI 10.1080/02813430600991980; Hoven JL, 2005, EUR J CLIN PHARMACOL, V60, P831, DOI 10.1007/s00228-004-0845-x; Johnell K, 2008, SCAND J PRIM HEALTH, V26, P86, DOI 10.1080/02813430802022196; Johnell K, 2007, ANN PHARMACOTHER, V41, P1243, DOI 10.1345/aph.1K154; Larsen Anna Bira, 2007, Res Social Adm Pharm, V3, P265, DOI 10.1016/j.sapharm.2006.10.002; McGraw C, 2000, Br J Community Nurs, V5, P326; MEANS BJ, 1975, AM J HOSP PHARM, V32, P186, DOI 10.1093/ajhp/32.2.186; Medical Products Agency, 2013, UTV DOSTJ, P10; Midlov P, 2005, PHARM WORLD SCI, V27, P116, DOI 10.1007/s11096-004-3705-y; Midlov P, 2012, INT J CLIN PHARM-NET, V34, P113, DOI 10.1007/s11096-011-9599-6; MURRAY MD, 1993, ANN PHARMACOTHER, V27, P616; Nordling S, 2009, VILKEN NYTTA HAR APO, P24, DOI The Swedish Institute for Health Economics; Olsson J, 2010, CLIN DRUG INVEST, V30, P289, DOI 10.2165/11534320-000000000-00000; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Sjoberg C, 2012, EUR J CLIN PHARMACOL, V68, P1095, DOI 10.1007/s00228-012-1230-9; Sjoberg C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026574; Sjoqvist F, 2012, INTERAKTION MELLAN L; Swedish Council on Technology Assessment in Health Care, 2009, CAN DRUG CONS ELD BE, p[12, 19]; Wekre LJ, 2012, SCAND J PUBLIC HEALT, V40, P523, DOI 10.1177/1403494812455468; Wekre LJ, 2011, SCAND J PRIM HEALTH, V29, P45, DOI 10.3109/02813432.2011.554002; Wekre LJ, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.038745	25	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67088	10.1371/journal.pone.0067088	http://dx.doi.org/10.1371/journal.pone.0067088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826197	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400101
J	Lemaitre, JF; Gaillard, JM				Lemaitre, Jean-Francois; Gaillard, Jean-Michel			Polyandry Has No Detectable Mortality Cost in Female Mammals	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; SPERM COMPETITION; MATING SYSTEMS; PREDATION RISK; MATE CHOICE; LIFE-SPAN; EVOLUTION; PATTERNS; SURVIVAL; BENEFITS	In several taxonomic groups, females mate with several males during a single reproductive cycle. Although there is evidence that polyandry provides some benefits to females, it often involves mortality costs. However, empirical evidences of mortality costs of polyandry have so far been reported only in invertebrates. Whether polyandry has mortality costs in vertebrates is currently unknown. In the present study, we aimed to fill the gap by investigating the relationships between the level of polyandry (measured either by male relative testes mass or the percentage of multiple paternities) and female patterns of mortality across mammals. While we found that the two metrics of female mortality co-varied with pace of life, we did not find any evidence that polyandry leads to either decreased median lifespan or increased aging rate in mammals. We discuss such an absence of detectable mortality costs of polyandry in female mammals in light of recent advances in the study of mammalian reproductive biology and life-history tactics.	[Lemaitre, Jean-Francois] Univ Lyon, Lyon, France; Univ Lyon 1, F-69622 Villeurbanne, France; CNRS, UMR5558, Lab Biometrie & Biol Evolut, Villeurbanne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Lemaitre, JF (corresponding author), Univ Lyon, Lyon, France.	jeff.lemaitre@gmail.com		Gaillard, Jean-Michel/0000-0003-0174-8451	Fyssen Foundation	Fyssen Foundation	The funder is the Fyssen Foundation that provides grants for young researchers in Behavioural Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2004, J REPROD IMMUNOL, V61, P31, DOI 10.1016/j.jri.2003.11.001; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birkhead TR, 1998, SPERM COMPETITION SE; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Bro-Jorgensen J, 2011, EVOL BIOL, V38, P28, DOI 10.1007/s11692-010-9105-4; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cappozzo HL, 2008, NATURWISSENSCHAFTEN, V95, P625, DOI 10.1007/s00114-008-0363-2; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cothran RD, 2004, ANIM BEHAV, V68, P1133, DOI 10.1016/j.anbehav.2003.09.021; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; DEWSBURY DA, 1972, Q REV BIOL, V47, P1, DOI 10.1086/407097; Dixson AF, 1998, FOLIA PRIMATOL, V69, P300, DOI 10.1159/000021643; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Fischer K, 2007, ECOL ENTOMOL, V32, P674, DOI 10.1111/j.1365-2311.2007.00922.x; Fitzpatrick JL, 2012, EVOLUTION, V66, P3595, DOI 10.1111/j.1558-5646.2012.01713.x; Fortes P, 2011, PHYSIOL ENTOMOL, V36, P215, DOI 10.1111/j.1365-3032.2011.00786.x; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gaillard JM, 2003, POPUL DEV REV, V29, P39; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gaillard JM, 2005, AM NAT, V166, P119, DOI 10.1086/430330; GINSBERG JR, 1990, BEHAV ECOL SOCIOBIOL, V26, P427; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; HARCOURT AH, 1995, FUNCT ECOL, V9, P468, DOI 10.2307/2390011; HART BL, 1987, PHYSIOL BEHAV, V41, P321, DOI 10.1016/0031-9384(87)90395-7; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hastie T., 2006, GAM GEN ADDITIVE MOD; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 2003, EVOL BIOL, V33, P173; Hosken DJ, 2002, PHYSIOL ENTOMOL, V27, P87, DOI 10.1046/j.1365-3032.2002.00271.x; Hotzy C, 2009, CURR BIOL, V19, P404, DOI 10.1016/j.cub.2009.01.045; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kawagoe T, 2001, ECOL ENTOMOL, V26, P258, DOI 10.1046/j.1365-2311.2001.00326.x; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; King BH, 2010, BEHAVIOUR, V147, P85, DOI 10.1163/000579509X12483520922241; Klemme I, 2008, P ROY SOC B-BIOL SCI, V275, P1095, DOI 10.1098/rspb.2008.0038; Klemme I, 2010, BIOL LETTERS, V6, P24, DOI 10.1098/rsbl.2009.0500; KREMENTZ DG, 1989, OIKOS, V56, P203, DOI 10.2307/3565337; Lemaitre JF, 2009, J EVOLUTION BIOL, V22, P2215, DOI 10.1111/j.1420-9101.2009.01837.x; Lemaitre JF, 2013, BEHAV ECOL, V24, P421, DOI 10.1093/beheco/ars179; Lemaitre JF, 2012, BEHAV ECOL SOCIOBIOL, V66, P97, DOI 10.1007/s00265-011-1257-4; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Long TAF, 2005, J EVOLUTION BIOL, V18, P209; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; McNamara KB, 2008, BEHAV ECOL SOCIOBIOL, V62, P1433, DOI 10.1007/s00265-008-0573-9; Moorad JA, 2012, AGING CELL, V11, P940, DOI 10.1111/j.1474-9726.2012.00861.x; Nunn CL, 2003, ANIM BEHAV, V66, P37, DOI 10.1006/anbe.2003.2130; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2012, AGING CELL, V11, P178, DOI 10.1111/j.1474-9726.2011.00771.x; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; Reale D, 1996, CAN J ZOOL, V74, P1812, DOI 10.1139/z96-202; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; SILVA M, 1995, CRC HDB MAMMALIAN BO; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; South A, 2011, BIOL REV, V86, P299, DOI 10.1111/j.1469-185X.2010.00145.x; Stearns S.C., 1992, pi; Stockley P, 2004, J EVOLUTION BIOL, V17, P1048, DOI 10.1111/j.1420-9101.2004.00742.x; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; Stockley P, 2002, EVOL ECOL, V16, P123, DOI 10.1023/A:1016323511091; Thrall PH, 1997, AM NAT, V149, P485, DOI 10.1086/286001; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Wlasiuk G, 2010, EVOLUTION, V64, P2204, DOI 10.1111/j.1558-5646.2010.00989.x; WOOTTON JT, 1987, EVOLUTION, V41, P732, DOI 10.1111/j.1558-5646.1987.tb05849.x	82	11	11	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66670	10.1371/journal.pone.0066670	http://dx.doi.org/10.1371/journal.pone.0066670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825000	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400147
J	Omata, K; Hanakawa, T; Morimoto, M; Honda, M				Omata, Kei; Hanakawa, Takashi; Morimoto, Masako; Honda, Manabu			Spontaneous Slow Fluctuation of EEG Alpha Rhythm Reflects Activity in Deep-Brain Structures: A Simultaneous EEG-fMRI Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; CEREBROSPINAL-FLUID FLOW; EMPIRICAL MODE DECOMPOSITION; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; THALAMUS; RESPONSES; ARTIFACT; STIMULATION; SUPPRESSION	The emergence of the occipital alpha rhythm on brain electroencephalogram (EEG) is associated with brain activity in the cerebral neocortex and deep brain structures. To further understand the mechanisms of alpha rhythm power fluctuation, we performed simultaneous EEGs and functional magnetic resonance imaging recordings in human subjects during a resting state and explored the dynamic relationship between alpha power fluctuation and blood oxygenation level-dependent (BOLD) signals of the brain. Based on the frequency characteristics of the alpha power time series (APTS) during 20-minute EEG recordings, we divided the APTS into two components: fast fluctuation (0.04-0.167 Hz) and slow fluctuation (0-0.04 Hz). Analysis of the correlation between the MRI signal and each component revealed that the slow fluctuation component of alpha power was positively correlated with BOLD signal changes in the brain stem and the medial part of the thalamus and anterior cingulate cortex, while the fast fluctuation component was correlated with the lateral part of the thalamus and the anterior cingulate cortex, but not the brain stem. In summary, these data suggest that different subcortical structures contribute to slow and fast modulations of alpha spectra on brain EEG.	[Omata, Kei; Morimoto, Masako; Honda, Manabu] Natl Ctr Neurol & Psychiat, Dept Funct Brain Res, Natl Inst Neurosci, Tokyo, Japan; [Omata, Kei] Hamamatsu Univ Sch Med, Dept Biofunct Imaging, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Hanakawa, Takashi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan; [Hanakawa, Takashi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Omata, Kei; Morimoto, Masako; Honda, Manabu] Japan Sci & Technol Agcy, CREST, Saitama, Japan	National Center for Neurology & Psychiatry - Japan; Hamamatsu University School of Medicine; National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Honda, M (corresponding author), Natl Ctr Neurol & Psychiat, Dept Funct Brain Res, Natl Inst Neurosci, Tokyo, Japan.	honda@ncnp.go.jp	HONDA, Manabu/AAO-1202-2020; Hanakawa, Takashi/AEU-7951-2022		Japan Science and Technology Agency, CREST; Health Labour Sciences Research Grant	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan)	This work was partly supported by Japan Science and Technology Agency, CREST (URL: http://www.jst.go.jp/kisoken/crest/en/research _area/ongoing/area02-1.html), a Grant-in-Aid for Scientific Research on Innovative Areas (Brain and Information Science on SHITSUKAN)(URL: http://shitsukan.jp/content/137, Number: C01-3) and a Health Labour Sciences Research Grant (URL: http://www.mhlw.go.jp/bunya/ kenkyuujigyou/hojokin-koubo20/07-03.html, Number: 33) to M.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASU T, 1984, J PHYSIOL-LONDON, V351, P583, DOI 10.1113/jphysiol.1984.sp015264; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; ANDERSEN P, 1967, J PHYSIOL-LONDON, V192, P257, DOI 10.1113/jphysiol.1967.sp008299; Astolfi L, 2008, IEEE T NEUR SYS REH, V16, P522, DOI 10.1109/TNSRE.2008.2009784; Bear MF, 2007, NEUROSCIENCE EXPLORI, Vxxxviii, P857, DOI DOI 10.1093/BRAIN/AWM203; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bridwell DA, 2013, NEUROIMAGE, V69, P101, DOI 10.1016/j.neuroimage.2012.12.024; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; de Munck JC, 2007, NEUROIMAGE, V35, P1142, DOI 10.1016/j.neuroimage.2007.01.022; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; DiFrancesco MW, 2008, J CLIN NEUROPHYSIOL, V25, P255, DOI 10.1097/WNP.0b013e3181879d56; DUN NJ, 1984, J PHYSIOL-LONDON, V351, P61, DOI 10.1113/jphysiol.1984.sp015232; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frackowiak RSJ., 2003, HUMAN BRAIN FUNCTION; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grouiller F, 2007, NEUROIMAGE, V38, P124, DOI 10.1016/j.neuroimage.2007.07.025; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Henning S, 2006, BRAIN RES, V1073, P359, DOI 10.1016/j.brainres.2005.12.058; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Hsu MM, 1997, NEUROREPORT, V8, P2701, DOI 10.1097/00001756-199708180-00013; Hsu MM, 2000, CHINESE J PHYSIOL, V43, P81; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; KOBAYASHI H, 1970, J PHYSIOL-LONDON, V208, P353, DOI 10.1113/jphysiol.1970.sp009125; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Laufs H, 2008, NEUROIMAGE, V40, P515, DOI 10.1016/j.neuroimage.2007.11.039; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Libet B, 1992, CAN J PHYSIOL PHARM, V70, pS311; Lindgren KA, 1999, BIOL PSYCHIAT, V45, P943, DOI 10.1016/S0006-3223(98)00350-3; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Makeig S., 1996, ADV NEURAL INFORM PR, V8; Michelsen KA, 2008, PROG BRAIN RES, V172, P233, DOI 10.1016/S0079-6123(08)00912-6; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Naidich TP, 2009, DUVERNOYS ATLAS HUMA, Vxi, P876; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Niedermeyer E., 2004, ELECTROENCEPHALOGRAP; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU, V4th ed, pxiv; Nikouline VV, 2000, NEUROSCI LETT, V294, P163, DOI 10.1016/S0304-3940(00)01562-7; Oohashi T, 2000, J NEUROPHYSIOL, V83, P3548, DOI 10.1152/jn.2000.83.6.3548; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Patel P, 1997, P INT SOC MAGN RES M, V3, P1653; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rechtschaffen A, 1986, MANUAL STANDARDIZED; Rilling G., 2003, IEEE EURASIP WORKSH, V3, P8; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; Salek-Haddadi A, 2003, BRAIN RES REV, V43, P110, DOI 10.1016/S0165-0173(03)00193-0; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; SCHROTH G, 1992, NEURORADIOLOGY, V35, P10, DOI 10.1007/BF00588271; SCHROTH G, 1992, NEURORADIOLOGY, V35, P1, DOI 10.1007/BF00588270; SCHROTH G, 1992, NEURORADIOLOGY, V35, P16, DOI 10.1007/BF00588272; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Tyvaert L, 2008, CLIN NEUROPHYSIOL, V119, P2762, DOI 10.1016/j.clinph.2008.07.284; Vecchiato G, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/643489; Vecchiato G, 2011, MED BIOL ENG COMPUT, V49, P579, DOI 10.1007/s11517-011-0747-x; WALLIS DI, 1988, BRIT J PHARMACOL, V93, P110, DOI 10.1111/j.1476-5381.1988.tb11411.x; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	71	31	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66869	10.1371/journal.pone.0066869	http://dx.doi.org/10.1371/journal.pone.0066869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824708	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400164
J	Jacka, B; Lamoury, F; Simmonds, P; Dore, GJ; Grebely, J; Applegate, T				Jacka, Brendan; Lamoury, Francois; Simmonds, Peter; Dore, Gregory J.; Grebely, Jason; Applegate, Tanya			Sequencing of the Hepatitis C Virus: A Systematic Review	PLOS ONE			English	Review							AMPLIFICATION; NOMENCLATURE; MUTATIONS; PROTEINS; PROTEASE	Since the identification of hepatitis C virus (HCV), viral sequencing has been important in understanding HCV classification, epidemiology, evolution, transmission clustering, treatment response and natural history. The length and diversity of the HCV genome has resulted in analysis of certain regions of the virus, however there has been little standardisation of protocols. This systematic review was undertaken to map the location and frequency of sequencing on the HCV genome in peer reviewed publications, with the aim to produce a database of sequencing primers and amplicons to inform future research. Medline and Scopus databases were searched for English language publications based on keyword/MeSH terms related to sequence analysis (9 terms) or HCV (3 terms), plus "primer" as a general search term. Exclusion criteria included non-HCV research, review articles, duplicate records, and incomplete description of HCV sequencing methods. The PCR primer locations of accepted publications were noted, and purpose of sequencing was determined. A total of 450 studies were accepted from the 2099 identified, with 629 HCV sequencing amplicons identified and mapped on the HCV genome. The most commonly sequenced region was the HVR-1 region, often utilised for studies of natural history, clustering/transmission, evolution and treatment response. Studies related to genotyping/ classification or epidemiology of HCV genotype generally targeted the 5'UTR, Core and NS5B regions, while treatment response/resistance was assessed mainly in the NS3-NS5B region with emphasis on the Interferon sensitivity determining region (ISDR) region of NS5A. While the sequencing of HCV is generally constricted to certain regions of the HCV genome there is little consistency in the positioning of sequencing primers, with the exception of a few highly referenced manuscripts. This study demonstrates the heterogeneity of HCV sequencing, providing a comprehensive database of previously published primer sets to be utilised in future sequencing studies.	[Jacka, Brendan; Lamoury, Francois; Dore, Gregory J.; Grebely, Jason; Applegate, Tanya] Univ New S Wales, Kirby Inst, Viral Hepatitis Clin Res Program, Sydney, NSW, Australia; [Simmonds, Peter] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland	University of New South Wales Sydney; Kirby Institute; University of Edinburgh	Jacka, B (corresponding author), Univ New S Wales, Kirby Inst, Viral Hepatitis Clin Res Program, Sydney, NSW, Australia.	bjacka@kirby.unsw.edu.au; tapplegate@kirby.unsw.edu.au	Dore, Gregory John/ABD-5665-2021; Jacka, Brendan/T-3553-2018	Dore, Gregory John/0000-0002-4741-2622; Jacka, Brendan/0000-0002-5910-853X; Simmonds, Peter/0000-0002-7964-4700; Lamoury, Francois/0000-0003-3060-9506; Applegate, Tanya/0000-0002-8657-4261	Australian Government Department of Health and Ageing; National Health and Medical Research Council Career Development Fellowship; National Health and Medical Research Council Practitioner Research Fellowship; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish; BBSRC [BBS/E/D/20241864] Funding Source: UKRI	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Practitioner Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Kirby Institute is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, University of New South Wales. BJ is an Australian Postgraduate Award scholar. JG is supported by a National Health and Medical Research Council Career Development Fellowship. GD is supported by a National Health and Medical Research Council Practitioner Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Z, 2000, J VIRAL HEPATITIS, V7, P93; ENOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021, DOI 10.1016/0006-291X(90)90494-8; Fan XF, 2001, BIOCHEM BIOPH RES CO, V284, P694, DOI 10.1006/bbrc.2001.5019; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lee JH, 1997, J HEPATOL, V26, P1001, DOI 10.1016/S0168-8278(97)80108-0; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Pawlotsky JM, 2006, CURR TOP MICROBIOL, V299, P261; Qiu P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-29; Saldanha J, 1999, VOX SANG, V76, P149, DOI 10.1046/j.1423-0410.1999.7630149.x; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SIMMONDS P, 1994, J GEN VIROL, V75, P1053, DOI 10.1099/0022-1317-75-5-1053; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Stumpf MPH, 2002, FEMS MICROBIOL LETT, V214, P143, DOI 10.1111/j.1574-6968.2002.tb11338.x; Tan SL, 2001, VIROLOGY, V284, P1, DOI 10.1006/viro.2001.0885; WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J	18	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67073	10.1371/journal.pone.0067073	http://dx.doi.org/10.1371/journal.pone.0067073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826196	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000023
J	Caproni, S; Muti, M; Principi, M; Ottaviano, P; Frondizi, D; Capocchi, G; Floridi, P; Rossi, A; Calabresi, P; Tambasco, N				Caproni, Stefano; Muti, Marco; Principi, Massimo; Ottaviano, Pierfausto; Frondizi, Domenico; Capocchi, Giuseppe; Floridi, Piero; Rossi, Aroldo; Calabresi, Paolo; Tambasco, Nicola			Complexity of Motor Sequences and Cortical Reorganization in Parkinson's Disease: A Functional MRI Study	PLOS ONE			English	Article							BASAL GANGLIA; FINGER MOVEMENTS; CORTEX; ACTIVATION; FMRI; HAND; TASK; PET; REPRESENTATIONS; CEREBELLUM	Motor impairment is the most relevant clinical feature in Parkinson's disease (PD). Functional imaging studies on motor impairment in PD have revealed changes in the cortical motor circuits, with particular involvement of the fronto-striatal network. The aim of this study was to assess brain activations during the performance of three different motor exercises, characterized by progressive complexity, using a functional fMRI multiple block paradigm, in PD patients and matched control subjects. Unlike from single-task comparisons, multi-task comparisons between similar exercises allowed to analyse brain areas involved in motor complexity planning and execution. Our results showed that in the single-task comparisons the involvement of primary and secondary motor areas was observed, consistent with previous findings based on similar paradigms. Most notably, in the multi-task comparisons a greater activation of supplementary motor area and posterior parietal cortex in PD patients, compared with controls, was observed. Furthermore, PD patients, compared with controls, had a lower activation of the basal ganglia and limbic structures, presumably leading to the impairment in the higher levels of motor control, including complexity planning and execution. The findings suggest that in PD patients occur both compensatory mechanisms and loss of efficiency and provide further insight into the pathophysiological role of distinct cortical and subcortical areas in motor dysfunction.	[Caproni, Stefano; Rossi, Aroldo; Calabresi, Paolo; Tambasco, Nicola] Univ Perugia, Azienda Osped, Neurol Clin, I-06100 Perugia, Italy; [Muti, Marco] Azienda Osped Terni, Serv Fis Sanit, Terni, Italy; [Principi, Massimo; Ottaviano, Pierfausto] Azienda Osped Terni, Serv Neuroradiol, Terni, Italy; [Frondizi, Domenico; Capocchi, Giuseppe] Azienda Osped Terni, UO Neurol, Terni, Italy; [Floridi, Piero] Azienda Osped Perugia, Serv Neuroradiol, Perugia, Italy; [Calabresi, Paolo] Fdn S Lucia, IRCCS, Rome, Italy	University of Perugia; Azienda Ospedaliera di Perugia; University of Perugia; Azienda Ospedaliera di Perugia; IRCCS Santa Lucia	Tambasco, N (corresponding author), Univ Perugia, Azienda Osped, Neurol Clin, I-06100 Perugia, Italy.	n.tambasco@libero.it	Tambasco, Nicola/K-4788-2018; Caproni, Stefano/GSE-1880-2022; Calabresi, Paolo/G-8496-2011	Tambasco, Nicola/0000-0003-1497-4482; Calabresi, Paolo/0000-0003-0326-5509	Novartis; Lundbeck; Boheringer Ingelheim; Bayer Schering; Biogen; Boehringer Ingelheim; Eisai; Sanofi-Aventis; Sigma-Tau; UCB Pharma; Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS; Italian Minister of Health and Agenzia Italiana del Farmaco (AIFA)	Novartis(Novartis); Lundbeck(Lundbeck Corporation); Boheringer Ingelheim; Bayer Schering(Bayer AG); Biogen(Biogen); Boehringer Ingelheim(Boehringer Ingelheim); Eisai(Eisai Co Ltd); Sanofi-Aventis(Sanofi-Aventis); Sigma-Tau; UCB Pharma(UCB Pharma SA); Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS; Italian Minister of Health and Agenzia Italiana del Farmaco (AIFA)	Nicola Tambasco has received funding for travel and speaker from Novartis, Lundbeck and Boheringer Ingelheim; Paolo Calabresi receives research support from Bayer Schering, Biogen, Boehringer Ingelheim, Eisai, Novartis, Lundbeck, Sanofi-Aventis, Sigma-Tau, and UCB Pharma; and from Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS (European Community Grants SYNSCAFF and REPLACES), the Italian Minister of Health and Agenzia Italiana del Farmaco (AIFA); Stefano Caproni, Marco Muti, Massimo Principi, Pierfausto Ottaviano, Domenico Frondizi, Giuseppe Capocchi, Aroldo Rossi and Piero Floridi declare no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aramaki Y, 2006, NEUROSCIENCE, V141, P2147, DOI 10.1016/j.neuroscience.2006.05.030; Beltramello A, 1998, ITAL J NEUROL SCI, V19, P277, DOI 10.1007/BF00713853; Boecker H, 1998, J NEUROPHYSIOL, V79, P1070, DOI 10.1152/jn.1998.79.2.1070; BRINKMAN J, 1973, BRAIN, V96, P653, DOI 10.1093/brain/96.4.653; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Catalan MJ, 1998, BRAIN, V121, P253, DOI 10.1093/brain/121.2.253; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Deiber MP, 1997, J NEUROPHYSIOL, V78, P977, DOI 10.1152/jn.1997.78.2.977; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Diciotti S, 2007, NEUROIMAGE, V38, P402, DOI 10.1016/j.neuroimage.2007.07.045; Eckert T, 2006, J NEUROL, V253, P199, DOI 10.1007/s00415-005-0956-z; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 2004, HUMAN BRAIN FUNCTION; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Furl N, 2011, J NEUROSCI, V31, P17572, DOI 10.1523/JNEUROSCI.4236-11.2011; Gheysen F, 2010, EXP BRAIN RES, V202, P795, DOI 10.1007/s00221-010-2186-6; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; Harrington DL, 2000, J COGNITIVE NEUROSCI, V12, P56, DOI 10.1162/08989290051137602; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Holden A, 2006, PARKINSONISM RELAT D, V12, P73, DOI 10.1016/j.parkreldis.2005.11.001; Humberstone M, 1997, ANN NEUROL, V42, P632, DOI 10.1002/ana.410420414; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; Lausberg H, 1999, NEUROPSYCHOLOGIA, V37, P253, DOI 10.1016/S0028-3932(98)00079-7; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Macri MA, 2006, MAGN RESON IMAGING, V24, P419, DOI 10.1016/j.mri.2005.12.035; Mallol R, 2007, BRAIN RES, V1147, P265, DOI 10.1016/j.brainres.2007.02.046; Menon V, 1998, NEUROREPORT, V9, P1567, DOI 10.1097/00001756-199805110-00058; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; Owen AM, 1998, BRAIN, V121, P949, DOI 10.1093/brain/121.5.949; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; Rauch SL, 1997, HUM BRAIN MAPP, V5, P124, DOI 10.1002/(SICI)1097-0193(1997)5:2<124::AID-HBM6>3.3.CO;2-P; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; SALINAS E, 1995, J NEUROSCI, V15, P6461; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Scholz VH, 2000, BRAIN RES, V879, P204, DOI 10.1016/S0006-8993(00)02749-9; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Talairach J., 1988, COPLANAR STEREOTAXIC; Toyokura M, 2002, J NEUROIMAGING, V12, P172, DOI 10.1111/j.1552-6569.2002.tb00116.x; Ukmar M, 2006, RADIOL MED, V111, P104, DOI 10.1007/s11547-006-0011-x; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Weiss PH, 2006, HUM BRAIN MAPP, V27, P1004, DOI 10.1002/hbm.20239; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	53	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66834	10.1371/journal.pone.0066834	http://dx.doi.org/10.1371/journal.pone.0066834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825570	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000031
J	Li, Y; Sun, Y; Liu, FY; Sun, L; Li, J; Duan, SB; Liu, H; Peng, YM; Xiao, L; Liu, YP; Xi, YY; You, YH; Li, H; Wang, M; Wang, S; Hou, T				Li, Ying; Sun, Yan; Liu, Fuyou; Sun, Lin; Li, Jun; Duan, Shaobin; Liu, Hong; Peng, Youming; Xiao, Li; Liu, Yuping; Xi, Yiyun; You, Yanhua; Li, Hua; Wang, Min; Wang, Shuai; Hou, Tao			Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							TGF-BETA; TUBULOINTERSTITIAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; DIABETIC-NEPHROPATHY; URETERAL OBSTRUCTION; SNAIL GENES; EXPRESSION; KIDNEY; CELLS; FIBROBLASTS	Epithelial-mesenchymal transition (EMT) is thought to contribute to the progression of renal tubulointerstitial fibrosis. Norcantharidin (NCTD) is a promising agent for inhibiting renal interstitial fibrosis. However, the molecular mechanisms of NCTD are unclear. In this study, a unilateral ureteral obstruction (UUO) rat model was established and treated with intraperitoneal NCTD (0.1 mg/kg/day). The UUO rats treated with NCTD showed a reduction in obstruction-induced upregulation of alpha-SMA and downregulation of E-cadherin in the rat kidney (P<0.05). Human renal proximal tubule cell lines (HK-2) stimulated with TGF-beta(1) were treated with different concentrations of NCTD. HK-2 cells stimulated by TGF-beta(1) in vitro led to downregulation of E-cadherin and increased de novo expression of alpha-SMA; co-treatment with NCTD attenuated all of these changes (P<0.05). NCTD reduced TGF-beta(1)-induced expression and phosphorylation of Smad2/3 and downregulated the expression of Snail1 (P<0.05). These results suggest that NCTD antagonizes tubular EMT by inhibiting the Smad pathway. NCTD may play a critical role in preserving the normal epithelial phenotype and modulating tubular EMT.	[Li, Ying; Liu, Fuyou; Sun, Lin; Li, Jun; Duan, Shaobin; Liu, Hong; Peng, Youming; Xiao, Li; Liu, Yuping; Xi, Yiyun; You, Yanhua; Li, Hua; Wang, Shuai; Hou, Tao] Cent S Univ, Xiangya Hosp 2, Div Nephrol, Changsha, Hunan, Peoples R China; [Sun, Yan] XinJiang Med Univ, Affiliated Hosp 1, Div Nephrol, Uramuq, Peoples R China; [Wang, Min] Cent S Univ, Xiangya Hosp 2, Dept Clin Lab, Changsha, Hunan, Peoples R China	Central South University; Xinjiang Medical University; Central South University	Li, Y (corresponding author), Cent S Univ, Xiangya Hosp 2, Div Nephrol, Changsha, Hunan, Peoples R China.	yachi20101213@gmail.com			National Natural Science Foundation of China [81100486]; Natural Science Foundation of Hunan Province of China [10JJ2011]; scientific project of the Research Center of Metabolic Syndrome in Central South University of China [DY-2008-02-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province of China(Natural Science Foundation of Hunan Province); scientific project of the Research Center of Metabolic Syndrome in Central South University of China	This study was supported by the National Natural Science Foundation of China (Grant No. 81100486), the Natural Science Foundation of Hunan Province of China (Grant No. 10JJ2011), and the scientific project of the Research Center of Metabolic Syndrome in Central South University of China (Grant No. DY-2008-02-03). The corresponding author and all the above grand funders played a role in designing and doing the experiment and writing the manuscript.	Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Batut J, 2008, DEVELOPMENT, V135, P2927, DOI 10.1242/dev.020842; Boutet A, 2008, M S-MED SCI, V24, P238, DOI 10.1051/medsci/2008243238; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Boutet A, 2007, CELL CYCLE, V6, P638, DOI 10.4161/cc.6.6.4022; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen CZC, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-7; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Flier SN, 2010, J BIOL CHEM, V285, P20202, DOI 10.1074/jbc.M110.102012; Galichon P, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-11; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Heikkinen PT, 2010, J BIOL CHEM, V285, P3740, DOI 10.1074/jbc.M109.042978; Hills CE, 2012, DIABETOLOGIA, V55, P812, DOI 10.1007/s00125-011-2409-9; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Huang Y, 2009, CYTOTECHNOLOGY, V59, P201, DOI [10.1007/s10616-009-9210-3, 10.1007/s10616-009-9221-0]; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kokudo T, 2008, J CELL SCI, V121, P3317, DOI 10.1242/jcs.028282; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Li Y, 2012, MOL CELL BIOCHEM, V361, P79, DOI 10.1007/s11010-011-1091-z; Li Y, 2011, LAB INVEST, V91, P1706, DOI 10.1038/labinvest.2011.119; Li Y, 2011, CELL BIOL INT, V35, P1239, DOI 10.1042/CBI20100850; Li Y, 2011, RENAL FAILURE, V33, P233, DOI 10.3109/0886022X.2011.553305; Liu FY, 2008, AM J NEPHROL, V28, P465, DOI 10.1159/000112850; Liu FY, 2007, AM J NEPHROL, V27, P176, DOI 10.1159/000100518; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Ohnuki K, 2012, J NEPHROL, V25, P233, DOI 10.5301/JN.2011.8449; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Stewart SG, 2007, BIOORGAN MED CHEM, V15, P7301, DOI 10.1016/j.bmc.2007.08.028; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616	39	23	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66356	10.1371/journal.pone.0066356	http://dx.doi.org/10.1371/journal.pone.0066356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825538	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000017
J	Okuyama, T; Isoe, Y; Hoki, M; Suehiro, Y; Yamagishi, G; Naruse, K; Kinoshita, M; Kamei, Y; Shimizu, A; Kubo, T; Takeuchi, H				Okuyama, Teruhiro; Isoe, Yasuko; Hoki, Masahito; Suehiro, Yuji; Yamagishi, Genki; Naruse, Kiyoshi; Kinoshita, Masato; Kamei, Yasuhiro; Shimizu, Atushi; Kubo, Takeo; Takeuchi, Hideaki			Controlled Cre/loxP Site-Specific Recombination in the Developing Brain in Medaka Fish, Oryzias latipes	PLOS ONE			English	Article							NEURAL STEM-CELLS; GENE INDUCTION; ADULT NEUROGENESIS; INFRARED-LASER; ZEBRAFISH; TELEOST; SYSTEM; DISSECTION; EXPRESSION; MARKER	Background: Genetic mosaic techniques have been used to visualize and/or genetically modify a neuronal subpopulation within complex neural circuits in various animals. Neural populations available for mosaic analysis, however, are limited in the vertebrate brain. Methodology/Principal Findings: To establish methodology to genetically manipulate neural circuits in medaka, we first created two transgenic (Tg) medaka lines, Tg (HSP:Cre) and Tg (HuC:loxP-DsRed-loxP-GFP). We confirmed medaka HuC promoter-derived expression of the reporter gene in juvenile medaka whole brain, and in neuronal precursor cells in the adult brain. We then demonstrated that stochastic recombination can be induced by micro-injection of Cre mRNA into Tg (HuC:loxP-DsRed-loxP-GFP) embryos at the 1-cell stage, which allowed us to visualize some subpopulations of GFP-positive cells in compartmentalized regions of the telencephalon in the adult medaka brain. This finding suggested that the distribution of clonally-related cells derived from single or a few progenitor cells was restricted to a compartmentalized region. Heat treatment of Tg(HSP:Cre x HuC:loxP-DsRed-loxP-GFP) embryos (0-1 day post fertilization [dpf]) in a thermalcycler (39 degrees C) led to Cre/loxP recombination in the whole brain. The recombination efficiency was notably low when using 2-3 dpf embyos compared with 0-1 dpf embryos, indicating the possibility of stage-dependent sensitivity of heat-inducible recombination. Finally, using an infrared laser-evoked gene operator (IR-LEGO) system, heat shock induced in a micro area in the developing brains led to visualization of clonally-related cells in both juvenile and adult medaka fish. Conclusions/Significance: We established a noninvasive method to control Cre/loxP site-specific recombination in the developing nervous system in medaka fish. This method will broaden the neural population available for mosaic analyses and allow for lineage tracing of the vertebrate nervous system in both juvenile and adult stages.	[Okuyama, Teruhiro; Isoe, Yasuko; Hoki, Masahito; Suehiro, Yuji; Yamagishi, Genki; Kubo, Takeo; Takeuchi, Hideaki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Okuyama, Teruhiro; Naruse, Kiyoshi; Kamei, Yasuhiro] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; [Suehiro, Yuji] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kinoshita, Masato] Kyoto Univ, Div Appl Biosci, Grad Sch Agr, Kyoto, Japan; [Shimizu, Atushi] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Women's Medical University; Kyoto University; Keio University	Takeuchi, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	takeuchi@biol.s.u-tokyo.ac.jp	Kamei, Yasuhiro/AAD-9281-2019; Takeuchi, Hideaki/W-6739-2018; KUBO, TAKEO/G-4951-2014; TAKEUCHI, HIDEAKI/G-4969-2014	Kamei, Yasuhiro/0000-0001-6382-1365; Takeuchi, Hideaki/0000-0001-6610-3895; Kubo, Takeo/0000-0002-5914-5269; Naruse, Kiyoshi/0000-0001-9185-3495	National Institute for Basic Biology Priority Collaborative Research Project [10-104]; Cell Science Research Foundation; Comprehensive Brain Science Network;  [23300115]; Grants-in-Aid for Scientific Research [23300115] Funding Source: KAKEN	National Institute for Basic Biology Priority Collaborative Research Project; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Comprehensive Brain Science Network; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Institute for Basic Biology Priority Collaborative Research Project (10-104), a Grant-in-Aid for Scientific Research (B) 23300115, a Grant-in-Aid for a JSPS postdoctoral SPD fellowship (to T.O.), the Cell Science Research Foundation (to T.O.), and the Comprehensive Brain Science Network (to T.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Deguchi T, 2009, DEV GROWTH DIFFER, V51, P769, DOI 10.1111/j.1440-169X.2009.01135.x; Fox DT, 2008, LINEAGE ANAL STEM CE; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hiratani I, 2001, DEV BIOL, V229, P456, DOI 10.1006/dbio.2000.9986; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Isoe Y, 2012, BIOCHEM BIOPH RES CO, V423, P627, DOI 10.1016/j.bbrc.2012.05.125; Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9; Ito M, 2013, CURR BIOL, V23, P644, DOI 10.1016/j.cub.2013.03.015; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kao CF, 2012, COLD SPRING HARB PRO, V2012; Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kimura E, 2013, ARTERIOSCL THROM VAS, V33, P1264, DOI 10.1161/ATVBAHA.112.300602; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kobayashi K, 2013, GENESIS, V51, P59, DOI 10.1002/dvg.22348; Kuroyanagi Y, 2010, BRAIN RES, V1323, P33, DOI 10.1016/j.brainres.2010.01.045; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Nakazawa N, 2012, DEV DYNAM, V241, P965, DOI 10.1002/dvdy.23784; Sato T, 2006, GENESIS, V44, P136, DOI 10.1002/gene.20196; Shimada A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2643; Shimizu A, 2013, TRANSGENIC RES, V22, P435, DOI 10.1007/s11248-012-9653-8; Suehiro Y, 2010, FEBS LETT, V584, P3545, DOI 10.1016/j.febslet.2010.06.047; Vopalensky P, 2010, BIOTECHNIQUES, V48, P235, DOI 10.2144/000113368; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; YASUMASU S, 1989, J BIOCHEM-TOKYO, V105, P204, DOI 10.1093/oxfordjournals.jbchem.a122640; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yu HH, 2013, CURR BIOL, V23, P633, DOI 10.1016/j.cub.2013.02.057; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; Zupanc GKH, 2008, J PHYSIOL-PARIS, V102, P357, DOI 10.1016/j.jphysparis.2008.10.007	42	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66597	10.1371/journal.pone.0066597	http://dx.doi.org/10.1371/journal.pone.0066597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825546	gold, Green Submitted, Green Published			2022-12-27	WOS:000321223000021
J	Villalobos-Duno, H; San-Blas, G; Paulinkevicius, M; Sanchez-Martin, Y; Nino-Vega, G				Villalobos-Duno, Hector; San-Blas, Gioconda; Paulinkevicius, Maryan; Sanchez-Martin, Yolanda; Nino-Vega, Gustavo			Biochemical Characterization of Paracoccidioides brasiliensis alpha-1,3-Glucanase Agn1p, and Its Functionality by Heterologous Expression in Schizosaccharomyces pombe	PLOS ONE			English	Article							CELL-WALL ALPHA-1,3-GLUCAN; ALPHA-GLUCANASE AGN1P; HISTOPLASMA-CAPSULATUM; CRYPTOCOCCUS-NEOFORMANS; ANTITUMOR-ACTIVITY; GENE; PROTEINS; SEPARATION; ALPHA-(1,3)-GLUCAN; IDENTIFICATION	alpha-1,3-Glucan is present as the outermost layer of the cell wall in the pathogenic yeastlike (Y) form of Paracoccidioides brasiliensis. Based on experimental evidence, this polysaccharide has been proposed as a fungal virulence factor. To degrade alpha-1,3-glucan and allow remodeling of the cell wall, alpha-1,3-glucanase is required. Therefore, the study of this enzyme, its encoding gene, and regulatory mechanisms, might be of interest to understand the morphogenesis and virulence process in this fungus. A single gene, orthologous to other fungal alpha-1,3-glucanase genes, was identified in the Paracoccidioides genome, and labeled AGN1. Transcriptional levels of AGN1 and AGS1 (alpha-1,3-glucan synthase-encoding gene) increased sharply when the pathogenic Y phase was cultured in the presence of 5% horse serum, a reported booster for cell wall alpha-1,3-glucan synthesis in this fungus. To study the biochemical properties of P. brasiliensis Agn1p, the enzyme was heterologously overexpressed, purified, and its activity profile determined by means of the degradation of carboxymethyl alpha-1,3-glucan (SCMG, chemically modified from P. brasiliensis alpha-1,3-glucan), used as a soluble substrate for the enzymatic reaction. Inhibition assays, thin layer chromatography and enzymatic reactions with alternative substrates (dextran, starch, chitin, laminarin and cellulose), showed that Agn1p displays an endolytic cut pattern and high specificity for SCMG. Complementation of a Schizosaccharomyces pombe agn1 Delta strain with the P. brasiliensis AGN1 gene restored the wild type phenotype, indicating functionality of the gene, suggesting a possible role of Agn1p in the remodeling of P. brasiliensis Y phase cell wall. Based on amino acid sequence, P. brasiliensis Agn1p, groups within the family 71 of fungal glycoside hydrolases (GH-71), showing similar biochemical characteristics to other members of this family. Also based on amino acid sequence alignments, we propose a subdivision of fungal GH-71 into at least five groups, for which specific conserved sequences can be identified.	[Villalobos-Duno, Hector; San-Blas, Gioconda; Paulinkevicius, Maryan; Nino-Vega, Gustavo] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Caracas, Venezuela; [Sanchez-Martin, Yolanda] Univ Salamanca, Inst Biol Funct & Genom, E-37008 Salamanca, Spain; [Sanchez-Martin, Yolanda] Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain	Venezuelan Institute Science Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Salamanca	Nino-Vega, G (corresponding author), Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Caracas, Venezuela.	gnino@ivic.gob.ve	Niño-Vega, Gustavo A/M-5333-2018; Sanchez, Yolanda/L-2847-2014; Niño-Vega, Gustavo/AAI-2621-2019	Niño-Vega, Gustavo A/0000-0003-3760-5620; Sanchez, Yolanda/0000-0002-7650-9319; Niño-Vega, Gustavo/0000-0003-3760-5620; Villalobos, Hector/0000-0003-4343-889X	Project ICGEB-VEN05 of the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy; FONACIT (Fondo Nacional de Ciencia, Tecnologia e Innovacion) Caracas, Venezuela; IVIC, Caracas Venezuela	Project ICGEB-VEN05 of the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy; FONACIT (Fondo Nacional de Ciencia, Tecnologia e Innovacion) Caracas, Venezuela; IVIC, Caracas Venezuela	This work was partially supported by Project ICGEB-VEN05 of the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy. HV-D was recipient of a Ph.D scholarship awarded by FONACIT (Fondo Nacional de Ciencia, Tecnologia e Innovacion) Caracas, Venezuela. MP was recipiente of a MSc scholarship awarded by IVIC, Caracas Venezuela. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Lahsen H, 2001, APPL ENVIRON MICROB, V67, P5833, DOI 10.1128/AEM.67.12.5833-5839.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao XF, 2001, CARBOHYD RES, V336, P127, DOI 10.1016/S0008-6215(01)00238-5; Barreto L, 2010, YEAST, V27, P293, DOI 10.1002/yea.1748; Beauvais A, 2005, APPL ENVIRON MICROB, V71, P1531, DOI 10.1128/AEM.71.3.1531-1538.2005; Bhushan R, 1997, BIOMED CHROMATOGR, V11, P59, DOI 10.1002/(SICI)1099-0801(199701)11:1<59::AID-BMC632>3.0.CO;2-Q; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bonfim SMRC, 2006, FEMS IMMUNOL MED MIC, V46, P269, DOI 10.1111/j.1574-695X.2005.00036.x; Calcagno AM, 1998, J CLIN MICROBIOL, V36, P1733, DOI 10.1128/JCM.36.6.1733-1736.1998; Castro ND, 2009, FEMS YEAST RES, V9, P103, DOI 10.1111/j.1567-1364.2008.00463.x; Santana LAD, 2012, MEM I OSWALDO CRUZ, V107, P310, DOI 10.1590/S0074-02762012000300004; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Dekker N, 2007, YEAST, V24, P279, DOI 10.1002/yea.1464; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Forsburg S. L., 2003, CURR PROTOC MOL BIOL, V64, P1316; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Francoise S, 2010, MED MYCOL, V48, P35, DOI 10.3109/13693780802713356; Fuglsang CC, 2000, J BIOL CHEM, V275, P2009, DOI 10.1074/jbc.275.3.2009; Garcia I, 2005, BIOL CELL, V97, P569; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Gonzalez A, 2005, INFECT IMMUN, V73, P2486, DOI 10.1128/IAI.73.4.2486-2495.2005; Grun CH, 2005, GLYCOBIOLOGY, V15, P245, DOI 10.1093/glycob/cwi002; Grun CH, 2006, FEBS LETT, V580, P3780, DOI 10.1016/j.febslet.2006.05.062; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HIRANO S, 1988, METHOD ENZYMOL, V161, P408; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hulo N, 2004, NUCLEIC ACIDS RES, V32, pD134, DOI 10.1093/nar/gkh044; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Dantas SFIM, 2009, MICROBES INFECT, V11, P895, DOI 10.1016/j.micinf.2009.05.009; KIHO T, 1989, CARBOHYD RES, V189, P273, DOI 10.1016/0008-6215(89)84103-5; Kobayashi G., 1994, MOL BIOL PATHOGENIC, P489; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorquet F, 2004, J BACTERIOL, V186, P3749, DOI 10.1128/JB.186.12.3749-3759.2004; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MCMAHON JP, 1995, J CLIN INVEST, V96, P1010, DOI 10.1172/JCI118086; Meeuwsen PJA, 2000, J BIOSCI BIOENG, V89, P107, DOI 10.1016/S1389-1723(00)88062-7; Nino-Vega GA, 2000, MED MYCOL, V38, P31, DOI 10.1080/mmy.38.1.31.39; Nino-Vega GA, 2009, MYCOL RES, V113, P1091, DOI 10.1016/j.mycres.2009.07.005; Oganesyan N, 2007, PROTEIN EXPRES PURIF, V52, P280, DOI 10.1016/j.pep.2006.09.015; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; San-Blas G, 1998, MED MYCOL, V36, P75, DOI 10.1080/02681219880000131; San-Blas G, 2001, FUNGAL PATHOGENESIS, P205; SANBLAS G, 1977, INFECT IMMUN, V15, P343, DOI 10.1128/IAI.15.2.343-346.1977; Sanz L, 2005, FEBS J, V272, P493, DOI 10.1111/j.1742-4658.2004.04491.x; SASAKI T, 1979, EUR J CANCER, V15, P211, DOI 10.1016/0014-2964(79)90062-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; Suga M, 2005, YEAST, V22, P799, DOI 10.1002/yea.1247; Sugawara T, 2003, J ELECTRON MICROSC, V52, P237, DOI 10.1093/jmicro/52.2.237; Theodoro RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037694; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Wei HJ, 2001, FUNGAL GENET BIOL, V34, P217, DOI 10.1006/fgbi.2001.1303; Wiater A, 2011, POL J MICROBIOL, V60, P293, DOI 10.33073/pjm-2011-042; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	63	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66853	10.1371/journal.pone.0066853	http://dx.doi.org/10.1371/journal.pone.0066853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825576	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000037
J	Walker, DM; Mahfooz, N; Kemme, KA; Patel, VC; Spangler, M; Drew, ME				Walker, Dawn M.; Mahfooz, Najmus; Kemme, Katherine A.; Patel, Viral C.; Spangler, Maribeth; Drew, Mark E.			Plasmodium falciparum Erythrocytic Stage Parasites Require the Putative Autophagy Protein PfAtg7 for Normal Growth	PLOS ONE			English	Article							LOW-COMPLEXITY REGIONS; MALARIA PARASITES; DEGRADATION; MECHANISM; MACROAUTOPHAGY; INHIBITION; CYTOPLASM; YEAST; E1	Analysis of the Plasmodium falciparum genome reveals a limited number of putative autophagy genes, specifically the four genes involved in ATG8 lipidation, an essential step in formation of autophagosomes. In yeast, Atg8 lipidation requires the E1-type ligase Atg7, an E2-type ligase Atg3, and a cysteine protease Atg4. These four putative P. falciparum ATG (PfATG) genes are transcribed during the parasite's erythrocytic stages. PfAtg7 has relatively low identity and similarity to yeast Atg7 (14.7% and 32.2%, respectively), due primarily to long insertions typical of P. falciparum. Excluding the insertions the identity and similarity are higher (38.0% and 70.8%, respectively). This and the fact that key residues are conserved, including the catalytic cysteine and ATP binding domain, we hypothesize that PfAtg7 is the activating enzyme of PfAtg8. To assess the role of PfAtg7 we have generated two transgenic parasite lines. In one, the PfATG7 locus was modified to introduce a C-terminal hemagglutinin tag. Western blotting reveals two distinct protein species, one migrating near the predicted 150 kDa and one at approximately 65 kDa. The second transgenic line introduces an inducible degradation domain into the PfATG7 locus, allowing us to rapidly attenuate PfAtg7 protein levels. Corresponding species are also observed in this parasite line at approximately 200 kDa and 100 kDa. Upon PfATG7 attenuation parasites exhibit a slow growth phenotype indicating the essentiality of this putative enzyme for normal growth.	[Walker, Dawn M.; Mahfooz, Najmus; Kemme, Katherine A.; Patel, Viral C.; Spangler, Maribeth; Drew, Mark E.] Ohio State Univ, Dept Microbial Infect & Immun, Wexner Med Ctr, Columbus, OH 43210 USA; [Drew, Mark E.] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Drew, ME (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Wexner Med Ctr, Columbus, OH 43210 USA.	mark.drew@osumc.edu			Ohio State University program for Public Health Preparedness for Infectious Diseases; Howard Hughes Medical Institute Med into Grad program	Ohio State University program for Public Health Preparedness for Infectious Diseases; Howard Hughes Medical Institute Med into Grad program	MED is supported by The Ohio State University program for Public Health Preparedness for Infectious Diseases. DMW was supported by the Howard Hughes Medical Institute Med into Grad program for a portion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Balu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013282; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Caza TN, 2012, CLIN IMMUNOL, V144, P200, DOI 10.1016/j.clim.2012.07.001; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Eastwood MD, 2012, AUTOPHAGY, V9; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghosh D, 2012, CELL MICROBIOL, V14, P589, DOI 10.1111/j.1462-5822.2011.01745.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herman M, 2008, AUTOPHAGY, V4, P294, DOI 10.4161/auto.5443; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Ikeda T, 2012, J PHARM SCI; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kitamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042977; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Liu C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-622; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Oh JE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00044; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rado-Trilla N, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-155; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sinai AP, 2012, TRENDS PARASITOL, V28, P358, DOI 10.1016/j.pt.2012.06.006; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sumpter R, 2011, AUTOPHAGY, V7, P260, DOI 10.4161/auto.7.3.14281; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292	53	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67047	10.1371/journal.pone.0067047	http://dx.doi.org/10.1371/journal.pone.0067047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825614	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000066
J	Zhu, SJ; Wang, GH; Liu, B; Wang, YD				Zhu, Shijia; Wang, Guohua; Liu, Bo; Wang, Yadong			Modeling Exon Expression Using Histone Modifications	PLOS ONE			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; CODING REGIONS; ACTIVE GENES; STEM-CELLS; TRANSCRIPTION; ACETYLATION; METHYLATION; CHROMATIN; NETWORK	Histones undergo numerous covalent modifications that play important roles in regulating gene expression. Previous investigations have focused on the effects of histone modifications on gene promoters, whereas efforts to unravel their effects on transcribed regions have lagged behind. To elucidate the effects of histone modification on transcribed regions, we constructed a quantitative model, which we suggest can predict the variation of gene expression more faithfully than the model constructed on promoters. Moreover, motivated by the fact that exon spicing is functionally coupled to transcription, we also devised a quantitative model to predict alternative exon expression using histone modifications on exons. This model was found to be general across different exon types and even cell types. Furthermore, an interaction network linking histone modifications to alternative exon expression was constructed using partial correlations. The network indicated that gene expression and specific histone modifications (H3K36me3 and H4K20me1) could directly influence the exon expression, while other modifications could act in an additive way to account for the stability and robustness. In addition, our results suggest that combinations of histone modifications contribute to exon splicing in a redundant and cumulative fashion. To conclude, this study provides a better understanding of the effects of histone modifications on gene transcribed regions.	[Zhu, Shijia; Wang, Guohua; Liu, Bo; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Biomed Informat, Harbin 150006, Peoples R China	Harbin Institute of Technology	Wang, YD (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Biomed Informat, Harbin 150006, Peoples R China.	ydwang@hit.edu.cn	Zhu, Shijia/K-7404-2019; Wang, Guohua/GLR-7939-2022		China National 863 High-Tech Program [2012AA020404]; National Natural Science Foundation of China [60973078, 60901075, 61173085]; Natural Science Foundation of Heilongjiang Province of China [LC2009C35]; Special Research Foundation for technological Innovation Talents of Harbin [2011RFLXG011]	China National 863 High-Tech Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Special Research Foundation for technological Innovation Talents of Harbin	This work is supported by China National 863 High-Tech Program (2012AA020404), the National Natural Science Foundation of China (60973078, 60901075, 61173085), the Natural Science Foundation of Heilongjiang Province of China (LC2009C35) and the Special Research Foundation for technological Innovation Talents of Harbin (2011RFLXG011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Butte A J, 2000, Pac Symp Biocomput, P418; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen L, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r3; Cheng C, 2011, GENOME BIOL, V12; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; de Almeida SF, 2008, FEBS LETT, V582, P1971, DOI 10.1016/j.febslet.2008.04.019; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Efron B, 2007, J AM STAT ASSOC, V102, P93, DOI 10.1198/016214506000001211; Enroth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029911; Gabriel K, 1969, SYSTEMAT ZOOL, V18, P20; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Howe KJ, 2002, BBA-GENE STRUCT EXPR, V1577, P308, DOI 10.1016/S0167-4781(02)00460-8; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim S, 2011, N KOREAN REV, V7, P3; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Magwene PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r100; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; van Steensel B, 2010, GENOME RES, V20, P190, DOI 10.1101/gr.098822.109; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; WASYLYK B, 1979, EUR J BIOCHEM, V98, P317, DOI 10.1111/j.1432-1033.1979.tb13191.x; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhao KJ, 2009, NUCL ACIDS RES, V37; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	72	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67448	10.1371/journal.pone.0067448	http://dx.doi.org/10.1371/journal.pone.0067448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825663	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000103
J	Erho, N; Crisan, A; Vergara, IA; Mitra, AP; Ghadessi, M; Buerki, C; Bergstralh, EJ; Kollmeyer, T; Fink, S; Haddad, Z; Zimmermann, B; Sierocinski, T; Ballman, KV; Triche, TJ; Black, PC; Karnes, RJ; Klee, G; Davicioni, E; Jenkins, RB				Erho, Nicholas; Crisan, Anamaria; Vergara, Ismael A.; Mitra, Anirban P.; Ghadessi, Mercedeh; Buerki, Christine; Bergstralh, Eric J.; Kollmeyer, Thomas; Fink, Stephanie; Haddad, Zaid; Zimmermann, Benedikt; Sierocinski, Thomas; Ballman, Karla V.; Triche, Timothy J.; Black, Peter C.; Karnes, R. Jeffrey; Klee, George; Davicioni, Elai; Jenkins, Robert B.			Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy	PLOS ONE			English	Article							GENE-EXPRESSION; ADJUVANT RADIOTHERAPY; TISSUE BIOMARKER; POSTOPERATIVE RADIOTHERAPY; SYSTEMIC PROGRESSION; RADIATION-THERAPY; HIGH-RISK; SIGNATURE; ANTIGEN; PROTEIN	Purpose: Clinicopathologic features and biochemical recurrence are sensitive, but not specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a genomic expression signature detected in the primary tumor represents true biological potential of aggressive disease and provides improved prediction of early prostate cancer metastasis. Methods: A nested case-control design was used to select 639 patients from the Mayo Clinic tumor registry who underwent radical prostatectomy between 1987 and 2001. A genomic classifier (GC) was developed by modeling differential RNA expression using 1.4 million feature high-density expression arrays of men enriched for rising PSA after prostatectomy, including 213 who experienced early clinical metastasis after biochemical recurrence. A training set was used to develop a random forest classifier of 22 markers to predict for cases - men with early clinical metastasis after rising PSA. Performance of GC was compared to prognostic factors such as Gleason score and previous gene expression signatures in a withheld validation set. Results: Expression profiles were generated from 545 unique patient samples, with median follow-up of 16.9 years. GC achieved an area under the receiver operating characteristic curve of 0.75 (0.67-0.83) in validation, outperforming clinical variables and gene signatures. GC was the only significant prognostic factor in multivariable analyses. Within Gleason score groups, cases with high GC scores experienced earlier death from prostate cancer and reduced overall survival. The markers in the classifier were found to be associated with a number of key biological processes in prostate cancer metastatic disease progression. Conclusion: A genomic classifier was developed and validated in a large patient cohort enriched with prostate cancer metastasis patients and a rising PSA that went on to experience metastatic disease. This early metastasis prediction model based on genomic expression in the primary tumor may be useful for identification of aggressive prostate cancer.	[Erho, Nicholas; Crisan, Anamaria; Vergara, Ismael A.; Ghadessi, Mercedeh; Buerki, Christine; Haddad, Zaid; Zimmermann, Benedikt; Sierocinski, Thomas; Triche, Timothy J.; Davicioni, Elai] GenomeDx Biosci, Res & Dev, Vancouver, BC, Canada; [Mitra, Anirban P.; Triche, Timothy J.] Univ So Calif, Dept Pathol & Lab Med, Los Angeles, CA USA; [Bergstralh, Eric J.; Ballman, Karla V.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Kollmeyer, Thomas; Fink, Stephanie; Klee, George; Jenkins, Robert B.] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN 55905 USA; [Black, Peter C.] Univ British Columbia, Dept Urol, Vancouver, BC V5Z 1M9, Canada; [Karnes, R. Jeffrey] Mayo Clin, Dept Urol, Rochester, MN USA	GenomeDx Biosciences; University of Southern California; Mayo Clinic; Mayo Clinic; University of British Columbia; Mayo Clinic	Jenkins, RB (corresponding author), Mayo Clin, Dept Pathol & Lab Med, Rochester, MN 55905 USA.	rjenkins@mayo.edu	Mitra, Anirban P/A-9101-2008; Black, Peter/AAE-8424-2020	Mitra, Anirban P/0000-0002-6549-5943; Black, Peter/0000-0002-2919-7068; Erho, Nicholas/0000-0002-5857-2701; Ballman, Karla/0000-0002-4492-0357; haddad, zaid/0000-0001-8483-4800; Davicioni, Elai/0000-0001-9136-099X; Vergara, Ismael/0000-0002-2960-2967	National Research Council of Canada, Industrial Research Assistance Program; Mayo Clinic Prostate Cancer [SPORE P50 CA91956]; GenomeDx Biosciences Inc.; National Research Council - Industrial Research Assistance Program; Beckman Coulter; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER	National Research Council of Canada, Industrial Research Assistance Program; Mayo Clinic Prostate Cancer; GenomeDx Biosciences Inc.; National Research Council - Industrial Research Assistance Program; Beckman Coulter; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Research Council of Canada, Industrial Research Assistance Program (http://www.nrc-cnrc.gc.ca/eng/irap/index.html), and the Mayo Clinic Prostate Cancer SPORE P50 CA91956 (PI: Donald Tindall Ph.D.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: NE, AC, IV, MG, CB, ZH, BZ, TS, TT, and ED are employees of GenomeDx Biosciences Inc. ED and TT own stock in GenomeDx Biosciences Inc. ED has received research funding from GenomeDx Biosciences Inc. and the National Research Council - Industrial Research Assistance Program. PB has received research funding from GenomeDx Biosciences Inc. GK has received research funding from Beckman Coulter. KB, EB, RC, SF, RK, RJ, and TK have declared that no competing interests exist. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Agell L, 2012, AM J PATHOL, V181, P1585, DOI 10.1016/j.ajpath.2012.08.005; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Bera TK, 2004, P NATL ACAD SCI USA, V101, P3059, DOI 10.1073/pnas.0308746101; Berney DM, 2009, BRIT J CANCER, V100, P888, DOI 10.1038/sj.bjc.6604951; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Bismar TA, 2006, NEOPLASIA, V8, P59, DOI 10.1593/neo.05664; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brimo F, 2013, EUR UROL, V63, P892, DOI 10.1016/j.eururo.2012.10.015; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen Q, 2006, CANCER LETT, V244, P274, DOI 10.1016/j.canlet.2005.12.027; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Crisan A, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.30_suppl.90; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Deftos LJ, 1998, PROSTATE, P23; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gorlov IP, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-48; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; KORN EL, 1986, STAT MED, V5, P255, DOI 10.1002/sim.4780050306; Kristiansen G, 2008, BRIT J CANCER, V99, P939, DOI 10.1038/sj.bjc.6604614; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Larkin SET, 2012, BRIT J CANCER, V106, P157, DOI 10.1038/bjc.2011.490; LaTulippe E, 2002, CANCER RES, V62, P4499; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Levin AM, 2008, CANCER RES, V68, P6492, DOI 10.1158/0008-5472.CAN-08-0348; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Meyer D., 2012, E1071 MISC FUNCTIONS; Mishra MV, 2011, FUTURE ONCOL, V7, P1429, DOI [10.2217/FON.11.120, 10.2217/fon.11.120]; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Olmos D, 2012, LANCET ONCOL, V13, P1114, DOI 10.1016/S1470-2045(12)70372-8; Patel AR, 2011, NAT REV UROL, V8, P385, DOI 10.1038/nrurol.2011.80; Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Ross RW, 2012, LANCET ONCOL, V13, P1105, DOI 10.1016/S1470-2045(12)70263-2; Roth TJ, 2007, CANCER RES, V67, P7893, DOI 10.1158/0008-5472.CAN-07-1068; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; Swanson GP, 2011, J CANCER, V2, P1, DOI 10.7150/jca.2.1; Talantov D, 2010, J UROLOGY, V184, P1521, DOI 10.1016/j.juro.2010.05.084; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; VANDENBERG C, 1995, CLIN CANCER RES, V1, P11; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; Vergara Ismael A., 2012, Frontiers in Genetics, V3, P23, DOI 10.3389/fgene.2012.00023; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yang G, 1998, CLIN CANCER RES, V4, P1873; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	72	416	435	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66855	10.1371/journal.pone.0066855	http://dx.doi.org/10.1371/journal.pone.0066855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826159	Green Published, gold			2022-12-27	WOS:000321738400069
J	Martinez-Vazquez, A; Gonzalez-Hernandez, A; Dominguez, A; Rachubinski, R; Riquelme, M; Cuellar-Mata, P; Guzman, JCT				Martinez-Vazquez, Azul; Gonzalez-Hernandez, Angelica; Dominguez, Angel; Rachubinski, Richard; Riquelme, Meritxell; Cuellar-Mata, Patricia; Torres Guzman, Juan Carlos			Identification of the Transcription Factor Znc1p, which Regulates the Yeast-to-Hypha Transition in the Dimorphic Yeast Yarrowia lipolytica	PLOS ONE			English	Article							CANDIDA-ALBICANS; FILAMENT FORMATION; INVASIVE GROWTH; GENE-EXPRESSION; PROTEIN-KINASE; REPRESSOR; PATHWAY; MORPHOGENESIS; COMPONENTS; REVEALS	The dimorphic yeast Yarrowia lipolytica is used as a model to study fungal differentiation because it grows as yeast-like cells or forms hyphal cells in response to changes in environmental conditions. Here, we report the isolation and characterization of a gene, ZNC1, involved in the dimorphic transition in Y. lipolytica. The ZNC1 gene encodes a 782 amino acid protein that contains a Zn(II)(2)C-6 fungal-type zinc finger DNA-binding domain and a leucine zipper domain. ZNC1 transcription is elevated during yeast growth and decreases during the formation of mycelium. Cells in which ZNC1 has been deleted show increased hyphal cell formation. Znc1p-GFP localizes to the nucleus, but mutations within the leucine zipper domain of Znc1p, and to a lesser extent within the Zn(II)(2)C-6 domain, result in a mislocalization of Znc1p to the cytoplasm. Microarrays comparing gene expression between znc1::URA3 and wild-type cells during both exponential growth and the induction of the yeast-to-hypha transition revealed 1,214 genes whose expression was changed by 2-fold or more under at least one of the conditions analyzed. Our results suggest that Znc1p acts as a transcription factor repressing hyphal cell formation and functions as part of a complex network regulating mycelial growth in Y. lipolytica.	[Martinez-Vazquez, Azul; Gonzalez-Hernandez, Angelica; Cuellar-Mata, Patricia; Torres Guzman, Juan Carlos] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato, Mexico; [Dominguez, Angel] Univ Salamanca, Dept Microbiol & Genet, CIETUS IBSAL, E-37008 Salamanca, Spain; [Rachubinski, Richard] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Riquelme, Meritxell] CICESE, Dept Microbiol, Ensenada, Baja California, Mexico	Universidad de Guanajuato; University of Salamanca; University of Alberta; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Guzman, JCT (corresponding author), Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Campus Guanajuato, Guanajuato, Mexico.	torguz@ugto.mx	Riquelme, Meritxell/K-8345-2015; Guzman, Juan Carlos Torres/K-7107-2012	Riquelme, Meritxell/0000-0002-2580-326X; Guzman, Juan Carlos Torres/0000-0002-1386-9499; Martinez-Vazquez, Ma Azul del Rocio/0000-0003-2658-350X	Consejo Nacional de Ciencia y Tecnologia (CONACyT); Consejo Estatal de Ciencia y Tecnologia del Estado de Guanajuato (CONCyTEG); Secretaria de Educacion Publica (SEP); University of Guanajuato; CONACyT, Mexico	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Estatal de Ciencia y Tecnologia del Estado de Guanajuato (CONCyTEG); Secretaria de Educacion Publica (SEP); University of Guanajuato; CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (www.conacyt.gob.mx); Consejo Estatal de Ciencia y Tecnologia del Estado de Guanajuato (CONCyTEG (www.concyteg.gob.mx); Secretaria de Educacion Publica (SEP) (www.sep.gob.mx); University of Guanajuato (www.ugto.mx). Azul Martinez-Vazquez received a fellowship from CONACyT, Mexico. Richard Rachubinski is an International Research Scholar of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akache B, 2001, NUCLEIC ACIDS RES, V29, P2181, DOI 10.1093/nar/29.10.2181; ARNDT K, 1986, P NATL ACAD SCI USA, V83, P8516, DOI 10.1073/pnas.83.22.8516; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Beckerich J M, 1998, Int Microbiol, V1, P123; Berman J, 2004, PATHOGENIC FUNGI: STRUCTURAL BIOLOGY AND TAXONOMY, P101; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Blanchin-Roland S, 2005, MICROBIOL-SGM, V151, P3627, DOI 10.1099/mic.0.28196-0; Bolker M, 2001, MICROBIOL-SGM, V147, P1395, DOI 10.1099/00221287-147-6-1395; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Cervantes-Chavez JA, 2007, FEMS YEAST RES, V7, P929, DOI 10.1111/j.1567-1364.2007.00265.x; Cervantes-Chavez JA, 2006, FEMS YEAST RES, V6, P801, DOI 10.1111/j.1567-1364.2006.00084.x; Cervantes-Chavez JA, 2009, FUNGAL GENET BIOL, V46, P390, DOI 10.1016/j.fgb.2009.02.005; Chang JL, 2007, EUKARYOT CELL, V6, P1528, DOI 10.1128/EC.00185-07; Chavel CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000883; Chen DC, 1997, APPL MICROBIOL BIOT, V48, P232, DOI 10.1007/s002530051043; Costa M, 2007, MICROBIOL-SGM, V153, P4194, DOI 10.1099/mic.0.2007/009332-0; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Dominguez A, 1998, Int Microbiol, V1, P131; Dominguez A, 2000, Contrib Microbiol, V5, P151; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fernandez-Abalos JM, 1998, MOL MICROBIOL, V27, P121, DOI 10.1046/j.1365-2958.1998.00664.x; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H; Hauser M, 2007, FEMS YEAST RES, V7, P84, DOI 10.1111/j.1567-1364.2006.00151.x; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Hogan DA, 2011, CURR OPIN MICROBIOL, V14, P682, DOI 10.1016/j.mib.2011.09.014; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hurtado CAR, 2000, J BACTERIOL, V182, P2376, DOI 10.1128/JB.182.9.2376-2386.2000; Hurtado CAR, 1999, J BACTERIOL, V181, P3051, DOI 10.1128/JB.181.10.3051-3057.1999; Hurtado CAR, 2002, MICROBIOL-SGM, V148, P3725, DOI 10.1099/00221287-148-11-3725; Hurtado CAR, 2002, EUKARYOT CELL, V1, P526, DOI 10.1128/EC.1.4.526-537.2002; Jimenez-Bremont JF, 2008, MICROBIOL RES, V163, P717, DOI 10.1016/j.micres.2008.05.001; KOBAYASHI N, 1993, MOL CELL BIOL, V13, P248, DOI 10.1128/MCB.13.1.248; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Liu HP, 2001, CURR OPIN MICROBIOL, V4, P728, DOI 10.1016/S1369-5274(01)00275-2; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Maicas S, 2005, COMP FUNCT GENOM, V6, P345, DOI 10.1002/cfg.492; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Mofunanya A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-41; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Morin M, 2007, J MASS SPECTROM, V42, P1453, DOI 10.1002/jms.1284; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nagoshi E, 2001, MOL CELL BIOL, V21, P2779, DOI 10.1128/MCB.21.8.2779-2789.2001; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; NUTTLEY WM, 1993, YEAST, V9, P507, DOI 10.1002/yea.320090506; OGRYDZIAK D, 1982, MOL GEN GENET, V188, P179, DOI 10.1007/BF00332672; Olmedo M, 2010, GENETICS, V184, P651, DOI 10.1534/genetics.109.109975; Perez-Campo FM, 2001, CURR MICROBIOL, V43, P429, DOI 10.1007/s002840010333; Ramon AM, 1999, RES MICROBIOL, V150, P95, DOI 10.1016/S0923-2508(99)80027-8; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Ruiz-Herrera J, 2002, ARCH MICROBIOL, V178, P477, DOI 10.1007/s00203-002-0478-3; Sambrook J., 2001, MOL CLONING LAB MANU; Szabo R, 2002, FEMS MICROBIOL LETT, V206, P45, DOI 10.1111/j.1574-6968.2002.tb10984.x; Szabo R, 2001, MOL GENET GENOMICS, V265, P172, DOI 10.1007/s004380000405; Morales-Vargas AT, 2012, RES MICROBIOL, V163, P378, DOI 10.1016/j.resmic.2012.03.002; TorresGuzman JC, 1997, MOL CELL BIOL, V17, P6283, DOI 10.1128/MCB.17.11.6283; van Dyk D, 2003, GENETICS, V165, P1045; Vienken K, 2005, GENETICS, V169, P619, DOI 10.1534/genetics.104.030767; Vienken K, 2006, MOL MICROBIOL, V61, P544, DOI 10.1111/j.1365-2958.2006.05257.x	66	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66790	10.1371/journal.pone.0066790	http://dx.doi.org/10.1371/journal.pone.0066790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826133	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400051
J	Cao, TT; Wang, YJ; Zhang, YQ				Cao, Ting-Ting; Wang, Yuan-Jing; Zhang, Yu-Qing			Effect of Strongly Alkaline Electrolyzed Water on Silk Degumming and the Physical Properties of the Fibroin Fiber	PLOS ONE			English	Article							SERICIN; PROTEIN; COCOON; SILKWORMS	Strongly alkaline electrolyzed water (SAEW) was prepared by electrolysis of tap water in a laboratory-made water electrolyzer. The pH of stored SAEW was stable for more than one month. The hardness of the electrolyzed water was 30% lower and the Na+ concentration was 18% higher than those of the tap water. Silkworm cocoon shells were boiled in pH 11.50 SAEW at a ratio of 1:40 similar to 80 (W/V) for 20 min and the sericin layers around the silk fibroin fibers were removed completely. The tensile properties and thermal decomposition temperature of a single filament of silk fibroin obtained by the SAEW method were almost the same as those for the fiber obtained by the neutral soap, and much higher than those for the fiber obtained by Na2CO3 degumming. The results demonstrate that SAEW is an environmentally friendly and pollution-free silk degumming agent that allows highly efficient, low cost recovery of sericin.	[Cao, Ting-Ting; Wang, Yuan-Jing; Zhang, Yu-Qing] Soochow Univ, Sch Biol & Basic Med Sci, Natl Engn Lab Modern Silk, Silk Biotechnol Lab, Suzhou, Peoples R China	Soochow University - China	Zhang, YQ (corresponding author), Soochow Univ, Sch Biol & Basic Med Sci, Natl Engn Lab Modern Silk, Silk Biotechnol Lab, Suzhou, Peoples R China.	sericult@suda.edu.cn		Zhang, Yu-Qing/0000-0001-7670-386X	earmarked fund for China Agriculture Research System [CARS-22-ZJ0504]; Priority Academic Program Development of Jiangsu Higher Education Institutions	earmarked fund for China Agriculture Research System; Priority Academic Program Development of Jiangsu Higher Education Institutions	The authors gratefully acknowledge the earmarked fund (CARS-22-ZJ0504) for China Agriculture Research System and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ADV ENVIRON BIOL; Arami M, 2007, J APPL POLYM SCI, V106, P267, DOI 10.1002/app.26492; Capar G, 2008, J MEMBRANE SCI, V325, P920, DOI 10.1016/j.memsci.2008.09.020; Fabiani C, 1996, DESALINATION, V105, P1, DOI 10.1016/0011-9164(96)00050-1; Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006; Fujii T, 1996, Japan Patent, Patent No. [JP8143595A, 8143595]; GULRAJANI ML, 1992, J SOC DYERS COLOUR, V108, P79; Gulrajani ML., 1992, INDIAN J FIBRE TEXT, V17, P39; Hasegawa T, 2003, Japan Patent, Patent No. [JP2003165843A, 2003165843]; Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145; Khan MMR, 2010, BIORESOURCE TECHNOL, V101, P8439, DOI 10.1016/j.biortech.2010.05.100; Kim YD, 2002, KOREAN J SERIC SCI, V47, P36; Kitagawa J, 1998, Japan Patent, Patent No. [JP10029909A, 10029909]; Makoto H, 2005, Japan Patent, Patent No. [JP2005052066A, 2005052066]; Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026; MCCONLOGUE WA, 1952, J AM OIL CHEM SOC, V29, P526, DOI 10.1007/BF02632644; Ogawa A, 2004, J BIOSCI BIOENG, V98, P217; Sarovart S, 2003, REV ADV MATER SCI, V5, P193; Sasaki M, 2000, ONCOL REP, V7, P1049; Seo BK, 2001, Korea Patent, Patent No. [KR2001079066, 2001079066]; Sun W, 2012, SCI CHINA LIFE SCI, V55, P483, DOI 10.1007/s11427-012-4334-7; Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667; Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608; Wang HY, 2012, FOOD FUNCT, V3, P150, DOI 10.1039/c1fo10148j; Wang YJ, 2011, ADV MATER RES-SWITZ, V175-176, P158, DOI 10.4028/www.scientific.net/AMR.175-176.158; Zhang Y. Q., 2002, ACTA SERICOLOGICA SI, V28, P75; Zhang Y.Q., 2012, China Patent, Patent No. [CN 201210082082 X, 201210082082, 201210082082.X]; Zhang Y.Q., 2004, China Patent, Patent No. [CN 1477141 A, 1477141]; Zhang YQ, 2010, SCI CHINA LIFE SCI, V53, P1330, DOI 10.1007/s11427-010-4084-3; Zhaorigetu S, 2001, BIOSCI BIOTECH BIOCH, V65, P2181, DOI 10.1271/bbb.65.2181	30	46	49	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65654	10.1371/journal.pone.0065654	http://dx.doi.org/10.1371/journal.pone.0065654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824061	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400018
J	Colombo, E; Calcaterra, F; Cappelletti, M; Mavilio, D; Della Bella, S				Colombo, Elena; Calcaterra, Francesca; Cappelletti, Monica; Mavilio, Domenico; Della Bella, Silvia			Comparison of Fibronectin and Collagen in Supporting the Isolation and Expansion of Endothelial Progenitor Cells from Human Adult Peripheral Blood	PLOS ONE			English	Article							CORD BLOOD; TRANSPLANTATION; ANGIOGENESIS; INCREASES; PHENOTYPE; SURVIVAL; REVEALS	Background: Endothelial colony-forming cells (ECFCs), are circulating endothelial progenitor cells increasingly studied in various diseases because of their potential for clinical translation. Experimental procedures for their ex vivo culture still lack standardization. In particular two different extracellular matrix proteins, either fibronectin or collagen, are commonly used by different Authors for coating plastic plates, both allowing to obtain cells that have all the features of ECFCs. However, possible differences in the impact of each substrate on ECFCs have not been analysed, so far. Therefore, in this study we investigated whether fibronectin and collagen may differentially affect ECFC cultures. Methodology/Principal Findings: ECFCs were isolated and cultured from peripheral blood mononuclear cells of healthy donors. The impact of fibronectin compared with collagen as the only variable of the experimental procedure was analysed separately in the phase of isolation of ECFC colonies and in the following phase of cell expansion. In the isolation phase, although similar frequencies of colonies were obtained on the two substrates, ECFC colonies appeared some days earlier when mononuclear cells were seeded on fibronectin rather than collagen. In the expansion phase, ECFCs cultured on collagen showed a longer lifespan and higher cell yields compared with ECFCs cultured on fibronectin, possibly related to the higher levels of IL-6 and IL-8 measured in their supernatants. ECFCs cultured on both substrates showed similar immunophenotype and ability for in vitro tube formation. Conclusions/Significance: Overall, the results of this study indicate that, although both fibronectin and collagen efficiently sustain ECFC cultures, each of them brings some advantages within individual steps of the entire process. We suggest that colony isolation performed on fibronectin followed by cell expansion performed on collagen may represent a novel and the most efficient strategy to obtain ECFCs from adult peripheral blood samples.	[Colombo, Elena; Calcaterra, Francesca; Cappelletti, Monica; Mavilio, Domenico; Della Bella, Silvia] Humanitas Clin & Res Ctr, Lab Clin & Expt Immunol, Rozzano, MI, Italy; [Calcaterra, Francesca; Mavilio, Domenico; Della Bella, Silvia] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	IRCCS Humanitas Research Hospital; University of Milan	Della Bella, S (corresponding author), Humanitas Clin & Res Ctr, Lab Clin & Expt Immunol, Rozzano, MI, Italy.	silvia.dellabella@unimi.it	Bella, Silvia Della/AAB-7904-2019; CALCATERRA, FRANCESCA/ACQ-0596-2022; Mavilio, Domenico/E-5194-2017	CALCATERRA, FRANCESCA/0000-0002-7625-1979; Della Bella, Silvia/0000-0003-0818-5049; Mavilio, Domenico/0000-0001-6147-0952	Ministero dell'Istruzione, dell'Universita e della Ricerca [2008A3E9WM-003]; Universita degli Studi di Milano [2009-ATE-0573]; Doctorate School of Molecular Medicine, University of Milan, Italy; Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Universita degli Studi di Milano; Doctorate School of Molecular Medicine, University of Milan, Italy; Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grant 2008A3E9WM-003 from Ministero dell'Istruzione, dell'Universita e della Ricerca (SDB) and Universita degli Studi di Milano (2009-ATE-0573) to SDB. EC and MC were supported by a fellowship of the Doctorate School of Molecular Medicine, University of Milan, Italy. FC is a recipient of a fellowship awarded by the Fondazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Botto S, 2011, BLOOD, V117, P352, DOI 10.1182/blood-2010-06-291245; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.0000097001.79750.78; Cobellis G, 2010, TRANSPL P, V42, P2816, DOI 10.1016/j.transproceed.2010.04.047; Colombo E, 2012, J PHYSIOL-LONDON, V590, P519, DOI 10.1113/jphysiol.2011.223032; Corselli M, 2008, EXP HEMATOL, V36, P340, DOI 10.1016/j.exphem.2007.10.008; CRISTER PJ, 2011, CELL PROLIFERAT, V44, P15; de Villeroche VJ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2934; Della Bella S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001520; Fadini GP, 2008, ARTERIOSCL THROM VAS, V28, P997, DOI 10.1161/ATVBAHA.107.159558; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015; Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Huang L, 2011, CYTOTHERAPY, V13, P712, DOI 10.3109/14653249.2010.548380; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Igreja C, 2007, HAEMATOLOGICA, V92, P469, DOI 10.3324/haematol.10723; Imanishi T, 2005, J HYPERTENS, V23, P1699, DOI 10.1097/01.hjh.0000176788.12376.20; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Krenning G, 2009, TRENDS MOL MED, V15, P180, DOI 10.1016/j.molmed.2009.02.001; Leicht SF, 2011, DIABETES, V60, P652, DOI 10.2337/db10-0240; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Ligi I, 2011, BLOOD, V118, P1699, DOI 10.1182/blood-2010-12-325142; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Mendonca MS, 2011, RADIAT RES, V176, P208, DOI 10.1667/RR2427.1; Meneveau N, 2011, BASIC RES CARDIOL, V106, P1397, DOI 10.1007/s00395-011-0220-x; MEZZANI A, 2012, INT J CARDIOL; Oh BJ, 2010, BIOCHEM BIOPH RES CO, V398, P627, DOI 10.1016/j.bbrc.2010.06.108; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Piaggio G, 2009, BLOOD, V114, P3127, DOI 10.1182/blood-2008-12-190991; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Rosti V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015277; Smadja DM, 2013, ANGIOGENESIS, V16, P147, DOI 10.1007/s10456-012-9306-9; Smadja DM, 2011, ANGIOGENESIS, V14, P17, DOI 10.1007/s10456-010-9192-y; Taddeo A, 2008, J INVEST DERMATOL, V128, P2125, DOI 10.1038/jid.2008.23; Thill M, 2008, INVEST OPHTH VIS SCI, V49, P2696, DOI 10.1167/iovs.07-0955; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Van Craenenbroeck EM, 2010, MICROVASC RES, V79, P184, DOI 10.1016/j.mvr.2009.12.009; WANG W, 2001, PLOS ONE, V6, P24868; Wassmann S, 2006, CIRC RES, V99, pE74, DOI 10.1161/01.RES.0000246095.90247.d4; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR101, DOI 10.1186/bcr958	47	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66734	10.1371/journal.pone.0066734	http://dx.doi.org/10.1371/journal.pone.0066734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824996	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400155
J	Fu, HX; Le, SM; Muniyappa, K; Yan, J				Fu, Hongxia; Le, Shimin; Muniyappa, Kalappa; Yan, Jie			Dynamics and Regulation of RecA Polymerization and De-Polymerization on Double-Stranded DNA	PLOS ONE			English	Article							SINGLE-MOLECULE; MAGNETIC TWEEZERS; S-DNA; PROTEIN; BINDING; FORCE; RECOMBINATION; FILAMENT	The RecA filament formed on double-stranded (ds) DNA is proposed to be a functional state analogous to that generated during the process of DNA strand exchange. RecA polymerization and de-polymerization on dsDNA is governed by multiple physiological factors. However, a comprehensive understanding of how these factors regulate the processes of polymerization and de-polymerization of RecA filament on dsDNA is still evolving. Here, we investigate the effects of temperature, pH, tensile force, and DNA ends (in particular ssDNA overhang) on the polymerization and de-polymerization dynamics of the E. coli RecA filament at a single-molecule level. Our results identified the optimal conditions that permitted spontaneous RecA nucleation and polymerization, as well as conditions that could maintain the stability of a preformed RecA filament. Further examination at a nano-meter spatial resolution, by stretching short DNA constructs, revealed a striking dynamic RecA polymerization and de-polymerization induced saw-tooth pattern in DNA extension fluctuation. In addition, we show that RecA does not polymerize on S-DNA, a recently identified novel base-paired elongated DNA structure that was previously proposed to be a possible binding substrate for RecA. Overall, our studies have helped to resolve several previous single-molecule studies that reported contradictory and inconsistent results on RecA nucleation, polymerization and stability. Furthermore, our findings also provide insights into the regulatory mechanisms of RecA filament formation and stability in vivo.	[Fu, Hongxia; Le, Shimin; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Fu, Hongxia; Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Muniyappa, Kalappa] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Yan, Jie] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Indian Institute of Science (IISC) - Bangalore; National University of Singapore	Yan, J (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore.	phyyj@nus.edu.sg	Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291; Fu, Hongxia/0000-0002-6893-8260; Le, Shimin/0000-0003-2359-1897	National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore	National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore(National Research Foundation, Singapore)	This work was supported by the National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore (to J.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Bosaeus N, 2012, P NATL ACAD SCI USA, V109, P15179, DOI 10.1073/pnas.1213172109; Chen H, 2011, BIOPHYS J, V100, P517, DOI 10.1016/j.bpj.2010.12.3700; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Cocco S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011910; Cox JM, 2006, J BIOL CHEM, V281, P12968, DOI 10.1074/jbc.M513736200; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Feinstein E, 2011, NUCLEIC ACIDS RES, V39, P3781, DOI 10.1093/nar/gkr013; Fu HX, 2013, NUCLEIC ACIDS RES, V41, P924, DOI 10.1093/nar/gks1162; Fu HX, 2011, NUCLEIC ACIDS RES, V39, P3473, DOI 10.1093/nar/gkq1278; Fu HX, 2010, NUCLEIC ACIDS RES, V38, P5594, DOI 10.1093/nar/gkq309; Fulconis R, 2004, BIOPHYS J, V87, P2552, DOI 10.1529/biophysj.104.043059; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Hsu HF, 2011, BIOCHEMISTRY-US, V50, P8270, DOI 10.1021/bi200423t; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Leger JF, 1998, P NATL ACAD SCI USA, V95, P12295, DOI 10.1073/pnas.95.21.12295; Mani A, 2010, NUCLEIC ACIDS RES, V38, P2036, DOI 10.1093/nar/gkp1177; Mazin AV, 1996, P NATL ACAD SCI USA, V93, P10673, DOI 10.1073/pnas.93.20.10673; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Shivashankar GV, 1999, P NATL ACAD SCI USA, V96, P7916, DOI 10.1073/pnas.96.14.7916; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; van der Heijden T, 2005, NUCLEIC ACIDS RES, V33, P2099, DOI 10.1093/nar/gki512; Vaze MB, 1999, BIOCHEMISTRY-US, V38, P3175, DOI 10.1021/bi9819125; Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905; Zhang XH, 2013, P NATL ACAD SCI USA, V110, P3865, DOI 10.1073/pnas.1213740110; Zhang XH, 2012, P NATL ACAD SCI USA, V109, P8103, DOI 10.1073/pnas.1109824109	31	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66712	10.1371/journal.pone.0066712	http://dx.doi.org/10.1371/journal.pone.0066712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825559	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000320576400152
J	Kapoula, Z; Gaertner, C; Yang, Q; Denise, P; Toupet, M				Kapoula, Zoi; Gaertner, Chrystal; Yang, Qing; Denise, Pierre; Toupet, Michel			Vergence and Standing Balance in Subjects with Idiopathic Bilateral Loss of Vestibular Function	PLOS ONE			English	Article							COMBINED EYE-MOVEMENTS; VESTIBULOOCULAR REFLEX; SUPERIOR COLLICULUS; POSTURAL CONTROL; SACCADES; CHILDREN; DISTANCE; PRIMATE; NEURONS; SIGNALS	There is a natural symbiosis between vergence and vestibular responses. Deficits in vergence can lead to vertigo, disequilibrium, and postural instability. This study examines both vergence eye movements in patients with idiopathic bilateral vestibular loss, and their standing balance in relation to vergence. Eleven patients participated in the study and 16 controls. Bilateral loss of vestibular function was objectified with many tests; only patients without significant response to caloric tests, to video head impulse tests and without vestibular evoked myogenic potentials were included in the study. Vergence testing (from 8 patients and 15 controls): A LED display with targets at 20, 40, and 100 cm along the median plane was used to elicit vergence eye movements, recorded with the IRIS device. Standing balance (11 patients and 16 controls): Four conditions were run, each lasting 1 min: fixation of a LED at 40 cm (convergence of 9 degrees), at 150 cm (convergence of 2.3 degrees); this last condition was repeated with eyes closed. Comparison of the eyes closed-eyes open conditions at 150 cm allowed evaluation of the Romberg Quotient. In the forth condition, two LEDS, at 20 and at 100 cm, were light on, one after the other for 1 sec, causing the eyes to converge then diverge. Standing balance was recorded with an accelerometer placed at the back near the center of mass (McRoberts, Dynaport). Results: Vergence: Relative to controls, convergence eye movements in patients showed significantly lower accuracy, lower mean velocity, and saccade intrusions of significantly higher amplitude. Balance: The normalized 90% area of body sway was significantly higher for patients than for controls for all conditions. Yet, similarly to controls, postural stability was better while fixating at near (sustained convergence) than at far, or while making active vergence movements. We argue that vestibular loss deteriorates convergence, but even deficient, convergence can be helpful for postural control.	[Kapoula, Zoi; Gaertner, Chrystal; Yang, Qing] Univ Paris 05, CNRS, Hop Europeen Georges Pompidou, Grp IRIS,Serv Ophthalmol,UMR 8194,Ctr Etud Sensor, F-75270 Paris, France; [Denise, Pierre] INSERM, U7075, Caen, France; [Toupet, Michel] Ctr Explorat Otoneurol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kapoula, Z (corresponding author), Univ Paris 05, CNRS, Hop Europeen Georges Pompidou, Grp IRIS,Serv Ophthalmol,UMR 8194,Ctr Etud Sensor, F-75270 Paris, France.	zoi.kapoula@egp.aphp.fr	Denise, Pierre/E-2174-2011	Denise, Pierre/0000-0002-9049-7692				Alkan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025866; Bucci MP, 2006, VISION RES, V46, P3594, DOI 10.1016/j.visres.2006.06.001; Bucci MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023125; Bucci MP, 2004, EXP BRAIN RES, V157, P286, DOI 10.1007/s00221-004-1842-0; Bucci MP, 2004, J NEUROL, V251, P204, DOI 10.1007/s00415-004-0304-8; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Coenen OJMD, 1998, THESIS U CALIFORNIA; Coubard OA, 2006, CEREB CORTEX, V16, P425, DOI 10.1093/cercor/bhi122; Erkelens CJ, 2000, VISION RES, V40, P2411, DOI 10.1016/S0042-6989(00)00120-6; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P417, DOI 10.1098/rspb.1989.0030; Erkelens CJ, 2001, VISION RES, V41, P3497, DOI 10.1016/S0042-6989(01)00004-9; Gaertner C, 2013, INVEST OPHTH VIS SCI, V54, P529, DOI 10.1167/iovs.12-10586; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; GAMLIN PDR, 1995, J NEUROPHYSIOL, V73, P2115, DOI 10.1152/jn.1995.73.5.2115; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; HAN Y, 1995, ACTA OPHTHALMOL SCAN, V73, P414; Jainta S, 2011, VISION RES, V51, P1845, DOI 10.1016/j.visres.2011.06.014; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kapoula Z, 2001, NEUROREPORT, V12, P4041, DOI 10.1097/00001756-200112210-00037; Kapoula Z, 2007, J NEUROL, V254, P1174, DOI 10.1007/s00415-006-0460-0; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Leigh, 2006, NEUROLOGY EYE MOVEME, P189; Liao K, 2008, NEUROLOGY, V70, P802, DOI 10.1212/01.wnl.0000304134.33380.1e; Liao K, 2010, RESTOR NEUROL NEUROS, V28, P91, DOI 10.3233/RNN-2010-0507; Lopez C, 2005, BIPUDIC CONTRUCLE PO; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mergner T, 2009, ANN NY ACAD SCI, V1164, P206, DOI 10.1111/j.1749-6632.2008.03722.x; Migliaccio AA, 2004, EXP BRAIN RES, V159, P92, DOI 10.1007/s00221-004-1936-8; Moschner C, 1999, BRAIN, V122, P2147, DOI 10.1093/brain/122.11.2147; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Ramat S, 2003, J NEUROPHYSIOL, V90, P887, DOI 10.1152/jn.01121.2002; Richter HO, 2004, EUR J NEUROSCI, V20, P2722, DOI 10.1111/j.1460-9568.2004.03743.x; Serra A, 2011, CURR OPIN NEUROL, V24, P32, DOI 10.1097/WCO.0b013e328341eebd; SNYDER LH, 1992, J NEUROPHYSIOL, V67, P861, DOI 10.1152/jn.1992.67.4.861; Suzuki S, 2004, NEUROSCI RES, V49, P39, DOI 10.1016/j.neures.2004.01.009; Takagi M, 2003, PROG BRAIN RES, V142, P19; Takagi M, 2001, INVEST OPHTH VIS SCI, V42, P1479; TAKAGI M, 1995, VISION RES, V35, P3373, DOI 10.1016/0042-6989(95)00073-N; Tzelepi A, 2004, EXP BRAIN RES, V155, P439, DOI 10.1007/s00221-003-1741-9; Versino M, 1996, BRAIN, V119, P1933, DOI 10.1093/brain/119.6.1933; Walton MMG, 2003, J NEUROPHYSIOL, V90, P1124, DOI 10.1152/jn.00877.2002; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; Yang Q, 2009, INVEST OPHTH VIS SCI, V50, P1145, DOI 10.1167/iovs.08-2474	46	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66652	10.1371/journal.pone.0066652	http://dx.doi.org/10.1371/journal.pone.0066652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825551	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400139
J	MacDonald, JT; Kelley, LA; Freemont, PS				MacDonald, James T.; Kelley, Lawrence A.; Freemont, Paul S.			Validating a Coarse-Grained Potential Energy Function through Protein Loop Modelling	PLOS ONE			English	Article							AB-INITIO CONSTRUCTION; STRUCTURE PREDICTION; FORCE-FIELD; BACKBONE RECONSTRUCTION; POLYPEPTIDE FRAGMENTS; NUCLEIC-ACIDS; ALGORITHM; ACCURATE; DESIGN; SIMULATIONS	Coarse-grained (CG) methods for sampling protein conformational space have the potential to increase computational efficiency by reducing the degrees of freedom. The gain in computational efficiency of CG methods often comes at the expense of non-protein like local conformational features. This could cause problems when transitioning to full atom models in a hierarchical framework. Here, a CG potential energy function was validated by applying it to the problem of loop prediction. A novel method to sample the conformational space of backbone atoms was benchmarked using a standard test set consisting of 351 distinct loops. This method used a sequence-independent CG potential energy function representing the protein using alpha-carbon positions only and sampling conformations with a Monte Carlo simulated annealing based protocol. Backbone atoms were added using a method previously described and then gradient minimised in the Rosetta force field. Despite the CG potential energy function being sequence-independent, the method performed similarly to methods that explicitly use either fragments of known protein backbones with similar sequences or residue-specific phi/psi-maps to restrict the search space. The method was also able to predict with sub-Angstrom accuracy two out of seven loops from recently solved crystal structures of proteins with low sequence and structure similarity to previously deposited structures in the PDB. The ability to sample realistic loop conformations directly from a potential energy function enables the incorporation of additional geometric restraints and the use of more advanced sampling methods in a way that is not possible to do easily with fragment replacement methods and also enable multi-scale simulations for protein design and protein structure prediction. These restraints could be derived from experimental data or could be design restraints in the case of computational protein design. C++ source code is available for download from http://www.sbg.bio.ic.ac.uk/phyre2/PD2/.	[MacDonald, James T.; Kelley, Lawrence A.; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	Imperial College London	MacDonald, JT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England.	j.macdonald@imperial.ac.uk		MacDonald, James/0000-0001-9675-4429; Freemont, Paul/0000-0002-5658-8486	EPSRC [EP/H019154/1]; BBSRC [BB/J019240/1]; Biotechnology and Biological Sciences Research Council [BB/J019240/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H019154/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	JTM was funded by the EPSRC (EP/H019154/1). LAK is funded by the BBSRC (BB/J019240/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2004, J COMPUT CHEM, V25, P16, DOI 10.1002/jcc.10314; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arkhipov A, 2006, BIOPHYS J, V91, P4589, DOI 10.1529/biophysj.106.093443; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chikenji G, 2003, J CHEM PHYS, V119, P6895, DOI 10.1063/1.1597474; Choi Y, 2010, PROTEINS, V78, P1431, DOI 10.1002/prot.22658; Clementi C, 2008, CURR OPIN STRUC BIOL, V18, P10, DOI 10.1016/j.sbi.2007.10.005; Coluzza I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020853; de Bakker PIW, 2003, PROTEINS, V51, P21, DOI 10.1002/prot.10235; DePristo MA, 2003, PROTEINS, V51, P41, DOI 10.1002/prot.10285; DILL KA, 1995, PROTEIN SCI, V4, P561; Ding F, 2005, BIOPHYS J, V88, P147, DOI 10.1529/biophysj.104.046375; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; Feig M, 2008, J CHEM THEORY COMPUT, V4, P1555, DOI 10.1021/ct800153n; Feig M, 2011, MULTISCALE APPROACHES TO PROTEIN MODELING, P85, DOI 10.1007/978-1-4419-6889-0_4; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gopal SM, 2010, PROTEINS, V78, P1266, DOI 10.1002/prot.22645; Gront D, 2007, J COMPUT CHEM, V28, P1593, DOI 10.1002/jcc.20624; Head-Gordon T, 2003, CURR OPIN STRUC BIOL, V13, P160, DOI 10.1016/S0959-440X(03)00030-7; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jamroz M, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-5; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Jones DT, 1997, PROTEINS, P185; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Kolinski A, 2004, ACTA BIOCHIM POL, V51, P349; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; Liwo A, 1997, J COMPUT CHEM, V18, P849, DOI 10.1002/(SICI)1096-987X(199705)18:7<849::AID-JCC1>3.0.CO;2-R; MacDonald JT, 2010, PROTEINS, V78, P1311, DOI 10.1002/prot.22651; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Milik M, 1997, J COMPUT CHEM, V18, P80, DOI 10.1002/(SICI)1096-987X(19970115)18:1<80::AID-JCC8>3.0.CO;2-W; Monnigmann M, 2005, PROTEINS, V61, P748, DOI 10.1002/prot.20669; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Pandini A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-97; Peng HP, 2007, BIOINFORMATICS, V23, P2836, DOI 10.1093/bioinformatics/btm456; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Sellers BD, 2008, PROTEINS, V72, P959, DOI 10.1002/prot.21990; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Skolnick J, 1997, J MOL BIOL, V265, P217, DOI 10.1006/jmbi.1996.0720; Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612; TAKETOMI H, 1975, INT J PEPT PROT RES, V7, P445; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Zhang Y, 2003, BIOPHYS J, V85, P1145, DOI 10.1016/S0006-3495(03)74551-2; Zhu K, 2006, PROTEINS, V65, P438, DOI 10.1002/prot.21040	64	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65770	10.1371/journal.pone.0065770	http://dx.doi.org/10.1371/journal.pone.0065770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824634	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400022
J	Sanchez-Catasus, CA; Cabrera-Gomez, J; Melian, WA; Benitez, JLG; Rojas, RR; Bayard, JB; Galan, L; Sanchez, RG; Fuentes, NP; Valdes-Sosa, P				Sanchez-Catasus, Carlos A.; Cabrera-Gomez, Jose; Almaguer Melian, William; Giroud Benitez, Jose Luis; Rodriguez Rojas, Rafael; Bosch Bayard, Jorge; Galan, Lidice; Galvizu Sanchez, Reinaldo; Pavon Fuentes, Nancy; Valdes-Sosa, Pedro			Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CLINICAL-COURSE; MATTER DAMAGE; MRI; AQUAPORIN-4; DEMYELINATION; PATHOGENESIS; DISTINCTION; MORPHOMETRY; IMPAIRMENT	Recent neuroimaging studies show that brain abnormalities in neuromyelitis optica (NMO) are more frequent than earlier described. Yet, more research considering multiple aspects of NMO is necessary to better understand these abnormalities. A clinical feature of relapsing NMO (RNMO) is that the incremental disability is attack-related. Therefore, association between the attack-related process and neuroimaging might be expected. On the other hand, the immunopathological analysis of NMO lesions has suggested that CNS microvasculature could be an early disease target, which could alter brain perfusion. Brain tissue volume changes accompanying perfusion alteration could also be expected throughout the attack-related process. The aim of this study was to investigate in RNMO patients, by voxel-based correlation analysis, the assumed associations between regional brain white (WMV) and grey matter volumes (GMV) and/or perfusion on one side, and the number of optic neuritis (ON) attacks, myelitis attacks and/or total attacks on the other side. For this purpose, high resolution T1-weighted MRI and perfusion SPECT imaging were obtained in 15 RNMO patients. The results showed negative regional correlations of WMV, GMV and perfusion with the number of ON attacks, involving important components of the visual system, which could be relevant for the comprehension of incremental visual disability in RNMO. We also found positive regional correlation of perfusion with the number of ON attacks, mostly overlapping the brain area where the WMV showed negative correlation. This provides evidence that brain microvasculature is an early disease target and suggests that perfusion alteration could be important in the development of brain structural abnormalities in RNMO.	[Sanchez-Catasus, Carlos A.; Cabrera-Gomez, Jose; Almaguer Melian, William; Rodriguez Rojas, Rafael; Galvizu Sanchez, Reinaldo; Pavon Fuentes, Nancy] Ctr Neurol Restorat, Havana, Cuba; [Giroud Benitez, Jose Luis] Salvador Allende Hosp, Havana, Cuba; [Sanchez-Catasus, Carlos A.; Bosch Bayard, Jorge; Galan, Lidice; Valdes-Sosa, Pedro] Cuban Neurosci Ctr, Havana, Cuba		Sanchez-Catasus, CA (corresponding author), Ctr Neurol Restorat, Havana, Cuba.	casanchezcatasus@gmail.com	Bosch-Bayard, Jorge F/L-3295-2015; Rodriguez-Rojas, Rafael/ABC-2361-2020; Valdes-Sosa, Pedro A./AFT-6873-2022; Rodriguez-Rojas, Rafael/B-2759-2017	Bosch-Bayard, Jorge F/0000-0001-7168-5551; Valdes-Sosa, Pedro A./0000-0001-5485-2661; Rodriguez-Rojas, Rafael/0000-0002-2903-199X; Sanchez Catasus, Carlos Alfredo/0000-0002-0411-2961	Center for Neurological Restoration; Cuban Neuroscience Center from Havana, Cuba	Center for Neurological Restoration; Cuban Neuroscience Center from Havana, Cuba	This study was supported by the Center for Neurological Restoration and the Cuban Neuroscience Center from Havana, Cuba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barnett MH, 2012, CURR OPIN NEUROL, V25, P215, DOI 10.1097/WCO.0b013e3283533a3f; Blanc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033878; Cabrera-Gomez JA, 2012, EUR J NEUROL, V19, P812, DOI 10.1111/j.1468-1331.2011.03565.x; Cabrera-Gomez JA, 2007, MULT SCLER, V13, P186, DOI 10.1177/1352458506070725; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Kiebel SJ, 2004, HUMAN BRAIN FUNCTION, P725; Kim JE, 2011, J NEUROL SCI, V302, P43, DOI 10.1016/j.jns.2010.12.001; Kister I, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/398259; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Lu ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022766; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177; Mevel K, 2007, NEUROIMAGE, V37, P18, DOI 10.1016/j.neuroimage.2007.04.048; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; Pfueller CF, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/869814; Pfueller CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018019; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Popescu BFG, 2010, NEUROLOGY, V75, P2103, DOI 10.1212/WNL.0b013e318200d80c; Quarantelli M, 2004, J NUCL MED, V45, P192; Rizzo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050230; Rocca MA, 2004, NEUROIMAGE, V21, P1061, DOI 10.1016/j.neuroimage.2003.10.013; Rocca MA, 2004, NEUROLOGY, V62, P476, DOI 10.1212/01.WNL.0000106946.08741.41; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Lopes FCR, 2012, RADIOLOGY, V263, P235, DOI 10.1148/radiol.12111241; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Simon JH, 2006, AM J NEURORADIOL, V27, P455; Sinnecker T, 2012, NEUROLOGY, V79, P708, DOI 10.1212/WNL.0b013e3182648bc8; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Waschbisch Anne, 2011, Exp Transl Stroke Med, V3, P7, DOI 10.1186/2040-7378-3-7; Waters P, 2008, Int MS J, V15, P99; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Wuerfel J, 2007, J NEUROL SCI, V259, P16, DOI 10.1016/j.jns.2007.02.011; Wuerfel JT, 2012, PLOS ONE, V6, DOI [10.1371/journal.pone.0036847, DOI 10.1371/J0URNAL.P0NE.0036847]; Yu CS, 2006, AM J NEURORADIOL, V27, P1009; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075; Zhao DD, 2012, NEUROIMAGE, V59, P3173, DOI 10.1016/j.neuroimage.2011.11.022; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844	55	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66271	10.1371/journal.pone.0066271	http://dx.doi.org/10.1371/journal.pone.0066271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824339	Green Submitted, gold, Green Published			2022-12-27	WOS:000320576400076
J	Kolber, MR; Wong, CKW; Fedorak, RN; Rowe, BH				Kolber, Michael R.; Wong, Clarence K. W.; Fedorak, Richard N.; Rowe, Brian H.		APC-Endo Study Phys	Prospective Study of the Quality of Colonoscopies Performed by Primary Care Physicians: The Alberta Primary Care Endoscopy (APC-Endo) Study	PLOS ONE			English	Article							SPECIALIST GASTROENTEROLOGY CARE; COLORECTAL-CANCER; WAIT TIMES; FAMILY PHYSICIAN; PRACTICE AUDIT; SCREENING COLONOSCOPIES; OUTPATIENT COLONOSCOPY; ADENOMA DETECTION; RISK-FACTORS; CASE SERIES	Background: The quality of colonoscopies performed by primary care physicians (PCPs) is unknown. Objective: To determine whether PCP colonoscopists achieve colonoscopy quality benchmarks, and patient satisfaction with having their colonoscopy performed by a primary care physician. Design: Prospective multi-center, multi-physician observational study. Colonoscopic quality data collection occurred via completion of case report forms and pathological confirmation of lesions. Patient satisfaction was captured by a telephone survey. Setting: Thirteen rural and suburban hospitals in Alberta, Canada. Measurements: Proportion of successful cecal intubations, average number of adenomas detected per colonoscopy, proportion of patients with at least one adenoma, and serious adverse event rates; patient satisfaction with their wait time and procedure, as well as willingness to have a repeat colonoscopy performed by their primary care endoscopist. Results: In the two-month study period, 10 study physicians performed 577 colonoscopies. The overall adjusted proportion of successful cecal intubations was 96.5% (95% CI 94.6-97.8), and all physicians achieved the adjusted cecal intubation target of >= 90%. The average number of ademonas detected per colonoscopy was 0.62 (95% CI 0.5-0.74). 46.4% (95% CI 38.5-54.3) of males and 30.2% (95% CI 22.3-38.2) of females >= 50 years of age having their first colonoscopy, had at least one adenoma. Four serious adverse events occurred (three post polypectomy bleeds and one perforation) and 99.3% of patients were willing to have a repeat colonoscopy performed by their primary care colonoscopist. Limitations: Two-month study length and non-universal participation by Alberta primary care endoscopists. Conclusions: Primary care physician colonoscopists can achieve quality benchmarks in colonoscopy. Training additional primary care physicians in endoscopy may improve patient access and decrease endoscopic wait times, especially in rural settings.	[Kolber, Michael R.] Univ Alberta, Dept Family Med, Edmonton, AB, Canada; [Wong, Clarence K. W.; Fedorak, Richard N.] Univ Alberta, Dept Gastroenterol, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Kolber, MR (corresponding author), Univ Alberta, Dept Family Med, Edmonton, AB, Canada.	mkolber@ualberta.ca		Fedorak, Richard/0000-0002-7382-0080	Alberta Rural Physician Action Plan	Alberta Rural Physician Action Plan	The study was funded by the Alberta Rural Physician Action Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alberta Cancer Board Division of Population Health, 2008, ALB CANC REG REG 200; [Anonymous], 2000, GASTROINTEST ENDOSC, V52, P831; Armstrong D, 2006, CAN J GASTROENTEROL, V20, P405, DOI 10.1155/2006/685960; Armstrong D, 2008, CAN J GASTROENTEROL, V22, P155, DOI 10.1155/2008/292948; Armstrong D, 2011, CAN J GASTROENTEROL, V25, P13, DOI 10.1155/2011/320904; Aslinia F, 2006, AM J GASTROENTEROL, V101, P721, DOI 10.1111/j.1572-0241.2006.00494.x; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Canadian Cancer Society's Steering Committee, 2010, CAN CANC STAT; Carr K W, 1998, Tenn Med, V91, P21; Chen SC, 2007, AM J GASTROENTEROL, V102, P856, DOI 10.1111/j.1572-0241.2006.01054.x; Cotterill M, 2005, CAN FAM PHYSICIAN, V51, P1224; Cotton PB, 2003, GASTROINTEST ENDOSC, V57, P352, DOI 10.1067/mge.2003.121; del Rio AS, 2007, EUR J GASTROEN HEPAT, V19, P896, DOI 10.1097/MEG.0b013e3281532bae; Dominitz JA, 2003, GASTROINTEST ENDOSC, V57, P441; Eckert Leigh D, 2009, J Grad Med Educ, V1, P89, DOI 10.4300/01.01.0014; Eisen GM, 2002, GASTROINTEST ENDOSC, V55, P784, DOI 10.1016/S0016-5107(02)70404-5; Godreau C J, 1992, Fam Pract Res J, V12, P313; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Hilsden RJ, 2007, CAN J GASTROENTEROL, V21, P843, DOI 10.1155/2007/563895; Hopper W, 1996, J FAM PRACTICE, V43, P561; Johanson JF, 2000, GASTROINTEST ENDOSC, V52, P827, DOI 10.1016/S0016-5107(00)70218-5; Kirby Erle, 2004, Can J Rural Med, V9, P89; Kolber M, 2009, CAN FAM PHYSICIAN, V55, P170; Leddin D, 2008, CAN J GASTROENTEROL, V22, P161, DOI 10.1155/2008/479684; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Maciosek MV, 2006, AM J PREV MED, V31, P80, DOI 10.1016/j.amepre.2006.03.009; Misra T, 2004, CAN J GASTROENTEROL, V18, P221, DOI 10.1155/2004/505970; Newman RJ, 2005, ANN FAM MED, V3, P122, DOI 10.1370/afm.268; Paterson WG, 2010, CAN J GASTROENTEROL, V24, P28, DOI 10.1155/2010/912970; Paterson WG, 2006, CAN J GASTROENTEROL, V20, P411, DOI 10.1155/2006/343686; Pierzchajlo RPJ, 1997, J FAM PRACTICE, V44, P473; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Quigley EM, 2009, AM COLL GASTROENTERO; Rabeneck L, 2010, CLIN GASTROENTEROL H, V8, P275, DOI 10.1016/j.cgh.2009.10.022; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Rex DK, 2006, GASTROINTEST ENDOSC, V63, pS16, DOI 10.1016/j.gie.2006.02.021; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Robertson RH, 2006, PREV MED, V42, P460, DOI 10.1016/j.ypmed.2006.01.014; Rodney W M, 1993, Fam Pract Res J, V13, P43; Shah HA, 2007, GASTROENTEROLOGY, V132, P2297, DOI 10.1053/j.gastro.2007.03.032; Short MW, 2007, MIL MED, V172, P1089, DOI 10.7205/MILMED.172.10.1089; Singh H, 2010, AM J GASTROENTEROL, V105, P2588, DOI 10.1038/ajg.2010.390; Singh H, 2009, GASTROINTEST ENDOSC, V69, P665, DOI 10.1016/j.gie.2008.09.046; Strayer SM, 2004, P 32 ANN N AM PRIM C; Wilkins T, 2009, ANN FAM MED, V7, P56, DOI 10.1370/afm.939; Xirasagar S, 2010, MED CARE, V48, P703, DOI 10.1097/MLR.0b013e3181e358a3	47	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67017	10.1371/journal.pone.0067017	http://dx.doi.org/10.1371/journal.pone.0067017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826186	Green Published, gold			2022-12-27	WOS:000321150000020
J	Ingleby, FC; Hunt, J; Hosken, DJ				Ingleby, Fiona C.; Hunt, John; Hosken, David J.			Genotype-by-Environment Interactions for Female Mate Choice of Male Cuticular Hydrocarbons in Drosophila simulans	PLOS ONE			English	Article							SEXUAL SELECTION; CONDITION-DEPENDENCE; COURTSHIP BEHAVIOR; GENETIC VARIANCE; EVOLUTION; ATTRACTIVENESS; PREFERENCES; PLASTICITY; EXPRESSION; FITNESS	Recent research has highlighted the potential importance of environmental and genotype-by-environment (GxE) variation in sexual selection, but most studies have focussed on the expression of male sexual traits. Consequently, our understanding of genetic variation for plasticity in female mate choice is extremely poor. In this study we examine the genetics of female mate choice in Drosophila simulans using isolines reared across two post-eclosion temperatures. There was evidence for GxEs in female choosiness and preference, which suggests that the evolution of female mate choice behaviour could differ across environments. However, the ranked order of preferred males was consistent across females and environments, so the same males are favoured by mate choice in spite of GxEs. Our study highlights the importance of taking cross-environment perspectives in order to gain a more comprehensive understanding of the operation of sexual selection.	[Ingleby, Fiona C.; Hunt, John; Hosken, David J.] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Tremough, Penryn, England; [Ingleby, Fiona C.] Univ Sussex, Brighton, E Sussex, England	University of Exeter; University of Sussex	Hosken, DJ (corresponding author), Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Cornwall Campus, Tremough, Penryn, England.	D.J.Hosken@exeter.ac.uk	Ingleby, Fiona C/C-4271-2014; Hunt, John/F-1279-2014	Hunt, John/0000-0002-4962-8750; Ingleby, Fiona/0000-0003-1800-2015	Association for the Study of Animal Behaviour; ESF; NERC; Royal Society; Natural Environment Research Council [NE/G005303/1] Funding Source: researchfish; NERC [NE/G005303/1] Funding Source: UKRI	Association for the Study of Animal Behaviour; ESF(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Association for the Study of Animal Behaviour (DJH), the ESF and NERC (DJH and JH), and a Royal Society Fellowship and Equipment grant (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Arienti M, 2010, INTEGR ZOOL, V5, P272, DOI 10.1111/j.1749-4877.2010.00213.x; Avent TD, 2008, ANIM BEHAV, V75, P1413, DOI 10.1016/j.anbehav.2007.09.015; Barron AB, 2000, J INSECT PHYSIOL, V46, P439, DOI 10.1016/S0022-1910(99)00129-8; Barth M, 1997, ANIM BEHAV, V53, P25, DOI 10.1006/anbe.1996.0275; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Danielson-Francois AM, 2006, J EVOLUTION BIOL, V19, P532, DOI 10.1111/j.1420-9101.2005.01006.x; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Delcourt M, 2010, EVOLUTION, V64, P2758, DOI 10.1111/j.1558-5646.2010.01031.x; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P325, DOI 10.1017/CBO9780511711909.016; Gosden TP, 2011, J EVOLUTION BIOL, V24, P685, DOI 10.1111/j.1420-9101.2010.02205.x; Greenfield MD, 2004, ANIM BEHAV, V68, P1461, DOI 10.1016/j.anbehav.2004.01.014; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; Higginson AD, 2009, P ROY SOC B-BIOL SCI, V276, P1153, DOI 10.1098/rspb.2008.1592; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; Hosken DJ, 2011, CURR BIOL, V21, pR62, DOI 10.1016/j.cub.2010.11.053; Ingleby FC, 2013, J EVOLUTION BIOL, V26, P311, DOI 10.1111/jeb.12045; Ingleby FC, 2013, J EVOLUTION BIOL, V26, P94, DOI 10.1111/jeb.12030; Ingleby FC, 2010, J EVOLUTION BIOL, V23, P2031, DOI 10.1111/j.1420-9101.2010.02080.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jia FY, 2000, EVOLUTION, V54, P953; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kokko H, 2008, GENETICA, V134, P55, DOI 10.1007/s10709-008-9249-7; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Lewandowski E, 2008, BIOL J LINN SOC, V94, P663, DOI 10.1111/j.1095-8312.2008.01021.x; Lynch M., 1998, GENETICS ANAL QUANTI; Marcillac F, 2004, J EXP BIOL, V207, P3927, DOI 10.1242/jeb.01236; Miller LK, 2005, EVOLUTION, V59, P2414; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Narraway C, 2010, J EVOLUTION BIOL, V23, P2550, DOI 10.1111/j.1420-9101.2010.02113.x; O'Donald P, 1979, GENETIC MODELS SEXUA; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; Rodriguez RL, 2011, GENETICA, V139, P871, DOI 10.1007/s10709-011-9591-z; Rodriguez RL, 2003, EVOLUTION, V57, P1304, DOI 10.1111/j.0014-3820.2003.tb00338.x; Shackleton MA, 2005, BEHAV ECOL SOCIOBIOL, V58, P1, DOI 10.1007/s00265-004-0907-1; Sharma MD, 2012, EVOLUTION, V106, P295; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Taylor ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P721, DOI 10.1007/s00265-007-0497-9; Taylor ML, 2007, CURR BIOL, V17, pR959, DOI 10.1016/j.cub.2007.09.054; Tolle AE, 2011, EVOLUTION, V65, P283, DOI 10.1111/j.1558-5646.2010.01123.x; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Zhou YH, 2011, EVOL ECOL, V25, P307, DOI 10.1007/s10682-010-9421-2	45	25	25	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67623	10.1371/journal.pone.0067623	http://dx.doi.org/10.1371/journal.pone.0067623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825675	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000111
J	Liu, XQ; Gao, RF; Chen, XM; Zhang, HL; Zheng, AS; Yang, DH; Ding, YB; Wang, YX; He, JL				Liu, Xueqing; Gao, Rufei; Chen, Xuemei; Zhang, Hailing; Zheng, Anshun; Yang, Dehui; Ding, Yubin; Wang, Yingxiong; He, Junlin			Possible Roles of mmu-miR-141 in the Endometrium of Mice in Early Pregnancy Following Embryo Implantation	PLOS ONE			English	Article							MAMMALIAN MICRORNAS; PTEN EXPRESSION; GENE-EXPRESSION; PROSTATE-CANCER; CARCINOMA; PROLIFERATION; APOPTOSIS; DECIDUALIZATION; POLYPLOIDY; PATTERNS	Objective: Embryo implantation is directly affected by genes related to uterine receptivity. Studies have demonstrated the important roles of miRNAs in the regulation of gene expression. Our early miRNA chip analyses revealed that the mmu-miR-141 expression in endometrial tissue is lower after embryo implantation than before it. However, the possible roles of miR-141 in embryo implantation have not yet been elucidated. Here, mmu-miR-141 was designed to detect the expression and role of miR-141 in the endometria of mice in early pregnancy following embryo implantation. Methods: Real-time PCR and in-situ hybridization were used to study mmu-miR-141 expression in mouse uterus. Cell proliferation was detected by tetrazolium dye (MTT) assay and flow cytometry. Real-time PCR and Western blot analysis were used to confirm the mRNA and protein levels of phosphatase and tensin homolog (PTEN) to determine whether it was the target gene of mmu-miR-141. Enhanced green fluorescent protein (EGFP) fluorescence reporter vector analysis was also performed. A functional study was performed by injecting mice uteri with mmu-miR-141 inhibitor or mimic vectors. Results: mmu-miR-141 expression was lower on day 6 (D6) than day 4 (D4) and could be increased by progesterone. Reduced mmu-miR-141 could decrease the proliferation activity of stromal cells and promote apoptosis. Upregulation of mmu-miR-141 inhibited PTEN protein expression but downregulation of mmu-miR-141 increased it, while the mRNA level remained unchanged. EGFP fluorescence reporter vector analysis showed that miR-141 targets the 39-untranslated region of the PTEN mRNA. In addition, when the physiological mmu-miR-141 level was altered on D2 by injecting with inhibitor or mimic, the embryo implantation sites were significantly decreased on D7. Conclusions: This study demonstrated that mmu-miR-141 might influence cell proliferation and apoptosis in the endometrium by negatively regulating PTEN expression, and could also influence the number of embryo implantation sites. mmu-miR-141 plays an essential role in embryo implantation.	[Liu, Xueqing; Gao, Rufei; Chen, Xuemei; Zhang, Hailing; Zheng, Anshun; Yang, Dehui; Ding, Yubin; Wang, Yingxiong; He, Junlin] Chongqing Med Univ, Sch Publ Hlth, Reprod Biol Lab, Chongqing, Peoples R China	Chongqing Medical University	He, JL (corresponding author), Chongqing Med Univ, Sch Publ Hlth, Reprod Biol Lab, Chongqing, Peoples R China.	hejunlin_11@aliyun.com			National Natural Science Foundation of China [31071278]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31071278) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Altmae S, 2012, REPROD SCI; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chegini N, 2002, J REPROD IMMUNOL, V56, P93, DOI 10.1016/S0165-0378(02)00043-8; Chen H, 2010, J INT MED RES, V38, P1801, DOI 10.1177/147323001003800527; Chen Xiao-Ling, 2008, Shengli Xuebao, V60, P119; Correia-da-Silva G, 2004, PLACENTA, V25, P538, DOI 10.1016/j.placenta.2003.11.007; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Fassan M, 2011, VIRCHOWS ARCH, V458, P413, DOI 10.1007/s00428-011-1046-5; Gao QL, 2009, J HUAZHONG U SCI-MED, V29, P59, DOI 10.1007/s11596-009-0112-6; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Imanaka Y, 2011, J HUM GENET, V56, P270, DOI 10.1038/jhg.2011.1; Kanamori Y, 2001, CLIN CANCER RES, V7, P892; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZZ, 2009, CHINESE J CELL BIOL, V31, P848; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Morales-Prieto DM, 2011, AM J REPROD IMMUNOL, V66, P57, DOI 10.1111/j.1600-0897.2011.01037.x; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Quenby S, 2007, REPROD BIOMED ONLINE, V14, P224, DOI 10.1016/S1472-6483(10)60791-2; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Tan J, 2002, MECH DEVELOP, V111, P99, DOI 10.1016/S0925-4773(01)00614-1; Tan Y, 2004, DEV BIOL, V265, P181, DOI 10.1016/j.ydbio.2003.09.019; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Veillette A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107136; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162	38	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67382	10.1371/journal.pone.0067382	http://dx.doi.org/10.1371/journal.pone.0067382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825654	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000097
J	Muller, TA; Yu, KF; Hausinger, RP; Meek, K				Mueller, Tina A.; Yu, Kefei; Hausinger, Robert P.; Meek, Katheryn			ALKBH1 Is Dispensable for Abasic Site Cleavage during Base Excision Repair and Class Switch Recombination	PLOS ONE			English	Article							DNA-DAMAGE; OXIDATIVE DEMETHYLATION; LYASE ACTIVITY; AID; PROTEIN; GENE; ENDONUCLEASE; ACCUMULATION; DEAMINATION; DEFICIENT	Potential roles of the abasic site lyase activity associated with AlkB homolog 1 (ALKBH1) were assessed by studies focusing on the two cellular processes that create abasic sites as intermediates: base excision repair and class switch recombination. Alkbh1(-/-) pups (lacking exon 3) were born at a lower than expected frequency from heterozygous parents, suggesting a reduced survival rate and non-Mendelian inheritance, and they exhibited a gender bias in favor of males (70% males and 30% females). To study ALKBH1's potential involvement in DNA repair, fibroblasts were isolated from Alkbh1(-/-) mice, spontaneously immortalized and tested for resistance to DNA damaging agents. Alkbh1(-/-) and isogenic cells expressing hALKBH1 showed no difference in survival to the DNA damaging agents methyl-methionine sulfate or H2O2. This result indicates that ALKBH1 does not play a major role in the base excision repair pathway. To assess ALKBH1's role in class switch recombination, splenic B cells were isolated from Alkbh1(-/-) and Alkbh1(+/+) mice and subjected to switching from IgM to IgG1. No differences were found in IgG1 switching, suggesting that Alkbh1 is not involved in class switch recombination of the immunoglobulin heavy chain during B lymphocyte activation.	[Mueller, Tina A.; Yu, Kefei; Hausinger, Robert P.; Meek, Katheryn] Michigan State Univ, E Lansing, MI 48824 USA	Michigan State University	Muller, TA (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	tmueller@msu.edu		Hausinger, Robert/0000-0002-3643-2054	National Institutes of Health [5R21AI79430-2, GM063582, AI048758]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079430, R01AI048758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063582, R01GM063584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (5R21AI79430-2 to T. A. M., GM063582 to R. P. H. and AI048758 to K. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lhomme J, 1999, BIOPOLYMERS, V52, P65, DOI 10.1002/1097-0282(1999)52:2<65::AID-BIP1>3.0.CO;2-U; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Muller TA, 2010, DNA REPAIR, V9, P58, DOI 10.1016/j.dnarep.2009.10.011; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nordstrand LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013827; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459; Ougland R, 2012, STEM CELLS; Pan Z, 2008, DEV DYN, V237; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Piersen CE, 2000, MUTAT RES-DNA REPAIR, V459, P43, DOI 10.1016/S0921-8777(99)00054-3; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; van Oers JMM, 2010, P NATL ACAD SCI USA, V107, P13384, DOI 10.1073/pnas.1008589107; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	44	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67403	10.1371/journal.pone.0067403	http://dx.doi.org/10.1371/journal.pone.0067403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825659	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000102
J	Na, R; Wu, YS; Xu, JF; Jiang, HW; Ding, Q				Na, Rong; Wu, Yishuo; Xu, Jianfeng; Jiang, Haowen; Ding, Qiang			Age-Specific Prostate Specific Antigen Cutoffs for Guiding Biopsy Decision in Chinese Population	PLOS ONE			English	Article							REFERENCE RANGES; CANCER INCIDENCE; TOTAL PSA; MEN; ESTABLISHMENT; TRENDS	Background: Age-specific prostate specific antigen (PSA) cutoffs for prostate biopsy have been widely used in the USA and European countries. However, the application of age-specific PSA remains poorly understood in China. Methods: Between 2003 and 2012, 1,848 men over the age of 40, underwent prostate biopsy for prostate cancer (PCa) at Huashan Hospital, Shanghai, China. Clinical information and blood samples were collected prior to biopsy for each patient. Men were divided into three age groups (<= 60, 61 to 80, and >80) for analyses. Digital rectal examination (DRE), transrectal ultrasound (prostate volume and nodule), total PSA (tPSA), and free PSA (fPSA) were also included in the analyses. Logistic regression was used to build the multi-variate model. Results: Serum tPSA levels were age-dependent (P = 0.008), while %fPSA (P = 0.051) and PSAD (P = 0.284) were age-independent. At a specificity of 80%, the sensitivities for predicting PCa were 83%, 71% and 68% with tPSA cutoff values of 19.0 ng/mL (age <= 60), 21.0 ng/mL (age 61-80), and 23.0 ng/mL (age >= 81). Also, sensitivities at the same tPSA levels were able to reach relatively high levels (70%-88%) for predicting high-grade PCa. Area (AUC) under the receive operating curves (ROCs) of tPSA, %fPSA, PSAD and multi-variate model were different in age groups. When predicting PCa, the AUC of tPSA, % fPSA, PSAD and multi-variate model were 0.90, 0.57, 0.93 and 0.87 respectively in men <= 60 yr; 0.82, 0.70, 0.88 and 0.86 respectively in men 61-80 yr; 0.79, 0.78, 0.87 and 0.88 respectively in men>80 yr. When predicting Gleason Score >= 7 or 8 PCa, there were no significant differences between AUCs of each variable. Conclusion: Age-specific PSA cutoff values for prostate biopsy should be considered in the Chinese population. Indications for prostate biopsies (tPSA, % fPSA and PSAD) should be considered based on age in the Chinese population.	[Na, Rong; Wu, Yishuo; Xu, Jianfeng; Jiang, Haowen; Ding, Qiang] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Na, Rong; Wu, Yishuo; Xu, Jianfeng; Jiang, Haowen; Ding, Qiang] Fudan Univ, Urol Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Wake Forest University; Wake Forest Baptist Medical Center; Fudan University	Jiang, HW (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	haowenj@yahoo.com; qiangd.urol@gmail.com	Na, Rong/AAN-8655-2021	Na, Rong/0000-0001-7470-5108				Aus G, 2001, EUR UROL, V40, P97, DOI 10.1159/000049758; Carter HB, 2004, JNCI-J NATL CANCER I, V96, P557, DOI 10.1093/jnci/djh111; Draisma G, 2006, INT J CANCER, V119, P2366, DOI 10.1002/ijc.22158; Etzioni R, 2002, J NATL CANCER I, V94, P981; Fang JY, 2001, UROLOGY, V58, P411, DOI 10.1016/S0090-4295(01)01304-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fitzpatrick JM, 2009, BJU INT, V103, P578, DOI 10.1111/j.1464-410X.2009.08345.x; Galen R S, 1982, Clin Lab Med, V2, P685; Guan Meng, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P586; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalish LA, 1999, UROLOGY, V54, P1022, DOI 10.1016/S0090-4295(99)00349-0; Kao CH, 1997, ANTICANCER RES, V17, P1361; Lein M, 1998, BRIT J UROL, V82, P231; Liu ZY, 2009, ASIAN J ANDROL, V11, P100, DOI 10.1038/aja.2008.17; Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502; Na R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049914; O'Dowd GJ, 2000, UROLOGY, V55, P553, DOI 10.1016/S0090-4295(00)00447-7; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; OESTERLING JE, 1995, J UROLOGY, V154, P1090, DOI 10.1016/S0022-5347(01)66984-2; Orozco R, 1998, UROLOGY, V51, P186, DOI 10.1016/S0090-4295(97)00620-1; Park Jae, 2003, Clin Prostate Cancer, V2, P173, DOI 10.3816/CGC.2003.n.026; Partin AW, 1996, J UROLOGY, V155, P1336, DOI 10.1016/S0022-5347(01)66260-8; Presti JC, 2003, J UROLOGY, V169, P125, DOI 10.1016/S0022-5347(05)64051-7; Sokoll LJ, 2010, CANCER EPIDEM BIOMAR, V19, P1193, DOI 10.1158/1055-9965.EPI-10-0007; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Veltri RW, 2002, UROLOGY, V60, P47, DOI 10.1016/S0090-4295(02)01695-3; Wolf JS, 2012, J UROLOGY, V188, P2454, DOI 10.1016/j.juro.2012.10.010; Ye DW, 2007, CHINA ONCOLOGY, V17, P4	29	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67585	10.1371/journal.pone.0067585	http://dx.doi.org/10.1371/journal.pone.0067585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825670	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000108
J	Sakai, H; Uchiyama, Y; Shin, D; Hayashi, MJ; Sadato, N				Sakai, Hiroyuki; Uchiyama, Yuji; Shin, Duk; Hayashi, Masamichi J.; Sadato, Norihiro			Neural Activity Changes Associated with Impulsive Responding in the Sustained Attention to Response Task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DEFAULT NETWORK; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; ERROR-DETECTION; WORKING-MEMORY; BRAIN; INHIBITION; MIND; PERFORMANCE	Humans can anticipate and prepare for uncertainties to achieve a goal. However, it is difficult to maintain this effort over a prolonged period of time. Inappropriate behavior is impulsively (or mindlessly) activated by an external trigger, which can result in serious consequences such as traffic crashes. Thus, we examined the neural mechanisms underlying such impulsive responding using functional magnetic resonance imaging (fMRI). Twenty-two participants performed a block-designed sustained attention to response task (SART), where each task block was composed of consecutive Go trials followed by a NoGo trial at the end. This task configuration enabled us to measure compromised preparation for NoGo trials during Go responses using reduced Go reaction times. Accordingly, parametric modulation analysis was conducted on fMRI data using block-based mean Go reaction times as an online marker of impulsive responding in the SART. We found that activity in the right dorsolateral prefrontal cortex (DLPFC) and the bilateral intraparietal sulcus (IPS) was positively modulated with mean Go reaction times. In addition, activity in the medial prefrontal cortex (MPFC) and the posterior cingulate cortex (PCC) was negatively modulated with mean Go reaction times, albeit statistically weakly. Taken together, spontaneously reduced activity in the right DLPFC and the IPS and spontaneously elevated activity in the MPFC and the PCC were associated with impulsive responding in the SART. These results suggest that such a spontaneous transition of brain activity pattern results in impulsive responding in monotonous situations, which in turn, might cause human errors in actual work environments.	[Sakai, Hiroyuki; Uchiyama, Yuji] Toyota Cent Res & Dev Labs Inc, Frontier Res Ctr, Nagakute, Aichi 48011, Japan; [Shin, Duk] Toyota Technol Inst, Precis & Intelligence Lab, Yokohama, Kanagawa, Japan; [Hayashi, Masamichi J.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Hayashi, Masamichi J.] Aalto Univ, Sch Sci, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland; [Hayashi, Masamichi J.] UCL, Inst Cognit Neurosci, London, England; [Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan	Toyota Central R&D Labs Inc; Toyota Technological Institute; University of Helsinki; Aalto University; University of London; University College London; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Sakai, H (corresponding author), Toyota Cent Res & Dev Labs Inc, Frontier Res Ctr, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.	sakai@mosk.tytlabs.co.jp	Shin, Duk/G-9620-2011; Uchiyama, Yuji/GVS-0186-2022	Uchiyama, Yuji/0000-0003-1581-8668; Sadato, Norihiro/0000-0002-9786-3907; Hayashi, Masamichi/0000-0003-2631-5177	Toyota Central Research and Development Laboratories, Inc.; Brain Research at Aalto University; University of Helsinki Consortium Postdoctoral Program	Toyota Central Research and Development Laboratories, Inc.; Brain Research at Aalto University; University of Helsinki Consortium Postdoctoral Program	This work was performed under the financial support of Toyota Central Research and Development Laboratories, Inc., which is funded by its stockholding companies (http://www.tytlabs.co.jp/english/comp/outline02.html). The fourth author (MJH) was supported by Brain Research at Aalto University and University of Helsinki Consortium Postdoctoral Program. The funders had no role in the study design, data collection and analysis and the decision to publish.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Beede KE, 2006, ACCIDENT ANAL PREV, V38, P415, DOI 10.1016/j.aap.2005.10.015; Bellgrove MA, 2006, CORTEX, V42, P838, DOI 10.1016/S0010-9452(08)70426-X; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Galera C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8105; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Jaffard M, 2007, BRAIN RES, V1179, P106, DOI 10.1016/j.brainres.2007.08.032; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Larson KE, 1997, ACCIDENT ANAL PREV, V88, P29; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Ogilvie RD, 2001, SLEEP MED REV, V5, P247, DOI 10.1053/smrv.2001.0145; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Reason J, 1995, Qual Health Care, V4, P80, DOI 10.1136/qshc.4.2.80; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Sakai H, 2011, ERGONOMICS, V54, P146, DOI 10.1080/00140139.2010.538724; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zandbelt BB, 2012, HUM BRAIN MAPP, V22, P1479; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	52	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67391	10.1371/journal.pone.0067391	http://dx.doi.org/10.1371/journal.pone.0067391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825657	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000321223000100
J	Becker, AM; Dao, KH; Han, BK; Kornu, R; Lakhanpal, S; Mobley, AB; Li, QZ; Lian, Y; Wu, TF; Reimold, AM; Olsen, NJ; Karp, DR; Chowdhury, FZ; Farrar, JD; Satterthwaite, AB; Mohan, C; Lipsky, PE; Wakeland, EK; Davis, LS				Becker, Amy M.; Dao, Kathryn H.; Han, Bobby Kwanghoon; Kornu, Roger; Lakhanpal, Shuchi; Mobley, Angela B.; Li, Quan-Zhen; Lian, Yun; Wu, Tianfu; Reimold, Andreas M.; Olsen, Nancy J.; Karp, David R.; Chowdhury, Fatema Z.; Farrar, J. David; Satterthwaite, Anne B.; Mohan, Chandra; Lipsky, Peter E.; Wakeland, Edward K.; Davis, Laurie S.			SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon Signature	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE-ACTIVITY; GENE-EXPRESSION; PROTEIN-INTERACTION; IFN-ALPHA; MEMORY; ACTIVATION; INTERLEUKIN-10; INFLAMMATION; LYMPHOPENIA	Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is characterized by defective immune tolerance combined with immune cell hyperactivity resulting in the production of pathogenic autoantibodies. Previous gene expression studies employing whole blood or peripheral blood mononuclear cells (PBMC) have demonstrated that a majority of patients with active disease have increased expression of type I interferon (IFN) inducible transcripts known as the IFN signature. The goal of the current study was to assess the gene expression profiles of isolated leukocyte subsets obtained from SLE patients. Subsets including CD19(+) B lymphocytes, CD3(+) CD4(+) T lymphocytes and CD33(+) myeloid cells were simultaneously sorted from PBMC. The SLE transcriptomes were assessed for differentially expressed genes as compared to healthy controls. SLE CD33(+) myeloid cells exhibited the greatest number of differentially expressed genes at 208 transcripts, SLE B cells expressed 174 transcripts and SLE CD3(+) CD4(+) T cells expressed 92 transcripts. Only 4.4% (21) of the 474 total transcripts, many associated with the IFN signature, were shared by all three subsets. Transcriptional profiles translated into increased protein expression for CD38, CD63, CD107a and CD169. Moreover, these studies demonstrated that both SLE lymphoid and myeloid subsets expressed elevated transcripts for cytosolic RNA and DNA sensors and downstream effectors mediating IFN and cytokine production. Prolonged upregulation of nucleic acid sensing pathways could modulate immune effector functions and initiate or contribute to the systemic inflammation observed in SLE.	[Becker, Amy M.; Mobley, Angela B.; Li, Quan-Zhen; Lian, Yun; Chowdhury, Fatema Z.; Farrar, J. David; Satterthwaite, Anne B.; Mohan, Chandra; Wakeland, Edward K.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Becker, Amy M.; Dao, Kathryn H.; Han, Bobby Kwanghoon; Kornu, Roger; Lakhanpal, Shuchi; Wu, Tianfu; Reimold, Andreas M.; Olsen, Nancy J.; Karp, David R.; Satterthwaite, Anne B.; Mohan, Chandra; Davis, Laurie S.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Lipsky, Peter E.] NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Davis, LS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Laurie.Davis@UTSouthwestern.edu	Mohan, Chandra/GPX-8233-2022; Wu, Tianfu/G-6672-2019	Wu, Tianfu/0000-0003-4406-1449; Wu, Tianfu/0000-0001-8235-5929	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [P50AR055503, R01AR45293]; UT Southwestern Arthritis Center Flow Cytometry Core; MedImmune; Novo Nordisk; Novo Nordisk, Genentech/Roche; Human Genome Sciences; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045293, P50AR055503] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UT Southwestern Arthritis Center Flow Cytometry Core; MedImmune(AstraZenecaMedimmune); Novo Nordisk(Novo Nordisk); Novo Nordisk, Genentech/Roche; Human Genome Sciences(GlaxoSmithKline); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant P50AR055503 (Mohan), the UT Southwestern Arthritis Center Flow Cytometry Core (Davis) and the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01AR45293 (Davis). Dr. Nancy Olsen has equity interest in a company, ArthroChip LLC, which develops assays for autoimmune diseases and she has also obtained funding from MedImmune, Novo Nordisk, Genentech/Roche and Human Genome Sciences. Dr. David Karp has received research funding from Human Genome Sciences. None of these funds were used for the current study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bell SG, 2009, CHEMBIOCHEM, V10, P55, DOI 10.1002/cbic.200800511; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Biesen R, 2008, ARTHRITIS RHEUM-US, V58, P1136, DOI 10.1002/art.23404; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Carella C, 2006, BLOOD, V107, P1124, DOI 10.1182/blood-2005-03-1196; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Choubey D, 2011, J INTERF CYTOK RES, V31, P893, DOI 10.1089/jir.2011.0073; Chowdhury FZ, 2011, BLOOD, V118, P3890, DOI 10.1182/blood-2011-05-357111; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Crow MK, 2008, NEW ENGL J MED, V358, P956, DOI 10.1056/NEJMe0800096; de Herve MGD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019366; Dorner T, 2004, LUPUS, V13, P283, DOI 10.1191/0961203304lu1014oa; Efremov DG, 2007, AUTOIMMUN REV, V7, P102, DOI 10.1016/j.autrev.2007.02.021; Ettinger R, 2008, ANN RHEUM DIS, V67, P83, DOI 10.1136/ard.2008.098400; Furukawa H, 2013, HUM IMMUNOL, V74, P170, DOI 10.1016/j.humimm.2012.11.007; Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844; Han BK, 2005, LUPUS, V14, P598, DOI 10.1191/0961203305lu2171oa; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; Harada T, 2007, AUTOIMMUNITY, V40, P1, DOI 10.1080/08916930601095148; Heinlen LD, 2010, J MOL MED, V88, P719, DOI 10.1007/s00109-010-0618-1; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; ISENBERG DA, 1982, ACTA HAEMATOL-BASEL, V67, P242, DOI 10.1159/000207070; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jenks SA, 2009, AUTOIMMUN REV, V8, P209, DOI 10.1016/j.autrev.2008.07.047; Jones BM, 1999, AUTOIMMUNITY, V31, P117, DOI 10.3109/08916939908994055; Katsiari CG, 2006, AUTOIMMUN REV, V5, P118, DOI 10.1016/j.autrev.2005.08.009; Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10; Kim K, 2009, GENES IMMUN, V10, P482, DOI 10.1038/gene.2009.5; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kleinewietfeld M, 2013, NATURE; Kyttaris VC, 2006, LUPUS, V15, P840, DOI 10.1177/0961203306069985; Kyttaris VC, 2007, J IMMUNOL, V178, P1960, DOI 10.4049/jimmunol.178.3.1960; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lee J, 2009, J IMMUNOL, V182, P4116, DOI 10.4049/jimmunol.0803391; Li QZ, 2010, CLIN EXP IMMUNOL, V159, P281, DOI 10.1111/j.1365-2249.2009.04057.x; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Liu Z, 2011, J IMMUNOL, V187, P1506, DOI 10.4049/jimmunol.1004142; Lugar PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044362; Mathian A, 2011, EUR J IMMUNOL, V41, P863, DOI 10.1002/eji.201040649; Mellor-Pita S, 2009, CYTOM PART B-CLIN CY, V76B, P261, DOI 10.1002/cyto.b.20468; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Nicholas MIW, 2008, CLIN IMMUNOL, V126, P189, DOI 10.1016/j.clim.2007.10.004; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Ohshima S, 2003, ARTHRITIS RHEUM-US, V48, P2788, DOI 10.1002/art.11287; Petri Michelle, 1995, Current Opinion in Rheumatology, V7, P395, DOI 10.1097/00002281-199509000-00006; RIVERO SJ, 1978, ARTHRITIS RHEUM, V21, P295, DOI 10.1002/art.1780210302; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Scatizzi JC, 2009, EUR J IMMUNOL, V39, P820, DOI 10.1002/eji.200838683; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shin DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027384; Silva FPG, 2008, LEUKEMIA, V22, P1639, DOI 10.1038/leu.2008.34; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Vinuesa Carola G., 2001, Current Molecular Medicine (Hilversum), V1, P689, DOI 10.2174/1566524013363276; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; WINFIELD JB, 1975, ARTHRITIS RHEUM, V18, P587, DOI 10.1002/art.1780180609; Wu C, 2013, NATURE; Wu TF, 2007, J CLIN INVEST, V117, P2186, DOI 10.1172/JCI30398; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557; Ye S, 2003, RHEUMATOLOGY, V42, P1155, DOI 10.1093/rheumatology/keg315; Yin XY, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-21; YTTERBERG SR, 1982, ARTHRITIS RHEUM, V25, P401, DOI 10.1002/art.1780250407	77	136	137	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67003	10.1371/journal.pone.0067003	http://dx.doi.org/10.1371/journal.pone.0067003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826184	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400092
J	Burzaco, J; Conde, M; Parada, LA; Zugaza, JL; Dehaye, JP; Marino, A				Burzaco, Jaione; Conde, Manuel; Parada, Luis A.; Zugaza, Jose L.; Dehaye, Jean-Paul; Marino, Aida			ATP Antagonizes Thrombin-Induced Signal Transduction through 12(S)-HETE and cAMP	PLOS ONE			English	Article							INDUCED PLATELET-AGGREGATION; EXTRACELLULAR ATP; CYCLIC-GMP; P2X(1) RECEPTORS; BLOOD-PLATELETS; PROTEIN-KINASE; P2 RECEPTORS; ACTIVATION; ADP; INHIBITION	In this study we have investigated the role of extracellular ATP on thrombin induced-platelet aggregation (TIPA) in washed human platelets. ATP inhibited TIPA in a dose-dependent manner and this inhibition was abolished by apyrase but not by adenosine deaminase (ADA) and it was reversed by extracellular magnesium. Antagonists of P2Y(1) and P2Y(12) receptors had no effect on this inhibition suggesting that a P2X receptor controlled ATP-mediated TIPA inhibition. ATP also blocked inositol phosphates (IP1, IP2, IP3) generation and [Ca2+]i mobilization induced by thrombin. Thrombin reduced cAMP levels which were restored in the presence of ATP. SQ-22536, an adenylate cyclase (AC) inhibitor, partially reduced the inhibition exerted by ATP on TIPA. 12-lipoxygenase (12-LO) inhibitors, nordihidroguaretic acid (NDGA) and 15(S)-hydroxy-5,8,11,13-eicosatetraenoic acid (15(S)-HETE), strongly prevented ATP-mediated TIPA inhibition. Additionally, ATP inhibited the increase of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(S)-HETE) induced by thrombin. Pretreatment with both SQ-22536 and NDGA almost completely abolished ATP-mediated TIPA inhibition. Our results describe for the first time that ATP implicates both AC and 12-LO pathways in the inhibition of human platelets aggregation in response to agonists.	[Burzaco, Jaione; Conde, Manuel; Marino, Aida] Univ Basque Country, Fac Sci & Technol, Dept Biochem & Mol Biol, Bilbao, Spain; [Parada, Luis A.] Univ Nacl Salta, Inst Patol Expt, Salta, Argentina; [Zugaza, Jose L.] Univ Basque Country, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Bilbao, Spain; [Zugaza, Jose L.] Achucarro Basque Ctr Neurosci, Zamudio, Spain; [Zugaza, Jose L.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Dehaye, Jean-Paul] Univ Libre Bruxelles, Inst Pharm, Biochem & Cellular Biol Lab, Brussels, Belgium	University of Basque Country; University of Basque Country; Basque Foundation for Science; Universite Libre de Bruxelles	Zugaza, JL (corresponding author), Univ Basque Country, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Bilbao, Spain.	joseluis.zugaza@ehu.es; aida.marino@ehu.es	Bustelo, Xose R./A-9526-2010	Bustelo, Xose R./0000-0001-9398-6072; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671; MARINO SANCHEZ, AIDA LUISA/0000-0003-3208-0677	Ministerio de Educacion y Ciencia of Spain [AP2000-2943]; Department of Education of the Basque Government [BFI01.108]; Department of Industry of the Basque Government [S-PE11UN018]; University of the Basque Country [EHU11/08, UFI 11/20, 42.310-15941/04]; Fonds de la Recherche Scientifique Medicale of Belgium [3.4.528.07]; Ministerio de Educacion y Ciencia [BFU2004-02124/BMC, BFU/2007-62728/BMC]	Ministerio de Educacion y Ciencia of Spain(Spanish Government); Department of Education of the Basque Government; Department of Industry of the Basque Government; University of the Basque Country; Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Ministerio de Educacion y Ciencia(Spanish Government)	J.B. was supported by grant AP2000-2943 from the Ministerio de Educacion y Ciencia of Spain. M.G.M. was supported by grant no BFI01.108 from the Department of Education of the Basque Government. J.L.Z. was supported by grants from Department of Industry of the Basque Government (S-PE11UN018) and University of the Basque Country (EHU11/08 and UFI 11/20), J.P.D. was supported by grant 3.4.528.07 from the Fonds de la Recherche Scientifique Medicale of Belgium and A. M. was supported in part by grants BFU2004-02124/BMC and BFU/2007-62728/BMC from the Ministerio de Educacion y Ciencia and 42.310-15941/04 from University of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, 2003, J THROMB HAEMOST, V1, P798, DOI 10.1046/j.1538-7836.2003.00138.x; Alexander S, 1995, MEASUREMENTS CYCLE A, P63; Alzola E, 1998, J BIOL CHEM, V273, P30208, DOI 10.1074/jbc.273.46.30208; AZULA FJ, 1993, AM J PHYSIOL, V265, pC1681, DOI 10.1152/ajpcell.1993.265.6.C1681; Azula FJ, 1996, MOL PHARMACOL, V50, P367; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Bursnstock G, 2012, BIOESSAYS, V34, P218; Calzada C, 1997, BIOCHEM J, V325, P495, DOI 10.1042/bj3250495; Cauwenberghs S, 2006, TRANSFUSION, V46, P1018, DOI 10.1111/j.1537-2995.2006.00837.x; CHAMBERS DA, 1967, ARCH BIOCHEM BIOPHYS, V119, P173, DOI 10.1016/0003-9861(67)90444-4; Corriden R, 2007, AM J PHYSIOL-CELL PH, V293, pC1420, DOI 10.1152/ajpcell.00271.2007; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; DRAGAN YP, 1990, BIOCHEM PHARMACOL, V39, P27, DOI 10.1016/0006-2952(90)90644-Z; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Erhardt JA, 2006, J THROMB HAEMOST, V4, P882, DOI 10.1111/j.1538-7836.2006.01849.x; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Fung CYE, 2007, J THROMB HAEMOST, V5, P910, DOI 10.1111/j.1538-7836.2007.02525.x; Gachet C, 2005, PHARMACOL THERAPEUT, V108, P180, DOI 10.1016/j.pharmthera.2005.03.009; Garcia AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026035; Gonzalez-Nunez D, 2001, HYPERTENSION, V37, P334, DOI 10.1161/01.HYP.37.2.334; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; GRANDT R, 1986, BIOCHEM J, V237, P669, DOI 10.1042/bj2370669; Gratacap MP, 2011, ADV ENZYME REGUL, V51, P106, DOI 10.1016/j.advenzreg.2010.09.011; Grenegard M, 2008, J BIOL CHEM, V283, P18493, DOI 10.1074/jbc.M800358200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Hechler B, 2005, J PHARMACOL EXP THER, V314, P232, DOI 10.1124/jpet.105.084673; Hechler B, 2011, PURINERG SIGNAL, V7, P293, DOI 10.1007/s11302-011-9247-6; HOURANI SMO, 1991, PHARMACOL REV, V43, P243; Ishii-Watabe A, 2000, BIOCHEM PHARMACOL, V59, P1345, DOI 10.1016/S0006-2952(00)00279-3; Jackson SP, 2004, BIOCHEM SOC T, V32, P387, DOI 10.1042/BST0320387; Johnson EN, 1998, P NATL ACAD SCI USA, V95, P3100, DOI 10.1073/pnas.95.6.3100; Kaur G, 2010, BLOOD, V115, P3128, DOI 10.1182/blood-2009-04-214601; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; KRISHNAMURTHI S, 1988, BIOCHEM J, V250, P209, DOI 10.1042/bj2500209; Lan Z, 2005, AM J CLIN PATHOL, V123, P172, DOI 10.1309/Y9EC63RW3XG1V313; Lechtenberg BC, 2012, BIOL CHEM, V393, P889, DOI 10.1515/hsz-2012-0178; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Mahaut-Smith MP, 2004, PLATELETS, V15, P131, DOI 10.1080/09537100410001682788; Marcondes S, 2006, P NATL ACAD SCI USA, V103, P3434, DOI 10.1073/pnas.0509397103; MAURICE DH, 1990, MOL PHARMACOL, V37, P671; MCMILLIAN MK, 1993, BRIT J PHARMACOL, V108, P453, DOI 10.1111/j.1476-5381.1993.tb12825.x; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Metioui M, 1996, J CELL PHYSIOL, V168, P462, DOI 10.1002/(SICI)1097-4652(199608)168:2<462::AID-JCP25>3.0.CO;2-3; Morita I, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17A, P219; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Nigam S, 2005, BIOCHEM BIOPH RES CO, V338, P161, DOI 10.1016/j.bbrc.2005.09.065; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Nylander S, 2003, BLOOD COAGUL FIBRIN, V14, P159, DOI 10.1097/00001721-200302000-00007; Oury C, 2001, THROMB HAEMOSTASIS, V86, P1264; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Rolf MG, 2001, THROMB HAEMOSTASIS, V85, P303, DOI 10.1055/s-0037-1615684; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Schoenwaelder SM, 2007, J BIOL CHEM, V282, P28648, DOI 10.1074/jbc.M704358200; SEILER S, 1991, THROMB RES, V62, P31, DOI 10.1016/0049-3848(91)90666-K; Shankar H, 2006, CURR DRUG TARGETS, V7, P1253, DOI 10.2174/138945006778559166; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; SOSLAU G, 1995, BBA-MOL CELL RES, V1268, P73, DOI 10.1016/0167-4889(95)00051-S; Soslau G, 1997, BBA-MOL CELL RES, V1355, P131, DOI 10.1016/S0167-4889(96)00123-1; SOSLAU G, 1993, BIOCHIM BIOPHYS ACTA, V1177, P199, DOI 10.1016/0167-4889(93)90041-M; Stafford NP, 2003, ARTERIOSCL THROM VAS, V23, P1928, DOI 10.1161/01.ATV.0000089330.88461.D6; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; Vaidyula VR, 2003, BRIT J HAEMATOL, V121, P491, DOI 10.1046/j.1365-2141.2003.04296.x; van Giezen JJJ, 2012, J CARDIOVASC PHARM T, V17, P164, DOI 10.1177/1074248411410883; ZOCCARATO F, 1991, BIOCHIM BIOPHYS ACTA, V1092, P72, DOI 10.1016/0167-4889(91)90178-Z	67	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67117	10.1371/journal.pone.0067117	http://dx.doi.org/10.1371/journal.pone.0067117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826207	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400105
J	Diezko, R; Suske, G				Diezko, Rolf; Suske, Guntram			Ligand Binding Reduces SUMOylation of the Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Activation Function 1 (AF1) Domain	PLOS ONE			English	Article							15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); SUMO MODIFICATION; GENE-EXPRESSION; RXR-ALPHA; PHOSPHORYLATION; TRANSREPRESSION; TRANSCRIPTION; REGULATOR; THIAZOLIDINEDIONES; ADIPOGENESIS	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-activated nuclear receptor regulating adipogenesis, glucose homeostasis and inflammatory responses. The activity of PPAR gamma is controlled by post-translational modifications including SUMOylation and phosphorylation that affects its biological and molecular functions. Several important aspects of PPAR gamma SUMOylation including SUMO isoform-specificity and the impact of ligand binding on SUMOylation remain unresolved or contradictory. Here, we present a comprehensive study of PPAR gamma 1 SUMOylation. We show that PPAR gamma 1 can be modified by SUMO1 and SUMO2. Mutational analyses revealed that SUMOylation occurs exclusively within the N-terminal activation function 1 (AF1) domain predominantly at lysines 33 and 77. Ligand binding to the C-terminal ligand-binding domain (LBD) of PPAR gamma 1 reduces SUMOylation of lysine 33 but not of lysine 77. SUMOylation of lysine 33 and lysine 77 represses basal and ligand-induced activation by PPAR gamma 1. We further show that lysine 365 within the LBD is not a target for SUMOylation as suggested in a previous report, but it is essential for full LBD activity. Our results suggest that PPAR gamma ligands negatively affect SUMOylation by interdomain communication between the C-terminal LBD and the N-terminal AF1 domain. The ability of the LBD to regulate the AF1 domain may have important implications for the evaluation and mechanism of action of therapeutic ligands that bind PPAR gamma.	[Diezko, Rolf; Suske, Guntram] Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany	Philipps University Marburg	Suske, G (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany.	Suske@imt.uni-marburg.de		Suske, Guntram/0000-0002-4807-0513	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) "Tumor and Inflammation''	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) "Tumor and Inflammation''	This work was supported by a grant of the priority research program Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) "Tumor and Inflammation'' to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbalagan Muralidharan, 2012, Nucl Recept Signal, V10, pe001, DOI 10.1621/nrs.10001; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014; Floyd ZE, 2004, OBES RES, V12, P921, DOI 10.1038/oby.2004.112; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jain MK, 2008, NAT MED, V14, P603, DOI 10.1038/nm0608-603; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Lim S, 2009, ATHEROSCLEROSIS, V206, P411, DOI 10.1016/j.atherosclerosis.2009.02.031; Liu B, 2009, MOL CELL, V35, P731, DOI 10.1016/j.molcel.2009.09.002; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Mohideen F, 2009, NAT STRUCT MOL BIOL, V16, P945, DOI 10.1038/nsmb.1648; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Shimizu M, 2006, MOL CELL BIOCHEM, V286, P33, DOI 10.1007/s11010-005-9052-z; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Treuter E, 2007, MOL CELL, V25, P178, DOI 10.1016/j.molcel.2007.01.009; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Wadosky KM, 2012, AM J PHYSIOL-HEART C, V302, pH515, DOI 10.1152/ajpheart.00703.2011; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x	41	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66947	10.1371/journal.pone.0066947	http://dx.doi.org/10.1371/journal.pone.0066947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826177	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400086
J	Goldring, ST; Griffiths, CJ; Martineau, AR; Robinson, S; Yu, C; Poulton, S; Kirkby, JC; Stocks, J; Hooper, R; Shaheen, SO; Warner, JO; Boyle, RJ				Goldring, Stephen T.; Griffiths, Chris J.; Martineau, Adrian R.; Robinson, Stephen; Yu, Christina; Poulton, Sheree; Kirkby, Jane C.; Stocks, Janet; Hooper, Richard; Shaheen, Seif O.; Warner, John O.; Boyle, Robert J.			Prenatal Vitamin D Supplementation and Child Respiratory Health: A Randomised Controlled Trial	PLOS ONE			English	Article							25-HYDROXYVITAMIN D LEVELS; D DEFICIENCY; PREGNANCY; SENSITIZATION; ASTHMA; WHEEZE; RISK; FOOD	Background: Observational studies suggest high prenatal vitamin D intake may be associated with reduced childhood wheezing. We examined the effect of prenatal vitamin D on childhood wheezing in an interventional study. Methods: We randomised 180 pregnant women at 27 weeks gestation to either no vitamin D, 800 IU ergocalciferol daily until delivery or single oral bolus of 200,000 IU cholecalciferol, in an ethnically stratified, randomised controlled trial. Supplementation improved but did not optimise vitamin D status. Researchers blind to allocation assessed offspring at 3 years. Primary outcome was any history of wheeze assessed by validated questionnaire. Secondary outcomes included atopy, respiratory infection, impulse oscillometry and exhaled nitric oxide. Primary analyses used logistic and linear regression. Results: We evaluated 158 of 180 (88%) offspring at age 3 years for the primary outcome. Atopy was assessed by skin test for 95 children (53%), serum IgE for 86 (48%), exhaled nitric oxide for 62 (34%) and impulse oscillometry of acceptable quality for 51 (28%). We found no difference between supplemented and control groups in risk of wheeze [no vitamin D: 14/50 (28%); any vitamin D: 26/108 (24%) (risk ratio 0.86; 95% confidence interval 0.49, 1.50; P = 0.69)]. There was no significant difference in atopy, eczema risk, lung function or exhaled nitric oxide between supplemented groups and controls. Conclusion: Prenatal vitamin D supplementation in late pregnancy that had a modest effect on cord blood vitamin D level, was not associated with decreased wheezing in offspring at age three years.	[Goldring, Stephen T.; Poulton, Sheree; Warner, John O.; Boyle, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Griffiths, Chris J.; Martineau, Adrian R.; Hooper, Richard; Shaheen, Seif O.] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, Asthma UK Ctr Appl Res, Barts & London Sch Med & Dent, London, England; [Robinson, Stephen; Yu, Christina] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Kirkby, Jane C.; Stocks, Janet] UCL, Inst Child Hlth, Portex Resp Unit, London, England	Imperial College London; University of London; Queen Mary University London; Imperial College London; University of London; University College London	Boyle, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England.	r.boyle@nhs.net	Warner, John/AAF-9587-2020; Martineau, Adrian R/A-3083-2010	Hooper, Richard/0000-0002-1063-0917; Boyle, Robert/0000-0002-4913-7580	Asthma UK [09/36]; Medical Research Council [G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10171] Funding Source: researchfish; Asthma UK [09/036] Funding Source: researchfish	Asthma UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	Supported by Grant number 09/36 from Asthma UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; [Anonymous], 2008, ANT CAR ROUT CAR HLT; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Cremers E, 2011, THORAX, V66, P474, DOI 10.1136/thx.2010.151985; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Erkkola M, 2009, CLIN EXP ALLERGY, V39, P875, DOI 10.1111/j.1365-2222.2009.03234.x; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Groenman F, 2005, BIOL NEONATE, V87, P164, DOI 10.1159/000082595; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Hypponen E, 2010, BRIT J NUTR, V104, P309, DOI 10.1017/S0007114510002436; Johnson DD, 2011, AM J PERINAT, V28, P7, DOI 10.1055/s-0030-1262505; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Liu X, 2011, ALLERGY, V66, P1442, DOI 10.1111/j.1398-9995.2011.02681.x; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Merewood A, 2010, PEDIATRICS, V125, P640, DOI 10.1542/peds.2009-2158; Millen AE, 2008, AM J CLIN NUTR, V87, p1102S, DOI 10.1093/ajcn/87.4.1102S; Miyake Y, 2010, EUR RESPIR J, V35, P1228, DOI 10.1183/09031936.00100609; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Novakovic B, 2012, AM J CLIN NUTR, V96, P188, DOI 10.3945/ajcn.112.035683; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Ross AC, 2011, DIETARY REFERENCE IN; Rothers J, 2011, J ALLERGY CLIN IMMUN, V128, P1093, DOI 10.1016/j.jaci.2011.07.015; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC; Weiland S, ISAAC PHASE 2 MODULE; Yu CKH, 2009, CLIN ENDOCRINOL, V70, P685, DOI 10.1111/j.1365-2265.2008.03403.x; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	32	109	111	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66627	10.1371/journal.pone.0066627	http://dx.doi.org/10.1371/journal.pone.0066627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826104	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400024
J	Jin, Z; Zhang, WH; Chai, WR; Zheng, YQ; Zhi, JM				Jin, Zhu; Zhang, Wenhui; Chai, Weiran; Zheng, Yanqian; Zhi, Jianming			Antibodies against AT1 Receptors Are Associated with Vascular Endothelial and Smooth Muscle Function Impairment: Protective Effects of Hydroxysafflor Yellow A	PLOS ONE			English	Article							ANGIOTENSIN-II; AGONISTIC AUTOANTIBODIES; CELLS; PREECLAMPSIA; EXPRESSION	Ample evidence has shown that autoantibodies against AT1 receptors (AT1-AA) are closely associated with human cardiovascular disease. The aim of this study was to investigate mechanisms underlying AT1-AA-induced vascular structural and functional impairments in the formation of hypertension, and explore ways for preventive treatment. We used synthetic peptide corresponding to the sequence of the second extracellular loop of the AT1 receptor (165-191) to immunize rats and establish an active immunization model. Part of the model received preventive therapy by losartan (20 mg/kg/day) and hyroxysafflor yellow A (HSYA) (10 mg/kg/day). The result show that systolic blood pressure (SBP) and heart rate (HR) of immunized rats was significantly higher, and closely correlated with the plasma AT1-Ab titer. The systolic response of thoracic aortic was increased, but diastolic effects were attenuated markedly. Histological observation showed that the thoracic aortic endothelium of the immunized rats became thinner or ruptured, inflammatory cell infiltration, medial smooth muscle cell proliferation and migration, the vascular wall became thicker. There was no significant difference in serum antibody titer between losartan and HSYA groups and the immunized group. The vascular structure and function were reversed, and plasma biochemical parameters were also improved significantly in the two treatment groups. These results suggest that AT1-Ab could induce injury to vascular endothelial cells, and proliferation of smooth muscle cells. These changes were involved in the formation of hypertension. Treatment with AT1 receptor antagonists and anti oxidative therapy could block the pathogenic effect of AT1-Ab on vascular endothelial and smooth muscle cells.	[Jin, Zhu; Zhang, Wenhui; Zheng, Yanqian; Zhi, Jianming] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200030, Peoples R China; [Chai, Weiran] Shanghai Jiao Tong Univ, Sch Med, Dept Assisted Reprod Technol, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhi, JM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200030, Peoples R China.	zhjm169lihl@gmail.com			National Natural Science Foundation of China [31101070]; Natural Science Foundation of Shanghai Jiao Tong University, School of Medicine [05xj21006, 12XJ10041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Jiao Tong University, School of Medicine	This work was supported by grants from the National Natural Science Foundation of China (No. 31101070). This work was also supported by the grant from Natural Science Foundation of Shanghai Jiao Tong University, School of Medicine (05xj21006 and 12XJ10041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlstrom M, 2010, HYPERTENSION, V56, P907, DOI 10.1161/HYPERTENSIONAHA.110.159301; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1; Dragun D, 2009, THROMB HAEMOSTASIS, V101, P643, DOI 10.1160/TH08-10-0710; He HB, 2008, PHYTOTHER RES, V22, P1107, DOI 10.1002/ptr.2468; Hu CP, 2007, HYPERTENSION, V50, P952, DOI 10.1161/HYPERTENSIONAHA.107.096446; Jin Z, 2011, ACTA BIOCH BIOPH SIN, V43, P970, DOI 10.1093/abbs/gmr096; LaMarca B, 2012, GENDER MED, V9, P139, DOI 10.1016/j.genm.2012.03.001; LaMarca B, 2011, CURR OPIN PHARMACOL, V11, P175, DOI 10.1016/j.coph.2011.01.003; LaMarca B, 2009, HYPERTENSION, V54, P905, DOI 10.1161/HYPERTENSIONAHA.109.137935; Liu X, 2009, BIOORG MED CHEM LETT, V19, P2896, DOI 10.1016/j.bmcl.2009.03.070; Lobysheva I, 2011, ARTERIOSCL THROM VAS, V31, P2098, DOI 10.1161/ATVBAHA.111.230623; Sun R.Y, 1987, PHARM STAT, P410; Tan X, 2011, J PHYSIOL PHARMACOL, V62, P21; Tian JW, 2008, PHARMACOLOGY, V82, P121, DOI 10.1159/000141653; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; Walther T, 2007, CURR HYPERTENS REP, V9, P128, DOI 10.1007/s11906-007-0023-5; Wang XW, 2011, CARDIOVASC DRUG THER, V25, P401, DOI 10.1007/s10557-011-6331-7; Wenzel K, 2011, HYPERTENSION, V58, P77, DOI 10.1161/HYPERTENSIONAHA.111.171348; Xia Y, 2007, J IMMUNOL, V179, P3391, DOI 10.4049/jimmunol.179.6.3391; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	21	13	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67020	10.1371/journal.pone.0067020	http://dx.doi.org/10.1371/journal.pone.0067020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826187	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400094
J	Mahoney, CE; Brewer, JM; Bittman, EL				Mahoney, Carrie E.; Brewer, Judy McKinley; Bittman, Eric L.			Central Control of Circadian Phase in Arousal-Promoting Neurons	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; CLOCK GENE-EXPRESSION; SUPRACHIASMATIC-NUCLEUS; LOCUS-COERULEUS; OREXIN NEURONS; IN-VIVO; PERIPHERAL-TISSUES; LOCOMOTOR-ACTIVITY; PHOTIC REGULATION; PACEMAKER OUTPUT	Cells of the dorsomedial/lateral hypothalamus (DMH/LH) that produce hypocretin (HCRT) promote arousal in part by activation of cells of the locus coeruleus (LC) which express tyrosine hydroxylase (TH). The suprachiasmatic nucleus (SCN) drives endogenous daily rhythms, including those of sleep and wakefulness. These circadian oscillations are generated by a transcriptional-translational feedback loop in which the Period (Per) genes constitute critical components. This cell-autonomous molecular clock operates not only within the SCN but also in neurons of other brain regions. However, the phenotype of such neurons and the nature of the phase controlling signal from the pacemaker are largely unknown. We used dual fluorescent in situ hybridization to assess clock function in vasopressin, HCRT and TH cells of the SCN, DMH/LH and LC, respectively, of male Syrian hamsters. In the first experiment, we found that Per1 expression in HCRT and TH oscillated in animals held in constant darkness with a peak phase that lagged that in AVP cells of the SCN by several hours. In the second experiment, hamsters induced to split their locomotor rhythms by exposure to constant light had asymmetric Per1 expression within cells of the middle SCN at 6 h before activity onset (AO) and in HCRT cells 9 h before and at AO. We did not observe evidence of lateralization of Per1 expression in the LC. We conclude that the SCN communicates circadian phase to HCRT cells via lateralized neural projections, and suggests that Per1 expression in the LC may be regulated by signals of a global or bilateral nature.	[Mahoney, Carrie E.; Brewer, Judy McKinley; Bittman, Eric L.] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA; [Brewer, Judy McKinley; Bittman, Eric L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Bittman, EL (corresponding author), Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA.	elb@bio.umass.edu			National Institute of Mental Health [RO1-MH-070019];  [5 T32 MH020051]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070019, T32MH020051] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by National Institute of Mental Health Grant RO1-MH-070019, and CEM was supported by the institutional training grant 5 T32 MH020051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2001, MOL BRAIN RES, V87, P92, DOI 10.1016/S0169-328X(00)00295-3; Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Abrahamson EE, 2001, NEUROREPORT, V12, P435, DOI 10.1097/00001756-200102120-00048; Akiyama M, 1999, J NEUROSCI, V19, P1115; Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Beuckmann CT, 2002, J MOL MED, V80, P329, DOI 10.1007/s00109-002-0322-x; BROWN MH, 1986, BRAIN RES BULL, V16, P705, DOI 10.1016/0361-9230(86)90142-5; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Butler MP, 2012, EUR J NEUROSCI, V36, P2556, DOI 10.1111/j.1460-9568.2012.08166.x; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Carr AJF, 2003, CURR BIOL, V13, P1543, DOI 10.1016/S0960-9822(03)00619-5; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cheng HYM, 2009, HUM MOL GENET, V18, P3110, DOI 10.1093/hmg/ddp252; Ciarleglio CM, 2009, J NEUROSCI, V29, P1670, DOI 10.1523/JNEUROSCI.3801-08.2009; Cvetkovic V, 2004, J NEUROCHEM, V91, P911, DOI 10.1111/j.1471-4159.2004.02776.x; DANTZ B, 1994, ELECTROEN CLIN NEURO, V90, P24, DOI 10.1016/0013-4694(94)90110-4; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; de la Iglesia HO, 2004, MOL BRAIN RES, V127, P121, DOI 10.1016/j.molbrainres.2004.05.018; de la Iglesia HO, 2003, J NEUROSCI, V23, P7412; de Lecea L, 2005, FEBS J, V272, P5675, DOI 10.1111/j.1742-4658.2005.04981.x; Deurveilher S, 2005, NEUROSCIENCE, V130, P165, DOI 10.1016/j.neuroscience.2004.08.030; Devilbiss DM, 2012, NEUROPSYCHOPHARMACOL, V37, P2020, DOI 10.1038/npp.2012.50; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Espana RA, 2005, J COMP NEUROL, V481, P160, DOI 10.1002/cne.20369; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; EVANS J, 2011, TLS TIMES LIT S 0909, P6, DOI DOI 10.1371/J0URNAL.P0NE.0015869); Fadel J, 2002, J NEUROSCI, V22, P6742; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gompf HS, 2008, BRAIN RES, V1224, P43, DOI 10.1016/j.brainres.2008.05.060; Gonzalez JA, 2012, EUR J NEUROSCI, V35, P1426, DOI 10.1111/j.1460-9568.2012.08057.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; Guilding C, 2010, NEUROSCIENCE, V169, P1630, DOI 10.1016/j.neuroscience.2010.06.015; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Hamada T, 2011, BIOCHEM BIOPH RES CO, V409, P727, DOI 10.1016/j.bbrc.2011.05.076; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Hickok JR, 2010, NEUROENDOCRINOLOGY, V91, P110, DOI 10.1159/000243163; Horvath TL, 1999, J COMP NEUROL, V415, P145; Hughes ATL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018926; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; INOUYE SIT, 1983, BRAIN RES, V279, P53, DOI 10.1016/0006-8993(83)90162-2; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Johnston JD, 2005, EUR J NEUROSCI, V21, P2967, DOI 10.1111/j.1460-9568.2005.04148.x; Jordan SD, 2012, MOL CELL ENDOCRINOL; Kalsbeek A, 2011, ESSAYS BIOCHEM, V49, P137, DOI [10.1042/bse0490137, 10.1042/BSE0480137]; Kalsbeek A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003194; Kilduff TS, 2001, J COMP NEUROL, V435, P1, DOI 10.1002/cne.1189; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kriegsfeld LJ, 2003, EUR J NEUROSCI, V17, P212, DOI 10.1046/j.1460-9568.2003.02431.x; Lee S, 2012, J COMP NEUROL, V520, P3617, DOI 10.1002/cne.23116; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; Li M, 2011, NEUROL SCI, V32, P625, DOI 10.1007/s10072-011-0597-1; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Mahoney CE, 2010, AM J PHYSIOL-REG I, V299, pR751, DOI 10.1152/ajpregu.00746.2009; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marston OJ, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-19; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; MEAD S, 1992, J NEUROSCI, V12, P2516; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Meyer-Bernstein EL, 1999, ENDOCRINOLOGY, V140, P207, DOI 10.1210/en.140.1.207; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Peyron C, 1998, J NEUROSCI, V18, P9996; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramanathan C, 2008, NEUROSCI LETT, V441, P86, DOI 10.1016/j.neulet.2008.06.019; REA MA, 1993, J BIOL RHYTHM, V8, pS59; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Salgado-Delgado R, 2010, J BIOL RHYTHM, V25, P421, DOI 10.1177/0748730410383403; Sellix MT, 2006, AM J PHYSIOL-REG I, V290, pR1309, DOI 10.1152/ajpregu.00555.2005; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHERMAN TG, 1988, J NEUROSCI, V8, P3785; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Tong YH, 2004, J BIOL RHYTHM, V19, P113, DOI 10.1177/0748730403262871; Torterolo Pablo, 2011, Front Neurol, V2, P14, DOI 10.3389/fneur.2011.00014; Torterolo P, 2009, BRAIN RES, V1268, P76, DOI 10.1016/j.brainres.2009.02.055; Tournier BB, 2003, NEUROSCIENCE, V118, P317, DOI 10.1016/S0306-4522(03)00008-3; Tsunematsu T, 2008, J NEUROSCI, V28, P228, DOI 10.1523/JNEUROSCI.3490-07.2008; van den Pol AN, 2002, J PHYSIOL-LONDON, V541, P169, DOI 10.1113/jphysiol.2002.017426; Watakabe A, 2010, METHODS, V52, P367, DOI 10.1016/j.ymeth.2010.07.003; Watanabe K, 2000, BRAIN RES, V877, P361, DOI 10.1016/S0006-8993(00)02724-4; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wendt MK, 2011, JOVE-J VIS EXP, DOI 10.3791/3245; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Yamamoto S, 2001, J COMP NEUROL, V430, P518; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yan L, 2005, J NEUROSCI, V25, P9017, DOI 10.1523/JNEUROSCI.2538-05.2005; Yan L, 2008, EUR J NEUROSCI, V28, P2108, DOI 10.1111/j.1460-9568.2008.06493.x; Yan LL, 2002, EUR J NEUROSCI, V15, P1153, DOI 10.1046/j.1460-9568.2002.01955.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Zeitzer JM, 2003, J NEUROSCI, V23, P3555; Zhang CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007151; Zhang SW, 2004, SLEEP, V27, P619, DOI 10.1093/sleep/27.4.619	110	13	14	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67173	10.1371/journal.pone.0067173	http://dx.doi.org/10.1371/journal.pone.0067173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826226	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400115
J	Shi, CZ; Liang, Y; Yang, J; Xia, Y; Chen, HQ; Han, HZ; Yang, YZ; Wu, W; Gao, RY; Qin, HL				Shi, Chenzhang; Liang, Yong; Yang, Jun; Xia, Yang; Chen, Hongqi; Han, Huazhong; Yang, Yongzhi; Wu, Wen; Gao, Renyuan; Qin, Huanlong			MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue Injury	PLOS ONE			English	Article							ULCERATIVE-COLITIS; BOWEL-DISEASE; INCREASED EXPRESSION; LIVER-REGENERATION; BARRIER FUNCTION; GENE-EXPRESSION; CDC42; MICE; DIFFERENTIATION; EFFECTOR	Background: MicroRNA-21 (miR-21) is overexpressed in most inflammatory diseases, but its physiological role in gut inflammation and tissue injury is poorly understood. The goal of this work is to understand the role of miR-21 in colitis and damage progression of intestine in a genetically modified murine model. Methods: Experimental colitis was induced in miR-21 KO and wild-type (WT) mice by 3.5% dextran sulphate sodium (DSS) administration for 7 days. Disease activity index(DAI), blood parameters, intestinal permeability, histopathologic injury, cytokine and chemokine production, and epithelial cells apoptosis were examined in colons of miR-21 KO and WT mice. Results: miR-21 was overexpressed in intestine of inflammatory bowel diseases (IBD) and acute intestinal obstruction (AIO) patients when compared with normal intestinal tissues. Likewise, miR-21 was up-regulated in colon of IL-10 KO mice when compared with control mice. WT mice rapidly lost weight and were moribund 5 days after treatment with 3.5% DSS, while miR-21 KO mice survived for at least 6 days. Elevated leukocytes and more severe histopathology were observed in WT mice when compared with miR-21 KO mice. Elevated levels of TNF-alpha and macrophage inflammatory protein-2(MIP-2) in colon culture supernatants from WT mice exhibited significant higher than miR-21 KO mice. Furthermore, CD3 and CD68 positive cells, intestinal permeability and apoptosis of epithelial cells were significantly increased in WT mice when compared with miR-21 KO mice. Finally, we found that miR-21 regulated the intestinal barrier function through modulating the expression of RhoB and CDC42. Conclusion: Our results suggest that miR-21 is overexpressed in intestinal inflammation and tissue injury, while knockout of miR-21 in mice improve the survival rate in DSS-induced fatal colitis through protecting against inflammation and tissue injury. Therefore, attenuated expression of miR-21 in gut may prevent the onset or progression of inflammatory bowel disease in patients.	[Shi, Chenzhang; Liang, Yong; Yang, Jun; Xia, Yang; Chen, Hongqi; Han, Huazhong; Yang, Yongzhi; Wu, Wen; Gao, Renyuan; Qin, Huanlong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Gen Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Qin, HL (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Gen Surg, Shanghai 200030, Peoples R China.	hlqin10@163.com	huanlong, Qin/B-3844-2015		National Natural Science Foundation Key projects of China [81230057]; National Natural Science Foundation of China [81172325]; Major Basic Research Program of Shanghai [12DZ1930502]	National Natural Science Foundation Key projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Program of Shanghai	This work was supported by grants from National Natural Science Foundation Key projects of China (No. 81230057), National Natural Science Foundation of China (No. 81172325), and the Major Basic Research Program of Shanghai (No 12DZ1930502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Danese S, 2007, GUT, V56, P855, DOI 10.1136/gut.2006.114314; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Flamant M, 2011, GUT, V60, P473, DOI 10.1136/gut.2010.229237; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han X, 2009, GUT, V58, P49, DOI 10.1136/gut.2007.145094; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Krause-Gruszczynska M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-32; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Liu H, 2013, J BIOL CHEM, V288, P9261, DOI 10.1074/jbc.M112.433730; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mesko B, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-15; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; Sakamori R, 2012, J CLIN INVEST, V122, P1052, DOI 10.1172/JCI60282; Sayed D, 2010, J BIOL CHEM, V285, P20281, DOI 10.1074/jbc.M110.109207; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Spencer DM, 2002, GASTROENTEROLOGY, V122, P94, DOI 10.1053/gast.2002.30308; Takagi T, 2010, J GASTROEN HEPATOL, V25, pS129, DOI 10.1111/j.1440-1746.2009.06216.x; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vetrano S, 2008, GASTROENTEROLOGY, V135, P173, DOI 10.1053/j.gastro.2008.04.002; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004; Yang YZ, 2013, BIOCHEM BIOPH RES CO, V434, P746, DOI 10.1016/j.bbrc.2013.03.122; Zhang XM, 2012, CANCER RES, V72, P4707, DOI 10.1158/0008-5472.CAN-12-0639; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	43	111	115	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66814	10.1371/journal.pone.0066814	http://dx.doi.org/10.1371/journal.pone.0066814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826144	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400058
J	Zhu, LX; Yan, ZQ; Zhang, ZJ; Zhou, QM; Zhou, JC; Wakeland, EK; Fang, XD; Xuan, ZY; Shen, DX; Li, QZ				Zhu, Lingxiang; Yan, Zhongqiang; Zhang, Zhaojun; Zhou, Qiming; Zhou, Jinchun; Wakeland, Edward K.; Fang, Xiangdong; Xuan, Zhenyu; Shen, Dingxia; Li, Quan-Zhen			Complete Genome Analysis of Three Acinetobacter baumannii Clinical Isolates in China for Insight into the Diversification of Drug Resistance Elements	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; IMIPENEM-RESISTANCE; CARBAPENEM RESISTANCE; IV SECRETION; RNA GENES; MDR-TJ; SEQUENCE; STRAIN; EPIDEMIOLOGY; EXPRESSION	Background: The emergence and rapid spreading of multidrug-resistant Acinetobacter baumannii strains has become a major health threat worldwide. To better understand the genetic recombination related with the acquisition of drug-resistant elements during bacterial infection, we performed complete genome analysis on three newly isolated multidrug-resistant A. baumannii strains from Beijing using next-generation sequencing technology. Methodologies/Principal Findings: Whole genome comparison revealed that all 3 strains share some common drug resistant elements including carbapenem-resistant bla(OXA-23) and tetracycline (tet) resistance islands, but the genome structures are diversified among strains. Various genomic islands intersperse on the genome with transposons and insertions, reflecting the recombination flexibility during the acquisition of the resistant elements. The blood-isolated BJAB07104 and ascites-isolated BJAB0868 exhibit high similarity on their genome structure with most of the global clone II strains, suggesting these two strains belong to the dominant outbreak strains prevalent worldwide. A large resistance island (RI) of about 121-kb, carrying a cluster of resistance-related genes, was inserted into the ATPase gene on BJAB07104 and BJAB0868 genomes. A 78-kb insertion element carrying tra-locus and bla(OXA-23) island, can be either inserted into one of the tniB gene in the 121-kb RI on the chromosome, or transformed to conjugative plasmid in the two BJAB strains. The third strains of this study, BJAB0715, which was isolated from spinal fluid, exhibit much more divergence compared with above two strains. It harbors multiple drug-resistance elements including a truncated AbaR-22-like RI on its genome. One of the unique features of this strain is that it carries both bla(OXA-23) and bla(OXA-58) genes on its genome. Besides, an Acinetobacter lwoffii adeABC efflux element was found inserted into the ATPase position in BJAB0715. Conclusions: Our comparative analysis on currently completed Acinetobacter baumannii genomes revealed extensive and dynamic genome organizations, which may facilitate the bacteria to acquire drug-resistance elements into their genomes.	[Zhu, Lingxiang; Zhou, Jinchun; Wakeland, Edward K.; Li, Quan-Zhen] Univ Texas SW Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX 75390 USA; [Zhu, Lingxiang; Zhang, Zhaojun; Fang, Xiangdong] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Yan, Zhongqiang; Shen, Dingxia] Peoples Liberat Army, Gen Hosp, Dept Clin Microbiol, Beijing, Peoples R China; [Zhou, Qiming] Chinese Acad Sci, State Key Lab Mycol, Beijing, Peoples R China; [Xuan, Zhenyu] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA; [Xuan, Zhenyu] Univ Texas Dallas, Ctr Syst Biol, Richardson, TX 75083 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Xuan, ZY (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA.	zxx091000@utdallas.edu; shengdx301@yahoo.com; quan.li@utsouthwestern.edu		Xuan, Zhenyu/0000-0001-9344-8493; zhou, qi ming/0000-0002-2892-6329	Capital Medical Development Research Fund, Beijing, China [2009-1023]; UT Dallas start-up fund for ZYX; National Institutes of Health [P50 CORT AR055503, R03 AR055778]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055503, R03AR055778] Funding Source: NIH RePORTER	Capital Medical Development Research Fund, Beijing, China; UT Dallas start-up fund for ZYX; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Capital Medical Development Research Fund, Beijing, China (No. 2009-1023), UT Dallas start-up fund for ZYX and National Institutes of Health grants P50 CORT AR055503, R03 AR055778. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2010, ANTIMICROB AGENTS CH, V54, P3569, DOI 10.1128/AAC.00057-10; Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bogaerts P, 2006, J CLIN MICROBIOL, V44, P4189, DOI 10.1128/JCM.00796-06; Bou G, 2000, ANTIMICROB AGENTS CH, V44, P1556, DOI 10.1128/AAC.44.6.1556-1561.2000; Calhoun JH, 2008, CLIN ORTHOP RELAT R, V466, P1356, DOI 10.1007/s11999-008-0212-9; Carvalho KR, 2009, INT J ANTIMICROB AG, V34, P25, DOI 10.1016/j.ijantimicag.2008.12.009; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen Chang-Hua, 2006, Journal of Microbiology Immunology and Infection, V39, P372; Chen CC, 2011, J BACTERIOL, V193, P2361, DOI 10.1128/JB.00244-11; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Domingues S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002837; Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P117, DOI 10.1111/j.1469-0691.2006.01596.x; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Gao F, 2011, J BACTERIOL, V193, P2365, DOI 10.1128/JB.00226-11; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hamidian M, 2011, J ANTIMICROB CHEMOTH, V66, P2484, DOI 10.1093/jac/dkr356; Harrison E, 2012, TRENDS MICROBIOL, V20, P262, DOI 10.1016/j.tim.2012.04.003; Heritier C, 2006, CLIN MICROBIOL INFEC, V12, P123, DOI 10.1111/j.1469-0691.2005.01320.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hou PF, 2012, CHEMOTHERAPY, V58, P152, DOI 10.1159/000335599; Huang H, 2012, J ANTIMICROB CHEMOTH, V67, P2825, DOI 10.1093/jac/dks327; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; Kwon KT, 2007, J ANTIMICROB CHEMOTH, V59, P525, DOI 10.1093/jac/dkl499; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012; Lin MF, 2011, J MICROBIOL IMMUNOL, V44, P39, DOI 10.1016/j.jmii.2011.01.008; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Lopes BS, 2012, J MED MICROBIOL, V61, P1103, DOI 10.1099/jmm.0.044156-0; Lopez-Otsoa F, 2002, J CLIN MICROBIOL, V40, P4741, DOI 10.1128/JCM.40.12.4741-4743.2002; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; Martinez JL, 2002, CLIN MICROBIOL REV, V15, P647, DOI 10.1128/CMR.15.4.647-679.2002; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; Naas T, 2005, J CLIN MICROBIOL, V43, P4826, DOI 10.1128/JCM.43.9.4826-4829.2005; Park JY, 2011, J BACTERIOL, V193, P6393, DOI 10.1128/JB.06109-11; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Russo TA, 2009, J INFECT DIS, V199, P513, DOI 10.1086/596317; Sahl JW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-291; Sambrook J., 2001, MOL CLONING LAB MANU; SCAIFE W, 1995, J ANTIMICROB CHEMOTH, V36, P585, DOI 10.1093/jac/36.3.585; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Soares SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030848; Song J, 2005, BIOINFORMATICS, V21, P2083, DOI 10.1093/bioinformatics/bti176; Standards NCfCL, 2003, APPROVED STANDARD M2; Stoeva T, 2008, CLIN MICROBIOL INFEC, V14, P723, DOI 10.1111/j.1469-0691.2008.02018.x; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; VILA J, 1995, ANTIMICROB AGENTS CH, V39, P1201, DOI 10.1128/AAC.39.5.1201; Vila J, 1997, J ANTIMICROB CHEMOTH, V39, P757, DOI 10.1093/jac/39.6.757; Yan ZQ, 2010, INT J ANTIMICROB AG, V35, P269, DOI 10.1016/j.ijantimicag.2009.10.016; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008; Zhou H, 2007, J MED MICROBIOL, V56, P1076, DOI 10.1099/jmm.0.47206-0; Zhou H, 2011, ANTIMICROB AGENTS CH, V55, P4506, DOI 10.1128/AAC.01134-10	75	53	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66584	10.1371/journal.pone.0066584	http://dx.doi.org/10.1371/journal.pone.0066584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826102	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400023
J	Ekouevi, DK; Balestre, E; Coffie, PA; Minta, D; Messou, E; Sawadogo, A; Minga, A; Sow, PS; Bissagnene, E; Eholie, SP; Gottlieb, GS; Dabis, F				Ekouevi, Didier K.; Balestre, Eric; Coffie, Patrick A.; Minta, Daouda; Messou, Eugene; Sawadogo, Adrien; Minga, Albert; Sow, Papa Salif; Bissagnene, Emmanuel; Eholie, Serge P.; Gottlieb, Geoffrey S.; Dabis, Francois		IeDEA West Africa Collaboration	Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; IMMUNOLOGICAL RESPONSE; DRUG-RESISTANCE; INTERNATIONAL COLLABORATION; HIV-2-INFECTED INDIVIDUALS; TYPE-1 HIV-1; INFECTION; RALTEGRAVIR; DIFFERENTIATION; INHIBITORS	Background: HIV-2 is endemic in West Africa. There is a lack of evidence-based guidelines on the diagnosis, management and antiretroviral therapy (ART) for HIV-2 or HIV-1/HIV-2 dual infections. Because of these issues, we designed a West African collaborative cohort for HIV-2 infection within the framework of the International epidemiological Databases to Evaluate AIDS (IeDEA). Methods: We collected data on all HIV-2 and HIV-1/HIV-2 dually seropositive patients (both ARV-naive and starting ART) and followed-up in clinical centres in the IeDEA-WA network including a total of 13 clinics in five countries: Benin, Burkina-Faso Cote d'Ivoire, Mali, and Senegal, in the West Africa region. Results: Data was merged for 1,754 patients (56% female), including 1,021 HIV-2 infected patients (551 on ART) and 733 dually seropositive for both HIV-1 and HIV 2 (463 on ART). At ART initiation, the median age of HIV-2 patients was 45.3 years, IQR: (38.3-51.7) and 42.4 years, IQR (37.0-47.3) for dually seropositive patients (p = 0.048). Overall, 16.7% of HIV-2 patients on ART had an advanced clinical stage (WHO IV or CDC-C). The median CD4 count at the ART initiation is 166 cells/mm(3), IQR (83-247) among HIV-2 infected patients and 146 cells/mm(3), IQR (55-249) among dually seropositive patients. Overall, in ART-treated patients, the CD4 count increased 126 cells/mm(3) after 24 months on ART for HIV-2 patients and 169 cells/mm(3) for dually seropositive patients. Of 551 HIV-2 patients on ART, 5.8% died and 10.2% were lost to follow-up during the median time on ART of 2.4 years, IQR (0.7-4.3). Conclusions: This large multi-country study of HIV-2 and HIV-1/HIV-2 dual infection in West Africa suggests that routine clinical care is less than optimal and that management and treatment of HIV-2 could be further informed by ongoing studies and randomized clinical trials in this population.	[Ekouevi, Didier K.; Balestre, Eric; Dabis, Francois] Univ Bordeaux Segalen, ISPED, Ctr INSERM, U897,Epidemiol Biostat, Bordeaux, France; [Ekouevi, Didier K.; Coffie, Patrick A.; Messou, Eugene] Programme PACCI, Abidjan, Cote Ivoire; [Ekouevi, Didier K.] Univ Lome, Dept Sci Fondamentales & Sante Publ, Lome, Togo; [Coffie, Patrick A.; Messou, Eugene; Bissagnene, Emmanuel; Eholie, Serge P.] Univ Felix Houphouet Boigny, UFR Sci Med, Dept Dermatol & Infectiol, Abidjan, Cote Ivoire; [Minta, Daouda] Hop Point G, Ctr Prise Charge Personnes Vivant Avec VIH, Bamako, Mali; [Messou, Eugene] ACONDA CePReF Adultes, Abidjan, Cote Ivoire; [Sawadogo, Adrien] CHU Souro Sanou, Hop Jour, Bobo Dioulasso, Burkina Faso; [Minga, Albert] Projet PRIMO CI, Ctr Med Suivi Donneurs Sang, Abidjan, Cote Ivoire; [Sow, Papa Salif] CHU Fann, Serv Malad Infect & Trop, Dakar, Senegal; [Bissagnene, Emmanuel; Eholie, Serge P.] CHU Treichville, Serv Malad Infect & Trop, Dakar, Senegal; [Gottlieb, Geoffrey S.] Univ Washington, Dept Med, Seattle, WA USA; [Gottlieb, Geoffrey S.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ekouevi, DK (corresponding author), Univ Bordeaux Segalen, ISPED, Ctr INSERM, U897,Epidemiol Biostat, Bordeaux, France.	didier.ekouevi@gmail.com	Leroy, Valeriane/AAO-5175-2020; EKOUEVI, Didier K/E-7960-2014; Eholie, Serge/T-6008-2019; Leroy, Valeriane/F-8129-2013; Leroy, Valeriane/GQB-1102-2022; Adebamowo, Clement/C-8778-2011; Wejse, Christian/C-8468-2014; DABIS, FRANCOIS/S-9298-2019; Anglaret, Xavier/F-7333-2013; Ostergaard, Lars/AAA-3020-2020	Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Adebamowo, Clement/0000-0002-6571-2880; Wejse, Christian/0000-0002-2534-2942; DABIS, FRANCOIS/0000-0002-1614-8857; Ostergaard, Lars/0000-0003-2459-0511; Erikstrup, Christian/0000-0001-6551-6647; Eugen-Olsen, Jesper/0000-0002-4630-4275; Ostergaard, Lars/0000-0002-7619-605X; HEMA, Arsene/0000-0002-5279-643X; Fomsgaard, Anders/0000-0003-4304-0603; Anglaret, Xavier/0000-0003-3319-8423; Gottlieb, Geoffrey/0000-0002-5749-481X; Sodemann, Morten/0000-0001-8992-2500	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) [5U01AI069919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060466, U01AI069919] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The International epidemiological Database to Evaluate AIDS in West Africa (IeDEA West Africa) is supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no.5U01AI069919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADJORLOLOJOHNSON G, 1994, JAMA-J AM MED ASSOC, V272, P462, DOI 10.1001/jama.272.6.462; [Anonymous], 2010, PRISE CHARGE MED PER; Balestre E, 2012, AIDS, V26, P951, DOI 10.1097/QAD.0b013e3283528ad4; Benard A, 2011, CLIN INFECT DIS, V52, P1257, DOI 10.1093/cid/cir123; Burgard M, 2010, CLIN INFECT DIS, V51, P833, DOI 10.1086/656284; Chang M, 2012, J CLIN VIROL, V55, P128, DOI 10.1016/j.jcv.2012.06.024; CLAVEL F, 1987, NEW ENGL J MED, V316, P1180, DOI 10.1056/NEJM198705073161903; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; CLAVEL F, 1987, AIDS, V1, P135; da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d; Damond F, 1998, J CLIN MICROBIOL, V36, P809, DOI 10.1128/JCM.36.3.809-811.1998; Damond F, 2011, J CLIN MICROBIOL, V49, P3491, DOI 10.1128/JCM.02389-10; Damond F, 2008, J CLIN MICROBIOL, V46, P2088, DOI 10.1128/JCM.00126-08; Damond F, 2008, AIDS, V22, P665, DOI 10.1097/QAD.0b013e3282f51203; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; Drylewicz J, 2008, AIDS, V22, P457, DOI 10.1097/QAD.0b013e3282f4ddfc; Drylewicz J, 2010, AIDS, V24, P1043, DOI 10.1097/QAD.0b013e3283377a06; Egger M, 2011, INT J EPIDEMIOL; Garrett N, 2008, AIDS, V22, P1091, DOI 10.1097/QAD.0b013e3282f9b165; Gilbert PB, 2003, STAT MED, V22, P573, DOI 10.1002/sim.1342; Gilleece Y, 2010, HIV MED, V11, P611, DOI 10.1111/j.1468-1293.2010.00889.x; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Hawes SE, 2008, AIDS, V22, P2517, DOI 10.1097/QAD.0b013e328315cdbc; Heitzinger K, 2012, INT J STD AIDS, V23, P710, DOI 10.1258/ijsa.2012.011219; IMAI M, 1995, J CLIN MICROBIOL, V33, P1727, DOI 10.1128/JCM.33.7.1727-1729.1995; Jallow S, 2006, AIDS, V20, P1455, DOI 10.1097/01.aids.0000233582.64467.8e; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Matheron S, 2006, AIDS, V20, P459, DOI 10.1097/01.aids.0000199829.57112.2f; Matheron S, 2008, AIDS, V22, P2073, DOI 10.1097/QAD.0b013e32830edd59; O'Donovan D, 2000, AIDS, V14, P441, DOI 10.1097/00002030-200003100-00019; Parkin NT, 2004, ANTIVIR THER, V9, P3; PEETERS M, 1992, LANCET, V340, P339, DOI 10.1016/0140-6736(92)91407-Y; Peterson I, 2011, AIDS, V25, P2167, DOI 10.1097/QAD.0b013e32834c4adb; Peterson K, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/463704; Popper SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010; Poveda E, 2005, AIDS REV, V7, P139; RESAPCI IMEA, 2011, WORKSH COH STUD HIV; RESAPSI IMEA, 2009, 4 WORKSH STRAT ANT T; Roquebert B, 2008, AIDS, V22, P2045, DOI 10.1097/QAD.0b013e32830f4c7d; Rouet F, 2004, J CLIN MICROBIOL, V42, P4147, DOI 10.1128/JCM.42.9.4147-4153.2004; Smith RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045372; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Togun T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-24; Torian LV, 2010, CLIN INFECT DIS, V51, P1334, DOI 10.1086/657117; Toro Carlos, 2008, Enferm Infecc Microbiol Clin, V26 Suppl 13, P66, DOI 10.1157/13128783; van der Ende ME, 2003, AIDS, V17, pS55, DOI 10.1097/00002030-200317003-00008; van der Loeff MFS, 2003, AIDS, V17, P2389, DOI [10.1097/01.aids.0000076344.42412.05, 10.1097/00002030-200311070-00015]; van Tienen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029026; Xu L, 2009, AIDS RES HUM RETROV, V25, P843, DOI 10.1089/aid.2009.0039	51	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66135	10.1371/journal.pone.0066135	http://dx.doi.org/10.1371/journal.pone.0066135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V6C3A	23824279	gold, Green Published, Green Submitted			2022-12-27	WOS:000420153300001
J	Guo, WL; Chen, RG; Gong, ZH; Yin, YX; Li, DW				Guo, Wei-Li; Chen, Ru-Gang; Gong, Zhen-Hui; Yin, Yan-Xu; Li, Da-Wei			Suppression Subtractive Hybridization Analysis of Genes Regulated by Application of Exogenous Abscisic Acid in Pepper Plant (Capsicum annuum L.) Leaves under Chilling Stress	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; MESSENGER-RNA; HIGH-SALINITY; STOMATAL CLOSURE; DROUGHT STRESS; GUARD-CELLS; SALT STRESS; COLD; EXPRESSION; RICE	Low temperature is one of the major factors limiting pepper (Capsicum annuum L.) production during winter and early spring in non-tropical regions. Application of exogenous abscisic acid (ABA) effectively alleviates the symptoms of chilling injury, such as wilting and formation of necrotic lesions on pepper leaves; however, the underlying molecular mechanism is not understood. The aim of this study was to identify genes that are differentially up-or downregulated in ABA-pretreated hot pepper seedlings incubated at 6 degrees C for 48 h, using a suppression subtractive hybridization (SSH) method. A total of 235 high-quality ESTs were isolated, clustered and assembled into a collection of 73 unigenes including 18 contigs and 55 singletons. A total of 37 unigenes (50.68%) showed similarities to genes with known functions in the non-redundant database; the other 36 unigenes (49.32%) showed low similarities or unknown functions. Gene ontology analysis revealed that the 37 unigenes could be classified into nine functional categories. The expression profiles of 18 selected genes were analyzed using quantitative RT-PCR; the expression levels of 10 of these genes were at least two-fold higher in the ABA-pretreated seedlings under chilling stress than water-pretreated (control) plants under chilling stress. In contrast, the other eight genes were downregulated in ABA-pretreated seedlings under chilling stress, with expression levels that were one-third or less of the levels observed in control seedlings under chilling stress. These results suggest that ABA can positively and negatively regulate genes in pepper plants under chilling stress.	[Guo, Wei-Li; Chen, Ru-Gang; Gong, Zhen-Hui; Yin, Yan-Xu; Li, Da-Wei] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Guo, Wei-Li; Chen, Ru-Gang; Gong, Zhen-Hui; Li, Da-Wei] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Gong, ZH (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	zhgong@nwsuaf.edu.cn			National Natural Science Foundation of China [31201615, 31272163]; "The Twelfth Five-Year'' Plan of National Science and Technology in Rural Areas [2011BAD12B03]; Natural Science Foundation of Shaanxi Province [2011JQ3010]; Shaanxi Provincial Science and Technology Coordinating Innovative Engineering Project [2012KTCL02-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "The Twelfth Five-Year'' Plan of National Science and Technology in Rural Areas(Chinese Academy of Sciences); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Shaanxi Provincial Science and Technology Coordinating Innovative Engineering Project	This work was supported by the National Natural Science Foundation of China (# 31201615, # 31272163), "The Twelfth Five-Year'' Plan of National Science and Technology in Rural Areas (# 2011BAD12B03), the Natural Science Foundation of Shaanxi Province (# 2011JQ3010) and the Shaanxi Provincial Science and Technology Coordinating Innovative Engineering Project (# 2012KTCL02-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaki M, 2012, PLANT CELL ENVIRON, V35, P281, DOI 10.1111/j.1365-3040.2011.02310.x; Assmann SM, 1999, PLANT PHYSIOL, V119, P809, DOI 10.1104/pp.119.3.809; Baisakh N, 2008, FUNCT INTEGR GENOMIC, V8, P287, DOI 10.1007/s10142-008-0075-x; Bertin P, 1996, PLANT BREEDING, V115, P268, DOI 10.1111/j.1439-0523.1996.tb00915.x; BRAY EA, 1988, PLANT PHYSIOL, V88, P1210, DOI 10.1104/pp.88.4.1210; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; Chak RKF, 2000, PLANTA, V210, P875, DOI 10.1007/s004250050692; Clement M, 2008, GENE, V426, P15, DOI 10.1016/j.gene.2008.08.016; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Faccioli P, 2001, PLANT BREEDING, V120, P497, DOI 10.1046/j.1439-0523.2001.00652.x; Di Mauro MF, 2012, PLANT SIGNAL BEHAV, V7, P188, DOI 10.4161/psb.18843; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gao M, 2012, PLANT PHYSIOL BIOCH, V58, P253, DOI 10.1016/j.plaphy.2012.07.009; Gulyani V, 2011, TREE GENET GENOMES, V7, P725, DOI 10.1007/s11295-011-0369-3; Guo WL, 2012, GENET MOL RES, V11, P4063, DOI 10.4238/2012.September.10.5; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; Hancock JT, 2005, PLANT PHYSIOL BIOCH, V43, P828, DOI 10.1016/j.plaphy.2005.07.012; HANNAH MA, 2005, PLOS GENET; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hemming MN, 2011, PLANT SCI, V180, P447, DOI 10.1016/j.plantsci.2010.12.001; Hossain Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030425; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ignatova LK, 2011, PHOTOSYNTH RES, V110, P89, DOI 10.1007/s11120-011-9699-0; Jeong MJ, 2000, BIOCHEM BIOPH RES CO, V278, P192, DOI 10.1006/bbrc.2000.3732; Jiang WJ, 2012, HORTTECHNOLOGY, V22, P137, DOI 10.21273/HORTTECH.22.1.137; Kim TE, 2002, PHYSIOL PLANTARUM, V115, P370, DOI 10.1034/j.1399-3054.2002.1150306.x; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Korkmaz A, 2010, ENVIRON EXP BOT, V67, P495, DOI 10.1016/j.envexpbot.2009.07.009; Krause G. H., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P43; Kumar S, 2008, J AGRON CROP SCI, V194, P449, DOI 10.1111/j.1439-037X.2008.00335.x; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; LEE TM, 1993, PLANT CELL ENVIRON, V16, P481, DOI 10.1111/j.1365-3040.1993.tb00895.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu YJ, 2011, J PLANT PHYSIOL, V168, P853, DOI 10.1016/j.jplph.2010.09.020; LOIK ME, 1993, PLANT PHYSIOL, V103, P871, DOI 10.1104/pp.103.3.871; Ma XW, 2008, PLANT GROWTH REGUL, V56, P77, DOI 10.1007/s10725-008-9287-2; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Maraschin SDF, 2006, PHYSIOL PLANTARUM, V127, P535, DOI 10.1111/j.1399-3054.2006.00673.x; Mateos RM, 2009, PHYSIOL PLANTARUM, V135, P130, DOI 10.1111/j.1399-3054.2008.01179.x; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; MITTELHEUSER CJ, 1969, NATURE, V221, P281, DOI 10.1038/221281a0; Nguyen HT, 2009, PLANT PHYSIOL BIOCH, V47, P116, DOI 10.1016/j.plaphy.2008.10.010; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Paquis S, 2011, MOL BIOL REP, V38, P3327, DOI 10.1007/s11033-010-0438-y; Pawlowski TA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-48; PEREZPRAT E, 1992, PLANT PHYSIOL, V100, P1471, DOI 10.1104/pp.100.3.1471; Pressman E, 2006, PHYSIOL PLANTARUM, V126, P618, DOI 10.1111/j.1399-3054.2005.00623.x; Pushpanathan M, 2012, PROTEIN PEPTIDE LETT, V19, P1289, DOI 10.2174/092986612803521620; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Schiott M, 2005, PHYSIOL PLANTARUM, V124, P278, DOI 10.1111/j.1399-3054.2005.00512.x; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Smallwood M, 2002, PHILOS T R SOC B, V357, P831, DOI 10.1098/rstb.2002.1073; Tan X, 2009, AM J PHYSIOL-ENDOC M, V296, pE223, DOI 10.1152/ajpendo.90807.2008; Topuz A, 2007, J FOOD COMPOS ANAL, V20, P596, DOI 10.1016/j.jfca.2007.03.007; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Vij S, 2007, PLANT BIOTECHNOL J, V5, P361, DOI 10.1111/j.1467-7652.2007.00239.x; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; WIMMERS LE, 1992, P NATL ACAD SCI USA, V89, P9205, DOI 10.1073/pnas.89.19.9205; WRIGHT M, 1974, PLANTA, V120, P63, DOI 10.1007/BF00388271; Yan YS, 2011, MOL PLANT, V4, P190, DOI 10.1093/mp/ssq066; Yang L, 2006, RUSS J PLANT PHYSL+, V53, P390, DOI 10.1134/S1021443706030150; Yoshimura K, 2008, PLANT CELL PHYSIOL, V49, P226, DOI 10.1093/pcp/pcm180; Yu S, 2007, BIOTECHNOL LETT, V29, P89, DOI 10.1007/s10529-006-9199-z; Zhang XH, 2011, PLANT CELL TISS ORG, V107, P1, DOI 10.1007/s11240-011-9950-6; Zhang Y, 2008, PLANT PHYSIOL, V148, P2121, DOI 10.1104/pp.108.126912; Zhou BY, 2006, PLANT GROWTH REGUL, V48, P195, DOI 10.1007/s10725-006-0005-7; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	74	35	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66667	10.1371/journal.pone.0066667	http://dx.doi.org/10.1371/journal.pone.0066667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825555	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400145
J	Mueller, JL; Harmany, ZT; Mito, JK; Kennedy, SA; Kim, Y; Dodd, L; Geradts, J; Kirsch, DG; Willett, RM; Brown, JQ; Ramanujam, N				Mueller, Jenna L.; Harmany, Zachary T.; Mito, Jeffrey K.; Kennedy, Stephanie A.; Kim, Yongbaek; Dodd, Leslie; Geradts, Joseph; Kirsch, David G.; Willett, Rebecca M.; Brown, J. Quincy; Ramanujam, Nimmi			Quantitative Segmentation of Fluorescence Microscopy Images of Heterogeneous Tissue: Application to the Detection of Residual Disease in Tumor Margins	PLOS ONE			English	Article							CELL-NUCLEI; AUTOMATIC SEGMENTATION; BREAST-CANCER; MOUSE MODEL; REPRESENTATIONS; DIAGNOSIS; THERAPY	Purpose: To develop a robust tool for quantitative in situ pathology that allows visualization of heterogeneous tissue morphology and segmentation and quantification of image features. Materials and Methods: Tissue excised from a genetically engineered mouse model of sarcoma was imaged using a subcellular resolution microendoscope after topical application of a fluorescent anatomical contrast agent: acriflavine. An algorithm based on sparse component analysis (SCA) and the circle transform (CT) was developed for image segmentation and quantification of distinct tissue types. The accuracy of our approach was quantified through simulations of tumor and muscle images. Specifically, tumor, muscle, and tumor+muscle tissue images were simulated because these tissue types were most commonly observed in sarcoma margins. Simulations were based on tissue characteristics observed in pathology slides. The potential clinical utility of our approach was evaluated by imaging excised margins and the tumor bed in a cohort of mice after surgical resection of sarcoma. Results: Simulation experiments revealed that SCA+CT achieved the lowest errors for larger nuclear sizes and for higher contrast ratios (nuclei intensity/background intensity). For imaging of tumor margins, SCA+CT effectively isolated nuclei from tumor, muscle, adipose, and tumor+muscle tissue types. Differences in density were correctly identified with SCA+CT in a cohort of ex vivo and in vivo images, thus illustrating the diagnostic potential of our approach. Conclusion: The combination of a subcellular-resolution microendoscope, acriflavine staining, and SCA+CT can be used to accurately isolate nuclei and quantify their density in anatomical images of heterogeneous tissue.	[Mueller, Jenna L.; Kennedy, Stephanie A.; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Harmany, Zachary T.; Willett, Rebecca M.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Mito, Jeffrey K.; Kirsch, David G.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Lab Vet Clin Pathol, Seoul, South Korea; [Dodd, Leslie] Univ N Carolina, Sch Med, Dept Pathol, Chapel Hill, NC USA; [Geradts, Joseph] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Kirsch, David G.] Duke Univ, Sch Med, Dept Radiat Oncol, Durham, NC USA; [Brown, J. Quincy] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA	Duke University; Duke University; Duke University; Seoul National University (SNU); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; Tulane University	Mueller, JL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	jenna.mueller@duke.edu	Harmany, Zachary/AAN-6389-2021; Ramanujam, Nimmi/AAA-7575-2021; Brown, J. Quincy/F-6090-2012	Harmany, Zachary/0000-0002-5871-1783; Ramanujam, Nimmi/0000-0001-7319-8415; 	Department of Defense (DOD) [W81XWH-09-1-0410]; Damon Runyon-Rachleff Innovation Award; NATIONAL CANCER INSTITUTE [R21CA159936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); Damon Runyon-Rachleff Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the Department of Defense (DOD) Grant Number W81XWH-09-1-0410 and a Damon Runyon-Rachleff Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Bigio IJ, 2000, J BIOMED OPT, V5, P221, DOI 10.1117/1.429990; Brown JQ, 2010, IEEE J SEL TOP QUANT, V16, P530, DOI 10.1109/JSTQE.2009.2033257; Bunyak F, 2011, ADV EXP MED BIOL, V696, P413, DOI 10.1007/978-1-4419-7046-6_41; Candes EJ, 2004, COMMUN PUR APPL MATH, V57, P219, DOI 10.1002/cpa.10116; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Clark AL, 2004, J BIOMED OPT, V9, P1271, DOI 10.1117/1.1805558; Clark AL, 2003, CLIN CANCER RES, V9, P4714; Cohen C, 1996, HUM PATHOL, V27, P482, DOI 10.1016/S0046-8177(96)90091-X; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Drezek RA, 2003, CANCER-AM CANCER SOC, V98, P2015, DOI 10.1002/cncr.11678; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Eng J, 2006, ROC ANAL WEB BASED C; FERGUSON LR, 1991, MUTAT RES, V258, P123, DOI 10.1016/0165-1110(91)90006-H; Figueiredo MAT, 2007, IEEE J-STSP, V1, P586, DOI 10.1109/JSTSP.2007.910281; Figueiredo MAT, 2010, IEEE T IMAGE PROCESS, V19, P3133, DOI 10.1109/TIP.2010.2053941; Gareau DS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149853; Gonzalez R. C., 2007, DIGITAL IMAGING PROC; Haka AS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247154; Harmany Z, 2011, P SPIE, V8138; Harmany ZT, 2012, IEEE T IMAGE PROCESS, V21, P1084, DOI 10.1109/TIP.2011.2168410; Karen JK, 2009, BRIT J DERMATOL, V160, P1242, DOI 10.1111/j.1365-2133.2009.09141.x; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Ko B, 2009, J DIGIT IMAGING, V22, P259, DOI 10.1007/s10278-008-9129-9; Korde VR, 2009, ANAL QUANT CYTOL, V31, P83; Korzynska A, 2007, PATTERN ANAL APPL, V10, P301, DOI 10.1007/s10044-007-0069-7; Krolenko SA, 2006, CELL BIOL INT, V30, P933, DOI 10.1016/j.cellbi.2006.06.017; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Millot C, 2000, HISTOL HISTOPATHOL, V15, P1185, DOI 10.14670/HH-15.1185; Mito JK, 2012, CANCER-AM CANCER SOC, V118, P5320, DOI 10.1002/cncr.27458; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; Muldoon TJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3406386; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Nyirenda N, 2011, BREAST CANCER RES TR, V126, P345, DOI 10.1007/s10549-010-0914-z; Pisters PWT, 1996, J CLIN ONCOL, V14, P859, DOI 10.1200/JCO.1996.14.3.859; Sabolch A, 2012, AM J CLIN ONCOL-CANC, V35, P151, DOI 10.1097/COC.0b013e318209cd72; SADOSKI C, 1993, J SURG ONCOL, V52, P223, DOI 10.1002/jso.2930520405; SAHOO PK, 1988, COMPUT VISION GRAPH, V41, P233, DOI 10.1016/0734-189X(88)90022-9; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Starck JL, 2005, IEEE T IMAGE PROCESS, V14, P1570, DOI 10.1109/TIP.2005.852206; Tanbakuchi AA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3207139; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Vachier C, 2005, J MATH IMAGING VIS, V22, P251, DOI 10.1007/s10851-005-4893-3; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wienert S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00503; Wilke LG, 2009, AM J SURG, V198, P566, DOI 10.1016/j.amjsurg.2009.06.018; Wittenberg T, 2004, METHOD INFORM MED, V43, P343; Wolf L, 2011, PLOS ONE, V6; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	50	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66198	10.1371/journal.pone.0066198	http://dx.doi.org/10.1371/journal.pone.0066198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824589	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400069
J	Famooto, A; Almujtaba, M; Dareng, E; Akarolo-Anthony, S; Ogbonna, C; Offiong, R; Olaniyan, O; Wheeler, CM; Doumatey, A; Rotimi, CN; Adeyemo, A; Adebamowo, CA				Famooto, Ayo; Almujtaba, Maryam; Dareng, Eileen; Akarolo-Anthony, Sally; Ogbonna, Celestine; Offiong, Richard; Olaniyan, Olayinka; Wheeler, Cosette M.; Doumatey, Ayo; Rotimi, Charles N.; Adeyemo, Adebowale; Adebamowo, Clement A.			RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian Women	PLOS ONE			English	Article							DIAMOND-BLACKFAN-ANEMIA; CERVICAL-CANCER; ASSOCIATION; REGISTRY; TOOL	High risk HPV (hrHPV) infection is a necessary cause of cervical cancer but the host genetic determinants of infection are poorly understood. We enrolled 267 women who presented to our cervical cancer screening program in Abuja, Nigeria between April 2012 and August 2012. We collected information on demographic characteristics, risk factors of cervical cancer and obtained samples of blood and cervical exfoliated cells from all participants. We used Roche Linear Array HPV Genotyping Test(R) to characterize the prevalent HPV according to manufacturer's instruction; Sequenom Mass Array to test 21 SNPs in genes/regions previously associated with hrHPV and regression models to examine independent factors associated with HPV infection. We considered a p<0.05 as significant because this is a replication study. There were 65 women with and 202 women without hrHPV infection. Under the allelic model, we found significant association between two SNPs, rs2305809 on RPS19 and rs2342700 on TYMS, and prevalent hrHPV infection. Multivariate analysis of hrHPV risk adjusted for age, body mass index, smoking, age of menarche, age at sexual debut, lifetime total number of sexual partners and the total number of pregnancies as covariates, yielded a p-value of 0.071 and 0.010 for rs2305809 and rs2342700, respectively. Our findings in this unique population suggest that a number of genetic risk variants for hrHPV are shared with other population groups. Definitive studies with larger sample sizes and using genome wide approaches are needed to understand the genetic architecture of hrHPV risk in multiple populations.	[Famooto, Ayo; Almujtaba, Maryam; Dareng, Eileen; Akarolo-Anthony, Sally; Ogbonna, Celestine; Adebamowo, Clement A.] Inst Human Virol, Dept Res & Training, Abuja, FCT, Nigeria; [Akarolo-Anthony, Sally; Adebamowo, Clement A.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Offiong, Richard] Univ Abuja, Teaching Hosp, Gwagwalada, FCT, Nigeria; [Olaniyan, Olayinka] Natl Hosp, Abuja, FCT, Nigeria; [Wheeler, Cosette M.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Doumatey, Ayo; Rotimi, Charles N.; Adeyemo, Adebowale] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Adebamowo, Clement A.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Inst Human Virol, Baltimore, MD 21201 USA; [Adebamowo, Clement A.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Adebamowo, CA (corresponding author), Inst Human Virol, Dept Res & Training, Abuja, FCT, Nigeria.	cadebamowo@som.umaryland.edu	Adebamowo, Clement/C-8778-2011	Adebamowo, Clement/0000-0002-6571-2880; Dareng, Eileen/0000-0003-0802-419X; Adebamowo, Sally/0000-0003-4713-2433; Adeyemo, Adebowale/0000-0002-3105-3231	National Cancer Institute [D43CA153792]; NATIONAL CANCER INSTITUTE [D43CA153792] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The project described was supported by Award Number D43CA153792 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franklin Joshua D, 2011, J Biomed Inform, V44 Suppl 1, pS103, DOI 10.1016/j.jbi.2011.05.008; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Hahn Robert, 2007, MMWR Recomm Rep, V56, P1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hemminki K, 1999, INT J CANCER, V82, P775, DOI 10.1002/(SICI)1097-0215(19990909)82:6<775::AID-IJC1>3.0.CO;2-V; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lipton JM, 2001, J PEDIAT HEMATOL ONC, V23, P39, DOI 10.1097/00043426-200101000-00009; Magnusson PKE, 2000, INT J CANCER, V88, P698, DOI 10.1002/1097-0215(20001201)88:5<698::AID-IJC3>3.0.CO;2-J; Magnusson PKE, 1999, NATURE, V400, P29, DOI 10.1038/21801; Mohlke KL, 2002, P NATL ACAD SCI USA, V99, P16928, DOI 10.1073/pnas.262661399; Moore EE, 2012, TWIN RES HUM GENET, V15, P79, DOI 10.1375/twin.15.1.79; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Safaeian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033619; Vlachos A, 2001, J PEDIAT HEMATOL ONC, V23, P377, DOI 10.1097/00043426-200108000-00015; Wang SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008667; Willig TN, 1999, PEDIATR RES, V46, P553, DOI 10.1203/00006450-199911000-00011; Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x; Zelmanowicz A, 2004, PAP REPORT, V15, P113; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	23	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66930	10.1371/journal.pone.0066930	http://dx.doi.org/10.1371/journal.pone.0066930			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826176	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000018
J	Lengert, L; Drossel, B				Lengert, Laurin; Drossel, Barbara			Deducing Underlying Mechanisms from Protein Recruitment Data	PLOS ONE			English	Article							KINETICS; REPAIR; DYNAMICS; FRAP	By using fluorescent labelling techniques, the distribution and dynamics of proteins can be measured within living cells, allowing to study in vivo the response of cells to a triggering event, such as DNA damage. In order to evaluate the reaction rate constants and to identify the proteins and reactions that are essential for the investigated process, mechanistic models are used, which often contain many proteins and associated parameters and are therefore underdetermined by the data. In order to establish criteria for assessing the significance of a model, we present here a systematic investigation of the information that can be reliably deduced from protein recruitment data, assuming that the complete set of reactions that affect the data of the considered protein species is not known. To this purpose, we study in detail models where one or two proteins that influence each other are recruited to a substrate. We show that in many cases the kind of interaction between the proteins can be deduced by analyzing the shape of the recruitment curves of one protein. Furthermore, we discuss in general in which cases it is possible to discriminate between different models and in which cases it is impossible based on the data. Finally, we argue that if different models fit experimental data equally well, conducting experiments with different protein concentrations would allow discrimination between the alternative models in many cases.	[Lengert, Laurin; Drossel, Barbara] Tech Univ Darmstadt, Inst Condensed Matter Phys, Darmstadt, Germany	Technical University of Darmstadt	Lengert, L (corresponding author), Tech Univ Darmstadt, Inst Condensed Matter Phys, Darmstadt, Germany.	lengert@fkp.tu-darmstadt.de			Deutsche Forschungsgemeinschaft within the Graduiertenkolleg 1657	Deutsche Forschungsgemeinschaft within the Graduiertenkolleg 1657	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) within the Graduiertenkolleg 1657 "Molecular and cellular responses to ionizing radiation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Friedland W, 2010, RADIAT RES, V173, P677, DOI 10.1667/RR1965.1; Jakob B, 2005, RADIAT RES, V163, P681, DOI 10.1667/RR3374; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Li YF, 2011, J THEOR BIOL, V283, P122, DOI 10.1016/j.jtbi.2011.05.015; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Selbach M, 2006, NAT METHODS, V3, P981, DOI 10.1038/nmeth972; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Tobias F, 2010, MUTAT RES-REV MUTAT, V704, P54, DOI 10.1016/j.mrrev.2009.11.004; Truong K, 2001, CURRENT OPINION STRU, V11	17	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66590	10.1371/journal.pone.0066590	http://dx.doi.org/10.1371/journal.pone.0066590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826103	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000006
J	Ligthart, ST; Coumans, FAW; Bidard, FC; Simkens, LHJ; Punt, CJA; de Groot, MR; Attard, G; de Bono, JS; Pierga, JY; Terstappen, LWMM				Ligthart, Sjoerd T.; Coumans, Frank A. W.; Bidard, Francois-Clement; Simkens, Lieke H. J.; Punt, Cornelis J. A.; de Groot, Marco R.; Attard, Gerhardt; de Bono, Johann S.; Pierga, Jean-Yves; Terstappen, Leon W. M. M.			Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer	PLOS ONE			English	Article							ABIRATERONE ACETATE; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; PROGRESSION-FREE; GENE STATUS; SURVIVAL; ENUMERATION; HER-2; CHEMOTHERAPY; PREDICT	Background: Presence of circulating tumor cells (CTC) in patients with metastatic breast, colorectal and prostate cancer is indicative for poor prognosis. An automated CTC (aCTC) algorithm developed previously to eliminate the variability in manual counting of CTC (mCTC) was used to extract morphological features. Here we validated the aCTC algorithm on CTC images from prostate, breast and colorectal cancer patients and investigated the role of quantitative morphological parameters. Methodology: Stored images of samples from patients with prostate, breast and colorectal cancer, healthy controls, benign breast and colorectal tumors were obtained using the CellSearch system. Images were analyzed for the presence of aCTC and their morphological parameters measured and correlated with survival. Results: Overall survival hazard ratio was not significantly different for aCTC and mCTC. The number of CTC correlated strongest with survival, whereas CTC size, roundness and apoptosis features reached significance in univariate analysis, but not in multivariate analysis. One aCTC/7.5 ml of blood was found in 7 of 204 healthy controls and 9 of 694 benign tumors. In one patient with benign tumor 2 and another 9 aCTC were detected. Significance of the study: CTC can be identified and morphological features extracted by an algorithm on images stored by the CellSearch system and strongly correlate with clinical outcome in metastatic breast, colorectal and prostate cancer.	[Ligthart, Sjoerd T.; Coumans, Frank A. W.; Terstappen, Leon W. M. M.] Univ Twente, MIRA Inst, Dept Med Cell BioPhys, NL-7500 AE Enschede, Netherlands; [Bidard, Francois-Clement; Pierga, Jean-Yves] Inst Curie, Dept Med Oncol, Paris, France; [Simkens, Lieke H. J.; Punt, Cornelis J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands; [de Groot, Marco R.] Med Spectrum Twente, Dept Internal Med, Enschede, Netherlands; [Attard, Gerhardt; de Bono, Johann S.] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England	University of Twente; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Amsterdam; Academic Medical Center Amsterdam; Medical Spectrum Twente; Royal Marsden NHS Foundation Trust	Terstappen, LWMM (corresponding author), Univ Twente, MIRA Inst, Dept Med Cell BioPhys, POB 217, NL-7500 AE Enschede, Netherlands.	l.w.m.m.terstappen@utwente.nl	terstappen, leon/O-4923-2018	terstappen, leon/0000-0001-5944-3787; Attard, Gerhardt/0000-0002-4811-7983; de Bono, Johann S/0000-0002-2034-595X; Bidard, Francois-Clement/0000-0001-5932-8949	Veridex LLC; Cancer Research UK; Cancer Medical Centre (ECMC) from Cancer Research UK; Department of Health [C51/A7401]; NHS; French government [PHRC AOM06156]; Cancer Research UK [13239] Funding Source: researchfish; National Institute for Health Research [CL-2008-22-001] Funding Source: researchfish	Veridex LLC; Cancer Research UK(Cancer Research UK); Cancer Medical Centre (ECMC) from Cancer Research UK; Department of Health; NHS; French government; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Veridex LLC. GA and JdB are employees of the Section of Medicine at The Institute of Cancer Research which is supported by a Cancer Research UK program grant and an Experimental Cancer Medical Centre (ECMC) grant from Cancer Research UK and the Department of Health (Ref: C51/A7401). GA and JdB also acknowledge NHS funding to the NIHR biomedical research centre. The IC2006-04 study was funded by a public grant from the French government (PHRC AOM06156). The IMMC-01, IMMC-06, and IMMC-38 studies were funded by Veridex LLC. The sponsors of this study had no role in study design, data analysis, data interpretation, or writing of the report. All authors had full access to all the data and the corresponding author had final responsibility for the decision to submit for publication.	Alix-Panabieres C, 2005, J IMMUNOL METHODS, V299, P177, DOI 10.1016/j.jim.2005.02.007; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Ashworth T R, 1869, MED J AUSTRALIA, V14, P146; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; ENGELL H C, 1955, Acta Chir Scand Suppl, V201, P1; Franken B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3333; Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c; Hayes DF, 2002, INT J ONCOL, V21, P1111; Hsieh HB, 2006, BIOSENS BIOELECTRON, V21, P1893, DOI 10.1016/j.bios.2005.12.024; Kagan M, 2002, J CLIN LIGAND ASSAY, V25, P104; Kahn HJ, 2004, BREAST CANCER RES TR, V86, P237, DOI 10.1023/B:BREA.0000036897.92513.72; Kraan J, 2010, CYTOM PART B-CLIN CY, V80B, P112; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Larson CJ, 2004, CYTOM PART A, V62A, P46, DOI 10.1002/cyto.a.20073; Ligthart ST, 2013, ANN ONCOL, V24, P1231, DOI 10.1093/annonc/mds625; Ligthart ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027419; Ligthart ST, 2012, CYTOKERATINS TOOLS O; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Matsusaka S, 2010, CANCER SCI, V101, P1067, DOI 10.1111/j.1349-7006.2010.01492.x; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; MYEROWITZ RL, 1977, CANCER, V40, P3107, DOI 10.1002/1097-0142(197712)40:6<3107::AID-CNCR2820400653>3.0.CO;2-5; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pachmann K, 2008, J CLIN ONCOL, V26, P1208, DOI 10.1200/JCO.2007.13.6523; Pierga JY, 2012, ANN ONCOL, V23, P618, DOI 10.1093/annonc/mdr263; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Saliba AE, 2010, P NATL ACAD SCI USA, V107, P14524, DOI 10.1073/pnas.1001515107; Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1; Scholten L, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.4_suppl.395; Schwarzenbach H, 2009, CLIN CANCER RES, V15, P1032, DOI 10.1158/1078-0432.CCR-08-1910; Stakenborg T, 2010, IEEE ENG MED BIO, P292, DOI 10.1109/IEMBS.2010.5627655; Swennenhuis JF, 2009, CYTOM PART A, V75A, P520, DOI 10.1002/cyto.a.20718; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; Tibbe AGJ, 2007, CYTOM PART A, V71A, P154, DOI 10.1002/cyto.a.20369; Tol J, 2010, ANN ONCOL, V21, P1006, DOI 10.1093/annonc/mdp463; van de Stolpe A, 2011, CANCER RES, V71, P5955, DOI 10.1158/0008-5472.CAN-11-1254; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; YAM LT, 1987, ACTA CYTOL, V31, P68; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	50	67	69	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67148	10.1371/journal.pone.0067148	http://dx.doi.org/10.1371/journal.pone.0067148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826219	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000035
J	Masaoka, A; Gassman, NR; Horton, JK; Kedar, PS; Witt, KL; Hobbs, CA; Kissling, GE; Tano, K; Asagoshi, K; Wilson, SH				Masaoka, Aya; Gassman, Natalie R.; Horton, Julie K.; Kedar, Padmini S.; Witt, Kristine L.; Hobbs, Cheryl A.; Kissling, Grace E.; Tano, Keizo; Asagoshi, Kenjiro; Wilson, Samuel H.			Interaction between DNA Polymerase beta and BRCA1	PLOS ONE			English	Article							BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MOUSE FIBROBLASTS; OXIDATIVE STRESS; COMET ASSAY; DAMAGE; CANCER; RADIATION	The breast cancer 1 (BRCA1) protein is a tumor suppressor playing roles in DNA repair and cell cycle regulation. Studies of DNA repair functions of BRCA1 have focused on double-strand break (DSB) repair pathways and have recently included base excision repair (BER). However, the function of BRCA1 in BER is not well defined. Here, we examined a BRCA1 role in BER, first in relation to alkylating agent (MMS) treatment of cells and the BER enzyme DNA polymerase beta (pol beta). MMS treatment of BRCA1 negative human ovarian and chicken DT40 cells revealed hypersensitivity, and the combined gene deletion of BRCA1 and pol beta in DT40 cells was consistent with these factors acting in the same repair pathway, possibly BER. Using cell extracts and purified proteins, BRCA1 and pol beta were found to interact in immunoprecipitation assays, yet in vivo and in vitro assays for a BER role of BRCA1 were negative. An alternate approach with the human cells of immunofluorescence imaging and laser-induced DNA damage revealed negligible BRCA1 recruitment during the first 60 s after irradiation, the period typical of recruitment of pol beta and other BER factors. Instead, 15 min after irradiation, BRCA1 recruitment was strong and there was gamma-H2AX co-localization, consistent with DSBs and repair. The rapid recruitment of pol beta was similar in BRCA1 positive and negative cells. However, a fraction of pol beta initially recruited remained associated with damage sites much longer in BRCA1 positive than negative cells. Interestingly, pol beta expression was required for BRCA1 recruitment, suggesting a partnership between these repair factors in DSB repair.	[Masaoka, Aya; Gassman, Natalie R.; Horton, Julie K.; Kedar, Padmini S.; Asagoshi, Kenjiro; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Witt, Kristine L.] NIEHS, Natl Toxicol Program, NIH, Res Triangle Pk, NC USA; [Kissling, Grace E.] NIEHS, Biostatist Branch, NIH, Res Triangle Pk, NC USA; [Hobbs, Cheryl A.] Integrated Lab Syst Inc, Res Triangle Pk, NC USA; [Tano, Keizo] Kyoto Univ, Inst Res Reactor, Dept Radiat Life Sci & Radiat Med Sci, Kumatori, Osaka 59004, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kyoto University	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Gassman, Natalie/0000-0002-8488-2332	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01-ES050158, Z01-ES050159]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20510051, 24510072]; NATIONAL CANCER INSTITUTE [U19CA177547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, Z01ES050158, ZIAES050159, Z01ES050159, ZIAES103106] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by Research Project Numbers Z01-ES050158 and Z01-ES050159 from the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(to SHW), and by Grants-in-Aid (20510051, 24510072) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Asagoshi K, 2010, DNA REPAIR, V9, P109, DOI 10.1016/j.dnarep.2009.11.002; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Horton JK, 2003, DNA REPAIR, V2, P27, DOI 10.1016/S1568-7864(02)00184-2; Hu HY, 2004, J BIOL CHEM, V279, P39736, DOI 10.1074/jbc.M402842200; Iijima J, 2010, CANCER RES, V70, P8467, DOI 10.1158/0008-5472.CAN-10-0267; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Masaoka A, 2012, J BIOL CHEM, V287, P27648, DOI 10.1074/jbc.M112.370759; Masaoka A, 2009, DNA REPAIR, V8, P1290, DOI 10.1016/j.dnarep.2009.08.004; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; MIZUMOTO K, 1993, BIOCHEM PHARMACOL, V46, P1811, DOI 10.1016/0006-2952(93)90587-M; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Saha T, 2010, J BIOL CHEM, V285, P19092, DOI 10.1074/jbc.M110.104430; Salmon' TB, 2004, NUCLEIC ACIDS RES, V32, P3712, DOI 10.1093/nar/gkh696; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sehl ME, 2009, CLIN CANCER RES, V15, P2192, DOI 10.1158/1078-0432.CCR-08-1417; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Tano K, 2007, DNA REPAIR, V6, P869, DOI 10.1016/j.dnarep.2007.01.011; Tarapore P, 2012, CELL CYCLE, V11, P2931, DOI 10.4161/cc.21396; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wei LZ, 2008, MOL CELL BIOL, V28, P7380, DOI 10.1128/MCB.01075-08; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66801	10.1371/journal.pone.0066801	http://dx.doi.org/10.1371/journal.pone.0066801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826138	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000010
J	Takem, EN; Affara, M; Amambua-Ngwa, A; Okebe, J; Ceesay, SJ; Jawara, M; Oriero, E; Nwakanma, D; Pinder, M; Clifford, C; Taal, M; Sowe, M; Suso, P; Mendy, A; Mbaye, A; Drakeley, C; D'Alessandro, U				Takem, Ebako N.; Affara, Muna; Amambua-Ngwa, Alfred; Okebe, Joseph; Ceesay, Serign J.; Jawara, Musa; Oriero, Eniyou; Nwakanma, Davis; Pinder, Margaret; Clifford, Caitlin; Taal, Makie; Sowe, Momodou; Suso, Penda; Mendy, Alphonse; Mbaye, Amicoleh; Drakeley, Chris; D'Alessandro, Umberto			Detecting Foci of Malaria Transmission with School Surveys: A Pilot Study in the Gambia	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; PLASMODIUM-FALCIPARUM; PRESCHOOL-CHILDREN; NUTRITIONAL-STATUS; CLINICAL MALARIA; WESTERN KENYA; AFRICA; AREA; SCHOOLCHILDREN; SURVEILLANCE	Background: In areas of declining malaria transmission such as in The Gambia, the identification of malaria infected individuals becomes increasingly harder. School surveys may be used to identify foci of malaria transmission in the community. Methods: The survey was carried out in May-June 2011, before the beginning of the malaria transmission season. Thirty two schools in the Upper River Region of The Gambia were selected with probability proportional to size; in each school approximately 100 children were randomly chosen for inclusion in the study. Each child had a finger prick blood sample collected for the determination of antimalarial antibodies by ELISA, malaria infection by microscopy and PCR, and for haemoglobin measurement. In addition, a simple questionnaire on socio-demographic variables and the use of insecticide-treated bed nets was completed. The cut-off for positivity for antimalarial antibodies was obtained using finite mixture models. The clustered nature of the data was taken into account in the analyses. Results: A total of 3,277 children were included in the survey. The mean age was 10 years (SD = 2.7) [range 4-21], with males and females evenly distributed. The prevalence of malaria infection as determined by PCR was 13.6% (426/3124) [95% CI = 12.2-16.3] with marked variation between schools (range 3-25%, p < 0.001), while the seroprevalence was 7.8% (234/2994) [95% CI = 6.4-9.8] for MSP1(19), 11.6% (364/2997) [95% CI = 9.4-14.5] for MSP2, and 20.0% (593/2973) [95% CI = 16.5-23.2) for AMA1. The prevalence of all the three antimalarial antibodies positive was 2.7% (79/2920). Conclusions: This survey shows that malaria prevalence and seroprevalence before the transmission season were highly heterogeneous.	[Takem, Ebako N.; Affara, Muna; Amambua-Ngwa, Alfred; Okebe, Joseph; Ceesay, Serign J.; Jawara, Musa; Oriero, Eniyou; Nwakanma, Davis; Pinder, Margaret; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Clifford, Caitlin] Univ Manchester, Manchester, Lancs, England; [Taal, Makie; Sowe, Momodou; Suso, Penda; Mendy, Alphonse] Natl Publ Hlth Lab, Kotu, Gambia; [Mbaye, Amicoleh] Minist Basic & Secondary Educ, Banjul, Gambia; [Drakeley, Chris] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium	University of London; London School of Hygiene & Tropical Medicine; University of Manchester; University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM)	Takem, EN (corresponding author), MRC Unit, Fajara, Gambia.	etakem@mrc.gm	Okebe, Joseph/Y-1664-2019; Amambua-Ngwa, Alfred/ABA-7305-2020; Amambua-Ngwa, Alfred/AHD-7882-2022; Amambua-Ngwa, Alfred/HGU-8062-2022; Pinder, Margaret/AAQ-7129-2020	Okebe, Joseph/0000-0001-5466-1611; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Oriero, Eniyou/0000-0002-7911-6457; Nwakanma, Davis/0000-0002-6706-6069	Medical Research Council Unit, The Gambia; Medical Research Council [MC_EX_MR/K02440X/1, MC_UP_A900_1119] Funding Source: researchfish; MRC [MC_EX_MR/K02440X/1, MC_UP_A900_1119] Funding Source: UKRI	Medical Research Council Unit, The Gambia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by Medical Research Council Unit, The Gambia (core funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton RA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-25; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bojang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011225; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Brooker S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-231; CAMPBELL H, 1987, LANCET, V1, P859; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Clarke SE, 2004, AM J TROP MED HYG, V71, P732, DOI 10.4269/ajtmh.2004.71.732; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004; Crookston BT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-39; Custodio E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-225; DALESSANDRO U, 1995, LANCET, V346, P462, DOI 10.1016/S0140-6736(95)91321-1; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Deribew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010775; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-108; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Fillol F, 2009, AM J TROP MED HYG, V80, P202, DOI 10.4269/ajtmh.2009.80.202; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Gitonga CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-306; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Kazadi W, 2004, AM J TROP MED HYG, V71, P97, DOI 10.4269/ajtmh.2004.71.97; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Koukounari A, 2008, INT J PARASITOL, V38, P1663, DOI 10.1016/j.ijpara.2008.05.013; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Magnussen P, 2001, TROP MED INT HEALTH, V6, P273, DOI 10.1046/j.1365-3156.2001.00720.x; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Midzi N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-169; Moore SE, 2003, ACTA PAEDIATR, V92, P170, DOI 10.1111/j.1651-2227.2003.tb00522.x; Ndyomugyenyi R, 2007, TROP MED INT HEALTH, V12, P230, DOI 10.1111/j.1365-3165.2006.01767.x; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Oduro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026305; Okello G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-185; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Poskitt EME, 1999, ARCH DIS CHILD, V80, P115, DOI 10.1136/adc.80.2.115; RILEY EM, 1993, PARASITE IMMUNOL, V15, P513, DOI 10.1111/j.1365-3024.1993.tb00639.x; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Sesay S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-2; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Wang SJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-40; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2007, MAL EL FIELD MAN LOW; World Health Organization, 1995, PHYS STAT US INT ANT	56	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67108	10.1371/journal.pone.0067108	http://dx.doi.org/10.1371/journal.pone.0067108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826205	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000321150000028
J	Chow, BA; Donahue, SW; Vaughan, MR; McConkey, B; Vijayan, MM				Chow, Brian A.; Donahue, Seth W.; Vaughan, Michael R.; McConkey, Brendan; Vijayan, Mathilakath M.			Serum Immune-Related Proteins are Differentially Expressed during Hibernation in the American Black Bear	PLOS ONE			English	Article							APOLIPOPROTEIN-A-IV; GROUND-SQUIRRELS; URSUS-AMERICANUS; GENE-EXPRESSION; METABOLIC SUPPRESSION; BLOOD-COAGULATION; BONE-FORMATION; DISUSE; PLASMA; LIVER	Hibernation is an adaptation to conserve energy in the face of extreme environmental conditions and low food availability that has risen in several animal phyla. This phenomenon is characterized by reduced metabolic rate (similar to 25% of the active basal metabolic rate in hibernating bears) and energy demand, while other physiological adjustments are far from clear. The profiling of the serum proteome of the American black bear (Ursus americanus) may reveal specific proteins that are differentially modulated by hibernation, and provide insight into the remarkable physiological adaptations that characterize ursid hibernation. In this study, we used differential gel electrophoresis (DIGE) analysis, liquid chromatography coupled to tandem mass spectrometry, and subsequent MASCOT analysis of the mass spectra to identify candidate proteins that are differentially expressed during hibernation in captive black bears. Seventy serum proteins were identified as changing by +/- 1.5 fold or more, out of which 34 proteins increased expression during hibernation. The majority of identified proteins are involved in immune system processes. These included alpha(2)-macroglobulin, complement components C1s and C4, immunoglobulin mu and J chains, clusterin, haptoglobin, C4b binding protein, kininogen 1, alpha(2)-HS-glycoprotein, and apoplipoproteins A-I and A-IV. Differential expression of a subset of these proteins identified by proteomic analysis was also confirmed by immunodetection. We propose that the observed serum protein changes contribute to the maintenance of the hibernation phenotype and health, including increased capacities for bone maintenance and wound healing during hibernation in bears.	[Chow, Brian A.; McConkey, Brendan; Vijayan, Mathilakath M.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Donahue, Seth W.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA; [Vaughan, Michael R.] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA	University of Waterloo; Colorado State University; Virginia Polytechnic Institute & State University	Vijayan, MM (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	matt.vijayan@ucalgary.ca	Vijayan, Mathilakath/AAC-2190-2020		Natural Sciences and Engineering Research Council of Canada Discovery Grant	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada Discovery Grant to MMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTTS B, 1979, CRYOBIOLOGY, V16, P179, DOI 10.1016/0011-2240(79)90029-4; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Barboza PS, 1997, CAN J ZOOL, V75, P2129, DOI 10.1139/z97-848; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertile F, 2009, PROTEOMICS, V9, P148, DOI 10.1002/pmic.200701001; BILLINGHAM RE, 1960, ANN SURG, V152, P975, DOI 10.1097/00000658-196012000-00008; Binkert C, 1999, J BIOL CHEM, V274, P28514, DOI 10.1074/jbc.274.40.28514; BIORCK G, 1962, ACTA PHYSIOL SCAND, V56, P334, DOI 10.1111/j.1748-1716.1962.tb02510.x; Bolling SF, 1997, ANN THORAC SURG, V64, P623, DOI 10.1016/S0003-4975(97)00631-0; Bouma HR, 2012, J CELL PHYSIOL, V227, P1285, DOI 10.1002/jcp.22850; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Bouwman FG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-24; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; Chandra Ranjit Kumar, 1997, American Journal of Clinical Nutrition, V66, p460S; Chow BA, 2010, GEN COMP ENDOCR, V167, P317, DOI 10.1016/j.ygcen.2010.03.027; Cray C, 2012, PROG MOL BIOL TRANSL, V105, P113, DOI 10.1016/B978-0-12-394596-9.00005-6; Donahue SW, 2006, J EXP BIOL, V209, P1630, DOI 10.1242/jeb.02185; Donahue SW, 2003, J EXP BIOL, V206, P4233, DOI 10.1242/jeb.00671; Epperson LE, 2010, AM J PHYSIOL-REG I, V298, pR329, DOI 10.1152/ajpregu.00416.2009; Fedorov VB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-171; Fedorov VB, 2009, PHYSIOL GENOMICS, V37, P108, DOI 10.1152/physiolgenomics.90398.2008; FOLK G E JR, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P107; Frobert O, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-11; FUJIMOTO K, 1992, AM J PHYSIOL, V262, pG1002, DOI 10.1152/ajpgi.1992.262.6.G1002; HALLER AC, 1977, J DENT RES, V56, P1552, DOI 10.1177/00220345770560122601; HAYASHI H, 1990, J LIPID RES, V31, P1613; HEIMARK RL, 1980, NATURE, V286, P456, DOI 10.1038/286456a0; Hellgren EC, 1998, URSUS-SERIES, V10, P467; HELLGREN EC, 1990, J MAMMAL, V71, P291, DOI 10.2307/1381939; Horton ND, 1998, COMP BIOCHEM PHYS B, V119, P787, DOI 10.1016/S0305-0491(98)00056-X; Iaizzo PA, 2012, INTEGR ZOOL, V7, P48, DOI [10.1111/j.1749-4877.2012.00275.x, 10.1111/j.1749-4877.2011.00280.x]; KAPLAN AP, 1987, BLOOD, V70, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECHLER E, 1963, AM J PHYSIOL, V205, P985, DOI 10.1152/ajplegacy.1963.205.5.985; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; LUNDBERG DA, 1976, MAYO CLIN PROC, V51, P716; Mcgee ME, 2008, BONE, V42, P396, DOI 10.1016/j.bone.2007.10.010; McGee-Lawrence ME, 2009, BONE, V45, P1186, DOI 10.1016/j.bone.2009.08.011; McGee-Lawrence ME, 2009, J BIOMECH, V42, P1378, DOI 10.1016/j.jbiomech.2008.11.039; McGee-Lawrence ME, 2008, AM J PHYSIOL-REG I, V295, pR1999, DOI 10.1152/ajpregu.90648.2008; Milbury PE, 1998, URSUS-SERIES, V10, P507; Mominoki K, 2005, COMP BIOCHEM PHYS A, V142, P472, DOI 10.1016/j.cbpa.2005.09.017; NELSON RA, 1973, AM J PHYSIOL, V224, P491, DOI 10.1152/ajplegacy.1973.224.2.491; OELTGEN PR, 1988, LIFE SCI, V43, P1565, DOI 10.1016/0024-3205(88)90406-7; Pacifici R, 2012, J BONE MINER RES, V27, P231, DOI 10.1002/jbmr.1500; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROBERTS NJ, 1979, MICROBIOL REV, V43, P241, DOI 10.1128/MMBR.43.2.241-259.1979; RUIT KA, 1987, J THERM BIOL, V12, P135; SCRIBA PC, 1979, ACTA ENDOCRINOL-COP, V91, P629, DOI 10.1530/acta.0.0910629; Seger RL, 2011, BONE, V49, P1205, DOI 10.1016/j.bone.2011.08.017; Sheikh AM, 2003, BIOCHIMIE, V85, P1027, DOI 10.1016/S0300-9084(03)00133-0; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; SRERE HK, 1995, AM J PHYSIOL-REG I, V268, pR1507, DOI 10.1152/ajpregu.1995.268.6.R1507; STEINBERG B, 1986, HISTOL HISTOPATHOL, V1, P155; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; WANG LCH, 1979, CAN J ZOOL, V57, P149, DOI 10.1139/z79-012; Weaver KN, 2009, ACTA CHIROPTEROL, V11, P220, DOI 10.3161/150811009X465866; Wildes D, 2010, P NATL ACAD SCI USA, V107, P4561, DOI 10.1073/pnas.0914495107; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	67	24	25	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66119	10.1371/journal.pone.0066119	http://dx.doi.org/10.1371/journal.pone.0066119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825529	gold, Green Submitted, Green Published			2022-12-27	WOS:000321223000008
J	Klatte-Schulz, F; Pauly, S; Scheibel, M; Greiner, S; Gerhardt, C; Hartwig, J; Schmidmaier, G; Wildemann, B				Klatte-Schulz, Franka; Pauly, Stephan; Scheibel, Markus; Greiner, Stefan; Gerhardt, Christian; Hartwig, Jelka; Schmidmaier, Gerhard; Wildemann, Britt			Characteristics and Stimulation Potential with BMP-2 and BMP-7 of Tenocyte-Like Cells Isolated from the Rotator Cuff of Female Donors	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOGENIC PROTEIN-1; STEM-CELLS; ARTHROSCOPIC REPAIR; COLLAGEN-SYNTHESIS; GENE-EXPRESSION; SINGLE-ROW; IN-VIVO; TENDON; ESTROGEN	Tendon bone healing of the rotator cuff is often associated with non-healing or recurrent defects, which seems to be influenced by the patient's age and sex. The present study aims to examine cellular biological characteristics of tenocyte-like cells that may contribute to this impaired rotator cuff healing. Moreover, a therapeutic approach using growth factors could possibly stimulate tendon bone healing. Therefore, our second aim was to identify patient groups who would particularly benefit from growth factor stimulation. Tenocyte-like cells isolated from supraspinatus tendons of female donors younger and older than 65 years of age were characterized with respect to different cellular biological parameters, such as cell density, cell count, marker expression, collagen-I protein synthesis, and stem cell potential. Furthermore, cells of the donor groups were stimulated with BMP-2 and BMP-7 (200 and 1000 ng/ml) in 3D-culture and analyzed for cell count, marker expression and collagen-I protein synthesis. Female donors older than 65 years of age showed significantly decreased cell count and collagen-I protein synthesis compared to cells from donors younger than 65 years. Cellular biological parameters including cell count, collagen-I and -III expression, and collagen-I protein synthesis of cells from both donor groups were stimulated with BMP-2 and BMP-7. The cells from donors older than 65 years revealed a decreased stimulation potential for cell count compared to the younger group. Cells from female donors older than 65 years of age showed inferior cellular biological characteristics. This may be one reason for a weaker healing potential observed in older female patients and should be taken into consideration for tendon bone healing of the rotator cuff.	[Klatte-Schulz, Franka; Pauly, Stephan; Scheibel, Markus; Greiner, Stefan; Gerhardt, Christian; Wildemann, Britt] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Julius Wolff Inst, Berlin, Germany; [Klatte-Schulz, Franka; Hartwig, Jelka; Wildemann, Britt] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Schmidmaier, Gerhard] Univ Klinikum Heidelberg, Dept Orthopadie Unfallchirurg & Paraplegiol, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg	Klatte-Schulz, F (corresponding author), Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Julius Wolff Inst, Berlin, Germany.	Franka.Klatte@charite.de	Wildemann, Britt/G-7732-2012; Klatte-Schulz, Franka/B-6734-2017	Wildemann, Britt/0000-0002-8365-1188; Klatte-Schulz, Franka/0000-0001-6079-228X	Deutsche Vereinigung fur Schulter- und Ellenbogenchirurgie (DVSE); Charite	Deutsche Vereinigung fur Schulter- und Ellenbogenchirurgie (DVSE); Charite	The study was financially supported by the Deutsche Vereinigung fur Schulter- und Ellenbogenchirurgie (DVSE, a non-profit organization, http://www.dvse.info/). We wish to confirm that there are no conflicts of interest associated with this publication and there has been no financial support for this work that could have influenced its outcome. Additionally the first author Franka Klatte-Schulz received a stipend from the Charite to finish her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne O., 1984, SURG SHOULDER, P167; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035; Bridgeman JT, 2010, FOOT ANKLE INT, V31, P1081, DOI 10.3113/FAI.2010.1081; Burgess KE, 2009, CLIN BIOMECH, V24, P504, DOI 10.1016/j.clinbiomech.2009.03.011; Burgess KE, 2010, J STRENGTH COND RES, V24, P2088, DOI 10.1519/JSC.0b013e3181aeb12b; Burks RT, 2009, AM J SPORT MED, V37, P674, DOI 10.1177/0363546508328115; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng MT, 2009, CELL PROLIFERAT, V42, P448, DOI 10.1111/j.1365-2184.2009.00611.x; Cho NS, 2011, AM J SPORT MED, V39, P2108, DOI 10.1177/0363546510397171; Chung SW, 2011, AM J SPORT MED, V39, P2099, DOI 10.1177/0363546511415659; Deutsch A, 2008, J SHOULDER ELB SURG, V17, P845, DOI 10.1016/j.jse.2008.04.004; Dexheimer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022980; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fossett E, 2012, J ORTHOP RES, V30, P1013, DOI 10.1002/jor.22057; Frank JB, 2008, AM J SPORT MED, V36, P1496, DOI 10.1177/0363546507313574; Gerber C, 1999, J BONE JOINT SURG AM, V81A, P1281, DOI 10.2106/00004623-199909000-00009; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Grasso A, 2009, ARTHROSCOPY, V25, P4, DOI 10.1016/j.arthro.2008.09.018; Hansen M, 2009, J APPL PHYSIOL, V106, P1435, DOI 10.1152/japplphysiol.90933.2008; Irie T, 2010, CONNECT TISSUE RES, V51, P179, DOI 10.3109/03008200903204669; Itaya T, 2009, J PERIODONTAL RES, V44, P425, DOI 10.1111/j.1600-0765.2008.01137.x; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Klatte-Schulz F, 2012, EUR CELLS MATER, V24, P74, DOI 10.22203/eCM.v024a06; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CB, 2007, AM J SPORT MED, V35, P597, DOI 10.1177/0363546506296312; Magnusson SP, 2007, INT J EXP PATHOL, V88, P237, DOI 10.1111/j.1365-2613.2007.00551.x; Martinek V, 2002, J BONE JOINT SURG AM, V84A, P1123, DOI 10.2106/00004623-200207000-00005; Mazzocca AD., 2011, KNEE SURG SPORTS TRA; Mihelic R, 2004, AM J SPORT MED, V32, P1619, DOI 10.1177/0363546504263703; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Neumann K, 2007, J CELL BIOCHEM, V102, P626, DOI 10.1002/jcb.21319; PATTE D, 1990, CLIN ORTHOP RELAT R, P81; Pauly S, 2010, EUR CELLS MATER, V20, P84, DOI 10.22203/eCM.v020a08; Pauly S, 2011, J SHOULDER ELBOW SUR; Razmjou H, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-66; Rodeo SA, 1999, AM J SPORT MED, V27, P476, DOI 10.1177/03635465990270041201; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Shu W, 2012, J CELL BIOCH; Sorensen AKB, 2007, J SHOULDER ELB SURG, V16, P174, DOI 10.1016/j.jse.2006.06.010; Steinert AF, 2011, TISSUE ENG PT A, V17, P1375, DOI [10.1089/ten.tea.2010.0413, 10.1089/ten.TEA.2010.0413]; Tashjian RZ, 2010, AM J SPORT MED, V38, P2435, DOI 10.1177/0363546510382835; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Thomopoulos S, 2005, J HAND SURG-AM, V30A, P441, DOI 10.1016/j.jhsa.2004.12.006; Tsai AD, 2003, J CELL BIOCHEM, V90, P777, DOI 10.1002/jcb.10666; van Rijn RM, 2010, SCAND J WORK ENV HEA, V36, P189, DOI 10.5271/sjweh.2895; Yamada M, 2008, J ORTHOP RES, V26, P42, DOI 10.1002/jor.20474; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835; Yeh LCC, 2008, J CELL BIOCHEM, V104, P2107, DOI 10.1002/jcb.21768; Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22; Yu WD, 2001, CLIN ORTHOP RELAT R, P268, DOI 10.1097/00003086-200102000-00031; Yu Y, 2007, ARTHROSCOPY, V23, P205, DOI 10.1016/j.arthro.2006.08.023	57	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67209	10.1371/journal.pone.0067209	http://dx.doi.org/10.1371/journal.pone.0067209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825642	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000090
J	Li, Y; Xu, SQ; Jiang, BB; Cohen, RA; Zang, MW				Li, Yu; Xu, Shanqin; Jiang, Bingbing; Cohen, Richard A.; Zang, Mengwei			Activation of Sterol Regulatory Element Binding Protein and NLRP3 Inflammasome in Atherosclerotic Lesion Development in Diabetic Pigs	PLOS ONE			English	Article							LIPID-METABOLISM; ACCELERATED ATHEROSCLEROSIS; INSULIN-RESISTANCE; DEFICIENT MICE; LIFE-SPAN; SIRT1; KINASE; STRESS; P53; ATHEROGENESIS	Background: Aberrantly elevated sterol regulatory element binding protein (SREBP), the lipogenic transcription factor, contributes to the development of fatty liver and insulin resistance in animals. Our recent studies have discovered that AMP-activated protein kinase (AMPK) phosphorylates SREBP at Ser-327 and inhibits its activity, represses SREBP-dependent lipogenesis, and thereby ameliorates hepatic steatosis and atherosclerosis in insulin-resistant LDLR-/- mice. Chronic inflammation and activation of NLRP3 inflammasome have been implicated in atherosclerosis and fatty liver disease. However, whether SREBP is involved in vascular lipid accumulation and inflammation in atherosclerosis remains largely unknown. Principal Findings: The preclinical study with aortic pouch biopsy specimens from humans with atherosclerosis and diabetes shows intense immunostaining for SREBP-1 and the inflammatory marker VCAM-1 in atherosclerotic plaques. The cleavage processing of SREBP-1 and -2 and expression of their target genes are increased in the well-established porcine model of diabetes and atherosclerosis, which develops human-like, complex atherosclerotic plaques. Immunostaining analysis indicates an elevation in SREBP-1 that is primarily localized in endothelial cells and in infiltrated macrophages within fatty streaks, fibrous caps with necrotic cores, and cholesterol crystals in advanced lesions. Moreover, concomitant suppression of NAD-dependent deacetylase SIRT1 and AMPK is observed in atherosclerotic pigs, which leads to the proteolytic activation of SREBP-1 by diminishing the deacetylation and Ser-372 phosphorylation of SREBP-1. Aberrantly elevated NLRP3 inflammasome markers are evidenced by increased expression of inflammasome components including NLPR3, ASC, and IL-1 beta. The increase in SREBP-1 activity and IL-1b production in lesions is associated with vascular inflammation and endothelial dysfunction in atherosclerotic pig aorta, as demonstrated by the induction of NF-kappa B, VCAM-1, iNOS, and COX-2, as well as by the repression of eNOS. Conclusions: These translational studies provide in vivo evidence that the dysregulation of SIRT1-AMPK-SREBP and stimulation of NLRP3 inflammasome may contribute to vascular lipid deposition and inflammation in atherosclerosis.	[Li, Yu; Xu, Shanqin; Jiang, Bingbing; Cohen, Richard A.; Zang, Mengwei] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, Boston, MA 02118 USA	Boston University	Zang, MW (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, Boston, MA 02118 USA.	mwzang1@bu.edu		/0000-0002-1070-6408; Li, Yu/0000-0001-6910-5933; Zang, Mengwei/0000-0002-2502-2586	National Institutes of Health [DK 076942, HL068758]; Wing Tat Lee Award at Boston University School of Medicine; National Natural Science Foundation of China [81270930]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wing Tat Lee Award at Boston University School of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by the National Institutes of Health grants DK 076942 (MZ) and HL068758 (RAC) and by the Wing Tat Lee Award at Boston University School of Medicine (MZ). YL is currently supported by a National Natural Science Foundation of China grant (81270930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Foretz M, 1999, MOL CELL BIOL, V19, P3760; GERRITY RG, 1979, AM J PATHOL, V95, P775; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Goldstein JL, 2008, J CLIN INVEST, V118, P1220, DOI 10.1172/JCI34973; Hansson GK, 2005, NEW ENGL J MED, V353, P429; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lin T, 2003, CIRC RES, V92, P1296, DOI 10.1161/01.RES.0000078780.65824.8B; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Xu SQ, 2011, J CARDIOVASC PHARM, V58, P263, DOI 10.1097/FJC.0b013e3182239eb7; Yeh M, 2004, CIRC RES, V95, P780, DOI 10.1161/01.RES.0000146030.53089.18; Yin HQ, 2012, HEPATOLOGY, V56, p1119A; Ying J, 2008, FREE RADICAL BIO MED, V45, P756, DOI 10.1016/j.freeradbiomed.2008.05.029; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zuccollo A, 2005, CIRCULATION, V112, P3001, DOI 10.1161/CIRCULATIONAHA.105.581892	44	22	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67532	10.1371/journal.pone.0067532	http://dx.doi.org/10.1371/journal.pone.0067532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825667	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000107
J	Ueyama, T; Donishi, T; Ukai, S; Ikeda, Y; Hotomi, M; Yamanaka, N; Shinosaki, K; Terada, M; Kaneoke, Y				Ueyama, Takashi; Donishi, Tomohiro; Ukai, Satoshi; Ikeda, Yorihiko; Hotomi, Muneki; Yamanaka, Noboru; Shinosaki, Kazuhiro; Terada, Masaki; Kaneoke, Yoshiki			Brain Regions Responsible for Tinnitus Distress and Loudness: A Resting-State fMRI Study	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; ANTERIOR CINGULATE; DEPRESSED-PATIENTS; HEAD MOTION; NETWORKS; STIMULATION; CORTEX; ACTIVATION; RELEVANCE; SEVERITY	Subjective tinnitus is characterized by the perception of phantom sound without an external auditory stimulus. We hypothesized that abnormal functionally connected regions in the central nervous system might underlie the pathophysiology of chronic subjective tinnitus. Statistical significance of functional connectivity (FC) strength is affected by the regional autocorrelation coefficient (AC). In this study, we used resting-state functional MRI (fMRI) and measured regional mean FC strength (mean cross-correlation coefficient between a region and all other regions without taking into account the effect of AC (rGC) and with taking into account the effect of AC (rGCa) to elucidate brain regions related to tinnitus symptoms such as distress, depression and loudness. Consistent with previous studies, tinnitus loudness was not related to tinnitus-related distress and depressive state. Although both rGC and rGCa revealed similar brain regions where the values showed a statistically significant relationship with tinnitus-related symptoms, the regions for rGCa were more localized and more clearly delineated the regions related specifically to each symptom. The rGCa values in the bilateral rectus gyri were positively correlated and those in the bilateral anterior and middle cingulate gyri were negatively correlated with distress and depressive state. The rGCa values in the bilateral thalamus, the bilateral hippocampus, and the left caudate were positively correlated and those in the left medial superior frontal gyrus and the left posterior cingulate gyrus were negatively correlated with tinnitus loudness. These results suggest that distinct brain regions are responsible for tinnitus symptoms. The regions for distress and depressive state are known to be related to depression, while the regions for tinnitus loudness are known to be related to the default mode network and integration of multi-sensory information.	[Ueyama, Takashi] Wakayama Med Univ, Grad Sch, Dept Anat & Cell Biol, Wakayama, Japan; [Donishi, Tomohiro; Kaneoke, Yoshiki] Wakayama Med Univ, Grad Sch, Dept Syst Neurophysiol, Wakayama, Japan; [Ukai, Satoshi; Shinosaki, Kazuhiro] Wakayama Med Univ, Grad Sch, Dept Neuropsychiat, Wakayama, Japan; [Ikeda, Yorihiko; Hotomi, Muneki; Yamanaka, Noboru] Wakayama Med Univ, Grad Sch, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan; [Terada, Masaki] Wakayama Minami Radiol Clin, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Wakayama Medical University	Ueyama, T (corresponding author), Wakayama Med Univ, Grad Sch, Dept Anat & Cell Biol, Wakayama, Japan.	tueyama@wakayama-med.ac.jp		Ukai, Satoshi/0000-0002-9776-8379	Grants-in-Aid for Scientific Research [24591303, 24590895] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Bauer CA, 2011, EAR HEARING, V32, P145, DOI 10.1097/AUD.0b013e3181f5374f; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; Chan Yvonne, 2009, Discov Med, V8, P133; Cheung SW, 2010, NEUROSCIENCE, V169, P1768, DOI 10.1016/j.neuroscience.2010.06.007; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dawdy D.R., 1964, HDB APPL HYDROLOGY C; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Elgoyhen AB, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00001; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fujii K, 2011, J EPIDEMIOL, V21, P299, DOI 10.2188/jea.JE20100124; Gardner A, 2002, NUCL MED COMMUN, V23, P429, DOI 10.1097/00006231-200205000-00002; Golm D, 2013, HEARING RES, V295, P87, DOI 10.1016/j.heares.2012.03.003; GOODWIN PE, 1980, ACTA OTO-LARYNGOL, V90, P353, DOI 10.3109/00016488009131736; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Hackett TA, 2011, HEARING RES, V271, P133, DOI 10.1016/j.heares.2010.01.011; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Henry J A, 2000, J Am Acad Audiol, V11, P138; Hiller W, 2007, AUDIOL NEURO-OTOL, V12, P391, DOI 10.1159/000106482; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; Hwang JH, 2009, AM J OTOLARYNG, V30, P432, DOI 10.1016/j.amjoto.2008.08.005; Kaneoke Y, 2012, FUNCTIONAL CONNECTIV, DOI [10.1109/ICCME, DOI 10.1109/ICCME]; Kaneoke Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038131; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Langguth B, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00015; Lanting CP, 2010, HEARING RES, V267, P78, DOI 10.1016/j.heares.2010.04.006; Larson PS, 2012, NEUROSURGERY, V70, P398, DOI 10.1227/NEU.0b013e3182320ab5; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Leicht G, 2013, BIOL PSYCHIAT, V73, P337, DOI 10.1016/j.biopsych.2012.09.004; Licata SC, 2013, NEUROIMAGE, V70, P211, DOI 10.1016/j.neuroimage.2012.12.055; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; MEIKLE MB, 1984, OTOLARYNG HEAD NECK, V92, P689, DOI 10.1177/019459988409200617; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pastor MA, 2008, J NEUROPHYSIOL, V100, P1699, DOI 10.1152/jn.01156.2007; Pastor MA, 2002, J NEUROSCI, V22, P10501; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schecklmann M, 2013, HUM BRAIN MAPP, V34, P233, DOI 10.1002/hbm.21426; Scheinost D, 2012, NEUROIMAGE, V62, P1510, DOI 10.1016/j.neuroimage.2012.05.073; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shi YB, 2009, OTOLARYNG HEAD NECK, V141, P285, DOI 10.1016/j.otohns.2009.05.020; Siedentopf CM, 2007, NEUROSCI LETT, V411, P189, DOI 10.1016/j.neulet.2006.08.049; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vanneste S, 2011, EUR J NEUROSCI, V34, P718, DOI 10.1111/j.1460-9568.2011.07793.x; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vernon JA, 2003, OTOLARYNG CLIN N AM, V36, P293, DOI 10.1016/S0030-6665(02)00162-7; Wallhausser-Franke E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034583	68	53	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67778	10.1371/journal.pone.0067778	http://dx.doi.org/10.1371/journal.pone.0067778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825684	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000118
J	Gibbs, HL; Sanz, L; Sovic, MG; Calvete, JJ				Gibbs, H. Lisle; Sanz, Libia; Sovic, Michael G.; Calvete, Juan J.			Phylogeny-Based Comparative Analysis of Venom Proteome Variation in a Clade of Rattlesnakes (Sistrurus sp.)	PLOS ONE			English	Article							SNAKE VENOMICS; PHOSPHOLIPASE A(2); EVOLUTION; DIET; SELECTION; MASSASAUGA; VIPERIDAE; CROTALUS; ORIGIN; TOOLS	A long-standing question in evolutionary studies of snake venoms is the extent to which phylogenetic divergence and diet can account for between-species differences in venom composition. Here we apply phylogeny-based comparative methods to address this question. We use data on venom variation generated using proteomic techniques for all members of a small clade of rattlesnakes (Sistrurus sp.) and two outgroups for which phylogenetic and diet information is available. We first complete the characterization of venom variation for all members of this clade with a "venomic" analysis of pooled venoms from two members of this genus, S. milarius streckeri and S. m. milarius. These venoms exhibit the same general classes of proteins as those found in other Sistrurus species but differ in their relative abundances of specific protein families. We then test whether there is significant phylogenetic signal in the relative abundances of major venom proteins across species and if diet (measured as percent mammals and lizards among all prey consumed) covaries with venom composition after phylogenetic divergence is accounted for. We found no evidence for significant phylogenetic signal in venom variation: K values for seven snake venom proteins and two composite venom variables [PC 1 and 2]) were all nonsignificant and lower (mean = 0.11+0.06 sd) than mean K values (>0.35) previously reported for a wide range of morphological, life history, physiological and behavioral traits from other species. Finally, analyses based on Phylogenetic Generalized Least Squares (PGLS) methods reveal that variation in abundance of some venom proteins, most strongly CRISP is significantly related to snake diet. Our results demonstrate that venom variation in these snakes is evolutionarily a highly labile trait even among very closely-related taxa and that natural selection acting through diet variation may play a role in molding the relative abundance of specific venom proteins.	[Gibbs, H. Lisle; Sovic, Michael G.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Gibbs, H. Lisle] Ohio State Univ, Ohio Biodivers Conservat Partnership, Columbus, OH 43210 USA; [Sanz, Libia; Calvete, Juan J.] CSIC, Inst Biomed Valencia, Valencia, Spain	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Gibbs, HL (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA.	gibbs.128@osu.edu	Calvete, Juan J/K-9619-2014; Calvete, Juan/P-2555-2019	Calvete, Juan J/0000-0001-5026-3122; Calvete, Juan/0000-0001-5026-3122; Sanz, Libia/0000-0003-4991-9598; Sovic, Michael/0000-0002-8556-3704	Ohio State University; Ministerio de Economia y Competitividad, Madrid, Spain [BFU2010-17373]; CSIC from the Generalitat Valenciana (Valencia, Spain); Generalitat Valenciana (Valencia, Spain) [PROMETEO/2010/005]	Ohio State University(Ohio State University); Ministerio de Economia y Competitividad, Madrid, Spain(Spanish Government); CSIC from the Generalitat Valenciana (Valencia, Spain); Generalitat Valenciana (Valencia, Spain)(Center for Forestry Research & Experimentation (CIEF))	This work was supported by funds from the Ohio State University and grants BFU2010-17373 (from the Ministerio de Economia y Competitividad, Madrid, Spain), Programa de Cooperacion Interuniversitaria e Investigacion Cientifica between CSIC and PROMETEO/2010/005 from the Generalitat Valenciana (Valencia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; Beavers RA, 1976, NAT, V20, P503; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bryson RW, 2011, J BIOGEOGR, V38, P2299, DOI 10.1111/j.1365-2699.2011.02565.x; Calvete JJ, 2010, TOXINS HEMOSTASIS BE, P45; Calvete JJ, 2007, J MASS SPECTROM, V42, P1405, DOI 10.1002/jms.1242; Calvete JJ, 2011, EXPERT REV PROTEOMIC, V8, P739, DOI [10.1586/EPR.11.61, 10.1586/epr.11.61]; Calvete JJ, 2009, J PROTEOME RES, V8, P3055, DOI 10.1021/pr900249q; Campbell J. A., 2004, VENOMOUS REPTILES W; Casewell NR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-564; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; Escalante T, 2011, J PROTEOMICS, V74, P1781, DOI 10.1016/j.jprot.2011.03.026; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Gibbs HL, 2008, J MOL EVOL, V66, P151, DOI 10.1007/s00239-008-9067-7; Gibbs HL, 2011, J PROTEOMICS, V74, P2169, DOI 10.1016/j.jprot.2011.06.013; Gibbs HL, 2011, J MOL EVOL, V72, P383, DOI 10.1007/s00239-011-9437-4; Gibbs HL, 2009, TOXICON, V53, P672, DOI 10.1016/j.toxicon.2009.01.034; Gibbs HL, 2009, J MOL EVOL, V68, P113, DOI 10.1007/s00239-008-9186-1; GLOYD H. K, 1990, SNAKES AGKISTRODON C; GREENE LJ, 1972, CIRC RES, V31, pII62; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; HAMILSTON W. J., 1955, NAT HIST MISC, V140, P1; Holder T.L., 1988, THESIS SW MISSOURI S; Holycross AT, 2002, J HERPETOL, V36, P454, DOI 10.2307/1566190; Juarez P, 2004, PROTEOMICS, V4, P327, DOI 10.1002/pmic.200300628; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Lomonte B, 2009, PROTEIN PEPTIDE LETT, V16, P860, DOI 10.2174/092986609788923356; Luft FC, 2008, J RENIN-ANGIO-ALDO S, V9, P57, DOI 10.3317/jraas.2008.009; Mackessy S.P., 2021, HDB VENOMS TOXINS RE, V2nd; Mackessy SP, 2010, HDB VENOMS TOXINS RE, P3; Mackessy SP, 2008, BIOL RATTLESNAKES, P495; Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3; Mebs D, 2001, TOXICON, V39, P87, DOI 10.1016/S0041-0101(00)00155-0; Meier Jurg, 1995, P367; Menez A., 2002, PERSPECTIVES MOL TOX; Murphy Robert W., 2002, P69; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nunn C. L., 2011, COMP APPROACH EVOLUT; Orme D., 2018, CAPER COMP ANAL PHYL; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; R Development Core Team, 2005, R LANG ENV STAT COMP; Ranganathan Y, 2011, PLANT SIGNAL BEHAV, V6, P113, DOI 10.4161/psb.6.1.14191; Rodrigues RS, 2012, J PROTEOMICS, V75, P2707, DOI 10.1016/j.jprot.2012.03.028; Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500; Sasa M, 1999, TOXICON, V37, P249, DOI 10.1016/S0041-0101(98)00121-4; Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931; Sunagar K, 2012, MOL BIOL EVOL, V29, P1807, DOI 10.1093/molbev/mss058; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; WILLIAMS V, 1988, TOXICON, V26, P1067, DOI 10.1016/0041-0101(88)90205-X; Wuster W, 1999, TOXICON, V37, P253	57	51	51	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67220	10.1371/journal.pone.0067220	http://dx.doi.org/10.1371/journal.pone.0067220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826238	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400120
J	Yoshikawa, M; Kojima, H; Yaguchi, Y; Okada, N; Saito, H; Moriyama, H				Yoshikawa, Mamoru; Kojima, Hiromi; Yaguchi, Yuichiro; Okada, Naoko; Saito, Hirohisa; Moriyama, Hiroshi			Cholesteatoma Fibroblasts Promote Epithelial Cell Proliferation through Overexpression of Epiregulin	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MIDDLE-EAR CHOLESTEATOMA; MESSENGER-RNA EXPRESSION; FACTOR RECEPTOR; CANCER-CELLS; AMPHIREGULIN; STROMA; INTERLEUKIN-1-ALPHA; BETACELLULIN; ANGIOGENESIS	To investigate whether keratinocytes proliferate in response to epiregulin produced by subepithelial fibroblasts derived from middle ear cholesteatoma. Tissue samples were obtained from patients undergoing tympanoplasty. The quantitative polymerase chain reaction and immunohistochemistry were performed to examine epiregulin expression and localization in cholesteatoma tissues and retroauricular skin tissues. Fibroblasts were cultured from cholesteatoma tissues and from normal retroauricular skin. These fibroblasts were used as feeder cells for culture with a human keratinocyte cell line (PHK16-0b). To investigate the role of epiregulin in colony formation by PHK16-0b cells, epiregulin mRNA expression was knocked down in fibroblasts by using short interfering RNA and epiregulin protein was blocked with a neutralizing antibody. Epiregulin mRNA expression was significantly elevated in cholesteatoma tissues compared with that in normal retroauricular skin. Staining for epiregulin was more intense in the epithelial cells and subepithelial fibroblasts of cholesteatoma tissues than in retroauricular skin. When PHK16-0b cells were cultured with cholesteatoma fibroblasts, their colony-forming efficiency was 50% higher than when these cells were cultured with normal skin fibroblasts. Also, knockdown of epiregulin mRNA in cholesteatoma fibroblasts led to greater suppression of colony formation than knockdown in skin fibroblasts. Furthermore, the colony-forming efficiency of PHK16-0b cells was significantly reduced after treatment with an epiregulin neutralizing antibody in co-culture with cholesteatoma fibroblasts, but not in co-culture with skin fibroblasts. These results suggest that keratinocyte hyperproliferation in cholesteatoma is promoted through overexpression of epiregulin by subepithelial fibroblasts via epithelial-mesenchymal interactions, which may play a crucial role in the pathogenesis of middle ear cholesteatoma.	[Yoshikawa, Mamoru] Toho Univ, Sch Med, Dept Otorhinolaryngol, Meguro Ku, Tokyo, Japan; [Kojima, Hiromi; Yaguchi, Yuichiro; Moriyama, Hiroshi] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Minato Ku, Tokyo, Japan; [Okada, Naoko; Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, Tokyo, Japan	Toho University; Jikei University; National Center for Child Health & Development - Japan	Yoshikawa, M (corresponding author), Toho Univ, Sch Med, Dept Otorhinolaryngol, Meguro Ku, Tokyo, Japan.	mamoru.yoshikawa@med.toho-u.ac.jp	岡田, 直子/GRI-9555-2022	岡田, 直子/0000-0002-3378-5778; Saito, Hirohisa/0000-0002-6630-8337	KAKEN; Grants-in-Aid for Scientific Research [24592582] Funding Source: KAKEN	KAKEN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKEN (http://kaken.nii.ac.jp/d/p/22591891.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Chung JW, 1998, ACTA OTO-LARYNGOL, V118, P386; El Ghalbzouri A, 2002, CELL TISSUE RES, V310, P189, DOI 10.1007/s00441-002-0621-0; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Inatomi O, 2006, INT J MOL MED, V18, P497; Ishibashi T, 1997, ACTA OTO-LARYNGOL, V117, P714, DOI 10.3109/00016489709113465; Kaminski A, 2006, INT J MOL MED, V18, P941; KOJIMA H, 1994, ACTA OTO-LARYNGOL, V114, P423, DOI 10.3109/00016489409126081; Kojima H, 1996, ARCH OTOLARYNGOL, V122, P157; Komurasaki T, 1997, ONCOGENE, V15, P2841, DOI 10.1038/sj.onc.1201458; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Kuramochi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-88; Li SW, 2008, P NATL ACAD SCI USA, V105, P3539, DOI 10.1073/pnas.0712397105; Li XD, 2010, ONKOLOGIE, V33, P353, DOI 10.1159/000315380; Lindvall C, 2003, CANCER RES, V63, P1743; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Olszewska E, 2004, EUR ARCH OTO-RHINO-L, V261, P6, DOI 10.1007/s00405-003-0623-x; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Riese DJ, 1996, ONCOGENE, V12, P345; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; SCHILLING V, 1992, AM J OTOL, V13, P350; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Shirakata Y, 2007, J DERMATOL SCI, V45, P69, DOI 10.1016/j.jdermsci.2006.08.010; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Sudhoff H, 2000, AM J OTOL, V21, P793; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; TOYODA H, 1995, J BIOL CHEM, V270, P7495, DOI 10.1074/jbc.270.13.7495; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Yamamoto T, 2004, ANTICANCER RES, V24, P2007; Yamamoto-Fukuda T, 2003, LAB INVEST, V83, P123, DOI 10.1097/01.LAB.0000050763.64145.CB; Yetiser S, 2002, OTOL NEUROTOL, V23, P647, DOI 10.1097/00129492-200209000-00007; Yoshikawa M, 2006, ARCH OTOLARYNGOL, V132, P734, DOI 10.1001/archotol.132.7.734	36	16	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66725	10.1371/journal.pone.0066725	http://dx.doi.org/10.1371/journal.pone.0066725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826119	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400039
J	Zeng, GH; Zhao, ZJ; Wan, SP; Zhong, W; Wu, WQ				Zeng, Guohua; Zhao, Zhijian; Wan, ShawPong; Zhong, Wen; Wu, Wenqi			Comparison of Children versus Adults Undergoing Mini-Percutaneous Nephrolithotomy: Large-Scale Analysis of a Single Institution	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; RENAL-CALCULI; EXPERIENCE; INFANTS; AGE; MANAGEMENT; CLASSIFICATION; COMPLICATIONS	Objective: As almost any version of percutaneous nephrolithotomy (PCNL) was safely and efficiently applied for adults as well as children without age being a limiting risk factor, the aim of the study was to compare the different characteristics as well as the efficacy, outcome, and safety of the pediatric and adult patients who had undergone mini-PCNL (MPCNL) in a single institution. Methods: We retrospective reviewed 331 renal units in children and 8537 renal units in adults that had undergone MPCNL for upper urinary tract stones between the years of 2000-2012. The safety, efficacy, and outcome were analyzed and compared. Results: The children had a smaller stone size (2.3 vs. 3.1 cm) but had smilar stone distribution (number and locations). The children required fewer percutaneous accesses, smaller nephrostomy tract, shorter operative time and less hemoglobin drop. The children also had higher initial stone free rate (SFR) (80.4% vs. 78.6%) after single session of MPCNL (p<0.05); but no difference was noted in the final SFR (94.7% vs. 93.5%) after auxiliary procedures. The complication rate (15.6% vs. 16.3%) and blood transfusion rate (3.1% vs. 2.9%) were similar in both group (p>0.05). Both groups had low rate of high grade Clavien complications. There was no grade III, IV, V complications and no angiographic embolization required in pediatric group. One important caveat, children who required multiple percutaneous nephrostomy tracts had significant higher transfusion rate than in adults (18.8% vs. 4.5%, p = 0.007). Conclusions: This contemporary largest-scale analysis confirms that the stone-free rate in pediatric patients is at least as good as in adults without an increase of complication rates. However, multiple percutaneous nephrostomy tracts should be practiced with caution in children.	[Zeng, Guohua; Zhao, Zhijian; Wan, ShawPong; Zhong, Wen; Wu, Wenqi] Guangzhou Med Univ, Affiliated Hosp 1, Dept Urol, Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China; [Zeng, Guohua; Zhao, Zhijian; Wan, ShawPong; Zhong, Wen; Wu, Wenqi] Guangdong Prov Key Lab Urol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Urol, Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.tom.com	Zhong, Wen/L-2138-2017	Zhong, Wen/0000-0003-0540-7195	National Natural Science Foundation, China [81170652]; Science and Technology Education Department of the Ministry of Health, China [201002010]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Science and Technology Education Department of the Ministry of Health, China	This work was supported by grants from National Natural Science Foundation, China (No. 81170652) and Science and Technology Education Department of the Ministry of Health, China (No. 201002010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2004, J UROLOGY, V172, P1600, DOI 10.1097/01.ju.0000138525.14552.1b; Anand A, 2010, J ENDOUROL, V24, P1725, DOI 10.1089/end.2010.0164; Aron M, 2005, J ENDOUROL, V19, P968, DOI 10.1089/end.2005.19.968; Badawy H, 1999, J UROLOGY, V162, P1710, DOI 10.1016/S0022-5347(05)68220-1; Bilen CY, 2010, J UROLOGY, V184, P2498, DOI 10.1016/j.juro.2010.08.039; Bilen CY, 2007, J UROLOGY, V177, P1867, DOI 10.1016/j.juro.2007.01.052; Desai MR, 2004, J ENDOUROL, V18, P23, DOI 10.1089/089277904322836613; Ei-Nahas AR, 2008, J UROLOGY, V180, P676, DOI 10.1016/j.juro.2008.04.046; Falahatkar S, 2011, J ENDOUROL, V25, P1831, DOI 10.1089/end.2011.0278; Guven S, 2013, BJU INT, V111, P148, DOI 10.1111/j.1464-410X.2012.11239.x; Guven S, 2010, UROL INT, V85, P455, DOI 10.1159/000316077; Jackman SV, 1998, UROLOGY, V52, P697, DOI 10.1016/S0090-4295(98)00315-X; Manohar T, 2006, J ENDOUROL, V20, P547, DOI 10.1089/end.2006.20.547; Ozden E, 2011, J UROLOGY, V185, P264, DOI 10.1016/j.juro.2010.09.023; Ozden Ender, 2008, J Pediatr Urol, V4, P295, DOI 10.1016/j.jpurol.2008.01.212; Salah MA, 2004, WORLD J UROL, V22, P277, DOI 10.1007/s00345-004-0454-4; Samad L, 2006, BJU INT, V97, P359, DOI 10.1111/j.1464-410X.2006.05932.x; Samad Lubna, 2007, J Pediatr Urol, V3, P36, DOI 10.1016/j.jpurol.2006.02.001; Smaldone MC, 2010, UROL CLIN N AM, V37, P253, DOI 10.1016/j.ucl.2010.03.006; Tefekli A, 2008, EUR UROL, V53, P184, DOI 10.1016/j.eururo.2007.06.049; Zeng GH, 2012, UROLOGY, V80, P408, DOI 10.1016/j.urology.2012.04.058; Zeren S, 2002, J ENDOUROL, V16, P75, DOI 10.1089/089277902753619546	22	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66850	10.1371/journal.pone.0066850	http://dx.doi.org/10.1371/journal.pone.0066850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826158	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400068
J	Van Colen, C; Thrush, SF; Vincx, M; Ysebaert, T				Van Colen, Carl; Thrush, Simon F.; Vincx, Magda; Ysebaert, Tom			Conditional Responses of Benthic Communities to Interference from an Intertidal Bivalve	PLOS ONE			English	Article							CERASTODERMA-EDULE; TERRIGENOUS SEDIMENT; ECOSYSTEM SERVICES; MACOMA-BALTHICA; COASTAL; HABITATS; HYDRODYNAMICS; DISTURBANCE; RESILIENCE; SANDFLATS	Habitat-modifying organisms that impact other organisms and local functioning are important in determining ecosystem resilience. However, it is often unclear how the outcome of interactions performed by key species varies depending on the spatial and temporal disturbance context which makes the prediction of disturbance-driven regime shifts difficult. We investigated the strength and generality of effects of the filter feeding cockle Cerastoderma edule on its ambient intertidal benthic physical and biological environment. By comparing the magnitude of the effect of experimental cockle removal between a non-cohesive and a sheltered cohesive sediment in two different periods of the year, we show that the outcome of cockle interference effects relates to differences in physical disturbance, and to temporal changes in suspended sediment load and ontogenetic changes in organism traits. Interference effects were only present in the cohesive sediments, though the effects varied seasonally. Cockle presence decreased only the density of surface-dwelling species suggesting that interference effects were particularly mediated by bioturbation of the surface sediments. Furthermore, density reductions in the presence of cockles were most pronounced during the season when larvae and juveniles were present, suggesting that these life history stages are most vulnerable to interference competition. We further illustrate that cockles may enhance benthic microalgal biomass, most likely through the reduction of surface-dwelling grazing species, especially in periods with high sediment load and supposedly also high bioturbation rates. Our results emphasize that the physical disturbance of the sediment may obliterate biotic interactions, and that temporal changes in environmental stressors, such as suspended sediments, may affect the outcome of key species interference effects at the local scale. Consequently, natural processes and anthropogenic activities that change bed shear stress and sediment dynamics in coastal soft-sediment systems will affect cockle-mediated influences on ecosystem properties and therefore the resilience of these systems to environmental change.	[Van Colen, Carl; Vincx, Magda] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Thrush, Simon F.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [Thrush, Simon F.] Univ Auckland, Sch Environm, Auckland 1, New Zealand; [Ysebaert, Tom] Netherlands Inst Sea Res NIOZ Yerseke, Yerseke, Netherlands	Ghent University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Auckland; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Van Colen, C (corresponding author), Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium.	carl.vancolen@ugent.be		Thrush, Simon/0000-0002-4005-3882	Flemish Fund for Scientific Research FWO [FWO-1.2.380.11.N.00]; Ghent University [BOF-GOA 01GA1911W]; Marie Curie International Fellowship [FP7-PEOPLE-2007-4-2-IIF-ENV221065]	Flemish Fund for Scientific Research FWO(FWO); Ghent University(Ghent University); Marie Curie International Fellowship(European Commission)	CVC is a postdoctoral fellow of the Flemish Fund for Scientific Research FWO (FWO-1.2.380.11.N.00). Additional financial support for this study came from the special research fund of Ghent University through project BOF-GOA 01GA1911W and a Marie Curie International Fellowship to SFT (FP7-PEOPLE-2007-4-2-IIF-ENV221065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson M.J., 2008, PERMANOVA PRIMER GUI; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Braeckman U, 2011, MAR ECOL PROG SER, V422, P179, DOI 10.3354/meps08910; Cesar CP, 2009, MAR ECOL-EVOL PERSP, V30, P123, DOI 10.1111/j.1439-0485.2009.00305.x; Chen MS, 2005, HYDROBIOLOGIA, V540, P79, DOI 10.1007/s10750-004-7122-y; Ciutat A, 2007, J EXP MAR BIOL ECOL, V346, P114, DOI 10.1016/j.jembe.2007.03.005; Commito JA, 1995, LIMNOL OCEANOGR, V40, P1513, DOI 10.4319/lo.1995.40.8.1513; COOSEN J, 1994, HYDROBIOLOGIA, V283, P235; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Flach EC, 1996, MAR ECOL-P S Z N I, V17, P87, DOI 10.1111/j.1439-0485.1996.tb00492.x; Gam M, 2010, J SEA RES, V63, P191, DOI 10.1016/j.seares.2010.01.003; Gorley C.K., 2006, GETTING STARTED PRIM; Grabowski RC, 2011, EARTH-SCI REV, V105, P101, DOI 10.1016/j.earscirev.2011.01.008; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; Hiddink JG, 2002, MAR BIOL, V140, P1149, DOI 10.1007/s00227-002-0794-9; Hunt HL, 2004, J EXP MAR BIOL ECOL, V312, P271, DOI 10.1016/j.jembe.2004.07.010; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Le Hir P, 2000, CONT SHELF RES, V20, P1433, DOI 10.1016/S0278-4343(00)00031-5; Lohrer AM, 2006, MAR ECOL PROG SER, V307, P115, DOI 10.3354/meps307115; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Montserrat F, 2009, ESTUAR COAST SHELF S, V83, P379, DOI 10.1016/j.ecss.2009.04.010; Navarro JM, 1997, MAR ECOL PROG SER, V152, P175, DOI 10.3354/meps152175; Norkko A, 2006, ECOLOGY, V87, P226, DOI 10.1890/05-0176; Rodil IF, 2011, ECOL APPL, V21, P416, DOI 10.1890/09-1845.1; Rossi F, 2008, MAR ECOL PROG SER, V354, P47, DOI 10.3354/meps07213; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; Struyf E, 1995, HYDROBIOLOGIA, V540, P26; Thrush SF, 2012, ECOL APPL, V22, P1213, DOI 10.1890/11-1403.1; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thrush SF, 2000, ECOLOGY, V81, P399, DOI 10.2307/177436; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Troost K, 2008, J SEA RES, V60, P157, DOI 10.1016/j.seares.2008.04.006; Van Colen C, 2010, MAR ECOL PROG SER, V406, P79, DOI 10.3354/meps08529; Van Colen C, 2010, J EXP MAR BIOL ECOL, V385, P79, DOI 10.1016/j.jembe.2010.01.009; Van Colen C, 2010, MAR POLLUT BULL, V60, P178, DOI 10.1016/j.marpolbul.2009.09.028; Van Colen C, 2008, MAR ECOL PROG SER, V372, P31, DOI 10.3354/meps07640; Van Colen C, 2009, MAR BIOL, V156, P2161, DOI 10.1007/s00227-009-1246-6; Wijnhoven S, 2011, MARINE ECOLOGY, V32, P1; Woodin SA, 2012, J EXP MAR BIOL ECOL, V413, P184, DOI 10.1016/j.jembe.2011.12.010	42	19	19	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65861	10.1371/journal.pone.0065861	http://dx.doi.org/10.1371/journal.pone.0065861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824689	Green Published, gold			2022-12-27	WOS:000320576400026
J	Lin, CM; Fang, CL; Hseu, YC; Chen, CL; Wang, JW; Hsu, SL; Tu, MD; Hung, ST; Tai, C; Uen, YH; Lin, KY				Lin, Chun-Mao; Fang, Chia-Lang; Hseu, You-Cheng; Chen, Chun-Liang; Wang, Jin-Wun; Hsu, Sheng-Lung; Tu, Ming-Dao; Hung, Shih-Ting; Tai, Chein; Uen, Yih-Huei; Lin, Kai-Yuan			Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR INVASION; EXPRESSION; GENES; MICRORNAS; CARCINOMA; APOPTOSIS; PROTEIN; MOUSE; MICE	Colon cancer is one of the most common malignant cancers worldwide but the current therapeutic approaches for advanced colon cancer are less efficient. This study investigated associations between the expression of nuclear transcription factor SOX4 and various clinicopathologic parameters as well as patients' survival. Expression levels of nuclear SOX4 were analyzed by immunohistochemistry; the data comprised colon tissues from 263 patients with colon cancer. Paired t tests were used to analyze the differences in nuclear SOX4 expression between tumor and non-tumor tissues from each patient. Two-tailed X-2 tests were performed to determine whether the differences in nuclear SOX4 expression and clinicopathologic parameters were significant. Time-to-event endpoints for clinicopathologic parameters were plotted using the Kaplan-Meier method, and statistical significance was determined using univariate log-rank tests. Cox proportional hazard model was used for multivariate analysis to determine the independence of prognostic effects of nuclear SOX4 expression. Overexpression of nuclear SOX4 was significantly correlated with depth of invasion (P = 0.0041), distant metastasis (P < 0.0001), and stage (P = 0.0001). Patients who displayed high expression levels of nuclear SOX4 achieved a significantly poorer disease-free survival rate, compared with patients with low SOX4 expression levels (P < 0.001). Univariate Cox regression analysis showed that overexpression of nuclear SOX4 was a clear prognostic marker for colon cancer (P = 0.001). Overexpression of nuclear SOX4 may be used as a marker to predict the outcome of patients with colon cancer.	[Lin, Chun-Mao] Taipei Med Univ, Coll Med, Sch Med, Dept Biochem, Taipei, Taiwan; [Lin, Chun-Mao] Taipei Med Univ Hosp, Orthoped Res Ctr, Taipei, Taiwan; [Fang, Chia-Lang] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan; [Fang, Chia-Lang] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Hseu, You-Cheng] China Med Univ, Dept Cosmeceut, Taichung, Taiwan; [Hseu, You-Cheng] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Chun-Liang; Wang, Jin-Wun; Hsu, Sheng-Lung] Chi Mei Hosp Chiali, Dept Surg, Tainan, Taiwan; [Tu, Ming-Dao] Chi Mei Hosp Chiali, Dept Family Med, Tainan, Taiwan; [Hung, Shih-Ting; Uen, Yih-Huei; Lin, Kai-Yuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Tai, Chein] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Uen, Yih-Huei] Chi Mei Hosp Chiali, Superintendents Off, Tainan, Taiwan; [Uen, Yih-Huei] Southern Taiwan Univ Sci & Technol, Inst Biomed Engn, Tainan, Taiwan; [Lin, Kai-Yuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Southern Taiwan University of Science & Technology; Chia Nan University of Pharmacy & Science	Lin, KY (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	d84306@yahoo.com.tw		Lin, Chun-Mao/0000-0002-8366-4026	Chi Mei Medical Center [101CM-TMU-03]	Chi Mei Medical Center	This work was supported by a grant from Chi Mei Medical Center (Grant No. 101CM-TMU-03) (http://www.chimei.org. tw). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kwon KA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-203; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Shin MS, 2004, CANCER RES, V64, P4419, DOI 10.1158/0008-5472.CAN-03-3885; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Voulgari A, 2009, BIOCHIM BIOPHYS ACTA, V1796, P5; Wang CG, 2010, WORLD J GASTROENTERO, V16, P2421, DOI 10.3748/wjg.v16.i19.2421; Wang CG, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-41; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67128	10.1371/journal.pone.0067128	http://dx.doi.org/10.1371/journal.pone.0067128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826209	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000030
J	Kyle, LM; John, TR; Schatzl, HM; Lewis, RV				Kyle, Leah M.; John, Theodore R.; Schaetzl, Hermann M.; Lewis, Randolph V.			Introducing a Rigid Loop Structure from Deer into Mouse Prion Protein Increases Its Propensity for Misfolding In Vitro	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; TRANSGENIC MICE; SPONGIFORM ENCEPHALOPATHIES; THERMODYNAMIC STABILITY; BETA-2-ALPHA-2 LOOP; INFECTIOUS PRIONS; LIPID-MEMBRANES; MOLECULAR-BASIS; NMR STRUCTURE; CONVERSION	Prion diseases are fatal neurodegenerative disorders characterized by misfolding of the cellular prion protein (PrPc) into the disease-associated isoform (PrPSc) that has increased beta-sheet content and partial resistance to proteolytic digestion. Prion diseases from different mammalian species have varying propensities for transmission upon exposure of an uninfected host to the infectious agent. Chronic Wasting Disease (CWD) is a highly transmissible prion disease that affects free ranging and farmed populations of cervids including deer, elk and moose, as well as other mammals in experimental settings. The molecular mechanisms allowing CWD to maintain comparatively high transmission rates have not been determined. Previous work has identified a unique structural feature in cervid PrP, a rigid loop between beta-sheet 2 and alpha-helix 2 on the surface of the protein. This study was designed to test the hypothesis that the rigid loop has a direct influence on the misfolding process. The rigid loop was introduced into murine PrP as the result of two amino acid substitutions: S170N and N174T. Wild-type and rigid loop murine PrP were expressed in E. coli and purified. Misfolding propensity was compared for the two proteins using biochemical techniques and cell free misfolding and conversion systems. Murine PrP with a rigid loop misfolded in cell free systems with greater propensity than wild type murine PrP. In a lipid-based conversion assay, rigid loop PrP converted to a PK resistant, aggregated isoform at lower concentrations than wild-type PrP. Using both proteins as substrates in real time quaking-induced conversion, rigid loop PrP adopted a misfolded isoform more readily than wild type PrP. Taken together, these findings may help explain the high transmission rates observed for CWD within cervids.	[Kyle, Leah M.; Schaetzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [John, Theodore R.; Schaetzl, Hermann M.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Lewis, Randolph V.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Lewis, Randolph V.] Utah State Univ, Synthet Bioprod Inst, Logan, UT 84322 USA	University of Wyoming; University of Wyoming; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Schatzl, HM (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	hschatzl@uwyo.edu		Schatzl, Hermann/0000-0003-4972-8740	Department of Defense [DOD 030542]; National Institute of Health [R01 NS076853-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Department of Defense (DOD 030542, to RVL), the National Institute of Health (R01 NS076853-01A1, to HMS), and was performed within the framework of the Wyoming Endowed Excellence Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Apetri AC, 2002, J BIOL CHEM, V277, P44589, DOI 10.1074/jbc.C200507200; Apetri AC, 2006, J AM CHEM SOC, V128, P11673, DOI 10.1021/ja063880b; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; Bett C, 2012, FASEB J, V26, P2868, DOI 10.1096/fj.11-200923; Bujdoso R, 2005, PROTEINS, V61, P840, DOI 10.1002/prot.20755; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Fasano C, 2006, J MOL NEUROSCI, V29, P195, DOI 10.1385/JMN:29:3:195; Fitzmaurice TJ, 2008, BIOCHEM J, V409, P367, DOI 10.1042/BJ20071122; Gilch S, 2011, TOP CURR CHEM, V305, P51, DOI 10.1007/128_2011_159; Gill AC, 2010, PRION, V4, P235, DOI 10.4161/pri.4.4.13394; Gorfe AA, 2007, FASEB J, V21, P3279, DOI 10.1096/fj.07-8292com; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Hasegawa K, 2010, PRION, V4, P38, DOI 10.4161/pri.4.1.10890; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; Paludi D, 2007, J NEUROCHEM, V103, P2291, DOI 10.1111/j.1471-4159.2007.04934.x; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Priola SA, 2006, MOL BIOTECHNOL, V33, P71; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Seelig DM, 2010, AM J PATHOL, V176, P2785, DOI 10.2353/ajpath.2010.090710; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Supattapone S, 2012, PRION, V6, DOI 10.4161/pri.21826; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Tamguney G, 2013, J GEN VIROL, V94, P443, DOI 10.1099/vir.0.045989-0; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Telling GC, 2011, TOP CURR CHEM, V305, P79, DOI 10.1007/128_2011_166; van der Kamp MW, 2009, PROTEIN ENG DES SEL, V22, P461, DOI 10.1093/protein/gzp039; Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	70	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66715	10.1371/journal.pone.0066715	http://dx.doi.org/10.1371/journal.pone.0066715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825561	gold, Green Submitted, Green Published			2022-12-27	WOS:000321223000024
J	Lambdin, BH; Bruce, RD; Chang, O; Nyandindi, C; Sabuni, N; Zamudio-Haas, S; McCurdy, S; Masao, F; Ivo, Y; Msami, A; Ubuguy, O; Mbwambo, J				Lambdin, Barrot H.; Bruce, R. Douglas; Chang, Olivia; Nyandindi, Cassian; Sabuni, Norman; Zamudio-Haas, Sophia; McCurdy, Sheryl; Masao, Frank; Ivo, Yovin; Msami, Amani; Ubuguy, Omar; Mbwambo, Jessie			Identifying Programmatic Gaps: Inequities in Harm Reduction Service Utilization among Male and Female Drug Users in Dar es Salaam, Tanzania	PLOS ONE			English	Article							GENDER INEQUALITY; HIV-INFECTION; WOMENS RISK; HEROIN; SAMPLE; MOSHI	Introduction: Current estimates suggest an HIV prevalence of 42% among people who inject drugs (PWIDs) in Dar es Salaam, while HIV prevalence is estimated to be 8.8% among the general population in the city. To address the HIV epidemic in this population, the government of Tanzania began establishing HIV prevention, treatment and care services including outreach and medication assisted treatment (MAT) for PWIDs in 2010. We assessed gender inequities in utilization of outreach and MAT services and evaluated differences in HIV risk behaviors between female and male PWIDs. Materials and Methods: Routine outreach data between December 2010 to mid-August 2012 and baseline data on clients enrolling in methadone from February 2011 to August 2012 were utilized. Binomial regression was used to estimate adjusted relative risk estimates comparing females to males. Results: From December 2010 to August 2012, 8,578 contacts were made to drug users; among them 1,898 were injectors. A total of 453 injectors were eligible and referred to MAT, of which, 443 enrolled in treatment. However, regarding total outreach contacts, outreach to PWID, referral to MAT and enrollment in MAT, 8% or less of drug users accessing services were women. In contrast, weighted estimations from surveys suggest that 34% of PWIDs are female, and this approximation is similar to recent population size estimations. Overall, 43% of traditional outreach workers conducting outreach with drug users were female. Though reporting higher levels of condom usage, female PWID were more likely to report multiple sex partners, anal sex, commercial sex work and struggle under a higher burden of addiction, mental disorders and abuse. Conclusions: Services have not been mobilized adequately to address the clear needs of females who inject drugs. A clear and urgent need exists for women-centered strategies that effectively engage female PWID into HIV prevention services.	[Lambdin, Barrot H.; Bruce, R. Douglas; Chang, Olivia] Pangaea Global AIDS Fdn, Oakland, CA USA; [Lambdin, Barrot H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Bruce, R. Douglas] Yale Univ, Sch Med, New Haven, CT USA; [Nyandindi, Cassian; Masao, Frank; Ubuguy, Omar; Mbwambo, Jessie] Muhimbili Univ Hlth & Allied Sci, Dept Psychiat, Dar Es Salaam, Tanzania; [Sabuni, Norman] Minist Hlth & Social Welf, Dept Mental Hlth & Substance Abuse, Dar Es Salaam, Tanzania; [Zamudio-Haas, Sophia] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [McCurdy, Sheryl] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Ivo, Yovin; Msami, Amani] Drug Control Commiss, Off Prime Minist, Dar Es Salaam, Tanzania	University of Washington; University of Washington Seattle; Yale University; Muhimbili University of Health & Allied Sciences; University of California System; University of California Berkeley; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Lambdin, BH (corresponding author), Pangaea Global AIDS Fdn, Oakland, CA USA.	blambdin@pgaf.org		McCurdy, Sheryl/0000-0003-0526-1608; Bruce, Robert/0000-0003-4184-8748	Drug Control Commission of Tanzania	Drug Control Commission of Tanzania	This work was supported by a contract from the Drug Control Commission of Tanzania. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claeson M, 2011, J PUBLIC HEALTH POL, V32, P231, DOI 10.1057/jphp.2011.11; El-Bassel N, 2010, LANCET, V376, P312, DOI 10.1016/S0140-6736(10)61026-4; Greenfield SF, 2007, DRUG ALCOHOL DEPEN, V86, P1, DOI 10.1016/j.drugalcdep.2006.05.012; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McCloskey LA, 2005, INT FAM PLAN PERSPEC, V31, P124, DOI 10.1363/3112405; McCurdy SA, 2005, AIDS CARE, V17, pS65, DOI 10.1080/09540120500120930; Mccurdy SA, 2011, COMMUNICATION; McCurdy S, 2007, INT J DRUG POLICY, V18, P155, DOI 10.1016/j.drugpo.2007.05.001; McCurdy SA, 2006, DRUG ALCOHOL DEPEN, V82, pS23, DOI 10.1016/S0376-8716(06)80004-9; McCurdy SA, 2010, ADDICTION, V105, P1062, DOI 10.1111/j.1360-0443.2010.02908.x; Nyandindi C, 2013, PLOS ONE IN PRESS; Pinkham S, 2008, REPROD HEALTH MATTER, V16, P168, DOI 10.1016/S0968-8080(08)31345-7; Ross MW, 2008, AM J TROP MED HYG, V79, P338, DOI 10.4269/ajtmh.2008.79.338; Sa ZH, 2008, J BIOSOC SCI, V40, P505, DOI 10.1017/S002193200700257X; STEFANIS CN, 1986, PSYCHOPATHOLOGY, V19, P124, DOI 10.1159/000285143; TACAIDS ZAC NBS OCGS ICF International, 2013, TANZ HIV AIDS IND SU; Tanzanian Drug Control Commission, 2009, INJ DRUG US EST TANZ; UNAIDS/WHO, 2010, GUID EST SIZ POP MOS; United Nations Office of Drugs and Crime, 2011, GLOB AFGH OP TRAD TH; United Nations Office on Drugs and Crime (UNODC), 2006, HIV AIDS PREV CAR FE; United Nations Programme on HIV/AIDS (UNAIDS), 2012, GLOB REP REP GLOB AI; Williams ML, 2007, AIDS BEHAV, V11, P137, DOI 10.1007/s10461-006-9102-x; Williams ML, 2009, AIDS EDUC PREV, V21, P474, DOI 10.1521/aeap.2009.21.5.474; Zierler S, 1997, ANNU REV PUBL HEALTH, V18, P401, DOI 10.1146/annurev.publhealth.18.1.401	24	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67062	10.1371/journal.pone.0067062	http://dx.doi.org/10.1371/journal.pone.0067062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175IB	23825620	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000072
J	Mohlendick, B; Bartenhagen, C; Behrens, B; Honisch, E; Raba, K; Knoefel, WT; Stoecklein, NH				Moehlendick, Birte; Bartenhagen, Christoph; Behrens, Bianca; Honisch, Ellen; Raba, Katharina; Knoefel, Wolfram T.; Stoecklein, Nikolas H.			A Robust Method to Analyze Copy Number Alterations of Less than 100 kb in Single Cells Using Oligonucleotide Array CGH	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; POLYMERASE-CHAIN-REACTION; DISSEMINATED TUMOR-CELLS; CORRESPONDING METASTASES; SEQUENCING LIBRARIES; GENETIC-ANALYSIS; AMPLIFICATION; CANCER; DNA; SAMPLES	Comprehensive genome wide analyses of single cells became increasingly important in cancer research, but remain to be a technically challenging task. Here, we provide a protocol for array comparative genomic hybridization (aCGH) of single cells. The protocol is based on an established adapter-linker PCR (WGAM) and allowed us to detect copy number alterations as small as 56 kb in single cells. In addition we report on factors influencing the success of single cell aCGH downstream of the amplification method, including the characteristics of the reference DNA, the labeling technique, the amount of input DNA, reamplification, the aCGH resolution, and data analysis. In comparison with two other commercially available non-linear single cell amplification methods, WGAM showed a very good performance in aCGH experiments. Finally, we demonstrate that cancer cells that were processed and identified by the CellSearch (R) System and that were subsequently isolated from the CellSearch (R) cartridge as single cells by fluorescence activated cell sorting (FACS) could be successfully analyzed using our WGAM-aCGH protocol. We believe that even in the era of next-generation sequencing, our single cell aCGH protocol will be a useful and (cost-) effective approach to study copy number alterations in single cells at resolution comparable to those reported currently for single cell digital karyotyping based on next generation sequencing data.	[Moehlendick, Birte; Behrens, Bianca; Knoefel, Wolfram T.; Stoecklein, Nikolas H.] Univ Dusseldorf, Dept Surg A, D-40225 Dusseldorf, Germany; [Moehlendick, Birte; Behrens, Bianca; Honisch, Ellen; Raba, Katharina; Knoefel, Wolfram T.; Stoecklein, Nikolas H.] Univ Hosp Dusseldorf, Dusseldorf, Germany; [Bartenhagen, Christoph] Univ Munster, Inst Med Informat, D-48149 Munster, Germany; [Honisch, Ellen] Univ Dusseldorf, Dept Obstet & Gynecol, D-40225 Dusseldorf, Germany; [Raba, Katharina] Univ Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Munster; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Mohlendick, B (corresponding author), Univ Dusseldorf, Dept Surg A, D-40225 Dusseldorf, Germany.	birte.moehlendick@uni-duesseldorf.de; nikolas.stoecklein@uni-duesseldorf.de	Raba, Katharina/B-8697-2017; Bartenhagen, Christoph/A-7814-2013	Raba, Katharina/0000-0001-8818-4219; Mohlendick, Birte/0000-0001-9093-8585	Deutsche Forschungsgemeinschaft (DFG) [STO 464/2-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) STO 464/2-2 to NHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Arneson Nona, 2012, ISRN Oncol, V2012, P710692, DOI 10.5402/2012/710692; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bi WM, 2012, PRENATAL DIAG, V32, P10, DOI 10.1002/pd.2855; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cheng JQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r80; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Dong H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-60; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; Fuhrmann C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn101; Gangnus R, 2004, CLIN CANCER RES, V10, P3457, DOI 10.1158/1078-0432.CCR-03-0818; Geigl JB, 2007, NAT PROTOC, V2, P3173, DOI 10.1038/nprot.2007.476; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gray JW, 2003, CANCER CELL, V4, P4, DOI 10.1016/S1535-6108(03)00167-3; Hjortland GO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-455; Hostetter G, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp881; Kalikaki A, 2008, BRIT J CANCER, V99, P923, DOI 10.1038/sj.bjc.6604629; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Knijnenburg J, 2007, CYTOM PART A, V71A, P585, DOI 10.1002/cyto.a.20412; Konings P, 2012, NAT PROTOC, V7, P281, DOI 10.1038/nprot.2011.426; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; Le Caignec C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl336; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Mathiesen RR, 2012, INT J CANCER, V131, pE405, DOI 10.1002/ijc.26444; Misale S, 2012, NATURE; Navin N, 2011, GENOME MED, V3, DOI 10.1186/gm247; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Pirker C, 2004, CYTOM PART A, V61A, P26, DOI 10.1002/cyto.a.20060; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shih IM, 2011, MODERN PATHOL, V24, P638, DOI 10.1038/modpathol.2010.230; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stoecklein NH, 2002, AM J PATHOL, V161, P43, DOI 10.1016/S0002-9440(10)64155-7; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Tsubosa Y, 2005, CANCER GENET CYTOGEN, V158, P156, DOI 10.1016/j.cancergencyto.2004.08.033; Vermaat JS, 2012, CLIN CANCER RES, V18, P688, DOI 10.1158/1078-0432.CCR-11-1965; Weckermann D, 2009, J CLIN ONCOL, V27, P1549, DOI 10.1200/JCO.2008.17.0563; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456	46	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67031	10.1371/journal.pone.0067031	http://dx.doi.org/10.1371/journal.pone.0067031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825608	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000060
J	Sommers, CL; Rouquette-Jazdanian, AK; Robles, AI; Kortum, RL; Merrill, RK; Li, WM; Nath, N; Wohlfert, E; Sixt, KM; Belkaid, Y; Samelson, LE				Sommers, Connie L.; Rouquette-Jazdanian, Alexandre K.; Robles, Ana I.; Kortum, Robert L.; Merrill, Robert K.; Li, Wenmei; Nath, Nandan; Wohlfert, Elizabeth; Sixt, Katherine M.; Belkaid, Yasmine; Samelson, Lawrence E.			miRNA Signature of Mouse Helper T Cell Hyper-Proliferation	PLOS ONE			English	Article							LYMPHOPROLIFERATIVE DISEASE; HOMEOSTATIC PROLIFERATION; ERK ACTIVATION; EXPRESSION; MIR-146A; LAT; MICRORNA-21; NAIVE; MODULATOR; SURVIVAL	Helper T cells from a mutant mouse model, LAT Y136F, hyper-proliferate and cause a severe lymphoproliferative disease that kills the mice by six months of age. LAT Y136F mice carry a tyrosine to phenylalanine mutation in the Linker for Activation of T cells (LAT) gene. This mutation leads to a number of changes in T cells that result in altered cytokine production including increased IL-4 production, increased proliferation, and decreased apoptosis. Hyper-proliferation of the mutant T cells contributes to lymphadenopathy, splenomegaly, and multi-organ T cell infiltration. miRNAs are short non-coding RNAs that regulate expression of cohorts of genes. This study investigates which miRNAs are expressed in LAT Y136F T cells and compares these to miRNAs expressed in wild type T cells that are undergoing proliferation in two other settings. The first setting is homeostatic proliferation, which was modeled by adoptive transfer of wild type T cells into T cell-deficient mice. The second setting is proliferation in response to infection, which was modeled by infection of wild type mice with the nematode H. polygyrus. By comparing miRNA expression in these three proliferative states (LAT Y136F hyper-proliferation, homeostatic proliferation and proliferation in response to H. polygyrus infection) to expression in wild type naive CD4(+) T cells, we found miRNAs that were highly regulated in all three proliferative states (miR-21 and miR-146a) and some that were more specific to individual settings of proliferation such as those more specific for LAT Y136F lymphoproliferative disease (miR-669f, miR-155 and miR-466a/b). Future experiments that modulate levels of the miRNAs identified in this study may reveal the roles of these miRNAs in T cell proliferation and/or lymphoproliferative disease.	[Sommers, Connie L.; Rouquette-Jazdanian, Alexandre K.; Kortum, Robert L.; Merrill, Robert K.; Li, Wenmei; Nath, Nandan; Sixt, Katherine M.; Samelson, Lawrence E.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Robles, Ana I.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sommers, Connie L.; Wohlfert, Elizabeth; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sommers, CL (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	sommersc@helix.nih.gov	wohlfert, beth/ABA-2255-2020	ROUQUETTE-JAZDANIAN, Alexandre K./0000-0003-2646-0040; Belkaid, Yasmine/0000-0001-9962-3571; Robles, Ana/0000-0001-5019-4374	National Cancer Institute Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010304] Funding Source: NIH RePORTER	National Cancer Institute Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Bhatti I, 2011, J GASTROINTEST SURG, V15, P199, DOI 10.1007/s11605-010-1381-x; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Cervo PRD, 2012, P NATL ACAD SCI USA, V109, P1133, DOI 10.1073/pnas.1112257109; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037366; Fenoglio C, 2011, NEUROSCI LETT, V504, P9, DOI 10.1016/j.neulet.2011.08.021; Garchow BG, 2011, EMBO MOL MED, V3, P605, DOI 10.1002/emmm.201100171; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kortum RL, 2013, TRENDS IMMU IN PRESS; Kortum RL, 2013, J IMMUNOL, V190, P147, DOI 10.4049/jimmunol.1201458; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Maizels RM, 2012, EXP PARASITOL, V132, P76, DOI 10.1016/j.exppara.2011.08.011; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Miyaji M, 2009, P NATL ACAD SCI USA, V106, P14502, DOI 10.1073/pnas.0903894106; Moxham VF, 2008, J IMMUNOL, V180, P3910, DOI 10.4049/jimmunol.180.6.3910; Muljo SA, 2012, WILEY INTERDISCIP RE, V2, P148; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rouquette-Jazdanian AK, 2012, MOL CELL, V48, P298, DOI 10.1016/j.molcel.2012.08.011; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126, P581, DOI 10.1016/j.jaci.2010.05.045; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tomankova T, 2012, SCAND J IMMUNOL, V75, P129, DOI 10.1111/j.1365-3083.2011.02650.x; Wang G, 2010, J RHEUMATOL, V37, P2516, DOI 10.3899/jrheum.100308; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035331; Zhang J, 2012, BRIT J CANCER, V107, P352, DOI 10.1038/bjc.2012.251; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66709	10.1371/journal.pone.0066709	http://dx.doi.org/10.1371/journal.pone.0066709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825558	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000023
J	Young, JA; Jefferies, W				Young, Joanne A.; Jefferies, Wilfred			Towards the Conservation of Endangered Avian Species: A Recombinant West Nile Virus Vaccine Results in Increased Humoral and Cellular Immune Responses in Japanese Quail (Coturnix japonica)	PLOS ONE			English	Article							T-CELLS; POPULATION; INFECTION; CD8	West Nile Virus (WNV) arrived in North America in 1999 and is now endemic. Many families of birds, especially corvids, are highly susceptible to WNV and infection often results in fatality. Avian species susceptible to WNV infection also include endangered species, such as the Greater Sage-Grouse (Centrocercus uropbasianuts) and the Eastern Loggerhead Shrike (Lanius ludovicianus migrans). The virus has been shown to contribute towards the likelihood of their extinction. Although a clear and present threat, there exists no avian WNV vaccine available to combat this lethal menace. As a first step in establishing an avian model for testing candidate WNV vaccines, avian antibody based reagents were assessed for cross-reactivity with Japanese quail (Coturnix japonica) T cell markers CD4 and CD8; the most reactive were found to be the anti-duck CD8 antibody, clone Du-CD8-1, and the anti-chicken/turkey CD4 antibody, clone CT4. These reagents were then used to assess vaccine performance as well as to establish T cell populations in quail, with a novel population of CD4/CD8 double positive T cells being identified in Japanese quail. Concurrently, non-replicating recombinant adenoviruses, expressing either the WNV envelope or NS3 'genes' were constructed and assessed for effectiveness as avian vaccines. Japanese Quail were selected for testing the vaccines, as they provide an avian model that parallels the population diversity of bird species in the wild. Both the level of WNV specific antibodies and the number of T cells in vaccinated birds were increased compared to unvaccinated controls. The results indicate the vaccines to be effective in increasing both humoral and cellular immune responses. These recombinant vaccines therefore may find utility as tools to protect and maintain domestic and wild avian populations. Their implementation may also arrest the progression towards extinction of endangered avian species and reduce the viral reservoir that potentiates infection in humans.	[Young, Joanne A.; Jefferies, Wilfred] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Young, Joanne A.; Jefferies, Wilfred] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Jefferies, Wilfred] Univ British Columbia, Dept Med Genet, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Young, Joanne A.; Jefferies, Wilfred] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Young, Joanne A.; Jefferies, Wilfred] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Jefferies, W (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.	wilf@msl.ubc.ca			International Canadian Commonwealth Scholarship Fund	International Canadian Commonwealth Scholarship Fund	JAY received funding from the International Canadian Commonwealth Scholarship Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babayan SA, 2011, ANN NY ACAD SCI, V1236, P17, DOI 10.1111/j.1749-6632.2011.06251.x; Bertelsen MF, 2004, J WILDLIFE DIS, V40, P538, DOI 10.7589/0090-3558-40.3.538; Erf GF, 1998, VET IMMUNOL IMMUNOP, V62, P339, DOI 10.1016/S0165-2427(97)00070-6; Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157; HALA K, 1991, ANIM GENET, V22, P279, DOI 10.1111/j.1365-2052.1991.tb00677.x; Lobigs M, 2004, IMMUNOL CELL BIOL, V82, P184, DOI 10.1046/j.0818-9641.2004.01218.x; Luhtala M, 1997, EUR J IMMUNOL, V27, P189, DOI 10.1002/eji.1830270128; Natugle DE, 2005, WILDLIFE SOC B, V33; Sharma D, 2000, BRIT POULTRY SCI, V41, P29, DOI 10.1080/00071660086367; Sharma D, 2001, ANIM BIOTECHNOL, V12, P111, DOI 10.1081/ABIO-100108337; Walker BL, 2007, AVIAN DIS, V51, P691, DOI 10.1637/0005-2086(2007)51[691:WNVAGS]2.0.CO;2; Zuckermann FA, 1999, VET IMMUNOL IMMUNOP, V72, P55, DOI 10.1016/S0165-2427(99)00118-X	12	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67137	10.1371/journal.pone.0067137	http://dx.doi.org/10.1371/journal.pone.0067137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825633	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000083
J	Hao, NB; He, YF; Zhang, D; Luo, G; Chen, BJ; Zhang, Y; Yang, SM				Hao, Ning-Bo; He, Ya-Fei; Zhang, Dan; Luo, Gang; Chen, Bai-Jun; Zhang, Yao; Yang, Shi-Ming			PLCE1 Polymorphism and Upper Gastrointestinal Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ESOPHAGEAL CANCER; GENETIC-VARIATION; PHOSPHOLIPASE-C; TEA DRINKING; POPULATION; SUSCEPTIBILITY; ASSOCIATION; ADENOCARCINOMA; TEMPERATURE	Background: In recent years, the PLCE1 rs2274223 polymorphism has been extensively investigated as a potential risk factor for upper gastrointestinal cancers, including squamous cell carcinoma (ESCC) and gastric cancer. However, the results of these studies have been inconsistent. Methods: A meta-analysis of 13 case-control studies was performed including more than 11,000 subjects with genotyped PLCE1 rs2274223 polymorphisms. Odds ratios (OR) with 95% confidence intervals (CI) were employed to assess the association of the PLCE1 rs2274223 polymorphism with a susceptibility to ESCC or gastric cancer. Results: A statistically significant increase in the risk of ESCC was associated with the PLCE1 rs2274223 polymorphism. This included the homozygous genetic model (OR = 1.46), heterozygous genetic model (OR = 1.25) and allelic genetic model (OR = 1.23). Similar results were consistently found for gastric cancer. In a subgroup analysis, the PLCE1 rs2274223 polymorphism was found to be a very sensitive marker for gastric cardia cancer as shown by the homozygous genetic model (OR = 2.23), heterozygous genetic model(OR = 1.59) and allelic genetic model (OR = 1.47). The risk associations of all of the gastric cardia cancer models were statistically significant. In contrast, none of the genetic models for non-cardia gastric cancer were significant. Conclusions: In this meta-analysis, the PLCE1 rs2274223 polymorphism was confirmed to have a statistically significant association with an increasing risk of ESCC and gastric cancer. The increase risk was especially observed for gastric cardia cancer.	[Hao, Ning-Bo; He, Ya-Fei; Zhang, Dan; Luo, Gang; Chen, Bai-Jun; Yang, Shi-Ming] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Zhang, Yao] Third Mil Med Univ, Dept Epidemiol, Chongqing, Peoples R China; [Yang, Shi-Ming] Third Mil Med Univ, Evidence Based Med & Clin Epidemiol Ctr, Chongqing, Peoples R China; [Zhang, Yao] Third Mil Med Univ, Chongqing Key Lab Dis Prote, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Zhang, Y (corresponding author), Third Mil Med Univ, Dept Epidemiol, Chongqing, Peoples R China.	sydzy2003@yahoo.com.cn; shimingyang@yahoo.com			Chongqing Science Fund for Distinguished Young Scholars (CSTC) [2009BA5045]	Chongqing Science Fund for Distinguished Young Scholars (CSTC)(Natural Science Foundation Project of CQ CSTC)	This work was supported by grants from the Chongqing Science Fund for Distinguished Young Scholars (CSTC, 2009BA5045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Baertschiger RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006657; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bunney TD, 2009, ADV ENZYME REGUL, V49, P54, DOI 10.1016/j.advenzreg.2009.01.004; Bye H, 2012, CARCINOGENESIS, V33, P2155, DOI 10.1093/carcin/bgs262; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dura P, 2012, EUR J CANCER PREV; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hu HC, 2012, ANN SURG ONCOL, V19, P2403, DOI 10.1245/s10434-011-2160-y; Islami Farhad, 2009, BMJ, V338, pb929, DOI 10.1136/bmj.b929; Islami F, 2009, INT J CANCER, V125, P491, DOI 10.1002/ijc.24445; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Luo DW, 2011, J GASTROENTEROL, V46, P1260, DOI 10.1007/s00535-011-0445-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mbulaiteye SM, 2009, FRONT BIOSCI-LANDMRK, V14, P1490, DOI 10.2741/3320; Miao XP, 2006, GASTROENTEROLOGY, V131, P420, DOI 10.1053/j.gastro.2006.05.050; Ou LP, 2010, CANCER GENET CYTOGEN, V200, P110, DOI 10.1016/j.cancergencyto.2010.01.021; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Wang XL, 2008, HEPATO-GASTROENTEROL, V55, P2039; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; Wu M, 2009, INT J CANCER, V124, P1907, DOI 10.1002/ijc.24142; Zhang HZ, 2011, CARCINOGENESIS, V32, P848, DOI 10.1093/carcin/bgr051; Zhang XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021894	34	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67229	10.1371/journal.pone.0067229	http://dx.doi.org/10.1371/journal.pone.0067229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826241	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400123
J	Liu, YL; Li, CL; Chen, PZ; Li, XG; Li, M; Guo, H; Li, JQ; Chu, RA; Wang, H				Liu, Yanling; Li, Chenglin; Chen, Peizhan; Li, Xiaoguang; Li, Mian; Guo, He; Li, Jingquan; Chu, Ruiai; Wang, Hui			Polymorphisms in the Vitamin D Receptor (VDR) and the Risk of Ovarian Cancer: A Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISMS; PUBLICATION BIAS; INHIBITION; EXPRESSION; EXPOSURE; BIOLOGY; CELLS; FILL; TRIM	The vitamin D receptor (VDR) principally mediates the anticancer activities of vitamin D. Various epidemiological studies have investigated the associations of VDR gene polymorphisms with ovarian cancer; however, the results have been inconclusive. In the current study, we evaluated, in a meta-analysis, the association of five common single nucleotide polymorphisms (SNPs) in the VDR gene (ApaI, BsmI, Cdx-2, FokI, and TaqI) with the risk of ovarian cancer. Six eligible studies, with a total of 4,107 cases and 6,661 controls, which evaluated the association of these variants and ovarian cancer risk, were identified from the MEDLINE and PubMed databases. The meta-analysis indicated that FokI was associated with an increased ovarian cancer risk, with a pooled odds ratio (OR) of 1.10 [95% confidence intervals (95% CI) = 1.00-1.20] for CT heterozygotes and 1.16 (95% CI = 1.02-1.30) for TT homozygotes relative to common CC carriers. Carriers of the T allele (also known as the f allele) showed an 11% (pooled OR = 1.11, 95% CI = 1.02-1.21; TT/CT vs. CC) increased risk of ovarian cancer relative to CC carriers. For FokI, no significant heterogeneity between the studies was found (I-2 = 0%, P = 0.62 for the Q test). There was no statistically significant association between the other four variants (ApaI, BsmI, Cdx-2 and TaqI) and risk of ovarian cancer. These data indicate that the polymorphism FokI on the VDR is a susceptibility factor for ovarian cancer. Nevertheless, more studies are warranted to elucidate the underlying mechanisms of the VDR in development of ovarian cancer.	[Liu, Yanling; Li, Chenglin; Chen, Peizhan; Li, Xiaoguang; Li, Mian; Guo, He; Li, Jingquan; Chu, Ruiai; Wang, Hui] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Food Safety Res,Inst Nutr Sci, Shanghai, Peoples R China; [Li, Jingquan; Chu, Ruiai; Wang, Hui] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Wang, H (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Food Safety Res,Inst Nutr Sci, Shanghai, Peoples R China.	huiwang@sibs.ac.cn	liu, yan/HCI-5542-2022		One Hundred Talents Program and Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R 10]; National Nature Science Foundation [81125020, 91029715, 31070680, 31101261, 81242002, 31200569]; Ministry of Science and Technology of China [2012BAK01B00, 2011BAK10B00, 2009CB919000]; Science and Technology Commission of Shanghai Municipality [12XD1407000, 12431900500, 10391902100]; Xuhui Central Hospital [CRC2011001, CRC2011004]; Director Foundation; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS; SA-SIBS scholarship program	One Hundred Talents Program and Knowledge Innovation Program of the Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Xuhui Central Hospital; Director Foundation; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS(Chinese Academy of Sciences); SA-SIBS scholarship program	This study was supported by grants from One Hundred Talents Program and Knowledge Innovation Program (KSCX2-EW-R 10) of the Chinese Academy of Sciences; the National Nature Science Foundation (81125020, 91029715, 31070680, 31101261, 81242002, and 31200569); the Ministry of Science and Technology of China (2012BAK01B00, 2011BAK10B00, and 2009CB919000); the Science and Technology Commission of Shanghai Municipality (12XD1407000, 12431900500, and 10391902100); Xuhui Central Hospital (CRC2011001 and CRC2011004), and Director Foundation and the Food Safety Research Center and Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS. Peizhan Chen gratefully acknowledges the support of SA-SIBS scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen MH, 2000, INT J CANCER, V86, P40, DOI 10.1002/(SICI)1097-0215(20000401)86:1<40::AID-IJC6>3.0.CO;2-E; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Bai YH, 2012, WORLD J GASTROENTERO, V18, P1672, DOI 10.3748/wjg.v18.i14.1672; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Brekelmans CTM, 2003, CURR OPIN OBSTET GYN, V15, P63, DOI 10.1097/00001703-200302000-00010; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Cheteri MBK, 2004, PROSTATE, V59, P409, DOI 10.1002/pros.20001; Clendenen TV, 2008, CANCER LETT, V260, P209, DOI 10.1016/j.canlet.2007.11.002; Colin EM, 2000, CLIN ENDOCRINOL, V52, P211, DOI 10.1046/j.1365-2265.2000.00909.x; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Grant DJ, 2012, GYNECOL ONCOL; Grant WB, 2012, ANTICANCER RES, V32, P223; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; John EM, 2005, CANCER RES, V65, P5470, DOI 10.1158/0008-5472.CAN-04-3134; Jurutka P W, 2001, Rev Endocr Metab Disord, V2, P203, DOI 10.1023/A:1010062929140; Kostner K, 2009, ANTICANCER RES, V29, P3511; Lurie G, 2007, CANCER EPIDEM BIOMAR, V16, P2566, DOI 10.1158/1055-9965.EPI-07-0753; Lurie G, 2011, INT J CANCER, V128, P936, DOI 10.1002/ijc.25403; MANOLAGAS SC, 1994, SEMIN NEPHROL, V14, P129; Mikhak B, 2007, PROSTATE, V67, P911, DOI 10.1002/pros.20570; Mocellin S, 2008, CANCER-AM CANCER SOC, V113, P2398, DOI 10.1002/cncr.23867; Mostowska A, 2013, GENET TEST MOL BIOMA, V17, P183, DOI 10.1089/gtmb.2012.0332; Orlow I, 2012, INT J CANCER, V130, P405, DOI 10.1002/ijc.26023; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Rukin NJ, 2007, CANCER LETT, V247, P328, DOI 10.1016/j.canlet.2006.05.012; Spina CS, 2007, J STEROID BIOCHEM, V103, P757, DOI 10.1016/j.jsbmb.2006.12.040; Tamez S, 2009, BRIT J CANCER, V101, P1957, DOI 10.1038/sj.bjc.6605414; Tworoger SS, 2009, CANCER RES, V69, P1885, DOI 10.1158/0008-5472.CAN-08-3515; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yamamoto H, 1999, J BONE MINER RES, V14, P240, DOI 10.1359/jbmr.1999.14.2.240; Yin M, 2009, INT J CLIN EXP MED, V2, P159	39	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66716	10.1371/journal.pone.0066716	http://dx.doi.org/10.1371/journal.pone.0066716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826116	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400036
J	Watanabe, K; Watson, E; Cremona, ML; Millings, EJ; Lefkowitch, JH; Fischer, SG; LeDuc, CA; Leibel, RL				Watanabe, Kazuhisa; Watson, Elizabeth; Cremona, Maria Laura; Millings, Elizabeth J.; Lefkowitch, Jay H.; Fischer, Stuart G.; LeDuc, Charles A.; Leibel, Rudolph L.			ILDR2: An Endoplasmic Reticulum Resident Molecule Mediating Hepatic Lipid Homeostasis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; INSULIN-RESISTANCE; TRANSCRIPTION FACTOR; LIPOPROTEIN RECEPTOR; METABOLIC DISEASE; DROPLET FORMATION; BINDING PROTEIN; VLDL SECRETION; FATTY LIVER	Ildr2, a modifier of diabetes susceptibility in obese mice, is expressed in most organs, including islets and hypothalamus, with reduced levels in livers of diabetes-susceptible B6. DBA mice congenic for a 1.8 Mb interval of Chromosome 1. In hepatoma and neuronal cells, ILDR2 is primarily located in the endoplasmic reticulum membrane. We used adenovirus vectors that express shRNA or are driven by the CMV promoter, respectively, to knockdown or overexpress Ildr2 in livers of wild type and ob/ob mice. Livers in knockdown mice were steatotic, with increased hepatic and circulating triglycerides and total cholesterol. Increased circulating VLDL, without reduction in triglyceride clearance suggests an effect of reduced hepatic ILDR2 on hepatic cholesterol clearance. In animals that overexpress Ildr2, hepatic triglyceride and total cholesterol levels were reduced, and strikingly so in ob/ob mice. There were no significant changes in body weight, energy expenditure or glucose/insulin homeostasis in knockdown or overexpressing mice. Knockdown mice showed reduced expression of genes mediating synthesis and oxidation of hepatic lipids, suggesting secondary suppression in response to increased hepatic lipid content. In Ildr2-overexpressing ob/ob mice, in association with reduced liver fat content, levels of transcripts related to neutral lipid synthesis and cholesterol were increased, suggesting "relief'' of the secondary suppression imposed by lipid accumulation. Considering the fixed location of ILDR2 in the endoplasmic reticulum, we investigated the possible participation of ILDR2 in ER stress responses. In general, Ildr2 overexpression was associated with increases, and knockdown with decreases in levels of expression of molecular components of canonical ER stress pathways. We conclude that manipulation of Ildr2 expression in liver affects both lipid homeostasis and ER stress pathways. Given these reciprocal interactions, and the relatively extended time-course over which these studies were conducted, we cannot assign causal primacy to either the effects on hepatic lipid homeostasis or ER stress responses.	[Watanabe, Kazuhisa; Watson, Elizabeth; Cremona, Maria Laura; Millings, Elizabeth J.; Fischer, Stuart G.; LeDuc, Charles A.; Leibel, Rudolph L.] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA; [Watanabe, Kazuhisa; Watson, Elizabeth; Cremona, Maria Laura; Millings, Elizabeth J.; Fischer, Stuart G.; LeDuc, Charles A.; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Lefkowitch, Jay H.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University; Columbia University	Leibel, RL (corresponding author), Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA.	rl232@columbia.edu	Watanabe, Kazuhisa/ABY-2241-2022	LeDuc, Charles/0000-0002-2073-5050; Watanabe, Kazuhisa/0000-0002-5640-0818	United States National Institutes of Health [RO1-DK 066518, P30 DK63608-09, P30 DK26687-31]; Manpei Suzuki Diabetes Foundation; Russell Berrie Foundation; National Science Foundation Graduate Research Fellowship Program [DGE 11-44155]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK066518, T32DK007647, P30DK063608] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; Russell Berrie Foundation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the United States National Institutes of Health (http://www.nih.gov/): RO1-DK 066518, P30 DK63608-09 (http://derc.cumc.columbia.edu/), P30 DK26687-31 (http://www.nyorc.org/), by a grant from the Manpei Suzuki Diabetes Foundation (http://www.suzuki-manpe-df.or.jp/english/index.html), by the Russell Berrie Foundation (http://www.russellberriefoundation.org/home.php), and by the National Science Foundation Graduate Research Fellowship Program (http://www.nsfgrfp.org/): DGE 11-44155. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; de Meijer VE, 2010, METABOLISM, V59, P1092, DOI 10.1016/j.metabol.2009.11.006; Dokmanovic-Chouinard M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000137; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Eto K, 2002, DIABETES, V51, pS414, DOI 10.2337/diabetes.51.2007.S414; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gentile CL, 2010, MOL CELL BIOCHEM, V344, P99, DOI 10.1007/s11010-010-0533-3; Halldorsdottir Solveig, 2009, Int J Body Compos Res, V7, P147; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hauge H, 2004, BIOCHEM BIOPH RES CO, V323, P970, DOI 10.1016/j.bbrc.2004.08.188; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Higashi T, 2012, J CELL SCI; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kamper N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035972; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lattuada G, 2011, CURR DIABETES REP, V11, P167, DOI 10.1007/s11892-011-0190-2; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, TOXICOL LETT, V211, P29, DOI 10.1016/j.toxlet.2012.02.017; Lee JS, 2012, AM J TRANSL RES, V4, P102; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Linnik KM, 1998, J BIOL CHEM, V273, P21368, DOI 10.1074/jbc.273.33.21368; Maris M, 2012, DIABETOLOGIA, V55, P1167, DOI 10.1007/s00125-011-2427-7; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Mesli S, 2004, EUR J BIOCHEM, V271, P3103, DOI 10.1111/j.1432-1033.2004.04223.x; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; NAGATA Y, 1987, J LIPID RES, V28, P684; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Stenger C, 2010, FASEB J, V24, P4218, DOI 10.1096/fj.10-160440; Strnad P, 2008, HISTOCHEM CELL BIOL, V129, P735, DOI 10.1007/s00418-008-0431-x; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Trak-Smayra V, 2011, INT J EXP PATHOL, V92, P413, DOI 10.1111/j.1365-2613.2011.00793.x; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yu R, 1997, MOL PHARMACOL, V51, P785, DOI 10.1124/mol.51.5.785; Zagaria A, 2012, LEUKEMIA RES, V36, P852, DOI 10.1016/j.leukres.2012.01.026; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	66	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67234	10.1371/journal.pone.0067234	http://dx.doi.org/10.1371/journal.pone.0067234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826244	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400124
J	Wolf, M; Chen, SL; Song, JY; Ankenbrand, M; Muller, T				Wolf, Matthias; Chen, Shilin; Song, Jingyuan; Ankenbrand, Markus; Mueller, Tobias			Compensatory Base Changes in ITS2 Secondary Structures Correlate with the Biological Species Concept Despite Intragenomic Variability in ITS2 Sequences - A Proof of Concept	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; RIBOSOMAL-RNA; COMMON CORE; DNA BARCODE; DATABASE; REGION; TOOL	Compensatory base changes (CBCs) in internal transcribed spacer 2 (ITS2) rDNA secondary structures correlate with Ernst Mayr's biological species concept. This hypothesis also referred to as the CBC species concept recently was subjected to large-scale testing, indicating two distinct probabilities. (1) If there is a CBC then there are two different species with a probability of similar to 0.93. (2) If there is no CBC then there is the same species with a probability of similar to 0.76. In ITS2 research, however, the main problem is the multicopy nature of ITS2 sequences. Most recently, 454 pyrosequencing data have been used to characterize more than 5000 intragenomic variations of ITS2 regions from 178 plant species, demonstrating that mutation of ITS2 is frequent, with a mean of 35 variants per species, respectively per individual organism. In this study, using those 454 data, the CBC criterion is reconsidered in the light of intragenomic variability, a proof of concept, a necessary criterion, expecting no intragenomic CBCs in variant ITS2 copies. In accordance with the CBC species concept, we could demonstrate that the probability that there is no intragenomic CBC is similar to 0.99.	[Wolf, Matthias; Ankenbrand, Markus; Mueller, Tobias] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany; [Chen, Shilin; Song, Jingyuan] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China	University of Wurzburg; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Wolf, M (corresponding author), Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany.	matthias.wolf@biozentrum.uni-wuerzburg.de	Ankenbrand, Markus/C-2564-2014; Ankenbrand, Markus J./V-6660-2019; Wolf, Matthias/A-5580-2008	Ankenbrand, Markus/0000-0002-6620-807X; Ankenbrand, Markus J./0000-0002-6620-807X; Wolf, Matthias/0000-0003-2004-1806	land Bavaria, Germany; Fundamental Research Funds for the Central Universities of China [2012C02]	land Bavaria, Germany; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	Matthias Wolf (corresponding author) as well as Tobias Muller (last author) are government employees of the land Bavaria, Germany. So the work has been supported by the land Bavaria, Germany. Additionally, we would like to add the following statement: Shilin Chen and Jingyuan Song have been supported by the Fundamental Research Funds for the Central Universities of China (No. 2012C02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bernoulli J, 1713, ARS CONJECTANDI OPUS; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2002, J MOL EVOL, V54, P246, DOI 10.1007/s00239-001-0006-0; Coleman AW, 2000, PROTIST, V151, P1, DOI 10.1078/1434-4610-00002; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI [10.3410/f.1163590.625341, DOI 10.3410/F.1163590.625341]; Engelmann JC, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2008.02199.x; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Merget B., 2012, JOVE-J VIS EXP   MAR, V61, P3806, DOI [10.3791/3806, DOI 10.3791/3806]; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; R Development Core Team, 2011, R LANG ENV STAT COMP; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102	32	97	100	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66726	10.1371/journal.pone.0066726	http://dx.doi.org/10.1371/journal.pone.0066726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826120	Green Published, gold			2022-12-27	WOS:000321738400040
J	Furmanov, K; Elnekave, M; Sa'eed, A; Segev, H; Eli-Berchoer, L; Kotton, DN; Bachrach, G; Hovav, AH				Furmanov, Karina; Elnekave, Mazal; Sa'eed, Abdallah; Segev, Hadas; Eli-Berchoer, Luba; Kotton, Darrell N.; Bachrach, Gilad; Hovav, Avi-Hai			Diminished Memory T-Cell Expansion Due to Delayed Kinetics of Antigen Expression by Lentivectors	PLOS ONE			English	Article							IN-VIVO; LENTIVIRAL VECTORS; DENDRITIC CELLS; ANTITUMOR IMMUNITY; VIRAL VECTORS; RESPONSES; VACCINE; IMMUNIZATION; PRIME; NAIVE	Memory CD8(+) T lymphocytes play a central role in protective immunity. In attempt to increase the frequencies of memory CD8(+) T cells, repeated immunizations with viral vectors are regularly explored. Lentivectors have emerged as a powerful vaccine modality with relatively low pre-existing and anti-vector immunity, thus, thought to be ideal for boosting memory T cells. Nevertheless, we found that lentivectors elicited diminished secondary T-cell responses that did not exceed those obtained by priming. This was not due to the presence of anti-vector immunity, as limited secondary responses were also observed following heterologous prime-boost immunizations. By dissecting the mechanisms involved in this process, we demonstrate that lentivectors trigger exceptionally slow kinetics of antigen expression, while optimal activation of lentivector-induced T cells relays on durable expression of the antigen. These qualities hamper secondary responses, since lentivector-encoded antigen is rapidly cleared by primary cytotoxic T cells that limit its presentation by dendritic cells. Indeed, blocking antigen clearance by cytotoxic T cells via FTY720 treatment, fully restored antigen presentation. Taken together, while low antigen expression is expected during secondary immunization with any vaccine vector, our results reveal that the intrinsic delayed expression kinetics of lentiviral-encoded antigen, further dampens secondary CD8(+) T-cell expansion.	[Furmanov, Karina; Elnekave, Mazal; Sa'eed, Abdallah; Segev, Hadas; Eli-Berchoer, Luba; Bachrach, Gilad; Hovav, Avi-Hai] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel; [Kotton, Darrell N.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Kotton, Darrell N.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Hebrew University of Jerusalem; Boston University; Boston University	Hovav, AH (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel.	avihaih@ekmd.huji.ac.il		Bachrach, Gilad/0000-0003-1350-2280	Marie Curie International Reintegration grant [230932]; United States-Israel Binational Science Foundation [T-2011215]	Marie Curie International Reintegration grant(European Commission); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the Marie Curie International Reintegration grant number 230932 for A.H.H. and the United States-Israel Binational Science Foundation Prof. Rahamimoff Travel Grant number T-2011215 for K.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2010, BLOOD, V115, P3025, DOI 10.1182/blood-2009-11-253641; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bedoui S, 2009, IMMUNOL CELL BIOL, V87, P255, DOI 10.1038/icb.2008.105; Beignon AS, 2009, J VIROL, V83, P10963, DOI 10.1128/JVI.01284-09; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Cockburn IA, 2008, J IMMUNOL, V180, P64, DOI 10.4049/jimmunol.180.1.64; CROFT M, 1994, J IMMUNOL, V152, P2675; Dai BB, 2009, P NATL ACAD SCI USA, V106, P20382, DOI 10.1073/pnas.0911742106; Dullaers M, 2006, GENE THER, V13, P630, DOI 10.1038/sj.gt.3302697; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Fleury S, 2003, CIRCULATION, V107, P2375, DOI 10.1161/01.CIR.0000065598.46411.EF; Furmanov K, 2010, J IMMUNOL, V184, P4889, DOI 10.4049/jimmunol.0903062; Hovav AH, 2007, J VIROL, V81, P12793, DOI 10.1128/JVI.01519-07; Iglesias MC, 2007, MOL THER, V15, P1203, DOI 10.1038/sj.mt.6300135; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Liu YJ, 2009, J IMMUNOL, V182, P5960, DOI 10.4049/jimmunol.0900008; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Paris RM, 2010, EXPERT REV VACCINES, V9, P1055, DOI 10.1586/ERV.10.106; Parker DGA, 2007, GENE THER, V14, P760, DOI 10.1038/sj.gt.3302921; Ranasinghe C, 2009, EXPERT REV VACCINES, V8, P1171, DOI 10.1586/ERV.09.86; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wilson AA, 2008, AM J RESP CELL MOL, V39, P133, DOI 10.1165/rcmb.2007-0133OC; Wilson AA, 2010, J CLIN INVEST, V120, P379, DOI 10.1172/JCI36666; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Xiao HY, 2011, J IMMUNOL, V187, P1788, DOI 10.4049/jimmunol.1101138; Yopp AC, 2006, CLIN TRANSPLANT, V20, P788, DOI 10.1111/j.1399-0012.2006.00570.x	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66488	10.1371/journal.pone.0066488	http://dx.doi.org/10.1371/journal.pone.0066488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824049	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400117
J	Iannilli, F; Zalfa, F; Gartner, A; Bagni, C; Dotti, CG				Iannilli, Francesca; Zalfa, Francesca; Gartner, Annette; Bagni, Claudia; Dotti, Carlos G.			Cytoplasmic TERT Associates to RNA Granules in Fully Mature Neurons: Role in the Translational Control of the Cell Cycle Inhibitor p15INK4B	PLOS ONE			English	Article							MESSENGER-RNA; HIPPOCAMPAL-NEURONS; STRESS GRANULES; SHORT TELOMERES; SURVIVAL; PROTEIN; BRAIN; MICE; TRANSPORT; PATHWAYS	The main role of Telomerase Reverse Transcriptase (TERT) is to protect telomere length from shortening during cell division. However, recent works have revealed the existence of a pool of TERT associated to mitochondria, where it plays a role in survival. We here show that in fully differentiated neurons the largest pool of cytoplasmic TERT associates to TIA1 positive RNA granules, where it binds the messenger RNA of the cyclin kinase inhibitor p15INK4B. Upon stress, p15INK4B and TERT dissociate and p15INK4B undergoes efficient translation, allowing its pro-survival function. These results unveil another mechanism implicated in the survival of fully differentiated neurons.	[Iannilli, Francesca; Gartner, Annette; Bagni, Claudia; Dotti, Carlos G.] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Gartner, Annette; Bagni, Claudia; Dotti, Carlos G.] VIB, Ctr Biol Dis, Louvain, Belgium; [Zalfa, Francesca; Bagni, Claudia] Univ Rome, Campus Biomed CIR Dept, Rome, Italy; [Dotti, Carlos G.] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	KU Leuven; Flanders Institute for Biotechnology (VIB); Sapienza University Rome; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Dotti, CG (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	cdotti@cbm.uam.es	Zalfa, Francesca/J-7759-2018; Dotti, Carlos G/I-5533-2015; Gaertner, Annette/B-5393-2013	Zalfa, Francesca/0000-0002-1922-9468; Dotti, Carlos G/0000-0003-4052-1719; Bagni, Claudia/0000-0002-4419-210X	Flanders Fund for Scientific Research [FWO G 0.666.10N]; NEUROBRAINNET IAP [7/16]; Flemish Government Methusalem Grant; Spanish Ministry of Science and Innovation Ingenio-Consolider [CSD2010-00064, SAF2010-14906]	Flanders Fund for Scientific Research(FWO); NEUROBRAINNET IAP; Flemish Government Methusalem Grant; Spanish Ministry of Science and Innovation Ingenio-Consolider(Ministry of Science and Innovation, Spain (MICINN))	This work was partially supported by Flanders Fund for Scientific Research (FWO G 0.666.10N), NEUROBRAINNET IAP 7/16, Flemish Government Methusalem Grant, Spanish Ministry of Science and Innovation Ingenio-Consolider CSD2010-00064 and SAF2010-14906. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson P, 2002, J CELL SCI, V115, P3227; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; di Penta A, 2009, J CELL BIOL, V184, P423, DOI 10.1083/jcb.200807033; Eitan E, 2012, REJUV RES, V15, P206, DOI 10.1089/rej.2011.1285; Eitan E, 2012, EMBO MOL MED, V4, P313, DOI 10.1002/emmm.201200212; Fortini P, 2003, MUTAT RES-FUND MOL M, V531, P127, DOI 10.1016/j.mrfmmm.2003.07.004; Fu WM, 2000, J MOL NEUROSCI, V14, P3, DOI 10.1385/JMN:14:1-2:003; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; GRAY EG, 1962, J ANAT, V96, P79; Guix FX, 2012, EMBO MOL MED, V4, P660, DOI 10.1002/emmm.201200243; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Lee CH, 2011, NEUROL RES, V33, P93, DOI 10.1179/016164110X12714125204399; Mangus DA, 1999, METHODS, V17, P28, DOI 10.1006/meth.1998.0704; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sodero AO, 2011, J NEUROCHEM, V116, P747, DOI 10.1111/j.1471-4159.2010.07079.x; Strong MA, 2011, MOL CELL BIOL, V31, P2369, DOI 10.1128/MCB.05312-11; Takubo K, 2010, GERIATR GERONTOL INT, V10, pS197, DOI 10.1111/j.1447-0594.2010.00605.x; Wright WE, 2005, J AM GERIATR SOC, V53, pS292, DOI 10.1111/j.1532-5415.2005.53492.x; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	32	34	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66602	10.1371/journal.pone.0066602	http://dx.doi.org/10.1371/journal.pone.0066602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825548	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400135
J	Menashe, I; Larsen, EC; Banerjee-Basu, S				Menashe, Idan; Larsen, Eric C.; Banerjee-Basu, Sharmila			Prioritization of Copy Number Variation Loci Associated with Autism from AutDB-An Integrative Multi-Study Genetic Database	PLOS ONE			English	Article							SPECTRUM DISORDERS; HUMAN GENOME; DEVELOPMENTAL-DISABILITIES; VARIANTS; 16P11.2; SCHIZOPHRENIA; COMMON; HETEROZYGOSITY; DUPLICATIONS; POLYMORPHISM	Copy number variants (CNVs) are thought to play an important role in the predisposition to autism spectrum disorder (ASD). However, their relatively low frequency and widespread genomic distribution complicates their accurate characterization and utilization for clinical genetics purposes. Here we present a comprehensive analysis of multi-study, genome-wide CNV data from AutDB (http://mindspec.org/autdb.html), a genetic database that accommodates detailed annotations of published scientific reports of CNVs identified in ASD individuals. Overall, we evaluated 4,926 CNVs in 2,373 ASD subjects from 48 scientific reports, encompassing similar to 2.12x10(9) bp of genomic data. Remarkable variation was seen in CNV size, with duplications being significantly larger than deletions, (P = 3x10(-105); Wilcoxon rank sum test). Examination of the CNV burden across the genome revealed 11 loci with a significant excess of CNVs among ASD subjects (P<7x10(-7)). Altogether, these loci covered 15,610 kb of the genome and contained 166 genes. Remarkable variation was seen both in locus size (20 - 4950 kb), and gene content, with seven multigenic (>= 3 genes) and four monogenic loci. CNV data from control populations was used to further refine the boundaries of these ASD susceptibility loci. Interestingly, our analysis indicates that 15q11.2-13.3, a genomic region prone to chromosomal rearrangements of various sizes, contains three distinct ASD susceptibility CNV loci that vary in their genomic boundaries, CNV types, inheritance patterns, and overlap with CNVs from control populations. In summary, our analysis of AutDB CNV data provides valuable insights into the genomic characteristics of ASD susceptibility CNV loci and could therefore be utilized in various clinical settings and facilitate future genetic research of this disorder.	[Menashe, Idan; Larsen, Eric C.; Banerjee-Basu, Sharmila] MindSpec, Mclean, VA USA; [Menashe, Idan] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel	Ben Gurion University	Menashe, I (corresponding author), MindSpec, Mclean, VA USA.	menashe.idan@gmail.com; sharmila@mindspec.org	Menashe, Idan/W-6214-2019; Menashe, Idan/AAC-8670-2020	Menashe, Idan/0000-0003-1961-1461	Simons Foundation	Simons Foundation	AutDB is funded by the Simons Foundation, which licenses it as SFARI Gene (https://gene.sfari.org/autdb/Welcome.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Brady K, 2009, MOL PSYCHIATR, V14, P590, DOI 10.1038/mp.2008.14; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; Coon H, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-8; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Degenhardt F, 2012, AM J MED GENET B, V159B, P263, DOI 10.1002/ajmg.b.32034; Gau SSF, 2012, AM J MED GENET B, V159B, P710, DOI 10.1002/ajmg.b.32074; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gjorlund MD, 2012, FASEB J, V26, P4174, DOI 10.1096/fj.11-202242; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Hallmayer J., 2011, ARCH GEN PSYCHIAT; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kumar RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004582; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Li JY, 2011, ARCH GEN PSYCHIAT, V68, P232, DOI 10.1001/archgenpsychiatry.2011.1; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Marshall CR, 2012, METHODS MOL BIOL, V838, P115, DOI 10.1007/978-1-61779-507-7_5; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Morris CP, 2012, DIS MARKERS, V33, P163, DOI [10.1155/2012/651707, 10.3233/DMA-2012-0921]; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Nazeer A, 2012, PEDIATR CLIN N AM, V59, P19, DOI 10.1016/j.pcl.2011.10.007; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Swanwick C. C., 2011, AUTISM SPECTRUM DISO, P65; van Bon BWM, 1993, 15Q13 3 MICRODELETIO; Walsh KM, 2011, GENET MED, V13, P377, DOI 10.1097/GIM.0b013e3182076c0c; Weiss LA, 2009, EXPERT REV MOL DIAGN, V9, P795, DOI 10.1586/ERM.09.59; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	51	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66707	10.1371/journal.pone.0066707	http://dx.doi.org/10.1371/journal.pone.0066707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825557	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400151
J	Banugaria, SG; Prater, SN; Patel, TT; DeArmey, SM; Milleson, C; Sheets, KB; Bali, DS; Rehder, CW; Raiman, JAJ; Wang, RA; Labarthe, F; Charrow, J; Harmatz, P; Chakraborty, P; Rosenberg, AS; Kishnani, PS				Banugaria, Suhrad G.; Prater, Sean N.; Patel, Trusha T.; DeArmey, Stephanie M.; Milleson, Christie; Sheets, Kathryn B.; Bali, Deeksha S.; Rehder, Catherine W.; Raiman, Julian A. J.; Wang, Raymond A.; Labarthe, Francois; Charrow, Joel; Harmatz, Paul; Chakraborty, Pranesh; Rosenberg, Amy S.; Kishnani, Priya S.			Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; ACID ALPHA-GLUCOSIDASE; ALGLUCOSIDASE ALPHA; CLINICAL-OUTCOMES; ANTIBODIES	Objective: Although enzyme replacement therapy (ERT) is a highly effective therapy, CRIM-negative (CN) infantile Pompe disease (IPD) patients typically mount a strong immune response which abrogates the efficacy of ERT, resulting in clinical decline and death. This study was designed to demonstrate that immune tolerance induction (ITI) prevents or diminishes the development of antibody titers, resulting in a better clinical outcome compared to CN IPD patients treated with ERT monotherapy. Methods: We evaluated the safety, efficacy and feasibility of a clinical algorithm designed to accurately identify CN IPD patients and minimize delays between CRIM status determination and initiation of an ITI regimen (combination of rituximab, methotrexate and IVIG) concurrent with ERT. Clinical and laboratory data including measures of efficacy analysis for response to ERT were analyzed and compared to CN IPD patients treated with ERT monotherapy. Results: Seven CN IPD patients were identified and started on the ITI regimen concurrent with ERT. Median time from diagnosis of CN status to commencement of ERT and ITI was 0.5 months (range: 0.1-1.6 months). At baseline, all patients had significant cardiomyopathy and all but one required respiratory support. The ITI regimen was safely tolerated in all seven cases. Four patients never seroconverted and remained antibody-free. One patient died from respiratory failure. Two patients required another course of the ITI regimen. In addition to their clinical improvement, the antibody titers observed in these patients were much lower than those seen in ERT monotherapy treated CN patients. Conclusions: The ITI regimen appears safe and efficacious and holds promise in altering the natural history of CN IPD by increasing ERT efficacy. An algorithm such as this substantiates the benefits of accelerated diagnosis and management of CN IPD patients, thus, further supporting the importance of early identification and treatment initiation with newborn screening for IPD.	[Banugaria, Suhrad G.; Prater, Sean N.; Patel, Trusha T.; DeArmey, Stephanie M.; Milleson, Christie; Sheets, Kathryn B.; Bali, Deeksha S.; Kishnani, Priya S.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Rehder, Catherine W.] Duke Univ Hlth Syst, Clin Mol Diagnost Labs, Durham, NC USA; [Raiman, Julian A. J.] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Wang, Raymond A.] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Labarthe, Francois] Univ Hosp, Hop Clocheville, Tours, France; [Charrow, Joel] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Harmatz, Paul] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Chakraborty, Pranesh] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Rosenberg, Amy S.] US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	Duke University; Duke University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Childrens Hospital of Orange County; CHU Tours; Northwestern University; Feinberg School of Medicine; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Ottawa; US Food & Drug Administration (FDA)	Kishnani, PS (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA.	priya.kishnani@duke.edu	Wang, Raymond Yu Jeang/H-8870-2019; Harmatz, Paul/AAY-5866-2020; Wang, Raymond Yu Jeang/CAJ-3535-2022	Wang, Raymond Yu Jeang/0000-0001-6494-7613; Harmatz, Paul/0000-0001-5603-2085; 	Lysosomal Disease Network, a part of National Institutes of Health Rare Diseases Clinical Research Network (RDCRN); NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS) [U54NS065768]; National Institute of Neurological Disorders and Stroke (NINDS) [U54NS065768]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U54NS065768]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065768] Funding Source: NIH RePORTER	Lysosomal Disease Network, a part of National Institutes of Health Rare Diseases Clinical Research Network (RDCRN); NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded in part by the Lysosomal Disease Network, a part of National Institutes of Health Rare Diseases Clinical Research Network (RDCRN). The Lysosomal Disease Network (U54NS065768) is a part of the National Institutes of Health (NIH) Rare Diseases Clinical Research Network (RDCRN), supported through collaboration between the NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS), the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank the patients and their families who participated in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MA, 2011, MOL GENET METAB, V104, P583, DOI 10.1016/j.ymgme.2011.08.003; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Bali DS, 2012, AM J MED GENET C, V160C, P40, DOI 10.1002/ajmg.c.31319; Banugaria SG, 2012, GENET MED; Banugaria SG, 2012, EXPERT REV CLIN IMMU, V8, P497, DOI 10.1586/ECI.12.40; Banugaria SG, 2012, MOL GENET METAB, V105, P677, DOI 10.1016/j.ymgme.2012.01.019; Banugaria SG, 2011, GENET MED, V13, P729, DOI 10.1097/GIM.0b013e3182174703; Chien YH, 2009, PEDIATRICS, V124, pE1116, DOI 10.1542/peds.2008-3667; HALL PD, 1993, PHARMACOTHERAPY, V13, P564; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Hirschhorn R, 2009, GLYCOGEN STORAGE DIS; Hunley TE, 2004, PEDIATRICS, V114, pE532, DOI 10.1542/peds.2003-0988-L; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khallaf HA, 2013, JIMD REPORTS CASE RE, P133; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Kishnani PS, 2009, PEDIATR RES, V66, P329, DOI 10.1203/PDR.0b013e3181b24e94; Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035; Mendelsohn NJ, 2009, NEW ENGL J MED, V360, P194, DOI 10.1056/NEJMc0806809; Messinger YH, 2012, GENET MED, V14, P135, DOI 10.1038/gim.2011.4; Moyer VA, 2008, HASTINGS CENT REP, V38, P32, DOI 10.1353/hcr.0.0011; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; Prater SN, 2012, GENET MED, V14, P800, DOI 10.1038/gim.2012.44; Rezvani AR, 2011, BEST PRACT RES CL HA, V24, P203, DOI 10.1016/j.beha.2011.02.009; Rigter T, 2012, MOL GENET METAB, V107, P448, DOI 10.1016/j.ymgme.2012.09.017; Rohrbach M, 2010, J INHERIT METAB DIS, V33, P751, DOI 10.1007/s10545-010-9209-0	26	82	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67052	10.1371/journal.pone.0067052	http://dx.doi.org/10.1371/journal.pone.0067052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825616	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000068
J	Hirano, K; Ohgomori, T; Kobayashi, K; Tanaka, F; Matsumoto, T; Natori, T; Matsuyama, Y; Uchimura, K; Sakamoto, K; Takeuchi, H; Hirakawa, A; Suzumura, A; Sobue, G; Ishiguro, N; Imagama, S; Kadomatsu, K				Hirano, Kenichi; Ohgomori, Tomohiro; Kobayashi, Kazuyoshi; Tanaka, Fumiaki; Matsumoto, Tomohiro; Natori, Takamitsu; Matsuyama, Yukihiro; Uchimura, Kenji; Sakamoto, Kazuma; Takeuchi, Hideyuki; Hirakawa, Akihiro; Suzumura, Akio; Sobue, Gen; Ishiguro, Naoki; Imagama, Shiro; Kadomatsu, Kenji			Ablation of Keratan Sulfate Accelerates Early Phase Pathogenesis of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURONS; FUNCTIONAL RECOVERY; PROGRESSION; ASTROCYTES; RECEPTOR; DISEASE; MODEL; ONSET; SOD1	Biopolymers consist of three major classes, i.e., polynucleotides (DNA, RNA), polypeptides (proteins) and polysaccharides (sugar chains). It is widely accepted that polynucleotides and polypeptides play fundamental roles in the pathogenesis of neurodegenerative diseases. But, sugar chains have been poorly studied in this process, and their biological/clinical significance remains largely unexplored. Amyotrophic lateral sclerosis (ALS) is a motoneuron-degenerative disease, the pathogenesis of which requires both cell autonomous and non-cell autonomous processes. Here, we investigated the role of keratan sulfate (KS), a sulfated long sugar chain of proteoglycan, in ALS pathogenesis. We employed ALS model SOD1(G93A) mice and GlcNAc6ST-1(-/-) mice, which are KS-deficient in the central nervous system. Unexpectedly, SOD1(G93A)GlcNAc6ST-1(-/-) mice exhibited a significantly shorter lifespan than SOD1(G93A) mice and an accelerated appearance of clinical symptoms (body weight loss and decreased rotarod performance). KS expression was induced exclusively in a subpopulation of microglia in SOD1(G93A) mice, and became detectable around motoneurons in the ventral horn during the early disease phase before body weight loss. During this phase, the expression of M2 microglia markers was transiently enhanced in SOD1(G93A) mice, while this enhancement was attenuated in SOD1(G93A)GlcNAc6ST-1(-/-) mice. Consistent with this, M2 microglia were markedly less during the early disease phase in SOD1(G93A)GlcNAc6ST-1(-/-) mice. Moreover, KS expression in microglia was also detected in some human ALS cases. This study suggests that KS plays an indispensable, suppressive role in the early phase pathogenesis of ALS and may represent a new target for therapeutic intervention.	[Hirano, Kenichi; Ohgomori, Tomohiro; Kobayashi, Kazuyoshi; Matsumoto, Tomohiro; Uchimura, Kenji; Sakamoto, Kazuma; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan; [Hirano, Kenichi; Kobayashi, Kazuyoshi; Matsumoto, Tomohiro; Ishiguro, Naoki; Imagama, Shiro] Nagoya Univ, Grad Sch Med, Dept Orthoped, Nagoya, Aichi 4648601, Japan; [Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; Yamanashi Gakuin Univ, Dept Hlth & Nutr, Kofu, Yamanashi, Japan; [Matsuyama, Yukihiro] Hamamatsu Univ Sch Med, Dept Orthoped, Hamamatsu, Shizuoka 4312102, Japan; [Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 4648601, Japan; [Hirakawa, Akihiro] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University; Hamamatsu University School of Medicine; Nagoya University; Nagoya University	Imagama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Orthoped, Nagoya, Aichi 4648601, Japan.	imagama@med.nagoya-u.ac.jp; kkadoma@med.nagoya-u.ac.jp	IMAGAMA, Shiro/I-7419-2014; Kadomatsu, Kenji/G-8083-2012; Uchimura, Kenji/C-9635-2014; Hirakawa, Akihiro/AAE-5936-2019; Sakamoto, Kazuma/B-7347-2016; Ishiguro, Naoki/I-1563-2012; Uchimura, Kenji/AFV-1802-2022	Uchimura, Kenji/0000-0003-3009-248X; Uchimura, Kenji/0000-0003-3009-248X; Takeuchi, Hideyuki/0000-0001-5912-7581	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23110002, 23790360]; MEXT [20390092]; Ministry of Health, Labor, and Welfare of Japan [H21-012]; Global COE program, MEXT; Grants-in-Aid for Scientific Research [25860234, 25293207] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global COE program, MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23110002 to KK) and a Grant-in-Aid for Young Scientists (B) (No. 23790360 to TO) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; by a Grant-in-Aid (No. 20390092 to KK) from MEXT; by a Grant-in-Aid from the Ministry of Health, Labor, and Welfare of Japan (Health Sciences Research Grant on Comprehensive Research on Disability Health and Welfare, H21-012 to KK); and by funds from the Global COE program, MEXT, to Nagoya University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Imagama S, 2011, J NEUROSCI, V31, P17091, DOI 10.1523/JNEUROSCI.5120-10.2011; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Ito Z, 2010, J NEUROSCI, V30, P5937, DOI 10.1523/JNEUROSCI.2570-09.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Mizuno H, 2008, J NEUROSCI RES, V86, P2512, DOI 10.1002/jnr.21702; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Vargas MR, 2008, J NEUROSCI RES, V86, P3515, DOI 10.1002/jnr.21797; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang HQ, 2006, GLYCOBIOLOGY, V16, P702, DOI 10.1093/glycob/cwj115	25	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66969	10.1371/journal.pone.0066969	http://dx.doi.org/10.1371/journal.pone.0066969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825599	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000053
J	Hubertus, J; Zitzmann, F; Trippel, F; Muller-Hocker, J; Stehr, M; von Schweinitz, D; Kappler, R				Hubertus, Jochen; Zitzmann, Ferdinand; Trippel, Franziska; Mueller-Hoecker, Josef; Stehr, Maximilian; von Schweinitz, Dietrich; Kappler, Roland			Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors	PLOS ONE			English	Article							GROWTH-FACTOR-II; IMPRINTED DOMAIN; NEURONATIN GENE; CTCF; INSULATOR; STAGE; LINK	Aberrant expression of imprinted genes, such as those coding for the insulin-like growth factor 2 (IGF2) and neuronatin (NNAT), is a characteristic of a variety of embryonic neoplasms, including Wilms tumor (WT). In case of IGF2, it is generally accepted that loss of imprinting in a differentially methylated region of the IGF2/H19 locus results in biallelic expression and, thus, upregulation of the gene. In this study we examined methylation pattern at potential regulatory elements of the paternally expressed NNAT gene in a cohort of WT patients in order to further characterize the molecular mechanism causing overexpression of this regulatory gene. We demonstrate that transcriptional upregulation of NNAT in WT is grossly independent of the bladder cancer-associated protein (BLCAP) gene, an imprinted gene within the imprinted domain of the NNAT locus. However, expression of the BLCAP transcript isoform v2a formerly known to be selectively expressed from the paternal allele in brain was associated with high expression of NNAT. This contrasts the situation we found at the IGF2/H19 locus, which shows high overexpression of IGF2 and inversely correlated expression of the H19 gene in WT. An analysis of DNA methylation in two potential regulatory regions of the NNAT locus by pyrosequencing revealed significant hypomethylation of the tumors compared to normal kidney tissue. Interestingly, the difference in DNA methylation was highest at CpGs that were observed within three putative binding sites of the CCCTC-binding factor CTCF. Most importantly, hypomethylation of both NNAT regulatory regions is significantly associated with the upregulation of NNAT expression and the BLCAP_v2a transcript. Our data indicate that the methylation status of a not-yet-described regulatory element within the NNAT locus that contains four potential CTCF binding sites determines the expression level of NNAT and the nearby located BLCAP_v2a transcript, thereby suggesting a functional role in the aberrant upregulation of NNAT in WT.	[Hubertus, Jochen; Zitzmann, Ferdinand; Trippel, Franziska; Stehr, Maximilian; von Schweinitz, Dietrich; Kappler, Roland] Univ Munich, Res Labs, Dept Pediat Surg, Munich, Germany; [Mueller-Hoecker, Josef] Univ Munich, Inst Pathol, D-80539 Munich, Germany	University of Munich; University of Munich	Hubertus, J (corresponding author), Univ Munich, Res Labs, Dept Pediat Surg, Munich, Germany.	jochen.hubertus@med.lmu.de	Hubertus, Jochen/AAW-7790-2021; Hubertus, Jochen/K-6512-2019	Hubertus, Jochen/0000-0003-3206-6170; Kappler, Roland/0000-0002-8581-2803	Friedrich-Baur foundation, Munich; Munchener Medizinische Wochenschrift, Munich	Friedrich-Baur foundation, Munich; Munchener Medizinische Wochenschrift, Munich	This work was supported by grants of the Friedrich-Baur foundation, Munich and the Munchener Medizinische Wochenschrift, Munich (to J.H.). But the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Cui HM, 2001, CANCER RES, V61, P4947; Davidoff Andrew M, 2012, Adv Pediatr, V59, P247, DOI 10.1016/j.yapd.2012.04.001; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dugu L, 2010, EUR J DERMATOL, V20, P580, DOI 10.1684/ejd.2010.0996; Dugu L, 2010, J DERMATOL, V37, P846, DOI 10.1111/j.1346-8138.2010.00873.x; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Evans HK, 2001, GENOMICS, V77, P99, DOI 10.1006/geno.2001.6612; Fukuzawa R, 2004, LANCET, V363, P446, DOI 10.1016/S0140-6736(04)15491-3; Hubertus J, 2011, ONCOL REP, V25, P817, DOI 10.3892/or.2010.1113; Ideraabdullah FY, 2011, DEV BIOL, V355, P349, DOI 10.1016/j.ydbio.2011.04.036; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; Ohlsson R, 1999, CANCER RES, V59, P3889; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Revill K, 2009, ENDOCR-RELAT CANCER, V16, P537, DOI 10.1677/ERC-09-0008; Schulz R, 2009, HUM MOL GENET, V18, P118, DOI 10.1093/hmg/ddn322; Singh Purnima, 2012, Frontiers in Genetics, V3, P214, DOI 10.3389/fgene.2012.00214; Szabo PE, 2012, MORE INSULATOR MULTI, P1, DOI [10.3389/ fgene. 2012.00214/abstract, DOI 10.3389/FGENE.2012.00214/ABSTRACT]; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Wang WH, 1996, J BIOL CHEM, V271, P27863, DOI 10.1074/jbc.271.44.27863; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; Wittmann S, 2008, GENE CHROMOSOME CANC, V47, P386, DOI 10.1002/gcc.20544; Xu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037811	28	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67605	10.1371/journal.pone.0067605	http://dx.doi.org/10.1371/journal.pone.0067605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825673	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000109
J	Liu, YB; Lu, PS; Hu, Y; Wang, ZG; Deng, XY; Ma, FB; Tao, H; Jia, CM; Ding, XY; Yang, HT; Liu, P; Min, J				Liu, Yuanbao; Lu, Peishan; Hu, Ying; Wang, Zhiguo; Deng, Xiuying; Ma, Fubao; Tao, Hong; Jia, Chengmei; Ding, Xiaoyan; Yang, Haitao; Liu, Pei; Min, Jie			Cross-Sectional Surveys of Measles Antibodies in the Jiangsu Province of China from 2008 to 2010: The Effect of High Coverage with Two Doses of Measles Vaccine among Children	PLOS ONE			English	Article							SUPPLEMENTARY IMMUNIZATION ACTIVITIES; YOUNG-ADULTS; IMMUNITY; RUBELLA; MUMPS; SEROEPIDEMIOLOGY; ELIMINATION; REVACCINATION; EXPERIENCE; PROGRESS	Background: Changes in the epidemiological characteristics of measles since 2007 appeared in the Jiangsu province. Although the reported coverage with two doses of measles vaccine was greater than 95% in most regions of the province, measles incidence remained high across the whole province. Cross-sectional serological surveys of measles antibodies in the Jiangsu province of China were conducted from 2008 to 2010 to assess and track population immunity. Methods: Measles-specific IgG levels were measured in serum samples using ELISA. GMTs and seroprevalence with 95% CIs were calculated by region, gender, and age. ANOVA and x 2 tests were used to test for statistically significant differences between groups for GMT levels and seroprevalence, respectively. Results: Seroprevalence showed a significantly increasing trend annually (CMH chi(2) = 40.32, p<0.0001). Although the seroprevalence among children aged 2-15 years was consistently over 95%, vaccine-induced measles antibodies may wane over time. Measles seropositivity in the Jiangsu province was 91.7% (95% CI: 90.1-93.2%) in 2010. Among adults aged 15 to 29-year-olds, the seropositivity rate was 88.4% (95% CI: 82.7-92.8%). Conclusions: Vaccination strategies may need to be adjusted depending on the individual age and regions, particularly individuals between the ages of 8 months-14 years old and 20-29 years old. Additional SIAs are likely required to eliminate measles in China.	[Liu, Yuanbao; Lu, Peishan; Hu, Ying; Wang, Zhiguo; Deng, Xiuying; Ma, Fubao; Tao, Hong; Jia, Chengmei; Ding, Xiaoyan; Yang, Haitao] Jiangsu Prov Ctr Dis Control & Prevent, Dept Expanded Programme Immunizat, Nanjing, Jiangsu, Peoples R China; [Liu, Pei; Min, Jie] Southeast Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Southeast University - China	Ma, FB (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Expanded Programme Immunizat, Nanjing, Jiangsu, Peoples R China.	jsepi_ma@163.com			department of health of Jiangsu Province [Y2012068]	department of health of Jiangsu Province	This study was guided by the preventive medicine scientific research project from department of health of Jiangsu Province (NO. Y2012068). We would like to thank the following institutions for their field works: Nanjing Center for Disease Control and Prevention (CDC), Wuxi CDC, Xuzhou CDC, Changzhou CDC, Suzhou CDC, Nantong CDC, Lianyungang CDC, Huaian CDC, Yancheng CDC, Yangzhou CDC, Zhenjiang CDC, Taizhou CDC, Suqian CDC. We appreciated Dr. Lance Rodewald in WHO and Dr. Xia wei in NIP to polish and review the manuscript.	Andrews N, 2000, EPIDEMIOL INFECT, V125, P127, DOI 10.1017/S0950268899004173; Bechini A, 2012, EUR J PUBLIC HEALTH, V22, P133, DOI 10.1093/eurpub/ckq134; Chao M., 2011, CHINESE J VACCINE IM, V17, P4; Chen CJ, 2012, VACCINE, V30, P6721, DOI 10.1016/j.vaccine.2012.05.019; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; CHRISTENSON B, 1994, VACCINE, V12, P129, DOI 10.1016/0264-410X(94)90049-3; De Serres G, 2012, CLIN INFECT DIS, V55, P394, DOI 10.1093/cid/cis439; Fiebelkorn AP, 2010, J INFECT DIS, V202, P1520, DOI 10.1086/656914; Fu CX, 2010, VACCINE, V28, P8219, DOI 10.1016/j.vaccine.2010.07.071; He HQ, 2013, VACCINE, V31, P533, DOI 10.1016/j.vaccine.2012.11.014; HO, FIELD GUID MEASL EL; Huiss S, 1997, CLIN EXP IMMUNOL, V109, P416, DOI 10.1046/j.1365-2249.1997.00137.x; Irons B, 2011, J INFECT DIS, V204, pS284, DOI 10.1093/infdis/jir212; Jaber SM, 2006, SAUDI MED J, V27, P63; Khetsuriani N, 2011, J INFECT DIS, V204, pS343, DOI 10.1093/infdis/jir074; Ki M, 2003, AM J EPIDEMIOL, V157, pS48; Kim SS, 2004, VACCINE, V23, P290, DOI 10.1016/j.vaccine.2004.07.030; Liu YB, 2011, VACCINE, V29, P1000, DOI 10.1016/j.vaccine.2010.11.081; MARKOWITZ LE, 1992, J INFECT DIS, V166, P205, DOI 10.1093/infdis/166.1.205; MARKOWITZ LE, 1990, PEDIATR INFECT DIS J, V9, P101, DOI 10.1097/00006454-199002000-00008; Muscat M, 2009, LANCET, V373, P383, DOI 10.1016/S0140-6736(08)61849-8; PAHO, 2005, MEASL EL FIELD GUID; R D Core Team., 2009, LANG ENV STAT COMP; Sasaki A, 2007, J INFECTION, V55, P179, DOI 10.1016/j.jinf.2007.04.004; Sniadack DH, 2011, J INFECT DIS, V204, pS439, DOI 10.1093/infdis/jir148; Sudfeld CR, 2010, INT J EPIDEMIOL, V39, P48, DOI 10.1093/ije/dyq021; Vyse AJ, 2006, EPIDEMIOL INFECT, V134, P1303, DOI 10.1017/S0950268806006340; Wenyuan Z, 2001, THEORY VACCINES IMMU; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P349; Yuanbao L, 2010, CHINESE J VACCINE IM, V16, P307; Zhuo JT, 2011, J INFECT DIS, V204, pS455, DOI 10.1093/infdis/jir063	31	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66771	10.1371/journal.pone.0066771	http://dx.doi.org/10.1371/journal.pone.0066771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825562	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000025
J	Rathleff, MS; Thorborg, K; Bandholm, T				Rathleff, Michael Skovdal; Thorborg, Kristian; Bandholm, Thomas			Concentric and Eccentric Time-Under-Tension during Strengthening Exercises: Validity and Reliability of Stretch-Sensor Recordings from an Elastic Exercise-Band	PLOS ONE			English	Article							SUBACROMIAL IMPINGEMENT SYNDROME; RANDOMIZED CONTROLLED-TRIAL; KNEE OSTEOARTHRITIS; CONTRACTION TYPES; MUSCLE STRENGTH; HOME EXERCISE; PROGRAM; TENDON; MANAGEMENT; ACHILLES	Background: Total, single repetition and contraction-phase specific (concentric and eccentric) time-under-tension (TUT) are important exercise-descriptors, as they are linked to the physiological and clinical response in exercise and rehabilitation. Objective: To investigate the validity and reliability of total, single repetition, and contraction-phase specific TUT during shoulder abduction exercises, based on data from a stretch-sensor attached to an elastic exercise band. Methods: A concurrent validity and interrater reliability study with two raters was conducted. Twelve participants performed five sets of 10 repetitions of shoulder abduction exercises with an elastic exercise band. Exercises were video-recorded to assess concurrent validity between TUT from stretch-sensor data and from video recordings (gold standard). Agreement between methods was calculated using Limits of Agreement (LoA), and the association was assessed by Pearson correlation coefficients. Interrater reliability was calculated using intraclass correlation coefficients (ICC 2.1). Results: Total, single repetition, and contraction-phase specific TUT-determined from video and stretch-sensor data-were highly correlated (r>0.99). Agreement between methods was high, as LoA ranged from 0.0 to 3.1 seconds for total TUT (2.6% of mean TUT), from -0.26 to 0.56 seconds for single repetition TUT (6.9%), and from -0.29 to 0.56 seconds for contraction-phase specific TUT (13.2-21.1%). Interrater reliability for total, single repetition and contraction-phase specific TUT was high (ICC>0.99). Interrater agreement was high, as LoA ranged from -2.11 to 2.56 seconds for total TUT (4.7%), from -0.46 to 0.50 seconds for single repetition TUT (9.7%) and from -0.41 to 0.44 seconds for contraction-phase specific TUT (5.2-14.5%). Conclusion: Data from a stretch-sensor attached to an elastic exercise band is a valid measure of total and single repetition time-under-tension, and the procedure is highly reliable. This method will enable clinicians and researchers to objectively quantify if home-based exercises are performed as prescribed, with respect to time-under-tension.	[Rathleff, Michael Skovdal] Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark; [Thorborg, Kristian] Univ Copenhagen Hosp, Arthroscop Ctr Amager, DK-2100 Copenhagen, Denmark; [Thorborg, Kristian; Bandholm, Thomas] Copenhagen Univ Hosp, Dept Orthoped Surg, Hvidovre, Denmark; [Thorborg, Kristian; Bandholm, Thomas] Copenhagen Univ Hosp, Dept Phys Therapy Phys Med & Rehabil Res Copenhag, Hvidovre, Denmark; [Bandholm, Thomas] Univ Copenhagen Hosp, Clin Res Ctr, DK-2100 Copenhagen, Denmark	Aalborg University; Aalborg University Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Rathleff, MS (corresponding author), Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark.	michaelrathleff@gmail.com	Bandholm, Thomas/AAZ-8632-2020	Bandholm, Thomas/0000-0001-6884-1971; Rathleff, Michael Skovdal/0000-0003-1173-0335	Bevica Foundation	Bevica Foundation	The Bevica Foundation paid supplied funding for the hardware used in the current study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RG, 2006, FOOT ANKLE INT, V27, P2, DOI 10.1177/107110070602700102; Andersen LL, 2011, PAIN, V152, P440, DOI 10.1016/j.pain.2010.11.016; Beers Amanda, 2008, Physiother Can, V60, P180, DOI 10.3138/physio.60.2.180; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown S, 2010, TLS-TIMES LIT SUPPL, P24; Buitrago S, 2012, EUR J APPL PHYSIOL, V112, P2739, DOI 10.1007/s00421-011-2249-9; Burd NA, 2012, J PHYSIOL-LONDON, V590, P351, DOI 10.1113/jphysiol.2011.221200; Comstock BA, 2011, J STRENGTH COND RES, V25, P2293, DOI 10.1519/JSC.0b013e318200b78c; Dunstan DW, 2005, DIABETES CARE, V28, P3, DOI 10.2337/diacare.28.1.3; ELIASZIW M, 1994, PHYS THER, V74, P777, DOI 10.1093/ptj/74.8.777; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2007, J APPL PHYSIOL, V102, P573, DOI 10.1152/japplphysiol.00866.2006; Holmgren T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e787; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Kappel SL, 2012, SENSORS; Kaux JF, 2013, J ORTHOP RES, V31, P119, DOI 10.1002/jor.22202; Kottner J, 2011, INT J NURS STUD, V48, P661, DOI 10.1016/j.ijnurstu.2011.01.016; Kuhn JE, 2009, J SHOULDER ELB SURG, V18, P138, DOI 10.1016/j.jse.2008.06.004; Mafi N, 2001, KNEE SURG SPORT TR A, V9, P42, DOI 10.1007/s001670000148; Malliaras P, 2013, SPORTS MED, V43, P267, DOI 10.1007/s40279-013-0019-z; McCarthy CJ, 2004, RHEUMATOLOGY, V43, P880, DOI 10.1093/rheumatology/keh188; McLean SM, 2010, MANUAL THER, V15, P514, DOI 10.1016/j.math.2010.05.012; Mohamad NI, 2011, STRENGTH COND J, V33, P81, DOI 10.1519/SSC.0b013e3181fe7164; Or CKL, 2011, J AM MED INFORM ASSN, V18, P51, DOI 10.1136/jamia.2010.007336; Rathleff MS, 2013, BRIT J SPORT MED; Ravaud P, 2004, ANN RHEUM DIS, V63, P703, DOI 10.1136/ard.2003.009803; Roig M, 2009, BRIT J SPORT MED, V43, P556, DOI 10.1136/bjsm.2008.051417; Schoenfeld BJ, 2010, J STRENGTH COND RES, V24, P2857, DOI 10.1519/JSC.0b013e3181e840f3; Thomas KS, 2005, ARTHRIT RHEUM-ARTHR, V53, P388, DOI 10.1002/art.21173; Thomas KS, 2002, BMJ-BRIT MED J, V325, P752, DOI 10.1136/bmj.325.7367.752; Toigo M, 2006, EUR J APPL PHYSIOL, V97, P643, DOI 10.1007/s00421-006-0238-1; Tran QT, 2006, EUR J APPL PHYSIOL, V98, P402, DOI 10.1007/s00421-006-0297-3; Walther M, 2004, J SHOULDER ELB SURG, V13, P417, DOI 10.1016/j.jse.2004.02.002; Yu J, 2013, AM J PHYS MED REHAB, V92, P68, DOI 10.1097/PHM.0b013e31826eda63	34	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e68172	10.1371/journal.pone.0068172	http://dx.doi.org/10.1371/journal.pone.0068172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825696	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000130
J	Ren, TJ; Qiang, R; Jiang, ZL; Wang, GH; Sun, L; Jiang, R; Zhao, GW; Han, LY				Ren, Tao-Jie; Qiang, Ren; Jiang, Zheng-Lin; Wang, Guo-Hua; Sun, Li; Jiang, Rui; Zhao, Guang-Wei; Han, Le-Yang			Improvement in Regional CBF by L-Serine Contributes to Its Neuroprotective Effect in Rats after Focal Cerebral Ischemia	PLOS ONE			English	Article							CT PERFUSION; BRAIN; NEUROTRANSMISSION; INHIBITION; OCCLUSION; RESPONSES; CHANNELS; ENZYME; ARTERY; DEATH	To investigate the mechanisms underlying the neuroprotective effect of L-serine, permanent focal cerebral ischemia was induced by occlusion of the middle cerebral artery while monitoring cerebral blood flow (CBF). Rats were divided into control and L-serine-treated groups after middle cerebral artery occlusion. The neurological deficit score and brain infarct volume were assessed. Nissl staining was used to quantify the cortical injury. L-serine and D-serine levels in the ischemic cortex were analyzed with high performance liquid chromatography. We found that L-serine treatment: 1) reduced the neurological deficit score, infarct volume and cortical neuron loss in a dose-dependent manner; 2) improved CBF in the cortex, and this effect was inhibited in the presence of apamin plus charybdotoxin while the alleviation of both neurological deficit score and infarct volume was blocked; and 3) increased the amount of L-serine and D-serine in the cortex, and inhibition of the conversion of L-serine into D-serine by aminooxyacetic acid did not affect the reduction of neurological deficit score and infarct volume by L-serine. In conclusion, improvement in regional CBF by L-serine may contribute to its neuroprotective effect on the ischemic brain, potentially through vasodilation which is mediated by the small-and intermediate-conductance Ca2+-activated K+ channels on the cerebral blood vessel endothelium.	[Ren, Tao-Jie; Jiang, Zheng-Lin; Wang, Guo-Hua; Sun, Li; Jiang, Rui; Zhao, Guang-Wei; Han, Le-Yang] Nantong Univ, Inst Naut Med, Dept Neuropharmacol, Nantong, Jiangsu, Peoples R China; [Qiang, Ren] Third Peoples Hosp, Dept Infect Dis, Nantong, Jiangsu, Peoples R China; [Ren, Tao-Jie; Jiang, Zheng-Lin; Sun, Li; Zhao, Guang-Wei] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Jiangsu, Peoples R China; [Ren, Tao-Jie] First Peoples Hosp, Dept Neurol, Yancheng, Jiangsu, Peoples R China	Nantong University; Nantong University	Jiang, ZL (corresponding author), Nantong Univ, Inst Naut Med, Dept Neuropharmacol, Nantong, Jiangsu, Peoples R China.	jiangzl@ntu.edu.cn; wgh@ntu.edu.cn	Wang, Guohua/AAD-8992-2022	Wang, Guohua/0000-0002-4810-8534	Chinese Natural Science Foundation [81000497, 81071614]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Administration of Science and Technology of Nantong, Jiangsu, China [BK2012086]; Qing-Lan Project of Jiangsu, China	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Administration of Science and Technology of Nantong, Jiangsu, China; Qing-Lan Project of Jiangsu, China	This work was supported by the Chinese Natural Science Foundation (Grant 81000497), the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Administration of Science and Technology of Nantong, Jiangsu, China (Project BK2012086). Guo-Hua Wang was sponsored by the Qing-Lan Project of Jiangsu, China, and Zheng-Lin Jiang is supported by the Chinese Natural Science Foundation (Grant 81071614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Cipolla MJ, 2009, STROKE, V40, P1451, DOI 10.1161/STROKEAHA.108.535435; de Koning TJ, 2004, CURR OPIN NEUROL, V17, P197, DOI 10.1097/00019052-200404000-00019; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DIRNAGL U, 1990, J CEREBR BLOOD F MET, V10, P327, DOI 10.1038/jcbfm.1990.61; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Guan XT, 2003, CHINESE MED J-PEKING, V116, P368; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hashimoto A, 2005, EUR J PHARMACOL, V525, P91, DOI 10.1016/j.ejphar.2005.08.055; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kiya T, 2011, NEUROSCIENCE, V174, P190, DOI 10.1016/j.neuroscience.2010.11.046; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; McNeish AJ, 2006, STROKE, V37, P1277, DOI 10.1161/01.STR.0000217307.71231.43; Mishra RC, 2008, HYPERTENSION, V51, P791, DOI 10.1161/HYPERTENSIONAHA.107.099598; Mishra RC, 2008, J HYPERTENS, V26, P2339, DOI 10.1097/HJH.0b013e328312c8a3; Miyoshi Y, 2009, J CHROMATOGR B, V877, P2506, DOI 10.1016/j.jchromb.2009.06.028; Nguelefack TB, 2006, J ETHNOPHARMACOL, V106, P70, DOI 10.1016/j.jep.2005.12.003; Stout RW, 2001, COMPARATIVE MED, V51, P524; Sun ZH, 2010, ACAD RADIOL, V17, P1535, DOI 10.1016/j.acra.2010.08.016; Takahashi K, 1997, J NEUROCHEM, V69, P1286; Trailovic SM, 2007, VET RES COMMUN, V31, P863, DOI 10.1007/s11259-007-0050-3; Wang GH, 2010, J NEUROSCI RES, V88, P2035, DOI 10.1002/jnr.22365; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x	27	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67044	10.1371/journal.pone.0067044	http://dx.doi.org/10.1371/journal.pone.0067044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825613	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000065
J	Seiler, M; Schwitzer, C; Gamba, M; Holderied, MW				Seiler, Melanie; Schwitzer, Christoph; Gamba, Marco; Holderied, Marc W.			Interspecific Semantic Alarm Call Recognition in the Solitary Sahamalaza Sportive Lemur, Lepilemur sahamalazensis	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; MICROCEBUS-MURINUS; AVOIDING PREDATORS; NONHUMAN PRIMATE; VERVET MONKEYS; SLEEPING SITES; RESPONSES; INFORMATION; BIRDS; SQUIRRELS	As alarm calls indicate the presence of predators, the correct interpretation of alarm calls, including those of other species, is essential for predator avoidance. Conversely, communication calls of other species might indicate the perceived absence of a predator and hence allow a reduction in vigilance. This "eavesdropping" was demonstrated in birds and mammals, including lemur species. Interspecific communication between taxonomic groups has so far been reported in some reptiles and mammals, including three primate species. So far, neither semantic nor interspecific communication has been tested in a solitary and nocturnal lemur species. The aim of this study was to investigate if the nocturnal and solitary Sahamalaza sportive lemur, Lepilemur sahamalazensis, is able to access semantic information of sympatric species. During the day, this species faces the risk of falling prey to aerial and terrestrial predators and therefore shows high levels of vigilance. We presented alarm calls of the crested coua, the Madagascar magpie-robin and aerial, terrestrial and agitation alarm calls of the blue-eyed black lemur to 19 individual Sahamalaza sportive lemurs resting in tree holes. Songs of both bird species' and contact calls of the blue-eyed black lemur were used as a control. After alarm calls of crested coua, Madagascar magpierobin and aerial alarm of the blue-eyed black lemur, the lemurs scanned up and their vigilance increased significantly. After presentation of terrestrial alarm and agitation calls of the blue-eyed black lemur, the animals did not show significant changes in scanning direction or in the duration of vigilance. Sportive lemur vigilance decreased after playbacks of songs of the bird species and contact calls of blue-eyed black lemurs. Our results indicate that the Sahamalaza sportive lemur is capable of using information on predator presence as well as predator type of different sympatric species, using their referential signals to detect predators early, and that the lemurs' reactions are based on experience and learning.	[Seiler, Melanie; Schwitzer, Christoph] Bristol Zoo Gardens, Bristol Conservat & Sci Fdn, Bristol, Avon, England; [Seiler, Melanie; Holderied, Marc W.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Gamba, Marco] Univ Turin, Dept Life Sci & Syst, Turin, Italy	University of Bristol; University of Turin	Holderied, MW (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	marc.holderied@bristol.ac.uk	Gamba, Marco/I-1184-2012; Zimmermann, Elke/D-2281-2015; Holderied, Marc/M-9382-2013	Gamba, Marco/0000-0001-9545-2242; Holderied, Marc/0000-0002-1573-7908	Bristol Conservation and Science Foundation; Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL); Conservation International Primate Action Fund; Margot Marsh Biodiversity Foundation [1230]; Mohamed bin Zayed Species Conservation Fund; Christian-Vogel-Fonds	Bristol Conservation and Science Foundation; Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL); Conservation International Primate Action Fund; Margot Marsh Biodiversity Foundation; Mohamed bin Zayed Species Conservation Fund; Christian-Vogel-Fonds	Bristol Conservation and Science Foundation - http://www.bcsf.org.uk/bcsf. Association Europeenne pour l'Etude et la Conservation des Lemuriens (AEECL) - www.aeecl.org. Conservation International Primate Action Fund - http://www.conservation.org/Pages/default.aspx. Margot Marsh Biodiversity Foundation - 1230 AVE OF THE AMERICAS; NEW YORK, NY 10020-0000. Mohamed bin Zayed Species Conservation Fund - http://www.mbzspeciesconservation.org/. International Primatological Society Conservation grant - http://www.internationalprimatologicalsociety.org/conservation.cfm. Christian-Vogel-Fonds - http://www.gf-primatologie.de/index.php?id=67. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBIN T, 1991, BEHAV PROCESS, V23, P103, DOI 10.1016/0376-6357(91)90061-4; Birkinshaw CR, 2004, RAVINTSARA, V2, P14; Blumstein DT, 1997, AM NAT, V150, P179, DOI 10.1086/286062; Brown GE, 2000, J CHEM ECOL, V26, P139, DOI 10.1023/A:1005445629144; De Kort SR, 2001, ANIM BEHAV, V61, P239, DOI 10.1006/anbe.2000.1552; Fallow PM, 2010, ANIM BEHAV, V79, P411, DOI 10.1016/j.anbehav.2009.11.018; Fichtel C, 2002, BEHAV ECOL SOCIOBIOL, V51, P262, DOI 10.1007/S00265-001-0436-0; Fichtel C, 2004, ANIM COGN, V7, P45, DOI 10.1007/s10071-003-0180-0; Fichtel C, 2007, AM J PRIMATOL, V69, P611, DOI 10.1002/ajp.20363; Forsman JT, 2001, ANIM BEHAV, V62, P1067, DOI 10.1006/anbe.2001.1856; Gamba M, 2007, ETHOL ECOL EVOL, V19, P323, DOI 10.1080/08927014.2007.9522555; Gamba M., 2005, J ANTHROPOL SCI, V83, P61; Goodman S. M., 2004, NATURAL HIST MADAGAS, P1221; GOODMAN SM, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P51; Gould L, 1996, INT J PRIMATOL, V17, P331, DOI 10.1007/BF02736625; Groves C, 2001, EVOL ANTHROPOL, V10, P192, DOI 10.1002/evan.10005; Harcourt C., 1990, IUCN RED DATA BOOK; Hart D., 2000, THESIS WASHINGTON U; HAUSER MD, 1988, BEHAVIOUR, V105, P187, DOI 10.1163/156853988X00016; Isbell Lynne A., 1994, Evolutionary Anthropology, V3, P61, DOI 10.1002/evan.1360030207; Janson Charles H., 2003, P103; Johnson FR, 2003, AUST J ZOOL, V51, P577, DOI 10.1071/ZO03031; Jurisevic MA, 1998, J AVIAN BIOL, V29, P61, DOI 10.2307/3677342; Karpanty SM, 2007, DEV PRIMATOL-PROG PR, P77, DOI 10.1007/978-0-387-34810-0_4; Karpanty SM, 1999, J RAPTOR RES, V33, P313; Karpanty SM, 2001, FOLIA PRIMATOL, V72, P100, DOI 10.1159/000049931; Kitchen DM, 2010, ANIM COGN, V13, P861, DOI 10.1007/s10071-010-0334-9; Lea AJ, 2008, BEHAV ECOL, V19, P1041, DOI 10.1093/beheco/arn064; Magrath RD, 2007, BEHAV ECOL, V18, P944, DOI 10.1093/beheco/arm063; Magrath RD, 2009, P ROY SOC B-BIOL SCI, V276, P769, DOI 10.1098/rspb.2008.1368; MARLER P, 1955, NATURE, V176, P6, DOI 10.1038/176006a0; Marler P, 1957, BEHAVIOUR, V11, DOI [DOI 10.1163/156853956X00066, 10.1163/156853956X00066]; Mirza RS, 2001, BEHAVIOUR, V138, P1249, DOI 10.1163/15685390152822201; MITTERMEIER RA, 2006, LEMURS MADAGASCAR; Mittermeier Russel A., 2007, Primate Conservation, V22, P1, DOI 10.1896/052.022.0101; Muller CA, 2008, ANIM BEHAV, V75, P897, DOI 10.1016/j.anbehav.2007.07.012; Nocera JJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P1769, DOI 10.1007/s00265-008-0605-5; Oda R, 1996, ETHOLOGY, V102, P441; Oda R, 1998, FOLIA PRIMATOL, V69, P357, DOI 10.1159/000021651; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Radespiel U, 1998, AM J PRIMATOL, V46, P77, DOI 10.1002/(SICI)1098-2345(1998)46:1<77::AID-AJP6>3.3.CO;2-#; Radespiel U, 2003, AM J PRIMATOL, V59, P139, DOI 10.1002/ajp.10071; Rainey HJ, 2004, P ROY SOC B-BIOL SCI, V271, P755, DOI 10.1098/rspb.2003.2619; Ramakrishnan U, 2000, J COMP PSYCHOL, V114, P3, DOI 10.1037/0735-7036.114.1.3; Randler C, 2006, ETHOLOGY, V112, P411, DOI 10.1111/j.1439-0310.2006.01191.x; Ranjard L, 2010, BEHAV ECOL SOCIOBIOL, V64, P1915, DOI 10.1007/s00265-010-1065-2; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; SAUTHER ML, 1989, INT J PRIMATOL, V10, P595, DOI 10.1007/BF02739366; Scheumann M, 2007, DEV PRIMATOL-PROG PR, P100, DOI 10.1007/978-0-387-34810-0_5; SCHWITZER C., 2006, P GERMAN MALAGASY RE, V11, P135; Schwitzer Nora, 2007, Primate Conservation, V22, P79, DOI 10.1896/052.022.0106; Schwitzer Nora, 2007, Endangered Species Research, V3, P239; Seiler M, 2012, THESIS U BRISTOL BRI; Seiler M, 2013, INT J PRIMATOL, V34, P260, DOI 10.1007/s10764-013-9658-z; SEYFARTH R, 1990, ANIM BEHAV, V40, P754, DOI 10.1016/S0003-3472(05)80704-3; SEYFARTH RM, 1986, ANIM BEHAV, V34, P1640, DOI 10.1016/S0003-3472(86)80252-4; Shriner WM, 1998, ANIM BEHAV, V55, P529, DOI 10.1006/anbe.1997.0623; Shriner WM, 1999, ETHOLOGY, V105, P747, DOI 10.1046/j.1439-0310.1999.00454.x; Stanford CB, 2002, INT J PRIMATOL, V23, P741, DOI 10.1023/A:1015572814388; SULLIVAN KA, 1984, BEHAVIOUR, V91, P294, DOI 10.1163/156853984X00128; Tattersall I, 1982, PRIMATES MADAGASCAR, pxiv; Templeton CN, 2007, P NATL ACAD SCI USA, V104, P5479, DOI 10.1073/pnas.0605183104; van Noordwijk Maria A., 1993, P77; Vitousek MN, 2007, BIOL LETTERS, V3, P632, DOI 10.1098/rsbl.2007.0443; Wright PC, 1998, BEHAVIOUR, V135, P483, DOI 10.1163/156853998793066186; Zuberbuhler K, 2000, COGNITION, V76, P195, DOI 10.1016/S0010-0277(00)00079-2	67	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67397	10.1371/journal.pone.0067397	http://dx.doi.org/10.1371/journal.pone.0067397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825658	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000101
J	Choi, HP; Juarez, S; Ciordia, S; Fernandez, M; Bargiela, R; Albar, JP; Mazumdar, V; Anton, BP; Kasif, S; Ferrer, M; Steffen, M				Choi, Han-Pil; Juarez, Silvia; Ciordia, Sergio; Fernandez, Marisol; Bargiela, Rafael; Albar, Juan P.; Mazumdar, Varun; Anton, Brian P.; Kasif, Simon; Ferrer, Manuel; Steffen, Martin			Biochemical Characterization of Hypothetical Proteins from Helicobacter pylori	PLOS ONE			English	Article							GTP CYCLOHYDROLASE-I; ACID; HYDROLASES; SYNTHASE	The functional characterization of Open Reading Frames (ORFs) from sequenced genomes remains a bottleneck in our effort to understand microbial biology. In particular, the functional characterization of proteins with only remote sequence homology to known proteins can be challenging, as there may be few clues to guide initial experiments. Affinity enrichment of proteins from cell lysates, and a global perspective of protein function as provided by COMBREX, affords an approach to this problem. We present here the biochemical analysis of six proteins from Helicobacter pylori ATCC 26695, a focus organism in COMBREX. Initial hypotheses were based upon affinity capture of proteins from total cellular lysate using derivatized nano-particles, and subsequent identification by mass spectrometry. Candidate genes encoding these proteins were cloned and expressed in Escherichia coli, and the recombinant proteins were purified and characterized biochemically and their biochemical parameters compared with the native ones. These proteins include a guanosine triphosphate (GTP) cyclohydrolase (HP0959), an ATPase (HP1079), an adenosine deaminase (HP0267), a phosphodiesterase (HP1042), an aminopeptidase (HP1037), and new substrates were characterized for a peptidoglycan deacetylase (HP0310). Generally, characterized enzymes were active at acidic to neutral pH (4.0-7.5) with temperature optima ranging from 35 to 55 degrees C, although some exhibited outstanding characteristics.	[Choi, Han-Pil; Kasif, Simon; Steffen, Martin] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Juarez, Silvia; Ciordia, Sergio; Fernandez, Marisol; Albar, Juan P.] CSIC, CNB Natl Ctr Biotechnol, Prote Facil, Madrid, Spain; [Bargiela, Rafael; Ferrer, Manuel] CSIC, Inst Catalysis, Madrid, Spain; [Mazumdar, Varun; Kasif, Simon] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Anton, Brian P.] New England Biolabs Inc, Ipswich, MA USA; [Steffen, Martin] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Boston University; New England Biolabs; Boston University	Ferrer, M (corresponding author), CSIC, Inst Catalysis, Madrid, Spain.	mferrer@icp.csic.es; steffen@bu.edu	Bargiela, Rafael/K-6783-2014; Ferrer, Manuel/K-4535-2014	Bargiela, Rafael/0000-0003-1442-3269; Ferrer, Manuel/0000-0003-4962-4714; Ciordia, Sergio/0000-0002-5726-853X	National Institutes of Health (NIGMS) [RC2-GM092602]; Spanish Ministry of Economy and Competitiveness [0315441A, BFU2008-04501-E/BMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092602] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Spanish Ministry of Economy and Competitiveness(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The cloning and biochemical testing of recombinant proteins was funded by RC2-GM092602 from the National Institutes of Health (NIGMS), awarded to COMBREX (SK, MS). Affinity enrichment and testing of native proteins was funded by the Spanish Ministry of Economy and Competitiveness (former MICINN), within the ERA NET PathoGenoMics2 call, grant number 0315441A and BFU2008-04501-E/BMC (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JM, 2005, J AM CHEM SOC, V127, P5689, DOI 10.1021/ja042717i; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beloqui A, 2010, APPL ENVIRON MICROB, V76, P5934, DOI 10.1128/AEM.00902-10; Bergmeyer HU, 1983, METHOD ENZYMAT AN, P135; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; BONTING SL, 1961, ARCH BIOCHEM BIOPHYS, V95, P416, DOI 10.1016/0003-9861(61)90170-9; Bracher A, 1998, J BIOL CHEM, V273, P28132, DOI 10.1074/jbc.273.43.28132; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Silva TCF, 2011, SOFT MATTER, V7, P1090, DOI 10.1039/c0sm00868k; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goddard JP, 2004, J AM CHEM SOC, V126, P11116, DOI 10.1021/ja0478330; Hatanaka T, 2011, APPL BIOCHEM BIOTECH, V164, P475, DOI 10.1007/s12010-010-9149-z; Hazell SL, 2001, HELICOBACTER PYLORI; He AM, 2003, APPL ENVIRON MICROB, V69, P7507, DOI 10.1128/AEM.69.12.7507-7513.2003; Janes LE, 1998, CHEM-EUR J, V4, P2324, DOI 10.1002/(SICI)1521-3765(19981102)4:11<2324::AID-CHEM2324>3.0.CO;2-I; Kamat SS, 2011, BIOCHEMISTRY-US, V50, P1917, DOI 10.1021/bi101788n; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Madupu R, 2012, NUCLEIC ACIDS RES, V40, pD237, DOI 10.1093/nar/gkr1133; Miller EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038727; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MURPHY J, 1982, ANAL BIOCHEM, V122, P328, DOI 10.1016/0003-2697(82)90291-3; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Proudfoot Michael, 2008, V426, P331, DOI 10.1007/978-1-60327-058-8_21; Rangrez AY, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-10; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; Sachs G, 1996, YALE J BIOL MED, V69, P301; Scheer Maurice, 2011, Nucleic Acids Res, V39, pD670, DOI 10.1093/nar/gkq1089; Shaik MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019207; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Varela C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-7; Wang G, 2012, MBIO, V3, DOI 10.1128/mBio.00409-12; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; Zheng Y, 2004, PLOS BIOL, V2, P452, DOI 10.1371/journal.pbio.0020081	41	43	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66605	10.1371/journal.pone.0066605	http://dx.doi.org/10.1371/journal.pone.0066605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825549	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400137
J	Gao, XG; Liu, HH; He, B; Fu, ZR				Gao, Xiaogang; Liu, Huanhai; He, Bin; Fu, Zhiren			Resistance to Streptozotocin-Induced Autoimmune Diabetes in Absence of Complement C3: Myeloid-Derived Suppressor Cells Play a Role	PLOS ONE			English	Article							T-CELLS; ARGINASE-I; TUMOR; EXPRESSION; ENCEPHALOMYELITIS; INHIBITION; ACTIVATION; CARCINOMA; RESPONSES; MODELS	The contribution of complement to the development of autoimmune diabetes has been proposed recently. The underlying mechanisms, however, remain poorly understood. We hypothesize that myeloid-derived suppressor cells (MDSC), which act as regulators in autoimmunity, play a role in resistance to diabetes in absence of complement C3. Indeed, MDSC number was increased significantly in STZ-treated C3-/- mice. These cells highly expressed arginase I and inducible nitric oxide synthase (iNOS). Importantly, depletion of MDSC led to the occurrence of overt diabetes in C3-/- mice after STZ. Furthermore, C3-/- MDSC actively suppressed diabetogenic T cell proliferation and prevented/delayed the development of diabetes in arginase and/or iNOS-dependent manner. Both Tregs and transforming growth factor-beta (TGF-beta) are crucial for MDSC induction in STZ-treated C3-/- mice as depletion of Tregs or blocking TGF-beta bioactivity dramatically decreased MDSC number. These findings indicate that MDSC are implicated in resistance to STZ-induced diabetes in the absence of complement C3, which may be helpful for understanding of mechanisms underlying preventive effects of complement deficiency on autoimmune diseases.	[Gao, Xiaogang; Fu, Zhiren] Second Mil Med Univ, Shanghai ChangZheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China; [Liu, Huanhai] Second Mil Med Univ, Shanghai ChangZheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [He, Bin] Shanghai Jiao Tong Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Xinhua Hosp, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University	Fu, ZR (corresponding author), Second Mil Med Univ, Shanghai ChangZheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China.	zhirenf@sh163.net			National Natural Science Foundation of China [31100639, 81100585, 30901470]; Natural Science Foundation of Shanghai [11ZR1448100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by grants from the National Natural Science Foundation of China (31100639, 81100585, 30901470) and Natural Science Foundation of Shanghai(11ZR1448100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Apetoh L, 2011, CURR MOL MED, V11, P365, DOI 10.2174/156652411795976574; Berezhnaya N. M., 2010, Experimental Oncology, V32, P159; Berger SP, 2007, SEMIN IMMUNOPATHOL, V29, P375, DOI 10.1007/s00281-007-0090-3; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Duncan RC, 2008, BIOCHIMIE, V90, P387, DOI 10.1016/j.biochi.2007.07.023; FFRENCHCONSTANT C, 1994, LANCET, V343, P271, DOI 10.1016/S0140-6736(94)91118-5; Gao XG, 2011, CLIN IMMUNOL, V140, P236, DOI 10.1016/j.clim.2011.02.004; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; Hawlisch H, 2004, MOL IMMUNOL, V41, P123, DOI 10.1016/j.molimm.2004.03.019; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Hoechst B, 2011, BLOOD, V117, P6532, DOI 10.1182/blood-2010-11-317321; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Li Q, 2009, AM J PATHOL, V175, P661, DOI 10.2353/ajpath.2009.081093; Lin M, 2010, DIABETES, V59, P2247, DOI 10.2337/db10-0044; Linton SM, 1999, MOL IMMUNOL, V36, P905, DOI 10.1016/S0161-5890(99)00113-3; Liu JB, 2008, J IMMUNOL, V180, P5882, DOI 10.4049/jimmunol.180.9.5882; Morales JK, 2010, BREAST CANCER RES TR, V123, P39, DOI 10.1007/s10549-009-0622-8; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636	30	15	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66334	10.1371/journal.pone.0066334	http://dx.doi.org/10.1371/journal.pone.0066334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824734	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400086
J	Gingold, R; Moens, T; Rocha-Olivares, A				Gingold, Ruth; Moens, Tom; Rocha-Olivares, Axayacatl			Assessing the Response of Nematode Communities to Climate Change-Driven Warming: A Microcosm Experiment	PLOS ONE			English	Article							BACTERIVOROUS NEMATODES; MARINE-SEDIMENTS; SANDY BEACH; BIODIVERSITY; ASSEMBLAGES; DIVERSITY; MEIOFAUNA; CHLOROPHYLL; ACCLIMATION; MEIOBENTHOS	Biodiversity has diminished over the past decades with climate change being among the main responsible factors. One consequence of climate change is the increase in sea surface temperature, which, together with long exposure periods in intertidal areas, may exceed the tolerance level of benthic organisms. Benthic communities may suffer structural changes due to the loss of species or functional groups, putting ecological services at risk. In sandy beaches, free-living marine nematodes usually are the most abundant and diverse group of intertidal meiofauna, playing an important role in the benthic food web. While apparently many functionally similar nematode species co-exist temporally and spatially, experimental results on selected bacterivore species suggest no functional overlap, but rather an idiosyncratic contribution to ecosystem functioning. However, we hypothesize that functional redundancy is more likely to observe when taking into account the entire diversity of natural assemblages. We conducted a microcosm experiment with two natural communities to assess their stress response to elevated temperature. The two communities differed in diversity (high [HD] vs. low [LD]) and environmental origin (harsh vs. moderate conditions). We assessed their stress resistance to the experimental treatment in terms of species and diversity changes, and their function in terms of abundance, biomass, and trophic diversity. According to the Insurance Hypothesis, we hypothesized that the HD community would cope better with the stressful treatment due to species functional overlap, whereas the LD community functioning would benefit from species better adapted to harsh conditions. Our results indicate no evidence of functional redundancy in the studied nematofaunal communities. The species loss was more prominent and size specific in the HD; large predators and omnivores were lost, which may have important consequences for the benthic food web. Yet, we found evidence for alternative diversity-ecosystem functioning relationships, such as the Rivets and the Idiosyncrasy Model.	[Gingold, Ruth; Rocha-Olivares, Axayacatl] Ctr Invest Cient & Educ Super Ensenada, Biol Oceanog Dept, Ensenada, Baja California, Mexico; [Gingold, Ruth; Moens, Tom] Univ Ghent, Dept Biol, B-9000 Ghent, Flanders, Belgium	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Ghent University	Gingold, R (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Biol Oceanog Dept, Ensenada, Baja California, Mexico.	ruth_gingold@hotmail.com	Rocha-Olivares, Axayacatl/A-9832-2008; Moens, Tom/AAB-8701-2019	Rocha-Olivares, Axayacatl/0000-0002-2700-9086; 	CONACYT; Flemish National Science Foundation (FWO) [3G019209W]; research council of UGent [BOF09/24J/148];  [CONACYT-SEMARNAT-2004-C01-300]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Flemish National Science Foundation (FWO); research council of UGent; 	This research was funded by the grant CONACYT-SEMARNAT-2004-C01-300 to ARO. The paper derived from the first author's PhD research at the Marine Ecology program at CICESE where she was supported by CONACYT. TM received funding from the Flemish National Science Foundation (FWO) through project 3G019209W and from the research council of UGent (project BOF09/24J/148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; AUSTEN MC, 1995, HYDROBIOLOGIA, V311, P175, DOI 10.1007/BF00008579; Bale A.J., 2005, METHODS STUDY MARINE, V3, P43, DOI DOI 10.1002/9780470995129.CH2; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Clarke KR, 1994, CHANGE MARINE COMMUN; COLIJN F, 1981, MAR ECOL PROG SER, V4, P9, DOI 10.3354/meps004009; COULL BC, 1995, MAR ECOL PROG SER, V125, P13, DOI 10.3354/meps125013; Danovaro R, 2002, MAR BIOL, V141, P667, DOI 10.1007/s00227-002-0857-y; De Mesel I, 2004, ENVIRON MICROBIOL, V6, P733, DOI 10.1111/j.1462-2920.2004.00610.x; De Mesel I, 2006, MAR ECOL PROG SER, V321, P157, DOI 10.3354/meps321157; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; DEJONGE VN, 1977, MAR BIOL, V42, P143, DOI 10.1007/BF00391564; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; dos Santos GAP, 2009, THESIS GHENT U GHENT; DUSENBERY DB, 1978, J EXP ZOOL, V206, P191, DOI 10.1002/jez.1402060208; Emmerson MC, 2000, OIKOS, V91, P195; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Franco MD, 2010, MAR ECOL-EVOL PERSP, V31, P276, DOI 10.1111/j.1439-0485.2009.00319.x; FROELICH PN, 1980, LIMNOL OCEANOGR, V25, P564; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Gheskiere T, 2004, J SEA RES, V52, P211, DOI 10.1016/j.seares.2004.02.001; Gingold R, 2010, MAR BIOL, V157, P1741, DOI 10.1007/s00227-010-1447-z; Hamels I, 2001, AQUAT MICROB ECOL, V26, P61, DOI 10.3354/ame026061; HAMERLYNCK O, 1993, J MAR BIOL ASSOC UK, V73, P453, DOI 10.1017/S0025315400032999; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Hubas C, 2010, MAR ECOL PROG SER, V419, P85, DOI 10.3354/meps08851; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; Li J, 1997, FUND APPL NEMATOL, V20, P487; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; MASSELINK G, 1993, J COASTAL RES, V9, P785; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Olafsson E, 2003, VIE MILIEU, V53, P249; Platt H.M., 1983, SYNOPSES BRIT FAUNA, V28; Platt HM, 1988, SYNOPSES BRIT FAUNA; Reyss JL, 1991, GEOPHYS RES LETT, V18, P1889; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rodriguez JG, 2003, ESTUAR COAST SHELF S, V58, P63, DOI 10.1016/S0272-7714(03)00039-8; Rodriguez JG, 2001, REV CHIL HIST NAT, V74, P885; Schratzberger M, 1998, MAR ECOL PROG SER, V164, P83, DOI 10.3354/meps164083; Sokal R.R., 2012, BIOMETRY; Somerfield P.J., 2005, P229, DOI 10.1002/9780470995129.ch6; StatSoft, 1993, STAT WIND OP SYST RE; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Van Der Meer J, 2005, METHODS STUDY MARINE; Waldbusser GG, 2004, LIMNOL OCEANOGR, V49, P1482, DOI 10.4319/lo.2004.49.5.1482; Warwick RM, 1998, SYNOPSES BRIT FAUNA; WIESER W., 1953, ARKIV ZOOL, V4, P439; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zar JH., 1999, BIOSTAT ANAL	57	32	33	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66653	10.1371/journal.pone.0066653	http://dx.doi.org/10.1371/journal.pone.0066653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825552	Green Published, gold			2022-12-27	WOS:000320576400140
J	Mangiacotti, M; Scali, S; Sacchi, R; Bassu, L; Nulchis, V; Corti, C				Mangiacotti, Marco; Scali, Stefano; Sacchi, Roberto; Bassu, Lara; Nulchis, Valeria; Corti, Claudia			Assessing the Spatial Scale Effect of Anthropogenic Factors on Species Distribution	PLOS ONE			English	Article							DISTRIBUTION MODELS; WALL LIZARD; NICHE; ECOLOGY; HABITAT; PERFORMANCE; PREVALENCE; PREDICTION; SELECTION; RICHNESS	Patch context is a way to describe the effect that the surroundings exert on a landscape patch. Despite anthropogenic context alteration may affect species distributions by reducing the accessibility to suitable patches, species distribution modelling have rarely accounted for its effects explicitly. We propose a general framework to statistically detect the occurrence and the extent of such a factor, by combining presence-only data, spatial distribution models and information-theoretic model selection procedures. After having established the spatial resolution of the analysis on the basis of the species characteristics, a measure of anthropogenic alteration that can be quantified at increasing distance from each patch has to be defined. Then the distribution of the species is modelled under competing hypotheses: H-0, assumes that the distribution is uninfluenced by the anthropogenic variables; H-1, assumes the effect of alteration at the species scale (resolution); and H-2, H-3 ... H-n add the effect of context alteration at increasing radii. Models are compared using the Akaike Information Criterion to establish the best hypothesis, and consequently the occurrence (if any) and the spatial scale of the anthropogenic effect. As a study case we analysed the distribution data of two insular lizards (one endemic and one naturalised) using four alternative hypotheses: no alteration (H-0), alteration at the species scale (H-1), alteration at two context scales (H-2 and H-3). H-2 and H-3 performed better than H-0 and H-1, highlighting the importance of context alteration. H-2 performed better than H-3, setting the spatial scale of the context at 1 km. The two species respond differently to context alteration, the introduced lizard being more tolerant than the endemic one. The proposed approach supplies reliably and interpretable results, uses easily available data on species distribution, and allows the assessing of the spatial scale at which human disturbance produces the heaviest effects.	[Mangiacotti, Marco; Scali, Stefano] Museo Civ Storia Nat Milano, Milan, Italy; [Sacchi, Roberto] Univ Pavia, Dipartimento Sci Terra & Ambiente, I-27100 Pavia, Italy; [Bassu, Lara; Nulchis, Valeria] Soc Herpetol Ital, Sez Sardegna, Oristano, Italy; [Corti, Claudia] Univ Florence, Sez Zool La Specola, Museo Storia Nat, Florence, Italy	University of Pavia; University of Florence	Mangiacotti, M (corresponding author), Museo Civ Storia Nat Milano, Milan, Italy.	marco.mangiacotti@gmail.com	MANGIACOTTI, MARCO/AAH-1282-2020; Sacchi, Roberto/E-2141-2011; Mangiacotti, Marco/AAZ-9550-2021	MANGIACOTTI, MARCO/0000-0001-7144-3851; Sacchi, Roberto/0000-0002-6199-0074; Corti, Claudia/0000-0001-6015-0092	Regione Sardegna	Regione Sardegna(Regione Sardegna)	The research was conducted without any external funding. Only field work by one of the authors (Lara Bassu) was partially supported by a bursary from "Regione Sardegna" (www.regionesardegna.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2012, J BIOGEOGR, V39, P1383, DOI 10.1111/j.1365-2699.2012.02713.x; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; [Anonymous], 2006, SOC HERPETOLOGICA IT; [Anonymous], 2011, ECOLOGICAL NICHES GE; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bender DJ, 2003, LANDSCAPE ECOL, V18, P17, DOI 10.1023/A:1022937226820; Brito JC, 2011, ACTA HERPETOL, V6, P105; BROWN RM, 1995, AM MIDL NAT, V133, P344, DOI 10.2307/2426399; Bruschi S, 2010, FAUNA ITALIA REPTILI, P417; Clipson A, 2003, BOOTSTRAP METHODS PE; Convertino M, 2011, ECOL COMPLEX, V8, P364, DOI 10.1016/j.ecocom.2011.07.007; Corti C., 2002, LIZARDS ITALY ADJACE; Corti C., 2010, FAUNA ITALIA, P407; Corti Claudia, 1999, Natura Croatica, V8, P287; Cozzi G, 2008, LANDSCAPE ECOL, V23, P269, DOI 10.1007/s10980-007-9178-3; Debinski DM, 2001, BIOL CONSERV, V98, P179, DOI 10.1016/S0006-3207(00)00153-1; Delaugerre M., 1992, ATLAS REPARTITION BA; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Findlay CS, 1997, CONSERV BIOL, V11, P1000, DOI 10.1046/j.1523-1739.1997.96144.x; Foa A, 1990, ETHOL ECOL EVOL, V2, P310, DOI [10.1080/08927014.1990.9525443, DOI 10.1080/08927014.1990.9525443]; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Graf RF, 2005, LANDSCAPE ECOL, V20, P703, DOI 10.1007/s10980-005-0063-7; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kattwinkel M, 2009, LANDSCAPE ECOL, V24, P929, DOI 10.1007/s10980-009-9371-7; Legendre P, 1998, NUMERICAL ECOLOGY, P870; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MARTIN AH, 2012, NY TIMES BK REV 0415, P22, DOI DOI 10.1890/11-2224.1.PUBMED:23387125; Mazerolle MJ, 1999, ECOSCIENCE, V6, P117, DOI 10.1080/11956860.1999.11952204; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; McInerny GJ, 2012, J BIOGEOGR, V39, P2112, DOI 10.1111/jbi.12031; McInerny GJ, 2012, J BIOGEOGR, V39, P2096, DOI 10.1111/jbi.12033; McInerny GJ, 2012, J BIOGEOGR, V39, P2103, DOI 10.1111/jbi.12032; Menke SB, 2009, GLOBAL ECOL BIOGEOGR, V18, P50, DOI 10.1111/j.1466-8238.2008.00420.x; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Pearson, 2010, LESSONS CONSERVATION, V3, P54, DOI [DOI 10.1016/S0140-6736(10)61462-6, 10.1016/S0140-6736(10)61462-6]; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perry G, 2002, ECOLOGY, V83, P1870, DOI 10.2307/3071771; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pineda E, 2012, GLOBAL ECOL BIOGEOGR, V21, P935, DOI 10.1111/j.1466-8238.2011.00741.x; Podnar M, 2005, MOL ECOL, V14, P575, DOI 10.1111/j.1365-294X.2005.02427.x; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Scali S, 2013, J ZOOL, V289, P196, DOI 10.1111/j.1469-7998.2012.00977.x; Scali S, 2011, AMPHIBIA-REPTILIA, V32, P223, DOI 10.1163/017353711X562171; Sillero N, 2009, ACTA HERPETOL, V4, P37; Smith AB, 2013, DIVERS DISTRIB, V19, P867, DOI 10.1111/ddi.12031; Smith AB, 2013, GLOBAL ECOL BIOGEOGR, V22, P334, DOI 10.1111/j.1466-8238.2012.00785.x; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; VANDAMME R, 1990, ACTA OECOL, V11, P503; Vanhooydonck B, 2000, FUNCT ECOL, V14, P358, DOI 10.1046/j.1365-2435.2000.00430.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Wilson E.O., 2002, FUTURE LIFE, P256	70	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67573	10.1371/journal.pone.0067573	http://dx.doi.org/10.1371/journal.pone.0067573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825669	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400188
J	Pesch, R; Zimmer, R				Pesch, Robert; Zimmer, Ralf			Complementing the Eukaryotic Protein Interactome	PLOS ONE			English	Article							INTERACTION NETWORKS; INTERACTION DATABASE; PHYLOGENETIC TREES; GENE ONTOLOGY; YEAST; TOOL; TRANSCRIPTION; ANNOTATION; RESOURCE; MODEL	Protein interaction networks are important for the understanding of regulatory mechanisms, for the explanation of experimental data and for the prediction of protein functions. Unfortunately, most interaction data is available only for model organisms. As a possible remedy, the transfer of interactions to organisms of interest is common practice, but it is not clear when interactions can be transferred from one organism to another and, thus, the confidence in the derived interactions is low. Here, we propose to use a rich set of features to train Random Forests in order to score transferred interactions. We evaluated the transfer from a range of eukaryotic organisms to S. cerevisiae using orthologs. Directly transferred interactions to S. cerevisiae are on average only 24% consistent with the current S. cerevisiae interaction network. By using commonly applied filter approaches the transfer precision can be improved, but at the cost of a large decrease in the number of transferred interactions. Our Random Forest approach uses various features derived from both the target and the source network as well as the ortholog annotations to assign confidence values to transferred interactions. Thereby, we could increase the average transfer consistency to 85%, while still transferring almost 70% of all correctly transferable interactions. We tested our approach for the transfer of interactions to other species and showed that our approach outperforms competing methods for the transfer of interactions to species where no experimental knowledge is available. Finally, we applied our predictor to score transferred interactions to 83 targets species and we were able to extend the available interactome of B. taurus, M. musculus and G. gallus with over 40,000 interactions each. Our transferred interaction networks are publicly available via our web interface, which allows to inspect and download transferred interaction sets of different sizes, for various species, and at specified expected precision levels.	[Pesch, Robert; Zimmer, Ralf] Univ Munich, Inst Informat, D-80539 Munich, Germany	University of Munich	Pesch, R (corresponding author), Univ Munich, Inst Informat, D-80539 Munich, Germany.	robert.pesch@bio.ifi.lmu.de	Zimmer, Ralf/L-9295-2019		DFG International Research Training Group (IRTG) [RECESS 1563]	DFG International Research Training Group (IRTG)(German Research Foundation (DFG))	This work was supported by the DFG International Research Training Group (IRTG) RECESS 1563 via scholarships to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bhardwaj N, 2005, BIOINFORMATICS, V21, P2730, DOI 10.1093/bioinformatics/bti398; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chautard E, 2011, NUCLEIC ACIDS RES, V39, pD235, DOI 10.1093/nar/gkq830; Chen PY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000118; Cote RG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-97; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; De Bodt S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-288; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Friedel CC, 2009, BIOINFORMATICS, V25, P2140, DOI 10.1093/bioinformatics/btp353; Gallone G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-289; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Garcia-Garcia J, 2012, NUCLEIC ACIDS RES, V40, pW147, DOI 10.1093/nar/gks553; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goll J, 2008, BIOINFORMATICS, V24, P1743, DOI 10.1093/bioinformatics/btn285; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lewis ACF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002645; Luo QB, 2011, NUCLEIC ACIDS RES, V39, pD724, DOI 10.1093/nar/gkq1200; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Michaut M, 2008, BIOINFORMATICS, V24, P1625, DOI 10.1093/bioinformatics/btn249; Mika S, 2006, PLOS COMPUT BIOL, V2, P698, DOI 10.1371/journal.pcbi.0020079; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sambourg L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-605; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Turinsky AL, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq026; Uetz P, 2004, NAT BIOTECHNOL, V22, P43, DOI 10.1038/nbt0104-43; van Dam TJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000132; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wiles AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-36; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zhang A, 2009, PROTEIN INTERACTION NETWORKS: COMPUTATIONAL ANALYSIS, P1, DOI 10.1017/CBO9780511626593; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200	63	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66635	10.1371/journal.pone.0066635	http://dx.doi.org/10.1371/journal.pone.0066635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825550	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400138
J	Swick, MC; Evangelista, MA; Bodine, TJ; Easton-Marks, JR; Barth, P; Shah, MJ; Chung, CAB; Stanley, S; McLaughlin, SF; Lee, CC; Sheth, V; Doan, Q; Hamill, RJ; Steffen, D; Becnel, LB; Sucgang, R; Zechiedrich, L				Swick, Michelle C.; Evangelista, Michael A.; Bodine, Truston J.; Easton-Marks, Jeremy R.; Barth, Patrick; Shah, Minita J.; Chung, Christina A. Bormann; Stanley, Sarah; McLaughlin, Stephen F.; Lee, Clarence C.; Sheth, Vrunda; Quynh Doan; Hamill, Richard J.; Steffen, David; Becnel, Lauren B.; Sucgang, Richard; Zechiedrich, Lynn			Novel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical Isolates	PLOS ONE			English	Article							B STRAINS REL606; ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; QUINOLONE RESISTANCE; GENOME SEQUENCE; MUTATIONS; GYRASE; GENE; EVOLUTION; DEATH	Current efforts to understand antibiotic resistance on the whole genome scale tend to focus on known genes even as high throughput sequencing strategies uncover novel mechanisms. To identify genomic variations associated with antibiotic resistance, we employed a modified genome-wide association study; we sequenced genomic DNA from pools of E. coli clinical isolates with similar antibiotic resistance phenotypes using SOLID technology to uncover single nucleotide polymorphisms (SNPs) unanimously conserved in each pool. The multidrug-resistant pools were genotypically similar to SMS-3-5, a previously sequenced multidrug-resistant isolate from a polluted environment. The similarity was evenly spread across the entire genome and not limited to plasmid or pathogenicity island loci. Among the pools of clinical isolates, genomic variation was concentrated adjacent to previously reported inversion and duplication differences between the SMS-3-5 isolate and the drug-susceptible laboratory strain, DH10B. SNPs that result in non-synonymous changes in gyrA (encoding the well-known S83L allele associated with fluoroquinolone resistance), mutM, ligB, and recG were unanimously conserved in every fluoroquinolone-resistant pool. Alleles of the latter three genes are tightly linked among most sequenced E. coli genomes, and had not been implicated in antibiotic resistance previously. The changes in these genes map to amino acid positions in alpha helices that are involved in DNA binding. Plasmid-encoded complementation of null strains with either allelic variant of mutM or ligB resulted in variable responses to ultraviolet light or hydrogen peroxide treatment as markers of induced DNA damage, indicating their importance in DNA metabolism and revealing a potential mechanism for fluoroquinolone resistance. Our approach uncovered evidence that additional DNA binding enzymes may contribute to fluoroquinolone resistance and further implicate environmental bacteria as a reservoir for antibiotic resistance.	[Swick, Michelle C.; Zechiedrich, Lynn] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Swick, Michelle C.; Evangelista, Michael A.; Bodine, Truston J.; Hamill, Richard J.; Zechiedrich, Lynn] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Evangelista, Michael A.; Barth, Patrick; Sucgang, Richard; Zechiedrich, Lynn] Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX USA; [Bodine, Truston J.; Hamill, Richard J.; Zechiedrich, Lynn] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Easton-Marks, Jeremy R.; Steffen, David; Becnel, Lauren B.; Zechiedrich, Lynn] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Easton-Marks, Jeremy R.; Steffen, David; Becnel, Lauren B.] Baylor Coll Med, Biomed Informat Grp, Houston, TX 77030 USA; [Barth, Patrick; Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Shah, Minita J.; Stanley, Sarah; McLaughlin, Stephen F.; Lee, Clarence C.; Sheth, Vrunda] Life Technol, Beverly, MA USA; [Chung, Christina A. Bormann; Quynh Doan] Life Technol, Foster City, CA USA; [Hamill, Richard J.; Becnel, Lauren B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Becnel, Lauren B.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Thermo Fisher Scientific; Thermo Fisher Scientific; Baylor College of Medicine; Baylor College of Medicine	Sucgang, R (corresponding author), Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX USA.	rsucgang@bcm.edu; elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019; Steffen, David L/B-2751-2013; Doan, Quynh/AAJ-6023-2021	Steffen, David L/0000-0001-9363-2629; Doan, Quynh/0000-0002-8435-7837; Zechiedrich, Lynn/0000-0003-0533-1637; Easton-Marks, Jeremy/0000-0002-2263-7454	National Institutes of Health (NIH) [RO1 AI054830]; Pharmacoinformatics Training Program of the W. M. Keck Center for Computational and Structural Biology of the Gulf Coast Consortia (NIH) [T90 DK070109]; NIH [T32 GM88129]; Life Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacoinformatics Training Program of the W. M. Keck Center for Computational and Structural Biology of the Gulf Coast Consortia (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) RO1 AI054830 (to LZ). MCS was supported by the Pharmacoinformatics Training Program of the W. M. Keck Center for Computational and Structural Biology of the Gulf Coast Consortia (NIH grant T90 DK070109) (https://gcc.rice.edu/former_training_programs/). TJB was supported by NIH grant T32 GM88129. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Life Technologies, the funders of the Applied Biosystems SOLID $ 10 K Sequencing Grant, assisted in the sample processing and generation of raw data at their in-house facility. They also assisted in the initial data processing. Minita J. Shah, Christina A. Bormann Chung, Sarah Stanley, Stephen F. McLaughlin, Clarence C. Lee, Vrunda Sheth and Quynh Doan are employed by Life Technologies. Drs. Richard Sucgang, Michelle C. Swick, and Lynn Zechiedrich are co-inventors on a patent application that cover the strategy and genes uncovered in the manuscript. The Life Technologies team was interested in promoting the SOLiD technology. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Boyd LB, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-4; Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Coculescu Bogdan-Ioan, 2009, J Med Life, V2, P114; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Everett MJ, 1996, ANTIMICROB AGENTS CH, V40, P2380, DOI 10.1128/AAC.40.10.2380; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Heisig P, 1996, ANTIMICROB AGENTS CH, V40, P879, DOI 10.1128/AAC.40.4.879; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577; Keller I, 2007, PLOS GENET, V3, P185, DOI 10.1371/journal.pgen.0030022; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lu T, 1999, ANTIMICROB AGENTS CH, V43, P2969, DOI 10.1128/AAC.43.12.2969; Mandsberg LF, 2011, FEMS MICROBIOL LETT, V324, P28, DOI 10.1111/j.1574-6968.2011.02383.x; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Mauldin PD, 2010, ANTIMICROB AGENTS CH, V54, P109, DOI 10.1128/AAC.01041-09; Mazzariol A, 2000, ANTIMICROB AGENTS CH, V44, P3441, DOI 10.1128/AAC.44.12.3441-3443.2000; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Morgan-Linnell SK, 2007, ANTIMICROB AGENTS CH, V51, P4205, DOI 10.1128/AAC.00647-07; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Orlen H, 2006, ANTIMICROB AGENTS CH, V50, P3454, DOI 10.1128/AAC.00783-06; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rudolph CJ, 2009, MOL MICROBIOL, V73, P352, DOI 10.1111/j.1365-2958.2009.06773.x; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Singh R, 2012, ANTIMICROB AGENTS CH, V56, P1680, DOI 10.1128/AAC.05693-11; Sriskanda V, 2001, NUCLEIC ACIDS RES, V29, P4930, DOI 10.1093/nar/29.24.4930; Stone PW, 2005, AM J INFECT CONTROL, V33, P542, DOI 10.1016/j.ajic.2005.08.003; Sutherland JH, 2010, J BACTERIOL, V192, P4445, DOI 10.1128/JB.00350-10; Swick MC, 2011, ANTIMICROB AGENTS CH, V55, P921, DOI 10.1128/AAC.00996-10; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang MG, 2003, ANTIMICROB AGENTS CH, V47, P2242, DOI 10.1128/AAC.47.7.2242-2248.2003; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	57	7	8	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65961	10.1371/journal.pone.0065961	http://dx.doi.org/10.1371/journal.pone.0065961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824211	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400041
J	You, JJ; Wen, L; Roufas, A; Madigan, MC; Sutton, G				You, Jingjing; Wen, Li; Roufas, Athena; Madigan, Michele C.; Sutton, Gerard			Expression of SFRP Family Proteins in Human Keratoconus Corneas	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; STEM-CELLS; WNT PATHWAY; PROLIFERATION; INHIBITION; EPITHELIUM; COLLAGEN; MATRIX; CANCER	We investigated the expression of the secreted frizzled-related proteins (SFRPs) in keratoconus (KC) and control corneas. KC buttons (similar to 8 mm diameter) (n = 15) and whole control corneas (n = 7) were fixed in 10% formalin or 2% paraformaldehyde and subsequently paraffin embedded and sectioned. Sections for histopathology were stained with hematoxylin and eosin, or Periodic Acid Schiff's reagent. A series of sections was also immunolabelled with SFRP 1 to 5 antibodies, visualised using immunofluorescence, and examined with a Zeiss LSM700 scanning laser confocal microscope. Semi-quantitative grading was used to compare SFRP immunostaining in KC and control corneas. Overall, KC corneas showed increased immunostaining for SFRP1 to 5, compared to controls. Corneal epithelium in all KC corneas displayed heterogeneous moderate to strong immunoreactivity for SFRP1 to 4, particularly in the basal epithelium adjacent to cone area. SFRP3 and 5 were localised to epithelial cell membranes in KC and control corneas, with increased SFRP3 cytoplasmic expression observed in KC. Strong stromal expression of SFRP5, including extracellular matrix, was seen in both KC and control corneas. In control corneas we observed differential expression of SFRP family proteins in the limbus compared to more central cornea. Taken together, our results support a role for SFRPs in maintaining a healthy cornea and in the pathogenesis of epithelial and anterior stromal disruption observed in KC.	[You, Jingjing; Wen, Li; Roufas, Athena; Madigan, Michele C.; Sutton, Gerard] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [You, Jingjing; Wen, Li; Roufas, Athena; Madigan, Michele C.; Sutton, Gerard] Univ Sydney, Discipline Clin Ophthalmol, Sydney, NSW 2006, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2033, Australia; [Sutton, Gerard] Univ Auckland, Auckland 1, New Zealand; [Sutton, Gerard] Vis Eye Inst, Chatswood, NSW, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney; University of Auckland	Madigan, MC (corresponding author), Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia.	m.madigan@unsw.edu.au	You, Jingjing/AAO-2671-2020	Sutton, Gerard/0000-0002-0645-018X; , Jingjing You/0000-0002-2461-0140	Sydney Eye Hospital Foundation; Sydney Foundation for Medical Research; Sydney Medical Foundation; Sydnovate, University of Sydney	Sydney Eye Hospital Foundation; Sydney Foundation for Medical Research; Sydney Medical Foundation; Sydnovate, University of Sydney	The research was funded by grants from The Sydney Eye Hospital Foundation, Sydney Foundation for Medical Research (MCM), Sydney Medical Foundation (GS) and Sydnovate, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian SA, 2013, CLIN EXPT OPHTHALMOL, DOI [10.1111/cxo.12038, DOI 10.1111/CX0.12038]; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Bourges JL, 2003, OPHTHALMOLOGY, V110, P1920, DOI 10.1016/S0161-6420(03)00617-1; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Burdon KP, 2013, CLIN EXPT OPHTHALMOL, DOI [10.1111/cxo.12024, DOI 10.1111/CX0.12024]; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; Fernandes BF, 2008, PATHOLOGY, V40, P623, DOI 10.1080/00313020802320648; Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Ha NT, 2004, CURR EYE RES, V28, P373, DOI 10.1080/02713680490502201; Han XZ, 2004, J BIOL CHEM, V279, P2832, DOI 10.1074/jbc.M308102200; HAY ED, 1973, J CELL BIOL, V57, P190, DOI 10.1083/jcb.57.1.190; Hirata H, 2010, CANCER RES, V70, P1896, DOI 10.1158/0008-5472.CAN-09-3549; Horvath LG, 2004, CLIN CANCER RES, V10, P615, DOI 10.1158/1078-0432.CCR-0707-03; Jones SE, 2000, INVEST OPHTH VIS SCI, V41, P1297; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Li CH, 2007, J DENT RES, V86, P873, DOI 10.1177/154405910708600913; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Lyu J, 2005, J BIOL CHEM, V280, P21653, DOI 10.1074/jbc.m500374200; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Mathew JH, 2011, OPTOMETRY VISION SCI, V88, P988, DOI 10.1097/OPX.0b013e31821ffbd4; McGhee CNJ, 2009, CLIN EXP OPHTHALMOL, V37, P160, DOI 10.1111/j.1442-9071.2009.02009.x; McLean I, 2002, INVEST OPHTHALMOL VI, V43; Meek KM, 2003, BIOPHYS J, V85, P2205, DOI 10.1016/S0006-3495(03)74646-3; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Mort Richard L, 2012, Results Probl Cell Differ, V55, P357, DOI 10.1007/978-3-642-30406-4_19; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Niederer RL, 2008, INVEST OPHTHALMOL VI, V49; Ordonez P, 2012, STEM CELLS, V30, P100, DOI 10.1002/stem.794; Osei-Bempong C, 2013, BIOESSAYS, V35, P211, DOI 10.1002/bies.201200086; Papadia M, 2008, CURR EYE RES, V33, P429, DOI 10.1080/02713680802130354; Proulx S, 2010, MOL VIS, V16, P2192; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Raecker ME, 2009, AM J OPHTHALMOL, V147, P227, DOI 10.1016/j.ajo.2008.08.001; Saini S, 2009, CANCER RES, V69, P6815, DOI 10.1158/0008-5472.CAN-09-1254; Sakimoto T, 2008, FEBS LETT, V582, P3674, DOI 10.1016/j.febslet.2008.09.052; Sutton G, 2010, CLIN EXP OPHTHALMOL, V38, P43, DOI 10.1111/j.1442-9071.2009.02216.x; Syed D, 2013, CORNEA, V26, DOI [10.1097/ICO.1090-b1013e318282987a, DOI 10.1097/IC0.1090-B1013E318282987A]; Sykakis E, 2012, PATHOLOGY, V44, P234, DOI 10.1097/PAT.0b013e3283511b42; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Wang W, 2009, BMC CANCER, V9, P1471; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Zhou YP, 2011, EXP EYE RES, V93, P355, DOI 10.1016/j.exer.2011.04.003	45	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66770	10.1371/journal.pone.0066770	http://dx.doi.org/10.1371/journal.pone.0066770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825088	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400157
J	Jhwueng, DC				Jhwueng, Dwueng-Chwuan			Assessing the Goodness of Fit of Phylogenetic Comparative Methods: A Meta-Analysis and Simulation Study	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; INDEPENDENT CONTRASTS; BODY-SIZE; CORRELATED EVOLUTION; ADAPTIVE EVOLUTION; MATING-SYSTEM; MODEL; REGRESSION; STRATEGIES; DROSOPHILA	Background: Phylogenetic comparative methods (PCMs) have been applied widely in analyzing data from related species but their fit to data is rarely assessed. Question: Can one determine whether any particular comparative method is typically more appropriate than others by examining comparative data sets? Data: I conducted a meta-analysis of 122 phylogenetic data sets found by searching all papers in JEB, Blackwell Synergy and JSTOR published in 2002-2005 for the purpose of assessing the fit of PCMs. The number of species in these data sets ranged from 9 to 117. Analysis Method: I used the Akaike information criterion to compare PCMs, and then fit PCMs to bivariate data sets through REML analysis. Correlation estimates between two traits and bootstrapped confidence intervals of correlations from each model were also compared. Conclusions: For phylogenies of less than one hundred taxa, the Independent Contrast method and the independent, non-phylogenetic models provide the best fit. For bivariate analysis, correlations from different PCMs are qualitatively similar so that actual correlations from real data seem to be robust to the PCM chosen for the analysis. Therefore, researchers might apply the PCM they believe best describes the evolutionary mechanisms underlying their data.	Feng Chia Univ, Dept Stat, Taichung 40724, Taiwan	Feng Chia University	Jhwueng, DC (corresponding author), Feng Chia Univ, Dept Stat, Taichung 40724, Taiwan.	djhwueng@umail.iu.edu	Jhwueng, Dwueng-Chwuan/G-8238-2014	Jhwueng, Dwueng-Chwuan/0000-0001-5893-3645	National Institute for Mathematical and Biological Synthesis; National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF (National Science Foundation) [EF-0832858]; University of Tennessee, Knoxville; National Science Council, Taiwan, ROC [NSC-101-2118-M-035-001]; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Institute for Mathematical and Biological Synthesis; National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF (National Science Foundation); University of Tennessee, Knoxville; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Institute for Mathematical and Biological Synthesis, an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF (National Science Foundation) Award #EF-0832858, with additional support from The University of Tennessee, Knoxville, and the National Science Council grant #NSC-101-2118-M-035-001, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; Aguirre LF, 2002, P ROY SOC B-BIOL SCI, V269, P1271, DOI 10.1098/rspb.2002.2011; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armbruster WS, 2002, AM J BOT, V89, P37, DOI 10.3732/ajb.89.1.37; Beaulieu JM, 2012, EVOLUTION, V66, P2369, DOI 10.1111/j.1558-5646.2012.01619.x; Bertelli S, 2002, BIOL J LINN SOC, V77, P423, DOI 10.1046/j.1095-8312.2002.00112.x; Bonnie K. E., 2005, J EXP BIOL, V208, P4529; Burham K. P., 2002, MODEL SELECTION MULT; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; CHEVERUD JM, 1985, EVOLUTION, V39, P1335, DOI 10.1111/j.1558-5646.1985.tb05699.x; Collar DC, 2005, EVOLUTION, V59, P1783, DOI 10.1111/j.0014-3820.2005.tb01826.x; Cruz FB, 2005, J EVOLUTION BIOL, V18, P1559, DOI 10.1111/j.1420-9101.2005.00936.x; Federle W, 2005, BIOL J LINN SOC, V84, P177, DOI 10.1111/j.1095-8312.2005.000423.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fisher DO, 2002, EVOLUTION, V56, P167; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Housworth EA, 2004, AM NAT, V163, P84, DOI 10.1086/380570; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jervis MA, 2003, FUNCT ECOL, V17, P375, DOI 10.1046/j.1365-2435.2003.00742.x; Johnston IA, 2003, J EXP BIOL, V206, P2595, DOI 10.1242/jeb.00474; LYNCH M, 1991, EVOLUTION, V45, P1065, DOI [10.2307/2409716, 10.1111/j.1558-5646.1991.tb04375.x]; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Martins EP, 1996, EVOLUTION, V50, P1750, DOI 10.1111/j.1558-5646.1996.tb03562.x; Mazzoldi C, 2005, J ZOOL SYST EVOL RES, V43, P307, DOI 10.1111/j.1439-0469.2005.00331.x; Melville J, 2003, J ZOOL, V261, P79, DOI 10.1017/S0952836903003984; Monnet JM, 2002, P ROY SOC B-BIOL SCI, V269, P2301, DOI 10.1098/rspb.2002.2170; Moreteau B, 2003, J ZOOL SYST EVOL RES, V41, P64, DOI 10.1046/j.1439-0469.2003.00195.x; Niewiarowski PH, 2004, EVOLUTION, V58, P619, DOI 10.1111/j.0014-3820.2004.tb01684.x; O'Meara BC, 2006, EVOLUTION, V60, P922; Olifiers N, 2004, GLOBAL ECOL BIOGEOGR, V13, P439, DOI 10.1111/j.1466-822X.2004.00115.x; Ord JK, 1975, J AM STAT ASSOC, V70, P120; Price T, 1997, PHILOS T ROY SOC B, V352, P519, DOI 10.1098/rstb.1997.0036; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Roulin A, 2004, BIOL J LINN SOC, V81, P565, DOI 10.1111/j.1095-8312.2004.00308.x; Sanchez JA, 2003, P ROY SOC B-BIOL SCI, V270, P2039, DOI 10.1098/rspb.2003.2471; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stone EA, 2011, SYST BIOL, V60, P245, DOI 10.1093/sysbio/syq098; Toigo C, 2003, OIKOS, V101, P376, DOI 10.1034/j.1600-0706.2003.12073.x; Tubaro PL, 2002, CONDOR, V104, P281, DOI 10.1650/0010-5422(2002)104[0281:AMOTSI]2.0.CO;2; Vanhooydonck B, 2002, J EXP BIOL, V205, P1037; Weiblen GD, 2004, SYST BIOL, V53, P128, DOI 10.1080/10635150490265012	47	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67001	10.1371/journal.pone.0067001	http://dx.doi.org/10.1371/journal.pone.0067001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826183	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000019
J	Wilbur, K; Hazi, H; El-Bedawi, A				Wilbur, Kerry; Hazi, Huda; El-Bedawi, Aya			Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities-A Systematic-Review	PLOS ONE			English	Review							OLDER-PEOPLE; PREVALENCE; CARE; EVENTS; UNIT; PREVENTABILITY; MEDICATIONS; FREQUENCY; SAFETY	Countless studies have demonstrated that many emergency-room visits and hospital admissions are drug-related and that a significant proportion of these drug-related visits (DRVs) are preventable. It has not been previously studied which DRVs could be prevented through enhanced monitoring of therapy. The objective of the study was to determine the incidence of DRVs attributed to laboratory or physiologic abnormalities. Three authors independently performed comprehensive searches in relevant health care databases using pre-determined search terms. Articles discussing DRV associated with poisoning, substance abuse, or studied among existing in-patient populations were excluded. Study country, year, sample, design, duration, DRV identification method, proportion of DRVs associated with laboratory or physiologic abnormalities and associated medications were extracted. The three authors independently assessed selected relevant articles according to the Strengthening the reporting of observational studies in epidemiology (STROBE) as applicable according to the studies' methodology. The initial literature search yielded a total of 1,524 articles of which 30 articles meeting inclusion criteria and reporting sufficient laboratory or physiologic data were included in the overall analysis. Half employed prospective methodologies, which included both chart review and patient interview; however, the overwhelming majority of identified studies assessed only adverse drug reactions (ADRs) as a drug-related cause for DRV. The mean (range) prevalence of DRVs found in all studies was 15.4% (0.44%-66.7%) of which an association with laboratory or physiologic abnormalities could be attributed to a mean (range) of 29.4% (4.3%-78.1%) of cases. Most laboratory-associated DRVs could be linked to immunosuppressant, antineoplastic, anticoagulant and diabetes therapy, while physiologic-associated DRVs were attributed to cardiovascular therapies and NSAIDs. Significant proportions of laboratory and physiologic abnormalities contribute to DRVs and are consistently linked to specific drugs. These therapies are potential targets for enhanced medication monitoring initiatives to proactively avert potential DRVs.	[Wilbur, Kerry; Hazi, Huda; El-Bedawi, Aya] Qatar Univ, Coll Pharm, Doha, Qatar	Qatar University	Wilbur, K (corresponding author), Qatar Univ, Coll Pharm, Doha, Qatar.	kwilbur@qu.edu.qa		Wilbur, Kerry/0000-0002-5936-4429	Qatar University	Qatar University(Qatar National Research Fund (QNRF))	The research was funded by a Qatar University student grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdukovic Maja, 2007, Pharm Pract (Granada), V5, P162; Alexopoulou A, 2008, EUR J INTERN MED, V19, P505, DOI 10.1016/j.ejim.2007.06.030; Atiqi R, 2010, INT J CLIN PHARM TH, V48, P517; Barry Arden R, 2012, Can Pharm J (Ott), V145, P174, DOI 10.3821/145.4.cpj174; Bhardwaja B, 2011, PHARMACOTHERAPY, V31, P346, DOI 10.1592/phco.31.4.346; Bolesta S, 2011, AM J PHARM EDUC, V75, DOI 10.5688/ajpe75229; Brvar Miran, 2009, BMC Clin Pharmacol, V9, P8, DOI 10.1186/1472-6904-9-8; Chan M, 2001, INTERN MED J, V31, P199, DOI 10.1046/j.1445-5994.2001.00044.x; Davies EC, 2010, BRIT J CLIN PHARMACO, V70, P749, DOI 10.1111/j.1365-2125.2010.03751.x; Easton KL, 2004, BRIT J CLIN PHARMACO, V57, P611, DOI 10.1111/j.1365-2125.2003.02052.x; Foisy M M, 2000, Can J Infect Dis, V11, P193; Fokter N, 2010, WIEN KLIN WOCHENSCHR, V122, P81, DOI 10.1007/s00508-009-1251-2; Franceschi M, 2008, DRUG SAFETY, V31, P545, DOI 10.2165/00002018-200831060-00009; Gallagher RM, 2011, J CLIN PHARM THER, V36, P194, DOI 10.1111/j.1365-2710.2010.01194.x; Goldman RE, 2010, J EVAL CLIN PRACT, V16, P1136, DOI 10.1111/j.1365-2753.2009.01282.x; Green CF, 2000, J CLIN PHARM THER, V25, P355, DOI 10.1046/j.1365-2710.2000.00298.x; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Hartholt KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013977; Hellstrom LM, 2011, EUR J CLIN PHARMACOL, V67, P741, DOI 10.1007/s00228-010-0982-3; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Herwaarden MFWV, 2012, DRUG SAFETY, V35, P245, DOI 10.2165/11596000-000000000-00000; Hofer-Dueckelmann C, 2011, INT J CLIN PHARM TH, V49, P577, DOI 10.5414/CP201514; Hohl CM, 2001, ANN EMERG MED, V38, P666, DOI 10.1067/mem.2001.119456; Hohl CM, 2010, ANN EMERG MED, V55, P493, DOI 10.1016/j.annemergmed.2009.10.008; Hopf Y, 2008, PHARM WORLD SCI, V30, P854, DOI 10.1007/s11096-008-9240-5; Howard RL, 2003, QUAL SAF HEALTH CARE, V12, P280, DOI 10.1136/qhc.12.4.280; Howard RL, 2006, BR J CLIN PHARM, V6, P136; James K, 2000, Crit Care Resusc, V2, P108; Jones TA, 2003, PHARMACOTHERAPY, V23, P855, DOI 10.1592/phco.23.7.855.32729; Juntti-Patinen L, 2006, BASIC CLIN PHARMACOL, V98, P212, DOI 10.1111/j.1742-7843.2006.pto_264.x; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Leendertse AJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-4; Leendertse AJ, 2010, DRUG SAFETY, V33, P233, DOI 10.2165/11319030-000000000-00000; Marcum ZA, 2012, J AM GERIATR SOC, V60, P34, DOI 10.1111/j.1532-5415.2011.03772.x; McDonnell PJ, 2002, ANN PHARMACOTHER, V36, P1331, DOI 10.1345/aph.1A333; Miranda V, 2011, J PAIN SYMPTOM MANAG, V42, P342, DOI 10.1016/j.jpainsymman.2010.11.014; Mjorndal T, 2002, PHARMACOEPIDEM DR S, V11, P65, DOI 10.1002/pds.667; Morrato EH, 2008, J CLIN PSYCHIAT, V69, P316, DOI 10.4088/JCP.v69n0219; Noize P, 2011, PHARMACOEPIDEM DR S, V20, P747, DOI 10.1002/pds.2128; Patel Hitesh, 2007, BMC Clin Pharmacol, V7, P9, DOI 10.1186/1472-6904-7-9; Raebel MA, 2005, ARCH INTERN MED, V165, P2395, DOI 10.1001/archinte.165.20.2395; Rivkin A, 2007, AM J HEALTH-SYST PH, V64, P1840, DOI 10.2146/ajhp060641; Rodenburg EM, 2011, BRIT J CLIN PHARMACO, V71, P95, DOI 10.1111/j.1365-2125.2010.03811.x; Rogers S, 2009, DRUG AGING, V26, P951, DOI 10.2165/11316750-000000000-00000; Samoy LJ, 2006, PHARMACOTHERAPY, V26, P1578, DOI 10.1592/phco.26.11.1578; Schumock G T, 1992, Hosp Pharm, V27, P538; Shojania KG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001096.pub2; Singh H, 2011, J PHARMACOL PHARMACO, V2, P17, DOI 10.4103/0976-500X.77095; Smith DH, 2009, AM J MANAG CARE, V15, P281; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Somers A, 2010, J NUTR HEALTH AGING, V14, P477, DOI 10.1007/s12603-009-0237-0; Steinman MA, 2011, J AM GERIATR SOC, V59, P1513, DOI 10.1111/j.1532-5415.2011.03500.x; Tija J, 2011, ANN PHARMACOTHER, V45, P1077; Tjia J, 2010, AM J MANAG CARE, V16, P489; van Mil JWF, 2004, ANN PHARMACOTHER, V38, P859, DOI 10.1345/aph.1D182; Varallo FR, 2011, J PHARM PHARM SCI, V14, P283, DOI 10.18433/J3P01J; von Euler M, 2006, PHARMACOEPIDEM DR S, V15, P179, DOI 10.1002/pds.1154; Wasserfallen J -B., 2001, Eur J Intern Med, V12, P442, DOI 10.1016/S0953-6205(01)00159-5; Wawruch M, 2009, ARCH GERONTOL GERIAT, V48, P186, DOI 10.1016/j.archger.2008.01.004; World Health Organization, 1970, DRUG INTELL CLIN PHA, V4, P101; Zed PJ, 2008, CAN MED ASSOC J, V178, P1563, DOI 10.1503/cmaj.071594	63	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66803	10.1371/journal.pone.0066803	http://dx.doi.org/10.1371/journal.pone.0066803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826139	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000011
J	Doumas, LAA; Hummel, JE				Doumas, Leonidas A. A.; Hummel, John E.			Comparison and Mapping Facilitate Relation Discovery and Predication	PLOS ONE			English	Article							COMPUTATIONAL ACCOUNT; INFERENCE; CATEGORIZATION; INSTANCES; WORDS; COLOR	Relational concepts play a central role in human perception and cognition, but little is known about how they are acquired. For example, how do we come to understand that physical force is a higher-order multiplicative relation between mass and acceleration, or that two circles are the same-shape in the same way that two squares are? A recent model of relational learning, DORA (Discovery of Relations by Analogy; Doumas, Hummel & Sandhofer, 2008), predicts that comparison and analogical mapping play a central role in the discovery and predication of novel higher-order relations. We report two experiments testing and confirming this prediction.	[Doumas, Leonidas A. A.] Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA; [Hummel, John E.] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA	University of Hawaii System; University of Hawaii Manoa; University of Illinois System; University of Illinois Urbana-Champaign	Doumas, LAA (corresponding author), Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA.	leonidas@hawaii.edu						CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; Dixon JA, 2004, COGNITIVE SCI, V28, P433, DOI 10.1016/j.cogsci.2003.12.004; Doumas L.A.A., 2005, CAMBRIDGE HDB THINKI, P73, DOI DOI 10.1007/S13398-014-0173-7.2; Doumas LAA, 2009, P 31 ANN C COGN SCI; DOUMAS LAA, 2010, P 32 ANN C COGN SCI; Doumas LAA, 2008, PSYCHOL REV, V115, P1, DOI 10.1037/0033-295X.115.1.1; Doumas LAA, 2010, COGNITIVE SCI, V34, P698, DOI 10.1111/j.1551-6709.2010.01103.x; FALKENHAINER B, 1989, ARTIF INTELL, V41, P1, DOI 10.1016/0004-3702(89)90077-5; Gentner D, 1999, COGNITIVE DEV, V14, P487, DOI 10.1016/S0885-2014(99)00016-7; GENTNER D, 1983, COGNITIVE SCI, V7, P155, DOI 10.1016/S0364-0213(83)80009-3; Gentner D., 1991, LANGUAGE CAREER SIMI, DOI [10.1017/CBO9780511983689.008, DOI 10.1017/CBO9780511983689.008]; Gentner D, 2003, BRADFORD BOOKS, P195; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; Holyoak K. J., 1995, MENTAL LEAPS ANALOGY; Hummel JE, 1997, PSYCHOL REV, V104, P427, DOI 10.1037/0033-295X.104.3.427; Hummel JE, 2003, PSYCHOL REV, V110, P220, DOI 10.1037/0033-295X.110.2.220; Kotovsky L, 1996, CHILD DEV, V67, P2797, DOI 10.1111/j.1467-8624.1996.tb01889.x; Kurtz KJ, 2004, P 22 ANN C COGN SCI; Morrison RG, 2011, DEVELOPMENTAL SCI, V14, P516, DOI 10.1111/j.1467-7687.2010.00999.x; Namy LL, 2002, J EXP PSYCHOL GEN, V131, P5, DOI 10.1037//0096-3445.131.1.5; Newell A., 1990, UNIFIED THEORIES COG; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Rattermann MJ, 1998, COGNITIVE DEV, V13, P453, DOI 10.1016/S0885-2014(98)90003-X; ROSS BH, 1990, COGNITIVE PSYCHOL, V22, P460, DOI 10.1016/0010-0285(90)90010-2; Sandhofer CM, 2008, J COGN DEV, V9, P194, DOI 10.1080/15248370802022639; Sandhofer CM, 2001, J EXP PSYCHOL GEN, V130, P600, DOI 10.1037//0096-3445.130.4.600; SMITH LB, 1988, COGNITIVE DEV, V3, P341, DOI 10.1016/0885-2014(88)90020-2; SMITH LB, 1989, SIMILARITY AND ANALOGICAL REASONING, P146, DOI 10.1017/CBO9780511529863.008; Son JY, 2010, J PROBL SOLVING, V3, P52, DOI 10.7771/1932-6246.1079; SPALDING TL, 1994, J EXP PSYCHOL LEARN, V20, P1251, DOI 10.1037/0278-7393.20.6.1251; Thompson RKR, 2000, COGNITIVE SCI, V24, P363; Yamauchi T, 2000, MEM COGNITION, V28, P64, DOI 10.3758/BF03211577; Yamauchi T, 1998, J MEM LANG, V39, P124, DOI 10.1006/jmla.1998.2566	34	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e63889	10.1371/journal.pone.0063889	http://dx.doi.org/10.1371/journal.pone.0063889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175IB	23825521	Green Submitted, Green Published, gold			2022-12-27	WOS:000321223000001
J	Qiu, ZH; Chen, X; Zhou, YZ; Lin, JB; Ding, D; Yang, SJ; Chen, F; Wang, M; Zhu, F; Yu, X; Zhou, ZH; Liao, YH				Qiu, Zhihua; Chen, Xiao; Zhou, Yanzhao; Lin, Jibin; Ding, Dan; Yang, Shijun; Chen, Fen; Wang, Min; Zhu, Feng; Yu, Xian; Zhou, Zihua; Liao, Yuhua			Therapeutic Vaccines against Human and Rat Renin in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ANGIOTENSIN SYSTEM; NORMOTENSIVE RATS; ALISKIREN; IMMUNIZATION; PRORENIN; NEUROPATHOLOGY; EPITOPES; BINDING; PEPTIDE; COMPLEX	Vaccination provides a promising approach for treatment of hypertension and improvement in compliance. As the initiation factor of renin-angiotensin system, renin plays a critical role in hypertension. In this study, we selected six peptides (rR32, rR72, rR215, hR32, hR72, and hR215) belonging to potential epitopes of rat and human renin. The main criteria were as follows: (1) include one of renin catalytic sites or the flap sequence; (2) low/no-similarity when matched with the host proteome; (3) ideal antigenicity and hydrophilicity. The peptides were coupled to keyhole limpet hemocyanin and injected into SpragueDawley (SD) rats, spontaneously hypertensive rats (SHRs) and Wistar-Kyoto rats. The antisera titers and the binding capacity with renin were detected. The effects of the anti-peptides antibodies on plasma renin activity (PRA) and blood pressure were also determined. All peptides elicited strong antibody responses. The antisera titers ranged from 1: 32,000 to 1: 80,000 in SD rats on day 63. All antisera could bind to renin in vitro. Compared with the control antibody, the antibodies against the rR32, hR32, rR72 and hR72 peptides inhibited PRA level by up to about 50%. Complete cross-reactivity of the anti-rR32 antibody and the anti-hR32 antibody was confirmed. The epitopes rR32 and hR32 vaccines significantly decreased systolic blood pressure (SBP) of SHRs up to 15mmHg (175 +/- 2 vesus 190 +/- 3 mmHg, P = 0.035; 180 +/- 2 vesus 195 +/- 3 mmHg, P = 0.039), while no obvious effect on SD rats. Additionally, no significant immune-mediated damage was detected in the vaccinated animals. In conclusion, the antigenic peptide hR32 vaccine mimicking the 32 Asp catalytic site of human renin may constitute a novel tool for the development of a renin vaccine.	[Qiu, Zhihua; Chen, Xiao; Zhou, Yanzhao; Lin, Jibin; Ding, Dan; Yang, Shijun; Chen, Fen; Wang, Min; Zhu, Feng; Yu, Xian; Zhou, Zihua; Liao, Yuhua] Huazhong Univ Sci & Technol, Tongji Med Coll, Lab Cardiovasc Immunol,Union Hosp, Key Lab Mol Targeted Therapies,Minist Educ,Inst C, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zhou, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Lab Cardiovasc Immunol,Union Hosp, Key Lab Mol Targeted Therapies,Minist Educ,Inst C, Wuhan 430074, Peoples R China.	zzhua2001@163.com; liaoyh27@163.com			National Natural Science Funds of China [30700295, 30971246]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Funds of China (No. 30700295, No. 30971246) (http://www.nsfc.gov.cn/Portal0/ default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Bachmann MF, 2004, NAT REV DRUG DISCOV, V3, P81, DOI 10.1038/nrd1284; BAGBY SP, 1979, HYPERTENSION, V1, P347, DOI 10.1161/01.HYP.1.4.347; Batenburg WW, 2008, ARTERIOSCL THROM VAS, V28, P1151, DOI 10.1161/ATVBAHA.108.164210; BenYedidia T, 1997, CURR OPIN BIOTECH, V8, P442, DOI 10.1016/S0958-1669(97)80066-3; BOUHNIK J, 1987, J BIOL CHEM, V262, P2913; Brown MJ, 2009, NAT REV CARDIOL, V6, P639, DOI 10.1038/nrcardio.2009.156; EVIN G, 1988, BIOCHEMISTRY-US, V27, P156, DOI 10.1021/bi00401a024; EVIN G, 1986, HYPERTENSION, V8, P72; Feldt S, 2008, HYPERTENSION, V51, P682, DOI 10.1161/HYPERTENSIONAHA.107.101444; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Galen F X, 1987, J Hypertens Suppl, V5, pS11; Gironacci MM, 2011, HYPERTENSION, V58, P176, DOI 10.1161/HYPERTENSIONAHA.111.173344; GOLDBLATT H, 1951, T ASSOC AM PHYSICIAN, V64, P122; INAGAMI T, 1989, J HYPERTENS, V7, pS3, DOI 10.1097/00004872-198904002-00002; Kanduc D, 2009, EXPERT OPIN BIOL TH, V9, P45, DOI [10.1517/14712590802614041, 10.1517/14712590802614041 ]; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lemere CA, 2007, CURR ALZHEIMER RES, V4, P427, DOI 10.2174/156720507781788800; Lucchese Alberta, 2004, J Transl Med, V2, P43, DOI 10.1186/1479-5876-2-43; Michel JB, 2004, CLIN SCI, V107, P145, DOI 10.1042/CS20040116; MICHEL JB, 1990, CIRCULATION, V81, P1899, DOI 10.1161/01.CIR.81.6.1899; Michel JB, 1987, P NATL ACAD SCI USA, V204, P281; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Reudelhuber TL, 2010, HYPERTENSION, V55, P1071, DOI 10.1161/HYPERTENSIONAHA.108.120279; SALI A, 1989, EMBO J, V8, P2179, DOI 10.1002/j.1460-2075.1989.tb08340.x; SEN S, 1972, CIRC RES, V31, P876, DOI 10.1161/01.RES.31.6.876; Stufano A, 2009, EXP MOL PATHOL, V86, P36, DOI 10.1016/j.yexmp.2008.11.009; TONG L, 1995, J MOL BIOL, V250, P211, DOI 10.1006/jmbi.1995.0372; Wood JM, 2003, BIOCHEM BIOPH RES CO, V308, P698, DOI 10.1016/S0006-291X(03)01451-7; Zhu F, 2008, CURR OPIN INVEST DR, V9, P286; Zhu Feng, 2008, DRUGS FUTURE, V33, P1	33	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66420	10.1371/journal.pone.0066420	http://dx.doi.org/10.1371/journal.pone.0066420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825541	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000019
J	Zebedin, A; Ladich, F				Zebedin, Angelika; Ladich, Friedrich			Does the Hearing Sensitivity in Thorny Catfishes Depend on Swim Bladder Morphology?	PLOS ONE			English	Article							AUDITORY-SENSITIVITY; GAS BLADDER; SILURIFORMES DORADIDAE; SCIAENID FISHES; TELEOSTEI; EAR; STIMULATION; THRESHOLDS; ABILITY	Background: Thorny catfishes exhibit large variations in swim bladder morphology. These organs are of different sizes, forms and may have simple or branched diverticula. The swim bladder plays an important role in otophysans because it enhances their hearing sensitivity by transmitting sound pressure fluctuations via ossicles to the inner ear. Methodology/Principal Findings: To investigate if a form-function relationship exists, the swim bladder morphology and hearing ability were analyzed in six species. The morphology was quantified by measuring the length, width and height and calculating a standardized swim bladder length (sSBL), which was then used to calculate the relative swim bladder length (rSBL). Hearing was measured using the auditory evoked potential (AEP) recording technique. Two species had simple apple-shaped and four species heart-shaped (cordiform) bladders. One of the latter species had short unbranched diverticula on the terminal margin, two had a secondary bladder and two had many long, branched diverticula. The rSBL differed significantly between most of the species. All species were able to detect frequencies between 70 Hz and 6 kHz, with lowest thresholds found between 0.5 and 1 kHz (60 dB re 1 mu Pa). Hearing curves were U-shaped except in Hemidoras morrisi in which it was ramp-like. Mean hearing thresholds of species possessing smaller rSBLs were slightly lower (maximum 8.5 dB) than those of species having larger rSBLs. Conclusions/Significance: The current findings reveal a relationship between swim bladder form and its function among thorny catfishes. Relatively smaller swim bladders resulted in relatively better hearing. This is in contrast to a prior inter-familial study on catfishes in which species with large unpaired bladders possessed higher sensitivity at higher frequencies than species having tiny paired and encapsulated bladders.	[Zebedin, Angelika; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna	Ladich, F (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	friedrich.ladich@univie.ac.at			Austrian Science Fund (FWF) [22319]; Austrian Science Fund (FWF) [P 22319] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF grant 22319 to FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER R. McN., 1964, PROC ZOO SOC LONDON, V142, P419; [Anonymous], 1995, BIOL FISHES; Bird NC, 2007, J MORPHOL, V268, P739, DOI 10.1002/jmor.10550; Birindelli JLO, 2012, J MORPHOL, V273, P651, DOI 10.1002/jmor.20012; Birindelli JLO, 2011, P ACAD NAT SCI PHILA, V161, P117, DOI 10.1635/053.161.0109; Birindelli JLO, 2011, J MORPHOL, V272, P890, DOI 10.1002/jmor.10961; Birindelli JL, 2009, P ACAD NAT SCI PHILA, V158, P261, DOI 10.1635/053.158.0114; Blaxter JHS, 1981, HEARING SOUND COMMUN, P39; Braun Christopher B., 2008, V32, P99; Chardon M, 2003, CATFISHES, VOLS 1-2, P71; Chardon M, 1997, NETH J ZOOL, V47, P383, DOI 10.1163/156854297X00076; Chardon M., 1968, Annls Mus r Afr cent (Ser Zool), VNo. 169, P1; Chranilov N. S., 1929, Zoologische Jahrbuecher Jena Anatomie, V51, P323; Chranilov N. S., 1927, Zoologische Jahrbuecher Jena Abteilungen Anatomie, V49, P501; COOMBS S, 1979, J COMP PHYSIOL, V132, P203, DOI 10.1007/BF00614491; Diogo R, 2004, ANIM BIOL, V54, P175, DOI 10.1163/1570756041445173; FAY RR, 1975, J EXP BIOL, V62, P379; FAY RR, 1974, J EXP BIOL, V61, P243; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Frisch K. von., 1932, Zeitschrift fuer Vergleichende Physiologie, V17, P686, DOI 10.1007/BF00339067; Hawkins A.D., 1993, Fish and Fisheries Series, V7, P129; Horodysky AZ, 2008, J EXP BIOL, V211, P1504, DOI 10.1242/jeb.016196; JONES FRH, 1953, BIOL REV, V28, P16, DOI 10.1111/j.1469-185X.1953.tb01370.x; Kaatz IM, 2012, CURR ZOOL, V58, P171, DOI 10.1093/czoolo/58.1.171; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; KLEEREKOPER H., 1959, CANADIAN JOUR ZOOL, V37, P1; Ladich F, 1999, BRAIN BEHAV EVOLUT, V53, P288, DOI 10.1159/000006600; Ladich F, 2003, HEARING RES, V182, P119, DOI 10.1016/S0378-5955(03)00188-6; Ladich F, 2003, CATFISHES, VOLS 1-2, P701; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F, 2001, ANAT REC, V263, P297, DOI 10.1002/ar.1105; Ladich Friedrich, 2006, P3; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Lechner W, 2011, J ZOOL, V283, P186, DOI 10.1111/j.1469-7998.2010.00762.x; Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436; Lechner W, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-10; Marceniuk AP, 2010, ZOOTAXA, P59, DOI 10.11646/zootaxa.2579.1.4; Papes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026479; POGGENDORF D, 1952, Z VERGL PHYSIOL, V34, P222, DOI 10.1007/BF00298202; POPPER AN, 1981, J COMP PHYSIOL, V144, P27, DOI 10.1007/BF00612794; Ramcharitar J, 2004, J ACOUST SOC AM, V116, P1687, DOI 10.1121/1.1771614; Ramcharitar JU, 2006, J ACOUST SOC AM, V119, P439, DOI 10.1121/1.2139068; Ramcharitar JU, 2004, J COMP NEUROL, V475, P531, DOI 10.1002/cne.20192; Ramcharttar J, 2006, T AM FISH SOC, V135, P1409, DOI 10.1577/T05-207.1; Schulz-Mirbach T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042292; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; WEISS BA, 1969, P NATL ACAD SCI USA, V64, P552, DOI 10.1073/pnas.64.2.552; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Wysocki LE, 2009, J EXP BIOL, V212, P3091, DOI 10.1242/jeb.033274; Yan HY, 2000, J COMP PHYSIOL A, V186, P435, DOI 10.1007/s003590050443	50	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67049	10.1371/journal.pone.0067049	http://dx.doi.org/10.1371/journal.pone.0067049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825615	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000067
J	Zhang, T; Liu, LL; Song, ZL; Ren, GX; Feng, YZ; Han, XH; Yang, GH				Zhang, Tong; Liu, Linlin; Song, Zilin; Ren, Guangxin; Feng, Yongzhong; Han, Xinhui; Yang, Gaihe			Biogas Production by Co-Digestion of Goat Manure with Three Crop Residues	PLOS ONE			English	Article							THERMOPHILIC ANAEROBIC-DIGESTION; SWINE MANURE; WASTE; METHANE; INHIBITION; SLUDGE; ENERGY; DAIRY; IMPROVEMENT; FRUIT	Goat manure (GM) is an excellent raw material for anaerobic digestion because of its high total nitrogen content and fermentation stability. Several comparative assays were conducted on the anaerobic co-digestion of GM with three crop residues (CRs), namely, wheat straw (WS), corn stalks (CS) and rice straw (RS), under different mixing ratios. All digesters were implemented simultaneously under mesophilic temperature at 35 +/- 1 degrees C with a total solid concentration of 8%. Result showed that the combination of GM with CS or RS significantly improved biogas production at all carbon-to-nitrogen (C/N) ratios. GM/CS (30:70), GM/CS (70:30), GM/RS (30:70) and GM/RS (50:50) produced the highest biogas yields from different co-substrates (14840, 16023, 15608 and 15698 mL, respectively) after 55 d of fermentation. Biogas yields of GM/WS 30:70 (C/N 35.61), GM/CS 70:30 (C/N 21.19) and GM/RS 50:50 (C/N 26.23) were 1.62, 2.11 and 1.83 times higher than that of CRs, respectively. These values were determined to be the optimal C/N ratios for co-digestion. However, compared with treatments of GM/CS and GM/RS treatments, biogas generated from GM/WS was only slightly higher than the single digestion of GM or WS. This result was caused by the high total carbon content (35.83%) and lignin content (24.34%) in WS, which inhibited biodegradation.	[Zhang, Tong; Song, Zilin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Zhang, Tong; Liu, Linlin; Song, Zilin; Ren, Guangxin; Feng, Yongzhong; Han, Xinhui; Yang, Gaihe] Northwest A&F Univ, Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China; [Liu, Linlin; Ren, Guangxin; Feng, Yongzhong; Han, Xinhui; Yang, Gaihe] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn	Feng, Yongzhong/F-5090-2012; ren, guangxin/Q-1234-2015	Feng, Yongzhong/0000-0002-5202-4368; ren, guangxin/0000-0001-9895-2680; Zhang, Tong/0000-0002-0146-243X	Ministry of Science and Technology Department of the People's Republic of China [2011BAD15B03]; Ministry of Education of the People's Republic of China [QM2012002]	Ministry of Science and Technology Department of the People's Republic of China(Ministry of Science and Technology, China); Ministry of Education of the People's Republic of China(Ministry of Education, China)	This work was supported by science and technology support projects "the biological technology integration and demonstration of high yield biogas digestion from the mix ingredients" (2011BAD15B03) from Ministry of Science and Technology Department of the People's Republic of China, and the Fundamental Research Funds for the Central Universities (QM2012002) from Ministry of Education of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2010, BIORESOURCE TECHNOL, V101, P1153, DOI 10.1016/j.biortech.2009.09.061; ANGELIDAKI I, 1993, APPL MICROBIOL BIOT, V38, P560; ANGELIDAKI I, 1992, APPL MICROBIOL BIOT, V37, P808, DOI 10.1007/BF00174850; [Anonymous], 2000, WATER SCI TECHNOL; [Anonymous], 1997, ANAEROBIC DIGESTION; [Anonymous], 2011, INT J CHEM REACT ENG; [Anonymous], 2002, BIORESOUR TECHNOL; APHA, 1995, STANDARD METHODS EXA; Bouallagui H, 2009, J ENVIRON MANAGE, V90, P1844, DOI 10.1016/j.jenvman.2008.12.002; Carucci G, 2005, J ENVIRON ENG, V131, P1037, DOI 10.1061/(ASCE)0733-9372(2005)131:7(1037); Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Creamer KS, 2010, BIORESOURCE TECHNOL, V101, P3020, DOI 10.1016/j.biortech.2009.12.029; Dai X, 2012, WASTE MANAGEMENT; DUARTE AC, 1982, WATER SCI TECHNOL, V14, P749, DOI 10.2166/wst.1982.0139; El-Mashad HM, 2010, BIORESOURCE TECHNOL, V101, P4021, DOI 10.1016/j.biortech.2010.01.027; Fernandez A, 2005, BIOCHEM ENG J, V26, P22, DOI 10.1016/j.bej.2005.02.018; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Habiba L, 2009, BIORESOURCE TECHNOL, V100, P1555, DOI 10.1016/j.biortech.2008.09.019; JAIN MK, 1981, AGR WASTES, V3, P65, DOI 10.1016/0141-4607(81)90007-X; Jiang D, 2012, RENEW SUST ENERG REV, V16, P1377, DOI 10.1016/j.rser.2011.12.012; Cuetos MJ, 2011, BIOTECHNOL BIOPROC E, V16, P1044, DOI 10.1007/s12257-011-0117-4; KANWAR SS, 1993, WORLD J MICROB BIOT, V9, P174, DOI 10.1007/BF00327830; Kayhanian M, 1999, ENVIRON TECHNOL, V20, P355, DOI 10.1080/09593332008616828; Luostarinen S, 2009, BIORESOURCE TECHNOL, V100, P79, DOI 10.1016/j.biortech.2008.06.029; Macias-Corral M, 2008, BIORESOURCE TECHNOL, V99, P8288, DOI 10.1016/j.biortech.2008.03.057; Madsen M, 2011, RENEW SUST ENERG REV, V15, P3141, DOI 10.1016/j.rser.2011.04.026; Ngan N.V.C., 2012, J VIET ENV, V3, P4, DOI DOI 10.13141/JVE.V0L3.N01.PP4-9; Panichnumsin P, 2010, BIOMASS BIOENERG, V34, P1117, DOI 10.1016/j.biombioe.2010.02.018; Song ZL, 2012, BIORESOURCES, V7, P3223; Veeken A, 1999, BIORESOURCE TECHNOL, V69, P249, DOI 10.1016/S0960-8524(98)00188-6; Wang FangHao, 2006, China Environmental Science, V26, P614; Wang XJ, 2012, BIORESOURCE TECHNOL, V120, P78, DOI 10.1016/j.biortech.2012.06.058; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Wu X, 2010, BIORESOURCE TECHNOL, V101, P4042, DOI 10.1016/j.biortech.2010.01.052; Xie S, 2011, BIORESOURCE TECHNOL, V102, P5728, DOI 10.1016/j.biortech.2011.03.009; Yang Z, 2008, PET SCI, V5, P183, DOI 10.1007/s12182-008-0029-x; Zhang PD, 2009, RENEW SUST ENERG REV, V13, P2571, DOI 10.1016/j.rser.2009.06.016; Zhu D., 2010, CODIGESTION DIFFEREN	38	82	87	3	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66845	10.1371/journal.pone.0066845	http://dx.doi.org/10.1371/journal.pone.0066845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825574	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000035
J	Bai, XS; Saab, AS; Huang, WH; Hoberg, IK; Kirchhoff, F; Scheller, A				Bai, Xianshu; Saab, Aiman S.; Huang, Wenhui; Hoberg, Isolde K.; Kirchhoff, Frank; Scheller, Anja			Genetic Background Affects Human Glial Fibrillary Acidic Protein Promoter Activity	PLOS ONE			English	Article							ASTROCYTE-SPECIFIC TRANSCRIPTION; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; TRANSGENIC MICE; MESSENGER-RNA; C57BL/6J MICE; MOUSE-BRAIN; IN-VIVO; EXPRESSION; GFAP	The human glial fibrillary acidic protein (hGFAP) promoter has been used to generate numerous transgenic mouse lines, which has facilitated the analysis of astrocyte function in health and disease. Here, we evaluated the expression levels of various hGFAP transgenes at different ages in the two most commonly used inbred mouse strains, FVB/N (FVB) and C57BL/6N (B6N). In general, transgenic mice maintained on the B6N background displayed weaker transgene expression compared with transgenic FVB mice. Higher level of transgene expression in B6N mice could be regained by crossbreeding to FVB wild type mice. However, the endogenous murine GFAP expression was equivalent in both strains. In addition, we found that endogenous GFAP expression was increased in transgenic mice in comparison to wild type mice. The activities of the hGFAP transgenes were not age-dependently regulated. Our data highlight the importance of proper expression analysis when non-homologous recombination transgenesis is used.	[Bai, Xianshu; Saab, Aiman S.; Huang, Wenhui; Hoberg, Isolde K.; Kirchhoff, Frank; Scheller, Anja] Univ Saarland, Dept Mol Physiol, Homburg, Germany	Saarland University	Scheller, A (corresponding author), Univ Saarland, Dept Mol Physiol, Homburg, Germany.	anja.scheller@uks.eu	Kirchhoff, Frank/B-9335-2008; Huang, Wenhui/M-6227-2013; Scheller, Anja/B-8577-2018; Bai, Xianshu/ABY-7478-2022	Kirchhoff, Frank/0000-0002-2324-2761; Huang, Wenhui/0000-0001-9865-0375; Scheller, Anja/0000-0001-8955-2634; Bai, Xianshu/0000-0002-4758-1645; Saab, Aiman S./0000-0003-3886-8369	DFG [SPP 1172, SFB 894]; European Commission [FP7-202167 NeuroGLIA, FP7-People ITN-237956 EdU-Glia]	DFG(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is supported by DFG SPP 1172, DFG SFB 894, European Commission FP7-202167 NeuroGLIA and FP7-People ITN-237956 EdU-Glia (http://www.eduglia.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESNARD F, 1991, J BIOL CHEM, V266, P18877; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brenner Michael, 1996, Methods (Orlando), V10, P351, DOI 10.1006/meth.1996.0113; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P4395, DOI 10.1128/MCB.8.10.4395; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Cheng PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022018; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; de Leeuw B, 2006, J NEUROSCI RES, V83, P744, DOI 10.1002/jnr.20776; Dobie K, 1997, TRENDS GENET, V13, P127, DOI 10.1016/S0168-9525(97)01097-4; ELDER GA, 1994, MOL BRAIN RES, V26, P177, DOI 10.1016/0169-328X(94)90089-2; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fukuda Shinji, 2005, Anatomical Science International, V80, P12; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Kim HJ, 2011, METHODS MOL BIOL, V793, P63, DOI 10.1007/978-1-61779-328-8_4; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lee Y, 2006, GLIA, V53, P677, DOI 10.1002/glia.20320; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; LEWIS SA, 1985, J NEUROCHEM, V45, P913, DOI 10.1111/j.1471-4159.1985.tb04080.x; LI HS, 1992, ACTA OTO-LARYNGOL, V112, P956, DOI 10.3109/00016489209137496; LI HS, 1991, ACTA OTO-LARYNGOL, V111, P827, DOI 10.3109/00016489109138418; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MASOOD K, 1993, J NEUROCHEM, V61, P160, DOI 10.1111/j.1471-4159.1993.tb03551.x; Messing A, 2003, GLIA, V43, P87, DOI 10.1002/glia.10219; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Namihira M, 2008, PHILOS T R SOC B, V363, P2099, DOI 10.1098/rstb.2008.2262; Nolte C, 2001, GLIA, V33, P72; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Restrepo A, 2011, NEURO-ONCOLOGY, V13, P42, DOI 10.1093/neuonc/noq145; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; SEEBURG PH, 1982, DNA-J MOLEC CELL BIO, V1, P239, DOI 10.1089/dna.1.1982.1.239; Shepherd CT, 2009, METHODS MOL BIOL, V526, P129, DOI 10.1007/978-1-59745-494-0_11; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Su M, 2004, NEUROCHEM RES, V29, P2075, DOI 10.1007/s11064-004-6881-1; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; TARDY M, 1989, J NEUROCHEM, V52, P162, DOI 10.1111/j.1471-4159.1989.tb10911.x; Weichman K, 1997, MOL CELL BIOL, V17, P5269, DOI 10.1128/MCB.17.9.5269; WILLOTT JF, 1993, J COMP NEUROL, V329, P402, DOI 10.1002/cne.903290310; Yoshida T, 1996, NEUROSCI LETT, V215, P107, DOI 10.1016/0304-3940(96)12966-9; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	61	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66873	10.1371/journal.pone.0066873	http://dx.doi.org/10.1371/journal.pone.0066873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826164	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400075
J	Harel, A; Bentin, S				Harel, Assaf; Bentin, Shlomo			Are All Types of Expertise Created Equal? Car Experts Use Different Spatial Frequency Scales for Subordinate Categorization of Cars and Faces	PLOS ONE			English	Article							OBJECT RECOGNITION; VISUAL EXPERTISE; BASIC-LEVEL; AREA; PERCEPTION; INFORMATION; CORTEX; INTERFERENCE; SENSITIVITY; COMPETITION	A much-debated question in object recognition is whether expertise for faces and expertise for non-face objects utilize common perceptual information. We investigated this issue by assessing the diagnostic information required for different types of expertise. Specifically, we asked whether face categorization and expert car categorization at the subordinate level relies on the same spatial frequency (SF) scales. Fifteen car experts and fifteen novices performed a category verification task with spatially filtered images of faces, cars, and airplanes. Images were categorized based on their basic (e.g. "car'') and subordinate level (e.g. "Japanese car'') identity. The effect of expertise was not evident when objects were categorized at the basic level. However, when the car experts categorized faces and cars at the subordinate level, the two types of expertise required different kinds of SF information. Subordinate categorization of faces relied on low SFs more than on high SFs, whereas subordinate expert car categorization relied on high SFs more than on low SFs. These findings suggest that expertise in the recognition of objects and faces do not utilize the same type of information. Rather, different types of expertise require different types of diagnostic visual information.	[Harel, Assaf] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; [Bentin, Shlomo] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [Bentin, Shlomo] Hebrew Univ Jerusalem, Ctr Neural Computat, Jerusalem, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Hebrew University of Jerusalem; Hebrew University of Jerusalem	Harel, A (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	assaf.harel@nih.gov		Harel, Assaf/0000-0002-4899-6156	NIMH [R01 MH 64458]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064458] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by NIMH grant R01 MH 64458 to Shlomo Bentin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault A, 2000, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P585; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Biederman I, 1999, PSYCHOL RES-PSYCH FO, V62, P131, DOI 10.1007/s004260050047; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; Boutet I, 2003, PERCEPT PSYCHOPHYS, V65, P1078, DOI 10.3758/BF03194835; Brants M, 2011, J COGNITIVE NEUROSCI, V23, P3949, DOI 10.1162/jocn_a_00072; Bukach CM, 2006, TRENDS COGN SCI, V10, P159, DOI 10.1016/j.tics.2006.02.004; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; CAREY S, 1992, PHILOS T ROY SOC B, V335, P95, DOI 10.1098/rstb.1992.0012; D'Lauro C, 2008, PSYCHON B REV, V15, P623, DOI 10.3758/PBR.15.3.623; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 2005, CURR DIR PSYCHOL SCI, V14, P30, DOI 10.1111/j.0963-7214.2005.00329.x; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2007, COGNITION, V103, P322, DOI 10.1016/j.cognition.2006.05.003; Gilaie-Dotan S, 2012, NEUROIMAGE, V62, P147, DOI 10.1016/j.neuroimage.2012.05.017; Goffaux V, 2005, PERCEPTION, V34, P77, DOI 10.1068/p5370; Goffaux V, 2003, COGNITIVE BRAIN RES, V16, P416, DOI 10.1016/S0926-6410(03)00056-9; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Harel A, 2007, VISION RES, V47, P2010, DOI 10.1016/j.visres.2007.04.004; Harel A, 2010, CEREB CORTEX, V20, P2304, DOI 10.1093/cercor/bhp316; Harel A, 2009, J EXP PSYCHOL HUMAN, V35, P1264, DOI 10.1037/a0013621; Johnson KE, 1997, J EXP PSYCHOL GEN, V126, P248, DOI 10.1037/0096-3445.126.3.248; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Loftus GR, 2004, J EXP PSYCHOL HUMAN, V30, P104, DOI 10.1037/0096-1523.30.1.104; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McGugin RW, 2010, J VISION, V10, DOI 10.1167/10.4.15; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Morrison DJ, 2001, PSYCHON B REV, V8, P454, DOI 10.3758/BF03196180; MURPHY GL, 1985, J EXP PSYCHOL LEARN, V11, P70, DOI 10.1037/0278-7393.11.1.70; Nederhouser M, 2007, VISION RES, V47, P2134, DOI 10.1016/j.visres.2007.04.007; Nishimura M, 2008, PERCEPTION, V37, P584, DOI 10.1068/p5740; Puce A, 1996, J NEUROSCI, V16, P5205; Rhodes G, 2004, J COGNITIVE NEUROSCI, V16, P189, DOI 10.1162/089892904322984508; Robbins R, 2007, COGNITION, V103, P34, DOI 10.1016/j.cognition.2006.02.008; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rossion B, 2004, P NATL ACAD SCI USA, V101, P14521, DOI 10.1073/pnas.0405613101; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Rossion B, 2007, J COGNITIVE NEUROSCI, V19, P543, DOI 10.1162/jocn.2007.19.3.543; Scott LS, 2006, J COGNITIVE NEUROSCI, V18, P1453, DOI 10.1162/jocn.2006.18.9.1453; Tanaka JW, 2005, PSYCHOL SCI, V16, P145, DOI 10.1111/j.0956-7976.2005.00795.x; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Xu YD, 2005, CEREB CORTEX, V15, P1234, DOI 10.1093/cercor/bhi006; Yue XM, 2006, VISION RES, V46, P3802, DOI 10.1016/j.visres.2006.06.017	54	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67024	10.1371/journal.pone.0067024	http://dx.doi.org/10.1371/journal.pone.0067024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23826188	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400095
J	Hung, HS; Tang, CM; Lin, CH; Lin, SZ; Chu, MY; Sun, WS; Kao, WC; Hsien-Hsu, H; Huang, CY; Hsu, SH				Hung, Huey-Shan; Tang, Cheng-Ming; Lin, Chien-Hsun; Lin, Shinn-Zong; Chu, Mei-Yun; Sun, Wei-Shen; Kao, Wei-Chien; Hsien-Hsu, Hsieh; Huang, Chih-Yang; Hsu, Shan-hui			Biocompatibility and Favorable Response of Mesenchymal Stem Cells on Fibronectin-Gold Nanocomposites	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ENDOTHELIAL-CELLS; POLYURETHANE NANOCOMPOSITES; IN-VITRO; VASCULAR GRAFTS; NITRIC-OXIDE; MIGRATION; SURFACE; DIFFERENTIATION; ATHEROSCLEROSIS	A simple surface modification method, comprising of a thin coating with gold nanoparticles (AuNPs) and fibronectin (FN), was developed to improve the biocompatibility required for cardiovascular devices. The nanocomposites from FN and AuNPs (FN-Au) were characterized by the atomic force microscopy (AFM), UV-Vis spectrophotometry (UV-Vis), and Fourier transform infrared spectroscopy (FTIR). The biocompatibility of the nanocomposites was evaluated by the response of monocytes and platelets to the material surface in vitro. FN-Au coated surfaces demonstrated low monocyte activation and platelet activation. The behavior of human umbilical cord-derived mesenchymal stem cells (MSCs) on FN-Au was further investigated. MSCs on FN-Au nanocomposites particularly that containing 43.5 ppm of AuNPs (FN-Au 43.5 ppm) showed cell proliferation, low ROS generation, as well as increases in the protein expression levels of matrix metalloproteinase-9 (MMP-9) and endothelial nitric oxide synthase (eNOS), which may account for the enhanced MSC migration on the nanocomposites. These results suggest that the FN-Au nanocomposite thin film coating may serve as a potential and simple solution for the surface modification of blood-contacting devices such as vascular grafts.	[Hung, Huey-Shan; Lin, Chien-Hsun; Chu, Mei-Yun; Sun, Wei-Shen; Kao, Wei-Chien; Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Hung, Huey-Shan; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Tang, Cheng-Ming] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigang Hosp, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Hsien-Hsu, Hsieh] Taichung Vet Gen Hosp, Blood Bank, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan; [Hsu, Shan-hui] Natl Taiwan Univ, Rehabil Engn Res Ctr, Taipei 10764, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; China Medical University Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; National Taiwan University; National Taiwan University	Huang, CY (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	cyhuang@mail.cmu.edu.tw; shhsu@ntu.edu.tw	Yuang, Chih-Yang/O-5111-2015; Lin, Shinn-Zong/AAX-2379-2020	Hsu, Shan-hui/0000-0003-3399-055X	National Science Council [NSC 100-2221-E-039-003]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC 100-2221-E-039-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI 10.1016/j.colsurfb.2007.11.015; Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Cairns ML, 2010, COLLOID SURFACE B, V78, P283, DOI 10.1016/j.colsurfb.2010.03.013; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Christenson EM, 2006, J BIOMED MATER RES A, V76A, P480, DOI 10.1002/jbm.a.30506; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058; Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498; Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7; de Mel A, 2011, CHEM REV, V111, P5742, DOI 10.1021/cr200008n; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Esumi K, 2004, LANGMUIR, V20, P2536, DOI 10.1021/la036299r; Esumi K, 2003, COLLOID SURFACE B, V32, P117, DOI 10.1016/S0927-7765(03)00151-6; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027; Ghajar CM, 2008, CRIT REV EUKAR GENE, V18, P251, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.30; Gu HY, 2004, BIOMATERIALS, V25, P3445, DOI 10.1016/j.biomaterials.2003.10.048; Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050; Ho TT, 2012, GOLD BULL, V45, P161, DOI 10.1007/s13404-012-0062-9; Hsu SH, 2000, ARTIF ORGANS, V24, P119, DOI 10.1046/j.1525-1594.2000.06338.x; Hsu SH, 2008, BIOMACROMOLECULES, V9, P241, DOI 10.1021/bm700471k; Hsu SH, 2006, J BIOMED MATER RES A, V79A, P759, DOI 10.1002/jbm.a.30879; Hsu SH, 2008, ACTA BIOMATER, V4, P1797, DOI 10.1016/j.actbio.2008.06.015; Huang CY, 2013, J MED BIOL ENG, V33, P139, DOI 10.5405/jmbe.1109; Hung HS, 2012, J BIOMED MATER RES A, V100A, P26, DOI 10.1002/jbm.a.33224; Hung HS, 2009, NEW BIOTECHNOL, V25, P235, DOI 10.1016/j.nbt.2009.01.003; Hung HS, 2009, BIOMATERIALS, V30, P1502, DOI 10.1016/j.biomaterials.2008.12.003; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Middleton CA, 2007, J BIOMED MATER RES A, V83A, P1032, DOI 10.1002/jbm.a.31382; Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318; Miller DC, 2004, EXPERT REV MED DEVIC, V1, P259, DOI 10.1586/17434440.1.2.259; Miller DC, 2007, J BIOMED MATER RES A, V81A, P678, DOI 10.1002/jbm.a.31093; Norment AM, 2000, SEMIN IMMUNOL, V12, P445, DOI 10.1006/smim.2000.0261; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sata M, 2003, CIRC J, V67, P983, DOI 10.1253/circj.67.983; SOTTILE J, 1994, J BIOL CHEM, V269, P17192; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Zhang Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.37; Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6	49	31	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65738	10.1371/journal.pone.0065738	http://dx.doi.org/10.1371/journal.pone.0065738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826082	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400004
J	Liabeuf, S; Glorieux, G; Lenglet, A; Diouf, M; Schepers, E; Desjardins, L; Choukroun, G; Vanholder, R; Massy, ZA				Liabeuf, Sophie; Glorieux, Griet; Lenglet, Aurelie; Diouf, Momar; Schepers, Eva; Desjardins, Lucie; Choukroun, Gabriel; Vanholder, Raymond; Massy, Ziad A.		European Uremic Toxin EUTox Work G	Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; INDOXYL SULFATE; CRESOL; PROGRESSION; CRESYLSULPHATE; TOXICITY; MODERATE	Background: Uremic toxins are emerging as important, non-traditional cardiovascular risk factors in chronic kidney disease (CKD). P-cresol has been defined as a prototype protein-bound uremic toxin. Conjugation of p-cresol creates p-cresylsulfate (PCS) as the main metabolite and p-cresylglucuronide (PCG), at a markedly lower concentration. The objective of the present study was to evaluate serum PCG levels, determine the latter's association with mortality and establish whether the various protein-bound uremic toxins (i.e. PCS, PCG and indoxylsulfate (IS)) differed in their ability to predict mortality. Methodology/Principal Findings: We studied 139 patients (mean +/- SD age: 67 +/- 12; males: 60%) at different CKD stages (34.5% at CKD stages 2-3, 33.5% at stage 4-5 and 32% at stage 5D). A recently developed high-performance liquid chromatography method was used to assay PCG concentrations. Total and free PCG levels increased with the severity of CKD. During the study period (mean duration: 779 +/- 185 days), 38 patients died. High free and total PCG levels were correlated with overall and cardiovascular mortality independently of well-known predictors of survival, such as age, vascular calcification, anemia, inflammation and (in predialysis patients) the estimated glomerular filtration rate. In the same cohort, free PCS levels and free IS levels were both correlated with mortality. Furthermore, the respective predictive powers of three Cox multivariate models (free PCS+other risk factors, free IS+other risk factors and free PCS+other risk factors) were quite similar - suggesting that an elevated PCG concentration has much the same impact on mortality as other uremic toxins (such as PCS or IS) do. Conclusions: Although PCG is the minor metabolite of p-cresol, our study is the first to reveal its association with mortality. Furthermore, the free fraction of PCG appears to have much the same predictive power for mortality as PCS and IS do.	[Liabeuf, Sophie; Lenglet, Aurelie; Desjardins, Lucie; Choukroun, Gabriel; Massy, Ziad A.] Jules Verne Univ Picardy, INSERM, U1088, Amiens, France; [Liabeuf, Sophie; Lenglet, Aurelie; Diouf, Momar; Desjardins, Lucie; Massy, Ziad A.] Amiens Univ Hosp, Clin Res Ctr, Div Clin Pharmacol, Amiens, France; [Liabeuf, Sophie; Lenglet, Aurelie; Diouf, Momar; Desjardins, Lucie; Massy, Ziad A.] Jules Verne Univ Picardy, Amiens, France; [Glorieux, Griet; Schepers, Eva; Vanholder, Raymond] Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium; [Choukroun, Gabriel] Amiens Univ Hosp, Div Nephrol Dialysis Transplantat, Amiens, France; [Massy, Ziad A.] Ambroise Pare Hosp, Div Nephrol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Ghent University; Ghent University Hospital; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Massy, ZA (corresponding author), Jules Verne Univ Picardy, INSERM, U1088, Amiens, France.	massy@u-picardie.fr	Gabriel, Choukroun/AAL-4969-2021; , liabeuf/AFB-7848-2022		Amiens University Hospital [PHRC:2006/0100]; EUTox Group	Amiens University Hospital; EUTox Group	This study was funded by a grant from Amiens University Hospital [PHRC:2006/0100 (March 27, 2006)] and supported also by EUTox Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizawa T, 2009, AM J KIDNEY DIS, V54, P459, DOI 10.1053/j.ajkd.2009.05.011; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Berge-Lefranc D, 2010, J PHYS CHEM B, V114, P1661, DOI 10.1021/jp9059517; CURTIUS HC, 1976, J CHROMATOGR, V126, P569, DOI 10.1016/S0021-9673(01)84102-9; de Loor H, 2005, CLIN CHEM, V51, P1535, DOI 10.1373/clinchem.2005.050781; De Smet R, 2003, CLIN CHEM, V49, P470, DOI 10.1373/49.3.470; Dou L, 2002, KIDNEY INT, V62, P1999, DOI 10.1046/j.1523-1755.2002.t01-1-00651.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3; Iwasaki Y, 2006, NEPHROL DIAL TRANSPL, V21, P2768, DOI 10.1093/ndt/gfl311; Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Liabeuf S, 2011, TOXINS, V3, P911, DOI 10.3390/toxins3070911; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251; Massy ZA, 2009, SEMIN DIALYSIS, V22, P405, DOI 10.1111/j.1525-139X.2009.00590.x; Meert N, 2012, NEPHROL DIAL TRANSPL, V27, P2388, DOI 10.1093/ndt/gfr672; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Meijers BK, 2009, AM J KIDNEY DIS; Nakamura T, 2004, KIDNEY BLOOD PRESS R, V27, P121, DOI 10.1159/000077536; Niwa T, 1997, MINER ELECTROL METAB, V23, P179; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Schulman G, 2006, AM J KIDNEY DIS, V47, P565, DOI 10.1053/j.ajkd.2005.12.036; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Temmar M, 2010, J HYPERTENS, V28, P163, DOI 10.1097/HJH.0b013e328331b81e; VANHOLDER R, 1994, SEMIN NEPHROL, V14, P205; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Vanholder R, 2008, PEDIATR NEPHROL, V23, P1211, DOI 10.1007/s00467-008-0762-9; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580; Zureik M, 2002, J HYPERTENS, V20, P85, DOI 10.1097/00004872-200201000-00013	34	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67168	10.1371/journal.pone.0067168	http://dx.doi.org/10.1371/journal.pone.0067168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826225	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400114
J	Wang, Y; Qian, GL; Li, YY; Wang, YS; Wang, YL; Wright, S; Li, YZ; Shen, YM; Liu, FQ; Du, LC				Wang, Yan; Qian, Guoliang; Li, Yaoyao; Wang, Yansheng; Wang, Yulan; Wright, Stephen; Li, Yuezhong; Shen, Yuemao; Liu, Fengquan; Du, Liangcheng			Biosynthetic Mechanism for Sunscreens of the Biocontrol Agent Lysobacter enzymogenes	PLOS ONE			English	Article							POLYCYCLIC TETRAMATE MACROLACTAM; IN-VITRO RECONSTITUTION; BIOLOGICAL-CONTROL; FATTY-ACID; POLYKETIDE SYNTHASE; GENE-CLUSTER; ANTIMICROBIAL ACTIVITY; CEPHEM ANTIBIOTICS; BACTERIAL ORIGIN; XANTHOMONADIN	Lysobacter are ubiquitous environmental bacteria emerging as novel biocontrol agents and new sources of anti-infectives. So far, very little effort has been invested in the study of the biology of these Gram-negative gliding bacteria. Many Lysobacter species are characterized by their yellow-orange appearance. Using transposon mutagenesis, we identified a stand-alone polyketide synthase (PKS) gene cluster required for the pigment production in L. enzymogenes OH11. The yellow pigments were abolished in the "white'' mutants generated by target-specific deletions of ketosynthase (KS), acyl carrier protein, or ketoreductase. Spectroscopic data suggested that the pigments belong to xanthomonadin-like aryl polyenes. Polyene-type polyketides are known to be biosynthesized by modular PKS (Type I), not by stand-alone PKS (Type II) which always contain the heterodimer KS-CLF (chain-length factor) as the key catalytic component. Remarkably, this aryl polyene PKS complex only contains the KS (ORF17), but not the CLF. Instead, a hypothetical protein (ORF16) is located immediately next to ORF17. ORF16-17 homologs are widespread in numerous uncharacterized microbial genomes, in which an ORF17 homolog is always accompanied by an ORF16 homolog. The deletion of ORF16 eliminated pigment production, and homology modeling suggested that ORF16 shares a structural similarity to the N-terminal half of CLF. A point-mutation of glutamine (Q166A) that is the conserved active site of known CLF abolished pigment production. The "white'' mutants are significantly more sensitive to UV/visible light radiation or H2O2 treatment than the wild type. These results unveil the first example of Type II PKS-synthesized polyene pigments and show that the metabolites serve as Lysobacter "sunscreens'' that are important for the survival of these ubiquitous environmental organisms.	[Wang, Yan; Wright, Stephen; Du, Liangcheng] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Qian, Guoliang; Wang, Yansheng; Wang, Yulan; Liu, Fengquan] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Yan; Li, Yaoyao; Li, Yuezhong; Shen, Yuemao] Shandong Univ, Coll Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; Nanjing Agricultural University; Shandong University	Liu, FQ (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ldu3@unl.edu; fqliu20011@sina.com	Li, Yaoyao/GRF-4155-2022; Li, Yuezhong/ACN-5179-2022	Li, Yuezhong/0000-0001-8336-6638; Shen, Yuemao/0000-0002-3881-0135; Wang, Yan/0000-0003-4632-5786	National Institutes of Health [R01AI097260]; Nebraska Research Initiatives; Nebraska Research Council; National Natural Science Foundation of China [31028019, 31101478]; National High Technology Research and Development Program of China [2011AA10A205]; Doctoral Fund of Ministry of Education of China [20100097120013]; China Scholarship Council; Postdoctoral Innovation Foundation of Shandong Province [201003070]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiatives; Nebraska Research Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); China Scholarship Council(China Scholarship Council); Postdoctoral Innovation Foundation of Shandong Province; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (R01AI097260), Nebraska Research Initiatives, Nebraska Research Council, National Natural Science Foundation of China (31028019, 31101478), National High Technology Research and Development Program of China (2011AA10A205), and Doctoral Fund of Ministry of Education of China (No. 20100097120013). YW was supported by a Scholarship from China Scholarship Council, and YL was supported by Postdoctoral Innovation Foundation of Shandong Province (201003070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWES AG, 1973, ACTA CHEM SCAND, V27, P2383, DOI 10.3891/acta.chem.scand.27-2383; ANDREWES AG, 1976, TETRAHEDRON LETT, P4023; Aparicio JF, 2000, CHEM BIOL, V7, P895, DOI 10.1016/S1074-5521(00)00038-7; Aparicio JF, 2003, APPL MICROBIOL BIOT, V61, P179, DOI 10.1007/s00253-002-1183-5; Bao WL, 1998, BIOCHEMISTRY-US, V37, P8132, DOI 10.1021/bi980466i; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; BONNER DP, 1988, J ANTIBIOT, V41, P1745, DOI 10.7164/antibiotics.41.1745; Brautaset T, 2000, CHEM BIOL, V7, P395, DOI 10.1016/S1074-5521(00)00120-4; Caffrey P, 2001, CHEM BIOL, V8, P713, DOI 10.1016/S1074-5521(01)00046-1; Carreras CW, 1998, BIOCHEMISTRY-US, V37, P2084, DOI 10.1021/bi972919+; Chiang SL, 1999, INFECT IMMUN, V67, P976, DOI 10.1128/IAI.67.2.976-980.1999; CHRISTENSEN P, 1978, INT J SYST BACTERIOL, V28, P367, DOI 10.1099/00207713-28-3-367; Demirev AV, 2006, FEMS MICROBIOL LETT, V255, P121, DOI 10.1111/j.1574-6968.2005.00067.x; Giesler LJ, 1998, CROP PROT, V17, P509, DOI 10.1016/S0261-2194(98)00049-0; Goel AK, 2002, J BACTERIOL, V184, P3539, DOI 10.1128/JB.184.13.3539-3548.2002; Harada K, 2001, J CHROMATOGR A, V932, P75, DOI 10.1016/S0021-9673(01)01235-3; HARADA S, 1984, J ANTIBIOT, V37, P1536, DOI 10.7164/antibiotics.37.1536; Hashizume H, 2004, J ANTIBIOT, V57, P52, DOI 10.7164/antibiotics.57.52; Hashizume H, 2001, J ANTIBIOT, V54, P1054, DOI 10.7164/antibiotics.54.1054; He YW, 2011, MOL PLANT MICROBE IN, V24, P948, DOI 10.1094/MPMI-02-11-0031; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Hou J, 2011, CHEM BIOL, V18, P655, DOI 10.1016/j.chembiol.2011.02.012; Ishikawa F, 2012, J AM CHEM SOC, V134, P769, DOI 10.1021/ja2082334; Kato A, 1998, J ANTIBIOT, V51, P929, DOI 10.7164/antibiotics.51.929; Kato A, 1997, J AM CHEM SOC, V119, P6680, DOI 10.1021/ja970895o; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; Kobayashi DY, 2005, CAN J MICROBIOL, V51, P719, DOI 10.1139/W05-056; Kobayashi DY, 2005, APPL ENVIRON MICROB, V71, P261, DOI 10.1128/AEM.71.1.261-269.2005; Li S, 2008, PHYTOPATHOLOGY, V98, P695, DOI 10.1094/PHYTO-98-6-0695; Li SJ, 2009, J EUKARYOT MICROBIOL, V56, P182, DOI 10.1111/j.1550-7408.2008.00384.x; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Li YY, 2012, MEDCHEMCOMM, V3, P982, DOI 10.1039/c2md20026k; Lou LL, 2012, BIOCHEMISTRY-US, V51, P4, DOI 10.1021/bi2015025; Lou LL, 2011, J AM CHEM SOC, V133, P643, DOI 10.1021/ja105732c; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; Meiser P, 2008, CHEM BIOL, V15, P771, DOI 10.1016/j.chembiol.2008.06.005; Nett M, 2007, NAT PROD REP, V24, P1245, DOI 10.1039/b612668p; ONO H, 1984, J ANTIBIOT, V37, P1528, DOI 10.7164/antibiotics.37.1528; OSULLIVAN J, 1988, J ANTIBIOT, V41, P1740, DOI 10.7164/antibiotics.41.1740; Peres CM, 2006, J BACTERIOL, V188, P8662, DOI 10.1128/JB.01312-06; Pirri G, 2009, CENT EUR J BIOL, V4, P258, DOI 10.2478/s11535-009-0031-3; Poplawsky AR, 2005, MOL PLANT PATHOL, V6, P653, DOI 10.1111/J.1364-3703.2005.00307.X; Poplawsky AR, 2000, APPL ENVIRON MICROB, V66, P5123, DOI 10.1128/AEM.66.12.5123-5127.2000; Qian GL, 2009, AGR SCI CHINA, V8, P68, DOI 10.1016/S1671-2927(09)60010-9; Rajagopal L, 1997, FEBS LETT, V415, P125, DOI 10.1016/S0014-5793(97)01109-5; Rajgarhia VB, 1997, J BACTERIOL, V179, P2690, DOI 10.1128/jb.179.8.2690-2696.1997; Reichenbach H, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P939, DOI 10.1007/0-387-30746-x_37; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seon LJ, 2008, J MICROBIOL BIOTECHN, V18, P427; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sohn YS, 2001, METAB ENG, V3, P380, DOI 10.1006/mben.2001.0200; STARR MP, 1964, J BACTERIOL, V87, P293, DOI 10.1128/JB.87.2.293-302.1964; STARR MP, 1977, ARCH MICROBIOL, V113, P1, DOI 10.1007/BF00428572; Sullivan RF, 2003, J APPL MICROBIOL, V94, P1079, DOI 10.1046/j.1365-2672.2003.01932.x; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Xie YX, 2012, NAT PROD REP, V29, P1277, DOI 10.1039/c2np20064c; Yu FG, 2007, ANTIMICROB AGENTS CH, V51, P64, DOI 10.1128/AAC.00931-06; Yu XY, 2011, P NATL ACAD SCI USA, V108, P18643, DOI 10.1073/pnas.1110852108; Yuen G. Y., 2001, International Turfgrass Society Research Journal, V9, P742; Yuen GY, 2001, CROP PROT, V20, P395, DOI 10.1016/S0261-2194(00)00154-X; Yuen GY, 2007, PLANT DIS MANAG REP, V1; Zhang W, 2011, ANTIMICROB AGENTS CH, V55, P5581, DOI 10.1128/AAC.05370-11; Zhang Z, 1999, PHYTOPATHOLOGY, V89, P817, DOI 10.1094/PHYTO.1999.89.9.817	63	31	32	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66633	10.1371/journal.pone.0066633	http://dx.doi.org/10.1371/journal.pone.0066633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826105	Green Published, gold			2022-12-27	WOS:000321738400025
J	Xia, RH; Song, XM; Wang, XJ; Li, J; Mao, L				Xia, Rong-Hui; Song, Xiao-Meng; Wang, Xiao-Jing; Li, Jiang; Mao, Li			The Combination of SMAD4 Expression and Histological Grade of Dysplasia Is a Better Predictor for the Malignant Transformation of Oral Leukoplakia	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; PANCREATIC-CANCER; NECK-CANCER; HEAD; DPC4; MUCOSA; CLASSIFICATION; CHROMOSOME-18; PROGRESSION	Oral leukoplakia (OL) is the most common premalignancy in the oral cavity and can progress to oral squamous cell carcinoma (OSCC). SMAD4 is a tumor suppressor implicated in multiple cancer types including OSCC. To assess the role of SMAD4 in oral leukoplakia malignant transformation, the authors investigated SMAD4 expression patterns in OL and OSCC using a highly specific antibody and correlated the patterns with the risk of malignant transformation oral leukoplakia. Immunohistochemistry and a quantitative imaging system were used to measure SMAD4 expression in OL from 88 OL patients, including 22 who later went through malignant transformation, and their OSCC counterpart. Forty-three (48.9%) of the 88 OL patients had strong SMAD4 expression. SMAD4 expression had no significant correlation with patients' clinicopathological parameters. Interestingly, 17 (39.5%) of the 43 OL lesions with strong SMAD4 expression went through malignant transformation whereas only 5 (11.1%) of the 45 OL lesions with weak SMAD4 expression did so (p = 0.002). The SMAD4 expression in OL was much higher than that in their OSCC counterpart. Kaplan-Meier analysis revealed that the combination of SMAD4 expression and histological grade of dysplasia (p = 0.007) is a better predictor for the malignant transformation of oral leukoplakia. In the multivariate analysis, both SMAD4 expression and grade of dysplasia were identified as independent factors for OL malignant transformation risk (p = 0.013 and 0.021, respectively). It was concluded that high SMAD4 expression may be indicative of an early carcinogenic process in OL and serve as an independent biomarker in assessing malignant transformation risk in patients with OL, and the combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.	[Xia, Rong-Hui; Li, Jiang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Pathol, Sch Med,Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China; [Xia, Rong-Hui; Song, Xiao-Meng; Mao, Li] Univ Maryland, Sch Med, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Song, Xiao-Meng; Wang, Xiao-Jing] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Maxillofacial Head & Neck Oncol, Sch Med,Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China; Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA	Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore; Shanghai Jiao Tong University; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, J (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Pathol, Sch Med,Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China.	lijiang182000@yahoo.com; LMao@umaryland.edu	Mao, Li/C-7570-2011	Mao, Li/0000-0001-7263-3358	Chinese Nature Science Foundation [81272976, 30872905, 81072211]; Shanghai Leading Academic Discipline Project [S30206]; Doctoral Innovation Foundation of Shanghai Jiao Tong University, School of Medicine [BXJ201029]	Chinese Nature Science Foundation; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Doctoral Innovation Foundation of Shanghai Jiao Tong University, School of Medicine	This work was supported by Chinese Nature Science Foundation (81272976, 30872905 and 81072211), the Shanghai Leading Academic Discipline Project (S30206) and the Doctoral Innovation Foundation of Shanghai Jiao Tong University, School of Medicine (BXJ201029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Danielsson K, 2010, J ORAL PATHOL MED, V39, P639, DOI 10.1111/j.1600-0714.2010.00902.x; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hahn SA, 1996, CANCER RES, V56, P490; He SM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-70; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Isaksson-Mettavainio M, 2012, INT J CANCER, V131, P779, DOI 10.1002/ijc.26473; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Kim SK, 1996, CANCER RES, V56, P2519; Liffers ST, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-137; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Osawa H, 2000, INT J ONCOL, V17, P723; Ottenhof NA, 2012, CELL ONCOL, V35, P119, DOI 10.1007/s13402-012-0072-x; Papadimitrakopoulou VA, 1998, CLIN CANCER RES, V4, P539; Reibel J, 2003, CRIT REV ORAL BIOL M, V14, P47, DOI 10.1177/154411130301400105; Shi Q, 2012, MOL MED REP, V5, P89, DOI 10.3892/mmr.2011.600; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; van der Waal I, 2010, ORAL ONCOL, V46, P423, DOI 10.1016/j.oraloncology.2010.02.016; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; vanderWaal I, 1997, ORAL ONCOL, V33, P291, DOI 10.1016/S1368-8375(97)00002-X; Wang XM, 2009, MOL BIOL REP, V36, P861, DOI 10.1007/s11033-008-9256-x; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wilentz RE, 2000, CANCER RES, V60, P2002; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie W, 2003, ONCOL RES, V14, P61, DOI 10.3727/000000003108748612	31	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66794	10.1371/journal.pone.0066794	http://dx.doi.org/10.1371/journal.pone.0066794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826135	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400052
J	Belo, AI; van der Sar, AM; Tefsen, B; van Die, I				Belo, Ana I.; van der Sar, Astrid M.; Tefsen, Boris; van Die, Irma			Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells	PLOS ONE			English	Article							TUMOR PROGRESSION; N-GLYCANS; IN-VIVO; EXPRESSION; ZEBRAFISH; CARCINOMA; GENES; ADHESION; BEHAVIOR; LECTINS	Galectin-4 (Gal-4) is a member of the galectin family of glycan binding proteins that shows a significantly higher expression in cystic tumors of the human pancreas and in pancreatic adenocarcinomas compared to normal pancreas. However, the putative function of Gal-4 in tumor progression of pancreatic cancer is still incompletely understood. In this study the role of Gal-4 in cancer progression was investigated, using a set of defined pancreatic cancer cell lines, Pa-Tu-8988S (PaTu-S) and Pa-Tu-8988T (PaTu-T), as a model. These two cell lines are derived from the same liver metastasis of a human primary pancreatic adenocarcinoma, but differ in their growth characteristics and metastatic capacity. We demonstrated that Gal-4 expression is high in PaTu-S, which shows poor migratory properties, whereas much lower Gal-4 levels are observed in the highly metastatic cell line PaTu-T. In PaTu-S, Gal-4 is found in the cytoplasm, but it is also secreted and accumulates at the membrane at sites of contact with neighboring cells. Moreover, we show that Gal-4 inhibits metastasis formation by delaying migration of pancreatic cancer cells in vitro using a scratch assay, and in vivo using zebrafish (Danio rerio) as an experimental model. Our data suggest that Gal-4 may act at the cell-surface of PaTu-S as an adhesion molecule to prevent release of the tumor cells, but has in addition a cytosolic function by inhibiting migration via a yet unknown mechanism.	[Belo, Ana I.; Tefsen, Boris; van Die, Irma] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [van der Sar, Astrid M.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Die, I (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	im.vandie@vumc.nl	Tefsen, Boris/J-1503-2012; van der Sar, Astrid M/A-3698-2008	Tefsen, Boris/0000-0001-6668-217X; van der Sar, Astrid M/0000-0001-5790-5036	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal [SFRH/BD/44820/2008]	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology)	This study was funded by Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grants SFRH/BD/44820/2008 awarded to AIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PM, 2011, PATHOL RES PRACT, V207, P236, DOI 10.1016/j.prp.2011.02.004; Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Bauer A, 2009, PANCREATOLOGY, V9, P34, DOI 10.1159/000178873; Brandt B, 2008, HISTOCHEM CELL BIOL, V129, P599, DOI 10.1007/s00418-008-0395-x; CHIU ML, 1992, J CELL BIOL, V119, P1689, DOI 10.1083/jcb.119.6.1689; CHIU ML, 1994, J BIOL CHEM, V269, P31770; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Cummings R.D., 2009, ANTIBODIES LECTINS G; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; DAVIDSON AJ, 2004, INFLAMMATORY BOWEL D; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Duerr EM, 2008, ENDOCR-RELAT CANCER, V15, P243, DOI 10.1677/ERC-07-0194; ELSASSER HP, 1992, VIRCHOWS ARCH B, V61, P295, DOI 10.1007/BF02890431; Garcia-Vallejo Juan J., 2006, V347, P187; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Granato M, 1996, CURR OPIN GENET DEV, V6, P461, DOI 10.1016/S0959-437X(96)80068-2; Hariharan D, 2008, HPB, V10, P58, DOI 10.1080/13651820701883148; Heinzelmann-Schwarz VA, 2007, J CLIN PATHOL, V60, P622, DOI 10.1136/jcp.2005.034223; Hippo Y, 2001, CANCER RES, V61, P889; Horiguchi N, 2003, J BIOCHEM, V134, P869, DOI 10.1093/jb/mvg213; Huflejt ME, 2003, GLYCOCONJUGATE J, V20, P247, DOI 10.1023/B:GLYC.0000025819.54723.a0; Huflejt ME, 1997, J BIOL CHEM, V272, P14294, DOI 10.1074/jbc.272.22.14294; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Kondoh N, 1999, CANCER RES, V59, P4990; Krejs GJ, 2010, DIGEST DIS, V28, P355, DOI 10.1159/000319414; Langbein S, 2007, HISTOPATHOLOGY, V51, P681, DOI 10.1111/j.1365-2559.2007.02852.x; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Lee S, 2006, ONCOL REP, V16, P747; Li M, 2010, J BIOSCIENCES, V35, P665, DOI 10.1007/s12038-010-0073-8; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Morelle W, 2009, BIOL CHEM, V390, P529, DOI 10.1515/BC.2009.075; Nakahara S, 2008, ANTI-CANCER AGENT ME, V8, P22; Paclik D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002629; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Rapoport EM, 2008, BIOCHEMISTRY-MOSCOW+, V73, P393, DOI 10.1134/S0006297908040032; Rechreche H, 1997, EUR J BIOCHEM, V248, P225, DOI 10.1111/j.1432-1033.1997.00225.x; Rumilla KM, 2006, ENDOCR PATHOL, V17, P243, DOI 10.1385/EP:17:3:243; Salatino M, 2011, METHODS MOL BIOL, V677, P355, DOI 10.1007/978-1-60761-869-0_23; Satelli A, 2011, INT J CANC, pn/a; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; Sison M, 2006, LAB ANIMAL, V35, P33, DOI 10.1038/laban0506-33; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Thiemann S, 2011, J CLIN IMMUNOL, V31, P2, DOI 10.1007/s10875-010-9460-z; Tripodi D, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-65; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wu HQ, 2011, WORLD J GASTROENTERO, V17, P996, DOI 10.3748/wjg.v17.i8.996; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719	59	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65957	10.1371/journal.pone.0065957	http://dx.doi.org/10.1371/journal.pone.0065957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824659	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400039
J	Hamp, T; Goldberg, T; Rost, B				Hamp, Tobias; Goldberg, Tatyana; Rost, Burkhard			Accelerating the Original Profile Kernel	PLOS ONE			English	Article							REMOTE HOMOLOGY DETECTION; STRING KERNELS; PROTEIN; FOLD; PREDICTION; TOOL	One of the most accurate multi-class protein classification systems continues to be the profile-based SVM kernel introduced by the Leslie group. Unfortunately, its CPU requirements render it too slow for practical applications of large-scale classification tasks. Here, we introduce several software improvements that enable significant acceleration. Using various non-redundant data sets, we demonstrate that our new implementation reaches a maximal speed-up as high as 14-fold for calculating the same kernel matrix. Some predictions are over 200 times faster and render the kernel as possibly the top contender in a low ratio of speed/performance. Additionally, we explain how to parallelize various computations and provide an integrative program that reduces creating a production-quality classifier to a single program call. The new implementation is available as a Debian package under a free academic license and does not depend on commercial software. For non-Debian based distributions, the source package ships with a traditional Makefile-based installer. Download and installation instructions can be found at https://rostlab.org/owiki/index.php/Fast_Profile_Kernel. Bugs and other issues may be reported at https://rostlab.org/bugzilla3/enter_bug.cgi?product=fastprofkernel.	[Hamp, Tobias; Goldberg, Tatyana; Rost, Burkhard] Tech Univ Munich, Dept Informat, Garching, Germany; [Goldberg, Tatyana] Tech Univ Munich, Grad Sch, Ctr Doctoral Studies Informat & Its Applicat CeDo, Garching, Germany; [Rost, Burkhard] Inst Adv Study TUM IAS, Garching, Germany; [Rost, Burkhard] Columbia Univ, New York Consortium Membrane Prot Struct NYCOMPS, New York, NY USA; [Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA	Technical University of Munich; Technical University of Munich; Columbia University; Columbia University	Rost, B (corresponding author), Tech Univ Munich, Dept Informat, Garching, Germany.	rost@in.tum.de	Rost, Burkhard/A-1908-2016	Rost, Burkhard/0000-0003-0179-8424	Alexander von Humboldt foundation through the German Ministry for Research and Education (BMBF: Bundesministerium fuer Bildung und Forschung	Alexander von Humboldt foundation through the German Ministry for Research and Education (BMBF: Bundesministerium fuer Bildung und Forschung	This work was supported by a grant from the Alexander von Humboldt foundation (www.avh.de) through the German Ministry for Research and Education (BMBF: Bundesministerium fuer Bildung und Forschung; www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Goldberg T, 2012, BIOINFORMATICS, V28, pI458, DOI 10.1093/bioinformatics/bts390; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamp T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S7; Hamp T, 2011, BIOINFORMATICS, V27, P204, DOI 10.1093/bioinformatics/btq618; Jaakkola T, 2000, J COMPUT BIOL, V7, P95, DOI 10.1089/10665270050081405; Kuang Rui, 2005, Journal of Bioinformatics and Computational Biology, V3, P527, DOI 10.1142/S021972000500120X; Leslie Christina, 2002, Pac Symp Biocomput, P564; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Liu B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-510; Mak MW, 2008, IEEE ACM T COMPUT BI, V5, P416, DOI 10.1109/TCBB.2007.70256; Melvin I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S2; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rangwala H, 2005, BIOINFORMATICS, V21, P4239, DOI 10.1093/bioinformatics/bti687; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Thanh N., 2009, P 13 INT EL C SYNTH, P1, DOI DOI 10.3390/ECSOC-13-00231; Toussaint NC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S7; Weston J, 2005, BIOINFORMATICS, V21, P3241, DOI 10.1093/bioinformatics/bti497	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68459	10.1371/journal.pone.0068459	http://dx.doi.org/10.1371/journal.pone.0068459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825697	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400196
J	Mitin, N; Rossman, KL; Currin, R; Anne, S; Marshall, TW; Bear, JE; Bautch, VL; Der, CJ				Mitin, Natalia; Rossman, Kent L.; Currin, Rachel; Anne, Sandeep; Marshall, Thomas W.; Bear, James E.; Bautch, Victoria L.; Der, Channing J.			The RhoGEF TEM4 Regulates Endothelial Cell Migration by Suppressing Actomyosin Contractility	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; EMBRYONIC STEM-CELLS; NUCLEOTIDE-EXCHANGE FACTORS; BINDING PROTEIN RHO; ACTIN STRESS FIBERS; FOCAL ADHESIONS; VASCULAR DEVELOPMENT; FLUORESCENT PROTEIN; ALPHA-ACTININ; LEADING-EDGE	Persistent cellular migration requires efficient protrusion of the front of the cell, the leading edge where the actin cytoskeleton and cell-substrate adhesions undergo constant rearrangement. Rho family GTPases are essential regulators of the actin cytoskeleton and cell adhesion dynamics. Here, we examined the role of the RhoGEF TEM4, an activator of Rho family GTPases, in regulating cellular migration of endothelial cells. We found that TEM4 promotes the persistence of cellular migration by regulating the architecture of actin stress fibers and cell-substrate adhesions in protruding membranes. Furthermore, we determined that TEM4 regulates cellular migration by signaling to RhoC as suppression of RhoC expression recapitulated the loss-of-TEM4 phenotypes, and RhoC activation was impaired in TEM4-depleted cells. Finally, we showed that TEM4 and RhoC antagonize myosin II-dependent cellular contractility and the suppression of myosin II activity rescued the persistence of cellular migration of TEM4-depleted cells. Our data implicate TEM4 as an essential regulator of the actin cytoskeleton that ensures proper membrane protrusion at the leading edge of migrating cells and efficient cellular migration via suppression of actomyosin contractility.	[Mitin, Natalia; Rossman, Kent L.; Currin, Rachel; Anne, Sandeep; Bear, James E.; Bautch, Victoria L.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Mitin, Natalia; Rossman, Kent L.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Marshall, Thomas W.; Bear, James E.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Bear, James E.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC USA; [Bautch, Victoria L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Bautch, Victoria L.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mitin, N (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	natalia_mitin@med.unc.edu		Der, Channing/0000-0002-7751-2747	NIH GI SPORE Developmental Research grant [CA106991]; NIH [CA129610, CA67771, GM083035]	NIH GI SPORE Developmental Research grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by an NIH GI SPORE Developmental Research grant (CA106991) and grants from the NIH (CA129610, CA67771, and GM083035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Bautch V L, 2002, Methods Mol Biol, V185, P117; Bautch VL, 2007, CURR PROTOC CELL BIO; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Drake CJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1351, DOI 10.1177/002215549904701101; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; HEATH JP, 1981, CELL BIOL INT REP, V5, P975, DOI 10.1016/0309-1651(81)90214-9; Ho TTG, 2011, MOL BIOL CELL, V22, P3263, DOI 10.1091/mbc.E11-01-0020; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Isogai M, 2011, BIOORG MED CHEM LETT, V21, P3021, DOI 10.1016/j.bmcl.2011.03.039; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kearney JB, 2003, METHOD ENZYMOL, V365, P83; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Mitin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041876; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Rose R, 2005, ACTA CRYSTALLOGR F, V61, P225, DOI 10.1107/S1744309105001065; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Rylova SN, 2008, METHOD ENZYMOL, V443, P103, DOI 10.1016/S0076-6879(08)02006-5; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; St Croix B, 2000, SCIENCE, V289, P1197; Tian MY, 2011, FEBS LETT, V585, P2199, DOI 10.1016/j.febslet.2011.06.016; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; VERNON RB, 1995, IN VITRO CELL DEV-AN, V31, P120; VERNON RB, 1995, AM J PATHOL, V147, P873; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; WANG R, 1992, DEVELOPMENT, V114, P303; Warshaw G, 2013, J BIOL CHEM; WILES MV, 1991, DEVELOPMENT, V111, P259; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Zamir E, 2001, J CELL SCI, V114, P3583	78	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66260	10.1371/journal.pone.0066260	http://dx.doi.org/10.1371/journal.pone.0066260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825001	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400072
J	Takeda, N; Jain, R; Li, DQ; Li, L; Lu, MM; Epstein, JA				Takeda, Norifumi; Jain, Rajan; Li, Deqiang; Li, Li; Lu, Min Min; Epstein, Jonathan A.			Lgr5 Identifies Progenitor Cells Capable of Taste Bud Regeneration after Injury	PLOS ONE			English	Article							FOLLICLE STEM-CELLS; PAPILLA DEVELOPMENT; MOUSE; SHH; WNT; EXPRESSION; TONGUE; MICE	Taste buds are composed of a variety of taste receptor cell types that develop from tongue epithelium and are regularly replenished under normal homeostatic conditions as well as after injury. The characteristics of cells that give rise to regenerating taste buds are poorly understood. Recent studies have suggested that Lgr5 (leucine-rich repeat-containing G-protein coupled receptor 5) identifies taste bud stem cells that contribute to homeostatic regeneration in adult circumvallate and foliate taste papillae, which are located in the posterior region of the tongue. Taste papillae in the adult anterior region of the tongue do not express Lgr5. Here, we confirm and extend these studies by demonstrating that Lgr5 cells give rise to both anterior and posterior taste buds during development, and are capable of regenerating posterior taste buds after injury induced by glossopharyngeal nerve transection.	[Takeda, Norifumi; Jain, Rajan; Li, Deqiang; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Takeda, Norifumi; Jain, Rajan; Li, Deqiang; Li, Li; Lu, Min Min; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Takeda, Norifumi; Jain, Rajan; Li, Deqiang; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Takeda, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	notakeda-tky@umin.ac.jp; epsteinj@upenn.edu		Epstein, Jonathan/0000-0001-8637-4465; TAKEDA, NORIFUMI/0000-0003-4818-3347	National Institutes of Health (NIH) [2T32 HL007843-16, R01 HL071546, U01 HL100405]; National Marfan Foundation (RJ); Spain fund for Regenerative Medicine; W. W. Smith Endowed Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546, T32HL007843, U01HL100405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation (RJ); Spain fund for Regenerative Medicine; W. W. Smith Endowed Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) (2T32 HL007843-16) and National Marfan Foundation (RJ) and the NIH (R01 HL071546, U01 HL100405), the Spain fund for Regenerative Medicine, and the W. W. Smith Endowed Chair (JAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Cooper D, 1998, DEV BRAIN RES, V105, P79, DOI 10.1016/S0165-3806(97)00167-3; Gaillard D, 2011, GENESIS, V49, P295, DOI 10.1002/dvg.20731; Hall JM, 1999, J COMP NEUROL, V406, P143, DOI 10.1002/(SICI)1096-9861(19990405)406:2<143::AID-CNE1>3.0.CO;2-X; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Miura H, 2003, GENE EXPR PATTERNS, V3, P427, DOI 10.1016/S1567-133X(03)00081-4; Miura H, 2010, ARCH ITAL BIOL, V148, P107; Miura H, 2001, MECH DEVELOP, V106, P143, DOI 10.1016/S0925-4773(01)00414-2; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; St John SJ, 2003, CHEM SENSES, V28, P33, DOI 10.1093/chemse/28.1.33; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; Takeda N, 2013, DEVELOPMENT, V140, P1655, DOI 10.1242/dev.093005; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338	24	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66314	10.1371/journal.pone.0066314	http://dx.doi.org/10.1371/journal.pone.0066314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824276	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400083
J	Tete, N; Fritsch, C; Afonso, E; Coeurdassier, M; Lambert, JC; Giraudoux, P; Scheifler, R				Tete, Nicolas; Fritsch, Clementine; Afonso, Eve; Coeurdassier, Michael; Lambert, Jean-Claude; Giraudoux, Patrick; Scheifler, Renaud			Can Body Condition and Somatic Indices be Used to Evaluate Metal-Induced Stress in Wild Small Mammals?	PLOS ONE			English	Article							MICE APODEMUS-SYLVATICUS; CROCIDURA-RUSSULA; RISK-ASSESSMENT; MICROTUS VOLES; HEAVY-METALS; POLLUTION; BIOACCUMULATION; POPULATION; LANDSCAPE; ECOLOGY	Wildlife is exposed to natural (e.g., food availability and quality, parasitism) and anthropogenic stressors (e.g., habitat fragmentation, toxicants). Individual variables (e.g., age, gender) affect behaviour and physiology of animals. Together, these parameters can create both great inter-individual variations in health indicators and interpretation difficulties. We investigated the relevance of body condition and somatic indices (liver, kidneys) as indicators of health status in wood mice (Apodemus sylvaticus, n= 560) captured along a metal pollution gradient in four landscape types (30 sampling squares 500-m sided). The indices were calculated using a recently proposed standard major axis regression instead of an ordinary least square regression. After considering age and gender for the body condition index, no landscape type influence was detected in the indices. However, important index variability was observed between sampling squares; this effect was included as a random effect in linear models. After integrating all individual and environmental variables that may affect the indices, cadmium (Cd) concentrations in both the liver and kidneys were negatively related to body condition and liver indices only for individuals from highly contaminated sites. Lead in the liver was negatively related to the liver index, and Cd in kidneys was positively linked to the kidney index, potentially suggesting metal-induced stress. However, interpretation of these indices as a wildlife ecotoxicology tool should be performed with caution due to the sensitivity of potentially confounding variables (e.g., individual factors and environmental parameters).	[Tete, Nicolas; Fritsch, Clementine; Afonso, Eve; Coeurdassier, Michael; Lambert, Jean-Claude; Giraudoux, Patrick; Scheifler, Renaud] Univ Franche Comte, Dept Chronoenvironm, UMR UFC CNRS USC INRA 6249, F-25030 Besancon, France; [Giraudoux, Patrick] Inst Univ France, Paris, France	INRAE; Universite de Franche-Comte; Institut Universitaire de France	Tete, N (corresponding author), Univ Franche Comte, Dept Chronoenvironm, UMR UFC CNRS USC INRA 6249, F-25030 Besancon, France.	nicolas.tete@univ-fcomte.fr	Afonso, Eve/L-1286-2013; Giraudoux, Patrick/B-9274-2011; Scheifler, Renaud/H-2971-2014	Afonso, Eve/0000-0001-5836-9909; Giraudoux, Patrick/0000-0003-2376-0136; Scheifler, Renaud/0000-0002-9620-0204; FRITSCH, Clementine/0000-0003-2062-5799	Agence Nationale de la Recherche (ANR) [ANR-05-ECCO-004]; ADEME [0572C0058]; Conseil Regional de Franche-Comte; ADEME	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); ADEME; Conseil Regional de Franche-Comte(Region Bourgogne-Franche-Comte); ADEME	Field experiments and chemical analyses were financially funded by the Agence Nationale de la Recherche (ANR, contract noANR-05-ECCO-004) and the ADEME (contract no0572C0058) within the framework of the STARTT program. Nicolas Tete was financially supported by the Conseil Regional de Franche-Comte and the ADEME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bivand RS, 2008, USE R, P1; Burel F, 2004, LANDSCAPE URBAN PLAN, V67, P195, DOI 10.1016/S0169-2046(03)00039-2; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; Chaline J., 1974, PROIES RAPACES PETIT; Damek-Poprawa M, 2003, TOXICOLOGY, V186, P1, DOI 10.1016/S0300-483X(02)00595-4; Fritsch C, 2010, THESIS U FRANCHE COM; Fritsch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020682; Fritsch C, 2010, CHEMOSPHERE, V81, P141, DOI 10.1016/j.chemosphere.2010.06.075; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; HALBROOK RS, 1993, ARCH ENVIRON CON TOX, V25, P438; HARJU A, 1994, ANN ZOOL FENN, V31, P229; Klemola T, 1997, OIKOS, V80, P61, DOI 10.2307/3546516; Knopper LD, 2004, ENVIRON TOXICOL CHEM, V23, P1512, DOI 10.1897/03-460; Kozakiewicz Michal, 2000, Polish Journal of Ecology, V48, P149; Le Louarn H., 2003, RONGEURS FRANCE FAUN; MA WC, 1989, ARCH ENVIRON CON TOX, V18, P617, DOI 10.1007/BF01055030; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; McMurry ST, 1996, J MAMMAL, V77, P335, DOI 10.2307/1382805; Milton A, 2003, ARCH ENVIRON CON TOX, V44, P405, DOI 10.1007/s00244-002-2014-5; Norrdahl K, 2004, OIKOS, V105, P312, DOI 10.1111/j.0030-1299.2004.12684.x; Nunes AC, 2001, ENVIRON POLLUT, V113, P87, DOI 10.1016/S0269-7491(00)00159-7; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pereira R, 2006, ENVIRON POLLUT, V139, P561, DOI 10.1016/j.envpol.2005.04.038; QUERE JP, 1989, MAMMALIA, V53, P287, DOI 10.1515/mamm.1989.53.2.287; R Development Core Team, 2012, R LANG ENV STAT COMP; Sanchez-Chardi A, 2007, CHEMOSPHERE, V70, P101, DOI 10.1016/j.chemosphere.2007.06.047; Sanchez-Chardi A, 2007, CHEMOSPHERE, V68, P703, DOI 10.1016/j.chemosphere.2007.01.042; Sanchez-Chardi A, 2009, CHEMOSPHERE, V76, P387, DOI 10.1016/j.chemosphere.2009.03.036; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Schulte-Hostedde AI, 2005, EVOL ECOL RES, V7, P143; SELDAL T, 1994, OIKOS, V70, P3, DOI 10.2307/3545692; Shore R. F., 2001, ECOTOXICOLOGY WILD M; SHORE RF, 1994, ECOTOX ENVIRON SAFE, V29, P101, DOI 10.1016/0147-6513(94)90035-3; Shore Richard F., 1994, Reviews of Environmental Contamination and Toxicology, V134, P49; Silva M, 2005, BIOL CONSERV, V126, P556, DOI 10.1016/j.biocon.2005.07.007; Sterckeman T, 2002, WATER AIR SOIL POLL, V135, P173, DOI 10.1023/A:1014758811194; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Tattersall FH, 2001, J ZOOL, V255, P487, DOI 10.1017/S095283690100156X; Van den Brink PJ, 2008, ENVIRON SCI TECHNOL, V42, P8999, DOI 10.1021/es801991c; Van Straalen N, 2003, ENVIRON SCI TECHNOL, V37, p324A; van Straalen NM, 2008, SCI TOTAL ENVIRON, V406, P479, DOI 10.1016/j.scitotenv.2008.06.054	42	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66399	10.1371/journal.pone.0066399	http://dx.doi.org/10.1371/journal.pone.0066399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824591	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400104
J	Zhang, JL; Zhou, Y; Zhou, GS; Xiao, CW				Zhang, Jingli; Zhou, Yong; Zhou, Guangsheng; Xiao, Chunwang			Structure and Composition of Natural Gmelin Larch (Larix gmelinii var. gmelinii) Forests in Response to Spatial Climatic Changes	PLOS ONE			English	Article							SPECIES RICHNESS; PINUS-SYLVESTRIS; COLD TOLERANCE; GROWTH; SUCCESSION; SURVIVAL; DOMINANCE; MONGOLICA; MOUNTAIN; DYNAMICS	Background: Many theoretical researches predicted that the larch species would decrease drastically in China under future climatic changes. However, responses of the structural and compositional changes of Gmelin larch (Larix gmelinii var. gmelinii) forests to climatic changes have rarely been reported. Methodology/Principal Findings: Field survey was conducted to examine the structures and compositions of natural Gmelin larch forests along a climatic gradient. Stepwise linear regression analyses incorporating linear and quadratic components of climatic and non-climatic factors were performed on the structural and compositional attributes of those natural Gmelin larch forests. Isothermality, Max Temperature of Warmest Month (TempWarmestMonth), Precipitation of Wettest Month (PrecipWettestMonth), Precipitation Seasonality (PrecipSeasonality) and Precipitation of Driest Quarter (PrecipDriestQuarter) were observed to be effective climatic factors in controlling structure and composition of Gmelin larch forests. Isothermality significantly affected total basal area of larch, while TempWarmestMonth, PrecipWettestMonth and PrecipSeasonality significantly affected total basal area of Mongolian pine, and PrecipDriestQuarter significantly affected mean DBH of larch, stand density of larch and total basal area of spruce and fir. Conclusions/Significance: The summer and winter temperatures and precipitations are all predicted to increase in future in Northeast China. Our results showed the increase of total basal area of spruce and fir, the suppression of regeneration and the decrease of stand density of larch under increased winter precipitation, and the decrease of total basal area of larch under increased summer temperature in the region of current Gmelin larch forest. Therefore, we suggest that larch would decrease and spruce and fir would increase in the region of future Gmelin larch forest.	[Zhang, Jingli; Zhou, Yong; Zhou, Guangsheng; Xiao, Chunwang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhang, Jingli; Zhou, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Meteorological Sciences (CAMS)	Xiao, CW (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	cwxiao@ibcas.ac.cn	Zhou, Yong/B-9795-2017; Zhou, Yong/H-9048-2019	Zhou, Yong/0000-0003-2546-8462; Zhou, Yong/0000-0003-2546-8462	National Research Program of China (973 Program) [2010CB951303]	National Research Program of China (973 Program)(National Basic Research Program of China)	This study was financially supported by the National Research Program of China (973 Program, number 2010CB951303). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault L, 1998, FOREST ECOL MANAG, V102, P61, DOI 10.1016/S0378-1127(97)00109-6; BAKER F. S., 1949, JOUR FOREST, V47, P179; Ban Y, 1998, J VEG SCI, V9, P529, DOI 10.2307/3237268; BAO SD, 1999, AGR SOIL CHEM ANAL, P263; BERGERON Y, 1989, VEGETATIO, V79, P51, DOI 10.1007/BF00044848; Bongers F, 1999, J VEG SCI, V10, P371, DOI 10.2307/3237066; Brooks ML, 2003, J APPL ECOL, V40, P344, DOI 10.1046/j.1365-2664.2003.00789.x; Bruun HH, 2006, J VEG SCI, V17, P37, DOI 10.1111/j.1654-1103.2006.tb02421.x; Bruun HH, 2000, ECOGRAPHY, V23, P641, DOI 10.1034/j.1600-0587.2000.230601.x; Cheng Xiao-Xa, 2007, Shengtaixue Zazhi, V26, P1277; [程肖侠 CHENG XiaoXia], 2008, [生态学报, Acta Ecologica Sinica], V28, P534; Devi N, 2008, GLOBAL CHANGE BIOL, V14, P1581, DOI 10.1111/j.1365-2486.2008.01583.x; Dulamsuren C, 2010, OECOLOGIA, V163, P1091, DOI 10.1007/s00442-010-1689-y; Dulamsuren C, 2009, CAN J FOREST RES, V39, P2520, DOI 10.1139/X09-156; Epstein HE, 1996, J VEG SCI, V7, P777, DOI 10.2307/3236456; FREY W, 1983, ARCTIC ALPINE RES, V15, P241, DOI 10.2307/1550925; Germino MJ, 2002, PLANT ECOL, V162, P157, DOI 10.1023/A:1020385320738; HADLEY JL, 1992, TREE PHYSIOL, V11, P1; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kharuk VI, 2009, SCAND J FOREST RES, V24, P130, DOI 10.1080/02827580902845823; Leng Wen-Fang, 2007, Zhiwu Shengtai Xuebao, V31, P825; Li Feng, 2006, Yingyong Shengtai Xuebao, V17, P2255; Liu PX, 1958, NATURE GEOGRAPHY NE, p20V33; Liu QJ, 1997, PLANT ECOL, V132, P97, DOI 10.1023/A:1009705319128; Lloyd AH, 2011, GLOBAL CHANGE BIOL, V17, P1935, DOI 10.1111/j.1365-2486.2010.02360.x; Mason WL, 2004, SILVA FENN, V38, P357, DOI 10.14214/sf.404; Moiseev PA, 2002, RUSS J ECOL+, V33, P7, DOI 10.1023/A:1013659319452; Qian C, 2009, J ANHUI AGR SCI, V37, P17730; RICHARDS JH, 1986, OECOLOGIA, V69, P16, DOI 10.1007/BF00399032; Schaberg PG, 2008, GLOBAL CHANGE BIOL, V14, P1282, DOI 10.1111/j.1365-2486.2008.01577.x; Schulze ED, 2005, OECOLOGIA, V146, P77, DOI 10.1007/s00442-005-0173-6; [尚建勋 Shang Jianxun], 2012, [生态学报, Acta Ecologica Sinica], V32, P1077; Sun JiaBao, 2010, Journal of Northeast Forestry University, V38, P30; TEERI JA, 1976, OECOLOGIA, V23, P1, DOI 10.1007/BF00351210; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; TYRRELL LE, 1994, ECOLOGY, V75, P370, DOI 10.2307/1939541; VEBLEN TT, 1987, VEGETATIO, V71, P113; Wang J, 2009, POWDER DIFFR, V24, P24, DOI 10.1154/1.3079687; Wang T, 2006, GLOBAL CHANGE BIOL, V12, P2404, DOI 10.1111/j.1365-2486.2006.01271.x; Wang Xiao-Chun, 2011, Chinese Journal of Plant Ecology, V35, P294, DOI 10.3724/SP.J.1258.2011.00294; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; WU HQ, 1990, VEGETATIO, V86, P21; Xu Y., 2006, CLIM CHANG RES, V02, P50; Zhang Xian-liang, 2011, Yingyong Shengtai Xuebao, V22, P3101; Zhang Xian-liang, 2010, Yingyong Shengtai Xuebao, V21, P2501; Zheng Guang-Yu, 2012, Bulletin of Botanical Research, V32, P191	46	4	5	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66668	10.1371/journal.pone.0066668	http://dx.doi.org/10.1371/journal.pone.0066668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824710	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400146
J	Laido, G; Mangini, G; Taranto, F; Gadaleta, A; Blanco, A; Cattivelli, L; Marone, D; Mastrangelo, AM; Papa, R; De Vita, P				Laido, Giovanni; Mangini, Giacomo; Taranto, Francesca; Gadaleta, Agata; Blanco, Antonio; Cattivelli, Luigi; Marone, Daniela; Mastrangelo, Anna M.; Papa, Roberto; De Vita, Pasquale			Genetic Diversity and Population Structure of Tetraploid Wheats (Triticum turgidum L.) Estimated by SSR, DArT and Pedigree Data	PLOS ONE			English	Article							WEIGHT GLUTENIN SUBUNIT; FREE-THRESHING HABIT; DURUM DESF. MACKEY; WILD EMMER WHEAT; LINKAGE DISEQUILIBRIUM; QUALITATIVE TRAITS; CULTIVARS; EVOLUTION; GERMPLASM; AFLP	Levels of genetic diversity and population genetic structure of a collection of 230 accessions of seven tetraploid Triticum turgidum L. subspecies were investigated using six morphological, nine seed storage protein loci, 26 SSRs and 970 DArT markers. The genetic diversity of the morphological traits and seed storage proteins was always lower in the durum wheat compared to the wild and domesticated emmer. Using Bayesian clustering (K = 2), both of the sets of molecular markers distinguished the durum wheat cultivars from the other tetraploid subspecies, and two distinct subgroups were detected within the durum wheat subspecies, which is in agreement with their origin and year of release. The genetic diversity of morphological traits and seed storage proteins was always lower in the improved durum cultivars registered after 1990, than in the intermediate and older ones. This marked effect on diversity was not observed for molecular markers, where there was only a weak reduction. At K >2, the SSR markers showed a greater degree of resolution than for DArT, with their identification of a greater number of groups within each subspecies. Analysis of DArT marker differentiation between the wheat subspecies indicated outlier loci that are potentially linked to genes controlling some important agronomic traits. Among the 211 loci identified under selection, 109 markers were recently mapped, and some of these markers were clustered into specific regions on chromosome arms 2BL, 3BS and 4AL, where several genes/quantitative trait loci (QTLs) are involved in the domestication of tetraploid wheats, such as the tenacious glumes (Tg) and brittle rachis (Br) characteristics. On the basis of these results, it can be assumed that the population structure of the tetraploid wheat collection partially reflects the evolutionary history of Triticum turgidum L. subspecies and the genetic potential of landraces and wild accessions for the detection of unexplored alleles.	[Laido, Giovanni; Cattivelli, Luigi; Marone, Daniela; Mastrangelo, Anna M.; Papa, Roberto; De Vita, Pasquale] Cereal Res Ctr, Consiglio Ric Sperimentaz Agr, Foggia, Italy; [Mangini, Giacomo; Taranto, Francesca; Gadaleta, Agata; Blanco, Antonio] Univ Bari, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Universita degli Studi di Bari Aldo Moro	De Vita, P (corresponding author), Cereal Res Ctr, Consiglio Ric Sperimentaz Agr, Foggia, Italy.	pasquale.devita@entecra.it	Taranto, Francesca/V-1670-2018; Gadaleta, Agata/H-2627-2012; cattivelli, luigi/AAE-7046-2020; papa, roberto/F-9510-2014	Taranto, Francesca/0000-0002-7849-9038; Gadaleta, Agata/0000-0002-6312-249X; cattivelli, luigi/0000-0002-6067-4600; papa, roberto/0000-0001-9598-3131; BLANCO, ANTONIO/0000-0002-2222-1133; Mastrangelo, Anna Maria/0000-0002-3618-0301; Marone, Daniela/0000-0002-2365-6091; De Vita, Pasquale/0000-0002-9573-0510; Mangini, Giacomo/0000-0002-6600-2178	Ministry of Agricultural, Food and Forestry Policies (Italy)	Ministry of Agricultural, Food and Forestry Policies (Italy)	This works has been funded by the research project Esplora, Biomassval, RGV-FAO and Sicerme2 from the Ministry of Agricultural, Food and Forestry Policies (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiriano E, 2008, SPAN J AGRIC RES, V6, P599, DOI 10.5424/sjar/2008064-353; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Allard RW, 1996, EUPHYTICA, V92, P1, DOI 10.1007/BF00022822; Altintas S, 2008, PLANT BREEDING, V127, P9, DOI 10.1111/j.1439-0523.2007.01424.x; Autrique E, 1996, CROP SCI, V36, P735, DOI 10.2135/cropsci1996.0011183X003600030036x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Blanco A, 1998, THEOR APPL GENET, V97, P721, DOI 10.1007/s001220050948; BOGGINI G, 1995, J CEREAL SCI, V22, P105, DOI 10.1016/0733-5210(95)90039-X; BRANLARD G, 1989, THEOR APPL GENET, V78, P353, DOI 10.1007/BF00265296; BUSHUK W, 1978, CAN J PLANT SCI, V58, P1019, DOI 10.4141/cjps78-155; Carmona S, 2010, BIOL PLANTARUM, V54, P69, DOI 10.1007/s10535-010-0010-6; COX TS, 1985, CROP SCI, V25, P1058, DOI 10.2135/cropsci1985.0011183X002500060039x; COX TS, 1990, THEOR APPL GENET, V79, P241, DOI 10.1007/BF00225958; DAMANIA AB, 1983, EUPHYTICA, V32, P877, DOI 10.1007/BF00042169; De Vita P, 2006, EUPHYTICA, V150, P195, DOI 10.1007/s10681-006-9107-6; De Vita P, 2007, EUR J AGRON, V26, P39, DOI 10.1016/j.eja.2006.08.009; Dedkova OS, 2009, RUSS J GENET+, V45, P1082, DOI 10.1134/S1022795409090099; Digesu AM, 2009, J CEREAL SCI, V50, P210, DOI 10.1016/j.jcs.2009.05.002; Donini P, 2000, THEOR APPL GENET, V100, P912, DOI 10.1007/s001220051370; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Ellis RP, 1997, MOL BREEDING, V3, P359, DOI 10.1023/A:1009602321815; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YB, 2006, THEOR APPL GENET, V112, P1239, DOI 10.1007/s00122-006-0225-2; Fu YB, 2005, THEOR APPL GENET, V110, P1505, DOI 10.1007/s00122-005-1988-6; Fu YB, 2009, CROP SCI, V49, P161, DOI 10.2135/cropsci2008.03.0125; Gadaleta A, 2009, THEOR APPL GENET, V118, P1015, DOI 10.1007/s00122-008-0958-1; GRANER A, 1994, CROP SCI, V34, P1199, DOI 10.2135/cropsci1994.0011183X003400050010x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Jantasuriyarat C, 2004, THEOR APPL GENET, V108, P261, DOI 10.1007/s00122-003-1432-8; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Kuckuck H., 1979, Wheat Information Service, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFIANDRA D, 1985, CEREAL CHEM, V62, P314; Li QY, 2006, PLANT BREEDING, V125, P120, DOI 10.1111/j.1439-0523.2006.01173.x; Li W, 2006, RUSS J GENET+, V42, P311, DOI 10.1134/S1022795406030124; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2003, THEOR APPL GENET, V107, P783, DOI 10.1007/s00122-003-1319-8; MACKEY J, 1988, BIOL ZBL, V107, P369; Manninen O, 1997, HEREDITAS, V126, P87, DOI 10.1111/j.1601-5223.1997.00087.x; MANTEL N, 1967, CANCER RES, V27, P209; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Marone D, 2012, MOL GENET GENOMICS, V287, P741, DOI 10.1007/s00438-012-0714-8; Marone D, 2009, MOL BREEDING, V24, P25, DOI 10.1007/s11032-009-9268-9; MARTIN JM, 1991, CROP SCI, V31, P1131, DOI 10.2135/cropsci1991.0011183X003100050009x; Martos V, 2005, FIELD CROP RES, V91, P107, DOI 10.1016/j.fcr.2004.06.003; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; McIntosh R.A., 2006, CATALOGUE GENE SYMBO; Medini M, 2005, GENET RESOUR CROP EV, V52, P21, DOI 10.1007/s10722-005-0225-0; Mikel MA, 2008, CROP SCI, V48, P1399, DOI 10.2135/cropsci2008.01.0029; Moragues M, 2007, GENET RESOUR CROP EV, V54, P1133, DOI 10.1007/s10722-006-9005-8; Moragues M, 2006, GENET RESOUR CROP EV, V53, P993, DOI 10.1007/s10722-004-7367-3; Nalam VJ, 2006, THEOR APPL GENET, V112, P373, DOI 10.1007/s00122-005-0140-y; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NietoTaladriz MT, 1997, THEOR APPL GENET, V95, P1155, DOI 10.1007/s001220050676; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Oliveira HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037063; Ozbek O, 2007, THEOR APPL GENET, V115, P19, DOI 10.1007/s00122-007-0536-y; PAN D, 2007, J PLANT SCI, V2, P416; Peleg Z, 2008, THEOR APPL GENET, V117, P103, DOI 10.1007/s00122-008-0756-9; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Pritchard JK, 2000, GENETICS, V155, P945; Riefolo C, 2011, CEREAL RES COMMUN, V39, P405, DOI 10.1556/CRC.39.2011.3.10; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Royo C, 2010, FIELD CROP RES, V119, P91, DOI 10.1016/j.fcr.2010.06.020; Ruiz M, 2012, CROP SCI, V52, P2262, DOI 10.2135/cropsci2012.02.0081; Russo MA, 2012, J PLANT INTERACT, V7, P290, DOI 10.1080/17429145.2011.640437; Schiemann E, 1948, WEIZEN ROGGEN GERSTE, P1; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Simonetti MC, 1999, GENET RESOUR CROP EV, V46, P267, DOI 10.1023/A:1008602009133; Sissons MJ, 2003, CEREAL CHEM, V80, P468, DOI 10.1094/CCHEM.2003.80.4.468; Soleiman VD, 2007, GENET RESOUR CROP EV, V54, P83, DOI 10.1007/s10722-005-1886-4; Soleimani VD, 2002, THEOR APPL GENET, V104, P350, DOI 10.1007/s001220100714; Sood S, 2009, THEOR APPL GENET, V119, P341, DOI 10.1007/s00122-009-1043-0; SOUZA E, 1989, CROP SCI, V29, P595, DOI 10.2135/cropsci1989.0011183X002900030008x; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Thuillet AC, 2005, GENETICS, V169, P1589, DOI 10.1534/genetics.104.029553; TINKER NA, 1993, J HERED, V84, P238, DOI 10.1093/oxfordjournals.jhered.a111330; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Van Slageren MW, 1994, WAGENINGEN AGR U PAP; Wang SL, 2011, GENOME, V54, P273, DOI [10.1139/G10-119, 10.1139/g10-119]; Zhang LY, 2009, THEOR APPL GENET, V119, P43, DOI 10.1007/s00122-009-1015-4; Zhang LY, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-42	87	98	100	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67280	10.1371/journal.pone.0067280	http://dx.doi.org/10.1371/journal.pone.0067280			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826256	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000056
J	Cai, PF; Piao, XY; Liu, S; Hou, N; Wang, H; Chen, QJ				Cai, Pengfei; Piao, Xianyu; Liu, Shuai; Hou, Nan; Wang, Heng; Chen, Qijun			MicroRNA-Gene Expression Network in Murine Liver during Schistosoma japonicum Infection	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; IDENTIFICATION; CELLS; INDUCTION; HEPATITIS; PATTERNS; MIRBASE; MIR-146; TARGETS	Background: Schistosomiasis japonica remains a significant public health problem in China and Southeast Asian countries. The most typical and serious outcome of the chronic oriental schistosomiasis is the progressive granuloma and fibrosis in the host liver, which has been a major medical challenge. However, the molecular mechanism underling the hepatic pathogenesis is still not clear. Methodology and Principal Findings: Using microarrays, we quantified the temporal gene expression profiles in the liver of Schistosoma japonicum-infected BALB/c mice at 15, 30, and 45 day post infection (dpi) with that from uninfected mice as controls. Gene expression alternation associated with liver damage was observed in the initial phase of infection (dpi 15), which became more magnificent with the onset of egg-laying. Up-regulated genes were dominantly associated with inflammatory infiltration, whereas down-regulated genes primarily led to the hepatic functional disorders. Simultaneously, microRNA profiles from the same samples were decoded by Solexa sequencing. More than 130 miRNAs were differentially expressed in murine liver during S. japonicum infection. MiRNAs significantly dysregulated in the mid-phase of infection (dpi 30), such as mmu-miR-146b and mmu-miR-155, may relate to the regulation of hepatic inflammatory responses, whereas miRNAs exhibiting a peak expression in the late phase of infection (dpi 45), such as mmu-miR-223, mmu-miR-146a/b, mmu-miR-155, mmu-miR-34c, mmu-miR-199, and mmu-miR-134, may represent a molecular signature of the development of schistosomal hepatopathy. Further, a dynamic miRNA-gene co-expression network in the progression of infection was constructed. Conclusions and Significance: This study presents a global view of dynamic expression of both mRNA and miRNA transcripts in murine liver during S. japonicum infection, and highlights that miRNAs may play a variety of regulatory roles in balancing the immune responses during the development of hepatic pathology. The data provide robust information for further researches on the pathogenesis and molecular events of hepatopathy induced by schistosome eggs.	[Cai, Pengfei; Piao, Xianyu; Liu, Shuai; Hou, Nan; Chen, Qijun] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Cai, Pengfei; Piao, Xianyu; Liu, Shuai; Hou, Nan; Chen, Qijun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Qijun] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Wang, Heng] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Microbiol & Parasitol, Beijing 100730, Peoples R China; [Wang, Heng] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, QJ (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	qijun.chen@ipbcams.ac.cn	Cai, Pengfe/AAF-2759-2020	Cai, Pengfei/0000-0003-4975-4615	National Natural Science Foundation of China [NSFC 81270026, 30901254]; National S & T Major Program [2012ZX10004-220, 2008ZX10004-011]; Institute of Pathogen Biology, CAMS [2012IPB207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program; Institute of Pathogen Biology, CAMS	This study was supported by the National Natural Science Foundation of China (NSFC 81270026 and 30901254), the National S & T Major Program (grant numbers 2012ZX10004-220 and 2008ZX10004-011), and the intramural grant from Institute of Pathogen Biology, CAMS (2012IPB207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000686; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Cai Pengfei, 2013, PLoS ONE, V8, pe64003, DOI 10.1371/journal.pone.0064003; Cai PF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001745; Cai PF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001256; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chaveles I, 2012, INT J MOL MED, V29, P747, DOI 10.3892/ijmm.2012.902; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han HX, 2013, MOL BIOCHEM PARASIT, V188, P1, DOI 10.1016/j.molbiopara.2013.02.001; Hao LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-55; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Harty MW, 2010, AM J PATHOL, V176, P1271, DOI 10.2353/ajpath.2010.090527; Huber W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S8; Iizuka M, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-12; Ji F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001724; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Jin X, 2009, DIGEST LIVER DIS, V41, P289, DOI 10.1016/j.dld.2008.08.008; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; La Flamme AC, 2003, J IMMUNOL, V170, P470, DOI 10.4049/jimmunol.170.1.470; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li SJ, 2009, J LIPID RES, V50, P1756, DOI 10.1194/jlr.M800509-JLR200; Li WQ, 2011, FEBS J, V278, P1522, DOI 10.1111/j.1742-4658.2011.08075.x; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Perry CR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001178; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Poh KW, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2011.02.002; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; ROBISHAW JD, 1985, AM J PHYSIOL, V248, pE1, DOI 10.1152/ajpendo.1985.248.1.E1; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; WARREN KS, 1975, AM J PATHOL, V80, P279; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024680	66	35	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67037	10.1371/journal.pone.0067037	http://dx.doi.org/10.1371/journal.pone.0067037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825609	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000061
J	Wong, DKH; Watanabe, T; Tanaka, Y; Seto, WK; Lee, CK; Fung, J; Lin, CK; Huang, FY; Lai, CL; Yuen, MF				Wong, Danny Ka-Ho; Watanabe, Tsunamasa; Tanaka, Yasuhito; Seto, Wai-Kay; Lee, Cheuk-Kwong; Fung, James; Lin, Che-Kit; Huang, Fung-Yu; Lai, Ching-Lung; Yuen, Man-Fung			Role of HLA-DP Polymorphisms on Chronicity and Disease Activity of Hepatitis B Infection in Southern Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VIRUS INFECTION; VIRAL-HEPATITIS; T-CELLS; CLEARANCE; GENE; SUSCEPTIBILITY; POPULATION; VARIANTS; HLA-DPA1	Background and Aim: The association between HLA-DP single nucleotide polymorphisms (SNPs) and chronic hepatitis B virus (HBV) infection varies between different populations. We aimed to study the association between HLA-DP SNPs and HBV infection and disease activity in the Chinese population of Hong Kong. Methods: We genotyped SNPs rs3077 (near HLA-DPA1) and rs9277378 and rs3128917 (both near HLA-DPB1) in 500 HBV carriers (hepatitis B surface antigen [HBsAg]-positive), 245 non-HBV infected controls (HBsAg- and antibody to hepatitis B core protein [anti-HBc]-negative), and 259 subjects with natural HBV clearance (HBsAg- negative, anti-HBc-positive). Inactive HBV carriers state was defined by HBV DNA levels,2,000 IU/ml and persistently normal alanine aminotransferase level for least 12 months. Results: Compared to the non-HBV infected subjects, the HBV carriers had a significantly lower frequency of the rs3077 T allele (p = 0.0040), rs9277378 A allele (p = 0.0068) and a trend for lower frequency of rs3128917 T allele (p = 0.054). These alleles were associated with an increased chance of HBV clearance (rs3077: OR = 1.41, p = 0.0083; rs9277378: OR = 1.61, p = 0.00011; rs3128917: OR = 1.54, p = 0.00017). Significant associations between HLA-DP genotypes and HBV clearance were also found under different genetic models. Haplotype TAT was associated with an increased chance of HBV clearance (OR = 1.64, p = 0.0013). No association was found between these SNPs and HBV disease activity. Conclusion: HLA-DP SNPs rs3077, rs9277378 and rs3128917 were associated with chronicity of HBV disease in the Chinese. Further studies are required to determine whether these SNPs influence the disease endemicity in different ethnic populations.	[Wong, Danny Ka-Ho; Seto, Wai-Kay; Fung, James; Huang, Fung-Yu; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Wong, Danny Ka-Ho; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Watanabe, Tsunamasa; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Watanabe, Tsunamasa; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Lee, Cheuk-Kwong; Lin, Che-Kit] Hosp Author, Hong Kong Red Cross Blood Transfus Serv, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Nagoya City University; Nagoya City University	Yuen, MF (corresponding author), Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hku.hk	Fung, James/AAG-4832-2020; SETO, Wai-Kay/H-4452-2012; Wong, Danny/H-6819-2016; Wong, Danny/S-6230-2019; LEE, Cheuk Kwong/F-3950-2017	SETO, Wai-Kay/0000-0002-9012-313X; LEE, Cheuk Kwong/0000-0002-3939-564X; Fung, James/0000-0002-1286-8902; Lai, Ching-Lung/0000-0002-5927-2436; /0000-0001-9078-5005; Tanaka, Yasuhito/0000-0002-2473-6966				Ahn SH, 2000, HEPATOLOGY, V31, P1371, DOI 10.1053/jhep.2000.7988; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; Ben-Ari Z, 2003, AM J GASTROENTEROL, V98, P144, DOI 10.1111/j.1572-0241.2003.07179.x; Chan KYK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028798; Deng GH, 2004, HEPATOLOGY, V40, P318, DOI 10.1002/hep.20318; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; Fontenot AP, 2000, P NATL ACAD SCI USA, V97, P12717, DOI 10.1073/pnas.220430797; Godkin A, 2005, HEPATOLOGY, V41, P1383, DOI 10.1002/hep.20716; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; LIN TM, 1989, ANTICANCER RES, V9, P737; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; Penna A, 1997, HEPATOLOGY, V25, P1022, DOI 10.1002/hep.510250438; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Thio CL, 2004, J VIROL, V78, P11258, DOI 10.1128/JVI.78.20.11258-11262.2004; Thomas HC, 1996, LANCET, V348, P1417, DOI 10.1016/S0140-6736(96)05409-8; Thursz M, 2001, ANTIVIR RES, V52, P113, DOI 10.1016/S0166-3542(01)00175-9; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Urbani S, 2005, HEPATOLOGY, V41, P826, DOI 10.1002/hep.20614; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032605; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608	31	34	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66920	10.1371/journal.pone.0066920	http://dx.doi.org/10.1371/journal.pone.0066920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825586	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000043
J	Cooper, MJ; Cox, NJ; Zimmerman, EI; Dewar, BJ; Duncan, JS; Whittle, MC; Nguyen, TA; Jones, LS; Roy, SG; Smalley, DM; Kuan, PF; Richards, KL; Christopherson, RI; Jin, J; Frye, SV; Johnson, GL; Baldwin, AS; Graves, LM				Cooper, Matthew J.; Cox, Nathan J.; Zimmerman, Eric I.; Dewar, Brian J.; Duncan, James S.; Whittle, Martin C.; Nguyen, Thien A.; Jones, Lauren S.; Roy, Sreerupa Ghose; Smalley, David M.; Kuan, Pei Fen; Richards, Kristy L.; Christopherson, Richard I.; Jin, Jian; Frye, Stephen V.; Johnson, Gary L.; Baldwin, Albert S.; Graves, Lee M.			Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-TYROSINE KINASES; BCR-ABL; IMATINIB-RESISTANT; LYN KINASE; QUANTITATIVE-ANALYSIS; PROTEOMICS ANALYSIS; JNK ACTIVATION; MEK INHIBITION; IKK-ALPHA	Protein kinases play key roles in oncogenic signaling and are a major focus in the development of targeted cancer therapies. Imatinib, a BCR-Abl tyrosine kinase inhibitor, is a successful front-line treatment for chronic myelogenous leukemia (CML). However, resistance to imatinib may be acquired by BCR-Abl mutations or hyperactivation of Src family kinases such as Lyn. We have used multiplexed kinase inhibitor beads (MIBs) and quantitative mass spectrometry (MS) to compare kinase expression and activity in an imatinib-resistant (MYL-R) and -sensitive (MYL) cell model of CML. Using MIB/MS, expression and activity changes of over 150 kinases were quantitatively measured from various protein kinase families. Statistical analysis of experimental replicates assigned significance to 35 of these kinases, referred to as the MYL-R kinome profile. MIB/MS and immunoblotting confirmed the over-expression and activation of Lyn in MYL-R cells and identified additional kinases with increased (MEK, ERK, IKK alpha, PKC beta, NEK9) or decreased (Abl, Kit, JNK, ATM, Yes) abundance or activity. Inhibiting Lyn with dasatinib or by shRNA-mediated knockdown reduced the phosphorylation of MEK and IKK alpha. Because MYL-R cells showed elevated NF-kappa B signaling relative to MYL cells, as demonstrated by increased I kappa B alpha and IL-6 mRNA expression, we tested the effects of an IKK inhibitor (BAY 65-1942). MIB/MS and immunoblotting revealed that BAY 65-1942 increased MEK/ERK signaling and that this increase was prevented by co-treatment with a MEK inhibitor (AZD6244). Furthermore, the combined inhibition of MEK and IKK alpha resulted in reduced IL-6 mRNA expression, synergistic loss of cell viability and increased apoptosis. Thus, MIB/MS analysis identified MEK and IKK alpha as important downstream targets of Lyn, suggesting that co-targeting these kinases may provide a unique strategy to inhibit Lyn-dependent imatinib-resistant CML. These results demonstrate the utility of MIB/MS as a tool to identify dysregulated kinases and to interrogate kinome dynamics as cells respond to targeted kinase inhibition.	[Cooper, Matthew J.; Cox, Nathan J.; Zimmerman, Eric I.; Dewar, Brian J.; Duncan, James S.; Whittle, Martin C.; Nguyen, Thien A.; Jones, Lauren S.; Roy, Sreerupa Ghose; Smalley, David M.; Johnson, Gary L.; Graves, Lee M.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Cooper, Matthew J.; Kuan, Pei Fen; Richards, Kristy L.; Johnson, Gary L.; Baldwin, Albert S.; Graves, Lee M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Cooper, Matthew J.; Baldwin, Albert S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Baldwin, Albert S.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Kuan, Pei Fen] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Richards, Kristy L.] Univ N Carolina, Sch Med, Dept Med, Div Hematol & Oncol, Chapel Hill, NC USA; [Christopherson, Richard I.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Jin, Jian; Frye, Stephen V.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Sydney; University of North Carolina; University of North Carolina Chapel Hill	Graves, LM (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.	lmg@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022; Graves, Lee/AAG-5470-2021; Kuan, Pei Fen/GRX-4622-2022; Christopherson, Richard/AAM-3115-2020; , Proteomics Core UNC/AAH-3777-2022; Core, Vector/CAF-4832-2022	Cox, Nathan/0000-0002-8573-5596	National Institutes of Health (NIH) [T32 AI07273, R01 GM101141, CA73756, CA75080]; NC TraCS; UCRF Team Science Innovation Award; University of North Carolina at Chapel Hill's Libraries; NATIONAL CANCER INSTITUTE [R01CA075080, R01CA073756, T32CA071341, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101141, T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NC TraCS; UCRF Team Science Innovation Award; University of North Carolina at Chapel Hill's Libraries; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research support was provided by National Institutes of Health (NIH) grants T32 AI07273 (MJC), R01 GM101141 (LMG and GLJ), CA73756 (ASB) and CA75080 ASB), and by NC TraCS (LMG) (http://tracs.unc.edu) and the UCRF Team Science Innovation Award (LMG) (http://unclineberger.org/ucrf). The University of North Carolina at Chapel Hill's Libraries provided support for open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Ault Patricia, 2007, Clin J Oncol Nurs, V11, P125, DOI 10.1188/07.CJON.125-129; Bantscheff M, 2007, PROTEOMICS BASED STR, V3, P1, DOI [10.1007/2789, DOI 10.1007/2789]; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bednarski BK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006992; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitkopf SB, 2010, J PROTEOME RES, V9, P6033, DOI 10.1021/pr1008527; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; Camarasa MV, 2005, J CELL BIOCHEM, V94, P98, DOI 10.1002/jcb.20278; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Duncan EA, 2008, MOL CANCER THER, V7, P391, DOI 10.1158/1535-7163.MCT-07-0305; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Engler JR, 2010, LEUKEMIA, V24, P765, DOI 10.1038/leu.2010.16; Fenouille N, 2010, CANCER RES, V70, P9659, DOI 10.1158/0008-5472.CAN-10-2034; Gioeli D, 2011, MOL CANCER THER, V10, P1581, DOI 10.1158/1535-7163.MCT-10-1033; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Grosso S, 2009, MOL CANCER THER, V8, P1924, DOI 10.1158/1535-7163.MCT-09-0168; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019169; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Hayette S, 2011, LEUKEMIA RES, V35, P38, DOI 10.1016/j.leukres.2010.06.030; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2011, CELL CYCLE, V10, P250, DOI 10.4161/cc.10.2.14537; Hochhaus A, 2009, BEST PRACT RES CL HA, V22, P367, DOI 10.1016/j.beha.2009.05.004; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Inohara N, 2000, J BIOL CHEM, V275, P27823; Ito T, 2007, EUR J HAEMATOL, V78, P417, DOI 10.1111/j.1600-0609.2007.00835.x; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Katagiri K, 1996, J BIOL CHEM, V271, P11557, DOI 10.1074/jbc.271.19.11557; Ketley NJ, 2000, LEUKEMIA, V14, P620, DOI 10.1038/sj.leu.2401715; Lee F, 2008, INT J BIOCHEM CELL B, V40, P334, DOI 10.1016/j.biocel.2007.10.001; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mauro Michael J, 2006, Hematology Am Soc Hematol Educ Program, P219; Mian AA, 2009, LEUKEMIA, V23, P1614, DOI 10.1038/leu.2009.69; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Nishioka C, 2010, LEUKEMIA, V24, P1631, DOI 10.1038/leu.2010.145; O'Dwyer ME, 2002, BLOOD, V100, P1628, DOI 10.1182/blood-2002-03-0777; O'Hare T, 2008, JNCI-J NATL CANCER I, V100, P908, DOI 10.1093/jnci/djn204; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; PAZDRAK K, 1995, J EXP MED, V181, P1827, DOI 10.1084/jem.181.5.1827; Pene-Dumitrescu T, 2008, ONCOGENE, V27, P7055, DOI 10.1038/onc.2008.330; Pocaly M, 2008, PROTEOMICS, V8, P2394, DOI 10.1002/pmic.200701035; Pratilas CA, 2010, CLIN CANCER RES, V16, P3329, DOI 10.1158/1078-0432.CCR-09-3064; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ruvolo PP, 2011, J CELL BIOCHEM, V112, P1696, DOI 10.1002/jcb.23090; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Skorta I, 2009, CANCER RES, V69, P9337, DOI 10.1158/0008-5472.CAN-09-0548; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Vondracek J, 2001, J LEUKOCYTE BIOL, V69, P794; Walters DK, 2006, LEUKEMIA RES, V30, P1097, DOI 10.1016/j.leukres.2006.01.001; Wang QZ, 2010, ACS CHEM BIOL, V5, P887, DOI 10.1021/cb100099h; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687; Wissing J, 2007, MOL CELL PROTEOMICS, V6, P537, DOI 10.1074/mcp.T600062-MCP200; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Wu ZX, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011635-1, 10.1074/mcp.M111.011635]; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhu FJ, 2009, OMICS, V13, P467, DOI 10.1089/omi.2009.0046; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176; Zimmerman EI, 2010, MOL PHARMACOL, V78, P811, DOI 10.1124/mol.110.066258	83	46	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66755	10.1371/journal.pone.0066755	http://dx.doi.org/10.1371/journal.pone.0066755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826126	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400044
J	Khatami, A; Talaee, R; Rahshenas, M; Khamesipour, A; Mehryan, P; Tehrani, S; Dowlati, Y; Firooz, A				Khatami, Alireza; Talaee, Rezvan; Rahshenas, Makan; Khamesipour, Ali; Mehryan, Pedram; Tehrani, Sepideh; Dowlati, Yahya; Firooz, Alireza			Dressings Combined with Injection of Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial	PLOS ONE			English	Article							INTRALESIONAL INJECTION; EFFICACY; CRYOTHERAPY; THERAPY	Background: Cutaneous leishmaniasis (CL) is a neglected infectious disease and a major health problem in several developing countries. Despite some reasonable explanation for their potential benefits, there is only trace evidence regarding the role of dressings in the treatment of CL. Methods: This randomized, assessor-blind, controlled, clinical trial was conducted in an endemic area for CL caused by Leishmania major in Iran to assess the efficacy of administration of weekly intralesional meglumine antimoniate (i.l.MA) either alone or combined with application of a silver or a non-silver polyester dressing on their lesions for 6 weeks. After screening of 241 patients with CL lesions, 83 eligible patients with 158 lesions were randomly allocated in three arms of the study. Eligibility criteria included parasitologically confirmed CL, age of 12 to 60 years; willingness to participate, duration of lesion, 3 months, number of lesions, 5, largest ulcer diameter, 5 cm. Pregnant or lactating women were excluded. The primary outcome was absolute risk reduction (ARR) based on the proportion of complete healing, which was defined as more than 75% reduction in the size of the lesion compared with baseline in each group at the termination of treatment and 1 month later. Findings: ARR (95% Confidence Interval [CI]) in i.l.MA versus i.l.MA+non-silver dressing groups was 5.98% (-7.07% to 20.25%), between i.l.MA versus i.l.MA+silver dressing groups was -0.23% (-13.53% to 14.82%), and between i.l.MA+non-silver dressing versus i.l.MA+silver dressing groups was -6.21%(-18.28% to 6.52%) after 6 weeks of treatment. ARR (95% CI) in i.l.MA versus i.l.MA+non-silver dressing groups was -2.22% (-22.12% to 18.10%), between i.l.MA versus i.l.MA+silver dressing groups was 3.64% (-15.36% to 22.82%), and between i.l.MA+non-silver dressing versus i.l.MA+silver dressing groups was 5.86% (-12.86% to 24.31%) 1 month later. Conclusion: It could not be demonstrated that the efficacy of i.l.MA was improved by either dressing.	[Khatami, Alireza; Khamesipour, Ali; Mehryan, Pedram; Dowlati, Yahya; Firooz, Alireza] Univ Tehran Med Sci, Ctr Res & Training Skin Dis & Leprosy, Tehran, Iran; [Talaee, Rezvan] Univ Med Sci, Dept Dermatol, Kashan, Iran; [Rahshenas, Makan] Islamic Azad Univ, Tehran Med Branch, Fac Med, Tehran, Iran; [Tehrani, Sepideh] Islamic Azad Univ, Tehran Med Branch, Fac Med, Dept Dermatol, Tehran, Iran	Tehran University of Medical Sciences; Islamic Azad University; Islamic Azad University	Firooz, A (corresponding author), Univ Tehran Med Sci, Ctr Res & Training Skin Dis & Leprosy, Tehran, Iran.	firozali@sina.tums.ac.ir	, firooz/AAC-8440-2020; Talaee, Rezvan/H-1751-2017	Talaee, Rezvan/0000-0003-3587-8158; Firooz, Alireza/0000-0001-7274-4840	Vice-Chancellery of Research of Tehran University of Medical Sciences [132/344]	Vice-Chancellery of Research of Tehran University of Medical Sciences	The budget of the research project has been provided by the Vice-Chancellery of Research of Tehran University of Medical Sciences through contract number: 132/344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Asilian A, 2004, INT J DERMATOL, V43, P281, DOI 10.1111/j.1365-4632.2004.02002.x; Asilian A, 2003, ANN TROP MED PARASIT, V97, P493, DOI 10.1179/000349803225001373; Bailey MS, 2007, CLIN DERMATOL, V25, P203, DOI 10.1016/j.clindermatol.2006.05.008; Demling RH, 2001, WOUNDS, V13, P4; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dow G, 2001, CHRONIC WOUND CARE C, P343; Dowlati Y, 1996, CLIN DERMATOL, V14, P425, DOI 10.1016/0738-081X(96)00058-2; Faghihi G, 2003, CLIN EXP DERMATOL, V28, P13, DOI 10.1046/j.1365-2230.2003.01169.x; Firooz Alireza, 2005, J Drugs Dermatol, V4, P73; Gonzalez U, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005067.pub3; Graham Caroline, 2005, Br J Nurs, V14, ppassim; Kashani MN, 2010, INT J DERMATOL, V49, P1034, DOI 10.1111/j.1365-4632.2010.04523.x; Khamesipour A, 2006, INDIAN J MED RES, V123, P423; Khatami A, 2007, J AM ACAD DERMATOL, V57, P335, DOI 10.1016/j.jaad.2007.01.016; Lecoeur H, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000034; Modabber Farrokh, 2007, Kinetoplastid Biol Dis, V6, P3, DOI 10.1186/1475-9292-6-3; Mujtaba G, 1999, INT J DERMATOL, V38, P607, DOI 10.1046/j.1365-4362.1999.00769.x; Navarro M, 2006, ARZNEIMITTELFORSCH, V56, P600; Nilforoushzadeh M, 2001, CUTANEOUS LEISHMANIA; NILFOROUSHZADEH MA, 2003, IRANIAN J DERMATOLOG, V2, P34; Ovington Liza G, 2004, Ostomy Wound Manage, V50, p1S; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Sadeghian G, 2007, CLIN EXP DERMATOL, V32, P371, DOI 10.1111/j.1365-2230.2007.02405.x; Sadeghian G, 2011, Indian J Dermatol, V56, P37, DOI 10.4103/0019-5154.77549; Sadeghian G, 2005, IRAN J DERMATOL, V8, P251; Sibbald RG, 2006, WOUND CARE CANADA, V4, pR6; Vermeulen H, 2007, COCHRANE DB SYST REV, V24; WHO, 2010, CONTR LEISHM M WHO E; Yang DJ, 2007, COMPREHENSIVE DERMAT, P525; Yanik M, 2004, CLIN EXP DERMATOL, V29, P464, DOI 10.1111/j.1365-2230.2004.01605.x	31	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66123	10.1371/journal.pone.0066123	http://dx.doi.org/10.1371/journal.pone.0066123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826087	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400009
J	Ma, YY; Zheng, SG; Wang, N; Duan, Y; Sun, XY; Jin, J; Zang, WQ; Li, M; Wang, YY; Zhao, GQ				Ma, Yunyun; Zheng, Shangen; Wang, Na; Duan, Yu; Sun, Xinyu; Jin, Jing; Zang, Wenqiao; Li, Min; Wang, Yuanyuan; Zhao, Guoqiang			Epidemiological Analysis of HTLV-1 and HTLV-2 Infection among Different Population in Central China	PLOS ONE			English	Article							VIRUS TYPE-I; T-CELL LEUKEMIA; SEXUALLY-TRANSMITTED INFECTIONS; NEUROLOGICAL DISEASE; CENTRAL-AFRICA; RISK-FACTORS; PREVALENCE; LYMPHOMA; TYPE-1; INDIVIDUALS	Background: HTLV-1 and HTLV-2 are retroviruses linked etiologically to various human diseases, and both of them can be transmitted by vertical route, sexual intercourse, blood transfusion and intravenous drug use. Recently, some HTLV-infected cases have been reported and this virus is mainly present in the Southeast coastal areas in China, but has not been studied for the people in Central China. Objectives: To know the epidemiologic patterns among different population samples in Central China and further identify risk factor for HTLV-1 and HTLV-2 infection. Methods: From January 2008 to December 2011, 5480 blood samples were screened for HTLV-1/2 antibodies by using enzyme immunoassay, followed by Western Blot. Results: The prevalence of HTLV-1 and HTLV-2 was found with infection rates 0.13% and 0.05% among all population samples for HTLV-1 and HTLV-2, respectively. The highest percentages of infection, 0.39% and 0.20%, were found in the high risk group, while only 0.06% and 0.03% in the blood donor group. There was only one case of HTLV-1 infection (0.11%) among patients with malignant hematological diseases. Of seven HTLV-1 positive cases, six were co-infected with HBV, two with HCV and one with HIV. Among three HTLV-2 positive individuals all were co-infected with HBV, one with HCV. Conclusions: HTLV-1 and HTLV-2 have been detected in the Central China at low prevalence, with the higher infection rate among high risk group. It was also found that co-infection of HTLV-1/2 with HIV and HBV occurred, presumably due to their similar transmission routes. HTLV-1/2 antibody screen among certain population would be important to prevent the spread of the viruses.	[Ma, Yunyun; Wang, Na; Zang, Wenqiao; Li, Min; Wang, Yuanyuan; Zhao, Guoqiang] Zhengzhou Univ, Basic Med Coll, Dept Immunol & Microbiol, Zhengzhou 450052, Henan, Peoples R China; [Ma, Yunyun; Jin, Jing] Henan Med Coll Staff & Workers, Dept Immunol & Microbiol, Zhengzhou, Henan, Peoples R China; [Zheng, Shangen] Wuhan Gen Hosp Guangzhou Mil, Dept Blood Transfus, Wuhan, Hubei, Peoples R China; [Duan, Yu] Zhengzhou Univ, Affiliated Hosp 1, Clin Lab, Zhengzhou 450052, Henan, Peoples R China; [Sun, Xinyu] Zhengzhou Cent Hosp, Dept Lab, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Zhao, GQ (corresponding author), Zhengzhou Univ, Basic Med Coll, Dept Immunol & Microbiol, Zhengzhou 450052, Henan, Peoples R China.	zhaogq@zzu.edu.cn						Andonov A, 2012, INFECT GENET EVOL, V12, P1822, DOI 10.1016/j.meegid.2012.07.015; Araujo A, 2004, ANN NEUROL, V56, P10, DOI 10.1002/ana.20126; Barrientos A, 2011, J MED VIROL, V83, P745, DOI 10.1002/jmv.22015; Berini CA, 2007, J MED VIROL, V79, P1914, DOI 10.1002/jmv.21036; Calattini S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-30; Calattini S, 2009, J INFECT DIS, V199, P561, DOI 10.1086/596206; China Ministry of Health and joint UN programme on HIV/AIDS WHO, 2009, EST HIV AIDS EP CHIN; deCarvalho SMF, 1997, J ACQ IMMUN DEF SYND, V15, P238, DOI 10.1097/00042560-199707010-00008; Fan J, 2010, J VIROL, V84, P7278, DOI 10.1128/JVI.02239-09; FEIGAL E, 1991, J INFECT DIS, V164, P36, DOI 10.1093/infdis/164.1.36; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Gilleece Y, 2005, CURR OPIN INFECT DIS, V18, P43, DOI 10.1097/00001432-200502000-00008; Giuliani M, 2000, SEX TRANSM DIS, V27, P87, DOI 10.1097/00007435-200002000-00006; HALL WW, 1994, SEMIN VIROL, V5, P165, DOI 10.1006/smvy.1994.1017; HINUMA Y, 1982, INT J CANCER, V29, P631, DOI 10.1002/ijc.2910290606; Kahn J, 2002, CLIN INFECT DIS, V35, P1382, DOI 10.1086/343044; KAPLAN JE, 1993, REV MED VIROL, V3, P137, DOI 10.1002/rmv.1980030304; KOENIG RE, 1992, AIDS RES HUM RETROV, V8, P221, DOI 10.1089/aid.1992.8.221; Lowis GW, 2002, ANN EPIDEMIOL, V12, P46, DOI 10.1016/S1047-2797(01)00231-9; Macdonald N, 2004, SEX TRANSM INFECT, V80, P492, DOI 10.1136/sti.2004.011197; MADELEINE MM, 1993, INT J CANCER, V54, P255, DOI 10.1002/ijc.2910540216; Mahieux R, 2009, PATHOL BIOL, V57, P161, DOI 10.1016/j.patbio.2008.02.015; Manns A, 1999, LANCET, V353, P1951, DOI 10.1016/S0140-6736(98)09460-4; Mauclere P, 2011, J INFECT DIS, V203, P1316, DOI 10.1093/infdis/jir031; Miyagi J, 2002, INT J HEMATOL, V75, P78, DOI 10.1007/BF02981984; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; Orland JR, 2003, NEUROLOGY, V61, P1588, DOI 10.1212/01.WNL.0000096011.92542.DA; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Shen YZ, 2013, HIV MED, V14, P167, DOI 10.1111/j.1468-1293.2012.01048.x; SHIMOTOHNO K, 1985, P NATL ACAD SCI USA, V82, P3101, DOI 10.1073/pnas.82.10.3101; SHIMOYAMA M, 1986, P NATL ACAD SCI USA, V83, P4524, DOI 10.1073/pnas.83.12.4524; van der Bij AK, 2005, SEX TRANSM INFECT, V81, P34, DOI 10.1136/sti.2003.007997; Van Dooren S, 2001, MOL BIOL EVOL, V18, P661, DOI 10.1093/oxfordjournals.molbev.a003846; Wang Hui-rong, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P428; Wang JX, 2013, TRANSFUSION, V53, P1240, DOI 10.1111/j.1537-2995.2012.03940.x; Wang YC, 2005, J MED VIROL, V76, P613, DOI 10.1002/jmv.20405; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zanella L, 2012, J VIROL, V86, P12451, DOI 10.1128/JVI.02258-12; Zeng Y., 1985, Chinese Journal of Virology, V1, P344; Zhuo JC, 1995, CHINESE MED J-PEKING, V108, P902	44	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66795	10.1371/journal.pone.0066795	http://dx.doi.org/10.1371/journal.pone.0066795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826136	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400053
J	Sato, T; Tsujino, I; Ohira, H; Oyama-Manabe, N; Ito, YM; Noguchi, T; Yamada, A; Ikeda, D; Watanabe, T; Nishimura, M				Sato, Takahiro; Tsujino, Ichizo; Ohira, Hiroshi; Oyama-Manabe, Noriko; Ito, Yoichi M.; Noguchi, Teruo; Yamada, Asuka; Ikeda, Daisuke; Watanabe, Taku; Nishimura, Masaharu			Paradoxical Interventricular Septal Motion as a Major Determinant of Late Gadolinium Enhancement in Ventricular Insertion Points in Pulmonary Hypertension	PLOS ONE			English	Article							MYOCARDIAL DELAYED ENHANCEMENT; CARDIAC MAGNETIC-RESONANCE; PRESSURE-OVERLOAD; ARTERIAL-HYPERTENSION; HEART; MRI; VOLUME; MASS	Background: This study investigated the major clinical determinants of late gadolinium enhancement (LGE) at ventricular insertion points (VIPs) commonly seen in patients with pulmonary hypertension (PH). Methods: Forty-six consecutive PH patients (mean pulmonary artery pressure >= 25 mmHg at rest) and 21 matched controls were examined. Right ventricular (RV) morphology, function and LGE mass volume at VIPs were assessed by cardiac magnetic resonance (CMR). Radial motion of the left ventricular (LV) wall and interventricular septum (IVS) was assessed by speckle-tracking echocardiography. Paradoxical IVS motion index was then calculated. Univariate and multivariate regression analysis were conducted to characterize the relationship between LGE volume at VIPs and PH-related clinical indices, including the paradoxical IVS motion index. Results: Mean pulmonary arterial pressure (MPAP) of PH patients was 3869 mmHg. LGE at VIPs was observed in 42 of 46 PH patients, and the LGE volume was 2.02 mL (0.47-2.99 mL). Significant correlations with LGE volume at VIPs were observed for MPAP (r = 0.50) and CMR-derived parameters [RV mass index (r = 0.53), RV end-diastolic volume index (r = 0.53), RV ejection fraction (r = -0.56), and paradoxical IVS motion index (r = 0.77)]. In multiple regression analysis, paradoxical IVS motion index alone significantly predicted LGE volume at VIPs (p<0.001). Conclusions: LGE at VIPs seen in patients with PH appears to reflect altered IVS motion rather than elevated RV pressure or remodeling. Long-term studies would be of benefit to characterize the clinical relevance of LGE at VIPs.	[Sato, Takahiro; Tsujino, Ichizo; Ohira, Hiroshi; Yamada, Asuka; Ikeda, Daisuke; Watanabe, Taku] Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido 060, Japan; [Oyama-Manabe, Noriko] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido 060, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan; [Noguchi, Teruo] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan; [Nishimura, Masaharu] Hokkaido Univ, Grad Sch Med, Dept Med 1, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; National Cerebral & Cardiovascular Center - Japan; Hokkaido University	Tsujino, I (corresponding author), Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido 060, Japan.	itsujino@med.hokudai.ac.jp		Watanabe, Taku/0000-0002-3195-2413; Ito, Yoichi M./0000-0001-5073-0827				Blyth KG, 2005, EUR HEART J, V26, P1993, DOI 10.1093/eurheartj/ehi328; Bradlow WM, 2010, CIRC-CARDIOVASC IMAG, V3, P501, DOI 10.1161/CIRCIMAGING.109.919779; Dohi K, 2008, AM J CARDIOL, V101, P1206, DOI 10.1016/j.amjcard.2007.11.077; Freed BH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-11; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gaynor SL, 2005, AM J PHYSIOL-HEART C, V288, pH2140, DOI 10.1152/ajpheart.00566.2004; JESSUP M, 1987, AM HEART J, V113, P1114, DOI 10.1016/0002-8703(87)90921-5; Junqueira FP, 2009, BRIT J RADIOL, V82, P821, DOI 10.1259/bjr/28241773; Kroeker CAG, 2006, AM J PHYSIOL-HEART C, V290, pH2432, DOI 10.1152/ajpheart.01140.2005; Kroeker CAG, 2006, AM J PHYSIOL-HEART C, V291, pH2229, DOI 10.1152/ajpheart.00077.2006; Lindqvist P, 2008, EUR J ECHOCARDIOGR, V9, P225, DOI 10.1016/j.euje.2007.04.002; Machin D, 1997, SAMPLE SIZE TABLES C; McCann GP, 2007, AM J ROENTGENOL, V188, P349, DOI 10.2214/AJR.05.1259; McCann GP, 2005, CIRCULATION, V112, pE268, DOI 10.1161/CIRCULATIONAHA.104.512848; McLure LER, 2009, EUR RESPIR J, V33, P1454, DOI 10.1183/09031936.00139907; RYAN T, 1985, J AM COLL CARDIOL, V5, P918, DOI 10.1016/S0735-1097(85)80433-2; Sanz J, 2007, AM J CARDIOL, V100, P731, DOI 10.1016/j.amjcard.2007.03.094; Sato T, 2012, INT J CARDIOL, V158, P156, DOI 10.1016/j.ijcard.2012.04.042; Sechtem U, 2007, HEART, V93, P1520, DOI 10.1136/hrt.2005.067355; Shehata ML, 2011, AM J ROENTGENOL, V196, P87, DOI 10.2214/AJR.09.4114; Spottiswoode B, 2008, CARDIOVASC J AFR, V19, P208; TANAKA H, 1980, CIRCULATION, V62, P558, DOI 10.1161/01.CIR.62.3.558; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477	23	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66724	10.1371/journal.pone.0066724	http://dx.doi.org/10.1371/journal.pone.0066724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826118	Green Published, gold			2022-12-27	WOS:000321738400038
J	Nsoesie, EO; Beckman, RJ; Shashaani, S; Nagaraj, KS; Marathe, MV				Nsoesie, Elaine O.; Beckman, Richard J.; Shashaani, Sara; Nagaraj, Kalyani S.; Marathe, Madhav V.			A Simulation Optimization Approach to Epidemic Forecasting	PLOS ONE			English	Article							INFLUENZA-A H1N1; SEASONAL INFLUENZA; SURVEILLANCE; NETWORK; SCHOOLCHILDREN; HETEROGENEITY; VACCINATION; POPULATION; STRATEGIES; OUTBREAKS	Reliable forecasts of influenza can aid in the control of both seasonal and pandemic outbreaks. We introduce a simulation optimization (SIMOP) approach for forecasting the influenza epidemic curve. This study represents the final step of a project aimed at using a combination of simulation, classification, statistical and optimization techniques to forecast the epidemic curve and infer underlying model parameters during an influenza outbreak. The SIMOP procedure combines an individual-based model and the Nelder-Mead simplex optimization method. The method is used to forecast epidemics simulated over synthetic social networks representing Montgomery County in Virginia, Miami, Seattle and surrounding metropolitan regions. The results are presented for the first four weeks. Depending on the synthetic network, the peak time could be predicted within a 95% CI as early as seven weeks before the actual peak. The peak infected and total infected were also accurately forecasted for Montgomery County in Virginia within the forecasting period. Forecasting of the epidemic curve for both seasonal and pandemic influenza outbreaks is a complex problem, however this is a preliminary step and the results suggest that more can be achieved in this area.	[Nsoesie, Elaine O.; Beckman, Richard J.; Shashaani, Sara; Nagaraj, Kalyani S.; Marathe, Madhav V.] Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA; [Marathe, Madhav V.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Nsoesie, EO (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA.	onelaine@vbi.vt.edu	Shashaani, Sara/AAQ-7147-2020	Shashaani, Sara/0000-0001-8515-5877; Nsoesie, Elaine/0000-0001-9170-8714	NSF [OCI-0904844, CNS-1011769]; DTRA [HDTRA1-11-1-0016]; DTRA CNIMS [HDTRA1-11-D-0016-0001]; NIH MIDAS [2U01GM070694-09]; Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center (DoI/NBC) [D12PC00337]; NSF SDCI [OCI-1032677]; Direct For Computer & Info Scie & Enginr [1032677] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DTRA(United States Department of DefenseDefense Threat Reduction Agency); DTRA CNIMS; NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center (DoI/NBC); NSF SDCI(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work has been partially supported by NSF PetaApps Grant OCI-0904844, NSF NetSE Grant CNS-1011769, NSF SDCI Grant OCI-1032677, DTRA Grant HDTRA1-11-1-0016, DTRA CNIMS Contract HDTRA1-11-D-0016-0001 NIH MIDAS Grant 2U01GM070694-09 and by the Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center (DoI/NBC) contract number D12PC00337; the U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett C, 2011, EPIDEMICS-NETH, V3, P19, DOI 10.1016/j.epidem.2010.11.002; Barrett CL, 2005, SCI AM, V292, P54, DOI 10.1038/scientificamerican0305-54; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Bera S, 2010, P INT MULT ENG COMP, V3; Bisset KR, 2009, ICS'09: PROCEEDINGS OF THE 2009 ACM SIGARCH INTERNATIONAL CONFERENCE ON SUPERCOMPUTING, P430, DOI 10.1145/1542275.1542336; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Carrat F, 1998, J EPIDEMIOLOGY COMMU, P32; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chao DL, 2011, AM J EPIDEMIOL, V173, P1121, DOI 10.1093/aje/kwq497; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Clothier HJ, 2005, COMMUN DIS INTELL, V29, P231; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Eubank S., 2010, Journal of Biological Dynamics, V4, P446, DOI 10.1080/17513751003778687; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Falcao IM, 1998, J EPIDEMIOL COMMUN H, V52, p39S; Fleming DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI 10.1017/S0950268807009910; Gates P, 2009, VACCINE, V27, P6669, DOI 10.1016/j.vaccine.2009.08.094; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goldstein E, 2010, J R SOC INTERFACE, V7, P755, DOI 10.1098/rsif.2009.0393; Goldstein E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023380; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hastie T, 2009, ELEMENTS STAT 519 LE; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2010, INFLUENZA OTHER RESP, V4, P187, DOI 10.1111/j.1750-2659.2010.00147.x; Huang Q. S., 2009, Morbidity and Mortality Weekly Report, V58, P918; Huang Q Sue, 2007, N Z Med J, V120, pU2581; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Nsoesie EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045414; Nsoesie Elaine O, 2011, STAT COMMUNICATIONS, V3; Ohkusa Y, 2011, J INFECT CHEMOTHER, V17, P468, DOI 10.1007/s10156-010-0200-3; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Pourbohloul B, 2005, EMERG INFECT DIS, V11, P1249; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Taylor C, 2010, INT J INFECT DIS, V14, pE792, DOI 10.1016/j.ijid.2010.02.2267; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wilson N, 2009, EUROSURVEILLANCE, V14; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; [No title captured]	50	25	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67164	10.1371/journal.pone.0067164	http://dx.doi.org/10.1371/journal.pone.0067164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826222	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000037
J	Tabe, Y; Shi, YX; Zeng, ZH; Jin, LH; Shikami, M; Hatanaka, Y; Miida, T; Hsu, FJ; Andreeff, M; Konopleva, M				Tabe, Yoko; Shi, Yue Xi; Zeng, Zhihong; Jin, Linhua; Shikami, Masato; Hatanaka, Yasuhito; Miida, Takashi; Hsu, Frank J.; Andreeff, Michael; Konopleva, Marina			TGF-beta-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACUTE MYELOID-LEUKEMIA; CHEMOKINE RECEPTOR CXCR4; KINASE INHIBITOR; STEM-CELLS; IN-VITRO; HEMATOPOIESIS; EXPRESSION; TGF-BETA-1; INDUCTION	Hypoxia and interactions with bone marrow (BM) stromal cells have emerged as essential components of the leukemic BM microenvironment in promoting leukemia cell survival and chemoresistance. High levels of transforming growth factor beta 1 (TGF beta 1) produced by BM stromal cells in the BM niche regulate cell proliferation, survival, and apoptosis, depending on the cellular context. Exogenous TGF beta 1 induced accumulation of acute myeloid leukemia (AML) cells in a quiescent G(0) state, which was further facilitated by the co-culture with BM-derived mesenchymal stem cells (MSCs). In turn, TGF beta-neutralizing antibody 1D11 abrogated rhTGF beta 1 induced cell cycle arrest. Blocking TGF beta with 1D11 further enhanced cytarabine (Ara-C)induced apoptosis of AML cells in hypoxic and in normoxic conditions. Additional constituents of BM niche, the stroma-secreted chemokine CXCL12 and its receptor CXCR4 play crucial roles in cell migration and stroma/leukemia cell interactions. Treatment with 1D11 combined with CXCR4 antagonist plerixafor and Ara-C decreased leukemia burden and prolonged survival in an in vivo leukemia model. These results indicate that blockade of TGF beta by 1D11 and abrogation of CXCL12/CXCR4 signaling may enhance the efficacy of chemotherapy against AML cells in the hypoxic BM microenvironment.	[Tabe, Yoko; Shi, Yue Xi; Zeng, Zhihong; Andreeff, Michael; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Tabe, Yoko; Jin, Linhua; Hatanaka, Yasuhito; Miida, Takashi] Juntendo Univ, Sch Med, Dept Clin Lab Med, Tokyo 113, Japan; [Shikami, Masato] Aichi Med Univ, Dept Hematol, Aichi, Japan; [Hsu, Frank J.] Genzyme Corp, Cambridge, MA USA	University of Texas System; UTMD Anderson Cancer Center; Juntendo University; Aichi Medical University; Sanofi-Aventis; Genzyme Corporation	Konopleva, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	mkonople@mdanderson.org	Miida, Takashi/A-5589-2012	Miida, Takashi/0000-0002-4294-8030	United States National Institutes of Helath [NIH/NCI 5 PO1 CA55164-19]; Juntendo University School of Medicine; Genzyme Corporporation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	United States National Institutes of Helath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juntendo University School of Medicine; Genzyme Corporporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the United States National Institutes of Helath (NIH/NCI 5 PO1 CA55164-19 to M. Andreeff); 2011 Project Research Program for Environmental and Gender-Specific Medicine from Juntendo University School of Medicine to Y. Tabe; and from the Genzyme Corporporation to M. Konopleva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Benito J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023108; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Chin BY, 1999, J BIOL CHEM, V274, P11362, DOI 10.1074/jbc.274.16.11362; DALLAS SL, 1994, J BIOL CHEM, V269, P6815; DASCH JR, 1989, J IMMUNOL, V142, P1536; Fiegl M, 2009, BLOOD, V113, P1504, DOI 10.1182/blood-2008-06-161539; Fortunel NO, 2000, BLOOD, V96, P2022; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Garrido SM, 2001, EXP HEMATOL, V29, P448, DOI 10.1016/S0301-472X(01)00612-9; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Hayashi T, 2004, CLIN CANCER RES, V10, P7540, DOI 10.1158/1078-0432.CCR-04-0632; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Katoh M, 2010, INT J ONCOL, V36, P415, DOI 10.3892/ijo_00000514; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Konopleva M, 2002, LEUKEMIA, V16, P1713, DOI 10.1038/sj.leu.2402608; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levis M, 2002, BLOOD, V99, P3885, DOI 10.1182/blood.V99.11.3885; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Morris JC, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.9028; Mortensen BT, 1998, BRIT J HAEMATOL, V102, P458; Nakao M, 1996, LEUKEMIA, V10, P1911; Narayan S, 2005, FRONT BIOSCI-LANDMRK, V10, P1135, DOI 10.2741/1606; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ruscetti FW, 2005, ONCOGENE, V24, P5751, DOI 10.1038/sj.onc.1208921; Ruzek MC, 2003, IMMUNOPHARM IMMUNOT, V25, P235, DOI 10.1081/IPH-120020473; Saed GM, 2002, AM J REPROD IMMUNOL, V48, P387, DOI 10.1034/j.1600-0897.2002.01090.x; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; SMALL D, 1994, P NATL ACAD SCI USA, V91, P459, DOI 10.1073/pnas.91.2.459; Soma T, 1996, BLOOD, V87, P4561, DOI 10.1182/blood.V87.11.4561.bloodjournal87114561; Tabe Y, 2004, BLOOD, V103, P1815, DOI 10.1182/blood-2003-03-0802; Tabe Y, 2007, CANCER RES, V67, P684, DOI 10.1158/0008-5472.CAN-06-3166; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Xu YY, 2008, BRIT J HAEMATOL, V142, P192, DOI 10.1111/j.1365-2141.2008.07130.x; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629	47	57	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e62785	10.1371/journal.pone.0062785	http://dx.doi.org/10.1371/journal.pone.0062785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826077	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000002
J	Fan, SJ; Pan, ZY; Geng, Q; Li, X; Wang, YF; An, Y; Xu, Y; Tie, L; Pan, Y; Li, XJ				Fan, Shengjun; Pan, Zhenyu; Geng, Qiang; Li, Xin; Wang, Yefan; An, Yu; Xu, Yan; Tie, Lu; Pan, Yan; Li, Xuejun			Layered Signaling Regulatory Networks Analysis of Gene Expression Involved in Malignant Tumorigenesis of Non-Resolving Ulcerative Colitis via Integration of Cross-Study Microarray Profiles	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CD4(+) T-CELLS; COLORECTAL-CANCER; BREAST-CANCER; BIOLOGICAL NETWORKS; B-CELLS; RECOMBINANT ERYTHROPOIETIN; TRANSCRIPTION FACTORS; MONONUCLEAR-CELLS; INFLAMMATION	Background: Ulcerative colitis (UC) was the most frequently diagnosed inflammatory bowel disease (IBD) and closely linked to colorectal carcinogenesis. By far, the underlying mechanisms associated with the disease are still unclear. With the increasing accumulation of microarray gene expression profiles, it is profitable to gain a systematic perspective based on gene regulatory networks to better elucidate the roles of genes associated with disorders. However, a major challenge for microarray data analysis is the integration of multiple-studies generated by different groups. Methodology/Principal Findings: In this study, firstly, we modeled a signaling regulatory network associated with colorectal cancer (CRC) initiation via integration of cross-study microarray expression data sets using Empirical Bayes (EB) algorithm. Secondly, a manually curated human cancer signaling map was established via comprehensive retrieval of the publicly available repositories. Finally, the co-differently-expressed genes were manually curated to portray the layered signaling regulatory networks. Results: Overall, the remodeled signaling regulatory networks were separated into four major layers including extracellular, membrane, cytoplasm and nucleus, which led to the identification of five core biological processes and four signaling pathways associated with colorectal carcinogenesis. As a result, our biological interpretation highlighted the importance of EGF/EGFR signaling pathway, EPO signaling pathway, T cell signal transduction and members of the BCR signaling pathway, which were responsible for the malignant transition of CRC from the benign UC to the aggressive one. Conclusions: The present study illustrated a standardized normalization approach for cross-study microarray expression data sets. Our model for signaling networks construction was based on the experimentally-supported interaction and microarray co-expression modeling. Pathway-based signaling regulatory networks analysis sketched a directive insight into colorectal carcinogenesis, which was of significant importance to monitor disease progression and improve therapeutic interventions.	[Fan, Shengjun; Li, Xin; Wang, Yefan; An, Yu; Tie, Lu; Pan, Yan; Li, Xuejun] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Fan, Shengjun; Li, Xin; Wang, Yefan; An, Yu; Tie, Lu; Pan, Yan; Li, Xuejun] Peking Univ, Beijing Key Lab Tumor Syst Biol, Beijing 100871, Peoples R China; [Pan, Zhenyu] Xian Childrens Hosp, Dept Pharm, Xian, Peoples R China; [Geng, Qiang] Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China; [Xu, Yan] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250100, Peoples R China	Peking University; Peking University; Peking University; Shandong University	Li, XJ (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	xjli@bjmu.edu.cn	Fan, Shengjun/AAH-1370-2021; An, Yu/O-2966-2013	Fan, Shengjun/0000-0002-3096-3508; An, Yu/0000-0002-9678-3382; /0000-0002-6232-791X	National Natural Science Foundation of China [91129727, 81020108031, 30973558, 81270049]; Ministry of Education of China [B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (No. 91129727, 81020108031, 30973558, 81270049) and Research Fund from Ministry of Education of China (111 Projects No.B07001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051301; Awan A, 2007, IET SYST BIOL, V1, P292, DOI 10.1049/iet-syb:20060068; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barbera-Guillem E, 2000, CANCER IMMUNOL IMMUN, V48, P541, DOI 10.1007/PL00006672; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Berg M, 2012, DISCOV MED, V14, P207; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; BOYLE P, 1995, BRIT J CANCER, V72, P528, DOI 10.1038/bjc.1995.368; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; BRAEGGER CP, 1994, ACTA PAEDIATR, V83, P18, DOI 10.1111/j.1651-2227.1994.tb13223.x; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen R, 2007, NAT METHODS, V4, P879, DOI 10.1038/nmeth1107-879; Chen T, 1999, Pac Symp Biocomput, P29; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Dagnon K, 2005, CLIN CANCER RES, V11, P993; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; DEVROEDE GJ, 1971, NEW ENGL J MED, V285, P17, DOI 10.1056/NEJM197107012850103; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; ERSLEV AJ, 1980, ANN CLIN LAB SCI, V10, P250; Fan SJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-152; FAQUIN W C, 1992, Blood, V79, P1987; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; Feldman L, 2006, PROSTATE, V66, P135, DOI 10.1002/pros.20310; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Fuseya C, 2012, HUM PATHOL, V43, P1964, DOI 10.1016/j.humpath.2012.02.005; Giatromanolaki A, 2003, J CLIN PATHOL, V56, P209, DOI 10.1136/jcp.56.3.209; Giovannucci E, 1996, CANCER CAUSE CONTROL, V7, P253, DOI 10.1007/BF00051301; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Gu ZG, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-32; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hartnett L, 2012, CARCINOGENESIS, V33, P723, DOI 10.1093/carcin/bgs006; Hendon Shane E., 2005, Keio Journal of Medicine, V54, P179, DOI 10.2302/kjm.54.179; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Holmes D, 2012, NAT REV DRUG DISCOV, V11, P337, DOI [10.1038/nrd3733, 10.1038/nrd3732]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; ISHIKAWA S, 1994, AM J PHYSIOL-GASTR L, V267, pG1067, DOI 10.1152/ajpgi.1994.267.6.G1067; Itzkowitz S H, 1995, Inflamm Bowel Dis, V1, P142, DOI 10.1002/ibd.3780010208; Jiang W, 2012, AM J SURG PATHOL, V36, P1385, DOI 10.1097/PAS.0b013e31825fa4b4; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanthan, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/597497, DOI 10.1155/2012/597497]; KAUFFMAN S, 1974, J THEOR BIOL, V44, P167, DOI 10.1016/S0022-5193(74)80037-8; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kelly DJ, 2005, DIS MARKERS, V21, P43, DOI 10.1155/2005/357089; KING AC, 1981, NEW ENGL J MED, V305, P77, DOI 10.1056/NEJM198107093050206; KRISTIANSEN SV, 1994, J IMMUNOL, V153, P2974; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; Lai SY, 2005, ONCOGENE, V24, P4442, DOI 10.1038/sj.onc.1208635; Lakatos PL, 2012, CLIN GASTROENTEROL H, V10, P1179, DOI 10.1016/j.cgh.2012.04.021; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee JH, 2007, J KOREAN MED SCI, V22, P1042, DOI 10.3346/jkms.2008.22.6.1042; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Leyland-Jones B, 2003, LANCET ONCOL, V4, P459, DOI 10.1016/S1470-2045(03)01163-X; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LUCK MS, 1993, J PHARMACOL EXP THER, V264, P984; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; Mahurkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057655; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; McBroom JW, 2005, GYNECOL ONCOL, V99, P571, DOI 10.1016/j.ygyno.2005.06.038; Merla Amartej, 2012, Chemother Res Pract, V2012, P387172, DOI 10.1155/2012/387172; Mohyeldin A, 2005, NEOPLASIA, V7, P537, DOI 10.1593/neo.04685; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; Nunnari G, 2012, EUR REV MED PHARMACO, V16, P1257; Okayasu I, 2012, PATHOL INT, V62, P368, DOI 10.1111/j.1440-1827.2012.02807.x; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parray FQ, 2012, INT J PREVENTIVE MED, V3, P749; Pedroso I, 2010, METHODS MOL BIOL, V628, P373, DOI 10.1007/978-1-60327-367-1_20; Pekow J, 2013, INFLAMM BOWEL DIS, V19, P461, DOI 10.1097/MIB.0b013e3182802bac; Phillips TM, 2007, NEOPLASIA, V9, P1122, DOI 10.1593/neo.07694; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; PROCACCINO F, 1994, GASTROENTEROLOGY, V107, P12, DOI 10.1016/0016-5085(94)90055-8; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Rossi S, 2010, INT J BIOCHEM CELL B, V42, P1291, DOI 10.1016/j.biocel.2009.05.018; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Schreiber S, 1996, NEW ENGL J MED, V334, P619, DOI 10.1056/NEJM199603073341002; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shimizu J, 1999, J IMMUNOL, V163, P5211; Silverman GJ, 1997, IMMUNOL TODAY, V18, P379, DOI 10.1016/S0167-5699(97)01101-8; Simoes RD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-38; SMITH MA, 1992, ANN RHEUM DIS, V51, P753, DOI 10.1136/ard.51.6.753; Smolle E, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7879; Snapper CM, 1996, J IMMUNOL, V157, P2229; Steitz J, 2001, CANCER RES, V61, P8643; Tadmor T, 2011, CANCER IMMUNOL IMMUN, V60, P609, DOI 10.1007/s00262-011-0972-z; Thurner S., 2009, ANAL COMPLEX NETWORK; Tiwari M, 2012, J CANCER RES THER, V8, P3, DOI 10.4103/0973-1482.95166; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Lunteren E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007832; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Woo EY, 2001, CANCER RES, V61, P4766; Woychik RP, 1998, MUTAT RES-FUND MOL M, V400, P3, DOI 10.1016/S0027-5107(98)00023-2; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Xing B, 2005, BIOINFORMATICS, V21, P4007, DOI 10.1093/bioinformatics/bti648; Xu L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-125; Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zakharkin SO, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-214; Zhang LJ, 2007, J CELL PHYSIOL, V211, P590, DOI 10.1002/jcp.21001; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626; Zhu H, 2012, ADV GENET, V79, P123, DOI 10.1016/B978-0-12-394395-8.00004-9; Zhu WL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006288	118	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67142	10.1371/journal.pone.0067142	http://dx.doi.org/10.1371/journal.pone.0067142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825635	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000085
J	Garratt, ES; Vickers, MH; Gluckman, PD; Hanson, MA; Burdge, GC; Lillycrop, KA				Garratt, Emma S.; Vickers, Mark H.; Gluckman, Peter D.; Hanson, Mark A.; Burdge, Graham C.; Lillycrop, Karen A.			Tissue-Specific 5 ' Heterogeneity of PPAR alpha Transcripts and Their Differential Regulation by Leptin	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; HEPATIC GENE-EXPRESSION; MESSENGER-RNA; 5'-UNTRANSLATED REGION; SECONDARY STRUCTURE; ENERGY-BALANCE; PROTEIN; PROMOTER; ACID; VARIANTS	The genes encoding nuclear receptors comprise multiple 5' untranslated exons, which give rise to several transcripts encoding the same protein, allowing tissue-specific regulation of expression. Both human and mouse peroxisome proliferator activated receptor (PPAR) alpha genes have multiple promoters, although their function is unknown. Here we have characterised the rat PPAR alpha promoter region and have identified three alternative PPAR alpha transcripts, which have different transcription start sites owing to the utilisation of distinct first exons. Moreover these alternative PPAR alpha transcripts were differentially expressed between adipose tissue and liver. We show that while the major adipose (P1) and liver (P2) transcripts were both induced by dexamethasone, they were differentially regulated by the PPAR alpha agonist, clofibric acid, and leptin. Leptin had no effect on the adipose-specific P1 transcript, but induced liver-specific P2 promoter activity via a STAT3/Sp1 mechanism. Moreover in Wistar rats, leptin treatment between postnatal day 3-13 led to an increase in P2 but not P1 transcription in adipose tissue which was sustained into adulthood. This suggests that the expression of the alternative PPAR alpha transcripts are in part programmed by early life exposure to leptin leading to persistent change in adipose tissue fatty acid metabolism through specific activation of a quiescent PPAR alpha promoter. Such complexity in the regulation of PPAR alpha may allow the expression of PPAR alpha to be finely regulated in response to environmental factors.	[Garratt, Emma S.; Hanson, Mark A.; Burdge, Graham C.] Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Southampton SO9 5NH, Hants, England; [Vickers, Mark H.; Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Vickers, Mark H.; Gluckman, Peter D.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand; [Lillycrop, Karen A.] Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England	University of Southampton; University of Auckland; University of Auckland; University of Southampton	Lillycrop, KA (corresponding author), Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England.	kal@soton.ac.uk	Burdge, Graham/A-2370-2014; Hanson, Mark/AAE-8236-2019	Burdge, Graham/0000-0002-7665-2967; Hanson, Mark/0000-0002-6907-613X; Lillycrop, Karen/0000-0001-7350-5489; Vickers, Mark/0000-0003-4876-9356	Health Research Council of New Zealand; National Research Centre for Growth and Development; British Heart Foundation	Health Research Council of New Zealand(Health Research Council of New Zealand); National Research Centre for Growth and Development; British Heart Foundation(British Heart Foundation)	This work was funded by the Health Research Council of New Zealand and the National Research Centre for Growth and Development. MAH receives salary support from the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Belikov S, 2004, J BIOL CHEM, V279, P49857, DOI 10.1074/jbc.M409713200; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Briana DD, 2010, ANN NY ACAD SCI, V1205, P82, DOI 10.1111/j.1749-6632.2010.05650.x; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Capri M, 1997, MECH DEVELOP, V68, P91, DOI 10.1016/S0925-4773(97)00130-5; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Chew CH, 2003, BIOCHEM BIOPH RES CO, V305, P235, DOI 10.1016/S0006-291X(03)00731-9; Cottrell EC, 2009, AM J PHYSIOL-REG I, V296, pR631, DOI 10.1152/ajpregu.90690.2008; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Fonseca Vania Matos, 2004, J Perinatol, V24, P751, DOI 10.1038/sj.jp.7211188; Fruchart J C, 2001, Curr Atheroscler Rep, V3, P83, DOI 10.1007/s11883-001-0015-x; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gauss KA, 2006, GENE, V366, P169, DOI 10.1016/j.gene.2005.09.012; GEARING KL, 1994, BIOCHEM BIOPH RES CO, V199, P255, DOI 10.1006/bbrc.1994.1222; GEBEL T, 1992, FEBS LETT, V309, P37, DOI 10.1016/0014-5793(92)80734-X; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Harris RG, 2002, J BIOL CHEM, V277, P34815, DOI 10.1074/jbc.M109609200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Nilsson C, 2003, J ENDOCRINOL, V176, P13, DOI 10.1677/joe.0.1760013; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; Pavithra L, 2010, FEBS LETT, V584, P1187, DOI 10.1016/j.febslet.2010.02.025; Payton SG, 2007, BBA-GENE STRUCT EXPR, V1769, P131, DOI 10.1016/j.bbaexp.2006.12.006; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; Thio GL, 2000, DEV BIOL, V221, P435, DOI 10.1006/dbio.2000.9690; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Valmaseda A, 1999, MOL CELL ENDOCRINOL, V154, P101, DOI 10.1016/S0303-7207(99)00081-7; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vohl MC, 2000, J LIPID RES, V41, P945; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Yang G, 2009, J BIOL CHEM, V284, P3719, DOI 10.1074/jbc.M804965200; Zhao XN, 2009, ACTA BIOCH BIOPH SIN, V41, P30, DOI 10.1093/abbs/gmn004; Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391	63	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67483	10.1371/journal.pone.0067483	http://dx.doi.org/10.1371/journal.pone.0067483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825665	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000321223000105
J	Ghio, M; Vaghi, MMS; Tettamanti, M				Ghio, Marta; Vaghi, Matilde Maria Serena; Tettamanti, Marco			Fine-Grained Semantic Categorization across the Abstract and Concrete Domains	PLOS ONE			English	Article							CONTEXT-AVAILABILITY; MOTOR SYSTEM; SENTENCE COMPREHENSION; FMRI EVIDENCE; WORDS; REPRESENTATIONS; ACQUISITION; KNOWLEDGE; LANGUAGE; NUMBER	A consolidated approach to the study of the mental representation of word meanings has consisted in contrasting different domains of knowledge, broadly reflecting the abstract-concrete dichotomy. More fine-grained semantic distinctions have emerged in neuropsychological and cognitive neuroscience work, reflecting semantic category specificity, but almost exclusively within the concrete domain. Theoretical advances, particularly within the area of embodied cognition, have more recently put forward the idea that distributed neural representations tied to the kinds of experience maintained with the concepts' referents might distinguish conceptual meanings with a high degree of specificity, including those within the abstract domain. Here we report the results of two psycholinguistic rating studies incorporating such theoretical advances with two main objectives: first, to provide empirical evidence of fine-grained distinctions within both the abstract and the concrete semantic domains with respect to relevant psycholinguistic dimensions; second, to develop a carefully controlled linguistic stimulus set that may be used for auditory as well as visual neuroimaging studies focusing on the parametrization of the semantic space beyond the abstract-concrete dichotomy. Ninety-six participants rated a set of 210 sentences across pre-selected concrete (mouth, hand, or leg action-related) and abstract (mental state-, emotion-, mathematics-related) categories, with respect either to different semantic domain-related scales (rating study 1), or to concreteness, familiarity, and context availability (rating study 2). Inferential statistics and correspondence analyses highlighted distinguishing semantic and psycholinguistic traits for each of the pre-selected categories, indicating that a simple abstract-concrete dichotomy is not sufficient to account for the entire semantic variability within either domains.	[Ghio, Marta] Scuola Normale Super Pisa, Lab Linguist G Nencioni, Pisa, Italy; [Vaghi, Matilde Maria Serena] Univ Vita Salute San Raffaele, Fac Psychol, Milan, Italy; [Tettamanti, Marco] Ist Sci San Raffaele, Dept Nucl Med, I-20132 Milan, Italy; [Tettamanti, Marco] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy	Scuola Normale Superiore di Pisa; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Tettamanti, M (corresponding author), Ist Sci San Raffaele, Dept Nucl Med, I-20132 Milan, Italy.	tettamanti.marco@hsr.it	Tettamanti, Marco/K-1510-2016; Vaghi, Matilde/GQH-9010-2022	Tettamanti, Marco/0000-0003-3039-1500; Vaghi, Matilde/0000-0002-0999-9055; Ghio, Marta/0000-0002-7481-7182				Altarriba J, 2004, AM J PSYCHOL, V117, P389, DOI 10.2307/4149007; Altarriba J, 1999, BEHAV RES METH INS C, V31, P578, DOI 10.3758/BF03200738; Dunabeitia JA, 2009, COGNITION, V110, P284, DOI 10.1016/j.cognition.2008.11.012; Andres M, 2008, CURR DIR PSYCHOL SCI, V17, P313, DOI 10.1111/j.1467-8721.2008.00597.x; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Baayen RH, 2011, LANGUAGER DATA SETS; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barros-Loscertales A, 2012, CEREB CORTEX, V22, P2554, DOI 10.1093/cercor/bhr324; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Ben-David BM, 2011, BRAIN INJURY, V25, P206, DOI 10.3109/02699052.2010.536197; Benzecri Jean-Paul, 1973, ANAL DONNEES, V2; Bertinetto P. M., 2005, CORPUS LESSICO FREQU; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 2005, J COGNITIVE NEUROSCI, V17, P905, DOI 10.1162/0898929054021102; Boersma Paul, 2002, GLOT INT, V5, P341; Brainerd CJ, 2008, PSYCHON B REV, V15, P1035, DOI 10.3758/PBR.15.6.1035; BRYANT P, 1988, BRIT J DEV PSYCHOL, V6, P395, DOI 10.1111/j.2044-835X.1988.tb01118.x; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Butterworth B, 1999, SCIENCE, V284, P928, DOI 10.1126/science.284.5416.928; Cacciari Cristina, 2001, PSICOLOGIA LINGUAGGI; Canessa N, 2008, CEREB CORTEX, V18, P740, DOI 10.1093/cercor/bhm110; Cappla SF, 2008, CURR OPIN NEUROL, V21, P669, DOI 10.1097/WCO.0b013e328316e6e0; Cardillo ER, 2010, BEHAV RES METHODS, V42, P651, DOI 10.3758/BRM.42.3.651; Carifio J, 2008, MED EDUC, V42, P1150, DOI 10.1111/j.1365-2923.2008.03172.x; Chatterjee A, 2010, LANG COGN, V2, P79, DOI 10.1515/LANGCOG.2010.004; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Crutch SJ, 2005, BRAIN, V128, P615, DOI 10.1093/brain/awh349; Davison A., 1997, BOOTSTRAP METHODS TH, P191, DOI DOI 10.1017/CBO9780511802843.006; de Winter J., 2010, PRACTICAL ASSESSMENT, V15, DOI [DOI 10.7275/BJ1P-TS64, 10.7275/bj1p-ts64]; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Della Rosa PA, 2010, BEHAV RES METHODS, V42, P1042, DOI 10.3758/BRM.42.4.1042; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Estes Z, 2008, EMOTION, V8, P441, DOI 10.1037/1528-3542.8.4.441; Ferretti TR, 2001, J MEM LANG, V44, P516, DOI 10.1006/jmla.2000.2728; Fischer MH, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00260; Frank MC, 2008, COGNITION, V108, P819, DOI 10.1016/j.cognition.2008.04.007; Frank MC, 2012, COGNITIVE PSYCHOL, V64, P74, DOI 10.1016/j.cogpsych.2011.10.004; Frijda NH, 2009, COGNITION EMOTION, V23, P1444, DOI 10.1080/02699930903093276; Gainotti G, 2004, NEUROPSYCHOLOGIA, V42, P299, DOI 10.1016/j.neuropsychologia.2003.08.006; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; GERNSBACHER MA, 1984, J EXP PSYCHOL GEN, V113, P256, DOI 10.1037/0096-3445.113.2.256; Ghio M, 2010, BRAIN LANG, V112, P223, DOI 10.1016/j.bandl.2008.11.002; Goldberg RF, 2006, J NEUROSCI, V26, P4917, DOI 10.1523/JNEUROSCI.5389-05.2006; Gonzalez J, 2006, NEUROIMAGE, V32, P906, DOI 10.1016/j.neuroimage.2006.03.037; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; HALE SC, 1988, PHILOS STUD, V53, P85, DOI 10.1007/BF00355677; Hanks P., 1990, COMPUT LINGUIST, V16, P22, DOI DOI 10.3115/981623.981633; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Holcomb PJ, 1999, J EXP PSYCHOL LEARN, V25, P721, DOI 10.1037/0278-7393.25.3.721; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; Kiefer M., 2012, ACTION SCI FDN EMERG; Kiefer M, 2008, J NEUROSCI, V28, P12224, DOI 10.1523/JNEUROSCI.3579-08.2008; Klein E, 2011, FRONT PSYCHOL, V2, DOI [10.3389/fpsya.2011.00197, 10.3389/fpsyg.2011.00197]; KNAPP TR, 1990, NURS RES, V39, P121; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lang PJ, 1993, ORG EMOTION TORONTO; LeDoux J, 1996, PROG BRAIN RES, V107, P437; Leys C, 2010, J EXP SOC PSYCHOL, V46, P684, DOI 10.1016/j.jesp.2010.02.007; Linnaeus C., 1735, SYSTEMA NATURAE SIVE, P1; Liversedge SP, 2003, PSYCHON B REV, V10, P667, DOI 10.3758/BF03196530; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Martin A, 1996, SCIENCE, V270, P102; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; McNamara T. P., 2005, SEMANTIC PRIMING PER, DOI DOI 10.4324/9780203338001; McRae K, 2013, OXFORD HDB COGNITIVE; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Moseley R, 2012, CEREB CORTEX, V22, P1634, DOI 10.1093/cercor/bhr238; Murtagh F, 2005, CORR AN DAT COD JAVA; Nanna MJ, 1998, PSYCHOL METHODS, V3, P55, DOI 10.1037/1082-989X.3.1.55; Nasrallah M, 2009, EMOTION, V9, P609, DOI 10.1037/a0016305; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Norris D, 2006, PSYCHOL REV, V113, P327, DOI 10.1037/0033-295X.113.2.327; Paivio, 1986, MENTAL REPRESENTATIO; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; Papafragou A, 2007, COGNITION, V105, P125, DOI 10.1016/j.cognition.2006.09.008; Pfeifer R., 2001, UNDERSTANDING INTELL; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; PLAUT DC, 1991, PROGRAM OF THE THIRTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P73; Previtali P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00363; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; R Core Team, 2012, R LANG ENV STAT COMP; Ranzini M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00147; Rotteveel M, 2004, EMOTION, V4, P156, DOI 10.1037/1528-3542.4.2.156; Rueschemeyer SA, 2010, J COGNITIVE NEUROSCI, V22, P1844, DOI 10.1162/jocn.2009.21310; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sato M, 2008, BRAIN LANG, V105, P83, DOI 10.1016/j.bandl.2007.10.001; Sato M, 2007, J COGNITIVE NEUROSCI, V19, P684, DOI 10.1162/jocn.2007.19.4.684; SCHWANENFLUGEL PJ, 1992, MEM COGNITION, V20, P96, DOI 10.3758/BF03208259; SCHWANENFLUGEL PJ, 1988, J MEM LANG, V27, P499, DOI 10.1016/0749-596X(88)90022-8; SCHWANENFLUGEL PJ, 1991, PSYCHOLOGY OF WORD MEANINGS, P223; Setti A, 2005, P 17 ANN C COGN SCI; Simmons WK, 2008, J PHYSIOL-PARIS, V102, P106, DOI 10.1016/j.jphysparis.2008.03.014; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; SPENCE DP, 1990, J PSYCHOLINGUIST RES, V19, P317, DOI 10.1007/BF01074363; Taylor KI, 2007, NEURAL BASIS OF SEMANTIC MEMORY, P265, DOI 10.1017/CBO9780511544965.012; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tettamanti M, 2012, NEUROIMAGE, V59, P1804, DOI 10.1016/j.neuroimage.2011.08.018; Tschentscher N, 2012, NEUROIMAGE, V59, P3139, DOI 10.1016/j.neuroimage.2011.11.037; Tyler LK, 2001, TRENDS COGN SCI, V5, P244, DOI 10.1016/S1364-6613(00)01651-X; Vinson D, 2011, ANN C COGN SCI SOC B; Wiemer-Hastings K, 2005, COGNITIVE SCI, V29, P719, DOI 10.1207/s15516709cog0000_33; Wiemer-Hastings K, 2001, P 23 ANN M COGN SCI, V23, P1106; Wiemer-Hastings K, 2003, P 25 ANN M COGN SCI, P1253; Willems RM, 2010, PSYCHOL SCI, V21, P67, DOI 10.1177/0956797609354072; Wilson-Mendenhall CD, 2011, NEUROPSYCHOLOGIA, V49, P1105, DOI 10.1016/j.neuropsychologia.2010.12.032	113	54	54	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67090	10.1371/journal.pone.0067090	http://dx.doi.org/10.1371/journal.pone.0067090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175IB	23825625	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000321223000077
J	Gonzalez-Sanchez, E; Martin-Caballero, J; Flores, JM; Hernandez-Losa, J; Montero, MA; Cortes, J; Mares, R; Barbacid, M; Recio, JA				Gonzalez-Sanchez, Elena; Martin-Caballero, Juan; Maria Flores, Juana; Hernandez-Losa, Javier; Montero, Ma Angeles; Cortes, Javier; Mares, Roso; Barbacid, Mariano; Recio, Juan A.			Lkb1 Loss Promotes Tumor Progression of BRAF(V600E)-Induced Lung Adenomas	PLOS ONE			English	Article							STEM-CELLS; RAS ONCOGENE; BRAF GENE; K-RAS; CANCER; MUTATIONS; LKB1/STK11; INITIATION; EXPRESSION; MELANOMA	Aberrant activation of MAP kinase signaling pathway and loss of tumor suppressor LKB1 have been implicated in lung cancer development and progression. Although oncogenic KRAS mutations are frequent, BRAF mutations (BRAF(V600E)) are found in 3% of human non-small cell lung cancers. Contrary to KRAS mutant tumors, BRAF(V600E)-induced tumors are benign adenomas that fail to progess. Interestingly, loss of tumor supressor LKB1 coexists with KRAS oncogenic mutations and synergizes in tumor formation and progression, however, its cooperation with BRAF(V600E) oncogene is unknown. Our results describe a lung cell population in neonates mice where expression of BRAF(V600E) leads to lung adenoma development. Importantly, expression of BRAF(V600E) concomitant with the loss of only a single-copy of Lkb1, overcomes senencence-like features of BRAF(V600E)-mutant adenomas leading malignization to carcinomas. These results posit LKB1 haploinsufficiency as a risk factor for tumor progression of BRAF(V600E) mutated lung adenomas in human cancer patients.	[Gonzalez-Sanchez, Elena; Recio, Juan A.] Autonomous Univ Barcelona, Vall Hebron Inst Res, Dept Anat Pathol, Anim Models & Canc Lab, Barcelona, Spain; [Martin-Caballero, Juan] Anim Lab Unit, Barcelona, Spain; [Maria Flores, Juana] Univ Complutense Madrid, Sch Vet, Dept Surg & Med, Madrid, Spain; [Hernandez-Losa, Javier; Mares, Roso] Vall Hebron Hosp, Dept Anat Pathol, Barcelona, Spain; [Montero, Ma Angeles] Royal Brompton & NHS Trust, Dept Histopathol, London, England; [Montero, Ma Angeles] Vall Hebron Hosp, VHIO, Dept Med Oncol, Barcelona, Spain; [Barbacid, Mariano] Ctr Nacl Invest Oncol, Mol Oncol Program, Madrid, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Complutense University of Madrid; Hospital Universitari Vall d'Hebron; Royal Brompton Hospital; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO)	Recio, JA (corresponding author), Autonomous Univ Barcelona, Vall Hebron Inst Res, Dept Anat Pathol, Anim Models & Canc Lab, Barcelona, Spain.	juan.recio@vhir.org	Montero, Angeles/AAQ-1696-2021; Javier, Hernandez Losa/C-1173-2008	Montero, Angeles/0000-0002-2381-6833; Javier, Hernandez Losa/0000-0003-1526-3201; Recio, Juan Angel/0000-0002-7320-3832; Cortes, Javier/0000-0001-7623-1583; mares, Roso/0000-0002-7339-0172	Spanish Ministry of Health [PI080653, PI1100384]; Fundacion Segunda Opinion en Oncologia (FUSEON)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Fundacion Segunda Opinion en Oncologia (FUSEON)	This work has been supported by the Spanish Ministry of Health grants FIS(PI080653) and FIS(PI1100384), and Fundacion Segunda Opinion en Oncologia (FUSEON). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTYANI Z, 1993, PIGM CELL RES, V6, P400; Brose MS, 2002, CANCER RES, V62, P6997; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Chen Huaiyong, 2009, Proc Am Thorac Soc, V6, P602, DOI 10.1513/pats.200907-078RM; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Downward J, 2006, SCIENCE, V314, P433, DOI 10.1126/science.1134727; Esteve-Puig R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004771; Gill RK, ONCOGENE, V30, P3784; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Haigis KM, 2007, GENE DEV, V21, P361, DOI 10.1101/gad.1532107; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kotton DN, 2008, CELL TISSUE RES, V331, P145, DOI 10.1007/s00441-007-0479-2; Liu W, CANC CELL, V21, P751; Lundin A, CANC LETT; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Naoki K, 2002, CANCER RES, V62, P7001; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shackelford DB, CANC CELL, V23, P143; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620	26	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66933	10.1371/journal.pone.0066933	http://dx.doi.org/10.1371/journal.pone.0066933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825589	gold, Green Submitted, Green Published			2022-12-27	WOS:000321223000046
J	Neville, FG; Williams, DJ; Goodall, CA; Murer, JS; Donnelly, PD				Neville, Fergus G.; Williams, Damien J.; Goodall, Christine A.; Murer, Jeffrey S.; Donnelly, Peter D.			An Experimental Trial Exploring the Impact of Continuous Transdermal Alcohol Monitoring upon Alcohol Consumption in a Cohort of Male Students	PLOS ONE			English	Article							INTERVENTIONS; DRINKING; RISK	Objective: To examine the impact of continuous transdermal alcohol monitoring upon alcohol consumption in male students at a Scottish university. Method: Using a within-subject mixed-methods design, 60 male university students were randomly allocated into three experimental conditions using AUDIT score stratified sampling. Participants in Conditions A and B were asked not to consume alcohol for a 14-day period, with those in Condition A additionally being required to wear a continuous transdermal alcohol monitoring anklet. Condition C participants wore an anklet and were asked to continue consuming alcohol as normal. Alcohol consumption was measured through alcohol timeline follow-back, and using data collected from the anklets where available. Diaries and focus groups explored participants' experiences of the trial. Results: Alcohol consumption during the 14-day trial decreased significantly for participants in Conditions A and B, but not in C. There was no significant relative difference in units of alcohol consumed between Conditions A and B, but significantly fewer participants in Condition A drank alcohol than in Condition B. Possible reasons for this difference identified from the focus groups and diaries included the anklet acting as a reminder of commitment to the study (and the agreement to sobriety), participants feeling under surveillance, and the use of the anklet as a tool to resist social pressure to consume alcohol. Conclusions: The study provided experience in using continuous transdermal alcohol monitors in an experimental context, and demonstrated ways in which the technology may be supportive in facilitating sobriety. Results from the study have been used to design a research project using continuous transdermal alcohol monitors with ex-offenders who recognise a link between their alcohol consumption and offending behaviour.	[Neville, Fergus G.; Williams, Damien J.; Donnelly, Peter D.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Goodall, Christine A.] Univ Glasgow, Sch Dent, Dept Oral Surg, Glasgow, Lanark, Scotland; [Murer, Jeffrey S.] Univ St Andrews, Sch Int Relat, St Andrews, Fife, Scotland	University of St Andrews; University of Glasgow; University of St Andrews	Neville, FG (corresponding author), Univ St Andrews, Sch Med, St Andrews, Fife, Scotland.	fgn@st-and.ac.uk	Goodall, Christine/AFM-7690-2022; Murer, Jeffrey Stevenson/ABF-7106-2021	Goodall, Christine/0000-0003-4949-6919; Murer, Jeffrey Stevenson/0000-0002-8056-9365; Donnelly, Peter/0000-0002-9878-9673; Neville, Fergus/0000-0001-7377-4507; Williams, Damien/0000-0003-2227-9789	Scottish School of Public Health; Violence Reduction Unit; Chief Scientist Office [SCPH/09] Funding Source: researchfish	Scottish School of Public Health; Violence Reduction Unit; Chief Scientist Office	The first author was supported through a grant from the Scottish School of Public Health (http://ssphr.ac.uk). The Violence Reduction Unit (http://www.actiononviolence.com) funded the hire of the SCRAMx anklets and the transcription of the focus groups. The funders had no role in study design, decision to publish, or preparation of the manuscript, although the Violence Reduction Unit necessarily helped with some elements of data collection (anklet fitting, removal and data upload).	AMS, 2013, S DAK 24 7 SOBR PROJ; Babor T., 2001, BRIEF INTERVENTION H; Barnett NP, 2011, DRUG ALCOHOL DEPEN, V118, P391, DOI 10.1016/j.drugalcdep.2011.04.023; Beeston C, 2011, MONITORING EVALUATIN; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bryman A., 2013, SOCIAL RES METHODS; Carey KB, 2011, ADDICTION, V106, P528, DOI 10.1111/j.1360-0443.2010.03193.x; Carey KB, 2010, ADDICT BEHAV, V35, P218, DOI 10.1016/j.addbeh.2009.10.011; Dougherty DM, 2012, EXP CLIN PSYCHOPHARM, V20, P373, DOI 10.1037/a0029021; Flango VE, 2009, COURT REV AM JUDGES, V44, P102; Flick U., 2002, INTRO QUALITATIVE RE, V2nd; Grant I., 2009, ALCOHOL ATTRIBUTABLE; Henry DB, 2012, AM J PREV MED, V43, pS51, DOI 10.1016/j.amepre.2012.04.025; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Houchin R., 2005, SOCIAL EXCLUSION IMP; Humphreys Keith, 2003, Recent Dev Alcohol, V16, P149; Johnson JE, 2006, J SUBST ABUSE TREAT, V31, P41, DOI 10.1016/j.jsat.2006.03.008; Kypri K, 2005, ADDICTION, V100, P713, DOI 10.1111/j.1360-0443.2005.01116.x; Leffingwell TR, 2013, ALCOHOL CLIN EXP RES, V37, P16, DOI 10.1111/j.1530-0277.2012.01869.x; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; Leyland AH, 2010, J EPIDEMIOL COMMUN H, V64, P432, DOI 10.1136/jech.2009.095018; Loudenberg R, 2010, S DAKOTA 24 7 SOBRIE; MacAskill S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-865; Marques PR, 2009, ALCOHOL CLIN EXP RES, V33, P703, DOI 10.1111/j.1530-0277.2008.00887.x; McKinlay W, 2009, MCKINLAY REPORT ALCO; Parkes T., 2011, PRISON HLTH NEEDS AS; Paton M.Q, 1990, QUALITATIVE EVALUATI; Raub Richard A, 2003, Traffic Inj Prev, V4 Suppl 1, P28, DOI 10.1080/1538-950391915786; Scottish Government, 2011, SCOTT CRIM JUST SURV; Scottish Government, 2012, SCOTT GOV STAT B; Skipper GE, 2004, ALCOHOL ALCOHOLISM, V39, P445, DOI 10.1093/alcalc/agh078; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Wolfson M, 2012, ALCOHOL CLIN EXP RES, V36, P1767, DOI 10.1111/j.1530-0277.2012.01786.x; World Health Organization, 2011, GLOB STAT REP ALC HL	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67386	10.1371/journal.pone.0067386	http://dx.doi.org/10.1371/journal.pone.0067386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825656	gold, Green Published, Green Accepted			2022-12-27	WOS:000321223000099
J	Wan, B; Qiao, SL; Li, P; Jin, QY; Liu, YC; Bao, DK; Liu, MY; Wang, YB; Zhang, GP				Wan, Bo; Qiao, Songlin; Li, Peng; Jin, Qianyue; Liu, Yunchao; Bao, Dengke; Liu, Mingyang; Wang, Yinbiao; Zhang, Gaiping			Impairment of the Antibody-Dependent Phagocytic Function of PMNs through Regulation of the Fc gamma Rs Expression after Porcine Reproductive and Respiratory Syndrome Virus Infection	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; ISOLATE ATCC VR-2332; TIME RT-PCR; ALVEOLAR MACROPHAGES; HAEMOPHILUS-PARASUIS; NEGATIVE REGULATION; MOLECULAR-CLONING; SWINE INFERTILITY; IMMUNE-COMPLEXES; GENE-EXPRESSION	Porcine reproductive and respiratory syndrome (PRRS) is identified as one of the most important etiological agents in multifactorial respiratory disease of swine and can predispose pigs to secondary infections by other pathogens, usually bacteria. To understand the mechanism for an increased susceptibility to secondary bacterial infections, we investigated the antibody-dependent phagocytosis behaviour and killing ability of PMNs after infection by PRRSV strains BJ-4 or HN07-1. PMN's antibody-dependent phagocytosis and their ability to kill E. coli were both noticeably decreased following PRRSV infection, in particular with the highly pathogenic strain HN07-1. As the change in this function of the PMNs may reflect a variation in the expression of Fc gamma Rs, the expression profiles of the activating and the inhibitory Fc gamma Rs were examined. We found that RNA expression of the inhibitory receptor Fc gamma RIIB was up-regulated post-infection, and this was greater after infection with the more virulent PRRSV strain HN07-1. The activating receptor Fc gamma RIIIA RNA expression was on the other hand inhibited to the same extent by both PRRSV strains. Neutralizing antibody titers post-infection by PRRSV strains BJ-4 or HN07-1 were also detected. All of the pigs in infection groups showed viraemia by the end of the study (56 DPI). These observations may help to understand the mechanism of increased susceptibility to secondary bacterial infections following PRRSV infection.	[Wan, Bo; Bao, Dengke; Wang, Yinbiao; Zhang, Gaiping] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China; [Wan, Bo; Qiao, Songlin; Li, Peng; Jin, Qianyue; Liu, Yunchao; Bao, Dengke; Liu, Mingyang; Wang, Yinbiao; Zhang, Gaiping] Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, Minist Agr, Key Lab Anim Immunol, Zhengzhou, Peoples R China	Jilin University; Henan Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Qiao, SL (corresponding author), Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, Minist Agr, Key Lab Anim Immunol, Zhengzhou, Peoples R China.	cdj565@gmail.com; zhanggaiping2003@163.com		Qiao, Songlin/0000-0001-9731-4943	National Natural Science Foundation of China [31272546, U1204327]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 31272546 and No. U1204327) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; ANDERSON CL, 1987, METHOD ENZYMOL, V150, P524; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Cavanagh D, 1997, ARCH VIROL, V142, P629; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; DEBETS JMH, 1988, J IMMUNOL, V141, P1197; DEHAAS M, 1995, BLOOD, V86, P2403, DOI 10.1182/blood.V86.6.2403.bloodjournal8662403; Diaz I, 2005, J GEN VIROL, V86, P1943, DOI 10.1099/vir.0.80959-0; DINARELLO CA, 1992, IMMUNOL REV, V127, P119, DOI 10.1111/j.1600-065X.1992.tb01411.x; ERBE DV, 1990, MOL IMMUNOL, V27, P57, DOI 10.1016/0161-5890(90)90060-D; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; FANGER MW, 1989, IMMUNOL TODAY, V10, P92, DOI 10.1016/0167-5699(89)90234-X; FENTON MJ, 1987, J IMMUNOL, V138, P3972; Fernandez MC, 1996, J LEUKOCYTE BIOL, V59, P598, DOI 10.1002/jlb.59.4.598; Fraile L, 2009, CAN J VET RES, V73, P308; Godornes C, 2007, CYTOKINE, V38, P1, DOI 10.1016/j.cyto.2007.04.002; GRESHAM HD, 1988, J CLIN INVEST, V82, P1192, DOI 10.1172/JCI113716; GROSCHUP MH, 1993, J VET MED B, V40, P681, DOI 10.1111/j.1439-0450.1993.tb00192.x; HALLORAN PJ, 1994, J IMMUNOL, V153, P2631; HALLORAN PJ, 1994, CELL IMMUNOL, V158, P400, DOI 10.1006/cimm.1994.1286; Jie HB, 2009, MOL IMMUNOL, V46, P1189, DOI 10.1016/j.molimm.2008.11.013; Jusa ER, 1996, J VET MED SCI, V58, P749, DOI 10.1292/jvms.58.749; LIAO GJ, 1994, J LEUKOCYTE BIOL, V55, P702, DOI 10.1002/jlb.55.6.702; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunney JK, 2010, VIRAL IMMUNOL, V23, P127, DOI 10.1089/vim.2009.0087; Malbec O, 1998, J IMMUNOL, V160, P1647; Malbec O, 1999, J IMMUNOL, V162, P4424; Martinez E, 2008, RES VET SCI, V85, P184, DOI 10.1016/j.rvsc.2007.10.003; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; Matsuda T, 1999, SHOCK, V12, P365; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; MORGAN EL, 1988, J IMMUNOL, V140, P3014; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Qiao SL, 2006, VET IMMUNOL IMMUNOP, V114, P178, DOI 10.1016/j.vetimm.2006.06.012; Qiao SL, 2011, VET MICROBIOL, V149, P213, DOI 10.1016/j.vetmic.2010.11.006; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Robbie-Ryan M, 2003, J IMMUNOL, V170, P1630, DOI 10.4049/jimmunol.170.4.1630; Rodriguez ME, 2001, J IMMUNOL, V167, P6545, DOI 10.4049/jimmunol.167.11.6545; ROTHLEIN R, 1982, J IMMUNOL, V129, P1859; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SKOOG WA, 1956, BLOOD, V11, P436, DOI 10.1182/blood.V11.5.436.436; Solano GI, 1997, VET MICROBIOL, V55, P247, DOI 10.1016/S0378-1135(96)01325-9; Solano GI, 1998, CAN J VET RES, V62, P251; Syam S, 2010, J IMMUNOL, V184, P2966, DOI 10.4049/jimmunol.0900016; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Thanawongnuwech R, 1998, VET PATHOL, V35, P398, DOI 10.1177/030098589803500509; TOSI MF, 1988, J IMMUNOL, V141, P2097; TREFZ G, 1987, BIOL CHEM H-S, V368, P1343, DOI 10.1515/bchm3.1987.368.2.1343; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Unkeless J C, 1995, Semin Immunol, V7, P37, DOI 10.1016/1044-5323(95)90006-3; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Yang JWJ, 2004, VET IMMUNOL IMMUNOP, V101, P123, DOI 10.1016/j.vetimm.2004.04.018; YOON IJ, 1994, J VET DIAGN INVEST, V6, P289; Yoon KJ, 1996, VIRAL IMMUNOL, V9, P51, DOI 10.1089/vim.1996.9.51; Zhang GP, 2006, IMMUNOGENETICS, V58, P845, DOI 10.1007/s00251-006-0143-0; Zhou YJ, 2009, VIRUS RES, V144, P136, DOI 10.1016/j.virusres.2009.04.013	63	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66965	10.1371/journal.pone.0066965	http://dx.doi.org/10.1371/journal.pone.0066965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825597	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000051
J	Barton, MD; Barton, HA				Barton, Michael D.; Barton, Hazel A.			Genomer - A Swiss Army Knife for Genome Scaffolding	PLOS ONE			English	Article							SOFTWARE	The increasing accessibility and reduced costs of sequencing has made genome analysis accessible to more and more researchers. Yet there remains a steep learning curve in the subsequent computational steps required to process raw reads into a database-deposited genome sequence. Here we describe "Genomer,'' a tool to simplify the manual tasks of finishing and uploading a genome sequence to a database. Genomer can format a genome scaffold into the common files required for submission to GenBank. This software also simplifies updating a genome scaffold by allowing a human-readable YAML format file to be edited instead of large sequence files. Genomer is written as a command line tool and is an effort to make the manual process of genome scaffolding more robust and reproducible. Extensive documentation and video tutorials are available at http://next.gs.	[Barton, Michael D.; Barton, Hazel A.] Univ Akron, Dept Biol, Akron, OH 44325 USA	University of Akron	Barton, MD (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	mail@michaelbarton.me.uk		Barton, Hazel/0000-0001-8585-9997; Barton, Michael/0000-0002-0064-2279	National Institute for Health: IDeA Network of Biomedical Research Excellence (KY-INBRE) grant [NIH 2P20 RR016481-09]; NIH R15 AREA Program grant [R15GM079775]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM079775] Funding Source: NIH RePORTER	National Institute for Health: IDeA Network of Biomedical Research Excellence (KY-INBRE) grant; NIH R15 AREA Program grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute for Health: IDeA Network of Biomedical Research Excellence (KY-INBRE) grant (NIH 2P20 RR016481-09) and the NIH R15 AREA Program grant (R15GM079775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton MD, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-4; Beckloff Nicholas, 2012, Methods Mol Biol, V881, P471, DOI 10.1007/978-1-61779-827-6_16; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Lopez-Fernandez H, 2011, NUCLEIC ACIDS RES, V39, pW562, DOI 10.1093/nar/gkr439; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Matsumoto Yukihiro, RUBY PROGRAMMING LAN; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Tanaka N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-368; Torvalds L., GIT DISTRIBUTED REVI; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Wilkinson MD, 2002, BIOINFORMATICS, V18, P1398, DOI 10.1093/bioinformatics/18.10.1398	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66922	10.1371/journal.pone.0066922	http://dx.doi.org/10.1371/journal.pone.0066922			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826173	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400083
J	Baxter, AJ; Patton, G; Scott, KM; Degenhardt, L; Whiteford, HA				Baxter, Amanda J.; Patton, George; Scott, Kate M.; Degenhardt, Louisa; Whiteford, Harvey A.			Global Epidemiology of Mental Disorders: What Are We Missing?	PLOS ONE			English	Article							MAJOR DEPRESSION; SCREENING INSTRUMENTS; ANXIETY DISORDERS; HEALTH SURVEY; PREVALENCE; POPULATION; MORTALITY; SCHIZOPHRENIA; SYMPTOMS; SAMPLE	Background: Population-based studies provide the understanding of health-need required for effective public health policy and service-planning. Mental disorders are an important but, until recently, neglected agenda in global health. This paper reviews the coverage and limitations in global epidemiological data for mental disorders and suggests strategies to strengthen the data. Methods: Systematic reviews were conducted for population-based epidemiological studies in mental disorders to inform new estimates for the global burden of disease study. Estimates of population coverage were calculated, adjusted for study parameters (age, gender and sampling frames) to quantify regional coverage. Results: Of the 77,000 data sources identified, fewer than 1% could be used for deriving national estimates of prevalence, incidence, remission, and mortality in mental disorders. The two major limitations were (1) highly variable regional coverage, and (2) important methodological issues that prevented synthesis across studies, including the use of varying case definitions, the selection of samples not allowing generalization, lack of standardized indicators, and incomplete reporting. North America and Australasia had the most complete prevalence data for mental disorders while coverage was highly variable across Europe, Latin America, and Asia Pacific, and poor in other regions of Asia and Africa. Nationally-representative data for incidence, remission, and mortality were sparse across most of the world. Discussion: Recent calls to action for global mental health were predicated on the high prevalence and disability of mental disorders. However, the global picture of disorders is inadequate for planning. Global data coverage is not commensurate with other important health problems, and for most of the world's population, mental disorders are invisible and remain a low priority.	[Baxter, Amanda J.; Whiteford, Harvey A.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Baxter, Amanda J.; Whiteford, Harvey A.] Queensland Ctr Mental Hlth Res, Wacol, Australia; [Patton, George] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Patton, George] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Scott, Kate M.] Univ Otago, Dept Psychol Med, Dunedin, New Zealand; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Sch Populat Hlth, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of Melbourne; Murdoch Children's Research Institute; University of Otago; University of New South Wales Sydney; University of Melbourne	Baxter, AJ (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	amanda_baxter@qcmhr.uq.edu.au	Degenhardt, Louisa J/D-4515-2012; Patton, George C/B-5246-2013; Whiteford, Harvey A/A-4840-2009; Ribeiro, Ana Cristina/HHN-7466-2022; Baxter, Amanda/E-5449-2011	Degenhardt, Louisa J/0000-0002-8513-2218; Patton, George C/0000-0001-5039-8326; Whiteford, Harvey A/0000-0003-4667-6623; Ribeiro, Ana Cristina/0000-0002-0493-8376; Baxter, Amanda/0000-0001-8198-9022	Queensland Department of Health; NH&MRC Senior Research Fellowships	Queensland Department of Health; NH&MRC Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	Core funding for QCMHR is provided by the Queensland Department of Health. George Patton and Louisa Degenhardt are funded by NH&MRC Senior Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Saba MB, 1999, J TRAUMA STRESS, V12, P201, DOI 10.1023/A:1024766920789; Afifi M., 2007, SMJ Singapore Medical Journal, V48, P385; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews G, 1999, PSYCHOL MED, V29, P797; [Anonymous], 2008, WHO WORLD MENTAL HLT; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Baxter AJ, 2011, FACTORS INFLUENCING; Beard JR, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-83; Bennett D, 2004, BRIT J PSYCHIAT, V185, P312, DOI 10.1192/bjp.185.4.312; Bobak M, 2006, BRIT J PSYCHIAT, V188, P359, DOI 10.1192/bjp.188.4.359; BRUCE ML, 1994, AM J PSYCHIAT, V151, P716; Burns JK, 2011, EUROPEAN SCI EDITING, V37, P4; Erskine HE, 2013, INT J EAT D IN PRESS; Fergusson DM, 2007, BRIT J PSYCHIAT, V191, P335, DOI 10.1192/bjp.bp.107.036079; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Ferrari AJ, 2011, J AFFECT DISORDERS, V134, P1, DOI 10.1016/j.jad.2010.11.007; Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7; Guiao I Z, 1994, Health Care Women Int, V15, P197; Harrison G, 2001, BRIT J PSYCHIAT, V178, P506, DOI 10.1192/bjp.178.6.506; Herrman Helen, 2010, Indian J Psychiatry, V52, pS43, DOI 10.4103/0019-5545.69207; Hollander AC, 2007, J NERV MENT DIS, V195, P955, DOI 10.1097/NMD.0b013e318159604b; Hollingworth SA, 2010, AUST NZ J PSYCHIAT, V44, P513, DOI 10.3109/00048670903555138; Horton R, 2007, LANCET, V6736, P61243; Hoyer J, 2002, J ANXIETY DISORD, V16, P113, DOI 10.1016/S0887-6185(01)00094-9; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; KOUZIS A, 1995, SOC PSYCH PSYCH EPID, V30, P165, DOI 10.1007/BF00790655; Kruijshaar ME, 2005, EUR J EPIDEMIOL, V20, P103, DOI 10.1007/s10654-004-1009-0; Levy BS, 2009, ANNU REV PUBL HEALTH, V30, P123, DOI 10.1146/annurev.publhealth.031308.100147; Lorenzo C R, 2002, Eat Weight Disord, V7, P202; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; Modrzejewska Renata, 2006, Psychiatr Pol, V40, P1117; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; Moffitt TE, 2007, ARCH GEN PSYCHIAT, V64, P651, DOI 10.1001/archpsyc.64.6.651; Mogga S, 2006, BRIT J PSYCHIAT, V189, P241, DOI 10.1192/bjp.bp.105.013417; MURPHY JM, 1987, ARCH GEN PSYCHIAT, V44, P473; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; Murray CJL, 1996, THE GLOBAL BURDEN OF; Patel V, 2008, LANCET, V372, P1354, DOI 10.1016/S0140-6736(08)61556-1; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Rastam M, 2003, EUR CHILD ADOLESC S1, V12, pI78, DOI DOI 10.1007/S00787-003-1111-Y; Reddy YGJ, 2003, ACTA PSYCHIAT SCAND, V107, P457; Richardson AJ, 2000, PROSTAG LEUKOTR ESS, V63, P79, DOI 10.1054/plef.2000.0196; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Schuurmans J, 2005, ACTA PSYCHIAT SCAND, V111, P420, DOI 10.1111/j.1600-0447.2005.00531.x; Scott KM, 2009, GLOBAL PERSPECTIVES; Sihvola E, 2010, EARLY ONSET DEPRESSI; Slade T, 2005, PSYCHOL MED, V35, P489, DOI 10.1017/S0033291704003708; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TEPLIN LA, 1990, AM J PUBLIC HEALTH, V80, P663, DOI 10.2105/AJPH.80.6.663; Van Hout HPJ, 2004, BRIT J PSYCHIAT, V185, P399, DOI 10.1192/bjp.185.5.399; Ventevogel P, 2007, SOC PSYCH PSYCH EPID, V42, P328, DOI 10.1007/s00127-007-0161-8; Wang JL, 2004, MED CARE, V42, P543, DOI 10.1097/01.mlr.0000128001.73998.5c; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Whiteford HA, 2012, MENTAL DISO IN PRESS; WHO, 2012, ICD 10 CLASS MENT BE; WHO, 2001, WORLD HLTH REPORT 20; Youngstrom E, 2005, BIOL PSYCHIAT, V58, P569, DOI 10.1016/j.biopsych.2005.04.004	61	112	118	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e65514	10.1371/journal.pone.0065514	http://dx.doi.org/10.1371/journal.pone.0065514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23826081	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400003
J	Smid, M; Dielis, AWJH; Spronk, HMH; Rumley, A; van Oerle, R; Woodward, M; ten Cate, H; Lowe, G				Smid, Machiel; Dielis, Arne W. J. H.; Spronk, Henri M. H.; Rumley, Ann; van Oerle, Rene; Woodward, Mark; ten Cate, Hugo; Lowe, Gordon			Thrombin Generation in the Glasgow Myocardial Infarction Study	PLOS ONE			English	Article							CORN TRYPSIN-INHIBITOR; TISSUE FACTOR; PLASMA; COAGULATION; SYSTEM; STABILITY; PROTEIN; DISEASE	Background: Thrombin is a key protease in coagulation also implicated in complex pathology including atherosclerosis. To address the role of thrombin in relation to myocardial infarction (MI) we explored thrombin generation analysis in plasma from patients and controls that had participated in the Glasgow MI Study (GLAMIS). Methods: Thrombin generation at 1 and 2 pM TF and with and without thrombomodulin (TM) was performed on plasmas from 356 subjects (171 cases, 185 age and sex matched controls) from GLAMIS collected between 3 and 9 months after the MI event. Results: Although thrombin generation was slightly delayed in cases (lag time increased from 3.3 to 3.6 min) at the highest trigger, the overall potential to generate thrombin was increased by 7% for the ETP and by 15% for the peak height (both at the 1 pM TF trigger) in cases. Addition of TM did not reveal differences. Furthermore, an increased thrombin generation was associated with MI [normalized ETP: adjusted OR for the highest percentile = 2.4 (95% CI 1.3-4.5) and normalized peak height: adjusted OR = 2.6 (1.3-5.0)] at the lowest trigger; normalized ETP and peak height being 2.1 (1.1-3.8) and 2.0 (1.0-4.1) at the higher 2 pM trigger. Conclusion: In GLAMIS, patients with a previous MI had an increased thrombin generation compared to controls. The absence of a clear difference in TM reduction suggests an unaltered anticoagulant activity in these patients. Further research is needed in order to unravel the underlying mechanisms of enhanced thrombin generation after MI.	[Smid, Machiel; Dielis, Arne W. J. H.; Spronk, Henri M. H.; van Oerle, Rene; ten Cate, Hugo] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Lab Clin Thrombosis & Haemostasis, Maastricht, Netherlands; [Rumley, Ann; Lowe, Gordon] Univ Glasgow, Inst Cardiovasc & Med Studies, Glasgow, Lanark, Scotland; [Woodward, Mark] Univ Sydney, George Inst, Sydney, NSW 2006, Australia	Maastricht University; University of Glasgow; University of Sydney	ten Cate, H (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Lab Clin Thrombosis & Haemostasis, Maastricht, Netherlands.	h.tencate@maastrichtuniversity.nl	Woodward, Mark/L-6817-2017; Woodward, Mark/D-8492-2015; Cate, Hugo ten/AAM-4000-2021	Woodward, Mark/0000-0001-9800-5296; Spronk, Henri/0000-0002-3858-334X; ten Cate, Hugo/0000-0001-7796-4463				Beijers HJBH, 2010, ARTERIOSCL THROM VAS, V30, P2639, DOI 10.1161/ATVBAHA.110.211946; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; BROZOVIC M, 1971, J CLIN PATHOL, V24, P690, DOI 10.1136/jcp.24.8.690; DAAE LNW, 1993, SCAND J CLIN LAB INV, V53, P19, DOI 10.3109/00365519309090694; Dargaud Y, 2007, BRIT J HAEMATOL, V139, P303, DOI 10.1111/j.1365-2141.2007.06785.x; Dielis AWJH, 2008, J THROMB HAEMOST, V6, P125; KOERNER K, 1984, INFUS KLIN ERN, V11, P46; Lowe G, 2006, BR J HAEMATOL; Lowe GDO, 2003, J THROMB HAEMOST, V1, P2312, DOI 10.1046/j.1538-7836.2003.00467.x; Macchia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032894; Mobarrez F, 2011, THROMB HAEMOSTASIS, V106, P344, DOI 10.1160/TH10-12-0810; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; Smid M, 2011, J THROMB HAEMOST, V9, P450, DOI 10.1111/j.1538-7836.2010.04162.x; Spronk HMH, 2008, THROMB HAEMOSTASIS, V100, P362, DOI 10.1160/TH08-03-0141; Spronk HMH, 2009, THROMB HAEMOSTASIS, V101, P1156, DOI 10.1160/TH08-10-0670; Tobin WO, 2013, J NEUROL, V260, P590, DOI 10.1007/s00415-012-6684-2; Undas A, 2005, ARTERIOSCL THROM VAS, V25, P287, DOI 10.1161/01.ATV.0000151647.14923.ec; Van Veen JJ, 2008, BLOOD COAGUL FIBRIN, V19, P183, DOI 10.1097/MBC.0b013e3282f4bb47; Winckers K, 2011, J THROMB HAEMOST, V9, P2243, DOI 10.1111/j.1538-7836.2011.04497.x; Woodward M, 2006, BLOOD COAGUL FIBRIN, V17, P1, DOI 10.1097/01.mbc.0000195919.71950.f7	20	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66977	10.1371/journal.pone.0066977	http://dx.doi.org/10.1371/journal.pone.0066977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826181	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000321738400090
J	Brunberg, E; Jensen, P; Isaksson, A; Keeling, LJ				Brunberg, Emma; Jensen, Per; Isaksson, Anders; Keeling, Linda J.			Behavioural and Brain Gene Expression Profiling in Pigs during Tail Biting Outbreaks - Evidence of a Tail Biting Resistant Phenotype	PLOS ONE			English	Article							GHRELIN; STRESS	Abnormal tail biting behaviour is a major welfare problem for pigs receiving the behaviour, as well as an indication of decreased welfare in the pigs performing it. However, not all pigs in a pen perform or receive tail biting behaviour and it has recently been shown that these 'neutral' pigs not only differ in their behaviour, but also in their gene expression compared to performers and receivers of tail biting in the same pen. To investigate whether this difference was linked to the cause or a consequence of them not being involved in the outbreak of tail biting, behaviour and brain gene expression was compared with 'control' pigs housed in pens with no tail biting. It was shown that the pigs housed in control pens performed a wider variety of pig-directed abnormal behaviour (belly nosing 0.95 +/- 1.59, tail in mouth 0.31 +/- 0.60 and 'other' abnormal 1.53 +/- 4.26; mean +/- S.D) compared to the neutral pigs (belly nosing 0.30 +/- 0.62, tail in mouth 0.13 +/- 0.50 and "other" abnormal 0.42 +/- 1.06). With Affymetrix gene expression arrays, 107 transcripts were identified as differently expressed (p < 0.05) between these two categories of pigs. Several of these transcripts had already been shown to be differently expressed in the neutral pigs when they were compared to performers and receivers of tail biting in the same pen in an earlier study. Hence, the different expression of these genes cannot be a consequence of the neutral pigs not being involved in tail biting behaviour, but rather linked to the cause contributing to why they were not involved in tail biting interactions. These neutral pigs seem to have a genetic and behavioural profile that somehow contributes to them being resistant to performing or receiving pig-directed abnormal behaviour, such as tail biting, even when housed in an environment that elicits that behaviour in other pigs.	[Brunberg, Emma; Keeling, Linda J.] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden; [Jensen, Per] Linkoping Univ, IFM Biol, Linkoping, Sweden; [Isaksson, Anders] Uppsala Univ, Sci Life Lab, Dept Med Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences; Linkoping University; Uppsala University	Brunberg, E (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden.	emma.brunberg@bioforsk.no	Keeling, Linda J/K-6542-2012	Keeling, Linda J/0000-0003-2629-0117; Isaksson, Anders/0000-0001-6576-7825	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning through Centre for functional genetics; Nordic Joint Commitee for Agricultural and Food Research	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning through Centre for functional genetics; Nordic Joint Commitee for Agricultural and Food Research	The study was funded by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (www.formas.se) through Centre for functional genetics (www.cfg.uu.se) and by the Nordic Joint Commitee for Agricultural and Food Research (www.nkj.nu) through the project "Tail biting and tail docking in the pig: biological mechanisms, prevention, treatment and economic aspects". The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Beattie VE, 2005, ANIM SCI, V80, P307, DOI 10.1079/ASC40040307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breuer K, 2005, LIVEST PROD SCI, V93, P87, DOI 10.1016/j.livprodsci.2004.11.009; Brunberg E, 2013, GENES BRAIN BEHAV, V12, P275, DOI 10.1111/gbb.12002; Brunberg E, 2011, POULTRY SCI, V90, P1145, DOI 10.3382/ps.2010-00961; Brunberg E, 2011, APPL ANIM BEHAV SCI, V133, P18, DOI 10.1016/j.applanim.2011.04.019; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Edwards SA, 2006, VET J, V171, P198, DOI 10.1016/j.tvjl.2005.04.010; EFSA, 2007, SCI REP RISKS ASS TA; Hillman JB, 2011, DISCOV MED, V11, P521; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keltikangas-Jarvinen L, 2006, GENES BRAIN BEHAV, V5, P11, DOI 10.1111/j.1601-183X.2005.00125.x; Kodomari I, 2009, NEUROCHEM INT, V54, P222, DOI 10.1016/j.neuint.2008.11.006; Kristenssson E, 2006, REGUL PEPTIDES, V134, P114, DOI 10.1016/j.regpep.2006.02.003; Lan J, 2009, MOL BIOL REP, V36, P2003, DOI 10.1007/s11033-008-9411-4; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Moinard C, 2003, APPL ANIM BEHAV SCI, V81, P333, DOI 10.1016/S0168-1591(02)00276-9; Nishizawa T, 2006, J CLIN BIOCHEM NUTR, V38, P33, DOI 10.3164/jcbn.38.33; Poletto R, 2006, BRAIN RES, V1068, P7, DOI 10.1016/j.brainres.2005.11.012; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Statham P, 2009, APPL ANIM BEHAV SCI, V121, P157, DOI 10.1016/j.applanim.2009.09.011; VANPUTTEN G, 1969, BRIT VET J, V125, P511, DOI 10.1016/S0007-1935(17)48710-0; ZAYAN R, 1991, BEHAV PROCESS, V25, P81, DOI 10.1016/0376-6357(91)90011-N; Zonderland JJ, 2011, ANIMAL, V5, P767, DOI 10.1017/S1751731110002326	27	20	20	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66513	10.1371/journal.pone.0066513	http://dx.doi.org/10.1371/journal.pone.0066513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824700	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400119
J	Chen, G; Chen, JW; Shi, CP; Shi, LM; Tong, WD; Shi, TL				Chen, Geng; Chen, Jiwei; Shi, Caiping; Shi, Leming; Tong, Weida; Shi, Tieliu			Dissecting the Characteristics and Dynamics of Human Protein Complexes at Transcriptome Cascade Using RNA-Seq Data	PLOS ONE			English	Article							MESSENGER-RNA; EXPRESSION; QUANTIFICATION; INTERACTOME; CANCER; ANNOTATION; LANDSCAPE; NETWORK; GENOME	Human protein complexes play crucial roles in various biological processes as the functional module. However, the expression features of human protein complexes at the transcriptome cascade are poorly understood. Here, we used the RNA-Seq data from 16 disparate tissues and four types of human cancers to explore the characteristics and dynamics of human protein complexes. We observed that many individual components of human protein complexes can be generated by multiple distinct transcripts. Similar with yeast, the human protein complex constituents are inclined to co-express in diverse tissues. The dominant isoform of the genes involved in protein complexes tend to encode the complex constituents in each tissue. Our results indicate that the protein complex dynamics not only correlate with the presence or absence of complexes, but may also be related to the major isoform switching for complex subunits. Between any two cancers of breast, colon, lung and prostate, we found that only a few of the differentially expressed transcripts associated with complexes were identical, but 5-10 times more protein complexes involved in differentially expressed transcripts were common. Collectively, our study reveals novel properties and dynamics of human protein complexes at the transcriptome cascade in diverse normal tissues and different cancers.	[Chen, Geng; Chen, Jiwei; Shi, Caiping; Shi, Tieliu] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Ctr Bioinformat & Computat Biol, Shanghai 200062, Peoples R China; [Chen, Geng; Chen, Jiwei; Shi, Caiping; Shi, Tieliu] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Shi, Leming; Tong, Weida] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	East China Normal University; East China Normal University; US Food & Drug Administration (FDA)	Shi, TL (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Ctr Bioinformat & Computat Biol, Shanghai 200062, Peoples R China.	tieliushi01@gmail.com	Shi, Leming/B-3150-2010	Shi, Leming/0000-0002-7143-2033; Chen, Jiwei/0000-0002-8783-8134; chen, jiwei/0000-0001-6550-331X; Chen, Geng/0000-0002-3452-9434	National 973 Key Basic Research Program [2010CB945401, 2012CB910400]; National Natural Science Foundation of China [31240038, 31071162, 31000590]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]; Graduate School of East China Normal University	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Graduate School of East China Normal University	This work was supported by the National 973 Key Basic Research Program (Grant Nos. 2010CB945401 and 2012CB910400), the National Natural Science Foundation of China (Grant No. 31240038, 31071162, and 31000590), the Science and Technology Commission of Shanghai Municipality (11DZ2260300) and the Graduate School of East China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Chen G, 2013, RNA, V19, P479, DOI 10.1261/rna.037473.112; Chen G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-590; Chen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028318; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1121, DOI 10.1007/s11427-011-4255-x; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Michaut M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001092; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Pereira-Leal JB, 2006, PHILOS T R SOC B, V361, P507, DOI 10.1098/rstb.2005.1807; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wang C, 2013, HUM GENET IN PRESS; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang QH, 2012, EUR J HUM GENET, V20, P1162, DOI 10.1038/ejhg.2012.74; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100	48	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66521	10.1371/journal.pone.0066521	http://dx.doi.org/10.1371/journal.pone.0066521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824284	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400121
J	Pacheco, SA; Powers, KM; Engelmann, F; Messaoudi, I; Purdy, GE				Pacheco, Sophia A.; Powers, Katelyn M.; Engelmann, Flora; Messaoudi, Ilhem; Purdy, Georgiana E.			Autophagic Killing Effects against Mycobacterium tuberculosis by Alveolar Macrophages from Young and Aged Rhesus Macaques	PLOS ONE			English	Article							CD8 T-CELLS; LATENT TUBERCULOSIS; EARLY RESISTANCE; MICE; IMMUNITY; EXPRESSION; PHAGOSOMES; SURVIVAL; ACIDIFICATION; REACTIVATION	Non-human primates, notably rhesus macaques (Macaca mulatta, RM), provide a robust experimental model to investigate the immune response to and effective control of Mycobacterium tuberculosis infections. Changes in the function of immune cells and immunosenescence may contribute to the increased susceptibility of the elderly to tuberculosis. The goal of this study was to examine the impact of age on M. tuberculosis host-pathogen interactions following infection of primary alveolar macrophages derived from young and aged rhesus macaques. Of specific interest to us was whether the mycobactericidal capacity of autophagic macrophages was reduced in older animals since decreased autophagosome formation and autophagolysosomal fusion has been observed in other cells types of aged animals. Our data demonstrate that alveolar macrophages from old RM are as competent as those from young animals for autophagic clearance of M. tuberculosis infection and controlling mycobacterial replication. While our data do not reveal significant differences between alveolar macrophage responses to M. tuberculosis by young and old animals, these studies are the first to functionally characterize autophagic clearance of M. tuberculosis by alveolar macrophages from RM.	[Pacheco, Sophia A.; Powers, Katelyn M.; Messaoudi, Ilhem; Purdy, Georgiana E.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Engelmann, Flora; Messaoudi, Ilhem] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Engelmann, Flora; Messaoudi, Ilhem] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA	Oregon Health & Science University; University of California System; University of California Riverside; Oregon Health & Science University; Oregon National Primate Research Center	Purdy, GE (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	purdyg@ohsu.edu			Pacific Northwest Regional Center for Excellence for Emerging Infections and Biodefense Career Development Award [U54 AI081680]; Medical Research Foundation of Oregon New Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI081680] Funding Source: NIH RePORTER	Pacific Northwest Regional Center for Excellence for Emerging Infections and Biodefense Career Development Award; Medical Research Foundation of Oregon New Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Pacific Northwest Regional Center for Excellence for Emerging Infections and Biodefense (U54 AI081680) Career Development Award and a Medical Research Foundation of Oregon New Investigator Award to G.E.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389; Boehmer ED, 2005, MECH AGEING DEV, V126, P1305, DOI 10.1016/j.mad.2005.07.009; Choi HS, 2002, AM J RESP CRIT CARE, V166, P178, DOI 10.1164/rccm.2201023; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Diedrich CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009611; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Flynn JL, 2003, TUBERCULOSIS, V83, P116, DOI 10.1016/S1472-9792(02)00059-8; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HIGASHIMOTO Y, 1993, MECH AGEING DEV, V69, P207, DOI 10.1016/0047-6374(93)90024-L; Kaushal D, 2012, J MED PRIMATOL, V41, P191, DOI 10.1111/j.1600-0684.2012.00536.x; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Mancuso P, 2001, MECH AGEING DEV, V122, P1899, DOI 10.1016/S0047-6374(01)00322-0; Mehra S, 2011, J MED PRIMATOL, V40, P233, DOI 10.1111/j.1600-0684.2011.00485.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; ORME IM, 1987, J IMMUNOL, V138, P4414; ORME IM, 1989, CELL IMMUNOL, V118, P229, DOI 10.1016/0008-8749(89)90372-9; Plowden J, 2004, CELL IMMUNOL, V229, P86, DOI 10.1016/j.cellimm.2004.07.001; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Rhoades ER, 1998, MECH AGEING DEV, V106, P145, DOI 10.1016/S0047-6374(98)00113-4; Rottinghaus EK, 2010, MECH AGEING DEV, V131, P405, DOI 10.1016/j.mad.2010.05.006; Safi H, 2003, AIDS RES HUM RETROV, V19, P585, DOI 10.1089/088922203322230950; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Turner J, 2002, INFECT IMMUN, V70, P4628, DOI 10.1128/IAI.70.8.4628-4637.2002; Vesosky B, 2006, EXP GERONTOL, V41, P1185, DOI 10.1016/j.exger.2006.08.006; Vesosky B, 2009, INFECT IMMUN, V77, P3355, DOI 10.1128/IAI.00295-09; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Via LE, 1998, J CELL SCI, V111, P897; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66985	10.1371/journal.pone.0066985	http://dx.doi.org/10.1371/journal.pone.0066985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825603	Green Submitted, gold, Green Published			2022-12-27	WOS:000320576400173
J	Sakai, F; Talekar, SJ; Klugman, KP; Vidal, JE				Sakai, Fuminori; Talekar, Sharmila J.; Klugman, Keith P.; Vidal, Jorge E.		Investigators Grp	Expression of Streptococcus pneumoniae Virulence-Related Genes in the Nasopharynx of Healthy Children	PLOS ONE			English	Article							SURFACE PROTEIN-A; TIME PCR ASSAYS; PNEUMOCOCCAL CARRIAGE; ANTIBODY-RESPONSE; BIOFILM FORMATION; GENOME SEQUENCE; ADHESIN-A; PNEUMOLYSIN; COLONIZATION; PROTECTION	Colonization and persistence in the human nasopharynx are prerequisites for Streptococcus pneumoniae disease and carriage acquisition, which normally occurs during early childhood. Animal models and in vitro studies (i.e. cell adhesion and cell cytotoxicity assays) have revealed a number of colonization and virulence factors, as well as regulators, implicated in nasopharyngeal colonization and pathogenesis. Expression of genes encoding these factors has never been studied in the human nasopharynx. Therefore, this study analyzed expression of S. pneumoniae virulence-related genes in human nasopharyngeal samples. Our experiments first demonstrate that a density of >= 10(4) CFU/ml of S. pneumoniae cells in the nasopharynx provides enough DNA and RNA to amplify the lytA gene by conventional PCR and to detect the lytA message, respectively. A panel of 21 primers that amplified S. pneumoniae sequences was designed, and their specificity for S. pneumoniae sequences was analyzed in silico and validated against 20 related strains inhabitants of the human upper respiratory tract. These primers were utilized in molecular reactions to find out that all samples contained the genes ply, pavA, lytC, lytA, comD, codY, and mgrA, whereas nanA, nanB, pspA, and rrgB were present in similar to 91-98% of the samples. Gene expression studies of these 11 targets revealed that lytC, lytA, pavA and comD were the most highly expressed pneumococcal genes in the nasopharynx whereas the rest showed a moderate to low level of expression. This is the first study to evaluate expression of virulence- and, colonization-related genes in the nasopharynx of healthy children and establishes the foundation for future gene expression studies during human pneumococcal disease.	[Sakai, Fuminori; Talekar, Sharmila J.; Klugman, Keith P.; Vidal, Jorge E.; Investigators Grp] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Vidal, JE (corresponding author), Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	jvidalg@emory.edu	Lanata, Claudio F./N-7997-2018	Lanata, Claudio F./0000-0002-6994-7425	Clinical and Translational Science Award program [UL1 RR025008]; NIH; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER	Clinical and Translational Science Award program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by PHS Grant UL1 RR025008 from the Clinical and Translational Science Award program, NIH, National Center for Research Resources (JEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051; Domenech M, 2013, ENVIRON MICROBIOL, V15, P502, DOI 10.1111/j.1462-2920.2012.02853.x; Douce G, 2010, VACCINE, V28, P3231, DOI 10.1016/j.vaccine.2010.02.014; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Eldholm V, 2009, MICROBIOL-SGM, V155, P2223, DOI 10.1099/mic.0.026328-0; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jounio U, 2010, CLIN RESPIR J, V4, P222, DOI 10.1111/j.1752-699X.2009.00179.x; Joyce EA, 2004, INFECT IMMUN, V72, P2964, DOI 10.1128/IAI.72.5.2964-2975.2004; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Moreno AT, 2012, CLIN VACCINE IMMUNOL, V19, P499, DOI 10.1128/CVI.05706-11; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Park HK, 2010, FEMS MICROBIOL LETT, V310, P48, DOI 10.1111/j.1574-6968.2010.02044.x; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Pettigrew MM, 2006, INFECT IMMUN, V74, P3360, DOI 10.1128/IAI.01442-05; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Rapola S, 2001, PEDIATR INFECT DIS J, V20, P482, DOI 10.1097/00006454-200105000-00003; Rapola S, 2000, J INFECT DIS, V182, P1146, DOI 10.1086/315822; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Rodgers Gail L, 2011, Vaccine, V29 Suppl 3, pC43, DOI 10.1016/j.vaccine.2011.07.047; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; RUBINS JB, 1992, INFECT IMMUN, V60, P1740, DOI 10.1128/IAI.60.5.1740-1746.1992; Salha D, 2012, INFECT IMMUN, V80, P2212, DOI 10.1128/IAI.06348-11; Seo SU, 2012, VACCINE, V30, P6816, DOI 10.1016/j.vaccine.2012.09.015; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Simell B, 2001, J INFECT DIS, V183, P887, DOI 10.1086/319246; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Sommer F, 2012, RHINOLOGY, V50, P157, DOI 10.4193/Rhino11.231; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Vadesilho CFM, 2012, MICROB PATHOGENESIS, V53, P243, DOI 10.1016/j.micpath.2012.08.007; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vidal JE, 2013, INFECT IMMUN, V81, P1341, DOI 10.1128/IAI.01096-12; Vidal JE, 2011, INFECT IMMUN, V79, P4050, DOI 10.1128/IAI.05186-11; Vidal JE, 2009, CELL MICROBIOL, V11, P1306, DOI 10.1111/j.1462-5822.2009.01332.x; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Wright AKA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002622; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	61	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67147	10.1371/journal.pone.0067147	http://dx.doi.org/10.1371/journal.pone.0067147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825636	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400177
J	Zhang, J				Zhang, Jay			Transcriptome Analysis Reveals Novel Entry Mechanisms and a Central Role of SRC in Host Defense during High Multiplicity Mycobacterial Infection	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NLRP3 INFLAMMASOME; GENE-EXPRESSION; FAMILY KINASES; TUBERCULOSIS; ACTIVATION; PARATUBERCULOSIS; RECOGNITION; MACROPHAGE; APOPTOSIS	Mycobacterium tuberculosis (MTB) infects an estimated one-third of the global population and is one of the main causes of mortality from an infectious agent. The characteristics of macrophages challenged by MTB with a high multiplicity of infection (MOI), which mimics both clinical disseminated infection and granuloma formation, are distinct from macrophages challenged with a low MOI. To better understand the cross talk between macrophage host cells and mycobacteria, we compared the transcription patterns of mouse macrophages infected with bacille Calmette-Guerin, H37Ra and M. smegmatis. Attention was focused on the changes in the abundance of transcripts related to immune system function. From the results of a transcriptome profiling study with a high mycobacterial MOI, we defined a pathogen-specific host gene expression pattern. The present study suggests that two integrins, ITGA5 and ITGAV, are novel cell surface receptors mediating mycobacterium entry into macrophages challenged with high MOI. Our results indicate that SRC likely plays a central role in regulating multiple unique signaling pathways activated by MTB infection. The integrated results increase our understanding of the molecular networks behind the host innate immune response and identify important targets that might be useful for the development of tuberculosis therapy.	Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Southport, Qld 4215, Australia	Griffith University; Menzies Health Institute Queensland	Zhang, J (corresponding author), Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Gold Coast Campus, Southport, Qld 4215, Australia.	jay_z@email.com			Griffith University [MSC1010]	Griffith University(Griffith University)	This work was funded by a postgraduate research account (No. MSC1010) from Griffith University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2008, FRONT BIOSCI-LANDMRK, V13, P4426, DOI 10.2741/3015; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Baruzzi A, 2008, CELL MOL LIFE SCI, V65, P2175, DOI 10.1007/s00018-008-8005-6; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Behera AK, 2006, J IMMUNOL, V177, P657, DOI 10.4049/jimmunol.177.1.657; Chen C.C., 2012, PLOS ONE, V7; Chin BY, 2009, CURR OPIN PHARMACOL, V9, P490, DOI 10.1016/j.coph.2009.06.025; Chopra M, 2011, CRIT REV TOXICOL, V41, P292, DOI 10.3109/10408444.2010.524635; Chung J, 2011, FUTURE VIROL, V6, P1319, DOI 10.2217/FVL.11.113; Coley W, 2009, EXPERT OPIN BIOL TH, V9, P1369, DOI 10.1517/14712590903257781; Colombo PE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2890; Creedon Helen, 2012, Critical Reviews in Oncogenesis, V17, P145; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Franzblau TPPaSG, 2007, CURRENT BIOACTIVE CO, V3, P8; Freudenburg W, 2010, J GEN VIROL, V91, P2278, DOI 10.1099/vir.0.022665-0; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; Karim AF, 2011, J BIOL CHEM, V286, P40307, DOI 10.1074/jbc.M111.266239; Kerkvliet NI, 2009, BIOCHEM PHARMACOL, V77, P746, DOI 10.1016/j.bcp.2008.11.021; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Kumar D, 2011, MICROBES INFECT, V13, P121, DOI 10.1016/j.micinf.2010.10.009; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lowell CA, 2011, COLD SPRING HARB PER, V3; Ma Ci, 2009, V99, P231; Maciag A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-48; Magee DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032034; Martino A, 2008, J BIOSCIENCES, V33, P137, DOI 10.1007/s12038-008-0029-4; McGarvey JA, 2004, CLIN EXP IMMUNOL, V136, P490, DOI 10.1111/j.1365-2249.2004.02490.x; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Motiwala AS, 2006, INFECT IMMUN, V74, P6046, DOI 10.1128/IAI.00326-06; Netea MG, 2011, CLIN DEV IMMUNOLOGY; O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128; Palanisamy GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026254; Rozen S, 2000, Methods Mol Biol, V132, P365; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Sharma S, 2011, J VIROL, V85, P5995, DOI 10.1128/JVI.00034-11; Thacker JD, 2012, ANTIMICROB AGENTS CH, V56, P1921, DOI 10.1128/AAC.06372-11; Ulanova M, 2009, J INNATE IMMUN, V1, P4, DOI 10.1159/000141865; van Helden PD, 2006, BMC EVOLUTIONARY BIO, V6; Velasco-Velazquez MA, 2003, MICROB PATHOGENESIS, V35, P125, DOI 10.1016/S0882-4010(03)00099-8; Wang F, 2010, PLOS ONE, V5; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wu R, 2007, J PHARMACOL EXP THER, V320, P448, DOI 10.1124/jpet.106.111773	56	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65128	10.1371/journal.pone.0065128	http://dx.doi.org/10.1371/journal.pone.0065128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824656	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400005
J	Diestel, U; Resch, M; Meinhardt, K; Weiler, S; Hellmann, TV; Mueller, TD; Nickel, J; Eichler, J; Muller, YA				Diestel, Uschi; Resch, Marcus; Meinhardt, Kathrin; Weiler, Sigrid; Hellmann, Tina V.; Mueller, Thomas D.; Nickel, Joachim; Eichler, Jutta; Muller, Yves A.			Identification of a Novel TGF-beta-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-beta-Receptor-3 (TGFR-3)	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; RECEPTOR-TYPE-III; LIGAND-BINDING; BETAGLYCAN; POLYMERIZATION; SUPERFAMILY; CORECEPTOR; MEMBRANE; PROTEINS; INSIGHTS	The zona pellucida (ZP) domain is present in extracellular proteins such as the zona pellucida proteins and tectorins and participates in the formation of polymeric protein networks. However, the ZP domain also occurs in the cytokine signaling co-receptor transforming growth factor beta (TGF-beta) receptor type 3 (TGFR-3, also known as betaglycan) where it contributes to cytokine ligand recognition. Currently it is unclear how the ZP domain architecture enables this dual functionality. Here, we identify a novel major TGF-beta-binding site in the FG loop of the C-terminal subdomain of the murine TGFR-3 ZP domain (ZP-C) using protein crystallography, limited proteolysis experiments, surface plasmon resonance measurements and synthetic peptides. In the murine 2.7 angstrom crystal structure that we are presenting here, the FG-loop is disordered, however, well-ordered in a recently reported homologous rat ZP-C structure. Surprisingly, the adjacent external hydrophobic patch (EHP) segment is registered differently in the rat and murine structures suggesting that this segment only loosely associates with the remaining ZP-C fold. Such a flexible and temporarily-modulated association of the EHP segment with the ZP domain has been proposed to control the polymerization of ZP domain-containing proteins. Our findings suggest that this flexibility also extends to the ZP domain of TGFR-3 and might facilitate co-receptor ligand interaction and presentation via the adjacent FG-loop. This hints that a similar C-terminal region of the ZP domain architecture possibly regulates both the polymerization of extracellular matrix proteins and cytokine ligand recognition of TGFR-3.	[Diestel, Uschi; Resch, Marcus; Meinhardt, Kathrin; Weiler, Sigrid; Muller, Yves A.] Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, Erlangen, Germany; [Hellmann, Tina V.; Mueller, Thomas D.] Univ Wurzburg, Lehrstuhl Bot 1, Julius von Sachs Inst Biowissensch, Wurzburg, Germany; [Nickel, Joachim] Univ Wurzburg, Lehrstuhl Tissue Engn & Regenerat Med, D-97070 Wurzburg, Germany; [Eichler, Jutta] Univ Erlangen Nurnberg, Dept Chem & Pharm, Erlangen, Germany	University of Erlangen Nuremberg; University of Wurzburg; University of Wurzburg; University of Erlangen Nuremberg	Muller, YA (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, Erlangen, Germany.	ymuller@biologie.uni-erlangen.de	Muller, Yves A/R-5397-2016; Eichler, Jutta/H-7847-2018	Muller, Yves A/0000-0003-0519-8928; Eichler, Jutta/0000-0001-6683-9456; Mueller, Thomas/0000-0003-1862-7357	'Dr. Hertha und Helmut Schmauser-Stiftung', Erlangen; 'BioMedTec International Graduate School of Science' (BIGSS) within the Elitenetzwerk Bayern; Collaborative Research Group SFB 769	'Dr. Hertha und Helmut Schmauser-Stiftung', Erlangen; 'BioMedTec International Graduate School of Science' (BIGSS) within the Elitenetzwerk Bayern; Collaborative Research Group SFB 769	This work was supported by the 'Dr. Hertha und Helmut Schmauser-Stiftung', Erlangen, and the 'BioMedTec International Graduate School of Science' (BIGSS) within the Elitenetzwerk Bayern and the Collaborative Research Group SFB 769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bilandzic M, 2011, MOL CELL ENDOCRINOL, V339, P180, DOI 10.1016/j.mce.2011.04.014; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Diestler DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.178101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Fivash M, 1998, CURR OPIN BIOTECH, V9, P97, DOI 10.1016/S0958-1669(98)80091-8; Franke R, 2007, ANGEW CHEM INT EDIT, V46, P1253, DOI 10.1002/anie.200603274; FUKUSHIMA D, 1993, J BIOL CHEM, V268, P22710; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Heiring C, 2001, PROTEIN ENG, V14, P183, DOI 10.1093/protein/14.3.183; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaname S, 1996, BIOCHEM J, V315, P815, DOI 10.1042/bj3150815; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Lin SJ, 2011, P NATL ACAD SCI USA, V108, P5232, DOI 10.1073/pnas.1010689108; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mendoza V, 2009, BIOCHEMISTRY-US, V48, P11755, DOI 10.1021/bi901528w; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; NISCHT R, 1991, EUR J BIOCHEM, V200, P529, DOI 10.1111/j.1432-1033.1991.tb16214.x; Pepin MC, 1995, FEBS LETT, V377, P368, DOI 10.1016/0014-5793(95)01378-4; PEPIN MC, 1994, P NATL ACAD SCI USA, V91, P6997, DOI 10.1073/pnas.91.15.6997; PUETT D, 1977, MOL CELL BIOCHEM, V15, P109, DOI 10.1007/BF01793332; ROBINSON JP, 1973, ARCH BIOCHEM BIOPHYS, V159, P615, DOI 10.1016/0003-9861(73)90498-0; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wiater E, 2006, J BIOL CHEM, V281, P17011, DOI 10.1074/jbc.M601459200; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	35	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67214	10.1371/journal.pone.0067214	http://dx.doi.org/10.1371/journal.pone.0067214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826237	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000045
J	Fouquet, C; Babayan, BM; Watilliaux, A; Bontempi, B; Tobin, C; Rondi-Reig, L				Fouquet, Celine; Babayan, Benedicte M.; Watilliaux, Aurelie; Bontempi, Bruno; Tobin, Christine; Rondi-Reig, Laure			Complementary Roles of the Hippocampus and the Dorsomedial Striatum during Spatial and Sequence-Based Navigation Behavior	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; NEURAL SYSTEMS-ANALYSIS; CAUDATE-NUCLEUS; DORSAL STRIATUM; BASAL GANGLIA; ELECTROPHYSIOLOGICAL EVIDENCE; ANTEROGRADE TRANSPORT; EPISODIC MEMORY; TEMPORAL-ORDER; CELL-ACTIVITY	We investigated the neural bases of navigation based on spatial or sequential egocentric representation during the completion of the starmaze, a complex goal-directed navigation task. In this maze, mice had to swim along a path composed of three choice points to find a hidden platform. As reported previously, this task can be solved by using two hippocampal-dependent strategies encoded in parallel i) the allocentric strategy requiring encoding of the contextual information, and ii) the sequential egocentric strategy requiring temporal encoding of a sequence of successive body movements associated to specific choice points. Mice were trained during one day and tested the following day in a single probe trial to reveal which of the two strategies was spontaneously preferred by each animal. Imaging of the activity-dependent gene c-fos revealed that both strategies are supported by an overlapping network involving the dorsal hippocampus, the dorsomedial striatum (DMS) and the medial prefrontal cortex. A significant higher activation of the ventral CA1 subregion was observed when mice used the sequential egocentric strategy. To investigate the potential different roles of the dorsal hippocampus and the DMS in both types of navigation, we performed region-specific excitotoxic lesions of each of these two structures. Dorsal hippocampus lesioned mice were unable to optimally learn the sequence but improved their performances by developing a serial strategy instead. DMS lesioned mice were severely impaired, failing to learn the task. Our data support the view that the hippocampus organizes information into a spatio-temporal representation, which can then be used by the DMS to perform goal-directed navigation.	[Fouquet, Celine; Babayan, Benedicte M.; Watilliaux, Aurelie; Tobin, Christine; Rondi-Reig, Laure] Univ Paris 06, CNRS, ENMVI Team, UMR7102, Paris, France; [Bontempi, Bruno] Univ Bordeaux 2, CNRS, Inst Malad Neurodegenerat, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Rondi-Reig, L (corresponding author), Univ Paris 06, CNRS, ENMVI Team, UMR7102, Paris, France.	laure.rondi@snv.jussieu.fr	Rondi-Reig, Laure/G-2816-2011; Rondi-Reig, Laure/M-6141-2016	Rondi-Reig, Laure/0000-0003-1006-0501	Fondation pour la Recherche Medicale, France [DEQ20120323730]; National Agency for Research, France [ANR-REG-07122001-01]; Region Ile de France; France Alzheimer [RAK09011DDA]	Fondation pour la Recherche Medicale, France(Fondation pour la Recherche Medicale); National Agency for Research, France; Region Ile de France(Region Ile-de-France); France Alzheimer	This work was supported by the Fondation pour la Recherche Medicale DEQ20120323730, France, and National Agency for Research ANR-REG-07122001-01, France. CF was supported by a Region Ile de France PhD grant and France Alzheimer grants no RAK09011DDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Brown TI, 2012, NEUROIMAGE, V60, P1316, DOI 10.1016/j.neuroimage.2012.01.046; Chudasama Y, 2011, BEHAV NEUROSCI, V125, P327, DOI 10.1037/a0023766; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Devan BD, 1999, J NEUROSCI, V19, P2789; Devan BD, 2011, NEUROBIOL LEARN MEM, V96, P95, DOI 10.1016/j.nlm.2011.06.002; DeVito LM, 2011, J NEUROSCI, V31, P3169, DOI 10.1523/JNEUROSCI.4202-10.2011; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ekstrom AD, 2007, LEARN MEMORY, V14, P645, DOI 10.1101/lm.575107; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FERINO F, 1987, EXP BRAIN RES, V65, P421; Floresco SB, 2008, NEUROSCIENCE, V154, P877, DOI 10.1016/j.neuroscience.2008.04.004; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Foster DJ, 2012, CURR OPIN NEUROBIOL, V22, P294, DOI 10.1016/j.conb.2011.12.005; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Fouquet C, 2011, NEUROBIOL AGING, V32, P1881, DOI 10.1016/j.neurobiolaging.2009.11.001; Fouquet C, 2010, BEHAV BRAIN RES, V215, P172, DOI 10.1016/j.bbr.2010.05.054; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; GROENEWEGEN HJ, 1987, NEUROSCIENCE, V23, P103, DOI 10.1016/0306-4522(87)90275-2; Gruber AJ, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00050; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Hoang LT, 2008, BEHAV NEUROSCI, V122, P9, DOI 10.1037/0735-7044.122.1.9; Hok V, 2005, P NATL ACAD SCI USA, V102, P4602, DOI 10.1073/pnas.0407332102; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Howland JG, 2008, HIPPOCAMPUS, V18, P251, DOI 10.1002/hipo.20396; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; Igloi K, 2009, HIPPOCAMPUS, V19, P1199, DOI 10.1002/hipo.20595; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kennedy PJ, 2009, P NATL ACAD SCI USA, V106, P10805, DOI 10.1073/pnas.0903259106; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; KESNER RP, 1993, EXP BRAIN RES, V93, P462; Khamassi M, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00079; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Kobayashi T, 2003, NEUROSCIENCE, V117, P1025, DOI 10.1016/S0306-4522(02)00700-5; Kumaran D, 2006, NEURON, V49, P617, DOI 10.1016/j.neuron.2005.12.024; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MALDONADOIRIZARRY CS, 1995, BEHAV PHARMACOL, V6, P527; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Mizumori SJY, 2007, HIPPOCAMPUS, V17, P851, DOI 10.1002/hipo.20317; Mizumori SJY, 2009, BEHAV BRAIN RES, V199, P32, DOI 10.1016/j.bbr.2008.11.014; Mizumori SJY, 2000, MOL NEUROBIOL, V21, P57, DOI 10.1385/MN:21:1-2:057; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moussa R, 2011, LEARN MEMORY, V18, P444, DOI 10.1101/lm.2123811; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Penner MR, 2012, PROG NEUROBIOL, V96, P96, DOI 10.1016/j.pneurobio.2011.08.010; Poucet B, 2004, REV NEUROSCIENCE, V15, P89; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Rondi-Reig L, 2006, J NEUROSCI, V26, P4071, DOI 10.1523/JNEUROSCI.3408-05.2006; Rondi-Reig L, 2001, P NATL ACAD SCI USA, V98, P3543, DOI 10.1073/pnas.041620798; Rondi-Reig L, 2001, NEUROSCIENCE, V104, P207, DOI 10.1016/S0306-4522(01)00050-1; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Schmitzer-Torbert NC, 2008, NEUROSCIENCE, V153, P349, DOI 10.1016/j.neuroscience.2008.01.081; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Voermans NC, 2004, NEURON, V43, P427, DOI 10.1016/j.neuron.2004.07.009; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; WHITE IM, 1993, BRAIN RES, V616, P71, DOI 10.1016/0006-8993(93)90194-R; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wiener SI, 1996, PROG NEUROBIOL, V49, P335, DOI 10.1016/0301-0082(96)00019-6; WIENER SI, 1993, J NEUROSCI, V13, P3802; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yeshenko O, 2004, BEHAV NEUROSCI, V118, P751, DOI 10.1037/0735-7044.118.4.751; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, LEARN MEMORY, V11, P459, DOI 10.1101/lm.81004	83	34	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67232	10.1371/journal.pone.0067232	http://dx.doi.org/10.1371/journal.pone.0067232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826243	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000047
J	Madathil, SK; Carlson, SW; Brelsfoard, JM; Ye, P; D'Ercole, AJ; Saatman, KE				Madathil, Sindhu K.; Carlson, Shaun W.; Brelsfoard, Jennifer M.; Ye, Ping; D'Ercole, A. Joseph; Saatman, Kathryn E.			Astrocyte-Specific Overexpression of Insulin-Like Growth Factor-1 Protects Hippocampal Neurons and Reduces Behavioral Deficits following Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; FIBRILLARY ACIDIC PROTEIN; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; IGF-I; FLUID-PERCUSSION; GLIAL SCAR; OLIGODENDROCYTE DEVELOPMENT; CASPASE-3 ACTIVATION; REACTIVE ASTROCYTES	Traumatic brain injury (TBI) survivors often suffer from long-lasting cognitive impairment that stems from hippocampal injury. Systemic administration of insulin-like growth factor-1 (IGF-1), a polypeptide growth factor known to play vital roles in neuronal survival, has been shown to attenuate posttraumatic cognitive and motor dysfunction. However, its neuroprotective effects in TBI have not been examined. To this end, moderate or severe contusion brain injury was induced in mice with conditional (postnatal) overexpression of IGF-1 using the controlled cortical impact (CCI) injury model. CCI brain injury produces robust reactive astrocytosis in regions of neuronal damage such as the hippocampus. We exploited this regional astrocytosis by linking expression of hIGF-1 to the astrocyte-specific glial fibrillary acidic protein (GFAP) promoter, effectively targeting IGF-1 delivery to vulnerable neurons. Following brain injury, IGF-1Tg mice exhibited a progressive increase in hippocampal IGF-1 levels which was coupled with enhanced hippocampal reactive astrocytosis and significantly greater GFAP levels relative to WT mice. IGF-1 overexpression stimulated Akt phosphorylation and reduced acute (1 and 3d) hippocampal neurodegeneration, culminating in greater neuron survival at 10d after CCI injury. Hippocampal neuroprotection achieved by IGF-1 overexpression was accompanied by improved motor and cognitive function in brain-injured mice. These data provide strong support for the therapeutic efficacy of increased brain levels of IGF-1 in the setting of TBI.	[Madathil, Sindhu K.; Carlson, Shaun W.; Brelsfoard, Jennifer M.; Saatman, Kathryn E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40508 USA; [Ye, Ping; D'Ercole, A. Joseph] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill	Saatman, KE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40508 USA.	k.saatman@uky.edu	Madathil, Sindhu K/E-9407-2012; Carlson, Shaun/HCH-8617-2022	Carlson, Shaun/0000-0002-1413-5075	National Institutes of Health (NIH) [NS058484, NS072302, NS051220]; Kentucky Spinal Cord and Head Injury Research Trust [KSCHIRT 7-20]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072302] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) NS058484, NS072302, and NS051220, and KSCHIRT 7-20 Kentucky Spinal Cord and Head Injury Research Trust fellowship to SKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; ANDERSSON IK, 1988, ACTA PHYSIOL SCAND, V132, P167, DOI 10.1111/j.1748-1716.1988.tb08314.x; Benito M, 1996, INT J BIOCHEM CELL B, V28, P499, DOI 10.1016/1357-2725(95)00168-9; Brywe KG, 2005, EUR J NEUROSCI, V21, P1489, DOI 10.1111/j.1460-9568.2005.03982.x; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Cao Y, 2003, J CEREBR BLOOD F MET, V23, P739, DOI 10.1097/01.WCB.0000067720.12805.6F; Cheng BX, 2011, MOL CELL NEUROSCI, V47, P181, DOI 10.1016/j.mcn.2011.04.002; CHERNAUSEK SD, 1993, J NEUROSCI RES, V34, P189, DOI 10.1002/jnr.490340206; Conte V., 2003, EUR J TRAUMA, V7, P335; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Delaney CL, 1999, J NEUROBIOL, V41, P540, DOI 10.1002/(SICI)1097-4695(199912)41:4<540::AID-NEU9>3.0.CO;2-P; Delaney CL, 2001, J NEUROPATH EXP NEUR, V60, P147, DOI 10.1093/jnen/60.2.147; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fletcher L, 2009, J NEUROSURG, V111, P164, DOI 10.3171/2009.2.JNS081199; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Giralt A, 2010, GENE THER, V17, P1294, DOI 10.1038/gt.2010.71; Giralt A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-71; Goddard DR, 1999, J NEUROSCI RES, V57, P74, DOI 10.1002/(SICI)1097-4547(19990701)57:1<74::AID-JNR8>3.0.CO;2-O; Guan J, 2001, NEUROSCIENCE, V105, P299, DOI 10.1016/S0306-4522(01)00145-2; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hatton J, 1997, J NEUROSURG, V86, P779, DOI 10.3171/jns.1997.86.5.0779; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hunsaker MR, 2008, BEHAV BRAIN RES, V188, P310, DOI 10.1016/j.bbr.2007.11.015; Karpova A, 2006, NEUROSCIENCE, V137, P833, DOI 10.1016/j.neuroscience.2005.10.012; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje; Lin SY, 2011, BRAIN RES, V1385, P246, DOI 10.1016/j.brainres.2011.02.013; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; McMorris FA, 1996, BRAIN PATHOL, V6, P313, DOI 10.1111/j.1750-3639.1996.tb00858.x; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun LY, 2006, ENDOCRINOLOGY, V147, P5480, DOI 10.1210/en.2006-0586; Takadera T, 1999, J NEUROCHEM, V73, P548, DOI 10.1046/j.1471-4159.1999.0730548.x; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yakar S, 2005, CYTOKINE GROWTH F R, V16, P407, DOI 10.1016/j.cytogfr.2005.01.010; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhu W, 2008, STROKE, V39, P1254, DOI 10.1161/STROKEAHA.107.500801; Zhu W, 2009, J CEREBR BLOOD F MET, V29, P1528, DOI 10.1038/jcbfm.2009.75	74	71	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67204	10.1371/journal.pone.0067204	http://dx.doi.org/10.1371/journal.pone.0067204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826235	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000044
J	Mullins, CD; Su, MY; Hucthagowder, V; Chu, L; Lu, L; Kulkarni, S; Novack, D; Vij, R; Tomasson, MH				Mullins, Chelsea D.; Su, Mack Y.; Hucthagowder, Vishwanathan; Chu, Liang; Lu, Lan; Kulkarni, Shashikant; Novack, Deborah; Vij, Ravi; Tomasson, Michael H.			Germinal Center B-Cells Resist Transformation by Kras Independently of Tumor Suppressor Arf	PLOS ONE			English	Article							K-RAS ONCOGENE; MULTIPLE-MYELOMA; CONDITIONAL EXPRESSION; ACTIVATING MUTATIONS; SOMATIC ACTIVATION; P16 GENE; METHYLATION; P16(INK4A); PATHWAY; CANCER	Activating mutations in Ras (N- and K-) are the most common point mutations found in patients with multiple myeloma (MM) and are associated with poor clinical outcome. We sought to directly examine the role of Ras activation in MM pathogenesis and used two different tissue-specific Cre recombinase mouse lines (C gamma 1-Cre and AID-Cre), to generate mice with mutant Kras (Kras(G12D)) activated specifically in germinal center B-cells. We also generated mice with activation of the Kras(G12D) allele in a tumor-prone Arf-null genetic background. Surprisingly, we observed no significant disruption in B-cell homeostasis in any of these models by serum immunoglobulin ELISA, SPEP, flow cytometry and histological examination. We observed development of non-overlapping tumor types due to off-target Cre expression, but despite successful recombination in germinal center and later B-cell populations, we observed no B-cell phenotype. Together, these data demonstrate that Ras activation is not sufficient to transform primary germinal center B-cells, even in an Arf-null context, and that the temporal order of mutation acquisition may be critical for myeloma development. Specific pathways, yet to be identified, are required before Kras can contribute to the development of MM.	[Mullins, Chelsea D.; Su, Mack Y.; Chu, Liang; Lu, Lan; Vij, Ravi; Tomasson, Michael H.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Hucthagowder, Vishwanathan; Kulkarni, Shashikant; Novack, Deborah] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Kulkarni, Shashikant] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Tomasson, MH (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	tomasson@dom.wustl.edu		Mullins, C. Daniel/0000-0003-4322-2490; Tomasson, Michael/0000-0003-4518-7123; Novack, Deborah/0000-0001-7101-5582	Barnes Hospital Foundation; National Institute on Aging [NIH R21AG040777]; Harvey and Linda Saligman Fund for Myeloma Research at Washington University in St. Louis; NATIONAL INSTITUTE ON AGING [R21AG040777] Funding Source: NIH RePORTER	Barnes Hospital Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Harvey and Linda Saligman Fund for Myeloma Research at Washington University in St. Louis; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Barnes Hospital Foundation, the National Institute on Aging (NIH R21AG040777) and the Harvey and Linda Saligman Fund for Myeloma Research at Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bezieau S, 2001, HUM MUTAT, V18, P212, DOI 10.1002/humu.1177; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chng WJ, 2008, LEUKEMIA, V22, P2280, DOI 10.1038/leu.2008.142; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dilworth D, 2000, BLOOD, V95, P1869, DOI 10.1182/blood.V95.5.1869.005k09_1869_1871; Gonzalez M, 2000, LEUKEMIA, V14, P183, DOI 10.1038/sj.leu.2401617; Gonzalez-Paz N, 2007, BLOOD, V109, P1228, DOI 10.1182/blood-2006-05-024661; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hucthagowder V, 2012, CANCER GENET-NY, V205, P474, DOI 10.1016/j.cancergen.2012.06.007; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kamijo T, 1999, CANCER RES, V59, P2217; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Liu PC, 1996, BLOOD, V88, P2699, DOI 10.1182/blood.V88.7.2699.bloodjournal8872699; Mateos MV, 2002, BRIT J HAEMATOL, V118, P1034, DOI 10.1046/j.1365-2141.2002.03749.x; Ng MHL, 1997, BLOOD, V89, P2500, DOI 10.1182/blood.V89.7.2500; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rasmussen T, 2010, HAEMATOL-HEMATOL J, V95, P1730, DOI 10.3324/haematol.2010.024778; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Tasaka T, 1997, BRIT J HAEMATOL, V96, P98, DOI 10.1046/j.1365-2141.1997.8552482.x; Taylor BJ, 2008, BLOOD, V112, P1894, DOI 10.1182/blood-2008-01-129221; VESCIO RA, 1995, J IMMUNOL, V155, P2487; Wong IHN, 1998, BRIT J HAEMATOL, V103, P168; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67941	10.1371/journal.pone.0067941	http://dx.doi.org/10.1371/journal.pone.0067941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825691	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000125
J	Parcej, D; Guntrum, R; Schmidt, S; Hinz, A; Tampe, R				Parcej, David; Guntrum, Renate; Schmidt, Sabine; Hinz, Andreas; Tampe, Robert			Multicolour Fluorescence-Detection Size-Exclusion Chromatography for Structural Genomics of Membrane Multiprotein Complexes	PLOS ONE			English	Article							PEPTIDE-LOADING COMPLEX; VIRUS PROTEIN ICP47; PICHIA-PASTORIS; INSECT CELLS; IN-VIVO; TAP; EXPRESSION; PURIFICATION; INHIBITION	Many interesting and important membrane proteins are hetero-oligomeric. However, besides naturally abundant examples, the structures of relatively few such complexes are known. Partly, this is due to difficulties in expression, stoichiometric assembly, and in the evaluation of their stability prior to crystallization trials. Here we describe a new approach, which allows rapid assessment of protein complex quality, assembly and stoichiometry, simplifying the search for conditions conducive to long-term stability and crystallization. Multicolour fluorescence size-exclusion chromatography (MC-FSEC) is used to enable tracking of individual subunits through expression, solubilization and purification steps. We show how the method has been applied to the heterodimeric transporter associated with antigen processing (TAP) and demonstrate how it may be extended in order to analyse membrane multisubunit assemblies.	[Parcej, David; Guntrum, Renate; Schmidt, Sabine; Hinz, Andreas; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, D-60054 Frankfurt, Germany; [Tampe, Robert] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, D-60054 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Parcej, David/AAW-7306-2020; Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	The German Research Foundation (SFB 807-Transport and Communication across Biological Membranes, TA157/7 to RT) and the European Drug Initiative on Channels and Transporters (EDICT to RT) funded by the European Commission Seventh Framework Program supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Cha HJ, 2004, BIOTECHNOL LETT, V26, P1157, DOI 10.1023/B:BILE.0000035489.09417.d4; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chen H, 2013, PROTEIN EXPRES PURIF, V88, P134, DOI 10.1016/j.pep.2012.12.003; Cherezov V, 2011, CURR OPIN STRUC BIOL, V21, P559, DOI 10.1016/j.sbi.2011.06.007; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew David, 2012, Methods Mol Biol, V866, P209, DOI 10.1007/978-1-61779-770-5_18; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Hammon J, 2009, PROTEIN SCI, V18, P121, DOI 10.1002/pro.18; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Hulpke S, 2012, FASEB J, V26, P5071, DOI 10.1096/fj.12-217489; Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lee JK, 2010, CURR OPIN STRUC BIOL, V20, P464, DOI 10.1016/j.sbi.2010.05.004; Leung J, 2013, MOL MEMBR BIOL, V30, P32, DOI 10.3109/09687688.2012.690572; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Neumann L, 1999, J MOL BIOL, V294, P1203, DOI 10.1006/jmbi.1999.3329; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Pedelacq JD, 2002, NAT BIOTECHNOL, V20, P927, DOI 10.1038/nbt732; Pfander R, 1999, BIOCHEMISTRY-US, V38, P13692, DOI 10.1021/bi9909647; Pieper U, 2013, NAT STRUCT MOL BIOL, V20, P135, DOI 10.1038/nsmb.2508; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Scholz C, 2011, J BIOL CHEM, V286, P13346, DOI 10.1074/jbc.M110.216416; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Stroud Robert Michael, 2011, F1000 Biol Rep, V3, P8, DOI 10.3410/B3-8; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02	34	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67112	10.1371/journal.pone.0067112	http://dx.doi.org/10.1371/journal.pone.0067112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825631	Green Published, gold			2022-12-27	WOS:000321223000081
J	Pierson, JC; Allendorf, FW; Drapeau, P; Schwartz, MK				Pierson, Jennifer C.; Allendorf, Fred W.; Drapeau, Pierre; Schwartz, Michael K.			Breed Locally, Disperse Globally: Fine-Scale Genetic Structure Despite Landscape-Scale Panmixia in a Fire-Specialist	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; BLACK-BACKED WOODPECKERS; POPULATION-DYNAMICS; PHILOPATRY; METAPOPULATIONS; EXTINCTION; FLOW; DIFFERENTIATION; RELATEDNESS; TRACKING	An exciting advance in the understanding of metapopulation dynamics has been the investigation of how populations respond to ephemeral patches that go 'extinct' during the lifetime of an individual. Previous research has shown that this scenario leads to genetic homogenization across large spatial scales. However, little is known about fine-scale genetic structuring or how this changes over time in ephemeral patches. We predicted that species that specialize on ephemeral habitats will delay dispersal to exploit natal habitat patches while resources are plentiful and thus display fine-scale structure. To investigate this idea, we evaluated the effect of frequent colonization of ephemeral habitats on the fine-scale genetic structure of a fire specialist, the black-backed woodpecker (Picoides arcticus) and found a pattern of fine-scale genetic structure. We then tested for differences in spatial structure between sexes and detected a pattern consistent with male-biased dispersal. We also detected a temporal increase in relatedness among individuals within newly burned forest patches. Our results indicate that specialist species that outlive their ephemeral patches can accrue significant fine-scale spatial structure that does not necessarily affect spatial structure at larger scales. This highlights the importance of both spatial and temporal scale considerations in both sampling and data interpretation of molecular genetic results.	[Pierson, Jennifer C.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Allendorf, Fred W.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Drapeau, Pierre] Univ Quebec, Dept Sci Biol, Ctr Etud Foret, Montreal, PQ H3C 3P8, Canada; [Schwartz, Michael K.] US Forest Serv, Rocky Mt Res Stn, Missoula, MT USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Quebec; University of Quebec Montreal; United States Department of Agriculture (USDA); United States Forest Service	Pierson, JC (corresponding author), CSIRO Black Mt Site, Canberra, ACT, Australia.	jencpierson@gmail.com	Schwartz, Michael K/C-3184-2014	Schwartz, Michael K/0000-0003-3521-3367; Drapeau, Pierre/0000-0002-1115-2531; Pierson, Jennifer/0000-0003-4140-010X	Montana Fish, Wildlife and Parks; Bureau of Land Management; Glacier National Park; Glacier Fund; U.S.D.A. Forest Service; Y2Y Science Grants; Wilburforce Foundation; McIntire-Stennis Cooperative Research Program; National Center for Landscape Fire Analysis; Northwest Scientific Association; Five Valleys Audubon; American Association of University Women; P.E.O. Scholar Award; National Science Foundation; University of Montana; Fonds quebecois de recherche sur la nature et les technologies (FQRNT); Grand Jardins Provincial Park; Natural Science and Engineering Research Council of Canada (NSERC)	Montana Fish, Wildlife and Parks; Bureau of Land Management; Glacier National Park; Glacier Fund; U.S.D.A. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Y2Y Science Grants; Wilburforce Foundation; McIntire-Stennis Cooperative Research Program; National Center for Landscape Fire Analysis; Northwest Scientific Association; Five Valleys Audubon; American Association of University Women; P.E.O. Scholar Award; National Science Foundation(National Science Foundation (NSF)); University of Montana; Fonds quebecois de recherche sur la nature et les technologies (FQRNT)(FQRNT); Grand Jardins Provincial Park; Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by Montana Fish, Wildlife and Parks, Bureau of Land Management, Glacier National Park, The Glacier Fund, U.S.D.A. Forest Service, Y2Y Science Grants and Wilburforce Foundation, McIntire-Stennis Cooperative Research Program, National Center for Landscape Fire Analysis, Northwest Scientific Association and Five Valleys Audubon. Support for J. Pierson was provided by the American Association of University Women, P.E.O. Scholar Award, National Science Foundation and The University of Montana. Financial support for the Grands Jardins study was provided by the Fonds quebecois de recherche sur la nature et les technologies (FQRNT) - Programme Action concertee - Fonds Forestier, Grand Jardins Provincial Park, and a Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grant (P. Drapeau). The authors received the Alberta Samples from Shawna Pelech. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Beck NR, 2008, MOL ECOL, V17, P4346, DOI 10.1111/j.1365-294X.2008.03906.x; Bonnot TW, 2008, CONDOR, V110, P450, DOI 10.1525/cond.2008.8460; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Dixon RD, 2000, BIRDS N AM, P509; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Ellegren H, 1999, HEREDITAS, V130, P291, DOI 10.1111/j.1601-5223.1999.00291.x; ELLEGREN H, 1992, AUK, V109, P886, DOI 10.2307/4088163; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Gaggiotti OE, 1996, THEOR POPUL BIOL, V50, P178, DOI 10.1006/tpbi.1996.0028; Giles BE, 1997, AM NAT, V149, P507, DOI 10.1086/286002; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Harrison Susan, 1997, P27, DOI 10.1016/B978-012323445-2/50004-3; Hutto RL, 2008, ECOL APPL, V18, P1827, DOI 10.1890/08-0895.1; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; Lecomte N, 2009, MOL ECOL, V18, P593, DOI 10.1111/j.1365-294X.2008.04067.x; Lee JW, 2009, MOL ECOL, V18, P2728, DOI 10.1111/j.1365-294X.2009.04228.x; Lewis PO, 2001, GENETIC DATA ANAL GD; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lynch M, 1999, GENETICS, V152, P1753; Mendez M, 2011, BIOL CONSERV, V144, P2615, DOI 10.1016/j.biocon.2011.07.011; Murphy EC, 1998, J WILDLIFE MANAGE, V62, P1359, DOI 10.2307/3802002; Nappi A, 2009, BIOL CONSERV, V142, P1381, DOI 10.1016/j.biocon.2009.01.022; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Ortego J, 2011, ANIM BEHAV, V82, P131, DOI 10.1016/j.anbehav.2011.04.007; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pierson J. C., 2009, THESIS U MONTANA; Pierson JC, 2010, EVOL APPL, V3, P263, DOI 10.1111/j.1752-4571.2009.00111.x; Piertney SB, 1998, MOL ECOL, V7, P1247; Saab VA, 2007, CONDOR, V109, P97, DOI 10.1650/0010-5422(2007)109[97:NDOCBI]2.0.CO;2; Saint-Germain M, 2008, DIVERS DISTRIB, V14, P713, DOI 10.1111/j.1472-4642.2007.00452.x; Schwartz MK, 2002, NATURE, V415, P520, DOI 10.1038/415520a; Shanahan DF, 2011, LANDSCAPE ECOL, V26, P137, DOI 10.1007/s10980-010-9542-6; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; THOMAS CD, 1994, CONSERV BIOL, V8, P373, DOI 10.1046/j.1523-1739.1994.08020373.x; Vierling KT, 2008, J WILDLIFE MANAGE, V72, P422, DOI 10.2193/2006-212; Vila M, 2008, MOL ECOL RESOUR, V8, P415, DOI 10.1111/j.1471-8286.2007.01976.x; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Wright S, 1943, GENETICS, V28, P114	45	19	20	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67248	10.1371/journal.pone.0067248	http://dx.doi.org/10.1371/journal.pone.0067248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825646	gold, Green Published, Green Submitted			2022-12-27	WOS:000321223000092
J	Silveira, SM; Villacis, RAR; Marchi, FA; Barros, MD; Drigo, SA; Neto, CS; Lopes, A; da Cunha, IW; Rogatto, SR				Silveira, Sara Martoreli; Rios Villacis, Rolando Andre; Marchi, Fabio Albuquerque; Barros Filho, Mateus de Camargo; Drigo, Sandra Aparecida; Neto, Cristovam Scapulatempo; Lopes, Ademar; da Cunha, Isabela Werneck; Rogatto, Silvia Regina			Genomic Signatures Predict Poor Outcome in Undifferentiated Pleomorphic Sarcomas and Leiomyosarcomas	PLOS ONE			English	Article							MALIGNANT FIBROUS HISTIOCYTOMAS; SOFT-TISSUE SARCOMAS; DNA COPY NUMBER; GENE-EXPRESSION ANALYSIS; HYBRIDIZATION ANALYSIS; CYTOGENETIC ANALYSIS; CANCER; CLASSIFICATION; AMPLIFICATION; ABERRATIONS	Undifferentiated high-grade pleomorphic sarcomas (UPSs) display aggressive clinical behavior and frequently develop local recurrence and distant metastasis. Because these sarcomas often share similar morphological patterns with other tumors, particularly leiomyosarcomas (LMSs), classification by exclusion is frequently used. In this study, array-based comparative genomic hybridization (array CGH) was used to analyze 20 UPS and 17 LMS samples from untreated patients. The LMS samples presented a lower frequency of genomic alterations compared with the UPS samples. The most frequently altered UPS regions involved gains at 20q13.33 and 7q22.1 and losses at 3p26.3. Gains at 8q24.3 and 19q13.12 and losses at 9p21.3 were frequently detected in the LMS samples. Of these regions, gains at 1q21.3, 11q12.2-q12.3, 16p11.2, and 19q13.12 were significantly associated with reduced overall survival times in LMS patients. A multivariate analysis revealed that gains at 1q21.3 were an independent prognostic marker of shorter survival times in LMS patients (HR = 13.76; P = 0.019). Although the copy number profiles of the UPS and LMS samples could not be distinguished using unsupervised hierarchical clustering analysis, one of the three clusters presented cases associated with poor prognostic outcome (P=0.022). A relative copy number analysis for the ARNT, SLC27A3, and PBXIP1 genes was performed using quantitative real-time PCR in 11 LMS and 16 UPS samples. Gains at 1q21-q22 were observed in both tumor types, particularly in the UPS samples. These findings provide strong evidence for the existence of a genomic signature to predict poor outcome in a subset of UPS and LMS patients.	[Silveira, Sara Martoreli; Rios Villacis, Rolando Andre; Barros Filho, Mateus de Camargo; Rogatto, Silvia Regina] AC Camargo Canc Ctr, Neogene Lab, Sao Paulo, Brazil; [Marchi, Fabio Albuquerque] Univ Sao Paulo, Inst Math & Stat, Interinst Program Bioinformat, BR-09500900 Sao Paulo, Brazil; [Drigo, Sandra Aparecida; Rogatto, Silvia Regina] Univ Estadual Paulista, Fac Med, Dept Urol, Sao Paulo, Brazil; [Neto, Cristovam Scapulatempo] Barretos Canc Hosp, Pio Fdn 12, Dept Pathol, Sao Paulo, Brazil; [Lopes, Ademar] AC Camargo Canc Ctr, Dept Pelv Surg, Sao Paulo, Brazil; [da Cunha, Isabela Werneck] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, Brazil	A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade Estadual Paulista; Hospital de Cancer de Barretos; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center	Rogatto, SR (corresponding author), AC Camargo Canc Ctr, Neogene Lab, Sao Paulo, Brazil.	silvia.rogatto@cipe.accamargo.org.br	Drigo, Sandra A/I-6514-2012; LINDE, SANDRA/S-3128-2019; Rogatto, Silvia R/E-6535-2012; Filho, Mateus C Barros/J-1544-2015; Marchi, Fabio A/N-9288-2018; Cunha, Isabela/H-3013-2012; Lopes, Ademar/G-8526-2014	Drigo, Sandra A/0000-0001-6747-6642; LINDE, SANDRA/0000-0001-6747-6642; Filho, Mateus C Barros/0000-0003-3893-5269; Marchi, Fabio A/0000-0001-5815-8423; Cunha, Isabela/0000-0002-2029-5139; Lopes, Ademar/0000-0002-8317-3817; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Villacis, Rolando/0000-0003-3851-2696; Rogatto, Silvia/0000-0003-4637-5687	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [1998/14335-2, 2008/55693-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (1998/14335-2 and 2008/55693-2) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Carneiro A, 2009, LAB INVEST, V89, P668, DOI 10.1038/labinvest.2009.18; Chibon F, 2003, CANCER GENET CYTOGEN, V141, P75, DOI 10.1016/S0165-4608(02)00664-7; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Curtis LJ, 1998, GENOMICS, V53, P42, DOI 10.1006/geno.1998.5405; Derre J, 2001, LAB INVEST, V81, P211, DOI 10.1038/labinvest.3780229; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Erlandson RA, 2004, ULTRASTRUCT PATHOL, V28, P283, DOI 10.1080/019131290882150; Fletcher CDM, 2006, HISTOPATHOLOGY, V48, P3, DOI 10.1111/j.1365-2559.2005.02284.x; Fletcher CDM., 2002, WHO CLASSIFICATION T; FORUS A, 1995, GENE CHROMOSOME CANC, V14, P8, DOI 10.1002/gcc.2870140103; Francis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-73; Fujiwara M, 2011, TUMOR BIOL, V32, P611, DOI 10.1007/s13277-011-0160-y; Gibault L, 2011, J PATHOL, V223, P64, DOI 10.1002/path.2787; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hallor KH, 2009, J PATHOL, V217, P716, DOI 10.1002/path.2513; Hu J, 2005, CANCER GENET CYTOGEN, V161, P20, DOI 10.1016/j.cancergencyto.2005.01.011; Kresse SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015378; Larramendy ML, 2008, CANCER GENET CYTOGEN, V187, P1, DOI 10.1016/j.cancergencyto.2008.06.005; Larramendy ML, 1997, AM J PATHOL, V151, P1153; Lee YF, 2003, BRIT J CANCER, V88, P510, DOI 10.1038/sj.bjc.6600766; Levy B, 2000, CANCER GENET CYTOGEN, V121, P1, DOI 10.1016/S0165-4608(00)00225-9; Liu SL, 2012, TARGET ONCOL, V7, P135, DOI 10.1007/s11523-012-0215-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis-Brennetot C, 2011, GENE CHROMOSOME CANC, V50, P896, DOI 10.1002/gcc.20909; Mairal A, 1999, CANCER GENET CYTOGEN, V111, P134, DOI 10.1016/S0165-4608(98)00227-1; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Mertens F, 1998, GENE CHROMOSOME CANC, V22, P16, DOI 10.1002/(SICI)1098-2264(199805)22:1<16::AID-GCC3>3.0.CO;2-A; Mills AM, 2011, AM J SURG PATHOL, V35, P583, DOI 10.1097/PAS.0b013e318211abd6; MULERIS M, 1995, GENE CHROMOSOME CANC, V14, P155, DOI 10.1002/gcc.2870140302; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nascimento AF, 2008, J SURG ONCOL, V97, P330, DOI 10.1002/jso.20972; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Oda Y, 2012, TOXICOL APPL PHARM, V260, P222, DOI 10.1016/j.taap.2012.02.012; Osuna D, 2009, REV RECENT CLIN TRIA, V4, P12, DOI 10.2174/157488709787047585; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pei ZT, 2009, CANCER RES, V69, P9175, DOI 10.1158/0008-5472.CAN-08-4689; Pei ZT, 2004, J BIOL CHEM, V279, P54454, DOI 10.1074/jbc.M410091200; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Szymanska J, 1997, CANCER GENET CYTOGEN, V99, P14, DOI 10.1016/S0165-4608(96)00436-0; Thompson FH, 1996, CANCER GENET CYTOGEN, V87, P55, DOI 10.1016/0165-4608(95)00248-0; Wang CYY, 2012, CANCER RES, V72, P1013, DOI 10.1158/0008-5472.CAN-11-2531; Wang R, 2001, GENE CHROMOSOME CANC, V31, P54, DOI 10.1002/gcc.1118; Wardelmann E, 2010, ANN ONCOL, V21, P265, DOI 10.1093/annonc/mdq381; Weng WH, 2003, BRIT J CANCER, V89, P720, DOI 10.1038/sj.bjc.6601069; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yamamoto J, 2004, LIFE SCI, V74, P1039, DOI 10.1016/j.lfs.2003.07.022; Yang JL, 2009, CANCER LETT, V275, P1, DOI 10.1016/j.canlet.2008.06.013	49	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67643	10.1371/journal.pone.0067643	http://dx.doi.org/10.1371/journal.pone.0067643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825676	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000112
J	Wu, YJ; Yang, X; Wang, XX; Qiu, MT; You, YZ; Zhang, ZX; Zhu, SM; Xu, L; Tang, FL				Wu, Yu-Jiao; Yang, Xin; Wang, Xiao-Xiao; Qiu, Man-Tang; You, Yi-Zhong; Zhang, Zhi-Xin; Zhu, Shan-Mei; Xu, Lin; Tang, Feng-Lei			Association of Vitamin D Receptor BsmI Gene Polymorphism with Risk of Tuberculosis: A Meta-Analysis of 15 Studies	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; FOKI POLYMORPHISMS; CLINICAL-TRIALS; REGULATORY ROLE; WEST-AFRICA; VDR GENE; HLA-DR; SUSCEPTIBILITY; VARIANTS	Background: Genetic variations in vitamin D receptor (VDR) may contribute to tuberculosis (TB) risk. Many studies have investigated the association between VDR BsmI gene polymorphism and TB risk, but yielded inconclusive results. Methodology/Principal Findings: We performed a comprehensive meta-analysis of 15 publications with a total of 2309 cases and 3568 controls. We assessed the strength of the association between VDR BsmI gene polymorphism and TB risk and performed sub-group analyses by ethnicity, sample size and Hardy-Weinberg equilibrium (HWE). We found a statistically significant correlation between VDR BsmI gene polymorphism and decreased TB risk in four comparison models: allele model (b vs. B: OR = 0.78, 95% CI = 0.67, 0.89; P-heterogeneity = 0.004), homozygote model (bb vs. BB: OR = 0.61, 95% CI = 0.43, 0.87; P-heterogeneity = 0.001), recessive model (bb vs. Bb+BB: OR = 0.70, 95% CI = 0.56, 0.88; P-heterogeneity = 0.005) and dominant model (bb+Bb vs. BB: OR = 0.77, 95% CI = 0.61, 0.97; P-heterogeneity = 0.010), especially in studies based on Asian population. Sub-group analyses also revealed that there was a statistically decreased TB risk in "small" studies (<500 participants) and studies with P-HWE>0.5. Meta-regression and stratification analysis both showed that the ethnicity and sample size contributed to heterogeneity. Conclusions: This meta-analysis suggests that VDR BsmI gene polymorphism is associated with a significant decreased TB risk, especially in Asian population.	[Wu, Yu-Jiao; Zhu, Shan-Mei; Tang, Feng-Lei] Changzhou Third Peoples Hosp, Dept Pharm, Changzhou, Peoples R China; [Wu, Yu-Jiao] Soochow Univ, Coll Pharm, Suzhou, Peoples R China; [Yang, Xin; Qiu, Man-Tang; Xu, Lin] Nanjing Med Univ, Clin Coll 4, Nanjing, Jiangsu, Peoples R China; [Yang, Xin; Qiu, Man-Tang; Xu, Lin] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Xiao-Xiao] Georgia Hlth Sci Univ, Dept Biostat, Augusta, GA USA; [You, Yi-Zhong] Changzhou First Peoples Hosp, Dept Pharm, Changzhou, Peoples R China; [Zhang, Zhi-Xin] Changzhou Third Peoples Hosp, Dept Pulm TB, Changzhou, Peoples R China	Soochow University - China; Nanjing Medical University; Nanjing Medical University; University System of Georgia; Augusta University	Xu, L (corresponding author), Nanjing Med Univ, Clin Coll 4, Nanjing, Jiangsu, Peoples R China.	xulin83cn@gmail.com; tangfengleicn@163.com	Qiu, Mantang/L-8937-2019					Alagarasu K, 2009, J CLIN IMMUNOL, V29, P196, DOI 10.1007/s10875-008-9234-z; Ates O, 2011, MOL BIOL REP, V38, P2633, DOI 10.1007/s11033-010-0404-8; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BOISSEL JP, 1988, EUR J CLIN PHARMACOL, V34, P535, DOI 10.1007/BF00615213; Borgdorff MW, 1998, NEW ENGL J MED, V339, P199; Bornman L, 2004, J INFECT DIS, V190, P1631, DOI 10.1086/424462; Bowen EF, 2000, LANCET, V356, P1488, DOI 10.1016/S0140-6736(00)02876-2; Cao S, 2012, CHINESE MED J-PEKING, V125, P920, DOI 10.3760/cma.j.issn.0366-6999.2012.05.033; DAVIES PDO, 1995, J ROY COLL PHYS LOND, V29, P113; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diagbouga S, 1999, SCAND J IMMUNOL, V49, P203, DOI 10.1046/j.1365-3083.1999.00467.x; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Hillerdal G, 2000, RESPIRATION, V67, P134, DOI 10.1159/000029498; Kang Tae Jin, 2011, Immune Netw, V11, P253, DOI 10.4110/in.2011.11.5.253; Lombard Z, 2006, HUM IMMUNOL, V67, P643, DOI 10.1016/j.humimm.2006.04.008; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marashian SM, 2010, TUBERK TORAK, V58, P147; Merza M, 2009, BRAZ J INFECT DIS, V13, P252, DOI 10.1590/S1413-86702009000400002; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Newport M J, 2004, Monaldi Arch Chest Dis, V61, P102; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Price P, 2012, AIDS RES HUM RETROV, V28, P1216, DOI 10.1089/aid.2011.0272; Qiu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050887; Raghavan S, 2012, TUBERCULOSIS, V92, P18, DOI 10.1016/j.tube.2011.08.004; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Selvaraj P, 2008, J CLIN IMMUNOL, V28, P306, DOI 10.1007/s10875-007-9152-5; Selvaraj P, 2004, J CLIN IMMUNOL, V24, P523, DOI 10.1023/B:JOCI.0000040923.07879.31; Selvaraj P, 2004, CLIN GENET, V65, P73, DOI 10.1111/j..2004.00183.x; Selvaraj P, 2009, J CLIN IMMUNOL, V29, P470, DOI 10.1007/s10875-009-9277-9; Selvaraj P, 2001, TUBERCULOSIS, V81, P335, DOI 10.1054/tube.2001.0307; Sharma PR, 2011, INFECT GENET EVOL, V11, P1456, DOI 10.1016/j.meegid.2011.05.019; Singh A, 2011, INT J TUBERC LUNG D, V15, P1468, DOI 10.5588/ijtld.11.0089; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Tachi Y, 2003, LIFE SCI, V73, P3313, DOI 10.1016/j.lfs.2003.03.001; TSUKADA Y, 1980, CELL MOL BIOL, V26, P493; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Verbeek W, 1997, BIOCHEM BIOPH RES CO, V238, P77, DOI 10.1006/bbrc.1997.7239; Vidyarani M, 2009, EXP MOL PATHOL, V86, P69, DOI 10.1016/j.yexmp.2008.10.002; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863	42	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66944	10.1371/journal.pone.0066944	http://dx.doi.org/10.1371/journal.pone.0066944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825591	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000048
J	Ashour, AE; Jamal, S; Cheryan, VT; Muthu, M; Zoheir, KMA; Alafeefy, AM; Abd-Allah, AR; Levi, E; Tarca, AL; Polin, LA; Rishi, AK				Ashour, Abdelkader E.; Jamal, Shazia; Cheryan, Vino T.; Muthu, Magesh; Zoheir, Khairy M. A.; Alafeefy, Ahmed M.; Abd-Allah, Adel R.; Levi, Edi; Tarca, Adi L.; Polin, Lisa A.; Rishi, Arun K.			CARP-1 Functional Mimetics: A Novel Class of Small Molecule Inhibitors of Medulloblastoma Cell Growth	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOSIS-REGULATORY PROTEIN-1; P75 NEUROTROPHIN RECEPTOR; IN-VITRO; ACTIVATION; EXPRESSION; CYCLE; KINASE; LINES; TRKC	Medulloblastomas (MBs) constitute an aggressive class of intracranial pediatric tumors. Current multimodality treatments for MBs include surgery, ionizing radiation, and chemotherapy. Toxic side effects of therapies coupled with high incidence of recurrence and the metastatic spread warrant development of more effective, less toxic therapies for this disease. CARP-1/CCAR1 is a peri-nuclear phospho-protein that is a co-activator of the cell cycle regulatory anaphase promoting complex/cyclosome (APC/C) E3 ligase. CARP-1 functional mimetics (CFMs) are a novel class of small molecule compounds that interfere with CARP-1 binding with APC/C subunit APC-2, and suppress growth of a variety of cancer cells in part by promoting apoptosis. Here we investigated MB growth inhibitory potential of the CFMs and found that CFM-4 inhibits growth of MB cells in part by inducing CARP-1 expression, promoting PARP cleavage, activating pro-apoptotic stress-activated protein kinases (SAPK) p38 and JNK, and apoptosis. Gene-array-based analysis of the CFM-4-treated Daoy MB cells indicated down-regulation of a number of key cell growth and metastasis-promoting genes including cell motility regulating small GTP binding protein p21Rac1, and extracellular matrix metallopeptidase (MMP)-10. Moreover, CFM-4 treatment stimulated expression of a number of molecules such as neurotrophin (NTF) 3, and NF-kappa B signaling inhibitors ABIN1 and 2 proteins. Overexpression of NTF3 resulted in reduced MB cell viability while knock-down of NTF3 interfered with CFM-4-dependent loss of viability. CFMs also attenuated biological properties of the MB cells by blocking their abilities to migrate, form colonies in suspension, and invade through the matrix-coated membranes. Together our data support anti-MB properties of CFM-4, and provide a proof-of-concept basis for further development of CFMs as potential anti-cancer agents for MBs.	[Jamal, Shazia; Cheryan, Vino T.; Muthu, Magesh; Levi, Edi; Rishi, Arun K.] John D Dingell Vet Affairs Med Ctr, Detroit, MI USA; [Rishi, Arun K.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Jamal, Shazia; Cheryan, Vino T.; Muthu, Magesh; Polin, Lisa A.; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Ashour, Abdelkader E.; Zoheir, Khairy M. A.; Abd-Allah, Adel R.] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Alafeefy, Ahmed M.] Salman Bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj, Saudi Arabia; [Zoheir, Khairy M. A.] Natl Res Ctr, Dept Cell Biol, Cairo, Egypt	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; King Saud University; Prince Sattam Bin Abdulaziz University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Rishi, AK (corresponding author), John D Dingell Vet Affairs Med Ctr, Detroit, MI USA.	Rishia@Karmanos.org	Alafeefy, Ahmed/AAB-3772-2019; Ashour, Abdelkader/ABH-8235-2020; Abdallah, Adel Rashad/AAA-4372-2022; muthu, magesh/N-6987-2017	Ashour, Abdelkader/0000-0003-3978-8045; Abdallah, Adel Rashad/0000-0002-6094-2847; muthu, magesh/0000-0003-3311-8120; Zoheir, Khairy/0000-0003-0896-4499; jamal, shazia/0000-0003-4555-9513; Levi, Edi/0000-0003-1809-2866	US Department of Veterans Affairs Merit Review grants; National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia [10-MED1188-02]; NATIONAL CANCER INSTITUTE [P30CA022453, R01CA140314] Funding Source: NIH RePORTER	US Department of Veterans Affairs Merit Review grants(US Department of Veterans Affairs); National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US Department of Veterans Affairs Merit Review grants (AKR), and a grant from the National Plan of Science, Technology and Innovation (Grant No. 10-MED1188-02), King Saud University, Riyadh, Saudi Arabia (AEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annabi B, 2008, MOL CANCER RES, V6, P907, DOI 10.1158/1541-7786.MCR-07-2184; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172; Berger R, 2011, MOL CANCER THER, V10, P1867, DOI 10.1158/1535-7163.MCT-11-0218; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bodey B, 2000, IN VIVO, V14, P667; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; Doroshow JH, 2001, CANC CHEMOTHERAPY BI, P500; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kim JYH, 1999, CANCER RES, V59, P711; KOZMIK Z, 1995, P NATL ACAD SCI USA, V92, P5709, DOI 10.1073/pnas.92.12.5709; Kunkele A, 2012, NEURO-ONCOLOGY, V14, P859, DOI 10.1093/neuonc/nos115; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu WK, 2004, BIOCHEM J, V378, P867, DOI 10.1042/BJ20031736; MILLS JC, 1995, METHOD CELL BIOL, V46, P217; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Muragaki Y, 1997, J NEUROSCI, V17, P530; Nakada M, 2003, FRONT BIOSCI, V8, pE261, DOI 10.2741/1016; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Raaf John, 1944, ARCH NEUROL AND PSYCHIAT, V52, P163; RAKIC P, 1970, J COMP NEUROL, V139, P473, DOI 10.1002/cne.901390407; Ranger A, 2010, J NEURO-ONCOL, V96, P181, DOI 10.1007/s11060-009-9962-9; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; Shaw Leslie M., 2004, V294, P97; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Studebaker AW, 2010, NEURO-ONCOLOGY, V12, P1034, DOI 10.1093/neuonc/noq057; Tan JL, 2009, APOPTOSIS, V14, P764, DOI 10.1007/s10495-009-0345-7; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Vince GH, 2001, J NEURO-ONCOL, V53, P99, DOI 10.1023/A:1012241031138; Washiyama K, 1996, AM J PATHOL, V148, P929; Webster NJG, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S1; Weeraratne SD, 2011, NEURO-ONCOLOGY, V13, P165, DOI 10.1093/neuonc/noq179; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	50	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66733	10.1371/journal.pone.0066733	http://dx.doi.org/10.1371/journal.pone.0066733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826121	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400041
J	Guy, F; Gouvard, F; Boistel, R; Euriat, A; Lazzari, V				Guy, Franck; Gouvard, Florent; Boistel, Renaud; Euriat, Adelaide; Lazzari, Vincent			Prospective in (Primate) Dental Analysis through Tooth 3D Topographical Quantification	PLOS ONE			English	Article							ENAMEL DISTRIBUTION PATTERNS; TECHNICAL NOTE; LOWER MOLARS; 3-DIMENSIONAL ANALYSIS; TISSUE PROPORTIONS; SEXUAL-DIMORPHISM; THICKNESS; OCCLUSAL; MORPHOLOGY; DIET	The occlusal morphology of the teeth is mostly determined by the enamel-dentine junction morphology; the enamel-dentine junction plays the role of a primer and conditions the formation of the occlusal enamel reliefs. However, the accretion of the enamel cap yields thickness variations that alter the morphology and the topography of the enamel-dentine junction (i.e., the differential deposition of enamel by the ameloblasts create an external surface that does not necessarily perfectly parallel the enamel-dentine junction). This self-reliant influence of the enamel on tooth morphology is poorly understood and still under-investigated. Studies considering the relationship between enamel and dentine morphologies are rare, and none of them tackled this relationship in a quantitative way. Major limitations arose from: (1) the difficulties to characterize the tooth morphology in its comprehensive tridimensional aspect and (2) practical issues in relating enamel and enamel-dentine junction quantitative traits. We present new aspects of form representation based exclusively on 3D analytical tools and procedures. Our method is applied to a set of 21 unworn upper second molars belonging to eight extant anthropoid genera. Using geometrical analysis of polygonal meshes representatives of the tooth form, we propose a 3D dataset that constitutes a detailed characterization of the enamel and of the enamel-dentine junction morphologies. Also, for the first time, to our knowledge, we intend to establish a quantitative method for comparing enamel and enamel-dentine junction surfaces descriptors (elevation, inclination, orientation, etc.). New indices that allow characterizing the occlusal morphology are proposed and discussed. In this note, we present technical aspects of our method with the example of anthropoid molars. First results show notable individual variations and taxonomic heterogeneities for the selected topographic parameters and for the pattern and strength of association between enamel-dentine junction and enamel, the enamel cap altering in different ways the "transcription" of the enamel-dentine junction morphology.	[Guy, Franck; Gouvard, Florent; Boistel, Renaud; Euriat, Adelaide; Lazzari, Vincent] Univ Poitiers, IPHEP Inst Paleoprimatol & Paleontol Humaine Evol, Ctr Natl Rech Sci, Inst Ecol & Environm,Fac Sci,UMR 7262, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers	Guy, F (corresponding author), Univ Poitiers, IPHEP Inst Paleoprimatol & Paleontol Humaine Evol, Ctr Natl Rech Sci, Inst Ecol & Environm,Fac Sci,UMR 7262, Poitiers, France.	franck.guy@univ-poitiers.fr		Lazzari, Vincent/0000-0002-8210-2646; GUY, Franck/0000-0001-7032-7963	Centre of Microtomographie of the University of Poitiers; Agence Nationale de la Recherche [ANR-09-BLAN-0238]; region Poitou-Charentes [07/RPC-R-100, 12/RPC-013]	Centre of Microtomographie of the University of Poitiers; Agence Nationale de la Recherche(French National Research Agency (ANR)); region Poitou-Charentes(Region Nouvelle-Aquitaine)	This work was made possible by the Centre of Microtomographie of the University of Poitiers and supported by the Agence Nationale de la Recherche (ANR-09-BLAN-0238) and the region Poitou-Charentes (Conventions Region #07/RPC-R-100 & #12/RPC-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2006, J DENT, V34, P503, DOI 10.1016/j.jdent.2005.12.001; Anemone RL, 2012, PALAEONTOL ELECTRON, V15; ANTHONY MRL, 1993, AM J SCI, V293A, P356, DOI 10.2475/ajs.293.A.356; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P11093, DOI 10.1073/pnas.0804159105; Benazzi S, 2011, J ANAT, V219, P259, DOI 10.1111/j.1469-7580.2011.01396.x; Benazzi S, 2009, J HUM EVOL, V56, P286, DOI 10.1016/j.jhevol.2008.07.006; Bernal V, 2007, HOMO, V58, P279, DOI 10.1016/j.jchb.2006.11.003; Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Boyer DM, 2008, J HUM EVOL, V55, P1118, DOI 10.1016/j.jhevol.2008.08.002; Bunn JM, 2011, AM J PHYS ANTHROPOL, V145, P247, DOI 10.1002/ajpa.21489; Bunn JM, 2009, AM J PRIMATOL, V71, P466, DOI 10.1002/ajp.20676; Butler PM, 1999, P 11 INT S DENT MORP, P26; Cleghorn BM, 2006, J ENDODONT, V32, P813, DOI 10.1016/j.joen.2006.04.014; CORRUCCINI RS, 1987, INT J PRIMATOL, V8, P99, DOI 10.1007/BF02735159; Dennis JC, 2004, AM J PHYS ANTHROPOL, V125, P152, DOI 10.1002/ajpa.10379; Durrleman S, 2012, J HUM EVOL, V62, P74, DOI 10.1016/j.jhevol.2011.10.004; Elewa AMT, 2011, COMPUTATIONAL PALEONTOLOGY, P1, DOI 10.1007/978-3-642-16271-8; Emonet EG, 2012, J HUM EVOL, V62, P146, DOI 10.1016/j.jhevol.2011.11.011; Evans A, 2007, J VERTEBR PALEONTOL, V27, p72A; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Evans AR, 1998, J ZOOL, V246, P391, DOI 10.1017/S0952836998009832; Fiorenza L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014769; Gilbert CC, 2009, J HUM EVOL, V57, P298, DOI 10.1016/j.jhevol.2009.05.013; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Guatelli-Steinberg D, 2005, P NATL ACAD SCI USA, V102, P14197, DOI 10.1073/pnas.0503108102; Harjunmaa E, 2012, NATURE, V483, P324, DOI 10.1038/nature10876; Hlusko LJ, 2006, AM J PHYS ANTHROPOL, V131, P420, DOI 10.1002/ajpa.20435; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Hu JCC, 2005, CELLS TISSUES ORGANS, V181, P219, DOI 10.1159/000091383; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; Koh C, 2010, AM J PHYS ANTHROPOL, V142, P246, DOI 10.1002/ajpa.21221; Kondo S, 2005, AM J PHYS ANTHROPOL, V128, P870, DOI 10.1002/ajpa.20084; Kono Reiko T., 2008, Bulletin of the National Science Museum Series D (Anthropology), V34, P1; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Kono RT, 2002, ARCH ORAL BIOL, V47, P867, DOI 10.1016/S0003-9969(02)00151-6; Kullmer O, 2012, ANAT REC, V295, P846, DOI 10.1002/ar.22440; Kullmer Ottmar, 2002, BAR International Series, V1049, P71; Kullmer O, 2009, AM J PHYS ANTHROPOL, V139, P600, DOI 10.1002/ajpa.21086; Lazzari V, 2010, J MAMM EVOL, V17, P177, DOI 10.1007/s10914-010-9139-5; Lazzari V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003607; Ledogar JA, 2013, AM J PHYS ANTHROPOL, V150, P107, DOI 10.1002/ajpa.22181; Lucas PW, 2008, J ANAT, V212, P486, DOI 10.1111/j.1469-7580.2008.00877.x; M'Kirera F, 2003, AM J PRIMATOL, V60, P31, DOI 10.1002/ajp.10077; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; McCollum MA, 2001, BIOESSAYS, V23, P481, DOI 10.1002/bies.1068; Morimoto N, 2009, 1 INT S BIOL SHAP AN, P266; Morimoto N, 2011, ANAT REC, V294, P589, DOI 10.1002/ar.21346; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Olejniczak AJ, 2008, J HUM EVOL, V54, P187, DOI 10.1016/j.jhevol.2007.09.014; Pilbrow V, 2006, J HUM EVOL, V51, P646, DOI 10.1016/j.jhevol.2006.07.008; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; Plyusnin I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001742; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramdarshan A, 2010, J HUM EVOL, V59, P96, DOI 10.1016/j.jhevol.2010.04.007; Rosenfeld A, 2004, DIGITAL GEOMETRY GEO; Rugis J, 2006, LECT NOTES COMPUT SC, V4319, P138; Russ JC., 2011, IMAGE PROCESSING HDB; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Shimizu D, 2002, J HUM EVOL, V43, P605, DOI 10.1006/jhev.2002.0593; Skinner MM, 2008, J HUM EVOL, V54, P173, DOI 10.1016/j.jhevol.2007.09.012; Skinner MM, 2010, AM J PHYS ANTHROPOL, V142, P157, DOI 10.1002/ajpa.21248; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Somma F, 2009, INT ENDOD J, V42, P165, DOI 10.1111/j.1365-2591.2008.01472.x; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Tafforeau P, 2012, J HUM EVOL, V62, P424, DOI 10.1016/j.jhevol.2012.01.001; Ulhaas L, 2004, ANN ANAT, V186, P487, DOI 10.1016/S0940-9602(04)80090-6; Ungar P, 2004, J HUM EVOL, V46, P605, DOI 10.1016/j.jhevol.2004.03.004; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; UNGAR PS, 1995, P NATL ACAD SCI USA, V92, P5479, DOI 10.1073/pnas.92.12.5479; Ungar PS, 2003, P NATL ACAD SCI USA, V100, P3874, DOI 10.1073/pnas.0637016100; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Zanolli C, 2010, CR PALEVOL, V9, P341, DOI 10.1016/j.crpv.2010.07.019; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI; Zuccotti LF, 1998, AM J PHYS ANTHROPOL, V107, P137, DOI 10.1002/(SICI)1096-8644(199809)107:1<137::AID-AJPA11>3.0.CO;2-1	84	28	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66142	10.1371/journal.pone.0066142	http://dx.doi.org/10.1371/journal.pone.0066142			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826088	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400010
J	Helmer, RA; Foreman, O; Dertien, JS; Panchoo, M; Bhakta, SM; Chilton, BS				Helmer, Rebecca A.; Foreman, Oded; Dertien, Janet S.; Panchoo, Marlyn; Bhakta, Suhani M.; Chilton, Beverly S.			Role of Helicase-Like Transcription Factor (Hltf) in the G2/M Transition and Apoptosis in Brain	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; JAK2 PHOSPHORYLATION; PASSENGER COMPLEX; SMC COMPLEXES; AURORA-B; DNA; CHROMATIN; GENE; PROLACTIN; REPLICATION	HLTF participates in transcription, chromatin remodeling, DNA damage repair, and tumor suppression. Aside from being expressed in mouse brain during embryonic and postnatal development, little is known about Hltf's functional importance. Splice variant quantification of wild-type neonatal (6-8 hour postpartum) brain gave a ratio of 5: 1 for Hltf isoform 1 (exons 1-25) to isoform 2 (exons 1-21 with exon 21 extended via a partial intron retention event). Western analysis showed a close correlation between mRNA and protein expression. Complete loss of Hltf caused encephalomalacia with increased apoptosis, and reduced viability. Sixty-four percent of Hltf null mice died, 48% within 12-24 hours of birth. An RNA-Seq snapshot of the neonatal brain transcriptome showed 341 of 20,000 transcripts were altered (p < 0.05) - 95 up regulated and 246 down regulated. MetaCore (TM) enrichment pathway analysis revealed Hltf regulates cell cycle, cell adhesion, and TGF-beta receptor signaling. Hltf's most important role is in the G2/M transition of the cell cycle (p = 4.672e-7) with an emphasis on transcript availability of major components in chromosome cohesion and condensation. Hltf null brains have reduced transcript levels for Rad21/Scc1, histone H3.3, Cap-E/Smc2, Cap-G/G2, and Aurora B kinase. The loss of Hltf in its yeast Rad5-like role in DNA damage repair is accompanied by down regulation of Cflar, a critical inhibitor of TNFRSF6-mediated apoptosis, and increased (p<0.0001) active caspase-3, an indicator of intrinsic triggering of apoptosis in null brains. Hltf also regulates Smad7/Bambi/Tgf-beta/Bmp5/Wnt10b signaling in brain. ChIP confirmed Hltf binding to consensus sequences in predicted (promoter Scgb3a1 gene) and previously unidentified (P-element on chromosome 7) targets. This study is the first to provide a comprehensive view of Hltf targets in brain. Moreover, it reveals how silencing Hltf disrupts cell cycle progression, and attenuates DNA damage repair.	[Helmer, Rebecca A.; Bhakta, Suhani M.; Chilton, Beverly S.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Foreman, Oded] Genentech Inc, San Francisco, CA USA; [Dertien, Janet S.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Panchoo, Marlyn] St Georges Univ, St Georges, Grenada	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Roche Holding; Genentech; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Chilton, BS (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	beverly.chilton@ttuhsc.edu		Chilton, Beverly/0000-0002-8066-8697	TTUHSC (Texas Tech University Health Sciences Center) Preliminary Data Seed Grant Program	TTUHSC (Texas Tech University Health Sciences Center) Preliminary Data Seed Grant Program	The work was supported by TTUHSC (Texas Tech University Health Sciences Center) Preliminary Data Seed Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Beck HN, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-12; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Carter SD, 2012, CRIT REV BIOCHEM MOL, V47, P1, DOI 10.3109/10409238.2011.614593; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chilton BS, 2008, BIOCHEM SOC T, V36, P632, DOI 10.1042/BST0360632; Clemessy M, 2012, J NEURO-ONCOL, V107, P29, DOI 10.1007/s11060-011-0715-1; Crockett S, 2011, NEUROREPORT, V22, P598, DOI 10.1097/WNR.0b013e3283494359; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Debauve G, 2008, CELL MOL LIFE SCI, V65, P591, DOI 10.1007/s00018-007-7392-4; Diaz-Martinez LA, 2007, PLOS ONE, V3, P1; Ding H, 1996, DNA CELL BIOL, V15, P429, DOI 10.1089/dna.1996.15.429; Ding H, 1999, J BIOL CHEM, V274, P19573, DOI 10.1074/jbc.274.28.19573; Fazzio TG, 2010, J CELL BIOL, V188, P491, DOI 10.1083/jcb.200908026; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; Fukuoka T, 2006, ANTICANCER RES, V26, P3333; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gong XH, 1997, DEV BIOL, V183, P166, DOI 10.1006/dbio.1996.8486; Guillaumond F, 2011, FASEB J, V25, P2740, DOI 10.1096/fj.10-178616; HaywardLester A, 1996, MOL ENDOCRINOL, V10, P1335, DOI 10.1210/me.10.11.1335; He MX, 2013, AUTHOPHAGY, V9; Helmer RA, 2011, MOL CELL ENDOCRINOL, V338, P79, DOI 10.1016/j.mce.2011.03.009; Helmer RA, 2010, MOL CELL ENDOCRINOL, V325, P143, DOI 10.1016/j.mce.2010.05.010; Hewetson A, 2004, BIOL REPROD, V71, P1907, DOI 10.1095/biolreprod.104.031435; Hewetson A, 2003, J BIOL CHEM, V278, P40177, DOI 10.1074/jbc.M303921200; Hewetson A, 2002, MOL ENDOCRINOL, V16, P2101, DOI 10.1210/me.2002-0064; Hewetson A, 2008, MOL ENDOCRINOL, V22, P813, DOI 10.1210/me.2007-0432; Hibi K, 2003, INT J CANCER, V104, P433, DOI 10.1002/ijc.10985; Hussain NK, 2010, J NEUROSCI, V30, P14786, DOI 10.1523/JNEUROSCI.4124-10.2010; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; Kang S, 2006, INT J CANCER, V118, P2168, DOI 10.1002/ijc.21609; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Leung WK, 2003, MOL CARCINOGEN, V37, P91, DOI 10.1002/mc.10124; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008; Longerich S, 2011, P NATL ACAD SCI USA, V108, P13881, DOI 10.1073/pnas.1110698108; Mahajan MC, 2002, BLOOD, V99, P348, DOI 10.1182/blood.V99.1.348; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Moinova HR, 2002, P NATL ACAD SCI USA, V99, P4562, DOI 10.1073/pnas.062459899; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Newman JJ, 2011, COLD SPRING HARB SYM, V75, P227; Prado Felix, 2012, Bioarchitecture, V2, P6; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Quenet D, 2012, CHROMOSOME RES, V20, P465, DOI 10.1007/s10577-012-9301-4; Resnick TD, 2009, GENETICS, V181, P875, DOI 10.1534/genetics.108.097741; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Rouquier S, 2007, MUTAT RES-FUND MOL M, V616, P95, DOI 10.1016/j.mrfmmm.2006.11.012; Sabbattini P, 2007, EMBO J, V26, P4657, DOI 10.1038/sj.emboj.7601875; Sandhu S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-18; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Sharif B, 2010, J CELL SCI, V123, P4292, DOI 10.1242/jcs.067447; SHERIDAN PL, 1995, J BIOL CHEM, V270, P4575, DOI 10.1074/jbc.270.9.4575; Stellfox ME, 2013, CELL MOL LIFE SCI, V70, P387, DOI 10.1007/s00018-012-1048-8; Stephens AD, 2011, J CELL BIOL, V193, P1167, DOI 10.1083/jcb.201103138; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Weischenfeldt J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r35; Wend P, 2012, ACTA PHYSIOL, V204, P34, DOI 10.1111/j.1748-1716.2011.02296.x; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Zhang Q, 1997, GENE, V202, P31, DOI 10.1016/S0378-1119(97)00446-0	69	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66799	10.1371/journal.pone.0066799	http://dx.doi.org/10.1371/journal.pone.0066799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826137	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400054
J	Li, P; Chen, XH; Su, LP; Li, CL; Zhi, QM; Yu, BQ; Sheng, H; Wang, JQ; Feng, RH; Cai, Q; Li, JF; Yu, YY; Yan, M; Liu, BY; Zhu, ZG				Li, Pu; Chen, Xuehua; Su, Liping; Li, Chenglong; Zhi, Qiaoming; Yu, Beiqin; Sheng, Hong; Wang, Junqing; Feng, Runhua; Cai, Qu; Li, Jianfang; Yu, Yingyan; Yan, Min; Liu, Bingya; Zhu, Zhenggang			Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MICRORNA EXPRESSION; CELL-PROLIFERATION; MIRNA SIGNATURE; CARCINOMA; METASTASIS; ESTABLISHMENT; ASSOCIATION; RESISTANCE; PROTEIN	MicroRNA has been recently recognized as playing a prominent role in tumorigenesis and metastasis. Here, we report that miR-338-3p was epigenetically silenced in gastric cancer, and its down-regulation was significantly correlated with gastric cancer clinicopathological features. Strikingly, restoring miR-338-3p expression in SGC-7901 gastric cancer cells inhibited proliferation, migration, invasion and tumorigenicity in vitro and in vivo, at least partly through inducing apoptosis. Furthermore, we demonstrate the oncogene SSX2IP is a target of miR-338-3p. We propose that miR-338-3p functions as a tumor suppressor in gastric cancer, and the methylation status of its CpG island could serve as a potential diagnostic marker for gastric cancer.	[Li, Pu; Chen, Xuehua; Su, Liping; Li, Chenglong; Zhi, Qiaoming; Yu, Beiqin; Sheng, Hong; Wang, Junqing; Feng, Runhua; Cai, Qu; Li, Jianfang; Yu, Yingyan; Yan, Min; Liu, Bingya; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Dept Surg, Shanghai Inst Digest Surg,Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Dept Surg, Shanghai Inst Digest Surg,Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China.	byliurj@sohu.com; zhenggang.zhu@yahoo.com	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762; /0000-0001-6874-9614	National Natural Science Foundation of China [30872476, 81072012, 81172324, 91229106, 30900670, 81272749]; Science and Technology Commission of Shanghai Municipality [10jc1411100, 09DZ1950100, 09DZ2260200, 11jc1407602, 101409042000]; Shanghai Key Discipline [S30204]; Key Projects in the National Science & Technology Pillar Program of China [2008BA152B03, 2011BA203191]; China Postdoctoral Science Foundation [2011M500796]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Key Discipline; Key Projects in the National Science & Technology Pillar Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by grants from National Natural Science Foundation of China (numbers 30872476, 81072012, 81172324, 91229106, 30900670 and 81272749), Science and Technology Commission of Shanghai Municipality (numbers 10jc1411100, 09DZ1950100, 09DZ2260200, 11jc1407602 and 101409042000), Shanghai Key Discipline (S30204), and Key Projects in the National Science & Technology Pillar Program of China (numbers 2008BA152B03 and 2011BA203191), China Postdoctoral Science Foundation (number 2011M500796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Asada M, 2003, J BIOL CHEM, V278, P4103, DOI 10.1074/jbc.M209832200; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; BARRANCO SC, 1983, CANCER RES, V43, P1703; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan SH, 2008, ANTICANCER RES, V28, P907; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047563; De Felice B, 2012, GENE, V508, P35, DOI 10.1016/j.gene.2012.07.058; Fabbri M, 2013, ADV EXP MED BIOL, V754, P137, DOI 10.1007/978-1-4419-9967-2_6; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Fu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043204; Fu XY, 2012, INT J MOL SCI, V13, P8514, DOI 10.3390/ijms13078514; Fukumoto Y, 2011, J BIOL CHEM, V286, P43537, DOI 10.1074/jbc.M111.308858; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Schoof CRG, 2012, AM J CANCER RES, V2, P414; Guinn B, 2009, BLOOD, V113, P1203, DOI 10.1182/blood-2008-09-178848; Guinn BA, 2008, BRIT J HAEMATOL, V140, P250, DOI 10.1111/j.1365-2141.2007.06892.x; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hayashi Y, 2012, GUT; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ke Yang, 1994, Zhonghua Zhongliu Zazhi, V16, P7; Kim K, 2011, EPIGENETICS-US, V6, P740, DOI 10.4161/epi.6.6.15874; Kos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031022; Li CL, 2012, ONCOL REP, V27, P1960, DOI 10.3892/or.2012.1719; Li CL, 2012, CANCER LETT, V320, P189, DOI 10.1016/j.canlet.2012.02.030; Li P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-52; LIN CH, 1984, CHINESE MED J-PEKING, V97, P831; LU Y, 1986, Zhonghua Zhongliu Zazhi, V8, P241; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; O'Hara SP, 2009, GASTROENTEROLOGY, V136, P17, DOI 10.1053/j.gastro.2008.11.028; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; PARK JG, 1990, CANCER RES, V50, P2773; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SEKIGUCHI M, 1978, JPN J EXP MED, V48, P61; Song JH, 2012, GASTROENTEROLOGY, V143, P35, DOI 10.1053/j.gastro.2012.05.003; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883; Zhang L, 2011, IMMUNOTHERAPY-UK, V3, P697, DOI [10.2217/IMT.11.50, 10.2217/imt.11.50]	43	59	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66782	10.1371/journal.pone.0066782	http://dx.doi.org/10.1371/journal.pone.0066782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826132	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400050
J	Chung, E; Cho, CW; So, HA; Kang, JS; Chung, YS; Lee, JH				Chung, Eunsook; Cho, Chang-Woo; So, Hyun-Ah; Kang, Jee-Sook; Chung, Young Soo; Lee, Jai-Heon			Overexpression of VrUBC1, a Mung Bean E2 Ubiquitin-Conjugating Enzyme, Enhances Osmotic Stress Tolerance in Arabidopsis	PLOS ONE			English	Article							FINGER E3 LIGASE; SIGNAL-TRANSDUCTION; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; POSITIVE REGULATOR; COMBINATORY ROLES; LOW-TEMPERATURE; IN-VITRO; PROTEIN; GENE	The ubiquitin conjugating enzyme E2 (UBC E2) mediates selective ubiquitination, acting with E1 and E3 enzymes to designate specific proteins for subsequent degradation. In the present study, we characterized the function of the mung bean VrUBC1 gene (Vigna radiata UBC 1). RNA gel-blot analysis showed that VrUBC1 mRNA expression was induced by either dehydration, high salinity or by the exogenous abscisic acid (ABA), but not by low temperature or wounding. Biochemical studies of VrUBC1 recombinant protein and complementation of yeast ubc4/5 by VrUBC1 revealed that VrUBC1 encodes a functional UBC E2. To understand the function of this gene in development and plant responses to osmotic stresses, we overexpressed VrUBC1 in Arabidopsis (Arabidopsis thaliana). The VrUBC1-overexpressing plants displayed highly sensitive responses to ABA and osmotic stress during germination, enhanced ABA- or salt-induced stomatal closing, and increased drought stress tolerance. The expression levels of a number of key ABA signaling genes were increased in VrUBC1overexpressing plants compared to the wild-type plants. Yeast two-hybrid and bimolecular fluorescence complementation demonstrated that VrUBC1 interacts with AtVBP1 (A. thaliana VrUBC1 Binding Partner 1), a C3HC4-type RING E3 ligase. Overall, these results demonstrate that VrUBC1 plays a positive role in osmotic stress tolerance through transcriptional regulation of ABA-related genes and possibly through interaction with a novel RING E3 ligase.	[Chung, Eunsook; Cho, Chang-Woo; So, Hyun-Ah; Kang, Jee-Sook; Chung, Young Soo; Lee, Jai-Heon] Dong A Univ, Dept Genet Engn, Coll Nat Resources & Life Sci, Pusan, South Korea	Dong A University	Lee, JH (corresponding author), Dong A Univ, Dept Genet Engn, Coll Nat Resources & Life Sci, Pusan, South Korea.	jhnlee@dau.ac.kr			Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) [PJ007970]; National Research Foundation of Korea (KRF); Ministry of Education, Science and Technology [KRF-2012-001205, KRF-2012-001273]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center)(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea (KRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was financially supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ007970), and Basic Science Research Program through the National Research Foundation of Korea (KRF) funded by the Ministry of Education, Science and Technology (KRF-2012-001205 and -2012-001273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Bu QY, 2009, PLANT PHYSIOL, V150, P463, DOI 10.1104/pp.109.135269; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Cho SK, 2006, PLANT PHYSIOL, V142, P1664, DOI 10.1104/pp.106.087965; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Chung E, 2004, MOL CELLS, V17, P377; Chung E, 2009, GENE, V443, P91, DOI 10.1016/j.gene.2009.05.005; Chung E, 2009, GENES GENOM, V31, P11, DOI 10.1007/BF03191133; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Criqui MC, 2002, PLANT PHYSIOL, V130, P1230, DOI 10.1104/pp.011353; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Feussner K, 1997, FEBS LETT, V409, P211, DOI 10.1016/S0014-5793(97)00509-7; GIRAUDAT J, 1994, PLANT MOL BIOL, V26, P1557, DOI 10.1007/BF00016490; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; Jeon EH, 2012, BIOCHEM BIOPH RES CO, V427, P309, DOI 10.1016/j.bbrc.2012.09.048; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Kim SY, 2002, PLANT PHYSIOL, V130, P688, DOI 10.1104/pp.003566; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu ZM, 1998, J BACTERIOL, V180, P3592, DOI 10.1128/JB.180.14.3592-3597.1998; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Luo JH, 2006, PLANT J, V46, P649, DOI 10.1111/j.1365-313X.2006.02730.x; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; REYNOLDS P, 1985, P NATL ACAD SCI USA, V82, P168, DOI 10.1073/pnas.82.1.168; Ryu MY, 2010, PLANT PHYSIOL, V154, P1983, DOI 10.1104/pp.110.164749; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; SULLIVAN ML, 1993, J BIOL CHEM, V268, P8777; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; vanNocker S, 1996, J BIOL CHEM, V271, P12150, DOI 10.1074/jbc.271.21.12150; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wan XR, 2011, J BIOSCI BIOENG, V111, P478, DOI 10.1016/j.jbiosc.2010.11.021; Wen R, 2006, PLANT MOL BIOL, V61, P241, DOI 10.1007/s11103-006-0007-x; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Xu L, 2009, PLANT J, V57, P279, DOI 10.1111/j.1365-313X.2008.03684.x; Zhang XD, 2003, BBA-GENE STRUCT EXPR, V1625, P269, DOI 10.1016/S0167-4781(02)00623-1; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; ZHEN M, 1993, MOL CELL BIOL, V13, P1371, DOI 10.1128/MCB.13.3.1371; Zhou GA, 2010, PLANT MOL BIOL, V72, P357, DOI 10.1007/s11103-009-9575-x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zwirn P, 1997, CURR GENET, V32, P309, DOI 10.1007/s002940050282	66	48	63	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66056	10.1371/journal.pone.0066056	http://dx.doi.org/10.1371/journal.pone.0066056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824688	Green Submitted, gold, Green Published			2022-12-27	WOS:000320576400051
J	Meng, WX; Pan, WQ; Zhang, AJX; Li, ZF; Wei, GW; Feng, LQ; Dong, ZY; Li, CF; Hu, XJ; Sun, CJ; Luo, QF; Yuen, KY; Zhong, NS; Chen, L				Meng, Weixu; Pan, Weiqi; Zhang, Anna J. X.; Li, Zhengfeng; Wei, Guowei; Feng, Liqiang; Dong, Zhenyuan; Li, Chufang; Hu, Xiangjing; Sun, Caijun; Luo, Qinfang; Yuen, Kwok-Yung; Zhong, Nanshan; Chen, Ling			Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases	PLOS ONE			English	Article							CHAIN GERMLINE SEQUENCES; CONVALESCENT PLASMA; H5N1; VIRUS; GENES; IMMUNOGENICITY; MORTALITY; FAMILY; CELLS	Background: The outbreaks of emerging infectious diseases caused by pathogens such as SARS coronavirus, H5N1, H1N1, and recently H7N9 influenza viruses, have been associated with significant mortality and morbidity in humans. Neutralizing antibodies from individuals who have recovered from an infection confer therapeutic protection to others infected with the same pathogen. However, survivors may not always be available for providing plasma or for the cloning of monoclonal antibodies (mAbs). Methodology/Principal Findings: The genome and the immunoglobulin genes in rhesus macaques and humans are highly homologous; therefore, we investigated whether neutralizing mAbs that are highly homologous to those of humans (human-like) could be generated. Using the H5N1 influenza virus as a model, we first immunized rhesus macaques with recombinant adenoviruses carrying a synthetic gene encoding hemagglutinin (HA). Following screening an antibody phage display library derived from the B cells of immunized monkeys, we cloned selected macaque immunoglobulin heavy chain and light chain variable regions into the human IgG constant region, which generated human-macaque chimeric mAbs exhibiting over 97% homology to human antibodies. Selected mAbs demonstrated potent neutralizing activities against three clades (0, 1, 2) of the H5N1 influenza viruses. The in vivo protection experiments demonstrated that the mAbs effectively protected the mice even when administered up to 3 days after infection with H5N1 influenza virus. In particular, mAb 4E6 demonstrated sub-picomolar binding affinity to HA and superior in vivo protection efficacy without the loss of body weight and obvious lung damage. The analysis of the 4E6 escape mutants demonstrated that the 4E6 antibody bound to a conserved epitope region containing two amino acids on the globular head of HA. Conclusions/Significance: Our study demonstrated the generation of neutralizing mAbs for potential application in humans in urgent preparedness against outbreaks of new influenza infections or other virulent infectious diseases.	[Meng, Weixu; Pan, Weiqi; Li, Zhengfeng; Wei, Guowei; Feng, Liqiang; Dong, Zhenyuan; Hu, Xiangjing; Sun, Caijun; Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Meng, Weixu; Pan, Weiqi; Li, Zhengfeng; Feng, Liqiang; Dong, Zhenyuan; Li, Chufang; Sun, Caijun; Luo, Qinfang; Zhong, Nanshan; Chen, Ling] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhang, Anna J. X.; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; University of Hong Kong	Chen, L (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.	chen002@gmail.com	Meng, Weixu/E-7301-2017	Meng, Weixu/0000-0001-7892-3014; Yuen, Kwok-yung/0000-0002-2083-1552	National Science Fund for Distinguished Young Scholars of China [30688004]; State Key Laboratory of Respiratory Disease	National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); State Key Laboratory of Respiratory Disease	This work was supported by the National Science Fund for Distinguished Young Scholars of China (30688004) and the funding from the State Key Laboratory of Respiratory Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andris JS, 1997, MOL IMMUNOL, V34, P237, DOI 10.1016/S0161-5890(97)00021-7; Bible JM, 2003, IMMUNOGENETICS, V54, P867, DOI 10.1007/s00251-003-0536-2; Bradbury ARM, 2004, PHAGE DISPLAY, P243; Calvas P, 1999, SCAND J IMMUNOL, V49, P595; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; De Marco D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034415; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Helmuth EF, 2000, IMMUNOGENETICS, V51, P519, DOI 10.1007/s002510000170; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Howard WA, 2005, IMMUNOGENETICS, V57, P655, DOI 10.1007/s00251-005-0020-2; Howard WA, 2005, IMMUNOGENETICS, V57, P210, DOI 10.1007/s00251-005-0794-2; Hu XJ, 2011, VIRUS RES, V155, P156, DOI 10.1016/j.virusres.2010.09.014; Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kendal AP, 1982, WHO COLLABORATING CT, pB17; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; Leonard JP, 2007, ANN ONCOL, V18, P1216, DOI 10.1093/annonc/mdm114; Link JM, 2002, IMMUNOGENETICS, V54, P240, DOI 10.1007/s00251-002-0468-2; Margolin DH, 2006, J IMMUNOL, V177, P1108, DOI 10.4049/jimmunol.177.2.1108; Pelat T, 2009, MABS, V1, P1; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Rosenwasser LJ, 2003, J ALLERGY CLIN IMMUN, V112, P563, DOI 10.1067/mai.2003.1709; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Scinicariello F, 2004, IMMUNOLOGY, V111, P66, DOI 10.1111/j.1365-2567.2004.01767.x; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Sundling C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003752; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	40	12	14	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66276	10.1371/journal.pone.0066276	http://dx.doi.org/10.1371/journal.pone.0066276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824680	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400077
J	Samykutty, A; Shetty, AV; Dakshinamoorthy, G; Bartik, MM; Johnson, GL; Webb, B; Zheng, G; Chen, AX; Kalyanasundaram, RS; Munirathinam, G				Samykutty, Abhilash; Shetty, Aditya Vittal; Dakshinamoorthy, Gajalakshmi; Bartik, Mary Margaret; Johnson, Gary Leon; Webb, Brian; Zheng, Guoxing; Chen, Aoshuang; Kalyanasundaram, Ramaswamy; Munirathinam, Gnanasekar			Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; IN-VIVO; CONSTITUTIVE ACTIVATION; GROWTH-INHIBITION; GENE-EXPRESSION; RECEPTOR GENE; CARCINOMA; STAT3; APOPTOSIS; ADENOCARCINOMA	Prostate cancer is the most common solid malignancy in men, with 32,000 deaths annually. Piperine, a major alkaloid constituent of black pepper, has previously been reported to have anti-cancer activity in variety of cancer cell lines. The effect of piperine against prostate cancer is not currently known. Therefore, in this study, we investigated the anti-tumor mechanisms of piperine on androgen dependent and androgen independent prostate cancer cells. Here, we show that piperine inhibited the proliferation of LNCaP, PC-3, 22RV1 and DU-145 prostate cancer cells in a dose dependent manner. Furthermore, Annexin-V staining demonstrated that piperine treatment induced apoptosis in hormone dependent prostate cancer cells (LNCaP). Using global caspase activation assay, we show that piperine-induced apoptosis resulted in caspase activation in LNCaP and PC-3 cells. Further studies revealed that piperine treatment resulted in the activation of caspase-3 and cleavage of PARP-1 proteins in LNCaP, PC-3 and DU-145 prostate cancer cells. Piperine treatment also disrupted androgen receptor (AR) expression in LNCaP prostate cancer cells. Our evaluations further show that there is a significant reduction of Prostate Specific Antigen (PSA) levels following piperine treatment in LNCaP cells. NF-kB and STAT-3 transcription factors have previously been shown to play a role in angiogenesis and invasion of prostate cancer cells. Interestingly, treatment of LNCaP, PC-3 and DU-145 prostate cancer cells with piperine resulted in reduced expression of phosphorylated STAT-3 and Nuclear factor-kappa B (NF-kB) transcription factors. These results correlated with the results of Boyden chamber assay, wherein piperine treatment reduced the cell migration of LNCaP and PC-3 cells. Finally, we show that piperine treatment significantly reduced the androgen dependent and androgen independent tumor growth in nude mice model xenotransplanted with prostate cancer cells. Taken together, these results support further investigation of piperine as a potential therapeutic agent in the treatment of prostate cancer.	[Samykutty, Abhilash; Shetty, Aditya Vittal; Dakshinamoorthy, Gajalakshmi; Zheng, Guoxing; Chen, Aoshuang; Kalyanasundaram, Ramaswamy; Munirathinam, Gnanasekar] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA; [Bartik, Mary Margaret; Johnson, Gary Leon] Midwest SciTech, Bloomington, MN USA; [Webb, Brian] Thermo Fisher Sci, Rockford, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Thermo Fisher Scientific	Munirathinam, G (corresponding author), Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA.	mgnanas@uic.edu	samykutty, Abhilash/J-6575-2019	samykutty, Abhilash/0000-0003-3551-045X				Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Agarwal C, 2007, CARCINOGENESIS, V28, P1463, DOI 10.1093/carcin/bgm042; Aghaei M, 2011, J CANCER RES CLIN, V137, P1511, DOI 10.1007/s00432-011-1031-z; Ahmad A, 2012, CARCINOGENESIS, V33, P2450, DOI 10.1093/carcin/bgs290; Barton BE, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-19; Bezerra DP, 2006, BRAZ J MED BIOL RES, V39, P801, DOI 10.1590/S0100-879X2006000600014; Bezerra DP, 2008, J APPL TOXICOL, V28, P156, DOI 10.1002/jat.1261; Biroccio A, 2004, ENDOCR-RELAT CANCER, V11, P407, DOI 10.1677/erc.1.00764; Coffey RNT, 2001, J UROLOGY, V165, P5, DOI 10.1097/00005392-200101000-00003; Davis JN, 1999, NUTR CANCER, V35, P167, DOI 10.1207/S15327914NC352_11; Duessel Sharon, 2008, Clin Lab Sci, V21, P151; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Elangovan I, 2012, BIOCHEM BIOPH RES CO, V417, P1133, DOI 10.1016/j.bbrc.2011.12.060; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Gasparian AV, 2002, J CELL SCI, V115, P141; Gnanasekar M, 2009, INT J ONCOL, V34, P1241, DOI 10.3892/ijo_00000252; Guo S, 2011, PLOS ONE, V3; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson JJ, 2012, CARCINOGENESIS, V33, P413, DOI 10.1093/carcin/bgr291; JOHRI RK, 1992, J ETHNOPHARMACOL, V37, P85, DOI 10.1016/0378-8741(92)90067-2; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Kakarala M, 2010, J AGR FOOD CHEM, V58, P6594, DOI 10.1021/jf100657r; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Krishnakumar N, 2009, FOOD CHEM TOXICOL, V47, P2813, DOI 10.1016/j.fct.2009.08.017; Li S, 2011, PHYTOMEDICINE, V19, P83, DOI 10.1016/j.phymed.2011.06.031; Linja MJ, 2001, CANCER RES, V61, P3550; Makhov P, 2012, PROSTATE, V72, P661, DOI 10.1002/pros.21469; Marech I, 2012, INT J ONCOL, V40, P1313, DOI 10.3892/ijo.2012.1364; Pradeep CR, 2004, INT IMMUNOPHARMACOL, V4, P1795, DOI 10.1016/j.intimp.2004.08.005; Quon H, 2011, BJU INT, V108, P1734, DOI 10.1111/j.1464-410X.2011.10197.x; Rago, 1998, Cancer Control, V5, P513; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reddy L, 2003, PHARMACOL THERAPEUT, V99, P1, DOI 10.1016/S0163-7258(03)00042-1; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Selvendiran K, 2006, PULM PHARMACOL THER, V19, P107, DOI 10.1016/j.pupt.2005.04.002; Selvendiran K, 2004, BIOMED PHARMACOTHER, V58, P264, DOI 10.1016/j.biopha.2003.08.027; Shetty AV, 2011, INT J ONCOL, V39, P635, DOI 10.3892/ijo.2011.1061; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Spiotto MT, 2000, PROSTATE, V42, P88, DOI 10.1002/(SICI)1097-0045(20000201)42:2<88::AID-PROS2>3.0.CO;2-P; Srinivasan K, 2007, CRIT REV FOOD SCI, V47, P735, DOI 10.1080/10408390601062054; Sunila ES, 2004, J ETHNOPHARMACOL, V90, P339, DOI 10.1016/j.jep.2003.10.016; Sweeney C, 2004, CLIN CANCER RES, V10, P5501, DOI 10.1158/1078-0432.CCR-0571-03; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; Yang J, 2012, NEURO-ONCOLOGY, V11, P36; Yoo J, 2008, J CELL BIOCHEM, V104, P1636, DOI 10.1002/jcb.21729	48	70	72	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65889	10.1371/journal.pone.0065889	http://dx.doi.org/10.1371/journal.pone.0065889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824300	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400031
J	Sasaki, T; Onodera, A; Hosokawa, H; Watanabe, Y; Horiuchi, S; Yamashita, J; Tanaka, H; Ogawa, Y; Suzuki, Y; Nakayama, T				Sasaki, Tetsuya; Onodera, Atsushi; Hosokawa, Hiroyuki; Watanabe, Yukiko; Horiuchi, Shu; Yamashita, Junji; Tanaka, Hitoshi; Ogawa, Yasumasa; Suzuki, Yutaka; Nakayama, Toshinori			Genome-Wide Gene Expression Profiling Revealed a Critical Role for GATA3 in the Maintenance of the Th2 Cell Identity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-3; HELPER TYPE-2 CELLS; HISTONE HYPERACETYLATION; INTERLEUKIN-5 GENE; ROR-GAMMA; DIFFERENTIATION; LINEAGE; MEMORY; RESPONSES; LOCUS	Functionally polarized CD4+ T helper (Th) cells such as Th1, Th2 and Th17 cells are central to the regulation of acquired immunity. However, the molecular mechanisms governing the maintenance of the polarized functions of Th cells remain unclear. GATA3, a master regulator of Th2 cell differentiation, initiates the expressions of Th2 cytokine genes and other Th2-specific genes. GATA3 also plays important roles in maintaining Th2 cell function and in continuous chromatin remodeling of Th2 cytokine gene loci. However, it is unclear whether continuous expression of GATA3 is required to maintain the expression of various other Th2-specific genes. In this report, genome-wide DNA gene expression profiling revealed that GATA3 expression is critical for the expression of a certain set of Th2-specific genes. We demonstrated that GATA3 dependency is reduced for some Th2-specific genes in fully developed Th2 cells compared to that observed in effector Th2 cells, whereas it is unchanged for other genes. Moreover, effects of a loss of GATA3 expression in Th2 cells on the expression of cytokine and cytokine receptor genes were examined in detail. A critical role of GATA3 in the regulation of Th2-specific gene expression is confirmed in in vivo generated antigen-specific memory Th2 cells. Therefore, GATA3 is required for the continuous expression of the majority of Th2-specific genes involved in maintaining the Th2 cell identity.	[Sasaki, Tetsuya; Onodera, Atsushi; Hosokawa, Hiroyuki; Watanabe, Yukiko; Horiuchi, Shu; Yamashita, Junji; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Sasaki, Tetsuya; Yamashita, Junji; Tanaka, Hitoshi; Ogawa, Yasumasa] Nihon Pharmaceut Co Ltd, Pharmaceut Res Lab, Div Res, Narita City, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom, Kashiwa, Chiba, Japan; [Nakayama, Toshinori] CREST, JST, Chiba, Japan	Chiba University; University of Tokyo; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan.	tnakayama@faculty.chiba-u.jp	Onodera, Atsushi/E-3136-2017; Nakayama, Toshinori/E-1067-2017; Horiuchi, Shu/GXH-4855-2022	Nakayama, Toshinori/0000-0002-1434-2007; Horiuchi, Shu/0000-0001-5982-0247; Hosokawa, Hiroyuki/0000-0002-9592-2889	Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Genome Science'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 221S0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Horiuchi S, 2011, J IMMUNOL, V186, P6378, DOI 10.4049/jimmunol.1100179; Inami M, 2004, J BIOL CHEM, V279, P23123, DOI 10.1074/jbc.M401248200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Klein-Hessling S, 2008, J BIOL CHEM, V283, P31030, DOI 10.1074/jbc.M805929200; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lohning M, 2002, ADV IMMUNOL, V80, P115, DOI 10.1016/S0065-2776(02)80014-1; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nakayama T, 2008, CURR OPIN IMMUNOL, V20, P265, DOI 10.1016/j.coi.2008.03.011; Nakayama T, 2009, SEMIN IMMUNOL, V21, P78, DOI 10.1016/j.smim.2009.02.001; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Omori M, 2003, IMMUNITY, V19, P281, DOI 10.1016/S1074-7613(03)00210-3; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2004, J BIOL CHEM, V279, P39454, DOI 10.1074/jbc.M405989200; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu J, 2010, ANN REV IMMUNOL; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	33	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66468	10.1371/journal.pone.0066468	http://dx.doi.org/10.1371/journal.pone.0066468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824597	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400112
J	Teramoto, M; Queck, SY; Ohnishi, K				Teramoto, Maki; Queck, Shu Yeong; Ohnishi, Kouhei			Specialized Hydrocarbonoclastic Bacteria Prevailing in Seawater around a Port in the Strait of Malacca	PLOS ONE			English	Article							PETROLEUM ALIPHATIC-HYDROCARBONS; SP-NOV; DEGRADING BACTERIA; MICROBIAL-POPULATIONS; GEN. NOV.; SP. NOV.; MARINE; CYCLOCLASTICUS; COMMUNITY; DEGRADATION	Major degraders of petroleum hydrocarbons in tropical seas have been indicated only by laboratory culturing and never through observing the bacterial community structure in actual environments. To demonstrate the major degraders of petroleum hydrocarbons spilt in actual tropical seas, indigenous bacterial community in seawater at Sentosa (close to a port) and East Coast Park (far from a port) in Singapore was analyzed. Bacterial species was more diverse at Sentosa than at the Park, and the composition was different: gamma-Proteobacteria (57.3%) dominated at Sentosa, while they did not at the Park. Specialized hydrocarbonoclastic bacteria (SHCB), which use limited carbon sources with a preference for petroleum hydrocarbons, were found as abundant species at Sentosa, indicating petroleum contamination. On the other hand, SHCB were not the abundant species at the Park. The abundant species of SHCB at Sentosa were Oleibacter marinus and Alcanivorax species (strain 2A75 type), which have previously been indicated by laboratory culturing as important petroleum-aliphatic-hydrocarbon degraders in tropical seas. Together with the fact that SHCB have been identified as major degraders of petroleum hydrocarbons in marine environments, these results demonstrate that the O. marinus and Alcanivorax species (strain 2A75 type) would be major degraders of petroleum aliphatic hydrocarbons spilt in actual tropical seas.	[Teramoto, Maki] Kochi Univ, Oceanog Sect, Nankoku, Kochi, Japan; [Queck, Shu Yeong] Nanyang Polytech, Sch Chem & Life Sci, Singapore, Singapore; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nankoku, Kochi, Japan	Kochi University; Nanyang Polytechnic; Kochi University	Teramoto, M (corresponding author), Kochi Univ, Oceanog Sect, Nankoku, Kochi, Japan.	maki.teramoto@kochi-u.ac.jp	Ohnishi, Kouhei/AAN-9527-2020					Abed RMM, 2005, INT BIODETER BIODEGR, V55, P29, DOI 10.1016/j.ibiod.2004.07.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Andreoni V, 2000, ENVIRON MICROBIOL, V2, P572, DOI 10.1046/j.1462-2920.2000.00134.x; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Balkwill DL, 1997, INT J SYST BACTERIOL, V47, P191, DOI 10.1099/00207713-47-1-191; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cui ZS, 2008, ENVIRON MICROBIOL, V10, P2138, DOI 10.1111/j.1462-2920.2008.01637.x; DYKSTERHOUSE SE, 1995, INT J SYST BACTERIOL, V45, P116, DOI 10.1099/00207713-45-1-116; GAUTHIER MJ, 1992, INT J SYST BACTERIOL, V42, P568, DOI 10.1099/00207713-42-4-568; Golyshin P. N., 2005, BERGEYS MANUAL SYSTE, V2, P295; Hara A, 2003, ENVIRON MICROBIOL, V5, P746, DOI 10.1046/j.1468-2920.2003.00468.x; Harayama S, 2004, CURR OPIN BIOTECH, V15, P205, DOI 10.1016/j.copbio.2004.04.002; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hedlund BP, 2001, INT J SYST EVOL MICR, V51, P61, DOI 10.1099/00207713-51-1-61; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Iannelli R, 2012, SCI TOTAL ENVIRON, V426, P56, DOI 10.1016/j.scitotenv.2012.03.033; Kasai Y, 2002, APPL ENVIRON MICROB, V68, P5625, DOI 10.1128/AEM.68.11.5625-5633.2002; Kasai Y, 2001, ENVIRON MICROBIOL, V3, P246, DOI 10.1046/j.1462-2920.2001.00185.x; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loaec M, 1998, CARBOHYD POLYM, V35, P65, DOI 10.1016/S0144-8617(97)00109-4; Loaec M, 1997, WATER RES, V31, P1171, DOI 10.1016/S0043-1354(96)00375-2; Lu J, 2003, INT J REMOTE SENS, V24, P3013, DOI 10.1080/01431160110076216; Maruyama A, 2003, MICROBIAL ECOL, V46, P442, DOI 10.1007/s00248-002-3010-z; Melcher RJ, 2002, APPL ENVIRON MICROB, V68, P2858, DOI 10.1128/AEM.68.6.2858-2868.2002; Nemeth AD, 2011, MARINE ENV ECOLOGY M, P157; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; PRINCE RC, 1994, ENVIRON SCI TECHNOL, V28, P142, DOI 10.1021/es00050a019; Prince RC, 2005, PETROLEUM MICROBIOLOGY, P317; Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67, DOI 10.1128/AEM.62.1.67-73.1996; Roling WFM, 2004, APPL ENVIRON MICROB, V70, P2603, DOI 10.1128/AEM.70.5.2603-2613.2004; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Sorkhoh NA, 2010, INT BIODETER BIODEGR, V64, P554, DOI 10.1016/j.ibiod.2010.06.007; Teira E, 2007, ENVIRON MICROBIOL, V9, P2551, DOI 10.1111/j.1462-2920.2007.01373.x; Teralmoto M, 2009, MICROBIOL-SGM, V155, P3362, DOI 10.1099/mic.0.030411-0; Teramoto M, 2011, INT J SYST EVOL MICR, V61, P375, DOI 10.1099/ijs.0.018671-0; Teramoto M, 2010, J BIOSCI BIOENG, V110, P48, DOI 10.1016/j.jbiosc.2009.12.008; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Whyte LG, 1997, APPL ENVIRON MICROB, V63, P3719, DOI 10.1128/AEM.63.9.3719-3723.1997; Wu YH, 2009, INT J SYST EVOL MICR, V59, P1321, DOI 10.1099/ijs.0.005702-0; Yakimov MM, 1998, INT J SYST BACTERIOL, V48, P339, DOI 10.1099/00207713-48-2-339; Yakimov MM, 2005, ENVIRON MICROBIOL, V7, P1426, DOI 10.1111/j.1462-5822.2005.00829.x	50	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66594	10.1371/journal.pone.0066594	http://dx.doi.org/10.1371/journal.pone.0066594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824553	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400133
J	Xiong, WS; Li, XR; Fu, DH; Mei, JQ; Li, QF; Lu, GY; Qian, LW; Fu, Y; Disi, JO; Li, JN; Qian, W				Xiong, Wanshan; Li, Xiaorong; Fu, Donghui; Mei, Jiaqin; Li, Qinfei; Lu, Guanyuan; Qian, Lunwen; Fu, Yin; Disi, Joseph Onwusemu; Li, Jiana; Qian, Wei			DNA Methylation Alterations at 5 '-CCGG Sites in the Interspecific and Intraspecific Hybridizations Derived from Brassica rapa and B. napus	PLOS ONE			English	Article							GENE-EXPRESSION; CYTOSINE METHYLATION; INTERSUBGENOMIC HETEROSIS; RICE; PATTERNS; HYBRIDS; YIELD; LINES; POPULATION; DOMINANCE	DNA methylation is an important regulatory mechanism for gene expression that involved in the biological processes of development and differentiation in plants. To investigate the association of DNA methylation with heterosis in Brassica, a set of intraspecific hybrids in Brassica rapa and B. napus and interspecific hybrids between B. rapa and B. napus, together with parental lines, were used to monitor alterations in cytosine methylation at 5'-CCGG sites in seedlings and buds by methylation-sensitive amplification polymorphism analysis. The methylation status of approximately a quarter of the methylation sites changed between seedlings and buds. These alterations were related closely to the genomic structure and heterozygous status among accessions. The methylation status in the majority of DNA methylation sites detected in hybrids was the same as that in at least one of the parental lines in both seedlings and buds. However, the association between patterns of cytosine methylation and heterosis varied among different traits and between tissues in hybrids of Brassica, although a few methylation loci were associated with heterosis. Our data suggest that changes in DNA methylation at 5'-CCGG sites are not associated simply with heterosis in the interspecific and intraspecific hybridizations derived from B. rapa and B. napus.	[Xiong, Wanshan; Fu, Donghui; Mei, Jiaqin; Li, Qinfei; Qian, Lunwen; Fu, Yin; Disi, Joseph Onwusemu; Li, Jiana; Qian, Wei] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Li, Xiaorong] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China; [Lu, Guanyuan] China Acad Agr Sci, Oil Crop Inst, Wuhan, Peoples R China	Southwest University - China; Southwest University - China; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS	Qian, W (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China.	qianwei666@hotmail.com			Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China [31171585]; CSTC [201180001]; 111 Project 13 [B12006]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CSTC(Natural Science Foundation Project of CQ CSTC); 111 Project 13	This work was supported financially by grants from the Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China (31171585), CSTC 201180001, and 111 Project 13 (B12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, DEVELOPMENT, V127, P2493; Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Chodavarapu RK, 2012, P NATL ACAD SCI USA, V109, P12040, DOI 10.1073/pnas.1209297109; Dahal D, 2012, PLANT J, V72, P70, DOI 10.1111/j.1365-313X.2012.05056.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jin HJ, 2008, THEOR APPL GENET, V117, P1271, DOI 10.1007/s00122-008-0861-9; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li MT, 2006, CROP SCI, V46, P234, DOI 10.2135/cropsci2004.0759; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Moghaddam AMB, 2010, THEOR APPL GENET, V120, P215, DOI 10.1007/s00122-009-1127-x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Qian W, 2005, THEOR APPL GENET, V110, P1187, DOI 10.1007/s00122-005-1932-9; Qian W, 2003, EUPHYTICA, V134, P9, DOI 10.1023/A:1026180823401; Rohlf FJ, 1997, NTSYSPC NUMERICAL TA; Ruiz-Garcia L, 2005, PLANTA, V222, P301, DOI 10.1007/s00425-005-1524-6; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; SAS, 2004, SAS US GUID STAT; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; Siegfried Z, 2010, WIRES SYST BIOL MED, V2, P362, DOI 10.1002/wsbm.64; Song RT, 2003, P NATL ACAD SCI USA, V100, P9055, DOI 10.1073/pnas.1032999100; STUBER CW, 1992, GENETICS, V132, P823; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Szadkowski E, 2010, NEW PHYTOL, V186, P102, DOI 10.1111/j.1469-8137.2010.03182.x; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; XIAO JH, 1995, GENETICS, V140, P745; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xiong LZ, 1998, MOL BREEDING, V4, P129, DOI 10.1023/A:1009685820649; Xu YH, 2009, PLANTA, V229, P471, DOI 10.1007/s00425-008-0844-8; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zhang MS, 2007, THEOR APPL GENET, V115, P195, DOI 10.1007/s00122-007-0555-8	45	7	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65946	10.1371/journal.pone.0065946	http://dx.doi.org/10.1371/journal.pone.0065946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824315	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400037
J	Cai, YY; Newth, D				Cai, Yiyong; Newth, David			Oil, Gas and Conflict: A Mathematical Model for the Resource Curse	PLOS ONE			English	Article							NATURAL-RESOURCES; SOCIAL-CONFLICT; GROWTH	Oil and natural gas are highly valuable natural resources, but many countries with large untapped reserves suffer from poor economic and social-welfare performance. This conundrum is known as the resource curse. The resource curse is a result of poor governance and wealth distribution structures that allow the elite to monopolize resources for self-gain. When rival social groups compete for natural resources, civil unrest soon follows. While conceptually easy to follow, there have been few formal attempts to study this phenomenon. Thus, we develop a mathematical model that captures the basic elements and dynamics of this dilemma. We show that when resources are monopolized by the elite, increased exportation leads to decreased domestic production. This is due to under-provision of the resource-embedded energy and industrial infrastructure. Decreased domestic production then lowers the marginal return on productive activities, and insurgency emerges. The resultant conflict further displaces human, built, and natural capital. It forces the economy into a vicious downward spiral. Our numerical results highlight the importance of governance reform and productivity growth in reducing oil-and-gas-related conflicts, and thus identify potential points of intervention to break the downward spiral.	[Cai, Yiyong; Newth, David] CSIRO, CSIRO Ctr Complex Syst Sci, Canberra, ACT, Australia; [Cai, Yiyong] Australian Natl Univ, Ctr Appl Macroecon Anal, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University	Cai, YY (corresponding author), CSIRO, CSIRO Ctr Complex Syst Sci, Canberra, ACT, Australia.	yiyong.cai@csiro.au	Newth, David/A-1848-2011; Cai, Yiyong/F-3620-2015	Newth, David/0000-0001-6882-7440; 	Australian Research Council [DP0988281]	Australian Research Council(Australian Research Council)	Yiyong Cai gratefully acknowledges financial support from Australian Research Council Discovery Grant DP0988281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2006, EC ORIGINS DICTATORS, P225; Alesina A, 1995, EUROPEAN EC REV, V40, P1203; Benhabib J., 1996, J ECON GROWTH, V1, P125, DOI DOI 10.1007/BF00163345; Besley T, 2011, Q J ECON, V126, P1411, DOI 10.1093/qje/qjr025; Besley T, 2009, AM ECON REV, V99, P292, DOI 10.1257/aer.99.2.292; Blattman C, 2010, J ECON LIT, V48, P3, DOI 10.1257/jel.48.1.3; Brunnschweiler CN, 2008, SCIENCE, V320, P616, DOI 10.1126/science.1154539; Caselli F, 2009, OXFORD ECON PAP, V61, P628, DOI 10.1093/oep/gpp023; Collier P, 2004, OXFORD ECON PAP, V56, P563, DOI 10.1093/oep/gpf064; Collier P, 2002, J CONFLICT RESOLUT, V46, P13, DOI 10.1177/0022002702046001002; Dal Bo E, 2011, J EUR ECON ASSOC, V9, P646, DOI 10.1111/j.1542-4774.2011.01025.x; Fearon JD, 2005, J CONFLICT RESOLUT, V49, P483, DOI 10.1177/0022002705277544; Garfinkel MR, 2008, J INT ECON, V76, P296, DOI 10.1016/j.jinteco.2008.07.005; Graetz M.J., 2011, END ENERGY UNMAKING; Grossman H. I., 1995, J ECON GROWTH, V1, P333, DOI [10.1007/BF00141042, DOI 10.1007/BF00141042]; GROSSMAN HI, 1991, AM ECON REV, V81, P912; Gylfason T, 2001, EUR ECON REV, V45, P847, DOI 10.1016/S0014-2921(01)00127-1; Hendrix CS, 2012, J PEACE RES, V49, P35, DOI 10.1177/0022343311426165; Hodler R, 2006, EUR ECON REV, V50, P1367, DOI 10.1016/j.euroecorev.2005.05.004; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Humphreys M, 2005, J CONFLICT RESOLUT, V49, P508, DOI 10.1177/0022002705277545; Koubi V, 2012, J PEACE RES, V49, P113, DOI 10.1177/0022343311427173; Lloyd-Ellis H, 2003, J DEV ECON, V72, P1, DOI 10.1016/S0304-3878(03)00066-X; Narayanan BG, 2012, GLOBAL TRADE ASSISTA; Persson T, 2000, POLITICAL EC EXPLAIN, P32; Ross ML, 2004, J PEACE RES, V41, P337, DOI 10.1177/0022343304043773; Sachs JD, 2001, EUR ECON REV, V45, P827, DOI 10.1016/S0014-2921(01)00125-8; Simon C.P., 1994, MATH EC; van der Ploeg F, 2011, J ECON LIT, V49, P366, DOI 10.1257/jel.49.2.366	29	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66706	10.1371/journal.pone.0066706	http://dx.doi.org/10.1371/journal.pone.0066706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IX	23826115	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000007
J	Gupta, P; Adkins, C; Lockman, P; Srivastava, SK				Gupta, Parul; Adkins, Chris; Lockman, Paul; Srivastava, Sanjay K.			Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; CANCER-CELLS; CRUCIFEROUS VEGETABLES; ANTITUMOR-ACTIVITY; CYCLE ARREST; EXPRESSION; SULFORAPHANE; ACTIVATION; INHIBITION	Breast tumor metastasis is a leading cause of cancer-related deaths worldwide. Breast tumor cells frequently metastasize to brain and initiate severe therapeutic complications. The chances of brain metastasis are further elevated in patients with HER2 overexpression. In the current study, we evaluated the anti-metastatic effects of phenethyl isothiocyanate (PEITC) in a novel murine model of breast tumor metastasis. The MDA-MB-231-BR (BR-brain seeking) breast tumor cells stably transfected with luciferase were injected into the left ventricle of mouse heart and the migration of cells to brain was monitored using a non-invasive IVIS bio-luminescent imaging system. In order to study the efficacy of PEITC in preventing the number of tumor cells migrating to brain, mice were given 10 mu mol PEITC by oral gavage for ten days prior to intra-cardiac injection of tumor cells labeled with quantum dots. To evaluate the tumor growth suppressive effects, 10 mmol PEITC was given to mice every day starting 14th day after intra-cardiac cell injection. Based on the presence of quantum dots in the brain section of control and treated mice, our results reveal that PEITC significantly prevented the metastasis of breast cancer cells to brain. Our results demonstrate that the growth of metastatic brain tumors in PEITC treated mice was about 50% less than that of control. According to Kaplan Meir's curve, median survival of tumor bearing mice treated with PEITC was prolonged by 20.5%. Furthermore as compared to controls, we observed reduced HER2, EGFR and VEGF expression in the brain sections of PEITC treated mice. To the best of our knowledge, our study for the first time demonstrates the anti-metastatic effects of PEITC in vivo in a novel breast tumor metastasis model and provides the rationale for further clinical investigation.	[Gupta, Parul; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA; [Gupta, Parul; Adkins, Chris; Lockman, Paul; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX USA; [Adkins, Chris; Lockman, Paul] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Srivastava, SK (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA.	sanjay.srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020; GUPTA, PARUL/AAF-1118-2019	Lockman, Paul/0000-0002-6995-9944	National Cancer Institute, National Institute of Health;  [CA106953];  [CA129038]; NATIONAL CANCER INSTITUTE [R01CA129038, R01CA106953] Funding Source: NIH RePORTER	National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by R01 grants CA106953 and CA129038 (to S.K.S) awarded by the National Cancer Institute, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggs DA, 2010, AM J EPIDEMIOL, V172, P1268, DOI 10.1093/aje/kwq293; BOOGERD W, 1993, J NEURO-ONCOL, V15, P165, DOI 10.1007/BF01053937; Boreddy SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025799; Brown JM, 1998, CANCER RES, V58, P1408; Brown KK, 2011, BBA-GEN SUBJECTS, V1810, P888, DOI 10.1016/j.bbagen.2011.06.004; Butler LM, 2010, AM J CLIN NUTR, V91, P1013, DOI 10.3945/ajcn.2009.28572; Chang EL, 2003, ONCOLOGIST, V8, P398, DOI 10.1634/theoncologist.8-5-398; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Claffey KP, 1996, CANCER METAST REV, V15, P165, DOI 10.1007/BF00437469; Coleman RE, 2012, NAT REV CLIN ONCOL, V9, P76, DOI 10.1038/nrclinonc.2011.198; Conaway CC, 1999, DRUG METAB DISPOS, V27, P13; CONLEY FK, 1979, CANCER RES, V39, P1001; DAXENBICHLER ME, 1977, J ASSOC OFF ANA CHEM, V60, P950; De Luca A, 2012, J CELL BIOCHEM, V113, P3363, DOI 10.1002/jcb.24212; Dieras V, 2011, B CANCER, V98, P385, DOI 10.1684/bdc.2011.1336; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Fidler IJ, 2010, MOL CELLS, V30, P93, DOI 10.1007/s10059-010-0133-9; Fokstuen T, 2000, BREAST CANCER RES TR, V62, P211, DOI 10.1023/A:1006486423827; Frisk G, 2012, BRIT J CANCER, V106, P1850, DOI 10.1038/bjc.2012.163; Gao N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.22; Gupta P, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-80; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; Jakubikova J, 2011, HAEMATOL-HEMATOL J, V96, P1170, DOI 10.3324/haematol.2010.029363; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong J, 2011, J KOREAN MED SCI, V26, P1569, DOI 10.3346/jkms.2011.26.12.1569; Ji Y, 2005, PHARM RES-DORDR, V22, P1658, DOI 10.1007/s11095-005-7097-z; Kandala PK, 2012, J BIOL CHEM; Kandala PK, 2012, ONCOTARGET, V3, P435; Kim JH, 2006, CARCINOGENESIS, V27, P475, DOI 10.1093/carcin/bgi272; Lassman AB, 2003, NEUROL CLIN, V21, P1, DOI 10.1016/S0733-8619(02)00035-X; Lau SKM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036753; Lee SA, 2008, AM J CLIN NUTR, V87, P753, DOI 10.1093/ajcn/87.3.753; Li XQ, 2012, EUR J GYNAECOL ONCOL, V33, P178; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Liu XL, 2011, BIOCHEM BIOPH RES CO, V409, P577, DOI 10.1016/j.bbrc.2011.05.052; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nickerson NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030255; Nie F, 2012, CANCER-AM CANCER SOC, V118, P5198, DOI 10.1002/cncr.27553; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Padovani L, 2012, PROG NEUROL SURG, V25, P156, DOI 10.1159/000331189; PALMER S, 1985, PROG FOOD NUTR SCI, V9, P283; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; PATANAPHAN V, 1988, SOUTHERN MED J, V81, P1109, DOI 10.1097/00007611-198809000-00011; Pazaiti A, 2011, WOMENS HEALTH, V7, P181, DOI [10.2217/whe.11.5, 10.2217/WHE.11.5]; Sahu RP, 2009, BRIT J CANCER, V100, P1425, DOI 10.1038/sj.bjc.6605039; STEWART PA, 1987, J NEUROSURG, V67, P697, DOI 10.3171/jns.1987.67.5.0697; Tsao MN, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003869.pub3; TSUKADA Y, 1983, CANCER-AM CANCER SOC, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B; Wang XH, 2009, BIOCHEM PHARMACOL, V78, P261, DOI 10.1016/j.bcp.2009.04.010; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu CL, 2011, J ORTHOP RES, V29, P1199, DOI 10.1002/jor.21350; Wu XA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-269; Wu XJ, 2007, CANCER BIOL THER, V6, P646, DOI 10.4161/cbt.6.5.4092; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Yang MD, 2010, ANTICANCER RES, V30, P2135; Yano S, 2000, CANCER RES, V60, P4959; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486	59	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67278	10.1371/journal.pone.0067278	http://dx.doi.org/10.1371/journal.pone.0067278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826254	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000054
J	Mesquita, DN; Barbieri, MA; Goldani, HAS; Cardoso, VC; Goldani, MZ; Kac, G; Silva, AAM; Bettiol, H				Mesquita, Denise N.; Barbieri, Marco A.; Goldani, Helena A. S.; Cardoso, Viviane C.; Goldani, Marcelo Z.; Kac, Gilberto; Silva, Antonio A. M.; Bettiol, Heloisa			Cesarean Section Is Associated with Increased Peripheral and Central Adiposity in Young Adulthood: Cohort Study	PLOS ONE			English	Article							GUT MICROBIOTA; WAIST CIRCUMFERENCE; RIBEIRAO-PRETO; RISK-FACTORS; 1ST HOUR; OBESITY; BIRTH; DELIVERY; CHILDHOOD; HEALTH	Background: Cesarean section (CS) has been associated with obesity, measured by body mass index (BMI), in some studies. It has been hypothesized that this association, if causal, might be explained by changes in gut microbiota. However, little is known about whether CS is also associated with increased adiposity as measured by indicators other than BMI. Objective: To assess the association between CS and indicators of peripheral and central adiposity in young adults. Methods: The study was conducted on 2,063 young adults aged 23 to 25 years from the 1978/79Ribeirao Preto birth cohort, Sao Paulo, Brazil. CS was the independent variable. The anthropometric indicators of adiposity were: waist circumference (WC), waist-height ratio (WHtR), waist-hip ratio (WHR), tricipital skinfold (TSF), and subscapular skinfold (SSF). The association between CS and indicators of adiposity was investigated using a Poisson model, with robust adjustment of variance and calculation of incidence rate ratio (IRR) with 95% confidence interval (95% CI), and adjustment for birth variables. Results: Follow-up rate was 31.8%. The CS rate was 32%. Prevalences of increased WC, WHtR, WHR were 32.1%, 33.0% and 15.2%, respectively. After adjustment for birth variables, CS was associated with increased risk of adiposity when compared to vaginal delivery: 1.22 (95% CI 1.07; 1.39) for WC, 1.25 (95% CI 1.10; 1.42) for WHtR, 1.45 (95% CI 1.18; 1.79) for WHR, 1.36 (95% CI 1.04; 1.78) for TSF, and 1.43 (95% CI 1.08; 1.91) for SSF. Conclusion: Subjects born by CS had a higher risk for increased peripheral and central adiposity during young adult age compared to those born by vaginal delivery. The association of CS with adiposity was consistently observed for all indicators and was robust after adjustment for a variety of early life confounders.	[Mesquita, Denise N.; Barbieri, Marco A.; Cardoso, Viviane C.; Bettiol, Heloisa] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Puericulture & Pediat, BR-14049 Ribeirao Preto, Brazil; [Goldani, Helena A. S.; Goldani, Marcelo Z.] Univ Fed Rio Grande do Sul, Fac Med, Dept Pediat & Puericulture, Porto Alegre, RS, Brazil; [Kac, Gilberto] Univ Fed Rio de Janeiro, Dept Social & Appl Nutr, Rio De Janeiro, Brazil; [Silva, Antonio A. M.] Univ Fed Maranhao, Dept Publ Hlth, Sao Luis, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro; Universidade Federal do Maranhao	Mesquita, DN (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Puericulture & Pediat, BR-14049 Ribeirao Preto, Brazil.	dfisiomesquita@yahoo.com.br	Cardoso, Viviane/D-6254-2012; Silva, Antonio A M/B-5410-2009; Goldani, Helena/AAJ-8406-2021; Barbieri, Marco/J-2597-2014; Kac, Gilberto/H-6862-2012; Bettiol, Heloisa/B-4190-2013; Goldani, Marcelo Zubaran/U-8596-2019	Cardoso, Viviane/0000-0002-2677-5600; Silva, Antonio A M/0000-0003-4968-5138; Kac, Gilberto/0000-0001-8603-9077; Bettiol, Heloisa/0000-0001-8744-4373; 	Sao Paulo Research Foundation (FAPESP) [93/0525-0, 97/09517-1, 00/09508-7]; National Research Council (CNPq) [186/2009-3]; University Hospital Research Foundation (FAEPA-HCFMRPUSP), Brazil	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University Hospital Research Foundation (FAEPA-HCFMRPUSP), Brazil	This study was supported by Sao Paulo Research Foundation (FAPESP, grants n. 93/0525-0, 97/09517-1, and 00/09508-7), National Research Council (CNPq, grant n. 186/2009-3), and University Hospital Research Foundation (FAEPA-HCFMRPUSP), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Almeida LEA, 1992, CAD SAUDE PUBLICA, V8, P90; Ashwell M, 1996, BRIT MED J, V312, P377; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barbieri MA, 2006, BRAZ J MED BIOL RES, V39, P1041, DOI 10.1590/S0100-879X2006000800007; Barbieri MA., 1989, CAD SAUDE PUBLICA, V5, P376; Barros FC, 2012, AM J CLIN NUTR, V95, P465, DOI 10.3945/ajcn.111.026401; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Boccolini CS, 2011, REV SAUDE PUBL, V45, P69, DOI 10.1590/S0034-89102010005000051; CAMERON N, 1984, MEASUREMENT HUMAN GR, P182; Cardoso VC, 2007, BRAZ J MED BIOL RES, V40, P1165, DOI 10.1590/S0100-879X2006005000148; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Goldani HAS, 2011, AM J CLIN NUTR, V93, P1344, DOI 10.3945/ajcn.110.010033; Gomes UA, 1999, INT J EPIDEMIOL, V28, P687, DOI 10.1093/ije/28.4.687; Gueimonde M, 2007, NEONATOLOGY, V92, P64, DOI 10.1159/000100088; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; JANOWITZ B, 1982, PUBLIC HEALTH, V96, P191, DOI 10.1016/S0033-3506(82)80063-2; Lamarche B, 1998, GROWTH HORM IGF RES, V8, P1, DOI 10.1016/S1096-6374(98)80018-X; Li H-T, 2012, INT J OBESITY, P1; Maffeis C, 2001, OBES RES, V9, P179, DOI 10.1038/oby.2001.19; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Marques NM, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e66; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oliveira ZAR, 2007, BRAZ J MED BIOL RES, V40, P1245, DOI 10.1590/S0100-879X2006005000135; Organization WH, 1998, WELLB MEAS PRIM HLTH; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254; Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Utz RL, 2008, POLICE PERSPECTIVES, V4; VICTORA CG, 1990, ARCH DIS CHILD, V65, P632, DOI 10.1136/adc.65.6.632; Vieira TO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-760; White IR, 2011, STAT METHODS MED RES; WHO, 2008, WAIST CIRCUMFERENCE; Zhou LS, 2011, EUR J PEDIATR, V170, P1401, DOI 10.1007/s00431-011-1416-7; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	45	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66827	10.1371/journal.pone.0066827	http://dx.doi.org/10.1371/journal.pone.0066827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826150	gold, Green Submitted, Green Published			2022-12-27	WOS:000321150000013
J	Das, RR; Singh, M				Das, Rashmi Ranjan; Singh, Meenu			Treatment of Severe Community-Acquired Pneumonia with Oral Amoxicillin in Under-Five Children in Developing Country: A Systematic Review	PLOS ONE			English	Review							AGED 2-59 MONTHS; CASE-MANAGEMENT; PENICILLIN; ETIOLOGY; DISTRICT; PAKISTAN; TRIAL	Objective: To assess the evidence regarding efficacy of oral amoxicillin compared to standard treatment for WHO-defined severe community acquired pneumonia in under-five children in developing country. Design: Systematic review and meta-analysis of data from published Randomized trials (RCTs). Data sources: MEDLINE (1970-July 2012) via PubMed, Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 7, July 2012), and EMBASE (1988-June 2012). Methods: Eligible trials compared oral amoxicillin administered in ambulatory setting versus standard treatment for WHO-defined severe community acquired pneumonia in children under-five. Primary outcomes were proportion of children developing treatment failure at 48 hr, and day 6. GRADE criteria was used to rate the quality of evidence. Results: Out of 281 full text articles assessed for eligibility, 5 trials including 12364 children were included in the meta-analysis. Oral amoxicillin administered either in hospital or community setting is effective in treatment of severe pneumonia and is not inferior to the standard treatment. None of the clinical predictors of treatment failure by 48 hr (very severe disease, fever and lower chest indrawing, and voluntary with-drawl and loss to follow up) was significant between the two groups. The clinical predictors of treatment failure that were significant by day 6 were very severe disease, inability to drink, change of antibiotic, and fever alone. The effect was almost consistent across the studies. Conclusion: Though oral amoxicillin is effective in treatment of severe CAP in under-five children in developing country, the evidence generated is of low-quality. More trials with uniform comparators are needed in order to strengthen the evidence.	[Das, Rashmi Ranjan] AIIMS, Dept Pediat, Bhubaneswar, Orissa, India; [Singh, Meenu] PGIMER, Dept Pediat, Chandigarh, India	All India Institute of Medical Sciences (AIIMS) Bhubaneswar; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Singh, M (corresponding author), PGIMER, Dept Pediat, Chandigarh, India.	meenusingh4@gmail.com	Das, Rashmi Ranjan/AAB-3313-2021	Das, Rashmi Ranjan/0000-0001-9587-0508; DAS, RASHMI/0000-0002-0347-6704				Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Addo-Yobo E, 2011, TROP MED INT HEALTH, V16, P995, DOI 10.1111/j.1365-3156.2011.02787.x; Atkinson M, 2007, THORAX, V62, P1102, DOI 10.1136/thx.2006.074906; Bari A, 2011, LANCET, V378, P1796, DOI 10.1016/S0140-6736(11)61140-9; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Kabra SK, 2010, COCHRANE DB SYST REV, V3; Patel A, 2011, PEDIATR RES, V70, P15, DOI 10.1038/pr.2011.240; Rojas MX, 2006, COCHRANE DB SYST REV, V2; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Schunemann H, 2008, GRADE HDB GRADING QU; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Soofi S, 2012, LANCET, V379, P729, DOI 10.1016/S0140-6736(11)61714-5; The Cochrane Collaboration, 2008, REV MAN REVMAN COMP; WHO, 2008, HOM TREATM PNUEM SAF; WHO and UNICEF, 2008, INT MAN CHILDH ILLN, P44; World Health Organization, 1990, 5 WHO	19	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e66232	10.1371/journal.pone.0066232	http://dx.doi.org/10.1371/journal.pone.0066232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825532	Green Published, gold, Green Submitted			2022-12-27	WOS:000321223000011
J	Li, M; Kang, RX; Shi, JG; Liu, GT; Zhang, JJ				Li, Min; Kang, Ruixia; Shi, Jiangong; Liu, Gengtao; Zhang, Jianjun			Anticonvulsant Activity of B2, an Adenosine Analog, on Chemical Convulsant-Induced Seizures	PLOS ONE			English	Article							PENTYLENETETRAZOLE-INDUCED SEIZURES; RECEPTOR ACTIVATION; FOS EXPRESSION; GRANULE CELLS; MOUSE MODEL; EPILEPSY; BRAIN; SUPPRESSION; BINDING; STIMULATION	Epilepsy is a chronic neurological disorder characterized by recurrent seizures. However, approximately one-third of epilepsy patients still suffer from uncontrolled seizures. Effective treatments for epilepsy are yet to be developed. N-6-(3-methoxyl-4-hydroxybenzyl) adenine riboside (B2) is a N-6-substitued adenosine analog. Here we describe an investigation of the effects and mechanisms of B2 on chemical convulsant-induced seizures. Seizures were induced in mice by administration of 4-aminopyridine (4-AP), pentylenetetrazol (PTZ), picrotoxin, kainite acid (KA), or strychnine. B2 has a dose-related anticonvulsant effect in these chemical-induced seizure models. The protective effects of B2 include increased latency of seizure onset, decreased seizure occurrence, shorter seizure duration and reduced mortality rate. Radioligand binding and cAMP accumulation assays indicated that B2 might be a functional ligand for both adenosine A(1) and A(2A) receptors. Furthermore, DPCPX, a selective A(1) receptor antagonist, but not SCH58261, a selective A(2A) receptor antagonist, blocked the anticonvulsant effect of B2 on PTZ-induced seizure. c-Fos is a cellular marker for neuronal activity. Immunohistochemical and western blot analyses indicated that B2 significantly reversed PTZ-induced c-Fos expression in the hippocampus. Together, these results indicate that B2 has significant anticonvulsant effects. The anticonvulsant effects of B2 may be attributed to adenosine A(1) receptor activation and reduced neuronal excitability in the hippocampus. These observations also support that the use of adenosine receptor agonist may be a promising approach for the treatment of epilepsy.	[Li, Min; Kang, Ruixia; Shi, Jiangong; Liu, Gengtao; Zhang, Jianjun] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Li, Min; Kang, Ruixia; Shi, Jiangong; Liu, Gengtao; Zhang, Jianjun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Min] Minist Hlth, Beijing Hosp, Dept Clin Pharmacol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital	Zhang, JJ (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	jjzhang@imm.ac.cn			China National Science and Technology Major Project Grant for Drug Discovery [2009ZX09301-003, 2008ZX09401-004]; National Natural Science Foundation of China [30973512]; National Science Fund for Distinguished Young Scholars of China [30825044]	China National Science and Technology Major Project Grant for Drug Discovery; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the China National Science and Technology Major Project Grant for Drug Discovery (2009ZX09301-003, 2008ZX09401-004), the National Natural Science Foundation of China (30973512) and the National Science Fund for Distinguished Young Scholars of China (30825044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Ying-Ying, 2002, Zhejiang Da Xue Xue Bao Yi Xue Ban, V31, P111; Boison D, 2005, NEUROSCIENTIST, V11, P25, DOI 10.1177/1073858404269112; Boison D, 1999, EXP NEUROL, V160, P164, DOI 10.1006/exnr.1999.7209; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHIN JH, 1989, ANN NEUROL, V26, P695, DOI 10.1002/ana.410260602; De Sarro G, 1999, EUR J PHARMACOL, V371, P137, DOI 10.1016/S0014-2999(99)00132-6; DRAGUNOW M, 1992, MOL BRAIN RES, V13, P119, DOI 10.1016/0169-328X(92)90051-C; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; Engel J.J., 1997, EPILEPSY COMPREHENSI, P2417; Fedele DE, 2006, EXP NEUROL, V200, P184, DOI 10.1016/j.expneurol.2006.02.133; Fredholm BB, 2003, DRUG NEWS PERSPECT, V16, P283, DOI 10.1358/dnp.2003.16.5.829316; Gouder N, 2003, EPILEPSIA, V44, P877, DOI 10.1046/j.1528-1157.2003.03603.x; Huber A, 2002, NEUROSCI LETT, V329, P289, DOI 10.1016/S0304-3940(02)00684-5; Huber A, 1993, BRIT J PHARMACOL, V110, P470; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jaworski J, 1999, J BIOL CHEM, V274, P28106, DOI 10.1074/jbc.274.40.28106; Kenakin T, 1996, PHARMACOL REV, V48, P413; Kim SK, 2003, J MED CHEM, V46, P4847, DOI 10.1021/jm0300431; KLOTZ KN, 1989, N-S ARCH PHARMACOL, V340, P679, DOI 10.1007/BF00717744; Li TF, 2007, NEURON GLIA BIOL, V3, P353, DOI 10.1017/S1740925X0800015X; LONDOS C, 1980, P NATL ACAD SCI-BIOL, V77, P2551, DOI 10.1073/pnas.77.5.2551; LOSCHER W, 1988, EPILEPSY RES, V2, P145, DOI 10.1016/0920-1211(88)90054-X; MacGregor DG, 2002, NEUROSCI LETT, V329, P289; Malhotra J, 1997, BRIT J PHARMACOL, V120, P282, DOI 10.1038/sj.bjp.0700869; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Masino SA, 2009, CURR NEUROPHARMACOL, V7, P257, DOI 10.2174/157015909789152164; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Muller CE, 2000, EUR J PHARM SCI, V10, P259, DOI 10.1016/S0928-0987(00)00064-6; NADLER JV, 1981, LIFE SCI, V29, P2031; NORDSTEDT C, 1990, ANAL BIOCHEM, V189, P231, DOI 10.1016/0003-2697(90)90113-N; Pagonopoulou O, 2006, NEUROSCI RES, V56, P14, DOI 10.1016/j.neures.2006.05.010; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sander JWAS, 1996, J NEUROL NEUROSUR PS, V61, P433, DOI 10.1136/jnnp.61.5.433; SCHRADER J, 1980, PFLUG ARCH EUR J PHY, V387, P245, DOI 10.1007/BF00580977; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; SMITH MC, 1991, CLIN NEUROPHARMACOL, V14, P97, DOI 10.1097/00002826-199104000-00001; Stepien KM, 2002, PHARM REP, V64, P1011; Sun Jing, 2011, Yaoxue Xuebao, V46, P1199; Tchilibon S, 2005, J MED CHEM, V48, P1745, DOI 10.1021/jm049580r; Uzbay TI, 2007, NEUROPSYCHOPHARMACOL, V32, P412, DOI 10.1038/sj.npp.1301143; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Yan Luo, 2003, Expert Opin Emerg Drugs, V8, P537, DOI 10.1517/eoed.8.2.537.21128; Zeraati M, 2006, SEIZURE-EUR J EPILEP, V15, P41, DOI 10.1016/j.seizure.2005.10.006	45	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67060	10.1371/journal.pone.0067060	http://dx.doi.org/10.1371/journal.pone.0067060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825618	Green Published, Green Submitted, gold			2022-12-27	WOS:000321223000070
J	Lu, J; Li, WH; Fu, Y; Long, B; Shen, J; Su, L; Yin, LX				Lu, Jing; Li, Wenhua; Fu, Ying; Long, Bin; Shen, Jie; Su, Li; Yin, Lixue			Hemodynamic Changes in Left Anterior Descending Coronary Artery and Anterior Interventricular Vein during Right Ventricular Apical Pacing: A Doppler Ultrasound Study in Open Chest Beagles	PLOS ONE			English	Article							BLOOD-FLOW-VELOCITY; BUNDLE-BRANCH BLOCK; ACTIVATION; PATTERNS	Objective: The aim of this study was to quantify the effects of right ventricular apical pacing (RVAP) on hemodynamics in left anterior descending coronary artery (LAD) and anterior interventricular vein (AIV) contrast to baseline condition in open chest beagles using Doppler ultrasound imaging. Methods: In 6 anesthetized open chest beagles, the spectral Doppler waveforms of the middle segmental LAD and the AIV were acquired with a 5 MHz linear array transducer at baseline condition and during RVAP. The aortic pressure-time curves were recorded synchronously. The Doppler hemodynamic parameters of the LAD and AIV at both states were derived and compared. Results: The spectral Doppler waveforms of the LAD had a principal diastolic positive wave (Dp), which heelled by a momentary negative wave and a positive wave during early systole at baseline condition. During RVAP, an additional negative wave appeared in the LAD at late systole. The duration of the Dp shortened (227.83 +/- 12.16 ms vs 188.50 +/- 8.97 ms, P<0.001), and the acceleration of the Dp decreased (11.85 +/- 2.22 m/s(2) vs 3.54 +/- 0.42 m/s(2), P<0.001). The spectral Doppler waveforms of the AIV only had a principal positive wave (Sp) at baseline condition, but an additional diastolic negative wave appeared during RVAP. The duration of the Sp shortened (242.99 +/- 7.98 ms vs 215.38 +/- 15.44 ms, P<0.001), and the acceleration of the Sp decreased (9.61 +/- 1.93 m/s(2) vs 1.0160.11 m/s(2), P<0.001). Conclusions: Obvious hemodynamic changes in the LAD and AIV during RVAP were observed, and these abnormal flow patterns in epicardial coronary arteries and vena coronaria may be sensitive and important hints of the disturbed cardiac electrical and mechanical activity sequences.	[Yin, Lixue] Sichuan Acad Med Sci, Dept Cardiovasc Ultrasound & Noninvas Cardiol, Chengdu, Sichuan, Peoples R China; Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Yin, LX (corresponding author), Sichuan Acad Med Sci, Dept Cardiovasc Ultrasound & Noninvas Cardiol, Chengdu, Sichuan, Peoples R China.	yinlixue@yahoo.com		, Jing/0000-0001-7602-5122	National Nature Foundation of China [30670547]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Foundation of China (No. 30670547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMITZUR G, 1995, PACE, V18, P697, DOI 10.1111/j.1540-8159.1995.tb04664.x; Anderson SE, 2009, ANAT REC, V292, P23, DOI 10.1002/ar.20766; ARAGAM JR, 1993, J AM COLL CARDIOL, V21, P478, DOI 10.1016/0735-1097(93)90692-T; CHILIAN WM, 1982, CIRC RES, V50, P775, DOI 10.1161/01.RES.50.6.775; Delgado V, 2009, CIRC-ARRHYTHMIA ELEC, V2, P135, DOI 10.1161/CIRCEP.108.814608; DOUCETTE JW, 1992, CIRCULATION, V85, P1899, DOI 10.1161/01.CIR.85.5.1899; Gillis AM, 2006, HEART RHYTHM, V3, P1367, DOI 10.1016/j.hrthm.2006.07.010; GOTO M, 1993, BIORHEOLOGY, V30, P323; Hadjiloizou N, 2008, AM J PHYSIOL-HEART C, V295, pH1198, DOI 10.1152/ajpheart.00510.2008; Healey JS, 2007, CURR OPIN CARDIOL, V22, P33, DOI 10.1097/HCO.0b013e32801177f2; HODGSON EJ, 1993, CAN J CARDIOL, V9, P821; Iwakura K, 1996, CIRCULATION, V94, P1269, DOI 10.1161/01.CIR.94.6.1269; KAJIYA F, 1989, CIRC RES, V65, P1172, DOI 10.1161/01.RES.65.5.1172; KAJIYA F, 1985, Heart and Vessels, V1, P16, DOI 10.1007/BF02066482; KAJIYA F, 1986, CIRC RES, V58, P476, DOI 10.1161/01.RES.58.4.476; KAJIYA F, 1985, J BIOMECH ENG-T ASME, V107, P10, DOI 10.1115/1.3138511; KAJIYA F, 1993, CARDIOVASC RES, V27, P845, DOI 10.1093/cvr/27.5.845; Kolettis TM, 1998, INT J CARDIOL, V66, P203, DOI 10.1016/S0167-5273(98)00215-0; Kyriakides ZS, 2007, INT J CARDIOL, V119, P3, DOI 10.1016/j.ijcard.2006.03.091; Pachon Mateos Jose Carlos, 2009, Expert Rev Cardiovasc Ther, V7, P789, DOI 10.1586/erc.09.60; PERMUTT S., 1962, MED THORACALIS, V19, P239; Prinzen FW, 1999, J AM COLL CARDIOL, V33, P1735, DOI 10.1016/S0735-1097(99)00068-6; Prinzen FW, 2002, PACE, V25, P484, DOI 10.1046/j.1460-9592.2002.00484.x; Skalidis EI, 1999, J AM COLL CARDIOL, V33, P1338, DOI 10.1016/S0735-1097(98)00698-6; Spaan JAE, 2006, CIRCULATION, V113, P446, DOI 10.1161/CIRCULATIONAHA.105.587196; STEIN PD, 1969, AM HEART J, V78, P331, DOI 10.1016/0002-8703(69)90040-4; Tops LF, 2009, J AM COLL CARDIOL, V54, P764, DOI 10.1016/j.jacc.2009.06.006; Trohman RG, 2004, LANCET, V364, P1701, DOI 10.1016/S0140-6736(04)17358-3; UHLIG PN, 1984, CIRC RES, V55, P238, DOI 10.1161/01.RES.55.2.238; Varma N, 2008, J CARDIOVASC ELECTR, V19, P114, DOI 10.1111/j.1540-8167.2007.00995.x; Wyman BT, 1999, AM J PHYSIOL-HEART C, V276, pH881, DOI 10.1152/ajpheart.1999.276.3.H881; Yin LX, 2008, PACE, V31, P536, DOI 10.1111/j.1540-8159.2008.01037.x; Youn HJ, 2005, J AM SOC ECHOCARDIOG, V18, P1093, DOI 10.1016/j.echo.2005.03.042; Zanon F, 2008, EUROPACE, V10, P580, DOI 10.1093/europace/eun089	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2013	8	6							e67196	10.1371/journal.pone.0067196	http://dx.doi.org/10.1371/journal.pone.0067196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175IB	23825640	gold, Green Submitted, Green Published			2022-12-27	WOS:000321223000088
J	Attig, L; Vige, A; Gabory, A; Karimi, M; Beauger, A; Gross, MS; Athias, A; Gallou-Kabani, C; Gambert, P; Ekstrom, TJ; Jais, JP; Junien, C				Attig, Linda; Vige, Alexandre; Gabory, Anne; Karimi, Moshen; Beauger, Aurore; Gross, Marie-Sylvie; Athias, Anne; Gallou-Kabani, Catherine; Gambert, Philippe; Ekstrom, Tomas J.; Jais, Jean-Philippe; Junien, Claudine			Dietary Alleviation of Maternal Obesity and Diabetes: Increased Resistance to Diet-Induced Obesity Transcriptional and Epigenetic Signatures	PLOS ONE			English	Article							HIGH-FAT DIET; GENE-EXPRESSION; METABOLIC SYNDROME; RAT; HYPOMETHYLATION; SUPPLEMENTATION; METHYLATION; MECHANISMS; EXPOSURE; GLUCOSE	According to the developmental origins of health and diseases (DOHaD), and in line with the findings of many studies, obesity during pregnancy is clearly a threat to the health and well-being of the offspring, later in adulthood. We previously showed that 20% of male and female inbred mice can cope with the obesogenic effects of a high-fat diet (HFD) for 20 weeks after weaning, remaining lean. However the feeding of a control diet (CD) to DIO mice during the periconceptional/gestation/lactation period led to a pronounced sex-specific shift (17% to 43%) from susceptibility to resistance to HFD, in the female offspring only. Our aim in this study was to determine how, in the context of maternal obesity and T2D, a CD could increase resistance on female fetuses. Transcriptional analyses were carried out with a custom-built mouse liver microarray and by quantitative RT-PCR for muscle and adipose tissue. Both global DNA methylation and levels of pertinent histone marks were assessed by LUMA and western blotting, and the expression of 15 relevant genes encoding chromatin-modifying enzymes was analyzed in tissues presenting global epigenetic changes. Resistance was associated with an enhancement of hepatic pathways protecting against steatosis, the unexpected upregulation of neurotransmission-related genes and the modulation of a vast imprinted gene network. Adipose tissue displayed a pronounced dysregulation of gene expression, with an upregulation of genes involved in lipid storage and adipocyte hypertrophy or hyperplasia in obese mice born to lean and obese mothers, respectively. Global DNA methylation, several histone marks and key epigenetic regulators were also altered. Whether they were themselves lean (resistant) or obese (sensitive), the offspring of lean and obese mice clearly differed in terms of several metabolic features and epigenetic marks suggesting that the effects of a HFD depend on the leanness or obesity of the mother.	[Attig, Linda; Gabory, Anne; Beauger, Aurore; Gross, Marie-Sylvie; Junien, Claudine] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Attig, Linda; Vige, Alexandre; Gabory, Anne; Beauger, Aurore; Gross, Marie-Sylvie; Gallou-Kabani, Catherine; Junien, Claudine] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Fac Med,INSERM U781, Paris, France; [Karimi, Moshen; Ekstrom, Tomas J.; Junien, Claudine] Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med, Lab Med Epigenet, Stockholm, Sweden; [Athias, Anne] CHU Bocage, Sante STIC IFR100, Dijon, France; [Gambert, Philippe] Lab Biochim Med, Sante STIC IFR100, Dijon, France; [Jais, Jean-Philippe] Univ Paris 05, Hop Necker Enfants Malad, Serv Biostat & Informat Med, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; CHU Dijon Bourgogne; Universite de Bourgogne; Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Junien, C (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	claudine.junien@jouy.inra.fr	Ekström, Tomas/B-7764-2013	Gabory, Anne/0000-0002-0059-7375	Nestle; Fondation pour la Recherche Medicale; Association Francaise d'Etudes et de Recherche sur l'Obesite studentship; Swedish Cancer Society; INRA; INSERM (ATC-Nutrition, PRNH); Association Francaise des Diabetiques; Institut Benjamin Delessert; Fondation Coeur et Arteres (FCA) [05-T4]; ANR-Agence Nationale de la Recherche (The French National Research Agency) under the Programme National de Recherche en Alimentation et Nutrition Humaine [ANR-06-PNRA-022-01]; Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab''OSEO-ISI [ISI IT-DIAB - 18/12/2008]; Fournier laboratory	Nestle(Nestle SA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise d'Etudes et de Recherche sur l'Obesite studentship; Swedish Cancer Society(Swedish Cancer Society); INRA; INSERM (ATC-Nutrition, PRNH)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise des Diabetiques; Institut Benjamin Delessert; Fondation Coeur et Arteres (FCA); ANR-Agence Nationale de la Recherche (The French National Research Agency) under the Programme National de Recherche en Alimentation et Nutrition Humaine(French National Research Agency (ANR)); Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab''OSEO-ISI; Fournier laboratory	This work was supported by Nestle, the Fondation pour la Recherche Medicale and an Association Francaise d'Etudes et de Recherche sur l'Obesite studentship awarded to AV, a Fournier-Pharma studentship awarded to CGK, a grant from the Swedish Cancer Society awarded to TJE, and by grants from INRA, INSERM (ATC-Nutrition, PRNH), Association Francaise des Diabetiques, Institut Benjamin Delessert, the Fondation Coeur et Arteres (FCA No 05-T4), the ANR-Agence Nationale de la Recherche (The French National Research Agency) under the Programme National de Recherche en Alimentation et Nutrition Humaine, project ANR-06-PNRA-022-01, and Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab''OSEO-ISI (ISI IT-DIAB - 18/12/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We have the following interest. We received funding from two commercial sources, Fournier laboratory and Nestle as fellowship to C. Gallou-Kabani and A. Vige in 2004 and 2006 respectively. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Beaudet AL, 2002, AM J HUM GENET, V70, P1389, DOI 10.1086/340969; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; Boujendar S, 2003, J NUTR, V133, P2820, DOI 10.1093/jn/133.9.2820; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Fauque P, 2010, HUM MOL GENET; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Gabory A, 2011, WORLD J DIABETES, V2, P164, DOI 10.4239/wjd.v2.i10.164; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Gallou-Kabani C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1095, DOI 10.1152/ajpendo.00390.2006; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Giraudo SQ, 2010, PHARMACOL BIOCHEM BE, V97, P121, DOI 10.1016/j.pbb.2010.04.017; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Joe MK, 2008, CELL SIGNAL; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kamiji MM, 2007, ENDOCR REV, V28, P664, DOI 10.1210/er.2007-0003; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kelly ML, 2009, INT J OBESITY, V33, P507, DOI 10.1038/ijo.2009.30; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Latour MG, 2002, AUTON NEUROSCI-BASIC, V95, P125, DOI 10.1016/S1566-0702(01)00390-3; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lin CH, 2001, CANCER RES, V61, P4238; Macfarlane DP, 2011, AM J PHYSIOL-ENDOC M, V300, pE402, DOI 10.1152/ajpendo.00331.2010; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Miao F, 2008, J IMMUNOL, V180, P2264, DOI 10.4049/jimmunol.180.4.2264; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Nathanielsz PW, 2007, OBSTET GYN CLIN N AM, V34, P201, DOI 10.1016/j.ogc.2007.03.006; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pembrey M., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P111; Pogribny IP, 2007, J NUTR, V137, p216S, DOI 10.1093/jn/137.1.216S; Puschel GP, 2004, ANAT REC PART A, V280A, P854, DOI 10.1002/ar.a.20091; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Siebel AL, 2010, BIOCHEM PHARMACOL, V80, P1853, DOI 10.1016/j.bcp.2010.06.005; Smith J, 2009, J CLIN ENDOCR METAB, V94, P4275, DOI 10.1210/jc.2009-0709; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Suzuki Hiromu, 2006, Asian Pac J Cancer Prev, V7, P177; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Uyama N, 2004, ANAT REC PART A, V280A, P808, DOI 10.1002/ar.a.20086; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Vatamaniuk MZ, 2003, LIFE SCI, V72, P1871, DOI 10.1016/S0024-3205(02)02506-7; Verrier L, 2011, BIOL CELL, V103, P381, DOI 10.1042/BC20110028; Viens L, 1996, J LIPID RES, V37, P2179; Vige A, 2006, CYTOGENET GENOME RES, V113, P253, DOI 10.1159/000090840; Villeneuve LM, 2010, DIABETES, V59, P2904, DOI 10.2337/db10-0208; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WATERLAND R, 2002, PUBLIC HLTH ISSUES I, V48, P317; Waterland RA, 2002, J NUTR, V132, P357, DOI 10.1093/jn/132.3.357; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317; Xie H, 1996, AM J PHYSIOL-ENDOC M, V271, pE587, DOI 10.1152/ajpendo.1996.271.3.E587; Yi CX, 2010, BBA-MOL BASIS DIS, V1802, P416, DOI 10.1016/j.bbadis.2010.01.006; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893	80	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66816	10.1371/journal.pone.0066816	http://dx.doi.org/10.1371/journal.pone.0066816			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826145	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400059
J	Brown, JK; Lauer, KB; Ironmonger, EL; Inglis, NF; Bourne, TH; Critchley, HOD; Horne, AW				Brown, Jeremy K.; Lauer, Katarina B.; Ironmonger, Emily L.; Inglis, Neil F.; Bourne, Tom H.; Critchley, Hilary O. D.; Horne, Andrew W.			Shotgun Proteomics Identifies Serum Fibronectin as a Candidate Diagnostic Biomarker for Inclusion in Future Multiplex Tests for Ectopic Pregnancy	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; PLACENTAL GROWTH-FACTOR; MANAGEMENT; PLASMA; MARKER	Ectopic pregnancy (EP) is difficult to diagnose early and accurately. Women often present at emergency departments in early pregnancy with a 'pregnancy of unknown location' (PUL), and diagnosis and exclusion of EP is challenging due to a lack of reliable biomarkers. The objective of this study was to identify novel diagnostic biomarkers for EP. Shotgun proteomics, incorporating combinatorial-ligand library pre-fractionation, was used to interrogate pooled sera (n = 40) from women undergoing surgery for EP, termination of viable intrauterine pregnancy and management of non-viable intrauterine pregnancy. Western blot was used to validate results in individual sera. ELISAs were developed to interrogate sera from women with PUL (n = 120). Sera were collected at time of first symptomatic presentation and categorized according to pregnancy outcome. The main outcome measures were differences between groups and area under the receiver operating curve (ROC). Proteomics identified six biomarker candidates. Western blot detected significant differences in levels of two of these candidates. ELISA of sera from second cohort revealed that these differences were only significant for one of these candidates, fibronectin. ROC analysis of ability of fibronectin to discriminate EP from other pregnancy outcomes suggested that fibronectin has diagnostic potential (ROC 0.6439; 95% CI 0.5090 to 0.7788; P>0.05), becoming significant when 'ambiguous' medically managed PUL excluded from analysis (ROC 0.6538; 95% CI 0.5158 to 0.7918; P<0.05). Fibronectin may make a useful adjunct to future multiplex EP diagnostic tests.	[Brown, Jeremy K.; Lauer, Katarina B.; Ironmonger, Emily L.; Critchley, Hilary O. D.; Horne, Andrew W.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland; [Inglis, Neil F.] Moredun Res Inst, Moredun Prote Facil, Penicuik, Midlothian, Scotland; [Bourne, Tom H.] Imperial Coll Natl Hlth Serv Trust, Queen Charlottes & Chelsea Hosp, London, England	University of Edinburgh; Moredun Research Institute; Imperial College London	Horne, AW (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland.	andrew.horne@ed.ac.uk	Bourne, Tom/I-6478-2012	Bourne, Tom/0000-0003-1421-6059; Lauer, Katharina Barbara/0000-0002-4347-7525; CRITCHLEY, HILARY/0000-0003-1913-4044; Horne, Andrew/0000-0002-9656-493X	United Kingdom Medical Research Council [MRC G0802808]; Medical Research Council [G1002033, G0802808] Funding Source: researchfish; MRC [G0802808, G1002033] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the United Kingdom Medical Research Council (MRC G0802808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart K, 2011, EXPERT REV MOL DIAGN, V11, P759, DOI [10.1586/erm.11.72, 10.1586/ERM.11.72]; Barnhart K, 2011, FERTIL STERIL, V95, P857, DOI 10.1016/j.fertnstert.2010.09.006; Beer LA, 2011, METHODS MOL BIOL, V728, P3, DOI 10.1007/978-1-61779-068-3_1; Beer LA, 2011, J PROTEOME RES, V10, P1126, DOI 10.1021/pr1008866; Boschetti E, 2008, J PROTEOMICS, V71, P255, DOI 10.1016/j.jprot.2008.05.002; BUCK RH, 1988, FERTIL STERIL, V50, P752; Cabar FR, 2010, FERTIL STERIL, V94, P1595, DOI 10.1016/j.fertnstert.2009.10.036; Chen H, 2012, ARCH GYNECOL OBSTET, V285, P1231, DOI 10.1007/s00404-011-2137-x; Condous G, 2004, HUM REPROD, V19, P1900, DOI 10.1093/humrep/deh341; Daponte A, 2011, J CLIN ENDOCR METAB, V96, pE1444, DOI 10.1210/jc.2011-0037; Duncan WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023595; Echan LA, 2005, PROTEOMICS, V5, P3292, DOI 10.1002/pmic.200401228; Florio P, 2011, GYNECOL ENDOCRINOL, V27, P391, DOI 10.3109/09513590.2010.495430; Goldfinch GM, 2008, PROTEOMICS, V8, P1909, DOI 10.1002/pmic.200700531; Horne AW, 2008, J CLIN ENDOCR METAB, V93, P2375, DOI 10.1210/jc.2008-0136; Horne AW, 2009, MOL HUM REPROD, V15, P287, DOI 10.1093/molehr/gap019; Horne AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041442; Horne AW, 2011, J CLIN ENDOCR METAB, V96, pE104, DOI 10.1210/jc.2010-1403; Horne AW, 2010, ACTA OBSTET GYN SCAN, V89, P299, DOI 10.3109/00016340903568191; Iyibozkurt AC, 2010, CLIN EXP OBSTET GYN, V37, P217; Jurkovic D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3397; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; MANTZAVINOS T, 1991, EUR J OBSTET GYN R B, V39, P117, DOI 10.1016/0028-2243(91)90074-U; Morelli SS, 2008, FERTIL STERIL, V90, P2068, DOI 10.1016/j.fertnstert.2007.10.063; Rasband W., 2006, IMAGEJ; Rausch ME, 2011, OBSTET GYNECOL, V117, P573, DOI 10.1097/AOG.0b013e31820b3c61; Rausch ME, 2011, FERTIL STERIL, V95, P1373, DOI 10.1016/j.fertnstert.2010.12.040; Sahraravand M, 2011, PLACENTA, V32, P999, DOI 10.1016/j.placenta.2011.10.005; Segal S, 2008, REPROD BIOMED ONLINE, V17, P789, DOI 10.1016/S1472-6483(10)60406-3; Sivalingam VN, 2011, J FAM PLAN REPROD H, V37, P231, DOI 10.1136/jfprhc-2011-0073; STERZIK K, 1989, INT J GYNECOL OBSTET, V28, P253, DOI 10.1016/0020-7292(89)90726-1; Varma R, 2012, CLIN EVID; Walker JJ, 2007, CLIN OBSTET GYNECOL, V50, P89, DOI 10.1097/GRF.0b013e31802f4f79; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397; Wiwanitkit V, 2011, FERTIL STERIL, V95, pE21, DOI 10.1016/j.fertnstert.2011.02.027	35	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66974	10.1371/journal.pone.0066974	http://dx.doi.org/10.1371/journal.pone.0066974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826180	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400089
J	Hirotsu, C; Tufik, S; Guindalini, C; Mazzotti, DR; Bittencourt, LR; Andersen, ML				Hirotsu, Camila; Tufik, Sergio; Guindalini, Camila; Mazzotti, Diego R.; Bittencourt, Lia R.; Andersen, Monica L.			Association Between Uric Acid Levels and Obstructive Sleep Apnea Syndrome in a Large Epidemiological Sample	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; CORONARY-ARTERY-DISEASE; CHRONIC HEART-FAILURE; CARDIOVASCULAR RISK-FACTORS; INDEPENDENT PREDICTOR; CREATININE RATIO; ENDOTHELIAL DYSFUNCTION; PULMONARY-HYPERTENSION; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS	Introduction: Recurrent hypoxia, which is associated with obstructive sleep apnea syndrome (OSAS), leads to an increase in the degradation of adenosine triphosphatase into xanthine, which in turn increases uric acid concentrations. Objective: The current study aimed to determine whether an association exists between OSAS and uric acid levels in the peripheral blood from a representative population of Sao Paulo (Brazil). Methods: A population-based survey adopting a probabilistic 3-stage cluster sample of Sao Paulo was used to represent the population according to gender, age, and socioeconomic class. A total of 1,042 volunteers underwent polysomnography recordings for OSAS diagnosis, blood pressure assessment, and biochemical blood analysis, and answered questionnaires. Results: Uric acid levels were correlated with most important risk factors for OSAS, such as AHI, desaturation time and index, minimum oxyhemoglobin saturation (SpO(2)), blood pressure, cholesterol, BMI, triglycerides and arousal, and with OSAS itself. Also, uric acid was increased in OSAS volunteers even after controlling for all confounders. Hyperuricemic volunteers presented lower mean and minimum SpO(2) and increased desaturation index. Importantly, minimum SpO(2) was a significant predictor of uric acid levels, which in turn was considered an independent predictor for OSAS in the binary logistic model. However, a ROC curve analysis for establishing cut-off points for uric acid levels as a biomarker of OSAS revealed moderate sensitivity and specificity. Conclusion: A strong association was found between uric acid levels and OSAS in a representative sample of the population of Sao Paulo. Although they do not qualify for a biomarker alone, uric acid levels may be involved in OSAS severity and should be considered in sleep apnea management in the future.	[Hirotsu, Camila; Tufik, Sergio; Guindalini, Camila; Mazzotti, Diego R.; Bittencourt, Lia R.; Andersen, Monica L.] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Andersen, ML (corresponding author), Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil.	ml.andersen12@gmail.com	Andersen, Monica L/C-7616-2012; Mazzotti, Diego/C-3968-2012; Bittencourt, Lia/C-6551-2012; Mazzotti, Diego R./S-1886-2019	Andersen, Monica L/0000-0002-1894-6748; Bittencourt, Lia/0000-0001-7738-0927; Mazzotti, Diego R./0000-0003-3924-9199; Guindalini, Camila/0000-0002-6278-5881; Hirotsu, Camila/0000-0002-6760-0663	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [CEPID 98/14303-3, 10/50129-1]; CNPq	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Associacao Fundo de Incentivo a Pesquisa (AFIP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (CEPID 98/14303-3 to ST; 10/50129-1 to CH). LRB, MLA and ST are recipients of CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Bergamini C, 2009, EUR J HEART FAIL, V11, P444, DOI 10.1093/eurjhf/hfp042; Bickel C, 2002, AM J CARDIOL, V89, P12, DOI 10.1016/S0002-9149(01)02155-5; Bonora E, 1996, INT J OBESITY, V20, P975; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; BRAGHIROLI A, 1993, AM REV RESPIR DIS, V148, P173, DOI 10.1164/ajrccm/148.1.173; Brodov Y, 2010, AM J CARDIOL, V106, P1717, DOI 10.1016/j.amjcard.2010.07.046; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; CHRISTENSEN EF, 1992, CHEST, V102, P556, DOI 10.1378/chest.102.2.556; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; Desai MY, 2005, AM J CARDIOL, V95, P865, DOI 10.1016/j.amjcard.2004.12.013; Dopp JM, 2011, RESPIRATION, V82, P458, DOI 10.1159/000329341; Drager LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012065; Duran M, 2012, ANGIOLOGY, V63, P448, DOI 10.1177/0003319711426868; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Garcia-Pachon E, 2007, LUNG, V185, P21, DOI 10.1007/s00408-006-0076-2; GEORGE CF, 1985, CLIN CHEST MED, V6, P595; Golbin Jason M, 2008, Proc Am Thorac Soc, V5, P200, DOI 10.1513/pats.200708-143MG; Gozal D, 2007, CURR OPIN PULM MED, V13, P505, DOI 10.1097/MCP.0b013e3282ef6880; GRUM CM, 1985, CHEST, V88, P763, DOI 10.1378/chest.88.5.763; GUILLEMINAULT C, 1984, LANCET, V1, P126; HARKNESS RA, 1983, CLIN SCI, V64, P333, DOI 10.1042/cs0640333; Hira HS, 2012, ANN SAUDI MED, V32, P37, DOI 10.5144/0256-4947.2012.37; Iber C., 2007, AASM MANUAL SCORING; Ioachimescu AG, 2008, ARTHRITIS RHEUM-US, V58, P623, DOI 10.1002/art.23121; Jankowska EA, 2007, INT J CARDIOL, V115, P151, DOI 10.1016/j.ijcard.2005.10.033; JENSEN MH, 1980, BIOL NEONATE, V38, P40; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jubber AS, 2004, INT J CLIN PRACT, V58, P573, DOI 10.1111/j.1368-5031.2004.00166.x; Kaditis A, 2010, SLEEP MED, V11, P489, DOI 10.1016/j.sleep.2009.06.011; Karagiannis A, 2007, CIRC J, V71, P1120, DOI 10.1253/circj.71.1120; Kojima S, 2005, AM J CARDIOL, V96, P489, DOI 10.1016/j.amjcard.2005.04.007; Lavie Lena, 2012, Front Biosci (Elite Ed), V4, P1391; Lazzeri C, 2010, INT J CARDIOL, V138, P206, DOI 10.1016/j.ijcard.2008.06.024; Lippi G, 2008, BIOCHEM MEDICA, V18, P37; Liu Wenjun, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P1074; MCKEON JL, 1990, AM REV RESPIR DIS, V142, P8, DOI 10.1164/ajrccm/142.1.8; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; Nagaya N, 1999, AM J RESP CRIT CARE, V160, P487, DOI 10.1164/ajrccm.160.2.9812078; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Patetsios P, 1996, ANN NY ACAD SCI, V800, P243, DOI 10.1111/j.1749-6632.1996.tb33318.x; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Plywaczewski Robert, 2005, Pneumonol Alergol Pol, V73, P254; Plywaczewski Robert, 2006, Pneumonol Alergol Pol, V74, P159; Puig JG, 1999, J HYPERTENS, V17, P869, DOI 10.1097/00004872-199917070-00001; RAIVIO KO, 1976, J PEDIATR-US, V88, P625, DOI 10.1016/S0022-3476(76)80023-6; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; REUNANEN A, 1982, ACTA MED SCAND, P49; Garcia AR, 2006, ARCH BRONCONEUMOL, V42, P492, DOI 10.1016/S1579-2129(06)60575-2; Sahebjami H, 1998, CHEST, V113, P1604, DOI 10.1378/chest.113.6.1604; Saito H, 2002, CHEST, V122, P1686, DOI 10.1378/chest.122.5.1686; Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001; Sato F, 1997, CIRCULATION, V96, P274; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Shimizu Y, 2002, CIRC J, V66, P571, DOI 10.1253/circj.66.571; SORLIE D, 1982, ACTA MED SCAND, V211, P281; Steiropoulos P, 2009, SLEEP, V32, P537, DOI 10.1093/sleep/32.4.537; Thomas JJ, 2012, CLIN EXP PHARM PHYSL; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Van Hoorenbeeck K, 2012, OBESITY, V20, P172, DOI 10.1038/oby.2011.282; Verhulst SL, 2007, CHEST, V132, P76, DOI 10.1378/chest.06-2930; Vijayan VK, 2012, EXPERT REV RESP MED, V6, P557, DOI [10.1586/ers.12.44, 10.1586/ERS.12.44]; World Medical Association Inc, 2009, J Indian Med Assoc, V107, P403; Wysocka E, 2013, ADV EXP MED BIOL, V756, P121, DOI 10.1007/978-94-007-4549-0_16; Yamazaki I, 1995, Nihon Kyobu Geka Gakkai Zasshi, V43, P26; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	69	37	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66891	10.1371/journal.pone.0066891	http://dx.doi.org/10.1371/journal.pone.0066891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826169	Green Published, gold			2022-12-27	WOS:000321738400080
J	Jin, Y; Korol, SV; Jin, Z; Barg, S; Birnir, B				Jin, Yang; Korol, Sergiy V.; Jin, Zhe; Barg, Sebastian; Birnir, Bryndis			In Intact Islets Interstitial GABA Activates GABA(A) Receptors That Generate Tonic Currents in alpha-Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GAMMA-AMINOBUTYRIC-ACID; SYNAPTIC-LIKE MICROVESICLES; GLUCAGON-SECRETION; GLUTAMATE-DECARBOXYLASE; GLUCOSE-INHIBITION; ENDOCRINE PANCREAS; INSULIN-SECRETION; MOUSE; EXOCYTOSIS	In the rat islets gamma-aminobutyric acid (GABA) is produced by the beta-cells and, at least, the alpha-cells express the GABA(A) receptors (GABA(A) channels). In this study, we examined in intact islets if the interstitial GABA activated the GABA(A) receptors. We used the patch-clamp technique to record whole-cell and single-channel currents and single-cell RT-PCR to identify the cell-type we recorded from, in the intact rat islets. We further identified which GABAA receptor subunits were expressed. We determined the cell-type of 43 cells we recorded from and of these 49%, 28% and 7% were alpha, beta and delta-cells, respectively. In the remaining 16% of the cells, mRNA transcripts of more than one hormone gene were detected. The results show that in rat islets interstitial GABA activates tonic current in the alpha-cells but not in the beta-cells. Seventeen different GABA(A) receptor subunits are expressed with high expression of alpha 1, alpha 2, alpha 4, alpha 6, beta 3, gamma 1, delta, rho 1, rho 2 and rho 3 subunits whereas no expression was detected for alpha 5 or e subunits. The abundance of the GABA(A) receptor subunits detected suggests that a number of GABA(A) receptor subtypes are formed in the islets. The single-channel and tonic currents were enhanced by pentobarbital and inhibited by the GABA(A) receptor antagonist SR-95531. The single-channel conductance ranged from 24 to 105 pS. Whether the single-channel conductance is related to subtypes of the GABA(A) receptor or variable interstitial GABA concentrations remains to be determined. Our results reveal that GABA is an extracellular signaling molecule in rat pancreatic islets and reaches concentration levels that activate GABA(A) receptors on the glucagon-releasing alpha-cells.	[Jin, Yang; Korol, Sergiy V.; Jin, Zhe; Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Barg, Sebastian] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Uppsala University; Uppsala University	Birnir, B (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	bryndis.birnir@neuro.uu.se	Korol, Sergiy V./S-3442-2016; Barg, Sebastian/F-9523-2010; Jin, Zhe/C-5150-2008	Korol, Sergiy V./0000-0001-8279-2790; Barg, Sebastian/0000-0003-4661-5724; Jin, Zhe/0000-0002-4717-1558; Birnir, Bryndis/0000-0002-1763-0266	Swedish Research Council; Swedish Diabetes Research Foundation; Ernfors Foundation; EXODIAB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Research Foundation; Ernfors Foundation; EXODIAB	The authors thank the Swedish Research Council, Swedish Diabetes Research Foundation, The Ernfors Foundation and EXODIAB for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2002, TISSUE CELL, V34, P1, DOI 10.1054/tice.2002.0217; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; BIRNIR B, 1994, J MEMBRANE BIOL, V142, P93; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Braun M, 2004, J PHYSIOL-LONDON, V559, P397, DOI 10.1113/jphysiol.2004.066563; Braun M, 2004, J GEN PHYSIOL, V123, P191, DOI 10.1085/jgp.200308966; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x; CHRISTGAU S, 1992, J CELL BIOL, V118, P309, DOI 10.1083/jcb.118.2.309; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Jin Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016188; Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009; Kash SF, 1999, HORM METAB RES, V31, P340, DOI 10.1055/s-2007-978750; Koh DS, 2012, J MOL NEUROSCI, V48, P429, DOI 10.1007/s12031-012-9752-2; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Leung YM, 2005, ENDOCRINOLOGY, V146, P4766, DOI 10.1210/en.2005-0803; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; MACDONALD RL, 1989, J PHYSIOL-LONDON, V410, P479, DOI 10.1113/jphysiol.1989.sp017545; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Mendu SK, 2011, MOL IMMUNOL, V48, P399, DOI 10.1016/j.molimm.2010.08.005; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SANDLER S, 1987, ENDOCRINOLOGY, V121, P1424, DOI 10.1210/endo-121-4-1424; Satin LS, 1998, ENDOCRINE, V8, P213, DOI 10.1385/ENDO:8:3:213; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Shi YG, 2000, AM J PHYSIOL-ENDOC M, V279, pE684, DOI 10.1152/ajpendo.2000.279.3.E684; Smismans A, 1997, DIABETOLOGIA, V40, P1411, DOI 10.1007/s001250050843; SUNDLER F, 1977, CELL TISSUE RES, V178, P307; Taneera J, 2012, DIABETOLOGIA, V55, P1985, DOI 10.1007/s00125-012-2548-7; TANIGUCHI H, 1979, DIABETES, V28, P629, DOI 10.2337/diabetes.28.7.629; TANIGUCHI H, 1977, ARCH HISTOL JAPON, V40, P87, DOI 10.1679/aohc1950.40.Supplement_87; Walker JN, 2011, DIABETES OBES METAB, V13, P95, DOI 10.1111/j.1463-1326.2011.01450.x; Wang C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1201, DOI 10.1152/ajpendo.00459.2006; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	40	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67228	10.1371/journal.pone.0067228	http://dx.doi.org/10.1371/journal.pone.0067228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826240	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400122
J	Liu, YZ; Zhang, DD; Ma, J; Li, D; Yin, HZ; Luo, YJ				Liu, Yunzhe; Zhang, Dandan; Ma, Jing; Li, Dan; Yin, Huazhan; Luo, Yuejia			The Attention Modulation on Timing: An Event-Related Potential Study	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; TIME PERCEPTION; DECISION-MAKING; BRAIN; FMRI; LOCALIZATION; MEMORY; TASKS; RESOLUTION; RESOURCES	The present study examined the neural mechanisms of attention modulation on timing using ERP and sLORETA measurements in a dual-task paradigm. We parametrically varied the attention to the durations of a 1000-Hz pure tone and further localized the cortical regions that were sensitive to the attention modulation on timing. Results demonstrated that the attention modulation might happen at early stage, approximately 200 ms after stimulus presentation. The P2 component at frontal area served as an early neural correlate of attention effects on timing. More importantly, the contingent negative variation (CNV) appeared at fronto-central area was sensitive to the attention effect. In addition, the supplementary motor area (SMA) was assumed to be one of the key regions for selectively attending to and estimating time. These findings provide temporal and spatial correlates of attention-modulated time processing and potentially help to investigate the neural mechanisms of patients with time perception deficits.	[Liu, Yunzhe; Zhang, Dandan; Luo, Yuejia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Ma, Jing] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Li, Dan; Yin, Huazhan] Chong Qing Normal Univ, Dept Psychol, Chongqing, Peoples R China	Shenzhen University; Southwest University - China; Chongqing Normal University	Yin, HZ (corresponding author), Chong Qing Normal Univ, Dept Psychol, Chongqing, Peoples R China.	yhz1979@sina.com			Ministry of Education of Humanities and Social Science project of China [12YJC190035]; China Postdoctoral Science Foundation [2013M530759]; National Natural Science Foundation of China [H0921]; Educational Commission Science Project of Chongqing [KJ120618]	Ministry of Education of Humanities and Social Science project of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Educational Commission Science Project of Chongqing	This study was supported by the Ministry of Education of Humanities and Social Science project of China (12YJC190035), China Postdoctoral Science Foundation (2013M530759), National Natural Science Foundation of China (H0921), and Educational Commission Science Project of Chongqing (KJ120618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Casini L, 1996, J PSYCHOPHYSIOL, V10, P252; Casini L, 1999, BEHAV PROCESS, V45, P73, DOI 10.1016/S0376-6357(99)00010-8; Casini L, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00035; Chen YG, 2010, NEUROREPORT, V21, P152, DOI 10.1097/WNR.0b013e328335b4f7; Coull JT, 2008, J COGNITIVE NEUROSCI, V20, P2185, DOI 10.1162/jocn.2008.20153; Coull JT, 2004, COGNITIVE BRAIN RES, V21, P216, DOI 10.1016/j.cogbrainres.2004.02.011; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gibbons H, 2005, COGNITIVE BRAIN RES, V25, P195, DOI 10.1016/j.cogbrainres.2005.05.009; Gibbons H, 2003, CORTEX, V39, P947, DOI 10.1016/S0010-9452(08)70872-4; Gonzalez-Garrido AA, 2008, INT J NEUROSCI, V118, P119, DOI 10.1080/00207450601042177; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Kononowicz TW, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00048; Kotz SAE, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00086; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; MACAR F, 1994, MEM COGNITION, V22, P673, DOI 10.3758/BF03209252; Macar F, 2004, J PSYCHOPHYSIOL, V18, P89, DOI 10.1027/0269-8803.18.23.89; Macar F, 2003, PSYCHOPHYSIOLOGY, V40, P950, DOI 10.1111/1469-8986.00113; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; Macar F, 2009, CAN J EXP PSYCHOL, V63, P227, DOI 10.1037/a0014457; MAURITZ KH, 1986, EXP BRAIN RES, V61, P229; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Paul I, 2011, BIOL PSYCHOL, V88, P94, DOI 10.1016/j.biopsycho.2011.06.013; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Pouthas V, 2000, HUM BRAIN MAPP, V10, P49, DOI 10.1002/(SICI)1097-0193(200006)10:2<49::AID-HBM10>3.0.CO;2-8; Praamstra P, 2006, J NEUROSCI, V26, P5448, DOI 10.1523/JNEUROSCI.0440-06.2006; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Sen S, 2010, NEUROSCIENCE, V166, P712, DOI 10.1016/j.neuroscience.2009.12.036; van Rijn H, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00091; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0	40	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66190	10.1371/journal.pone.0066190	http://dx.doi.org/10.1371/journal.pone.0066190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826089	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400011
J	Perl, S; Perlman, J; Weitzel, RP; Phang, O; Hsieh, MM; Tisdale, J				Perl, Shira; Perlman, Jordan; Weitzel, R. P.; Phang, Oswald; Hsieh, Matthew M.; Tisdale, John			Addition of Rapamycin to Anti-CD3 Antibody Improves Long-Term Glycaemia Control in Diabetic NOD Mice	PLOS ONE			English	Article							T-CELLS; TYPE-1; TRIAL	Aims/Hypothesis: Non-Fc-binding Anti CD3 antibody has proven successful in reverting diabetes in the non-obese diabetes mouse model of type 1 diabetes and limited efficacy has been observed in human clinical trials. We hypothesized that addition of rapamycin, an mTOR inhibitor capable of inducing operational tolerance in allogeneic bone marrow transplantation, would result in improved diabetes reversal rates and overall glycemia. Methods: Seventy hyperglycemic non-obese diabetic mice were randomized to either a single injection of anti CD3 alone or a single injection of anti CD3 followed by 14 days of intra-peritoneal rapamycin. Mice were monitored for hyperglycemia and metabolic control. Results: Mice treated with the combination of anti CD3 and rapamycin had similar rates of diabetes reversal compared to anti CD3 alone (25/35 vs. 22/35). Mice treated with anti CD3 plus rapamycin had a significant improvement in glycemia control as exhibited by lower blood glucose levels in response to an intra-peritoneal glucose challenge; average peak blood glucose levels 30 min post intra-peritoneal injection of 2 gr/kg glucose were 6.9 mmol/L in the anti CD3 plus rapamycin group vs. 10 mmo/L in the anti CD3 alone (P<0.05). Conclusions/Interpretation: The addition of rapamycin to anti CD3 results in significant improvement in glycaemia control in diabetic NOD mice.	[Perl, Shira] NHLBI, Ctr Human Immunol, NIH, Bethesda, MD 20892 USA; [Perl, Shira; Perlman, Jordan; Weitzel, R. P.; Phang, Oswald; Hsieh, Matthew M.; Tisdale, John] NHLBI, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Perl, S (corresponding author), NHLBI, Ctr Human Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	perls@nhlbi.nih.gov			National Heart, Lung, and Blood Institute at the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIAHL006009] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the intramural research program of the National Heart, Lung, and Blood Institute at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002757; Bach JF, 2011, LANCET, V378, P459, DOI 10.1016/S0140-6736(11)60980-X; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Greenbaum CJ, 2012, DIABETES, V61, P2066, DOI 10.2337/db11-1538; Haller MJ, 2005, NEW ENGL J MED, V353, P2086; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Monti P, 2008, DIABETES, V57, P2341, DOI 10.2337/db08-0138; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Valle A, 2009, DIABETES, V58, P875, DOI 10.2337/db08-1432; Waickman AT, 2012, J IMMUNOL, V188, P4721, DOI 10.4049/jimmunol.1103143; Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173	11	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67189	10.1371/journal.pone.0067189	http://dx.doi.org/10.1371/journal.pone.0067189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826229	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400116
J	Dor-Haim, H; Berenfeld, O; Horowitz, M; Lotan, C; Swissa, M				Dor-Haim, Horesh; Berenfeld, Omer; Horowitz, Michal; Lotan, Chaim; Swissa, Moshe			Reduced Ventricular Arrhythmogeneity and Increased Electrical Complexity in Normal Exercised Rats	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS; ATRIAL-FIBRILLATION; VIGOROUS EXERCISE; CANINE MODEL; MORTALITY; HYPERTROPHY; SUSCEPTIBILITY	Background: The mechanisms whereby aerobic training reduces the occurrence of sudden cardiac death in humans are not clear. We test the hypothesis that exercise-induced increased resistance to ventricular tachycardia and fibrillation (VT/VF) involve an intrinsic remodeling in healthy hearts. Methods and Results: Thirty rats were divided into a sedentary (CTRL, n = 16) and two exercise groups: short-(4 weeks, ST, n = 7) and long-term (8 weeks, LT, n = 7) trained groups. Following the exercise program hearts were isolated and studied in a Langendorff perfusion system. An S-1-S-2 pacing protocol was applied at the right ventricle to determine inducibility of VT/VF. Fast Fourier transforms were applied on ECG time-series. In-vivo measurements showed training-induced increase in aerobic capacity, heart-to-body weight ratio and a 50% low-to-high frequency ratio reduction in the heart rate variability (p<0.05). In isolated hearts the probability for VF decreased from 26.1 +/- 14.4 in CTRL to 13.9 +/- 14.1 and 6.7 +/- 8.5% in the ST and LT, respectively (p<0.05). Duration of VF also decreased from 19.0 +/- 5.7 in CTRL to 8.8 +/- 7.1 and 6.0 +/- 5.8 sec in ST and LT respectively (p<0.05). Moreover, the pacing current required for VF induction increased following exercise (2.9 +/- 1.7 vs. 5.4 +/- 2.1 and 8.5 +/- 0.9 mA, respectively; p<0.05). Frequency analysis of ECG revealed an exercise-induced VF transition from a narrow single peak spectrum at 17 Hz in CTRL to a broader range of peaks ranging between 8.8 and 22.5 Hz in the LT group (p<0.05). Conclusion: Exercise in rats leads to reduced VF propensity associated with an intrinsic cardiac remodeling related to a broader spectral range and faster frequency components in the ECG.	[Dor-Haim, Horesh; Lotan, Chaim] Hadassah Hebrew Univ Med Ctr, Inst Heart, Jerusalem, Israel; [Berenfeld, Omer] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Horowitz, Michal] Hadassah Hebrew Univ Med Ctr, Dept Physiol, Jerusalem, Israel; [Swissa, Moshe] Kaplan Med Ctr, Cardiac Res Ctr, Rehovot, Israel	Hebrew University of Jerusalem; University of Michigan System; University of Michigan; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Kaplan Medical Center	Swissa, M (corresponding author), Kaplan Med Ctr, Cardiac Res Ctr, Rehovot, Israel.	swissam@mail.huji.ac.il	Dor-Haim, Horesh/AAG-5001-2019	Berenfeld, Omer/0000-0001-9532-7871; Swissa, Moshe/0000-0001-7726-1178				Agabiti-Rosei E, 1997, ADV EXP MED BIOL, V432, P199; Anichkov DA, 2007, INT J CLIN PRACT, V61, P777, DOI 10.1111/j.1742-1241.2006.01099.x; BARTELS R, 1997, MED KLIN, P92; Berenfeld O, 2002, CIRC RES, V90, P1173, DOI 10.1161/01.RES.0000022854.95998.5C; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Biffi A, 2008, AM J CARDIOL, V101, P1792, DOI 10.1016/j.amjcard.2008.02.081; BILLMAN GE, 1984, CIRCULATION, V69, P1182, DOI 10.1161/01.CIR.69.6.1182; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Calderone A, 2001, J APPL PHYSIOL, V91, P771, DOI 10.1152/jappl.2001.91.2.771; Campbell K, 2012, J PHYSIOL-LONDON, V590, P6363, DOI 10.1113/jphysiol.2012.238758; Collins HL, 2005, AM J PHYSIOL-HEART C, V289, pH1020, DOI 10.1152/ajpheart.00156.2005; Collins HL, 2005, AM J PHYSIOL-HEART C, V288, pH532, DOI 10.1152/ajpheart.00873.2004; EHSANI AA, 1978, AM J CARDIOL, V42, P52, DOI 10.1016/0002-9149(78)90984-0; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Galinier M, 2000, EUR HEART J, V21, P475, DOI 10.1053/euhj.1999.1875; Gaussin V, 2003, CIRCULATION, V108, P2926, DOI 10.1161/01.CIR.0000101922.18151.7B; Hou LQ, 2010, CIRC RES, V107, P1503, DOI 10.1161/CIRCRESAHA.110.232470; Iemitsu M, 2001, AM J PHYSIOL-REG I, V281, pR2029, DOI 10.1152/ajpregu.2001.281.6.R2029; Jalife J, 2003, J INTERV CARD ELECTR, V9, P119, DOI 10.1023/A:1026215919730; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kozakova M, 2000, HYPERTENSION, V36, P343, DOI 10.1161/01.HYP.36.3.343; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; Lujan HL, 2010, AM J PHYSIOL-HEART C, V298, pH1330, DOI 10.1152/ajpheart.00955.2009; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Manzo A, 2009, LAB ANIM-UK, V43, P41, DOI 10.1258/la.2007.007085; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; McIntyre H, 1997, J CARDIOVASC ELECTR, V8, P887, DOI 10.1111/j.1540-8167.1997.tb00850.x; MORRIS JN, 1980, LANCET, V2, P1207; Motte S, 2005, AM J PHYSIOL-HEART C, V289, pH1729, DOI 10.1152/ajpheart.01129.2004; Mozaffarian D, 2008, CIRCULATION, V118, P800, DOI 10.1161/CIRCULATIONAHA.108.785626; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; NOAKES TD, 1983, CIRCULATION, V67, P24, DOI 10.1161/01.CIR.67.1.24; Noujaim SF, 2007, P NATL ACAD SCI USA, V104, P20985, DOI 10.1073/pnas.0709758104; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Oikarinen L, 2004, HYPERTENSION, V43, P1029, DOI 10.1161/01.HYP.0000125230.46080.c6; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; POSEL D, 1989, CIRCULATION, V80, P138, DOI 10.1161/01.CIR.80.1.138; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; SCHWARTZ PJ, 1984, CIRCULATION, V69, P790, DOI 10.1161/01.CIR.69.4.790; SHAPIRO LM, 1984, BRIT HEART J, V52, P130; Strom CC, 2005, FEBS J, V272, P2684, DOI 10.1111/j.1742-4658.2005.04684.x; Swissa M, 2004, J AM COLL CARDIOL, V43, P858, DOI 10.1016/j.jacc.2003.07.053; Swissa M, 2005, AM J PHYSIOL-HEART C, V289, pH1851, DOI 10.1152/ajpheart.00083.2005; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; TOMANEK RJ, 1979, TEX REP BIOL MED, V39, P111; Weber K T, 1987, J Cardiovasc Pharmacol, V10 Suppl 6, pS37, DOI 10.1097/00005344-198706106-00006; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wisloff U, 2001, CARDIOVASC RES, V50, P495, DOI 10.1016/S0008-6363(01)00210-3; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66658	10.1371/journal.pone.0066658	http://dx.doi.org/10.1371/journal.pone.0066658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825553	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400142
J	Guttery, MR; Dahlgren, DK; Messmer, TA; Connelly, JW; Reese, KP; Terletzky, PA; Burkepile, N; Koons, DN				Guttery, Michael R.; Dahlgren, David K.; Messmer, Terry A.; Connelly, John W.; Reese, Kerry P.; Terletzky, Pat A.; Burkepile, Nathan; Koons, David N.			Effects of Landscape-Scale Environmental Variation on Greater Sage-Grouse Chick Survival	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; CENTROCERCUS-UROPHASIANUS; ECOLOGICAL RESPONSES; TEMPORAL VARIATION; MICROBIAL ACTIVITY; MOUNTAIN SNOWPACK; CLIMATE-CHANGE; BROOD HABITAT; NEST SURVIVAL; UNITED-STATES	Effective long-term wildlife conservation planning for a species must be guided by information about population vital rates at multiple scales. Greater sage-grouse (Centrocercus urophasianus) populations declined substantially during the twentieth century, largely as a result of habitat loss and fragmentation. In addition to the importance of conserving large tracts of suitable habitat, successful conservation of this species will require detailed information about factors affecting vital rates at both the population and range-wide scales. Research has shown that sage-grouse population growth rates are particularly sensitive to hen and chick survival rates. While considerable information on hen survival exists, there is limited information about chick survival at the population level, and currently there are no published reports of factors affecting chick survival across large spatial and temporal scales. We analyzed greater sage-grouse chick survival rates from 2 geographically distinct populations across 9 years. The effects of 3 groups of related landscape-scale covariates (climate, drought, and phenology of vegetation greenness) were evaluated. Models with phenological change in greenness (NDVI) performed poorly, possibly due to highly variable production of forbs and grasses being masked by sagebrush canopy. The top drought model resulted in substantial improvement in model fit relative to the base model and indicated that chick survival was negatively associated with winter drought. Our overall top model included effects of chick age, hen age, minimum temperature in May, and precipitation in July. Our results provide important insights into the possible effects of climate variability on sage-grouse chick survival.	[Guttery, Michael R.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Dahlgren, David K.] Kansas Dept Wildlife & Pk, Hays, KS USA; [Messmer, Terry A.; Terletzky, Pat A.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Connelly, John W.] Idaho Dept Fish & Game, Blackfoot, ID USA; [Reese, Kerry P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Burkepile, Nathan] Northland Fish & Game, Whangarei, New Zealand; [Koons, David N.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Koons, David N.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	University of Wisconsin System; University of Wisconsin Madison; Utah System of Higher Education; Utah State University; Idaho; University of Idaho; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Guttery, MR (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	micrgutt@gmail.com			Idaho Department of Fish and Game Federal Aide in Wildlife Restoration Project [W-160-R]; United States Natural Resources Conservation Service; U.S. Bureau of Land Management; Utah State University Quinney Professorship for Wildlife Conflict Management; Jack H. Berryman Institute of Wildlife Damage Management; Utah State University Extension Service	Idaho Department of Fish and Game Federal Aide in Wildlife Restoration Project; United States Natural Resources Conservation Service; U.S. Bureau of Land Management; Utah State University Quinney Professorship for Wildlife Conflict Management; Jack H. Berryman Institute of Wildlife Damage Management; Utah State University Extension Service	This research was supported by the Idaho Department of Fish and Game Federal Aide in Wildlife Restoration Project W-160-R, the United States Natural Resources Conservation Service, U.S. Bureau of Land Management, Utah State University Quinney Professorship for Wildlife Conflict Management, Jack H. Berryman Institute of Wildlife Damage Management, Utah State University Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Anthony RG, 2009, J WILDLIFE MANAGE, V73, P538, DOI 10.2193/2008-177; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; BARROS N, 1995, THERMOCHIM ACTA, V249, P161, DOI 10.1016/0040-6031(95)90686-X; Baxter RJ, 2008, J WILDLIFE MANAGE, V72, P179, DOI 10.2193/2006-402; Beck JL, 2006, WILDLIFE SOC B, V34, P1070, DOI 10.2193/0091-7648(2006)34[1070:MASOJG]2.0.CO;2; Beck JL, 2003, WEST N AM NATURALIST, V63, P203; Beck T. D. I., 1975, SEX AGE DETERMINATIO; Blomberg EJ, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00304.1; Bohn HL, 1999, ENVIRON PROG, V18, P156, DOI 10.1002/ep.670180311; BOX EO, 1989, VEGETATIO, V80, P71, DOI 10.1007/BF00048034; Brown TJ, 2004, CLIMATIC CHANGE, V62, P365, DOI 10.1023/B:CLIM.0000013680.07783.de; Burkepile NA, 2002, WILDLIFE SOC B, V30, P93; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caswell, 2000, MATRIX POPULATION MO; Chambers Jeanne C., 2008, Rangelands, V30, P29, DOI 10.2111/1551-501X(2008)30[29:CCIONA]2.0.CO;2; Connelly JW, 2011, STUD AVIAN BIOL, P53; Dahlgren, 2009, GREATER SAGE GROUSE; Dahlgren DK, 2010, J WILDLIFE MANAGE, V74, P1286, DOI 10.2193/2009-093; Daly C, 2000, T ASAE, V43, P1957, DOI 10.13031/2013.3101; Dixon Philip M., 1993, P290; DRUT MS, 1994, GREAT BASIN NAT, V54, P170; DRUT MS, 1994, J RANGE MANAGE, V47, P90, DOI 10.2307/4002848; Dunbar MR, 2005, J ZOO WILDLIFE MED, V36, P422, DOI 10.1638/04-065.1; Fang JY, 2001, SCIENCE, V293, P1723, DOI 10.1126/science.293.5536.1723a; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; Fondell TF, 2008, J WILDLIFE MANAGE, V72, P1614, DOI 10.2193/2007-480; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Garton EO, 2011, STUD AVIAN BIOL, P293; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; Gregg MA, 2008, RANGELAND ECOL MANAG, V61, P535, DOI 10.2111/08-037.1; Gregg MA, 2009, J WILDLIFE MANAGE, V73, P904, DOI 10.2193/2007-410; Guttery MR, 2011, THESIS UTAH STATE U; Hamel S, 2010, ECOLOGY, V91, P2034, DOI 10.1890/09-1311.1; Hannon SJ, 2006, J ZOOL, V269, P422, DOI 10.1111/j.1469-7998.2006.00159.x; Harris W, 2001, CANADIAN SAGE GROUSE; Herman-Brunson KM, 2009, WILDLIFE BIOL, V15, P237, DOI 10.2981/09-005; Hohensee SD, 2001, P NAT WILD TURK S, V8, P85; Holloran MJ, 2005, J WILDLIFE MANAGE, V69, P638, DOI 10.2193/0022-541X(2005)069[0638:GSNHSA]2.0.CO;2; Hughes NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013114; Iles DT, 2013, J ANIM ECOL, V82, P683, DOI 10.1111/1365-2656.12038; Jensen J. R., 2005, INTRO DIGITAL IMAGE; JOHNSON GD, 1990, J WILDLIFE MANAGE, V54, P89, DOI 10.2307/3808906; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; KARL TR, 1986, J CLIM APPL METEOROL, V25, P77, DOI 10.1175/1520-0450(1986)025<0077:TSOTPD>2.0.CO;2; KLEBENOW DA, 1969, J WILDLIFE MANAGE, V33, P649, DOI 10.2307/3799390; KLEBENOW DA, 1968, J RANGE MANAGE, V21, P80, DOI 10.2307/3896359; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Lehman CP, 2008, J WILDLIFE MANAGE, V72, P1765, DOI 10.2193/2007-519; Lehman Chad P., 2008, Intermountain Journal of Sciences, V14, P78; Manly BFJ, 2001, J WILDLIFE MANAGE, V65, P258, DOI 10.2307/3802905; Miller RF, 2011, STUD AVIAN BIOL, P145; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Moynahan BJ, 2006, ECOL APPL, V16, P1529, DOI 10.1890/1051-0761(2006)016[1529:FCTPVI]2.0.CO;2; Norris K, 2004, J APPL ECOL, V41, P413, DOI 10.1111/j.0021-8901.2004.00910.x; Palmer W.C, 1965, METEOROLOGICAL DROUG, V30; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PARUELO JM, 1995, ECOLOGY, V76, P1888, DOI 10.2307/1940721; PETERSON J G, 1970, Journal of Wildlife Management, V34, P147, DOI 10.2307/3799502; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROBERTS SD, 1995, J WILDLIFE MANAGE, V59, P437, DOI 10.2307/3802449; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Schroeder M.A., 1999, Birds of North America, V425, P1; Schroeder TA, 2006, REMOTE SENS ENVIRON, V103, P16, DOI 10.1016/j.rse.2006.03.008; Schwinning S, 2005, J ARID ENVIRON, V61, P61, DOI 10.1016/j.jaridenv.2004.07.013; Sveum CM, 1998, GREAT BASIN NAT, V58, P344; Syrotuck W.G., 1972, SCENT SCENTING DOG; Taylor RL, 2012, J WILDLIFE MANAGE, V76, P336, DOI 10.1002/jwmg.267; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; WALKER DA, 1993, BIOSCIENCE, V43, P287, DOI 10.2307/1312061; WALLESTAD RO, 1971, J WILDLIFE MANAGE, V35, P129, DOI 10.2307/3799881; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Webb Stephen L., 2012, Ecological Processes, V1; Wenninger EJ, 2008, J ARID ENVIRON, V72, P24, DOI 10.1016/j.jaridenv.2007.04.005; Zavala MAL, 2005, COMPOST SCI UTIL, V13, P208; Zheng BY, 2000, STAT MED, V19, P1265, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1265::AID-SIM486>3.3.CO;2-L	83	45	46	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65582	10.1371/journal.pone.0065582	http://dx.doi.org/10.1371/journal.pone.0065582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824519	gold, Green Published			2022-12-27	WOS:000320576400011
J	Hermann, PC; Trabulo, SM; Sainz, B; Balic, A; Garcia, E; Hahn, SA; Vandana, M; Sahoo, SK; Tunici, P; Bakker, A; Hidalgo, M; Heeschen, C				Hermann, Patrick C.; Trabulo, Sara M.; Sainz, Bruno, Jr.; Balic, Anamaria; Garcia, Elena; Hahn, Stephan A.; Vandana, Mallaredy; Sahoo, Sanjeeb K.; Tunici, Patrizia; Bakker, Annette; Hidalgo, Manuel; Heeschen, Christopher			Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts	PLOS ONE			English	Article							SELF-RENEWAL; GEMCITABINE	Purpose: In spite of intense research efforts, pancreatic ductal adenocarcinoma remains one of the most deadly malignancies in the world. We and others have previously identified a subpopulation of pancreatic cancer stem cells within the tumor as a critical therapeutic target and additionally shown that the tumor stroma represents not only a restrictive barrier for successful drug delivery, but also serves as a paracrine niche for cancer stem cells. Therefore, we embarked on a large-scale investigation on the effects of combining chemotherapy, hedgehog pathway inhibition, and mTOR inhibition in a preclinical mouse model of pancreatic cancer. Experimental Design: Prospective and randomized testing in a set of almost 200 subcutaneous and orthotopic implanted whole-tissue primary human tumor xenografts. Results: The combined targeting of highly chemoresistant cancer stem cells as well as their more differentiated progenies, together with abrogation of the tumor microenvironment by targeting the stroma and enhancing tissue penetration of the chemotherapeutic agent translated into significantly prolonged survival in preclinical models of human pancreatic cancer. Most pronounced therapeutic effects were observed in gemcitabine-resistant patient-derived tumors. Intriguingly, the proposed triple therapy approach could be further enhanced by using a PEGylated formulation of gemcitabine, which significantly increased its bioavailability and tissue penetration, resulting in a further improved overall outcome. Conclusions: This multimodal therapeutic strategy should be further explored in the clinical setting as its success may eventually improve the poor prognosis of patients with pancreatic ductal adenocarcinoma.	[Hermann, Patrick C.; Trabulo, Sara M.; Sainz, Bruno, Jr.; Balic, Anamaria; Heeschen, Christopher] Spanish Natl Canc Res Ctr CNIO, Clin Res Programme, Stem Cells & Canc Grp, Madrid, Spain; [Garcia, Elena; Hidalgo, Manuel] Spanish Natl Canc Res Ctr CNIO, Clin Res Programme, Gastrointestinal Canc Clin Res Unit, Madrid, Spain; [Hahn, Stephan A.] Ruhr Univ Bochum, Dept Mol GI Oncol, Bochum, Germany; [Vandana, Mallaredy; Sahoo, Sanjeeb K.] Inst Life Sci, Nanomed Lab, Bhubaneswar, Orissa, India; [Tunici, Patrizia] Siena Biotech SpA, Dept Oncol, Siena, Italy; [Bakker, Annette] Childrens Tumor Fdn, New York, NY USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Ruhr University Bochum; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Siena Biotech	Heeschen, C (corresponding author), Spanish Natl Canc Res Ctr CNIO, Clin Res Programme, Stem Cells & Canc Grp, Madrid, Spain.	cheeschen@cnio.es	Guba, Markus/M-4309-2019; Hahn, Stephan/E-3880-2010; Hermann, Patrick/Y-6254-2019; Anding, Bruno Sainz/ABH-5365-2020; Hahn, Stephan A./AAV-6062-2021; HIDALGO, MANUEL/I-4995-2015; Sanjeeb, Sahoo/ABF-3419-2020	Hahn, Stephan/0000-0003-0855-9741; Hermann, Patrick/0000-0003-0418-0478; Anding, Bruno Sainz/0000-0003-4829-7651; Hahn, Stephan A./0000-0003-0855-9741; HIDALGO, MANUEL/0000-0002-3765-3318; Balic, Anamaria/0000-0001-6796-1197; Heeschen, Christopher/0000-0002-1158-8554; bakker, annette/0000-0001-8420-7831	Siena Biotech, an ERC [Pa-CSC 233460]; Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria; Ministerio de Ciencia e Innovacion, Spain [PS09/02129]; Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (Modalidad ACI-PLAN E Celulas Madre Proyectos [PLE2009-0105]; Modalidad ACI-Colobra India	Siena Biotech, an ERC; Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (Modalidad ACI-PLAN E Celulas Madre Proyectos; Modalidad ACI-Colobra India	The present work was supported by unrestricted research grant from Siena Biotech, an ERC Advanced Investigator Grant (Pa-CSC 233460), the Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria (PS09/02129, Ministerio de Ciencia e Innovacion, Spain) and the Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (Modalidad ACI-PLAN E Celulas Madre Proyectos PLE2009-0105 and Modalidad ACI-Colobra India, both Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuthkar S, 2012, EXPERT OPIN INV DRUG, V21, P143, DOI 10.1517/13543784.2012.651124; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cosco D, 2009, CANCER CHEMOTH PHARM, V64, P1009, DOI 10.1007/s00280-009-0957-1; Ferruzzi P, 2012, INT J CANCER, V131, pE33, DOI 10.1002/ijc.27349; Gallmeier E, 2011, STEM CELLS, V29, P418, DOI 10.1002/stem.595; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Lonardo E, 2012, CELL CYCLE, V11, P1282, DOI 10.4161/cc.19679; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Matano E, 2000, BRIT J CANCER, V82, P1772, DOI 10.1054/bjoc.1999.1139; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Philip PA, 2009, J CLIN ONCOL, V27, P5660, DOI 10.1200/JCO.2009.21.9022; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rothenberg ML, 1996, ANN ONCOL, V7, P347; Vandana M, 2010, BIOMATERIALS, V31, P9340, DOI 10.1016/j.biomaterials.2010.08.010; Von Hoff DD, 2011, J CLIN ONCOLOGY; Von Hoff DD, 2011, CELL STEM CELL; Wang Y, 2007, KIDNEY INT; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028	28	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66371	10.1371/journal.pone.0066371	http://dx.doi.org/10.1371/journal.pone.0066371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825539	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400094
J	Matsumoto, T; Yamada, A; Aizawa, R; Suzuki, D; Tsukasaki, M; Suzuki, W; Nakayama, M; Maki, K; Yamamoto, M; Baba, K; Kamijo, R				Matsumoto, Takashi; Yamada, Atsushi; Aizawa, Ryo; Suzuki, Dai; Tsukasaki, Masayuki; Suzuki, Wataru; Nakayama, Mutsuko; Maki, Koutaro; Yamamoto, Matsuo; Baba, Kazuyoshi; Kamijo, Ryutaro			BMP-2 Induced Expression of Alx3 That Is a Positive Regulator of Osteoblast Differentiation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; PROTEINS; INSULIN; BINDING; DLX3	Bone morphogenetic proteins (BMPs) regulate many aspects of skeletal development, including osteoblast and chondrocyte differentiation, cartilage and bone formation, and cranial and limb development. Among them, BMP-2, one of the most potent osteogenic signaling molecules, stimulates osteoblast differentiation, while it inhibits myogenic differentiation in C2C12 cells. To evaluate genes involved in BMP-2-induced osteoblast differentiation, we performed cDNA microarray analyses to compare BMP-2-treated and -untreated C2C12 cells. We focused on Alx3 (aristaless-like homeobox 3) which was clearly induced during osteoblast differentiation. Alx3, a homeobox gene related to the Drosophila aristaless gene, has been linked to developmental functions in craniofacial structures and limb development. However, little is known about its direct relationship with bone formation. In the present study, we focused on the mechanisms of Alx3 gene expression and function during osteoblast differentiation induced by BMP-2. In C2C12 cells, BMP-2 induced increase of Alx3 gene expression in both time- and dose-dependent manners through the BMP receptors-mediated SMAD signaling pathway. In addition, silencing of Alx3 by siRNA inhibited osteoblast differentiation induced by BMP-2, as showed by the expressions of alkaline phosphatase (Alp), Osteocalcin, and Osterix, while over-expression of Alx3 enhanced osteoblast differentiation induced by BMP-2. These results indicate that Alx3 expression is enhanced by BMP-2 via the BMP receptors mediated-Smad signaling and that Alx3 is a positive regulator of osteoblast differentiation induced by BMP-2.	[Matsumoto, Takashi; Yamada, Atsushi; Aizawa, Ryo; Suzuki, Dai; Tsukasaki, Masayuki; Suzuki, Wataru; Nakayama, Mutsuko; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Tokyo 142, Japan; [Matsumoto, Takashi; Suzuki, Wataru; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Tokyo 142, Japan; [Aizawa, Ryo; Yamamoto, Matsuo] Showa Univ, Sch Dent, Dept Periodont, Tokyo 142, Japan; [Nakayama, Mutsuko; Maki, Koutaro] Showa Univ, Sch Dent, Dept Orthodont, Tokyo 142, Japan	Showa University; Showa University; Showa University; Showa University	Yamada, A (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Tokyo 142, Japan.	yamadaa@dent.showa-u.ac.jp	Baba, Kazuyoshi/AAY-2304-2021	Baba, Kazuyoshi/0000-0001-8025-2168	Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [25893243] Funding Source: KAKEN	Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Project to Establish Strategic Research from the Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science, and Technology, and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beverdam A, 2001, MECH DEVELOP, V107, P163, DOI 10.1016/S0925-4773(01)00450-6; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Brouwer A, 2003, MECH DEVELOP, V120, P241, DOI 10.1016/S0925-4773(02)00416-1; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Garcia-Sanz P, 2013, BIOCHEM J, V450, P199, DOI 10.1042/BJ20120962; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lakhwani S, 2010, DEV BIOL, V344, P869, DOI 10.1016/j.ydbio.2010.06.002; Meijlink F, 1999, INT J DEV BIOL, V43, P651; Mirasierra M, 2006, MOL ENDOCRINOL, V20, P2876, DOI 10.1210/me.2005-0472; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morimura N, 2001, J BIOL CHEM, V276, P42172, DOI 10.1074/jbc.M103216200; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; NELSON C, 1990, GENE DEV, V4, P1035, DOI 10.1101/gad.4.6.1035; Perez-Villamil B, 2004, J BIOL CHEM, V279, P38062, DOI 10.1074/jbc.M400800200; RUDNICK A, 1994, P NATL ACAD SCI USA, V91, P12203, DOI 10.1073/pnas.91.25.12203; Samee N, 2007, CRIT REV EUKAR GENE, V17, P173, DOI 10.1615/CritRevEukarGeneExpr.v17.i3.10; Singh M, 2012, J CELL PHYSIOL, V227, P390, DOI 10.1002/jcp.22791; Suzuki D, 2012, CALCIFIED TISSUE INT, V91, P88, DOI 10.1007/s00223-012-9614-5; ten Berge D, 1998, DEV BIOL, V199, P11, DOI 10.1006/dbio.1998.8921; Twigg SRF, 2009, AM J HUM GENET, V84, P698, DOI 10.1016/j.ajhg.2009.04.009; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200	26	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e68774	10.1371/journal.pone.0068774	http://dx.doi.org/10.1371/journal.pone.0068774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825702	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400201
J	Mueller, S; Keeser, D; Samson, AC; Kirsch, V; Blautzik, J; Grothe, M; Erat, O; Hegenloh, M; Coates, U; Reiser, MF; Hennig-Fast, K; Meindl, T				Mueller, Sophia; Keeser, Daniel; Samson, Andrea C.; Kirsch, Valerie; Blautzik, Janusch; Grothe, Michel; Erat, Okan; Hegenloh, Michael; Coates, Ute; Reiser, Maximilian F.; Hennig-Fast, Kristina; Meindl, Thomas			Convergent Findings of Altered Functional and Structural Brain Connectivity in Individuals with High Functioning Autism: A Multimodal MRI Study	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; WHITE-MATTER; ASPERGER-SYNDROME; CORPUS-CALLOSUM; SENTENCE COMPREHENSION; SPECTRUM DISORDERS; DISTINCT PATTERNS; FRONTAL-CORTEX; DIFFUSION; UNDERCONNECTIVITY	Brain tissue changes in autism spectrum disorders seem to be rather subtle and widespread than anatomically distinct. Therefore a multimodal, whole brain imaging technique appears to be an appropriate approach to investigate whether alterations in white and gray matter integrity relate to consistent changes in functional resting state connectivity in individuals with high functioning autism (HFA). We applied diffusion tensor imaging (DTI), voxel-based morphometry (VBM) and resting state functional connectivity magnetic resonance imaging (fcMRI) to assess differences in brain structure and function between 12 individuals with HFA (mean age 35.5, SD 11.4, 9 male) and 12 healthy controls (mean age 33.3, SD 9.0, 8 male). Psychological measures of empathy and emotionality were obtained and correlated with the most significant DTI, VBM and fcMRI findings. We found three regions of convergent structural and functional differences between HFA participants and controls. The right temporo-parietal junction area and the left frontal lobe showed decreased fractional anisotropy (FA) values along with decreased functional connectivity and a trend towards decreased gray matter volume. The bilateral superior temporal gyrus displayed significantly decreased functional connectivity that was accompanied by the strongest trend of gray matter volume decrease in the temporal lobe of HFA individuals. FA decrease in the right temporoparietal region was correlated with psychological measurements of decreased emotionality. In conclusion, our results indicate common sites of structural and functional alterations in higher order association cortex areas and may therefore provide multimodal imaging support to the long-standing hypothesis of autism as a disorder of impaired higher-order multisensory integration.	[Mueller, Sophia; Keeser, Daniel; Blautzik, Janusch; Erat, Okan; Coates, Ute; Reiser, Maximilian F.; Meindl, Thomas] Univ Munich, Inst Clin Radiol, Munich, Germany; [Keeser, Daniel; Hegenloh, Michael; Hennig-Fast, Kristina] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Samson, Andrea C.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Kirsch, Valerie] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Kirsch, Valerie] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Grothe, Michel] Univ Rostock, Dept Psychiat, D-18055 Rostock, Germany; [Hegenloh, Michael] Univ Munich, Dept Psychol, Munich, Germany	University of Munich; University of Munich; Stanford University; University of Munich; University of Munich; University of Rostock; University of Munich	Mueller, S (corresponding author), Univ Munich, Inst Clin Radiol, Munich, Germany.	Sophia.Mueller@med.uni-muenchen.de	Keeser, Daniel/C-8888-2016; Samson, Andrea C/ABG-6296-2021; Grothe, Michel J./S-7374-2018; Samson, Andrea/K-3928-2017	Keeser, Daniel/0000-0002-0244-1024; Samson, Andrea C/0000-0001-6807-3132; Grothe, Michel J./0000-0003-2600-9022; Samson, Andrea/0000-0001-6807-3132; Kirsch, Valerie/0000-0002-9397-436X	internal funds of the Department of Psychology; Institute of Clinical Radiology; Ludwig Maximilians University Munich; German Research Foundation [MU 3222/2-1]	internal funds of the Department of Psychology; Institute of Clinical Radiology; Ludwig Maximilians University Munich; German Research Foundation(German Research Foundation (DFG))	This study was supported by internal funds of the Department of Psychology and the Institute of Clinical Radiology, Ludwig Maximilians University Munich. Sophia Mueller receives a research fellowship from the German Research Foundation (MU 3222/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Ameis Stephanie H, 2012, Front Psychiatry, V3, P46, DOI 10.3389/fpsyt.2012.00046; Ameis SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028044; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Belmonte MK, 2003, COGNITIVE BRAIN RES, V17, P651, DOI 10.1016/S0926-6410(03)00189-7; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Eysenck HJ, 1994, MANUAL EYSENCK PERSO; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Freitag CM, 2007, J AUTISM DEV DISORD, V37, P948, DOI 10.1007/s10803-006-0235-6; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; FRITH U, 1989, BRIT J DISORD COMMUN, V24, P123; Ghaziuddin M, 2004, J AUTISM DEV DISORD, V34, P279, DOI 10.1023/B:JADD.0000029550.19098.77; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Groves AR, 2012, NEUROIMAGE, V63, P365, DOI 10.1016/j.neuroimage.2012.06.038; Groves AR, 2011, NEUROIMAGE, V54, P2198, DOI 10.1016/j.neuroimage.2010.09.073; Hall GBC, 2003, AM J PSYCHIAT, V160, P1439, DOI 10.1176/appi.ajp.160.8.1439; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Hardan AY, 2000, NEUROLOGY, V55, P1033, DOI 10.1212/WNL.55.7.1033; Heilman KM, 1998, J CLIN NEUROPHYSIOL, V15, P409, DOI 10.1097/00004691-199809000-00005; Hienrichs M, 2007, CURR OPIN PSYCHIATR, V20, P158, DOI 10.1097/YCO.0b013e3280146a13; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Howard MA, 2000, NEUROREPORT, V11, P2931, DOI 10.1097/00001756-200009110-00020; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kosaka H, 2010, NEUROIMAGE, V50, P1357, DOI 10.1016/j.neuroimage.2010.01.085; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kwon H, 2004, DEV MED CHILD NEUROL, V46, P760, DOI 10.1017/S0012162204001306; LAIRD AR, 2011, J COGN NEUROSCI; Lee JE, 2007, NEUROSCI LETT, V424, P127, DOI 10.1016/j.neulet.2007.07.042; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Lombardo MV, 2011, NEUROIMAGE, V56, P1832, DOI 10.1016/j.neuroimage.2011.02.067; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI [10.1203/PDR.0b013e3182130c54, 10.1109/SPL.2011.5782616]; McAlonan GM, 2009, PSYCHOL MED, V39, P1885, DOI 10.1017/S0033291709005728; McAlonan GM, 2008, J CHILD PSYCHOL PSYC, V49, P1287, DOI 10.1111/j.1469-7610.2008.01933.x; MEINDL C, 1998, ENTWICKLUNG VALIDIER; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Muller RA, 2007, MENT RETARD DEV D R, V13, P85, DOI 10.1002/mrdd.20141; MUELLER S, 2011, AJNR AM J NEURORADIO; MUELLER S, 2012, ANN M ORG HUM BRAIN; Mundy P, 2003, J CHILD PSYCHOL PSYC, V44, P793, DOI 10.1111/1469-7610.00165; Nelson H., 1991, NATL ADULT READING T; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; OMANAND K, 2005, NEUROBIOLOGY AUTISM, P150; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Selg H, 2010, FPI R FREIBURGER PER; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; WHO, 2012, ICD 10 CLASS MENT BE; Woodbury-Smith M, 2005, J AUTISM DEV DISORD, V35, P235, DOI 10.1007/s10803-004-2002-x; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	90	96	98	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67329	10.1371/journal.pone.0067329	http://dx.doi.org/10.1371/journal.pone.0067329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825652	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400183
J	Svanella-Dumas, L; Candresse, T; Hulle, M; Marais, A				Svanella-Dumas, Laurence; Candresse, Thierry; Hulle, Maurice; Marais, Armelle			Distribution of Barley yellow dwarf virus-PAV in the Sub-Antarctic Kerguelen Islands and Characterization of Two New Luteovirus Species	PLOS ONE			English	Article							PLANT; HOST; INFECTION; INVASIONS; IMPACTS; DISEASE; CROZET	A systematic search for viral infection was performed in the isolated Kerguelen Islands, using a range of polyvalent genus-specific PCR assays. Barley yellow dwarf virus (BYDV) was detected in both introduced and native grasses such as Poa cookii. The geographical distribution of BYDV and its prevalence in P. cookii were analyzed using samples collected from various sites of the archipelago. We estimate the average prevalence of BYDV to be 24.9% in P. cookii, with significant variability between sites. BYDV genetic diversity was assessed using sequence information from two genomic regions: the P3 open reading frame (ORF) (encoding the coat protein) and the hypervariable P6 ORF region. The phylogenetic analysis in the P3 region showed that BYDV sequences segregate into three major lineages, the most frequent of which (Ker-I cluster) showed close homology with BYDV-PAV-I isolates and had very low intra-lineage diversity (0.6%). A similarly low diversity was also recorded in the hypervariable P6 region, suggesting that Ker-I isolates derive from the recent introduction of BYDV-PAV-I. Divergence time estimation suggests that BYDV-PAV-I was likely introduced in the Kerguelen environment at the same time frame as its aphid vector, Rhopalosiphum padi, whose distribution shows good overlap with that of BYDV-Ker-I. The two other lineages show more than 22% amino acid divergence in the P3 region with other known species in the BYDV species complex, indicating that they represent distinct BYDV species. Using species-specific amplification primers, the distribution of these novel species was analyzed. The high prevalence of BYDV on native Poaceae and the presence of the vector R. padi, raises the question of its impact on the vulnerable plant communities of this remote ecosystem.	[Svanella-Dumas, Laurence; Candresse, Thierry; Marais, Armelle] INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Svanella-Dumas, Laurence; Candresse, Thierry; Marais, Armelle] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Hulle, Maurice] INRA, Inst Genet Environm & Protect Plantes, UMR 1349, Le Rheu, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Marais, A (corresponding author), INRA, UMR Biol Fruit & Pathol 1332, CS20032, Villenave Dornon, France.	amarais@bordeaux.inra.fr		Candresse, Thierry/0000-0001-9757-1835; Marais, Armelle/0000-0003-2482-1543; Hulle, Maurice/0000-0002-9520-3454	French ANR VMC project EVINCE [ANR-07-VULN-04-003]; French Polar Institute (IPEV) [136]	French ANR VMC project EVINCE(French National Research Agency (ANR)); French Polar Institute (IPEV)	This work was supported by the French ANR VMC project EVINCE (ANR-07-VULN-04-003) and by the French Polar Institute (IPEV, programme 136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VIRUS TAXONOMY; Candresse T, 2013, PHYTOPATHOLOGY, V103, P293, DOI 10.1094/PHYTO-10-12-0275-R; Chapuis JL, 2004, BIOL CONSERV, V117, P167, DOI 10.1016/S0006-3207(03)00290-8; Convey Peter, 2009, Papers and Proceedings of the Royal Society of Tasmania, V143, P33; Cooper I, 2006, ADV VIRUS RES, V67, P1, DOI 10.1016/S0065-3527(06)67001-2; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Fakhfakh H., 2001, Journal of Plant Pathology, V83, P3; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; Frenot Y, 2001, BIOL CONSERV, V101, P33, DOI 10.1016/S0006-3207(01)00052-0; Frenot Yves, 1997, P358; Halbert Susan, 1995, P217; Hulle M, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P308; Hulle M, 2003, ANTARCT SCI, V15, P203, DOI 10.1017/S0954102003001184; James D, 2006, CAN J PLANT PATHOL, V28, P16, DOI 10.1080/07060660609507267; Lebouvier M, 2011, BIOL INVASIONS, V13, P1195, DOI 10.1007/s10530-011-9946-5; Liu F, 2007, ARCH VIROL, V152, P1365, DOI 10.1007/s00705-007-0947-8; Malmstrom CM, 2007, J ECOL, V95, P1153, DOI 10.1111/j.1365-2745.2007.01307.x; Malmstrom CM, 2006, J ECOL, V94, P264, DOI 10.1111/j.1365-2745.2006.01101.x; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Malmstrom CM, 2004, J VIROL METHODS, V120, P69, DOI 10.1016/j.jviromet.2004.04.005; Marais A, 2010, PLANT DIS, V94, P477, DOI 10.1094/PDIS-94-4-0477B; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Miller WA, 1997, ANNU REV PHYTOPATHOL, V35, P167, DOI 10.1146/annurev.phyto.35.1.167; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Polischuk V, 2007, FEMS MICROBIOL ECOL, V59, P409, DOI 10.1111/j.1574-6941.2006.00242.x; REMAUDIERE G, 1988, AGRON TROP, V43, P327; ROCHOW WF, 1970, SCIENCE, V167, P875, DOI 10.1126/science.167.3919.875; Roossinck MJ, 2011, CURR OPIN VIROL, V1, P63, DOI 10.1016/j.coviro.2011.05.022; Roossinck MJ, 2011, CURR OPIN VIROL, V1, P50, DOI 10.1016/j.coviro.2011.05.012; Skotnicki ML, 2003, POLAR BIOL, V26, P1, DOI [10.1525/pol.2003.26.1.1, 10.1007/s00300-002-0421-8]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WEN F, 1991, J GEN VIROL, V72, P2217, DOI 10.1099/0022-1317-72-9-2217; Wren JD, 2006, PLOS BIOL, V4, P314, DOI 10.1371/journal.pbio.0040080; Wu BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016896	36	19	20	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e67231	10.1371/journal.pone.0067231	http://dx.doi.org/10.1371/journal.pone.0067231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23825645	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400180
J	Tabana, H; Doherty, T; Rubenson, B; Jackson, D; Ekstrom, AM; Thorson, A				Tabana, Hanani; Doherty, Tanya; Rubenson, Birgitta; Jackson, Debra; Ekstrom, Anna Mia; Thorson, Anna			Testing Together Challenges the Relationship': Consequences of HIV Testing as a Couple in a High HIV Prevalence Setting in Rural South Africa	PLOS ONE			English	Article							DISCORDANT COUPLES; TRANSMISSION; PREVENTION	Objective: We conducted qualitative individual and combined interviews with couples to explore their experiences since the time of taking an HIV test and receiving the test result together, as part of a home-based HIV counselling and testing intervention. Methods: This study was conducted in October 2011 in rural KwaZulu-Natal, South Africa, about 2 years after couples tested and received results together. Fourteen couples were purposively sampled: discordant, concordant negative and concordant positive couples. Findings: Learning about each other's status together challenged relationships of the couples in different ways depending on HIV status and gender. The mutual information confirmed suspected infidelity that had not been discussed before. Negative women in discordant partnerships remained with their positive partner due to social pressure and struggled to maintain their HIV negative status. Most of the couple relationships were characterized by silence and mistrust. Knowledge of sero-status also led to loss of sexual intimacy in some couples especially the discordant. For most men in concordant negative couples, knowledge of status was an awakening of the importance of fidelity and an opportunity for behaviour change, while for concordant positive and discordant couples, it was seen as proof of infidelity. Although positive HIV status was perceived as confirmation of infidelity, couples continued their relationship and offered some support for each other, living and managing life together. Sexual life in these couples was characterized by conflict and sometimes violence. In the concordant negative couples, trust was enhanced and behaviour change was promised. Conclusions: Findings suggest that testing together as couples challenged relationships in both negative and positive ways. Further, knowledge of HIV status indicated potential to influence behaviour change especially among concordant negatives. In the discordant and concordant positive couples, traditional gender roles exposed women's vulnerability and their lack of decision-making power.	[Tabana, Hanani; Doherty, Tanya] Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Tabana, Hanani; Rubenson, Birgitta; Ekstrom, Anna Mia; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Rubenson, Birgitta; Ekstrom, Anna Mia; Thorson, Anna] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Doherty, Tanya; Jackson, Debra] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of the Western Cape	Tabana, H (corresponding author), Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa.	Hanani.Tabana@mrc.ac.za	Tabana, Hanani/AAJ-5361-2020; Tabana, Hanani/AAP-8143-2020	Tabana, Hanani/0000-0003-1576-2238; Tabana, Hanani/0000-0003-1576-2238; Jackson, Debra/0000-0003-3307-632X; Thorson, Anna/0000-0002-8703-6561	Medical Research Council of South Africa	Medical Research Council of South Africa(South African Medical Research Council)	The study received financial support from the Medical Research Council of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg B.L., 2001, QUALITATIVE RES METH; Binagwaho A, 2010, PAN AFRICAN MED; Bishop M, 2010, SERODISCORDANT COUPL; BRITTON PJ, 1993, AIDS CARE, V5, P43, DOI 10.1080/09540129308258583; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Burton J, 2010, AIDS BEHAV, V14, P1, DOI 10.1007/s10461-008-9471-4; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Dolezal C, 2006, J URBAN HLTH B NEW Y, V83; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Ekstrom AM, 2010, BMC PUBLIC HEALTH, V10, P1; Government of South Africa, 2010, COMM SURV HIV AIDS; Hunter M, 2005, CULT HEALTH SEX, V7, P209, DOI 10.1080/13691050412331293458; International Organization for Migration, 2005, HIV AIDS POP MOB MIG; Jaffar S, 2011, BMC PUBLIC HEALTH, V11, P1; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Lurie MN, 2004, 5 U OXF U U CAP TOWN; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; Moore J, 1998, FACTORS INFLUENCING; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; National Department of Health South Africa, 2021, 2019 NAT ANT HIV SEN; Njau B, 2012, AIDS CARE, V24, P413, DOI 10.1080/09540121.2011.608796; Popenoe R, 2010, BMC PUBLIC HEALTH, V10, P1421; Posel D, 2011, MARRIAGE ILOBOLO BRI; Republic of South Africa, 2008, UN GEN ASS SPEC SESS; Rispel LC, 2012, CULT HEALTH SEX, V14, P257, DOI 10.1080/13691058.2011.621448; Rispel LC, 2011, REPROD HEALTH MATTER, V19, P184, DOI 10.1016/S0968-8080(11)37552-0; Shisana O., 2009, S AFRICAN NATL HIV P; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; UMzimkhulu Local Municipality, 2010, INT DEV PLAN 2009 20; UNAIDS, 2012, REP GLOB AIDS EP; UNAIDS, 2010, UNAIDS EX DIR JOINT; UNAIDS/WHO, 2011, GLOBAL HIV AIDS RESP; UNAIDS/WHO, 2008, AIDS EP UPD SPEC REP; VanDevanter N, 1999, AIDS CARE, V11, P181, DOI 10.1080/09540129948072; World Health Organization, 2012, GUID OR PREEXP PROPH	37	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66390	10.1371/journal.pone.0066390	http://dx.doi.org/10.1371/journal.pone.0066390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23824067	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400100
J	Lin, HJ; Weng, SF; Yang, CM; Wu, MP				Lin, Huey-Juan; Weng, Shih-Feng; Yang, Chun-Ming; Wu, Ming-Ping			Risk of Hospitalization for Acute Cardiovascular Events among Subjects with Lower Urinary Tract Symptoms: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; OVERACTIVE BLADDER; ERECTILE DYSFUNCTION; NERVOUS-SYSTEM; HEALTH-CARE; INCONTINENCE; PREVALENCE; BURDEN; MEN	Background and Purpose: Lower urinary tract symptoms (LUTS) have been reported to be associated with metabolic syndrome and may predispose subjects to cardiovascular disease. The magnitude of the impact on the medical care remains to be elucidated. Based on a population-based claims dataset in Taiwan, we explored the association between LUTS and the risk of subsequent hospitalization for acute cardiovascular events. Materials and Methods: Among a representative sample of one million subjects from nationwide health insurance enrollees, subjects with codes of LUTS in service claims and without previous cardiovascular diseases including stroke were compared with age-and sex-matched non-LUTS subjects in subsequent hospitalization for acute coronary syndrome or stroke from the recruited date (between 2001-2004) to 2009. The risk of outcomes was assessed with Kaplan-Meier curves and the impact of LUTS was estimated with Poison regression analysis and Cox proportional hazards models. Results: We included 4,553 LUTS subjects and 22,765 matched non-LUTS subjects, with a mean age of 47 years and 43% of men. Hypertension, diabetes, and hyperlipidemia were more prevalent in the LUTS group. The incidence rate of the composite endpoint was significantly higher in the LUTS group than in the non-LUTS group (5.4/1000 vs. 4.0/1000 person-years). The difference mainly derived from stroke rather than acute coronary syndrome. After adjusting for age, sex, diabetes, hypertension, and hyperlipidemia in multivariable analysis, LUTS remained a significant predictor (hazard ratio, 1.29; 95% confidence incidence, 1.06-1.50). Conclusion: Subjects free of cardiovascular disease and presenting with LUTS are at risk of subsequent hospitalization for acute cardiovascular events, mainly stroke. The information might prompt practitioners encountering such patients to undergo appropriate diagnostic and preventive measures.	[Lin, Huey-Juan; Yang, Chun-Ming] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Weng, Shih-Feng; Wu, Ming-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wu, Ming-Ping] Chi Mei Med Ctr, Dept Obstet & Gynecol, Div Urogynecol, Tainan, Taiwan; [Lin, Huey-Juan] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan, Taiwan; [Wu, Ming-Ping] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Weng, Shih-Feng] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science	Wu, MP (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	mpwu@mail.chimei.org.tw		Weng, Shih-Feng/0000-0001-8684-3487	Chi Mei Medical Center	Chi Mei Medical Center	The study was funded by Chi Mei Medical Center (http://www.chimei.org.tw/main/cmh_department/54220/english/2012/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2010, BJU INT, V106, P268, DOI 10.1111/j.1464-410X.2009.09073.x; Asche CV, 2012, BJU INT, V109, P572, DOI 10.1111/j.1464-410X.2011.10436.x; Baumhakel M, 2007, INT J CLIN PRACT, V61, P361, DOI 10.1111/j.1742-1241.2006.01274.x; Bouwman II, 2009, EUR J GEN PRACT, V15, P128, DOI 10.3109/13814780903329536; Coyne KS, 2009, BJU INT, V103, P4, DOI 10.1111/j.1464-410X.2009.08371.x; Glavind K, 2011, INT UROGYNECOL J, V22, P907, DOI 10.1007/s00192-011-1411-6; Hubeaux K, 2011, NEUROUROL URODYNAM, V30, P1467, DOI 10.1002/nau.21154; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Karatas OF, 2010, INT J CARDIOL, V144, P452, DOI 10.1016/j.ijcard.2009.03.099; Kirby MG, 2010, NEUROUROL URODYNAM, V29, P1360, DOI 10.1002/nau.20892; Lukacz ES, 2011, INT J CLIN PRACT, V65, P1026, DOI 10.1111/j.1742-1241.2011.02763.x; Malmsten UGH, 2010, EUR UROL, V58, P149, DOI 10.1016/j.eururo.2010.03.014; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Parthasarathy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030969; Penson DF, 2011, J UROLOGY, V186, P2316, DOI 10.1016/j.juro.2011.07.067; Wehrberger C, 2011, UROLOGY, V78, P1063, DOI 10.1016/j.urology.2011.05.065; Wu MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057825; Wu MP, 2013, UROLOGY, V81, P61, DOI 10.1016/j.urology.2012.08.033; Zhang XW, 2011, UROL INT, V86, P173, DOI 10.1159/000321895	19	62	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66661	10.1371/journal.pone.0066661	http://dx.doi.org/10.1371/journal.pone.0066661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23826095	Green Submitted, Green Published, gold			2022-12-27	WOS:000320322400114
J	Zhang, L; Xiao, RJ; Xiong, J; Leng, J; Ehtisham, A; Hu, Y; Ding, QS; Xu, H; Liu, SW; Wang, J; Tang, DG; Zhang, QP				Zhang, Li; Xiao, Ruijing; Xiong, Jie; Leng, Jun; Ehtisham, Altaf; Hu, Yi; Ding, Qianshan; Xu, Hui; Liu, Shengwu; Wang, Jin; Tang, Dean G.; Zhang, Qiuping			Activated ERM Protein Plays a Critical Role in Drug Resistance of MOLT4 Cells Induced by CCL25	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; ACTIN CYTOSKELETON; MYELOID-LEUKEMIA; IN-VITRO; EXPRESSION; TRANSPORTERS; MECHANISM; APOPTOSIS; EZRIN	We have previously demonstrated that the CCR9/CCL25 signaling pathway plays an important role in drug resistance in human acute T-lymphocytic leukemia (T-ALL) by inducing activation of ERM protein with polarized distribution in T-ALL cell line MOLT4. However, the mechanism of action of the activated ERM protein in the drug resistance of MOLT4 cells induced by CCL25 remains uncharacterized. Here we investigated the mechanism of CCR9/CCL25-initiated drug resistance in CCR9-high-expressing T-ALL cells. Our results showed that 1) the function of P-gp was increased after treatment with CCL25; 2) P-gp colocalized and co-immunoprecipitated with p-ERM and F-actin in CCL25 treated cells; and 3) ERM-shRNA conferred drug sensitivity coincident with release of ERM interactions with P-gp and F-actin after treatment with CCL25. These data suggest it is pivotal that P-gp associate with the F-actin cytoskeleton through p-ERM in CCR9/CCL25 induced multidrug resistance of T-ALL cells. Strategies aimed at inhibiting P-gp-F-actin cytoskeleton association may be helpful in increasing the efficiency of therapies in T-ALL.	[Zhang, Li; Xiao, Ruijing; Xiong, Jie; Leng, Jun; Ehtisham, Altaf; Hu, Yi; Ding, Qianshan; Xu, Hui; Liu, Shengwu; Wang, Jin; Zhang, Qiuping] Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan 430072, Peoples R China; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	Wuhan University; University of Texas System; UTMD Anderson Cancer Center	Zhang, QP (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Immunol, Wuhan 430072, Peoples R China.	qpzhang@whu.edu.cn	zhang, qiu/GXG-5600-2022; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174	National Science Foundation of China [30570780, 30971280, 30801336]; National Ministry of Doctoral Fund [200804860039]; Fundamental Research Funds for the Central Universities [301274622]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Doctoral Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Science Foundation of China (No.30570780, 30971280, 30801336), National Ministry of Doctoral Fund (No.200804860039) and the Fundamental Research Funds for the Central Universities (No.301274622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2004, CARCINOGENESIS, V25, P941, DOI 10.1093/carcin/bgh060; Asakura K, 2004, MOL CANCER RES, V2, P339; Brambilla D, 2012, INT J CANCER, V130, P2824, DOI 10.1002/ijc.26285; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Cohen JD, 2011, TOXICOL SCI, V122, P361, DOI 10.1093/toxsci/kfr118; Ding KF, 2009, CARCINOGENESIS, V30, P35, DOI 10.1093/carcin/bgn251; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; Galski H, 2006, LEUKEMIA RES, V30, P1151, DOI 10.1016/j.leukres.2006.02.016; Goler-Baron V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016007; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hayashi K, 1999, J CELL SCI, V112, P1149; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Villar VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037735; Kater L, 2012, TOXICOL IN VITRO, V26, P119, DOI 10.1016/j.tiv.2011.09.010; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Liu ZL, 2002, CANCER CHEMOTH PHARM, V49, P391, DOI 10.1007/s00280-001-0411-5; Luciani F, 2002, BLOOD, V99, P641, DOI 10.1182/blood.V99.2.641; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Meschini S, 2000, INT J CANCER, V87, P615, DOI 10.1002/1097-0215(20000901)87:5<615::AID-IJC1>3.3.CO;2-W; Molinari A, 2002, CURR PROTEIN PEPT SC, V3, P653, DOI 10.2174/1389203023380413; Padanyi R, 2010, J BIOL CHEM, V285, P31704, DOI 10.1074/jbc.M110.164137; PUI CH, 1993, BLOOD, V82, P343; Raaijmakers MHGP, 2007, LEUKEMIA, V21, P2094, DOI 10.1038/sj.leu.2404859; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Rudd LP, 2011, CHEM-BIOL INTERACT, V194, P113, DOI 10.1016/j.cbi.2011.08.012; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Stege A, 2004, CANCER GENE THER, V11, P699, DOI 10.1038/sj.cgt.7700751; Tong XL, 2009, CELL MOL IMMUNOL, V6, P181, DOI 10.1038/cmi.2009.25; TSURUO T, 1981, CANCER RES, V41, P1967; Walter RB, 2007, BLOOD, V109, P4168, DOI 10.1182/blood-2006-09-047399; Willemse MJ, 2002, BLOOD, V99, P4386, DOI 10.1182/blood.V99.12.4386; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Zhang QP, 2004, CANCER RES, V64, P7579, DOI 10.1158/0008-5472.CAN-04-0641; Zhou BB, 2010, LEUKEMIA RES, V34, P769, DOI 10.1016/j.leukres.2009.11.025	37	104	111	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52384	10.1371/journal.pone.0052384	http://dx.doi.org/10.1371/journal.pone.0052384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326330	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500013
J	Siegmund, U; Heller, J; van Kan, JAL; Tudzynski, P				Siegmund, Ulrike; Heller, Jens; van Kan, Jan A. L.; Tudzynski, Paul			The NADPH Oxidase Complexes in Botrytis cinerea: Evidence for a Close Association with the ER and the Tetraspanin Pls1	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; APPRESSORIUM-MEDIATED PENETRATION; GRAY MOLD FUNGUS; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; ASCOSPORE GERMINATION; CELL-DIFFERENTIATION; FUNCTIONAL-ANALYSIS; LOCALIZATION; ACTIVATION	NADPH oxidases (Nox) are major enzymatic systems that generate reactive-oxygen species (ROS) in multicellular eukaryotes. In several fungi they have been shown to be involved in sexual differentiation and pathogenicity. However, in contrast to the well characterized mammalian systems, basic information on the composition, recruitment, and localization of fungal Nox complexes and on the molecular mechanisms of their cellular effects are still lacking. Here we give a detailed analysis of components of the Nox complexes in the gray mold fungus Botrytis cinerea. It had previously been shown that the two catalytic transmembrane subunits BcNoxA and B are important for development of sclerotia and for full virulence, with BcNoxA being involved in spreading of lesions and BcNoxB in penetration; BcNoxR functions as a regulator of both subunits. Here we present evidence (using for the first time a functional GFP fusion able to complement the Delta bcnoxA mutant) that BcNoxA localizes mainly to the ER and at the plasma membrane; BcNoxB shows a similar localization pattern, while the regulator BcNoxR is found in vesicles throughout the hyphae and at the hyphal tip. To identify possible interaction partners, which could be involved in the localization or recruitment of the Nox complexes, we functionally characterized the tetraspanin Pls1, a transmembrane protein, which had been suggested to be a NoxB-interacting partner in the saprophyte Podospora anserina. Knock-out experiments and GFP fusions substantiate a link between BcNoxB and BcPls1 because both deletion mutants have overlapping phenotypes (especially a defect in penetration), and the proteins show a similar localization pattern (ER). However, in contrast to the corresponding protein in P. anserina BcPls1 is important for female fertility, but not for ascospore germination.	[Siegmund, Ulrike; Heller, Jens; Tudzynski, Paul] Westfael Wilhelms Univ Muenster, Inst Biol & Biotechnol Pflanzen, Munster, Germany; [van Kan, Jan A. L.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Tudzynski, P (corresponding author), Westfael Wilhelms Univ Muenster, Inst Biol & Biotechnol Pflanzen, Munster, Germany.	tudzyns@uni-muenster.de		van Kan, Jan/0000-0003-3563-1550	Deutsche Forschungsgemeinschaft (DFG) [Tu50/17]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding agency: Deutsche Forschungsgemeinschaft (DFG; www.dfg.de), project Tu50/17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chin CF, 2012, MOL BIOL CELL, V23, P45, DOI 10.1091/mbc.E11-05-0434; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597; Clergeot PH, 2001, P NATL ACAD SCI USA, V98, P6963, DOI 10.1073/pnas.111132998; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fernandes DC, 2009, ARCH BIOCHEM BIOPHYS, V484, P197, DOI 10.1016/j.abb.2009.01.022; Giesbert S, 2008, MOL PLANT PATHOL, V9, P317, DOI [10.1111/j.1364-3703.2008.00466.x, 10.1111/J.1364-3703.2008.00466.X]; Gourgues M, 2004, MOL MICROBIOL, V51, P619, DOI 10.1046/j.1365-2958.2003.03866.x; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Gronover CS, 2001, MOL PLANT MICROBE IN, V14, P1293, DOI 10.1094/MPMI.2001.14.11.1293; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Jonkers W, 2011, MOL PLANT PATHOL, V12, P548, DOI 10.1111/J.1364-3703.2010.00689.X; KANGATHARALINGAM N, 1984, CURR MICROBIOL, V10, P99, DOI 10.1007/BF01575767; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Lalucque H, 2003, TRENDS MICROBIOL, V11, P9, DOI 10.1016/S0966-842X(02)00007-0; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lambou K, 2008, EUKARYOT CELL, V7, P1809, DOI 10.1128/EC.00149-08; Lambou K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-63; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; Lardy B, 2005, BBA-MOL CELL RES, V1744, P199, DOI 10.1016/j.bbamcr.2005.02.004; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Letourneur F, 1998, J BIOL CHEM, V273, P33273, DOI 10.1074/jbc.273.50.33273; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Masaki R, 1996, J BIOL CHEM, V271, P16939, DOI 10.1074/jbc.271.28.16939; Meitinger F, 2010, J CELL SCI, V123, P1851, DOI 10.1242/jcs.063891; Miller, 1972, EXPT MOL GENETICS; Pagani M, 2001, FEBS LETT, V508, P117, DOI 10.1016/S0014-5793(01)03034-4; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; Roca MG, 2012, FUNGAL BIOL-UK, V116, P379, DOI 10.1016/j.funbio.2011.12.007; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schouten A, 2002, MOL PLANT PATHOL, V3, P227, DOI 10.1046/j.1364-3703.2002.00114.x; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Takemoto D, 2011, P NATL ACAD SCI USA, V108, P2861, DOI 10.1073/pnas.1017309108; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Tenberge KB, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P67; Tudzynski P., 2009, MYCOTA, P29; VANDERVLUGTBERGMANS CJB, 1993, MYCOL RES, V97, P1193, DOI 10.1016/S0953-7562(09)81284-7; Veneault-Fourrey C, 2005, FUNGAL GENET BIOL, V42, P306, DOI 10.1016/j.fgb.2005.01.009; Vogel H.J., 1956, MICROB GENET B, V13, P42; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zhang G, 2006, J CELL BIOL, V174, P207, DOI 10.1083/jcb.200604094	72	53	56	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55879	10.1371/journal.pone.0055879	http://dx.doi.org/10.1371/journal.pone.0055879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418468	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300059
J	Wu, JY; Chen, CH; Wang, CZ; Ho, ML; Yeh, ML; Wang, YH				Wu, Jyun-Yi; Chen, Chia-Hsin; Wang, Chau-Zen; Ho, Mei-Ling; Yeh, Ming-Long; Wang, Yan-Hsiung			Low-Power Laser Irradiation Suppresses Inflammatory Response of Human Adipose-Derived Stem Cells by Modulating Intracellular Cyclic AMP Level and NF-kappa B Activity	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TOLL-LIKE RECEPTORS; THERAPY LLLT; SIGNALING PATHWAY; RAT; NM; FIBROBLASTS; MECHANISMS; PROTEIN; MUSCLE	Mesenchymal stem cell (MSC)-based tissue regeneration is a promising therapeutic strategy for treating damaged tissues. However, the inflammatory microenvironment that exists at a local injury site might restrict reconstruction. Low-power laser irradiation (LPLI) has been widely applied to retard the inflammatory reaction. The purpose of this study was to investigate the anti-inflammatory effect of LPLI on human adipose-derived stem cells (hADSCs) in an inflammatory environment. We showed that the hADSCs expressed Toll-like Receptors (TLR) 1, TLR2, TLR3, TLR4, and TLR6 and that lipopolysaccharide (LPS) significantly induced the production of pro-inflammatory cytokines (Cyclooxygenase-2 (Cox-2), Interleukin-1b (IL-1b), Interleukin-6 (IL-6), and Interleukin-8 (IL-8)). LPLI markedly inhibited LPS-induced, pro-inflammatory cytokine expression at an optimal dose of 8 J/cm(2). The inhibitory effect triggered by LPLI might occur through an increase in the intracellular level of cyclic AMP (cAMP), which acts to down-regulate nuclear factor kappa B (NF-kappa B) transcriptional activity. These data collectively provide insight for further investigations of the potential application of anti-inflammatory treatment followed by stem cell therapy.	[Wu, Jyun-Yi; Yeh, Ming-Long] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling; Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Yeh, ML (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	mlyeh@mail.ncku.edu.tw; yhwang@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Ho, Mei-Ling/0000-0001-8064-8488; Chen, Chia-Hsin/0000-0002-6557-9848	National Health Research Institutes [NHRI-EX101-9914EC]; Kaohsiung Municipal Ta-Tung Hospital [KMTTH-99-013]; Kaohsiung Medical University of Taiwan [KMU-Q099018]	National Health Research Institutes(National Health Research Institutes, Japan); Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University of Taiwan	This study was supported by a grant from the National Health Research Institutes (NHRI-EX101-9914EC), a grant from the Kaohsiung Municipal Ta-Tung Hospital (KMTTH-99-013), and a grant from the Kaohsiung Medical University (KMU-Q099018) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimbire F, 2008, INFLAMMATION, V31, P189, DOI 10.1007/s10753-008-9064-4; Aimbire F, 2008, INT IMMUNOPHARMACOL, V8, P603, DOI 10.1016/j.intimp.2007.12.007; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Bortone F, 2008, INT IMMUNOPHARMACOL, V8, P206, DOI 10.1016/j.intimp.2007.09.004; Boschi ES, 2008, LASER SURG MED, V40, P500, DOI 10.1002/lsm.20658; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Correa F, 2007, PHOTOMED LASER SURG, V25, P245, DOI 10.1089/pho.2007.2079; Crisostomo PR, 2007, SHOCK, V28, P375, DOI 10.1097/shk.0b013e318058a817; de Lima FM, 2011, LASER MED SCI, V26, P389, DOI 10.1007/s10103-010-0874-x; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; KARU TI, 1985, DOKL AKAD NAUK SSSR+, V281, P1242; Lombardo E, 2009, TISSUE ENG PT A, V15, P1579, DOI 10.1089/ten.tea.2008.0340; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Parry GCN, 1997, J IMMUNOL, V159, P5450; Pires D, 2011, LASER MED SCI, V26, P85, DOI 10.1007/s10103-010-0811-z; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Sakurai Y, 2000, EUR J ORAL SCI, V108, P29, DOI 10.1034/j.1600-0722.2000.00783.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046393, 10.1371/journal.pone.0044027]; Xiong Fang, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P449; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zungu IL, 2009, PHOTOCHEM PHOTOBIOL, V85, P987, DOI 10.1111/j.1751-1097.2008.00523.x	33	54	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54067	10.1371/journal.pone.0054067	http://dx.doi.org/10.1371/journal.pone.0054067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23825677	Green Published, gold			2022-12-27	WOS:000313682700083
J	Niu, Q; Zhang, RK; Zhao, M; Zeng, SG; Huang, XB; Jiang, H; An, YF; Zhang, LW				Niu, Qian; Zhang, Ruke; Zhao, Min; Zeng, Sugen; Huang, Xunbei; Jiang, Hong; An, Youfang; Zhang, Luwen			Differences in Platelet Indices between Healthy Han Population and Tibetans in China	PLOS ONE			English	Article							HIGH-ALTITUDE; RISK-FACTOR; VOLUME; STROKE; ADAPTATION; REACTIVITY; HYPOXIA; DISEASE	Introduction: The present data on the evaluation of platelet (PLT) parameters in Chinese Han population and Tibetans are still limited. The objective of this study was to determine the differences in common PLT indices between Han population and Tibetans in China, through a large-scale investigation of healthy people. Methods: 2131 Han people from Chengdu Plain, 1099 Tibetans from Qinghai-Tibet Plateau and 956 Plateau Han migrants were included in this study. All the subjects were healthy people through the health screening. PLT indices were measured with Sysmex XE-2100 and XT-1800i blood cell automatic analyzer. Results: Compared with Han people in Chendu Plain, Tibetans had higher PLT count (P<0.01) but lower mean platelet volume (MPV), platelet distribution width (PDW) and platelet-large cell ratio (P-LCR) (P<0.01); while Plateau Han migrants had lower PLT count, MPV and P-LCR (P<0.05). When compared with Tibetans, Plateau Han migrants had lower levels of mean PLT count but higher PDW and P-LCR (P<0.05). Conclusions: There are ethnic differences in PLT indices between Chinese Han population and Tibetans. Based on this finding, it would be reasonable to conduct formal prospective studies to determine the clinical significance of these differences and to explore the effects of genetic background on these indices.	[Niu, Qian; Zhang, Ruke; Zeng, Sugen; Huang, Xunbei; Jiang, Hong] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China; [Zhao, Min] Peoples Hosp Tibet Autonomous Reg, Dept Lab Med, Lhasa, Peoples R China; [An, Youfang; Zhang, Luwen] Hosp Off Tibet Autonomous Reg Chengdu, Dept Lab Med, Chengdu, Peoples R China	Sichuan University	Jiang, H (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China.	jianghong6656@126.com		Zhao, Mei/0000-0003-3530-0233	Science and Technology Planning Project of Sichuan Province of China [2009SZ0157]; Science and Technology Project of Chengdu Government of Sichuan [12PPYB064SF-002]	Science and Technology Planning Project of Sichuan Province of China; Science and Technology Project of Chengdu Government of Sichuan	This study was supported by the Science and Technology Planning Project of Sichuan Province of China (Grant No. 2009SZ0157)(http://www.scst.gov.cn/info/), and the Science and Technology Project of Chengdu Government of Sichuan (Grant No. 12PPYB064SF-002)(http://www.cdst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Lorido JC, 2012, IRISH J MED SCI, V181, P179, DOI 10.1007/s11845-011-0755-8; Basset FA, 2006, EXP PHYSIOL, V91, P391, DOI 10.1113/expphysiol.2005.031682; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Dunleavy M, 2005, EXP PHYSIOL, V90, P411, DOI 10.1113/expphysiol.2004.029306; Gilmartin GS, 2008, AM J PHYSIOL-HEART C, V295, pH778, DOI 10.1152/ajpheart.00653.2007; Gupta N, 2012, SEMIN THROMB HEMOST, V38, P156, DOI 10.1055/s-0032-1301413; Ihara A, 2006, PATHOPHYSIOL HAEMO T, V35, P376, DOI 10.1159/000097692; Kamisli O, 2012, CLIN A IN PRESS 0719; Korkmaz L, 2012, ANATOL J CARDIOL, V12, P35, DOI 10.5152/akd.2012.007; Lehmann T, 2006, J APPL PHYSIOL, V100, P690, DOI 10.1152/japplphysiol.00991.2005; Ntaios G, 2008, ACTA HAEMATOL-BASEL, V119, P173, DOI 10.1159/000135658; Sahlin C, 2008, ARCH INTERN MED, V168, P297, DOI 10.1001/archinternmed.2007.70; Suades R, 2012, THROMB HAEM IN PRESS, V108; Sucu M, 2010, CLIN APPL THROMB-HEM, V16, P563, DOI 10.1177/1076029609338046; Wang RT, 2011, PLATELETS, V22, P447, DOI 10.3109/09537104.2011.565431; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao YH, 2010, STROKE, V41, P2739, DOI 10.1161/STROKEAHA.110.586669	17	75	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67203	10.1371/journal.pone.0067203	http://dx.doi.org/10.1371/journal.pone.0067203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	24324824	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400118
J	Chen, XH; Yang, GX; Song, JH; Xu, H; Li, D; Goldsmith, J; Zeng, HY; Parsons-Wingerter, PA; Reinecker, HC; Kelly, CP				Chen, Xinhua; Yang, Guoxun; Song, Joo-Hye; Xu, Hua; Li, Dan; Goldsmith, Jeffrey; Zeng, Huiyan; Parsons-Wingerter, Patricia A.; Reinecker, Hans-Christian; Kelly, Ciaran P.			Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation	PLOS ONE			English	Article							DIFFICILE TOXIN-A; ANTIBIOTIC-ASSOCIATED DIARRHEA; ENDOTHELIAL GROWTH-FACTOR; SACCHAROMYCES-BOULARDII; BOWEL-DISEASE; ULCERATIVE-COLITIS; CHOLERA-TOXIN; PATHOGENESIS; PREVENTION; CELLS	Background and Aims: Saccharomyces boulardii (Sb) can protect against intestinal injury and tumor formation, but how this probiotic yeast controls protective mucosal host responses is unclear. Angiogenesis is an integral process of inflammatory responses in inflammatory bowel diseases (IBD) and required for mucosal remodeling during restitution. The aim of this study was to determine whether Sb alters VEGFR (vascular endothelial growth factor receptor) signaling, a central regulator of angiogenesis. Methods: HUVEC were used to examine the effects of Sb on signaling and on capillary tube formation (using the ECMatrix (TM) system). The effects of Sb on VEGF-mediated angiogenesis were examined in vivo using an adenovirus expressing VEGF-A(164) in the ears of adult nude mice (NuNu). The effects of Sb on blood vessel volume branching and density in DSS-induced colitis was quantified using VESsel GENeration (VESGEN) software. Results: 1) Sb treatment attenuated weight-loss (p<0.01) and histological damage (p<0.01) in DSS colitis. VESGEN analysis of angiogenesis showed significantly increased blood vessel density and volume in DSS-treated mice compared to control. Sb treatment significantly reduced the neo-vascularization associated with acute DSS colitis and accelerated mucosal recovery restoration of the lamina propria capillary network to a normal morphology. 2) Sb inhibited VEGF-induced angiogenesis in vivo in the mouse ear model. 3) Sb also significantly inhibited angiogenesis in vitro in the capillary tube assay in a dose-dependent manner (p<0.01). 4) In HUVEC, Sb reduced basal VEGFR-2 phosphorylation, VEGFR-2 phosphorylation in response to VEGF as well as activation of the downstream kinases PLC gamma and Erk1/2. Conclusions: Our findings indicate that the probiotic yeast S boulardii can modulate angiogenesis to limit intestinal inflammation and promote mucosal tissue repair by regulating VEGFR signaling.	[Chen, Xinhua; Yang, Guoxun; Xu, Hua; Li, Dan; Kelly, Ciaran P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Song, Joo-Hye; Reinecker, Hans-Christian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA USA; [Goldsmith, Jeffrey] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol & Lab Med, Boston, MA 02215 USA; [Zeng, Huiyan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Mol & Vasc Med, Boston, MA 02215 USA; [Parsons-Wingerter, Patricia A.] John Glenn NASA Res Ctr, Cleveland, OH USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Aeronautics & Space Administration (NASA)	Chen, XH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA.	xchen1@bidmc.harvard.edu			NIH [PO1 DK 33506, DK-068181, DK-043351, AI-093588]; Crohn's & Colitis Foundation of America; Global Probiotic Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, R01DK068181, P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; Global Probiotic Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants PO1 DK 33506 (CPK, HCR), DK-068181, DK-043351 and AI-093588 (HCR), Crohn's & Colitis Foundation of America (Research Fellowship and Career Development Award, XC) and Global Probiotic Council (Young Investigator Award, XC). NASA and PPW have filed a United States patent application for the VESGEN software. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandao RL, 1998, APPL ENVIRON MICROB, V64, P564; BUTS JP, 1990, DIGEST DIS SCI, V35, P251, DOI 10.1007/BF01536771; Castagliuolo I, 1999, INFECT IMMUN, V67, P302, DOI 10.1128/IAI.67.1.302-307.1999; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Chen XH, 2008, THERAPEUTIC MICROBIOLOGY: PROBIOTICS AND RELATED STRATEGIES, P51; Chen XH, 2009, GASTROENTEROLOGY, V137, P914, DOI 10.1053/j.gastro.2009.05.050; Chidlow JH, 2007, AM J PHYSIOL-GASTR L, V293, pG5, DOI 10.1152/ajpgi.00107.2007; Chidlow JH, 2006, AM J PATHOL, V169, P2014, DOI 10.2353/ajpath.2006.051021; Czerucka D, 2002, MICROBES INFECT, V4, P733, DOI 10.1016/S1286-4579(02)01592-7; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Danese S, 2008, PATHOBIOLOGY, V75, P22, DOI 10.1159/000113791; Danese S, 2007, GUT, V56, P855, DOI 10.1136/gut.2006.114314; DIAS RS, 1995, BRAZ J MED BIOL RES, V28, P323; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Guslandi M, 2000, DIGEST DIS SCI, V45, P1462, DOI 10.1023/A:1005588911207; Guslandi M, 2003, EUR J GASTROEN HEPAT, V15, P697, DOI 10.1097/00042737-200306000-00017; Guslandi M, 2011, J CLIN GASTROENTEROL, V45, P475, DOI 10.1097/MCG.0b013e318207f584; Guslandi M, 2010, J CLIN GASTROENTEROL, V44, P385, DOI 10.1097/MCG.0b013e3181cb4233; Hatoum OA, 2005, INFLAMM BOWEL DIS, V11, P304, DOI 10.1097/01.MIB.0000160772.78951.61; Im E, 2009, AM J PHYSIOL-GASTR L, V297, pG999, DOI 10.1152/ajpgi.00204.2009; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kapsoritakis A, 2003, INT J COLORECTAL DIS, V18, P418, DOI 10.1007/s00384-003-0495-y; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; McFarland Lynne V, 2007, Travel Med Infect Dis, V5, P97, DOI 10.1016/j.tmaid.2005.10.003; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; Nagy JA, 2008, METHOD ENZYMOL, V444, P43, DOI 10.1016/S0076-6879(08)02803-6; Papa A, 2008, DIGEST DIS, V26, P149, DOI 10.1159/000116773; Parsons-Wingerter P, INVEST OPHTHALMOL VI, V51, P498; POTHOULAKIS C, 1993, GASTROENTEROLOGY, V104, P1108, DOI 10.1016/0016-5085(93)90280-P; Qamar A, 2001, INFECT IMMUN, V69, P2762, DOI 10.1128/IAI.69.4.2762-2765.2001; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Rodrigues ACP, 1996, J APPL BACTERIOL, V81, P251, DOI 10.1111/j.1365-2672.1996.tb04325.x; Sandor Z, 2006, BIOCHEM BIOPH RES CO, V350, P147, DOI 10.1016/j.bbrc.2006.09.021; Scaldaferri F, 2009, GASTROENTEROLOGY, V136, P585, DOI 10.1053/j.gastro.2008.09.064; Sitohy B, CANC RES, V72, P1909; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Sullivan A, 2002, INT J ANTIMICROB AG, V20, P313, DOI 10.1016/S0924-8579(02)00199-1; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; Vickerman MB, 2009, ANAT REC, V292, P320, DOI 10.1002/ar.20862	48	56	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64227	10.1371/journal.pone.0064227	http://dx.doi.org/10.1371/journal.pone.0064227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23826208	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100060
J	Chen, JY; Tang, YA; Li, WS; Chiou, YC; Shieh, JM; Wang, YC				Chen, Jia-Yang; Tang, Yen-An; Li, Wen-Shan; Chiou, Yu-Ching; Shieh, Jiunn-Min; Wang, Yi-Ching			A Synthetic Podophyllotoxin Derivative Exerts Anti-Cancer Effects by Inducing Mitotic Arrest and Pro-Apoptotic ER Stress in Lung Cancer Preclinical Models	PLOS ONE			English	Article							ANTIMITOTIC ACTIVITY; NATURAL-PRODUCTS; BINDING AGENTS; DRUG DISCOVERY; RESISTANCE; TUBULIN; MITOSIS; MICROTUBULES; EXPRESSION; KINASES	Some potent chemotherapy drugs including tubulin-binding agents had been developed from nature plants, such as podophyllotoxin and paclitaxel. However, poor cytotoxic selectivity, serious side-effects, and limited effectiveness are still the major concerns in their therapeutic application. We developed a fully synthetic podophyllotoxin derivative named Ching001 and investigated its anti-tumor growth effects and mechanisms in lung cancer preclinical models. Ching001 showed a selective cytotoxicity to different lung cancer cell lines but not to normal lung cells. Ching001 inhibited the polymerization of microtubule resulting in mitotic arrest as evident by the accumulation of mitosis-related proteins, survivin and aurora B, thereby leading to DNA damage and apoptosis. Ching001 also activated pro-apoptotic ER stress signaling pathway. Intraperitoneal injection of 2 mg/kg Ching001 significantly inhibited the tumor growth of A549 xenograft, while injection of 0.2 mg/kg Ching001 decreased the lung colonization ability of A549 cells in experimental metastasis assay. These anti-tumor growth and lung colonization inhibition effects were stronger than those of paclitaxel treatment at the same dosage. The xenograft tumor tissue stains further confirmed that Ching001 induced mitosis arrest and tumor apoptosis. In addition, the hematology and biochemistry tests of blood samples as well as tissue examinations indicated that Ching001 treatment did not show apparent organ toxicities in tested animals. We provided preclinical evidence that novel synthetic microtubule inhibitor Ching001, which can trigger DNA damage and apoptosis by inducing mitotic arrest and ER stress, is a potential anti-cancer compound for further drug development.	[Chen, Jia-Yang; Tang, Yen-An; Wang, Yi-Ching] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Li, Wen-Shan; Chiou, Yu-Ching] Acad Sinica, Inst Chem, Taipei 115, Taiwan; [Chiou, Yu-Ching] Natl Taiwan Normal Univ, Dept Chem, Taipei, Taiwan; [Shieh, Jiunn-Min] Chi Mei Med Ctr, Dept Internal Med, Div Chest Med, Tainan, Taiwan; [Shieh, Jiunn-Min] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Tainan, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; National Taiwan Normal University; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; National Cheng Kung University	Shieh, JM (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Div Chest Med, Tainan, Taiwan.	shieh225@ms29.hinet.net; ycw5798@mail.ncku.edu.tw	Li, Wen-Shan/F-1972-2015; CHEN, JIA-YANG/M-8413-2014; Wang, Yi-Ching/J-8702-2019; Peng, Hongquan/AAI-6239-2021; Chen, Jianping/C-4225-2009	Li, Wen-Shan/0000-0002-8359-4582; CHEN, JIA-YANG/0000-0001-9159-7591; Wang, Yi-Ching/0000-0002-7694-2067; Peng, Hongquan/0000-0003-4893-7903; Li, Wei/0000-0002-9991-7892; Chen, Jianping/0000-0001-6494-5271; Chen, Hui/0000-0002-0048-0193	Chi Mei Medical Center, Taiwan [CMNCKU10107]; National Science Council, Taiwan [NSC 101-2325-B-006-008]	Chi Mei Medical Center, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants CMNCKU10107 from the Chi Mei Medical Center, Taiwan (JMS) and NSC 101-2325-B-006-008 from the National Science Council, Taiwan (YCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Bohlin L, 1996, DRUG DISCOV TODAY, V1, P343, DOI 10.1016/1359-6446(96)10028-3; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chang JY, 2004, MOL PHARMACOL, V65, P77, DOI 10.1124/mol.65.1.77; Chen JJW, 2001, CANCER RES, V61, P5223; Cragg GM, 1998, MED RES REV, V18, P315, DOI 10.1002/(SICI)1098-1128(199809)18:5<315::AID-MED3>3.0.CO;2-W; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Desbene Stephanie, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P71, DOI 10.2174/1568011023354353; Domingo-Sananes MR, 2011, PHILOS T R SOC B, V366, P3584, DOI 10.1098/rstb.2011.0087; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; Imbert TF, 1998, BIOCHIMIE, V80, P207, DOI 10.1016/S0300-9084(98)80004-7; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kawanobe T, 2012, BIOCHEM BIOPH RES CO, V418, P736, DOI 10.1016/j.bbrc.2012.01.090; Komericki P, 2011, SEX TRANSM DIS, V38, P216, DOI 10.1097/OLQ.0b013e3181f68ebb; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Liu EH, 2009, MINI-REV MED CHEM, V9, P1547, DOI 10.2174/138955709790361520; Lv M, 2011, MINI-REV MED CHEM, V11, P901, DOI 10.2174/138955711796575461; Mano M, 2006, CANCER TREAT REV, V32, P106, DOI 10.1016/j.ctrv.2005.12.008; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; PEDERSENBJERGAARD J, 1992, LEUKEMIA RES, V16, P61, DOI 10.1016/0145-2126(92)90102-D; SACKETT DL, 1993, PHARMACOL THERAPEUT, V59, P163, DOI 10.1016/0163-7258(93)90044-E; Schonbrunn E, 1999, J STRUCT BIOL, V128, P211, DOI 10.1006/jsbi.1999.4183; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Tapia C, 2006, AM J SURG PATHOL, V30, P83, DOI 10.1097/01.pas.0000183572.94140.43; Wall ME, 1998, MED RES REV, V18, P299	29	265	274	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62082	10.1371/journal.pone.0062082	http://dx.doi.org/10.1371/journal.pone.0062082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646116	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300026
